陈立新 张琳 黄颖：中美欧日韩五局专利报告3115.doc

█武汉大学科教管理与评价研究中心 陈立新 张琳 黄颖

微信号：chenlixinip5

附录2  2021年PCT国际专利申请统计分析报告

附录2.7 各技术领域的PCT专利申请状况

附录2.7.5 药物和家庭日用化学品领域的PCT专利申请状况

第5个技术领域是药物和家庭日用化学品，主要包括医用配置品和药物制剂，以及盥洗、梳妆和化妆等家庭日用化学品。2021年，该领域的PCT专利申请总计12906项（增长率为6.1%），占总申请量的4.9%，是申请量第1多的领域。

2021年，中国局在药物和家庭日用化学品领域上申请PCT专利1236项，占该领域申请量的9.6%。美国局在该领域上申请专利5256项，份额为40.7%。日本局申请专利1180项，份额为9.1%。欧洲局申请专利2195项，份额为17%。

 

附表2.7.5-1  2021年药物和家庭日用化学品领域各专利局的PCT专利申请数量

	专利局	申请数量	占本局比例	占领域比例
1	中国	1236	1.8%	9.6%
2	美国	5256	9.4%	40.7%
3	日本	1180	2.5%	9.1%
4	欧洲	2195	5.9%	17.0%
5	韩国	742	4.0%	5.7%
6	国际	862	6.9%	6.7%
7	英国	271	7.9%	2.1%
8	法国	85	3.4%	0.7%
9	加拿大	113	6.1%	0.9%
10	澳大利亚	126	8.2%	1.0%
11	土耳其	152	10.6%	1.2%
12	德国	10	0.7%	0.1%
13	以色列	152	10.9%	1.2%
14	瑞典	24	1.9%	0.2%
15	其他	502	--	3.9%
	小计	12906	--	100%

注：本表按照提交PCT国际专利申请的专利局进行统计。

 

附图2.7.5-1  2021年药物和家庭日用化学品领域各专利局的PCT专利申请数量对比

 

2021年，在药物和家庭日用化学品领域上PCT专利申请最多的机构是欧莱雅、加州大学、株式会社资生堂。

 

附表2.7.5-2  2021年药物和家庭日用化学品领域的PCT国际专利申请前10机构

	机构名称	国家	机构英文名称	2021
1	欧莱雅	法国	L'OREAL	187
2	加州大学	美国	THE REGENTS OF THE UNIVERSITY OF   CALIFORNIA	142
3	株式会社资生堂	日本	SHISEIDO COMPANY, LTD.	91
4	联合利华知识产权控股私人有限公司	荷兰	UNILEVER IP HOLDINGS B.V.	88
5	汉高股份有限及两合公司	德国	HENKEL AG & CO., KGAA	85
6	宝洁公司	美国	THE PROCTER & GAMBLE COMPANY	72
7	法国国家健康与医学研究院	法国	INSERM (INSTITUT NATIONAL DE LA   SANTé ET DE LA RECHERCHE MéDICALE)	67
8	花王株式会社	日本	KAO CORPORATION	65
9	拜尔斯道夫公司	德国	BEIERSDORF AG	64
10	诺华公司	瑞士	NOVARTIS AG	58

注：本表数据按照第一申请人进行统计。

 

附图2.7.5-2  2021年药物和家庭日用化学品领域的PCT国际专利申请前10机构

 

 

 

 

 

 

 

致谢

感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时，向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。

如需要中美欧日韩五局及PCT专利数据、专利报告，以及咨询相关专利问题请添加微信号。

微信号：chenlixinip5

 

 

附表  2021年该领域PCT国际专利申请

 

ID	Title	Applicant
WO/2021/087536	DENTAL FLOSS	LENZING PLASTICS GMBH & CO KG
WO/2021/159155	COMPOSITION	BENTSEN, Paal
WO/2021/222964	IMMUNOGENIC COMPLEXES AND METHODS OF PRODUCING AND USING THE  SAME	ESS HOLDING GMBH
WO/2021/222965	MANNOSE-BINDING LECTIN FOR TREATMENT OR PROPHYLAXIS OF  INFECTIOUS DISEASES	ESS HOLDING GMBH
WO/2021/000004	METHODS OF TREATING MYOCARDITIS AND/OR CARDIOMYOPATHY AND  REAGENTS THEREFOR	CELLMID LIMITED
WO/2021/051149	BIODEGRADABLE DRUG-POLYMER CONJUGATE	POLYACTIVA PTY LTD
WO/2021/051151	ORAL HEALTH IMPROVING PRODUCTS	YNDK PTY. LTD.
WO/2021/051153	PROTEIN PARTICLES COMPRISING A DIPHTHERIA TOXIN CROSS REACTING  MATERIAL (CRM) AMINO ACID SEQUENCE AND USES THEREOF	GRIFFITH UNIVERSITY
WO/2021/056048	THERAPEUTIC FORMULATIONS AND USES THEREOF	BIONOMICS LIMITED
WO/2021/016652	METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND  PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS	THE UNIVERSITY OF MELBOURNE
WO/2021/127722	PHARMACEUTICAL COMPOSITIONS	PROTA THERAPEUTICS PTY LTD
WO/2021/174284	COMBINATION TREATMENT FOR MICROORGANISMS	THE UNIVERSITY OF ADELAIDE
WO/2021/000013	COMPOSITIONS AND METHODS OF USE	THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
WO/2021/000024	METHODS AND AAV VECTORS FOR <i>IN VIVO</i>  TRANSDUCTION	CHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/007610	INJECTABLE NUTRITIONAL SUPPLEMENT	CHEMVET AUSTRALIA PTY LTD
WO/2021/003531	PEPTIDES AND USES THEREOF	LATERAL IP PTY LTD
WO/2021/003535	METHOD FOR GUT MUCOSA PREPARATION TO ENHANCE MICROBIAL  ENGRAFTMENT	MILIS, Antony
WO/2021/007618	IMMUNO-ONCOLOGY THERAPY USING ISOFLAVONE COMPOUNDS	NOXOPHARM LIMITED
WO/2021/007623	COMPOSITIONS FOR MAINTAINING OR MODULATING MIXTURES OF ETHER  LIPID MOLECULES IN A TISSUE OF A HUMAN SUBJECT	BAKER HEART AND DIABETES INSTITUTE
WO/2021/016663	KLF INDUCED CARDIOMYOGENESIS	VICTOR CHANG CARDIAC RESEARCH INSTITUTE
WO/2021/016668	IMMUNOCONJUGATE	DENDROCYTE BIOTECH PTY LTD
WO/2021/022336	COMPOSITIONS OF PROBIOTICS AND BIOMASS AND METHODS FOR  PROMOTING HEALTH IN A SUBJECT	COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/022340	USES OF LONG-CHAIN POLYUNSATURATED FATTY ACIDS	SWINBURNE UNIVERSITY OF TECHNOLOGY
WO/2021/030867	METHOD OF MODULATING ADIPOSITY	BAKER HEART AND DIABETES INSTITUTE
WO/2021/035289	THERAPEUTIC METHODS AND USES THEREOF	EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO)
WO/2021/035310	TARGETED DENDRIMER CONJUGATES	STARPHARMA PTY LTD
WO/2021/042171	CANCER IMMUNOTHERAPY	ENA THERAPEUTICS PTY LTD
WO/2021/042174	CANCER TREATMENT	ENA THERAPEUTICS PTY LTD
WO/2021/042178	TREATMENT OF OPIOID WITHDRAWAL	KINOXIS THERAPEUTICS PTY LTD
WO/2021/056051	METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASE	DIMERIX BIOSCIENCE PTY LTD
WO/2021/051172	LIPID PRODRUGS OF CELECOXIB AND USES THEREOF	MONASH UNIVERSITY
WO/2021/056053	SILICONE DROPLETS	FORMULAE 8 PTY LTD
WO/2021/056056	PHARMACEUTICAL COMPOUNDS AND METHODS OF USE	DERMCARE-VET PTY LTD
WO/2021/056064	TREATMENT OF TAUOPATHIES	MACQUARIE UNIVERSITY
WO/2021/056071	TREATMENT OF DEMENTIA	MACQUARIE UNIVERSITY
WO/2021/056072	TREATMENT OF EXCITOTOXICITY-RELATED CONDITIONS	MACQUARIE UNIVERSITY
WO/2021/056077	THERAPEUTIC DENDRIMER	STARPHARMA PTY LTD
WO/2021/062472	MEDICINAL COGNITIVE TREATMENTS	ACTINOGEN MEDICAL LIMITED
WO/2021/062481	COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF  TRAUMATIC BRAIN INJURY	INCANNEX HEALTHCARE LIMITED
WO/2021/077162	MODULATION OF CELLULAR VIABILITY	MACQUARIE UNIVERSITY
WO/2021/077166	CONTRAST AGENTS	MONASH UNIVERSITY
WO/2021/077174	METHODS OF TREATING CANCER USING ANDROGEN RECEPTOR ANTAGONISTS	GARVAN INSTITUTE OF MEDICAL RESEARCH
WO/2021/081580	TREATMENT OF RENAL CYSTIC DISEASE	MONASH UNIVERSITY
WO/2021/081581	ANTIBODIES FOR BINDING PLASMINOGEN	MONASH UNIVERSITY
WO/2021/097537	MAGNETIC TRACER COMPOSITIONS	FERRONOVA PTY LTD
WO/2021/097538	BONE FORMATION	THE UNIVERSITY OF SYDNEY
WO/2021/097540	IMMUNOSTIMULATORY COMPOSITIONS COMPRISING SOLUBLE PARASITE  EXTRACTS AND USES THEREOF	GRIFFITH UNIVERSITY
WO/2021/102508	METHODS OF TREATING HIV-1 INFECTION	BIOTRON LIMITED
WO/2021/102510	METHODS AND PRODUCTS FOR REDUCING SIDE EFFECTS ASSOCIATED WITH  USE OF IMMUNE AGONIST ANTIBODIES	SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE LIMITED
WO/2021/102513	LEGIONELLA TREATMENT USING CANNABINOIDS	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/102514	MORAXELLA TREATMENT USING CANNABINOIDS	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/102515	ANTIBACTERIAL TREATMENT USING A CANNABINOID AND AN ACTIVE  AGENT	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/102516	NEISSERIA TREATMENT USING CANNABINOIDS	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/108853	POLYMER NANOPARTICLES	THE UNIVERSITY OF QUEENSLAND
WO/2021/108855	NEUROLOGICALLY ACTIVE FLAVONOID COMPOSITIONS AND METHODS OF  USE THEREOF	GRETALS AUSTRALIA PTY LTD
WO/2021/108861	TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND  AMYLOID-BETA ANTIBODIES	THE UNIVERSITY OF QUEENSLAND
WO/2021/108867	METHODS OF ACTIVATING CYTOTOXIC LEUKOCYTES USING PTP1B AND  PTPN2 INHIBITORS	MONASH UNIVERSITY
WO/2021/108868	ANTIGEN LOADING	DENDROCYTE BIOTECH PTY LTD
WO/2021/113912	THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/113914	THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/113917	THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND  TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/113926	BOTULINUM TOXIN FORMULATIONS AND METHODS FOR INTRANASAL  DELIVERY THEREOF FOR THE TREATMENT OF ALLERGIC RHINITIS	BARBAGALLO, Francesco
WO/2021/119749	TREATMENT OF GASTROINTESTINAL DISEASE	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/127736	ALLERGY TREATMENT	PROTA THERAPEUTICS PTY LTD
WO/2021/127749	COMPOSITIONS COMPRISING TERPENES AND THEIR USE IN THE  TREATMENT OR ALLEVIATION OF PAIN OR ANXIETY	CANNADOL PHARMACEUTICALS LTD
WO/2021/127752	CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN  (LANCL) AND USES THEREOF	LATERAL IP PTY LTD
WO/2021/222967	TREATMENT OF PROLIFERATIVE DISEASES OF THE CNS	AUCENTRA THERAPEUTICS PTY LTD
WO/2021/237270	METHOD OF TREATING LEUKAEMIA	ST VINCENT'S HOSPITAL SYDNEY LIMITED
WO/2021/138721	SELF-ASSEMBLING, SELF-ADJUVANTING SYSTEM FOR DELIVERY OF  VACCINES	THE UNIVERSITY OF QUEENSLAND
WO/2021/142513	COMPOSITIONS AND METHOD	MONASH UNIVERSITY
WO/2021/142514	COMPOSITIONS AND METHODS	MONASH UNIVERSITY
WO/2021/142516	ORAL PEPTIDE ADMINISTRATION	THE UNIVERSITY OF SYDNEY
WO/2021/151156	DRUG DELIVERY DEVICE	SIDERIS, Anders William James
WO/2021/151168	METHOD OF CANNABINOID THERAPY	AUSCANN GROUP HOLDINGS LTD
WO/2021/151169	CANNABINOID COMPOSITION AND MANUFACTURING METHOD	AUSCANN GROUP HOLDINGS LTD
WO/2021/155427	COMPOSITION AND METHOD	SNORETOX PTY LTD
WO/2021/155443	PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING  OR PREVENTING CORONAVIRUS INFECTION	CENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/159187	METHOD OF TREATMENT USING META-ARSENITE	KOMIPHARM INTERNATIONAL AUSTRALIA PTY LTD
WO/2021/168516	METHODS OF TREATMENT AND RELATED COMPOSITIONS	ASCEND BIOPHARMACEUTICALS LTD
WO/2021/168518	S1P RECEPTOR MODULATORS	AKAAL PHARMA PTY LTD
WO/2021/179047	TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE  TOXICITY	CULLIS-HILL, Sydney David
WO/2021/179050	VIRAL INHIBITION	MONASH UNIVERSITY
WO/2021/184059	TREATMENT METHODS	NEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/195691	METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN  INFLAMMATORY CONDITION	INCANNEX HEALTHCARE LIMITED
WO/2021/184062	COMPOSITIONS FOR TREATING RESPIRATORY TRACT INFECTION AND USES  THEREOF	LATERAL IP PTY LTD
WO/2021/184070	ANTIVIRAL COMPOSITION FOR ORAL CARE	ADVANCE NANOTEK LTD.
WO/2021/189109	QUERCETIN ENHANCEMENT FORMULATION	SMARTDNA PTY LTD
WO/2021/195694	ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION  AGAINST COVID-19	SEMENTIS LIMITED
WO/2021/195698	METHODS FOR THE TREATMENT OF INFLAMMATION ASSOCIATED WITH  INFECTION	NOXOPHARM LIMITED
WO/2021/195703	COMBINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE	SERVATUS LTD
WO/2021/195706	NEW DYNAMIN INHIBITORS AND USES	CHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/243396	THERAPEUTIC METHODS OF USING CD 14 ANTAGONISTIC ANTIBODIES IN  TREATING CONDITIONS ASSOCIATED WITH A CORONAVIRUS INFECTION INCLUDING  SARS-COV-2 (COVID-19)	IMPLICIT BIOSCIENCE LIMITED
WO/2021/195723	METHODS FOR TREATMENT OF CORONAVIRUS INFECTIONS	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/203168	TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTION	THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH
WO/2021/203174	TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH  POLYSULFATED POLYSACCHARIDES	PARADIGM BIOPHARMACEUTICALS LTD
WO/2021/207790	METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY  SYNCYTIAL VIRUS INFECTION	STARPHARMA PTY LTD
WO/2021/207801	IMMUNE CELLS WITH ENHANCED FUNCTION	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/212168	METHODS AND COMPOSITIONS	MONASH UNIVERSITY
WO/2021/212181	METHODS AND COMPOSITIONS FOR TREATING FUNGAL INFECTIONS	NEOCULI PTY LTD
WO/2021/212183	PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING  OR PREVENTING MICROBIAL INFECTIONS	CENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/217221	PREVENTING AND TREATING VIRAL INFECTIONS	MUCPHARM PTY LTD
WO/2021/222971	TREATMENT FOR VIRUS INDUCED ACUTE RESPIRATORY DISTRESS  SYNDROME	DIMERIX BIOSCIENCE LTD
WO/2021/222972	TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROME	DIMERIX BIOSCIENCE LTD
WO/2021/222987	COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF  FIBROTIC AND INFLAMMATORY CONDITIONS	GRETALS AUSTRALIA PTY LTD
WO/2021/222988	CELL ENTRY-MODULATING AGENTS AND USES THEREFOR	GRIFFITH UNIVERSITY
WO/2021/226662	USE OF AMINOACETONITRILE COMPOUNDS FOR THE TREATMENT OF  INFECTION AND DISEASE	PITNEY PHARMACEUTICALS PTY LIMITED
WO/2021/226664	A HEPATITIS C NUCLEIC ACID VACCINE COMPRISING A VARIABLE  DOMAIN DELETED E2 POLYPEPTIDE	MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC  HEALTH LIMITED
WO/2021/226672	METHODS AND COMPOSITIONS FOR ATI DIGESTION	GLUTAGEN PTY LTD
WO/2021/226677	TREATMENT OF THROMBOSIS AND ASSOCIATED DISORDERS WITH AN  ANTI-PLATELET AGENT.	THE HEART RESEARCH INSTITUTE LTD
WO/2021/237273	METHODS OF TREATING PULMONARY FIBROSIS	AMPLIA THERAPEUTICS PTY LTD
WO/2021/232094	HEDGEHOG SIGNALING -DEPENDENT CANCER TREATMENT	HUDSON INSTITUTE OF MEDICAL RESEARCH
WO/2021/237291	TREATMENT OF CORONAVIRUS	AXELIA ONCOLOGY PTY LTD
WO/2021/237295	CELL HARVEST METHOD	THE UNIVERSITY OF MELBOURNE
WO/2021/237297	ANTI-VIRAL EXTRACELLULAR VESICLES, THEIR METHODS OF  PREPARATION AND USES	EXOPHARM LIMITED
WO/2021/237299	METHODS OF ANTIPATHOGENIC TREATMENT	CROFT INFRASTRUCTURE DESIGNS PTY LTD
WO/2021/243399	METHODS FOR TREATING MAJOR DEPRESSIVE DISORDER AND  TREATMENT-RESISTANT DEPRESSION	IX BIOPHARMA LIMITED
WO/2021/243410	ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITION COMPRISING  ARTHROSPIRA EXTRACTS AND AN ORGANIC ACID	BIOVITE AUSTRALIA PTY LTD
WO/2021/243415	THERAPEUTIC CONJUGATES	STARPHARMA PTY LTD
WO/2021/243417	IMMUNOGENIC FORMULATIONS	CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
WO/2021/243424	METHOD OF TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS  SYNDROME	CSL INNOVATION PTY LTD
WO/2021/248189	COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN  PRECANCER	UNIQUEST PTY LTD
WO/2021/248196	IMPROVED VIRUCIDAL FORMULATIONS	FIREBRICK PHARMA LIMITED
WO/2021/248207	COMPOSITION AND METHOD FOR TREATING CHRONIC PAIN	ZELIRA THERAPEUTICS OPERATIONS PTY LTD
WO/2021/248210	TREATMENT METHODS AND FORMULATIONS	CURTIN UNIVERSITY
WO/2021/253087	NOVEL ANTIBACTERIAL HYDROGELS	NEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/253098	AMIDO COMPOUNDS	ANAXIS PHARMA PTY LTD
WO/2021/258140	CD83 BINDING PROTEIN CONJUGATES FOR TREATING LYMPHOMA	KIRA BIOTECH PTY LIMITED
WO/2021/258150	METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING	LACHESIS BIOSCIENCES LIMITED
WO/2021/258159	HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS	PHARMAXIS LTD.
WO/2021/258163	LIQUID DISPERSIBLE CURCUMINOID COMPOSITIONS AND METHODS OF  IMPROVING COGNITIVE FUNCTION	PHARMAKO BIOTECHNOLOGIES PTY LTD
WO/2021/168522	METHOD FOR OBTAINING OF AN ANTITUMOR COMPOSITION, AN ANTITUMOR  COMPOSITION AND ITS USE	HADJIEVA, Nasya Spartakova
WO/2021/007626	ORAL MEDICATION FOR TREATING LIPOEDEMA	BENITTI, Daniel Augusto
WO/2021/016679	ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGEL	L'OREAL
WO/2021/016680	ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGEL	L'OREAL
WO/2021/016682	ANHYDROUS COSMETIC COMPOSITION WITH HIGH CONCENTRATION OF  HYDROPHOBIC FILLERS AND USE THEREOF FOR REDUCING SKIN LESIONS AND OILINESS	L'OREAL
WO/2021/016683	ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITION, PROCESS  FOR ITS PRODUCTION AND USE THEREOF	L'OREAL
WO/2021/016684	COSMETIC COMPOSITION, PROCESS FOR MANUFACTURING THE COSMETIC  COMPOSITION AND ITS USE	L'OREAL
WO/2021/022344	COSMETIC COMPLEX FOR MOISTURIZING SKIN, USE OF THE COSMETIC  COMPLEX, COSMETIC COMPOSITION AND SKIN MOISTURIZING METHOD	NATURA COSMéTICOS S.A.
WO/2021/022345	TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND TONIC  FOR FACIAL APPLICATION	NATURA COSMéTICOS S.A.
WO/2021/022346	TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND SERUM  FOR FACIAL APPLICATION	NATURA COSMéTICOS S.A.
WO/2021/022347	TOPICAL COSMETIC COMPOSITION, USE OF THE COSMETIC COMPOSITION  AND MASK FOR FACIAL APPLICATION	NATURA COSMéTICOS S.A.
WO/2021/046622	NATURAL SILICONE REPLACEMENT COMPOSITION, PRODUCTION METHOD  AND USE THEREOF	MAIAN INDUSTRIA DE PRODUTOS QUIMICOS LTDA
WO/2021/056086	ORAL-HEALTH COMPOSITION AND PREPARATION METHOD FOR ORAL-HEALTH  COMPOSITION	MMF&T DESENVOLVIMENTO TECNOLóGICO E INOVAÇÃO LTDA.
WO/2021/119770	COSMETIC COMPOSITION FOR A KERATIN SUBSTANCE, PROCESS FOR  MANUFACTURING A COSMETIC COMPOSITION AND USE OF THE COSMETIC COMPOSITION	L'OREAL
WO/2021/119771	COSMETIC COMPOSITION, PROCESS OF MANUFACTURING THE COSMETIC  COMPOSITION AND USE OF THE COSMETIC COMPOSITION	L'OREAL
WO/2021/134118	COSMETIC COMPOSITION COMPRISING A FATTY AMINE, A FATTY  ALCOHOL, A VEGETABLE FAT, A CATIONIC SURFACTANT AND A SILICONE CROSS-POLYMER  FOR USE IN HAIR CARE	L'OREAL
WO/2021/151174	ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND  INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR  OBTAINING SAME AND USES	VILHENA, Fabiano Vieira
WO/2021/151177	COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION, PROCESS  FOR THE PREPARATION OF A COSMETIC COMPOSITION AND METHOD FOR STYLING THE HAIR	L'OREAL
WO/2021/203180	HAIR COSMETIC COMPOSITION AND PROCESS FOR SHAPING OR ALTERING  THE SHAPE OF THE HAIR	L'OREAL
WO/2021/217225	HAIR CARE COSMETIC COMPOSITION, METHOD FOR TREATING AND/OR  SHAPING HAIR, AND PROCESS FOR MANUFACTURING A HAIR CARE COSMETIC COMPOSITION	L'OREAL
WO/2021/072514	COMPOSITION, USE OF A COMBINATION OF SILVER NANOPARTICLES AND  OF A NITRIC OXIDE DONOR, PHARMACEUTICAL KIT FOR TREATING CANCER, AND METHOD  FOR TREATING CANCER	FUNDAÇÃO UNIVERSIDADE FEDERAL DO ABC -UFABC
WO/2021/237317	ANTIPERSPIRANT COMPOSITION, PROCESS FOR ITS PRODUCTION AND USE  THEREOF	L'OREAL
WO/2021/237318	COSMETIC COMPOSITION COMPRISING UNSATURATED DIOIC ACID AND  USES THEREOF	L'OREAL
WO/2021/000037	METHOD FOR OBTAINING BIOACTIVE INGREDIENTS, USE OF  SUBCRITICAL-WATER EXTRACTION PROCESS, BIOACTIVE INGREDIENT, USE OF BIOACTIVE  INGREDIENT AND COSMETIC COMPOSITION	NATURA COSMéTICOS S.A.
WO/2021/003543	IMMUNOMODULATORY COMPOUNDS AND/OR THE PHARMACEUTICALLY  ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITION INCLUDING  IMMUNOMODULATORY COMPOUNDS AND USE OF IMMUNOMODULATORY COMPOUNDS IN THE  PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL  DISEASES	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/007635	PROCESS FOR OBTAINING A FREEZE-DRIED COMPOSITION OF  CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN, FREEZE-DRIED COMPOSITION  OF CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN AND USE IN THE TREATMENT  OF WOUNDS	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/012028	HAIR TREATMENT COMPOSITION, METHOD FOR OBTAINING SAME, USE OF  THE COMPOSITION AND HAIR TREATMENT METHOD	CHEMYUNION LTDA
WO/2021/207806	LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH CONTROLLED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF ENDOMETRIOSIS	LUIZ PERACCHI, Edson
WO/2021/237321	LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF CHRONIC ADRENAL INSUFFICIENCY OR HYPOCORTISOLISM	LUIZ PERACCHI, Edson
WO/2021/237322	LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED  RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR  THE TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA	LUIZ PERACCHI, Edson
WO/2021/042193	METHOD AND USE OF PNPP-19 FOR PREVENTING AND TREATING EYE  DISEASES	BIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACêUTICOS
WO/2021/042194	COMPOUND DERIVED FROM QUINOLINE, USE OF A COMPOUND,  COMPOSITION AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A CONDITION CAUSED  BY A BLOOD PARASITE	FUNDAÇÃO OSWALDO CRUZ
WO/2021/092667	PHOTOPROTECTIVE COMPOSITIONS, PHOTOPROTECTIVE FORMULATIONS  INCLUDING PHOTOPROTECTIVE COMPOSITIONS, PREPARATION METHODS AND USES THEREOF	BIOART BIOCOSMéTICOS LTDA - ME
WO/2021/151178	WATER-BASED PROPYLENE GLYCOL-FREE MICROEMULSION FOR DELIVERY  OF MINOXIDIL IN THE TREATMENT OF HAIR LOSS AND METHOD FOR OBTAINING SAME	GERALDI, Katia Solange Cardoso Rodrigues Dos Santos
WO/2021/077191	METHOD FOR OBTAINING CB-AG-NMS AND CB-AG-<sb>  </sb><sb>  </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES, CB-AG-NMS AND CB-AG-<sb>  </sb><sb> </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES, AND USE OF CB-AG-NMS AND  CB-AG-<sb> </sb><sb>  </sb><sb><i>P</i></sb><sb>  </sb><sb> </sb>ABA DEVICES	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/108884	PROCESS FOR PRODUCING A PROPHYLACTIC AND THERAPEUTIC DNA  IMMUNOLOGICAL COMPOSITION FOR HPV AND CANCERS ASSOCIATED WITH THE VIRUS,  HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND USES THEREOF	INSTITUTO BUTANTAN
WO/2021/113938	VITAMIN AND MINERAL FOOD SUPPLEMENT	CELLAVIT REPRESENTAÇÃO DE PRODUTOS NATURAIS LTDA
WO/2021/163776	SUBCUTANEOUS IMPLANTS FOR SLOW CONTROLLED RELEASE OF ACTIVE  AGENTS	BITTENCOURT, Marco Antonio
WO/2021/119791	OLEAGINOUS COMPLEX OBTAINED FROM ACHIOTE SEEDS AND RELATED  USES	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/127768	ANTI-PERSPIRANT COMPOSITION, COSMETIC USE AND METHOD FOR  APPLYING SAME	HART'S ALIMENTOS NATURAIS LTDA
WO/2021/127769	COMPOSITION FOR TREATING CONJUNCTIVITIS	NARDINI, Antonio Roberto
WO/2021/151185	HERBAL MEDICINE, HERBAL MEDICINAL PRODUCT AND USE THEREOF	EVOLUÇÕES CIENTíFICAS E TECNOLóGICAS LTDA
WO/2021/184094	ADDITIVE FOR DETOXIFICATION	SILVA, Wellington Nascimbeni
WO/2021/184095	BIOACTIVE SUPPLEMENT	SILVA, Wellington
WO/2021/163777	COSMETIC COMPOSITION FOR KERATIN FIBERS AND APPLICATION  METHODS FOR SAID COMPOSITION	GLOSS EXPRESS DO BRASIL COMERCIO DE PRODUTOS DE BELEZA LTDA -  EPP
WO/2021/159198	METHOD FOR PRODUCING DECELLULARIZED BIOMATERIAL,  DECELLULARIZED BIOMATERIAL AND USE THEREOF	KHEIROS PATER INOVAÇÃO S.A
WO/2021/189121	PARAMAGNETIC NANOPARTICLES, MANUFACTURING METHOD AND USE  THEREOF WITH MAGNETIC RESONANCE IMAGING CONTRAST	UNIVERSIDADE DE SÃO PAULO - USP
WO/2021/195730	ANTIBACTERIAL COMBINATION COMPOSITION FOR REDUCING THE  RESISTANCE OF BACTERIA TO THE MEDICINAL DRUGS IN USE AND METHOD FOR OBTAINING  SAME	WEGHER, Ermete Antonio
WO/2021/207813	TERPENE-CONTAINING COMPOSITION AND ITS COSMETIC USE	BERACA INGREDIENTES NATURAIS S.A.
WO/2021/232123	TASTE-MASKING SYSTEM	OUROFINO SAUDE ANIMAL LTDA
WO/2021/222997	COMPOSITION FOR REGULATING THE NEURO-IMMUNE-ENDOCRINE SYSTEM	ABOU NEHMI FILHO, Victor
WO/2021/223001	NIGHT-TIME ORAL GEL COMPOSITION	OLIVEIRA, Eder Gonzaga De
WO/2021/258180	PROCESS FOR OBTAINING ANTIGEN-PRESENTING VESICLES (APV) THAT  ENABLES THE COUPLING OF ONE OR MORE ANTIGENS	INSTITUTO BUTANTAN
WO/2021/046628	STABLE MEDICINAL CANNABIDIOL COMPOSITIONS	CARDIOL THERAPEUTICS INC.
WO/2021/081619	HEMP PEPTIDE COMPOSITIONS FOR NUTRACEUTICAL AND PERSONAL CARE  PRODUCTS	EC LABS INC.
WO/2021/243432	PHARMACEUTICAL COMPOSITIONS FOR STAINING MEMBRANES AND OTHER  BIOLOGICAL STRUCTURES	TANG, Connie
WO/2021/003553	COMPOUNDS FOR TREATMENT OF DIARRHEA, INFLAMMATORY BOWEL  DISEASE AND METHODS THEREOF	ALGERNON PHARMACEUTICALS INC.
WO/2021/081624	USE OF GLUTAMATE 2B RECEPTOR ANTAGONISTS AND SIGMA RECEPTOR  AGONSISTS AS ANTITUSSIVES	ALGERNON PHARMACEUTICALS INC.
WO/2021/000046	QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND  RELATED METHODS	MICROSINTESIS INC.
WO/2021/012046	CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID  MONOGLYCERIDES, METHODS AND USES THEREOF	SCF PHARMA INC.
WO/2021/016710	CONTROLLED RELEASE FORMULATIONS OF MULTIPLE ACTIVE  PHARMACEUTICAL AGENTS, AND PSILOCYBE-DERIVED AGENTS IN COMBINATION WITH  CANNABIS-DERIVED AGENTS AND METHODS FOR THEIR USE	TASSILI LIFE SCIENCES, CORP.
WO/2021/022377	PERIVASCULAR LYSATES AND USES THEREOF	TISSUE REGENERATION THERAPEUTICS INC.
WO/2021/022378	ORAL FORMULATIONS OF CANNABIS EXTRACTS AND METHODS OF MAKING  SAME	NEPTUNE WELLNESS SOLUTIONS INC.
WO/2021/026653	CHOLINERGIC POTENTIATION OF BINOCULAR VISION	THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL  UNIVERSITY
WO/2021/035335	COMPOSITION AND METHOD FOR FORMING A COMPOSITION FOR  INCREASING DERMAL NITRIC OXIDE	SPINAL RELIEF CENTRES OF CANADA INC.
WO/2021/030913	CANNABINOID COMPOSITIONS, METHODS OF MAKING SAME AND USES  THEREOF	HEXO OPERATIONS INC.
WO/2021/035344	METHODS FOR REDUCING THC CONTENT IN COMPLEX CANNABINOID  MIXTURES IN WHICH THC IS A MINOR COMPONENT	CANOPY GROWTH CORPORATION
WO/2021/046634	METHODS OF TREATING CANCER BY THE USE OF PD-1 AXIS INHIBITORS  AND ANTI-PERIOSTIN ANTIBODIES	BOEHRINGER INGELHEIM IO CANADA, INC.
WO/2021/046646	AVOCATIN B FOR THE TREATMENT OF DISEASES AND CONDITIONS	SP NUTRACEUTICALS INC.
WO/2021/046652	INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE  MYOCARDIAL INFARCTION	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/051192	COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLES	ABK BIOMEDICAL INCORPORATED
WO/2021/056098	NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS	KORANEX CAPITAL
WO/2021/056105	COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTS	CENTRE HOSPITALIER DE L'UNIVERSITé DE MONTRéAL
WO/2021/056106	LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS	DDS RESEARCH INC.
WO/2021/056109	GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE  DELIVERY SYSTEM	MEDISCA PHARMACEUTIQUE INC.
WO/2021/062546	USE OF IBALIZUMAB FOR THE TREATMENT OF HIV-2 INFECTION	TAIMED BIOLOGICS INC.
WO/2021/062554	ORAL CARE COMPOSITION COMPRISING CUTTLEFISH BONE POWDER	VISIONATUROLAB INC.
WO/2021/062555	TOPICAL FORMULATIONS AND INSTILLATES, KITS, AND METHODS FOR  TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF	VINSAN THERAPEUTICS INC.
WO/2021/072530	CONTROLLED RELEASE FORMULATIONS OF PSILOCYBE-DERIVED AGENTS  AND METHOD FOR THEIR USE, AND METHODS AND COMPOSITIONS FOR THREATING MILD  TRAUMATIC BRAIN INJURY WITH POST TRAUMATIC STRESS DISORDER.	TASSILI LIFE SCIENCES, CORP.
WO/2021/072535	OIL-IN-WATER EMULSION FORMULATIONS FOR DELIVERY OF ACTIVE OR  THERAPEUTIC AGENTS	IMMUNOVACCINE TECHNOLOGIES INC.
WO/2021/072538	SKIN CARE FORMULATION WITH LIPOPHILIC PEPTIDES	DECIEM BEAUTY GROUP INC.
WO/2021/072555	COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PROPHYLAXIS  OF DIABETES AND OTHER CONDITIONS	LIFELOCK SOLUTIONS INC.
WO/2021/077211	CANNABIDIOL COMPOSITIONS FOR USE IN TREATING HEART CONDITIONS	CARDIOL THERAPEUTICS INC.
WO/2021/081634	FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGE	MURPHY, Kieran
WO/2021/081640	FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE  CONCENTRATIONS	CANOPY GROWTH CORPORATION
WO/2021/081642	BIOPHOTONIC COMPOSITIONS, USES AND METHODS FOR MODULATING  MITOCHONDRIAL DYNAMICS AND FUNCTIONALITY IN SKIN AND SOFT TISSUE CONDITIONS	ZAGO, Michela
WO/2021/081652	METHODS AND RELATED SYSTEMS FOR MAKING A RECONSTITUTED  CANNABIS MATERIAL	1769474 ALBERTA LTD.
WO/2021/081654	SELF-EMULSIFYING DRUG DELIVERY SYSTEM AND USES THEREOF	SP NUTRACEUTICALS INC.
WO/2021/092684	CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS	LONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/097562	TOP LIQUID FILL METHOD AND APPARATUS FOR HARD CAPSULES	CAO, Karl Wei
WO/2021/108911	USE OF PSILOCIN, PSILOCYBIN OR ANALOGS THEREOF IN WEIGHT LOSS,  TREATMENT OF OBESITY AND COMPULSIVE EATING DISORDER	NEONMIND BIOSCIENCES INC.
WO/2021/108918	TREATMENT FOR ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC  SYNDROME	UNIVERSITY HEALTH NETWORK
WO/2021/108923	COMBINED USE OF SODIUM  TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] AND ETOMOXIR FOR TREATING  CANCERS	BOLD THERAPEUTICS INC.
WO/2021/108929	SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES  THEREOF FOR TREATING CANCER	THERATECHNOLOGIES INC.
WO/2021/113982	MINERAL SUPPLEMENTS FOR RUMINANT NUTRITION	ALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113983	CHOLINE BOLUS COMPOSITIONS FOR RUMINANTS	ALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113986	COMPLEXES COMPRISING A CARBOHYDRATE POLYMER AND AN ACTIVE  INGREDIENT AND PROCESSES FOR THEIR PREPARATION	FOLIUM LABS INC.
WO/2021/119810	ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING  PROTEIN/POLYSACCHARIDE COACERVATES	9286-3620 QUéBEC INC.
WO/2021/119817	HASHISH PRODUCT HAVING ENHANCED USER EXPERIENCE AND  MANUFACTURING PROCEDURE FOR OBTAINING SAME	HEXO OPERATIONS INC.
WO/2021/119822	EMULSIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS INCLUDING OILS	NATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/119826	EXTRACTS ENRICHED WITH POLYPHENOLIC COMPOUNDS AND RELATED  METHODS	ROTHSTEIN, Steven
WO/2021/119827	USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR  THE TREATMENT OF ENTERIC NEUROPATHIES	TRANSFERT PLUS, SOCIéTé EN COMMANDITE
WO/2021/119834	MODULATORS OF CULLIN 3 ADAPTOR KBTBD4 AS ANTI-CANCER COMPOUNDS	UNIVERSITE DE MONTREAL
WO/2021/119844	EMULSIFYING FORMULATIONS OF CANNABINOIDS AND/OR CANNABINOID  EXTRACTS	ORGANIGRAM INC.
WO/2021/127786	CANNABICHROMENE COMPOSITIONS AND METHODS OF SYNTHESIZING  CANNABICHROMENE	CANOPY GROWTH CORPORATION
WO/2021/127787	CANNABICITRAN COMPOSITIONS AND METHODS OF SYNTHESIZING  CANNABICITRAN	CANOPY GROWTH CORPORATION
WO/2021/127788	METHODS OF SYNTHESIZING HIGH-PURITY CANNABICYCLOL AND  ARTIFICIAL RESINS COMPRISING CANNABICYCLOL	CANOPY GROWTH CORPORATION
WO/2021/138742	COMPOSITION THAT PROMOTE PRO-RESOLVING MEDIATORS	ACASTI PHARMA INC.
WO/2021/146812	USE OF ANTI-AGING GLYCOPEPTIDES FOR INHIBITION OF IMMUNE  REJECTION OF A GRAFT	PROTOKINETIX INC.
WO/2021/151212	SYSTEM AND METHOD FOR QUANTIFYING, FORMULATING AND ENHANCING  USER EXPERIENCE PROFILE OF CANNABIS	HEXO OPERATIONS INC.
WO/2021/159213	METHOD FOR PRODUCING AN EXTRACT OF MUSHROOM AND MUSHROOM  EXTRACT MADE THEREFROM	NEONMIND BIOSCIENCES INC.
WO/2021/163796	METHODS AND COMPOSITIONS FOR THE INHIBITION OF HEPATITIS B AND  HEPATITIS D VIRUS INFECTIONS	REPLICOR INC.
WO/2021/163802	USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY  AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS	THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL  UNIVERSITY
WO/2021/163811	POLYMERIC BINDER AND HIGH MOLECULAR WEIGHT POLYMER ANTIFOULING  COMPOSITIONS	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/207822	DETECTION, TREATMENT, AND MONITORING OF MICROBIOME-DEPENDANT  PROTEIN FERMENTATION METABOLITES	MCPHARMA BIOTECH INC.
WO/2021/168561	PROCESSES FOR THE PREPARATION OF MULTICOMPONENT CRYSTALLINE  FORMS OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SOLVENT VAPOUR	APOTEX INC
WO/2021/168572	STABLE LIQUID DISPERSINB COMPOSITIONS	KANE BIOTECH INC.
WO/2021/168573	NANOSTRUCTURE LIPID CARRIER DELIVERY SYSTEM, COMPOSITION, AND  METHODS	CAPCIUM INC.
WO/2021/168577	GENE DELIVERY SYSTEM	SYMVIVO CORPORATION
WO/2021/174351	COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINB	KANE BIOTECH INC.
WO/2021/179072	METHODS AND APPARATUSES TO REDUCE SETTLING RATE OF A  MICRO-PARTICLE SUSPENSION	SKINLIFE TECHNOLOGIES INC.
WO/2021/179081	USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE  DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATION	PROTOKINETIX INC.
WO/2021/179087	TERPENE-ENHANCED COMPOSITIONS AND USES THEREOF	HEXO OPERATIONS INC.
WO/2021/179088	TERPENE-ENHANCED COMPOSITIONS AND USES THEREOF	HEXO OPERATIONS INC.
WO/2021/179094	COMPOSITION AND USE OF A CAFFEIC ACID PHENETHYL ESTER (CAPE)  COMPOUND TO TREAT CANCER	UNIVERSITY OF NEW BRUNSWICK
WO/2021/184115	USE OF BUCILLAMINE IN THE TREATMENT OF INFECTIOUS DISEASES	REVIVE THERAPEUTICS LTD.
WO/2021/184116	METHOD FOR PRODUCING ENHANCED ANTI-INFLAMMATORY/  ANTI-CATABOLIC AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUID	ANTNOR LIMITED
WO/2021/207824	USE OF PSILOCYBIN IN THE TREATMENT OF NEUROLOGICAL BRAIN  INJURY AND MIGRAINES	REVIVE THERAPEUTICS LTD.
WO/2021/184123	COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS  INFECTION AND RESPIRATORY COMPROMISE	SZEWCZUK, Myron R.
WO/2021/184125	DISCOVERY OF FIFTEEN NEW ANTI-AGING PLANT EXTRACTS AND  IDENTIFICATION OF CELLULAR PROCESSES THEY AFFECT AS NEW CALORIC RESTRICTION  MIMETICS	IDUNN TECHNOLOGIES
WO/2021/184128	METHODS OF TREATING A CORONAVIRUS INFECTION USING COLCHICINE	INSTITUT DE CARDIOLOGIE DE MONTREAL
WO/2021/189151	ANTIMICROBIAL COMPOSITION	COVALON TECHNOLOGIES INC.
WO/2021/189153	USE OF FENRETINIDE FOR THE TREATMENT OF SARS-CORONA VIRUS  INFECTION	LAURENT PHARMACEUTICALS INC.
WO/2021/195750	METHODS FOR TREATING ALZHEIMER'S DISEASE	JEFFERIES, Wilfred
WO/2021/195763	ANTIVIRAL RUTHENATE(III) THERAPEUTICS	BOLD THERAPEUTICS INC.
WO/2021/195765	DAPSONE FORMULATIONS AND METHODS OF USING SAME	PULMONEM INC.
WO/2021/212209	CANNABICHROMENE FORMULATION FOR PAIN MANAGEMENT	ZYUS LIFE SCIENCES INC.
WO/2021/195777	FUROSEMIDE COMPOSITIONS AND USES THEREOF FOR SUPPORTIVE  THERAPY IN CORONAVIRUS INFECTION	UNIVERSITY HEALTH NETWORK
WO/2021/195782	METHODS OF USING MYT1 INHIBITORS	REPARE THERAPEUTICS INC.
WO/2021/195785	FERRITIN FOR CELLULAR TRACKING UTILIZING T1-WEIGHTED MRI	THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
WO/2021/203190	COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4	UNIVERSITY HEALTH NETWORK
WO/2021/203198	COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRIDAE  INFECTIONS	PICCHIO INTERNATIONAL INC.
WO/2021/203205	PROBIOTIC COMPOSITIONS AND METHODS OF USE	CHANDLER BIOPHARMACEUTICAL CORPORATION
WO/2021/203206	COMBINATION OF CANNABIDIOL AND A PPAR AGONIST	LAVIOLETTE, Steven Robert
WO/2021/207828	METHODS FOR TREATING CYTOKINE RELEASE SYNDROME	UNIVERSITY HEALTH NETWORK
WO/2021/207833	METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL  SPECIES USING SUGAR GLASSES	MCMASTER UNIVERSITY
WO/2021/207850	WATER SOLUBLE FORMULATIONS CONTAINING CANNABINOIDS	NATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/212215	COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND  DIAGNOSING MYCOBACTERIAL INFECTIONS	UNIVERSITY OF SASKATCHEWAN
WO/2021/212222	COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROME	EDESA BIOTECH RESEARCH INC.
WO/2021/212239	USES OF SUPER-OXYGENATED WATER AND GEL	GIS GAS INFUSION SYSTEMS INC.
WO/2021/217259	BIOMEDICAL IMAGING OF BACTERIA AND BACTERIOPHAGE	MULTI-MAGNETICS INCORPORATED
WO/2021/217275	IMMUNOMODULATORY AND ANTIVIRAL ACTION OF BOSWELLIA GUM RESIN  EXTRACTS, DERIVED FORMULATIONS, AND BOSWELLIC ACIDS AGAINST RESPIRATORY  VIRUSES AND USES THEREOF	KONDOR PHARMA INC.
WO/2021/226725	HASHISH HAVING SUBSTANTIALLY UNIFORM CHARACTERISTICS AND  METHOD FOR PRODUCING SAME AT AN INDUSTRIAL SCALE	HEXO OPERATIONS INC.
WO/2021/232156	CANNABINOID PHARMACEUTICAL COMPOSITION	AMACATHERA INC.
WO/2021/232169	SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING  TARGETING NANOPARTICLES	NUECOLOGY BIOMEDICAL INC.
WO/2021/237366	TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	PEMI31 THERAPEUTICS INC.
WO/2021/243460	METHOD FOR WEIGHT LOSS WITH THERAPY	NEONMIND BIOSCIENCES INC.
WO/2021/243461	USE OF LSD, ESA, OR DMT FOR WEIGHT LOSS.	NEONMIND BIOSCIENCES INC.
WO/2021/243467	CANNABINOID-HYALURONIC ACID BIOCONJUGATES	LONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/248251	USE OF PHYTOCANNABINOIDS FOR TREATING MULTIPLE MYELOMA	ENTOURAGE BIOSCIENCES INC.
WO/2021/253116	COMPOSITIONS COMPRISING PSYCHOACTIVE COMPOUNDS FROM  PSYCHOACTIVE ORGANISMS	PSILO SCIENTIFIC LTD
WO/2021/253123	EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM PSYCHEDELIC FUNGUS	PSILO SCIENTIFIC LTD
WO/2021/253124	METHANOL-BASED EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM  FUNGUS	PSILO SCIENTIFIC LTD
WO/2021/258206	WATER-SOLUBLE ARTESUNATE-BASED THERAPY FOR CORONAVIRUS  INFECTION	SOLSTAR PHARMA
WO/2021/258209	COMPOSITE COATING FOR AN ACTIVE AGENT	13400719 CANADA INC.
WO/2021/258218	USE OF SOLUBLE NRP1 POLYPEPTIDES FOR THE TREATMENT OF  CORONAVIRUS INFECTIONS	SEMATHERA INC.
WO/2021/207860	COMPOSITION OF HERBS AND SPICES FOR USE IN MEDICINE	MUESSLI, Daniel
WO/2021/000057	FORMULATION THAT ALLOWS THE PROTECTION OF POLYPHENOLS,  PARTICULARLY THOSE OBTAINED FROM BEE POLLEN EXTRACT	PONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/022386	WATER-SOLUBLE FILM WITH BIOACTIVE AGENTS OR NATURAL EXTRACTS  FOR COSMETIC USE	UNIVERSIDAD DE CHILE
WO/2021/077236	ONION SKIN EXTRACT WITH PROPERTIES THAT PROTECT THE  GASTROINTESTINAL MUCOSA AGAINST DAMAGE INDUCED BY NON-STEROIDAL  ANTI-INFLAMMATORY DRUGS OR BY ALCHOL, PHARMACEUTICAL COMPOSITION OR FOOD  COMPRISING IT, METHOD OF OBTAINMENT, AND USE TO PREVENT, TREAT AND/OR  MITIGATE THE ADVERSE EFFECTS OF NSAIDS OR ALCOHOL	UNIVERSIDAD DE CHILE
WO/2021/097584	AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A  NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPARϒ  ACTIVITY	UNIVERSIDAD ANDRES BELLO
WO/2021/119858	METHOD FOR GENERATING ALLERGEN-SPECIFIC TOLEROGENIC CELLS,  TOLEROGENIC CELLS OBTAINED, AND METHODS FOR INDUCING ALLERGEN TOLERANCE BY  MEANS OF AUTOLOGOUS IMMUNOTHERAPY	PONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/127793	ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF <i>DURVILLAEA  ANTARCTICA</i>, USEFUL FOR TREATING LESIONS CAUSED BY  ALPHAHERPESVIRINAE VIRUSES	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/127794	ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF  <i>MACROCYSTIS PYRIFERA</i>, USEFUL FOR TREATING LESIONS CAUSED  BY ALPHAHERPESVIRINAE VIRUSES	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/119864	MULTI-POLYMER HYDROGEL AS A DEVICE FOR ADMINISTERING  PHARMACEUTICAL AND CELLULAR THERAPEUTIC COMPONENTS	UNIVERSIDAD DE CONCEPCIóN
WO/2021/119866	USE OF STRAINS OF <i>LACTOBACILLUS KUNKEEI</i> AND  <i>BIFIDOBACTERIUM ASTEROIDES</i> AS A PROBIOTIC BIOSTIMULANT FOR  BEES	UNIVERSIDAD DE CONCEPCIóN
WO/2021/119868	PROBIOTIC STRAINS OF <i>LACTOBACILLUS SP.</i> AND  OF <i>PEDIOCOCCUS SP</i>. AND USE THEREOF IN THE PREPARATION OF A  PROBIOTIC FORMULATION FOR THE PREVENTION OF DIARRHEA CAUSED BY BACTERIAL  PATHOGENS THAT AFFECT DOGS AND CATS	UNIVERSIDAD DE CONCEPCIóN
WO/2021/127797	NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A  RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST HMPV	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/195797	NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN  RESPIRATORY SYNCYTIAL VIRUS PROTEIN AGAINST HMPV IN CATTLE	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/000062	USE OF COMBINATION OF COMPOUND OF SCLEROTIORIN AND RIFAMPICIN  IN PREPARATION OF ANTI-TUBERCULOSIS DRUG	SUN YAT-SEN UNIVERSITY
WO/2021/000067	CELL-BINDING MOLECULE-TUBULYSIN DERIVATIVE CONJUGATE AND  PREPARATION METHOD THEREFOR	HANGZHOU DAC BIOTECH CO., LTD.
WO/2021/003687	COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2  ANTIBODY	YALE UNIVERSITY
WO/2021/007741	AQUEOUS-BASED NON-AEROSOL DRY SHAMPOO COMPOSITION	HENKEL AG & CO. KGAA
WO/2021/007800	ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF	INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/012065	APPLICATION OF BEZOAR SEDATIVE PILL IN PREPARING DRUG FOR  TREATING DEPRESSION	BEIJING TONG REN TANG CHINESE MEDICINE CO., LTD.
WO/2021/012138	USE OF DIAMINOGUANIDINE DERIVATIVE AND FEED COMPOSITION  THEREOF IN PREPARATION OF VETERINARY DRUG	GUANGZHOU INSIGHTER BIOTECHNOLOGY CO.,LTD
WO/2021/012269	ANTI-INFLAMMATORY AND ANTI-SWELLING PHARMACEUTICAL  COMPOSITION, AND USE THEREOF	HU, Ping
WO/2021/016729	COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUP FROM KERATIN  MATERIALS	L'OREAL
WO/2021/016924	CATIONIC POLYMER AND PARTICLES USABLE TO TREAT PSORIASIS	SUN YAT-SEN UNIVERSITY
WO/2021/016941	UTILIZING STRUCTURE AND MECHANOGATING MECHANISM OF PIEZO  CHANNELS FOR PREPARATION OF MEDICAMENTS AND TECHNOLOGIES	TSINGHUA UNIVERSITY
WO/2021/022466	MEDICAMENT FOR TREATING STROKE CAUSED BY DEEP FUNGAL  INFECTIONS	XIAO, Mingchun
WO/2021/022562	PURE NATURAL COMPOUND ESSENTIAL OIL HAVING BROAD-SPECTRUM  BACTERICIDAL ACTIVITY AND PREPARATION AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL PLANT DEVELOPMENT, CHINESE ACADEMY OF  MEDICAL SCIENCE
WO/2021/007899	INJECTABLE HYDROGEL MATERIAL AND PREPARATION METHOD THEREFOR  AND USE THEREOF	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/030932	PHARMACEUTICAL COMPOSITIONS COMPRISING ONCOLYTIC HERPES  SIMPLEX VIRUS FOR SYSTEMIC ADMINISTRATION	IMMVIRA CO., LTD
WO/2021/030978	USE OF NICLOSAMIDE ETHANOLAMINE SALT IN PREPARATION OF DRUGS  FOR TREATING CHEMOTHERAPY-REALATED MUSCLE INJURY	SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/031102	CRYSTAL FORM OF DAPRODUSTAT, PREPARATION METHOD THEREFOR AND  USE THEREOF	SHENZHEN RENTAI PHARMATECH LTD.
WO/2021/026949	PHASE-INVERTED EMULSION AND PREPARATION METHOD	ZHONGSHANSHI BOSHEN CHEMICAL CO., LTD.
WO/2021/031200	CD8+T CELL AND/OR B CELL REGULATION	TONGJI HOSPITAL, TONGJI MEDICAL COLLEGE OF HUAZHONG UNIVERSITY  OF SCIENCE AND TECHNOLOGY
WO/2021/035378	METHOD TO INCORPORATE OLEANOLIC ACID INTO ORAL CARE  COMPOSITIONS AND ORAL CARE COMPOSITIONS BASED THEREOF	COLGATE-PALMOLIVE COMPANY
WO/2021/035386	SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONES	BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/035390	MEDICINE FOR TREATING PULMONARY MYCOSIS	XIAO, Mingchun
WO/2021/035498	ANTI-TUMOR PLATINUM-BASED DRUG MINERALIZED PROTEIN  NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOF	SOOCHOW UNIVERSITY
WO/2021/035655	MEDICINE FOR INJECTION AND PREPARATION METHOD THEREFOR	SICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/000417	USE OF PALMITOLEIC ACID FOR PREPARING COMPOSITION FOR  PREVENTING OR TREATING INFLAMMATORY DISEASES	REVAISSANT (SHENZHEN) BIOSCIENCES CO., LTD.
WO/2021/042274	TRADITIONAL CHINESE AND WESTERN MEDICINE COMPOSITION FOR  TREATING OSTEOARTHRITIS	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042275	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  OSTEOARTHRITIS	LUNAN PHARMACEUTICALGROUP CORPORATION
WO/2021/042276	COMBINATION DRUG FOR TREATING OSTEOARTHRITIS	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042278	MULTI-UNIT SUSTAINED-RELEASE ACIPIMOX PELLET TABLET AND  PREPARATION METHOD THEREFOR	LUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/007933	APPLICATION OF MAGGOTS IN TREATMENT OF DIABETES	HUA, Xiangrong
WO/2021/007934	APPLICATION OF LIQUOR PRODUCT WITH SOAKED LUCILIA SERICATA FOR  TREATING DIABETES	HUA, Xiangrong
WO/2021/042325	COMPOSITION OF TEMPORARY DENTAL MATERIAL	TAIPEI UNIVERSITY OF TECHNOLOGY
WO/2021/042369	NANOPARTICLE HAVING CGAS-STING PATHWAY ACTIVATION FUNCTION,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/046706	A SUNSCREEN FORMULATION	SUN, Yimin
WO/2021/046765	AN ANTICANCER COMBINATION OF CHIDAMIDE AND CELECOXIB	GNT BIOTECH & MEDICALS CORPORATION
WO/2021/017115	APPARATUS AND METHOD FOR PRODUCING FREEZE-DRIED FACIAL MASK	BEIJING BENZHENGONGFANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/051260	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  TRAUMATIC INJURY AND USE THEREOF	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051261	NOVEL USE OF CHINESE MEDICINE COMPOSITION	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051262	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREPARING DRUGS  FOR TREATING EDEMA	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051271	USE OF PICEATANNOL IN PREPARING A DRUG FOR PREVENTING AND  TREATING NEURODEGENERATIVE DISEASES	SHENZHEN UNIVERSITY
WO/2021/051272	USE OF BISMUTH POTASSIUM CITRATE IN PREPARING DRUG FOR  PREVENTING OR TREATING NEURODEGENERATIVE DISEASES	SHENZHEN UNIVERSITY
WO/2021/031270	BACTERIAL MEMBRANE VESICLES, AND SEPARATION AND PREPARATION  SYSTEM AND METHOD THEREFOR	SICHUAN UNIVERSITY
WO/2021/051352	ISOLATED ANTIGEN-BINDING PROTEIN AND USE THEREOF	SPH BIOTHERAPEUTICS (HK) LIMITED
WO/2021/056231	KIT FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/056248	TECHNOLOGY FOR FACIAL FAT DEGRADATION AND FIRMING AND  APPLICATION OF TECHNOLOGY	SHANGHAI TONGBAI BIOTECHNOLOGY CO., LTD
WO/2021/056412	TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/056431	NON-DRUG HELICOBACTER PYLORI BACTERICIDAL COMPOSITION	ECO-GEO BIO-TECHNOLOGY COMPANY LIMITED
WO/2021/007957	MESOPOROUS SPONGE SPICULE AND PREPARATION METHOD AND USE  THEREFOR	XIAMEN UNIVERSITY
WO/2021/056522	COSMETIC COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/062607	ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO  ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/062611	DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND  NEUTRAL AMINO ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/062621	ORAL CARE COMPOSITIONS COMPRISING STANNOUS ION SOURCE, NEUTRAL  AMINO ACID, AND POLYPHOSPHATE	THE PROCTER & GAMBLE COMPANY
WO/2021/062623	DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILM	THE PROCTER & GAMBLE COMPANY
WO/2021/062631	DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILM	THE PROCTER & GAMBLE COMPANY
WO/2021/003864	USE OF GLYCINE IN PREPARATION OF DRUG DELIVERY REINFORCER AND  CELL TRANSPLANTATION REAGENT	TIANJIN MEDICAL UNIVERSITY
WO/2021/056609	SEQUENCE OF STRUCTURALLY SENSITIVE POLYPEPTIDE ANTIGEN OF VON  WILLEBRAND FACTOR	SOOCHOW UNIVERSITY
WO/2021/068188	WS-635 USES THEREOF IN MEDICINE	WATERSTONE PHARMACEUTICALS(WUHAN) CO., LTD.
WO/2021/068196	METHODS OF USING IL-33 PROTEIN IN TREATING CANCERS	GENERAL REGENERATIVES (SHANGHAI) LIMITED
WO/2021/068203	USE OF CHLOROQUINE OR DERIVATIVE HYDROXYCHLOROQUINE	THE FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY
WO/2021/068239	VAGINAL SLOW-RELEASE ADMINISTRATION SYSTEM FOR LUTEAL SUPPORT,  PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING
WO/2021/068242	AN AGENT THAT ENABLES SIRT7 GENE EXPRESSION AND THE USE  THEREOF	SHENZHEN UNIVERSITY
WO/2021/072595	MEDICAL USE OF MESENCHYMAL STEM CELLS IN TREATMENT OF HEARING  IMPAIRMENT	MARIA VON MED-BIOTECHNOLOGY CO., LTD.
WO/2021/072642	USE OF PHENYLQUINOLINONES AND FLAVONOID DERIVATIVES FOR  TREATING NEUROPATHIC PAIN	HANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD.
WO/2021/072661	ELECTROACTIVE AND DEGRADABLE SUPRAMOLECULAR MICROGEL AND  DRUG-LOADED SUPRAMOLECULAR MICROGEL, AND PREPARATION METHOD AND USE THEREOF	NANJING FORESTRY UNIVERSITY
WO/2021/072683	TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/031320	NANO-PARTICLE BASED ON DNA PHOTOTHERMAL MELTING, PREPARATION  METHOD THEREFOR, AND APPLICATION THEREOF	QINGDAO UNIVERSITY
WO/2021/031321	MULTI-COLOR UP-CONVERSION NANOPROBE, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	QINGDAO UNIVERSITY
WO/2021/042451	DUAL DRUG DELIVERY SYSTEM BASED ON TARGETING NUCLEOLIN,  PREPARATION METHOD THEREFOR AND USE THEREOF	QINGDAO UNIVERSITY
WO/2021/072747	COMPOSITION AND METHOD FOR TREATMENT OF DIABETES	SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/072773	ORLISTAT CAPSULE AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/072780	METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW  HEMATOPOIETIC FUNCTIONS	SUN YAT-SEN UNIVERSITY
WO/2021/022678	ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF	MABPLEX INTERNATIONAL CO., LTD.
WO/2021/077320	COMPOSITION FOR CARING FOR THE SKIN	L'OREAL
WO/2021/046976	APPLICATION OF CAS13A IN ANTAGONIZING VIRUSES	INSTITUTE OF PATHOGEN BIOLOGY, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/017222	SUPERMOLECULAR FORMULATIONS OF RETINOL AND DERIVATIVES THEREOF  AND PREPARATION METHODS THEREFOR	PROYA COSMETICS CO., LTD.
WO/2021/081782	SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA  NANOSPHERES	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/081859	SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP  KERATIN MATERIALS	L'OREAL
WO/2021/081876	SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP  KERATIN MATERIALS	L'OREAL
WO/2021/012460	MEDICINE FOR PREVENTING AND TREATING BACTERIAL ENTERITIS OF  EELS, AND PREPARATION METHOD THEREFOR	JIMEI UNIVERSITY
WO/2021/031371	APPLICATION OF TYROSINE KINASE INHIBITOR AS THERAPEUTIC DRUG  FOR ACUTE KIDNEY INJURY	SHANDONG UNIVERSITY
WO/2021/087838	TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOF	SHENZHEN GINO BIOTECHNOLOGY CO., LTD.
WO/2021/017255	PROTEIN PEPTIDE MOISTURIZING LIQUID DISSOLVED IN WEAK ALKALINE  WATER AND PREPARATION METHOD THEREFOR	SUZHOU LVZHONGYUAN TEXTILE TECHNOLOGY CO. LTD
WO/2021/092802	A HAIR STYLING PREPARATION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/092892	APPLICATION OF QUINOLINE OR QUINAZOLINE COMPOUND IN  PREPARATION OF ANTITUMOR DRUGS	PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/092893	USE OF DIARYL ETHER COMPOUND IN PREPARATION OF ANTI-TUMOR DRUG	PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/097651	PHARMACEUTICAL COMPOSITION COMPRISING ORLISTAT AND  PLANT-DERIVED LIPASE INHIBITOR	ZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097652	ORLISTAT NANOSPHERES AND USE THEREOF IN PREPARATION OF  MEDICINES FOR TREATMENT OF OBESITY	ZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097684	NEW ANTI-SOLUBLE CD14 SUBTYPE ANTIBODY AND USE THEREOF	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
WO/2021/097691	POROUS DISSOLVABLE SOLID STRUCTURE	THE PROCTER & GAMBLE COMPANY
WO/2021/022718	APPLICATION OF PYRAZOLOPYRIMIDINE COMPOUND IN PREPARATION OF  DRUGS FOR PREVENTING/TREATING TUMORS	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/102624	COVALENT PROTEIN DRUGS DEVELOPED VIA PROXIMITY-ENABLED  REACTIVE THERAPEUTICS (PERX)	HANGZHOU BRANCH OF TECHNICAL INSTITUTE OF PHYSICS AND  CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/027181	USE OF IRON-CONTAINING MATERIAL IN PREPARATION OF PRODUCT FOR  INHIBITING TRANSMISSION OF DENGUE VIRUS	TSINGHUA UNIVERSITY
WO/2021/017335	PREPARATION METHOD FOR XANTHAN GUM COPOLYMER NANOMICELLES AND  APPLICATION THEREOF	JIANGNAN UNIVERSITY
WO/2021/102674	APPLICATION OF COMBINATION OF AMPK-TARGETING INHIBITOR/SIRNA  AND PROTEASOME INHIBITOR IN ANTICANCER	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/017339	APPLICATION OF HYDROXYSAFFLOR YELLOW A IN PREPARATION OF  MEDICATION FOR TREATMENT OR ADJUVANT TREATMENT OF OBESITY DISEASE	BEIJING SHIJITAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/102714	A CONDITIONING COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102715	A CONDITIONING COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/056805	WILD JUJUBE SEED FLAVONE AND PHOSPHOLIPID COMPOSITE AS WELL AS  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	TAIZHOU GUOKEHUAWU BIOMEDICAL TECHNOLOGIES CO., LTD
WO/2021/036058	TERIPARATIDE SUSTAINED RELEASE GEL INJECTION SOLUTION AND  PREPARATION METHOD THEREFOR	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/003961	SKIN CARE COMPOSITION CONTAINING PLANT EXTRACT, AND  PREPARATION METHOD THEREFOR	ZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003962	SKINCARE COMPOSITION FOR REPAIRING SKIN, AND PREPARATION  METHOD THEREFOR	ZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003963	SKINCARE COMPOSITION FOR TIGHTENING SKIN, AND PREPARATION  METHOD THEREFOR	ZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/102873	AN OIL-IN-WATER SUNSCREEN COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102874	AN OIL-IN-WATER SUNSCREEN COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102886	COMPOSITION FOR CARING FOR/MAKING UP KERATAIN FIBERS	L'OREAL
WO/2021/102897	TWO-PHASE COMPOSITION FOR TOPICAL APPLICATION	L'OREAL
WO/2021/102935	FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES HAVING  LARGE PORES AND METHOD OF MAKING SAME	THE PROCTER & GAMBLE COMPANY
WO/2021/103018	METHOD FOR PREPARING RED POMEGRANATE EXTRACT AND SKINCARE  CREAM COMPRISING SAME	CHEN, Bohao
WO/2021/103019	METHOD FOR PREPARING COMPOSITION COMPRISING RICE WASHING WATER  AND SHAMPOO COMPRISING COMPOSITION COMPRISING RICE WASHING WATER	CHEN, Bohao
WO/2021/056815	CHEMOTHERAPEUTIC IMMUNE DRUG COMPOSITION AND PREPARATION  METHOD THEREOF	SUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/109132	COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOF	BIOMODI BIOTECH (SUZHOU) CO., LTD
WO/2021/103119	APPLICATIONS OF MACELIGNAN IN PREPARING MEDICAMENT FOR  PREVENTING AND TREATING NEURODEGENERATIVE DISEASES	SHENZHEN UNIVERSITY
WO/2021/114020	PHARMACEUTICAL COMPOSITION OF ALKYNYL-CONTAINING COMPOUND,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/114024	COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS	L'OREAL
WO/2021/077566	APPLICATION OF DIVALENT MANGANESE IN PREPARING IMMUNITY  ENHANCING DRUG OR ANTITUMOR DRUG	PEKING UNIVERSITY
WO/2021/114089	METHODS OF USING CROCETIN IN TREATING SOLID TUMORS	HANGZHOU MENGLANRUISI BIOTECHNOLOGY CO., LTD.
WO/2021/017365	CRA4S1 GENE, ENCODED CRA4S1 PROTEIN, AND APPLICATION	ZHENJIANG YANGTZE GREEN BIOTECHNOLOGY CO. LTD
WO/2021/114125	USE OF LEVISTOLIDE A IN PREPARATION OF DRUGS FOR TREATING OR  PREVENTING RENAL DISEASES	LIAONING SHUANGSHILI PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/068401	TWO-DOSAGE-FORM ESSENCE AND PREPARATION METHOD THEREFOR	GUANGZHOU BIOHOPE CO., LTD.
WO/2021/114159	SPECIAL NON-WOVEN FABRIC FOR FACIAL MASK FOR SENSITIVE SKIN	JIANGSU AIKOP NEW MATERIALS CO., LTD.
WO/2021/114218	MYCOSPORINE-LIKE AMINO ACIDS PORPHYRA-334 AND SHINORINE AND  METHOD FOR EXTRACTING PORPHYRA-334 AND SHINORINE FROM SEAWEEDS	LE, Zhanxian
WO/2021/114256	DRUG FOR TREATING PULMONARY FIBROSIS	THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY
WO/2021/114315	USE OF HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE  PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES	SHANGHAI EAST HOSPITAL
WO/2021/119902	USE OF NAPHTHYLUREA COMPOUND	SUZHOU RAYMON PHARMACEUTICALS COMPANY, LTD.
WO/2021/119966	DRUG FOR TREATING DIGESTIVE SYSTEM MYCOSIS	XIAO, Mingchun
WO/2021/012589	PREPARATION METHOD AND APPLICATION OF STANDARD LILY BULB AND  REHMANNIA DECOCTION HAVING ANTIDEPRESSANT EFFECT	SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/051685	COMPOUND FORMULATION FOR REMOVING HPV	JIANGXI SHANXING BIOTECHNOLOGY CO., LTD.
WO/2021/109251	ESSENTIAL OIL COMPOSITION, PREPARATION METHOD THEREFOR AND USE  THEREOF	GAIN SURE LIMITED
WO/2021/120084	SOLID COMPOSITION IN THE FORM OF WATER-IN-OIL EMULSION	L'OREAL
WO/2021/093087	TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING EFFECT OF  IMPROVING COGNITION, PREPARATION METHOD THEREFOR, AND TRADITIONAL CHINESE  MEDICINE PREPARATION	CHENLAND NUTRITIONALS, INC.
WO/2021/088219	APPLICATION OF TRPC1 PEPTIDE MOLECULE IN PREPARATION OF DRUG  FOR TREATING INFLAMMATION CAUSED BY VIRAL INFECTION	JIANGNAN UNIVERSITY
WO/2021/047099	METHOD FOR SYNTHESIZING NOVEL FERRIHYDRITE  NANO-PHOTOSENSITIZER AND USE THEREOF IN COUNTERACTING CANCER AND BACTERIA	NORTHWESTERN POLYTECHNICAL UNIVERSITY
WO/2021/093090	TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION HAVING  FUNCTION OF REGULATING DEPRESSION, PREPARATION METHOD THEREFOR, AND CHINESE  MEDICINE PREPARATION	CHENLAND NUTRITIONALS, INC.
WO/2021/120213	DEEP BEAUTY-TREATMENT MASSAGE CREAM AND PREPARATION METHOD AND  APPLICATION METHOD	TANGSHAN HARBIN SHIP TECHNOLOGY CO., LTD.
WO/2021/109276	COMPLEX, TISSUE REPAIR MATERIAL, PREPARATION METHOD THEREFOR  AND USE THEREOF	SHAANXI BIO REGENERATIVE MEDICINE CO., LTD
WO/2021/127814	PHOTO-NANOVACCINE FOR CANCER TREATMENT, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	SHENZHEN PEOPLE'S HOSPITAL
WO/2021/103232	PREPARATION METHOD FOR CORE-SHELL NANOPARTICLES BASED ON LIPID  MEMBRANE AND METAL ORGANIC FRAMEWORK	SHANGHAI NATIONAL ENGINEERING RESEARCH CENTER FOR  NANOTECHNOLOGY LTD.
WO/2021/128027	TACI-FC FUSION PROTEIN AND USE THEREOF	REMEGEN CO., LTD.
WO/2021/008084	ADRENALINE INJECTION AND PREPARATION METHOD THEREFOR	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/103238	TRADITIONAL CHINESE MEDICINE COMPOUND PREPARATION FOR  PREVENTING AND TREATING PORCINE DIARRHEA AND PREPARATION METHOD THEREFOR	GUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103239	COLISTIN SULPHATE PREMIX AND PREPARATION METHOD THEREFOR	GUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103240	SOLUBLE GRANULE FOR IMPROVING PIG IMMUNITY AND METHOD FOR  PREPARATION THEREOF	GUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/128045	COMPOSITION FOR CONDITIONING KERATAIN FIBERS	L'OREAL
WO/2021/128054	COMPOSITION FOR CONDITIONING KERATAIN FIBRES	L'OREAL
WO/2021/128055	COMPOSITION FOR CONDITIONING KERATAIN FIBERS	L'OREAL
WO/2021/128119	KIT FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/120268	MUPIROCINE OINTMENT AND PREPARATION METHOD THEREFOR	FRONT PHARMACEUTICAL PLC.
WO/2021/128232	OPHIOPOGONIS RADIX DEGRADATION EXTRACT AND USE THEREOF IN  PREPARATION OF HYPOGLYCEMIC DRUGS	GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
WO/2021/128292	COMPOSITION AND METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS	WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/128307	FLAVOR COMPOSITION AND ELECTRONIC CIGARETTE LIQUID CONTAINING  FLAVOR COMPOSITION	SHENZHEN RELX TECHNOLOGY CO., LTD.
WO/2021/098011	METHOD FOR COMPREHENSIVELY EXTRACTING AUTOLOGOUS LEUKOCYTES  AND PLATELET PLASMA	SICHUAN I LOVE WOLAI AUTOMOBILE CLUB CO., LTD
WO/2021/134171	COMPOSITION FOR BRIGHTENING OR WHITENING KERATIN MATERIALS	L'OREAL
WO/2021/134194	ANHYDROUS COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/134394	COMPOSITION COMPRISING PHENOLIC COMPOUNDS AND HYDROTROPES	L'OREAL
WO/2021/134420	COMPOSITION FOR CARING FOR KERATIN MATERIALS AND USE THEREOF	L'OREAL
WO/2021/134454	COMPOSITION FOR COSMETIC PRODUCTS	L'OREAL
WO/2021/134458	COMPOSITION FOR CONDITIONING KERATIN MATERIALS	L'OREAL
WO/2021/134460	COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/134463	COMPOSITION FOR CONDITIONING KERATIN MATERIALS	L'OREAL
WO/2021/134469	COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/134482	DIRECT COMPRESSED ACTIVATED CARBON TABLET FORMULATION	FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
WO/2021/062960	APPLICATION OF PEG INTERFERON AND PROTO-ONCOGENE PRODUCT  TARGETING INHIBITOR IN SYNERGISTIC TREATMENT OF RENAL CARCINOMA	SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/062961	APPLICATION OF PEG-INTERFERON AND PROTOONCOGENE PRODUCT  TARGETING INHIBITOR IN SYNERGISTIC INHIBITION OF TUMORS	SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/134623	TERTIARY AMINE PHARMACEUTICAL COMPOSITION AND INDUSTRIAL BATCH  PREPARATION METHOD THEREFOR	AC PHARMACEUTICALS CO., LTD
WO/2021/134647	SUSTAINED RELEASE COMPOSITION AND PREPARATION METHOD THEREFOR	DIQI PHARMACEUTICALS CO., LTD.
WO/2021/000558	ACTIVATING AGENT FOR SIMULTANEOUSLY ACTIVATING OXIDATIVE  PHOSPHORYLATION PATHWAY AND INHIBITING GLYCOLYTIC PATHWAY AND APPLICATION  THEREOF	LANZHOU UNIVERSITY
WO/2021/008100	SYNERGISTIC EFFECT OF COBRA NEUROTOXIN POLYPEPTIDE ON  INHIBITING OPIOID HYPERALGESIA AND TOLERANCE AND ALLEVIATING PAIN ASSOCIATED  THEREWITH	QI, Zhankai
WO/2021/042645	APPLICATION OF COBRA NEUROTOXIN PEPTIDE MOLECULE IN TREATING  NEPHRITIS PROTEINURIA	QI, Zhankai
WO/2021/051720	CLASS OF ANTI-HUMAN EGFR ANTIBODY DRUG CONJUGATE AND  PREPARATION METHOD AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/068432	APPLICATION OF ELAPIDAE SNAKE POSTSYNAPTIC NEUROTOXIN MONOMER  MOLECULE IN TREATMENT OF ALZHEIMER'S DISEASE	QI, Zhankai
WO/2021/093134	USE OF GROUP OF SNAKE NERVE GROWTH FACTORS AND SNAKE NERVE  GROWTH FACTOR PRECURSORS IN TREATMENT OF SENILE DEMENTIA	QI, Zhankai
WO/2021/103288	CELL CAPABLE OF BEING TRACED IN ORGANISM, PREPARATION METHOD  THEREFOR, AND USE THEREOF IN CELL PHARMACOKINETICS RESEARCH	SHANGHAI HEXAELL BIOTECH CO., LTD.
WO/2021/138759	PREPARATION METHOD FOR AND USE OF COMBINATION OF ANTIBODY  TARGETING TUMOR ANTIGEN AND INKT CELLS	SHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/138824	A COSMETIC CLEANSING COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/031519	ASCIDIAN EXTRACT RICH IN VARIOUS PLASMALOGENS AND PREPARATION  AND ANALYSIS METHODS THEREFOR	TIAN, Bing
WO/2021/109319	BATH MOISTURIZER HAVING HIGH MOISTURE RETENTION EFFECT AND  PREPARATION METHOD THEREFOR	JOMOO KITCHEN&BATH CO., LTD
WO/2021/142577	ARYLAMIDE COMPOUND BASED ON BENZENE RING SUPRAMOLECULAR  INTERACTION, SELF-ASSEMBLY MORPHOLOGY, AND USE	YI, Tianqi
WO/2021/047137	MEDICINE FOR TREATING PERIODONTAL DISEASE CAUSED BY  PERIODONTAL PATHOGEN INFECTION	HOSPITAL OF STOMATOLOGY, SUNYAT-SEN UNIVERSITY
WO/2021/017434	APPLICATION OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1  IN PREPARATION OF MEDICINES FOR TREATING DIABETES	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/142733	COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS,  AND INSULIN AND/OR INSULIN ANALOGS	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142736	DOSING REGIMEN OF GLP-1	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142737	COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC  STEATOHEPATITIS (NASH)	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/134842	USE OF ZC3H12B GENE OR PROTEIN AND ESTABLISHMENT METHOD FOR  LIVER DISEASE ANIMAL MODEL	SHANGHAI OCEAN UNIVERSITY
WO/2021/142815	BERBERINE AND COPTISINE, OR ACTIVE METABOLITES THEREOF, AND  APPLICATION OF SALTS THEREOF IN MEDICATION FOR PREVENTING AND/OR TREATING  URIC ACID NEPHROPATHY	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/017448	EXTERNAL COMPOSITION FOR SKIN HAVING ITCHING RELIEVING EFFECT	YANGSHENGTANG (ANJI) COSMETICS CO., LTD.
WO/2021/068439	SYNERGISTIC ANTI-SKIN-AGING PREPARATION COMPRISING EXOSOME AND  SPONGE SPICULE OR ANALOGUE THEREOF	SHENZHEN PEOPLE'S HOSPITAL
WO/2021/056946	APPLICATION OF ANTI-LCN2 ANTIBODY IN PREPARATION OF DRUG FOR  TREATING LUPUS NEPHRITIS	NANJING DRUM TOWER HOSPITAL
WO/2021/151251	TREATING TREATMENT-RESISTANT DIABETES WITH GLUCOKINASE  ACTIVATOR	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/151259	USE OF 3-(4-HYDROXYPHENYL)PROPIONIC ACID IN PREPARATION OF  DRUGS FOR PREVENTING AND TREATING RESPIRATORY TRACT INFECTION	SUN YAT-SEN UNIVERSITY
WO/2021/155580	COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCER	COTHERA BIOSCIENCE, INC.
WO/2021/082298	COMPOSITION CAPABLE OF RELIEVING ECZEMA SKIN CONDITION, AND  PREPARATION METHOD THEREFOR	SHENZHEN YUANGUANGZHOUTECHNOLOGY CO., LTD.
WO/2021/120376	COMPOSITE PROBIOTIC COMPOSITION HAVING ANTI-AGING EFFECT AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	YANG, Bo
WO/2021/159547	POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING OVARIAN CANCER  AND USE THEREOF	ZHUHAI TENGBAI PHARMACEUTICAL CO., LTD.
WO/2021/031536	USE OF NADH AND/OR NMN IN PREPARING MEDICAMENTS AND HEALTH  CARE PRODUCTS FOR BRAIN FUNCTION RECOVERY	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/163874	RECOMBINANT VIRAL VECTOR, IMMUNOGENIC COMPOSITION COMPRISING  SAME, AND USES	VACDIAGN BIOTECHNOLOGY CO., LTD.
WO/2021/163897	PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE,  NUTRIENT OR/AND CONVENTIONAL ANTITUMOR DRUG, AND APPLICATION THEREOF	CHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/163915	MILD CLEANSING COMPOSITION CONTAINING NEARLY SATURATED,  SATURATED OR SUPERSATURATED ACTIVE INGREDIENTS AND PREPARATION METHOD  THEREFOR	HUANG, Yaokun
WO/2021/163965	FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES CONTAINING  CATIONIC SURFACTANT	THE PROCTER & GAMBLE COMPANY
WO/2021/163980	SUBSTANCE TARGETING MASP-2 AND N PROTEIN OR BINDING THEREOF  FOR PREVENTING AND/OR TREATING CORONAVIRUS INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY  SCIENCE, PLA.
WO/2021/164037	MEDICATION FOR TREATING INFLUENZA OR INFECTIOUS DISEASE	XIAO, Mingchun
WO/2021/142884	USE OF ASPIRIN IN PREPARATION OF PLATELET-TARGETED DRUG  DELIVERY SYSTEM	SOUTHEAST UNIVERSITY
WO/2021/138979	PROBIOTIC MINERAL MATERIAL COMPOSITE PREPARATION AND  APPLICATION OF MINERAL MATERIALS IN PREPARATION OF DRUGS FOR INHIBITING  MALIGNANT TUMOR GROWTH	NANJING UNIVERSITY
WO/2021/168684	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/168696	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/068452	DNA VACCINE CAPABLE OF EFFECTIVELY TREATING AND/OR PREVENTING  TYPE 1 DIABETES AND USE THEREOF	THE FIFTH MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
WO/2021/174406	MEDICAL USE OF ANEMOSIDE B4 IN TREATING ORAL ULCER	LIU, Qi
WO/2021/174416	DETECTION METHOD FOR CIRCULATING TUMOR CELL	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/168876	ANTI-CORONAVIRUS APPLICATION OF ASCORBYL PALMITATE	SUN YAT-SEN UNIVERSITY
WO/2021/164054	APPLICATION OF CANNABIDIOL IN PREPARATION OF SKINCARE PRODUCTS  HAVING SOOTHING AND ANTI-IRRITATION EFFECTS	DOCTOR PLANT GUANGDONG BIOTECHNOLOGY CO., LTD.
WO/2021/051750	TRADITIONAL CHINESE MEDICINE FOR TREATING DISEASES OF BODY  CAUSED BY BODY DAMPNESS, AND PREPARATION METHOD THEREFOR	YEUNG, Tak Wai Waisees
WO/2021/159570	APPLICATION OF BAICALEIN IN PREPARING DRUG FOR PREVENTING  AND/OR TREATING NOVEL CORONOVIRUS INFECTIOUS DISEASE	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES & PEKING UNION MEDICAL COLLEGE
WO/2021/179106	APPLICATION OF GP73 INHIBITOR IN PREPARATION OF DRUG FOR  TREATING DIABETES	BEIJING SUNGEN BIOMEDICAL TECHNOLOGY CO. LTD.
WO/2021/134913	APPLICATION OF HUMAN CRYPTOCHROME PROTEIN I (HCRY1) IN  PREPARATION OF ANTI-ULTRAVIOLET RADIATION PREPARATION	GUANGZHOU DOUBLLE BIOPRODUCT CO., LTD
WO/2021/103342	POLYETHYLENE GLYCOL CONJUGATED DRUG, AND PREPARATION METHOD  THEREFOR AND USE THEREOF	CHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/109351	POLYETHYLENE GLYCOL CONJUGATE DRUG, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	CHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/017475	OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE,  PREPARATION METHOD AND USE THEREOF	SHENYANG XINGQI PHARMACEUTICAL CO., LTD.
WO/2021/179214	Methods for enhancing anti-apoptotic pathway to prevent DOX  toxicity	SHENZHEN UNIVERSITY
WO/2021/012686	NALOXONE HYDROCHLORIDE INJECTION AND PREPARATION METHOD  THEREFOR	GUANGDONG QIFANG MEDICINES CO., LTD.
WO/2021/147151	USE OF FUCOSAN SULFATE IN PROMOTING FOAM CELL AUTOPHAGY TO  DECOMPOSE OX-LDL	SHANDONG UNIVERSITY
WO/2021/179319	COMPOSITION CONTAINING HYDROLYZED CHONDROITIN SULFATE FOR  PREVENTING AND TREATING OSTEOARTHROPATHY	NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174581	NEW USE OF INDAZOLE COMPOUND	TARAPEUTICS SCIENCE INC.
WO/2021/008149	APPLICATION OF AKKERMANSIA MUCINIPHILA IN PREPARATION OF  ANTIDEPRESSANT DRUG OR HEALTH CARE PRODUCT	JIANGSU PROVINCE HOSPITAL OF CHINESE MEDICINE
WO/2021/168930	TABLET OF REMDESIVIR AND PREPARATION METHOD THEREFOR	GU, Shihai
WO/2021/036230	RANOLAZINE SUSTAINED-RELEASE COMPOSITION AND PREPARATION  METHOD THEREFOR	HYBIO PHARMACEUTICAL CO.,LTD.
WO/2021/168931	SUBMICRO EMULSION CONTAINING ACER TRUNCATUM SEED OIL AND  PREPARATION METHOD THEREFOR	SHENZHEN JINFENG BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/142920	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING LUNG  CANCER, AND PREPARATION AND USE THEREOF	DONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/147162	USE OF LACTOBACILLUS REUTERI FROM BREAST MILK IN REGULATING  MATERNAL AND INFANT IMMUNE FUNCTION	FINE (HUNAN) BIOTECHNOLOGY CO., LTD.
WO/2021/012694	ETHYL METHYL HYDROXYPYRIDINE MALATE OR PHARMACEUTICAL  COMPOSITION THEREOF, AND A USE IN PREVENTING AND/OR TREATING TYPE-II DIABETES	KENO PHARMA LIMITED
WO/2021/073041	APPLICATION OF MULTI-LINEAGE DIFFERENTIATING STRESS ENDURING  CELLS, MEDICAMENT FOR TREATING PERIPHERAL NERVE INJURY AND PREPARATION METHOD  THEREFOR	NANTONG UNIVERSITY
WO/2021/068459	SUSPENSION CONTAINING LOW METHOXYLATION PECTIN AND  MONTMORILLONITE FOR TREATING ACUTE DIARRHEA	AFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/073042	USE OF MULTILINEAGE DIFFERENTIATION STRESS-ENDURING CELL, DRUG  FOR TREATING DIABETES AND PREPARATION METHOD THEREFOR	NANTONG UNIVERSITY
WO/2021/008161	DRUG FOR ALLEVIATING PSEUDOMONAS KERATITIS	SHANDONG EYE INSTITUTE
WO/2021/142934	APPLICATION OF JAK-1 SIGNALING PATHWAY INHIBITOR IN  PREPARATION OF MEDICAMENT FOR TREATING BRAIN INJURY	SOOCHOW UNIVERSITY
WO/2021/189256	USE OF MENTHOL FOR PREPARING EXTERNAL COMPOSITION FOR TREATING  NEURODEGENERATIVE DISEASE AND STROKE	CHINA MEDICAL UNIVERSITY
WO/2021/155631	ERYTHROCYTE GEL DELIVERY SYSTEM, AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/179351	IMMUNE COMBINATION FOR INDUCING BROAD-SPECTRUM NEUTRALIZING  ANTIBODY AGAINST HIV-1	SHANGHAI PUBLIC HEALTH CLINICAL CENTER
WO/2021/189279	METHOD FOR REDUCING BEHAVIORAL ABNORMALITIES	BENED BIOMEDICAL CO., LTD.
WO/2021/184404	COMPOSITION OF NOVEL IMMUNE AGONIST COMPOUND AND USE THEREOF  IN MEDICINE CAPABLE OF RESISTING MULTIPLE DISEASES	HANGZHOU XINGAO BIOTECHNOLOGY CO., LTD.
WO/2021/134935	USE OF CANNABIDIOL IN PREPARATION OF DRUGS FOR PROMPTING  HEALING OF ORAL MUCOSA	SICHUAN UNIVERSITY
WO/2021/151264	USE OF ACYLATED SPIRAMYCIN IN PREPARATION OF MEDICAMENT FOR  TREATING CORONAVIRUS INFECTIOUS DISEASE	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/184405	LIPOSOME COMPRISING GULURONIC ACID OLIGOSACCHARIDE,  PREPARATION METHOD, AND USE THEREOF FOR PROMOTING IMMUNE ACTIVITY	SHENZHEN UNIVERSITY
WO/2021/189355	AMINO ACID MEDIATED GENE DELIVERY AND ITS USES	CHINESE INSTITUTE FOR BRAIN RESEARCH, BEIJING
WO/2021/031565	Treatment of Neuronal Diseases	CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/189390	MEDICAMENT FOR PREVENTING/TREATING TYPE 2 DIABETES AND USES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189444	USE OF RIFAMYCIN ANTIBIOTICS IN PREPARATION OF DRUGS AGAINST  YELLOW FEVER VIRUS INFECTIONS	THE NAVAL MEDICAL UNIVERSITY OF PLA
WO/2021/195820	TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/155633	USE OF ALKYL RESORCINOL COMPOUND IN PREPARATION OF DRUG FOR  PREVENTING OR TREATING ALZHEIMER'S DISEASE	BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY
WO/2021/195877	FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS  FOR PRODUCING SAME	SICHUAN LUZHOU BUCHANG BIO-PHARMACEUTICAL CO., LTD.
WO/2021/195883	APPLICATION OF TFF2 PROTEIN AND IFN-κ PROTEIN COMBINATION IN  TREATMENT OF A NOVEL CORONAVIRUS INFECTION	SHANDONG RUIYING PIONEER PHARMACEUTICAL CO., LTD
WO/2021/195904	USE OF COMPOSITION CONTAINING ASTRAGALI RADIX, PUERARIAE  LOBATAE RADIX AND ERIGERONTIS HERBA	CHONGQING TAIJI INDUSTRIAL (GROUP) CO., LTD
WO/2021/195905	COSMETIC COMPOSITION FOR SKIN CARE	L'OREAL
WO/2021/195931	COSMETIC COMPOSITION IN THE FORM OF A GEL	L'OREAL
WO/2021/077681	HYALURONIC ACID GEL COMPOSITION FOR WATER OPTOINJECTION, AND  PREPARATION METHOD THEREFOR	BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
WO/2021/077683	HYALURONIC ACID GEL FOR HYALURONIC ACID INJECTION AND USE  METHOD FOR HYALURONIC ACID GEL	BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD
WO/2021/196079	ENERGY-ACTIVATING, ANTI-WRINKLE, ANTI-INFLAMMATORY, AND  WHITENING ORCHID EMBRYO TISSUE EXTRACT	LIANG, Chiahua
WO/2021/196086	METHOD FOR INHIBITING CELL ACTIVITY BY MEANS OF INTRACELLULAR  POLYMERIZATION AND PRO-DRUG IMPLEMENTING METHOD	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189517	USE OF MTHFD1 INHIBITOR IN INHIBITING AND KILLING VIRUSES	TSINGHUA UNIVERSITY
WO/2021/057007	RAPAMYCIN NANOSCALE SUSTAINED-RELEASE AGENT AND PREPARATION  METHOD THEREOF	YAN, Pengke
WO/2021/196105	ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA,  PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD.
WO/2021/164107	NOVEL APPLICATION OF IL-6 RECEPTOR ANTIBODIES	UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
WO/2021/203236	BAT-DERIVED CORONAVIRUS VACCINE FOR PREVENTION OF COVID-19	SICHUAN CHENGYU BIOLOGICAL PRODUCTS INC.
WO/2021/168996	CATALASE NANOCAPSULES AND METHODS FOR USE	VIVIBABA, INC.
WO/2021/184449	PREPARATION METHOD FOR AND APPLICATION OF GENETICALLY  ENGINEERED ANTITUMOR MICROPARTICLE	WUHAN SHENGRUN BIOTECHNOLOGY CO., LTD
WO/2021/031579	ANTI-ACETYLCHOLINESTERASE ACTIVE COMPOSITION IN CAULIS  MAHONIAE AND SCREENING METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN INSTITUTE FOR DRUG CONTROL (SHENZHEN TESTING CENTER  OF MEDICAL DEVICES)
WO/2021/203377	BENDAMUSTINE COMPOSITION AND USE THEREOF	BIKA BIOTECH (GUANGZHOU) CO., LTD
WO/2021/203419	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  DERMATITIS OR ECZEMA	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/203434	NANO MATERIAL FOR OSTEOCLAST ACIDIC CLOSED REGION AND  PREPARATION METHOD THEREFOR	SIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/196275	APPLICATION OF EMETINE IN PREPARATION OF DRUG FOR TREATING OR  PREVENTING NOVEL CORONAVIRUSES SARS-COV-2	HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF  SCIENCES
WO/2021/179396	NEW APPLICATION OF HUWE1 INHIBITOR BI8622	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/208060	GAS SUPPLY DEVICE, USE THEREOF FOR LIGHTENING HAIR COLOR AND  METHOD	TO2M CORPORATION
WO/2021/208080	USE OF OVATODIOLIDE AGAINST NOVEL CORONAVIRUS	CNS BIOTEK CORP.
WO/2021/212253	IBRUTINIB GLUCONOLACTONE CO-CRYSTAL AND PREPARATION METHOD  THEREFOR	TIANJIN CREATRON BIOTECHNOLOGY CO., LTD.
WO/2021/212267	COMPOSITION FOR CARING FOR THE SKIN	L'OREAL
WO/2021/212269	APPLICATION OF ELLAGIC ACID IN PREVENTING AND TREATING NOVEL  CORONAVIRUS INFECTION	YUNNAN AGRICULTURAL UNIVERSITY
WO/2021/212270	APPLICATION OF AMARONOL A IN PREVENTION AND TREATMENT OF NOVEL  CORONAVIRUS INFECTION	YUNNAN AGRICULTURAL UNIVERSITY
WO/2021/114540	PEONY FACE MASK FOR CLEANSING PORES AND PREPARATION METHOD  THEREFOR	SHANXI LU'AN MINING (GROUP) CO., LTD
WO/2021/068478	POLYPEPTIDE AND POLYPEPTIDE COMPOSITION FOR INHIBITING  HELICOBACTER PYLORI FROM FORMING BIOLOGICAL MEMBRANE AND ELIMINATING  BIOLOGICAL MEMBRANE FORMED BY HELICOBACTER PYLORI	ANHUI SCIENCE AND TECHNOLOGY UNIVERSITY
WO/2021/036294	VAGINAL ACID-BASE BUFFER GEL AND PREPARATION METHOD	NANJING TIANLANG PHARMACEUTICAL CO., LTD.
WO/2021/051807	PREPARATION CONTAINING HUMAN ALBUMIN AND PREPARATION METHOD  THEREFOR	TONGHUA ANRATE BIOPHARMACEUTICAL CO., LTD
WO/2021/212360	TREATING UNTREATED OR TREATMENT-RESISTANT DIABETES WITH  GLUCOKINASE ACTIVATOR AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/098141	AEROSOL ALCOHOL-FREE NO-WASH ANTIBACTERIAL HAND SANITIZER AND  PREPARATION METHOD THEREFOR	ZHEJIANG LUDAO TECHNOLOGY CO., LTD.
WO/2021/212404	TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME	HENKEL AG & CO. KGAA
WO/2021/088327	TOOTH MINERALIZATION SOLUTION AND MINERALIZATION METHOD  THEREOF	ZHEJIANG UNIVERSITY
WO/2021/057022	PEARL PREPARATION AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOF	OSM BIOLOGY CO., LTD.
WO/2021/208138	TOAD SKIN STERENE TOTAL LACTONE EXTRACT, AND PREPARATION  METHOD THEREFOR AND USE THEREOF	HEFEI HUAFANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174656	CHINESE PATENT MEDICINE FOR TREATING SUB-HEALTH CHRONIC  DISEASES	WU, Guanlin
WO/2021/217388	MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE AND  PREPARATION METHOD THEREFOR	JIANGSU TASLYDIYI PHARMACEUTICAL CO., LTD.
WO/2021/120486	LITHIUM ION COMPOSITION AND APPLICATION THEREOF	QINGDAO DEBAO SHANGJIA HOUSEHOLD PRODUCTS CO. , LTD
WO/2021/169026	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING  EPIDEMICS, AND PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU PROVINCE HOSPITAL OF TCM
WO/2021/196334	APPLICATION OF PYR3 IN PREPARATION OF DRUG FOR PROTECTING  AGAINST LIVER DAMAGE	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/196335	USE OF PYR3	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/217560	KIT FOR CARING FOR THE SKIN	L'OREAL
WO/2021/217568	ASSEMBLED JADE-ACTIVATING MATERIAL FOR MAINTAINING BEAUTY AND  KEEPING YOUNG, AND ASSEMBLING AND SYNTHESIZING METHOD THEREFOR AND USE  THEREOF	SICHUAN SANTAI PHARMACEUTICAL TECHNOLOGY CO. LTD
WO/2021/169034	APPLICATIONS OF TRANSFERRIN OR OVEREXPRESSED TRANSFERRIN IN  PREPARING MEDICAMENT FOR TREATING AND/OR PREVENTING ULCERATIVE COLITIS	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/223143	O/W EMULSION AND W/O EMULSION INVERTED THEREFROM, AND PERSONAL  CARE COMPOSITION CONTAINING SAME	MOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/217693	USE OF SYMBIOTIC FERMENTATION PRODUCT OF HYDROLYZED CANDIDA  AND JAPANESE SAKE YEAST	HANGZHOU QIANMEI COSMETIC CO., LTD
WO/2021/004145	USE OF MIR-132 AND 212 IN PREPARATION OF DRUG FOR TREATING  ADDICTION	SHENZHEN KANGNING HOSPITAL (SHENZHEN MENTAL HEALTH INSTITUTE,  SHENZHEN MENTAL HEALTH CENTER)
WO/2021/226736	TREATMENT OF ADVERSE EFFECTS CAUSED BY ATYPICAL ANTIPSYCHOTICS	SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/226738	MOLECULAR-LEVEL PHARMACEUTICAL COMPOSITION COMPRISING  LENVATINIB AND PREPARATION METHOD THEREFOR AND USE THEREOF	BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RESEARCH CO. LTD.
WO/2021/217702	MEDICINE AND FOOD FOR PREVENTING OR TREATING COVID-19, AND  APPLICATION THEREOF	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/226762	TUMOR MICROENVIRONMENT RESPONSE-TYPE NANO-COMPOSITE DRUG  LOADING SYSTEM, AND PREPARATION METHOD THEREFOR AND USE THEREOF	WANG, Shubin
WO/2021/203515	PREPARATION METHOD FOR MICRORNA MICRO/NANOSPHERES AND  APPLICATION THEREOF IN HEALING SPINAL CORD INJURY	YAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/082391	COLLAGEN NANO INSTANT FACIAL MASK OF YEAST RECOMBINANT  COLLAGEN AND PREPARATION METHOD THEREFOR	NOX BELLCOW COSMETICS CO., LTD.
WO/2021/226849	IMMUNOLOGICALLY ACTIVE PEPTIDE-BILIVERDIN CONJUGATE,  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	INSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/098164	METHOD FOR EXTRACTING KELP POLYPHENOLS	QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/226883	COMPOSITIONS AND METHODS FOR TREATING CANCER SUBMISSION OF  SEQUENCE LISTING ON ASCII TEXT FILE	ADAGENE AG
WO/2021/103434	RECOMBINANT VARICELLA-ZOSTER VIRUS VACCINE	BEIJING LUZHU BIOTECHNOLOGY CO., LTD.
WO/2021/008215	POLYMER COMPOSITE MICROSPHERE, PREPARATION METHOD THEREFOR AND  USE THEREOF	GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS
WO/2021/217740	COMPOSITIONS AND METHODS FOR INHIBITING VIRUS INFECTION	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227077	AMINO ACID COMPOSITION AND METHOD FOR CATALYTIC SYNTHESIS OF  AMINO ACID BY MEANS OF ENERGY RADIATION	BEIJING GUANGHE ORIGINAL TECHNOLOGY CO., LTD.
WO/2021/057042	DRUG COMPOSITION CONTAINING ABIRATERONE ACETATE, AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	HUNAN HUIZE BIO-PHARMACEUTICAL CO., LTD
WO/2021/232334	TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING ANTI-ACNE  EFFECT, PREPARATION METHOD THEREFOR, AND USE THEREOF	JOHNSON BIOTECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/237456	ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/237609	NOVEL USE OF ORIDONIN OR ORIDONIN DERIVATIVE	TSINGHUA UNIVERSITY
WO/2021/047210	IMMUNIZATION-PURPOSE SUSPENDING AGENT, VACCINE SUSPENSION  PREPARATION METHOD AND SPRAY-DROP IMMUNIZATION METHOD	FOSHAN STANDARD BIO-TECH CO., LTD.
WO/2021/159636	USE OF COMPOUND ZZ-8 IN PREPARING DRUG FOR TREATMENT OF  OBESITY	KEY LABORATORY OF SOUTH SUBTROPICAL PLANT DIVERSITY, FAIRY  LAKE BOTANICAL GARDEN, SHENZHEN & CHINESE ACADEMY OF SCIENCES
WO/2021/012789	PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOF	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/237691	DEFORMABLE SOLID COMPOSITION FOR CLEANSING THE SKIN	L'OREAL
WO/2021/237697	COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS	L'OREAL
WO/2021/042777	MULTI-COMPONENT GEL SUSTAINED-RELEASE PHARMACEUTICAL  COMPOSITION FOR TREATMENT OF TUMORS	SUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/042778	TEMPERATURE-SENSITIVE GEL PHARMACEUTICAL COMPOSITION FOR  TREATMENT OF TUMORS	SUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/155651	USE OF 4-AMINOQUINOLINE COMPOUND IN TREATMENT OF CORONAVIRUS  INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/212617	SEAWEED MASK, PREPARATION METHOD THEREFOR AND APPLICATION  THEREOF	SHANDONG UNIVERSITY
WO/2021/008265	ANTI-AGING SOFT CAPSULE FOR MENOPAUSAL WOMEN AND PREPARATION  METHOD THEREFOR	ZAOZHUANG UNIVERSITY
WO/2021/068533	DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND  RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOF	NANJING AGRICULTURAL UNIVERSITY
WO/2021/135071	USE OF PIPERAZINE FERULATE TABLETS	SHENZHAN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/227156	COMPOSITIONS AND METHODS FOR TREATING CANCER	ADAGENE AG
WO/2021/243645	GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH RENAL  IMPAIRMENT	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/243646	GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC  IMPAIRMENT	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/243658	TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTION	WATERSTONE PHARMACEUTICALS (WUHAN) CO., LTD.
WO/2021/243669	USE OF A COMPOUND CONTAINING TWO OR MORE ALCOHOLIC HYDROXYL  GROUPS OR PHENOLIC HYDROXYL GROUPS AS A MICROBIOME REGULATOR ON SCALP	HENKEL AG & CO. KGAA
WO/2021/093315	COMPOSITION FOR PROTECTING LIVER, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/063016	COMPOSITION WITH HYPOLIPIDEMIC FUNCTION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/057089	COMPOSITION WITH CHLOASMA REMOVAL FUNCTION, PREPARATION METHOD  THEREFOR AND USE THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/022891	COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION  METHOD THEREFOR	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109509	COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION  METHOD THEREFOR	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109510	COMPOSITION HAVING DIGESTION PROMOTING FUNCTION, PREPARATION  METHOD AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109511	ANTI-FATIGUE COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/114586	IMMUNE RESPONSE-IMPROVING COMPOSITION, PREPARATION METHOD AND  APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/196402	PHARMACEUTICAL COMPOSITION AND USE THEREOF	DONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/217788	METHOD FOR PREPARING COMPOUND-TYPE TABLETS FOR PROTECTING  LIVER AND DISPELLING EFFECTS OF ALCOHOL	JIANG SU ZHONGXING PHARM.CO., LTD
WO/2021/227166	APPLICATION OF SUCCINYLATION MODIFICATION OF PROTEIN IN  PREPARATION OF TUMOR CELL METABOLISM REGULATOR	TANG, Bo
WO/2021/174714	MELANIN-BASED SUNSCREEN COMPOSITION AND PREPARATION METHOD  THEREFOR	JIANGNAN UNIVERSITY
WO/2021/174715	PERSONAL CARE SUNSCREEN COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOF	JIANGNAN UNIVERSITY
WO/2021/073131	MEDICAMENT FOR EFFICIENTLY KILLING DRUG-RESISTANT DISEASE  BACTERIA AND APPLICATION THEREOF IN INHIBITING DRUG-RESISTANT DISEASE  BACTERIA	OCEAN UNIVERSITY OF CHINA
WO/2021/073132	APPLICATION OF HIGH PURITY NERVONIC ACID IN WHITENING AND  PREPARATION METHOD FOR HIGH PURITY NERVONIC ACID	NANJING KANGQI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/004229	NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN  PREVENTING RECURRENCE OF PSORIASIS	RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/253147	METHOD FOR PREPARING CELL-MEDIATED SARS-COV-2 VACCINES	YIN, Xiushan
WO/2021/114596	PHENYLETHANOID GLYCOSIDE EXTRACT FROM ACANTHUS ILICIFOLIUS,  AND PREPARATION METHOD THEREOF AND APPLICATION AS DRUG FOR RESISTING LIVER  DAMAGE	OCEAN UNIVERSITY OF CHINA
WO/2021/143042	PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE BURNS AND SKIN  GANGRENE AND APPLICATION THEREOF	BEIJING GUANGJIE-YOUNG HEALTH SCIENCE AND TECHNOLOGY CO. LTD
WO/2021/189678	WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION  THEREOF	SOOCHOW UNIVERSITY
WO/2021/217816	COMPOSITION FOR PREVENTING AND TREATING PNEUMONIA, AND  PREPARATION METHOD THEREFOR AND USE THEREOF IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING PNEUMONIA	INSTITUTE OF SCIENCE AND TECHNOLOGY, GUANGDONG UNIVERSITY OF  CHINESE MEDICINE
WO/2021/077770	MINI COMBINED ADJUVANT NANOPARTICLE, PREPARATION METHOD  THEREFOR AND APPLICATION THEREFOR	INSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/248532	VORICONAZOLE PREPARATION FOR EXTERNAL USE AND PREPARATION  METHOD THEREFOR	ZHEJIANG POLY PHARM CO., LTD
WO/2021/217823	DIHYDROMYRICETIN HAVING FUNCTION OF DISPELLING EFFECTS OF  ALCOHOL	SONG, Kunyuan
WO/2021/243756	PHARMACEUTICAL USE OF MYRICETIN IN INHIBITION OF NOVEL  CORONAVIRUS	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/243757	PHARMACEUTICAL APPLICATION OF GALLIC ACID	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/217826	PHARMACEUTICAL APPLICATION OF DIMYRICETIN-YL-DISELENIDE	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/253338	USE OF ROMIDEPSIN IN PREVENTING AND TREATING  CORONAVIRUS-RELATED DISEASES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/120562	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  EGFR-TKIS-RELATED SKIN RASH, AND USE THEREOF	LIN, Lizhu
WO/2021/068550	ACTIVE POLYPEPTIDE COMPOUND	SHAANXI MICOT TECHNOLOGY CO., LTD.
WO/2021/253380	ORAL FORMULATIONS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/212635	APPLICATION OF BRUCEA JAVANICA FRUIT FAT-SOLUBLE EXTRACT IN  PREPARATION OF DRUG FOR PROMOTING PERIPHERAL NERVE REGENERATION	NANTONG UNIVERSITY
WO/2021/212638	CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN  ANALOGS	HANGZHOU DAC BIOTECH CO., LTD.
WO/2021/227200	ORAL CAVITY CLEANING COMPOSITION AND APPLICATION THEREOF	GUANGZHOU ZHONGYU BIOTECHNOLOGY CO., LTD.
WO/2021/147235	APPLICATION OF FAVIPIRAVIR IN TREATING CORONAVIRUS INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147236	USE OF SUBSTITUTED AMINOPROPIONATE COMPOUND IN TREATMENT OF  SARS-COV-2 INFECTIONS	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/114605	LIVER-TARGETED THERAPEUTIC DRUG BASED ON SUGAR-BASED METAL  FRAMEWORK MATERIAL AND PREPARATION METHOD THEREOF	JIANGNAN UNIVERSITY
WO/2021/208237	APPLICATION OF HEPTOSE CHAIN-CONTAINING OLIGOSACCHARIDE  COMPOUND IN PREPARATION OF HELICOBACTER PYLORI VACCINE	JIANGNAN UNIVERSITY
WO/2021/109549	JOINT APPLICATION OF QUERCETIN AND ANTIBACTERIAL MEDICAMENT	CHINA AGRICULTURAL UNIVERSITY
WO/2021/000770	HETEROCYCLIC COMPOUND CAPABLE OF ENHANCING IMMUNE ACTIVITY,  PREPARATION METHOD THEREFOR AND APPLICATION IN MEDICINE	CAMPHOR PHARMACEUTICALS LIMITED
WO/2021/169100	APPLICATION OF TRISACCHARIDE REPEATING UNIT OLIGOSACCHARIDE  CHAIN IN PREPARATION OF STAPHYLOCOCCUS AUREUS VACCINES	JIANGNAN UNIVERSITY
WO/2021/258326	APPLICATION OF MIDAZOLAM NANOCRYSTALS IN PREPARING DRUG FOR  IMPROVING BLOOD-BRAIN BARRIER PERMEABILITY	MILITARY MEDICAL INSTITUTE, ACADEMY OF MILITARY SCIENCES, PLA
WO/2021/258337	HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED  DISEASES	HUAHUI HEALTH LTD.
WO/2021/258341	BARNYARD GRASS EXTRACT, AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOF	LEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/258342	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DRUG WITHDRAWAL,  AND APPLICATION THEREOF	LEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/042830	RECOMBINANT HUMAN PAPILLOMA VIRUS VACCINE COMPOSITION AND USE  THEREOF	IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
WO/2021/063047	USE OF EXTRACT OF OVERGROUND PART OF SCUTELLARIAE RADIX IN  AQUACULTURE	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/012886	ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOF	GUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/179482	TRADITIONAL CHINESE MEDICINE COMPOUND COMPOSITION HAVING  EFFECT OF PROMOTING BONE HEALTH AS WELL AS PREPARATION METHOD THEREFOR AND  APPLICATION THEREOF	CHENLAND NUTRITIONALS, INC.
WO/2021/227214	STERILIZATION AND DISINFECTION COMPOSITION	NANJING GREEN INTERFACE NEW MATERIALS RESEARCH INSTITUTE CO.,  LTD
WO/2021/143060	MAGNOLIA OFFICINALIS PLANT PRESERVATIVE AND BACTERIOSTATIC  COMPOSITION, PREPARATION PROCESS THEREFOR, AND APPLICATION THEREOF	YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO., LTD.
WO/2021/057152	KIT FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/027425	ANTI-INFLAMMATORY TARGETED DELIVERY SYSTEM AND PREPARATION  METHOD THEREFOR	SOOCHOW UNIVERSITY
WO/2021/179494	DRUG FOR PREVENTING AND/OR TREATING BRAIN TUMOR AND  APPLICATION THEREOF	GUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/000899	A PHARMACEUTICAL COMBINATION CONTAINING mTOR INHIBITOR AND USE  THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/000926	USE OF GINSENOSIDE M1 FOR TREATING CANCER	LEE, Sheau-Long
WO/2021/000950	PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE AND PREPARATION  METHOD THEREFOR	SHENZHEN RADAK BIO CORPORATION
WO/2021/000953	SUBSTANCE AND METHOD FOR TREATING TUMOR	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/237879	USE OF AITC	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/004422	MICROMOLECULE PI4KIIIα INHIBITOR COMPOSITION, PREPARATION  METHOD THEREFOR AND USE THEREOF	NUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/114647	APPLICATION OF SODIUM P-HYDROXYBENZOATE IN PREPARATION OF  DRUGS FOR TREATMENT OR PREVENTION OF INFLAMMATORY BOWEL DISEASE	GUILIN MEDICAL UNIVERSITY
WO/2021/082512	USE OF BLUE-LIGHT ACTIVATED BLEBBISTATIN ANALOGUES IN KILLING  DRUG-RESISTANT BACTERIA	SHENZHEN THIRD PEOPLE'S HOSPITAL
WO/2021/243797	USE OF DROSOPHILA MELANOGASTER HSP22 PROTEIN IN PREPARATION OF  ANTI-TUMOR DRUG	AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIVERSITY
WO/2021/174738	BIONIC NANOPARTICLE COATED WITH MESENCHYMAL STEM CELL MEMBRANE  HAVING SURFACE OVEREXPRESSING PD-L1 MOLECULE, AND PREPARATION THEREFOR AND  APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/248601	USE OF LYCHEE PEEL EXTRACT MAINLY CONTAINING MULTIMERIC  POLYPHENOL IN PREPARATION OF α-AMYLASE INHIBITOR	GUANGXI ZHUANG AUTONOMOUS REGION AND CHINESE ACADEMY OF  SCIENCE, GUANGXI INSTITUTE OF BOTANY
WO/2021/042865	ORAL DRUG DOSAGE FORMS HAVING A DESIRED PK PROFILE AND METHODS  OF DESIGNING AND PRODUCING THEREOF	TRIASTEK, INC.
WO/2021/004477	MITOCHONDRIA-BASED DRUG DELIVERY SYSTEM AND USE THEREOF	TANG, Lingfeng
WO/2021/243804	TRADITIONAL CHINESE MEDICINE EPIDEMIC-PREVENTION BAG	BEIJING GUORUN JIUHE HEALTH TECHNOLOGY CO., LTD
WO/2021/036537	USE OF KOUMINE IN PREPARATION OF DRUGS FOR TREATING  INFLAMMATORY BOWEL DISEASE	FUJIAN MEDICAL UNIVERSITY
WO/2021/004524	PEGYLATED SYNTHETIC KL4 PEPTIDE, COMPOSITIONS AND METHODS  THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/088399	MOISTURIZING AND HYDRATING FACIAL MASK COMPOSITION, FACIAL  MASK, AND PREPARATION METHOD FOR FACIAL MASK COMPOSITION	HUBEI CHUANGJIE BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/184610	GALANTAMINE PAMOATE SUSTAINED-RELEASE MICROPARTICLES FOR  INJECTION, AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/196443	LIQUID PREPARATION OF RECOMBINANT HUMANIZED ANTI-PD-1  MONOCLONAL ANTIBODY	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/184611	TABLET OF STEROID CYP17 INHIBITOR SOLID DISPERSION AND  PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/217889	USE OF COMBINATION OF SMALL MOLECULE COMPOUND MLN4924 AND IFNα  IN RESISTING HBV	ZHEJIANG UNIVERSITY
WO/2021/174741	APPLICATION OF DIMETHYL BERBAMINE COMPOUND IN INHIBITION OF  SARS-COV-2	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/253545	CHITOSAN OLIGOSACCHARIDE COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/008501	ENGINEERED VACCINIA VIRUS	SHENZHEN HUA YAO KANG MING BIOPHARMACEUTICAL CO., LTD.
WO/2021/169149	CATALASE NANOPARTICLES AND METHODS FOR USE	VIVIBABA, INC.
WO/2021/098240	USE OF RECOMBINANT SECRETED DDRGK1	SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY  SCHOOL OF MEDICINE
WO/2021/008520	STABLE AST-3424 INJECTION PREPARATION AND PREPARATION METHOD	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/179505	FORSYTHIA SUSPENSA AND ASTRAGALUS MEMBRANACEUS COMPOUND  PREPARATION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	YAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/073178	AVIAN EGG DROP SYNDROME VIRUS TFIBER PROTEIN FRAGMENT, VACCINE  COMPOSITION PREPARED THEREFROM, PREPARATION METHOD, AND APPLICATION	PULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/022984	AZO CALIXARENE PHARMACEUTICAL ADJUVANT AND USE THEREOF	TANGSHAN TIANQUAN TECHNOLOGY CO. LTD.
WO/2021/147272	USE OF BENZOATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONS	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/208280	APPLICATION OF DRIED FLY LARVA IN PREPARATION OF DRUGS FOR  PREVENTING AND TREATING BREAST HYPERPLASIA	HANGZHOU YIKETANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/155654	APPLICATION OF RITONAVIR IN TREATING SARS-COV-2 INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147273	APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF,  TIZOXANIDE, IN TREATMENT OF SARS-COV-2 INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/017833	ANTI-AGING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017834	SKIN COMPOSITION FOR EXTERNAL USE HAVING ANTI-INFLAMMATORY  EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017835	ENHANCED WHITENING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/008565	USE OF ACETYLCHOLINE PATHWAY MODULATORS IN TREATMENT OF CANCER	TSINGHUA UNIVERSITY
WO/2021/031750	MIXED BIRCH SAP AND APPLICATION THEREOF IN SKIN CARE COSMETIC  COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017838	TOPICAL SKIN COMPOSITION WITH ANTI-ECZEMA EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017839	EXTERNAL SKIN COMPOSITION HAVING ANTI-ACNE EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/013028	PHARMACEUTICAL COMBINATION AND USE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/017844	EXTERNAL COMPOSITION FOR SKIN HAVING ENHANCED ANTI-ECZEMA  EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017845	ANTI-HAIR LOSS HAIR GROWTH COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017846	ENHANCED ANTI-AGING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017877	WHITENING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017878	COMPOSITION WITH ACNE REMOVAL EFFECT FOR EXTERNAL APPLICATION  TO SKIN	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/103581	SKIN TOPICAL COMPOSITION HAVING EFFICACY OF PROMOTING WOUND  HEALING AND/OR SCAR REPAIR	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/063076	APPLICATION OF ALBIZIAE CORTEX LIGNAN COMPOUND IN IMPROVING  STEATOSIS	JIANGNAN UNIVERSITY
WO/2021/063078	LIGNAN GLYCOSIDE COMPOUND FROM BARK OF ALBIZIA JULIBRISSIN FOR  PROMOTING ENDOTHELIAL CELL PROLIFERATION AND USE THEREOF	JIANGNAN UNIVERSITY
WO/2021/008600	CATIONIC POLYMER NANOPARTICLE/HIL-22BP GENE COMPOUND FOR  PREVENTING AND TREATING CANCER AND PREPARATION METHOD THEREFOR AND  APPLICATION THEREOF	SICHUAN UNIVERSITY
WO/2021/036572	COMPOSITION FOR PREVENTING OR TREATING URIC ACID-RELATED  DISEASE	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/017910	EXTERNAL SKIN TREATMENT COMPOSITION WITH ENHANCED  ANTI-INFLAMMATORY EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017911	ENHANCED HAIR LOSS PREVENTION AND HAIR GROWTH PROMOTION  COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/008622	APPLICATION OF CARBON-BASED NANOMATERIAL IN PREPARATION OF  DRUG FOR RELIEVING OR TREATING HD	SOOCHOW UNIVERSITY
WO/2021/017912	MOISTURIZING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017913	ENHANCED MOISTURE-RETAINING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/017925	APPLICATION OF RADIX PSEUDOSTELLARIAE CYCLIC PEPTIDE B IN  IMPROVING MEMORY AND/OR PREVENTING AND TREATING ALZHEIMER’S DISEASE	GUANGDONG OCEAN UNIVERSITY
WO/2021/027509	PROTON-TRIGGERING-BASED NANODRUG SYSTEM HAVING  HYDROPHILIC-HYDROPHOBIC-SIZE DOUBLE CONVERSION CHARACTERISTICS AND  PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/212678	ORAL MSCS LIQUID-FILLED CAPSULE FOR TREATING INFLAMMATORY  BOWEL DISEASES AND OTHER INTESTINAL DISEASES	NANJING DRUM TOWER HOSPITAL
WO/2021/208284	METHOD FOR PREPARING ORAL MICROSPHERE LOADED WITH MSCS-DERIVED  EXOSOMES AND APPLICATION THEREOF	NANJING DRUM TOWER HOSPITAL
WO/2021/013204	METHOD FOR TREATING DISEASES BASED ON INTERFERON	XIAMEN AMOYTOP BIOTECH CO., LTD.
WO/2021/013207	MULTIVARIABLE DOSING METHOD FOR USE IN TREATING HIGH-EGFR  EXPRESSION CANCER	SINOCELLTECH LTD
WO/2021/013214	USE OF NEUTROPHILIC GRANULOCYTES IN PREPARATION OF DRUGS FOR  TREATING AND/OR PREVENTING AUTOIMMUNE HEPATITIS	SICHUAN UNIVERSITY
WO/2021/031791	DEXIBUPROFEN FAT EMULSION INJECTION AND PREPARATION METHOD  THEREFOR	SOOCHOW UNIVERSITY
WO/2021/013232	AIE-ACTIVE PHOTOSENSITIZER FOR SELECTIVE BACTERIAL ELIMINATION  AND CANCER CELL ABLATION	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/018026	LIQUID PREPARATION AND APPLICATION THEREOF	ZHANG, Jinyu
WO/2021/018032	PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF  FOR PREVENTING AND/OR TREATING DISEASE	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/018046	SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/013262	NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	BEIJING SHNOGEN PHARMA GROUP LTD
WO/2021/013270	PHARMACEUTICAL COMPOSITION FOR TREATING POLYP	NANJING SANTONG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/143096	WHITENING, ACNE-REMOVING, BLACKHEAD-REMOVING AND ANTI-AGING  COMPOSITION, AND USE AND PREPARATION THEREOF	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/031810	APPLICATION OF PTBP1 INHIBITOR IN PREVENTING AND/OR TREATING  NERVOUS SYSTEM DISEASE RELATED TO FUNCTIONAL NEURONAL DEATH	CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/023069	APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE	SHANGHAI RIXIN BIOTECHNOLOGY CO., LTD.
WO/2021/036654	GRAPHENE ALKALI TARGETING DNA MAJOR GROOVE AND INHIBITING  TOPOISOMERASE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI UNIVERSITY
WO/2021/036656	ODOR-MASKING COMPOSITION, PREPARATION METHOD THEREFOR, AND USE  THEREOF	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/208290	USE OF GPHB5 GLYCOPROTEIN HORMONE IN LOWERING LIPID AND  IMPROVING INSULIN SENSITIVITY	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/093376	USE OF PHOSPHODIESTERASE 5 INHIBITOR IN PREPARATION OF  MEDICAMENT FOR RESISTING FIBROTIC DISEASES	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/184636	SHOUHUI TONGBIAN MICROCAPSULE PREPARATION AND PREPARATION  METHOD THEREFOR	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027576	COMBINATION PRODUCT COMPRISING LIMONOIDS AND SGLT-2 INHIBITORS	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/027577	COMBINATION PRODUCT CONTAINING LIMONOID AND α-GLUCOSIDASE  INHIBITOR	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/189743	APPLICATION OF CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER  FORMULATION IN PREPARING ANTI-CORONAVIRUS DRUG AND PREPARATION METHOD FOR  CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER FORMULATION	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/196469	USE OF PREPARATION FOR REMOVING FOOD RETENTION AND RELIEVING  COUGH IN CHILDREN IN PREPARATION OF DRUG FOR TREATING FEVER SYNDROMES AND  PREPARATION METHOD THEREFOR	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027581	COMBINATION PRODUCT COMPRISING LIMONOID AND DPP-4 INHIBITORS	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/027582	COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND  THIAZOLIDINEDIONE	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/184639	MICROCAPSULE PREPARATION FOR ELIMINATING FOOD STAGNATION AND  RELIEVING COUGHS IN CHILDREN AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/027583	COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND  SULFONYLUREA DRUG	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/018237	DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE  TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/018240	COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A  CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF  DISEASES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/212686	METHOD FOR RHO-ADRP BASED ON GENE EDITING, AND COMPOSITION	CHIGENOVO CO., LTD.
WO/2021/004549	USE FOR DUAL TARGET VASCULAR INHIBITOR IN PREPARING DRUGS FOR  PREVENTING OR TREATING FIBROSIS	BINZHOU MEDICAL UNIVERSITY
WO/2021/068614	APPLICATION OF HONOKIOL AND MAGNOLOL IN PREPARING MCR-1 ENZYME  INHIBITOR	UNIV JILIN
WO/2021/023099	BRUCINE GEL FORMULATION AND PREPARATION METHOD THEREFOR	BEIJING INCREASEPHARM CORPORATION LIMITED
WO/2021/103632	SAFE AND ENVIRONMENTALLY FRIENDLY IRIDESCENT NAIL POLISH	JINHUA KVS CHEMICAL CO., LTD.
WO/2021/208294	APPLICATION OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR  INHIBITING PROLIFERATION IN GLIOMA	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/208295	USE OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR TREATING  LEUKEMIA	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/023108	ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOF	CTTQ-AKESO (SHANGHAI) BIOMED. TECH. CO., LTD.
WO/2021/023118	USE OF 5-METHYLTETRAHYDROFOLIC ACID AND COMPOSITION OF  5-METHYLTETRAHYDROFOLIC ACID	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/139147	BIVALENT ADENOVIRUS VACCINE	GUANGZHOU N BIOMED LTD.
WO/2021/018310	AMINOPYRIDINE DERIVATIVES FOR TREATMENT OF NON-SMALL CELL LUNG  CANCER	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/031839	TARGETED POLYPEPTIDE-MODIFIED DRUG-LOADED LIPOPROTEIN  NANO-DRUG DELIVERY SYSTEM, AND PREPARATION AND APPLICATION THEREOF	SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/023178	USE OF PYRROLO-FUSED SIX-MEMBERED HETEROCYCLIC COMPOUND IN  PREPARATION OF MEDICAMENT FOR TREATING FGFR2 GENE MUTATION TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164210	APPLICATION OF GALLIC ACID DERIVATIVE IN PREVENTION AND  TREATMENT OF ATHEROSCLEROSIS DISEASE	QILU UNIVERSITY OF TECHNOLOGY
WO/2021/023231	PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE  ORAL SOLID TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/023237	METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING  INTESTINAL MICROORGANISMS	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023238	METHOD FOR TREATING ALZHEIMER’S DISEASE BY INHIBITING UPTAKE  OF AMINO ACIDS BY T CELLS	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023239	USE OF MANNURONIC ACID OLIGOSACCHARIDES OR COMPOSITION  COMPRISING SAME IN TREATMENT OF TH1-DOMINANCE RELATED DISEASES	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023240	METHOD FOR IDENTIFYING CARBOHYDRATE DRUG-SENSITIVE PATIENT IN  PATIENTS HAVING ALZHEIMER'S DISEASE	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023241	METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO  ACID LEVEL	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023263	PHARMACEUTICAL COMPOSITION PRODUCING SAFE AMOUNT OF NITRIC  OXIDE IN BODY AND USE THEREOF	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/023264	PHARMACEUTICAL COMPOSITION FOR TREATING AFRICAN SWINE FEVER  AND USE THEREOF	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/189753	PHARMACEUTICAL COMPOSITION FOR STRENGTHENING BODY AND TREATING  LUNG DISEASES AND APPLICATION THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/023267	PREPARATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, AND  PREPARATION METHOD THEREFOR AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/023290	APPLICATION OF ZINC PYRITHIONE IN TREATMENT OF LUNG CANCER	XIAMEN UNIVERSITY
WO/2021/023291	USE OF PROFLAVINE IN TREATMENT OF LUNG CANCERS	XIAMEN UNIVERSITY
WO/2021/027704	APPLICATION OF POLYPEPTIDE OR DERIVATIVE THEREOF	CHENGDU HUITAI BIOMEDICINE CO., LTD.
WO/2021/036752	HYPOXIC-TUMOR-TARGETING SHORT-CHAIN POLYPEPTIDE MICROMOLECULE  SELF-ASSEMBLY NANOMETER MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/077856	SIRNA AND NANO DELIVERY SYSTEM CAPABLE OF SILENCING PCSK9  PROTEIN, AND APPLICATION OF NANO DELIVERY SYSTEM	GUANGZHOU MEDICAL UNIVERSITY
WO/2021/031893	PROSTATITIS TREATMENT	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/248674	ANTIBACTERIAL NANOZYME AND PREPARATION METHOD THEREFOR	QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088446	METHOD FOR STAGGERED POWERING-ON OF SERVER HARD DISKS, DEVICE,  AND MEDIUM	CHENGDU QINGZHIXIN BIOTECHNOLOGY CO., LTD
WO/2021/212700	PHARMACEUTICAL COMPOSITION FOR IMPROVING MOTION SICKNESS OF  PETS, PREPARATION METHOD THEREFOR AND USE METHOD THEREOF	JIANGSU NANJING AGRICULTURAL UNIVERSITY ANIMAL PHARMACEUTICAL  CO., LTD
WO/2021/036793	PYROPTOSIS-INDUCED IMMUNOTHERAPY	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/036803	USE OF LONG-ACTING PROTEIN PREPARATION FOR IMPROVING SEXUAL  DYSFUNCTION	XINTRUM PHARMACEUTICALS, LTD.
WO/2021/027912	CHIDAMIDE-CONTAINING ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND  USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/031991	COMPOSITION AND METHOD FOR TREATING HORMONE-DEPENDENT DISEASES  AND REDUCING DRUG TOLERANCE OF PATIENTS WITH HORMONE-DEPENDENT DISEASES	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/169194	APPLICATION OF TETRAHYDROPALMATINE IN PREPARATION OF DRUGS  AGAINST OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY	ZHEJIANG UNIVERSITY
WO/2021/027971	FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD  THEREFOR AND USE THEREOF	SHANGHAI SEME CELL TECHNOLOGY CO., LTD
WO/2021/203605	COMPOUND AMINO ACID INJECTION FOR LIVESTOCK AND PREPARATION  METHOD THEREFOR	HEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/032073	IN-SITU GEL CONTAINING CYCLOSPORINE MICELLES AS SUSTAINED  OPHTHALMIC DRUG DELIVERY SYSTEM	IVIEW THERAPEUTICS (ZHUHAI) CO., LTD.
WO/2021/032078	NOVEL ANTI-SIRPA ANTIBODIES	ELPISCIENCE (SUZHOU) BIOPHARMA, LTD.
WO/2021/203606	PREPARATION METHOD FOR COMPOUND AMINO ACID INJECTION FOR  LIVESTOCK	HEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/203607	METHOD FOR PREPARING COMPOUND AMINO ACID INJECTION FOR  LIVESTOCK	HEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/248688	APPLICATION OF ITPP IN PREPARATION OF DRUGS FOR PREVENTING  AND/OR TREATING HYPOXIC-ISCHEMIC INJURY AND LUNG INJURY	SYMEPILIN PHARMACEUTICALS CO., LTD.
WO/2021/036884	APPLICATION OF HERNANDEZINE OR PHARMACEUTICALLY ACCEPTABLE  SALT THEREOF IN DRUGS FOR DIABETES OR DIABETIC COMPLICATIONS	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/032128	APPLICATION OF FLUORO-SUBSTITUTED 2-AMINOTHIAZOLE-5-AROMATIC  CARBOXAMIDE	HUNAN WARRANT PHARMACEUTICAL CO., LTD
WO/2021/073249	USE OF β-NMN IN PREPARATION OF DRUG FOR TREATING AND  PREVENTING SEPSIS-INDUCED ORGAN DAMAGE	SOOCHOW UNIVERSITY
WO/2021/036896	PLANT EXTRACTION METHOD	BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD
WO/2021/196505	USES OF CYCLOCARYA PALIURUS LEAF FLAVONE EXTRACT IN  PREPARATION OF ANTIBACTERIAL MEDICAMENTS AND/OR ANTIBACTERIAL AGENTS	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/032179	APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING  INFECTION ASSOCIATED WITH BURN OR SCALD INJURY	SICHUAN UNIVERSITY
WO/2021/036922	COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK	BEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/036923	SILVER-/GOLD-COMPOUNDS AND METHODS THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/103679	LIPODISSOLVE	SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSTIY  SCHOOL OF MEDICINE
WO/2021/036937	APPLICATION OF PDE3 INHIBITOR AND CYTOKINE IN TREATMENT OF  TUMOR	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/036975	PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/032212	ANTI-AGING MEDICINE D/A TARGETING AGING CELLS IN TISSUE  MICROENVIRONMENT AND USE THEREOF	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/032213	ANTI-AGING MEDICINE D/S TARGETING AGING CELLS IN TISSUE  MICROENVIRONMENT AND USE THEREOF	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/077889	PARACETAMOL SUSTAINED-RELEASE PREPARATION AND 3D PRINTING  PREPARATION METHOD THEREFOR	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/037013	NOVEL APPLICATION OF PHENOTHIAZINES OR COMPOUND HAVING SIMILAR  STRUCTURE IN PHARMACEUTICS	GUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD.
WO/2021/037077	PATENTIFLORIN A ANALOGS AS ANTIVIRAL AGENTS	HONG KONG BAPTIST UNIVERSITY
WO/2021/037091	CHIDAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/082683	USE OF TRAMETINIB IN PREPARATION OF MEDICINE FOR PREVENTING  AND/OR TREATING NON-ALCOHOLIC HEPATITIS AND/OR NON-ALCOHOLIC FATTY LIVER  DISEASE	BEIJING GIGACEUTICALS TECH. CO., LTD
WO/2021/037122	STABLE GEL COMPOSITION HAVING HIGH OIL CONTENT, AND  PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SIRIO PHARMA CO., LTD.
WO/2021/037128	CHIDAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION AND USE  THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/223346	APPLICATION OF YAM PROTEIN EXTRACT IN PREPARATION OF  MEDICATION FOR TREATING ERECTILE DYSFUNCTION	ZHAO, Daqing
WO/2021/037188	PHARMACEUTICAL USE OF PYRIMIDO[5,4-B]PYRROLIZINE COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/057380	COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKIN  CARE PRODUCTS FOR REGULATING SKIN BIORHYTHM	HUNAN YUJIA COSMETICS MANUFACTURING CO., LTD
WO/2021/037199	TRANSDERMAL AMIDE LOCAL ANESTHETIC-CONTAINING PHARMACEUTICAL  COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/217982	FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN AND VACCINE  COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF VACCINE  COMPOSITION	PULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/037212	COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF  COMPOSITION	INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/037230	USE OF ANNEXIN A5	SUZHOU YABAO PHARMACEUTICAL R&D CO., LTD.
WO/2021/128919	APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER  IMMUNE DYSREGULATION DISEASES	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/037244	PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/052153	APPLICATION OF CYCLIC ADENOSINE MONOPHOSPHATE, DERIVATIVES  THEREOF OR PRODRUGS THEREOF IN PREPARATION OF DRUGS FOR PREVENTING AND/OR  TREATING DEPRESSIVE DISORDER	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/203614	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CORONAVIRUS  DISEASES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/057391	COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKINCARE  PRODUCTS FOR NIGHT OWLS	HUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/037265	SIRNA CAPABLE OF INHIBITING EXPRESSION OF MCM7 GENE,  COMPOSITION, AND APPLICATION THEREOF	ENZHI (GUANGZHOU) PHARMACEUTICALS, LTD.
WO/2021/253643	APPLICATION OF SULPHATED POLYSACCHARIDES AGAINST NOVEL  CORONAVIRUS	DALIAN POLYTECHNIC UNIVERSITY
WO/2021/043120	COMPOUND AMINO ACID DIPEPTIDE INJECTION AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	ZHONGSHAN HOSPITAL, FUDAN UNIVERSITY
WO/2021/232614	CHITOOLIGOSACCHARIDE ORAL LIQUID AND APPLICATION THEREFOR IN  PREPARATION OF WEIGHT LOSS DRUGS	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/043145	CATIONIC NANODRUG, PREPARATION METHOD THEREFOR, AND  DRUG-LOADED IMPLANTABLE MEDICAL DEVICE	SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
WO/2021/093425	ROOT OF MEMBRANOUS MILKVETCH-PAECILOMYCES CICADAE FERMENTATIVE  BACTERIUM FERMENTATION SUBSTANCE AND APPLICATION THEREOF	BINZHOU MEDICAL UNIVERSITY
WO/2021/047437	PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL INFLUENZA AND  PREPARATION THEREOF	GUANGDONG RAYNOVENT BIOTECH CO., LTD.
WO/2021/043196	USE OF 5-METHYLTETRAHYDROFOLATE	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/212721	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DISPELLING  DAMPNESS AND CLEARING LUNG AND APPLICATION THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208334	QI-TONIFYING, DAMPNESS-ELIMINATING AND SORE-THROAT-RELIEVING  DIETARY THERAPY FORMULA, AND PREDATION METHOD THEREFOR AND APPLICATION  THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208335	TRADITIONAL CHINESE MEDICINE COMPOSITION CAPABLE OF REMOVING  TOXINS, DISPELLING DAMPNESS, AND DISINHIBITING THROAT, AND APPLICATION  THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208336	TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/043227	COATED GRANULE, SOLID DISPERSION, AND PREPARATION CONTAINING  VORTIOXETINE HYDROBROMIDE FOR ORAL TASTE MASKING	SEASONS BIOTECHNOLOGY (TAIZHOU) CO., LTD.
WO/2021/043231	DUAL-TARGETING MATERIAL AND USE THEREOF IN DRUG DELIVERY	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/043234	USE OF BERBAMINE OR ITS ANALOGUE FOR PREVENTING OR TREATING  RNA VIRUS INFECTION	CITY UNIVERSITY OF HONG KONG
WO/2021/253647	USE OF SMALL MOLECULE INHIBITOR IN TREATMENT OF RESPIRATORY  VIRAL PNEUMONIA	INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/047451	DNA NANOVACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/047464	USE OF 4-[9-(6-AMINOPURINYL)]-2(S)-HYDROXYMETHYL BUTYRATE FOR  PREPARING OPHTHALMIC PREPARATIONS	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/184699	MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION AND  PREPARATION METHOD THEREFOR	SHIJIAZHUANG NO. 4 PHARMACEUTICAL CO., LTD
WO/2021/139193	SUSTAINED-RELEASE LONG-LASTING ANTIBACTERIAL HAND SANITIZER  AND PREPARATION METHOD THEREFOR	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/139194	NANO-SCALE PLANT ANTIBACTERIAL AGENT FOR HAND SANITIZER AND  PREPARATION METHOD THEREFOR	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/047573	USE OF MEK INHIBITOR IN COMBINATION WITH CDK4/6 INHIBITOR IN  PREPARATION OF DRUGS FOR TREATING TUMORS	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/159704	17β-ESTRADIOL AND VITAMIN C MOLECULAR COMPLEX, PREPARATION  METHOD THEREFOR AND APPLICATION THEREOF	ZHEJIANG MEDICINE CO., LTD.XINCHANG PHARMACEUTICAL FACTORY
WO/2021/047607	APPLICATION OF NON-IGF1R-BINDING SUBSTANCE IN PREVENTION  AND/OR TREATMENT OF INFLAMMATORY DISEASES	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/047623	TREATMENT OF CANCER USING A COMBINATION COMPRISING  MULTI-TYROSINE KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR	BEIGENE, LTD.
WO/2021/047629	COMPOSITION FOR LIGHTENING SPOTS, MICRONEEDLE PATCH COMPRISING  COMPOSITION, AND PREPARATION METHOD THEREFOR	BEIJING CAS MICRONEEDLE TECHNOLOGY LTD.
WO/2021/052269	WATER-SOLUBLE COMPOSITION, PREPARATION METHOD AND APPLICATION  THEREOF	GUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052274	CEFUROXIME AXETIL PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFOR	SINOPHARM ZHIJUN (SHENZHEN) PHARMACEUTICAL CO., LTD
WO/2021/052305	USE OF EIGHT-TREASURE PILL IN PREPARATION OF MEDICINE FOR  PREVENTING OR TREATING DISEASES RELATED TO IL-6 INFLAMMATORY CYTOKINE STORM	XIAMEN TRADITIONAL CHINESE MEDICINE CO., LTD.
WO/2021/052386	COMBINATION OF SMALL MOLECULE INHIBITOR OF THE PD-1/PD-L1  INTERACTION AND ANTI-PD-1 ANTIBODY FOR TREATING CANCER	GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/052398	GEL COMPOSITION WITH HIGH OIL CONTENT, THE PREPARATION METHOD  AND THE USE OF THE SAME	BASF SE
WO/2021/227326	COMPOSITIONS AND METHODS FOR TREATING CANCER	ADAGENE AG
WO/2021/057599	APPLICATION OF PIRFENIDONE IN PREPARING MEDICAMENT FOR  PREVENTING AND TREATING RHEUMATOID ARTHRITIS	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/052440	USE OF CHIGLITAZAR AND DERIVATIVES THEREOF IN TREATING TYPE 2  DIABETES ACCOMPANIED BY ABNORMAL LIPIDS METABOLISM	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/052441	USES OF COMPLEX OF ANGIOTENSIN II RECEPTOR ANTAGONIST  METABOLITE AND NEP INHIBITOR IN TREATING HEART FAILURE	SHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/218004	APPLICATION OF PRUSSIAN BLUE NANOPARTICLES IN PREPARATION OF  DRUG FOR PREVENTING, DELAYING OR TREATING NERVOUS SYSTEM DEGENERATIVE DISEASE	TIANJIN UNIVERSITY
WO/2021/043319	TRANSDERMAL PENETRATION ENHANCING COMPOSITION AND APPLICATION  THEREOF IN TIMOLOL PREPARATION	WUHAN CONFORM PHARMACEUTICAL CO., LTD.
WO/2021/052450	REVERSED PHASE CHROMATOGRAPHY ISOLATION OF ACTIVE COMPONENT IN  AMNIOTIC FLUID OF NON-HUMAN ANIMAL	ZHEJIANG HYGEIANCELLS BIOMEDICAL CO. LTD
WO/2021/258565	APPLICATION OF CARNOSIC ACID IN PREPARATION OF ANTI-PHOTOAGING  PRODUCTS	CENTRAL SOUTH UNIVERSITY
WO/2021/103777	SPRAYING AGENT FOR PREVENTING AND TREATING ALLERGIC ASTHMA  COMBINED WITH ALLERGIC RHINITIS IN CHILDREN AND TEENAGERS	LEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/052496	IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY  CYTOKINES	CARSGEN THERAPEUTICS CO., LTD.
WO/2021/057661	PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD SUGAR	SHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/057680	APPLICATION OF 2,4-DIHYDROXYBENZOIC ACID OR ISOMER THEREOF IN  RELATED DISEASES OR CONDITIONS CAUSED BY IRON OVERLOAD	ZHANG, Jianguo
WO/2021/057694	LOW-CONTENT FLURBIPROFEN AXETIL PHARMACEUTICAL COMPOSITION,  AND APPLICATION THEREOF	BEIJING PODCONLEY MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/128995	WHITENING AND MOISTURIZING HAND MASK AND PREPARATION METHOD  THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128996	NATURAL PLANT BACTERIOSTATIC OINTMENT CONTAINING ARTEMISIA  ARGYI EXTRACT AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128997	NATURAL PLANT EYE SPRAY AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/179567	CHINESE MUGWORT LEAF COMPOSITE ESSENTIAL OIL FOR RELIEVING  SORE THROAT AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/057721	SPECIFIC ANTIDOTAL DRUG FOR TREATING PARAQUAT ACUTE POISONING	ENVIRONMENT AND PLANT PROTECTION INSTITUTE, CHINESE ACADEMY OF  TROPICAL AGRICULTURAL SCIENCES
WO/2021/018318	PHARMACEUTICAL COMPOSITION CONTAINING CHIDAMIDE AND SURFACTANT	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/057764	USE OF PD-1 ANTIBODY IN COMBINATION WITH TAXOID COMPOUND IN  PREPARATION OF DRUGS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/057881	OSELTAMIVIR PREPARATION	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/169273	USE OF ALBIFLORIN IN TREATMENT OF CORONAVIRUS PNEUMONIA	ZHANG, Zuoguang
WO/2021/057906	IMMUNE EFFECTOR CELL EXPRESSING IL-15	CARSGEN THERAPEUTICS CO., LTD.
WO/2021/057942	GENE-ENGINEERED MESENCHYMAL STEM CELLS AND APPLICATIONS  THEREOF	CHINA MEDICAL UNIVERSITY
WO/2021/057955	METHOD FOR TREATING MOOD DISORDERS	JIANGSU NUO-BETA PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/077990	USE OF VITAMIN E COMPOUND	HUIYU HEALTH (HANGZHOU) PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/058005	PHARMACEUTICAL COMPOSITION CONTAINING HUMANIZED ANTI-HUMAN  IL-17A MONOCLONAL ANTIBODY	HUABO BIOPHARM (SHANGHAI) CO., LTD.
WO/2021/058014	ORNIDAZOLE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD  AND USE THEREOF	YANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING  PHARMACEUTICAL CO., LTD.
WO/2021/063331	USE OF COMBINATION OF EZH2 INHIBITOR AND TGF-β  RECEPTOR-CONTAINING FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING  TUMORS	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/063332	USE OF EZH2 INHIBITOR COMBINED WITH CDK4/6 INHIBITOR IN  PREPARATION OF DRUG FOR TREATING TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/058021	DRUG COMBINATION CONTAINING TLR7 AGONIST	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/063340	USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR AND TYROSINE KINASE INHIBITOR IN PREPARATION OF MEDICATION FOR  TREATING TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/253681	FAVIPIRAVIR COMPOSITION AND PREPARATION METHOD THEREOF	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/068802	APPLICATION OF NADH AND SALT AND/OR NMN THEREOF IN PREPARATION  OF DRUG OR HEALTH CARE PRODUCT FOR ENHANCING MUSCLE OR INHIBITING MUSCLE  VOLUME REDUCTION	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/073426	APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF SKIN  PIGMENT INHIBITOR	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/078000	APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF DRUGS  OR HEALTH FOOD FOR PREVENTING AND TREATING PHARYNGITIS	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/109704	CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF	LO, Hsu En
WO/2021/063366	DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143208	METHOD FOR PREPARING HAND WASH HAVING ULTRA-STRONG  DECONTAMINATION EFFECT	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/143209	METHOD FOR PREPARING HAND SANITIZER SUITABLE FOR INFANT SKIN	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/063376	UV LIGHT-RESPONSIVE HYPERBRANCHED POLY-β-AMINO ESTER HAVING  HIGH-EFFICIENCY GENE DELIVERY ABILITY AND PREPARATION METHOD AND APPLICATION  THEREOF	SOOCHOW UNIVERSITY
WO/2021/063378	ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO  ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/063384	DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND  NEUTRAL AMINO ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/103816	USE OF UTERINE CAVITY FLUID-DERIVED EXOSOME IN PREPARATION OF  THERAPEUTIC DRUGS AND ADJUVANT THERAPEUTIC AGENTS FOR TREATING  INFERTILITY-RELATED DISEASES	PHARCHOICE THERAPEUTICS INC
WO/2021/063387	USE OF COMPOSITION OF IMATINIB AND DERIVATIVE THEREOF IN  PREPARATION OF DRUG FOR PREVENTING, TREATING AND CONTROLLING ADDICTION  RELAPSE	WUHAN UNIVERSITY
WO/2021/063391	CORNU GORAIS KERATIN, PREPARATION METHOD THEREFOR,  PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/063408	PREPARATION OF DRUG FOR TREATING ALZHEIMER'S DISEASE	PLANTARX LIMITED
WO/2021/063414	USE OF VALERIC ACID DERIVATIVE IN TREATMENT OF DOWN'S SYNDROME	XIAMEN UNIVERSITY
WO/2021/068868	COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATION	COTHERA BIOSCIENCE, INC.
WO/2021/218039	BIOMIMETIC AND CAMELLIA EXTRACT-CONTAINING SKIN BARRIER REPAIR  COMPOSITION AND APPLICATION THEREOF	SHANGHAI FOREST CABIN BIOLOGICAL-TECH CO., LTD.
WO/2021/088585	PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND  APPLICATION THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/068879	ANTIBODY COMPLEX MODIFIED BY TARGETED FUNCTIONAL MOLECULE,  COMPOSITION AND USE THEREOF	FUDAN UNIVERSITY
WO/2021/027977	USE FOR ULVA POLYSACCHARIDE IN SUPPRESSING β-AMYLOID PROTEIN  AGGREGATION	TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/068890	LYSOSOME-TARGETING ANTIBODY-DRUG CONJUGATE AND APPLICATION  THEREOF	SUN YAT-SEN UNIVERSITY
WO/2021/082882	METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF  LIVING CELL	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068909	AMERICAN COCKROACH EXTRACT, PREPARATION THEREOF, PREPARATION  METHODS THEREFOR AND APPLICATIONS THEREOF	LIANGSHAN JIANENGDA BIOMATERIALS BREEDING CO., LTD.
WO/2021/203648	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING  GINGIVAL ATROPHY AND/OR TREATING GINGIVITIS	SICHUAN GREEN HERB TECHNOLOGY DEVELOPMENT CO., LTD
WO/2021/068951	MEDICAL USE OF BENZENESULFONAMIDE COMPOUND AND PHARMACEUTICAL  COMPOSITION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068957	TREATMENT AND PREVENTION OF NEPHROTOXIN-INDUCED KIDNEY  INJURIES	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/082889	ENVIRONMENTALLY-FRIENDLY METHOD OF PREPARING COMPOSITION  CONTAINING ANTI-INFLAMMATORY ACTIVE INGREDIENT AND APPLICATION THEREOF	SHANGHAI JAKA BIOTECH CO., LTD.
WO/2021/068961	INHALATION SOLUTION PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFOR	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/068971	ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY  FOR TREATMENT OF CD20 POSITIVE DISEASES	BIO-THERA SOLUTIONS, LTD.
WO/2021/073518	USE OF INHIBITOR OF PLASMIN INHIBITORY FACTOR FOR PREVENTING  OR TREATING PRE-ECLAMPSIA OR ECLAMPSIA	INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/073535	METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH  ADMINISTRATION OF VEGFR AND/OR VEGF INHIBITOR	ONQUALITY PHARMACEUTICALS CHINA LTD.
WO/2021/073547	APPLICATION OF BORTEZOMIB IN PREPARATION OF DRUGS FOR  TREATMENT OF OSTEOSARCOMA	XI'AN JIAOTONG UNIVERSITY
WO/2021/073548	PHARMACEUTICAL COMPOSITION	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/073563	COMPOSITION AND METHOD FOR TREATMENT OF DIABETES	SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/103833	MOLECULARLY IMPRINTED POLYMERS FOR SEQUESTERING ACETATE AND  OTHER MOLECULES	CLAVES LIFE SCIENCES LIMITED
WO/2021/073586	DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE  THEREOF	BLUELIGHT PHARMATECH CO ., LTD
WO/2021/073610	METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW  HEMATOPOIETIC FUNCTIONS	SUN YAT-SEN UNIVERSITY
WO/2021/073620	USE OF ACELLULAR ADIPOSE TISSUE EXTRACT IN PROMOTING HAIR  GROWTH AND RETENTION	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/232667	STARCH-BASED COLON-TARGETING CONTROLLED-RELEASE CRYSTAL  INCLUSION COMPLEX AND PREPARATION METHOD THEREFOR	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/078087	TRADITIONAL CHINESE MEDICINE PILL REALIZING TARGETED RELEASE,  AND PREPARATION METHOD THEREFOR	RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD.
WO/2021/073643	DRUG FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135520	SUNFLOWER SEED COMPOSITION RICH IN PLEASANT HORMONE PRECURSOR  AND ANTIDEPRESSANT USE THEREOF	CHACHA FOOD CO., LTD.
WO/2021/078110	DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL  SYNDROME	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/078126	METHOD FOR TREATING CANCERS	ACURA NANOMEDICINE CORPORATION
WO/2021/174868	CHLORIN NANOMETER PHOTOSENSITIZER, AND PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/143243	USE OF IGF1 IN COMBINATION WITH IGF1EC24 IN PREPARATION OF  MEDICINE FOR PROMOTING TISSUE REPAIR AND REGENERATION	CHONGQING UNIVERSITY
WO/2021/088645	CRYSTAL FORM OF APROCITENTAN, PREPARATION METHOD THEREFOR AND  USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/243925	APPLICATION OF ZIF-8 NANO MATERIAL IN DEGRADATION OF  BROAD-SPECTRUM MUTANT P53 PROTEIN	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/179616	NOVEL USE OF XIAOCHAIHU GRANULES IN COMBINATION WITH  CHLOROQUINE PHOSPHATE	GUANGZHOU BAIYUNSHAN GUANGHUA PHARMACEUTICAL CO., LTD
WO/2021/078246	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS,  KIT, USE THEREOF AND TREATMENT METHOD THEREOF	SHENZHEN MYTANG BIOTECHNOLOGY CO., LTD.
WO/2021/093553	NOVEL THERAPEUTIC DRUG FOR ISCHEMIC BRAIN DAMAGE	CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE  TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/078252	USE OF LIRIODENDRON CHINENSE (HEMSL.) SARG OR EXTRACT THEREOF  IN PREPARATION OF MEDICINE FOR REDUCING SERUM URIC ACID LEVEL AND PREVENTING  AND TREATING URIC ACID NEPHROPATHY	SICHUAN CREATION PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/078288	ACTIVATED INSULIN, COMPOUND MOMORDICA CHARANTIA PEPTIDE ORAL  MEDICINE FOR TREATMENT OF DIABETES, AND PREPARATION METHOD	LI, Yubao
WO/2021/078295	BOTANICAL MEDICINE FOR TREATING HYPERLIPIDEMIA AND CORONARY  HEART DISEASE AND METHOD FOR PREPARATION THEREOF	GUOZHONGXINGHE BIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/058038	USE OF CD200 PROTEIN AND CD200 FUSION PROTEIN IN PREPARING A  DRUG FOR TREATING PSORIASIS	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/088672	COMPOSITION CONTAINING LEGOAMODIPINE BESYLATE HYDRATE AND  PREPARATION METHOD THEREFOR	SHIHUIDA PHARMACEUTICALS GROUP (JILIN) LTD.
WO/2021/078301	PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF  DISEASES	SHANGHAITECH UNIVERSITY
WO/2021/083089	PHARMACEUTICAL COMPOSITION CONTAINING ALGINATE OLIGOSACCHARIDE  DIACID	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/258590	APPLICATION OF β-GLUCAN AS ADHESIVE IN PREPARATION OF TABLET  OR GRANULE	YICHUN WANSHEN PHARMACEUTICAL MACHINERY CO. LTD
WO/2021/114909	PHOTODYNAMIC THERAPY SYSTEM, PREPARATION METHOD THEREFOR, AND  USE THEREOF IN PHOTODYNAMIC THERAPY	SHENZHEN HANGUANG TECHNOLOGY CO., LTD.
WO/2021/169345	METHOD AND APPLICATION FOR IMPROVING MITOCHONDRIAL FUNCTION OF  PERIPHERAL BLOOD MONONUCLEAR CELLS	INSTITUTE OF ENVIRONMENTAL AND OPERATIONAL MEDICINE, ACADEMY  OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY SCIENCE
WO/2021/184762	GOLD CLUSTERS (AuCs), COMPOSITION AND METHOD FOR TREATMENT OF  LIVER CIRRHOSIS	WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/243932	USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING  INFLAMMATORY BOWEL DISEASE	JIANGSU TARGET BIOMEDICAL RESEARCH INSTITUTE CO. , LTD.
WO/2021/083290	RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR  COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF RSV DISEASES  USING THE SAME	SHANGHAI ARK BIOPHARMACEUTICAL CO. LTD.
WO/2021/083306	GLP-1/GCG DUAL-ACCEPTOR AGONIST POLYPEPTIDE	DONGGUAN HEC BIOPHARMACEUTICAL R&D CO., LTD.
WO/2021/083315	ORALLY ADMINISTERED SOLID DOSAGE FORM DRUG	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/083336	USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF  GPR39 AGONIST	PEKING UNIVERSITY
WO/2021/083346	PHARMACEUTICAL COMPOSITION COMPRISING QUINAZOLINE DERIVATIVE  OR SALT THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/088739	METHOD AND DEVICE FOR DETERMINING INTESTINAL PROBIOTIC  SUPPLEMENT FORMULA, STORAGE MEDIUM, AND PROCESSOR	SHENZHEN DIGITAL LIFE INSTITUTE
WO/2021/083370	PREPARATION AND USE OF NANOMATERIAL SPECIFICALLY ACTIVATING  IMMUNE SYSTEM	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/083372	SOLID COMPOSITION CONTAINING ANGIOTENSIN II, PREPARATION  METHOD AND USE METHOD THEREFOR AND USE THEREOF	NANJING HAIWEI PHARMACEUTICAL TECHNOLOGIES CO., LTD.
WO/2021/109771	METHOD FOR PREPARING MICROPOWDER MIXTURE OF ACTIVE  PHARMACEUTICAL INGREDIENTS OF GLYCOPYRRONIUM BROMIDE AND INDACATEROL	CF PHARMTECH, INC.
WO/2021/129160	NANOCONJUGATE OF PEGYLATED ICD INDUCER-IDO INHIBITOR,  PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/208410	SKIN WHITENING, FIRMING AND MOISTURIZING FACE CREAM AND  PREPARATION METHOD THEREFOR	YUHUAN ZITI COSMETICS CO., LTD.
WO/2021/208411	WHITENING MOISTURIZING FACE MASK IN FORM OF PASTE, AND  PREPARATION METHOD THEREFOR	YUHUAN ZITI COSMETICS CO., LTD.
WO/2021/093632	ACTIVE ESSENCE COMPOUNDED WITH POSTBIOTICS AND PREPARATION  METHOD	BIO-RACE BIOTECH HANGZHOU CO., LTD.
WO/2021/129166	APPLICATION OF MONASCINOL IN PREPARATION OF FAT-REDUCING  PRODUCT	TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088846	FGFR4/PD-1 COMBINATION TREATMENTS	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/088853	DRUG COMBINATION OF QUINOLINE DERIVATIVE AND PD-1 MONOCLONAL  ANTIBODY	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/174894	NANOBOWL-SUPPORTED DRUG-LOADED LIPOSOME, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/088927	ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2	LANOVA MEDICINES LIMITED COMPANY
WO/2021/088957	AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOF	GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD
WO/2021/109796	ANTI-TUMOR DRUG SENSITIZER EMPLOYING  5-CARBOXY-8-HYDROXYQUINOLINE, AND APPLICATION THEREOF	ZHEJIANG UNIVERSITY
WO/2021/088975	USE OF COMPOUND IN PREVENTING OR TREATING GRAFT VERSUS HOST  DISEASE	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/088983	7,8-DIHYDROXYFLAVONE COMPOSITE NANO-BIOMATERIAL WITH HIGH  BIOAVAILABILITY, PREPARATION METHOD, AND APPLICATION THEREOF	HANGZHOU U-MATE TECHNOLOGY CO., LTD.
WO/2021/089005	USE OF FGFR INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/089038	USE OF MULTI-TARGET PROTEIN KINASE INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/143313	ACTIVE GENE MODIFIED PORCINE SKIN FOR COVERING AND REPAIRING  HUMAN SKIN WOUNDS AND USE THEREOF	GENEO MEDICINE CO., LTD.
WO/2021/089053	NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION,  AND PREPARATION AND USE THEREOF	SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/227405	ETAMSYLATE INJECTION AND PREPARATION METHOD THEREFOR	SHANDONG FANGMING PHARMACEUTICAL GROUP CO., LTD
WO/2021/135654	USE OF DISULFIRAM IN PREPARATION OF MEDICAMENT FOR PREVENTION  AND TREATMENT OF DISEASES RELATED TO NLRP3 INFLAMMASOME	GUANGZHOU MEDICAL UNIVERSITY
WO/2021/098557	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  PSORIASIS, PREPARATION METHOD THEREFOR AND USE THEREOF	TASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/258614	VAGINAL GEL PREPARATION AND PREPARATION METHOD THEREFOR	ZHUHAI SHU TONG MEDICAL TECHNOLOGY CO., LTD.
WO/2021/093764	PHARMACEUTICAL COMBINATION AND USE THEREOF	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/109823	CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING  SAME	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/135665	APPLICATION OF TETRAHYDROCANNABIVARIN IN PREVENTION AND/OR  TREATMENT OF PULMONARY ARTERIAL HYPERTENSION	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/104034	USE OF 4-HYDROXYBENZALDEHYDE IN TREATING INFLAMMATORY BOWEL  DISEASE	MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT  CENTER
WO/2021/120937	APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING  DROP	TONGYAN (SHANGHAI) MEDICAL DEVICE CO., LTD.
WO/2021/196628	NATURAL EDIBLE SHAMPOO AND PREPARATION METHOD THEREFOR	NINGBO YUFANGTANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/098606	LIPID NANO DRUG DELIVERY SYSTEM TARGETING BRAIN LESION AND  PREPARATION METHOD AND APPLICATION THEREOF	SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/135682	MICROBUBBLE DISPERSION SYSTEM USED FOR EFFICIENTLY SUPPLYING  OXYGEN TO VEINS AND STABILIZED BY POLYDOPAMINE NANOPARTICLES AND PREPARATION  METHOD FOR MICROBUBBLE DISPERSION SYSTEM	ZHEJIANG UNIVERSITY
WO/2021/223397	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL  CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF	BEIJING HANDIAN PHARMACEUTICAL CO., LTD.
WO/2021/093864	USE OF HETEROLOGOUS TISSUE CELL COMPOSITION FOR TREATING  CANCERS	CHINA MEDICAL UNIVERSITY
WO/2021/098621	IMMUNOADJUVANT-ENCAPSULATED NANOPARTICLE AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/093881	COMPOSITION FOR REGULATING IMMUNE RESPONSE IN ACIDIC  ENVIRONMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/104086	METHOD FOR OVERCOMING TUMOR DRUG RESISTANCE	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104088	NANOPARTICLE DRUG DELIVERY SYSTEM, PREPARATION METHOD THEREFOR  AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/203701	APPLICATION OF SOFOSBUVIR IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING CORONAVIRUS	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203702	USE OF PYROGLUTAMIC ACID IN PREPARATION OF DRUGS FOR  PREVENTING AND TREATING NOVEL CORONAVIRUS OF NOVEL CORONAVIRUS PNEUMONIA	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203703	USE OF CARGLUMIC ACID IN PREPARATION OF DRUGS FOR PREVENTING  AND TREATING CORONAVIRUSES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203704	USE OF BACITRACIN A IN PREPARATION OF DRUGS FOR PREVENTING AND  TREATING CORONAVIRUSES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/203706	USE OF FOSCARNET SODIUM IN PREPARATION OF MEDICINES FOR  PREVENTING AND TREATING CORONAVIRUSES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF  SCIENCES
WO/2021/098679	USE OF FAK INHIBITOR IN PREPARATION OF DRUG FOR TREATING  TUMORS HAVING NRAS MUTATION	INXMED (NANJING) CO., LTD.
WO/2021/164344	TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF IN  PREVENTION AND TREATMENT OF VIRAL PNEUMONIA	GUANGZHOU EIGHTH PEOPLE'S HOSPITAL
WO/2021/227417	METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY	TALENGEN INTERNATIONAL LIMITED
WO/2021/098686	PREPARATION METHOD FOR THERAPEUTIC DRUG DELIVERY SYSTEM  CAPABLE OF CROSSING BLOOD-BRAIN BARRIER AND SPECIFICALLY TARGETING GLIOMA	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098688	LIVING ORGANISM OXYGEN SELF-PRODUCING PHOTOSENSITIZER AND USE  THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104112	NOVEL METHOD FOR IMPROVING TUMOR HYPOXIA	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/115070	INDOCYANINE GREEN LIPOSOME FOR NEAR-INFRARED REGION II  FLUORESCENCE DETECTION, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098692	APPLICATION OF CHERRY PLUM PRODUCT IN INHIBITING THROMBOSIS	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO.,  LTD.
WO/2021/104120	POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD  THERFOR AND USE THEREOF	CHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/120966	SHEEP HORN KERATIN, PREPARATION METHOD THEREFOR,  PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/098755	NEW APPLICATION OF BIFIDOBACTERIUM LACTIS BL-99 IN INHIBITING  INTESTINAL INFLAMMATION	INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/196654	USE OF GLYCOSYL POLYETHER COMPOUND IN PREPARATION OF ANTI-RNA  VIRUS DRUGS	WUHAN UNIVERSITY
WO/2021/184807	COPPER CLUSTERS, COMPOSITION, AND METHOD FOR TREATMENT OF  LIVER CIRRHOSIS	WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/098769	TREATMENT OF CANCER WITH ANTI-OX40 ANTIBODIES AND MULTI-KINASE  INHIBITORS	BEIGENE, LTD.
WO/2021/098771	TREATMENT METHOD WITH IAP INHIBITOR	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/120972	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  DEFICIENCY OF BOTH QI AND BLOOD, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN NEO-GREEN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO.,  LTD
WO/2021/098791	TRANSDERMAL PATCH CONTAINING MEMANTINE	CHENGDU KANGHONG PHARMACEUTICAL CO.LTD.
WO/2021/232717	CONJUGATE CONTAINING MONO-PHOSPHORYLATED LIPID A AND  GLYCOANTIGEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232718	CONJUGATE AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232719	CONJUGATE CONTAINING α-GALACTOSYL CERAMIDE ANALOGUE AND  CARBOHYDRATE ANTIGEN AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE(GUANGZHOU INSTITUTE  OF TRADITIONAL CHINESE MEDICINE)
WO/2021/104155	HYDROGEL TABLET FOR DISPELLING EFFECT OF ALCOHOL AND  PROTECTING LIVER, AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG OCEAN UNIVERSITY
WO/2021/109879	COMPOSITION HAVING WHOLESOME PERSONALIZED INTESTINAL FLORA  DIVERSITY FUNCTION AND APPLICATION	NII, Keni
WO/2021/196659	GLYCOSYL POLYETHER COMPOUND LIPOSOME, PREPARATION METHOD  THEREFOR AND MEDICINE THEREOF	WUHAN UNIVERSITY
WO/2021/109880	PHARMACEUTICAL COMPOSITION, COMPLEMENTARY KIT AND APPLICATION  THEREOF	SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
WO/2021/098826	USE OF ALBIFLORIN OR PAEONIFLORIN IN THE PREVENTION AND/OR  TREATMENT OF RENAL ANEMIA	ZHANG, Zuoguang
WO/2021/115100	NOVEL USE OF SULFORAPHANE AND PHARMACEUTICAL COMPOSITION  COMPRISING SAME	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/098874	HAIR CARE COMPOSITION AND PREPARATION METHOD THEREFOR	BIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/196666	USE OF HOMOHARRINGTONINE IN PREPARATION OF HUMAN BODY  BETA-CORONAVIRUS REPLICATION INHIBITOR	SUN YAT-SEN UNIVERSITY
WO/2021/104208	ENDOGENOUS SMALL RNA MOLECULAR TARGET FOR PREVENTING SKIN  AGING AND PREMATURE AGING AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/104213	APPLICATION OF FU TEA EXTRACT IN PREPARING ANTIFUNGAL DRUG	PHARCHOICE THERAPEUTICS INC
WO/2021/104214	USE OF EXOSOME DERIVED FROM CARCASS IN SKIN REGULATION PRODUCT	PHARCHOICE THERAPEUTICS INC
WO/2021/218129	COPPER @ RHUBARB ANTHRAQUINONE METAL ORGANIC FRAMEWORK  COMPOSITE AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE  OF CHINESE MEDICINE)
WO/2021/104253	IBUPROFEN PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/104276	USES OF FU TEA EXTRACT IN PREPARING SKIN-CONDITIONING PRODUCT	PHARCHOICE THERAPEUTICS INC
WO/2021/104319	COMBINED PHARMACEUTICAL COMPOSITION OF QUINAZOLINE DERIVATIVE  OR SALT THEREOF AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104340	SUBSTITUTED CROTONAMIDE PHARMACEUTICAL COMPOSITION AND  PREPARATION METHOD THEREFOR	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104341	APPLICATION OF SUBSTITUTED CROTONAMIDE	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104363	COMPOSITION CONTAINING AROMATIC HETEROCYCLIC COMPOUND IN  AMORPHOUS FORM, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/104371	ANTIBODIES TO CD3 AND BCMA, AND BISPECIFIC BINDING PROTEINS  MADE THEREFROM	SHANGHAI EPIMAB BIOTHERAPEUTICS CO., LTD.
WO/2021/109924	USE OF MYRICETIN IN THE PREPARATION OF SALMONELLA TYPE Ⅲ  SECRETION SYSTEM INHIBITOR	JILIN UNIVERSITY
WO/2021/104442	METHOD AND COMPOSITIONS FOR PREDICTING ANTI-CANCER EFFICACY OF  COMPOUNDS TARGETING APOPTOSIS PATHWAY	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/104454	USE OF BI853520 IN CANCER TREATMENT	INXMED (NANJING) CO., LTD.
WO/2021/104460	PREPARATION METHOD FOR PALIPERIDONE PALMITATE SUSPENSION	NHWA PHARMA. CORPORATION
WO/2021/258642	USE OF GCS INHIBITOR IN PREPARING DRUG FOR TREATING COCAINE  ADDICTION	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/104487	COMPOSITION INCLUDING RILPIVIRINE AND USE THEREOF FOR TREATING  TUMORS OR CANCER	APTORUM THERAPEUTICS LIMITED
WO/2021/109945	WEAKLY ACIDIC DERIVATIVE OF POORLY SOLUBLE DRUG, AND LIPOSOME  PREPARATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/104511	APPLICATION OF CAR T-CELLS IN PREPARING DRUG FOR TREATING  CANCER	SUZHOU NOVA THERAPEUTICS CO. LTD
WO/2021/109970	XANTHINE DERIVATIVE PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFOR	CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD
WO/2021/258643	SOAP/AMINO ACID-TYPE FACIAL CLEANSING PRODUCT AND PREPARATION  METHOD THEREFOR	HUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/110049	APPLICATION OF MANGANESE-TYPE HIGH-STABILITY SUPEROXIDE  DISMUTASE IN PREVENTION OR TREATMENT OF STROKE	CARRY HEALTH BIOPHARMACEUTICALS (HANGZHOU) CO., LTD.
WO/2021/121038	EXOSOME FORMULATION FOR TREATING DRUG-RESISTANT BACTERIAL  INFECTIONS	NANJING UNIVERSITY
WO/2021/110064	NEW MULTI-FUNCTIONAL OLIGOPEPTIDES	JIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/110071	METHODS FOR INDUCING INTERMITTENT FASTING AND MODULATING  AUTOPHAGY	THE HONG KONG POLYTECHNIC UNIVERSITY
WO/2021/110073	PHARMACEUTICAL COMPOSITION CONTAINING ELEMENE, PREPARATION  METHOD THEREFOR, AND USE THEREOF	CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135798	APPLICATION OF MULBERROSIDE A AND DERIVATIVES THEREOF IN  PREPARATION OF DRUGS FOR PROTECTING INTESTINAL BARRIER	NANJING UNIVERSITY
WO/2021/110097	N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2  INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/129340	TANDOSPIRONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND USE THEREOF	SICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/110105	USE OF NEUREGULIN-1 IN PREPARATION OF PRODUCT FOR ENHANCING  TRPC6 CHANNEL ACTIVITY	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH  INSTITUTE OF CHINESE MEDICINE)
WO/2021/253742	APPLICATION OF WUBI CHINESE YAM PILLS IN PREPARATION OF DRUG  FOR TREATMENT OF PREMATURE OVARIAN INSUFFICIENCY	HANGZHOU HUQINGYUTANG PHARMACEUTICAL CO., LTD.
WO/2021/110120	ANTI-TUMOR VACCINE MOLECULE, PREPARATION METHOD THEREFOR AND  USE THEREOF	CENTRAL CHINA NORMAL UNIVERSITY
WO/2021/110121	HDAC6 SELECTIVE INHIBITOR AND COMBINATION THERAPY THEREOF	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/110127	METHOD OF TREATING INFLAMMATORY BOWEL DISEASE	CHEER GLOBAL LIMITED
WO/2021/110134	THREE-LAYER HAIR CARE COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	GUANGZHOU UNIASIA COSMETIC TECHNOLOGY CO., LTD.
WO/2021/110136	PHARMACEUTICAL COMBINATION AND USE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/218154	DRUG, FOOD AND APPLICATION OF ANTI-CORONAVIRUS INFECTION	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/110148	SIRNA CONJUGATE, DOUBLE-STRANDED SIRNA CONJUGATE, SALT THEREOF  AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/212858	APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO  SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINE	FUZHOU UNIVERSITY
WO/2021/110164	LIQUID PREPARATION CONTAINING ANTI-IL-17 ANTIBODY	LIVZON MABPHARM INC.
WO/2021/143392	DRUG FOR REGULATING IMMUNE FUNCTION OR TREATING IMMUNE-RELATED  DISEASES	SHENZHEN YUANJIAN LIFE TECHNOLOGY CO., LTD.
WO/2021/129362	USE OF AMHR2 RECOMBINANT PROTEIN OR FUSION PROTEIN IN  PREPARATION OF DRUGS FOR TREATING AMH SIGNAL AXIS ABNORMAL ACTIVATION RELATED  DISEASES	PHARCHOICE THERAPEUTICS INC
WO/2021/258654	SILVER ION ANTIBACTERIAL HAND SANITIZER, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	GUANGZHOU HWASUEN HEALTH INDUSTRY CO., LTD
WO/2021/110173	LIPOSOME FORMULATION OF FLUTICASONE PROPIONATE	ANOVENT PHARMACEUTICALS CO., LTD
WO/2021/253746	USE OF DALBAVANCIN IN PREPARATION OF MEDICAMENT FOR INHIBITING  BINDING OF SARS-COV-2 TO ACE2	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/115272	CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION  THEREOF	BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.
WO/2021/121082	SCAVENGER RECEPTOR-A TARGETED DRUG CARRIER, AND PREPARATION  METHOD AND APPLICATION THEREOF	SICHUAN UNIVERSITY
WO/2021/115321	PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION	REMEGEN CO., LTD.
WO/2021/212865	COMPOUND ALLICIN SOFT CAPSULE AND METHOD FOR PREPARING AND  PACKAGING SAME	GUANGZHOU HONGKANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/115389	FULVESTRANT PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/169484	NANOVACCINE AND PREPARATION METHOD THEREFOR	ZHEJIANG UNIVERSITY
WO/2021/115408	PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115409	PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115410	IMMUNOSTIMULATORY COMPOSITION AND USE THEREOF	JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115412	USE OF NITRIC OXIDE SYNTHASE PATHWAY INHIBITOR IN PREPARATION  OF MEDICINE	ZHUJIANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY
WO/2021/115415	METHODS FOR TREATING BACTERIAL INFECTIONS	MICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/115425	PHARMACEUTICAL COMPOSITION CONTAINING BPI-7711 AND PREPARATION  METHOD THEREOF	BETA PHARMA (SUZHOU) , LTD.
WO/2021/115426	ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE  THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/073659	VACCINE VECTOR PREPARED ON BASIS OF ANIONIC POLYMERS AND  DERIVATIVES THEREOF	SICHUAN UNIVERSITY
WO/2021/073660	LYOPHILIZED PREPARATION OF VACCINE CONTAINING ALUMINUM  ADJUVANT AND PREPARATION METHOD AND USE THEREFOR	SICHUAN UNIVERSITY
WO/2021/258668	METHOD FOR PREPARING P/H MICROSPHERES WITH HYDROPHOBIC SOLID  POWDER WRAPPED THEREIN	ZHEJIANG UNIVERSITY
WO/2021/196734	CONTROLLED-RELEASE BRIVARACETAM PREPARATION AND PREPARATION  METHOD THEREFOR	JIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/244004	ZEOLITE ENERGY MASK AND PREPARATION METHOD THEREFOR	JIANGSU FULE BIOLOGICAL ENVIRONMENTAL PROTECTION TECHNOLOGY  CO., LTD
WO/2021/164399	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/227493	USE OF FGF21 IN PREPARATION OF MEDICINE FOR TREATING  COLORECTAL CANCER	JIANGNAN UNIVERSITY
WO/2021/121277	A METHOD AND COMPOSITION FOR TREATMENT OF A CANCER	TUAN, Mei-Nan
WO/2021/164401	USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION  OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/135980	SOLVENT SYSTEM CAPABLE OF EFFECTIVELY DISSOLVING ORNIDAZOLE OR  LEVORNIDAZOLE, AND APPLICATION THEREOF	CHONGQING DIANSUO MEDICAL TECHNOLOGY CO., LTD
WO/2021/121366	LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS	ALAR PHARMACEUTICALS INC.
WO/2021/258683	APPLICATION OF BERBERINE-ORYZANOL TABLET IN TREATMENT OF  DIABETES	YICHUN WANSHEN PHARMACEUTICAL MACHINERY CO., LTD
WO/2021/121387	APPLICATION OF COMPOUND IN DRUG PREPARATION	MEDSHINE DISCOVERY INC.
WO/2021/121388	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING  EGFR-TKIS RELATED SKIN RASH AND USE THEREOF	YANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI  PHARMACEUTICAL CO., LTD.
WO/2021/232777	AEROSOL	YUNNAN HEMPSON BIO-TECH CO., LTD.
WO/2021/129600	JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITION	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/129616	PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND HISTONE  DEACEYLASE INHIBITOR, USE THEREOF, AND USAGE METHOD THEREFOR	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129635	SUSTAINED-RELEASE DRUG DELIVERY SYSTEM	NANJING DELOVA BIOTECH CO. LTD.
WO/2021/129649	USE OF α-KETOGLUTARATE IN PREPARATION OF DRUG	TONGJI UNIVERSITY
WO/2021/129658	APPLICATION OF FUSION PROTEIN IN TREATING AGE-RELATED MACULAR  DEGENERATION	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129673	ANTI-CSF1R MOLECULES AND USE THEREOF	ADAGENE (SUZHOU) LIMITED
WO/2021/129678	CONJUGATE WITH RADIATION-RESPONSIVE GROUP AND USE THEREOF	PEKING UNIVERSITY
WO/2021/129735	SOLID PREPARATION, AND PREPARATION METHOD THEREFOR AND USE  THEREOF	SINOTHERAPEUTICS INC.
WO/2021/129744	COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND  CANCERS BY TARGETING IGSF8	SHANGHAI XBH BIOTECHNOLOGY CO., LTD.
WO/2021/129775	ANTI-CTLA-4 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/129796	EASILY CLEANSING MAKEUP BASE COSMETIC FOR SKIN	SHISEIDO COMPANY, LTD.
WO/2021/143485	CURCUMIN COMPLEX, PREPARATION METHOD THEREFOR AND DETECTION  METHOD THEREFOR	CHENLAND NUTRITIONALS INC.
WO/2021/136089	ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND METHOD FOR  INCREASING SOLUBILITY OF COMPOUND	BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
WO/2021/212892	BROAD-SPECTRUM ANTIVIRAL DRUG AND USE THEREOF	METHYCURE BIOTECH CORP.
WO/2021/136169	FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND  APPLICATION IN SOFT CAPSULE	SIRIO PHARMA CO., LTD.
WO/2021/136226	APPLICATIONS OF IMINOSTILBENE IN TERMS OF PREVENTING AND  TREATING CARDIAC CEREBRAL ISCHEMIA/REPERFUSION INJURY	CHINESE ACADEMY OF MEDICAL SCIENCES INSTITUTE OF MEDICINAL  PLANT DEVELOPMENT
WO/2021/136262	TWO-DIMENSIONAL NANO COMPOSITE MATERIAL, PREPARATION METHOD  THEREFOR AND USE THEREOF	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING,  CHINESE ACADEMY OF SCIENCES
WO/2021/136274	FORMULATION CONTAINING ANTI-TROP2 ANTIBODY-DRUG CONJUGATE AND  PREPARATION METHOD AND APPLICATION THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/136275	MULTI-STAGE FAT-PROTECTING SKINCARE COMPOSITION FOR PROTECTING  SKIN BARRIER OF INFANTS	LUNALER HEALTH TECHNOLOGY (GUANGZHOU) CO LTD
WO/2021/136381	PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE  TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/184918	USE OF EPHB4 AS TARGET IN SCREENING OF DRUGS OR MODELS FOR  INCREASING INSULIN SENSITIVITY	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL  SCIENCES
WO/2021/136405	ANTI-INFECTION USE OF CLASS OF THIAZOLE-CONTAINING COMPOUNDS	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/136488	CRYSTAL FORM OF PYRIDOPYRIMIDINE DERIVATIVE AND PREPARATION  METHOD THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/136492	GASTRIC RETENTION TABLET	GUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136494	GASTRIC RETENTION TABLET	GUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136507	PHARMACEUTICAL COMPOSITION OF DIPEPTIDYL PEPTIDASE-4  INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/253803	PREPARATION METHOD FOR FIRE-PURGING TABLET	HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.
WO/2021/136513	METHOD FOR PREPARING PH-RESPONSIVE INTESTINE-TARGETED ACTIVE  FACTOR TRANSPORTATION SYSTEM BASED ON ANIONIC SODIUM ALGINATE	DALIAN POLYTECHNIC UNIVERSITY
WO/2021/136520	NEW METHOD FOR TARGETED EDITING OF RNA	EDIGENE INC.
WO/2021/136523	PHARMACEUTICAL COMBINATION FOR TREATING TUMORS AND APPLICATION  THEREOF	FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/174995	USE OF JQ-1 IN PREPARATION OF MEDICINE FOR TREATING PANCREATIC  CANCER AND METHOD FOR VERIFYING INHIBITION OF JQ-1 ON EXOSOME SECRETION OF  PANCREATIC CANCER	AFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/196808	NOVEL THERAPEUTIC VACCINE AGAINST NOVEL CORONAVIRUS,  PREPARATION METHOD THEREFOR, AND USE THEREOF	HANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/253807	ANTI-NOVEL CORONAVIRUS COMPLEX AND PREPARATION METHOD THEREFOR	HANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/136541	APPLICATION OF A REAGENT DOWN-REGULATING CIRCULAR GENE  EXPRESSION IN PREPARATION OF A DRUG TO PREVENT AND/OR TREAT PULMONARY  FIBROSIS, AND DRUG	BINZHOU MEDICAL UNIVERSITY
WO/2021/203769	USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF DRUGS FOR TREATING  ACRAL LENTIGINOUS MELANOMA	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244027	APPLICATION OF COBRA POSTSYNAPTIC NEUROTOXIN IN TREATMENT OF  DISEASES RELATED TO INFLAMMATORY CYTOKINE OVEREXPRESSION	SHEN, Zhejing
WO/2021/203779	COMPOUND FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, AND  APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/136549	APPLICATION OF CINEPAZIDE MALEATE IN PREPARATION OF DRUGS FOR  PREVENTION AND TREATMENT OF STROKE	BEIJING SIHUAN PHARMACEUTICAL CO., LTD.
WO/2021/139642	PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE  THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139661	APPLICATION OF GENE EXPRESSION INHIBITOR POU2F1 IN PREPARATION  OF DRUG FOR TREATING TISSUE FIBROSIS DISEASES	PEKING UNIVERSITY THIRD HOSPITAL
WO/2021/139697	APPLICATION OF SUPERNATANT OF TUMOR CELLS AFTER ACTION OF  CHEMOTHERAPEUTIC DRUG	ZHUKANG BIOTECHNOLOGY CO. , LTD.
WO/2021/159892	HEMOSTATIC AGENT FOR CENTRAL HEMANGIOMA HEMORRHAGE OF JAW,  PREPARATION METHOD THEREFOR AND USE THEREOF	NANTONG UNIVERSITY
WO/2021/139739	CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND  MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/238232	PRAMIPEXOLE HYDROCHLORIDE ORAL SOLUTION	CHANGZHOU NO.4 PHARMACEUTICAL FACTORY CO. LTD
WO/2021/227541	TRADITIONAL CHINESE MEDICINAL COMPOSITION FOR TREATING  DEMENTIA AND PREPARATION METHOD THEREFOR	WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/143671	PHARMACEUTICAL COMPOSITION OF ANTI-PD-1 ANTIBODY AND  QUINAZOLINE DERIVATIVE, USES OF COMPOSITION, AND METHOD FOR USING SAME	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/147740	USE OF MAPK/ERK PATHWAY INHIBITOR IN ANTAGONIZING SKIN AGING  AND RADIATION-INDUCED PREMATURE AGING	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF  SCIENCES
WO/2021/143736	COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET  AGENT	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/143741	TARGETING POLYPEPTIDE-DRUG CONJUGATE AND USE THEREOF	BEIJING HOPE PHARMACEUTICAL CO. LTD.
WO/2021/143745	LONG-ACTING ROPIVACAINE PHARMACEUTICAL COMPOSITION,  PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143746	NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143751	INJECTABLE LONG-ACTING ANALGESIC PHARMACEUTICAL COMPOSITION,  PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/143754	COMBINATION FOR THE TREATMENT OF CANCER AND APPLICATION  THEREOF	EVERFRONT BIOTECH INC.
WO/2021/143767	PREPARATION OF BISPECIFIC ANTIBODY COMBINING PD-1 AND PD-L1  AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143785	PHARMACEUTICAL COMPOSITION OF AEROSOL INHALANT CONTAINING  INDACATEROL AND PREPARATION METHOD THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/143791	PHARMACEUTICAL USE OF ESRRA GENE ENCODING FOR ESTROGEN-RELATED  RECEPTOR α	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143799	USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH FRUQUINTINIB IN  PREPARATION OF MEDICAMENTS FOR TREATING CANCER	GENOR BIOPHARMA CO. LTD
WO/2021/143806	APPLICATION OF WIDE-SPECTRUM FLAVIVIRUS-AGAINST ACTIVITY OF  HSP70 INHIBITOR	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/143826	RECOMBINANT ANTI-PROGRAMMED CELL DEATH PROTEIN 1 AND  ANTI-CLUSTER OF DIFFERENTIATION ANTIGEN 137 BISPECIFIC ANTIBODY PREPARATION  AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/143861	COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC  STEATOHEPATITIS (NASH)	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143879	COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS,  AND INSULIN AND/OR INSULIN ANALOGS	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143906	METHOD FOR TREATMENT OF NERVE INJURY AND RELATED DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/143912	THERAPEUTIC ACTION OF CELL-FREE FAT EXTRACT ON FATTY LIVER AND  COMPLICATIONS THEREOF	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/151366	HEALTH FOOD OR TRADITIONAL CHINESE MEDICINE MEDICINAL FORMULA  FOR IMPROVING MALE SEXUAL FUNCTION, AND ULTRASONIC WAVE PREPARATION METHOD	JIANGSU UNIVERSITY
WO/2021/143919	PHARMACEUTICAL COMPOSITION AND USE THEREOF	HENAN TAIFENG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/147854	RECOMBINANT FULLY HUMAN ANTI-TIGIT MONOCLONAL ANTIBODY  PREPARATIONS, PREPARATION METHOD THEREFOR AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143928	QUINOLINE DERIVATIVE FOR TREATING RHEUMATOID ARTHRITIS	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208551	APPLICATION OF THYROID HORMONE AND ANALOGUE THEREOF IN  PREPARATION OF DRUG FOR TREATING SICKLE-CELL DISEASE	RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/208552	USE OF THYROID HORMONE AND ANALOGUE THEREOF IN PREPARATION OF  DRUGS FOR TREATING ALPHA-THALASSEMIA	RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF  MEDICINE
WO/2021/232836	CANNABINOID COMPOUNDS AND APPLICATION THEREOF IN TREATMENT OF  PARKINSON'S DISEASE	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/238242	USE OF FULL-SPECTRUM HEMP OIL IN TREATMENT OF EPILEPSY	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/169682	TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION  METHOD THEREFOR AND APPLICATION THEREOF	BEIJING REGEN-PHARMATECH CO., LTD.
WO/2021/147922	EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTS	EV CELL BIOTECH (GUANGZHOU) CO., LTD.
WO/2021/148003	DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF IN MEDICINE	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/203798	USE OF SPLICING FACTOR PRPF31 INHIBITOR IN PREPARING DRUG	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/244044	EYE DROP SUITABLE FOR LIMBAL STEM CELL DEFICIENCY AND  PREPARATION	QINGDAO HAIER BIOTECH CO.LTD
WO/2021/218249	SPINOSYN DERIVATIVE AS ARGININOSUCCINATE SYNTHETASE ACTIVATOR  AND APPLICATION THEREOF	CENTRAL SOUTH UNIVERSITY
WO/2021/155748	INHIBITORS OF MALARIAL AND PLASMODIUM FALCIPARUM HEXOSE  TRANSPORTER AND USES THEREOF	TSINGHUA UNIVERSITY
WO/2021/179817	PROGESTERONE EMULSION INJECTION AND PREPARATION METHOD  THEREFOR	JIANGSU JIAERKE PHARMACEUTICAL GROUP CO., LTD.
WO/2021/155751	TRADITIONAL CHINESE MEDICINE COMPOUND WITH FUNCTIONS OF  CLEARING LUNGS AND DETOXIFICATION, AND APPLICATION THEREOF	INSTITUTE OF BASIC RESEARCH IN CLINICAL MEDICINE,CHINA ACADEMY  OF CHINESE MEDICAL SCIENCES
WO/2021/179828	USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR  TREATING ACUTE LUNG INJURY	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/151387	PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/169724	SUSTAINED-RELEASE DOSAGE FORM OF TOFACITINIB, PREPARATION  METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/164523	AKKERMANSIA MUCINIPHILA COMPOSITION	SHANGHAI INSTITUTE OF ENDOCRINE AND METABOLIC DISEASES
WO/2021/155764	COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGS	INXMED (NANJING) CO., LTD.
WO/2021/129890	MEDICATION FOR BLOCKING MICROBIAL INFECTION, REDUCING  CHOLESTEROL, AND PREVENTING AND TREATING ASSOCIATED TUMORS, AND USE THEREOF	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/151391	APPLICATION OF ISOVALERYLSPIRAMYCIN COMPOUND AND COMPOSITION  THEREOF IN PREPARATION OF ANTIVIRAL DRUG	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/179843	ANTI-TUMOR NANO ADJUVANT BASED ON VESICLE FORMED BY  CROSS-LINKED BIODEGRADABLE POLYMER, PREPARATION METHOD THEREFOR AND USE  THEREOF	SOOCHOW UNIVERSITY
WO/2021/155777	USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING  NOVEL CORONAVIRUS PNEUMONIA	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/184987	AD7 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTION	GUANGZHOU N BIOMED LTD.
WO/2021/184988	AD35 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTION	GUANGZHOU N BIOMED LTD.
WO/2021/155795	PHARMACEUTICAL COMPOSITION AND USE THEREOF	QIN, Caidong
WO/2021/155798	USE OF IMMUNE POLYPEPTIDE IN ANTIVIRAL DRUG	CHENG, Yun
WO/2021/184990	SENSITIZER DRUG, DRUG COMBINATION AND USE	SUN YAT-SEN MEMORIAL HOSPITAL, SUN YAT-SEN UNIVERSITY
WO/2021/227572	USE OF MICRO-NANO MGH<sb>2</sb> COMPOUND PARTICLES  IN INHIBITION OF LEISHMANIA INFECTION AND TREATMENT OF LEISHMANIASIS	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/196884	USE OF CATECHOL AND DERIVATIVES IN PREPARATION OF DRUGS FOR  TREATING SLEEP DISTURBANCES	XI'AN LIBANG ZHAOXIN BIOTECHNOLOGY CO., LTD.
WO/2021/155825	USE OF PAX6 GENE OR EXPRESSION PRODUCT THEREOF IN PREPARATION  OF DRUG FOR INHIBITING FIBROSIS	PEKING UNIVERSITY THIRD HOSPITAL
WO/2021/155840	USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF MALIGNANT TUMORS	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/155846	PREPARATION METHOD FOR NOVEL CORONAVIRUS PNEUMONIA BIVALENT  VACCINE	WENG, Binghuan
WO/2021/160049	BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND  USE THEREOF	SHENZHEN EULIKAN BIOTECHNOLOGY CO., LTD
WO/2021/203828	USE OF INHIBITOR IN PREPARATION OF DRUGS FOR TREATING  SARS-COV-2 PNEUMONIA AND COMPLICATIONS THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCES, PLA
WO/2021/223480	CONTROLLED-RELEASE TICAGRELOR TABLET AND PREPARATION METHOD  THEREFOR	JIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/164600	USE OF COMPOSITION IN TREATING ATHEROSCLEROSIS	INNOLIFE CO., LTD.
WO/2021/155867	METHOD AND DRUG FOR PREVENTING AND TREATING MULTIPLE SCLEROSIS	TALENGEN INTERNATIONAL LIMITED
WO/2021/185006	LENVATINIB PHARMACEUTICAL COMPOSITION, PREPARATION METHOD  THEREFOR AND APPLICATION THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/160092	METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA	TALENGEN INTERNATIONAL LIMITED
WO/2021/160104	FOLIUM APOCYNI VENETI EXTRACT, AND PREPARATION METHOD THEREFOR  AND USE THEREOF	XIAMEN UNIVERSITY
WO/2021/179878	3CLPRO-TARGETING PHILLYRIN, DERIVATIVE THEREOF, AND USE  THEREOF AGAINST NOVEL CORONAVIRUS	DALIAN FUSHENG NATURAL MEDICINE DEVELOPMENT CO., LTD.
WO/2021/160115	USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST  CANCER	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160120	OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR	BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160124	OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR	BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160131	FIBROTIC DISEASE MECHANISM AND THERAPEUTIC DRUG THEREFOR	GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER
WO/2021/179881	APPLICATION OF HERBAL MEDICINE COMPOSITION IN PREPARATION OF  MEDICINE FOR PREVENTING AND TREATING CORONAVIRUS COMPLICATED WITH LUNG INJURY	GUANGDONG LEIYUNSHANG PHARMACEUTICAL CO., LTD.
WO/2021/169812	USE OF PAX4 INHIBITOR IN PREPARATION OF DRUG FOR INHIBITING  FIBROSIS	PEKING UNIVERSITY THIRD HOSPITAL
WO/2021/160139	9,10-DIHYDROPHENANTHRENE COMPOUNDS AND USE THEREOF IN  TREATMENT OF LIVER INJURY	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/164672	ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/160144	METHOD FOR PREVENTING OR TREATING THROMBOEMBOLISMS BY MEANS OF  APIXABAN INJECTION	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/160151	USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF TUMORS	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/160152	USE OF ANTI-PD-1 ANTIBODY IN TREATING NEUROENDOCRINE TUMORS	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/232864	TREATING TUMOR USING IMMUNE EFFECTOR CELL	CAFA THERAPEUTICS LIMITED
WO/2021/160163	METHODS FOR PREVENTION OR TREATMENT OF VIRUS-INDUCED ORGAN  INJURY OR FAILURE WITH IL-22 DIMER	EVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164685	GROUP OF PEPTIDE COMPOUNDS OMICSYNIN HAVING ANTIVIRAL ACTIVITY  AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF  MEDICAL SCIENCES
WO/2021/160170	METHODS OF USE OF SOLUBLE CD24 FOR TREATING SARS-COV-2  INFECTION	ONCOIMMUNE, INC.
WO/2021/160173	METHODS OF USE OF SOLUBLE CD24 FOR TREATING VIRAL PNEUMONIA	ONCOIMMUNE, INC.
WO/2021/164689	APPLICATION OF NELFINAVIR IN PREPARATION OF DRUG FOR  PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/160183	ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH	RANIR, LLC
WO/2021/164706	PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE AND  APPLICATION THEREOF	CHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/169845	METHOD FOR PREVENTING, TREATING OR DELAYING HEART FAILURE BY  USING NEUREGULIN, AND COMPOSITION	ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
WO/2021/164717	ANTI-TNF-α ANTIBODY PREPARATION, PREPARATION METHOD THEREFOR  AND USE THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/164723	GINSENOSIDE M1 AS A MODULATOR OF ANGIOTENSIN REGULATING  ENZYMES AND ITS USE FOR TREATING DISEASES OR CONDITIONS INCLUDING SYMPTOMS  CAUSED BY CORONAVIRUS	LEE, Sheau-Long
WO/2021/164728	PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-4R ANTIBODY AND  USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164740	USE OF INTERFERON IN PREPARING DRUG FOR PREVENTING CORONAVIRUS  INFECTION OR PREVENTING DISEASE CAUSED BY CORONAVIRUS INFECTION	SHANGHAI GANYI MEDICAL BIOTECHNOLOGY INC.
WO/2021/164744	METHODS FOR TREATING GRAFT VERSUS HOST DISEASE	EVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164755	OLAPARIB PHARMACEUTICAL COMPOSITION, PREPARATION THEREOF,  PREPARATION METHOD THEREFOR AND USE THEREOF	SINOTHERAPEUTICS INC.
WO/2021/169861	USE OF NUCLEOSIDE COMPOUND IN TREATMENT OF CORONAVIRUS  INFECTIOUS DISEASES	GENUINE BIOTECH CO., LTD.
WO/2021/169884	USE OF RAPAMYCIN AND DERIVATIVES THEREOF IN PREPARATION OF  DRUGS FOR PREVENTING AND TREATING ADE CAUSED BY VIRUSES	ZHENG, Yunfeng
WO/2021/179902	USE OF CORYDALIS SAXICOLA AND PREPARATION THEREOF IN  PREPARATION OF DRUG FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASES	NANJING ZHONGSHAN PHARMACEUTICAL CO., LTD.
WO/2021/169957	APPLICATION OF N-SUBSTITUTED PYRIDYL BENZISOSELENAZOLONE  COMPOUND	SHANGHAITECH UNIVERSITY
WO/2021/212995	ANTI-AGEING COMPOSITION, DRUG AND HEALTHCARE PRODUCT  COMPRISING SAME, AND APPLICATION THEREFOR	BIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/169974	COMBINED PHARMACEUTICAL COMPOSITION FOR RESISTING DOUBLE-HIT  LYMPHOMAS, AND USE THEREOF	THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY
WO/2021/169978	USE OF RECOMBINANT CYTOKINE GENE DERIVED PROTEIN OR FRAGMENT  THEREOF	GENOVA INC.
WO/2021/169984	ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE  INHIBITOR	FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/227597	USE FOR CORDYCEPS SINENSIS EXTRACT IN PREPARING DRUG FOR  PROMOTING ANGIOGENESIS AND/OR TREATING ISCHEMIC CARDIOVASCULAR AND  CEREBROVASCULAR DISEASES	INSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES
WO/2021/170045	METHODS OF TREATING DLBCL USING BTK INHIBITORS AND  COMBINATIONS THEREOF	BEIGENE SWITZERLAND GMBH
WO/2021/170060	PURIFICATION OF BISPECIIFC ANTIBODIES	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/170064	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/170065	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/170073	USE OF SMALL MOLECULE COMPOUNDS IN TREATING DISEASES MEDIATED  BY LUNG EPITHELIAL CELL INJURY AND/OR VASCULAR ENDOTHELIAL CELL INJURY	GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD.
WO/2021/170078	USE OF CSF-1R KINASE INHIBITOR	SHANGHAI RUNSHI MEDICAL TECHNOLOGY CO., LTD
WO/2021/170093	APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCE	SHANGHAITECH UNIVERSITY
WO/2021/170099	METHOD AND DRUG FOR PREVENTING AND TREATING ABNORMAL BLOOD  PRESSURE CONDITION	TALENGEN INTERNATIONAL LIMITED
WO/2021/175175	PHARMACEUTICAL FORMULATION COMPRISING BEVACIZUMAB	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/170137	ANTI-TUMOR COMPOSITION	SPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/170138	ANTI-TUMOR COMPOSITION	SPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/175186	USE OF SMALL MOLECULE SHORT PEPTIDE IN PREPARATION OF PRODUCT  FOR TREATING ACNE	JINAN UNIVERSITY
WO/2021/175192	TREATMENT METHODS AND BIOMARKERS FOR MDM2 INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/175200	FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDES	SIRONAX LTD
WO/2021/179947	USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTIBACTERIAL  DRUG	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179950	USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTI-VIRAL DRUG	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179952	APPLICATION OF GW8510 IN PREPARATION OF DRUGS FOR PROLONGING  LIVES, IMPROVING COGNITIVE ABILITY, AND THE LIKE OF MAMMALS IN NATURAL AGING	PEKING UNIVERSITY
WO/2021/185071	COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND METHODS OF USE THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/179959	PHARMACEUTICAL COMPOSITION COMPRISING JAK3/JAK1/TBK1 INHIBITOR  AND METHOTREXATE AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/175240	APPLICATION OF FULLERENE AND DERIVATIVE THEREOF IN REGULATING  INTESTINAL FLORA	XIAMEN FUNANO NEW MATERIAL TECHNOLOGY CO., LTD.
WO/2021/179967	APPLICATION OF IFN-γ IN PREPARING ANTI-TUMOR ADJUVANT DRUG	WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/175250	COMPOUNDS AND METHODS FOR TREATING DISEASES AND/OR CONDITIONS  CAUSED BY CORONAVIRUS	APTORUM THERAPEUTICS LIMITED
WO/2021/175274	OLAPARIB DISSOLUTION ENHANCING COMPOSITION	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/175275	HYDROPHOBICALLY MODIFIED ALBUMIN, PREPARATION METHOD THEREFOR,  AND APPLICATION THEREOF	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/175279	APPLICATION OF PHYSICAL TRANSDERMAL TECHNOLOGY IN  SUPPLEMENTARY NUTRITION SUPPLEMENTING	SUZHOU NASHENG MICROELECTRONICS CO., LTD
WO/2021/175295	APPLICATION OF MYRICETIN COMPOUND IN PREPARATION OF DRUGS FOR  PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS PNEUMONIA	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227614	PHARMACEUTICAL COMPOSITION FOR CLEARING LUNG AND PULMONARY  FIBROSIS AND USE THEREOF	ZHANG, Yingwen
WO/2021/175311	PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE AND  CANNABINOID COMPOUNDS AND USE THEREOF IN MEDICINE	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/175326	COMBINED USE OF CTB006 AND PONATINIB	BEIJING SINOTAU BIO-PHARMACEUTICALS TECHNOLOGY CO., LTD.
WO/2021/196982	ANTI-ARRHYTHMIC PHARMACEUTICAL COMPOSITION AND PREPARATION  METHOD THEREFOR	JIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/180027	PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND  MULTI-RECEPTOR TYROSINE KINASE INHIBITOR AND METHOD FOR USING SAME	HUTCHISON MEDIPHARMA LIMITED
WO/2021/180032	Novel Therapeutic Methods	GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/175333	SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING  OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA	NANJING SHIJIANG MEDICINE TECHNOLOGY CO., LTD
WO/2021/180055	USE OF BRD4 INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/180068	METHOD AND DRUG FOR TREATING DISEASES CAUSED BY 2019 NOVEL  CORONAVIRUS	TALENGEN INTERNATIONAL LIMITED
WO/2021/180087	MEDICAL USE OF ANYHDROICARITIN	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/180110	USE OF ANTI-BASIGIN HUMANIZED ANTIBODY FOR PREPARING  MEDICAMENT FOR TREATING NOVEL CORONAVIRUS PNEUMONIA	THE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/218422	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/213058	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUGS FOR TREATING OR PREVENTING INFECTION WITH CORONAVIRUSES	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/213059	USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION  OF DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/180184	USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOMES	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/185154	PHARMACEUTICAL COMPOSITION COMPRISING TIZOXANIDE AND  PHARMACEUTICAL USE THEREOF	BEIJING JUNKE HUAYUAN MED TECH CO., LTD.
WO/2021/180196	COMPOSITION OF PIPERAZINE-BASED DRUGS	DONGGUAN HEC GENERIC DRUG R&D CO., LTD.
WO/2021/180205	PVRIG BINDING PROTEIN AND ITS MEDICAL USES	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/223514	HOUSING-LIKE DENTAL INSTRUMENT HAVING ANTICARIES FUNCTION AND  MANUFACTURING METHOD THEREFOR	WUXI EA BIOTECHNOLOGY LIMITED
WO/2021/180219	ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITOR	NUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO. LTD
WO/2021/180225	NEW APPLICATION OF C60 AND METHOD FOR MEASURING ACTIVITY OF  PRODUCTS THEREOF	QINGDAO AGRICULTURAL UNIVERSITY
WO/2021/203914	PERAMIVIR DRY POWDER INHALANT AND PREPARATION METHOD THEREFOR	GUANGZHOU NUCIEN PHARMACEUTICAL CO., LTD
WO/2021/143951	COLCHICINE SOLUBLE MICRONEEDLE PATCH AND PREPARATION METHOD  THEREFOR	NANJING UNIVERSITY
WO/2021/180237	ATOMIZED INHALATION FORMULATION CONTAINING HUMAN CELL-DERIVED  EXTRACELLULAR VESICLES, PREPARATION METHOD AND USE THEREOF	CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
WO/2021/185234	COMBINED PHARMACEUTICAL COMPOSITION OF COMPOUND AS C-MET  KINASE INHIBITOR AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/213086	DEXTRAN-DOCOSAHEXAENOIC ACID COUPLING POLYMER, SYNTHESIS  METHOD THEREFOR AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/185265	ORAL PHARMACEUTICAL COMPOSITION	SICHUAN HAISCO PHARMACEUTICAL CO LTD
WO/2021/213089	A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE  NANOCARRIERS, METHODS OF MAKING AND USING THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/203933	TRADITIONAL CHINESE MEDICINE FOR DISPERSING LUNG QI AND  DETOXICATION	SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
WO/2021/185292	USE OF ASTRAGALUS MEDICINAL COMPOSITION FOR PREPARING DRUG FOR  ENHANCING CANCER THERAPY	PHYTOHEALTH CORPORATION
WO/2021/185340	USE OF MITOCHONDRIA FOR PROMOTING WOUND REPAIR AND/OR WOUND  HEALING	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185341	USE OF MITOCHONDRIAL EXTRACT FOR TREATMENT OR/AND PREVENTION  OF KIDNEY INJURY-RELATED DISEASES	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185342	USE OF MITOCHONDRIA FOR TREATMENT AND/OR PREVENTION OF TENDON  DAMAGE OR RELATED DISEASES	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185343	GLYBURIDE LIPOSOME COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185344	METHOD FOR TREATING CHOLESTEROL-RELATED DISEASES	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185356	USE OF BUTYLPHTHALIDE AND DERIVATIVE THEREOF	CSPC NBP PHARMACEUTICAL CO., LTD
WO/2021/185359	Modified red blood cells and uses thereof for delivering  agents	WESTLAKE THERAPEUTICS (HANGZHOU) CO. LIMITED
WO/2021/185364	CELL CULTURE COMPOSITION AND USE THEREOF	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185373	MICROPARTICLE FOR DRUG LOADING, DRUG LOADING MICROPARTICLE,  PARTICLE CONTAINING TUBE, AND IMPLANTATION SYSTEM FOR MICROPARTICLE	SUZHOU YIBEN LIFE TECHNOLOGY CO., LTD
WO/2021/185376	COMPOSITION CONTAINING MITOCHONDRIA AND USE THEREOF FOR  REPAIRING CARTILAGE DAMAGE OR AMELIORATING DEGENERATIVE ARTHRITIS	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185377	COMPOSITION FOR PROMOTING HAIR REGENERATION THAT CONTAINS  PLASMA RICH IN MITOCHONDRIA, AND MANUFACTURING METHOD THEREFOR AND USE  THEREOF	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185382	METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL  COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL  COMPOSITION OBTAINED THEREFROM	YU, Chongxi
WO/2021/238367	APPLICATION OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG  FOR DIAGNOSING AND TREATING DISEASE RELATED TO THYROIDECTOMY	SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL  CO., LTD
WO/2021/203959	HEPARIN NANO DRUG CARRIER SYSTEM FOR LOADING AMINO ANTI-TUMOR  DRUG, AND PREPARATION METHOD THEREFOR	NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO., LTD.
WO/2021/190495	PEGYLATED HEPARIN NANO-MICELLE LOADED WITH CARBOXYLIC ACID  ANTI-TUMOR DRUG AND PREPARATION METHOD THEREFOR	KINDOS PHARMACEUTICALS CO., LTD.
WO/2021/190546	PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN KINASE INHIBITOR  AND CHEMOTHERAPEUTIC DRUG AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/190553	ANTI-IL-1β ANTIBODY, AND PHARMACEUTICAL COMPOSITION CONTAINING  SAME, AND USE THEREOF	AKESO BIOPHARMA, INC
WO/2021/190558	METHOD AND DRUG FOR TREATING ALZHEIMER DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/190561	METHOD AND DRUG FOR TREATING PARKINSON'S DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/190562	METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN  AND AGGREGATE THEREOF	TALENGEN INTERNATIONAL LIMITED
WO/2021/190563	METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/190573	MAGNETIC NANOCOMPOSITE MATERIAL AND PREPARATION METHOD  THEREFOR AND USE THEREOF	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING,  CHINESE ACADEMY OF SCIENCES
WO/2021/190581	PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE  AND USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190582	ANTI-OX40 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/218506	APPLICATION OF PROGESTIN IN PREPARATION OF DRUG INHIBITING  CYTOKINE STORM	SHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/190588	HERBA LYCOPI EXTRACT AND PREPARATION METHOD THEREFOR AND USE  THEREOF	XIAMEN UNIVERSITY
WO/2021/190611	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR RECOVERY PHASE OF  EXOGENOUS FEVER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING UNIVERSITY OF CHINESE MEDICINE THIRD AFFILIATED  HOSPITAL
WO/2021/190616	METHODS FOR INHIBITING CASEIN KINASES	GRITSCIENCE BIOPHARMACEUTICALS CO., LTD.
WO/2021/190624	PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF  USING THEREOF	GANNEX PHARMA CO., LTD.
WO/2021/190631	METHOD FOR DISPLAYING BISPECIFIC ANTIBODY ON SURFACE OF  MAMMALIAN CELL AND VECTOR	DDBIO.CO, LTD., (SHANG HAI)
WO/2021/190637	COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR  TREATMENT	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/190641	METHODS FOR TREATING CYTOKINE STORM SYNDROME AND RELATED  DISEASES	FU, Xin-Yuan
WO/2021/190647	USE OF BERBERINE ANALOG AND JAK INHIBITOR IN TREATMENT OF  INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT	ENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/197254	USE OF MICROORGANISMS IN REGULATION OF BODYWEIGHT AND  CHOLESTEROL LEVEL	MICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/208711	APPLICATION OF TYLOPHORA ALKALOID OR SALT THEREOF IN RESISTING  CORONAVIRUS	NANKAI UNIVERSITY
WO/2021/197285	SEMI-DRY NASAL AND ORAL CAVITY NURSING TOWEL, NURSING MASK AND  PREPARATION METHOD	YANG LING ANDIYUAN BIOTECHNOLOGY CO., LTD.
WO/2021/197290	NOVEL APPLICATION OF ACETYLCHOLINESTERASE ACTIVITY INHIBITOR	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/197297	PHARMACEUTICAL COMPOSITION CONTAINING GINSENOSIDES RH3, PPD,  AND RH2	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197333	PHARMACEUTICAL COMBINATION AND USE THEREOF	NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197334	PHARMACEUTICAL COMBINATION AND USE THEREOF	NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197335	ANTIBODIES BINDING CD40 AND USES THEREOF	BIOSION INC.
WO/2021/197346	VACCINE ADJUVANT CONTAINING TRPV2 AGONIST AND USE THEREOF	TSINGHUA UNIVERSITY
WO/2021/197372	ANTI-TUMOR COMPOSITION CONTAINING RARE GINSENOSIDES RK2, CK,  AND PPT	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197376	A FEBUXOSTAT TABLET	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244120	SARS-COV-2 VACCINE	CANSINO BIOLOGICS INC.
WO/2021/208749	MEDICAL USE OF RIBOSOMAL PROTEIN SA ANTIBODIES IN  IMMUNOREGULATION	JILIN UNIVERSITY
WO/2021/197430	COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN  ALLOGENEIC CELL THERAPY	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/204060	COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/197451	MULTIPLE FORMULATION OF TICAGRELOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/227700	ANTI-DRY AND ANTI-SENSITIVITY COMPOSITION AND PREPARATION  METHOD THEREFOR	GUANGZHOU KENENG COSMETICS RESEARCH CO. LTD
WO/2021/197492	BREAST MILK OLIGOSACCHARIDES FOR IMPROVING RESISTANCE OF  ORGANISM AGAINST STAPHYLOCOCCUS AUREUS INFECTION	INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/204179	NUCLEIC ACID VACCINES FOR CORONAVIRUS	SUZHOU ABOGEN BIOSCIENCES CO., LTD.
WO/2021/204188	UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD  THEREFOR AND USE THEREOF	BEIJING BIOSTAR PHARMACEUTICALS CO., LTD.
WO/2021/204192	USE OF COMPOUND AS SIRT1 RECEPTOR AGONIST	CATCH BIO-SCIENCE & TECHNOLOGY CO., LTD.
WO/2021/204197	APPLICATION OF ACRIDINEDIONE COMPOUND IN PREPARATION OF  ANTI-DIABETIC DRUGS	THE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/204223	PHARMACEUTICAL COMPOSITION INCLUDING NICOTINAMIDE	YANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING  PHARMACEUTICAL CO., LTD.
WO/2021/218594	REAGENT AND METHOD FOR REGULATING INTEGRIN β SUBUNIT	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE  ACADEMY OF SCIENCES
WO/2021/204279	PROBIOTIC COMPOSITION FOR TREATING RAPID EYE MOVEMENT SLEEP  BEHAVIOR DISORDER, FORMULATION AND USE	BEIJING FRIENDSHIP HOSPITAL AFFILIATED TO CAPITAL MEDICAL  UNIVERSITY
WO/2021/208842	USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160192	USE OF KAURANE COMPOUNDS IN PREPARATION OF DRUG FOR PREVENTION  AND TREATMENT OF SEPSIS AND MULTIPLE ORGAN DAMAGE	KEY-PHARMA BIOMEDICAL INC.
WO/2021/208860	MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION  METHOD THEREFOR AND USE THEREOF	SICHUAN UNIVERSITY
WO/2021/208910	POLYMER PREPARATION FOR TREATING VIRUS INFECTION, AND  PREPARATION METHOD THEREFOR AND USE THEREOF	SHANDONG HUBBLE KISEN BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/249009	RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/208947	COFFEE SILVERSKIN EXTRACT, PREPARATION METHOD THEREFOR AND USE  THEREOF	INGREDI BIOTECH CO., LTD.
WO/2021/208976	SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR  AND USE THEREOF	SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/218638	DRUG COMBINATION FOR TREATING DIABETES MELLITUS AND  COMPLICATIONS THEREOF AND PHARMACEUTICAL COMPOSITION OF DRUG COMBINATION	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/213230	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARATION OF DRUG FOR TREATING OR PREVENTING FATTY LIVER DISEASE	NG, Tit
WO/2021/213232	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN  PREPARING DRUG FOR TREATING OR PREVENTING HYPERLIPIDEMIA	NG, Tit
WO/2021/208984	APPLICATION OF ABELMOSCHI COROLLA EXTRACT AS TRPC ION CHANNEL  INHIBITOR	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208985	USE OF QUERCETIN-3'-O-β-D-GLUCOSIDE AS CALCIUM CHANNEL  INHIBITOR	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/209003	PREVENTION AND TREATMENT OF ORGAN INJURIES	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/209007	ANTIBODY-DRUG CONJUGATE	SHENZHEN ENDURING BIOTECH, LTD.
WO/2021/209010	METHOD AND DRUG FOR TREATING HURLER SYNDROME	EDIGENE INC.
WO/2021/209017	PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOF	DINGFU BIOTARGET, CO., LTD.
WO/2021/175339	ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY  RESPONSE	SHENZHEN XBIOME BIOTECH CO., LTD.
WO/2021/209025	PHARMACEUTICAL COMPOSITIONS	SHENZHEN PHARMACIN CO., LTD
WO/2021/209028	METHODS OF TREATING VIRAL INFECTIONS USING ARGINASE	BIO-CANCER TREATMENT INTERNATIONAL LIMITED
WO/2021/213287	USE OF IRAK4 INHIBITOR IN TREATMENT OF ACUTE LUNG INJURY  ALI/ARDS	SHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
WO/2021/213327	COMPOSITION CONTAINING 7-ETHYL-10-HYDROXYCAMPTOTHECIN,  PREPARATION METHOD THEREFOR AND USE THEREOF	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/209070	GINSENOSIDE COMPOSITION HAVING ALCOHOLIC FATTY  LIVER-PREVENTING AND -TREATING FUNCTION	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/218687	STEM CELL DRUG FOR TREATING DIABETES	SOOCHOW UNIVERSITY
WO/2021/213455	DRUG COMBINATION AND USE THEREOF	NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/218763	PERIPLOSIDE COMPOSITION, PREPARATION METHOD THEREFOR AND USE  THEREOF IN PREPARATION OF DRUG FOR TREATMENT OF AUTOIMMUNE DISEASES	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/180250	PREPARATION FOR INHIBITING CANDIDA ALBICANS	NORTHWEST UNIVERSITY
WO/2021/213483	APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES	ZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213484	APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER  COMPOUND THEREOF IN KILLING MITES	ZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213485	USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING  MITES	ZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213492	DRUG-CARRYING MACROMOLECULE AND PREPARATION METHOD THEREFOR	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/238529	TECHNETIUM CARBON MICROSPHERE INJECTION, PREPARATION METHOD  THEREFOR AND USE THEREOF	CHENGDU NEW RADIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/218802	ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING  REGULATED AND CONTROLLED BY MICRORNA AND USE THEREOF	HANGZHOU CONVERD CO., LTD.
WO/2021/213502	SLEEP-IMPROVING PHARMACEUTICAL COMPOSITION CONTAINING RARE  GINSENOSIDES RG6 AND F4	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/213504	USE OF VEGF INHIBITOR IN PREPARATION OF MEDICAMENT FOR  TREATING HYPOXIA-RELATED DISEASES	QILU HOSPITAL OF SHANDONG UNIVERSITY
WO/2021/213512	A FORMULATION FOR TREATING OPHTHALMIC CONDITIONS	GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGY CO.,  LTD.
WO/2021/213520	ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIES	SINGLE CELL TECHNOLOGY, INC.
WO/2021/213523	USES OF COMBINATION OF ANTI-PD-1 ANTIBODY AND ANTI-CTLA-4  ANTIBODY IN PREVENTING OR TREATING CANCER	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/218884	USE OF ARYL GUANIDINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE  SALT THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/227868	PHARMACEUTICAL COMPOSITION PREPARATION	WANG, Zhaolin
WO/2021/218945	ANTIBACTERIAL ANTIVIRAL PHARMACEUTICAL COMPOSITION AND  APPLICATION THEREOF	YUNNAN BAIYAO GROUP CO., LTD
WO/2021/218964	EXTRACT FROM CORIOLUS VERSICOLOR FOR TREATING VAGINAL OR  CERVICAL DISORDERS CAUSED BY INFECTIOUS AGENTS	PROCARE HEALTH IBERIA, S.L.
WO/2021/218965	APPLICATION OF RUBIACEAE TYPE CYCLIC PEPTIDE COMPOUNDS IN  PREPARATION OF DRUGS AS CGAS-STING SIGNAL PATHWAY ACTIVATORS	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/218974	USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS  FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN  CONVERTING ENZYME 2	ALPS BIOTECH CO., LTD.
WO/2021/219001	COMPOSITION FOR IMPROVING IMMUNITY	THE CHINESE UNIVERSITY OF HONG KONG
WO/2021/219009	DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF  PIWI AND/OR NMD COMPLEX PROTEIN	SHANGHAITECH UNIVERSITY
WO/2021/219029	SARS-COV-2 VIRAL PROTEINS AND USE THEREOF	VERSITECH LIMITED
WO/2021/219031	TRADITIONAL CHINESE MEDICINE COMPOSITION, AND APPLICATION OF  PREPARATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE  FOR PREVENTING AND/OR TREATING ‎CORONAVIRUS DISEASE 2019	TASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219040	HISTONE DEACETYLASE INHIBITORS FOR IMMUNOMODULATION IN TUMOR  MICROENVIRONMENT	GNT BIOTECH & MEDICALS CORPORATION
WO/2021/219047	METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN	SINOCELLTECH LIMITED
WO/2021/227887	COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY  CORONAVIRUS AND USE THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/223652	COSMETIC PRODUCT AND MAKING-UP METHOD	MOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/219077	PROTEOLYSIS TARGETING COMPOUND HAVING TISSUE TARGETING  CAPABILITY AND USE THEREOF	TAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD
WO/2021/258851	PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND  PREPARATION METHOD THEREFOR	GUANGZHOU LIXIN PHARMACEUTICAL CO., LTD
WO/2021/223659	EXTRACELLULAR VESICLES TARGETING CANCER CELLS AND USES THEREOF	NANJING IASO BIOTHERAPEUTICS CO., LTD.
WO/2021/223664	METHODS FOR TREATING CORONAVIRUS INFECTIONS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/219112	ISOVALERYL SPIRAMYCIN COMPOUND OR APPLICATION OF ISOVALERYL  SPIRAMYCIN COMPOSITION IN PREPARATION OF DRUG FOR TREATING SEPSIS DISEASE	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219113	USE OF ISOVALERYL SPIRAMYCIN COMPOUND OR COMPOSITION THEREOF  IN PREPARATION OF MEDICAMENT FOR TREATING IMMUNE DISORDERS	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219137	AMINOPYRIDINE DERIVATIVE FOR TREATING DISEASES CAUSED BY MET  GENETIC ABNORMALITIES	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219138	COMBINATION DRUG FOR TREATING KIDNEY CANCER	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/223713	APPLICATION OF SMS2 INHIBITOR IN PREPARATION OF DRUG FOR  TREATMENT OF HIGHLY INVASIVE BREAST CANCER	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/227937	METHOD FOR ENHANCING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN  BY MEANS OF FORMING FUSION PROTEIN WITH MODIFIED FC FRAGMENT	SINOCELLTECH LIMITED
WO/2021/223732	BLOOD PURIFICATION CONCENTRATE	XIA, Yongbiao
WO/2021/180251	CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION  AND METHOD OF TREATMENT	1GLOBE BIOMEDICAL CO., LTD.
WO/2021/228037	COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTI-VIRAL THERAPY	VERSITECH LIMITED
WO/2021/228044	DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES  THEREOF	HUNILIFE BIOTECHNOLOGY, INC.
WO/2021/228069	USE OF COMBINATION OF ANTI-VEGF ANTIBODY AND ANTI-PD-1  ANTIBODY FOR PREVENTING OR TREATING DISEASE	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/244235	APPLICATION OF POLYINOSINIC ACID AND SARS-COV-2 SPIKE PROTEIN  IN CONSTRUCTION OF MOUSE ARDS MODEL	CHINA-US (HENAN) HORMEL CANCER INSTITUTE
WO/2021/228086	METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY	TALENGEN INTERNATIONAL LIMITED
WO/2021/228106	ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR FOR TREATING TUMORS	JOINT BIOSCIENCES (SH) LTD.
WO/2021/180252	NOVEL APPLICATION AND MANUFACTURING METHOD FOR HYALURONIC ACID  FRAGMENT	QINGDAO AGRICULTURAL UNIVERSITY
WO/2021/228113	PREPARATION COMPRISING ANTI-IL-23P19 ANTIBODY, PREPARATION  METHOD THEREFOR AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/228141	ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE  THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/228146	USE OF LSD1 INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO.,  LTD.
WO/2021/228178	COMPOSITIONS AND METHODS FOR TREATING CANCER	ADAGENE AG
WO/2021/254054	VACCINE FOR PREVENTING DISEASE CAUSED BY CORONAVIRUS	ACADEMAY OF MILITARY MEDICAL SCIENCES, AMS, PLA
WO/2021/228213	COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN  PREPARATION OF MEDICAMENT FOR TREATING HBV	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/228222	COMBINATION FOR TREATING HEPATITIS B	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/238689	CHINESE MEDICINE COMPOSITION FOR SOOTHING NERVES AND AIDING  SLEEP, AND CHINESE MEDICINE SACHET AND APPLICATION	CHENG, Yawei
WO/2021/238690	TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL  CHINESE MEDICINE SACHET USED FOR PREVENTING COLDS AND APPLICATION THEREOF	CHENG, Yawei
WO/2021/233237	TUMOR VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/233239	APPLICATION OF ACTIVE INGREDIENT OF ROOT OF LIGULILOBE SAGE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREPARING ANTIVIRAL DRUG	SOUTHERN MEDICAL UNIVERSITY
WO/2021/238695	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING AND  TREATING COLD IN SPRING AND GRANULES AND APPLICATION THEREOF	CHENG, Yawei
WO/2021/238698	TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL  CHINESE MEDICINE SACHET HELPING TO BOOST MOOD AND APPLICATION THEREOF	CHENG, Yawei
WO/2021/228260	PHARMACEUTICAL USE OF IRIDOID GLYCOSIDE COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/233346	TARGETEDLY MODIFIED EXOSOME LOADED WITH DRUG, AND PREPARATION  METHOD AND USE THEREFOR	BEIJING TIANTAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/238752	PROBIOTIC PREPARATION BASED ON  W<sb>1</sb>/O/W<sb>2</sb> TYPE DUAL EMULSION  STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	HUAZHONG AGRICULTURAL UNIVERSITY
WO/2021/238761	THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS  INFECTION	BEIJING BJUT SCIENCE AND TECHNOLOGY PARK CO., LTD
WO/2021/233402	BREXPIPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION AND  PREPARATION METHOD THEREFOR	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/197507	RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD,  RECOMBINANT PLASMID, AND USE THEREFOR	JIANGSU KANIONREAL BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/233432	BLOOD-PURIFICATION MOLECULAR CONCENTRATE, PREPARATION METHOD  THEREFOR, AND APPLICATION THEREOF	XIA, Yongbiao
WO/2021/238836	CANTHARIDIN ANTIVIRAL AND ANTIBACTERIAL PREPARATION,  PREPARATION METHOD THEREFOR, AND USE THEREOF FOR PREVENTING AND TREATING  NOVEL CORONAVIRUS INFECTION	GANSU YUANMEI PHARMACEUTICAL CO., LTD.
WO/2021/238957	USE OF FAMITINIB IN PREPARATION OF MEDICATION FOR TREATING  TUMOR HAVING C-KIT OR PDGFRA MUTATION	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/238978	PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE PRODRUG, AND  PREPARATION METHOD AND APPLICATION THEREFOR	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/238982	PHARMACEUTICAL COMPOSITION COMPRISING POLYNUCLEOTIDES AND USE  THEREOF FOR PREVENTION OR TREATMENT OF COVID-19	LIAONING YISHENG BIOPHARMA CO., LTD.
WO/2021/254118	APPLICATIONS OF HPK1 KINASE INHIBITOR IN PREVENTING AND/OR  TREATING ANIMAL PATHOGEN INFECTION	ZHUHAI YUFAN BIOTECHNOLOGIES CO., LTD
WO/2021/244421	ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES  THEREOF	STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/239106	APPLICATION OF ATP POTASSIUM CHANNEL MODIFIER IN PREPARATION  OF ANTI-DIABETIC NEPHROPATHY DRUG	HANGZHOU QIAN BIOTECHNOLOGY LTD
WO/2021/239130	PHARMACEUTICAL PREPARATION AND PREPARATION METHOD THEREFOR	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/239134	LIPOSOME CONTAINING ETHYLENEDIAMINE TETRAACETIC ACID OR SALT  THEREOF AND ERIBULIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244460	BIOMARKER RELATED TO ORAL SQUAMOUS CELL CARCINOMA AND  DIAGNOSIS AND TREATMENT METHODS	QINGDAO MEDINTELL BIOMEDICAL CO., LTD
WO/2021/254132	ANTI-SIGLEC15 ANTIBODY AND USE THEREOF	SHENGHE (CHINA) BIOPHARMACEUTICAL CO., LTD.
WO/2021/249228	CAMPTOTHECIN DRUG HAVING HIGH-STABILITY HYDROPHILIC CONNECTING  UNIT AND CONJUGATE THEREOF	SICHUAN BAILI PHARM CO., LTD
WO/2021/244481	COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION	THE UNIVERSITY OF HONG KONG
WO/2021/239147	β-CORONAVIRUS ANTIGEN, β-CORONAVIRUS BIVALENT VACCINE,  PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/249236	USE OF 12,15-DIOXO-α-SELENENE IN PHARMACEUTICALS	KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES
WO/2021/249240	USE OF PALOVAROTENE IN TREATMENT AGAINST HBV VIRUS	YANG SHENG TANG COMPANY, LTD.
WO/2021/244515	PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY SYSTEM  DAMAGE AND A USE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR IMPROVING  RESPIRATORY SYSTEM DAMAGE	BUFFALO BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/244547	APPLICATION OF NATURAL COMPOUND AND DERIVATIVE THEREOF IN  TREATING ARTERIAL LESIONS	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/244551	COMBINED PHARMACEUTICAL COMPOSITION OF C-MET KINASE INHIBITOR  AND ANTI-PD-L1 ANTIBODY	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249250	NOVEL IMMUNOLOGIC ADJUVANT, COMPOUND AND APPLICATION THEREOF	WANG, Zhulin
WO/2021/244597	METHOD FOR PREPARING FATTY ACID-BASED VC LIPOSOME	JIANGNAN UNIVERSITY
WO/2021/244606	GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC  IMPAIRMENT	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/249286	NEW DRUG FORMULA FOR IMMUNOTHERAPY AND TABLET STRUCTURE  THEREOF	XU, Xinpeng
WO/2021/249288	VORICONAZOLE EXTERNAL PREPARATION AND PREPARATION METHOD  THEREFOR	HAINAN POLY PHARM CO., LTD.
WO/2021/249289	APPLICATION OF NORHARMANE IN IMPROVEMENT OF ANTIBIOTIC  ANTIBACTERIAL ACTIVITY	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/244627	ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOF	LONGBIO PHARMA (SUZHOU) CO., LTD.
WO/2021/244628	PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND  APPLICATION THEREOF	SHANGHAI BAO PHARMACEUTICALS CO., LTD.
WO/2021/249352	CONJUGATE OF DOUBLE-STRANDED SIRNA ANALOGUE	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249373	STABLE HIGH-CONCENTRATION ANTI-HUMAN IL-5 MONOCLONAL ANTIBODY  LIQUID PREPARATION	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249376	USE OF TLR4 PATHWAY INHIBITOR AND/OR ANTAGONIST IN PREPARATION  OF DRUG	ZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY
WO/2021/249402	EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE  POLARIZATION MODULATION AND DISEASE TREATMENT	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254221	STABLE LIQUID PREPARATION OF ANTI-IL-4Rα MONOCLONAL ANTIBODIES	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249420	USE OF KADSURA HETEROCLITA (ROXB.) CRAIB AGENT IN PREPARATION  OF MEDICAMENT FOR RESISTING RHEUMATOID ARTHRITIS	HUNAN UNIVERSITY OF CHINESE MEDICINE
WO/2021/249445	PHARMACEUTICAL COMPOSITION OF ANTI-IL-17A ANTIBODIES AND USE  THEREOF	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/249452	RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249484	CONJUGATE GROUP AND CONJUGATE	MEDSHINE DISCOVERY INC.
WO/2021/249492	METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/249501	ANTIVIRAL PREPARATION	SUNTRAP LIFE TECHNOLOGIES LTD.
WO/2021/254265	USE OF COMPOUND IN PREVENTION AND/OR TREATMENT OF PATHOGEN  INFECTION IN ANIMALS	GARGAMEL (ZHUHAI) BIOTECH LTD.
WO/2021/249548	PHARMACEUTICAL COMPOSITION OF NOVEL CORONAVIRUS ANTIBODY AND  USE THEREOF	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/254277	MICROSUSPENSION OF AN MDM2 INHIBITOR AND THERAPEUTIC  APPLICATIONS THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/249551	LIQUID PREPARATION OF ANTI-PD-1 MONOCLONAL ANTIBODIES	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/254287	NOVEL CORONAVIRUS TANDEM EPITOPE POLYPEPTIDE VACCINE AND USE  THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF  SCIENCES
WO/2021/249561	THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY  DISEASES	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254296	BIOACTIVE SUBSTANCE COMPOSITION, SERUM-FREE CULTURE MEDIUM  COMPRISING THE COMPOSITION, AND USES THEREOF	ZHEJIANG UNIVERSITY
WO/2021/254299	USE OF BACTERIA IN CHILDREN DEVELOPMENT ASSESSMENT AND  TREATMENT	THE CHINESE UNIVERSITY OF HONG KONG
WO/2021/254327	ENVELOPE REPLACEMENT-TYPE VIRAL VECTOR VACCINE AND  CONSTRUCTION METHOD THEREFOR	FANTASIA BIOPHARMA (ZHEJIANG) CO. LTD
WO/2021/254337	NEW USE OF ACTIVE INGREDIENT WGX50 IN ZANTHOXYLUM BUNGEANUM  MAXIM. EXTRACT	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/254360	CARBOHYDRATE MOLECULAR CLUSTER AND PREPARATION METHOD THEREFOR  AND MEDICAL USE THEREOF	TUOJIE BIOTECH (SHANGHAI) CO., LTD.
WO/2021/254447	STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL  ANTIBODY	SINOCELLTECH LIMITED
WO/2021/259143	PHARMACEUTICAL USE OF (E)-3-ARYLHETEROCYCLYL PROP-2-ENOIC ACID  DERIVATIVES	MEDCURIUS INC.
WO/2021/254471	ORAL FORMULATIONS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/259195	COMBINED DRUG FOR TREATING CORONAVIRUS DISEASE 2019	SICHUAN UNIVERSITY WEST CHINA HOSPITAL
WO/2021/259211	ANTISEPTIC COMPOSITIONS	RHT LIMITED
WO/2021/259215	ANTISEPTIC COMPOSITIONS	RHT LIMITED
WO/2021/259288	AGONIST OF DEACETYLASE AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH  INSTITUTE OF CHINESE MEDICINE)
WO/2021/259334	SELF-REGULATING CHIMERIC ANTIGEN RECEPTOR AND APPLICATION  THEREOF IN TUMOR IMMUNITY	NANJING BOWANG PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/244676	NOVEL COMPOSITION FOR ENAMEL REMINERALIZATION	IBRITE SUZHOU TECHNOLOGY CO., LTD.
WO/2021/254537	USE OF CYCLOVIROBUXINE	SOUTHWEST UNIVERSITY
WO/2021/249578	MEDICATION FOR THE PREVENTION AND TREATMENT OF ASTHMA, CHRONIC  OBSTRUCTIVE PULMONARY DISEASE, OR ALLERGIC DISEASES	LIU, Li
WO/2021/249579	MEDICATION FOR THE PREVENTION AND TREATMENT OF COLD OR VIRAL  DISEASES	LIU, Li
WO/2021/043345	HUMAN RECOMBINANT HYPOSIALYLATED ERYTHROPOIETIN, METHODS OF  PURIFICATION AND THERAPEUTIC USES THEREOF	CENTRO DE INMUNOLOGIA MOLECULAR
WO/2021/129897	PROTEIN-BASED PHARMACEUTICAL COMPOSITION WITH NEUROPROTECTIVE,  IMMUNOMODULATING, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITY	CENTRO NACIONAL DE BIOPREPARADOS
WO/2021/155871	ORAL SUSPENSION WITH ANTI-ULCEROUS AND CHEMOPROTECTIVE EFFECT  ON COLON CANCER AND PREPARATION METHOD THEREOF	CENTRO NACIONAL DE INVESTIGACIONES CIENTIFICAS
WO/2021/209080	PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROME	CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/233484	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY  DISEASES OF VIRAL ORIGIN	CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/239165	PEPTIDE FOR TREATING CORONAVIRUS INFECTIONS	CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/098892	DEVICE FOR THE PREPARATION OF FUNCTIONALISED SUBSTANCES	GRADE MEDICAL S.R.O.
WO/2021/110185	PHENOLIC DIHYDROBENZOFURANE DERIVATIVES, MEDICAL AND COSMETIC  PREPARATIONS CONTAINING THESE DERIVATIVES, AND USE THEREOF	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/233486	MESYLATE SALT OF <i>PARA</i>-TOPOLIN, COMPOSITIONS  CONTAINING SAID SALT AND USE THEREOF	USTAV EXPERIMENTALNI BOTANIKY AV ČR, V. V. I.
WO/2021/047699	GLYCOPOLYMER, METHOD OF PREPARATION THEREOF, USE THEREOF AS  MEDICAMENT	USTAV MAKROMOLEKULARNI CHEMIE AV CR, V. V.I.
WO/2021/073667	METHOD FOR THE PREPARATION OF POLYMERIC CARRIERS FOR PH-  CONTROLLED DRUG RELEASE AND THEIR CONJUGATES WITH DRUGS	USTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/115502	N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF  CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/115503	LIPOPHOSPHONOXINS, THEIR PREPARATION AND USE	USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I.
WO/2021/121446	COPOLYMER WITH HYDROLYTIC RELEASE OF CANCEROSTATIC AGENT  CYTARABINE, METHOD OF ITS PREPARATION AND USE THEREOF	USTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/249581	METHOD OF PREPARATION OF THE TRANSFER FACTOR MEDICINE,  TRANSFER FACTOR MEDICINE, METHOD OF TESTING ITS BIOLOGICAL ACTIVITY,  PHARMACEUTICAL FORM AND ITS USE	AUMED, A.S.
WO/2021/148065	A METHOD OF TRANSFORMATION OF GENES INTO BACTERIAL CELLS	UNIVERZITA KARLOVA, LEKARSKA FAKULTA V PLZNI
WO/2021/148066	DENTAL PREPARATION COMPRISING FIBERS BASED ON HYALURONIC ACID  WITH REGULATED BIODEGRADABILITY	CONTIPRO A.S.
WO/2021/013283	ORAL HYGIENE AGENTS CONTAINING CAFFEINE AND L-LYSIN AS BITTER  BLOCKING AGENTS	DR. KASCHNY HEALTHCARE GMBH
WO/2021/027984	PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES	KORTH, Ruth-Maria
WO/2021/093912	NEW FORMULATION OF LACTOBACILLUS STRAINS FOR THE TREATMENT AND  PREVENTION OF <i>HELICOBACTER PYLORI</i> COLONISATION IN THE  UPPER AIRWAYS AND THE DIGESTIVE SYSTEM	BELANO MEDICAL AG
WO/2021/008652	NANOSTRUCTURED IBUOPROFEN COMPOSITIONS, METHODS FOR THEIR  PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM	MYBIOTECH GMBH
WO/2021/032252	ADHESIVE PLASTER CONTAINING A SPECIALLY DESIGNED RESERVOIR FOR  A PHARMACEUTICAL PREPARATION	ABU-GHAZALEH, Adrian
WO/2021/143962	PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND  BACTERIOPHAGE APPLICATION DEVICE	JUNGHANS, Simon Frank
WO/2021/209093	TREATMENT OF NON-TRANSMISSIBLE INFLAMMATORY DISEASES WITH A  SUBSTANCE THAT INHIBITS TRANSCRIPTION OF THE CEBPB GENE OR THE FUNCTION OF  THE CEBPB PROTEIN	DERMAGNOSTIX R&D GMBH
WO/2021/213587	COMBINATION WHICH CAN BE USED FOR THE TREATMENT AND  PROPHYLAXIS OF CORONAVIRUS-INDUCED PULMONARY DYSFUNCTION AND DAMAGE	KIESEWETTER, Holger
WO/2021/259423	USE OF COENZYME ANTAGONISTS IN ORDER TO SLOW DOWN A METABOLIC  PROCESS	TAVARGENIX GMBH
WO/2021/259425	BISPHOSPHONATE-MODIFIED LIPOSOMES CONTAINING NANOPARTICLES	PHARMA DEVELOPMENT HOLDING GMBH
WO/2021/069036	COMPRESSED NICOTINE LOZENGE	FERTIN PHARMA A/S
WO/2021/001006	A SKIN CARE COMPOSITION	COLOPLAST A/S
WO/2021/023351	TOPICAL FORMULATIONS COMPRISING CANNABIDIOL, METHOD OF  PREPARING THE COMPOSITION AND USE THEREOF	CS GROUP APS
WO/2021/069044	AN ION-EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE  POLYMERS	FERTIN PHARMA A/S
WO/2021/069046	A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF MUCUS  BARRIER PROPERTIES	CIRQLE BIOMEDICAL CONTRACEPTION ApS
WO/2021/083467	ADMINISTRATION OF CD22, CD33 AND/OR TIM-3 ANTIBODIES USING  OMMAYA RESERVOIRS FOR THE TREATMENT OF CNS CANCER OR NEURODEGENERATIVE  DISEASES	Y-MABS THERAPEUTICS, INC.
WO/2021/151442	METHOTREXATE DOSAGE FORM	ROS THERAPEUTICS APS
WO/2021/164832	STARCH PROPIONATE USED AS A FOOD ADDITIVE AND/OR DIETARY  SUPPLEMENT FOR PREVENTION OF OVERWEIGHT AND OBESITY	ABILDGAARD, Ole
WO/2021/170193	COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR  WOUND HEALING	SAHEBI, Sükrüye
WO/2021/213601	B7H3 ANTIBODIES WITH CHELATORS	Y-MABS THERAPEUTICS, INC.
WO/2021/223824	FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTS	FERTIN PHARMA A/S
WO/2021/223825	ORAL POWDER MIXTURE WITH SMALL SIZED PARTICLES	FERTIN PHARMA A/S
WO/2021/223826	MOUTHWASH FOR ORAL CARE BENEFITS	FERTIN PHARMA A/S
WO/2021/244721	ANTI-B7H3 ANTIBODIES FOR THE TREATMENT OF CANCER	Y-MABS THERAPEUTICS, INC.
WO/2021/259434	METHOD FOR MANUFACTURING A MULTI-LAYERED FILM STRUCTURE AND  METHOD FOR MANUFACTURING MULTI-LAYERED MICROSTRUCURES	MLMC THERAPEUTICS APS
WO/2021/078349	PHARMACEUTICAL COMPOSITION BASED ON PLANT EXTRACTS FOR THE  TREATMENT OF FIBROMYALGIA, RHEUMATOID ARTHRITIS, LUPUS AND OTHER AUTOIMMUNE  DISEASES	PORTILLO ROSADO, Rosa Maria
WO/2021/037322	COMPOSITION FOR DELAYING AND DYEING GREY HAIR	PORTILLO ROSADO, Rosa Maria
WO/2021/180293	A COMPOSITION FOR NORMALIZING BLOOD LIPID LEVEL	DIKOVSKIY, Aleksander Vladimirovich
WO/2021/043382	NOVEL BIOLOGICAL ENTERIC DIALYSIS METHOD FOR CKD AND ESRD	HESEN, Sherif Salah Abdulaziz
WO/2021/028005	A MEDICAMENT COMPRISING ANABASINE FOR TREATMENT OF ASTHMA,  CHEST ALLERGY AND ATOPIC DERMATITS	ELKAZAZ, Mohamed, Fadly, Abd el Ghany
WO/2021/151450	TARGETED DRUG DELIVERY SYSTEM USING BACTERIAL GHOSTS OF  SALMONELLA TOWARD HEPATIC CANCER CELLS	AHMED, Sameh Rabea Mohamed
WO/2021/254582	EFFICACY OF (SOFOSBUVIR PLUS LEDIPASVIR) IN EGYPTIAN PATIENTS  WITH COVID-19COMPARED TO STANDARD OF CARE TREATMENT.	ALMAZA MILITARY FEVER HOSPITAL
WO/2021/013315	OINTMENT FOR DIABETIC FOOT ULCER TREATMENT	MOSTAFA, Mariam Mohamed Kamel
WO/2021/259441	A NEW AND SAFE PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND  TREATMENT OF RESPIRATORY VIRAL INFECTIONS, ESPECIALLY CORONA VIRUSES	KHALIL, Ibrahim Taha Ibrahim
WO/2021/063468	STABLE PARENTERAL PHARMACEUTICAL COMPOSITION CONTAINING  TIGECYCLINE AND PROCESS FOR THE PREPARATION THEREOF	ANFARM HELLAS S.A.
WO/2021/008668	PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION CONTAINING CYCLOSPORINE	PHARMATHEN S.A.
WO/2021/001023	RNA FORMULATIONS SUITABLE FOR THERAPY	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001029	BLEND OF BEESWAX AND A LACTYLATE ESTER	SYMRISE AG
WO/2021/008669	PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF OPA1 FOR  USE IN THE TREATMENT OF CANCER	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/008678	USE OF N-ACYLHYDROXY AMINO ACID ESTER FOR INDUCING THE  EXPRESSION OF SUPEROXIDE-DISMUTASE AND/OR HEM OXYGENASE	SYMRISE AG
WO/2021/018377	COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN  REGENERATIVE EFFECT	GIULIANI S.P.A.
WO/2021/018387	DIFFERENT FORMS OF  6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE	QURIENT CO., LTD.
WO/2021/028024	IMPROVED DOSAGE OF BALOXAVIR MARBOXIL FOR PEDIATRIC PATIENTS	F. HOFFMANN-LA ROCHE AG
WO/2021/032271	INDUCTION OF FUNCTIONAL ASTROCYTES FROM PLURIPOTENT STEM CELLS	LU LICENSE AB
WO/2021/037383	COSMETIC USE OF β-L-ASPARTYL-L-ARGININE	SYMRISE AG
WO/2021/043389	GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT FOR  TREATMENT OR PREVENTION OF AN IMPAIRED COGNITION	BOTALYS SA
WO/2021/043392	ANTIPERSPIRANT EMULSION	BEIERSDORF AG
WO/2021/043394	ANTIPERSPIRANT ACTIVE EMULSION	BEIERSDORF AG
WO/2021/047783	VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCER	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/052597	SKIN-CARE PRODUCT CONTAINING HYALURONIC ACID (OR A SALT  THEREOF) AND A PLANT STEM CELL EXTRACT	PM-INTERNATIONAL AG
WO/2021/058091	TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2  (IL2)	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/037387	PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUS	ELANCO US INC.
WO/2021/058117	METHOD OF TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT  ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)	VOLUTION IMMUNO PHARMACEUTICALS SA
WO/2021/073742	AGONIST OF TACR2	UNIVERSITY OF COPENHAGEN
WO/2021/078359	USE OF INHIBITORS OF CUBILIN FOR THE TREATMENT OF CHRONIC  KIDNEY DISEASES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/073761	COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES	SYMRISE AG
WO/2021/073762	COMBINATION DRUG FOR MEDICAL USE FOR THE TREATMENT OF A  DISORDER CAUSED BY DAMAGE TO RENAL TUBULAR   FUNCTION	PROSALIX AG
WO/2021/104639	USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE  PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOID	ROTTAPHARM BIOTECH S.R.L.
WO/2021/110239	STAINLES STEEL CAN FOR PRESSURISED METERED DOSE INHALERS	CHIESI FARMACEUTICI S.P.A.
WO/2021/013372	LIQUID ANTIBODY FORMULATION	ICHNOS SCIENCES SA
WO/2021/115601	BIODEGRADABLE MICROCAPSULE SYSTEMS	PAPIERFABRIK AUGUST KOEHLER SE
WO/2021/115610	METHOD FOR PREPARING A COMPOSITION AND USE OF THE COMPOSITION  FOR TREATMENT OR PROPHYLAXIS OF DISEASE	QUANTUM PHARMACEUTICALS SA
WO/2021/121566	UTILIZATION OF A COMPOSITION COMPRISING ORGANIC SILICA FOR THE  IMPROVEMENT OF THE QUALITY OF CARTILAGENOUS TISSUES	AA HEALTHCARE SàRL
WO/2021/063526	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063527	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063528	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063529	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063530	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063531	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063532	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/121627	IMPROVED PERTUSSIS VACCINE COMPOSITION	UNIVERSITé D'AIX-MARSEILLE
WO/2021/151452	OIL-IN-WATER-TYPE EMULSION COSMETIC	L V M H RECHERCHE
WO/2021/129927	TREATMENT WITH IMMUNE EFFECTOR CELLS ENGINEERED TO EXPRESS AN  ANTIGEN RECEPTOR	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/129945	<i>IN VITRO</i> AND <i>IN VIVO</i>  GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED  WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/121645	A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION  COMPRISING ZILEUTON	QURIENT CO., LTD.
WO/2021/013384	SKINCARE COMPOSITIONS	THE BOOTS COMPANY PLC
WO/2021/018414	PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATE	ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/037396	DENTAL COMPOSITION	DENTSPLY SIRONA INC.
WO/2021/078412	FRACTAL FORMULATIONS	MESSADEK, Jallal
WO/2021/139872	SOLUBLE MELATONIN TRIPARTATE ADDUCT FOR THE PREVENTION AND  TREATMENT OF RARE AND SEVERE EYE SIGHT-THREATENING CONDITIONS AND  NEURO-OPHTHALMIC DISORDERS	WORPHMED SRL
WO/2021/139874	COGNITIVE DISORDER PREVENTION AND THERAPY	ANIMA
WO/2021/144020	ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME	IMMATICS BIOTECHNOLOGIES GMBH
WO/2021/073775	ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN	SYMRISE AG
WO/2021/013385	PROCESSES FOR OBTAINING A HIGHLY CONCENTRATED ANTIBODY  SOLUTION	ICHNOS SCIENCES SA
WO/2021/148124	COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM  BODY SURFACE LESIONS	DEBX MEDICAL BV
WO/2021/155916	TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS  BINDING TO PD-L1 AND CD137	BIONTECH SE
WO/2021/164848	NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING  NUCLEOSIDES AS MEDICAMENTS	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/170218	STABLE, LIQUID EMULSIFIERS ON THE BASIS OF CITRATE ESTERS AND  THEIR USE	SYMRISE AG
WO/2021/170223	ANTIPERSPIRANT ACTIVE EMULSION	BEIERSDORF AG
WO/2021/175405	COMPOSITE RNA PARTICLES	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/175432	METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENT	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175450	COMPOSITION OR OAT EXTRACT COMPRISING AVENANTHRAMIDE AND  ß-GLUCAN	SYMRISE AG
WO/2021/175451	COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L	SYMRISE AG
WO/2021/175452	COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE  THEREOF WITH IMPROVED SKIN PENETRATION	SYMRISE AG
WO/2021/175453	COMPOSITION COMPRISING AN AVENTHRAMIDE OR AN ANALOGUE THEREOF  WITH IMPROVED STABILITY	SYMRISE AG
WO/2021/175454	AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY  COMPRISING 4-HYDROXYPHENONE	SYMRISE AG
WO/2021/037400	METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION  FRACTION WITH DAPAGLIFLOZIN	ASTRAZENECA AB
WO/2021/139901	PEPTIDE-CONTAINING COMPOSITION FOR USE FOR TREATING NEOPLASTIC  LESIONS	CYTOVATION AS
WO/2021/047798	VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCER	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/083555	ALK INHIBITORS FOR TREATMENT OF ALK-NEGATIVE CANCER AND PLASMA  CELL-MEDIATED DISEASES	UNIVERSITETET I OSLO
WO/2021/190735	COSMETIC COMPOSITION FOR MAKING UP OR CARING FOR KERATIN  MATERIALS COMPRISING A FLUORESCENT COMPOUND FROM THE FAMILY OF  4-BORA-3A,4A-DIAZA-S-INDACENES, AND/OR FROM THE FAMILY OF DIFLUOROBORANE  BETA-DIKETONATES	CRIME SCIENCE TECHNOLOGY
WO/2021/190770	INHIBITORS OF C5A FOR THE TREATMENT OF CORONA VIRUS Infection	INFLARX GMBH
WO/2021/197589	TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN  VACCINATION	BIONTECH SE
WO/2021/148143	TREATMENT OF CARDIAC REMODELLING	UNIVERSITETET I OSLO
WO/2021/197639	COMPOSITIONS COMPRISING 15-HEPE FOR TREATING OR PREVENTING  HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASES	AFIMMUNE LIMITED
WO/2021/204371	ANTI-POLLUTION COMPOSITION	BEIERSDORF AG
WO/2021/073778	COMPOSITIONS AND METHODS FOR VACCINATING PIGLETS AGAINST  <i>STREPTOCOCCUS</i>	CEVA SANTE ANIMALE
WO/2021/209134	ANTIMICROBIAL SILVER COORDINATION COMPLEXES	PENTA SCIENCE INDUSTRIES HOLDING B.V.
WO/2021/136602	ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS	LABOSERVE PHARMACEUTICAL COMPANY S.A.
WO/2021/180338	COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF DNA METHYLTRANSFERASE POST STEM CELL TRANSPLANT	APREA THERAPEUTICS AB
WO/2021/219202	VISUALIZATION OF HER2 EXPRESSION IN HUMAN PATIENTS	HOBER BIOTECH AB
WO/2021/004673	SOLID HAIR CONDITIONING COMPOSITIONS	HENKEL AG & CO. KGAA
WO/2021/004674	SOLID HAIR CONDITIONING COMPOSITIONS	HENKEL AG & CO. KGAA
WO/2021/094000	DOSING REGIMEN FOR ANTI-BCMA AGENTS	AMGEN RESEARCH (MUNICH) GMBH
WO/2021/228358	A SOLID MUCOADHESIVE COMPOSITION	SYMRISE AG
WO/2021/228363	PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE  SYSTEM	VAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/228365	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228366	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228414	METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN  FORMULATIONS	PHARMA MAR, S.A.
WO/2021/098991	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/233534	USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOF	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/233549	CLEAVABLE POLYMER DRUG CONJUGATES FOR VIRAL DISEASES	RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM  SIRKETI
WO/2021/233551	OLIGONUCLEOTIDES FOR SPLICE MODULATION OF CARD9	F.HOFFMANN-LA ROCHE AG
WO/2021/098992	METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN  FORMULATIONS	PHARMA MAR, S.A.
WO/2021/001104	LIPID MIXTURE CONSISTING OF LIQUID OILS, HYDROGENATED  VEGETABLE OILS, AND SHEA BUTTER	BEIERSDORF AG
WO/2021/244733	HYPOXIA-RESISTANT NATURAL KILLER CELLS	ONK THERAPEUTICS LIMITED
WO/2021/004711	FATTY ACID POLYGLYCERYL ESTER-CONTAINING CLEANSING PREPARATION	BEIERSDORF AG
WO/2021/004712	CLEANSING EMULSION CONTAINING FATTY ACID POLYGLYCERYL ESTERS	BEIERSDORF AG
WO/2021/018443	METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6 ALKOXY-SILANE AND AN AMINO ACID AND/OR AN AMINO ACID DERIVATIVE	HENKEL AG & CO. KGAA
WO/2021/013419	INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN  MATERIAL	HENKEL AG & CO. KGAA
WO/2021/018444	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENT	HENKEL AG & CO. KGAA
WO/2021/018445	OXIDANT-FREE METHOD FOR DYEING KERATIN MATERIAL, COMPRISING  THE APPLICATION OF AN ORGANIC C1-C6-ALKOXY SILANE AND AN OXIDANT-FREE DYE  PRECURSOR	HENKEL AG & CO. KGAA
WO/2021/018446	METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE  APPLICATION OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN AMINO ACID AND/OR AMINO  ACID DERIVATIVE	HENKEL AG & CO. KGAA
WO/2021/013420	INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN  MATERIAL	HENKEL AG & CO. KGAA
WO/2021/028093	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/018447	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENT	HENKEL AG & CO. KGAA
WO/2021/028094	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/028095	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/023415	COMESTIC NANOEMULSION	BEIERSDORF AG
WO/2021/249641	PHARMACEUTICAL COMPOSITIONS CONTAINING ENTEROKINE-RELEASING  SUBSTANCES IN MULTIPLE DOSAGE FORMS IN COMBINATION WITH GELLING AGENTS	APHAIA PHARMA IP AG
WO/2021/254588	SOLID CLEANSING COMPOSITION	BEIERSDORF AG
WO/2021/004736	REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR  DHA	DSM IP ASSETS B.V.
WO/2021/254628	FRAGRANCE MIXTURES CONTAINING 1-(4,4-DIMETHYLCYCLOHEXEN-1-YL)  ETHANON	SYMRISE AG
WO/2021/254637	ASSOCIATION OF NATURAL ACTIVES INGREDIENTS TO FIGHT SKIN AGING	TOMCAT INTERNATIONAL LIMITED
WO/2021/004770	HAIR CARE COMPOSITION COMPRISING ANTIDANDRUFF AGENT	UNILEVER N.V.
WO/2021/018479	PROCESS AND APPARATUS FOR PRODUCTION OF A GRANULAR CANNABINOID  MATERIAL ESSENTIALLY SOLUBLE IN AQUEOUS MEDIUM	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/259454	TINTED SUNSCREEN	BEIERSDORF AG
WO/2021/013452	TSG6 POLYPEPTIDE FRAGMENT FOR DRY EYE DISEASE	THE UNIVERSITY OF MANCHESTER
WO/2021/008822	TOPICAL COMPOSITIONS AND METHODS OF USING SAME AGAINST  MITOCHONDRIAL FRAGMENTATION	UNILEVER PLC
WO/2021/008823	STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS	UNILEVER PLC
WO/2021/008824	BIOENERGETIC COMBINATIONS AND METHODS OF USING SAME	UNILEVER PLC
WO/2021/259471	DERMAL FILLER WITH HIF-1α ACTIVITY MODULATORS	THOR, Dominik
WO/2021/259472	MICELLAR DOCETAXEL FOR USE IN THE TREATMENT OF CANCER	OASMIA PHARMACEUTICAL AB
WO/2021/001281	METHOD OF DEPOSITING A SUBSTANCE ON A SUBSTRATE	DBV TECHNOLOGIES
WO/2021/001286	A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1  POSITIVE ALLOSTERIC MODULATOR	UCB BIOPHARMA SRL
WO/2021/001288	A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1  POSITIVE ALLOSTERIC MODULATOR	UCB BIOPHARMA SRL
WO/2021/001290	COMPOSITION COMPRISING STABILIZED PHYCOCYANIN AND ITS USES	CALICEA
WO/2021/001306	METHYLTHIONINIUM AS ENHANCERS OF THE COGNITIVE FUNCTION	WISTA LABORATORIES LTD.
WO/2021/013476	HAIR CARE COMPOSITION	UNILEVER N.V.
WO/2021/001326	METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIES	WISTA LABORATORIES LTD.
WO/2021/001332	METHOD FOR OBTAINING A BOTANICAL THERMAL INFUSION	LABORATOIRES LéA
WO/2021/013479	MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER  DYSFUNCTION	UNIVERSITEIT ANTWERPEN
WO/2021/001349	INHALABLE COMPOSITION COMPRISING CYCLODEXTRIN FOR USE IN THE  TREATMENT OF NASAL INFLAMMATIONS	AQUILON PHARMACEUTICALS
WO/2021/001356	CD5 SPECIFIC T CELL RECEPTOR CELL OR GENE THERAPY	MAX-DELBRüCK-CENTRUM FüR MOLEKULARE MEDIZIN IN DER  HELMHOLTZ-GEMEINSCHAFT
WO/2021/001360	PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES  THEREOF	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/121677	RETINOL-BASED SERUM	L'OREAL
WO/2021/001362	PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES  THEREOF	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/001365	PROPHYLAXIS AND TREATMENT OF A HUMAN PAPILLOMAVIRUS (HPV)  INFECTION OF THE CERVIX	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTÄT
WO/2021/001366	METHOD FOR STABILIZING THE PH OF AN AQUEOUS COMPOSITION  COMPRISING A DRUG	OCULIS SA
WO/2021/001374	PHARMACEUTICAL COMPOSITIONS FOR GLUCAGON AND GLP-1 CO-AGONIST  PEPTIDES	MEDIMMUNE LIMITED
WO/2021/001377	cPLA2e INDUCING AGENTS AND USES THEREOF	FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/001380	THERAPEUTIC INTERACTIONS OF LEUCOMETHYLTHIONINIUM	WISTA LABORATORIES LTD.
WO/2021/001393	COSMETIC COMPOSITION COMPRISING SILICONES BEARING A CARBOXYLIC  GROUP AND ANIONIC DIRECT DYES, AND COSMETIC TREATMENT PROCESS	L'OREAL
WO/2021/008870	Cosmetic composition comprising anionic and amphoteric  surfactants, cationic polysaccharides and unsaturated fatty alcohols, and  cosmetic treatment process	L'OREAL
WO/2021/001405	COMPOUND AND COMPOSITIONS FOR MULTITARGET TREATMENT OF TAU  PROTEIN-RELATED DISORDERS	FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
WO/2021/001417	RNA FORMULATIONS SUITABLE FOR THERAPY	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001427	METHODS FOR THE PROPHYLACTIC TREATMENT OF CANCER IN PATIENTS  SUFFERING FROM PANCREATITIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/001431	USE OF PI3KA-SELECTIVE INHIBITORS FOR TREATING METASTATIC  DISEASE IN PATIENTS SUFFERING FROM PANCREATIC CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/001457	CRYSTALLINE (R)-2-AMINO-3-PHENYLPROPYLCARBAMATE ACID ADDITION  SALTS	SANDOZ AG
WO/2021/001458	ANTI-CD154 ANTIBODIES AND USES THEREOF	TONIX PHARMA HOLDINGS LIMITED
WO/2021/001461	ORAL THIN FILM	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/001462	CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS	INTERVET INTERNATIONAL B.V.
WO/2021/001464	COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS	BIONURE FARMA, S.L.
WO/2021/001508	METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINE	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/004910	COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY  MYCOPLASMA GENITALIUM	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/001518	PXR LIGANDS FOR THE PREVENTION OR TREATMENT OF METABOLIC  DISORDERS	MEDIZINISCHE UNIVERSITÄT GRAZ
WO/2021/004913	COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN  FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004915	COMPOSITIONS AND METHODS USING TRIGONELLINE AND MINERALS FOR  PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004919	COMPOSITIONS AND METHODS USING TRIGONELLINE AND VITAMINS FOR  PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004922	COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE  INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR  PREVENTING PHYSIOLOGICAL DISORDERS OR STATES	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/001528	NOVEL GALACTOSIDE INHIBITOR OF GALECTINS	GALECTO BIOTECH AB
WO/2021/001538	NOVEL GALACTOSIDE INHIBITOR OF GALECTINS	GALECTO BIOTECH AB
WO/2021/001540	DETOXIFICATION OF PROTEINS	PROXI BIOTECH APS
WO/2021/004942	DRY COSMETIC AND/OR SKIN CARE COMPOSITION	OMYA INTERNATIONAL AG
WO/2021/004945	COMPOSITION COMPRISING A NATURAL DYE, AN ANTHRAQUINONE  CATIONIC DIRECT DYE AND AN AROMATIC COMPOUND	L'OREAL
WO/2021/004948	COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO  CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUND	L'OREAL
WO/2021/004950	COMPOSITION COMPRISING A NATURAL DYE, A TRIARYLMETHANE DIRECT  DYE AND AN AROMATIC COMPOUND	L'OREAL
WO/2021/004958	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/001567	MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPY	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/001568	METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINE	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/013509	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING  POLYMER II	HENKEL AG & CO. KGAA
WO/2021/013510	COATED EFFECT PIGMENTS AND PRODUCTION THEREOF	HENKEL AG & CO. KGAA
WO/2021/013511	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING  POLYMER IV	HENKEL AG & CO. KGAA
WO/2021/013512	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT III	HENKEL AG & CO. KGAA
WO/2021/013513	COLOURING EFFECT PIGMENTS AND PRODUCTION THEREOF	HENKEL AG & CO. KGAA
WO/2021/013516	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A FILM-FORMING POLYMER  II	HENKEL AG & CO. KGAA
WO/2021/052647	SKIN LIGHTENING COMPOSITION	BELLA AURORA LABS, S.A.
WO/2021/052648	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A SEALING REAGENT I	HENKEL AG & CO. KGAA
WO/2021/013517	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT I	HENKEL AG & CO. KGAA
WO/2021/005011	TABLETING OF SPECIFIC POLYMER STABILIZERS	BASF SE
WO/2021/005059	MODIFIED ESCHERICHIA COLI STRAIN NISSLE AND TREATMENT OF  GASTROINTESTINAL DISORDER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/005064	A COMPOSITION, A KIT AND USE THEREOF	THERAVET SA
WO/2021/005069	A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITION	THERAVET SA
WO/2021/005071	A COMPOSITION, A KIT AND USE THEREOF	THERAVET SA
WO/2021/098996	OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION	UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
WO/2021/005077	PHARMACEUTICAL PREPARATION	MERCK PATENT GMBH
WO/2021/013546	A WATER-IN-OIL EMULSION COMPOSITION FOR ENHANCED DELIVERY OF  WATER SOLUBLE SKIN BENEFIT AGENTS	UNILEVER N.V.
WO/2021/005101	PHARMACEUTICAL COMPOSITION COMPRISING A  TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUND	IDORSIA PHARMACEUTICALS LTD
WO/2021/005104	COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR  HAIR CARE COMPOSITION	BASF SE
WO/2021/005117	TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE  AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN  CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005118	TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE  AGENT-CONTAINING LAYER COMPRISING AN ACRYLIC POLYMER AND A SKIN CONTACT LAYER  COMPRISING A SILICONE GEL ADHESIVE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005129	COMBINATION OF IBUPROFEN AND TRAMADOL FOR RELIEVING PAIN	FARMALíDER, S.A.
WO/2021/259506	COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND  A SAPONIN OR A LIGAND-SAPONIN CONJUGATE	SAPREME TECHNOLOGIES B.V.
WO/2021/259507	CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN  EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME,  THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION	SAPREME TECHNOLOGIES B.V.
WO/2021/259508	CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY,  PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF	SAPREME TECHNOLOGIES B.V.
WO/2021/005147	COMBINATION	GENESIS PHARMA SA
WO/2021/005153	SELF-ASSEMBLING PEPTIDES IN THE PREVENTION AND TREATMENT OF  CAVITATED CARIOUS LESIONS	CREDENTIS AG
WO/2021/005169	TREATMENT OF PATIENTS UNDER ANTIPLATELET MEDICATION  EXPERIENCING BLEEDING	FÄLKER, Knut
WO/2021/005176	TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD)	GENETHON
WO/2021/005183	INHIBITOR OF MAP KINASE INTERACTING SERINE/THREONINE KINASE 1  (MNK1) AND MAP KINASE INTERACTING SERINE/THREONINE KINASE 2 (MNK2), CANCER  THERAPY AND THERAPEUTIC COMBINATIONS	FUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/005189	NOVEL PFAR-INHIBITING COMPOUNDS	UNIVERSITE DE BRETAGNE OCCIDENTALE (UBO)
WO/2021/047804	IN VITRO METHOD FOR TRANSDUCTION OF T CELLS IN THE PRESENCE OF  MALIGNANT CELLS	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/009020	EXCIPIENT FOR BIOTHERAPEUTICS	LUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009027	HIGH CONCENTRATION INSULIN FORMULATION	NOVO NORDISK A/S
WO/2021/009029	TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE  IN THE TREATMENT AND/OR PREVENTION OF CANCER	UNIVERSIDAD DE MURCIA
WO/2021/009040	PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH A VOLATILE  ORGANIC ACTIVE	BASF SE
WO/2021/009050	REDUCING MALARIA TRANSMISSION	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/009083	PROCESS FOR TREATING KERATIN FIBERS, COMBINING A COMPOSITION  COMPRISING A WATER-SOLUBLE SILICATE AND A COMPOSITION COMPRISING AN AMINO  ACID AND/OR AN OLIGOPEPTIDE	L'OREAL
WO/2021/009091	METHODS FOR PREDICTING AND TREATING CARDIAC DYSFUNCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/058157	KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/009110	COSMETIC PREPARATIONS COMPRISING NATURAL ACTIVATORS	ETH ZURICH
WO/2021/058158	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ETHOXYLATED FATTY ACID ESTER	HENKEL AG & CO. KGAA
WO/2021/058159	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND AN ORGANIC CARBONIC ACID ESTER	HENKEL AG & CO. KGAA
WO/2021/009126	SIRNA SEQUENCES TARGETING THE EXPRESSION OF HUMAN GENES JAK1  OR JAK3 FOR A THERAPEUTIC USE	COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
WO/2021/009142	COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING  THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR	LABORATOIRES EXPANSCIENCE
WO/2021/018565	SKIN CARE OIL IN WATER EMULSION	BEIERSDORF AG
WO/2021/009177	ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION	MONASTERIUM LABORATORY SKIN & HAIR RESEARCH SOLUTIONS GMBH
WO/2021/073788	NATURAL NON-PATHOGENIC MICROORGANISMS CAPABLE OF ASSOCIATING  GLYCOLIPIDS OR LIPOPEPTIDES AND USE THEREOF	ACARYON GMBH
WO/2021/009197	DOSE DUMPING RESISTANT PHARMACEUTICAL COMPOSITIONS COMRISING  VERINURAD	ASTRAZENECA AB
WO/2021/009219	A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE  PHARMACOKINETIC PROFILE	FLUOGUIDE A/S
WO/2021/009237	A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE	RIGSHOSPITALET
WO/2021/018596	LIQUID ORAL CARE COMPOSITION	MEDA PHARMA S.P.A.
WO/2021/009266	PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATION	ZEALAND PHARMA A/S
WO/2021/009267	ANTI-PD-L1 ANTIBODIES	CAPELLA BIOSCIENCE LTD
WO/2021/013693	ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS	BAYER PHARMA AKTIENGESELLSCHAFT
WO/2021/009288	COMBINATION COMPRISING ALPHA-1 ANTITRYPSIN FOR USE IN TREATING  ISCHAEMIA IN A SUBJECT	FUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/018619	STABILIZING THERAPEUTIC PROTEINS WITH PIPERAZIN- OR  MORPHOLINE-CONTAINING ZWITTERIONIC BUFFERING SUBSTANCES	LUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009331	IMPROVED TREATMENT USING EYP001	ENYO PHARMA
WO/2021/009332	METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERON	ENYO PHARMA
WO/2021/009333	SYNERGISTIC EFFECT OF EYP001 AND IFN FOR THE TREATMENT OF HBV  INFECTION	ENYO PHARMA
WO/2021/009336	METHODS FOR INDUCING FULL ABLATION OF HEMATOPOIESIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013712	POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT  OF MUSCLE DISEASES	ANAGENESIS BIOTECHNOLOGIES S.A.S.
WO/2021/013713	MESNA COMPOSITION, KIT COMPRISING MESNA AND METHOD FOR  VISUALIZATION OF A MESNA COMPOSITION APPLIED TO TISSUES	AUXIN SURGERY SA
WO/2021/013714	COMPOSITION AND INSTRUMENT COMPRISING MESNA FOR USE IN A  METHOD OF ROBOT-ASSISTED SURGERY	AUXIN SURGERY SA
WO/2021/009355	SOLID FORMULATION OF A 1,2,4-OXADIAZOLE DERIVATIVE	ABAXYS THERAPEUTICS
WO/2021/009358	ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC  PATIENTS	BIOINVENT INTERNATIONAL AB
WO/2021/009362	BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE  DERIVATIVES FOR THE MODULATION OF STING	CTXT PTY LIMITED
WO/2021/009363	MEDICAL USES, METHODS AND USES	AOUADI, Myriam
WO/2021/009365	BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE  DERIVATIVES FOR THE MODULATION OF STING	CTXT PTY LIMITED
WO/2021/009367	GLYCOPEPTIDES INCREASING LIPID SYNTHESIS	TFCHEM
WO/2021/013764	P21 EXPRESSING MONOCYTES FOR CANCER CELL THERAPY	INSTITUT GUSTAVE ROUSSY
WO/2021/013771	FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF  TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT)	VIFOR (INTERNATIONAL) AG
WO/2021/013772	FERROPORTIN-INHIBITORS FOR THE USE IN THE PREVENTION AND  TREATMENT OF KIDNEY INJURIES	VIFOR (INTERNATIONAL) AG
WO/2021/013798	THERAPEUTIC VIRAL VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/009384	NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION  INHIBITORS	CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
WO/2021/013815	METHODS OF TREATING MULTIPLE SCLEROSIS	ACTELION PHARMACEUTICALS LTD
WO/2021/013825	SOFT CHEWABLE VETERINARY DOSAGE FORM	INTERVET INTERNATIONAL B.V.
WO/2021/013861	SUSTAINED RELEASE TREPROSTINIL-COMPOUND MICROPARTICLE  COMPOSITIONS	NANOMI, B.V.
WO/2021/018682	HYBRID MINERAL-ORGANIC COMPLEX, AND USE THEREOF FOR  MAINTAINING THE MICROBIOLOGICAL BALANCE OF THE SKIN AND/OR OF A COSMETIC  AND/OR DERMOPHARMACEUTICAL COMPOSITION	BIONUCLEI
WO/2021/023512	BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPY	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/013884	INHIBITORS OF CHI3L1 AND THEIR USES	HUMANITAS MIRASOLE S.P.A.
WO/2021/013903	NEW USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES	UNIVERSITé DE LIèGE
WO/2021/013904	ANTIBODY AGAINST THE OPRF PROTEIN OF <i>PSEUDOMONAS  AERUGINOSA</i>, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL  COMPOSITION CONTAINING SAME	UNIVERSITé GRENOBLE ALPES
WO/2021/028180	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/013911	INHIBITORS OF THE STING PATHWAY FOR THE TREATMENT OF  HIDRADENITIS SUPPURATIVA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013921	THE SERPINB3 INHIBITOR PIPERIDINPROPIONIC ACID FOR TUMOR  TREATMENT	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/013931	ANTIMYCOTIC	KARL-FRANZENS-UNIVERSITÄT GRAZ
WO/2021/013942	USE OF MYELOPEROXIDASE INHIBITORS FOR THE TREATMENT OF  CARDIOVASCULAR DISEASES IN PATIENTS SUFFERING FROM MYELOPROLIFERATIVE  NEOPLASMS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/013944	FAECALIBACTERIUM PRAUSNITZII AND CHRISTENSENELLA BACTERIAL  STRAINS FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATION	INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE,  L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/013950	IMMUNE CELLS DEFECTIVE FOR SUV39H1	MNEMO THERAPEUTICS
WO/2021/013951	VETERINARY COMPOSITIONS COMPRISING MELATONIN AND THEIR USES  FOR RUMINANTS	CEVA SANTE ANIMALE
WO/2021/018747	HAIR TREATMENT COMPOSITION	UNILEVER GLOBAL IP LIMITED
WO/2021/018750	OPHTHALMIC COMPOSITIONS COMPRISING VISCOSIFYING POLYMERS AND  NUCLEIC ACIDS	PROQR THERAPEUTICS II B.V.
WO/2021/018754	AN ANTIDANDRUFF COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/018755	AN ANTIDANDRUFF COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/013973	COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES  THEREOF	ALUMIER EUROPE LIMITED
WO/2021/013981	CRYSTALLINE FORM OF TELMAPITANT OR  (5R,8S)-8-[[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]METHYL]-8-PHENYL-1,3,7-TRIAZASPIRO[4.5]DECANE-2,4-DIONE	INTERVET INTERNATIONAL B.V.
WO/2021/013999	RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES	ONTOCHEM GMBH
WO/2021/018786	USE OF FFAR2 AGONISTS FOR THE TREATMENT OF BACTERIAL  SUPERINFECTIONS POST-VIRAL INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/018792	OSTEOCRIN, LEBETIN OR ANP FOR DESTROYING BACTERIAL BIOFILMS	UNIVERSITé DE ROUEN-NORMANDIE
WO/2021/014014	TREATMENT AND/OR PREVENTION OF LESIONS IN THE CENTRAL AUDITORY  NERVOUS SYSTEM	SENSORION
WO/2021/018798	COMPOSITION COMPRISING STEROL DERIVATIVES FOR USE IN THE  TREATMENT OF A NEURONAL PATHOLOGY RELATED TO HYPOXIA, HYPOGLYCEMIA AND/OR  HYPERGLYCEMIA	DENDROGENIX
WO/2021/014019	SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW	SAPREME TECHNOLOGIES B.V.
WO/2021/018806	IGG-DEPLETED PORCINE SERUM AND THE USES THEREOF	CEVA SANTE ANIMALE
WO/2021/018816	ALGINATE-BASED FACIAL MASK	BEIERSDORF AG
WO/2021/018824	USE OF  (R)-9-(2,5-DIFLUOROPHENETHYL)-4-ETHYL-2-METHYL-1-OXA-4,9-DIAZASPIRO[5.5]UNDECAN-3-ONE  FOR THE TREATMENT OF NOCICEPTIVE PAIN, NEUROPATHIC PAIN, OSTEOARTHRITIS PAIN  AND CANCER PAIN, WHILE HAVING REDUCED SIDE EFFECTS COMPARED TO OPIOIDS	ESTEVE PHARMACEUTICALS, S.A.
WO/2021/037455	ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSION	BEIERSDORF AG
WO/2021/037456	ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSION	BEIERSDORF AG
WO/2021/023547	PREPARATION AND FULLY COMPOUNDED STOCK FOR USE IN MEDICAL OR  DENTAL APPLICATIONS, MEDICAL OR DENTAL PRODUCT AND USE AND PREPARATION  THEREOF	GEBR. BRASSELER GMBH & CO. KG
WO/2021/018839	ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF  PARASITIC INFECTIONS	BAYER ANIMAL HEALTH GMBH
WO/2021/014026	BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY	SAPREME TECHNOLOGIES B.V.
WO/2021/014027	PHOSPHOLIPASE-A2 INHIBITORS FOR THE PREVENTION OF CANCER  METASTASIS	COEGIN PHARMA AS
WO/2021/018859	ANTIBODIES BINDING TO GPRC5D	F. HOFFMANN-LA ROCHE AG
WO/2021/018862	SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSM	FUNDACIó INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I  SANT PAU
WO/2021/018866	MEK INHIBITOR FOR TREATMENT OF STROKE	EDVINCE AB
WO/2021/018879	PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTS	FUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/018898	METHODS FOR TREATING TUMORS	NH THERAGUIX
WO/2021/018899	USE OF GDF15 AS A MARKER FOR EXERCISE MANAGEMENT	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/018917	PROCESS FOR PREPARING ADHESIVE COMPOUNDS FOR USE IN A  TRANSDERMAL THERAPEUTIC SYSTEM	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/018923	PEPTIDES AS INHIBITORS OF FIBROTIC MATRIX ACCUMULATION	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/018928	NEW PHARMACEUTICAL FORMULATION	F. HOFFMANN-LA ROCHE AG
WO/2021/018931	COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITIS	DERMOPHISIOLOGIQUE S.R.L. SOCIETà BENEFIT
WO/2021/018934	TREATMENT OF SEBACEOUS GLAND DISORDERS	ECHO PHARMACEUTICALS B.V.
WO/2021/018935	TREATMENT OF AGING OR UV-DAMAGED SKIN	ECHO PHARMACEUTICALS B.V.
WO/2021/018936	TREATMENT OF INFLAMMATORY SKIN CONDITIONS	ECHO PHARMACEUTICALS B.V.
WO/2021/018950	COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN  REGENERATIVE EFFECT	GIULIANI S.P.A.
WO/2021/018965	ACTIVATORS OF SIRTUINS AND USES THEREOF	EPI-C S.R.L.
WO/2021/018967	SEROTONERGIC AGENT AND 5-HT1A-RECEPTOR ANTAGONIST	ATLAS PHARMACEUTICALS BV
WO/2021/023600	COMBINATION PRODUCT FOR HELPING MAINTAIN THE NATURAL DEFENSES  OF THE ORGANISM AND AIDING WITH RECOVERY	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/018990	PREVENTION AND REDUCTION OF CORNIFICATION DISORDERS AND  RELATED COSMETIC AGENTS	MERCK PATENT GMBH
WO/2021/023609	COMBINATION OF A TYPE I PROTEIN ARGININE METHYLTRANSFERASE  (TYPE I PRMT) INHIBITOR AND A METHIONINE ADENOSYLTRANSFERASE II ALPHA (MAT2A)  INHIBITOR	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/023616	ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE  IN EPILEPSY OR SEIZURES	H. LUNDBECK A/S
WO/2021/023617	ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS	H. LUNDBECK A/S
WO/2021/019023	COMPOUNDS FOR USE IN A METHOD OF TREATING OR PREVENTING  NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERS	THE BECKLEY FOUNDATION
WO/2021/019033	DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR  PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY  CROVALIMAB	F. HOFFMANN-LA ROCHE AG
WO/2021/019036	DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR  PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY  CROVALIMAB	F. HOFFMANN-LA ROCHE AG
WO/2021/023631	NOVEL FORM OF A DEPILATORY COMPOSITION , AND PREPARATION  METHOD THEREFOR	L.C.M. LABORATOIRE DE COSMéTOLOGIE MODERNE
WO/2021/023644	NEUTRALIZING GRANZYME B FOR PROVIDING CARDIOPROTECTION IN A  SUBJECT WHO EXPERIENCED A MYOCARDIAL INFARCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/023646	MELANOCYTE-REGULATING PEPTIDES	IDP DISCOVERY PHARMA, S.L.
WO/2021/019067	VETERINARY COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF  CRYPTOSPORIDIOSIS	CEVA SANTE ANIMALE
WO/2021/023649	BI-FUNCTIONALIZED NANOPARTICLES, PROCESS FOR ITS PREPARATION  AND USES THEREOF	FUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE  RECERCA
WO/2021/023662	PYRAZOLO[4,3-C]PYRIDINE COMPOUNDS FOR USE IN THE TREATMENT OF  HBV INFECTION	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/019078	LIPOSOMES AND USES THEREOF	UNIVERSITà DEGLI STUDI DI MILANO - BICOCCA
WO/2021/019081	C3/C5 CONVERTASE ASSAYS	UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF
WO/2021/019092	TOPICAL COMPOSITIONS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/023673	PROCESS FOR PREVENTING AND/OR TREATING TRANSPIRATION AND  ASSOCIATED COMPOSITION	L'OREAL
WO/2021/023675	LACOSAMIDE FOR THE TREATMENT OF ADD/ADHD	SANCHEZ, Hector Mario
WO/2021/019097	MEMBRANE FILTRATION OF PLANT EXTRACTS BY MEANS OF CYCLODEXTRIN	BIONORICA SE
WO/2021/023691	IMMUNOGENIC COMPOSITION	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023692	PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D  POLYPEPTIDE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023695	COMBINATIONS OF OLIGOSACCHARIDES AND XYLITOL FOR  DERMATOLOGICAL TREATMENT	MEDA PHARMA S.P.A.
WO/2021/023698	ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE  TREATMENT OF CANCER	LANTHIOPEP B.V
WO/2021/019102	A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A  POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A  POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS  COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES	ACM BIOLABS PTE LTD
WO/2021/069126	CLEANSING PREPARATION CONTAINING CAESALPINIA SPINOSA GUM	BEIERSDORF AG
WO/2021/023733	TARGETED NANOPARTICLES OF WELL-DEFINED AND REPRODUCIBLE SIZES	STAMS DIAGNOSTICS GMBH
WO/2021/023796	COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A  CELL COMPRISING HETEROCYCLIC COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND  THEIR APPLICATIONS	POLYPLUS TRANSFECTION
WO/2021/023798	COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A  CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR  APPLICATIONS	POLYPLUS TRANSFECTION
WO/2021/037511	SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONES	BEIERSDORF AG
WO/2021/028299	VIRAL PARTICLES FOR USE IN TREATING SYNUCLEINOPATHIES SUCH AS  PARKINSON'S DISEASES BY GENE THERAPY	FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/023805	COMPOUND FOR COMBINATION TREATMENT	INITIATOR PHARMA A/S
WO/2021/023809	ETIFOXINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO  ACTIVATED MAST CELLS	MC SCIENCES UG
WO/2021/023811	SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2  INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/023817	SOLID COMPOSITION COMPRISING A PYY COMPOUND AND A SALT OF  N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/023820	EXTRACT OF SILYBUM MARIANUM (L.) GAERTN. AKENES FOR PROMOTING  HAIR GROWTH	PIERRE FABRE DERMO-COSMETIQUE
WO/2021/023837	INHIBITION OF METASTASIS DEVELOPMENT BY NANGPTL-4	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/028328	TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUE	NOVALIQ GMBH
WO/2021/023848	METHOD OF PREPARING A SOLID DOSAGE FORM AND A LUBRICANT	EVONIK OPERATIONS GMBH
WO/2021/023849	DOWN STREAMING PROCESS FOR THE PRODUCTION OF POLYUNSATURATED  FATTY ACID SALTS	EVONIK OPERATIONS GMBH
WO/2021/023850	METHOD OF PREPARING A SOLID DOSAGE FORM AND A BINDER	EVONIK OPERATIONS GMBH
WO/2021/023855	SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT  OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/023857	SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE ACTIVES	EVONIK OPERATIONS GMBH
WO/2021/028336	(HETERO)ARYL-METHYL-THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/028337	PEPTIDE ANTIGENS AND USES THEREOF	HUMANITAS MIRASOLE S.P.A.
WO/2021/028347	HLA-DR/CII PEPTIDE COMPLEXES FOR TREATING ARTHRITIS	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/028350	PRODUCTION OF MHC II/CII COMPLEXES	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/023876	GNRH ANTAGONISTS FOR THE TREATMENT OF ESTROGEN-DEPENDENT  DISORDERS	OBSEVA S.A.
WO/2021/023877	COMPOSITIONS AND METHODS FOR THE TREATMENT OF  ESTROGEN-DEPENDENT DISORDERS	OBSEVA S.A.
WO/2021/023885	LIQUID DRESSING COMPOSITIONS AND THEIR USES	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/023886	LIQUID DRESSING COMPOSITIONS AND THEIR VETERINARY USES	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/037532	METHOD FOR TRAINING PATIENTS WITH THERAPEUTIC GAS MIXTURES	EGOROV, Egor
WO/2021/028382	[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES	BAYER AKTIENGESELLSCHAFT
WO/2021/028402	IMMUNOGENIC COMPOSITION	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/028406	CHIKUNGUNYA VACCINE FORMULATIONS	VALNEVA SE
WO/2021/028407	SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE	VALNEVA SE
WO/2021/028415	PERSONAL HYGIENE PRODUCT	CRODA INTERNATIONAL PLC
WO/2021/028438	TARGETING WNK1 IN BLOOD CANCERS	KØBENHAVNS UNIVERSITET
WO/2021/028456	HOLLOW THREE-DIMENSIONAL UNIT MADE FROM RETINAL TISSUE AND USE  THEREOF IN THE TREATMENT OF RETINOPATHIES	TREEFROG THERAPEUTICS
WO/2021/028469	COMPOSITIONS AND METHODS FOR TREATING CYTOKINE RELEASE  SYNDROME AND NEUROTOXICITY	SITOKINE LIMITED
WO/2021/028479	COMPOSITIONS COMPRISING TIGOLANER FOR CONTROLLING PARASITES	VETOQUINOL S.A.
WO/2021/028502	IMPLANTABLE CAPSULE	MAXIVAX SA
WO/2021/028512	ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC  MODULATORS	F. HOFFMANN-LA ROCHE AG
WO/2021/032582	PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL  COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS	GALAPAGOS NV
WO/2021/028529	NON-OXIDATIVE HAIR DYE COMPOSITION AND METHOD	KAO CORPORATION
WO/2021/028530	DYEING COMPOSITION, METHOD, USE, AND KIT-OF-PARTS THEREOF	KAO CORPORATION
WO/2021/028532	KIT-OF-PARTS AND COMPOSITION FOR DYEING OF KERATIN FIBERS,  METHOD, AND USE THEREOF	KAO CORPORATION
WO/2021/028538	MIRABEGRON COMPOSITION AND USES THEREOF	BIOHORM S.L.
WO/2021/063581	AN ORAL CARE SPRAY COMPOSITION COMPRISING HEXAMETAPHOSPHATE	UNILEVER GLOBAL IP LIMITED
WO/2021/028559	METHOD FOR OBTAINING EFFICIENT COMPOSITIONS COMPRISING VIRAL  VECTORS FOR VACCINATION OR GENE THERAPY	LEUKOCARE AG
WO/2021/032611	HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY	CUROVIR AB
WO/2021/028578	FILM FORMULATION COMPRISING CARRIERS	KLARIA PHARMA HOLDING AB
WO/2021/032643	COMPOUNDS SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF MUSCLE  WASTING AND OTHER CONDITIONS	ADAMS, Volker
WO/2021/032646	STABILIZING BUFFER FOR FACTOR VIII AND VWF	OCTAPHARMA AG
WO/2021/028585	BACTERIUM COMPRISING MYO-INOSITOL TO PROPIONATE PATHWAY	WAGENINGEN UNIVERSITEIT
WO/2021/028587	PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES  DIRECTED AGAINST CD3 AND CD20 AND THEIR USES	GENMAB A/S
WO/2021/032648	COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE	THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER  MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIV. TRINITY OF QUEEN
WO/2021/032650	PEPTIDES FOR TREATING MUSCLE ATROPHY	NURITAS LIMITED
WO/2021/032657	COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN AND LIPOPHILIC  UV FILTER SUBSTANCES	BEIERSDORF AG
WO/2021/037597	ISAVUCONAZONIUM SALTS AND PROCESS FOR PREPARING THEREOF	SYNTHON B.V.
WO/2021/032687	ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES	UCB BIOPHARMA SRL
WO/2021/028598	REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT  DISEASES	TECHNISCHE UNIVERSITÄT DARMSTADT
WO/2021/032700	COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN	BEIERSDORF AG
WO/2021/032777	OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE	MINA THERAPEUTICS LIMITED
WO/2021/037629	COMPOSITION, PROCESS AND KIT FOR SEMI-PERMANENT STRAIGHTENING  AND CURLING OF KERATIN FIBERS	KAO CORPORATION
WO/2021/032784	PLATINUM ISOTOPE COMBINED WITH BONE-TARGETING AGENTS FOR USE  IN ANTICANCER DRUGS	NUCLEAR RESEARCH AND CONSULTANCY GROUP
WO/2021/032807	COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND  ALPHA-LACTOGLUBULIN-OLEIC ACID COMPLEX FOR CANCER THERAPY	HAMLET PHARMA AB
WO/2021/037656	SOLUBILIZED FOLIC ACID	AQUANOVA AG
WO/2021/032844	FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES	MüHLBAUER TECHNOLOGY GMBH
WO/2021/037676	HAIR TREATMENT COMPOSITION IN FOAM FORMAT	UNILEVER GLOBAL IP LIMITED
WO/2021/037679	USE OF HAIR TREATMENT COMPOSITION IN FOAM FORMAT	UNILEVER GLOBAL IP LIMITED
WO/2021/058206	KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/032861	COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENT	AMAZENTIS SA
WO/2021/037702	PHARMACEUTICAL COMBINATION OF A SPECIFIC THIENOPYRIDONE  DERIVATIVE WITH AN FXR AGONIST FOR THE TREATMENT OF LIVER DISEASES	POXEL
WO/2021/032873	COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA  (I), AT LEAST ONE ALKOXYSILANE OF FORMULA (II), AT LEAST ONE NONAMINO  SILICONE, AND OPTIONALLY PIGMENTS AND/OR DIRECT DYES	L'OREAL
WO/2021/037713	OIL SUBSTITUTE FOR COSMETIC PREPARATIONS	BEIERSDORF AG
WO/2021/037714	PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONS	BEIERSDORF AG
WO/2021/037716	PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONS	BEIERSDORF AG
WO/2021/037717	ETHYL-CELLULOSE-CONTAINING SUNSCREEN SPRAY	BEIERSDORF AG
WO/2021/037719	HYDROXYPROPYLCELLULOSE-CONTAINING SUNSCREEN SPRAY	BEIERSDORF AG
WO/2021/037733	TROPOELASTIN FOR USE IN TREATMENT OF ACNE SCARRING	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/037750	NOVEL COMPOUNDS FOR SKIN LIGHTENING	UNILEVER GLOBAL IP LIMITED
WO/2021/032883	COMBINATION THERAPY OF A PATIENT SUBGROUP	BERGENBIO ASA
WO/2021/032891	BINDING MOLECULES TO ARGINASE II (ARG2)	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/180342	COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY  SYSTEM	ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
WO/2021/032894	NANOPARTICLE COMPOSITION COMPRISING CHITOSAN AND CLATHRIN	BIOCYTO LIMITED
WO/2021/052720	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A FILM-FORMING POLYMER	HENKEL AG & CO. KGAA
WO/2021/052721	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/052722	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND AN  ACIDIFIER	HENKEL AG & CO. KGAA
WO/2021/047900	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/037871	SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B6	DSM IP ASSETS B.V.
WO/2021/037873	SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B1	DSM IP ASSETS B.V.
WO/2021/037874	SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B12	DSM IP ASSETS B.V.
WO/2021/037933	COMBINATION OF AZD2811 NANOPARTICLES, 5-AZACITIDINE AND  VENETOCLAX FOR USE IN THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/043656	COMPOSITIONS CONTAINING DI-SUBSTITUTED TEREPHTHALATES AND  LIGHT PROTECTION FILTER SUBSTANCES, DEODORANTS AND/OR ANTIPERSPIRANTS	EVONIK OPERATIONS GMBH
WO/2021/037956	COMBINATIONS OF MEK INHIBITORS WITH CAP-DEPENDENT ENDONUCLEASE  INHIBITORS	ATRIVA THERAPEUTICS GMBH
WO/2021/037960	PHARMACEUTICAL FORMULATION	KLARIA PHARMA HOLDING AB
WO/2021/038014	CONTROLLED RELEASE TOFACITINIB COMPOSITIONS	SYNTHON B.V.
WO/2021/043673	P-GP INDUCERS AS PROTECTORS AGAINST CHEMOTHERAPY-INDUCED SIDE  EFFECTS, SUCH AS PERIPHERAL NEUROPATHY (CIPN) AND HAIR LOSS	SYDDANSK UNIVERSITET
WO/2021/038022	NEW USE OF CYCLIC DINUCLEOTIDES	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/038029	LOADED GRANULES, THEIR PROCESS OF PRODUCTION AND THEIR USES	SAKSO
WO/2021/038035	SCYLLO-INOSITOL AND B-CELL MEDIATED DISORDERS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/038036	B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTS	KING'S COLLEGE LONDON
WO/2021/038043	TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND  HEPATOCELLULAR CARCINOMA (HCC) WITH COMPOUNDS BINDING THE ECTODOMAIN OF  PLATELET GLYCOPROTEIN IB (GPIB) ALPHA	DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN  RECHTS
WO/2021/038062	T CELL EPITOPES OF HCMV AND USES OF THEREOF	EBERHARD KARLS UNIVERSITÄT TüBINGEN, MEDIZINISCHE FAKULTÄT
WO/2021/038076	USE OF BETA-L-ASPARTYL-L-ARGININE ON SENESCENT SKIN	SYMRISE AG
WO/2021/038078	THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR TREATMENT OF  SHOCK	4TEEN4 PHARMACEUTICALS GMBH
WO/2021/038080	TREATMENT	PNEUMAGEN LTD
WO/2021/038084	BIOADHESIVE PARTICLES COMPRISING ACTIVE AGENTS, AND USES  THEREOF	SKINOSIVE
WO/2021/038097	METHOD FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME USING AN  INHIBITORY OR CYTOTOXIC AGENT AGAINST PLASMA CELLS	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/058230	METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A PREMIX OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/043718	ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING  6-AMINONICOTINAMIDE	UNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043719	ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING  THIONICOTINAMIDE	UNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043721	USE OF COSMETIC PREPARATIONS FOR IMPROVING THE VISIBILITY OF  SUBEPIDERMAL PIGMENTS	BEIERSDORF AG
WO/2021/043723	METHODS AND COMPOSITIONS FOR TREATING PAX6- DEFICIENCY RELATED  DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/043724	USE OF PYRVINIUM FOR THE TREATMENT OF A RAS PATHWAY MUTATED  ACUTE MYELOID LEUKEMIA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/043726	OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO  IMPLANTATION AND PREVENTING MISCARRIAGE	OBSEVA S.A.
WO/2021/063609	BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM  BLUE LIGHT	BEIERSDORF AG
WO/2021/063610	NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR  PROTECTION AGAINST BLUE LIGHT	BEIERSDORF AG
WO/2021/043757	FACTOR VIII PROTEIN WITH INCREASED HALF-LIFE	BIOTEST AG
WO/2021/058240	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ESTER OIL	HENKEL AG & CO. KGAA
WO/2021/058241	KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF  AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/043771	FORMULATIONS AND TREATMENT METHODS	CAMURUS AB
WO/2021/052753	RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED  ACTIVITY	THALLER, Arno
WO/2021/047971	METHOD FOR REMINERALIZING AND/OR REDUCING SENSITIVITY OF TEETH	UNILEVER IP HOLDINGS B.V.
WO/2021/043799	COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A  L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYE	L'OREAL
WO/2021/043803	PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDES	NOVO NORDISK A/S
WO/2021/043804	IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES	INSTITUT CURIE
WO/2021/043813	PHENAZINE DERIVATIVE AND USE THEREOF FOR THE TREATMENT OF  CANCER	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/043835	REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CELIAC  DISEASE	SQUARE POWER LTD
WO/2021/043840	REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CANCER	SQUARE POWER LTD
WO/2021/043846	REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S  DISEASE	SQUARE POWER LTD
WO/2021/043862	THIORIDAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF  CANCER	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/043864	COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A  L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYE	L'OREAL
WO/2021/043869	INFLUENZA VIRUS VACCINES AND USES THEREOF	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/249661	ECOBIOLOGICAL LIPO-ALCOHOLIC COMPOSITION	NAOS INSTITUTE OF LIFE SCIENCE
WO/2021/043905	VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS	ORYZON GENOMICS, S.A.
WO/2021/047997	ORAL CARE WATER-IN-OIL EMULSIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/043926	MANGANESE CHELATE ISOMERS	GE HEALTHCARE LIMITED
WO/2021/043927	GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT	BOTALYS SA
WO/2021/043949	LURBINECTEDIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA	PHARMA MAR S.A.
WO/2021/043951	DRUG ANTIBODY CONJUGATES	PHARMA MAR, S.A.
WO/2021/048003	CHIMERIC FILOVIRUS VACCINES	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/043955	COMPOSITIONS AND METHODS FOR TREATING EXTENSIVE STAGE SMALL  CELL LUNG CANCER (ES-SCLC)	ASTRAZENECA AB
WO/2021/043961	DOSING REGIMEN FOR THE TREATMENT OF CANCER WITH AN ANTI ICOS  AGONISTIC ANTIBODY AND CHEMOTHERAPY	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/052779	ELECTROSTATICALLY SPRAYABLE COSMETIC FORMULATION	IONIQ SKINCARE GMBH & CO. KG
WO/2021/044009	HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES	DEUTSCHES ZENTRUM FüR NEURODEGENERATIVE ERKRANKUNGEN E.V.  (DZNE)
WO/2021/044013	USE OF A COMPOSITION CONTAINING AN EXTRACT OF TULIPA  GESNERIANA	FRANCE COSMEPHYL-LAB
WO/2021/044045	OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITIS	NOVALIQ GMBH
WO/2021/069158	SUNSCREEN CONTAINING A NATURAL, FILM-FORMING POLYMER	BEIERSDORF AG
WO/2021/048034	GLUCOCEREBROSIDASE MUTANTS	F. HOFFMANN-LA ROCHE AG
WO/2021/048041	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/044058	FAST CONSOLIDATING COMPOUNDS	UNIVERSITÄT INNSBRUCK
WO/2021/044061	TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC  ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT	KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MüNCHEN
WO/2021/048081	IMMUNOTHERAPEUTIC COMPOSITIONS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/052811	NEW ONCOLYTIC NEWCASTLE DISEASE VIRUSES AND RECOMBINANT NDV  STRAINS	THALLER, Arno
WO/2021/048129	USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND  CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/048135	PHARMACEUTICAL COMBINATIONS COMPRISING A  FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF  NEOPLASTIC DISEASES	BASILEA PHARMACEUTICA INTERNATIONAL AG
WO/2021/048162	COMPOUND FOR INHIBITING CELL DEATH	CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL
WO/2021/048171	METHOD TO IMPROVE PHAGOCYTOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/048172	DELIVERY VEHICLE FOR IN SITU DELIVERING OF PHARMACEUTICAL  AGENTS	RIVER STONE BIOTECH APS
WO/2021/048200	NOVEL QUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE  DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/048235	TREATMENT OF HR DEFICIENT CANCER	THE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/048266	TREATMENT OF TYPE 2 DIABETES MELLITUS	SANOFI
WO/2021/048268	USE OF HDL IN THE PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE	ETABLISSEMENT FRANÇAIS DU SANG
WO/2021/052855	STABLE PERFUMING COMPOSITIONS HAVING GOOD SPRAY PROPERTIES	SOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/052856	STABILIZER CONCENTRATES FOR WAX DISPERSIONS	BASF SE
WO/2021/048283	METHOD FOR PROMOTING WEIGHT LOSS BY ADMINISTERING A DIET RICH  IN ARABINOXYLAN OLIGOSACCHARIDES	UNIVERSITY OF COPENHAGEN
WO/2021/048313	DENTAL COMPOSITION	DENTSPLY SIRONA INC.
WO/2021/048314	REBAMIPIDE FOR USE IN PREVENTION AND/OR TREATMENT OF ARTERIAL  STIFFNESS	SQUARE POWER LTD
WO/2021/048315	USE OF DUOX1 INHIBITORS FOR TREATING CANCER	INSTITUT GUSTAVE ROUSSY
WO/2021/048322	GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND  PREVENTION OF PULMONARY DISEASES	AQUILON PHARMACEUTICALS
WO/2021/048324	NOVEL MOLECULES FOR DIAGNOSIS	AC IMMUNE SA
WO/2021/223894	PEPTIDE FOR PREVENTION OR TREATMENT OF COVID-19	APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH
WO/2021/052877	PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAME	UNILEVER IP HOLDINGS B.V.
WO/2021/048338	COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION	INTERVET INTERNATIONAL B.V.
WO/2021/048339	VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF  CANCER	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/048359	METHODS OF TREATING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)  USING IL-17RA ANTIBODY	BAUSCH HEALTH IRELAND LIMITED
WO/2021/048402	LASSAVIRUS VACCINES	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/048412	COMBINATION THERAPIES COMPRISING PANOBINOSTAT FOR THE  TREATMENT OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048417	COMBINATION THERAPIES COMPRISING DASATINIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048418	COMBINATION THERAPIES COMPRISING BORTEZOMIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048419	COMBINATION THERAPIES COMPRISING TRAMETINIB FOR THE TREATMENT  OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048430	COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES	AMABIOTICS
WO/2021/048431	COMPOUNDS FOR TREATING ATAXIA	AMABIOTICS
WO/2021/104700	METHOD FOR IMPROVING COLOUR RETENTION OF DYED KERATINOUS  MATERIAL, ESPECIALLY HUMAN HAIR	HENKEL AG & CO. KGAA
WO/2021/104701	IMPROVING THE PERFORMANCE OF PIGMENT-BASED DYES BY USING A  PRETREAMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/104702	METHOD FOR IMPROVING THE TACTILE SENSATION OF DYED KERATINOUS  MATERIAL, ESPECIALLY HUMAN HAIR	HENKEL AG & CO. KGAA
WO/2021/104703	AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, A CHROMOPHORIC COMPOUND AND PHOSPHOROUS-CONTAINING SURFACTANT	HENKEL AG & CO. KGAA
WO/2021/048436	POLYETHYLENE GLYCOL FOR USE IN THE TREATMENT AND PREVENTION OF  ABDOMINAL INFLAMMATORY DISEASES AND/OR ASSOCIATED DISEASES	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/104704	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, PIGMENT, POLYSACCHARIDE AND A FATTY CONSTITUENT	HENKEL AG & CO. KGAA
WO/2021/104705	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/048438	INHIBITOR OF METADHERIN EXPRESSION	SECARNA PHARMACEUTICALS GMBH & CO. KG
WO/2021/048441	METHOD AND APPARATUS FOR CELL ISOLATION AND ISOLATED CELLS FOR  WOUND HEALING	VERITACELL
WO/2021/052923	ACTIVE SUBSTANCE DELIVERY SYSTEM WITH DELAYED DELIVERY	CAPNOMED GMBH
WO/2021/052926	AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC  DISORDERS	CHIESI FARMACEUTICI S.P.A.
WO/2021/052952	METHODS OF TREATMENT AND/OR PREVENTION OF DISORDERS AND  SYMPTOMS RELATED TO BKCA AND/OR SK CHANNELOPHATHIES	UNIVERSITE DE BORDEAUX
WO/2021/052960	STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/052962	TREATMENT OF SPINAL CORD INJURY	INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/053001	CAMPHORSULFONIC ACID AND COMBINATIONS THEREOF WITH CATIONIC  EXCIPIENTS AS VISCOSITY REDUCING AGENTS IN HIGH CONCENTRATED PROTEIN  FORMULATIONS	MERCK PATENT GMBH
WO/2021/053018	TARGETING MISSPLICED TRANSCRIPTS IN GENETIC DISORDERS	UNIQURE IP B.V.
WO/2021/104706	AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING  AMINOSILICONE, PIGMENT AND POLYSACCHARIDE	HENKEL AG & CO. KGAA
WO/2021/063686	AN ORAL CARE COMPOSITION COMPRISING HEXAMETAPHOSPHATE AND A  PIGMENT	UNILEVER IP HOLDINGS B.V.
WO/2021/053040	METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/053047	BIOACTIVE IMPLANTS FOR DRUG DELIVERY	THE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/053058	ALVELESTAT FOR USE IN THE TREATMENT OF GRAFT REJECTION,  BRONCHIOLITIS OBLITERANS SYNDROME AND GRAFT VERSUS HOST DISEASE	MEREO BIOPHARMA 4 LIMITED
WO/2021/115648	DOSAGE FORM COMPRISING AN ALKALINE AGENT AND AN ENTERIC  COATING LAYER	EVONIK OPERATIONS GMBH
WO/2021/115649	DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASE	EVONIK OPERATIONS GMBH
WO/2021/115650	DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASE	EVONIK OPERATIONS GMBH
WO/2021/053076	COMBINATION THERAPY WITH VILDAGLIPTIN AND METFORMIN	NOVARTIS AG
WO/2021/053078	NICOTINE POUCH	ENORAMA PHARMA AB
WO/2021/053093	ANTIPERSPIRANT COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/053126	METHOD OF TREATING HBV INFECTION USING A CORE PROTEIN  ALLOSTERIC MODULATOR	F. HOFFMANN-LA ROCHE AG
WO/2021/053155	COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF AN ANTIAPOPTOTIC BCL-2 FAMILY PROTEIN	APREA THERAPEUTICS AB
WO/2021/053163	IMMUNE STIMULATING MICELLE COMPOSITION	DANMARKS TEKNISKE UNIVERSITET
WO/2021/053167	EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE	AMW GMBH
WO/2021/053171	EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE	AMW GMBH
WO/2021/053173	METHODS FOR TRIGGERING M1 MACROPHAGE POLARIZATION	NH THERAGUIX
WO/2021/053178	PREPARATION FOR REMOVAL AND/OR PREVENTION OF AN INFECTION  ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIDIS	RLS GLOBAL AB
WO/2021/053185	MELFLUFEN FORMULATIONS AND THEIR USE IN THE TREATMENT OR  PROPHYLAXIS OF OSTEOSARCOMA	ONCOPEPTIDES AB
WO/2021/053194	KV1.3 BLOCKERS	ZEALAND PHARMA A/S
WO/2021/053198	POLYMER OR POLYCONDENSATE BASED ON PEPTIDE, LINKER AND  OPTIONALLY OTHER MONOMERS AND METHOD FOR PREPARING THE SAME	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/058416	HETEROCYCLIC COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/058423	COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER  AGENT	CAPNOMED GMBH
WO/2021/058428	COMPOSITIONS FOR USE IN REDUCING INFLAMMATION	EVONIK OPERATIONS GMBH
WO/2021/053234	COMPOUNDS AND COMPOSITIONS FOR TREATING KIDNEY DISEASE	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/053240	A NOVEL HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE	UNIVERSITEIT ANTWERPEN
WO/2021/063727	A POUCH PRODUCT SUITABLE FOR APPLICATION IN AN ORAL CAVITY	SCHJÖLIN, Evaggelos
WO/2021/053246	ORAL DELIVERY SYSTEM	UNIVERSITY COLLEGE DUBLIN
WO/2021/063734	CDK4/6 INHIBITORS FOR THE TREATMENT OF PSORIASIS	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/063737	AGENT FOR THE TREATMENT OF PSORIASIS	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/058454	NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR  INHALATION	CHIESI FARMACEUTICI S.P.A.
WO/2021/058463	A LIPOSOME SYSTEM COMPRISING A LIPID, AN ACTIVE COMPOUND AND A  VECTOR PEPTIDE	WESTFÄLISCHE WILHELMS-UNIVERSITÄT MüNSTER
WO/2021/058469	ANHYDROUS COMPOSITIONS	DSM IP ASSETS B.V.
WO/2021/058472	TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2  (IL2)	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/058492	NANOPARTICLE COMPOSITIONS FOR GENE THERAPY	UNIVERSITY COLLEGE DUBLIN
WO/2021/104709	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED BY APPLYING A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/104710	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS  BEEN DYED USING AN AMINO SILICONE AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/058514	COMPOSITIONS AND METHODS USING ADENOSYLCOBALAMIN	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/058521	A TOPICAL PLANT EXTRACT FORMULATION COMPRISING URTICA DIOICA  AND VITAMIN A	THE CEUTICS COMPANY GESMBH
WO/2021/058548	ANTIBODIES FOR THE DIAGNOSIS AND/OR TREATMENT OF  ATHEROSCLEROSIS	CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III  (F.S.P.)
WO/2021/058549	RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/058604	HYPOCHLORITE COMPOSITION AND SYSTEM AND METHOD FOR PREPARING A  HYPOCHLORITE COMPOSITION AND USE OF THE SAME	KONINKLIJKE PHILIPS N.V.
WO/2021/058611	KIT, SYSTEM AND METHOD FOR PREPARING AND USE OF A  PEROXIDE-CONTAINING COMPOSITION	KONINKLIJKE PHILIPS N.V.
WO/2021/058628	SCYLLO-INOSITOL AND ITS USE AS INSULIN SENSITIZER	SOCIéTé DES PRODUITS NESTLé SA
WO/2021/058636	ANTI-NRP1A ANTIBODIES AND THEIR USES FOR TREATING EYE OR  OCULAR DISEASES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/058651	HYDROGEL COMPOSITIONS FOR THE CONTROLLED AND CONSTANT RELEASE  OF ACTIVE AGENTS	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/058656	RIFAXIMIN LIQUID FORMULATIONS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/058670	PHARMACEUTICAL DELIVERY DEVICE AND METHOD OF MANUFACTURE	UNIVERSITY OF ULSTER
WO/2021/058679	POWDER AND PROCESS FOR CLEANING TEETH BY USE OF SUCH POWDER	FERTON HOLDING S.A.
WO/2021/058684	MODIFIED VESICULAR STOMATITIS VIRUS GLYCOPROTEIN AND USES  THEREOF FOR THE TREATMENT OF BRAIN TUMORS	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/058715	HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS	BMG PHARMA S.P.A.
WO/2021/063813	PROCESS FOR PREPARING NANOPARTICLES IN THE FORM OF A POWDER  COMPRISING A BIO-RESORBABLE POLYESTER	EVONIK OPERATIONS GMBH
WO/2021/058735	CANCER TREATMENT WITH ANTI-MET ANTIBODY COMPOSITIONS	SYMPHOGEN A/S
WO/2021/058744	USE OF MüLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING  CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/058748	FORMULATION FOR TOPICAL APPLICATION TO THE SKIN OR MUCOUS  MEMBRANES	SEBBAN, Sandrine
WO/2021/058754	PHARMACEUTICAL COMPOUNDS	SENTINEL ONCOLOGY LIMITED
WO/2021/058758	CELL COMPOSITION COMPRISING RADIOLABLED MESENCHYMAL STEM  CELLS, USE THEREOF AND METHOD FOR PREPARING RADIOLABELED MESENCHYMAL STEM  CELLS	GLOBAL STEM CELL TECHNOLOGY NV
WO/2021/058794	DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY  ADVANCED SQUAMOUS CELL CARCINOMA	DEBIOPHARM INTERNATIONAL S.A.
WO/2021/058798	USE OF FGFR INHIBITORS IN FGFR-GENETICALLY ALTERED CANCERS TO  ENHANCE PATIENT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN SEQUENTIAL  TREATMENT SETTINGS	JANSSEN PHARMACEUTICA NV
WO/2021/058804	BINDING MODULES COMPRISING MODIFIED EHD2 DOMAINS	UNIVERSITÄT STUTTGART
WO/2021/058807	TRIVALENT BINDING MOLECULES	UNIVERSITÄT STUTTGART
WO/2021/058810	PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT  THEREOF	ANGELINI S.P.A.
WO/2021/058811	SHORT-CHAIN FATTY ACID PENTANOATE AS ENHANCER FOR CELLULAR  THERAPY AND ANTI-TUMOR THERAPY	PHILIPPS-UNIVERSITÄT MARBURG
WO/2021/058818	NOVEL MEDICAL USES OF THIOL-FUNCTIONALIZED POLYGLYCEROL  DERIVATIVES	FREIE UNIVERSITÄT BERLIN
WO/2021/083593	LAG TIME REDUCTION/ICE SPRAY	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/058831	THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED  MYCOBACTERIA	UNIVERSIDAD DE ZARAGOZA
WO/2021/058835	CONTROL OF TUMOUR GROWTH AND GUT BLEEDING BY BIOSURFACTANTS	UNIVERSITY OF ULSTER
WO/2021/063917	VACCINE AGAINST CHLAMYDIA IN SWINE	UNIVERSITEIT GENT
WO/2021/069256	SILICA FOR ORAL CARE COMPOSITIONS	RHODIA OPERATIONS
WO/2021/063945	COMBINED THERAPY COMPRISING AN INHIBITOR OF INTERLEUKIN-17  ACTIVITY AND A VITAMIN D RECEPTOR AGONIST	SERVEI DE SALUT DE LES ILLES BALEARS – IBSALUT
WO/2021/063967	NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS,  PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF	SANOFI
WO/2021/064009	PROTEIN BINDERS TO IRHOM2 EPITOPES	SCIRHOM GMBH
WO/2021/064034	A PUNICA GRANATUM EXTRACT AND ITS COSMETIC USES	L'OREAL
WO/2021/064050	IMMUNOGENIC COMPOSITIONS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/064069	METHODS FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064072	USE OF RETINOIC ACID RECEPTOR (RAR) AGONISTS FOR REVERSING,  PREVENTING, OR DELAYING CALCIFICATION OF AORTIC VALVE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064076	LIPOSOMES COMPRISING ANTI-LOX ANTIBODY	ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI  TUMORI (I.R.S.T.) S.R.L.
WO/2021/064088	BETA-GLUCANS HAVING SUPERIOR IMMUNO-STIMULATING PROPERTIES	UNIVERSITEIT GENT
WO/2021/064105	EXTRACT OF ORGANIC HUMIFIED MATERIALS	FELLNER, Stefan Johannes
WO/2021/064116	COMPOSITIONS WITH POLYMERIC OR OLIGOMERIC HYDROXY PHENYL  TRIAZINE UV FILTER	BASF SE
WO/2021/064123	PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE	SYNTHON B.V.
WO/2021/064132	TREATMENT OF MENOPAUSAL SYNDROME AND/OR SYMPTOMS ASSOCIATED  WITH MENOPAUSE	BESINS HEALTHCARE IRELAND LIMITED
WO/2021/064142	HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND  THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER	TOLREMO THERAPEUTICS AG
WO/2021/064151	COMBINATION OF THE ETHYL ESTERS OF DOCOSAHEXAENOIC AND  EICOSAPENTAENOIC ACID PLUS VITAMIN D3 FOR PREVENTION OF AGE-RELATED DISEASES	UNIVERSITÄT ZüRICH
WO/2021/064152	HYBRID ANTIBODY	EPSILOGEN LTD
WO/2021/064153	HYBRID ANTIBODY	EPSILOGEN LTD
WO/2021/064159	RETINOID DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES  ASSOCIATED WITH SULFATASE DEFICIENCIES	GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN  RECHTS, UNIVERSITÄTSMEDIZIN
WO/2021/064167	COMBINATION PRODUCT FOR RELIEVING THE BRONCHI	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064169	COMBINATION PRODUCT FOR RELIEVING THE BRONCHI AND FACILITATING  FALLING ASLEEP	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064173	USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTI-GLYCATION  ANTI-AGEING SKIN TREATMENT	SEDERMA
WO/2021/064180	METHODS AND COMPOSITIONS FOR MODULATING MACROPHAGES  POLARIZATION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064184	METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF  OVARIAN CANCER, BREAST CANCER OR PANCREATIC CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/064186	NOVEL PYRIDIN-2(1<i>H</i>)ONE DERIVATIVES, THEIR  PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/064188	COMBINATION COMPRISING HDAC INHIBITOR, CTLA-4 INHIBITOR AND A  PD-1 INHIBITOR OR PD-L1 INHIBITOR FOR CANCER TREATMENT	4SC AG
WO/2021/064197	ISOLATED POLYPEPTIDE AND POLYPEPTIDE COMPLEXES FOR PREVENTION,  ALLEVIATION AND/OR TREATMENT OF HCV INFECTIONS	KØBENHAVNS UNIVERSITET
WO/2021/064217	METHOD FOR TREATING AND/OR PREVENTING A PARASITIC INFECTION IN  A TELEOST	PREVIWO AS
WO/2021/064227	SINGLE DOMAIN ANTIBODIES SPECIFICALLY BINDING GLOBO - SERIES  GLYCANS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/069339	HOMOPIPERAZINYL AND HOMOPIPERIDINYL QUINAZOLIN-4(3H)-ONE  DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN	ESTEVE PHARMACEUTICALS, S.A.
WO/2021/069344	PROCESS FOR THE PREPARATION OF A NANOPARTICULATE ACTIVE  INGREDIENT	BAYER AKTIENGESELLSCHAFT
WO/2021/069345	PROCESS FOR PRODUCING NANOPARTICULATE RIVAROXABAN	BAYER AKTIENGESELLSCHAFT
WO/2021/069349	PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING  CRYSTALLINE AND AMORPHOUS FRACTIONS OF AN ACTIVE SUBSTANCE	BAYER AKTIENGESELLSCHAFT
WO/2021/069350	PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING  ACTIVE SUBSTANCE, POLYMER AND SURFACTANT	BAYER AKTIENGESELLSCHAFT
WO/2021/083616	HAIR CARE COMPOSITION	GIVAUDAN SA
WO/2021/069426	PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN  AND ITS APPENDAGES	SEDERMA
WO/2021/073961	SOLUTION OF CELLULOSE IN A QUATERNARY AMMONIUM COMPOUND AND A  CO-SOLVENT	BASF SE
WO/2021/104728	BIODEGRADABLE BEADS	BASF SE
WO/2021/104729	BIODEGRADABLE BEADS WITH DYES AND PIGMENTS	BASF SE
WO/2021/069486	MEK INHIBITORS FOR THE TREATMENT OF HANTAVIRUS INFECTIONS	ATRIVA THERAPEUTICS GMBH
WO/2021/069496	AN ANHYDROUS PHARMACEUTICAL COMPOSITION FOR MAINTENANCE  TREATMENT OF PSORIASIS	LEO PHARMA A/S
WO/2021/069497	SYSTEMIC ADMINISTRATION OF PEPTIDES FOR THE TREATMENT OF  SPINAL CORD INJURY AND/OR FOR REMYELINATION	AXOLTIS PHARMA
WO/2021/069523	CALRETICULIN FOR TREATING OR PREVENTING AN ANGIOGENIC EYE  DISEASE	UAB BALTYMAS
WO/2021/069527	NON-DEGRADABLE EMBOLISATION MICROSPHERE	GUERBET
WO/2021/069528	NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE	GUERBET
WO/2021/069533	HAIR TREATMENT COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/073988	ANTIPERSPIRANT EMULSION	UNILEVER IP HOLDINGS B.V.
WO/2021/073989	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/069542	ZAFIRLUKAST DERIVATIVES FOR USE AS CONTRACEPTIVE AGENTS	RIGSHOSPITALET
WO/2021/069553	USE OF LIVER PROGENITOR OR STEM CELLS, LYSATES THEREOF, AND/OR  CONDITIONED MEDIUM IN DISORDERS CHARACTERIZED BY VASCULAR HYPERPERMEABILITY	PROMETHERA BIOSCIENCES S.A./N.V.
WO/2021/069558	COMPOSITIONS OF THE OLEA EUROPAEA V. SYLVESTRIS WITH  ANTIMICROBIAL EFFICACY	TAPROGGE GMBH
WO/2021/069567	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/069571	POLYMORPH OF LORLATINIB	SANDOZ AG
WO/2021/069576	A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID	BLACKHAWK PARTNERS LTD
WO/2021/069578	RIBOFLAVIN FOR USE IN CONTROLLING BLOOD PRESSURE DURING  PREGNANCY	DSM IP ASSETS B.V.
WO/2021/069590	GELATIN CAPSULES WITH GROUND CALCIUM CARBONATE	CAPSUGEL FRANCE SAS
WO/2021/069615	IMPROVED ANTI-HANGOVER COMPOSITION, ITS PREPARATION AND USES	ZOBRIUS PHARMA AS
WO/2021/074012	HAIR TREATMENT METHOD	UNILEVER IP HOLDINGS B.V.
WO/2021/074025	USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT  OF CYSTIC FIBROSIS	UNIVERSITà DEGLI STUDI DI ROMA “LA SAPIENZA”
WO/2021/069671	HEXAHYDRO-5,8-EPOXYCYCLOHEPTA[c]PYRAZOLE DERIVATIVES USEFUL AS  MODULATORS OF THE CB1 AND/OR CB2 RECEPTORS	JANSSEN PHARMACEUTICA NV
WO/2021/069685	FLUORESCENT VANCOMYCIN ANALOGUE	UNIVERSITE DE STRASBOURG
WO/2021/069686	NOVEL THERAPEUTIC COMBINATIONS COMPRISING DERIVATIVES OF  OXAZAPHOSPHORINES FOR THE TREATMENT OF CANCER	INSTITUT GUSTAVE ROUSSY
WO/2021/069698	HEALING AND CONDUCTIVE COMPOSITION COMPRISING COLLAGEN	MONDERNA HEALTH & WELLNESS
WO/2021/204409	OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES	OBLITA THERAPEUTICS BVBA
WO/2021/069705	ISOINDOLINONE COMPOUNDS	MONTE ROSA THERAPEUTICS
WO/2021/069709	ANTI-CHEMOKIN LIKE RECEPTOR 1 HUMANIZED ANTIBODIES AND THEIR  THERAPEUTIC APPLICATIONS	OSE IMMUNOTHERAPEUTICS
WO/2021/078553	NOVEL PEDIATRIC COMBINATION	CESSATECH A/S
WO/2021/069736	NEW CARBAZOLE DERIVATIVES SENSITIZING CELLS TO ANTI-CANCER  AGENTS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/069740	METHOD FOR PREVENTING HUMAN GLANDS FROM RADIATION DAMAGE	KCM CONSULTING GMBH
WO/2021/083657	COSMETIC PREPARATION COMPRISING ALKALINE EARTH METAL SALTS,  CARBOXYLIC ACIDS AND EMULSIFIERS HAVING BRANCHED HYDROPHOBIC CHAINS	BEIERSDORF AG
WO/2021/089278	MICROMETRIC SIZE COMPOSITION AND ITS USE AS A PLANT ALKALOID  COADJUVANT AGENT	BEIJING ENBIWO BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/074118	LIQUID OMEGA-3 FATTY ACID COMPOSITIONS FOR DIRECT ORAL  ADMINISTRATION	HERMES ARZNEIMITTEL GMBH
WO/2021/110306	MULTI-TONE HAIR DYEING METHOD IN THREE STEPS	HENKEL AG & CO. KGAA
WO/2021/115664	HAIR STYLING COMPOSITION I CONTAINING SUGAR	HENKEL AG & CO. KGAA
WO/2021/074158	ORAL CARE COMPOSITION	LACER, S.A.
WO/2021/074159	MEMBRANE-BASED TWO COMPONENT THERAPEUTIC GAS RELEASE SYSTEM  FOR ORAL ADMINISTRATION	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/074164	ORAL CARE COMPOSITION	LACER, S.A.
WO/2021/074197	THIENOPYRIMIDONES AS TRPA1 INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/074198	NOVEL TETRAZOLES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/078611	COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY	UNILEVER IP HOLDINGS B.V.
WO/2021/074261	B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATES	HEIDELBERG PHARMA RESEARCH GMBH
WO/2021/074284	USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION  AND/OR TREATMENT OF RHEUMATOID ARTHRITIS, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/074314	AQUEOUS FORMULATIONS COMPRISING BUFFERED TIOTROPIUM BROMIDE  FOR TOPICAL TREATMENT OF HYPERHIDROSIS	NOTOXINS IP B.V.
WO/2021/074352	NOVEL VACCINE COMPOSITIONS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/074357	THIOPHENE DERIVATIVES FOR USE IN TREATING PORTAL INFLAMMATION  AND FIBROSIS	ENYO PHARMA
WO/2021/121715	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND,  A  HYDROXYCARBOXYLIC ACID ESTER, A COLOURING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/121716	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, SHELLAC,  A  DYEING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/121717	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  DYEING COMPOUND AND A OLIGOMERESTER	HENKEL AG & CO. KGAA
WO/2021/121718	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND  TANNIC ACID	HENKEL AG & CO. KGAA
WO/2021/121719	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED BY USING THE  PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/121720	PIGMENT SUSPENSION AND METHOD FOR DYING KERATINOUS MATERIAL  USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/089300	4-[5-[(RAC)-1-[5-(3-CHLOROPHENYL)-3-ISOXAZOLYL]ETHOXY]-4-METHYL-4<i>H</i>-1,2,4-TRIAZOL-3-YL]PYRIDINE  FOR USE IN PREVENTION AND/OR TREATMENT OF SURMENAGE IN A MAMMAL	THULIN, Claes
WO/2021/121721	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A DYEING COMPOUND AND A PRE-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/074368	IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR  MAGNETIC RESONANCE IMAGING	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/121722	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A HYDROXYCARBOXYLIC ACID ESTER,  C<sb>1</sb>-C<sb>10</sb> ALCOHOL AND A DYEING  COMPOUND	HENKEL AG & CO. KGAA
WO/2021/121723	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A  DYEING COMPOUND	HENKEL AG & CO. KGAA
WO/2021/121724	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A  DYEING COMPOUND AND SHELLAC	HENKEL AG & CO. KGAA
WO/2021/121725	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  COPOLYMER OF (METH)ACRYLIC ACID AND MALEIC ACID (ANHYDRIDE)	HENKEL AG & CO. KGAA
WO/2021/121726	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A  DYEING COMPOUND AND  GALACTOMANNAN	HENKEL AG & CO. KGAA
WO/2021/121727	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A  COPOLYMER OF STYRENE AND MALEIC ACID (ANHYDRIDE)	HENKEL AG & CO. KGAA
WO/2021/074389	IMMUNOGENIC COMPOUNDS FOR TREATMENT OF ADRENAL CANCER	ENTEROME S.A.
WO/2021/074398	A PROCESS FOR PRODUCING MICROPARTICLES FOR USE AS MICROBEADS  AND MICROPARTICLES PRODUCED ACCORDING TO THE PROCESS	SEAGREEN BIO LIMITED
WO/2021/074399	CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC  PHYSIOLOGICALLY ACTIVE SUBSTANCES	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074403	CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC  PHYSIOLOGICALLY ACTIVE SUBSTANCES	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074409	COMPOSITION FOR THE TREATMENT OF (PRE)OBESITY AND/OR  ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/074414	OXAZOLE AND THIOAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE  COMPOUNDS AND USES THEREOF	CEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074418	CARBAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES  THEREOF	CEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074423	VACCINE PRODUCT	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/074431	MICROBIAL COMPOSITIONS, STRAINS AND METHODS	UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
WO/2021/110313	METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF  AN ORGANIC C1-C6 ALKOXY SILANE AND TWO STRUCTURALLY DIFFERENT CELLULOSE TYPES	HENKEL AG & CO. KGAA
WO/2021/089306	ANTI-INFLAMMATORY COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/110314	METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF  AN ORGANIC C1-C6 ALKOXYSILANE AND FIBRES	HENKEL AG & CO. KGAA
WO/2021/078685	METHOD OF REDUCING DENTAL HYPERSENSITIVITY	UNILEVER IP HOLDINGS B.V.
WO/2021/074452	COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL  PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID  DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATE	DMG DEUTSCHE MALARIA GMBH
WO/2021/078726	PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS	BRACCO IMAGING SPA
WO/2021/197646	AQUEOUS OCTENIDINE-CONTAINING COMPOSITION FOR TREATING AND/OR  PREVENTING AN EXACERBATION OF DISEASES CAUSED BY A CORONAVIRUS INFECTION	SCHüLKE & MAYR GMBH
WO/2021/078761	TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL  ADMINISTRATION OF FINGOLIMOD	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/121734	MODIFIED GRPR ANTAGONIST PEPTIDES FOR IMAGING AND THERAPY OF  CANCER	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083766	TREATMENT OF PRURITUS IN HORSES	EVAX AG
WO/2021/078810	SCHIZOPHRENIC DISORDER TREATMENT USING COMBINATION THERAPY	CAMBRIDGE COGNITION LTD.
WO/2021/078814	USE OF CYCLODEXTRINS AS A RADIOSTABILIZER	GE HEALTHCARE LIMITED
WO/2021/078835	PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAG	ACTELION PHARMACEUTICALS LTD
WO/2021/078864	COMPOSITIONS FOR THE TREATMENT OF EPITHELIAL LESIONS	GIELLEPI S.P.A.
WO/2021/078889	METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE WITH  A FERROPORTIN INHIBITOR (VIT-2763)	VIFOR (INTERNATIONAL) AG
WO/2021/078910	IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES	INSTITUT CURIE
WO/2021/083790	DRY SHAMPOO COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/078912	TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	NURITAS LIMITED
WO/2021/078920	COMPOSITIONS COMPRISING 2'-FUCOSYLLACTOSE TO PREVENT ASTHMA	FRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/078925	METHODS OF TREATING CANCER	ASTRAZENECA AB
WO/2021/078937	TREATMENT OF STAT3 RELATED DISEASES BY IRON CHELATORS	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/078939	RNA OLIGONUCLEOTIDES FOR PREVENTING AGGREGATION OF PROTEINS	UNIVERSITÄT WIEN
WO/2021/078942	COMPOUNDS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE	UNIVERSIDAD DEL PAíS VASCO / EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/078952	ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL  COMPOSITION COMPRISING SAME	SORBONNE UNIVERSITE
WO/2021/078958	COMPOUNDS FOR USE (IN PARTICULAR RIPA-56) IN THE PREVENTION  AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	SORBONNE UNIVERSITE
WO/2021/078959	AMH-COMPETITIVE ANTAGONIST ANTIBODY	GAMAMABS PHARMA
WO/2021/078964	ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOF	AUTHENDA PHARMACEUTICALS AG
WO/2021/078982	PRODUCT FOR COSMETIC SKIN CARE	S.I.P.R.E.S. S.R.L.
WO/2021/078987	COMBINATION TREATMENTS FOR CANCER	CELEX ONCOLOGY INNOVATIONS LIMITED
WO/2021/078988	RECOMBINANT L-ASPARAGINASE	JAZZ PHARMACEUTICALS IRELAND LTD.
WO/2021/078991	TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEM	KWOK, Jessica
WO/2021/104770	ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND GLYCERYL  STEARATE CITRATE AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID  ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/104772	ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND CARRAGEENAN AND  COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE  COMBINATIONS	BEIERSDORF AG
WO/2021/104773	ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND HYALURONIC ACID  AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE  COMBINATIONS	BEIERSDORF AG
WO/2021/104775	ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL AND CREATINE AND  COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE  COMBINATIONS	BEIERSDORF AG
WO/2021/104777	ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND ONE OR MORE  EMULSIFIERS FROM THE GROUP OF PHOSPHATES AND SULFATES, AND COSMETIC OR  DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/079010	ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS  THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER  NEURODEGENERATIVE CONDITIONS	INSTITUT PASTEUR DE MONTEVIDEO
WO/2021/099072	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/099073	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/104780	ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND  COPOLYMERS	UNILEVER IP HOLDINGS B.V.
WO/2021/083867	PHARMACEUTICAL COMPOSITION INCLUDING A SYNERGISTIC COMBINATION  OF IBUPROFEN AND N-ACETYLCYSTEINE	E-PHARMA TRENTO S.P.A.
WO/2021/104781	ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND UBIQUINONE,  COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE  COMBINATIONS, AND USE OF UBIQUINOL TO IMPROVE THE EFFICACY OF COSMETIC OR  DERMATOLOGICAL PREPARATIONS WITH AN UBIQUINONE CONTENT	BEIERSDORF AG
WO/2021/083879	BROMODOMAIN INHIBITORS	RHEINISCH-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN
WO/2021/083899	PROCESS FOR PREPARING A DYE COMPOSITION COMPRISING THE MIXING  OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION CONTAINING ARGININE, AND THE  USE THEREOF	L'OREAL
WO/2021/083900	METHOD FOR THE TREATMENT OF KERATIN FIBRES BY MEANS OF A  COMPOSITION CONTAINING ARGININE AND OF AN OXIDIZING COMPOSITION	L'OREAL
WO/2021/083901	PROCESS FOR PREPARING A DYE COMPOSITION, COMPRISING THE MIXING  OF AT LEAST TWO TYPES OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION, AND USE  THEREOF	L'OREAL
WO/2021/083902	ALKALINE COMPOSITION COMPRISING AT LEAST THREE DIFFERENT  ALKALINE AGENTS FOR THE TREATMENT OF KERATIN FIBRES, METHODS AND USES	L'OREAL
WO/2021/083903	COATED COLOURING SOLID PARTICLES COMPRISING AT LEAST ONE  DIRECT DYE AND/OR ONE OXIDATION DYE PRECURSOR	L'OREAL
WO/2021/083904	PROCESS FOR PREPARING A DYE COMPOSITION BY MIXING SOLID  PARTICLES AND AN OXIDIZING COMPOSITION AND AN ALKALINE COMPOSITION	L'OREAL
WO/2021/083910	DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE	ASTRAZENECA AB
WO/2021/083912	COMBINATION THERAPY HAVING ANTIOXYDANT PROPERTIES	GENFIT
WO/2021/083919	COMPOSITION CONTAINING PREBIOTIC BACTERIA AND LICOCHALCONE A	BEIERSDORF AG
WO/2021/083920	COMPOSITION CONTAINING PREBIOTIC BACTERIA AND PROTECTOR  STRAINS	BEIERSDORF AG
WO/2021/104782	USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL  PREPARATIONS FOR THE CARE OF TATTOOED HUMAN SKIN AND IN PARTICULAR FOR  INCREASING BRILLIANCY  OF TATTOOS ON  DARK HUMAN SKIN	BEIERSDORF AG
WO/2021/104785	A CONDITIONING COMPOSITION	BEIERSDORF AG
WO/2021/104786	A CONDITIONING COMPOSITION	BEIERSDORF AG
WO/2021/083958	NOVEL PEPTIDES INDUCING SATIETY	SPECIALITES PET FOOD
WO/2021/083959	METHODS AND COMPOSITIONS FOR TREATING UVEAL MELANOMA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/083964	NEW MEANS AND METHODS FOR THERAPY AND DIAGNOSIS OF DNA VIRUS  INFECTIONS	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083970	MEDICAL COMPOSITIONS AND THEIR USE IN TREATING INFLAMMATORY  BOWEL DISEASE	BIOMILLENIA SAS
WO/2021/083989	PROCESS FOR PREPARING NANO- OR MICROPARTICLES COMPRISING A  CARRIER-POLYMER AND ONE OR MORE BIOLOGICALLY ACTIVE INGREDIENTS	EVONIK OPERATIONS GMBH
WO/2021/083992	DENTAL COMPOSITE MATERIAL	KULZER GMBH
WO/2021/084007	FOAM PRECURSOR LIQUID AND FOAM CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084013	NEW TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL  DISEASES OR CONDITIONS	BIONURE FARMA, S.L.
WO/2021/084022	HYDROPYRAZINO[1,2-D][1,4]DIAZEPINE COMPOUNDS FOR THE TREATMENT  OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/099088	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084030	ORAL PHARMACEUTICAL COMPOSITION COMPRISING A MELT-AGGLOMERATED  ACTIVE INGREDIENT CORE	HERMES ARZNEIMITTEL GMBH
WO/2021/084055	BLEACHING POWDER COMPOSITION	KAO GERMANY GMBH
WO/2021/084058	COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF  THE RESPIRATORY SYSTEM	NEILOS S.R.L.
WO/2021/084062	ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE  TREATMENT OF LEUKEMIA OR LYMPHOMA	MORPHOSYS AG
WO/2021/089419	THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO  TREAT B-CELL MALIGNANCIES	ASTRAZENECA AB
WO/2021/084064	SEQUENTIAL ANTI-CD19 THERAPY	MORPHOSYS AG
WO/2021/099089	SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION FROM  BLUE LIGHT	BEIERSDORF AG
WO/2021/084068	COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR  MODULATOR	IDORSIA PHARMACEUTICALS LTD
WO/2021/099090	NOVEL SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION  AGAINST BLUE LIGHT	BEIERSDORF AG
WO/2021/084082	COSMETIC COMPOSITION FOR IMPROVED BLEACHING OR DYEING OF  KERATIN FIBERS	KAO CORPORATION
WO/2021/084083	AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVES	KAO CORPORATION
WO/2021/084084	AQUEOUS OXIDIZING COMPOSITION COMPRISING AMINO ACIDS	KAO CORPORATION
WO/2021/084085	TWO-PART OXIDATIVE DYEING COMPOSITION	KAO CORPORATION
WO/2021/084087	BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE  AGENTS	CIS PHARMA AG
WO/2021/089433	SOLID DISPERSIONS OF URSOLIC ACID POTASSIUM SALT	INDENA S.P.A.
WO/2021/084120	LIQUID ORAL FORMULATION OF BUMETANIDE	NEUROCHLORE
WO/2021/089445	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084124	COMBINED INHIBITION OF PD-1, TGFβ AND ATM TOGETHER WITH  RADIOTHERAPY FOR THE TREATMENT OF CANCER	ARES TRADING S.A.
WO/2021/084136	COSMETIC COMPOSITION CONTAINING AN EXTRACT FROM OPUNTIA FICUS  INDICA	WELEDA AG
WO/2021/089500	SUNSCREEN COMPOSITION WITH LOW STICKINESS	DSM IP ASSETS B.V.
WO/2021/089501	NOVEL METHOD	DSM IP ASSETS B.V.
WO/2021/089502	SUNSCREEN COMPOSITION WITH LOW STICKINESS	DSM IP ASSETS B.V.
WO/2021/089513	TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC  ANTIBODY AND LENALIDOMIDE	F. HOFFMANN-LA ROCHE AG
WO/2021/089554	INTRANASAL ADMINISTRATION OF MEROTOCIN FOR IMPROVING LACTATION	FERRING B.V.
WO/2021/089563	METHODS OF USING IL-33 ANTAGONISTS	MEDIMMUNE LIMITED
WO/2021/089580	ORAL FORMULATION OF X842	CINCLUS PHARMA AG
WO/2021/089581	TOOTH WHITENING COMPOSITION	UNIVERSITAT AUTONOMA DE BARCELONA
WO/2021/110341	WATER-RESISTANT COSMETIC SUNSCREEN	BEIERSDORF AG
WO/2021/089588	HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF  CANCER	PIERIS PHARMACEUTICALS GMBH
WO/2021/094156	A FILM AND A KIT FOR WHITENING TEETH	UNILEVER IP HOLDINGS B.V.
WO/2021/104813	SIMULTANEOUS IMAGE REPRESENTATION OF TWO DIFFERENT FUNCTIONAL  AREAS	SIEMENS HEALTHCARE GMBH
WO/2021/099117	A COSMETIC COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/089644	METAL COMPLEXES BEARING BISSTYRYL-BIPYRIDINE LIGAND AND THEIR  USE AS PHOTOSENSITIZER AGENT IN ONE AND TWO-PHOTON PHOTODYNAMIC THERAPY	PARIS SCIENCES ET LETTRES - QUARTIER LATIN
WO/2021/089649	ANDROGEN RECEPTOR INHIBITORS FOR THE TREATMENT OF  NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN SUBJECTS WITH SEVERE  HEPATIC IMPAIRMENT	JANSSEN PHARMACEUTICA NV
WO/2021/089651	DIAGNOSTIC METHOD	AMAZENTIS SA
WO/2021/089678	GLP-1 RECEPTOR AGONISTS IN DEMENTIA	NOVO NORDISK A/S
WO/2021/089692	INHIBITOR OF BINDING BETWEEN PODOCIN AND KERATIN 8 FOR USE IN  THE TREATMENT OF NEPHROTIC SYNDROME	THE UNIVERSITY OF BRISTOL
WO/2021/094192	SOLID PARTICLES CONTAINING SOLID PRIMARY PARTICLES THAT  CONSIST ESSENTIALLY OF NATIVE CELLULOSE	EVONIK OPERATIONS GMBH
WO/2021/089704	COMBINED INHIBITION OF PD-1, TGFB AND TIGIT FOR THE TREATMENT  OF CANCER	MERCK PATENT GMBH
WO/2021/089715	USE OF COLCHICINE IN THE TREATMENT AND PREVENTION OF LUNG  CANCER	MURRAY AND POOLE ENTERPRISES, LTD.
WO/2021/089721	TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL INFECTION.	HERCULES PHARMACEUTICALS B.V.
WO/2021/089729	BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF  <i>PSEUDOMONAS AERUGINOSA</i>	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/089736	COMBINED THERAPY FOR MUSCULAR DISEASES	ASSOCIATION INSTITUT DE MYOLOGIE
WO/2021/089752	SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2  INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/089761	SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF  N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/094209	SUBSTITUTED PYRROLO TRIAZINE CARBOXAMIDE DERIVATIVES AS  PROSTAGLANDIN EP3 RECEPTOR ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/094210	SUBSTITUTED PYRAZINE CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN  EP3 RECEPTOR ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/089768	TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDER	INFLAZOME LIMITED
WO/2021/089769	TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN  INFLAMMATORY BRAIN DISORDER	INFLAZOME LIMITED
WO/2021/089770	PROTEIN PURIFICATION	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/089776	TREATMENT AND PREVENTION OF A TRAUMATIC BRAIN DISORDER	INFLAZOME LIMITED
WO/2021/089781	TREATMENT OR PREVENTION OF PSYCHIATRIC BRAIN DISORDERS USING  THE NLRP3 INHIBITOR N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-1  -ISOPROPYL-1 H-PYRAZOLE-3-SULFONAMIDE	INFLAZOME LIMITED
WO/2021/089782	TREATMENT OF AUTOINFLAMMATORY DISORDERS	INFLAZOME LIMITED
WO/2021/089783	TREATMENT OF ARTHRITIS	INFLAZOME LIMITED
WO/2021/089790	MITROCHONDRIA-TARGETING ANTIOXIDANTS	GIVAUDAN SA
WO/2021/089791	METHODS FOR THE TREATMENT OF CANCERS THAT HAVE ACQUIRED  RESISTANCE TO KINASE INHIBITORS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/089794	METHODS OF TREATING CANCER WITH A COMBINATION OF A  PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE	GENMAB A/S
WO/2021/089807	ANTIVIRAL PREPARATION FROM CHESTNUT SHELLS OF  <i>CASTANEA SATIVA</i> MILL	MICRONATURE S.R.L.
WO/2021/089824	5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION	LOPHORA APS
WO/2021/104834	COMBINATION THERAPY	ADC THERAPEUTICS SA
WO/2021/089840	FERMENTATION METHOD FOR THE PRODUCTION OF PHYTOESTROGENS	MRM HEALTH N.V.
WO/2021/089845	CD93 INHIBITORS FOR USE IN THE TREATMENT OF CANCER	UNIVERSITÄT BERN
WO/2021/089848	USE OF SODIUM OCTENYL-SUCCINATE STARCHES AS A BINDER IN  CONTINUOUS WET GRANULATION	ROQUETTE FRERES
WO/2021/094259	NPY2 RECEPTOR AGONISTS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/104844	CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/094296	USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE  WITH PRESERVED EJECTION FRACTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/094331	INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING  THE PROGRESSION, OR PREVENTING CARDIOVASCULAR CALCIFICATION	SANIFIT THERAPEUTICS, S.A.
WO/2021/094334	CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/094344	POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII	CSL BEHRING LENGNAU AG
WO/2021/094378	TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUS	ASTRAZENECA AB
WO/2021/094379	EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS  FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/094390	(S)-2-(1-(5-(CYCLOHEXYLCARBAMOYL)-6-(PROPYLTHIO)PYRIDIN-2-YL)PIPERIDIN-3-YL)  ACETIC ACID FOR USE IN TREATING WOUNDS	UNIVERSITY OF LEEDS
WO/2021/094396	COMPOSITION FOR ANTIMICROBIAL PHOTODYNAMIC THERAPY	CMS DENTAL A/S
WO/2021/094424	AN INHIBITOR OF AN IRON-CONTAINING HYDROGENASE OF A  METHANOGENIC ARCHAEON FOR USE IN THE TREATMENT OR PREVENTION OF A  PARKINSONIAN CONDITION	UNIVERSITé DU LUXEMBOURG
WO/2021/094429	DEODORANT COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/094469	ANTI-CLAUDIN-1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND  TREATMENT OF FIBROTIC DISEASES	UNIVERSITé DE STRASBOURG
WO/2021/094561	RINSABLE OILY SOLUTION FOR CONTROLLING LICE	DERMOWAVE
WO/2021/094562	ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL  MALIGNANCY	ENTEROME S.A.
WO/2021/094563	TREATMENT AND PREVENTION OF DENGUE DISEASE	JANSSEN PHARMACEUTICALS, INC
WO/2021/129977	PLANT EXTRACTS FOR TREATMENT OF INCREASED FACIAL VASCULARITY	ORIFLAME COSMETICS AG
WO/2021/099241	COMPOSITIONS AND METHODS FOR GLUTATHIONE ENHANCEMENT FOR USE  IN BRAIN HEALTH	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/115730	HAIR STYLING COMPOSITION CONTAINING DISACCHARIDES	HENKEL AG & CO. KGAA
WO/2021/115731	MICROPLASTIC-FREE COMPOSITION	HENKEL AG & CO. KGAA
WO/2021/094610	CHITOSAN FOR USE IN A METHOD OF PREVENTING OR TREATING A  CARDIOVASCULAR DISEASE	BIOMEDICA PHARMA GMBH
WO/2021/094626	MEDICAL COMPOSITION FOR TREATING CARDIAC WASTING AND CACHEXIA	RELAXERA PHARMAZEUTISCHE GMBH & CO. KG
WO/2021/121823	TINTING CONDITIONER HAVING IMPROVED DYEING PERFORMANCE	HENKEL AG & CO. KGAA
WO/2021/099292	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/099346	PHARMACEUTICAL DELIVERY DEVICE	FERRING B.V.
WO/2021/099402	PHARMACEUTICAL COMPOSITIONS COMPRISING AN INHIBITOR OF A  HISTON-DEACETYLASE (HDACI) AND AN AGONIST OF TOLL-LIKE-RECEPTOR 7 AND/OR 8  (TLR7 AND/OR TLR8) AND THEIR USE IN THE TREATMENT OF CANCER	STRUMBERG, Dirk
WO/2021/121843	COMPOSITION COMPRISING THROMBIN DERIVED PEPTIDES AND USE  THEREOF	IN2CURE AB
WO/2021/099444	A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS	INTERVET INTERNATIONAL B.V.
WO/2021/099446	A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS	INTERVET INTERNATIONAL B.V.
WO/2021/099450	INHIBITORS OF HSP70 PROTEIN	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/099453	AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING AND/OR  TREATING PERIPHERAL CHEMOTHERAPY-INDUCED NEUROPATHIES AND THE SYMPTOMS  THEREOF, AND CORRESPONDING COMPOSITION AND USE	ALGOSOURCE
WO/2021/099458	A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS	INTERVET INTERNATIONAL B.V.
WO/2021/099460	CURABLE COMPOSITION FOR DENTAL IMPRESSION	DENTSPLY SIRONA INC.
WO/2021/099462	CURABLE COMPOSITION FOR DENTAL IMPRESSION	DENTSPLY SIRONA INC.
WO/2021/099481	SOLID COMPOSITION CONTAINING RUFINAMIDE	MEDICHEM, S.A.
WO/2021/099515	PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A  (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF  POLYMER(S)AND A COLORING AGENT	L'OREAL
WO/2021/099517	COMPOSITION COMPRISING A (POLY)CARBODIIMIDE COMPOUND AND A  COLORING AGENT	L'OREAL
WO/2021/099531	ZONISAMIDE ORODISPERSIBLE TABLETS	BIOHORM, S.L.
WO/2021/121859	HAIR TREATMENT PROCESS	L'OREAL
WO/2021/121860	COSMETIC COMPOSITION COMPRISING A SILICONE RESIN AND A  PARTICULAR AMINO SILICONE	L'OREAL
WO/2021/099555	COSMETIC PREPARATION CONTAINING ANISIC ACID AND LEVULINIC  ACID, HAVING SELECTIVE ANTIMICRIOBIAL EFFECT	BEIERSDORF AG
WO/2021/099572	MEDICAL USES OF 4-1BBL ADJUVANTED RECOMBINANT MODIFIED  VACCINIA VIRUS ANKARA (MVA)	BAVARIAN NORDIC A/S
WO/2021/099575	MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES LOADED  WITH AT LEAST ONE PHOTOSENSITIZER AND USES THEREOF FOR THE TREATMENT OF  PERITONEAL CARCINOMATOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/099586	RECOMBINANT MVA VIRUSES FOR INTRATUMORAL AND/OR INTRAVENOUS  ADMINISTRATION FOR TREATING CANCER	BAVARIAN NORDIC A/S
WO/2021/099608	METHODS FOR MANUFACTURING TISSUE INTERFACING COMPONENTS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/099611	INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF  BETA-LACTOGLOBULIN	ARLA FOODS AMBA
WO/2021/099616	MASITINIB FOR THE TREATMENT OF SICKLE CELL DISEASE	AB SCIENCE
WO/2021/099624	COMPOSITIONS COMPRISING A BACTERIAL STRAIN OF THE GENUS  FUSICATENIBACTER	4D PHARMA RESEARCH LIMITED
WO/2021/105040	MULTIPLE UNIT PELLET SYSTEM TABLET COMPRISING RIBOFLAVIN	DSM IP ASSETS B.V.
WO/2021/105041	MUPS TABLET COMPRISING RIBOFLAVIN	DSM IP ASSETS B.V.
WO/2021/105051	COMPOSITION FOR THE 3D PRINTING OF SEMISOLID DRUGS	FUNDACION IDONIAL
WO/2021/099635	NEW SOLID STATE FORM OF LURBINECTEDIN	PHARMA MAR, S.A.
WO/2021/105059	UK 114 SALMON PROTEINS FOR USE IN THE TREATMENT, DIAGNOSIS AND  PREVENTION OF MALIGNANT TUMOURS	BARTORELLI CUSANI, Alberto
WO/2021/099638	COMPOSITION AND FOOD SUPPLEMENT, IN PARTICULAR FOR ORAL AND  DENTAL CARE	SMILLEAN
WO/2021/105061	WHOLE CELL VACCINES AND METHODS OF PRODUCTION THEREOF	GOTOVAX AB
WO/2021/105073	BENZOCOUMARIN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS  AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105074	DIRECT AMPK ACTIVATOR COMPOUNDS COMBINED WITH INDIRECT AMPK  ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105075	DIBENZOPYRAN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS  AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105076	Z-STILBENE AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND  USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105093	FREEZE-DRIED POWDER CONTAINING  2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGEL	CLEVEXEL PHARMA
WO/2021/121882	HAIR DYEING PROCESS USING AT LEAST ONE SILICONE COMPRISING AT  LEAST ONE CARBOXYLIC ACID ANHYDRIDE GROUP, AT LEAST ONE AMINO SILICONE AND AT  LEAST ONE PIGMENT AND/OR DIRECT DYE	L'OREAL
WO/2021/105137	TREM-1 INHIBITORS FOR THE TREATMENT OF VASO-OCCLUSIONS AND  TISSUE INJURIES IN PATIENTS SUFFERING FROM SICKLE CELL DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105164	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY  VASCULAR DISEASE AND/OR CARDIAC DYSFUNCTION IN FONTAN-PALLIATED PATIENTS	ACTELION PHARMACEUTICALS LTD
WO/2021/105167	TRIPLE VACCINE AGAINST AVIBACTERIUM PARAGALLINARUM AND AVIAN  ENCEPHALOMYELITIS VIRUS AND FOWL POX VIRUS	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/105217	USE OF RHAMNOSE AND ARABINOSE FOR DENTAL POWDER JET CLEANING	FERTON HOLDING S.A.
WO/2021/105219	PARTHANATOS CELL DEATH INHIBITORS FOR USE IN THE TREATMENT OF  PSORIASIS	UNIVERSIDAD DE MURCIA
WO/2021/105224	KDM SUBFAMILY 6 PROTEIN INHIBITOR FOR USE IN THE TREATMENT OF  CANCER	FUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/110544	METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID  ADMINISTRATION FORM	MERCK PATENT GMBH
WO/2021/110545	DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL  INGREDIENTS ON CARRIERS	MERCK PATENT GMBH
WO/2021/105331	METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSION	ACTELION PHARMACEUTICALS LTD
WO/2021/105339	SHAMPOO VETERINARY COMPOSITIONS	CEVA SANTE ANIMALE
WO/2021/105340	NON-RINSED VETERINARY COMPOSITIONS	CEVA SANTE ANIMALE
WO/2021/115800	TREATMENT OF HEMORRHOIDS WITH ANTICOAGULANT DRUGS	DE KEULENAER, Hendrik
WO/2021/105353	COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A NUTRIENT  AND/OR MINERAL FOR THE PREVENTION OR TREATMENT OF MASTITIS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105361	COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A N-3 FATTY ACID  FOR THE PREVENTION OR TREATMENT OF MASTITIS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105368	USE OF NEUROPILIN ANTAGONISTS FOR THE TREATMENT OF  ENDOMETRIOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105371	METHODS FOR STRATIFYING DIABETES PATIENTS	IMCYSE SA
WO/2021/105384	TARGETING THE NLS REGION OF NUPR1 PROTEIN TO TREAT CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105391	COMBINATION COMPRISING NUPR1 INHIBITORS TO TREAT CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/105392	SUSPENSION COMPRISING A PROTEIN PARTICLE SUSPENDED IN A  NON-AQUEOUS VEHICLE	NOVALIQ GMBH
WO/2021/105393	PROCESSES FOR OBTAINING STABLE GLP-1 COMPOSITIONS	NOVO NORDISK A/S
WO/2021/105407	miRNA-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR  THE PREVENTION AND THE TREATMENT OF TISSUE DISORDERS	NOVADIP BIOSCIENCES
WO/2021/105414	USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE  PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOID	ROTTAPHARM BIOTECH S.R.L.
WO/2021/105419	(R)-4-(1-(6-(4-(TRIFLUOROMETHYL)BENZYL)-6-AZASPIRO[2.5]OCTANE-5-CARBOXAMIDO)-CYCLOPROPYL)  BENZOIC ACID OR ITS SALT ALSO IN POLYMORPHIC FORM A FOR USE IN THE PREVENTION  OF HETEROTOPIC OSSIFICATION	ROTTAPHARM BIOTECH S.R.L.
WO/2021/110561	INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE IN  TREATING HEPATITIS B INFECTION	EVOTEC INTERNATIONAL GMBH
WO/2021/105435	PROOXIDATIVE CHAIN-TRANSFER AGENTS FOR USE IN THE TREATMENT OF  MALIGNANT TUMOUR OR INFECTIOUS DISEASES	UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/110562	INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS AND USES  THEREOF	EVOTEC INTERNATIONAL GMBH
WO/2021/105461	USE OF COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF  ANKYLOSING SPONDYLITIS, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/105474	NEW COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4  EXPRESSION	FACIO INTELLECTUAL PROPERTY B.V.
WO/2021/105481	NOVEL COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4  EXPRESSION	FACIO INTELLECTUAL PROPERTY B.V.
WO/2021/115825	COSMETIC COMPOSITION IN THE FORM OF AN OIL-IN-WATER  NANOEMULSION COMPRISING AT LEAST ONE LIQUID FATTY SUBSTANCE, AT LEAST ONE  SOLID FATTY SUBSTANCE AND AT LEAST ONE CATIONIC SURFACTANT	L'OREAL
WO/2021/105509	CHIMERIC OPSIN GPCR PROTEINS	UNIVERSITÄT BERN
WO/2021/110608	PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS AND MEDICINE	LIPOTRUE, S.L.
WO/2021/110625	HAIR TREATMENT PROCESS COMPRISING THE APPLICATION OF A  COMPOSITION COMPRISING CATIONIC POLYMERS AND ORGANOSILANES, FOLLOWED BY A  WASHING STEP	L'OREAL
WO/2021/110697	SOLID PHARMACEUTICAL FORMULATIONS OF  6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(-4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE	ASTRAZENECA AB
WO/2021/110732	METHOD FOR PRODUCING SPRAY-FREEZE-DRIED PARTICLES, AND  PARTICLES PRODUCED ACCORDINGLY	RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/110733	A COSMETIC COMPOSITION AND THE USE THEREOF AND A METHOD FOR  IMPROVING SENSORY CHARACTERISTICS	BASF SE
WO/2021/110737	USE OF MASITINIB FOR THE TREATMENT OF EOSINOPHILIC ASTHMA	AB SCIENCE
WO/2021/110748	A DAY-AND-NIGHT AND INSIDE-OUTSIDE COLLAGEN-CONTAINING  TREATMENT	LABORATORIO GENOVE, S.A.
WO/2021/122005	DIALIPHATIC KETONE MIXTURES, COMPOSITIONS COMPRISING SAME AND  USE THEREOF	SOLVAY SA
WO/2021/110768	COSMETIC CLEANING COMPOSITIONS IN POWDER FORM	YODI SAS
WO/2021/115886	A HEMOSTATIC AGENT AND USES THEREOF	ROYAL COLLEGE OF SURGEONS IN IRELAND
WO/2021/115887	DOT PRINTING METHOD AND DEVICE FOR ADDITIVE MANUFACTURING OF  DOSAGE FORMS WHICH CONTAIN ACTIVE SUBSTANCES	DIHESYS DIGITAL HEALTH SYSTEMS GMBH
WO/2021/110782	THE CHOLESTEROL-SYNTHESIS INTERMEDIATES FOR TREATMENT  DEMYELINATING DISORDERS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/130002	FOOD SUPPLEMENT FOR ALZHEIMER	FOLIUM BIOSCIENCES EUROPE B.V.
WO/2021/110796	INHIBITORS OF SHP2	BAYER AKTIENGESELLSCHAFT
WO/2021/110805	COMBINATION OF AN AZETIDINE LPA1 RECEPTOR ANTAGONIST WITH  PIRFENIDONE AND/OR NINTEDANIB FOR USE IN THE TREATMENT OF FIBROTIC DISEASES	IDORSIA PHARMACEUTICALS LTD
WO/2021/110817	POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS  TARGETING TNFA AND OX40L	ABLYNX NV
WO/2021/110833	TOOLS AND METHODS TO DETECT AND ISOLATE COLIBACTIN PRODUCING  BACTERIA	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
WO/2021/115919	TOPICAL ORAL COMPOSITION	KONINKLIJKE PHILIPS N.V.
WO/2021/122039	COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM  OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A  4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE	L'OREAL
WO/2021/122041	COSMETIC COMPOSITION COMPRISING WATER-SOLUBLE OR  WATER-DISPERSIBLE UV-SCREENING AGENTS, HYDROPHILIC THICKENERS AND HYDROPHILIC  SURFACTANTS	L'OREAL
WO/2021/110860	REACTIVE CONJUGATES	DEBIOPHARM RESEARCH & MANUFACTURING S.A.
WO/2021/110883	BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORS	ALBIREO AB
WO/2021/110884	BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORS	ALBIREO AB
WO/2021/110885	BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORS	ALBIREO AB
WO/2021/110886	BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORS	ALBIREO AB
WO/2021/110887	BENZOTHIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID  MODULATORS	ALBIREO AB
WO/2021/110915	METHOD FOR TRANSFORMING AN ESSENTIAL OIL	PRANARÔM INTERNATIONAL S.A.
WO/2021/110919	TREATMENT OF DISEASES RELATED TO HEPATITIS B VIRUS	ISA PHARMACEUTICALS
WO/2021/110923	PERSONAL DENTAL CARE PRODUCT FOR PREVENTING DEMINERALISATION	CREDENTIS AG
WO/2021/110942	PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG  BIS(MONOETHANOLAMINE)	SYNTHON B.V.
WO/2021/110959	PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG  BIS(MONOETHANOLAMINE)	SYNTHON B.V.
WO/2021/110968	MACROCYCLES COMPRISING A 4-AMIDO-2,4-PENTADIENOATE MOIETY FOR  THE TREATMENT OF HYPOXIC CANCERS	AARHUS UNIVERSITET
WO/2021/110976	PEPTIDE COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES	AXOLTIS PHARMA
WO/2021/110978	DEEP-LAYER REMINERALIZATION OF HYDROXYLAPATITE	DR. KURT WOLFF GMBH & CO. KG
WO/2021/110979	LIPID VESICLES AS OXIDATIVE STRESS SENSORS	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/110983	CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCE	ZERION APS
WO/2021/110989	VACCINE CONJUGATES	ULTIMOVACS AB
WO/2021/110990	ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF	OSE IMMUNOTHERAPEUTICS
WO/2021/110991	CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR  STRUCTURES IN THE KIDNEY	UNIVERSITÄT ZüRICH
WO/2021/115977	LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINE	ADAMED PHARMA S.A.
WO/2021/116000	INVERSE LATEX FOR A COSMETIC COMPOSITION COMPRISING A SPECIFIC  CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A  NEUTRAL FUNCTION	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/116009	INVERSE LATEX FOR A COSMETIC COMPOSITION, COMPRISING A  SPECIFIC CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID  FUNCTION AND A WEAK ACID FUNCTION	SOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/111005	NOVEL AGENTS AND USES THEREOF	FIORETOS, Thoas
WO/2021/111007	STABLE COMPOSITIONS OF FC MULTIMERS	CSL BEHRING LENGNAU AG
WO/2021/116114	AEROSOL HAIR DYEING DEVICE BASED ON A CROTONIC ACID COPOLYMER  AND A FATTY AMINE	L'OREAL
WO/2021/116119	ANTIBODIES HAVING SPECIFICITY TO HER4 AND USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/116182	POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS  TARGETING IL-13 AND TSLP	ABLYNX NV
WO/2021/116188	COMBINATION PRODUCT CONTRIBUTING TO THE WELL-BEING OF PREGNANT  WOMEN, COMPRISING EPA, DHA, VITAMINS AND MINERALS	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/122239	INHIBITION OF TMEM16A BY BENZBROMARONE OR NICLOSAMIDE FOR  TREATING POLYCYSTIC KIDNEY DISEASE AND/OR POLYCYSTIC LIVER DISEASE	UNIVERSITÄT REGENSBURG
WO/2021/116203	COMPOSITION OF EXTRACT OF DRIED STIGMAS OF CROCUS SATIVUS  (SAFFRON) AND OF FLAVONOID(S) FOR THE TREATMENT OF SEVERE ALLERGIC ASTHMA	STRUNDEN, Christian
WO/2021/130022	VIRUS-MIMETIC NANOPARTICLES	UNIVERSITÄT REGENSBURG
WO/2021/116244	MODULATION OF DRUG RELEASE AND BIOAVAILABILITY OF COMPOSITIONS  CONTAINING DOLUTEGRAVIR SODIUM AND OTHER ANTI HIV DRUGS	SANDOZ AG
WO/2021/144080	METHOD FOR INCORPORATING ACTIVE SUBSTANCES INTO THE SKIN	BEIERSDORF AG
WO/2021/116260	QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS	CHIESI FARMACEUTICI S.P.A.
WO/2021/122278	NON-STICK ANTIBIOTIC GELS	AO TECHNOLOGY AG
WO/2021/116275	DENTAL RESIN MODIFIED GLASS-IONOMER COMPOSITION AND KIT  COMPRISING SAID COMPOSITION	DENTSPLY SIRONA INC.
WO/2021/116331	STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES  COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116367	CELLULOSE NANOCRYSTAL EFFECT PIGMENTS FOR COSMETIC  APPLICATIONS	BASF COLORS & EFFECTS GMBH
WO/2021/116370	THICKENING SILICA AS FLUORIDE CARRIER FOR TAILORED DELIVERY  AND SLOW RELEASE	GABA INTERNATIONAL HOLDING GMBH
WO/2021/116372	INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC  INFLAMMATORY MYOPATHIES	UNIVERSITEIT ANTWERPEN
WO/2021/116389	EPAC1 INHIBITORS FOR THE TREATMENT OF IDIOPATHIC PULMONARY  FIBROSIS	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/116420	USE OF TLR7 AND/OR TLR8 AGONISTS FOR THE TREATMENT OF  LEPTOSPIROSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/122382	AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC  POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A  FATTY PHASE AND A PIGMENT	L'OREAL
WO/2021/122383	AQUEOUS COMPOSITION COMPRISING A CATIONIC CELLULOSIC POLYMER,  AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY  PHASE AND A PIGMENT	L'OREAL
WO/2021/116432	BIODEGRADABLE MICROCAPSULE SYSTEMS	PAPIERFABRIK AUGUST KOEHLER SE
WO/2021/116443	COMPOSITION COMPRISING PROPOLIS PARTICLES	POLLENERGIE
WO/2021/116475	AMPHOTERICIN B CONJUGATED STABILIZED GOLD NANOPARTICLES AND  USES THEREOF	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/116476	AGONISTS OF RNA ADENOSINE N-6 METHYLATION FOR USE IN  SUPPRESSING HIV-1 LATENT PROVIRUS ACTIVATION AND REPLICATION	CHEMESTMED LTD.
WO/2021/116477	METHOD OF SUPPRESSING CANCER BY RNA m6A METHYLTRANSFERASE  METTL16 INHIBITORS	CHEMESTMED LTD.
WO/2021/228422	OXYBUTYNIN FOR INTRAVESICAL USE	FARCO-PHARMA GMBH
WO/2021/122412	AQUEOUS COMPOSITION FOR TREATING KERATIN FIBRES, COMPRISING A  PLANT OIL, A HYDROCARBON-BASED OIL, A GLYCEROLATED NONIONIC SURFACTANT, A  POLYSACCHARIDE AND A SOLVENT	L'OREAL
WO/2021/130038	USE OF LOSARTAN FOR THE TREATMENT OF FIBROTIC DISEASES, IN  PARTICULAR EPIDERMOLYSIS BULLOSA	ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/116487	COMPOUNDS FOR USE IN THE TREATMENT OF NIEMANN-PICK C DISEASE	SOM INNOVATION BIOTECH, S.A.
WO/2021/122434	COMBINATION OF AN AHR-INHIBITOR AND AN PD1-INHIBITOR ANTIBODY  AND ITS USE IN THE TREATMENT OF CANCER	BAYER AKTIENGESELLSCHAFT
WO/2021/122481	COMPOSITION COMPRISING A NATURAL DYE AND A FATTY AMINE	L'OREAL
WO/2021/122482	COSMETIC OR DERMATOLOGICAL COMPOSITION ACTING IN PARTICULAR ON  THE EFFECTS OF BLUE LIGHT ON SKIN AND ITS APPENDAGES, AND ASSOCIATED USES	SEDERMA
WO/2021/116498	ESKETAMINE FORMULATIONS AND METHODS FOR PREPARATION AND  STORAGE	JANSSEN PHARMACEUTICA NV
WO/2021/197655	SYRINGE AND KIT FOR INTRAVESICAL USE	FARCO-PHARMA GMBH
WO/2021/122507	INACTIVATED PISCINE ORTHOREOVIRUS VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/122515	PARASITE CONTROL IN RUMINANTS	INTERVET INTERNATIONAL B.V.
WO/2021/122545	USE OF THE GDF-5 MUTANT FOR THE TREATMENT OF PAIN AND  CARTILAGE DESTRUCTION	MERCK PATENT GMBH
WO/2021/122608	LOW-MOLECULAR GELLING AGENT AS FRAGRANT SUBSTANCE DISPENSING  SYSTEM	HENKEL AG & CO. KGAA
WO/2021/122638	DEVICE FOR SPRAYING A TWO-PHASE COMPOSITION COMPRISING AN  AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AND AN OILY PHASE COMPRISING  NON-SILICONE OILS	L'OREAL
WO/2021/122639	TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING  ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY  PHASE COMPRISING NON-SILICONE OILS	L'OREAL
WO/2021/122647	HIGH VISCOSITY ELASTIC GELS AND USES THEREFOR	WARWICK INTERNATIONAL GROUP LTD.
WO/2021/122717	NEW HENNA-BASED EXTRACT FOR USE IN DYEING KERATIN FIBERS, ITS  PREPARATION METHOD AND COMPOSITIONS CONTAINING IT	L'OREAL
WO/2021/122733	BISPECIFIC ANTI-CCL2 ANTIBODIES	F. HOFFMANN-LA ROCHE AG
WO/2021/122741	PREBIOTIC AND PROBIOTIC TREATMENT TO REDUCE ORAL DYSBIOSIS AND  PROMOTE EUBIOSIS	FUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y  BIOMéDICA DE LA COMUNITAT VALENCIANA
WO/2021/122758	COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS  VASORELAXANT	EVONIK OPERATIONS GMBH
WO/2021/122809	COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION  AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR  MICROBIOME-PROTECTION	EUROPEAN MOLECULAR BIOLOGY LABORATORY
WO/2021/122813	ANGIOGENESIS PROMOTING AGENTS FOR PREVENTION OF METASTATIC  CANCER	UNIVERSITÄT BASEL
WO/2021/122838	NON-ELICITED DEDIFFERENTIATED <i>LAVANDULA  ANGUSTIFOLIA</i> PLANT CELLS, EXTRACTS THEREOF AND COSMETIC USES  THEREOF	L'OREAL
WO/2021/122840	COSMETIC COMPOSITION COMPRISING A CATIONIC ASSOCIATIVE  POLYMER, A CARBOXYLIC ANIONIC SURFACTANT, OPTIONALLY A NONIONIC SURFACTANT  AND AN AMPHOTERIC OR ZWITTERIONIC SURFACTANT	L'OREAL
WO/2021/130088	COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST  ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE  SURFACTANT	L'OREAL
WO/2021/249664	ANTI-BLYS ANTIBODY FOR TREATING PROTEINURIC KIDNEY DISEASE	GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED
WO/2021/122873	PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING A HETEROCYCLIC  ORGANIC ANION	L'OREAL
WO/2021/122874	PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC  ORGANIC ANION	L'OREAL
WO/2021/122875	ANTIBODIES BINDING TO HLA-A2/MAGE-A4	F. HOFFMANN-LA ROCHE AG
WO/2021/122876	PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION  COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC  ORGANIC ANION	L'OREAL
WO/2021/122896	CRYPTOSPORIDIOSIS VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/122923	STABILIZATION OF SELENITE IN A NUTRITIONAL SOLUTION BY  DISSOLVED OXYGEN	BAXTER INTERNATIONAL INC.
WO/2021/122925	PARENTERAL NUTRITION SOLUTION COMPRISING A SELENIUM SOURCE	BAXTER INTERNATIONAL INC.
WO/2021/122928	ORAL RESPIRATORY VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/122935	METHOD FOR THE COSMETIC TREATMENT OF KERATIN FIBRES COMPRISING  A STAGE OF APPLICATION OF A RARE EARTH METAL COMPOSITION AND A STAGE OF  APPLICATION OF A COMPOSITION COMPRISING SURFACTANTS	L'OREAL
WO/2021/122946	METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS  EMPLOYING A RARE EARTH METAL COMPOSITION AND AN ALKALINE COMPOSITION	L'OREAL
WO/2021/122957	DENTAL ROOT CANAL FILLING COMPOSITION	DENTSPLY DETREY GMBH
WO/2021/122996	A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203	QURIENT CO., LTD.
WO/2021/123003	PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A  DETERGENT COMPOSITION AND A RARE EARTH METAL COMPOSITION	L'OREAL
WO/2021/123011	ASSOCIATION OF FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573  WITH PENTASA<sp>®</sp> FOR THE TREATMENT AND PREVENTION OF  GASTROINTESTINAL INFLAMMATION	EXELIOM BIOSCIENCES
WO/2021/123013	SMART DRUG DELIVERY SYSTEM AND PHARMACEUTICAL KIT FOR DUAL  NUCLEAR MEDICAL CYTOTOXIC THERANOSTICS	JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/123033	NOVEL G-CSF MIMICS AND THEIR APPLICATIONS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123047	MACROCYCLIC PEPTIDES	HERANTIS PHARMA OYJ
WO/2021/164925	COLLAGEN HYDROLYSATE AS ACTIVE SUBSTANCE AGAINST PERIODONTITIS  OR GINGIVITIS	GELITA AG
WO/2021/123061	PROCESS FOR PREPARING A COMPOSITION FOR DYEING THE HAIR  STARTING FROM A COMPOSITION IN POWDER FORM AND AN AQUEOUS COMPOSITION	L'OREAL
WO/2021/123084	EGFR INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/123087	EGFR INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/123088	A PHARMACEUTICAL COMPOSITION OF A PYRAZOLE COMPOUND DISPERSED  IN A POLYMER MATRIX	INTERVET INTERNATIONAL B.V.
WO/2021/123089	ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR  <i>ALPHA</i>	INTERVET INTERNATIONAL B.V.
WO/2021/123104	MULTIVALENT HVT VECTOR VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/123108	A PYRAZOLE PHARMACEUTICAL COMPOSITION	INTERVET INTERNATIONAL B.V.
WO/2021/123110	SEMI-SOLID NATURAL PERFUME	EXPRESSIONS PARFUMEES
WO/2021/123117	METHOD FOR PRODUCING OIL-IN-WATER EMULSIONS	FRESENIUS KABI AUSTRIA GMBH
WO/2021/123119	TREATMENT OF ACUTE HEART FAILURE	LUND, Lars H.
WO/2021/123121	LIPID-BASED COMPOSITIONS COMPRISING LIPOPHILIC SALTS AND  ACIDIC PH MODIFIERS	CAPSUGEL BELGIUM NV
WO/2021/123131	COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND/OR  ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/123142	COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH  EXCESSIVE VASCULARISATION	ACTIVE BIOTECH AB
WO/2021/123144	PRO-PERFUME COMPOSITIONS	FIRMENICH SA
WO/2021/123164	OILY SOLID COSMETIC	L V M H RECHERCHE
WO/2021/123165	DOSAGE FORM COMPRISING AMORPHOUS SOLID SOLUTION OF  EMPAGLIFLOZIN WITH POLYMER	KRKA, D.D., NOVO MESTO
WO/2021/123170	COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLAR OIL, AN  ALIPHATIC MONOALCOHOL, A MIXTURE OF POLYOLS AND AT LEAST ONE HYDROPHILIC  ACTIVE AGENT	L'OREAL
WO/2021/123174	SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF	UNIVERSITE DE STRASBOURG
WO/2021/123192	EDOXABAN TABLETS	BIOHORM, S.L.
WO/2021/123198	LEUKEMIA TREATMENT	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/123202	FORMULATIONS OF ANTI-PD1 ANTIBODIES	FORMYCON AG
WO/2021/123228	PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUE	KRKA, D.D., NOVO MESTO
WO/2021/130126	LIQUID COMPOSITION COMPRISING IBUPROFEN AND PHENYLEPHRINE	NUTRA ESSENTIAL OTC, S.L.
WO/2021/123229	SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE  MODIFICATION OF PROTEINS	GENIE BIOTECH UK LTD.
WO/2021/123232	NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTS	EVAXION BIOTECH APS
WO/2021/123233	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/123243	METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/123245	NAD-PRECURSORS AND DIETARY RESTRICTION FOR TREATING  AGE-RELATED MEDICAL CONDITIONS	LEIBNIZ-INSTITUT FüR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT  E.V. (FLI)
WO/2021/123280	DIETARY SUPPLEMENT FOR LIPEDEMA PATIENTS	PANTEA GMBH
WO/2021/123289	SOLUBLE REAR LAYER FOR OTF	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/123291	OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/123297	OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/123300	TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERS	LIFESEARCH
WO/2021/123302	COMPOSITION COMPRISING A ROSEWOOD EXTRACT	L'OREAL
WO/2021/123306	COMPOSITION COMPRISING A CATIONIC CELLULOSE-BASED POLYMER, A  SULFONIC ANIONIC POLYMER AND A FIXING POLYMER	L'OREAL
WO/2021/123309	COMPOSITION COMPRISING A DISPERSION OF POLYMER PARTICLES IN A  NON-AQUEOUS MEDIUM, A CATIONIC POLYMER AND AN ANIONIC POLYMER	L'OREAL
WO/2021/123311	COMPOSITION COMPRISING A SOLUBILIZED SOLID FATTY ALCOHOL AND A  MONOALCOHOL	L'OREAL
WO/2021/123323	LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR  A CEBP-DELTA INHIBITOR AS THERAPEUTICS	LINNANE PHARMA AB
WO/2021/123325	COMPOSITION COMPRISING A NATURAL DYE, A DISPERSANT, AN OIL AND  A FATTY-PHASE THICKENER	L'OREAL
WO/2021/123329	HAIR DYEING COMPOSITION COMPRISING A DIRECT DYE, A  SCLEROGLUCAN GUM AND A NON-IONIC ASSOCIATIVE POLYMER	L'OREAL
WO/2021/123332	LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS	CUREVAC AG
WO/2021/123337	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/123341	COMPOSITION COMPRISING DIOSMIN	KRKA, D.D., NOVO MESTO
WO/2021/123345	PROCESS FOR COLOURING KERATIN MATERIALS USING A PARTICULAR  OILY DISPERSION AND AT LEAST TWO AMINE COMPOUNDS THAT ARE DIFFERENT FROM EACH  OTHER	L'OREAL
WO/2021/123347	PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A  RARE-EARTH METAL AND A PARTICULAR POLYMER	L'OREAL
WO/2021/123352	RETINOL-BASED SERUM	L'OREAL
WO/2021/123355	PROBIOTICS FOR REGULATING BLOOD GLUCOSE	GENBIOMA APLICACIONES, S.L.
WO/2021/123377	COMPOSITION FOR THE TREATMENT OF INFLAMMATION AND/OR  ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/123378	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/123399	MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR  VESICLES FOR TARGETED CARGO DELIVERY	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123419	COMPOSITION FOR THE TREATMENT OF AMYLOID-BETA ASSOCIATED  DISEASES	BASF SE
WO/2021/130168	A PHARMACEUTICAL FORMULATION	WARSZAWSKIE ZAKLADY FARMACEUTYCZNE POLFA SA
WO/2021/123430	POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTS	THE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF  TRINITY COLLEGE DUBLIN
WO/2021/123432	IGG:TGFBETARII FUSION PROTEIN COMPOSITION	ARES TRADING S.A.
WO/2021/130170	PROCESS FOR THE PREPARATION OF DISPERSIONS COMPRISING  INHALABLE IMMUNOSUPPRESSIVE ACTIVE INGREDIENTS	ZAMBON S.P.A.
WO/2021/130180	TOPICAL COMPOSITIONS COMPRISING PEA PROTEINS AND POLYPHENOLS	DEVINTEC SAGL
WO/2021/130181	NOVEL FAECAL COMPOSITION	LAURIDSEN, Hengameh, Chloe
WO/2021/130182	CAPSULE COMPRISING A FAECAL COMPOSITION	LAURIDSEN, Hengameh, Chloe
WO/2021/130192	COMPOSITION COMPRISING ASCORBIC ACID	L'OREAL
WO/2021/130195	METHOD OF TREATING VIRUS INFECTION USING A TLR7 AGONIST	F. HOFFMANN-LA ROCHE AG
WO/2021/130210	PROCESS FOR DESIGNING A RECOMBINANT POXVIRUS FOR A THERAPEUTIC  VACCINE	TRANSGENE
WO/2021/130215	GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY	UNIVERSIDAD DEL PAíS VASCO/EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/130219	USES OF LIPOTEICHOIC ACID FROM BIFIDOBACTERIA	BIOPOLIS, S.L.
WO/2021/130223	TREATMENT INVOLVING IMMUNE EFFECTOR CELLS GENETICALLY MODIFIED  TO EXPRESS ANTIGEN RECEPTORS	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130225	IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS  USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS  (DARPINS)	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130226	COMPOSITION FOR THE PREPARATION OF PERINDOPRIL ARGININE  GRANULES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION  COMPRISING THE GRANULES	KRKA, D.D., NOVO MESTO
WO/2021/130232	BILE ACID DERIVATIVES IN THE MEDICAL INTERVENTION OF ANXIETIES  AND/OR STRESS SYMPTOMS	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/130237	uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL  THERAPY	RIGSHOSPITALET
WO/2021/130255	DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES	UCB BIOPHARMA SRL
WO/2021/130257	DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES	UCB BIOPHARMA SRL
WO/2021/130259	DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE DERIVATIVES  COMPOUNDS	UCB BIOPHARMA SRL
WO/2021/130260	TETRAHYDROBENZO-QUINOLINE SULFONAMIDE DERIVATIVES USEFUL AS  IGE MODULATORS	UCB BIOPHARMA SRL
WO/2021/130262	TETRAHYDROBENZO-QUINOLINE SULFONAMIDES DERIVATIVE COMPOUNDS	UCB BIOPHARMA SRL
WO/2021/130264	TRANSPARENT COMPOSITION FOR USE IN SKINCARE AND/OR HAIRCARE	S.P.C.M. SA
WO/2021/130269	COMBINATION OF AN ALPHA-PLL WITH A BETA-LACTAM FOR TREATING  ANTIBIOTIC BACTERIAL RESISTANCE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/130270	PHARMACEUTICAL COMBINATION OF ANTIVIRAL AGENTS TARGETING HBV  AND/OR AN IMMUNE MODULATOR FOR TREATMENT OF HBV	F. HOFFMANN-LA ROCHE AG
WO/2021/170283	BIO-FERMENTED SURFACTANTS FOR REDUCING ABRASION OF DENTAL  ENAMEL	HENKEL AG & CO. KGAA
WO/2021/130291	TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODIES	SOTIO A.S.
WO/2021/130305	COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC  REACTION	APOSCIENCE AG
WO/2021/130329	RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT  OF CXCR4 EXPRESSING TUMORS	ISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/130335	EMULSIFIED LIP GEL	L'OREAL
WO/2021/130349	COSMETIC COMPOSITIONS COMPRISING MELANOIDINS	KAFFE BUENO APS
WO/2021/130377	POLYMERIC NANOPARTICLES FOR ENHANCED CANCER TREATMENT	THE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/130381	COMBINATION OF A HDAC INHIBITOR AND VX MOLECULES, AND ITS USE  FOR THE TREATMENT OF CYSTIC FIBROSIS	CENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/130382	COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND  ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN  CONFORMATIONAL DISORDER	CENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/148229	COMPOSITION FOR WEIGHT MANAGEMENT OF A SUBJECT	MRS-BIOTECH
WO/2021/136763	ISOQUINOLINE DERIVATIVES FOR USE IN TREATING GLUT1 DEFICIENCY  SYNDROME	GLIAPHARM SA
WO/2021/136784	A COMPOSITION FOR THE TREATMENT OF MALE INFERTILITY	LABORATORIO REIG JOFRé, S.A.
WO/2021/136786	PREPARATION COMPRISING ELEMENTAL SILVER FOR TREATMENT AND  PREVENTION OF PERIODONTITIS	GUGGENBICHLER, Joseph Peter
WO/2021/136788	PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE  APPLICATION OF A COMPOSITION COMPRISING A PARTICULAR COMPOUND COMPRISING AT  LEAST TWO TETRAZOLES GROUPS	L'OREAL
WO/2021/136808	CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTS	ASCENDIS PHARMA A/S
WO/2021/136812	BACTERIAL DELIVERY VEHICLES FOR IN VIVO DELIVERY OF A DNA  PAYLOAD	ELIGO BIOSCIENCE
WO/2021/136827	COMPOUND FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS  SYSTEM DISORDERS	ABAXYS THERAPEUTICS
WO/2021/136835	COMPOSITIONS AND METHODS FOR THE PREVENTION OF S.  <i>AUREUS </i>INFECTION	ANTAGONIS
WO/2021/136841	PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF  POST-SURGICAL PAIN	PEPTINOV
WO/2021/151619	USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE  INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASES	METRIOPHARM AG
WO/2021/151620	USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE  TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASES	METRIOPHARM AG
WO/2021/170290	INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF  CORONAVIRAL INFECTIONS	IMMUNOLOGIK GMBH
WO/2021/190783	5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF  ACUTE LUNG INJURY	METRIOPHARM AG
WO/2021/219244	6'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL  INFECTIONS	IMMUNOLOGIK GMBH
WO/2021/233571	TREATMENT AGENT FOR ANTIVIRAL THERAPY, APPLICATOR, AND METHOD  FOR PRODUCING A TREATMENT AGENT	NINODERM UG (HAFTUNGSBESCHRÄNKT)
WO/2021/244771	METHOD FOR SOLUBILIZING NATURAL, ENDOGENOUS AND SYNTHETIC  CANNABINOIDS	ATHENION AG
WO/2021/249667	COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS	METRIOPHARM AG
WO/2021/148241	COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING  NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKIN	ASC REGENITY LTD
WO/2021/160346	NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS	INSTITUT PASTEUR
WO/2021/204423	USE OF 15-MEMBERED AZALIDES AS ACTIVE AGENTS IN THE TREATMENT  OF VIRAL INFECTIONS	UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE
WO/2021/209173	NOVEL THERAPEUTIC USE OF PLEUROMUTILINS	NABRIVA THERAPEUTICS GMBH
WO/2021/209174	THERAPEUTIC USE OF PLEUROMUTILINS	NABRIVA THERAPEUTICS GMBH
WO/2021/223914	PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION COMPRISING BRIMONIDINE	PHARMATHEN S.A.
WO/2021/228434	PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC  ADMINISTRATION CONTAINING CYCLOSPORINE	PHARMATHEN S.A.
WO/2021/254662	CROSSLINKED STARCH DERIVATIVE-BASED MATRIX	ROQUETTE FRERES
WO/2021/175497	METHOD FOR COLORING KERATIN MATERIAL, COMPRISING THE USE OF  TWO STRUCTURALLY DIFFERENT SILANES AND TWO STRUCTURALLY DIFFERENT POLYMERS	HENKEL AG & CO. KGAA
WO/2021/197673	AGENTS FOR IMPROVED OXIDATIVE LIGHTENING OF KERATIN FIBRES	HENKEL AG & CO. KGAA
WO/2021/180369	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, ALGINIC ACID (SALT),   A DYEING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/180370	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, A GLYCEROL ESTER, A COLORING COMPOUND AND A  POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/180372	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/140101	PREPARATION AND USE OF CANNABIS NANO-FORMULATION	CANNAXAN GMBH
WO/2021/140103	COGNITIVE DISORDER PREVENTION AND THERAPY	ANIMA
WO/2021/140111	HAIR CONDITIONER ALLOWING THE USE OF SOAP AS SHAMPOO	LYNELINE SàRL
WO/2021/140113	CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/175499	PERSONAL CARE COMPOSITION AND METHODS	UNILEVER IP HOLDINGS B.V.
WO/2021/140123	VACCINES TARGETING NEISSERIA GONORRHOEAE	EVAXION BIOTECH APS
WO/2021/140131	USE OF TAXODIONE AS AN ANTI-GLYCATION AGENT	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/148249	NEW COMPOSITION AS SHAVING PREPARATION	BEIERSDORF AG
WO/2021/140141	COSMETIC TREATMENT METHOD	L'OREAL
WO/2021/140174	GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF CHRONIC  KIDNEY DISEASE AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES	MEDIMMUNE LIMITED
WO/2021/140183	ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING  GASTROINTESTINAL DISORDERS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/140194	COMPOUNDS FOR PROMOTING FOLLICLE MATURATION	AARHUS UNIVERSITET
WO/2021/136848	COMPOSITION FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS	BIOSEARCH, S.A.
WO/2021/140228	COSMETIC COMPOSITION	CREASEARCH BV
WO/2021/140229	COSMETIC COMPOSITION	CREASEARCH BV
WO/2021/144211	EDIBLE TOOTHPASTE COMPOSITION TO BE SUCKED OR CHEWED, METHOD  FOR PREPARING SAID TOOTHPASTE COMPOSITION	DANA, Jean Dominique
WO/2021/144231	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084139	NANO-DRY MELTING	BAYER AKTIENGESELLSCHAFT
WO/2021/144245	NATIVE AND POROUS STARCH AS WHITE PIGMENT IN TOOTHPASTE	ROQUETTE FRERES
WO/2021/144249	HYPOPARATHYROIDISM TREATMENT	ASCENDIS PHARMA BONE DISEASES A/S
WO/2021/144254	SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN  ANTIBIOTIC	VAXIMM AG
WO/2021/144267	HAIR TREATMENT COMPOSITIONS AND METHODS	UNILEVER IP HOLDINGS B.V.
WO/2021/144272	HAIR TREATMENT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/144274	USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF JOINT PAIN  INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/144302	BIOMARKERS FOR DETERMINING SUSCEPTIBILITY TO OXOPIPERAZINE  DERIVATIVES AND METHODS OF USING SAME	INTHERA BIOSCIENCE AG
WO/2021/180378	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, HYALURONIC ACID (SALT),  A DYEING COMPOUND AND A POST-TREATMENT  AGENT	HENKEL AG & CO. KGAA
WO/2021/180379	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN  ORGANOSILICON COMPOUND, TWO DYEING COMPOUNDS AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/144313	VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES	SYNAFFIX B.V.
WO/2021/144314	VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES	SYNAFFIX B.V.
WO/2021/144315	CONJUGATES OF ANTIBODIES AN IMMUNE CELL ENGAGERS	SYNAFFIX B.V.
WO/2021/144326	TOPICAL COMPOSITION COMPRISING HYDROXAMIC ACID AND  ATRACTYLENOLIDE	UNILEVER IP HOLDINGS B.V.
WO/2021/144330	USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D  VIRUS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/144333	PROBIOTIC COMPOSITION FOR USE AS AN ANTIOXIDANT	BIOPOLIS, S.L.
WO/2021/144338	METHOD OF TREATMENT OF CANCER OR TUMOUR	ADAPTIMMUNE LIMITED
WO/2021/160366	POLYACRYLATE-FREE COSMETIC PREPARATION	BEIERSDORF AG
WO/2021/144360	SMALL MOLECULE CSF-1R INHIBITORS IN THERAPEUTIC AND COSMETIC  USES	F. HOFFMANN-LA ROCHE AG
WO/2021/144364	PARTICLES OF A MIXTURE OF IRON(III)-OXYHYDROXIDE, SUCROSE AND  ONE OR MORE STARCHES, PREFERABLY OF SUCROFERRIC OXYHYDROXIDE	VIFOR (INTERNATIONAL) AG
WO/2021/144365	PRODUCT AND MANUFACTURING PROCESS FOR A GUM	MCNEIL AB
WO/2021/144367	LOZENGE	MCNEIL AB
WO/2021/144369	FIMH MUTANT, COMPOSITIONS THEREWITH AND USE THEREOF	JANSSEN PHARMACEUTICALS, INC.
WO/2021/144370	PRODUCT AND METHOD OF MANUFACTURING A GUM	MCNEIL AB
WO/2021/144381	COMPOSITIONS FOR ALLEVIATING THE SYMPTOMS OF LOW ANTERIOR  RESECTION SYNDROME BY TOPICAL ADMINISTRATION TO THE NEORECTUM	REPOCEUTICALS A/S
WO/2021/164959	METHOD FOR PROVIDING PERSONALIZED CELLS WITH CHIMERIC ANTIGEN  RECEPTORS (CAR) AGAINST TUMOR MICROENVIRONMENT CELLS	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/144403	DOSAGE FORM WITH SUSTAINED RELEASE MELATONIN PELLETS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/148314	ACCELERATED ELIMINATION OF  (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL	IDORSIA PHARMACEUTICALS LTD
WO/2021/144415	IMMUNOGLOBULIN SINGLE DOMAIN ANTIBODIES FOR DELIVERY OF  MUCOSAL VACCINES	UNIVERSITEIT GENT
WO/2021/144446	PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF LIVER STEATOSIS	MEDA PHARMA S.P.A.
WO/2021/144447	PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR  AND METABOLIC DISEASES	MEDA PHARMA S.P.A.
WO/2021/144450	A COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING  PEPTIDE CONJUGATE	FLUOGUIDE A/S
WO/2021/144457	FORMULATIONS OF CD38 ANTIBODIES AND USES THEREOF	GENMAB A/S
WO/2021/144460	CONTROLLED RELEASE FORMULATIONS	UNIVERSIDAD DE ZARAGOZA
WO/2021/151694	SUNSCREEN WITH PIGMENT FILTER SEPARATION	BEIERSDORF AG
WO/2021/156043	TESTOSTERONE CONTAINING PHARMACEUTICAL COMPOSITION	DIURNAL LIMITED
WO/2021/148347	BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINE	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/219255	NATURAL MATERIAL PAD	ORGANOID TECHNOLOGIES GMBH
WO/2021/148362	DIRECTLY COMPRESSIBLE POLYMER COMBINATIONS FOR MATRIX TABLETS  WITH EXTENDED DRUG RELEASE	MERCK PATENT GMBH
WO/2021/148366	PLANT-BASED COMPOSITION IN A FORM SUITABLE FOR TOPICAL  ADMINISTRATION AND ASSOCIATED PRODUCTION METHOD	MENELIK
WO/2021/148396	EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS  FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/148405	INHIBITORS OF INTRACELLULAR BACTERIAL GROWTH AND PERSISTENCE  AS ANTIBIOTICS	CONSEJO SUPERIOR DE INVESTIGACIONES (CSIC)
WO/2021/148427	HYDRATABLE CONCENTRATED SURFACTANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/148428	ISOTROPIC CONCENTRATE AND WASH COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/148436	SUBSTANCE COMBINATION WITH ISOQUINOLINE ALKALOIDS AND A  COCCIDIOSTAT OR COCCIDIOSIS INOCULANT	PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH
WO/2021/148439	METHODS FOR STIMULATING CEREBROVASCULAR FUNCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/151756	BASE EDITOR LACKING HNH AND USE THEREOF	ETH ZURICH
WO/2021/164974	SHAVING AID CONTAINING HYDROXYALKYL CELLULOSES	BEIERSDORF AG
WO/2021/148496	USE OF TETRAPEPTIDES AND FUNCTIONALISED MICROCAPSULES AS SKIN  PENETRATION CARRIERS	INFINITEC ACTIVOS, S.L.
WO/2021/148500	COMPOUNDS AND CONJUGATES THEREOF	MEDIMMUNE LIMITED
WO/2021/148501	COMPOUNDS AND CONJUGATES THEREOF	MEDIMMUNE LIMITED
WO/2021/148511	LIPID NANOPARTICLES	ETHERNA IMMUNOTHERAPIES NV
WO/2021/148572	COMPOSITION COMPRISING HYALURONIC ACID AND A POLYOL AND/OR  CARBOXYMETHYL CELLULOSE	LABORATOIRES GENEVRIER SAS
WO/2021/148619	TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANT	BAUSCH HEALTH IRELAND LIMITED
WO/2021/148633	COMPLEX OF 7-DEACETYFORSKOLINE AND PVP	SCIPHARM S.à R.L.
WO/2021/148634	TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT  ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE	LUYE PHARMA SWITZERLAND AG
WO/2021/148646	MICRIBIOTA-DERIVED PROTEINS INDUCING IL-10 RELEASE FROM HUMAN  CELLS AND USES THEREOF	ENTEROME S.A.
WO/2021/148667	AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTH	IVOCLAR VIVADENT AG
WO/2021/151828	THE USE OF A POLYLYSINE FOR INCREASING THE GLOSS OF HAIR	BASF SE
WO/2021/151857	PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED  PHARMACEUTICAL FORMULATION	CHIESI FARMACEUTICI S.P.A.
WO/2021/151865	MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY	EVOTEC INTERNATIONAL GMBH
WO/2021/151872	ALLERGEN PROTECTION AGAINST URUSHIOLS	BEIERSDORF AG
WO/2021/151877	TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES FOR  PROTECTING SKIN FROM ALLERGENS	BEIERSDORF AG
WO/2021/156104	METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF LAVENDER,  COMPOSITIONS COMPRISING SUCH AN EXTRACT AND THEIR COSMETIC USES	ISP INVESTMENTS LLC.
WO/2021/151879	PROTECTING SKIN FROM ALLERGENS	BEIERSDORF AG
WO/2021/151889	ANTI-αVβ8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY  DISEASE	MEDIMMUNE LIMITED
WO/2021/151905	TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF  RENAL DISEASE	TRANSITION THERAPEUTICS (IRELAND 2) LIMITED
WO/2021/151918	COSMETIC PRODUCT CAKE WITH ECOLOGICAL SUPPORT AND  MANUFACTURING PROCESS THEREOF	INTERCOS S.P.A.
WO/2021/165001	HUMECTANT-FREE TOOTHPASTE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/151937	ECOLOGICAL SUPPORT FOR COSMETIC PRODUCTS AND RELATED FORMATION  PROCESS.	INTERCOS S.P.A.
WO/2021/151946	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/151956	COMPOSITION FOR TREATING INTESTINAL OR PULMONARY DISEASES	INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE,  L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/151963	PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON  NON-HUMAN ORGANISMS	BAYER ANIMAL HEALTH GMBH
WO/2021/151964	USE OF AZOLE COMPOUNDS TO STIMULATE THE IMMUNE SYSTEM AND AS  INHIBITORS FOR S-PLA2GIB	DIACCURATE
WO/2021/151974	INTERFERING WITH MRNA SPLICING TO ENHANCE RESPONSE TO  CHECKPOINT IMMUNOTHERAPIES.	STICHTING HET NEDERLANDS KANKER INSTITUUT - ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/151984	TREATMENT OF CANCER	INNATE PHARMA
WO/2021/152009	GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A  PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCT	ALTERNO LABS D.O.O.
WO/2021/156140	POLYMORPH OF RUCAPARIB MESYLATE	SANDOZ AG
WO/2021/152060	CONTROLLED RELEASE SELEXIPAG COMPOSITION	ACTELION PHARMACEUTICALS LTD
WO/2021/152065	APREPITANT FOR USE IN THE TOPICAL TREATMENT OF FACIAL  NEURALGIA	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/156145	ADONIRUBIN AND DHA FOR HEART HEALTH	DSM IP ASSETS B.V.
WO/2021/152115	BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/152119	HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT  OF INFLAMMATORY PULMONARY DISEASES	ADVITA LIFESCIENCE GMBH
WO/2021/152129	AMORPHOUS SOLID DISPERSION OF  8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE	ABIVAX
WO/2021/152136	PASTE COMPRISING MAGNETIC ALKOXYSILANE-COATED METAL CONTAINING  NANOPARTICLES	MAGFORCE AG
WO/2021/190810	IMPROVING THE FASTNESS TO WASHING OF PIGMENT-CONTAINING DYES  BY USING AN OXIDATIVE PRETREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/156172	PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A  STABILIZING AGENT	BAYER AKTIENGESELLSCHAFT
WO/2021/152172	HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZER	FREIE UNIVERSITÄT BERLIN
WO/2021/152175	PULMONARY DELIVERY OF ANTIBODIES	SANOFI
WO/2021/156213	LIPID NANOPARTICLES FOR DELAYED DELIVERY OF FRAGRANCE WITH  ENHANCED WATER SOLUBILITY, THEIR PREPARATION AND USE	CLARIANT INTERNATIONAL LTD
WO/2021/152184	COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST  AND A GLP-1 RECEPTOR AGONIST	ADOCIA
WO/2021/156223	NANOFORMULATIONS OF METHYL  {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATE	ADVERIO PHARMA GMBH
WO/2021/156227	METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL  HYPERTENSION WITH SELEXIPAG	ACTELION PHARMACEUTICALS LTD
WO/2021/156242	FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE	FIRMENICH SA
WO/2021/156258	TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS  BINDING TO PD-L1 AND CD137	BIONTECH SE
WO/2021/156267	CORONAVIRUS VACCINE	CUREVAC AG
WO/2021/156275	COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR  HYPERTENSION	NICOX S.A.
WO/2021/156277	IMMUNE CELL EXPRESSING ADAPTER CHIMERIC ANTIGEN RECEPTOR FOR  SENSING SOLUBLE ANTIGENS	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/156289	COMBINATION CONTAINING A DUOCARMYCIN DERIVATIVE-COMPRISING  ANTIBODY-DRUG CONJUGATE AND THIOSULFATE	BYONDIS B.V.
WO/2021/156291	CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS  SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF	I+MED S. COOP.
WO/2021/156310	TAFA4 POLYPEPTIDE OR POLYNUCLEOTIDE FOR TREATING INFLAMMATORY  DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156326	ANTIBODIES FOR USE IN THERAPY	GENMAB A/S
WO/2021/156330	ORAL CARE COMPOSITION FOR ANIMALS	DR. KURT WOLFF GMBH & CO. KG
WO/2021/156340	PDAC TREATMENT REGIMEN	SWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/156345	INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATION	MERZ PHARMA GMBH & CO. KGAA
WO/2021/156360	METHODS FOR DISCONTINUING A TREATMENT WITH A TYROSINE KINASE  INHIBITOR (TKI)	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156369	USE OF LOW DOSES OF HYDROXYCHLOROQUINE FOR THE TREATMENT OF  LIPIN-1 DEFICIENCY	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156381	ACTIVE INGREDIENT OF AN ERYTHROCYTES-CONTAINING COMPOSITION	GHASHGHAEINIA, Mehrdad
WO/2021/156385	LIPID COMPOSITION COMPRISING OMEGA-3 FATTY ACIDS	WELLNESS HOLDING B.V.
WO/2021/160519	TREATMENT OF PRIMARY BILIARY CHOLANGITIS WITH ELAFIBRANOR	GENFIT
WO/2021/156404	TREATMENT OF HPV-RELATED DISEASES	ISA PHARMACEUTICALS
WO/2021/156435	MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED  ON PREACTIVATED THIOMERS	BIOADHESIVE OPHTHALMICS
WO/2021/156437	FENFLURAMINE FOR USE IN TREATING PATIENTS WITH LENNOX-GASTAUT  SYNDROME	ZOGENIX INTERNATIONAL LIMITED
WO/2021/156439	TRIAZOLE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS	ASTRAZENECA AB
WO/2021/170374	COMPOSITION FOR USE IN PREVENTION OR TREATMENT OF OESOPHAGEAL  DISEASES LINKED TO EPITHELIAL BARRIER DEFECTS	THELIAL B.V.
WO/2021/156451	C-X-C MOTIF CHEMOKINE RECEPTOR 4 ANTAGONIST	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/156455	LITCHI PRODUCTS AS DERMATOLOGICAL AND COSMETIC AGENTS	DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL
WO/2021/156490	CORONA VIRUS BINDERS	VIB VZW
WO/2021/170380	IMPROVED PREPARATION	BEIERSDORF AG
WO/2021/160543	METHOD FOR TREATING VASO OCCLUSIVE CRISES ASSOCIATED WITH  SICKLE CELL DISEASE	NICOX S.A.
WO/2021/156504	TREATMENT OF PANX1 ASSOCIATES DISEASES	NURITAS LIMITED
WO/2021/160608	PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND  METFORMIN	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/160650	A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCER	ABILITY PHARMACEUTICALS S.L.
WO/2021/160659	GAS-FILLED MICROVESICLES FOR THERAPEUTIC USE	BRACCO SUISSE SA
WO/2021/170409	USE OF A COMBINATION OF A SACCHARIDE AND GLYCEROL FOR  PREBIOTIC BENEFITS	UNILEVER IP HOLDINGS B.V.
WO/2021/160700	COMPOSITION COMPRISING RAMIPRIL AND INDAPAMIDE	ADAMED PHARMA S.A.
WO/2021/160708	COMBINATION OF REGORAFENIB AND MSLN-TTC FOR TREATING CANCER	BAYER AKTIENGESELLSCHAFT
WO/2021/160724	PROCESS FOR SITE-SPECIFIC MODIFICATION OF AN ANTIBODY	ORANO MED
WO/2021/204441	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF A  ORGANOSILICON COMPOUND, A POLYSACCHARIDE, A COLORING COMPOUND AND A  POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/160763	FGFR TYROSINE KINASE INHIBITORS AND ANTI-PD1 AGENTS FOR THE  TREATMENT OF UROTHELIAL CARCINOMA	JANSSEN PHARMACEUTICA NV
WO/2021/160764	FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK  NON-MUSCLE INVASIVE BLADDER CANCER	JANSSEN PHARMACEUTICA NV
WO/2021/160766	LIPID COMPOSITION AND USE THEREOF FOR DELIVERY OF A  THERAPEUTICALLY ACTIVE AGENT TO ENDOTHELIUM	PANTHERNA THERAPEUTICS GMBH
WO/2021/160768	COMPOUNDS USEFUL AS ANTI-VIRAL AGENTS	NATURE CRETE PHARMACEUTICALS PC
WO/2021/160769	A BACTERIAL COMPOSITION FOR THE TREATMENT OF CANCER	UNIVERSITÄT ZüRICH
WO/2021/160850	MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND  VACCINES	INSTITUT PASTEUR
WO/2021/160873	NANOPARTICLES ENCAPSULATING SMALL MOLECULES	ETH ZURICH
WO/2021/165177	USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT  OF CARDIAC DISEASES IN FELINES	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/160881	INTRANASAL MRNA VACCINES	ETHERNA IMMUNOTHERAPIES NV
WO/2021/165204	TOPICALLY ADMINISTRABLE LYSATE OF DEDIFFERENTIATED CELLS OF  THE PLANT HELICHRYSUM STOECHAS FOR MOISTURIZING SKIN	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165205	TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS  OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF  THE SKIN	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165206	TREATMENT OF DRY AMD WITH INTEGRIN ANTAGONISTS	OXURION NV
WO/2021/165207	TRANSPARENT COLORED COSMETIC INGREDIENT FOR COSMETIC PRODUCTS,  POSSIBLY CAPABLE OF AUTOMATICALLY CHANGING COLOR WHEN IRRADIATED BY  ULTRAVIOLET LIGHT.	INTERCOS S.P.A.
WO/2021/165226	SUBCUTANEOUS ADMINISTRATION OF FACTOR VIII	BIOTEST AG
WO/2021/165227	AMPHIPHILIC POLYMERS AND THEIR USE FOR IMPROVED PRODUCTION OF  NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENS	TOPAS THERAPEUTICS GMBH
WO/2021/165240	TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIA	DILAFOR AB
WO/2021/175577	TRANSPARENT DENTIFRICE COMPRISING ZINC	UNILEVER IP HOLDINGS B.V.
WO/2021/175583	LIPID NANOPARTICLES COMPRISING A FRAGRANCE	CLARIANT INTERNATIONAL LTD
WO/2021/165273	PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCH	LEADXPRO AG
WO/2021/144476	PHARMACEUTICAL FORMULATIONS	NOVO NORDISK A/S
WO/2021/144477	GLP-1 COMPOSITIONS AND USES THEREOF	NOVO NORDISK A/S
WO/2021/165285	MONO- AND MULTI-TRIAZOLOMINIGASTRINS FOR TARGETING OF  CCK2R-POSITIVE NEOPLASMS	PAUL SCHERRER INSTITUT
WO/2021/165306	OPTIMIZATION OF PEPTIDE-MELANIN BINDING	ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/165312	VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEX	SOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES - SEPPIC
WO/2021/165316	PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/165348	PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED  PHARMACEUTICAL FORMULATION	CHIESI FARMACEUTICI S.P.A.
WO/2021/165369	TREATMENT OF CORNEAL VASCULARISATION	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/175605	OXYGEN/CARBON DIOXIDE COMPOSITIONS FOR MEDICAL USES	AVIATION WORKS LIMITED
WO/2021/175606	AN EFFECTIVE ANTI-ACNE PERSONAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/165402	CAPSULE COMPRISING A VITAMIN E ESTER FOR PREVENTING THE ONSET  OF VAGINAL DYSBIOSIS AND RESULTING VAGINAL PATHOLOGIES	HULKA S.R.L.
WO/2021/165405	A PHARMACEUTICAL COMBINATION OF AN ARTEMISININ COMPOUND,  5-AMINOLEVULINIC ACID OR METHYL-5-AMINOLEVULINIC ACID AND A CHEMOTHERAPEUTIC  AGENT	JLP HEALTH GMBH
WO/2021/165420	METHOD FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE	MESOBLAST INTERNATIONAL SàRL
WO/2021/170489	AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE	UCL BUSINESS PLC
WO/2021/165424	AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2	UCL BUSINESS PLC
WO/2021/165426	ANTIMICROBIAL COMPOSITIONS	FIRMENICH SA
WO/2021/165429	CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID  COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	DOMPE' FARMACEUTICI SPA
WO/2021/165452	MOLECULES TARGETING MUTANT RAS PROTEIN	AELIN THERAPEUTICS
WO/2021/165453	MOLECULES TARGETING PROTEINS	AELIN THERAPEUTICS
WO/2021/165456	MOLECULES TARGETING RAS PROTEIN	AELIN THERAPEUTICS
WO/2021/165463	METHOD OF TREATING BACTERIAL INFECTIONS AND PHARMACEUTICAL  COMPOSITION FOR TREATING BACTERIAL INFECTIONS	INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE,  L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/165472	MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT  SUBPOPULATION	AB SCIENCE
WO/2021/165477	USE OF MICA IN PRESSED POWDER	IMERTECH SAS
WO/2021/165484	DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR  PRODUCTION OF BIOLOGICAL ENTITIES	UNIVERSITé DE LIèGE
WO/2021/165499	INHIBITORS AND USES THEREOF	ENTHERA S.R.L.
WO/2021/165510	CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE  IN THE TREATMENT OF CANCER-RELATED FATIGUE	DOMPE' FARMACEUTICI SPA
WO/2021/170516	FORMULATION BASED ON NATURAL INGREDIENTS FOR USE IN TREATING  PROCTOLOGICAL DISORDERS	NATHURA S.P.A.
WO/2021/165537	A METHOD FOR SEPARATION OR DEPLETION OF EMPTY AAV CAPSIDS FROM  FULL AAV CAPSIDS	BIA SEPARATIONS D.O.O.
WO/2021/165538	IMPROVED ANTI-SENESCENCE COMPOUNDS AND USES THEREOF	CLEARA BIOTECH B.V.
WO/2021/165543	PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE  TREATMENT	ORIGIMM BIOTECHNOLOGY GMBH
WO/2021/170548	PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  DYSMENORRHEA AND/OR PREMENSTRUAL SYNDROME (PMS)	CORNELLI, Umberto
WO/2021/170566	RESHAPING COMPOSITION FOR KERATIN FIBERS	KAO GERMANY GMBH
WO/2021/170568	RESHAPING COMPOSITION FOR KERATIN FIBERS	KAO GERMANY GMBH
WO/2021/175660	PREPARATION FOR MAGNETIZING KIDNEY STONES AND KIDNEY STONE  FRAGMENTS AND KIT FOR REMOVING KIDNEY STONES AND KIDNEY STONE FRAGMENTS	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/165549	TREATMENT OF MEDICAL INDICATION	VALLAURIX TRADING SARL MC
WO/2021/170614	AEROSOL COMPRISING 5-METHOXY-N.N-DIMETHYLTRYPTAMINE	GH RESEARCH LIMITED
WO/2021/170618	COMPOSITIONS COMPRISING <i>LUFFA CYLINDRICA</i>  ROOT EXTRACT	CLARIANT INTERNATIONAL LTD
WO/2021/170627	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/175672	COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED  ELASTICITY AND EXTENSIBILITY	COVESTRO DEUTSCHLAND AG
WO/2021/170684	KRAS EPITOPES AND ANTIBODIES	OBLIQUE THERAPEUTICS AB
WO/2021/170741	TREATMENT OF HBV	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/170763	ANTI-ADM-ANTIBODIES BINDING TO THE FREE N-TERMINUS FOR  ACCELERATED TRANSITION OF ADM-GLY TO BIO-ADM IN PATIENTS WITH ADM-GLY/  BIO-ADM RATIO ABOVE A THRESHOLD AND COMBINATION WITH VITAMIN C	SPHINGOTEC GMBH
WO/2021/170772	COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR  OF CD47 MEDIATED SIGNALING	APREA THERAPEUTICS AB
WO/2021/170784	GENE THERAPY FOR MAPLE SYRUP URINE DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/170793	COMBINATION COMPRISING ALPELISIB AND  6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC  ACID	SANOFI
WO/2021/170806	USES AND COMPOSITIONS BASED ON POLYPHENOLS FOR IMPROVING THE  ORAL BIOAVAILABILITY OF HYDROXYTYROSOL	BIOSEARCH, S.A.
WO/2021/170807	DAPTOMYCIN FORMULATION	XELLIA PHARMACEUTICALS APS
WO/2021/175716	COMPOSITE RNA PARTICLES	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/170811	METHOD OF TREATING EYE DISEASE USING TRPV4 ANTAGONISTS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/170816	USE OF PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR  THERAPEUTIC PURPOSE	PAM THERAGNOSTICS GMBH
WO/2021/170817	COMPOSITION FOR DISPERSING A LIPOSOLUBLE COMPOUND IN AN  AQUEOUS PHASE	SENSIENT COSMETIC TECHNOLOGIES
WO/2021/170821	METHOD FOR VIRUS PRODUCTION	TECHNISCHE HOCHSCHULE MITTELHESSEN
WO/2021/170828	HIGH POLYOL WASH COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/170831	ENZYME REPLACEMENT THERAPY FOR TREATING POMPE DISEASE	ELEVA GMBH
WO/2021/170834	COMPOSITION FOR THE PREVENTION AND TREATMENT OF DYSBIOSIS	MUCOSA INNOVATIONS, S.L.
WO/2021/170841	PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE  AND METHODS OF THEIR USE	BIOSERGEN AS
WO/2021/170848	INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES  MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE	ACADEMISCH MEDISCH CENTRUM
WO/2021/175740	FOLATE PREPARATIONS FOR THE TREATMENT OF OCULAR DISEASES	APROFOL AG
WO/2021/175755	FORMULATION OF LISINOPRIL AND AMLODIPINE	ALKALOID AD SKOPJE
WO/2021/175763	TOPICAL COMPOSITION COMPRISING CANNABIDIOL	EMMAC LIFE SCIENCES LTD.
WO/2021/170869	CORONAVIRUS VACCINES	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/175773	DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL  PHOSPHORIC ACID SALT	GRüNENTHAL GMBH
WO/2021/175775	COSMETIC COMPOSITION WITH OPTIMIZED STARCH AND COSMETIC  APPLICATIONS THEREOF	INTERCOS S.P.A.
WO/2021/170874	A METHOD OF PRODUCING A CRYSTALLINE FORM OF SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  TRIHYDRATE	AIC246 GMBH & CO. KG
WO/2021/170875	PHARMACEUTICAL COMPOSITIONS COMPRISING  2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETATE  AND SODIUM IONS	AIC246 GMBH & CO. KG
WO/2021/170878	SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  AND PHARMACEUTICAL COMPOSITIONS THEREOF	AIC246 GMBH & CO. KG
WO/2021/170879	SODIUM  2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE  MONOHYDRATE, ITS PREPARATION AND USE	AIC246 GMBH & CO. KG
WO/2021/170882	POTASSIUM SALT OF  2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETIC  ACID	AIC246 GMBH & CO. KG
WO/2021/175816	COMPOUNDS FOR USE IN A METHOD OF TREATING, PREVENTING AND/OR  REDUCING THE SYMPTOMS OF PAIN	THE BECKLEY FOUNDATION
WO/2021/175823	PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUS	PHARMA MAR, S.A.
WO/2021/175824	METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENT	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175826	COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION	PHARMA MAR, S.A.
WO/2021/175829	COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS	PHARMA MAR, S.A.
WO/2021/175831	COMPOUNDS FOR USE IN VIRAL INFECTIONS	PHARMA MAR, S.A.
WO/2021/175857	COMPOUNDS FOR USE IN INFLAMMATORY CONDITIONS	PHARMA MAR, S.A.
WO/2021/175877	COMPOSITION FOR USE IN A TREATMENT OF CERVICAL CELL  ABNORMALITIES COMPRISING SELENITE COMPOUND AND ACID	SELO MEDICAL GMBH
WO/2021/175914	CONDITIONING REGIMEN FOR TRANSPLANT	HANSA BIOPHARMA AB
WO/2021/175924	TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR  USE IN COMBINATION THERAPY	ACTIVE BIOTECH AB
WO/2021/175926	COMPOSITION FOR POLYAMINE BIOSYNTHESIS	BM HEALTH GMBH
WO/2021/175960	FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE  PRODUCTION TO PROTECT AGAINST CORONAVIRUSES	ROCKETVAX AG
WO/2021/175971	HETEROCYCLIC DERIVATIVES AS TRMP8 ANTAGONISTS	GIVAUDAN SA
WO/2021/175998	COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC  SYNDROME AND INFLAMMATORY BOWEL DISEASES	INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE,  L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/176000	PROCESS FOR PRODUCING A HYDROLYSATE OF SCUTELLARIA ROOT, WHICH  IS ENRICHED AND STANDARDIZED WITH FLAVONOIDS OF INTEREST, THE HYDROLYSATE  OBTAINED BY SUCH A PROCESS, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF  SUCH A HYDROLYSATE	EXSYMOL
WO/2021/176001	METHOD FOR TREATING INFLAMMATORY LUNG DISEASES USING  MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS	MESOBLAST INTERNATIONAL SàRL
WO/2021/176010	ANTIVIRAL TREATMENT	ECOSYNTH NV
WO/2021/176017	TREATMENT OF VIRAL INFECTION	PNEUMAGEN LTD
WO/2021/176026	COSMETIC COMPOSITION	GIVAUDAN SA
WO/2021/176035	BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE  REGENERATION	NOVYSTEM S.P.A.
WO/2021/176038	SYNERGISTIC AND TARGETING COMPOSITIONS FOR TREATMENT OF  ARTERIAL AND VENOUS THROMBOSIS	ASTRAZENECA AB
WO/2021/176044	LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC  LATERAL SCLEROSIS	CENTRE HOSPITALIER UNIVERSITAIRE DE NIMES
WO/2021/176045	IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12	BAYER AKTIENGESELLSCHAFT
WO/2021/254667	COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS  INFECTIONS	UNIVERSITÄT HEIDELBERG
WO/2021/176070	METHODS OF SLOWING BRAIN VOLUME LOSS	ACTELION PHARMACEUTICALS LTD
WO/2021/176074	COMPOSITION COMPRISING AN AVENANTHRAMIDE WITH IMPROVED SKIN  PENETRATION	SYMRISE AG
WO/2021/176082	VIRAL MULTIMERIC PEPTIDE CONSTRUCTS FOR TARGETING PDZ DOMAINS	UNIVERSITY OF COPENHAGEN
WO/2021/176083	PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND  USES THEREOF	ZENTIVA K.S.
WO/2021/176085	STEROIDAL NITRONE F2 FOR USE IN THE PREVENTION AND/OR  TREATMENT OF PERMANENT CEREBRAL ISCHAEMIA	ISQUAEMIA BIOTECH, S.L.
WO/2021/176088	COMPOUNDS FOR THE TREATMENT OF COVID-19	DOMPE' FARMACEUTICI SPA
WO/2021/176093	NICOTINAMIDE MONONUCLEOTIDE AND BIS-NICOTINAMIDE DINUCLEOTIDE  DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIA	NUVAMID SA
WO/2021/176094	LIPID CONJUGATED PEPTIDE INHIBITORS OF PICK1	UNIVERSITY OF COPENHAGEN
WO/2021/180602	SARS-COV-2 (SARS2, COVID-19) ANTIBODIES	HARBOUR ANTIBODIES BV
WO/2021/180603	SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALS	BAYER ANIMAL HEALTH GMBH
WO/2021/176096	PHARMACEUTICAL COMPOSITION COMPRISING SGLT2 INHIBITOR	KRKA, D.D., NOVO MESTO
WO/2021/180604	SARS-COV-2 (SARS2, COVID-19) ANTIBODIES	HARBOUR ANTIBODIES BV
WO/2021/176098	MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERS	UNIVERSITé DE LAUSANNE
WO/2021/180612	MIXTURE COMPOSITION COMPRISING GLYCOLIPIDS AND TRIETHYL  CITRATE	EVONIK OPERATIONS GMBH
WO/2021/176100	IONTOPHORETIC COMPOSITION FOR ADMINISTERING S-KETAMINE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/180643	HSD11B1 INHIBITORS FOR USE IN IMMUNOTHERAPY AND USES THEREOF	UNIVERSITE DE GENEVE
WO/2021/180727	THERAPEUTIC AGENT TARGETING HER2	HOBER BIOTECH AB
WO/2021/180731	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES AND  CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180732	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180739	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180740	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF LUNG DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180741	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE  RIBOSIDE FOR PREVENTION AND TREATMENT OF PANCREATIC DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180742	METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS  INFECTIONS SUCH AS COV-2	GARNIER, Patrice
WO/2021/180774	MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY	EVOTEC INTERNATIONAL GMBH
WO/2021/180780	TREATMENT AND/OR DIAGNOSIS OF A CANCER TYPE CHARACTERIZED BY  EXPRESSING ZINC TRANSPORTER ZIP4	UNIVERSITAT POMPEU FABRA
WO/2021/180787	PROTEOLYSIS TARGETING CHIMERA (PROTAC) FOR DEGRADATION OF  AURORA A-KINASE	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180821	COMPOSITIONS OF IL-6/IL-6R ANTIBODIES AND METHODS OF USE  THEREOF	TIZIANA LIFE SCIENCES PLC
WO/2021/180832	HYBRID CAR AND HYBRID TCR CELLS TO TREAT INFECTIOUS DISEASES	UNIVERSITEIT GENT
WO/2021/180839	ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES	BASF SE
WO/2021/180848	SUNFLOWER PHOSPHOLIPID COMPOSITION CONTAINING  PHOSPHATIDYLCHOLINE	LIPOID GMBH
WO/2021/180850	METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I	MESOBLAST INTERNATIONAL SàRL
WO/2021/180851	METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE II	MESOBLAST INTERNATIONAL SàRL
WO/2021/180857	COMBINATIONS OF BETA-LACTAM COMPOUNDS, PROBENECID, AND  VALPROIC ACID AND USES THEREOF	ITERUM THERAPEUTICS INTERNATIONAL LIMITED
WO/2021/180862	PHARMACEUTICAL COMPOSITIONS COMPRISING ELAGOLIX SODIUM	SYNTHON B.V.
WO/2021/180867	A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASE	UNIVERSITÄT REGENSBURG
WO/2021/180884	FETUIN A FOR TREATMENT OF RENAL DISORDERS	UNIVERSITAET BERN
WO/2021/180885	TREATMENT OF STEM CELL DEFICIENCY	OSPEDALE SAN RAFFAELE S.R.L.
WO/2021/185675	PERSONAL CARE COMPOSITION, METHOD FOR USING SUCH COMPOSITIONS  AND ITS IMPROVEMENT OF DEPOSITION EFFECT	BASF SE
WO/2021/180890	CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE  LYMPHOBLASTIC LEUKEMIA (B-ALL)	FUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/180896	TOPICAL PREPARATIONS	EPITHEAL LIMITED
WO/2021/197802	TOPICAL COMPOSITION BASED ON POROUS PARTICLES AND A  CROSSPOLYMER COMPRISING ADIPIC ACID AND NEOPENTYLGLYCOL	UNILEVER IP HOLDINGS B.V.
WO/2021/185680	A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE  9, SEQUENCE TYPE 16	INTERVET INTERNATIONAL B.V.
WO/2021/180908	THERAPEUTIC SYSTEM FOR THE TOPIC, TRANSDERMAL AND  TRANSCUTANEOUS APPLICATION OF CARBON MONOXIDE	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180913	NEW USE AND METHOD OF TREATMENT	REDWOOD PHARMA AB
WO/2021/180915	USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS  DERIVATIVES FOR PREVENTING AND/OR TREATING DORSAL PAIN, AND CORRESPONDING  COMPOSITIONS	NUVAMID SA
WO/2021/180916	USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS  DERIVATIVES FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON  PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/180919	METHOD FOR THE TREATMENT OF A RESPIRATORY DISEASE, DISORDER,  OR CONDITION RESULTING FROM A VIRAL INFECTION	SOFTHALE NV
WO/2021/180943	COMPOSITIONS IMPROVING POXVIRUS STABILITY	BAVARIAN NORDIC A/S
WO/2021/180963	A PROTEASE INHIBITOR REGIMEN FOR TREATING SUBJECTS INFECTED  WITH HIV	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/180969	CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING  ALPHA-V-BETA-6 INTEGRIN IN VIVO	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/180972	DETOXIFIED LIPOPOLYSACCHARIDES (LPS), NATURALLY NON-TOXIC LPS,  AND USES THEREOF	HEPHAISTOS-PHARMA
WO/2021/180973	BIFIDOBACTERIUM LONGUM	PRECISIONBIOTICS GROUP LIMITED
WO/2021/185719	RGD-CONTAINING PEPTIDE AND USE THEREOF FOR CANCER TREATMENT	AC BIOSCIENCE SA
WO/2021/185723	THERAPEUTIC TREATMENT OF CHROMATINOPATHIES	UNIVERSITA' DEGLI STUDI DI TRENTO
WO/2021/185728	BIOCOMPOSITES COMPRISING PROBIOTICS, COLLAGEN AND BACTERIAL  EXTRACELLULAR POLYSACCHARIDE AND USES THEREOF	BIOSEARCH, S.A.
WO/2021/185736	CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES  DEFINED BY THE MEAN TOTAL SURFACE AREA	GIVAUDAN SA
WO/2021/185746	COMPOUNDS FOR USE IN TREATMENT OF RESPIRATORY DISEASE	AARHUS UNIVERSITET
WO/2021/180981	STABILIZATION OF PHARMACEUTICAL COMPOSITIONS COMPRISING  POLYSORBATE	LEK PHARMACEUTICALS D.D.
WO/2021/185773	GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONS	PRODUKEM MOLEKULARES DESIGN GMBH
WO/2021/185775	ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/190979	WHITENING ORAL CARE COMPOSITIONS	RHODIA OPERATIONS
WO/2021/185783	COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/185791	TREATMENT OF EPILEPSY	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/185798	POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND  ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYNDROMES	PHARIS BIOTEC GMBH
WO/2021/185802	COMPOSITION FOR ENHANCING UROLITHIN PRODUCTION IN A HUMAN  SUBJECT	MIGALIS APS
WO/2021/185804	SCORED TABLET	GRüNENTHAL GMBH
WO/2021/185807	A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A  METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE  IN A MAMMAL	GEMOAB GMBH
WO/2021/190993	COMPOSITIONS CONTAINING RHAMNOLIPIDE, ALKYL POLYGLYCOSIDE AND  ACYL LACTYLATE	EVONIK OPERATIONS GMBH
WO/2021/185821	LIQUID FORMULATIONS OF GLUCAGON ANALOGUES	ZEALAND PHARMA A/S
WO/2021/185832	NEW THERAPEUTIC TREATMENT	SWEDISH ORPHAN BIOVITRUM AG
WO/2021/185838	NEW THERAPEUTIC USE OF ANAKINRA FOR COVID-19	SWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/185842	USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOF	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185844	USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND  MEDICAL TREATMENTS OR USES THEREOF	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185851	VACCINE COMPOSITIONS FOR HIV PREVENTION AND TREATMENT	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/185874	USE OF LACTOFERRIN	MEAD JOHNSON NUTRITION COMPANY
WO/2021/185876	USE OF LACTOFERRIN	MEAD JOHNSON NUTRITION COMPANY
WO/2021/185887	REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH FOR TREATING  INITIAL NON-RESPONDERS	GRüNENTHAL GMBH
WO/2021/185890	GINSENOSIDE COMPOSITIONS	GIVAUDAN SA
WO/2021/185897	GINSENOSIDE COMPOSITIONS	GIVAUDAN SA
WO/2021/185912	METHOD FOR THE TREATMENT NLRP3-ASSOCIATED DISEASES	SOFTHALE NV
WO/2021/185920	PROCESS FOR BLEACHING KERATIN FIBERS USING AN OXIDIZING  COMPOSITION AND UV-VISIBLE RADIATION	L'OREAL
WO/2021/185921	LIQUID FORMULATION OF GM-CSF FOR INHALATION	DRUGRECURE APS
WO/2021/185948	A STABILIZED PROTEIN OF INTEREST	MICREOS HUMAN HEALTH B.V.
WO/2021/185953	COSMETIC COMPOSITION AND TREATMENT FOR TREATING SKIN SAGGING	SEDERMA
WO/2021/185959	ESTROGEN-RELATED RECEPTOR ALPHA AGONISTS FOR THE TREATMENT AND  THE PROGNOSIS OF BONE METASTASES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/185969	VARIANTS OF HLYA AND USES THEREOF	NUMAFERM GMBH
WO/2021/186000	IMPROVED LIQUID COMPOSITION FOR CLEANING, SANITIZING AND/OR  DISINFECTING	CORTICALIS AS
WO/2021/186001	DOSE TREATMENTS OF TAUOPATHIES	AC IMMUNE SA
WO/2021/186024	NEW ANTI-VEGFC ANTIBODIES AND USES THEREOF	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
WO/2021/204517	COMPOSITION FOR USE IN PREVENTING ATHEROSCLEROSIS DEVELOPPMENT	ALGOSOURCE
WO/2021/186035	CYCLOTIDES IN COMBINATION WITH KAPPA OPIOID RECEPTOR LIGANDS  FOR MS THERAPY	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/186041	JOSAMYCIN FOR USE IN PREVENTION AND TREATMENT OF FIBROSIS	UNIVERSITÄT ROSTOCK
WO/2021/186042	PLASMID COMPRISING ALOPECIA ANTIGEN	NOVO NORDISK A/S
WO/2021/186053	COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION  & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE  INFECTION	ABIVAX
WO/2021/186054	SORTILIN ANTAGONISTS FOR USE IN THE TREATMENT OF DIABETIC  RETINOPATHY	INSUSENSE APS
WO/2021/186060	RADIOLABELED GASTRIN ANALOGUE FOR USE IN A METHOD OF TREATING  AND/OR IMAGING CCKB RECEPTOR POSITIVE DISEASES, IN PARTICULAR PULMONARY AND  EXTRAPULMONARY SMALL-CELL CARCINOMA	DEBIOPHARM INTERNATIONAL S.A.
WO/2021/186061	IDEBENONE FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS  SYNDROME (ARDS) IN PATIENTS DIAGNOSED WITH A CORONAVIRUS INFECTION	BEMIDO SA
WO/2021/204520	COMPOSITION COMPRISING RESVERATROL	GALENUS G.H. AG
WO/2021/186074	COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER	STALICLA SA
WO/2021/191094	ERBB-TARGETED THERAPIES FOR NEUROPATHIC PAIN	UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/191108	TREATMENT OR PREVENTION OF ACUTE ORGAN DAMAGE INDUCED BY VIRAL  INFECTION WITH A NK1 INHIBITOR AND/OR A GABAPENTINOID	PLUS VITECH, S.L.
WO/2021/191131	PROTEIN DISULFIDE ISOMERASE INHIBITORS FOR USE IN THE  TREATMENT OF ALPHA 1-ANTITRYPSIN DEFICIENCY	UNIVERSITE DE BORDEAUX
WO/2021/191136	DMEH ENHANCER	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/186078	METHOD FOR PRODUCING POLYMERSOMES	HEIDELBERG UNIVERSITY
WO/2021/186079	COLLOIDAL CARRIER SYSTEMS FOR TRANSFER OF AGENTS TO A DESIRED  SITE OF ACTION	HEIDELBERG UNIVERSITY
WO/2021/186080	HEAT-TREATED PLATELET-DERIVED GROWTH FACTOR EXTRACT FOR USE IN  A METHOD OF PREVENTING OR TREATING A TISSUE DEFECT	PANGERŠIČ, Rok
WO/2021/213749	COLOR-STABLE SUNSCREEN	BEIERSDORF AG
WO/2021/197906	CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/197908	METHOD OF TREATING THE SCALP	UNILEVER IP HOLDINGS B.V.
WO/2021/191169	1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME  FOR USE IN THE TREATMENT OF COVID-19	ARTEMIFLOW GMBH
WO/2021/213752	TRANSPARENT COSMETIC GEL	BEIERSDORF AG
WO/2021/213753	ENVIRONMENTALLY FRIENDLY COSMETIC SUNSCREEN	BEIERSDORF AG
WO/2021/213760	ENVIRONMENTALLY FRIENDLY SUNSCREEN	BEIERSDORF AG
WO/2021/191185	COMPOSITIONS COMPRISING NATURALLY DERIVED PRESERVATIVES	UNILEVER IP HOLDINGS B.V.
WO/2021/191197	COMBINATION THERAPY COMPRISING AN AXL INHIBITOR	BERGENBIO ASA
WO/2021/191226	MOUTHWASH, IN PARTICULAR FOR TREATING THE HUMAN ORAL AND  PHARYNGEAL CAVITY	SANIXTREME GMBH & CO. KG
WO/2021/191236	NUCLEOTIDE ANALOGUES FOR THE TREATMENT OF CORONAVIRUSES	R.G.C.C. HOLDINGS AG
WO/2021/191240	COMBINATION THERAPY	ANTABIO SAS
WO/2021/191243	PIGMENT COMPRISING RAPHANUS SATIVUS EXTRACT AND  MONTMORILLONITE	GIVAUDAN SA
WO/2021/191251	COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF  LacNAc-Lac	FRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/191253	METHODS FOR PRODUCING HEME PEROXIDASES	TECHNISCHE UNIVERSITÄT WIEN
WO/2021/191265	RNA PARTICLES COMPRISING POLYSARCOSINE	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/191266	AEROSOLIZATION OF HDL FOR THE TREATMENT OF LUNG INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/191268	A MODIFIED RELEASE MULTIPLE UNIT ORAL DOSAGE FORM OF  DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE AND A PROCESS FOR ITS  PREPARATION	INIBSA GINECOLOGíA, S.A.
WO/2021/191273	COMPOSITIONS FOR USE IN TREATING MEIBOMIAN GLAND DYSFUNCTION	HOVIONE SCIENTIA LIMITED
WO/2021/191274	NEW STRATEGY TO TREAT AND PREVENT DISEASES CAUSED BY  ENTEROBACTERIAE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/191278	DIMALEATE FORM OF  1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA	LEK PHARMACEUTICALS D.D.
WO/2021/239292	TREATMENT OF CANCER	IMMUTEP S.A.S.
WO/2021/191297	VIRUCIDAL HAND CREAM FORMULATION	UNIVERSITÄT BASEL
WO/2021/191305	CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19	DOMPE' FARMACEUTICI SPA
WO/2021/191312	METHODS OF TREATING COVID-19 WITH RIFAXIMIN	BAUSCH HEALTH IRELAND LIMITED
WO/2021/191318	SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT  HEPATIC ENCEPHALOPATHY	BAUSCH HEALTH IRELAND LIMITED
WO/2021/191320	OPHTHALMIC FORMULATION COMPRISING  N-[5-(AMINOSULFONYL)-4-METHYL-1,3-  THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)PHENYL]ACETAMIDE HEMIHYDRATE	AICURIS GMBH & CO. KG
WO/2021/191336	A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE  INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATION	AC BIOSCIENCE SA
WO/2021/191342	VIRUSTATIC AGENT	REINMüLLER, Johannes
WO/2021/191353	METHODS FOR PROVIDING A VACCINE	WüRFEL, Wolfgang
WO/2021/198041	A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE,  CHLOROQUINE, OR METABOLITE THEREOF	BLACKHAWK PARTNERS LIMITED
WO/2021/198051	BIO-BASED POLYURETHANE DISPERSIONS FOR DECORATIVE COSMETIC  APPLICATIONS	COVESTRO DEUTSCHLAND AG
WO/2021/191412	CATHEPSIN SUBSTRATES & CATHEPSIN INHIBITORS AND USES  THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/191413	DISINFECTANT COMPOSITIONS	ARCH UK BIOCIDES LTD
WO/2021/191416	DRY POWDER FORMULATION FOR PULMONARY DELIVERY AND METHODS OF  USE	ASTRAZENECA AB
WO/2021/191417	COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES	SOM INNOVATION BIOTECH, S.A.
WO/2021/191422	NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF  BACTERIAL INFECTIONS	NUVAMID SA
WO/2021/191431	A CONSUMABLE PRODUCT COMPRISING MALTED CEREALS FOR PROMOTING  RECOVERY AT PHYSICAL ACTIVITY	LANTMÄNNEN FUNCTIONAL FOODS AB
WO/2021/191432	TARGETING QUORUM-SENSING PEPTIDES FOR DIAGNOSIS, TREATMENT  AND/OR PREVENTION OF COLORECTAL CANCER METASTASIS	UNIVERSITEIT GENT
WO/2021/191435	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  ADRENOLEUKODYSTROPHY OR ADRENOMYELONEUROPATHY	POXEL
WO/2021/191436	METHODS FOR TREATMENT OF VIRUS	APEIRON BIOLOGICS AG
WO/2021/198099	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  DIABETIC NEPHROPATHY	POXEL
WO/2021/204568	A TOPICAL COMPOSITION FOR TREATMENT OF PRURITUS	UNIVERSITÄT BASEL
WO/2021/191455	NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND  ANTI-INTERFERON EFFECT	UNIVERSITE DE PARIS
WO/2021/191456	COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION	VECTURA LIMITED
WO/2021/198115	TREATMENT	UNION THERAPEUTICS A/S
WO/2021/198116	FORMULATION	UNION THERAPEUTICS A/S
WO/2021/191460	NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND  ANTI-INTERFERON EFFECT	UNIVERSITE DE PARIS
WO/2021/191461	AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR  TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENT	SORBONNE UNIVERSITE
WO/2021/191462	COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES	SHARED VISION TECHNOLOGY LTD.
WO/2021/204572	BEADS COMPRISING A BUFFER SYSTEM	CHEMISCHE FABRIK BUDENHEIM KG
WO/2021/198135	METHOD OF TREATING VIRAL INFECTIONS	IMMUPHARMA FRANCE SA
WO/2021/198139	VIRUCIDAL COMPOSITIONS AND USE THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/228465	METHOD FOR TREATING HUMAN HAIR WITH AGENTS CONTAINING MIXTURES  OF ORGANIC C1-C6 ALKOXY SILOXANES	HENKEL AG & CO. KGAA
WO/2021/191464	USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND  GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING  IMMUNOMODULATORY EFFECTS IN CANCER TREATMENT	INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/198176	POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL  INFECTIONS	PHARIS BIOTEC GMBH
WO/2021/198177	BIOMATERIAL COMPRISING A POROUS RESORBABLE MATRIX AND  ASSOCIATED MANUFACTURING METHOD	UNIVERSITE GRENOBLE ALPES
WO/2021/198191	QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A  CANCER	ENYO PHARMA
WO/2021/191469	COMPOSITION FOR THE TREATMENT OF GASTRO-INTESTINAL DYSFUNCTION  AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/191470	COMPOSITION COMPRISING GLYCERIDES FOR THE TREATMENT OF  GASTRO-INTESTINAL DYSFUNCTION AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/198195	AGONIST COMBINATION	ZEALAND PHARMA A/S
WO/2021/198196	GLP-1/GLP-2 DUAL AGONISTS	ZEALAND PHARMA A/S
WO/2021/198198	OIL-IN-WATER EMULSION COMPRISING A SOLID LIPID MATERIAL	FIRMENICH SA
WO/2021/191474	ACTIVITY-DEPENDENT GENE THERAPY FOR NEUROLOGICAL DISORDERS	UCL BUSINESS LTD.
WO/2021/198212	OPHTHALMIC FORMULATION AND ITS USE	OY FINNSUSP AB
WO/2021/198216	NEW METHOD TO TREAT THE HEPATOTOXICITY INDUCED BY AMANITINS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/198220	TREATMENT AND PREVENTION OF SECONDARY INFLAMMATION IN PATIENTS  SUFFERING FROM A VIRAL INFECTION	ALLERO THERAPEUTICS B.V.
WO/2021/198223	TREATMENT OF SYMPTOMATIC VIRAL DISEASES	SYNACT PHARMA APS
WO/2021/198229	SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY  FOR IMAGING AND THERAPY PURPOSES	ANTAROS MEDICAL AB
WO/2021/198253	USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/198254	BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1 -RELATED  RETINOPATHIES	UNIVERSITÄT REGENSBURG
WO/2021/198255	AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING  FROM SEPSIS, SEPTIC SHOCK,, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR  MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)	NERRE THERAPEUTICS LIMITED
WO/2021/198256	COMPOSITION HAVING IMPROVED VOLUNTARY ACCEPTANCE	BAYER ANIMAL HEALTH GMBH
WO/2021/198258	TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN  VACCINATION	BIONTECH SE
WO/2021/198284	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  CARDIOVASCULAR DISEASES	POXEL
WO/2021/198285	HOMOGENEOUS LIQUID COMPOSITION COMPRISING 1,2-OCTANEDIOL AND  USE THEREOF	MINASOLVE SAS
WO/2021/198288	METHODS AND COMPOSITIONS	ALLIGATOR BIOSCIENCE AB
WO/2021/198312	VIRAL INFECTIONS- TREATMENT WITH CONVALESCENT PLASMA/SERUM	REGEN LAB SA
WO/2021/198316	COMPOUNDS, COMPOSITIONS AND DEVICES FOR USE IN THE PREVENTION  OR TREATMENT OF CORONA-VIRUS INFECTIONS	VOSSENSTEYN
WO/2021/198327	LIQUID PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED  PRODRUGS OF ADRENOMEDULLIN AND USE	BAYER AKTIENGESELLSCHAFT
WO/2021/198328	PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED PRODRUGS  OF ADRENOMEDULLIN AND USE	BAYER AKTIENGESELLSCHAFT
WO/2021/198332	CONDENSATION PRODUCT FOR USE IN A METHOD FOR THE TREATMENT OF  COVID-19	BASF SE
WO/2021/198333	BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP	F. HOFFMANN-LA ROCHE AG
WO/2021/198336	USE OF HAEMOGLOBIN FROM ANNELIDS FOR TREATING ACUTE  RESPIRATORY DISTRESS SYNDROME	HEMARINA
WO/2021/198346	EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19	DR. NESSELHUT BESITZGESELLSCHAFT MBH
WO/2021/198353	A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOS	DANMARKS TEKNISKE UNIVERSITET
WO/2021/198369	AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF  RETINAL PIGMENT EPITHELIUM ASSOCIATED DISEASES	PANDA-JONAS, Songhomitra
WO/2021/198376	NOVEL SALMONELLA-BASED CORONAVIRUS VACCINE	VAXIMM AG
WO/2021/204634	TOPICAL PHARMACEUTICAL COMPOSITION IN THE FORM OF AN AQUEOUS  GEL COMPRISING AT LEAST AMITRIPTYLINE	ALGOTHERAPEUTIX
WO/2021/198395	SURFACTANT PROTEIN D FOR USE IN TREATING CORONAVIRUS  INFECTIONS	TRIMUNOCOR LIMITED
WO/2021/198399	COMPOSITIONS AND METHODS CONTAINING N-ACETYLCYSTEIN AND  NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES  AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/204649	GM-CSF ANTAGONISTS FOR USE IN THE TREATMENT OF SEVERE  PULMONARY COVID-19, CYTOKINE RELEASE SYNDROME AND/OR ACUTE RESPIRATORY  DISTRESS SYNDROME	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/204655	MODIFIED VECTORS FOR PRODUCTION OF RETROVIRUS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/198410	AMYLOSE/CAROTENOIDS COMPLEXATION PROCESS	ECLYPSE INK BIOTECHNOLOGY
WO/2021/198413	STABILIZED VACCINE COMPOSITIONS	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/198415	METHODS OF TREATMENT USING NICLOSAMIDE	SOFTHALE NV
WO/2021/198439	REDUCED CALORIC INTAKE AND IMMUNOTHERAPY FOR THE TREATMENT OF  CANCER	IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/198440	COMPOSITIONS FOR CORONAVIRUS INFECTION TREATMENT AND/OR  PREVENTION	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/198442	ISOQUINOLINE DERIVATIVES FOR USE IN THERAPY	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/198449	TUMOR ANTIGENS FOR LIVER CANCER IMMUNOTHERAPY	ISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/198454	METHOD FOR TREATING HYPERINFLAMMATION USING MESENCHYMAL  LINEAGE PRECURSOR OR STEM CELLS	MESOBLAST INTERNATIONAL SàRL
WO/2021/198464	WOUND CARE COMPOSITIONS AND METHODS OF PREPARATION THEREOF	T.J.SMITH AND NEPHEW,LIMITED
WO/2021/204705	CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS  FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH  LIVER DISEASES	NEMYSIS LTD.
WO/2021/204713	AXL INHIBITORS FOR ANTIVIRAL THERAPY	BERGENBIO ASA
WO/2021/198500	NOVEL IMMUNOMODULATOR	VIROKINE THERAPEUTICS LTD
WO/2021/209274	HYDRATABLE COSMETIC COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/204717	AMINOQUINOLINES FOR TREATING CORONAVIRUS INFECTIONS	OXANDIA LTD
WO/2021/198504	ACTIVE SUBSTANCES FOR MEDICAL USE	INFLAMED PHARMA GMBH
WO/2021/198506	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF  AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)	POXEL
WO/2021/198511	METHODS AND COMPOSITIONS FOR TREATMENT OF SARS-COV-2 INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/198516	COMPOSITION	INOCELLS B.V.
WO/2021/198517	COMPOSITION	INOCELLS B.V.
WO/2021/198524	REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH	GRüNENTHAL GMBH
WO/2021/204751	PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASES	POXEL
WO/2021/204755	PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASES	POXEL
WO/2021/204756	METHODS FOR THE TREATMENT OF HEADACHE DISORDERS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/204757	TREATMENT OF ARDS AND OTHER PARAMETERS RELATED TO COVID-19	STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
WO/2021/204762	CRYSTALLINE FORMS OF A TYK2 INHIBITOR	SAREUM LIMITED
WO/2021/204781	ARTC1 LIGANDS FOR CANCER TREATMENT	UNIVERSITÄT ZüRICH
WO/2021/204800	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/204801	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/204802	LABELLED SUBSTANCE AND METHODS OF DETECTION OF INFLAMMATION  AND INFECTION USING SAID SUBSTANCE	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/204812	25-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITY	CARBOGEN AMCIS B.V.
WO/2021/204814	NACHR, SUCH AS NICOTINE, FOR USE IN THE PREVENTION AND THE  TREATMENT OF COVID-19 DISEASE	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/198534	PLASMA KALLIKREIN INHIBITORS FOR USE IN THE TREATMENT OF  CORONAVIRAL DISEASE	OXURION NV
WO/2021/204825	INACTIVATED SARS-CoV-2 VIRUS VACCINE	VALNEVA AUSTRIA GMBH
WO/2021/198535	USE OF AN ARSENIC COMPOUND FOR TREATING A SHORT OR LONG  CYTOKINE STORM IN VARIOUS AUTOIMMUNE/INFLAMMATORY DISEASES IN HUMANS OR  ANIMALS	MEDSENIC
WO/2021/204843	TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDREN	LABORATOIRES C.T.R.S.
WO/2021/204861	COMPOSITIONS FOR USE IN THE INHIBITION OF CORONAVIRUS  REPLICATION	NORDIC PHARMA LAB APS
WO/2021/204873	IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A  LIPOSOMAL FORMULATION, METHOD OF PRODUCING THE COMPOSITION, THE COMPOSITION  FOR USE AS A MEDICAMENT, IN PARTICULAR FOR USE AS A VACCINE	INNOMEDICA HOLDING AG
WO/2021/239307	NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF	UNIVERSITÄT ZüRICH
WO/2021/204883	PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL  DISEASES	CVASTHERA
WO/2021/204889	METHOD FOR PRODUCING A POROUS ACTIVE INGREDIENT CARRIER BY  MEANS OF HOT-MELT EXTRUSION	RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
WO/2021/204923	PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS FOR USE IN THE  TREATMENT OF A CORONAVIRUS INFECTION	VIRONOVA MEDICAL AB
WO/2021/204924	COMPOUNDS FOR USE IN THE TREATMENT OF HYPERCYTOKINEMIA	VIRONOVA MEDICAL AB
WO/2021/204935	MEMBRANES FOR MEDICAL DEVICES	DEFYMED
WO/2021/204955	COMPOUNDS FOR TREATING PNEUMONIA, SEPSIS, AND CORONAVIRUS  INFECTION	HEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/204969	PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY  AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/204985	USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/204991	IMMUNOSTIMULATORY COMPOSITIONS	BAYER ANIMAL HEALTH GMBH
WO/2021/204994	OFATUMUMAB FOR TREATING MS WHILE MAINTAINING SERUM IGG	NOVARTIS AG
WO/2021/204998	NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPY	HEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/205010	NUCLEIC ACIDS ENCODING HUMAN FUS PROTEIN AND USE IN THE  TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)	INSERM - INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE
WO/2021/205017	IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE	VALNEVA AUSTRIA GMBH
WO/2021/205025	COMBINATORY TREATMENT FOR LYMPHOMA	UNIVERSITE DE PARIS
WO/2021/205026	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR  RNA VIRUS INDUCED INFECTIONS AND DISORDERS	LOGICK ENERGETICS B.V.
WO/2021/205027	INDIVIDUALIZED THERAPEUTIC ANTICANCER VACCINE	VACCIBODY AS
WO/2021/205029	USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019  (COVID-19)	AB SCIENCE
WO/2021/213822	COMPOSITIONS COMPRISING CYS-PEPTIDES	EVONIK OPERATIONS GMBH
WO/2021/209402	IMMUNOCONJUGATES	F. HOFFMANN-LA ROCHE AG
WO/2021/209405	MULTI-PHASE COSMETIC COMPOSITION COMPRISING AT LEAST TWO  IMMISCIBLE OILY PHASES	CHANEL PARFUMS BEAUTE
WO/2021/219360	COMPRESSED TABLET COMPRISING L-THEANINE	DSM IP ASSETS B.V.
WO/2021/209419	BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF  HEPATITIS E	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209425	ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209427	SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF  HEPATITIS E	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209437	NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS  PREVENTION AND TREATMENT WITHOUT PRESERVATIVES	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E. V.
WO/2021/209441	USE OF A POLAR EXTRACT OF <i>SKELETONEMA</i> IN  PHOTODYNAMIC THERAPY	IFREMER
WO/2021/209442	NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS  PREVENTION AND TREATMENT	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E. V.
WO/2021/209450	RESINIFERATOXIN COMPOSITIONS	MESTEX AG
WO/2021/209452	DOSAGE UNITS AND REGIMEN, USES, METHODS OR FORMULATIONS OF  COMPOSITIONS COMPRISING A RECOMBINANT PROTEIN COMPRISING INTERLEUKIN-12 AND  AN ANTIBODY BINDING THE EXTRA-DOMAIN B OF FIBRONECTIN	PHILOGEN S.P.A.
WO/2021/209455	COMPOSITION FOR IMPROVING COGNITIVE FUNCTION	ACTIV'INSIDE
WO/2021/209458	COMBINATION TREATMENT OF CANCER	ARES TRADING S.A.
WO/2021/209459	METHODS OF USING SOLID DISPERSIONS OF RIFAXIMIN FOR THE  TREATMENT OF SICKLE CELL DISEASE	BAUSCH HEALTH IRELAND LIMITED
WO/2021/223966	ADENOMYOSIS ASSOCIATED INFERTILITY AND HDAC INHIBITORS	NADEZHDA REPRODUCTIVE SCIENCE OOD
WO/2021/209465	PEPTIDE FOR THE TREATMENT OF NET-ASSOCIATED DISEASES	UNIVERSITEIT MAASTRICHT
WO/2021/209471	ULIPRISTAL ACETATE OTF	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209472	ORAL THIN FILM WITH SMOOTH FUSED FILM	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209493	MEANS AND METHODS OF PREVENTING AND TREATING INFECTIONS	SOLYPLUS GMBH
WO/2021/219376	PERSONAL CARE COMPOSITIONS WITH ENHANCED SOLUBILITY ACTIVES	UNILEVER IP HOLDINGS B.V.
WO/2021/219378	STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE	UNILEVER IP HOLDINGS B.V.
WO/2021/209510	INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/209520	MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS	ISTITUTO EUROPEO DI ONCOLOGIA S.R.L.
WO/2021/209521	VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCY	GENETHON
WO/2021/209539	PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF  THE NLRP3 INFLAMMASOME PATHWAY	JANSSEN PHARMACEUTICA NV
WO/2021/209541	TAXIFOLIN FORMULATION COMPRISING THIAMINE	EVANIUM HEALTHCARE GMBH
WO/2021/209545	COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACID	EVER VALINJECT GMBH
WO/2021/209548	COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED  CONDITIONS	HENLEZ APS
WO/2021/209552	PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS  OF THE NLRP3 INFLAMMASOME PATHWAY	JANSSEN PHARMACEUTICA NV
WO/2021/209562	LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF  PATHOGENIC INFECTION	STATENS SERUM INSTITUT
WO/2021/209563	COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY  RESPIRATORY SYNDROME-RELATED CORONAVIRUS	SOM INNOVATION BIOTECH, S.A.
WO/2021/213891	USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES,  MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS	H4 ORPHAN PHARMA
WO/2021/209566	O/W EMULSION CONTAINING ETHANOL	DR. KURT WOLFF GMBH & CO. KG
WO/2021/213898	A CHIMERIC ENDOLYSIN POLYPEPTIDE.	MICREOS HUMAN HEALTH B.V.
WO/2021/209589	PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL  AND BACTERIAL PNEUMONIA AND SEPSIS	ANDREAS HETTICH GMBH & CO. KG
WO/2021/209590	IMPROVED PROBIOTIC STRAINS AND USES THEREOF	AMUCIN OY LTD
WO/2021/233614	COMPOSITIONS AND METHODS FOR PROVIDING SCALP CARE BENEFITS	UNILEVER IP HOLDINGS B.V.
WO/2021/209591	CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS	ESTETRA SRL
WO/2021/209593	ACTIVE PRINCIPLE COMPRISING A PEEL EXTRACT OF IMMATURE PUNICA  GRANATUM FRUIT AND USES FOR PREVENTING AND/OR COMBATTING ACNE	SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
WO/2021/209594	BROMODOMAIN INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF  CORONAVIRUS INFECTIONS AND DISEASES CAUSED THEREBY	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/209596	THERAPEUTIC USE OF PLEUROMUTILINS	NABRIVA THERAPEUTICS GMBH
WO/2021/209607	SCD83 FOR WOUND HEALING, HAIR GROWTH, AND SKIN AND HAIR CARE	FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NüRNBERG
WO/2021/209608	MEDICAL METHODS AND MEDICAL USES	JOSEPH, Bertrand Marie René
WO/2021/213923	MEDICAL USE OF DARIDOREXANT	IDORSIA PHARMACEUTICALS LTD
WO/2021/213924	CORONAVIRUS VACCINE	BIONTECH SE
WO/2021/213931	NOVEL NON-PROTEINIC FURIN INHIBITOR	EPHYLA
WO/2021/209620	CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR  TREATMENT OF CORONAVIRUS	ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/209623	COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID  AND METHOD FOR MANUFACTURING SAME	ELEONOR SPRL
WO/2021/209625	HIGH POTENCY NATURAL KILLER CELLS	ONK THERAPEUTICS LIMITED
WO/2021/228492	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/209627	MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPY	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/209631	FMT PERFORMANCE PREDICTION TEST TO GUIDE AND OPTIMIZE  THERAPEUTIC MANAGEMENT OF GVHD PATIENTS	MAAT PHARMA
WO/2021/209633	METHODS AND FORMULATIONS FOR ADMINISTRATION OF THIOCARBAMATE  DERIVATIVES A2A INHIBITORS	ITEOS BELGIUM SA
WO/2021/213946	PROPHYLAXIS AND TREATMENT OF CORONAVIRUS INFECTION	ENGLMEIER, Ludwig
WO/2021/213948	A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE	INTERVET INTERNATIONAL B.V.
WO/2021/213949	A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG	INTERVET INTERNATIONAL B.V.
WO/2021/209644	USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED  ACUTE RESPIRATORY DISTRESS	PHARMING INTELLECTUAL PROPERTY B.V.
WO/2021/209645	COMPOSITION FOR TREATING KERATIN TISSUE	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/213992	METHOD OF GENERATING A DRIED DRUG FORMULATION	HOFFMANN-LA ROCHE INC.
WO/2021/228502	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/228503	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/214018	TREATMENT REGIMEN WITH MINOXIDIL AND CAFFEINE	DR. KURT WOLFF GMBH & CO. KG
WO/2021/214023	COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE  TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES	BAYER AKTIENGESELLSCHAFT
WO/2021/219428	METHOD FOR DELIPIDATING PLANT EXTRACTS	MAX ZELLER SOEHNE AG
WO/2021/214033	VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL  DISEASES	IMMUNIC AG
WO/2021/214043	IMMUNIZATION SCHEME FOR VARIANT SURFACE GLYCOPROTEIN CARRIERS	DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN  RECHTS
WO/2021/214045	HPMC CAPSULE WITH REDUCED POWDER RETENTION	CAPSUGEL FRANCE SAS
WO/2021/214053	PROCESS FOR DENSIFYING KERATIN FIBERS, BASED ON SILICONE, AN  ALKOXYSILANE AND A COLORING AGENT	L'OREAL
WO/2021/214055	COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA  (I), AT LEAST ONE NON AMINO SILICONE OF FORMULA (II) AND AT LEAST ONE  COLORING AGENT	L'OREAL
WO/2021/214056	PROCESS FOR THE TREATMENT OF KERATIN FIBERS EMPLOYING A  COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA (I), AT LEAST ONE  NON AMINO SILICONE OF FORMULA (II) HAVING A WEIGHT-AVERAGE MOLECULAR WEIGHT  OF LESS THAN OR EQUAL TO 1500 G/MOL AND AT LEAST ONE COLORING AGENT	L'OREAL
WO/2021/214081	SARS-COV-2 VACCINES	NEC ONCOIMMUNITY AS
WO/2021/233630	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/228519	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND  OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/214119	THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER	IFOM - FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/214126	DRUG ANTIBODY CONJUGATES	PHARMA MAR, S.A.
WO/2021/214129	ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF  CANCER	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/219458	GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS  EXCIPIENT	OMYA INTERNATIONAL AG
WO/2021/214139	COMPOSITION FOR USE IN THE TREATMENT OF GROUP-B STREPTOCOCCUS  (GBS) INFECTIONS	GIELLEPI S.P.A.
WO/2021/214158	CO-CRYSTAL OF GABAPENTIN, KETOPROFEN AND LYSINE,  PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE	DOMPE' FARMACEUTICI SPA
WO/2021/214163	SYNERGISTIC ADMIXTURES OF GABAPENTIN AND KETOPROFEN,  PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE	DOMPE' FARMACEUTICI SPA
WO/2021/214170	ORALLY ADMINISTERED HYDROGEL COMPOSITION, KIT AND USE	KIFIK
WO/2021/214175	ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR  THE TREATMENT OF SPLEEN DISORDERS	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/214179	SYNTHETIC <i>STREPTOCOCCUS PNEUMONIAE</i>  SACCHARIDE CONJUGATES TO CONSERVED MEMBRANE PROTEIN	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/214200	ROCK INHIBITORS FOR USE IN TREATING OR PREVENTING PULMONARY  EDEMA	ATRIVA THERAPEUTICS GMBH
WO/2021/214205	PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT	FIRMENICH SA
WO/2021/214209	PRODUCT AND PROCESS FOR THE DECONTAMINATION OF NANOPARTICLES  FROM THE SKIN	LEIBNIZ-INSTITUT FüR POLYMERFORSCHUNG DRESDEN E.V.
WO/2021/214220	GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR  AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/214221	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND FOLFIRI	SANOFI
WO/2021/214222	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES, TRIFLURIDINE AND TIPIRACIL	SANOFI
WO/2021/214223	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND FOLFOX	SANOFI
WO/2021/214227	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY  CONJUGATES AND CETUXIMAB	SANOFI
WO/2021/214233	TREATMENT OF HYPOTHALAMIC OBESITY	SANIONA A/S
WO/2021/214234	SYNERGISTIC PRESERVATIVE/PERSONAL CARE COMPOSITION CONTAINING  AN ALKYLENE GLYCOL ESTER	ARCH UK BIOCIDES LTD
WO/2021/214245	NOVEL PHARMACOLOGICAL CHAPERONE COMPOUNDS OF HUMAN ACID  ALPHA-GLUCOSIDASE AND THE THERAPEUTIC USE THEREOF	UNIVERSITé GRENOBLE ALPES
WO/2021/214253	DOSAGE REGIMEN FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/214254	PHARMACEUTICAL FORMULATIONS	ASTRAZENECA AB
WO/2021/219495	METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR  INHIBITING VIRAL REPLICATION	DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH
WO/2021/214270	COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC  ANTIGEN RECEPTORS	ASTRAZENECA AB
WO/2021/214279	REPLICATION-COMPETENT CONTROLLED HERPESVIRUSES EXPRESSING A  SARS COV-2 ANTIGEN	HSF PHARMACEUTICALS
WO/2021/214282	METHODS FOR PREVENTING INDUCTION OF IMMUNE RESPONSES TO THE  TRANSDUCED CELLS EXPRESSING A TRANSGENE PRODUCT AFTER OCULAR GENE THERAPY	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/214292	COMPOSITION COMPRISING FIBRE AND MULBERRY	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214293	COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A  METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURY	KLINIKUM DER UNIVERSITÄT MüNCHEN (KUM)
WO/2021/214296	TREATMENT OF CORONA VIRUS INFECTIONS	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/239346	METHODS OF TREATMENT OF VIRAL DISEASES	SOFTHALE NV
WO/2021/214297	IMMUNIZATION AGAINST SARS-COV-RELATED DISEASES	ISA PHARMACEUTICALS B.V.
WO/2021/214300	COMPOSITION COMPRISING A FIBROUS MATERIAL	WEIDMANN HOLDING AG
WO/2021/214303	PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF  MYELOPROLIFERATIVE NEOPLASMS	UNIVERSITÄTSKLINIKUM JENA
WO/2021/214320	PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG  DYSFUNCTION	PREVIPHARMA CONSULTING GMBH
WO/2021/214321	NOVEL COMBINATION FOR THE TREATMENT OF AIDS	21C BIO
WO/2021/214326	USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE  RESPONSE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214328	PH-DEPENDENT RELEASE NANOPARTICLES FOR INCORPORATION OF ACTIVE  SUBSTANCES, PREPARATION METHOD AND THERAPEUTIC USES OF SAME	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116503	THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY  DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS	SMALL PHARMA LTD
WO/2021/214337	SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR COELIAC  DISEASE	DR. FALK PHARMA GMBH
WO/2021/214338	SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR TG2-RELATED  DISEASES	DR. FALK PHARMA GMBH
WO/2021/214339	VACCINE AGAINST HUMAN-PATHOGENIC CORONAVIRUSES	ACM BIOLABS PTE LTD
WO/2021/214341	SRC KINASE ACTIVATORS AND/OR ENG FUNCTION INHIBITORS AS  ENHANCERS OF SKIN HOMEOSTASIS/REGENERATION AND HAIR GROWTH	DERMA INNOVATE S.L.
WO/2021/219543	SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS	NOVO NORDISK A/S
WO/2021/219545	COMPOSITION FOR TREATING AND/OR PREVENTING VESTIBULODYNIA	PEPTONIC MEDICAL AB
WO/2021/219547	ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS,  MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDS	L'OREAL
WO/2021/219576	MULTIPARTICULATE DOSAGE FORM CONTAINING EVA COPOLYMER AND  ADDITIONAL EXCIPIENT	GRüNENTHAL GMBH
WO/2021/219577	DOSAGE FORM COMPRISING HOT-MELT EXTRUDED PELLETS CONTAINING  EVA COPOLYMER AND GLIDING AGENT	GRüNENTHAL GMBH
WO/2021/219581	SYSTEM AND METHOD FOR PROVIDING FERTILITY ENHANCING DIETARY  RECOMMENDATIONS IN INDIVIDUALS WITH PROSTATE CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/239360	PEG-FREE SOAP GEL PREPARATION	BEIERSDORF AG
WO/2021/224058	COMPOSITION COMPRISING ALBUMIN FOR USE IN THE TREATMENT OF  AMYOTROPHIC LATERAL SCLEROSIS (ALS) BY PLASMA EXCHANGE	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/219619	METHODS TO GENERATE VACCINE COMPOSITIONS THAT PRIME HUMAN  LEUKOCYTE ANTIGEN CLASS I RESTRICTED CD8 T-CELL RESPONSES AGAINST VIRAL  NON-VIRION-INTEGRAL DERIVED EPITOPES	GENOVIE AB
WO/2021/219622	HAND SANITISER COMPOSITION	DSM IP ASSETS B.V.
WO/2021/219624	A NICOTINE ORAL DELIVERY PRODUCT	JT INTERNATIONAL SA
WO/2021/219634	METHOD FOR PRODUCING MILK LIKE PRODUCTS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/219635	METHOD FOR PRODUCING MILK LIKE PRODUCTS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/219639	PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE  RESPONSE	R.G.C.C. HOLDINGS AG
WO/2021/224068	PEPTIDES CONTAINING A PCNA INTERACTING MOTIF FOR USE IN THE  TREATMENT OF SOLID CANCER	THERAPIM PTY LTD
WO/2021/219671	TREATMENT OF PULMONARY COMPLICATIONS OF CORONAVIRUS INFECTIONS	NOORIK BIOPHARMACEUTICALS AG
WO/2021/219691	DAPAGLIFLOZIN AND AMBRISENTAN FOR THE PREVENTION AND TREATMENT  OF COVID-19	ASTRAZENECA AB
WO/2021/219710	SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE	NOVO NORDISK A/S
WO/2021/219719	METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219720	METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219722	AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING AT LEAST  ONE SILICONE ACRYLIC COPOLYMER AND AT LEAST ONE PROPELLANT	L'OREAL
WO/2021/219750	ANTI-CANCER VACCINES AND RELATED THERAPY	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/219762	USE OF A SYNTHETIC AAV CAPSID FOR GENE THERAPY OF MUSCLE AND  CENTRAL NERVOUS SYSTEM DISORDERS	GENETHON
WO/2021/219763	IONIC LIQUID AS AN ANTIPERSPIRANT	NOVIGO GMBH & CO. KG
WO/2021/228570	USE OF SULCONAZOLE COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/219808	SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN A	RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224114	ANTIBACTERIAL COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/228574	SUNSCREEN HAVING LOW TACKINESS AND HIGH UV PROTECTION	BEIERSDORF AG
WO/2021/219817	LIQUISOLID PHARMACEUTICAL FORMULATION AND PROCESS FOR  MANUFACTURING	RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224118	PERSONAL CARE COMPOSITIONS COMPRISING A METAL PIROCTONE  COMPLEX	UNILEVER IP HOLDINGS B.V.
WO/2021/219846	STIMULATION OF THE GROWTH OF GUT BIFIDOBACTERIA	ADARE PHARMACEUTICALS SAS
WO/2021/239384	MINERAL-OIL-FREE W/O EMULSION WITH A VARIABLE CONSISTENCY	BEIERSDORF AG
WO/2021/239385	SUNSCREEN WITH A COMBINATION OF CARNAUBA WAX AND HYDROGENATED  RAPESEED OIL	BEIERSDORF AG
WO/2021/224133	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/219857	HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19  PATIENTS	SEIDEL, Dietrich
WO/2021/224138	METHODS OF REDUCING MORTALITY RISK IN SUBJECTS SUFFERING FROM  AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONE	BAUSCH HEALTH IRELAND LIMITED
WO/2021/219879	TREATMENTS OF INFLAMMATORY BOWEL DISEASE	AQILION AB
WO/2021/219881	5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-QUINOLINE-3-CARBOXAMIDE  POTASSIUM SALT FOR TREATING INFLAMMATORY BOWEL DISEASES	AQILION AB
WO/2021/224144	METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  COVID-19	WISTA LABORATORIES LTD.
WO/2021/224145	METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  COVID-19	WISTA LABORATORIES LTD.
WO/2021/224146	METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF  HYPOXEMIA	WISTA LABORATORIES LTD.
WO/2021/224153	COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS  PRODUCTION OF HYDROGEN SULFIDE (H<sb>2</sb>S)	PARTHENOGEN SAGL
WO/2021/224167	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/254685	SUBSTANCE FOR DYEING KERATIN FIBERS, CONTAINING SPECIFIC  NONIONIC EMULSIFIERS, PIGMENTS AND AMINOSILICONES	HENKEL AG & CO. KGAA
WO/2021/224169	HYDROGEL IRRADIATION	ASCENDIS PHARMA A/S
WO/2021/259538	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/259539	METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A  POLYETHYLENE GLYCOL ETHER OF A PROPYLENE GLYCOL FATTY ACID ESTER	HENKEL AG & CO. KGAA
WO/2021/219896	TREATMENT AND/OR PREVENTION OF A DISEASE OR A SYNDROME RELATED  TO A VIRUS INFECTION	ATLAS BIOTECHNOLOGY S.A.
WO/2021/224198	Mifepristone oral form for its use in cervix ripening and  labour induction	DISPHAR INTERNATIONAL BV
WO/2021/224203	THE USE OF HYPERBRANCHED COPOLYMERS FOR BALANCING MICROBIAL  GROWTH	DSM IP ASSETS B.V.
WO/2021/233672	METHOD FOR OBTAINING AN EXTRACT OF SANDALWOOD, COMPOSITIONS  COMPRISING SAME AND COSMETIC USES THEREOF	ISP INVESTMENTS LLC.
WO/2021/224234	ANTIVIRAL USE OF CILENGITIDE	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/224235	USE OF DOPAMINE D3 PARTIAL AGONISTS FOR TREATING CENTRAL  NERVOUS SYSTEM DISORDERS	BIOPROJET PHARMA
WO/2021/224259	METHOD FOR COSMETIC TREATMENT BY COMBINED ILLUMINATION AND  APPLICATION OF A COMPOSITION COMPRISING NIACINAMIDE, AND ASSOCIATED DEVICE	LIGHTINDERM
WO/2021/224260	EXOSOME-ANCHORING FUSION PROTEINS AND VACCINES	BIOVELOCITA S.R.L
WO/2021/224261	SOLUBLE TORS AND FUSIONS TO ANTI-CD3 RECOGNISING KRAS G12D FOR  THE TREATMENT OF CANCER	IMMUNOCORE LIMITED
WO/2021/224264	ANTIPATHOGEN VESICLE	EK BIOSCIENCES GMBH
WO/2021/224270	METHOD TO TREAT VIRAL INFECTION INDUCED BY A CORONAVIRUS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/224301	PEPTIDES FOR PREVENTING OR TREATING VIRAL INFECTIONS	SORBONNE UNIVERSITE
WO/2021/224313	NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS	DISRUPTIVE MATERIALS PHARMA AB
WO/2021/233681	DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES  FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES  THEREOF	CELLBITEC, S.L.
WO/2021/224334	COMBINATION CONTAINING TWO NICOTINE-CONTAINING DRUGS FOR THE  TREATMENT OF COVID-19	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224338	TREATMENT OF HYPERURICEMIA	FREDERIKSBERG HOSPITAL
WO/2021/224354	PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A  INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM	QUANTUM GENOMICS
WO/2021/224356	NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE	4LIVING BIOTECH
WO/2021/144478	COMBINATION TREATMENT FOR FUMARATE-RELATED DISEASES	IMCYSE SA
WO/2021/224381	COMBINATION THERAPY FOR TREATING CANCER	ASTRAZENECA AB
WO/2021/224382	COMPOUNDS FOR THE TREATMENT OF COVID-19	DOMPE' FARMACEUTICI SPA
WO/2021/254687	PIGMENT SUSPENSION AND COSMETIC PRODUCT PREPARED USING THE  PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/224397	IMMUNOGENIC PEPTIDES WITH EXTENDED OXIDOREDUCTASE MOTIFS	IMCYSE SA
WO/2021/254688	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, AN ALKYL(POLY)GLYCOSIDE, A DYEING COMPOUND AND A  POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/259543	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF  AN ORGANOSILICON COMPOUND, A DERIVATIVE OF ALKYLATED SILANOL, A COLORING  COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/259544	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE  PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/224403	IMMUNOGENIC PEPTIDES WITH NEW OXIDOREDUCTASE MOTIFS	IMCYSE SA
WO/2021/224416	METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF  THERAPEUTIC PROTEINS	CELLECTIS S.A.
WO/2021/224419	PHOTOOXIDATIVE INACTIVATION OF PATHOGENS INCLUDING SARS-CoV-2	SCHIKORA, Detlef
WO/2021/224429	EXOSOME-ANCHORING CORONAVIRUS FUSION PROTEINS AND VACCINES	BIOVELOCITA S.R.L
WO/2021/224432	IL-18 BINDING PROTEIN (IL-18BP) IN RESPIRATORY DISEASES	AB2 BIO SA
WO/2021/224439	CLICK OMVs	DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS,  MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT
WO/2021/224444	PROCESS FOR PRODUCING AN ORAL THIN FILM COMPRISING  MICROPARTICLES	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224449	STEM CELLS FOR TREATMENT OF RESPIRATORY DISORDERS	XINTELA AB
WO/2021/224455	COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN  HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY	LEGACY HEALTHCARE (SWITZERLAND) SA
WO/2021/228714	ANTIVIRAL COMPOSITION COMPRISING EEYARESTATIN I	UNIVERSIDAD DE CASTILLA LA MANCHA
WO/2021/224463	COSMETIC COMPOSITION COMPRISING CELLODEXTRINS	PFEIFER & LANGEN GMBH & CO. KG
WO/2021/224467	TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE  ACETATE AND NIRAPARIB	JANSSEN PHARMACEUTICA NV
WO/2021/224469	TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE  ACETATE AND NIRAPARIB	JANSSEN PHARMACEUTICA NV
WO/2021/224471	PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND  NIRAPARIB	JANSSEN PHARMACEUTICA NV
WO/2021/224494	NEW TREATMENTS OF VIRAL INFECTIONS	KANCERA AB
WO/2021/224499	BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20	GENMAB A/S
WO/2021/228731	FELINE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/224503	PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS  INFECTIONS	AICURIS GMBH & CO. KG
WO/2021/228746	A NOVEL ANTIBODY BINDING SPECIFICALLY TO HUMAN CEACAM1/3/5 AND  USE THEREOF	LEUKOCOM GMBH
WO/2021/228750	COMPATIBLE SOLUTES FOR PREVENTING OR TREATING SARS-COV-2  INFECTIONS	BITOP AG
WO/2021/228758	ATR INHIBITORS FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/228760	FORMULATIONS OF ANTI-IL-33 ANTIBODIES	MEDIMMUNE LIMITED
WO/2021/228762	USE OF TMPRSS2 INHIBITORS FOR THE TREATMENT OF LUNG VIRAL  INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/228768	PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE  SYSTEM	VAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/224505	MODULATION OF MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN  SIGNALING	EBERHARD KARLS UNIVERSITÄT TüBINGEN
WO/2021/228783	METHODS FOR TREATING MULTIPLE MYELOMA	JANSSEN PHARMACEUTICA NV
WO/2021/228788	COMPOSITION COMPRISING METHYLFOLATE	ALFASIGMA S.P.A.
WO/2021/228800	SLOW RELEASE PLASMINOGEN ACTIVATOR FORMULATION FOR USE IN THE  TREATMENT OF THROMBOTIC OR HAEMORRHAGIC DISEASE	OP2LYSIS
WO/2021/228805	METHODS AND COMPOSITIONS USING SERPIN PRODUCING BACTERIA	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/228816	ADMINISTRATION OF HOMOLOGOUS ADENOVIRAL VECTORS	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/228817	EMID2 PROTEIN AS ANTI-CANCER TREATMENT	INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY  - ICGEB
WO/2021/228824	COSMETIC COMPOSITION BASED ON BIOSOURCED ISODODECANE AND  PREPARATION METHOD THEREOF	GLOBAL BIOENERGIES
WO/2021/228832	RED CELL EXTRACELLULAR VESICLES (RCEVS) CONTAINING CARGOES AND  METHODS OF USE AND PRODUCTION THEREOF	ERYTECH PHARMA
WO/2021/228846	COMPOUND FOR PREVENTING OR TREATING A VIRAL INFECTION	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/228849	USE OF DI- AND TRICARBOXYLIC FATTY ACIDS IN THE PREVENTION OF  BIOFILM FORMATION	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/228852	SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE  LIPOSOLUBLE ACTIVE SUBSTANCE	METABOLIC TUNING AG
WO/2021/233735	PHARMACEUTICAL PREPARATION FOR USE IN THE TREATMENT OF  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)	CYTOPHARMA GMBH
WO/2021/228853	VACCINE AGAINST SARS-COV VIRUS	OSE IMMUNOTHERAPEUTICS
WO/2021/228863	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228865	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228866	AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE  PREVENTION AND/OR TREAETMENT OF THROMBOCYTOPENIA	APLAGON OY
WO/2021/228867	METHODS FOR IMAGE-GUIDED RADIOTHERAPY	UNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/228875	TREATMENT OF RESPIRATORY VIRAL INFECTIONS	KYON BIOTECH AG
WO/2021/239463	CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELS	LUMENDO AG
WO/2021/228917	PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN  SOLUTIONS	F. HOFFMANN-LA ROCHE AG
WO/2021/228921	INHALABLE LACTOSE CONTAINING COMPOSITION	MEGGLE GMBH & CO. KG
WO/2021/228937	UROGENITAL CLEANSING COMPOSITION	PEPTONIC MEDICAL AB
WO/2021/228942	PROTEASE FORMULATION FOR TREATMENT OF MICROBIAL INFECTIONS	ZYMIQ TECHNOLOGY AB
WO/2021/254697	METAMIZOLE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF  PULMONARY HYPERTENSION	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/228956	NEW METHOD TO TREAT CUTANEOUS T-CELL LYMPHOMAS AND TFH DERIVED  LYMPHOMAS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/228983	A PHARMACEUTICAL COMPOSITION COMPRISING AN ARSENIC COMPOUND,  AN INDUCTOR OF TYPE-1 IFN AND A PROTEIN KINASE INHIBITOR FOR TREATING CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239471	CANCER TREATMENT STRATEGIES USING ARENAVIRUS VECTORS	HOOKIPA BIOTECH GMBH
WO/2021/229002	TREATMENT OF COMPLICATIONS CAUSED BY INFECTIONS OF SEVERE  ACUTE RESPIRATORY SYNDROME CORONAVIRUS	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/229013	PEPTIDIC SCAFFOLDS, PROCESSES FOR MANUFACTURING THE SAME, AND  USES THEREOF AS SOLUBLE SUPPORTS	SYNHELIX
WO/2021/229014	COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED  IMMUNOGENIC FRAGMENTS	LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229015	COMPOSITION OF NANOPARTICLES	LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229020	NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS	LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229035	UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER	FUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/244831	THERAPEUTIC SOLID DOSAGE FORMS	SMALL PHARMA LTD
WO/2021/239478	SUNSCREEN WITH A COMBINATION OF WAXES, CETYL PALMITATE AND  HYDROGENATED RAPESEED OIL	BEIERSDORF AG
WO/2021/229065	NEW IMMUNOGENIC COMPOSITIONS AND USE THEREOF FOR PREPARING  HEPATITIS C AND HEPATITIS B VACCINES	UNIVERSITE DE TOURS
WO/2021/229086	COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF MARINE  MOLLUSC VIRAL INFECTION	IFREMER
WO/2021/233796	MCT FORMULATIONS FOR IMPROVING COGNITIVE FUNCTIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/259554	BIODEGRADABLE ADHESIVE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/229100	BRADYKININ B2 RECEPTOR ANTAGONIST FOR TREATMENT OF  SARS-COV2-INFECTION	HELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR  GESUNDHEIT UND UMWELT (GMBH)
WO/2021/229101	STEM CELLS FOR TREATING SKIN LESIONS	RIGSHOSPITALET
WO/2021/229102	MEANS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL  AGGREGATION	VIB VZW
WO/2021/233834	SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE  SAME	ASTRAZENECA UK LIMITED
WO/2021/229104	ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND  TREATMENT	UNIVERSITé DE LIèGE
WO/2021/233851	NEW MALONITRILE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/233853	THE USE OF CHELATORS FOR THE PREVENTION OF VISIBLE PARTICLE  FORMATION IN PARENTERAL PROTEIN SOLUTIONS	F. HOFFMANN-LA ROCHE AG
WO/2021/233874	ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING  CHOLANGITIS	GENFIT
WO/2021/233885	MIMOTOPE PEPTIDES OF THE SPIKE PROTEIN FROM THE SARS-COV-2  VIRUS	SYNTHETIC VACCINES LTD
WO/2021/233899	USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS  INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233901	PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE	RRW B.V.
WO/2021/233902	PLANT COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE	RRW B.V.
WO/2021/259557	COSMETIC PREPARATION COMPRISING ANTIPERSPIRANT INORGANIC  SALTS, CARBOXYLIC ACIDS AND 1,3-PROPANEDIOL	BEIERSDORF AG
WO/2021/233923	IMPROVEMENT OF INSOLUBLE FIBRE FERMENTABILITY AND SHORT CHAIN  FATTY ACID PRODUCTION BY BIFIDOBACTERIUM LONGUM	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233924	METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES	HANSA BIOPHARMA AB
WO/2021/233927	ANTIBODY THAT BINDS SPECIFICALLY TO THE SARS COV 2 SPIKE  PROTEIN, AND METHODS FOR ITS MANUFACTURE	IGNOVA GMBH
WO/2021/233944	PARA-AMINO-BENZYL LINKERS, PROCESS FOR THEIR PREPARATION AND  THEIR USE IN CONJUGATES	LES LABORATOIRES SERVIER
WO/2021/233948	METHOD TO TREAT A PATHOGEN LUNG INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233950	COMPOUNDS FOR USE IN THE REACTIVATION OF HIV IN LATENT  HIV-INFECTED CELLS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/233956	EZETIMIBE FOR TREATING ENVELOPED VIRUS INFECTIONS	MELETIOS THERAPEUTICS
WO/2021/233960	USE OF HUMAN MILK OLIGOSACCHARIDES IN NUTRITIONAL COMPOSITIONS  FOR ENHANCING BONE DEVELOPMENT AND/OR BONE STRENGTH	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233962	METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE  SYNDROME	INSTITUT CURIE
WO/2021/233966	METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/233967	INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	INTERVET INTERNATIONAL B.V.
WO/2021/233971	BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITIS	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/233973	COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF	FIRMENICH SA
WO/2021/233988	COMPOSITION COMBINING JONZAC THERMAL SPRING WATER AND A  CENTELLA ASIATICA EXTRACT AND THE REPAIRING/HEALING EFFECT THEREOF	LABORATOIRES LéA
WO/2021/233989	VIRAL VACCINE VECTOR FOR IMMUNIZATION AGAINST A  BETACORONAVIRUS	HENNRICH, Alexandru Adrian
WO/2021/234005	A PERSONAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/234006	COMPOSITIONS AND METHODS FOR TREATING CANCER EXPRESSING CD90  AND CD326	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/244852	THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST  SARS-COV-2 GLYCOPROTEIN S	CORAT THERAPEUTICS GMBH
WO/2021/234007	PROPOFOL FOR DIAGNOSIS OF PRIMARY HEADACHE	TESA LABTEC GMBH
WO/2021/234008	ORAL FILM FOR SAFE ADMINISTRATION OF API	TESA LABTEC GMBH
WO/2021/234009	ANTI-AGING COSMETIC COMPOSITIONS COMPRISING NMN	NUVAMID SA
WO/2021/239544	OPHTHALMIC COMPOSITION BASED ON HYALURONIC ACID TO PROTECT  FROM DAMAGES CAUSED BY ENVIRONMENTAL POLLUTION	COLOMBO, Stefano
WO/2021/234014	ANTI-ACNE COMPOSITIONS	L'OREAL
WO/2021/244854	USE OF SAA, RSAA, OR INHIBITORS OF SAA IN THE TREATMENT OF  DYSREGULATED INFLAMMATION	LIKA ANTISEPSIS GBR
WO/2021/239546	USE OF A MINERAL BLEND AS COSMETIC AGENT FOR WET COSMETIC  COMPOSITIONS	OMYA INTERNATIONAL AG
WO/2021/234031	A PARTICLE ENCAPSULATING HYDROPHILIC OR AMPHIPHILIC BIOLOGICAL  COMPOUNDS	SPHERA ENCAPSULATION S.R.L.
WO/2021/259560	CO-GROUND ACTIVE(S) COMPRISING PRODUCT COMPRISING  SURFACE-REACTED CALCIUM CARBONATE	OMYA INTERNATIONAL AG
WO/2021/234055	COMPOSITIONS AND METHODS FOR PROVIDING SKIN CARE BENEFITS	UNILEVER IP HOLDINGS B.V.
WO/2021/234057	PEPTIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF A  DISEASE CAUSED BY A VIRUS AFFECTING THE RESPIRATORY TRACT	FUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y  BIOMéDICA DE LA COMUNITAT VALENCIANA (FISABIO)
WO/2021/234074	COMPOSITION COMPRISING DIFFERENT SPECIFIC COLLAGENS AND USES  ON THE SKIN	MONDERNA HEALTH & WELLNESS
WO/2021/234084	MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE  X ASSOCIATED DISORDERS	KAERUS BIOSCIENCE LIMITED
WO/2021/234094	CEFTRIAXONE COMPOSITIONS WITH MAGNESIUM COMPONENT	XELLIA PHARMACEUTICALS APS
WO/2021/234097	MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS  INFECTIONS AND/OR COVID-19 CYTOKINE STORM	ATRIVA THERAPEUTICS GMBH
WO/2021/254721	AGENT FOR DYEING KERATINOUS FIBRES, CONTAINING PIGMENTS AND  C<sb>2</sb>-C<sb>30</sb> ALKYL METHICONES	HENKEL AG & CO. KGAA
WO/2021/239578	EMULSIONS FOR CONTROLLED DRUG RELEASE	AVIGNON UNIVERSITE
WO/2021/234111	COMPOSITION COMPRISING SAFRANAL AND PROBIOTICS	ACTIV' INSIDE
WO/2021/234127	NUCLEOSIDE ANALOGUE TO INHIBIT THE MAIN PROTEASE OF SARS-CoV-2  VIRUS	INSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/234128	NUCLEOSIDE ANALOGUES TO INHIBIT THE MAIN PROTEASE OF A  CORONAVIRUS	INSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/254723	A PERSONAL CARE COMPOSITION BASED ON TITANIUM OXIDE AND A  CROSSPOLYMER OF ADIPIC ACID AND NEOPENTYL GLYCOL	UNILEVER IP HOLDINGS B.V.
WO/2021/234134	BARK-FREE, STABLE DOUBLE EMULSION	CAPSUM
WO/2021/234135	BARK-FREE, STABLE DISPERSION	CAPSUM
WO/2021/239622	BRANCHED AMINO-ACID-BASED POLYMERS FOR HAIR STRENGTHENING	BASF SE
WO/2021/234159	MORINGA PEREGRINA SEED EXTRACT RICH IN 2,5-DIFORMYLFURAN,  PROCESS FOR OBTAINING SAME AND USE THEREOF IN COSMETIC COMPOSITIONS	AGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/234165	PROTEIN HYDROLYSATE OF <i>MORINGA PEREGRINA</i>  SEED CAKE FOR ITS APPLICATION AS A MEDICAMENT, PROCESS FOR OBTAINING SAME AND  PHARMACEUTICAL AND DERMATOLOGICAL COMPOSITIONS	AGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/234166	EXTRACT OF MORINGA PEREGRINA SEED CAKE, METHOD FOR OBTAINING  SAME AND USE THEREOF IN COSMETIC OR NUTRICOSMETIC COMPOSITIONS	AGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/249751	COSMETIC PRODUCT WITH HIGH DEGREE OF EMPTYING OF THE  PREPARATION FROM THE PACKAGING	BEIERSDORF AG
WO/2021/254729	AVERMECTINS FOR USE IN TREATING CORONAVIRIDAE INFECTION	HUVEPHARMA EOOD
WO/2021/239643	BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS	CHIESI FARMACEUTICI S.P.A.
WO/2021/239662	PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF  FIBROPROLIFERATIVE VASCULAR DISEASES	KITHER BIOTECH S.R.L.
WO/2021/234178	TNFα IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORS	PHILOGEN S.P.A
WO/2021/239666	THERAPEUTIC METHODS	DIACCURATE
WO/2021/239667	NEW THERAPY FOR THE TREATMENT OF TUMORS	UNIVERSITà DEGLI STUDI DI TRENTO
WO/2021/239687	TCDTA-DERIVED FE(III) COMPLEXES FOR USE IN MAGNET RESONANCE  IMAGING WITH LIVER AND KIDNEY EXCRETION	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/249760	A COSMETIC COMPOSITION COMPRISING 6-METHYL-PICOLINAMIDE	UNILEVER IP HOLDINGS B.V.
WO/2021/239709	METHOD FOR PRODUCING A LIPOSOME DISPERSION	LEON-NANODRUGS GMBH
WO/2021/239720	COSMETIC COMPOSITION COMPRISING AT LEAST 30% BY WEIGHT OF  BRANCHED ALKANE AND A COMBINATION OF PARTICULAR SILICONES	L'OREAL
WO/2021/239730	NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC  COMBINATIONS THEREOF	NANOBIOTIX
WO/2021/234181	USE OF FAP INHIBITOR IN A METHOD OF DIAGNOSIS	UNIVERSITÄT HEIDELBERG
WO/2021/259580	HIGHLY VISCOUS COSMETIC NANOEMULSION	BEIERSDORF AG
WO/2021/239742	ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES  AND PROCESS FOR ITS PREPARATION	GIVAUDAN SA
WO/2021/239786	EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG  CANCER	ASTRAZENECA AB
WO/2021/244910	HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR  PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A  DONOR	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239790	METHOD FOR THE TREATMENT OF VIRUS INFECTION WITH IVIG AND  CONVALESCENT PLASMA	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239796	METHOD FOR THE TREATMENT OF A VIRAL INFECTION WITH HUMAN  ALPHA-1 ANTITRYPSIN	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239798	SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS)	EVONIK OPERATIONS GMBH
WO/2021/239809	TREATMENT OF COVID-19 PATIENTS	ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/239812	POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY	QUELL THERAPEUTICS LIMITED
WO/2021/239815	FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL  NERVOUS SYSTEM DISORDERS	UNIVERSITAT AUTòNOMA DE BARCELONA
WO/2021/239817	THERAPEUTIC COMBINATIONS COMPRISING AGONISTS OF FERROPTOSIS  FOR TREATING PROLIFERATIVE DISORDERS	CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS
WO/2021/254750	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254751	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254752	USE OF DIINDOLYLMETHANE COMPOUNDS FOR TREATING SIGNS OF SKIN  AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254753	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254754	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/239838	SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)  POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239844	SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF  HYPOGLYCAEMIA IN PREDIABETES	UNIVERSITÄTSSPITAL BASEL
WO/2021/239850	USE OF NMN TO REDUCE IMMUNODEPRESSION AND IMMUNOSENESCENCE	NUVAMID SA
WO/2021/239878	TREATMENT OF INFECTIONS	ACT THERAPEUTICS LTD
WO/2021/239880	NUCLEIC ACID BASED COMBINATION VACCINES	CUREVAC AG
WO/2021/239890	BIFIDOBACTERIA FOR PREVENTING, REDUCING OR TREATING SKIN AGING	DUPONT NUTRITION BIOSCIENCES APS
WO/2021/239892	MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USE	ATTGENO AB
WO/2021/239893	AMORPHOUS SOLID DISPERSION OF ACALABRUTINIB	BEND RESEARCH, INC.
WO/2021/239905	COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF  THROMBI	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/239906	MONO- AND BIS-NITROSYLATED ALKYL POLYOLS FOR THERAPEUTIC USE	ATTGENO AB
WO/2021/239915	FOXO INHIBITORS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY  ABNORMAL PROCESSING OF TDP-43 AND/OR FUS PROTEINS	ADMINISTRACIóN GENERAL DE LA COMUNIDAD AUTóNOMA DE EUSKADI
WO/2021/239917	COMBINATION SOLID ORAL DOSAGE FORMS OF GONADOTROPIN-RELEASING  HORMONE ANTAGONISTS	MYOVANT SCIENCES GMBH
WO/2021/244964	COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHY	BLACK CAT BIO LIMITED
WO/2021/239935	NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUS	UNIVERSITÄT ZU KÖLN
WO/2021/239938	COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY FOR  RETINOIC ACID PRECURSOR	UNILEVER IP HOLDINGS B.V.
WO/2021/239943	AZELASTINE AS ANTIVIRAL TREATMENT	CEBINA GMBH
WO/2021/239961	A COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING  INFERTILITY	FERRING B.V.
WO/2021/239965	CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES  THEREOF	FUNDACIó PRIVADA INSTITUT D'INVESTIGACIó ONCOLòGICA DE VALL  HEBRON
WO/2021/239968	CD40 BINDING PROTEIN	STRIKE PHARMA AB
WO/2021/239976	TRIARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR TREATING CANCER	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE  (INSERM)
WO/2021/244983	COOLING PERSONAL CARE COMPOSITION COMPRISING A POLYOL AND A  POLYOXYEHTYLENE-POLYOXYPROPYLENE BLOCK COPOLYMER	UNILEVER IP HOLDINGS B.V.
WO/2021/239980	A PEPTIDE COCKTAIL	HUBRO THERAPEUTICS AS
WO/2021/239987	MULTISPECIFIC ANTIBODY	NUMAB THERAPEUTICS AG
WO/2021/239992	ANTIFUNGAL PRODRUGS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/239996	IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPY	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/240004	PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE  AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A  GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION	ADOCIA
WO/2021/240006	PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE  AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A  GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION	ADOCIA
WO/2021/244996	SYNTHETIC OLIGOSACCHARIDE VACCINES AGAINST STREPTOCOCCUS  PNEUMONIAE WITH MICROPARTICLE ADJUVANT FORMULATIONS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/245001	MICROEMULSION FOR THE TREATMENT OF DRY EYE SYNDROME	AZAD PHARMA AG
WO/2021/240013	VACCINE FORMULATIONS	IMNATE SARL
WO/2021/245018	A HIGH SPF SKIN CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/245032	NUTRACEUTIC COMPOSITION CONTAINING LIMONENE AND A DRY EXTRACT  OF COCOA FIBRE FOR THE TREATMENT OF OBESITY	TARGETING GUT DISEASE SRL
WO/2021/254773	A TOPICAL ANTIMICROBIAL COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/245081	COMPOSITION COMPRISING AT LEAST THREE TYPES OF  POLYSACCHARIDES, AT LEAST ONE PASTY COMPOUND OF PLANT ORIGIN AND WATER	L'OREAL
WO/2021/245082	A HIGH UV PROTECTION CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/245095	METHOD TO IMPROVE IMMUNOTHERAPIES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245107	MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE  CHECKPOINT FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROM	INSTITUT GUSTAVE ROUSSY
WO/2021/245111	RECOMBINANT RHABDOVIRUS ENCODING FOR A CD80 EXTRACELLULAR  DOMAIN FC-FUSION PROTEIN	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/245140	DIAGNOSIS, PREVENTION AND TREATMENT OF CORONAVIRUS INFECTION	EMERGEX VACCINES HOLDING LIMITED
WO/2021/245159	NATURALLY DERIVED SURFACTANT SYSTEM AND COMPOSITION COMPRISING  THE SAME	UNILEVER IP HOLDINGS B.V.
WO/2021/245160	NATURALLY DERIVED SURFACTANT SYSTEM WITH POLYGLYCEROL ESTERS  AND COMPOSITIONS COMPRISING THE SAME	UNILEVER IP HOLDINGS B.V.
WO/2021/245172	STABILIZATION OF 1,2,4-TRIOXANE COMPOUNDS BY CHLOROGENIC ACIDS	ARTEMIFLOW GMBH
WO/2021/245179	LIQUID OPHTHALMIC COMPOSITION COMPRISING A SPIRULINA PLATENSIS  FULL EXTRACT	WELIFEPHARMA SAGL
WO/2021/245184	HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME  CORONAVIRUS-2 (SARS-CoV-2)	NEURIMMUNE AG
WO/2021/245199	GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES	KØBENHAVNS UNIVERSITET
WO/2021/254790	AN ANTIMICROBIAL COMPOSITION FOR TACKLING MALODOUR	UNILEVER IP HOLDINGS B.V.
WO/2021/245204	STABLE FORMULATION OF EFINACONAZOLE	THE MATERIA COMPANY LIMITED
WO/2021/245206	TOPICAL SOLUTION OF EFINACONAZOLE WITH HIGH SUBUNGUAL  PENETRATION	THE MATERIA COMPANY LIMITED
WO/2021/245207	USE OF E. COLI STRAINS EXPRESSING HIGH LEVEL OF ALPHA-GAL TO  MODULATE IMMUNITY AND PROVIDE PROTECTION AGAINST INFECTIOUS DISEASES IN  ANIMALS	INSTITUT NATIONAL DE RECHERCHE POUR L' AGRICULTURE, L'  ALIMENTATION ET L' ENVIRONNEMENT
WO/2021/245223	HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL  WRINKLES	MERZ PHARMA GMBH & CO. KGAA
WO/2021/245224	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR  DISEASES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245233	IMPROVING ANTIBODY TOLERABILTY ASSOCIATED WITH INTRAVENOUS  ADMINISTRATION	BIOINVENT INTERNATIONAL AB
WO/2021/249886	AQUEOUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN  MATERIALS COMPRISING A FATTY ACID MONOESTER, A FATTY ACID SALT, A PULLULAN  AND A POLYOL	L'OREAL
WO/2021/245237	MODEL FOR PREDICTION OF TOLERABILITY ISSUES IN CONNECTION WITH  INTRAVENOUS ADMINISTRATION OF THERAPEUTIC ANTIBODIES	BIOINVENT INTERNATIONAL AB
WO/2021/245238	IMPROVING ANTIBODY TOLERABILITY ASSOCIATED WITH INTRAVENOUS  ADMINISTRATION	BIOINVENT INTERNATIONAL AB
WO/2021/245249	TREATMENT OF CD30-POSITIVE CANCER	TESSA THERAPEUTICS LTD.
WO/2021/245254	USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY  DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL  INFECTIONS	H4 ORPHAN PHARMA
WO/2021/245260	THERAPEUTIC NANOCARRIER SYSTEM AND METHODS OF USE	GREGORIOU, Yiota
WO/2021/245263	PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER  RADIOTHERAPY AND IMAGING	RIGSHOSPITALET
WO/2021/245280	USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF  TOURETTE SYNDROME	NOEMA PHARMA AG
WO/2021/245281	METHODS OF TREATMENT OF TUBEROUS SCLEROSIS COMPLEX	NOEMA PHARMA AG
WO/2021/249921	NANOPARTICLES AS BIORESORBABLE AND RADIOPAQUE  ACTIVE-INGREDIENT CARRIERS FOR THE THERAPY OF CANCERS OF THE PANCREAS	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN  FORSCHUNG E.V.
WO/2021/254803	THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR LIGHTENING  PRODUCT	HENKEL AG & CO. KGAA
WO/2021/254804	AGENT FOR DYEING KERATINOUS MATERIAL, IN PARTICULAR HUMAN  HAIR, CONTAINING AMINOSILICONES, PIGMENTS AND ALKYLPOLYGLYCOSIDES	HENKEL AG & CO. KGAA
WO/2021/249951	METHODS AND COMPOSITIONS FOR TREATMENT OF BRAIN VIRAL  INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/245291	TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT  SUFFERING FROM A CORONAVIRUS INFECTION	INOTREM
WO/2021/249960	COMPOSITIONS COMPRISING NARCISSUS SPP. PLANT EXTRACT AND USE  THEREOF	CLARIANT INTERNATIONAL LTD
WO/2021/249969	COMBINATION PRODUCT FOR THE TREATMENT OF CANCER DISEASES	MERCK PATENT GMBH
WO/2021/249974	FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR  TARGETED THROMBOLYTIC THERAPY	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/249982	ANTIVIRAL COMPOUND	SIBYLLA BIOTECH S.R.L.
WO/2021/249990	ANTI-HBV ANTIBODIES AND METHODS OF USE	HOFFMANN-LA ROCHE INC.
WO/2021/249996	COMPOSITIONS COMPRISING 2X-121 AND METHODS FOR TREATING  CORONAVIRUS INFECTION	ONCOLOGY VENTURE APS
WO/2021/250001	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/250008	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/250010	ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS	MV BIOTHERAPEUTICS SA
WO/2021/254835	A TOPICAL ANTIMICROBIAL COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/250019	COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF URINARY TRACT  INFECTIONS AND FOR USE IN COSMETICS	G. POHL-BOSKAMP GMBH & CO. KG
WO/2021/250025	SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND  THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER	UNIVERSITÄT ZüRICH
WO/2021/250029	SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION	UNIVERSITÄT ZüRICH
WO/2021/250038	COMPOUND AND METHOD FOR THE TREATMENT OF CORONAVIRUSES	APTEEUS
WO/2021/250043	ASSAY FOR THE DETECTION OF THE CYS-LIKE PROTEASE (MPRO) OF  SARS-COV-2	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/250061	PROTEIN OR PEPTIDE, ESPECIALLY FOR PROPHYLAXIS AND/OR  TREATMENT OF AN INFECTION AND/OR INFECTIOUS DISEASE AND/OR A SEQUELA THEREOF	PROF. DR. MED. CHRISTOPH KARLE PRAXIS FüR DIAGNOSTIK HOHENLOHE
WO/2021/250081	NRF2 ACTIVATOR FOR USE IN TREATING DILATED CARDIOMYOPATHIES	GENETHON
WO/2021/250082	TREATMENT OF DILATED CARDIOMYOPATHIES	GENETHON
WO/2021/254851	PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION  TRIGGERED BY COVID-19	HORPHAG RESEARCH IP (PYC) LTD.
WO/2021/250110	PROCESS FOR THE PREPARATION OF AN EXTRACT OF EPILOBIUM SPP.  WITH HIGH OENOTHEIN B CONTENT	ISTITUTO FARMOCHIMICO FITOTERAPICO EPO S.R.L. ED IN FORMA  ABBREVIATA: EPO S.R.L.
WO/2021/250130	PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL	FIRMENICH SA
WO/2021/250178	NOVEL LACTOCOCCUS LACTIS STRAIN FOR THE PRODUCTION OF  BIOACTIVE COMPOUNDS HAVING ANTIMICROBIAL EFFECT	INNOVACIóN EN GESTIóN Y CONSERVACIóN DE UNGULADOS S.L.  (INGULADOS)
WO/2021/250193	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF  CHRONIC KIDNEY DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250194	SMALL MOLECULE MODULATORS OF IL-17	LEO PHARMA A/S
WO/2021/250196	NEW USE OF RABEXIMOD	CYXONE AB
WO/2021/250198	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF  FGFR3-RELATED COGNITIVE DEFICIT	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/250199	RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS	CYXONE AB
WO/2021/250200	CANCER THERAPY	PROKARIUM LIMITED
WO/2021/250204	ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMOD	CYXONE AB
WO/2021/259663	COSMETIC COMPOSITION FOR IMPROVING APPEARANCE OF SKIN	UNILEVER IP HOLDINGS B.V.
WO/2021/250205	IMPROVED ADHESIVE DRUG CARRIER	UMC UTRECHT HOLDING B.V.
WO/2021/250207	BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT  FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION,  BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN  PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT  OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR  ANIMAL	URSAPHARM ARZNEIMITTEL GMBH
WO/2021/250212	PEPTIDES FOR TREATMENT OF SEPSIS AND CANCER	NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU)
WO/2021/250219	A RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) VACCINE  AGAINST CORONAVIRUS DISEASE	BAVARIAN NORDIC A/S
WO/2021/259668	USE OF A BORON CLUSTER AS TRANSMEMBRANE CARRIER	JACOBS UNIVERSITY BREMEN GGMBH
WO/2021/250231	THIENOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF  CORONAVIRUS INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/259669	NANOPARTICULATE COMPOSITION	ALGIAX PHARMACEUTICALS GMBH
WO/2021/250236	COMPOSITION COMPRISING NANOPARTICLES, METHOD FOR THE  PREPARATION OF A COMPOSITION COMPRISING NANOPARTICLES AND USES OF THE  COMPOSITION FOR DENTAL TREATMENT	UNIVERSITAT INTERNACIONAL DE CATALUNYA, FUNDACIó PRIVADA
WO/2021/250239	A HYDROALCOHOLIC GEL AND A METHOD OF MANUFACTURING SAID GEL	VIRAMAL LIMITED
WO/2021/250240	DIAZA-18-CROWN-6 DERIVATIVE USEFUL FOR CHELATING RADIUM,  CONJUGATE AND RADIUM CHELATE COMPRISING THE SAME, AND USES THEREOF	ORANO
WO/2021/259673	HYDROXYCHLOROQUINE LIQUID COMPOSITIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/254909	THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR DYEING  PRODUCT	HENKEL AG & CO. KGAA
WO/2021/250260	MODULATORS OF TIGHT JUNCTION PERMEABILITY	THE UNIVERSITY OF BATH
WO/2021/250263	LIPID NANOPARTICLES	ETHERNA IMMUNOTHERAPIES NV
WO/2021/254919	SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOF	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/254928	METHYLENE BLUE AND RIBOFLAVIN FOR PROPHYLACTIC AND THERAPEUTIC  ANTI-VIRAL THERAPY	CERNY, Erich, H.
WO/2021/254937	FECAL MATTER FOR TREATMENT OF CACHEXIA	ACADEMISCH MEDISCH CENTRUM
WO/2021/250275	ANTIBODY FORMULATION DILUENT	ICHNOS SCIENCES SA
WO/2021/254978	COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS	MERCK PATENT GMBH
WO/2021/254982	COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS	MERCK PATENT GMBH
WO/2021/254998	BIODEGRADABLE UV ABSORBERS	BASF SE
WO/2021/255003	IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS	GIVAUDAN SA
WO/2021/255025	IMPROVEMENTS IN ULTRASOUND-MEDIATED THERAPY	BRACCO SUISSE SA
WO/2021/255046	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255047	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255048	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255049	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255050	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255051	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255129	NOVEL USE OF A MODULATOR OF GLUCOSYLCERAMIDE DEGRADATION FOR  VIRAL INFECTIONS	SPEDDING RESEARCH SOLUTIONS, SAS
WO/2021/259742	MODIFIED EXOTOXIN A PROTEINS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/259743	KLEBSIELLA PNEUMONIAE O-ANTIGEN VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/255156	NOVEL DIPEPTIDE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF  AND A NOVEL THERAPEUTIC USE OF DIPEPTIDE COMPOUNDS	UNIVERSITE PARIS-SACLAY
WO/2021/259748	COMPOSITIONS COMPRISING ZINC AND ANTIMICROBIAL AGENT	UNILEVER IP HOLDINGS B.V.
WO/2021/255159	FORMULATION COMPRISING DAPRODUSTAT	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/255160	METHOD FOR PRODUCING PERSONALIZED COSMETICS	BASF SE
WO/2021/255172	MARC1 INHIBITORS FOR TREATMENT OF LIPID METABOLISM DISORDERS	CLEMENT, Bernd
WO/2021/255177	METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION	BASF SE
WO/2021/255179	PLASMA-TREATED HYDROGEL COMPOSITIONS AND USES THEREOF	UNIVERSITAT POLITèCNICA DE CATALUNYA
WO/2021/255182	TREATMENT AND PREVENTION OF DISEASE CAUSED BY TYPE IV COLLAGEN  DYSFUNCTION	SINGAPORE HEALTH SERVICES PTE. LTD.
WO/2021/255194	COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALT AND AT  LEAST ONE LONG-CHAIN FATTY ACID	L'OREAL
WO/2021/255200	GELLED COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALT	L'OREAL
WO/2021/255204	NEW STRATEGY FOR TREATING PANCREATIC CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/255217	AMATOXIN AND AMATOXIN CONJUGATES FOR USE IN INHIBITION OF RNA  VIRUS REPLICATION	HEIDELBERG PHARMA RESEARCH GMBH
WO/2021/255218	A PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-VIRAL  PROTONOPHORE AND A SERINE PROTEASE INHIBITOR	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/255219	SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID  CONSTRUCT HAVING A SPECIFIC ORDER OF GENES	INTERVET INTERNATIONAL B.V.
WO/2021/255222	SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA  REPLICON PARTICLES	INTERVET INTERNATIONAL B.V.
WO/2021/259772	PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE  PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAE	EVONIK OPERATIONS GMBH
WO/2021/255226	ANTIVIRAL USE OF CALIXARENES	CEBINA GMBH
WO/2021/259783	POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND  CARGO MOLECULES	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/255239	OXOPIPERAZINE DERIVATIVES FOR THE TREATMENT OF CANCER	INTHERA BIOSCIENCE AG
WO/2021/255245	GENE THERAPY EXPRESSION SYSTEM ALLOWING AN ADEQUATE EXPRESSION  IN THE MUSCLES AND IN THE HEART OF SGCG	GENETHON
WO/2021/255246	ACALABRUTINIB MALEATE DOSAGE FORMS	ACERTA PHARMA B.V.
WO/2021/255251	PULMONARY FORMULATION COMPRISING CANNABINOIDS	CANNOVEX BV
WO/2021/255252	FORMULATION COMPRISING CANNABINOIDS	CANNOVEX BV
WO/2021/255255	COMPOSITION COMPRISING A POLYOL, A POLYGLYCEROL ESTER, A  HYALURONIC ACID SALT AND A SPECIFIC HYDROPHILIC POLYMER	L'OREAL
WO/2021/255260	COMPOSITION COMPRISING A POLYOL AND AT LEAST ONE POLYGLYCERYL  ESTER	L'OREAL
WO/2021/255264	BIODEGRADABLE COMPOSITIONS AND IMPLANTS	RE-VANA THERAPEUTICS LTD
WO/2021/255270	SELF-AMPLIFYING SARS-COV-2 RNA VACCINE	ZIPHIUS VACCINES
WO/2021/259809	PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A  SACCHARINATE SALT AND COMPOSITION COMPRISING THEM	L'OREAL
WO/2021/259810	COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN  FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS  COMPOSITION	L'OREAL
WO/2021/255282	CONJUGATED AND LABELLED APELIN, PREPARATION AND USES THEREOF	UNIVERSITE D'AIX MARSEILLE
WO/2021/255295	SWELLABLE GELATIN COMPOSITIONS	UNIVERSITEIT GENT
WO/2021/259866	DIMETHYL SULFONE FOR TREATMENT OF CHRONICALLY HEAT STRESSED  POULTRY	EVONIK OPERATIONS GMBH
WO/2021/259869	OXINE-CONTAINING CELL RADIOLABELLING AGENTS	KING'S COLLEGE LONDON
WO/2021/259925	CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY,  PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF	SAPREME TECHNOLOGIES B.V.
WO/2021/259927	ANTI-CD2 ANTIBODIES	ZELARION MALTA LIMITED
WO/2021/259928	COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND  A SAPONIN OR A LIGAND-SAPONIN CONJUGATE	SAPREME TECHNOLOGIES B.V.
WO/2021/259943	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/259944	CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN  EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME,  THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION	SAPREME TECHNOLOGIES B.V.
WO/2021/259962	COMPOSITIONS AND KITS OF PARTS COMPRISING  N,N-DIMETHYLTRYPTAMINE AND HARMINE AND THEIR USE IN THERAPY	UNIVERSITY OF ZüRICH
WO/2021/259963	IMMUNIZATION AGAINST WNT4 FOR TREATMENT AND PROPHYLAXIS OF  BREAST CANCER	PANDORA ENDOCRINE INNOVATION B.V.
WO/2021/259972	ANTICANCER COMBINATION THERAPY COMPRISING A SOS1 INHIBITOR AND  A KRAS G12C INHIBITOR	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/259973	COMPOSITION COMPRISING A PARTICULAR SILICONE EMULSION, A  PARTICULAR (METH)ACRYLAMIDE POLYMER, SURFACTANTS AND A CATIONIC  POLYSACCHARIDE	L'OREAL
WO/2021/259974	COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE  CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND A CHEMICAL  OXIDIZING AGENT AND/OR AN OXIDATION DYE	L'OREAL
WO/2021/260048	COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE  COPOLYMER COMPRISING AT LEAST TWO DIFFERENT POLYMER UNITS BEARING A(N)  (UN)SATURATED HYDROCARBON-BASED CHAIN IN A FATTY MEDIUM	L'OREAL
WO/2021/260054	SAPONIN DERIVATIVES FOR USE IN MEDICINE	SAPREME TECHNOLOGIES B.V.
WO/2021/260061	SAPONIN DERIVATIVES FOR USE IN MEDICINE	SAPREME TECHNOLOGIES B.V.
WO/2021/260062	PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE  APPLICATION OF A MAKEUP-REMOVING COMPOSITION, THE KERATIN FIBRES HAVING BEEN  DYED BEFOREHAND	L'OREAL
WO/2021/260065	MVA-BASED VACCINE AGAINST COVID-19 EXPRESSING SARS-COV-2  ANTIGENS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/260068	VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOF	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/260078	COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE  COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A SURFACTANT	L'OREAL
WO/2021/260079	COSMETIC COMPOSITION COMPRISING A GRAFTED POLYHYDROXYALKANOATE  COPOLYMER IN A FATTY MEDIUM	L'OREAL
WO/2021/260093	SOFT GELATIN CAPSULES	ITF RESEARCH PHARMA, S.L.U
WO/2021/260109	A COMBINATION OF A CBP/p300 BROMODOMAIN INHIBITOR AND AN EGFR  INHIBITOR FOR USE IN TREATING EGFR-MUTANT NSCLC	TOLREMO THERAPEUTICS AG
WO/2021/260110	HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND  THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF FIBROTIC DISEASE	TOLREMO THERAPEUTICS AG
WO/2021/260111	COMBINATION OF A CBP/P300 BROMODOMAIN INHIBITOR AND A KRAS  INHIBITOR FOR THE TREATMENT OF CANCER	TOLREMO THERAPEUTICS AG
WO/2021/260120	ARIMOCLOMOL FOR TREATING GAUCHER DISEASE	ORPHAZYME A/S
WO/2021/260129	HUMANIZED ANTIGEN BINDING UNITS FOR TARGETING OSTEOSARCOMA  CELLS	OSLO UNIVERSITETSSYKEHUS HF
WO/2021/260131	VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSION	SAIBA AG
WO/2021/260139	METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS  ASSOCIATED WITH INTENSE STRESS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE  MéDICALE)
WO/2021/260141	COMPOSITION	INEOS SERVICES BELGIUM SA
WO/2021/260145	METHOD FOR INCORPORATING ORGANIC COMPOUNDS IN SOLUTION WITHIN  A HYDROGEL	LABORATOIRES VIVACY
WO/2021/260152	INHIBITORS OF ACID SPHINGOMYELINASE FOR PREVENTING AND  TREATING THE COVID-19 DISEASE	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/260164	THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONS	IN2CURE AB
WO/2021/260168	USE OF COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING  COMPOSITIONS THEREOF	CHEMCOM S.A.
WO/2021/260176	SYNTHETIC EPITOPES OF BETACORONAVIRUSES	VIROMETIX AG
WO/2021/260186	ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT  RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS	JUNO THERAPEUTICS GMBH
WO/2021/260193	PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID  BETA 1-42	MEDIMMUNE LIMITED
WO/2021/260197	ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION	F. HOFFMANN-LA ROCHE AG
WO/2021/260198	AGARICUS BLAZEI FERMENTED GRAINS AGAINST LAWSONIA  INTRACELLULARIS INFECTION	NUTRECO IP ASSETS B.V.
WO/2021/260202	METHODS AND PREBIOTIC COMPOUNDS FOR IMPROVING ORAL HYGIENE AND  RELATED ORAL CARE COMPOSITIONS	S&C CONSULTANCY
WO/2021/260208	SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION	BAYER AKTIENGESELLSCHAFT
WO/2021/260209	CCR8 ANTIBODIES AND USES THEREOF	BAYER AKTIENGESELLSCHAFT
WO/2021/260210	ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS & COMBINATION  THERAPIES	BAYER AKTIENGESELLSCHAFT
WO/2021/260211	TARGETED RELEASE RIFAXIMIN COMPOSITIONS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/105524	PHARMACEUTICAL COMPOSITION OF IBUPROFEN SALT WITH LYSINE IN  THE FORM OF AN ORAL SOLUTION	MMC INTERNATIONAL HEALTH HOLDING, S.L.
WO/2021/219903	CANNABINOIDS FOR USE IN SUPRESSING CANCER STEM CELLS	EMERALD HEALTH BIOTECHNOLOGY ESPAÑA S.L.
WO/2021/250289	PROBIOTIC FOR THE TREATMENT OF INFERTILITY AND RECURRENT  PREGNANCY LOSS	BIOSEARCH, S.A.
WO/2021/019116	PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR  THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIA	UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
WO/2021/023903	HYPOLEPTINEMIC COMPOSITION AND USE THEREOF	UNIVERSITAT ROVIRA I VIRGILI
WO/2021/023908	FOOD PRODUCT DERIVED FROM THE OLIVE PLANT, PRODUCTION METHOD  AND ASSOCIATED USES	ROQUE INICIATIVAS SL
WO/2021/044073	RECOMBINANT NANNOCHLOROPSIS GADITANA PROTEIN	UNIVERSIDAD DE CáDIZ
WO/2021/058847	COMBINED USE OF BIOTIN AND THIAMINE IN THE TREATMENT OF  HUNTINGTON'S DISEASE	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/099662	THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND  IMAGING AGENTS TO CANCER CELLS	UNIVERSITAT POLITèCNICA DE VALèNCIA
WO/2021/099665	PLACENTAL DECIDUA PARIETALIS STEM CELLS FOR USE IN CHRONIC  STRESS URINARY INCONTINENCE	FUNDACIóN PARA LA INVESTIGACIóN BIOMéDICA DEL HOSPITAL 12 DE  OCTUBRE
WO/2021/136862	LIQUID GALENIC COMPOSITION FOR ORAL USE COMPRISING MELATONIN  AND A ZINC SALT AND CORRESPONDING METHOD AND USE	LABORATORIOS VIÑAS S.A.
WO/2021/152192	LOW AND VERY LOW MOLECULAR WEIGHT HEPARINS FOR THE TREATMENT  OF DEEP VEIN THROMBOSIS	LABORATORIOS FARMACéUTICOS ROVI, S.A.
WO/2021/165558	BREAKABLE GALENIC CAPSULE	FINGERCLIK, S.L.
WO/2021/198545	USE OF BREASTMILK EXOSOMES AS RADIOISOTOPE VEHICLE FOR THE  DIAGNOSIS AND TREATMENT OF NEOPLASMS	INSTITUTO DE SALUD CARLOS III (ISCIII)
WO/2021/205049	COMPOUNDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROME	SERVICIO ANDALUZ DE SALUD
WO/2021/205053	INJECTABLE MELATONIN COMPOSITION FOR THE TREATMENT OF VIRAL  DISEASES	UNIVERSIDAD DE GRANADA
WO/2021/209667	METHOD FOR OBTAINING A BOTANICAL EXTRACT	EUROMED, S.A.
WO/2021/209670	THERAPEUTIC TREATMENT FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS  USING A MONOCLONAL ANTIBODY AGAINST THE PRE-T CELL RECEPTOR	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS
WO/2021/214361	LONG LASTING ANTISEPTIC FOR HYGIENIC FRICTION WASHING AND  PRE-SURGICAL WASHING OF HANDS	UNIVERSIDAD COMPLUTENSE DE MADRID
WO/2021/214364	THERAPEUTIC USE OF A MAQUI EXTRACT IN CROHN'S DISEASE	UNIVERSIDAD DE SEVILLA
WO/2021/214370	SELF-ADHERENT PATCHES OF POLYMER FIBRES FOR THE CONTROLLED  RELEASE OF PERFUME	BIOINICIA, S.L.
WO/2021/229119	SELF-ADHESIVE PATCHES MADE OF FIBRES FOR THE CONTROLLED  RELEASE OF BIOACTIVES	BIOINICIA, S.L.
WO/2021/229131	IN VITRO METHOD FOR RECOVERING THE EXPRESSION OF THE F5 GENE  ENCODING COAGULATION FACTOR V	UNIVERSIDAD COMPLUTENSE DE MADRID
WO/2021/245315	PREVENTION AND/OR TREATMENT OF COGNITIVE IMPAIRMENT ASSOCIATED  WITH DEMENTIA SYNDROMES	UNIVERSIDAD DE MáLAGA
WO/2021/255310	STRAIN OF THE BACTEROIDES GENUS FOR USE IN THE TREATMENT  AND/OR PREVENTION OF EATING DISORDERS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/001601	METHODS FOR ADMINISTERING  (R)-N-[4-(1,4,5,6-TETRAHYDRO-6-OXO-3-PYRIDAZINYL)PHENYL]ACETAMIDE	ORION CORPORATION
WO/2021/001603	PHARMACEUTICAL COMPOSITION OF DAROLUTAMIDE	ORION CORPORATION
WO/2021/005268	PIEZO AGONISTS FOR PREVENTING OR REVERTING ABNORMAL AMYLOID  DEPOSITION	ITÄ-SUOMEN YLIOPISTO
WO/2021/019128	A DENTAL MATERIAL	STICK TECH OY
WO/2021/023914	A METHOD AND A COMPOUND FOR PREVENTING MAMMALIAN CANCER CELL  PROLIFERATION AND FOR TREATING CANCER	OY GRANULA AB LTD
WO/2021/023915	METHOD OF ENHANCING THE ANTIMICROBIAL ACTION OF SYSTEMICALLY  ADMINISTERED ANTIBIOTICS	KOITE HEALTH OY
WO/2021/038125	CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF  BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES	MEDICORTEX FINLAND OY
WO/2021/123506	STABILE CONJUGATE	GLYKOS BIOMEDICAL OY
WO/2021/152214	COMPOSITION COMPRISING RASPBERRY KETONE	KOIVUBIOTECH OY
WO/2021/156540	STABLE PHARMACEUTICAL COMPOSITIONS OF ROPINIROLE	ORION CORPORATION
WO/2021/160937	THERAPY OF RAS-DEPENDENT CANCERS	TURUN YLIOPISTO
WO/2021/160938	SYSTEMIC ADMINISTRATION OF A PHARMACEUTICAL COMPOSITION  COMPRISING CDNF OR MANF POLYPEPTIDE FOR USE IN THE TREATMENT OF REPERFUSION  INJURY	HERANTIS PHARMA OYJ
WO/2021/170915	METHOD AND KIT FOR TREATING SKIN INFECTIONS	KOITE HEALTH OY
WO/2021/176146	PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR	ORION CORPORATION
WO/2021/191496	MEDICINE FOR COVID-19 AND TREATMENT	THERAPEUTICA BOREALIS OY
WO/2021/205074	INHALABLE FORMULATION	AALTO UNIVERSITY FOUNDATION SR
WO/2021/205075	COMBINATORY TREATMENT	AALTO UNIVERSITY FOUNDATION SR
WO/2021/205077	MIMETIC NANOPARTICLES FOR PREVENTING THE SPREADING AND  LOWERING THE INFECTION RATE OF NOVEL CORONAVIRUSES	FINNCURE OY
WO/2021/205079	NOVEL VACCINE COMPOSITIONS	FINNCURE OY
WO/2021/219939	SALVE COMPOSITION, METHOD OF MANUFACTURE AND USE OF THE  COMPOSITION	NORDIC BIOTECH GROUP OY
WO/2021/219940	HOMING PEPTIDE-GUIDED DECORIN CONJUGATES FOR USE IN TREATING  EPIDERMOLYSIS BULLOSA	TAMPERE UNIVERSITY FOUNDATION SR
WO/2021/255336	STABLE ANTI-CLEVER-1 ANTIBODY FORMULATION	FARON PHARMACEUTICALS OY
WO/2021/069807	COSMETIC COMPOSITION, METHOD FOR PREPARATION AND USE OF SAME  AS A MASK FOR THE COSMETIC TREATMENT OF SKIN, PARTICULARLY THE FACE	S.A. THALGO TCH
WO/2021/181010	COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY  SYSTEM	ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
WO/2021/084166	GOLD NANOSTRUCTURE COMPRISING ENZYMES AND ANTIOXIDANTS	BIO EVEN SAS
WO/2021/014057	COSMETIC SKIN WHITENING COMPOSITION COMPRISING  HEXYLRESORCINOL, UNDECYLENOYL PHENYLALANINE AND TRIMETHOXYBENZYLIDENE  PENTANEDIONE	LABORATOIRE GARANCIA
WO/2021/064299	ANTI-UV COSMETIC COMPOSITION	COATEX
WO/2021/014063	USE IN AN ELECTRIC PERFUME DIFFUSER OF AN AQUEOUS PERFUME  COMPOSITION CONTAINING A SURFACTANT AND A PRESERVATIVE	PRODUITS BERGER
WO/2021/001637	SOLID COSMETIC COMPOSITION	CHANEL PARFUMS BEAUTE
WO/2021/001638	SOLID HYDRATING COSMETIC COMPOSITION	CHANEL PARFUMS BEAUTE
WO/2021/009443	GOLD NANOPARTICLES COMPRISING A PLANT EXTRACT AND THEIR  COSMETIC USE	TORSKAL
WO/2021/005310	COMPOSITION FOR THE TREATMENT OF EMOTIONAL DISORDERS	MOUSSET, Pierre-Yves
WO/2021/009445	SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING  COMPOSITION AND USES THEREOF	LABORATOIRES DE BIOLOGIE VéGéTALE YVES ROCHER
WO/2021/019151	COSMETIC COMPOSITION IN THE FORM OF A COMPACT,  IMPACT-RESISTANT POWDER	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES SEPPIC
WO/2021/014103	PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS  FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURS	UNIVERSITE DE FRANCHE COMTE
WO/2021/014108	NASAL OR ORAL SPRAY COMPOSITION CONTAINING SULFUR	LABORATOIRES GRIMBERG
WO/2021/014109	CONTINUOUS METHOD FOR NANO-EMULSIFICATION BY CONCENTRATION  PHASE INVERSION	UNIVERSITé D'ANGERS
WO/2021/019185	COMPOSITIONS COMPRISING A MIXTURE OF VITAMINS AND MINERALS IN  THE FORM OF A COMBINATION OF A GASTRO-SOLUBLE ORAL FORM AND A  GASTRO-RESISTANT ORAL FORM, AND USE THEREOF	LABORATOIRES GRIMBERG
WO/2021/023938	STICK OF COSMETIC PRODUCT COMPRISING TWO COMPOSITIONS, METHOD  AND DEVICE FOR MANUFACTURING SUCH A STICK OF COSMETIC PRODUCT	PARFUMS CHRISTIAN DIOR
WO/2021/028632	PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM  OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY  PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES SEPPIC
WO/2021/028633	ANHYDROUS COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A  DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASE	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES  CHIMIQUES SEPPIC
WO/2021/023952	NOVEL COSMETIC USE OF AN EPILOBIUM ANGUSTIFOLIUM EXTRACT	BASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/028640	LOW-DOSAGE ORODISPERSIBLE OPIOID TABLET AND METHOD FOR  PREPARING SAME	ETHYPHARM
WO/2021/028642	NANOPARTICLES FOR THE TREATMENT OF CANCER BY RADIOFREQUENCY  RADIATION	NH THERAGUIX
WO/2021/064316	COMBINATION OF CICLOPIROXOLAMINE AND PIROCTONE OLAMINE FOR  COMBATING DANDRUFF	PIERRE FABRE DERMO-COSMETIQUE
WO/2021/064332	ANTI-CD30-DRUG CONJUGATES AND THEIR USE IN THERAPY	MC SAF
WO/2021/064334	COSMETIC OR NUTRACEUTICAL USE OF A <i>TERMINALIA  CATAPPA</i> EXTRACT	BASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/069828	COMPOSITION CONTAINING CAROTENOIDS AND USE THEREOF FOR  PROTECTING NEURONS AGAINST NEURODEGENERATION	SERIVE, Benoît
WO/2021/069836	MASKING THE TASTE OF ISOSORBIDE	ROQUETTE FRERES
WO/2021/074532	NOVEL COSMETIC USE OF N-METHYLGLYCINE FOR INCREASING THE  DIVERSITY OF SKIN MICROBIAL FLORA	BASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/074542	NOVEL HYDROCORTISONE HEMISUCCINATE LYOPHILISATE	LABORATOIRE AGUETTANT
WO/2021/084200	POLYSACCHARIDE-BASED GELLED FOAM	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/084211	EMULSION USABLE IN PARTICULAR AS A TECHNOLOGICAL AUXILIARY IN  THE FIELD OF PLASTICS, OR AS AN ENCAPSULATION SYSTEM FOR ACTIVE AGENTS,  PREPARATION METHOD AND APPLICATIONS THEREOF	LACTIPS
WO/2021/084213	USE OF NEUROSPORENE TO PROTECT THE SKIN FROM THE HARMFUL  EFFECTS OF BLUE LIGHT	DEINOVE
WO/2021/099715	USE OF A GLYCINE BETAINE DERIVATIVE AS AN AGENT FOR  CONDITIONING KERATIN FIBRES	SURFACTGREEN
WO/2021/094687	COSMETIC USE OF AN AROMATIC RAW MATERIAL EXTRACT FOR  PROTECTING SKIN FROM BLUE LIGHT	ROBERTET S.A.
WO/2021/094697	PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL  COMPOSITION WITH COLONIC DELIVERY	ETHYPHARM
WO/2021/099742	SYNTHESIS OF MELDRUM'S ACID DERIVATIVES HAVING ANTI-UVA AND  ANTI-BLUE LIGHT, ANTI-PIGMENTATION AND/OR ANTIOXIDANT ACTIVITIES	INSTITUT DES SCIENCES ET INDUSTRIES DU VIVANT ET DE  L'ENVIRONNEMENT - AGROPARISTECH
WO/2021/105620	BIOCOMPATIBLE OILY FERROFLUID AND PREPARATION PROCESS	UNIVERSITE DE BORDEAUX
WO/2021/111065	THREE-PHASE COSMETIC COMPOSITION	LABORATOIRES M&L
WO/2021/105634	COMPOSITION COMPRISING ACTIVATED CARBON AND FRUCTANS FOR  PREVENTING, REGULATING AND/OR TREATING INTESTINAL FUNCTIONAL DISORDERS	POUGNAS, Jean-Luc
WO/2021/105637	MICROGELS AND THE STIMULABLE PHOTONIC AND INTERFERENCE  APPLICATIONS THEREOF	LVMH RECHERCHE
WO/2021/123531	MEDICAL COMPOSITION OR DEVICE COMPRISING OLIGO(ETHYLENE  GLYCOL) POLYMERS	LVMH RECHERCHE
WO/2021/105638	USE OF HYDROPEROXY ALCOHOLS AND THE DERIVATIVES THEREOF AS  ANTIMICROBIAL AGENTS	DEMETA
WO/2021/123532	MEDICAL COMPOSITION OR DEVICE COMPRISING OLIGO(ETHYLENE  GLYCOL) POLYMERS	LVMH RECHERCHE
WO/2021/105641	N2-ARYLMETHYL-4-HALOALKYL-PYRIDAZIN-3-ONE CFTR MODULATORS FOR  THE TREATMENT OF CYSTIC FIBROSIS	UNIVERSITE DE REIMS CHAMPAGNE-ARDENNE
WO/2021/111096	COSMETIC COMPOSITION COMPRISING EXTRACTS OF KIGELIA AND  NASTURTIUM	L V M H RECHERCHE
WO/2021/116573	COSMETIC COMPOSITION COMPRISING EXTRACTS OF KIGELIA AND ORCHID	L V M H RECHERCHE
WO/2021/116611	FORMULATION FOR METHYLENE BLUE AND METHOD	UNIVERSITE DE BORDEAUX
WO/2021/116616	COSMETIC COMPOSITION COMPRISING EXTRACTS OF POMEGRANATE AND  PEONY	L V M H RECHERCHE
WO/2021/116623	COSMETIC CARE COMPOSITIONS, REINFORCEMENT AND/OR REPAIR OF  KERATIN FIBERS COMPRISING THE COMBINATION OF BABASSU OIL AND SODIUM  DILAURAMIDOGLUTAMIDE LYSINE	PIERRE FABRE DERMO-COSMETIQUE
WO/2021/123600	PERFUME REMOVER COMPOSITION	L V M H RECHERCHE
WO/2021/123624	COSMETIC COMPOSITION COMPRISING D-CHIRO-INOSITOL	L V M H RECHERCHE
WO/2021/123631	COSMETIC COMPOSITION COMPRISING ASCORBIC ACID 2-GLUCOSIDE AND  ACETYLATED HYALURONIC ACID OR A SALT THEREOF	L V M H RECHERCHE
WO/2021/123660	CURCUMINOID-FREE EXTRACT OF CURCUMA LONGA IN INFLAMMATORY  DERMATOSES	PIERRE FABRE DERMO-COSMETIQUE
WO/2021/123667	COSMETIC COMPOSITION HAVING GLOSS AND LASTING PROPERTIES	L V M H RECHERCHE
WO/2021/123669	LIQUID COSMETIC COMPOSITION WITH GLOSS AND LASTING PROPERTIES	L V M H RECHERCHE
WO/2021/123670	ULTRA LONG-LASTING MAKE-UP FOUNDATION	L V M H RECHERCHE
WO/2021/123699	COSMETIC COMPOSITION COMPRISING A YEAST EXTRACT DEBARYOMYCES  NEPALENSIS	L V M H RECHERCHE
WO/2021/130453	ANTI-INFLAMMATORY DENDRIMER FORMULATION FOR THE TREATMENT OF  PSORIASIS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -
WO/2021/136913	NON-WOVEN AND DRY TEXTILE MATERIAL IMPREGNATED WITH A COSMETIC  OR DERMOCOSMETIC COMPOSITION AND THE COSMETIC OR DERMOCOSMETIC USE THEREOF	PRONEEM
WO/2021/144528	COMBINATION OF DILTIAZEM AND VIRAL POLYMERASE INHIBITORS	UNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/152250	COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A TAMARINDUS  INDICA L. EXTRACT AND/OR A COMPOSITION COMPRISING IT	BASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/156556	MURRAYA KOENIGII EXTRACT AND USE THEREOF IN COSMETICS	GATTEFOSSé SAS
WO/2021/152265	TWO-PHASE COMPOSITION FOR MAKEUP REMOVAL AND/OR CLEANSING	LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER
WO/2021/160968	COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE,  4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF  IN THE TREATMENT OF PARKINSON'S DISEASE	PETITJEAN, Olivier
WO/2021/165623	NOVEL COSMETIC AND/OR DERMATOLOGIC COMPOSITION WITH OSMOTIC  SYNERGY AND RELATED PRODUCTION METHOD	BIANCHIN, Claire
WO/2021/170961	ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY	MC SAF
WO/2021/181037	COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY  SYSTEM	ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
WO/2021/181044	COMPOSITION COMPRISING DILTIAZEM FOR TREATING A VIRAL  INFECTION CAUSED BY SARS-COV-2 VIRUSES	UNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/181052	COSMETIC USE OF REOTIER WATER FOR MAINTAINING THE BALANCE OF  SKIN MICROBIOTA	LABORATOIRES M&L
WO/2021/191525	PLATELET LYSATE FOAM FOR CELL CULTURE, CELL THERAPY AND  TISSULAR REGENERATION AND METHOD FOR OBTAINING SAME	UNIVERSITE PAUL SABATIER TOULOUSE III
WO/2021/186131	ESTOLIDE COMPOSITION FOR TOPICAL APPLICATIONS	TOTAL MARKETING SERVICES
WO/2021/198588	PHYTOECDYSONES AND DERIVATIVES THEREOF FOR USE IN TREATING  DISORDERED RESPIRATORY FUNCTION ON VIRAL INFECTION	BIOPHYTIS
WO/2021/209722	TOOTHPASTE-TYPE ORODENTAL COMPOSITION	PIERRE FABRE DERMO-COSMETIQUE
WO/2021/219963	METHOD FOR EXTRACTING ODOUR FROM A PLANT MATERIAL, IN  PARTICULAR FROM MUTE FLOWERS, IN SOLID FORM	GENIALIS
WO/2021/219968	FRAGRANT COMPOSITION	LVMH RECHERCHE
WO/2021/224575	COSMETIC COMPOSITION COMPRISING AT LEAST ONE CALCAREOUS RED  ALGAE	SETALG
WO/2021/229170	MUCOADHESIVE TABLET FOR TREATING OROPHARYNGEAL FUNGAL  INFECTIONS	VECTANS PHARMA
WO/2021/234262	USE OF POLYAMINES, TYRAMINE AND/OR A PLANT EXTRACT CONTAINING  SAME TO STABILISE MICROORGANISMS	AGRO INNOVATION INTERNATIONAL
WO/2021/234270	COSMETIC NAIL CARE COMPOSITION IN THE FORM OF A VARNISH	FIABILA
WO/2021/234271	COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM  ENDOMETRIOSIS	GYNOV
WO/2021/234295	COMPOSITION COMPRISING A METAL ASCORBOCAMPHORATE COMPOUND FOR  USE IN THE TREATMENT OF INFECTIONS CAUSED BY HERPES VIRUSES	M.G.B. PHARMA
WO/2021/234299	COMPOSITION COMPRISING A METAL ASCORBOCAMPHORATE COMPOUND FOR  USE IN THE TREATMENT OF PAPILLOMAVIRUS INFECTIONS	M.G.B. PHARMA
WO/2021/234301	USE OF A PROTEIN EXTRACT OF MORINGA OLEIFERA SEEDS AS AN  ANTI-POLLEN AGENT	BASF BEAUTY CARE SOLUTIONS FRANCE SAS
WO/2021/240099	COUPLED TERPENE CONJUGATE	LABORATOIRES ERIGER
WO/2021/234324	COMPOUND AND COMPOSITION FOR INDUCING NEUROPROTECTION	REST THERAPEUTICS
WO/2021/019194	BIOACTIVE PHYTOCHEMICALS	PHYTOQUEST LIMITED
WO/2021/028643	HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER	ARTIOS PHARMA LIMITED
WO/2021/028644	NOVEL THERAPEUTIC USE	ARTIOS PHARMA LIMITED
WO/2021/028646	ADMINISTRATION REGIMES OF CANNABINOIDS IN COMBINATION WITH  CHEMOTHERAPEUTICS AGAINST CANCER	JAY PHARMA INC.
WO/2021/032933	ENZYME INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/032936	ENZYME INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/111098	NEW COMPOSITION	NANEXA AB
WO/2021/245365	<i>IMPROVED IMMUNOMODULATOR COMPOSITIONS AND VIRAL  PATHOGEN TREATMENTS</i>	REMEDY RESEARCH LIMITED
WO/2021/148763	PEPTIDE INHIBITORS OF GUANINE NUCLEOTIDE EXCHANGE FACTOR-H1	UCL BUSINESS LTD
WO/2021/032937	ENZYME INHIBITORS	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/186137	V DELTA1+ T CELLS FOR THE TREATMENT OF MYELOID MALIGNANCIES	GAMMADELTA THERAPEUTICS LIMITED
WO/2021/005325	PHARMACEUTICAL COMPOSITION FOR NASAL DELIVERY	OREXO AB
WO/2021/001646	APOLIPOPROTEIN B ANTAGONIST	ARGONAUTE RNA LIMITED
WO/2021/001650	PI3K INHIBITOR FOR USE IN THE THERAPY OF B CELL LYMPHOMA	KARUS THERAPEUTICS LTD.
WO/2021/001651	HDAC INHIBITORS FOR USE IN THE THERAPY OF BILIARY TRACT  CANCERS	KARUS THERAPEUTICS LTD.
WO/2021/005337	SONODYNAMIC THERAPY	INNOVATION ULSTER LIMITED
WO/2021/005338	NOVEL CANCER ANTIGENS AND METHODS	THE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/005340	HYDROPHOBICALLY ASSOCIATING POLYMER COUNTER ION PAIR COMPLEXES	MALVERN COSMECEUTICS LIMITED
WO/2021/001661	ANTIBACTERIAL AND ANTIPARASITIC QUINOXALINE-2,3-DIAMINE  DERIVATIVES	ABERYSTWYTH UNIVERSITY
WO/2021/005374	DIAGNOSTIC REAGENT	THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS
WO/2021/009487	SEXUAL PLEASURE ENHANCEMENT COMPOSITIONS	BEAUTY DNA LTD.
WO/2021/009504	NEW FORMULATIONS	BALTICGRUPPEN BIO AB
WO/2021/009505	NEW FORMULATIONS	BALTICGRUPPEN BIO AB
WO/2021/009510	METHOD FOR PRECONDITIONING A SUBJECT WHO IS ABOUT TO RECEIVE A  T-CELL THERAPY	AUTOLUS LIMITED
WO/2021/014132	CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS  AND METHODS OF PREPARATION THEREOF	GW RESEARCH LIMITED
WO/2021/014153	COSMETIC COMPOSITION COMPRISING AN ORAL CAPSULE CONTAINING  HYALURONIC ACID AND WHEAT GRAIN OIL WITH PHYTOCERAMIDES	IIAA LTD
WO/2021/019214	TREATMENT OF PITT-HOPKINS SYNDROME	HEALX LTD
WO/2021/014166	PYRIDINE DERIVATIVES AS TMEM16A MODULATORS FOR USE IN THE  TREATMENT OF RESPIRATORY CONDITIONS	ENTERPRISE THERAPEUTICS LIMITED
WO/2021/014168	SOLID FORMS OF  4-[[2-(5-CHLORO-2-HYDROXY-PHENYL)ACETYL]AMINO]-N-(1,1-DIMETHYLPROP-2-YNYL)PYRIDINE-2-CARBOXAMIDE	ENTERPRISE THERAPEUTICS LIMITED
WO/2021/014169	CRYSTALLINE FORM OF  4-[[2-(5-CHLORO-2-HYDROXY-PHENYL)ACETYL]AMINO]-N-CYCLOHEXYL-PYRIDINE-2-CARBOXAMIDE	ENTERPRISE THERAPEUTICS LIMITED
WO/2021/014174	TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF	INSTIL BIO (UK) LIMITED
WO/2021/019222	P2X7 RECEPTOR TARGETED THERAPY	BIOSCEPTRE (UK) LIMITED
WO/2021/019231	USE OF CANNABIDIOL IN THE TREATMENT OF DRAVET SYNDROME	GW RESEARCH LIMITED
WO/2021/019232	AFRICAN SWINE FEVER VACCINE	THE PIRBRIGHT INSTITUTE
WO/2021/019234	PHARMACEUTICAL DEVELOPMENT	HELPERBY THERAPEUTICS LIMITED
WO/2021/019235	HANTAVIRUS ANTIGENIC COMPOSITION	SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE
WO/2021/019243	HETEROTANDEM BICYCLIC PEPTIDE COMPLEX	BICYCLETX LIMITED
WO/2021/019244	HETEROTANDEM BICYCLIC PEPTIDE COMPLEX	BICYCLETX LIMITED
WO/2021/019245	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2	BICYCLETX LIMITED
WO/2021/019246	HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES	BICYCLETX LIMITED
WO/2021/019249	CLOZAPINE FOR USE IN TREATING PATHOGENIC IMMUNOGLOBULIN DRIVEN  B CELL DISEASE	ZARODEX THERAPEUTICS LIMITED
WO/2021/023977	FORMULATIONS COMPRISING CORTICOTROPIN RELEASING HORMONE (CRH)  AND ALPHA-2 MACROGLOBULIN	TARIAN BIOLOGICS LIMITED
WO/2021/019253	ULTRASOUND-TRIGGERED LIPOSOME PAYLOAD RELEASE	IMPERIAL COLLEGE INNOVATIONS LTD
WO/2021/028655	SOLID COSMETIC COMPOSITION COMPRISING VEGETABLE BUTTER AND  VEGETABLE OIL	COSMETIC WARRIORS LIMITED
WO/2021/028666	CONJUGATE AND USES THEREOF	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/028679	PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE	VERONA PHARMA PLC
WO/2021/028686	MODIFIED MULTIMERIC BICYCLIC PEPTIDE LIGANDS	BICYCLETX LIMITED
WO/2021/032955	TREATMENT	QUEEN MARY UNIVERSITY OF LONDON
WO/2021/028696	AMOEBICIDAL COMPOSITIONS FOR CONTACT LENS SOLUTIONS	UNIVERSITY OF THE WEST OF SCOTLAND
WO/2021/028697	VACCINE	UNIVERSITY OF SURREY
WO/2021/028698	TREATMENT OF FRAGILE X SYNDROME	HEALX LTD
WO/2021/032958	PROCESS FOR THE PREPARATION OF A PYRIMIDINO-DIAZEPINE  DERIVATIVE	CYCLACEL LIMITED
WO/2021/032959	CRYSTALLINE FORMS OF PYRIMIDINO DIAZEPINE DERIVATIVE	CYCLACEL LIMITED
WO/2021/028700	BACTERIAL COMPOSITIONS FOR THE TREATMENT OF DISEASE	MICROBIOTICA LIMITED
WO/2021/032960	NOVEL ANTI-TCR DELTA VARIABLE 1 ANTIBODIES	GAMMADELTA THERAPEUTICS LIMITED
WO/2021/032963	THERAPEUTIC USES OF ANTI-TCR DELTA VARIABLE 1 ANTIBODIES	GAMMADELTA THERAPEUTICS LIMITED
WO/2021/032966	DETECTION OF A-BETA OLIGOMERS	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/032990	PHARMACEUTICAL COMPOSITIONS COMPRISING 1,1-DIFLUOROETHANE AND  A CANNABINOID	MEXICHEM FLUOR S.A. DE C.V.
WO/2021/032993	METHOD FOR MAKING MICRONEEDLES USING A HIGH VISCOSITY  COMPOSITION	INNOTURE IP LIMITED
WO/2021/032997	THERAPEUTIC CONJUGATE	PORTON BIOPHARMA LIMITED
WO/2021/038219	USE OF CANNABINOIDS IN THE TREATMENT OF DYSKINESIA ASSOCIATED  WITH PARKINSON'S DISEASE	GW RESEARCH LIMITED
WO/2021/038241	TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO  NEUROTROPHINS	ALZECURE PHARMA AB
WO/2021/038249	ENGINEERED REGULATORY T CELL	KING'S COLLEGE LONDON
WO/2021/038250	PARASITIC NEMATODE VACCINE	THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/038253	TREATMENT OF OBESITY AND RELATED CONDITIONS	UNIVERSITY OF GREENWICH
WO/2021/044158	TREATMENT OF FRAGILE X SYNDROME WITH IBUDILAST IN COMBINATION  WITH METFORMIN, CANNBIDIOL, SERTRALINE OR QUERCETIN	HEALX LTD
WO/2021/044175	NOVEL METHOD	BABRAHAM INSTITUTE
WO/2021/048554	COMBINATION OF ZIDOVUDINE AND FLUOROQUINOLONE ANTIBIOTIC	HELPERBY THERAPEUTICS LIMITED
WO/2021/053331	PROINSULIN PEPTIDES FOR TYPE 1 DIABETES	KING'S COLLEGE LONDON
WO/2021/053344	NEW COMPOUNDS	VICORE PHARMA AB
WO/2021/058967	COMBINATION OF GOLD COMPLEXES WITH OLAPARIB OR OTHER PARP1/2  INHIBITORS FOR USE IN THE TREATMENT OF CANCER RESISTANT TO SAID PARP1/2  INHIBITORS	VARSITY PHARMACEUTICALS LIMITED
WO/2021/058969	TRIPHENYLENE DERIVATIVES FOR USE IN IMAGING BIOLOGICAL TISSUE  OR FLUID	CHROMATWIST LIMITED
WO/2021/058974	NOVEL TREATMENT	CELLERON THERAPEUTICS LIMITED
WO/2021/074584	MICROSPHERE-DRUG COMBINATION	UCL BUSINESS LTD
WO/2021/058977	FORMULATION	HEWLETT HEALTHCARE LIMITED
WO/2021/058979	THERAPY	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/064357	ORAL FILMS AND A METHODS FOR THE MANUFACTURE AND DELIVERY  THEREOF	BIOFILM LIMITED
WO/2021/064369	NON-TOXIC CLOSTRIDIAL NEUROTOXIN POLYPEPTIDES FOR USE IN  TREATING NEUROLOGICAL DISORDERS	IPSEN BIOPHARM LIMITED
WO/2021/069875	COMPOSITION FOR DELIVERING NITRIC OXIDE TO SKIN	INSENSE LIMITED
WO/2021/069876	COMPOSITION FOR DELIVERING NITRIC OXIDE TO SKIN	INSENSE LIMITED
WO/2021/069890	TREATMENT OF OSTEOPENIA AND/OR OSTEOPOROSIS	THE UNIVERSITY OF BIRMINGHAM
WO/2021/069891	ANTIVIRAL COMPOUNDS AND METHODS	THE UNIVERSITY OF NOTTINGHAM
WO/2021/069901	LACTOSE PARTICLES AND METHOD OF PRODUCTION THEREOF	UNIVERSITY OF HUDDERSFIELD
WO/2021/074598	COMBINATION OF ZIDOVUDINE WITH A TETRACYCLINE ANTIBIOTIC	HELPERBY THERAPEUTICS LIMITED
WO/2021/069927	PROSTAGLANDIN EP<sb>4</sb> RECEPTOR ANTAGONIST  COMPOUNDS	HEPTARES THERAPEUTICS LIMITED
WO/2021/074614	TREATMENT OR PREVENTION OF LEUKAEMIA	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/074622	BICYCLIC PEPTIDE LIGAND DRUG CONJUGATES	BICYCLETX LIMITED
WO/2021/074646	NEW FORMULATIONS	BALTICGRUPPEN BIO AB
WO/2021/074647	METHODS FOR TREATING CANCER	BICYCLERD LIMITED
WO/2021/074648	VECTOR FOR CANCER TREATMENT	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/074654	HAIR CARE FORMULATION	KDC/ONE SWALLOWFIELD LIMITED
WO/2021/074655	CANCER VACCINE	UNIVERSITY OF SOUTHAMPTON
WO/2021/079122	ENGINEERED REGULATORY T CELL	UCL BUSINESS LTD
WO/2021/116651	TOPICAL COMPOSITION AND METHODS OF MEASURING THE COOLING  ABAILITY OF A TOPICAL COMPOSITION	FUTURA MEDICAL DEVELOPMENTS LIMITED
WO/2021/079129	DOSING REGIMEN	CYCLACEL LIMITED
WO/2021/084229	TRANSDERMAL PATCH	UNIVERSITY OF SUNDERLAND
WO/2021/079134	POLYMORPHS OF AVAPRITINIB AND METHODS FOR PREPARING THE  POLYMORPHS	JOHNSON MATTHEY PUBLIC LIMITED COMPANY
WO/2021/079135	(-)-CIS TETRAHYDROCANNABINOL ((-)-CIS-THC) FOR USE AS A  MEDICAMENT	GW RESEARCH LIMITED
WO/2021/079136	(+)-CIS TETRAHYDROCANNABINOL ((+)-CIS-THC) FOR USE AS A  MEDICAMENT	GW RESEARCH LIMITED
WO/2021/079137	(+)-TRANS TETRAHYDROCANNABINOL ((+)-TRANS-THC) FOR USE AS A  MEDICAMENT	GW RESEARCH LIMITED
WO/2021/079142	ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS	NUSEED PTY LTD.
WO/2021/079148	CANNABIDIVARIN PREPARATIONS FOR USE AS A MEDICAMENT	GW RESEARCH LIMITED
WO/2021/079150	USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF FRAGILE X  SYNDROME	GW RESEARCH LIMITED
WO/2021/079151	USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF TEMPORAL  LOBE EPILEPSY	GW RESEARCH LIMITED
WO/2021/079152	USE OF CANNABIDIOL PREPARATIONS IN THE TREATMENT OF ABSENCE  EPILEPSY	GW RESEARCH LIMITED
WO/2021/090003	METHOD FOR SELECTIVE RECOVERY OF HYDROPHOBIC COMPOUNDS	GROW BIOTECH PLC
WO/2021/090013	NEW COMPOSITION COMPRISING AMORPHOUS NANOPOROUS SILICA  PARTICLES	NANOLOGICA AB
WO/2021/090015	NEW COMPOSITIONS	VICORE PHARMA AB
WO/2021/090018	NEW COMPOSITIONS	VICORE PHARMA AB
WO/2021/090019	NEW COMPOSITIONS	VICORE PHARMA AB
WO/2021/094752	PRODUCTION SYSTEM	OXFORD BIOMEDICA (UK) LIMITED
WO/2021/099775	CANNABIDIOL-TYPE CANNABINOID COMPOUND	GW RESEARCH LIMITED
WO/2021/099777	CANNABIDIOL-TYPE CANNABINOID COMPOUND	GW RESEARCH LIMITED
WO/2021/099781	CANNABIDIOL-TYPE CANNABINOID COMPOUND	GW RESEARCH LIMITED
WO/2021/099783	CANNABIDIOL-TYPE CANNABINOID COMPOUND	GW RESEARCH LIMITED
WO/2021/099792	GELLED OIL-IN-WATER EMULSION COMPRISING AT LEAST ONE  CANNABINOID	VITUX GROUP AS
WO/2021/099803	COMPOUNDS FOR USE IN THE TREATMENT OF ACUTE INTERMITTENT  PORPHYRIA	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/105664	BONDED NEUROTOXINS	THE UNIVERSITY OF SHEFFIELD
WO/2021/105666	SOLID COSMETIC COMPOSITION COMPRISING LUMINESCENT ZINC  SULPHIDE	COSMETIC WARRIORS LIMITED
WO/2021/105688	PHAGOCYTOSED SELF-ASSEMBLING PROTEINS	CELL GUIDANCE SYSTEMS LIMITED
WO/2021/105694	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 AND USES THEREOF	BICYCLETX LIMITED
WO/2021/105695	NEW USE OF ANGIOTENSIN II RECEPTOR AGONIST	VICORE PHARMA AB
WO/2021/105697	TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION	UCL BUSINESS LTD
WO/2021/105720	PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS FOR THE TREATMENT  OF RETINOBLASTOMA	OXULAR LIMITED
WO/2021/111128	IMPROVEMENTS IN WEIGHT CONTROL	JUDD HEALTH LIMITED
WO/2021/111143	METHODS AND COMPOSITIONS PRODUCED THEREBY	ALBUMEDIX LIMITED
WO/2021/111149	NEW PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS	NANEXA AB
WO/2021/116670	TREATMENT OR PREVENTION OF ISCHAEMIC STROKE REPERFUSION INJURY	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/116679	TREATMENTS OF DIABETIC MACULAR EDEMA AND IMPAIRED VISUAL  ACUITY	KALVISTA PHARMACEUTICALS LIMITED
WO/2021/116701	CHEMOTHERAPEUTIC DRUG IMPLANT	EXTRUDED PHARMACEUTICALS LTD
WO/2021/116703	COMPOUNDS AND THEIR USE FOR THE TREATMENT OF  α<sb>1</sb>-ANTITRYPSIN DEFICIENCY	Z FACTOR LIMITED
WO/2021/116705	COLLAGEN PRODUCTION	3D BIO-TISSUES LIMITED
WO/2021/116709	COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN  DEFICIENCY	Z FACTOR LIMITED
WO/2021/123750	NEW THERAPY	UCL BUSINESS LTD
WO/2021/123773	ANTIMICROBIAL COMPOSITIONS	OXY SOLUTIONS AS
WO/2021/123779	(R)-3-HYDROXYBUTYRATE, ESTERS AND OLIGOMERS THEREOF FOR THE  TREATMENT OF MULTIPLE SCLEROSIS	TDELTAS LIMITED
WO/2021/123784	PERSONAL LUBRICANT COMPOSITION	RECKITT BENCKISER HEALTH LIMITED
WO/2021/123799	RED BLOOD CELL-DERIVED VESICLE	IMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/123800	CELL	AUTOLUS LIMITED
WO/2021/123804	ORAL CANNABINOID FORMULATIONS	GW RESEARCH LIMITED
WO/2021/123810	ANTIGEN-BINDING DOMAIN BINDING TO PSMA	AUTOLUS LIMITED
WO/2021/123813	TREATMENT AND PROGNOSIS OF PANCREATIC CANCER	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/130483	COMPOSITIONS	JVS PRODUCTS LTD
WO/2021/130498	COMBINATION THERAPY	TURBINE SIMULATED CELL TECHNOLOGIES LTD
WO/2021/136933	IMMUNOTHERAPEUTIC TREATMENT OF CANCER	IMMODULON THERAPEUTICS LIMITED
WO/2021/160982	COMPOSITIONS AND APPLICATIONS THEREOF	NASALEZE PATENTS LIMITED
WO/2021/229200	ANTI-VIRAL PREPARATION AND METHOD OF MANUFACTURING AN ANTI-  VIRAL PREPARATION	SKIN LOGISTICS LTD
WO/2021/140331	ANTIMICROBIAL FIBRES	ADVANCED MEDICAL SOLUTIONS LIMITED
WO/2021/140340	COMPOSITIONS AND METHODS COMPRISING SANSHOOL AS LIP  INTERACTING COMPONENTS	DIET SHIELD LTD
WO/2021/140343	LIGAND DRUG CONJUGATES AND MODIFIED BET INHIBITORS	HOVIONE SCIENTIA LIMITED
WO/2021/148779	POLYHEDRIN DELIVERY SYSTEM RELEASING GROWTH FACTORS	CELL GUIDANCE SYSTEMS LIMITED
WO/2021/148788	ENGINEERED IMMUNE CELLS	UCL BUSINESS LTD
WO/2021/148805	TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING  IMIDAZO[1,2-B]PYRIDAZINE COMPOUNDS	BENEVOLENTAI BIO LIMITED
WO/2021/148807	PHARMACEUTICAL COMPOSITIONS AND THEIR USES	BENEVOLENTAI BIO LIMITED
WO/2021/152314	IMPROVED ASSAY FOR DETERMINING NEUTRALISING ANTIBODY TITRE TO  A VIRAL VEKTOR	FREELINE THERAPEUTICS LIMITED
WO/2021/152328	TREATMENT OF SKIN CONDITIONS	IPSEN BIOPHARM LIMITED
WO/2021/156607	DRUG FORMULATIONS	THE UNIVERSITY OF NOTTINGHAM
WO/2021/161023	COMPOUNDS USEFUL IN INHIBITING KETOHEXOKINASE AND METHODS OF  MAKING AND USING THE SAME	INORBIT THERAPEUTICS AB
WO/2021/161032	METHOD OF TREATMENT OF CANCER OR TUMOUR	ADAPTIMMUNE LIMITED
WO/2021/161034	USE OF COMPOUNDS THAT ARE ABLE TO CROSS-LINK THE EXTRACELLULAR  MATRIX FOR PREVENTING OR INHIBITING THE MIGRATION OF CANCER CELLS	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/161043	PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED  BY CORONAVIRUS	IMMODULON THERAPEUTICS LIMITED
WO/2021/161047	USP7 INHIBITOR FOR USE IN THE TREATMENT OF CANCER	ALMAC DISCOVERY LIMITED
WO/2021/165667	2019-NCOV (SARS-COV-2) VACCINE	VAXBIO LTD
WO/2021/165685	GENE THERAPY	UCL BUSINESS LTD
WO/2021/170982	THERAPY	UCL BUSINESS LTD
WO/2021/171003	<i>EX VIVO</i> GAMMA DELTA T CELL POPULATIONS	GAMMADELTA THERAPEUTICS LIMITED
WO/2021/171028	ANTI-INFECTIVE BICYCLIC PEPTIDE CONJUGATES	BICYCLETX LIMITED
WO/2021/171034	LIQUID PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE AND  GLYCOPYRROLATE	VERONA PHARMA PLC
WO/2021/171035	COMPOSITIONS AND USES THEREOF	BENEVOLENTAI CAMBRIDGE LIMITED
WO/2021/171036	TREATMENT OF LIVER FAILURE	HEPYX LIMITED
WO/2021/171042	COMPOSITION FOR MODULATING INTESTINAL PERMEABILITY AND/OR  TREATING AND/OR PREVENTING LEAKY GUT RELATED DISEASES, AND METHOD FOR  MODULATING INTESTINAL PERMEABILITY AND/OR TREATING AND/OR PREVENTING LEAKY  GUT RELATED DISEASES	INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
WO/2021/171045	METHODS OF TREATING TUBEROUS SCLEROSIS COMPLEX WITH  CANNABIDIOL AND EVEROLIMUS	GW RESEARCH LIMITED
WO/2021/176214	PHARMACEUTICAL FORMULATIONS COMPRISING  6-CHLORO-7-(4-(4-CHLOROBENZYL)PIPERAZIN-1 -YL)-2-(1,3-DIMETHYL-1  HPYRAZOL-4-YL)-3H- IMIDAZO[4,5-B]PYRIDINE	ELLIPSES PHARMA LTD
WO/2021/176234	VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION	THE PIRBRIGHT INSTITUTE
WO/2021/176235	VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION	THE PIRBRIGHT INSTITUTE
WO/2021/176236	VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION	THE PIRBRIGHT INSTITUTE
WO/2021/181096	GENE THERAPY OF NIEMANN-PICK DISEASE TYPE C	UCL BUSINESS LTD
WO/2021/181098	SOLID CLEANSING COMPOSITION	INNOSPEC ACTIVE CHEMICALS LLC
WO/2021/181099	SOLID CLEANSING COMPOSITION COMPRISING AN ACYL ALKYL  ISETHIONATE	INNOSPEC ACTIVE CHEMICALS LLC
WO/2021/181100	COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/186151	AZD1656 FOR USE IN THE TREATMENT OF PNEUMONITIS AND/OR  MYCORDITIS CAUSED BY A CORONAVIRUS	EXCALIBUR MEDICINES LIMITED
WO/2021/181115	COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES	ILC THERAPEUTICS LIMITED
WO/2021/181122	GPR52 MODULATOR COMPOUNDS	HEPTARES THERAPEUTICS LIMITED
WO/2021/186160	MODIFIED BOTULINUM NEUROTOXIN FOR TREATING LIMB SPASTICITY	IPSEN BIOPHARM LIMITED
WO/2021/186162	HYBRID INTERFERONS FOR TREATING VIRAL INFECTIONS	ILC THERAPEUTICS LIMITED
WO/2021/209739	METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR  TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY	MEREO BIOPHARMA 4 LIMITED
WO/2021/186166	GLP RECEPTOR AGONISTS	HEPTARES THERAPEUTICS LIMITED
WO/2021/209740	METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR  TREATING CORONAVIRUS INFECTION	MEREO BIOPHARMA 4 LIMITED
WO/2021/186167	TREATMENT OF UPPER FACIAL LINES	IPSEN BIOPHARM LIMITED
WO/2021/186169	ORAL GLP RECEPTOR AGONISTS	HEPTARES THERAPEUTICS LIMITED
WO/2021/186180	IMIDAZOLYL THIOPEHENE SULFONYL CARBAMATES FOR USE IN THE  TREATMENT OF DISEASES ASSOCIATED WITH ANGIOTENSIN II	VICORE PHARMA AB
WO/2021/186185	NOVEL COMPOUNDS USEFUL IN THE TREATMENT AND/OR PREVENTION OF A  DISEASE, DISORDER OR CONDITION ASSOCIATED WITH ANGIOTENSIN II	VICORE PHARMA AB
WO/2021/191592	NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST	VICORE PHARMA AB
WO/2021/191630	CORONAVIRUS VACCINE	IMPERIAL COLLEGE INNOVATIONS LIMITED
WO/2021/198675	CANCER THERAPY WITH MICROBUBBLES.	INNOVATION ULSTER LIMITED
WO/2021/198684	POLYPEPTIDES DERIVED FROM THE C-TERMINUS OF  ACETYLCHOLINESTERASE FOR USE IN SKIN CONDITIONS	NEURO-BIO LTD
WO/2021/198686	CYCLIC PEPTIDES FROM THE C-TERMINUS OF ACETYLCHOLINESTERASE  FOR TREATMENT OF SKIN DISORDERS AND FOR COSMETICAL USE	NEURO-BIO LTD
WO/2021/198691	SODIUM BUTYRATE FOR USE IN THE PREVENTION OR TREATMENT OF  RHINOVIRUS INFECTION	EDINBURGH NAPIER UNIVERSITY
WO/2021/198694	NOVEL FORMULATIONS	ARECOR LIMITED
WO/2021/198701	INFLUENZA VACCINES	DIOSYNVAX LTD
WO/2021/198705	CORONAVIRUS VACCINE	PEPTC VACCINES LIMITED
WO/2021/198709	NAPHTHYRIDINE COMPOUNDS AS INHIBITORS OF MER TYROSINE KINASE  AND AXL TYROSINE KINASE	KINSENSUS LIMITED
WO/2021/205153	NEW USE OF <i>N,N-</i>BIS-2-MERCAPTOETHYL  ISOPHTHALAMIDE	EMERAMED LIMITED
WO/2021/205161	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLP	BICYCLETX LIMITED
WO/2021/205171	CRYSTALLINE COMPLEXES	EVGEN PHARMA PLC
WO/2021/205172	CELL	AUTOLUS LIMITED
WO/2021/205173	METHOD	AUTOLUS LIMITED
WO/2021/205185	PHARMACEUTICAL FORMULATIONS	BLUE EARTH DIAGNOSTICS LTD
WO/2021/209762	INJECTABLE OIL-BASED PHARMACEUTICAL COMPOSITION	NANEXA AB
WO/2021/214439	METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING  TUBERCULOSIS	THIRTY RESPIRATORY LIMITED
WO/2021/214440	NITRIC OXIDE OR NITRIC OXIDE RELEASING COMPOSITIONS FOR USE IN  TREATING SARS-COV AND SARS-COV-2	THIRTY RESPIRATORY LIMITED
WO/2021/214451	TREATMENT OF PULMONARY FIBROSIS	NOORDEEN, Mohamed Hamza
WO/2021/214462	TRANSFECTION AND TRANSDUCTION SYSTEM	N4 PHARMA UK LIMITED
WO/2021/214467	A DIAGNOSTIC TOOL IMPROVEMENT COMPRISING A PATHOGEN BINDING  MOLECULE	CELLBIO
WO/2021/214475	NEW USES	AIVIVO LTD
WO/2021/214486	NEW CAPSULE COMPOSITION FOR PERORAL ADMINISTRATION	VICORE PHARMA AB
WO/2021/214487	NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION	VICORE PHARMA AB
WO/2021/214488	NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION	VICORE PHARMA AB
WO/2021/214492	METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION  OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR	BERGENBIO ASA
WO/2021/214494	INTERLEUKIN INHIBITORS	UNIVERSITY OF GREENWICH
WO/2021/214495	DIAZINE AND TRIAZINE COMPOUNDS TO TREAT CYTOKINE STORM  SYNDROME	UNIVERSITY OF GREENWICH
WO/2021/219990	T CELL THERAPY	ACHILLES THERAPEUTICS UK LIMITED
WO/2021/220011	ANTI-INFECTIVE BICYCLIC PEPTIDE CONJUGATES	BICYCLETX LIMITED
WO/2021/220012	5-(1H-INDOL-3-YL)-OXAZOLE, -OXADIAZOLE AND -FURAN DERIVATIVES  AS ENHANCERS OF SPERM MOTILITY	SPERMATECH AS
WO/2021/224618	DISSOLVABLE HYDROGEN PEROXIDE TEETH WHITENING STRIP OR FILM	BIOFILM LIMITED
WO/2021/224629	CELL	AUTOLUS LIMITED
WO/2021/224634	VITAMIN A FOR USE IN THE TREATMENT OF TRAUMATIC BRAIN INJURY	NOORDEEN, Mohamed Hamza
WO/2021/224641	DOSAGE REGIMEN OF AMLODIPINE	CLOSED LOOP MEDICINE LTD
WO/2021/229212	MODIFIED IPSCS	ADAPTIMMUNE LIMITED
WO/2021/229218	METHOD	AUTOLUS LIMITED
WO/2021/229221	TARGET SPECIFC DEGRADERS AND THEIR MEDICAL USE	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/229234	METHOD OF TREATMENT OF CANCER OR TUMOUR	ADAPTIMMUNE LIMITED
WO/2021/229235	METHOD OF TREATMENT OF CANCER OR TUMOUR	ADAPTIMMUNE LIMITED
WO/2021/229237	CYCLOSPORINE ANALOGUES	UCL BUSINESS LTD
WO/2021/234362	TOPICAL DISULFIRAM FOR TREATING VIRAL INFECTIONS	UNIVERSITY OF WOLVERHAMPTON
WO/2021/234366	NEW PHARMACEUTICAL COMPOSITION FOR DRUG DELIVERY	OREXO AB
WO/2021/234381	TREATMENT FOR VIRAL RESPIRATORY INFECTIONS	NASSER, Syed Muhammad Tahir
WO/2021/234383	SINGLE DOMAIN ANTIBODIES AGAINST HACE2 AND THEIR USE TO  PREVENT SARS-COV-2 INFECTION	AUTOLUS LIMITED
WO/2021/234386	FORMULATION COMPRISING A PROTEINACEOUS MICROGEL	UNIVERSITY OF LEEDS
WO/2021/234391	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 AND USES  THEREOF	BICYCLETX LIMITED
WO/2021/234407	IBUPROFEN-CONTAINING SOFT GELATIN CAPSULES	RECKITT BENCKISER HEALTH LIMITED
WO/2021/234408	NOVEL FORMULATION	RECKITT BENCKISER HEALTH LIMITED
WO/2021/234409	IBUPROFEN CONTAINING SOFT GELATINE CAPSULE	RECKITT BENCKISER HEALTH LIMITED
WO/2021/234412	ANTIMICROBIAL MATERIAL	COPPER CLOTHING LIMITED
WO/2021/234414	ANTIVIRAL POLYMERS	THE UNIVERSITY OF MANCHESTER
WO/2021/240145	ANTI-VIRAL THERAPY	NOVABIOTICS LIMITED
WO/2021/240155	ANTIBODY-DRUG CONJUGATES	SPIREA LIMITED
WO/2021/240163	COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OR  PREVENTION OF HAIR LOSS	CHOPRA, Sunil
WO/2021/245405	INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT	NEOPHORE LIMITED
WO/2021/245426	N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED  COMPOUNDS AS MODULATORS OF GPR65	PATHIOS THERAPEUTICS LIMITED
WO/2021/245427	N-PHENYLAMINOCARBONYL PYRIDINO-, PYRIMIDINO AND BENZO-TROPANES  AS MODULATORS OF GPR65	PATHIOS THERAPEUTICS LIMITED
WO/2021/250402	COMPOSITION FOR TREATMENT OF FRAGILE X SYNDROME	HEALX LTD
WO/2021/250421	FLUID GEL COMPOSITIONS	THE UNIVERSITY OF BIRMINGHAM
WO/2021/250422	FLUID GEL COMPOSITIONS	THE UNIVERSITY OF BIRMINGHAM
WO/2021/250423	POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS	THE UNIVERSITY OF BIRMINGHAM
WO/2021/250434	COMPOSITION COMPRISING A BENZOATE SALT OF  5-METHOXY-N,N-DIMETHYLTRYPTAMINE	BECKLEY PSYTECH LIMITED
WO/2021/255420	ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE,  PIOGLITAZONE OR ROSIGLITAZONE	THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/255432	JELLYFISH COLLAGEN USE	JELLAGEN PTY LTD
WO/2021/255438	COMBINATION OF DEXAMETHASONE AND A MINERALOCORTICOID RECEPTOR  ANTAGONIST FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME	IMAGINATIVES GROUP LIMITED
WO/2021/255440	ULTRASOUND-SENSITIVE BIODEGRADEABLE MULTI-CAVITY MICRO-  PARTICLES	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/255441	BIODEGRADABLE MULTI-CAVITY MICROPARTICLES AND THEIR USE IN  TREATMENT	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/255446	USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY	GW RESEARCH LIMITED
WO/2021/255457	SKINCARE FORMULATION	CREIGHTONS PLC
WO/2021/255464	NUTRACEUTICAL COMPOSITION	HAHN, Norman
WO/2021/255472	ANTIMICROBIAL COMBINATIONS	MARVELBIOTICS LIMITED
WO/2021/255474	TOOTH WHITENING AND TOOTH SENSITIVITY STRIP OR FILM	BIOFILM LIMITED
WO/2021/255483	COMPOSITION FOR TOPICAL DERMATOLOGICAL DELIVERY	LIMEWAY PHARMA DESIGN LIMITED
WO/2021/260379	THERAPEUTICS FOR THE TREATMENT OF FSHD	UCL BUSINESS LTD
WO/2021/260387	MMP-9 AND MMP-12 INHIBITION FOR TREATING SPINAL CORD INJURY OR  RELATED INJURY TO NEUROLOGICAL TISSUE	THE UNIVERSITY OF BIRMINGHAM
WO/2021/260390	THERAPEUTIC TREATMENT USING PROTEIN KINASE C (PKC) INHIBITORS  AND CYTOTOXIC AGENTS	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/260391	NATURAL PLANT BASED DELIVERY SYSTEM	UNIVERSITY OF HUDDERSFIELD
WO/2021/058987	NON RINSABLE MIXTURES FOR CARING ANIMALS WITH GOLD  NANOPARTICLES	PLIN - NANOTECHNOLGY S.A.
WO/2021/240183	PREPARATION METHOD OF A COLLOIDAL SYSTEM OF STABILISATION AND  CONTOLLED RELEASE OF ROYAL JELLY COMPONENTS FOR VARIOUS USES	APIVITA S.A.
WO/2021/094792	METHOD FOR THE DEVELOPMENT OF A DELIVERY PLATFORM TO PRODUCE  DELIVERABLE PTD-IVT-mRNA THERAPEUTICS	ARISTOTLE UNIVERSITY OF THESSALONIKI E.L.K.E.
WO/2021/229247	FENDILINE AGAINST NEURODEGENERATIVE OR NEURODEVELOPMENTAL  DISEASES, CANCER OR COVID 19 PROLIFERATION	VAMVAKIDES, Alexandre
WO/2021/245432	NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF COVID-19  PATIENTS, SEPSIS AND HYPOXEMIA	BIOHELLENIKA S.A.
WO/2021/214497	PHARMACEUTICAL COMPOSITION COMPRISING L-TRIIODOTHYRONINE (T3)  FOR USE IN THE TREATMENT OF TISSUE HYPOXEMIA AND SEPSIS	UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A.
WO/2021/009525	MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL  INSTILLATION, PREPARATION AND USE THEREOF	LOVáSZ, Sándor
WO/2021/024005	MONOAMINE OXIDASE B INHIBITORS FOR USE IN THE PREVENTION OR  TREATMENT OF PROSTATE CARCINOMA	TOXIE EUROPE INTELLIGENS KéMIAI SZENZOROKAT KUTATó, FEJLESZTŐ  KORLáTOLT FELELŐSSéGŰ TáRSASáG
WO/2021/069941	APPARATUS FOR OPENING AND CLOSING OF TWO-PART MATERIAL  CONTAINERS, PREFERABLY CAPSULES	HADAS, Tamás
WO/2021/130509	ICAN DERIVATIVES FOR ANTIFUNGAL USE	DEBRECENI EGYETEM
WO/2021/220022	URINARY ALKALIZING MEDICINAL AND/OR PHARMACEUTICAL COMPOSITION  FOR THE ORAL TREATMENT OF INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME  (IC/BPS) AND FORMULATION THEREOF	LOVáSZ, Sándor
WO/2021/229249	INHIBITION OF SARS-COV-2 INFECTION THROUGH SYNDECANS	PHARMACOIDEA KFT
WO/2021/191643	COMPOSITIONS COMPRISING DEUTERIUM DEPLETED WATER FOR THE  NORMALIZATION OF LEPTIN CONCENTRATION IN THE BODY SYSTEM	HYD RáKKUTATó éS GYóGYSZERFEJLESZTŐ KFT.
WO/2021/224646	METHOD FOR THE TREATMENT OF RNA VIRUS INVOLVED DISEASES	TURNSOLE BIOLOGICS LLC.
WO/2021/224648	METHOD OF MODIFYING THE DRUG RELEASE RATE OF A POLYMERIC  CARRIER CONTAINING AN ACTIVE SUBSTANCE AND A PHARMACEUTICAL PRODUCT  COMPRISING A POLYMERIC CARRIER CONTAINING AN ACTIVE SUBSTANCE TREATED BY SAID  METHOD	KOVáCS, Zsolt
WO/2021/240187	BENZAMIDE DERIVATIVES AS ANTI-INFLAMMATORY COMPOUNDS AND USES  THEREOF	SEMMELWEIS EGYETEM
WO/2021/048577	OIL-IN- WATER EMULSION GEL COMPOSITION	L V M H RECHERCHE
WO/2021/033003	HORMONE D (VITAMIN D) AND ITS DERIVATIVES FOR THE TREATMENT  AND PREVENTION OF CANCER	INDUSTRIAL TECHNOLOGIES & BIOTECHNOLOGIES
WO/2021/019268	METHODS FOR TREATING TUMORS	NH THERAGUIX
WO/2021/069944	PHARMACEUTICAL COMPOSITION COMPRISING MIRABEGRON AND PROCESS  FOR MANUFACTURING THE SAME	ALVOGEN KOREA CO., LTD.
WO/2021/058990	MIDAZOLAM IN FLEXIBLE BAGS	INFORLIFE SA
WO/2021/044183	ANTI-CANCER AGENT	ISHII, Hitoshi
WO/2021/014184	READY-TO-ADMINISTER FENTANYL FORMULATIONS	HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/105733	PHAGE-RESISTANT MICROORGANISMS	MIRELES, Ivan Alejandro De La, Peña
WO/2021/123857	OIL-IN-WATER EMULSIFIED COSMETIC	L V M H RECHERCHE
WO/2021/123859	OILY SOLID COSMETIC	L V M H RECHERCHE
WO/2021/123860	WATER-IN-OIL EMULSIFIED COSMETIC COMPOSITION	L V M H RECHERCHE
WO/2021/123861	OIL-IN-WATER EMULSIFIED COSMETIC	L V M H RECHERCHE
WO/2021/019278	ENHANCING DRUG ACTIVITY THROUGH ACCENTUATED BUCCAL/SUBLINGUAL  ADMINISTRATION	BANERJEE, Debasish
WO/2021/024028	HERBAL MEDICATION FOR ERADICATION OF HELICOBACTER PYLORI  INFECTION AND TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERS	BORDBAR, Ghasem
WO/2021/038283	AUTOANTIGENIC PEPTIDES (CALVICIFIV), PRESENTED BY TOLEROGENIC  DENTRITIC CELLS, USEFUL FOR THE PERSONALIZED TREATMENT OF RHEUMATOID  ARTHRITIS	UNIVERSIDAD DE CHILE
WO/2021/048595	A METHOD FOR PREVENTING HUMAN VIRUS ASSOCIATED DISORDERS IN  PATIENTS	NOVARTIS AG
WO/2021/084308	SULFATE-FREE, FOAMABLE SOLID CLEANSER	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/033020	ALKALI METAL SALT OF CARBOXYALKYL ETHER OF TAMARIND GUM WITH  IMPROVED COMPOSITION	TANNA, Raj Mahendra
WO/2021/105742	AN IMPROVED PROCESS FOR THE PREPARATION OF PREGABALIN	HIKAL LIMITED
WO/2021/111172	A COLLAGEN-HYDROXYAPATITE DEVICE FOR NON-SURGICAL PERIODONTAL  TREATMENT	DATUM DENTAL LTD.
WO/2021/094820	METHOD OF MANUFACTURING ZINC OXIDE NANOPARTICLES	POLITECHNIKA KRAKOWSKA IM. TADEUSZA KOŚCIUSZKI
WO/2021/123874	CANNABINOID COMPOSITIONS WITH HIGH SOLUBILITY AND  BIOAVAILABILTY	PISAK, Mehmet Nevzat
WO/2021/123883	MACROCYCLIC AMIDES ACTING AS PLASMEPSIN INHBITORS FOR THE  TREATMENT OF MALARIA	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/053383	METHOD FOR PREVENTING PROGRESSION TO METABOLIC SYNDROME	DASMAN DIABETES INSTITUTE
WO/2021/090054	GUT-PROTECTIVE COMPOSITIONS COMPRISING BOSWELLIC ACID	INVENTIA HEALTHCARE LIMITED
WO/2021/198715	REGIMEN FOR TREATING A NEISSERIA GONORRHOEAE INFECTION WITH  GEPOTIDACIN	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/229255	TOOLS AND METHOD FOR PREVENTING A A￥ NEUTRALIZATION BY  ANTIBODIES	GENETHON
WO/2021/019295	SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS	REMMEREIT, Jan
WO/2021/014217	ARTICLES COMPRISING STEROID DIMERS AND THEIR USE IN THE  DELIVERY OF THERAPEUTIC AGENTS	RIPPLE THERAPEUTICS CORPORATION
WO/2021/048610	ANTIBIOTIC COMBINATION THERAPIES	BIOVERSYS AG
WO/2021/048611	RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS	BIOVERSYS AG
WO/2021/048612	RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS	BIOVERSYS AG
WO/2021/044208	ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN  ROR1, AND USE FOR THE SAME	LEGOCHEM BIOSCIENCES, INC.
WO/2021/009567	NLRP3 MODULATORS	ZOMAGEN BIOSCIENCES LTD
WO/2021/038289	COMPOSITIONS FOR MONOCYTE AND MACROPHAGE POLARIZATION AND  METHODS OF USE	ORBSEN THERAPEUTICS LIMITED
WO/2021/048626	COMPOSITIONS FOR THE TREATMENT OF SOLID TUMORS	RAZIEL THERAPEUTICS LTD.
WO/2021/053389	METHODS OF TREATING EPILEPTIC PATIENTS WITH FENFLURAMINE	ZOGENIX INTERNATIONAL LIMITED
WO/2021/059017	HETEROCYCLIC COMPOUND AND USE THEREOF	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/053397	COSMETIC OR DERMATOLOGICAL COMPOSITION FOR CLEANSING AND/OR  REMOVING MAKE-UP, COMPRISING SUCCINIC ACID FOR PREVENTING, REDUCING OR  ELIMINATING SKIN IMPERFECTIONS, TREATING SKIN DISORDERS AND PREVENTING,  TREATING AND COMBATING HYPER-SEBORRHEIC CONDITIONS OF THE SCALP.	ROQUETTE FRERES
WO/2021/105761	COMPOSITIONS AND THEIR USES FOR TREATING CANCERS	INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE  (INSERM)
WO/2021/053400	DMSO-FREE SYNTHESIS OF OLIGOPEPTIDE-MODIFIED POLY(BETA-AMINO  ESTER)S AND THEIR USE IN NANOPARTICLE DELIVERY SYSTEMS	ARATINGA.BIO TNP
WO/2021/059023	COMPOUNDS USEFUL FOR TREATING LIVER DISEASES	ABIONYX PHARMA SA
WO/2021/074689	IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE  CHECKPOINT INHIBITORS	ALKERMES PHARMA IRELAND LIMITED
WO/2021/079188	COMBINATION THERAPIES WITH VENETOCLAX AND TIM-3 INHIBITORS	NOVARTIS AG
WO/2021/090058	METERED DOSE FOR DEMODEX AND DISORDERS RELATED THERETO	AZURA OPHTHALMICS LTD.
WO/2021/090061	METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE  CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN  INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR	RESVERLOGIX CORP.
WO/2021/094827	USE OF BISANTRENE TO TREAT MEASURABLE RESIDUAL DISEASE IN  ACUTE MYELOID LEUKEMIA	RACE ONCOLOGY LTD.
WO/2021/090067	COMPOSITIONS AND METHODS FOR PRODUCING A VIRAL VACCINE WITH  REDUCED PARTICLE SIZE	SEQIRUS UK LIMITED
WO/2021/079195	TIM-3 INHIBITORS AND USES THEREOF	NOVARTIS AG
WO/2021/090069	METHODS AND COMPOSITIONS FOR USE OF GROWTH FACTOR ANTIBODIES  IN COMBINATION WITH NON-TYROSINE TARGETING KINASE INHIBITORS	IN3BIO LTD.
WO/2021/090070	METERED DOSE FOR DISORDERS IN OR AROUND THE EYE	AZURA OPHTHALMICS LTD.
WO/2021/111185	COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION	INTOCELL, INC.
WO/2021/130532	PROCESS FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING  MICRO PARTICLES	SUNSTAR INC.
WO/2021/123908	CAR-T CELL THERAPY TARGETING NGCGM3	LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
WO/2021/255492	DRUG COMPRISING PLGA NANOPARTICLES LOADED WITH CAPE TARGETED  WITH ANGIOPEP-2 PEPTIDE	YILDIZ TEKNIK üNIVERSITESI
WO/2021/136968	MANUFACTURING OF SELENIUM DISULFIDE COMPOSITIONS	AZURA OPHTHALMICS LTD.
WO/2021/205196	COMPOSITIONS AND PREVENTION AND INTERVENTION METHODS FOR  COVID-19 WITH DIVINE AYATS' FITRA30 COVID-19 PROTOCOL	MUHAMMAD, Taliah
WO/2021/130541	TRANSDERMAL SIRNA DELIVERY COMPOSITION AND USE THEREFOR	XIAMEN UNIVERSITY
WO/2021/148845	OPHTHALMIC COMPOSITION FOR THE TREATMENT OF DRY EYE DISEASE	VISUFARMA S.P.A.
WO/2021/161064	CORE/SHELL MICROCAPSULES AND A METHOD FOR THE FABRICATION OF  CORE/SHELL MICROCAPSULES	POLITECHNIKA WARSZAWSKA
WO/2021/165724	SELF-EMULSIFYING COMPOSITION, INTENDED FOR ADMINISTRATION ONTO  THE SKIN, CONTAINING BIOSURFACTANT, COSURFACTANT AND OIL PHASE	INVENTIONBIO SPóŁKA Z OGRANICZONA ODPOWIEDZIALNOŚCIĄ
WO/2021/001694	CONSTRUCTIVE ARRANGEMENT APPLIED TO SURGICAL FIELD FOR  CESAREAN DELIVERY	CLíNICA MéDICA TRINA LTDA
WO/2021/009572	AEROSOL FORMULATION, CANISTER AND INHALER CONTAINING THE  FORMULATION, AND METHOD OF USE	KINDEVA DRUG DELIVERY L.P.
WO/2021/176257	COMPOSITION FOR USE AS A MEDICAMENT FOR THE TREATMENT OF  SUDDEN ATTACKS OF COVID-19 AND OTHER PATHOGENIC EPIDEMICS, SERA SET AND  METHOD FOR IDENTIFYING VIRAL ANTIGENS AND EFFECTIVE ANTIBODIES	LAW, Peter K.
WO/2021/181132	METHOD OF ACTIVATION OF A SONOSENSITIZING AGENT	POLITECNICO DI TORINO
WO/2021/181139	METHODS AND COMPOSITIONS FOR TREATMENT OF LUNG CANCER	INNOPHARMASCREEN, INC
WO/2021/009573	AEROSOL FORMULATION, CANISTER AND INHALER CONTAINING THE  FORMULATION, AND METHOD OF USE	KINDEVA DRUG DELIVERY L.P.
WO/2021/191652	COMPOSITION AND METHODS FOR PREVENTION AND TREATMENT OF  VASCULAR DISORDERS	JAFARI JAVID, Mihan
WO/2021/198725	FOSALVUDINE AND FOZIVUDINE TIDOXIL FOR USE IN THE TREATMENT OF  COVID-19, AND USE OF THE STRUCTURALLY SIMPLIFIED DERIVATIVES THEREOF	CHIRACON GMBH
WO/2021/198739	NOVEL MEDICINAL COMPOUND FOR COMBATING VIRAL INFECTIONS LIKE  CORONA VIRUS INFECTION AND METHOD OF MITIGATING THE CONDITIONS	RANAWEERA, Ananda Sarath
WO/2021/198740	METHOD FOR OBTAINING ANTIOXIDANTS, DIET FIBER, AND OTHER  NUTRIENTS FROM PLANT BY-PRODUCTS	ASESORíA, INVESTIGACIóN Y PRODUCCIóN DE ALIMENTOS MAURICIO  ANDRéS POBLETE BUSTAMANTE EIRL
WO/2021/198745	DRUG FOR PREVENTION OR TREATMENT OF IRRITABLE BOWEL SYNDROME  OR INFLAMMATORY BOWEL DISEASE	ANTONIOLI, Luca
WO/2021/001697	NOVEL BORONIC ACID CONTAINING PEPTIDOMIMETICS AS MALARIAL  SERINE PROTEASE INHIBITORS	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/059027	SUSTAINED RELEASE FORMULATION CONTAINING ASPALATHUS LINEARIS  EXTRACT	CAPE PENINSULA UNIVERSITY OF TECHNOLOGY
WO/2021/224659	PHARMACEUTICAL COMPOSITION AND KIT-OF-PARTS FOR USE AGAINST  INFECTIONS CAUSED BY CORONAVIRUSES	ARISTIZABAL BERNAL, Beatriz Helena
WO/2021/224660	INHIBITION OF CORONAVIRUS (COVID-19) INFECTION BY MEANS OF  APIVIRINE EXTRACT - DICHROSTACHYS GLOMERATA	AGON, Achidi Valentin
WO/2021/224664	APPLICATION OF DALARGIN FOR THE PREVENTION OF VRIS AND  PREVENTION OF THE DEVELOPMENT OF COMPLICATIONS DURING VRIS	PVP LABS PTE. LTD.
WO/2021/229270	RECOMBINANT VACCINE AGAINST COVID-19 IN A VIRAL VECTOR	LABORATORIO AVI-MEX, S.A. DE C.V.
WO/2021/234429	PERSIAN GULF BROWN ALGAE, SALVADORA PERSICA MICROPARTICLE AND  PURSLANE EXTRACT AS HERBAL TOOTHPASTE	RAZMPOUR, Farkhondeh
WO/2021/234430	MODIFIED RELEASE DOSAGE FORM COMPRISING VILDAGLIPTIN AND  PROCESS FOR MANUFACTURING THE SAME	LOTUS INTERNATIONAL PTE. LTD.
WO/2021/191664	A METHOD AND COMPOSITION FOR TREATING COVID-19	SOLANKE, Rekha Vijaysing
WO/2021/240204	SPERM HEAD FOR RESOLUTION OF INFLAMMATION, TISSUE REPAIR &  REGENERATION, AND RESTORATION OF TISSUE FUNCTION: NEW APPROACH OF CELL  THERAPY	PAKRAVAN, Nafiseh
WO/2021/240206	ENZALUTAMIDE FORMULATION	LOTUS INTERNATIONAL PTE. LTD.
WO/2021/123925	HERBAL COMPOSITIONS AND ADMINISTRATION METHODS FOR THE  TREATMENT OF INFECTIONS AND INFLAMMATION OF VULVOVAGINAL AND THE PELVIC  ORGANS	BANOOYE ARMAGHAN TEB
WO/2021/229278	<i>CONCENTRATED LIQUID NON-STEROIDAL ANTIANDROGEN  SOLUTION AND METHOD FOR PREPARING THE SOLUTION</i>	NOVOCAP S.A
WO/2021/260409	PHARMACEUTICAL COMPOSITION FOR SARS-COV-2 PREVENTION AND/OR  TREATMENT	AHMED MAHMOUD METWALLY ALKHATIP, Ahmed Abdelaal
WO/2021/038318	HERBAL COMPOSITION FOR REDUCING FAT, SUGAR, ARSENIC, GLUTEN  AND GLYCEMIC INDEX OF NATURAL FOOD	MR. N. M., Sasi Kumar
WO/2021/005436	COMBINATION THERAPY OF GPR119 AGONISTS AND DPP-4 INHIBITORS	MANKIND PHARMA LTD.
WO/2021/176263	TOPICAL FORMULATIONS CONTAINING MTOR INHIBITORS	SHANGHAI AUCTA PHARMACEUTICALS CO., LTD.
WO/2021/001728	PROCESS FOR PREPARATION OF EDOXABAN	GLENMARK LIFE SCIENCES LIMITED
WO/2021/186231	AN INSTANTLY SEMI-SOLID DERMAL PRODUCT MANUFACTURING METHOD  BASED ON A FRESH EXTRACT AND AN APPARATUS THEREOF	KHORI, Vahid
WO/2021/209800	TREATMENT FOR HUMAN INFECTION FROM CORONA VIRUS AND INFLUENZA  VIRUS (H1N1) (PIGS FLU.)	ELHAYESH, Mohamed Khairy Abd Ellatif
WO/2021/001743	TRANSLATION INHIBITORS AND USES THEREOF	EFFECTOR THERAPEUTICS, INC.
WO/2021/009595	CYCLOPHOSPHAMIDE INJECTABLE COMPOSITION AND METHODS FOR  PRODUCING SAME	HETERO HEALTHCARE LIMITED
WO/2021/009605	DISPERSIBLE TABLETS OF ABIRATERONE ACETATE	SHILPA MEDICARE LIMITED
WO/2021/001789	THERAPEUTIC USES OF OXIDISING HYPOTONIC ACID SOLUTIONS	APR APPLIED PHARMA RESEARCH, S.A.
WO/2021/005478	COMPRESSED MACITENTAN COMPOSITIONS, METHODS AND USES THEREOF	TECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/001804	ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE	CADILA HEALTHCARE LIMITED
WO/2021/005483	EXTRACTION OF ANIMAL-DERIVED PULMONARY SURFACTANTS	MAHBOUDI, Fereidoun
WO/2021/001805	STABLE DIPYRIDAMOLE FORMULATIONS AND THEIR METHODS OF  PREPARATION	OCULAR DISCOVERY LTD.
WO/2021/001806	STABLE DIPYRIDAMOLE FORMULATIONS WITH REDUCED IMPURITIES	OCULAR DISCOVERY LTD.
WO/2021/005493	CGRP ANTAGONISTS AND BOTULINUM TOXINS FOR THE TREATMENT OF  INFLAMMATORY AND NEUROLOGIC DISORDERS	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/005494	CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT  OF NEUROPSYCHIATRIC AND NEUROLOGICAL DISORDERS	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/005497	CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT  OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERS	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/005500	STABLE FORMULATIONS OF RECOMBINANT PROTEINS	UNICHEM LABORATORIES LTD
WO/2021/005501	NALTREXONE FORMULATION	INTAS PHARMACEUTICALS LTD.
WO/2021/005541	ADMINISTRATION OF STING AGONIST AND CHECKPOINT INHIBITORS	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/005544	STABLE ORAL COMPOSITION OF CYCLOPHOSPHAMIDE	INTAS PHARMACEUTICALS LTD.
WO/2021/009623	LIQUID FORMULATION, IN PARTICULAR TO TREAT A CORNEAL TISSUE	VISION ENGINEERING ITALY SRL
WO/2021/005549	A PROCESS FOR ISOLATING S-ISOMER CRYSTALS OF INDOXACARB	GHARDA CHEMICALS LIMITED
WO/2021/005562	EMOLLIENT HUMECTANT FORMULATION COMPRISING SYNTHETIC WAX  ESTERS BASED ON PALM OIL	ZUÑIGA, Rafael
WO/2021/009633	SYNTHETIC CHROMATIN VACCINE	MASSEY UNIVERSITY
WO/2021/009640	THERAPEUTIC POTENTIAL OF CURCUMIN/CYCLODEXTRIN/CELLULOSE  NANOCRYSTALS IN THE TREATMENT OF PERIPHERAL NEUROPATHIES	UNIVERSITE DE LIMOGES
WO/2021/005580	USE OF A HERBAL EXTRACT COMPRISING VERBASCOSIDE AND AUCUBIN  FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE	LABIOTRE S.R.L.
WO/2021/009658	COMPOSITIONS FOR TREATMENT OF ASHERMAN'S SYNDROME, METHODS FOR  PREPARING THE SAME AND APPLICATIONS THEREOF	PALANIVEL, Vasanthi
WO/2021/009659	COMPOSITIONS FOR TREATMENT OF ERECTILE DYSFUNCTION, METHODS  FOR PREPARING THE SAME AND APPLICATIONS THEREOF	PALANIVEL, Vasanthi
WO/2021/009660	COMPOSITION AND METHODS FOR IMPROVING THICKNESS AND  RECEPTIVITY OF ENDOMETRIAL LINING	PALANIVEL, Vasanthi
WO/2021/009661	COMPOSITIONS AND METHODS FOR MANAGING FEMALE INFERTILITY	PALANIVEL, Vasanthi
WO/2021/009662	COMPOSITIONS FOR TREATMENT OF INFERTILITY CAUSED BY POOR SEMEN  QUALITY, METHODS FOR PREPARING THE SAME AND APPLICATIONS THEREOF	PALANIVEL, Vasanthi
WO/2021/009663	COMPOSITIONS FOR TREATMENT OF AZOOSPERMIA, METHODS FOR  PREPARING THE SAME AND APPLICATIONS THEREOF	PALANIVEL, Vasanthi
WO/2021/009664	METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X  RECEPTOR AGONISTS	NOVARTIS AG
WO/2021/009684	MODIFIED AAV CAPSID PROTEINS FOR TREATMENT OF ARTHRITIC  DISEASE	MEIRAGTX UK II LIMITED
WO/2021/014275	ORODISPERSIBLE POWDER COMPOSITION COMPRISING A TRIPTAN	BIOPHARMA SYNERGIES, S.L.
WO/2021/009686	PHARMACEUTICAL COMPOSITION OF IMATINIB	INTAS PHARMACEUTICALS LTD.
WO/2021/024057	POLYLYSINE POLYMERS WITH ANTIMICROBIAL AND/OR ANTICANCER  ACTIVITY	INTERNATIONAL BUSINESS MACHINES CORPORATION
WO/2021/009692	TRIPARTITE SYSTEMS FOR PROTEIN DIMERIZATION AND METHODS OF USE	MEDIMMUNE LIMITED
WO/2021/009694	FUNCTIONAL BINDERS SYNTHESIZED AND SECRETED BY IMMUNE CELLS	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/009695	FORMULATIONS OF  (S)-3-AMINO-6-METHOXY-N-(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPYL)-5-(TRIFLUOROMETHYL)PICOLINAMIDE	NOVARTIS AG
WO/2021/009697	HIV BINDING AGENTS	LAUSANNE UNIVERSITY HOSPITAL
WO/2021/009700	PHARMACEUTICAL COMPOSITION OF TEMOZOLOMIDE.	INTAS PHARMACEUTICALS LTD.
WO/2021/019350	COMPOSITION AND METHODS FOR THE TREATMENT OF ANAL AND RECTAL  DISORDERS	CELLIX BIO PRIVATE LIMITED
WO/2021/014292	COSMETIC PRODUCT, PACKAGING AND PREPARATION PROCEDURE	IKA S.R.L.
WO/2021/009706	CROCIN-SORAFENIB COMBINATION THERAPY FOR LIVER CANCER	UNITED ARAB EMIRATES UNIVERSITY
WO/2021/028743	NUTRITIONAL COMPOSITIONS FOR MANAGEMENT OF IRRITABLE BOWEL  DISEASE/SYNDROME AND IMPROVE GUT HEALTH	JEYAKODI, Shankaranarayanan
WO/2021/123928	DEUTERATED ANALOGUES OF SELENOPHENOCHROMENES, SYNTHESIS  THEREOF, AND METHODS OF USING SAME AGENTS	LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
WO/2021/014348	PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS  FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS	NICOX OPHTHALMICS, INC.
WO/2021/014349	TREATMENT COMPRISING FXR AGONISTS	NOVARTIS AG
WO/2021/014350	COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS	NOVARTIS AG
WO/2021/014351	TREATMENT COMPRISING SGLT INHIBITORS, E.G. SGLT 1/2 INHIBITORS	NOVARTIS AG
WO/2021/014356	FOAM COMPOSITIONS FOR WOUND TREATMENT, SYSTEMS OF DELIVERY,  AND METHODS OF USE	KCI LICENSING, INC.
WO/2021/014360	ORAL MODIFIED RELEASE DOSAGE FORMS	PFIZER INC.
WO/2021/014368	METHOD OF PRODUCING CAR-T CELLS, NUCLEIC ACID-INTRODUCING  CARRIER AND KIT	KABUSHIKI KAISHA TOSHIBA
WO/2021/014370	PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND  PREVENTION OF MOTION SICKNESS	ZANOTTI, Eros
WO/2021/014372	BROMOCRIPTINE FOR USE IN TREATING EYE DISEASES ASSOCIATED WITH  ELEVATED LEVEL OF VEGF AND A PHARMACEUTICAL COMPOSITION COMPRISING  BROMOCRIPTINE	OSEKA, Maciej
WO/2021/014376	A WATER-IN-OIL EMULSION WITH EMOLLIENT AND METHODS OF USING  THE SAME	SHISEIDO COMPANY, LTD.
WO/2021/014386	SELECTIVE ESTROGEN RECEPTOR DEGRADER	SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
WO/2021/019375	KV1.3 ANTAGONISTS FOR USE IN THE TREATMENT OF CHRONIC AND  ACUTE PAIN	SEA4US - BIOTECNOLOGIA E RECURSOS MARINHOS, LDA.
WO/2021/014395	PROCESS FOR THE SYNTHESIS OF DEUTERATED CAPSAICIN,  CAPSAICINOIDS AND SYNTHETIC CAPSAICIN ANALOGS	DR. REDDY’S INSTITUTE OF LIFE SCIENCES
WO/2021/014398	INTEGRATED HUMAN CYTOMEGALOVIRUS / GLIOBLASTOMA VACCINE	UNIVERSITY OF RIJEKA FACULTY OF MEDICINE
WO/2021/240225	IMMUNITY BOOSTER PRODUCT FOR PATIENTS OF COVID-19	NATUREVIVE IINNOVATION PRIVATE LIMITED
WO/2021/014407	PRESSED POWDER COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/019395	FOOD SUPPLEMENT, FOR USE AS ADJUVANT, FOR PREVENTING VASCULAR  DEMENTIA	CRISTALFARMA S.R.L.
WO/2021/014420	USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2  DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENT	LEXICON PHARMACEUTICALS, INC.
WO/2021/014422	INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T	UNIVERSITà DEGLI STUDI DI ROMA "LA SAPIENZA"
WO/2021/014426	A COMPOSITION COMPRISING SIMETHICONE AND SUCROSE ESTERS AND  USE THEREOF AS AN ANTIFOAM AGENT	S.I.I.T. S.R.L. - SERVIZIO INTERNAZIONALE IMBALLAGGI  TERMOSALDANTI
WO/2021/161084	N-(4-FLUOROPHENYL)-5-PHENYL-[1,2,4] TRIAZOLO [1,5-A]  PYRIDINE-2-CARBOXAMIDE DERIVATIVES AND THEIR SYNTHESIS THEREOF	NINGEGOWDA, Raghu
WO/2021/019421	ASCORBATE IN THE PREVENTION OF STATIN INDUCED VASCULAR  CALCIFICATION	RATH, Matthias
WO/2021/028752	ANTI-TFN ANTIBODIES FOR TREATING TYPE I DIABETES	JANSSEN BIOTECH, INC.
WO/2021/019434	COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF  SYMPTOMS RELATED TO TIREDNESS AND FATIGUE	NEILOS S.R.L.
WO/2021/024101	PHARMACEUTICAL COMPOSITION OF S1PR MODULATORS	UNIVERSITà DEGLI STUDI DI FIRENZE
WO/2021/024105	TULOBUTEROL TRANSDERMAL PATCH AND IT'S PROCESS	AZISTA INDUSTRIES PVT LTD
WO/2021/019464	USES OF DAN FAMILY BMP ANTAGONISTS FOR INHIBITING OCULAR  NEOVASCULARIZATION AND TREATING OCULAR CONDITIONS	9636137 CANADA INC.
WO/2021/019479	NEW FORMULATIONS OF AMISULPRIDE	LABORATORI BALDACCI S.P.A.
WO/2021/024108	ORAL ANTI-HYPERGLYCEMIC FORMULATION	DOUND, Yogesh
WO/2021/019493	PHARMACEUTICAL COMPOSITION COMPRISING HMG-COA REDUCTASE  INHIBITORS AND FENOFIBRATE	INTAS PHARMACEUTICALS LTD.
WO/2021/019499	SOLID ORAL MULTIPLE-UNIT IMMEDIATE RELEASE COMPOSITIONS,  METHODS AND USES THEREOF	TECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/044231	COMPOUNDS COMPRISING CURCUMIN AND BASIC AMINO ACIDS	ALPARIS, S.A. DE C.V.
WO/2021/019506	MULTIPARTICULATE MICROPARTICLE CONTROLLED RELEASE FORMULATION  COMPRISING COMBINATION OF AMINO ACIDS AND PHYTOCOMPOUND	VETAGRO INTERNATIONAL S.R.L.
WO/2021/005586	TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS	NOVARTIS AG
WO/2021/024141	PREVENTION OR TREATMENT OF DISEASES AND DISORDERS ASSOCIATED  WITH TISSUE DAMAGE	LI, Xiaoxiang
WO/2021/024150	PROCESS FOR THE PREPARATION OF ANTHRAQUINONE TOPICAL  FORMULATION	NEUHEIT PHARMA TECHNOLOGIES PVT. LTD
WO/2021/028772	CHOLECALCIFEROL FOR USE IN THE TREATMENT OF CELIAC DISEASE	ABIOGEN PHARMA SPA
WO/2021/024158	TREATMENT FOR ALL CANCERS	BROMLEY, Peter
WO/2021/024170	INCREASING CANCER CELLS' SENSITIVITY TO TUMOR TREATING FIELDS  (TTFIELDS) BY INHIBITING IL11 ACTIVITY	VOLOSHIN-SELA, Tali
WO/2021/024191	COMBINATION TREATMENTS WITH BENZODIAZEPINONE COMPOUNDS AND  PHOSPHOINOSITIDE 3-KINASE PATHWAY INHIBITORS FOR TREATING CANCER	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/024211	ANTIMICROBIAL TOPICAL COMPOSITIONS CONTAINING MANUKA OIL	MANUKA THERAPEUTICS LTD.
WO/2021/024216	PROBIOTIC MIXTURE	UNIVERSITà CATTOLICA DEL SACRO CUORE
WO/2021/024220	USE OF THE ANTI-P-SELECTIN ANTIBODY CRIZANLIZUMAB FOR TREATING  SICKLE CELL NEPHROPATHY AND CHRONIC KIDNEY DISEASE ASSOCIATED WITH SICKLE  CELL DISEASE	NOVARTIS AG
WO/2021/024231	METFORMIN COMPLEXES WITH TRANSITION METALS AND P GROUP  ELEMENTS	UNIVERSIDAD SANTIAGO DE CALI
WO/2021/024237	INFUSION DOSAGE FORM OF NOREPINEPHRINE	SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/028832	AMMONIA AS A PROCESSING AID FOR SPRAYED SOLID DISPERSIONS	CAPSUGEL BELGIUM NV
WO/2021/028838	INTRATHECAL ADMINISTRATION OF LEVETIRACETAM	SINTETICA S.A.
WO/2021/028842	A STABLE READY-TO-USE INJECTABLE COMPOSITION OF GEMCITABINE OR  ITS SALT AND METHODS FOR PRODUCING SAME	HETERO HEALTHCARE LIMITED
WO/2021/033081	STABLE AEROSOL COMPOSITION FOR INHALATION COMPRISING  GLYCOPYRRONIUM, FORMOTEROL AND CORTICOSTEROID	GLENMARK PHARMACEUTICAL LIMITED
WO/2021/033143	NON-STAINING CURCUMINOID COMPOSITION	INVENTIA HEALTHCARE LIMITED
WO/2021/033144	ORAL SUSPENSION OF CAPECITABINE	INTAS PHARMACEUTICALS LTD.
WO/2021/033145	NOVEL INJECTABLE FORMULATIONS OF ARTESUNATE	LEIUTIS PHARMACEUTICALS PVT LTD
WO/2021/033149	COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY  ANANDAMIDE DEFICIENCY AND USES THEREOF	BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/033154	COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANTERIOR  BLEPHARITIS AND POSTERIOR BLEPHARITIS	PADMANABHAN, Vishwanath
WO/2021/038426	SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN  THE TREATMENT OF DISEASE	NOVARTIS AG
WO/2021/038460	TREATMENT OF MENSTRUAL CYCLE-INDUCED SYMPTOMS	PERIOD PILL BV
WO/2021/038480	COMBINATIONS FOR TREATING INFLUENZA VIRUS	JANSSEN PHARMACEUTICALS, INC.
WO/2021/038486	FORMULATIONS COMPRISING ARGININE AND/OR A PHARMACEUTICALLY  ACCEPTABLE SALT THEREOF AND AN ACID ACTIVE INGREDIENT WITH A PKA OF 1 -5	GRAAL S.R.L.
WO/2021/038487	COMPOUNDS USEFUL TO TREAT PAIN	KASHIV BIOSCIENCES, LLC
WO/2021/038500	ESKETAMINE FOR THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE  DISORDER, INCLUDING SUICIDALITY	JANSSEN PHARMACEUTICALS, INC.
WO/2021/038508	JET MIXING LIPID NANOPARTICLE MANUFACTURING PROCESS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/038519	METHODS OF MANUFACTURING ANAMORELIN TABLETS HAVING IMPROVED  STABILITY	HELSINN HEALTHCARE SA
WO/2021/038529	TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/038532	NOVEL FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY  ACTIVE ANTIBODY	KASHIV BIOSCIENCES, LLC
WO/2021/044280	SELENOSUGARS AND COSMETIC USES THEREOF	SELENO THERAPEUTICS PTY LTD.
WO/2021/044283	EYE DROPS BASED ON A STERILIZABLE LIPOSOMAL FORMULATION BASED  ON CURCUMIN AND OPHTHALMIC USE THEREOF	OFFHEALTH S.P.A.
WO/2021/176264	LIPOSOMAL COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF	DOUND, Yogesh
WO/2021/044287	TREATMENT OF LIVER DISEASE OR DISORDER COMPRISING ACTRII  RECEPTOR ANTAGONISTS	NOVARTIS AG
WO/2021/048688	PRODUCT FOR THE TREATMENT OF ERECTILE DYSFUNCTION	PVP LABS PTE. LTD.
WO/2021/044327	SOLID FORMS OF FILGOTINIB MALEATE AND PROCESSES THEREOF	DR. REDDY'S LABORATORIES LIMITED
WO/2021/044328	CABAZITAXEL LIQUID FORMULATIONS	SHILPA MEDICARE LIMITED
WO/2021/044350	SOLID FORMS OF ENCEQUIDAR MESYLATE AND PROCESSES THEREOF	DR. REDDY’S LABORATORIES LIMITED
WO/2021/044351	METHODS OF TREATING LIVER DISEASE USING LTA4H INHIBITORS	NOVARTIS AG
WO/2021/044357	PHARMACEUTICAL COMPOSITION	RENOWN PHARMA INC.
WO/2021/044360	THERAPEUTIC FUSION PROTEINS	NOVARTIS AG
WO/2021/044361	THERAPEUTIC FUSION PROTEINS	NOVARTIS AG
WO/2021/044362	THERAPEUTIC FUSION PROTEINS	NOVARTIS AG
WO/2021/044376	MIXOTROPHIC PROBIOTIC COMPOSITIONS AND USES THEREOF IN THE  TREATMENT OF BLOATING	WHITE DOG LABS, INC.
WO/2021/044377	UNIVERSAL DONOR CELLS	CRISPR THERAPEUTICS AG
WO/2021/186233	COMPOSITION, LIPID PARTICLE MANUFACTURING KIT, SUBSTANCE  DELIVERY METHOD, AND DETECTION METHOD	SHINSHU UNIVERSITY
WO/2021/048736	TREATMENT OF HIDRADENITIS WITH JAK INHIBITORS	PFIZER INC.
WO/2021/048748	PHARMACEUTICAL FORMULATIONS COMPRISING DICLOFENAC	FTF PHARMA PRIVATE LIMITED
WO/2021/038543	TREATMENT OF DIMINISHED OVARIAN RESERVE USING MENSTRUAL BLOOD  STROMAL CELLS	KAZEMNEJADLEILI, Somaieh
WO/2021/053476	PROCESS FOR PREPARATION OF DIROXIMEL FUMARATE	GLENMARK LIFE SCIENCES LIMITED
WO/2021/048806	METHODS FOR TREATING OCULAR DISEASES	NOVARTIS AG
WO/2021/048809	NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES	CADILA HEALTHCARE LIMITED
WO/2021/048817	DRUG DELIVERY FORMULATIONS	MEDINCELL S.A.
WO/2021/048821	USE OF AN OREXIN 2 RECEPTOR AGONIST FOR THE TREATMENT OF  EXCESSIVE SLEEPINESS	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/048822	TAK-925 FOR USE IN TREATING NARCOLEPSY	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/053486	TRANSPARENT WOUND DRESSINGS CONTAINING THYMOL NANOPARTICLES	MOHAMMADI PURFARD, Amin
WO/2021/053489	USE OF AN MDM2 INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS	NOVARTIS AG
WO/2021/053490	USE OF HIGH-AFFINITY, LIGAND-BLOCKING, HUMANIZED ANTI-T-CELL  IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN-3 (TIM-3) IGG4 ANTIBODY FOR THE  TREATMENT OF MYELOFIBROSIS	NOVARTIS AG
WO/2021/059075	ANTI-CEACAM ANTIBODIES AND USES THEREOF	JANSSEN BIOTECH, INC.
WO/2021/053493	COMPOSITIONS FOR USE IN INHIBITING SRC KINASE AND TREATING AND  PREVENTING ASSOCIATED DISORDERS	ENZENE BIOSCIENCES LIMITED
WO/2021/053495	BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE	NOVARTIS AG
WO/2021/059082	GEL-CHEWABLE DOSAGE FORM	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/053518	A METHOD OF SNAKE FISH EXTRACTION	BASILIANUS BASUKI NUGROHO, Edward
WO/2021/053523	COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF  BIS-DIOXOPIPERAZINES	TRYP THERAPEUTICS
WO/2021/053542	PHARMACEUTICAL COMPOSITIONS FOR OBESITY MANAGEMENT	DR. REDDY’S LABORATORIES LIMITED
WO/2021/053555	GLUE DEGRADERS AND METHODS OF USE THEREOF	NOVARTIS AG
WO/2021/053560	COMBINATION THERAPY WITH ENTPD2 AND CD73 ANTIBODIES	NOVARTIS AG
WO/2021/053564	PHARMACEUTICAL COMPOSITION COMPRISING REMOGLIFLOZIN OR SALT OR  ESTER THEREOF AND TENELIGLIPTIN OR SALT THEREOF	GLENMARK PHARMACEUTICALS LIMITED
WO/2021/053581	A MICRORNA DYSLIPIDEMIA INHIBITOR	DASMAN DIABETES INSTITUTE
WO/2021/053586	WET-PACKED SOFT HYDROGEL OCULAR INSERTS	ALCON INC.
WO/2021/053587	BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD3	STREIN, Klaus
WO/2021/053589	COMPOUNDS FOR THE INDUCTION OF ANTIGEN-SPECIFIC IMMUNE  TOLERANCE	ANOKION SA
WO/2021/053618	TREATMENT COMPRISING FXR AGONISTS	NOVARTIS AG
WO/2021/053636	BACTERIAL STRAINS, THEIR COMPOSITIONS AND THEIR USE FOR THE  TREATMENT OF GASTROINTESTINAL DISORDERS	SOFAR S.P.A.
WO/2021/053641	COMPOSITIONS BASED ON BACTERIAL STRAINS AND BERRY EXTRACTS AND  THEIR USE AS ANTI-INFLAMMATORIES	SOFAR S.P.A.
WO/2021/053642	COMPOSITIONS BASED ON BACTERIAL STRAINS AND THEIR USE AS  ANTI-INFLAMMATORIES	SOFAR S.P.A.
WO/2021/059133	POLYMERIC MICELLE, METHODS OF PRODUCTION AND USES THEREOF	ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING AND CELL  BASED TECHNOLOGIES & THERAPIES A4TEC - ASSOCIAÇÃO
WO/2021/059140	LACTIC ACID VAGINAL FILM AND IT'S PROCESS	AZISTA INDUSTRIES PVT LTD
WO/2021/059142	NOVEL POLYMORPH FORM OF (  R)-2-[2-AMINO-3-(INDOL-3-YL)PROPIONYLAMINO]-2-METHYLPROPIONIC ACID AND USES  THEREOF	GALIMEDIX THERAPEUTICS INC.
WO/2021/059151	ORAL CARE COMPOSITION WITH AMMONIUM ALKYL SULFONATE OR  CARBONATE COMPONENTS FOR TREATING CARIES	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/074718	CREAM FOR TREATING ACNE AND MELASMA	TRIPOD, Maria
WO/2021/059181	NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF	PFIZER INC.
WO/2021/059215	ORAL CARE COMPOSITION	CHURCH & DWIGHT CO., INC.
WO/2021/059221	BENRALIZUMAB FOR USE IN METHODS OF TREATING LATE-ONSET ASTHMA	ASTRAZENECA AB
WO/2021/059234	STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL  ANTI-INFLAMMATORY DRUGS (NSAIDS)	CADILA HEALTHCARE LIMITED
WO/2021/059240	TREATMENT OF CELIAC DISEASE	INTREXON ACTOBIOTICS NV D/B/A PRECIGEN ACTOBIO
WO/2021/059241	MICROBIOME COMPOSITIONS AND METHODS OF TREATMENT OF ATOPIC  DISEASES	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/064550	LIQUID POLYMER COMPOSITIONS AND SYSTEMS FOR EXTENDED DELIVERY  OF PEPTIDES AS ACTIVE PHARMACEUTICAL INGREDIENTS	TOLMAR INTERNATIONAL LIMITED
WO/2021/064567	COMBINATION TREATMENT FOR CANCER	ASTRAZENECA AB
WO/2021/064575	TREATMENT COMPRISING THE USE OF FXR AGONISTS	NOVARTIS AG
WO/2021/064580	CONTROLLED RELEASE INJECTABLE ONDANSETRON FORMULATIONS	SHILPA MEDICARE LIMITED
WO/2021/064589	INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINE	CADILA HEALTHCARE LIMITED
WO/2021/053651	EXTRACT OF COCCULUS HIRSUTUS FOR TREATMENT OF COVID-19	SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/064608	CAPSULE FOR FUNCTIONALIZING A PRODUCT, METHOD AND USES THEREOF	CENTITVC - CENTRO DE NANOTECNOLOGIA E MATERIAIS TéCNICOS  FUNCIONAIS E INTELIGENTES
WO/2021/064614	TOLL-LIKE RECEPTOR 7 AND/OR 8 AGONISTS AND USES THEREOF	JANSSEN BIOPHARMA, INC.
WO/2021/064618	METHOD FOR TREATING HIV WITH CABOTEGRAVIR AND RILPIVIRINE	VIIV HEALTHCARE COMPANY
WO/2021/064636	ESSENTIALLY SODIUM-FREE EFFERVESCENT SOLID PHARMACEUTICAL  COMPOSITIONS	INTAS PHARMACEUTICALS LTD.
WO/2021/084345	PHARMACEUTICAL COMPOSITION COMPRISING MITOTANE ADMINISTERED  ORALLY FOR TREATMENT OF ADRENOCORTICAL CARCINOMA AND CUSHING'S SYNDROME	SKIBA, Mohamed
WO/2021/064678	HYDROGEL-LIKE PARTICLES, METHODS ANS USES THEREOF	ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING AND CELL  BASED TECHNOLOGIES & THERAPIES A4TEC - ASSOCIAÇÃO
WO/2021/064682	PEDIATRIC SUSPENSION FORMULATION	XEOLAS PHARMACEUTICALS LTD.
WO/2021/070039	DETECTING HOMOLOGOUS RECOMBINATION DEFICIENCIES (HRD) IN  CLINICAL SAMPLES	IMMUNITYBIO, INC.
WO/2021/070066	IMPROVED TOPICAL COMPOSITION OF COLCHICINE	ZENVISION PHARMA LLP
WO/2021/070090	2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS	NOVARTIS AG
WO/2021/070093	CANNABIDIOL-ENHANCED PROBIOTIC COMPOSITIONS AND USES THEREOF  FOR TREATMENT OF INFECTIONS	BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/090086	GREEN SYNTHESIS OF SILVER NANOPARTICLES USING CMC POWDER AND  INVESTIGATION OF ITS ANTIBACTERIAL ACTIVITY	AHARI, Hamed
WO/2021/070120	TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE  IN THE TREATMENT OF SEIZURE DISORDERS	PIKE THERAPEUTICS, INC., 1219014 B.C. LTD.
WO/2021/070121	GASTROINTESTINAL HEALTH COMPOSITION	ANATARA LIFESCIENCES LIMITED
WO/2021/070123	SOLID FORMS OF OMECAMTIV MECARBIL DIHYDROCHLORIDE AND  PROCESSES THEREOF	DR. REDDY’S LABORATORIES LIMITED
WO/2021/070125	NOVEL AMIDE DERIVATIVES OF LINAGLIPTIN AND PROCESS FOR THE  PREPARATION THEREOF	ZENVISION PHARMA LLP
WO/2021/074763	XANTHOPHYLL COMPOSITION COMPRISING LUTEIN AND ZEAXANTHIN WITH  ENHANCED BIOAVAILABILITY	OMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/070150	AN INHALABLE DRY POWDER COMPOSITION FOR PULMONARY DISEASES	GLENMARK SPECIALTY S.A.
WO/2021/074769	COMBINATION THERAPY FOR TREATING A HEMATOLOGICAL MALIGNANCY	ASTRAZENECA AB
WO/2021/074772	MODULATORS OF PNPLA3 EXPRESSION	ASTRAZENECA AB
WO/2021/074782	COMPOSITION AND USE OF AN OPHTHALMIC SOLUTION BASED ON  HYALURONIC ACID AND ARABINOGALACTAN	MD ITALY SRL
WO/2021/074790	TRANSDERMAL DELIVERY OF CANNABIDIOL	PIKE THERAPEUTICS, INC., 1219014 B.C. LTD.
WO/2021/074808	PHARMACEUTICAL COMPOSITION COMPRISING SACUBITRIL AND VALSARTAN  AND PROCESS FOR PREPARATION THEREOF	AUROBINDO PHARMA LIMITED
WO/2021/214536	PHARMACEUTICAL COMPOSITION OF CHLORINE FOR TREATMENT OF  RESPIRATORY VIRAL INFECTION	LIFEACTIVUS PRIVATE LIMITED
WO/2021/074833	TOPICAL COMPOSITIONS COMPRISING PARTHENOLIDE	SKINCARE SAGL
WO/2021/084361	USE OF EXFOLIATED BLACK PHOSPHORUS FOR THE TREATMENT OF  PROSTATE CANCERS	MATERIAS S.R.L.
WO/2021/079253	COMPOSITION FOR THE CARDIOVASCULAR RISK REDUCTION	NEILOS S.R.L.
WO/2021/079254	A TOPICAL ANTIBIOTIC CONTAINING PHARMACEUTICAL COMPOSITION FOR  BACTERIAL INFECTIONS AND WOUND HEALING	SULUR, Vishagan Vanangamudi
WO/2021/074912	MIXTURE AND COMPOSITION COMPRISING FRUIT EXTRACTS, POLYPHENOLS  AND INULIN, AND USE THEREOF IN THE TREATMENT OF ACUTE AND CHRONIC  INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT	GHS - GEMELLI HEALTH SYSTEM S.R.L.
WO/2021/074913	MIXTURE COMPRISING FRUIT EXTRACTS, POLYPHENOLS EXTRACTED FROM  <i>OLEA EUROPAEA L.</i> AND INULIN, AND USE THEREOF IN THE  TREATMENT OF INFLAMMATORY DISEASES OF THE CARDIOVASCULAR SYSTEM	GHS - GEMELLI HEALTH SYSTEM S.R.L.
WO/2021/019523	A PROCESS FOR THE PREPARATION OF CARIPRAZINE SALT	SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/079273	COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF  ACUTE MYELOID LEUKEMIA	RHIZEN PHARMACEUTICALS AG
WO/2021/079300	COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE  PULMONARY DISEASES (COPD)	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/079302	PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITORS	LUPIN LIMITED
WO/2021/079303	PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  CYSTITIS OF VARIOUS ETIOLOGIES	FIDIA FARMACEUTICI S.P.A.
WO/2021/099860	PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN  AGMAT-POSITIVE CELLS IN LAYER 2/3 OF MOUSE CORTEX	FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
WO/2021/079339	A STABLE PARENTERAL DOSAGE FORM OF CETRORELIX ACETATE	SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/084401	CONFECTIONERY PRODUCT FOR INSTANT OPTICAL TOOTH WHITENING	PERFETTI VAN MELLE S.P.A.
WO/2021/084411	SUBSTANTIALLY PURE CLARITHROMYCIN 9-OXIME AND ITS PREPARATION  THEREOF	HIKAL LIMITED
WO/2021/084428	COMPOSITIONS FOR THE CARDIOVASCULAR RISK REDUCTION	NEILOS S.R.L.
WO/2021/084441	METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER	ENZYCHEM LIFESCIENCES CORPORATION
WO/2021/084483	METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1  AND LOW MEAN ARTERIAL PRESSURE	MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
WO/2021/084494	NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER	SYMTHERA CANADA LTD.
WO/2021/105792	RECTAL-USE COMPOSITION FOR THE TREATMENT OF CONSTIPATION	CAPRIKA SRL
WO/2021/084495	THE USE OF A SPLICING MODULATOR FOR A TREATMENT SLOWING  PROGRESSION OF HUNTINGTON'S DISEASE	NOVARTIS AG
WO/2021/033174	SYNTHESIS, CHARACTERIZATION, AND BIOLOGICAL EVALUATION OF  IBUPROFEN DERIVATIVE AGAINST COLON AND BREAST CANCER CELL-LINES	AL-OBAIDI, Zaid Mahdi Jaber
WO/2021/123949	PHARMACEUTICAL COMPOSITIONS COMPRISING  N-[1-(5-CYANO-PYRIDIN-2-YLMETHYL)-1H-PYRAZOL-3-YL]-2-[4-(1-TRIFLUOROMETHYL-CYCLOPROPYL)-PHENYL]-ACETAMIDE	IDORSIA PHARMACEUTICALS LTD
WO/2021/090146	COMBINATION THERAPY FOR TREATING CANCER	ASTRAZENECA AB
WO/2021/084522	BIMATOPROST 0.01% SOLUTION COMPOSITIONS FOR THE TREATMENT OF  OCULAR HYPERTENSION	RAFARM UK LIMITED
WO/2021/090154	THE INTEGRATED ACTIVE COMPOSITION FOR OSTEOARTHRITIS AND JOINT  WELLNESS	OMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/090177	COMPOUNDS FOR TREATMENT OF DENGUE INFECTION	SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/044401	PYRIMIDINE DERIVATIVES AS ANTI-DIABETIC AGENTS	UNITED ARAB EMIRATES UNIVERSITY
WO/2021/090214	BERBERINE COMPOSITIONS AND THEIR USE	ALESCO S.R.L.
WO/2021/090228	COMPOSITIONS COMPRISING BACTERIAL STRAINS FOR USE IN  INCREASING THE BIOAVAILABILITY OF AMINO ACIDS DERIVED FROM PROTEINS	SOFAR S.P.A.
WO/2021/090283	SHORTENING TUBERCULOSIS THERAPY AND REDUCING RELAPSE BY  CO-ADMINISTERING CHLOROQUINE IN TB AND HIV-TB COINFECTED CONDITIONS	FOUNDATION FOR NEGLECTED DISEASE RESEARCH
WO/2021/090284	COMPOSITION FOR THE MAKING OF AN EMULSIFIABLE TRIPHASIC  FORMULATION, AND KIT FOR THE USE OF SUCH COMPOSITION	LEVA, Francesco
WO/2021/094893	NANOPARTICLES FOR MEDICAL AND DIAGNOSTIC APPLICATIONS	FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
WO/2021/094917	STABLE AQUEOUS ANTI-TFPI ANTIBODY FORMULATION	PFIZER INC.
WO/2021/094921	GOLD NANOCLUSTER IN THE TREATMENT OF FRIEDREICH'S ATAXIA	UNIVERSITA' DEGLI STUDI DI MILANO
WO/2021/094924	LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC  SUBSTANCES	COCHLEAR LIMITED
WO/2021/094933	EZETIMIBE AND CURCUMIN FOR USE IN CANCER TREATMENT	UNIVERSITY OF SOUTH AFRICA
WO/2021/094948	COMPOSITION FOR REDUCING CARDIOVASCULAR RISK	NEILOS S.R.L.
WO/2021/094953	1-(((2S,3S,4S)-3-ETHYL-4-FLUORO-5-OXOPYRROLIDIN-2-YL)METHOXY)-7-METHOXYISOQUINOLINE-6-CARBOXAMIDE  COMBINATIONS AND ORAL DOSAGE FORMS	PFIZER INC.
WO/2021/094959	AN INJECTABLE INSECTICIDAL FORMULATION	COROMANDEL INTERNATIONAL LTD.
WO/2021/094974	HETEROCYCLIC TRPML1 AGONISTS	LIBRA THERAPEUTICS, INC.
WO/2021/094983	POLYPEPTIDES RELATED TO HMGB1 USEFUL FOR PROMOTING TISSUE  REGENERATION, COMPOSITIONS COMPRISING SAME, AND USES THEREOF	OXFORD UNIVERSITY INNOVATION LIMITED
WO/2021/094984	DOSAGE REGIMENS FOR VACCINES	AELIX THERAPEUTICS, S.L.
WO/2021/094989	HOMEOPATHIC TOPICAL COMPOSITION	V P LYF
WO/2021/099901	STABLE TOPICAL PHARMACEUTICAL COMPOSITION	INTAS PHARMACEUTICALS LTD.
WO/2021/094992	AMORPHOUS PHARMACEUTICAL COMPOSITIONS OF ABIRATERONE ACETATE	SUVEN LIFE SCIENCES LIMITED
WO/2021/094993	SYNTHETIC COMPOSITION FOR BALANCING THE BILE ACID PROFILE IN  THE INTESTINE	GLYCOM A/S
WO/2021/099906	VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES	JANSSEN BIOTECH, INC.
WO/2021/095008	PHARMACEUTICAL FORMULATION OF LONAFARNIB WITH A  SULFOBUTYLETHER B-CYCLODEXTRIN	CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTD.
WO/2021/095009	THERAPY FOR HEMATOPOIETIC CELL MALIGNANCIES USING GENETICALLY  ENGINEERED T CELLS TARGETING CD70	CRISPR THERAPEUTICS AG
WO/2021/095010	RENAL CELL CARCINOMA (RCC) THERAPY USING GENETICALLY  ENGINEERED T CELLS TARGETING CD70	CRISPR THERAPEUTICS AG
WO/2021/095011	CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS  TARGETING CD70	CRISPR THERAPEUTICS AG
WO/2021/099924	METHODS OF TREATING LUPUS NEPHRITIS USING INTERLEUKIN-17  (IL-17) ANTAGONISTS	NOVARTIS AG
WO/2021/099935	PHARMACEUTICAL FORMULATIONS FOR MANAGING URIC ACID CONTENT IN  HUMAN BODY	ZYCIE TECHNOLEGAL LLP
WO/2021/099966	NOVEL BENZOTHIOPHENE DERIVATIVES AND USE THEREOF FOR  STIMULATING MITOCHONDRIAL TURNOVER	NIBN, THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV  LTD.
WO/2021/099973	INJECTABLE COMPOSITIONS OF URSODEOXYCHOLIC ACID	SHILPA MEDICARE LIMITED
WO/2021/099974	COLOURING COMPOSITION BASED ON DYE PLANTS AND USE THEREOF FOR  HAIR DYEING	GIULIANI S.P.A.
WO/2021/099977	CROSSLINKED BUTYRATE OR BUTYRATE-FORMATE DERIVATIVES OF  HYALURONIC ACID AND THE CROSSLINKING PROCESS THEREOF	BMG PHARMA S.P.A.
WO/2021/099982	DOSAGE AND ADMINISTRATION OF A BACTERIAL SACCHARIDE  GLYCOCONJUGATE VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/099983	LANTIBIOTIC SOLUTION AGAINST BACTERIAL INFECTIONS	STERIFY S.R.L.
WO/2021/123960	CANNABINOID COMPOSITIONS WITH HIGH SOLUBILITY AND  BIOAVAILABILITY	PISAK, Mehmet Nevzat
WO/2021/090301	APREMILAST LOW-DOSE TOPICAL PHARMACEUTICAL COMPOSITIONS	SARUDBHAVA FORMULATIONS PRIVATE LIMITED
WO/2021/105840	PROCESS FOR PURIFICATION OF FLURALANER	HIKAL LIMITED
WO/2021/100027	ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL  DISORDERS	COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
WO/2021/105857	1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS	NOVARTIS AG
WO/2021/105866	NOVEL EXTRACTION PROCESS FOR THE PREPARATION OF WATER SOLUBLE  CURCUMIN OLEORESIN	SHRINIVASAN, Sowmmya
WO/2021/105869	ORAL CARE COMPOSITION WITH CHOLIC ACID COMPONENTS FOR TREATING  CARIES	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/116808	TOPICAL SKIN CARE COMPOSITION AND METHODS FOR TREATING ECZEMA	AVICANNA INC.
WO/2021/165735	BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES  THEREOF	UNIVERSITà DEGLI STUDI DEL PIEMONTE ORIENTALE "AMEDEO  AVOGADRO"
WO/2021/105900	SYSTEM AND METHOD FOR DELIVERY OF GAS TO A TISSUE	BEYOND AIR, INC.
WO/2021/105901	METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR  GROWTH	BEYOND AIR, INC.
WO/2021/234442	NOSODES FOR THE PREVENTON, ALLEVIATION OF SYMPTOMS AND  TREATMENT OF VIRAL INFECTIONS	SHAH, Rajesh
WO/2021/105922	PHARMACEUTICAL COMPOSITIONS	DOUGLAS PHARMACEUTICALS LIMITED
WO/2021/105943	MIXTURE OF HMOs	GLYCOM A/S
WO/2021/105964	MIXTURE OF HMOS FOR IMPROVING THE MICROBIOTA OF PREGNANT WOMEN	GLYCOM A/S
WO/2021/100030	STABLE PARENTERAL FORMULATIONS OF DULOXETINE	LEIUTIS PHARMACEUTICALS PRIVATE LIMITED
WO/2021/064718	TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING  LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS	CASE WESTERN RESERVE UNIVERSITY
WO/2021/111286	PREPARATION OF MICRO-ORGANISMS FOR EXTRACTING ACTIVE PLANT  INGREDIENTS, EXTRACTS OBTAINED AND THEIR USES	BIOCORIUM
WO/2021/116824	ORAL PRODUCT COMPRISING A CANNABINOID	NICOVENTURES TRADING LIMITED
WO/2021/116826	ORAL PRODUCT COMPRISING A CANNABINOID	NICOVENTURES TRADING LIMITED
WO/2021/111312	CURCUMIN COMPOSITIONS FOR OSTEOARTHRITIS AND JOINT WELLNESS	OMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/111320	METHODS FOR TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN  PATIENTS WITH DEMENTIA	SUVEN LIFE SCIENCES LIMITED
WO/2021/111330	TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA  PATIENTS	SUVEN LIFE SCIENCES LIMITED
WO/2021/111339	(S)-3-[1-METHYLPYRROLIDIN-2-YL]PYRIDINE, ANALOGUES THEREOF,  PRECURSORS THEREOF, OR ITS DERIVATIVES, FOR THE USE AS A PHARMACEUTICAL IN  FORM OF A HOMOGENEOUS, VISCOUS, SEMI-SOLID TOPICAL MEDICATION AND TOPICAL  MEDICATION	SOLIS HERRERA, Arturo
WO/2021/111340	(S)-3-[1-METHYLPYRROLIDIN-2-YL]PYRIDINE, ANALOGUES THEREOF,  PRECURSORS THEREOF, OR ITS DERIVATIVES, FOR THE USE AS A PHARMACEUTICAL IN  FORM OF A SOLID SUBSTANCE AND A TABLET	SOLIS HERRERA, Arturo
WO/2021/111358	COMPOSITION COMPRISING BUDESONIDE FOR OPHTHALMIC USE	NTC S.R.L.
WO/2021/111364	NANOSTRUCTURED DRUG DELIVERY SYSTEM AS A MULTIFUNCTIONAL  PLATFORM FOR THERAPY	UNIVERSIDADE DE COIMBRA
WO/2021/123996	USES OF ANTI-TGF-BETA ANTIBODIES AND CHECKPOINT INHIBITORS FOR  THE TREATMENT OF PROLIFERATIVE DISEASES	NOVARTIS AG
WO/2021/116854	ORAL PRODUCTS WITH ACTIVE INGREDIENT COMBINATIONS	NICOVENTURES TRADING LIMITED
WO/2021/111372	EYE TOPICAL COMPOSITION CONTAINING METABOLITES OF THE  FERMENTATION OF LACTOBACILLUS	SIFI S.P.A.
WO/2021/100031	DRUG FOR TREATMENT OR PREVENTION OF CEREBRAL HEMORRHAGE, AND  METHOD FOR TREATMENT OR PREVENTION OF CEREBRAL HEMORRHAGE USING SAID DRUG	TMS CO., LTD.
WO/2021/111385	SUSTAINED RELEASE ESTROGEN VAGINAL RING PESSARY FOR TREATMENT  OF ATROPHY, CYSTITIS AND UTEROVAGINAL PROLAPSE	CHOWDARY, Prathima
WO/2021/111404	FORMULATIONS COMPRISING A MINERAL AND/OR A VITAMIN AND A  POLYSACCHARIDE, COMPOSITIONS THEREOF AND USE THEREOF IN SUPPLEMENTING SAID  MINERAL AND/OR VITAMIN	ALESCO S.R.L.
WO/2021/111407	SOLID FORM FORMULATION COMPRISING CHROMIUM OR COPPER OR A  VITAMIN, COMPOSITIONS AND USES THEREOF	ALESCO S.R.L.
WO/2021/111419	MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF RIOCIGUAT	CADILA HEALTHCARE LIMITED
WO/2021/111422	COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR  REDUCING PAIN	GLYCOM A/S
WO/2021/116872	PHARMACEUTICAL COMPOSITIONS COMPRISING CABOTEGRAVIR	VIIV HEALTHCARE COMPANY
WO/2021/116873	ORAL CARE COMPOSITION WITH N-ACETYL AMINO ACID COMPONENTS FOR  TREATING CARIES	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/111426	HISTATIN-1 FORMULATION FOR THE TREATMENT, REPAIR OR  REGENERATION OF BONE TISSUE IN A SUBJECT	UNIVERSIDAD DE CHILE
WO/2021/116887	LIPID-CONTAINING ORAL COMPOSITION	NICOVENTURES TRADING LIMITED
WO/2021/116892	ORAL COMPOSITIONS WITH REDUCED WATER ACTIVITY	NICOVENTURES TRADING LIMITED
WO/2021/116897	PROCESS FOR THE PREPARATION OF VILDAGLIPTIN	OPTIMUS DRUGS (P) LTD
WO/2021/116901	FORMS OF BINIMETINIB AND PROCESS FOR PREPARATION THEREOF	BIOCON LIMITED
WO/2021/116907	DISSOLVABLE POLYMERIC EYE INSERTS WITH A BIODEGRADABLE POLYMER	ALCON INC.
WO/2021/116918	ORAL COMPOSITIONS INCLUDING GELS	NICOVENTURES TRADING LIMITED
WO/2021/090303	FORMULATION OF SAFFRON AND A METHOD OF PREPARATION THEREOF	ANVAR, Amirali
WO/2021/124023	GOLD- AND GRAPHENE-BASED MIXTURE AND COMPOSITIONS AND USE  THEREOF	IDI INTEGRATORI DIETETICI ITALIANI S.R.L.
WO/2021/116929	COMPOSITION COMPRISING THE BH3-MIMETIC ABT-199 (VENETOCLAX)  AND AT LEAST ONE INHIBITOR OF THE NADPH PRODUCTION	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/124028	NANOPARTICLES FOR CANCER TREATMENT	UNIVERSIDAD DE GUADALAJARA
WO/2021/116986	HAIR CLEANSER COMPOSITION, KIT AND METHOD FOR HAIR CLEANING	KAO CORPORATION
WO/2021/124044	PHARMACEUTICAL COMPOSITION OF CYCLOOXYGENASE – 2 INHIBITORS	THEMIS MEDICARE LIMITED
WO/2021/117016	COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH  STEROIDS AND A MODULATOR	BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/176268	NANOPARTICULATE FORMULATION FOR DIAGNOSIS AND/OR TREATMENT OF  CANCER	INDIAN INSTITUTE OF TECHNOLOGY KANPUR
WO/2021/171083	COMBINATION OF NICLOSAMIDE AND DOXORUBICIN	INDIAN INSTITUTE OF TECHNOLOGY KANPUR
WO/2021/124095	TREATMENT OF ULCERATIVE COLITIS WITH KINASE INHIBITORS	PFIZER INC.
WO/2021/124096	ONCE DAILY CANCER TREATMENT REGIMEN WITH A PRMT5 INHIBITOR	PFIZER INC.
WO/2021/124152	COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFECTION USING  CATIONIC POLYMERS AND STABILIZERS	PFIZER INC.
WO/2021/124172	3-(5-METHOXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE  DERIVATIVES AND USES THEREOF	NOVARTIS AG
WO/2021/124191	ORALLY ADMINISTERED COMBINATIONS OF AMOXICILLIN AND AVIBACTAM  DERIVATIVES FOR TREATING MYCOBACTERIAL INFECTIONS	ARIXA PHARMACEUTICALS, INC.
WO/2021/124210	TREATMENT WITH SITE SPECIFIC HER2 ANTIBODY-DRUG CONJUGATES	PFIZER INC.
WO/2021/124222	PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS	NOVARTIS AG
WO/2021/124244	GASTRO-RESISTANT MICROPARTICLES COMPRISING INOSITOL AND/OR  GYMNEMA SYLVESTRE EXTRACT, PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS  THEREOF AND USES THEREOF	IDI INTEGRATORI DIETETICI ITALIANI S.R.L.
WO/2021/124249	USE OF HYALURONIC ACID DERIVATIVES IN THE REGENERATION OF BONE  AND CARTILAGE TISSUES	SILDEHA SWISS S.A.
WO/2021/124253	A MULTICOMPONENT COMPOSITION COMPRISING A COLLAGEN,  RESVERATROL AND ASTAXANTHIN AND THE USE THEREOF FOR THE TREATMENT OF  TENDINOPATHIES	KOLINPHARMA S.P.A.
WO/2021/124264	VETERINARY FORMULATIONS COMPRISING RAPAMYCIN AND METHODS OF  USING THE SAME FOR TREATING ANIMAL DISEASES	TRIVIUMVET DAC
WO/2021/124266	PEGYLATION OF A TRAIL LIGAND	UNIVERSITà DEGLI STUDI "G. D'ANNUNZIO"  CHIETI-PESCARA
WO/2021/124272	CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF	LIMINAL BIOSCIENCES LIMITED
WO/2021/124277	COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS	NUEVOLUTION A/S
WO/2021/124279	COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS	NUEVOLUTION A/S
WO/2021/130638	DIACYLGLYCEROL KINASE MODULATING COMPOUNDS	CARNA BIOSCIENCES, INC.
WO/2021/124301	FORMULATIONS AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES	VYOME THERAPEUTICS INC.
WO/2021/130647	PROBIOTIC FORMULATIONS FOR LIVER AND ORAL HEALTH AND  ENHANCEMENT OF IMMUNITY	S A PHARMACHEM PRIVATE LIMITED
WO/2021/124306	COMPOSITION FOR THE PROTECTION OF THE GASTROINTESTINAL MUCOSA  AND FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED THEREWITH	NEILOS S.R.L.
WO/2021/144639	COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE PREVENTION  AND TREATMENT OF CHEMOTHERAPY SIDE EFFECTS	PROFESSIONAL DIETETICS S.P.A.
WO/2021/144640	COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND/OR  TREATMENT OF CANCER	PROFESSIONAL DIETETICS S.P.A.
WO/2021/148868	ELETRIPTAN HYDROBROMIDE FOR TREATMENT OF SPINAL CORD INJURY  AND IMPROVEMENT OF LOCOMOTOR FUNCTION	TECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA,  S.A.
WO/2021/137101	ANTIOXIDANT EXTRACTS AND COMPOSITIONS	NEXTFERM TECHNOLOGIES LTD.
WO/2021/130675	COMPOSITION AND METHODS OF MANUFACTURE	PHOENIX EAGLE COMPANY PTY LTD
WO/2021/130677	COMPOSITION WITH SUPERABSORBENT POLYMER	SHISEIDO COMPANY, LTD.
WO/2021/130684	ORALLY DISSOLVING FORMULATIONS OF PRUCALOPRIDE	SHILPA MEDICARE LIMITED
WO/2021/130700	COMPOUND FOR THE TREATMENT OF THE HEMOLYTIC-UREMIC SYNDROME	ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA
WO/2021/130728	LIQUID COMPOSITIONS COMPRISING TERPENES AND CANNABINOIDS	BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/130729	THERAPEUTIC MOLECULES FOR COMBATING SEPSIS	CENTRE FOR CELLULAR AND MOLECULAR PLATFORMS
WO/2021/130732	ANTIBACTERIAL QUINOLINES	TECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/137147	DOSAGE REGIME WITH ESKETAMINE FOR TREATING MAJOR DEPRESSIVE  DISORDER	CLEXIO BIOSCIENCES LTD.
WO/2021/137148	DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR  NEUROLOGICAL CONDITIONS	CLEXIO BIOSCIENCES LTD.
WO/2021/137152	CURABLE ORAL CARE COMPOSITION CONTAINING SILVER AND FLUORIDE	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/137154	AQUEOUS ZINC ORAL CARE COMPOSITIONS WITH FLUORIDE	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/137160	STABLE IMMEDIATE RELEASE TABLET AND CAPSULE FORMULATIONS OF  1-((2S,5R)-5-((7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)-2-METHYLPIPERIDIN-1-YL)PROP-2-EN-1-ONE	PFIZER R&D UK LIMITED
WO/2021/140417	INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY	AZURA OPHTHALMICS LTD.
WO/2021/140418	METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE  CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN  INHIBITOR AND A DIPEPTIDYL PEPTIDASE 4 INHIBITOR	RESVERLOGIX CORP.
WO/2021/144649	ADENO ASSOCIATED VIRUS BASED GENE THERAPY FOR PHENYLKETONURIA	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/209808	CER-001 THERAPY FOR TREATING KIDNEY DISEASE	ABIONYX PHARMA SA
WO/2021/144657	COMBINATION COMPRISING A TIM-3 INHIBITOR AND A HYPOMETHYLATING  AGENT FOR USE IN TREATING MYELODYSPLASTIC SYNDROME OR CHRONIC MYELOMONOCYTIC  LEUKEMIA	NOVARTIS AG
WO/2021/152390	COMPOSITIONS FOR THE TREATMENT OF ANGIOLIPOMA	RAZIEL THERAPEUTICS LTD.
WO/2021/152396	METHODS FOR PROMOTING WEIGHT LOSS	89BIO LTD.
WO/2021/152398	DOSAGES AND METHODS FOR TREATING PULMONARY ARTERIAL  HYPERTENSION WITH RODATRISTAT	ALTAVANT SCIENCES GMBH
WO/2021/171088	NANOCARRIERS FOR DELIVERY OF MOLECULES TO CLINICALLY RELEVANT  CELL TYPES	<<QR.BIO>>, LIMITED LIABILITY COMPANY
WO/2021/165749	PEPTIDES FOR TREATING MUCOSA	CARRUTHERS, Jean
WO/2021/176273	ORAL SOLID PREPARATIONS	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/176276	METHOD OF TREATING A VIRAL INFECTION	BOUKARI, Morou
WO/2021/181157	TREATMENT OF CORONAVIRUS INFECTION	REDHILL BIOPHARMA LTD.
WO/2021/181159	COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR  HEMORRHAGE AFTER RECANALIZATION THERAPY	GNT PHARMA CO., LTD.
WO/2021/186243	SKIN CARE COMPOSITIONS COMPRISING 8 OR MORE RECOMBINANT HUMAN  GROWTH FACTORS AND USE THEREOF FOR REDUCING SINGS OF AGING	SKINGEN INTERNATIONAL INC.
WO/2021/186244	ROTOMERIC ISOMERS OF  4-ALKYL-5-HETEROARYL-3H-1,2-DITHIOLE-3-THIONES	ST IP HOLDING AG
WO/2021/186245	HIGH CONCENTRATION ANTI-Aß PROTOFIBRIL ANTIBODY FORMULATIONS  AND METHODS OF USE THEREOF	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/191676	HIGHLY PURIFIED EICOSAPENTAENOIC ACID, AS FREE FATTY ACID FOR  TREATMENT OF CORONAVIRUSES AND SPECIFICALLY NOVEL CORONAVIRUS-19 (COVID-19)	S.L.A. PHARMA AG
WO/2021/186246	TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM	TRIZELL LTD.
WO/2021/191677	COMPOSITIONS AND METHODS FOR TARGETING HPV-INFECTED CELLS	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/191686	TARGETED POLY(BETA-AMINO ESTER)S	ARATINGA.BIO TNP
WO/2021/186248	FREE FATTY ACIDS AND METHODS OF MANUFACTURE AND USE FOR  TREATING CORONAVIRUS AND OTHER VIRAL RESPIRATORY INFECTIONS	LIPID PHARMACEUTICALS EHF
WO/2021/198769	VACCINE COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS	VARIATION BIOTECHNOLOGIES INC.
WO/2021/198774	SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING  CORONAVIRUS INFECTION	LIFESCIENCE AS
WO/2021/220050	NEW COMPOSITIONS USEFUL FOR TREATING ELEVATED BLOOD LIPID  LEVELS	HEALTH AND HAPPINESS (H&H) HONG KONG LIMITED
WO/2021/198777	COMPOSITIONS AND METHODS FOR TREATING CANCER	TRIZELL LTD.
WO/2021/198778	1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE FOR  PREVENTION OR TREATMENT OF EMOTIONAL BLUNTING	H. LUNDBECK A/S
WO/2021/198786	USE OF MITOCHONDRIA-TARGETED ANTIOXIDANTS TO TREAT SEVERE  INFLAMMATORY CONDITIONS	MITOTECH S.A.
WO/2021/205225	25-HYDROXYVITAMIN D FOR THE TREATMENT OF SARS-COV-2 INFECTION	EIRGEN PHARMA LTD.
WO/2021/186250	METHODS OF TREATING VIRAL INFECTIONS AND HEALTH CONSEQUENCES	DAVIDOFF, Allen
WO/2021/209815	TRANSDERMAL MICRO-DOSING DELIVERY OF PSYCHEDELICS DERIVATIVES	PIKE THERAPEUTICS, INC.
WO/2021/214544	ORAL DELIVERY SYSTEM COMPRISING HYDROXYCHLOROQUINE AND/OR  CHLOROQUINE	GLANIS PHARMACEUTICALS, INC.
WO/2021/214545	TRANSDERMAL AND/OR TOPICAL PHARMACEUTICAL FORMULATIONS  COMPRISING CANNABIDIOL AND/OR TETRAHYDROCANNABINOL FOR THE TREATMENT OF  CHRONIC PAIN	PIKE THERAPEUTICS, INC.
WO/2021/214547	COMPOSITIONS AND METHODS FOR TREATING UPPER RESPIRATORY  INFECTIONS	SANOTIZE RESEARCH AND DEVELOPMENT CORP.
WO/2021/209822	CER-001 THERAPY FOR TREATING KIDNEY DISEASE	ABIONYX PHARMA SA
WO/2021/209823	METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING  PROTEIN- BASED COMPLEXES	ABIONYX PHARMA SA
WO/2021/224679	COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS  FOR PREVENTING OR TREATING MACULAR DEGENERATION	GENOFOCUS, INC.
WO/2021/220059	COMPOSITION FOR REDUCING HEPATIC TRIGLYCERIDES AND/OR  IMPROVING GLUCOSE METABOLISM	COMPAGNIE GERVAIS DANONE
WO/2021/229294	TREATMENT FOR DEPRESSION	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/234452	COMPOSITIONS AND METHODS FOR INHIBITING REPLICATION OF  ENVELOPED RESPIRATORY VIRUSES	TSG THERAPEUTICS PTE. LTD.
WO/2021/234457	AN INHALED IL-1 BLOCKADE TREATMENT FOR RESPIRATORY TRACT  IMMUNOPATHOLOGY	ALTAVANT SCIENCES GMBH
WO/2021/234458	ADAMTS13 COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING  COMPLICATIONS OF CORONAVIRUS DISEASE	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/245458	HARD CAPSULE DOSAGE FORM AND USES THEREOF	EIRGEN PHARMA LTD.
WO/2021/250462	HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR USE IN THE TREATMENT  OF CORNEAL NERVE DAMAGE OR LOSS	I. COM MEDICAL GMBH
WO/2021/255518	COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA	RIKEN
WO/2021/250468	SYNTHETIC METHODS FOR PREPARATION OF  4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/260427	HYALURONIC ACID-BASED FORMULATIONS FOR TREATMENT AND  PREVENTION OF OCULAR HYPERTENSION AND GLAUCOMA	I.COM MEDICAL GMBH
WO/2021/255522	TRANSDERMAL DRUG DELIVERY SYSTEM FOR KETAMINE	GUANGZHOU DAZHOU BIOMEDICINE LTD.
WO/2021/255524	COMPOSITIONS AND METHODS FOR TREATING FRONTOTEMPORAL DEMENTIA	BIOASIS TECHNOLOGIES, INC.
WO/2021/191689	TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND  PHARMACEUTICAL COMPOSITIONS	YUYU PHARMA, INC.
WO/2021/260430	USE OF HIGH MOLECULAR WEIGHT HYALURONIC ACID AS OCULAR  TRANSPORTING VEHICLE	I.COM MEDICAL GMBH
WO/2021/260437	MULTI-LAYERED MEDICAMENT FOR INHALATION	MYLAN PHARMA UK LIMITED
WO/2021/260438	ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-B7-H3 ANTIBODIES	INTOCELL, INC.
WO/2021/260441	FORMULATIONS INCLUDING  5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE	MYLAN PHARMA UK LIMITED
WO/2021/260443	COMBINATIONS OF 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES	BAYER AKTIENGESELLSCHAFT
WO/2021/140424	FINGOLIMOD EXTENDED RELEASE INJECTABLE SUSPENSION	SHILPA MEDICARE LIMITED
WO/2021/140425	A PROCESS FOR PREPARATION OF IMATINIB BY USING VILSMEIER  REAGENT	SAKAR HEALTHCARE LIMITED
WO/2021/140427	PRMT5 INHIBITOR FOR USE IN A METHOD OF TREATING PSORIASIS AND  OTHER AUTOIMMUNE CONDITIONS	PFIZER INC.
WO/2021/140435	RECOMBINANT VACCINIA VIRUS	PFIZER INC.
WO/2021/140437	ANIONIC ALKYL SULPHATE COMPONENT FOR TREATING CARIES	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/140443	METHODS FOR TREATMENT OF DAMAGED BILIARY DUCTS	MOR RESEARCH APPLICATIONS LTD.
WO/2021/140478	COMBINATION THERAPY FOR TREATING CANCER	ASTRAZENECA AB
WO/2021/144720	TREATMENT OF LATE-ONSET NEURODEGENERATIVE DISEASES IN  HETEROZYGOUS NPC1 GENE MUTATION CARRIERS	INTRABIO LTD
WO/2021/144721	GRAPE SEED EXTRACTS FOR USE IN THE PREVENTION OR REDUCTION OF  STRESS	INDENA S.P.A.
WO/2021/144727	COMPOSITION FOR THE PROTECTION OF GASTRIC MUCOSA	NEILOS S.R.L.
WO/2021/144746	USE OF ICRF-193 DERIVATIVES AND PHARMACEUTICAL PREPARATIONS  CONTAINING THEREOF FOR THE PREVENTION OF CHRONIC CUMULATIVE CARDIOTOXICITY  CAUSED BY THERAPY WITH ANTHRACYCLINE ANTICANCER DRUGS	UNIVERZITA KARLOVA V PRAZE
WO/2021/144759	GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC  CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN CANCER THERAPY	CRISPR THERAPEUTICS AG
WO/2021/148969	MEDICAMENT COMPRISING A COMBINATION OF AMNIOTIC MEMBRANE AND  UMBILICAL CORD BLOOD SERUM FOR WOUND HEALING	PLACELTA (PTY) LTD
WO/2021/152430	METHOD FOR ADMINISTRATION OF URSODEOXYCHOLIC ACID	SHILPA MEDICARE LIMITED
WO/2021/148973	MULTIFUNCTIONAL NANOPARTICLES BASED ON METALLIC NANOALLOYS FOR  DIAGNOSTIC AND THERAPEUTIC USE	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/148983	ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE	PFIZER INC.
WO/2021/148986	COSMETIC COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/148990	CELLULAR UPTAKE	AXCESS LIMITED
WO/2021/148992	PHARMACEUTICAL COMPOSITIONS OF RALTEGRAVIR	LUPIN LIMITED
WO/2021/149004	A SYNERGISTIC BACTERICIDE AND BACTERIOSTATIC ORGANIC  SANITIZING/DISINFECTANT/CLEANING FORMULATION	UNIVERSIDAD DE CONCEPCIóN
WO/2021/149012	METHODS OF STIMULATING BONE GROWTH WITH ABALOPARTIDE AND  DENOSUMAB	RADIUS HEALTH, INC.
WO/2021/152441	PHARMACEUTICAL COMPOSITION FOR REDUCING PROTEIN BOUND UREMIC  TOXINS	FRIMLINE PRIVATE LIMITED
WO/2021/156698	A SINGLE LAYER CHEWABLE TABLET COMPRISING CETIRIZINE	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/152462	PROCESS FOR PREPARATION OF LASMIDITAN	GLENMARK LIFE SCIENCES LIMITED
WO/2021/152467	COMBINATIONS COMPRISING BH3-MIMETIC COMPOUNDS AND INHIBITORS  OF EARLY STAGES OF AUTOPHAGY FOR USE IN THE TREATMENT OF NON-HODGKIN'S B-CELL  LYMPHOMAS AND LYMPHOID AND/OR MYELOID LEUKEMIAS	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/152488	METHODS OF TREATING AN INFLAMMATORY OR OBSTRUCTIVE AIRWAY  DISEASE USING ANTI-TSLP ANTIBODY	NOVARTIS AG
WO/2021/152492	BUTYRIC ACID SALT-BASED COMPOSITION FOR RECTAL APPLICATION FOR  THE TREATMENT OF PROCTOLOGY DISORDERS	CAPRIKA SRL
WO/2021/152495	COMBINATION TREATMENTS AND USES AND METHODS THEREOF	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/152497	BETA-GLUCAN FOR USE IN MODULATION OF AN IMMUNE RESPONSE IN A  REMISSION	PLEURAN, S.R.O.
WO/2021/152501	COMPOUNDS FOR USE IN THE TREATMENT OF LEUKEMIA	UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA"
WO/2021/156718	METHOD AND COMPOSITION FOR MICROBIOME BASED AMELIORATION OF  SKIN ASSOCIATED AUTOIMMUNE INFLAMMATORY DISEASES	TATA CONSULTANCY SERVICES LIMITED
WO/2021/152555	NOVEL IMMUNOTHERAPY FOR TUMOURS AND CANCERS, AND ASSOCIATED  INFLAMMATION	MEDASANI, Munisekhar
WO/2021/156735	STABLE OPHTHALMIC FORMULATIONS BASED ON LOW-CONCENTRATION  POVIDONE IODIDE IN PLASTIC CONTAINERS	MEDIVIS S.R.L.
WO/2021/209826	USE OF BACTERIAL COMPOSITIONS IN THE TREATMENT AND PROPHYLAXIS  OF AIRWAY DISEASES	DE SIMONE, Claudio
WO/2021/156769	METHODS FOR TREATING NEUROLOGICAL SYMPTOMS ASSOCIATED WITH  LYSOSOMAL STORAGE DISEASES	GENZYME CORPORATION
WO/2021/156774	COMBINATION THERAPY FOR TREATING MPS1	GAIN THERAPEUTICS SA
WO/2021/156777	MICROBIAL COMBINATIONS AND USES THEREOF	BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/156787	HETEROCYCLIC COMPOUNDS AS DIHYDROOROTATE DEHYDROGENASE  INHIBITORS	JANSSEN BIOTECH, INC.
WO/2021/156792	TARGETED PLASMA PROTEIN DEGRADATION	NOVARTIS AG
WO/2021/156797	METHOD OF TREATING POSTPRANDIAL INFLAMMATION	DASMAN DIABETES INSTITUTE
WO/2021/156811	NOVEL PROCESSES FOR PREPARATION OF TEZACAFTOR	LAURUS LABS LIMITED
WO/2021/156813	XANTHAN-BASED OPHTHALMIC TOPICAL FORMULATIONS WITH A REDUCED  DOSAGE REGIMEN	SIFI S.P.A.
WO/2021/156831	MIRNA-485 INHIBITOR FOR GENE UPREGULATION	BIORCHESTRA CO., LTD.
WO/2021/156832	USE OF MIRNA-485 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL  SCLEROSIS (ALS)	BIORCHESTRA CO., LTD.
WO/2021/156833	USE OF MIRNA-485 INHIBITORS FOR TREATING TAUOPATHY	BIORCHESTRA CO., LTD.
WO/2021/156839	COMPOSITION IN THE FORM OF POWDER CONTAINING AN EXTRACT OF  CANNABIS SATIVA FOR THE TREATMENT OF INFLAMMATIONS OR INFECTIONS OR ALLERGIES  OF THE RESPIRATORY SYSTEM AND /OR HYPERSECRETION OF THE MUCUS, AND DEVICE FOR  ITS DOSAGE	SOFAR S.P.A.
WO/2021/161203	USE OF AN ALIPHATIC ESTER OF A POLYGLYCEROL PHOSPHATE AS AN  EMULSIFIER FOR THE PREPARATION OF COMPOSITIONS FOR TRICHOLOGICAL USE	GREENGREDIENTS S.R.L.
WO/2021/161205	MICROBIAL COMBINATIONS WITH MODULATORS OF THE OPIOID SYSTEM  AND USES THEREOF	EYAL RESEARCH CONSULTANTS LTD
WO/2021/165795	ASCORBIC ACID COMPONENT FOR USE IN A METHOD OF TREATING THE  SURFACE OF A PREPARED TOOTH	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/161211	MASSAGE BAR	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/161216	FARNESOID X RECEPTOR MODULATING COMPOUNDS AND METHODS OF USING  THE SAME	INORBIT THERAPEUTICS AB
WO/2021/161218	SULFINIC ACID AND SULFONIC ACID COMPOUNDS FOR USE IN  MODULATING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS	INORBIT THERAPEUTICS AB
WO/2021/161230	SMALL MOLECULE STING ANTAGONISTS	CURADEV PHARMA PVT. LTD.
WO/2021/165802	COMPOSITION FOR THE TREATMENT OF SKIN AND MUCOUS MEMBRANE  DISEASES	NEILOS S.R.L.
WO/2021/161244	NEOANTIGENS EXPRESSED IN OVARIAN CANCER AND THEIR USES	JANSSEN BIOTECH, INC.
WO/2021/161245	NEOANTIGENS EXPRESSED IN MULTIPLE MYELOMA AND THEIR USES	JANSSEN BIOTECH, INC.
WO/2021/161251	COSMETIC PRODUCT	BAKEL S.R.L.
WO/2021/161262	TREATMENT OF PATIENTS HAVING c-MET EXON 14 SKIPPING MUTATIONS	JANSSEN BIOTECH, INC.
WO/2021/161263	GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF	ABBVIE INC.
WO/2021/161274	MICRORNA ANGPTL3 INHIBITOR	DASMAN DIABETES INSTITUTE
WO/2021/161283	COMPOUNDS FOR TREATING CORONAVIRUS INFECTION	NLC PHARMA LTD
WO/2021/165841	COMPOUND FOR THE TREATMENT OF A GLYCOGENOSIS	ENEA - AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENERGIA E  LO SVILUPPO ECONOMICO SOSTENIBILE
WO/2021/165846	COMPOSITION FOR THE PROTECTION OF THE GASTROINTESTINAL MUCOSA  AND FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED THEREWITH	NEILOS S.R.L.
WO/2021/165849	THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR FOR USE IN  TREATING BRAF MUTANT NSCLC	NOVARTIS AG
WO/2021/165859	A COMPOSITION COMPRISING VITAMIN K2-7 IN COMBINATION WITH  VITAMIN K-1 IN PUREST FORM	DOUND, Yogesh
WO/2021/165876	NOVEL THERAPEUTICAL TOOLS AND METHODS USING  TEMPERATURE-SENSTIVE RECEPTORS FOR TREATING BLINDNESS	FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
WO/2021/165888	COMBINATION TREATMENT OF STROKE WITH PLASMIN-CLEAVABLE PSD-95  INHIBITOR AND REPERFUSION	NONO INC.
WO/2021/165891	INHIBITION OF REPERFUSION INJURY WITH A PSD-95 INHIBITOR	NONO INC.
WO/2021/165924	AZELAIC ACID ESTERS IN THE TREATMENT OR PREVENTION OF  DYSLIPIDEMIA AND ASSOCIATED CONDITIONS	NEW FRONTIER LABS, LLC
WO/2021/165926	A STABLE READY TO USE PHARMACEUTICAL COMPOSITION OF  LEVOTHYROXINE	INTAS PHARMACEUTICALS LTD.
WO/2021/171163	COMBINATIONS OF DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS  AND ACETYL-COA CARBOXYLASE INHIBITOR	PFIZER INC.
WO/2021/171164	COMBINATIONS FOR TREATMENT OF NAFLD/NASH AND RELATED DISEASES	PFIZER INC.
WO/2021/229311	RECOMBINANT VACCINE AGAINST COVID-19 BASED ON A PARAMYXOVIRUS  VIRAL VECTOR	LABORATORIO AVI-MEX, S.A. DE C.V.
WO/2021/171196	HYBRID COSMETIC PRODUCT CONSISTING OF CREAMY COMPACT POWDER	ART COSMETICS S.R.L.
WO/2021/171206	METHODS FOR ENHANCING TRANSDERMAL DELIVERY OF  GLYCOSAMINOGLYCANS (GAGS)	B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/171215	TOPICAL COMPOSITIONS DESIGNED TO MAINTAIN AND/OR RESTORE THE  INTEGRITY OF THE MUCOSA AND DAMAGED EPIDERMIS	RICERFARMA S.R.L.
WO/2021/171216	ANTI-AGEING COSMETIC COMPOSITIONS FOR MEN AND WOMEN,  CONTAINING BIOACTIVE PROTEIN, AND THE METHOD OF ITS PRODUCTION	REELABS PVT. LTD.
WO/2021/171222	DRY SHAMPOO COMPOSITION	CHURCH & DWIGHT CO., INC.
WO/2021/171237	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION	HK INNO.N CORPORATION
WO/2021/171239	PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE  COMPOUND	HK INNO.N CORPORATION
WO/2021/171261	A TRIPLE PHARMACEUTICAL COMBINATION COMPRISING DABRAFENIB, AN  ERK INHIBITOR AND A SHP2 INHIBITOR	NOVARTIS AG
WO/2021/176327	LIPOSOMAL COMPOSITIONS OF CURCUMIN AND PROCESS FOR PREPARATION  THEREOF	DOUND, Yogesh
WO/2021/176330	METHODS TO TREAT CANCER USING  (R)-N-(3-FLUORO-4-((3-((1-HYDROXYPROPAN-2-YL)AMINO)-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)OXY)PHENYL)-3-(4-FLUOROPHENYL)-1-ISOPROPYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXAMIDE	ARRAY BIOPHARMA INC.
WO/2021/176349	COMBINATION OF AN ANAPLASTIC LYMPHOMA KINASE INHIBITOR AND A  CYCLIN DEPENDENT KINASE INHIBITOR	PFIZER INC.
WO/2021/176352	CUSTOMMUNE: A WEB TOOL FOR DESIGNING PERSONALIZED AND  POPULATION-TARGETED PEPTIDE VACCINES	TAREK, Mohammad
WO/2021/181205	ENZYMES WITH IMPROVED THERMOSTABILITY FOR THE DEGRADATION OF  PLASTIC PRODUCTS	RODRíGUEZ CHAMORRO, Daniel Eduardo
WO/2021/176367	INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/176369	METHODS OF INHIBITING SARS-COV-2 REPLICATION AND TREATING  CORONAVIRUS DISEASE 2019	PFIZER INC.
WO/2021/186278	T CELLS THAT RESPOND TO PATIENT NEOEPITOPES	IMMUNITYBIO, INC.
WO/2021/176387	NEW USE OF PROBIOTICS	LA MARCA, Antonio
WO/2021/181221	SMALL MOLECULES FOR REGULATION OF LONG NON-CODING RNAS	CELLIDO THERAPEUTICS B.V.
WO/2021/176397	EXPRESSION OF SARS-COV PROTEINS, NUCLEIC ACID CONSTRUCTS,  VIRUS LIKE PROTEINS (VLPS) AND METHODS RELEVANT THERETO	PREMAS BIOTECH PVT. LTD
WO/2021/176409	PRESERVATIVE COMBINATION FOR VACCINE COMPOSITION	SANOFI HEALTHCARE INDIA PRIVATE LIMITED
WO/2021/181234	BACTERICIDAL DEBRIDEMENT COMPOSITIONS FOR SURGICAL SITE  INFECTIONS AND CHRONIC WOUND HEALING	DEPUY SYNTHES PRODUCTS, INC.
WO/2021/176424	ANTI-CD36 ANTIBODIES AND THEIR USE TO TREAT CANCER	ONA THERAPEUTICS, S.L.
WO/2021/176428	PHENANTHROLINE, CARBAZOLE AND FLAVYLIUM BASED CYANINES AND  COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME	JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/181248	COMPOSITIONS COMPRISING FUNCTIONAL FRAGRANCES AND  CANNABIS-DERIVED COMPOUNDS	THIS WORKS PRODUCTS LIMITED
WO/2021/224693	CANNABINOID-COMPRISING COSMETIC COMPOSITIONS	THIS WORKS PRODUCTS LIMITED
WO/2021/181258	COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF BENIGN  PROSTATIC HYPERTROPHY (BPH)	IDI INTEGRATORI DIETETICI ITALIANI S.R.L.
WO/2021/181261	LACTOFERRIN FOR ORAL INHALATION USE FOR THE TREATMENT OF A  DISEASE CAUSED BY A SARS-CORONA VIRUS	SOFAR S.P.A.
WO/2021/181262	CONTROLLED RELEASE FORMULATIONS COMPRISING DROTAVERINE OR SALT  THEREOF	ALMENDRO PROPERTIES AND TRADING LLP
WO/2021/181268	ADAM10 ENDOCYTOSIS INHIBITOR PEPTIDES AND RELATED USES FOR THE  TREATMENT OF ALZHEIMER'S DISEASE	UNIVERSITA' DEGLI STUDI DI MILANO
WO/2021/181272	BACTERIAL STRAINS AND COMPOSITIONS THEREOF FOR ORAL USE IN THE  TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY SYSTEM	SOFAR S.P.A.
WO/2021/181276	COMPOSITION COMPRISING LACTOFERRIN AND PROBIOTIC BACTERIAL  STRAINS FOR ORAL USE WITH ANTIVIRAL ACTION	SOFAR S.P.A.
WO/2021/181279	COMPOSITIONS AND METHODS FOR TREATING COVID-19 INFECTIONS  AND/OR SYMPTOMS THEREOF	ENZYCHEM LIFESCIENCES CORPORATION
WO/2021/186296	OPHTHALMIC DEVICES CONTAINING TRANSITION METAL COMPLEXES AS  HIGH ENERGY VISIBLE LIGHT FILTERS	JOHNSON & JOHNSON VISION CARE, INC.
WO/2021/181309	COMPOSITIONS AND METHODS FOR AGE RELATED EYE DISEASES  COMPRISING HIGH CONCENTRATIONS OF VITAMINS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/181310	COMPOSITIONS AND METHODS FOR EYE HEALTH COMPRISING AREDS AND  VITAMIN B COMPLEX	BAUSCH HEALTH IRELAND LIMITED
WO/2021/181311	COMPOSITIONS AND METHODS FOR EYE HEALTH COMPRISING VERY LONG  CHAIN FATTY ACIDS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/181317	MONOCLONAL ANTIBODY PHARMACEUTICAL COMPOSITION	LUPIN LIMITED
WO/2021/181366	MATERIALS AND METHODS FOR BINDING SIGLEC-3/CD33	JANSSEN BIOTECH, INC
WO/2021/186325	ALMITRINE FOR TREATING THE HYPOXEMIA OF A CORONAVIRUS  INFECTION	FORREST, Michael, David
WO/2021/181368	METHODS OF TREATING RESPIRATORY DISEASE WITH DEUPIRFENIDONE	PURETECH LYT 100, INC.
WO/2021/186334	HYDRO-SOLVO-THERMAL GRAPHENE OXIDE SYNTHESIS METHOD	SAHOO, Nanda Gopal
WO/2021/186348	DIHYDRO-SPIRO[INDOLINE-3:1'-ISOQUINOLIN]-2-ONES AS  ANTIMALARIAL AGENTS	THE UNIVERSITY OF BUEA
WO/2021/186354	CONTROLLED-RELEASE PHARMACEUTICAL FORMULATIONS FOR TREATMENT  OF INTESTINAL INFECTIONS	DPL PHARMA S.P.A.
WO/2021/186356	FORMULATION COMPRISING HIF PROLYL HYDROXYLASE INHIBITORS	CADILA HEALTHCARE LIMITED
WO/2021/186366	OPHTHALMIC CHLOROPROCAINE GEL HAVING IMPROVED FUNCTIONALITY	SINTETICA S.A.
WO/2021/186392	COMPOSITION	CARROLL, Noel
WO/2021/186396	TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFOR	ONCOTELIC INC.
WO/2021/186398	ANTI-<i>KLEBSIELLA PNEUMONIAE</i> ANTIBODIES AND  USES THEREOF	MEDIMMUNE LIMITED
WO/2021/186401	METHODS OF TREATING LYMPHEDEMA WITH DEUPIRFENIDONE	PURETECH LYT 100, INC.
WO/2021/186409	MODIFIED RELEASE FORMULATIONS AND DOSAGE REGIMENS	INVEX THERAPEUTICS LTD
WO/2021/198844	INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS	ORPHA BIOTECH S.R.L.
WO/2021/191788	LEAVE-ON LIGHT OIL HAIR COMPOSITION	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/191790	LEAVE-ON PENETRATING OIL HAIR COMPOSITION	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/191792	LEAVE-ON SERUM HAIR COMPOSITION	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/205268	COMPOSITION FOR SUPPOSITORIES FOR THE TREATMENT OF THE  PROSTATIC DISEASES	CAPRIKA SRL
WO/2021/191796	COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL  INFECTIONS, INCLUDING CORONAVIRUS INFECTIONS, AND METHODS OF USING THE SAME	ENGENEIC MOLECULAR DELIVERY PTY LTD
WO/2021/191800	ANTIMICROBIAL SOLUTIONS AND METHODS OF USING THE SAME IN THE  TREATMENT OR PREVENTION OF INFECTIONS	KERECIS AG
WO/2021/191803	ORAL TERPENE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES	CZAP RESEARCH AND DEVELOPMENT, LLC
WO/2021/191811	A NOVEL WOUND GEL COMPOSITION	ACUPHARM INVESTMENTS (PTY) LIMITED
WO/2021/191812	TREATMENT OF TYPE 2 DIABETES OR OBESITY OR OVERWEIGHT WITH  2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL}  PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC  ACID OR A PHARMACEUTICALLY SALT THEREOF	PFIZER INC.
WO/2021/191815	COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS  EXTRACTS AND METHODS OF USING SAME	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/191826	MODULATING AN IMMUNE RESPONSE WITH CUPROUS COMPLEXES	C LAB PHARMA INTERNATIONAL, S.A.
WO/2021/191827	TRIPEPTIDES DERIVATIVES FOR TREATING SARS-COV-2 INFECTIONS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/191840	COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS  EXTRACTS AND METHODS OF USING SAME	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/191855	BACTERIAL STRAINS, THE COMPOSITIONS THEREOF AND USE THEREOF IN  A METHOD FOR THE TREATMENT OF VITAMIN D DEFICIENCY, AND DISORDERS ASSOCIATED  THEREWITH	SOFAR S.P.A.
WO/2021/198863	COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF  PATHOGENIC ESCHERICHIA COLI	INTRON BIOTECHNOLOGY, INC.
WO/2021/191864	FOOD SUPPLEMENTS FOR THE PREVENTION OF COVID-19	DOUND, Yogesh
WO/2021/191871	IN VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING  THE EFFICACY OF ADOPTIVE CELL THERAPY	DCPRIME B.V.
WO/2021/191875	CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL  INFECTIONS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/191883	SMALL MOLECULES INDUCING THE DEGRADATION OF THE CELLULAR PRION  PROTEIN	ISTITUTO NAZIONALE DI FISICA NUCLEARE
WO/2021/198880	STABILIZED IGG4 ANTIBODIES AND USES THEREOF	MEDIMMUNE, LLC
WO/2021/198908	OPHTHALMIC COMPOSITIONS FOR TREATING CORONAVIRUSES	CORONEO, Minas Theodore
WO/2021/198909	COMPOSITIONS FOR TREATMENT OF SPINAL CORD INJURY, METHODS AND  USES THEREOF	UNIVERSIDADE DO MINHO
WO/2021/198921	SYNERGISTIC HERBAL COMPOSITION AS A BROAD-SPECTRUM  PROPHYLACTIC MAJOR AND METHOD TO PREPARE THE SAME	SINGH, Pawan Kumar
WO/2021/198927	COMPOSITIONS FOR THERAPY OR TREATMENT OF PARKINSON'S DISEASE,  METHODS AND USES THEREOF	UNIVERSIDADE DO MINHO
WO/2021/198929	ANTI-IL6 AGENT FOR TREATING CORONAVIRUS INFECTION	JANSSEN BIOTECH, INC.
WO/2021/198938	DIISOPROPYLAMINE COMPOUND AND IODINE FOR TREATING CANCER,  ENDOMETRIOSIS AND PAIN IN PATIENTS WITH CANCER OR ENDOMETRIOSIS	THAI MINH PHARMACEUTICALS JSC
WO/2021/198940	COMPOSITION FOR PREVENTING OR TREATING CHRONIC OR ACUTE VIRUS  INFECTION AND/OR SEPSIS IN HUMANS OR ANIMALS	THAI MINH PHARMACEUTICALS JSC
WO/2021/205289	METHOD FOR TRANSFORMING INHOMOGENEOUS AQUEOUS SOLUTIONS  COMPRISING INORGANIC AND ORGANIC COMPONENTS INTO HOMOGENEOUS SOLUTION	INNOSTUDIO ZRT.
WO/2021/198949	DUAL ANTAGONIST OF PGD2/DPR2 AND THROMBOXANE A2/TPR RECEPTORS  AND USE FOR TREATMENT OF MALAPTIVE IMMUNE RESPONSE OR THROMBOTIC DIATHESIS	GUPTA, Nisha
WO/2021/198954	EXOSOME-ENRICHED EXTRACELLUALR VESICLES ISOLATION, METHOD AND  USES THEREOF	UNIVERSIDADE DO MINHO
WO/2021/198962	METHOD FOR TREATING VIRAL DISEASES	CYTOCOM INC.
WO/2021/198965	NEODEGRADER CONJUGATES	ORUM THERAPEUTICS, INC.
WO/2021/198966	CONJUGATES	ORUM THERAPEUTICS, INC.
WO/2021/205296	METHOD OF TREATING COVID-19	PFIZER INC.
WO/2021/205297	ADMINISTRATION OF mTOR INHIBITORS INTO THE CENTRAL NERVOUS  SYSTEM	DOLCETTA, Diego
WO/2021/198980	METHODS OF TREATING CORONAVIRUS DISEASE 2019	PFIZER INC.
WO/2021/198981	ANTIVIRAL COMPOUNDS AND USES THEREOF	JANSSEN BIOPHARMA, INC.
WO/2021/198985	TETRAHYDROCANNABINOL EMULSION AND METHOD OF MAKING AND USING	BROWN, Brian
WO/2021/198995	STABLE AQUEOUS PARENTERAL SOLUTIONS OF DESGLYMIDODRINE	CADILA HEALTHCARE LIMITED
WO/2021/205303	FORMULATION COMPRISING OZONATED OIL FOR USE IN THE PREVENTION  AND/OR TREATMENT OF LEISHMANIASIS	PROJECT & COMMUNICATIONS LTD
WO/2021/199003	OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF INFLAMMATION OR  INFECTIOUS DISEASE CAUSED BY CORONAVIRUS INFECTION	VASCULAR BIOGENICS LTD.
WO/2021/205326	CURABLE COMPOSITIONS AND METHODS OF USING THE SAME	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/205338	ALISPORIVIR FOR USE IN HUMAN VIRAL INFECTIONS	DEBIOPHARM INTERNATIONAL SA
WO/2021/205341	1-METHYLNICOTINAMIDE FOR THE PREVENTION/TREATMENT OF  INFLAMMATORY AIRWAY DISEASES	PHARMENA S.A.
WO/2021/176434	CPG-ADJUVANTED SARS-COV-2 VIRUS VACCINE	VALNEVA AUSTRIA GMBH
WO/2021/205350	HA-PACLITAXEL CONJUGATE FOR TREATMENT OF MESOTHELIOMA	FIDIA FARMACEUTICI S.P.A.
WO/2021/205358	COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY	JANSSEN BIOTECH, INC.
WO/2021/205359	ANTI-PHF-TAU ANTIBODIES AND USES THEREOF	JANSSEN BIOTECH, INC.
WO/2021/205363	CO-TREATMENT WITH CDK4/6 AND CDK2 INHIBITORS TO SUPPRESS TUMOR  ADAPTATION TO CDK2 INHIBITORS	PFIZER INC.
WO/2021/209863	CORONAVIRUS-INHIBITOR MEDICAL AID	ADAMAS BIOTECH S.R.L.
WO/2021/205367	USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF LIVER  CANCER, MELANOMA, LYMPHOMA AND LEUKEMIA	ASKAT INC.
WO/2021/205376	CALORIC RESTRICTION MIMETIC COMPOSITIONS	SOLONGEVITY NUTRACEUTICALS S.R.L.
WO/2021/205391	TARGETED PROTEASE DEGRADATION (TED) PLATFORM	EUBULUS BIOTHERAPEUTICS INC.
WO/2021/205395	USE OF BACTERIAL STRAINS LACTOBACILLUS BREVIS, LACTOBACILLUS  PLANTARUM AND/OR LACTOBACILLUS PENTOSUS IN THE REDUCTION OF AN INGESTED OR  ACCUMULATED AMOUNT OF PHOSPHONATES IN THE HUMAN MICROBIOTA	PROBIOTICAL S.P.A.
WO/2021/205402	ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER	JINA PHARMACEUTICALS, INC.
WO/2021/205403	ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER	JINA PHARMACEUTICALS, INC.
WO/2021/205404	ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER	JINA PHARMACEUTICALS, INC.
WO/2021/205405	ENDOXIFEN FOR THE TREATMENT OF BIPOLAR I DISORDER	JINA PHARMACEUTICALS, INC.
WO/2021/205408	IGY IMMUNOGLOBULINS TARGETING CORONAVIRUS, METHODS OF  PREPARING SAME, AND METHODS OF USING SAME	IGY IMMUNE TECHNOLOGIES AND LIFE SCIENCES INC.
WO/2021/205411	COMPOSITIONS COMPRISING NANOPARTICLES, METHOD OF MAKING AND  USES THEREOF	ORGANICELL REGENERATIVE MEDICINE, INC.
WO/2021/205412	2-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL  DISEASE, IN PARTICULAR OF COVID-19	EXPLORATION INVEST PTE LTD
WO/2021/234471	AN ANTIBODY FRAGMENT BASED ANTIMICROBIAL CONJUGATE SELECTIVELY  TARGETING PSEUDOMONAS	ABGENICS LIFESCIENCES PRIVATE LIMITED
WO/2021/214588	ANTI-TNF ALPHA AGENT FOR TREATING CORONAVIRUS INFECTIONS	JANSSEN BIOTECH, INC.
WO/2021/209892	PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE  COMPOUND	HK INNO.N CORPORATION
WO/2021/209893	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING  AMIN OP YRIMIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE, OR  SOLVATE THEREOF	JANSSEN BIOTECH, INC.
WO/2021/209897	PSMA AND STEAP1 VACCINES AND THEIR USES	JANSSEN BIOTECH, INC.
WO/2021/209900	INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION	VIIV HEALTHCARE UK (NO.5) LIMITED
WO/2021/209910	3-AZA-BICYCLE[3.2.1]OCTANE CARBOXYLIC ACIDS AND THEIR  DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATIONS	MINERVA S.R.L.
WO/2021/209919	SOLID ORAL DOSAGE FORM COMPRISING POMALIDOMIDE	TECNIMEDE - SOCIEDADE TéCNICO-MEDICINAL, SA
WO/2021/209925	CORONAVIRUS SEROLOGY ASSAY	PFIZER INC.
WO/2021/209935	PROCESS FOR THE SYNTHESIS OF A CONJUGATE OF HYALURONIC ACID  AND PACLITAXEL	FIDIA FARMACEUTICI S.P.A.
WO/2021/209940	PHARMACEUTICAL COMPOSITION CONTAINING  N-(4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE,  (2S)-HYDROXYBUTANEDIOATE	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/209942	MICROBIAL TREATMENT FOR WATER SYSTEMS AND SOIL REMEDIATION	NEW LIFE BIOSCIENCES LLC
WO/2021/209945	METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER	TAVANTA THERAPEUTICS HUNGARY INCORPORATED
WO/2021/209947	STABLE READY TO DILUTE FORMULATIONS OF CARFILZOMIB	KASHIV BIOSCIENCES, LLC
WO/2021/220099	SEMI-SOLID FORMULATION FOR VOLUNTARY ORAL ADMINISTRATION OF  BIOACTIVE COMPOUNDS TO RODENTS	UNIVERSIDADE DE COIMBRA
WO/2021/209956	METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS  WITH DIVALPROEX SODIUM	FLAMEL IRELAND LIMITED
WO/2021/209965	A SAPOGENIN POLYETHYLENE GLYCOL ESTER COMPLEX OF FORMULA-I, A  COMPOSITION, PROCESS OF PREPARATION, AND APPLICATIONS THEREOF	PHYTOSOL INDIA PRIVATE LIMITED
WO/2021/209970	SARS COV-2 SPIKE PROTEIN CONSTRUCT	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/209975	OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT  LINEAR HYALURONIC ACID	WELIFEPHARMA SAGL
WO/2021/214623	DOSING REGIMEN FOR TREATING A DISEASE MODULATED BY CSF-1R	NOVARTIS AG
WO/2021/214624	METHODS AND COMPOSITIONS FOR INHIBITING ENVELOPED VIRUSES  USING LOW MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERS	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/214625	METHODS OF INHIBITING ENVELOPED VIRUSES USING LOW MOLECULAR  WEIGHT HYDROPHOBICALLY MODIFIED POLYMERS	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/214626	METHODS AND COMPOSITIONS FOR INHIBITING INFLUENZA VIRUSES  USING LOW MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERS AND POLYALKYLENE  GLYCOLS	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/214627	METHODS AND COMPOSITIONS FOR INHIBITING ENVELOPED VIRUSES  USING HIGH MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERS	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/214628	METHODS AND COMPOSITIONS FOR INHIBITING ENVELOPED VIRUSES  USING HIGH MOLECULAR WEIGHT HYDROPHOBICALLY MODIFIED POLYMERS	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/214637	COMPOSITION AND METHODS FOR TREATING RESPIRATORY DISEASES	ST. JUDE CHILDREN'S RESEARCH HOSPITAL
WO/2021/214658	PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PRODUCTS OF  HETERODIMERIC HUMAN INTERLEUKIN-15 (HETIL-15)	NOVARTIS AG
WO/2021/214661	ORAL COMPOSITION COMPRISING S-ADENOSYL METHIONINE AND A  PROBIOTIC AND ITS USE FOR TREATING AND/OR PREVENTING MOOD DISORDERS	MONTEFARMACO OTC S.P.A.
WO/2021/234475	MODIFIED RELEASE COMPOSITIONS AND METHODS OF MEMANTINE HCL  EXTENDED RELEASE, DONEPEZIL HCL IMMEDIATE RELEASE PELLETS	PELLETS PHARMA LIMITED
WO/2021/214674	FOAMING MAKEUP REMOVER	ELEGANT BEST INVESTMENT LIMITED
WO/2021/214688	PHARMACEUTICAL COMPOSITIONS AND ANTI-VIRAL USES THEREOF	ZION MEDICAL B.V.
WO/2021/214703	A VACCINE AGAINST SARS-COV-2 AND PREPARATION THEREOF	CADILA HEALTHCARE LIMITED
WO/2021/214717	DOSING REGIMEN FOR THE USE OF SIPONIMOD FOR THE TREATMENT OF  ACUTE RESPIRATORY DISTRESS SYNDROME	NOVARTIS AG
WO/2021/220124	A PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING  L-CARNOSINE AND GLUTATHIONE, ITS PRECURSORS OR DERIVATIVES THEREOF	SINGH, Shyam Sunder
WO/2021/220132	METHODS AND COMPOSITIONS FOR OCULAR CELL THERAPY	NOVARTIS AG
WO/2021/220133	NOVEL MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF  TAMSULOSIN AND SOLIFENACIN	ZIM LABORATORIES LIMITED
WO/2021/214738	OXYSTEROL FOR THE USE IN THE TREATMENT AND THE PREVENTION OF  CORONAVIRUS DISEASES	PANOXYVIR SRL
WO/2021/220136	COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF  RESPIRATORY TRACT INFECTIONS	TDC TECHNOLOGY DEDICATED TO CARE SRL
WO/2021/220137	PANNEXIN-1 INHIBITORS FOR THE TREATMENT OF SARS-COV-2 INFECTED  COVID-19 PATIENTS WITH OR WITHOUT AN ASSOCIATED ACUTE RESPIRATORY SYNDROME	SAPIR PHARMACEUTICALS INC.
WO/2021/245473	TLR 9 INHIBITORS	INSILICO MEDICINE IP LIMITED
WO/2021/224724	ANTI-CANCER PROTEINS	UNICHEM LABORATORIES LTD
WO/2021/220178	IAP ANTAGONISTS AND THEIR THERAPEUTIC APPLICATIONS	COMINNEX ZRT.
WO/2021/220194	OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF  BRINZOLAMIDE AND BRIMONIDINE	SENTISS PHARMA PRIVATE LIMITED
WO/2021/220199	CCR7 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER	NOVARTIS AG
WO/2021/220211	SUPERFOOD FOR PROLONGING THE LONGEVITY OF AN INDIVIDUAL	GIULIANI S.P.A.
WO/2021/220216	METHODS FOR CLEARING VITREOUS HEMORRHAGE	MOR RESEARCH APPLICATIONS LTD.
WO/2021/220236	PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY	CADILA HEALTHCARE LIMITED
WO/2021/220246	RECOMBINANT SARS-COV-2 POLYPEPTIDES AND USES	UNIVERSITY OF CAPE TOWN
WO/2021/234483	INHIBITORS OF CORONAVIRUS PROTEASE	SUNSHINE BIOPHARMA INC.
WO/2021/220250	LERIGLITAZONE FOR TREATING LUNG INFLAMMATION AND INTERSTITIAL  LUNG DISEASE	MINORYX THERAPEUTICS S.L.
WO/2021/220251	AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN	KASHIV BIOSCIENCES, LLC
WO/2021/220253	AN IMPROVED PROCESS OF AFFINITY CHROMATOGRAPHY	KASHIV BIOSCIENCES, LLC
WO/2021/224766	METHODS FOR TREATING CORONAVIRUS DISEASE	SIBCELL BIOTECH AB
WO/2021/224784	COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS	LANDA LABS (2012) LTD.
WO/2021/224785	COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS	LANDA LABS (2012) LTD.
WO/2021/224786	COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS	LANDA LABS (2012) LTD.
WO/2021/224789	COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS	LANDA LABS (2012) LTD.
WO/2021/224793	COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS	LANDA LABS (2012) LTD.
WO/2021/224794	COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS	LANDA LABS (2012) LTD.
WO/2021/224803	PEPTIDE INHIBITORS OF SARSR-COV INFECTION	NONO INC.
WO/2021/224809	PROLINE HYDROXYLASE INHIBITORS FOR USE IN THE SKELETAL MUSCLE  REGENERATION	POLICLINICO SAN DONATO S.P.A. - ISTITUTO DI RICOVERO E CURA A  CARATTERE SCIENTIFICO
WO/2021/224813	DISEASE MODIFYING AGENTS, DRUG DELIVERY SYSTEM AND METHOD  THEREOF FOR THE MANAGEMENT OF OSTEOARTHRITIS	INDIAN INSTITUTE OF TECHNOLOGY KANPUR
WO/2021/224815	STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL  ANTI-INFLAMMATORY DRUG (NSAID)	CADILA HEALTHCARE LIMITED
WO/2021/224818	ISOINDOLONE COMPOUNDS AS HPK1 INHIBITORS	PFIZER INC.
WO/2021/224823	METHODS OF TREATING CROHN'S DISEASE WITH ANTI-IL23 SPECIFIC  ANTIBODY	JANSSEN BIOTECH, INC.
WO/2021/224825	COMPOSITIONS COMPRISING THYMOL FOR USE IN THE TREATMENT OF  INFLAMMATORY OR FUNCTIONAL BOWEL DISORDERS BY MODULATING THE ENDOCANNABINOID  SYSTEM	VETAGRO INTERNATIONAL S.R.L.
WO/2021/224836	A SYNERGISTIC FORMULATION FOR MANAGEMENT OF RESPIRATORY  PATHOGENS INCLUDING CORONAVIRUSES	SABHARANJAK, Shefali
WO/2021/224854	COMPOSITION FOR THE PREVENTION AND TREATMENT OF FOLATE AND/OR  VITAMIN B12 DEFICIENCY CONDITIONS, PARTICULARLY HYPERHOMOCYSTEINEMIA	INPHA RESEARCH S.R.L.
WO/2021/224867	PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND NAZARTINIB	NOVARTIS AG
WO/2021/224890	METHODS OF TREATING OR PREVENTING CORONAVIRUS INFECTION	AURINIA PHARMACEUTICALS INC.
WO/2021/229397	COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF  PATHOGENIC ESCHERICHIA COLI	INTRON BIOTECHNOLOGY, INC.
WO/2021/229419	SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC  MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE  GASTROINTESTINAL TRACT	MOGON PHARMACEUTICALS SAGL
WO/2021/229420	SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC  MATRICES FOR CHRONOTROPIC ADMINISTRATION IN THE GASTROINTESTINAL TRACT OF  FOODS, DIET SUPPLEMENTS, NUTRACEUTICALS AND MEDICAL DEVICES	GIELLEPI S.P.A.
WO/2021/229433	COMPOSITIONS COMPRISING BACTERIAL STRAINS AND USE THEREOF FOR  THE TREATMENT OF OCULAR DISEASES AND LESIONS	PROBIOTICAL S.P.A.
WO/2021/229439	THERAPEUTIC COMBINATIONS COMPRISING A CRAF INHIBITOR	NOVARTIS AG
WO/2021/229442	STABLE FORMULATIONS OF TEMOZOLOMIDE FOR ORAL ADMINISTRATION	SHORLA PHARMA LTD
WO/2021/229448	RNA REPLICON ENCODING A STABILIZED CORONA VIRUS SPIKE PROTEIN	JANSSEN PHARMACEUTICALS, INC.
WO/2021/229450	SARS-COV-2 VACCINES	JANSSEN PHARMACEUTICALS, INC.
WO/2021/229452	PURINE DERIVATIVES AS SIK-3 INHIBITORS	RHIZEN PHARMACEUTICALS AG
WO/2021/229461	MYELIN NANOVESICLES AND USES THEREOF	CONSIGLIO NAZIONALE DELLE RICERCHE
WO/2021/229466	PHARMACEUTICAL COMPOSITION CONTAINING EDARAVONE AS AN ACTIVE  AGENT	TOV «MEDYCHNYI TSENTR «M.T.K.»
WO/2021/229467	COMBINED HYPEROSMOLAR SOLUTION FOR INFUSION	M.T.K. MEDICAL CENTER LIMITED LIABILITY COMPANY
WO/2021/240281	ORAL LIQUID FORMULATIONS OF LENVATINIB	SHILPA MEDICARE LIMITED
WO/2021/229479	COMPOSITION FOR PREVENTING OR TREATING OBESITY-RELATED DISEASE  CONTAINING AMPHIREGULIN-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE STRUCTURE	BIONEER CORPORATION
WO/2021/229480	POLYMORPH OF RIFAXIMIN, PROCESS FOR THE PREPARATION THEREOF  AND PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMIN	ATRA PHARMACEUTICALS LIMITED
WO/2021/229501	MIXTURE AND COMPOSITION FOR THE PREVENTION AND TREATMENT OF  DISEASES OF THE CIRCULATORY SYSTEM AND OF RELATED SYMPTOMS	NEILOS S.R.L.
WO/2021/229513	TOOLS AND METHOD FOR PREVENTING AAV NEUTRALIZATION BY  ANTIBODIES	GENETHON
WO/2021/229514	PHARMACEUTICAL IVERMECTIN COMPOSITIONS	ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED
WO/2021/229519	STEROLS IN THE TREATMENT AND/OR PREVENTION OF SARS-COV-2  INFECTION	BAR PHARMACEUTICALS SOCIETA' A RESPONSABILITA' LIMITATA
WO/2021/250482	OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF  FLUOROQUINOLONE ANTIBACTERIAL AGENT AND AN ANTI-INFLAMMATORY AGENT	SENTISS PHARMA PRIVATE LIMITED
WO/2021/229533	A FATTY ACID BASED COMPOSITION FOR TREATMENT AND/OR PREVENTION  OF ENVELOPED-VIRUS RELATED INFECTIONS	PALANI LLC
WO/2021/234526	NOVEL EXTENDED RELEASE COMPOSITION OF  2-(2-AMINOTHIAZOL-4-YL)-N-[4-(2-{[(2R)-2-HYDROXY2-PHENYLETHYL] AMINO} ETHYL)  PHENYL] ACETAMIDE	ZIM LABORATORIES LIMITED
WO/2021/234527	AN ANTIBODY FRAGMENT BASED ANTIFUNGAL CONJUGATE SELECTIVELY  TARGETING CANDIDA	ABGENICS LIFESCIENCES PRIVATE LIMITED
WO/2021/234530	NOVEL EXTENDED RELEASE COMPOSITION OF TOFACITINIB, ITS  DERIVATIVES AND SALTS	ZIM LABORATORIES LIMITED
WO/2021/240293	COMBINATION OF ACTIVE INGREDIENTS, COMPOSITIONS CONTAINING IT  AND THEIR USE TO SUSTAIN AND STRENGTHEN THE IMMUNE SYSTEM	APHARM SRL
WO/2021/234532	PHARMACEUTICAL FORMULATIONS AND THEIR PREPARATIONS FOR  TREATMENT OF CANCER	CELLIX BIO PRIVATE LIMITED
WO/2021/240295	PROCESS FOR PREPARATION OF FAVIPIRAVIR	GLENMARK LIFE SCIENCES LIMITED
WO/2021/234536	LIPOPHILIC EYE CONTOUR GEL AND METHOD FOR THE PREPARATION  THEREOF	OFFHEALTH S.P.A.
WO/2021/234538	PROCESS FOR PREPARING AN ACTIVE LIPOSOME, RELATED COMPOSITIONS  AND USES	LABIOTRE S.R.L.
WO/2021/234548	LIPID-POLYMER COMPOSITIONS AND METHODS OF USE	MAX BIOLOGY CO. LTD.
WO/2021/234560	COMPOSITIONS COMPRISING A T CELL REDIRECTION THERAPEUTIC AND A  VLA-4 ADHESION PATHWAY INHIBITOR	JANSSEN BIOTECH, INC.
WO/2021/234562	SLOW-RELEASE MEDICAL PLASTER	FIDIA FARMACEUTICI S.P.A.
WO/2021/234584	PHARMACEUTICAL COMPOSITIONS COMPRISING ADALIMUMAB	SHILPA BIOLOGICALS PRIVATE LIMITED
WO/2021/234634	METHOD OF TREATING INFLAMMATORY BOWEL DISEASE WITH A  COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF ALPHA	JANSSEN BIOTECH, INC.
WO/2021/234642	THE COMBINATION OF ACETYL LEUCINE AND 4-AMINOPYRIDINE OR  ACETAZOLAMIDE FOR TREATING ATAXIA	INTRABIO LTD
WO/2021/234650	METHOD OF TREATING OR PREVENTING AN INFECTION	SUPERBREWED FOOD, INC.
WO/2021/234660	COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DISEASES  OF THE RESPIRATORY TRACT AND AS A STIMULANT OF THE IMMUNE SYSTEM	NEILOS S.R.L.
WO/2021/234662	GENETICALLY ENGINEERED CAR T CELLS THAT SECRETE INTERLEUKIN-12  AND THERAPEUTIC USES THEREOF	CRISPR THERAPEUTICS AG
WO/2021/234668	SYSTEM, METHOD AND USE OF A CERTAIN MEDICATION FOR REDUCING  VIRAL REPLICATION IN THE AIRWAYS MUCOSAE	RIVEROS, Carlos Alberto
WO/2021/240330	PHARMACEUTICAL COMPOSITION OF EXTENDED-RELEASE ORAL SUSPENSION  AND PROCESS FOR PREPARATION THEREOF	LYRUS LIFE SCIENCES PVT LTD
WO/2021/234676	COMPOUNDS AND METHODS FOR SUPPRESSING AN IMMUNE RESPONSE TO  SUBSTANCES CONTAINING POLYETHYLENE GLYCOL	AAB THERAPEUTICS, LLC
WO/2021/240333	CRYSTALLINE FORMS OF SOLVATES OF TRYPTOPHAN DERIVATIVES,  COMPOSITIONS COMPRISING THEM AND USES THEREOF	GALIMEDIX THERAPEUTICS INC.
WO/2021/240340	PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1  IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES	UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA"
WO/2021/240352	PHARMACEUTICAL FORMULATIONS OF PILOCARPINE R-(+)-LIPOATE	CELLIX BIO PRIVATE LIMITED
WO/2021/240368	TREATMENT OF AUTISM SPECTRUM DISORDER WITH CANNABIDIOL	ZYNERBA PHARMACEUTICALS, INC.
WO/2021/240371	METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS  INFECTION AND ASSOCIATED COAGULOPATHY	UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/240373	DOSING REGIMENS FOR  <i>N</i>-((5-FLUORO-2,3-DIHYDROBENZOFURAN-4-YL)METHYL)-8-(2-METHYLPYRIDIN-3-YL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE,  OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR USE IN TREATING  PRC2-MEDIATED DISEASES OR DISORDERS	NOVARTIS AG
WO/2021/240375	METHOTREXATE FOR USE IN THE PHARMACEUTICAL OR VETERINARY  PREVENTION AND/OR TREATMENT OF VIRAL INFECTIONS	BLUEPRINT PHARMA S.R.L.
WO/2021/240376	OPHTHALMIC NANOEMULSION COMPOSITIONS	LUPIN LIMITED
WO/2021/240382	COMPOSITION COMPRISING PEPSTATIN AND ALGINIC ACID OR A SALT  THEREOF, AND USE THEREOF	DRUGS MINERALS AND GENERICS ITALIA S.R.L. IN FORMA ABBREVIATA  D.M.G. ITALIA S.R.L.
WO/2021/240383	TABLET COMPRISING OPICAPONE	ONO PHARMACEUTICAL CO., LTD.
WO/2021/240388	PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES  THEREOF	JANSSEN BIOTECH, INC.
WO/2021/245499	NOVEL SMALL MOLECULES FOR TARGETED DEGRADATION OF UNTARGETABLE  KRAS IN CANCER THERAPY	PILLAI UNIVERSAL LLC
WO/2021/240398	COMPOSITIONS COMPRISING A DERIVATIVE OF <i>CANNABIS  SATIVA</i> AND BACTERIAL STRAINS AND THERAPEUTIC USE THEREOF	SOFAR S.P.A.
WO/2021/240399	COMPOSITIONS COMPRISING A DERIVATIVE OF CANNABIS SATIVA AND  BACTERIAL STRAINS AND THERAPEUTIC USE THEREOF	SOFAR S.P.A.
WO/2021/245503	PROCESS FOR THE PREPARATION OF EFLORNITHINE DERIVATIVES AND  THEIR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF	CELLIX BIO PRIVATE LIMITED
WO/2021/240436	COMPOSITIONS AND METHODS FOR TREATING NONINFLAMMATORY PAIN IN  SUBJECTS WITH RHEUMATOID ARTHRITIS	SANOFI BIOTECHNOLOGY
WO/2021/240454	TREATMENT FOR PSORIASIS AND SKIN INFLAMMATORY DISEASES	CADILA HEALTHCARE LIMITED
WO/2021/245512	NEUROKININ (NK)-1 RECEPTOR ANTAGONISTS FOR USE IN THE  TREATMENT OF PULMONARY FIBROSIS CONDITIONS PROMOTED BY MECHANICAL INJURY TO  THE LUNGS	NERRE THERAPEUTICS LIMITED
WO/2021/255560	ANATABINE POWDER COMPOSITIONS	PHILIP MORRIS PRODUCTS S.A.
WO/2021/240458	AN IMPROVED PROCESS OF STORING AND PREPARING THE PROTEIN	KASHIV BIOSCIENCES, LLC
WO/2021/240461	DIETARY SUPPLEMENTS	NEOLIFE INTERNATIONAL LLC
WO/2021/245518	BETA-CRYPTOXANTHIN COMPOSITION FOR EYE HEALTH	OMNIACTIVE HEALTH TECHNOLOGIES LIMITED
WO/2021/245519	FAST DISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING  CAPECITABINE	SHILPA MEDICARE LIMITED
WO/2021/245520	COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF  PATHOGENIC ESCHERICHIA COLI	INTRON BIOTECHNOLOGY, INC.
WO/2021/245522	LIQUID CANNABIS COMPOSITIONS AND USES THEREOF	BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD.
WO/2021/245533	TREATMENT FOR THE INFLAMMATORY BOWEL DISEASE	CADILA HEALTHCARE LIMITED
WO/2021/245539	DRUG CONJUGATE HAVING ENHANCED DRUG DELIVERY AND  INTERNALIZATION EFFICIENCY	BIK THERAPEUTICS INC.
WO/2021/245541	A COMPOSITION OF PEGYLATED INTERFERON ALPHA-2B FOR THE  TREATMENT OF SARS-COV-2 INFECTION AND RELATED MANIFESTATIONS	CADILA HEALTHCARE LIMITED
WO/2021/245547	LIPOSOMAL SYSTEM WITH KILLER TNF-APOPTOSIS INDUCED LIGAND  (KILLERTRAIL), PRO-APOPTOTIC-DIRECTING	UNIVERSITà DEGLI STUDI "G. D'ANNUNZIO"  CHIETI-PESCARA
WO/2021/245569	PHARMACEUTICAL COMPOSITION COMPRISING: A BISABOLOL COMPOUND,  VALENCENE AND A|TERPINENE COMPOUND	RHEA GENETICS PTE. LTD.
WO/2021/245590	AN IMPROVED PROCESS FOR THE PREPARATION OF TRIAZOLE  DERIVATIVES	METROCHEM API PRIVATE LIMITED
WO/2021/245611	MODIFIED BETACORONAVIRUS SPIKE PROTEINS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/250519	COMPOSITIONS FOR TOPICAL TREATMENT OF ACQUIRED MELANOSIS OF  THE SKIN	PROFESSIONAL DIETETICS S.P.A.
WO/2021/250571	BIOAVAILABLE SUGAR-BASED DICLOFENAC FORMULATIONS	APR APPLIED PHARMA RESEARCH, S.A.
WO/2021/250606	COMPOSITION FOR TREATING CORONAVIRUS DISEASE-19 (COVID-19)	JW PHARMACEUTICAL CORPORATION
WO/2021/250611	CONTROLLED RELEASE OF SELF-EMBEDDING PARTICLES FOR LOCALIZED  DRUG DELIVERY	JANSSEN BIOTECH, INC.
WO/2021/250620	COMPOSITIONS AND METHODS FOR ENHANCING  N-ACETYLGALACTOSAMINE-6-SULFATASE ENZYME ACTIVITY AND TREATING  MUCOPOLYSACCHARIDOSIS TYPE IVA	PONTIFICIA UNIVERSIDAD JAVERIANA
WO/2021/250628	BACTERIAL IMMUNIZATION USING NANOPARTICLE VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/260486	COMPOSITIONS FOR TREATING KERATIN FIBERS	REVLON CONSUMER PRODUCTS CORPORATION
WO/2021/255621	TREATMENT OF FOOD ALLERGY USING ANTI-IGE ANTIBODIES	NOVARTIS AG
WO/2021/255622	COMBINATION OF ALCAFTADINE AND A CORTICOSTEROID	ALKEM LABORATORIES LIMITED
WO/2021/255625	PROTEASE COMPOSITION	ANATARA LIFESCIENCES LIMITED
WO/2021/255639	SYNTHESIS OF A GUANYLATE CYCLASE AGONIST BY FRAGMENTS BASED  APPROACH	ANTHEM BIOSCIENCES PRIVATE LIMITED
WO/2021/255648	HYPERIMMUNE GLOBULINS FOR TREATMENT OF INFLUENZA A	EMERGENT BIOSOLUTIONS CANADA INC.
WO/2021/255667	IFENPRODIL FOR USE IN THE TREATMENT OF CHRONIC SEIZURES	INSTYTUT BIOLOGII DOŚWIADCZALNEJ IM. MARCELEGO NENCKIEGO  POLSKA AKADEMIA NAUK
WO/2021/255681	A SIMPLE PROCESS FOR THE PREPARATION OF FAVIPIRAVIR AND ITS  INTERMEDIATES THEREOF	HIKAL LIMITED
WO/2021/255684	SHIGELLA-TETRAVALENT (SHIGELLA4V) BIOCONJUGATE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/255690	IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM)  DIFFICILE AND METHODS THEREOF	PFIZER INC.
WO/2021/255691	COMPOSITIONS AND METHODS FOR TREATING VIRUS INFECTION	NOVMETAPHARMA CO., LTD.
WO/2021/260511	MULTIPHASIC CONTRACEPTIVE AND/OR HORMONE REPLACEMENT THERAPY	MILLICENT PHARMA LIMITED
WO/2021/260516	AN ORGANIC AMINE SALT OF FAVIPIRAVIR AND A PROCESS FOR THE  PURIFICATION OF FAVIPIRAVIR	PI INDUSTRIES LTD.
WO/2021/260525	COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS  SYSTEMS FOR THE|DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES	UNIVERSITA' DEGLI STUDI DI TORINO
WO/2021/260528	DOSING REGIMEN COMPRISING  3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES	NOVARTIS AG
WO/2021/260530	LONG ACTING GLP-1/GIP DUAL AGONISTS	SUN PHARMACEUTICAL INDUSTRIES LIMITED
WO/2021/240488	COMPOSITIONS AND METHODS FOR TREATING NEOVASCULARIZATION AND  ISCHEMIC RETINOPATHIES BY TARGETING ANGIOGENESIS AND CHOLESTEROL TRANSPORT	BAYLOR COLLEGE OF MEDICINE
WO/2021/260546	COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF VAGINAL  DISEASES	NEILOS S.R.L.
WO/2021/260552	METHOD FOR TREATMENT OF PANCREATITIS	NOVMETAHEALTH CO., LTD.
WO/2021/260558	AQUEOUS MEDIUM-SOLUBLE POWDER FOR BLOOD FLOW SIMULATION	BIOMODEX, S.A.S.
WO/2021/260560	COMPOSITION FOR TREATING PULMONARY FIBROSIS	JW PHARMACEUTICAL CORPORATION
WO/2021/260567	DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIR	VIIV HEALTHCARE COMPANY
WO/2021/260569	FORMULATIONS	VIIV HEALTHCARE COMPANY
WO/2021/260577	METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH TL1A  ANTIBODIES	PFIZER INC.
WO/2021/260578	COMBINATION OF ANTIBODY-DRUG CONJUGATE AND CDK9 INHIBITOR	ASTRAZENECA UK LIMITED
WO/2021/260579	COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATR INHIBITOR	ASTRAZENECA UK LIMITED
WO/2021/260580	COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATM INHIBITOR	ASTRAZENECA UK LIMITED
WO/2021/260582	COMBINATION OF ANTIBODY-DRUG CONJUGATE AND AURORA B INHIBITOR	ASTRAZENECA UK LIMITED
WO/2021/260583	COMBINATION OF ANTIBODY-DRUG CONJUGATE AND DNA-PK INHIBITOR	ASTRAZENECA UK LIMITED
WO/2021/260591	METHODS OF REDUCING MORTALITY IN PATIENTS SUFFERING FROM COPD	PEARL THERAPEUTICS, INC.
WO/2021/260602	HYPERIMMUNE GLOBULINS FOR TREATMENT AND PREVENTION OF COVID-19	EMERGENT BIOSOLUTIONS CANADA INC.
WO/2021/260622	OPHTHALMIC COMPOSITION AND USE THEREOF IN THE TREATMENT OF EYE  DISEASES	SIFI S.P.A.
WO/2021/260636	A PHARMACEUTICAL COMPOSITION COMPRISING L-CARNOSINE AND GINKGO  BILOBA EXTRACT	SINGH, Shyam Sunder
WO/2021/260641	ORAL FILM OF HIV DRUGS	LAURUS LABS LIMITED
WO/2021/260657	ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING  GENETICALLY ENGINEERED T CELLS TARGETING CD19	CRISPR THERAPEUTICS AG
WO/2021/260662	NON-ALCOHOLIC ANTISEPTIC GEL CONSISTS OF BENZALKONIUM CHLORIDE	FARAHMNAD, Farrokh
WO/2021/260667	COMPOSITION FOR HAIR FOLLICLE MODULATION, METHODS AND USES  THEREOF	UNIVERSIDADE DO MINHO
WO/2021/260671	EXTRACT OF A FUNGUS OF THE BOLETUS FUNGI FAMILY FOR USE IN  PARTICULAR IN THE PREVENTION OF COVID-19 DISEASE	VAN ELSLANDE, Aude
WO/2021/260675	AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/024247	OIL- SUSPENSION OF EDIBLE SOLIDS AND METHODS OF PREPARING THE  SAME	OMEGA 3 GALILEE LTD.
WO/2021/009761	COMBINATION THERAPY FOR THE TREATMENT OF CANCER	BIOLINERX LTD.
WO/2021/009763	METHODS OF TREATING PAIN	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/014447	TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF-EGFR  INHIBITOR COMPOSITIONS	SOL-GEL TECHNOLOGIES LTD.
WO/2021/014453	TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT  OF INFLAMMATORY SKIN CONDITIONS	SOL-GEL TECHNOLOGIES LTD.
WO/2021/024256	ANTICANCER AGENTS	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD
WO/2021/024258	COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES	CARMEL HAIFA UNIVERSITY ECONOMIC CORPORATION LTD.
WO/2021/024263	COMPOSITIONS TARGETING GPM6A AND METHODS FOR DIAGNOSIS AND  TREATMENT OF CANCER	TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
WO/2021/024265	METHODS OF TREATING NON-INFECTIOUS INFLAMMATORY DISORDERS	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/028908	METHODS FOR PREVENTING AN IMMUNOGLOBULIN E-RELATED DISEASE	MY-OR DIAGNOSTICS LTD.
WO/2021/028916	PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF OPIOID  ANTAGONISTS	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/028917	PHYTOCANNABINOIDS FOR PREVENTING OR TREATING NON-ALCOHOLIC  FATTY LIVER DISEASE, DYSLIPIDEMIA, AND TYPE 2 DIABETES	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/028919	METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED  BY BIOLOGICAL TARGETED CANCER DRUGS	HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED
WO/2021/028921	ANTIBODIES AGAINST ILT2 AND USE THEREOF	BIOND BIOLOGICS LTD.
WO/2021/028926	SKIN-CARE COMPOSITIONS AND USES THEREOF	AHAVA - DEAD SEA LABORATORIES LTD.
WO/2021/028927	COMBINATION OF ALPHA-1-ANTITRYPSIN AND STEROIDS AND USES  THEREFOR	KAMADA LTD
WO/2021/033180	ADHESIVE DRUG DELIVERY MICROPARTICLES AND A PRODUCT COMPRISING  THEREOF	PENHASI, Adel
WO/2021/033182	ADHESIVE DRUG DELIVERY FILM AND A MICROPARTICLE COMPRISING  THEREOF	PENHASI, Adel
WO/2021/044405	THERAPEUTIC APOPTOTIC CELLS FOR TREATMENT OF OSTEOARTHRITIS	ENLIVEX THERAPEUTICS LTD
WO/2021/038563	PROTEIN BASED CANNABIS COMPOSITIONS	IZUN PHARMACEUTICALS CORP.
WO/2021/038569	TREATMENT OF BACTERIAL VAGINOSIS	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/038573	DRUG CONTAINING TARGETING LIPOSOMES	NEXTAR CHEMPHARMA SOLUTIONS LTD.
WO/2021/038574	CANNABINOID CONTAINING TARGETING LIPOSOMES	NEXTAGE CANNABIS INNOVATION LTD.
WO/2021/044413	ATP-REGULATED POTASSIUM CHANNEL OPENERS COMPRISING GUANIDINE  AND USES THEREOF	SALZMAN GROUP LTD.
WO/2021/044420	LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE  AND USES THEREOF	NEURODERM, LTD.
WO/2021/048852	METHODS OF TREATING BREAST CANCER	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/053667	COMBINATION CANCER THERAPY AND CYTOKINE CONTROL THERAPY FOR  CANCER TREATMENT	ENLIVEX THERAPEUTICS LTD
WO/2021/053681	IL-2 CHIMERIC PROTEINS FOR IMMUNOSUPPRESSION	NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/059266	ANTI-AGING COMPOSITIONS AND METHODS OF USE THEREOF	S.I.S. SHULOV INNOVATIVE SCIENCE LTD.
WO/2021/059267	COMPOSITIONS AND METHODS FOR TREATING DEGENERATIVE,  AGE-RELATED AND TRAUMA-INDUCED DISORDERS	S.I.S. SHULOV INNOVATIVE SCIENCE LTD.
WO/2021/059270	TREATMENT OF GENETIC DISEASES CHARACTERIZED BY UNSTABLE mRNAs	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/059275	THIAMINE THERAPY FOR FATTY LIVER ASSOCIATED DISEASES	THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL  DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER)
WO/2021/059281	TREATMENT OF SKIN DISORDERS WITH TOPICAL COMBINATION  COMPOSITIONS COMPRISING TAPINAROF AND AN ADDITIONAL AHR ACTIVATOR	SOL-GEL TECHNOLOGIES LTD.
WO/2021/059283	TREATMENT OF CUTANEOUS ADVERSE EFFECTS CAUSED BY ONCOLOGICAL  THERAPY WITH TOPICAL TAPINAROF COMPOSITIONS	SOL-GEL TECHNOLOGIES LTD.
WO/2021/064729	INJECTABLE COMPOSITION FOR THE TREATMENT OF MUSCULOSKELETAL  DISORDERS AND METHODS OF USE THEREOF	PATCHOR LTD.
WO/2021/064730	LIPOSOMAL CANNABINOIDS AND USES THEREOF	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD
WO/2021/070181	ANTIBODIES AGAINST THE POLIOVIRUS RECEPTOR (PVR) AND USES  THEREOF	NECTIN THERAPEUTICS LTD.
WO/2021/070183	A COMPOSITION FOR BOOSTING THE IMMUNE SYSTEM	MAOLAC LTD.
WO/2021/070184	COMPOSITIONS AND METHODS FOR INHIBITING COLLAGEN LOSS	LYCORED LTD.
WO/2021/084527	SELF-EMULSIFYING CANNABIS EXTRACT	ISRAEL PLASTICS AND RUBBER CENTER LTD.
WO/2021/084534	METHODS AND COMPOSITIONS FOR TREATING, AMELIORATING,  PREVENTION AND RECURRENCE-PREVENTION OF ANORECTAL DISORDERS	GINSBERG, Ori
WO/2021/084540	INHIBITORS OF MMEJ PATHWAY FOR PREVENTION AND TREATMENT OF  PRE-MYELOID AND MYELOID MALIGNANCIES	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/084541	TREATMENT OF HAIR LOSS DISORDERS WITH A TOPICAL EGFR INHIBITOR	SOL-GEL TECHNOLOGIES LTD.
WO/2021/084543	TREATMENT OF TOOTH DECAY USING A CHEWING GUM COMPOSITION  COMPRISING CANNABINOIDS	M. MUSTIX LTD
WO/2021/090309	ORALLY ADMINISTRABLE FILMS COMPRISING POORLY WATER SOLUBLE  ACTIVE INGREDIENTS AND PREPARATION THEREOF	MAABAROT PRODUCTS LTD.
WO/2021/090322	METHOD OF TREATING PALMOPLANTAR KERATODERMA	SOL-GEL TECHNOLOGIES LTD.
WO/2021/095032	GLUCOSE UPTAKE INHIBITORS AND USES THEREOF	METABOMED LTD
WO/2021/100041	TREATING ALZHEIMER'S DISEASE	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/100051	TREATMENT OF SKIN DISORDERS WITH TOPICAL COMPOSITIONS  COMPRISING TAPINAROF AND A PDE4 INHIBITOR	SOL-GEL TECHNOLOGIES LTD.
WO/2021/105996	CANNABINOID AND LYCOPENE ANTI-INFLAMMATORY SYNERGISTIC  COMBINATIONS	LYCORED LTD.
WO/2021/124316	HIGH CBD CANNABIS SATIVA LINES AND EXTRACTS WITH  ANTI-INFLAMMATORY POTENCIES FOR ORAL AND GUT HEALTH	SWYSH INC.
WO/2021/111441	USE OF MMP INHIBITION	BIOND BIOLOGICS LTD.
WO/2021/111446	BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION  AND USES THEREOF	B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/137222	METHODS OF TREATING ATOPIC DERMATITIS	ICHILOV TECH LTD.
WO/2021/137224	CANNABIDIOLIC ACID ESTERS FOR TREATING MUSCULAR DYSTROPHY	EPM GROUP, INC.
WO/2021/137225	FLOATING DRUG DELIVERY SYSTEMS COMPRISING CANNABINOIDS	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/137229	COMPOSITIONS, KITS AND METHODS FOR ENHANCING THERAPEUTIC  COMPLIANCE	RIVIA RESEARCH PTE. LTD.
WO/2021/137230	METHODS OF CULTURING T CELLS AND USES OF SAME	KAHR MEDICAL LTD.
WO/2021/137234	A MOLDED COMPOSITION FOR TOPICAL APPLICATION AND USES THEREOF	FISCHER PHARMACEUTICALS LTD
WO/2021/137237	MICROBIAL CONSORTIUM AND USES THEREOF	BIOMICA LTD.
WO/2021/137241	DELIVERY COMPOSITIONS AND METHODS	EDITY THERAPEUTICS LTD.
WO/2021/144792	STRESS MANAGEMENT IN HUMAN SUBJECTS IN NEED THEREOF	YEDA RESEARCH & DEVELOPMENT CO. LTD.
WO/2021/144794	COMPOUNDS FOR USE IN TREATMENT AND/OR PREVENTION OF  CLOSTRIDIAL NEUROTOXINS INTOXICATION	THE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH (IIBR)
WO/2021/144798	PEPTIDE COMPOUNDS AND METHODS OF TREATING DISEASES USING SAME	IMMUNITY PHARMA LTD.
WO/2021/144799	CANNABINOIDS FOR USE IN TREATMENT	CAN-FITE BIOPHARMA LTD.
WO/2021/152575	COMPOSITIONS FOR HEMORRHOID TREATMENT	INNOCAN PHARMA LTD.
WO/2021/152576	MAGNETIC DRUG DELIVERY CAPSULES AND SYSTEMS	PILLUETTE LTD.
WO/2021/149064	COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY  CONDITIONS AND DISEASES OF THE SKIN	LANDVER, Guy
WO/2021/152579	PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF  FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETES	THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
WO/2021/152587	TREATING ACUTE LIVER DISEASE WITH TLR-MIK INHIBITORS	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/152589	ALPHA-1-ANTITRYPSIN MUTANTS, COMPOSITIONS COMPRISING SAME, AND  USE THEREOF	B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/152590	ARTICLES OF MANUFACTURE COMPRISING ANTI PD-L1 ANTIBODIES AND  THEIR USE IN THERAPY	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/181372	AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS	AMORPHICAL LTD.
WO/2021/152601	NOVEL ACTIVATORS OF THE LIPIDATING TRANSPORTER ATP BINDING  CASSETTE PROTEIN TYPE 1 (ABCA1) AND THERAPEUTIC USES THEREOF	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/156856	TOPICAL OPTHALMOLOGICAL COMPOSITION CONTAINING HYALURONATE AND  TAURINE HAVING NON-NEWTONIAN RHEOLOGICAL PROPERTIES	RESDEVCO RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/156857	COMPOSITIONS COMPRISING AMELOGENIN AND USES THEREOF	PRUDENTIX LTD.
WO/2021/156869	ASPACYTARABINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	BIOSIGHT LTD.
WO/2021/161317	STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING VALGANCYCLOVIR  AND USES THEREOF	CTS CHEMICAL INDUSTRIES LTD.
WO/2021/161319	COMBINATION THERAPY FOR TREATING AMYOTROPHIC LATERAL USING  PRIDOPIDINE AND ANOTHER ACTIVE AGENT	PRILENIA NEUROTHERAPEUTICS LTD.
WO/2021/165960	IMPROVED ANTIDEPRESSANT THERAPY	ICHILOV TECH LTD.
WO/2021/171285	USE OF EARLY APOPTOTIC CELLS FOR TREATING COVID-19	ENLIVEX THERAPEUTICS LTD
WO/2021/171294	BACTERIAL CULTURES FOR INCREASING VITAMIN B12 IN PLANTS	HINOMAN LTD.
WO/2021/171297	COMPOSITIONS COMPRISING LTB AND PATHOGENIC ANTIGENS, AND USE  THEREOF	MIGAL GALILEE RESEARCH INSTITUTE LTD.
WO/2021/191886	COMPOSITIONS COMPRISING TERPENES AND TERPENOIDS AND USE  THEREOF FOR PREVENTING AND TREATING VIRAL-INDUCED INFECTIONS OF THE  RESPIRATORY SYSTEM	EYBNA TECHNOLOGIES LTD.
WO/2021/181390	ANTIGEN SPECIFIC EPITOPE–BASED ANTI-INFECTIVE VACCINES	VAXIL BIOTHERAPEUTICS LTD.
WO/2021/191888	<i>CANNABIS SATIVA</i> (HEMP AND CANNABIS)  PRODUCTS FOR VIRAL DISEASE PREVENTION AND MANAGEMENT	I.P. ISRAEL PATENTS LTD.
WO/2021/181394	METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND  SEQUELAE THEREOF	PLURISTEM LTD.
WO/2021/181398	CXCR4 INHIBITOR FOR THE TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROME AND VIRAL INFECTIONS	BIOLINERX LTD.
WO/2021/186430	NANO-DELIVERY SYSTEM AND THERAPEUTIC AND DIAGNOSTIC USE  THEREOF	BAR ILAN UNIVERSITY
WO/2021/186435	POLYMERIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION	NASUS PHARMA LTD.
WO/2021/186437	TREATMENT WITH POWDERED INTRANASAL EPINEPHRINE	NASUS PHARMA LTD.
WO/2021/186438	MOLECULES THAT TARGET PROTEINS OF CORONAVIRUSES AND USES  THEREOF AS ANTI-VIRAL "COCKTAIL"	BAR-ILAN UNIVERSITY
WO/2021/186439	MOLECULES THAT TARGET PROTEINS OF CORONAVIRUSES AND USES  THEREOF AS ANTI-VIRAL "COCKTAIL"	BAR-ILAN UNIVERSITY
WO/2021/186453	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING A  CORONAVIRUS INFECTION	ALKALAY, Rachel
WO/2021/186454	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING  NON-MALIGNANT RESPIRATORY DISEASE	ALKALAY, Rachel
WO/2021/186455	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING  INFLAMMATORY DISEASES INCLUDING DIABETES MELLITUS 10 TYPE I AND TYPE II AND  THYROID DISEASES	ALKALAY, Rachel
WO/2021/186456	COMPOSITIONS AND METHODS FOR TREATING SOLID AND SOFT TUMORS  AND PROLIFERATIVE DISEASES	ALKALAY, Rachel
WO/2021/191891	CANNABINOID COMPOSITIONS AND AEROSOLS	ROXX LABS LTD.
WO/2021/191895	PHARMACEUTICAL COMPOSITIONS AND USE THEREOF	HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
WO/2021/191903	PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES  AND METHODS OF USE THEREOF	BONE SCI. BIO LTD.
WO/2021/191904	METHODS FOR PREVENTING AND TREATING VIRAL INFECTION	TREE OF LIFE PHARMA LTD.
WO/2021/191907	LIPOSOMAL FORMULATIONS COMPRISING AT1 RECEPTOR BLOCKERS AND  USES THEREOF	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/199028	COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS	SPLISENSE LTD.
WO/2021/199029	COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS	SPLISENSE LTD.
WO/2021/199032	MITOCHONDRIAL AUGMENTATION THERAPY	MINOVIA THERAPEUTICS LTD.
WO/2021/199035	MEANS AND METHODS FOR ENHANCING CANNABINOIDS EFFICACY	MOLAD, Ami
WO/2021/199039	VARIANTS OF BETA-GLUCOCEREBROSIDASE FOR USE IN TREATING  GAUCHER DISEASE	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/199040	MITOCHONDRIA-ENRICHED GENETICALLY ENGINEERED CELLS AND USES  THEREOF	MINOVIA THERAPEUTICS LTD.
WO/2021/199041	SYSTEM AND A METHOD FOR OBTAINING AN IMPROVED PLASMA EXTRACT	ESTAR TECHNOLOGIES LTD
WO/2021/199046	IMMUNOMODULATORY COMPOSITIONS AND USE THEREOF	BIOND BIOLOGICS LTD.
WO/2021/205437	PHARMACEUTICAL COMPOSITIONS FOR TREATING CORONA VIRUS DISEASE	VECHT-LIFSHITZ, Susan Eve
WO/2021/205438	ANTIBODIES TO NKP46 AND CONSTRUCTS THEREOF FOR TREATMENT OF  CANCERS AND INFECTIONS	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/205446	PICKERING EMULSION-BASED VACCINES	THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL  DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER)
WO/2021/205459	CANNABIDIOL-CONTAINING COMPOSITIONS AND USES THEREOF	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/209990	COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDS	CANNABICS PHARMACEUTICALS INC.
WO/2021/209992	COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASES	RAMOT AT TEL-AVIV UNIVERSITY LTD.
WO/2021/209993	USE OF METABOLIC REGULATORS FOR THE TREATMENT OF COVID-19	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/209995	CELL-DERIVED VESICLES COMPRISING WILD-TYPE P53 PROTEIN FOR  ANTIVIRAL THERAPY	EXOPROTHER MEDICAL LTD.
WO/2021/209998	COMPOSITION FOR THE TREATMENT OF RESPIRATORY SYMPTOMS AND  METHODS THEREOF	MOLAD, Ami
WO/2021/210002	CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE  THEREOF IN THERAPY	ICHILOV TECH LTD.
WO/2021/214764	SOLID DISPERSIONS AND PARTICLES AND METHODS FOR  CONTROLLED-RELEASE OF LIPID-SOLUBLE OR DISPESIBLE ACTIVES	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/214767	NOVEL THRERAPY FOR ACUTE DAMAGE TO LUNG TISSUE	REMODELESS CV LTD
WO/2021/214771	GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR PREVENTION AND  TREATMENT OF VIRAL DISEASES	THE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH (IIBR)
WO/2021/214772	METHODS AND REGIMENS FOR THE TREATMENT OF HEMATOLOGICAL CANCER	BIOSIGHT LTD.
WO/2021/220273	PHARMACEUTICAL COMPOSITIONS FOR RELIEF OF COVID-19 SYMPTOMS  AND METHODS OF PRODUCING AND USING THEM	ZALTZMAN, Pinchas
WO/2021/220284	E PROTEIN CHANNEL BLOCKERS AND ORF3 INHIBITORS AS  ANTI-COVID-19 AGENTS	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/224912	GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY  OF JERUSALEM LTD.
WO/2021/224914	TREATMENT OF VIRAL INFECTION, DISEASE OR DISORDER USING A  SELECTIVE S1R AGONIST	PRILENIA NEUROTHERAPEUTICS LTD.
WO/2021/224920	METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS	PLURISTEM LTD.
WO/2021/224924	CANNABIDIOLIC ACID ESTERS FOR TREATING RESPIRATORY DISTRESS  INCLUDING ACUTE RESPIRATORY DISTRESS SYNDROME AND CORONAVIRUS	EPM (IP), INC.
WO/2021/224930	PRO-LYCOPENE RICH COMPOSITION AND METHODS OF USING SAME	LYCORED LTD.
WO/2021/229566	COMPOSITIONS OF TRYPTOPHOL DERIVATIVES AND 4-ETHYL-PHENOL  DERIVATIVES, AND METHODS OF USING SAME	B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION  UNIVERSITY
WO/2021/229574	COMPOSITIONS FOR INHALATION AND USES THEREOF FOR DISINFECTING  THE UPPER RESPIRATORY AIRWAYS	COROLABS LTD.
WO/2021/229577	COLLAGEN AS A DELIVERY TOOL FOR METAL-BASED ANTI-VIRAL AGENTS	COLLPLANT LTD.
WO/2021/229578	COMPOSITIONS FOR DELIVERY OF BIOACTIVE AGENTS INTO HAIR  FOLLICLES	FOLLICLE PHARMA LTD
WO/2021/234687	ANTIVIRAL COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED  ASCORBYL GLUCOSIDE AND NATURAL EXTRACTS	BIONEXT LABS LTD
WO/2021/229581	DE-NOVO DESIGNED TRANSMEMBRANE POLYPEPTIDES AND THEIR USES IN  CELLULAR IMMUNOTHERAPY	YEDA RESEARCH AND DEVELOPMENT CO. LTD.
WO/2021/240505	COMPOSITIONS FOR TREATMENT OF PSORIASIS OF THE SCALP	INNOCAN PHARMA LTD.
WO/2021/234697	COMPOSITIONS AND METHODS FOR THE TREATMENT AND MANAGEMENT OF  INFLAMMATION USING HYDROXYNORKETAMINE	SPIRIFY PHARMA INC.
WO/2021/234700	PHOTOSYNTHETICALLY CONTROLLED SPIRULINA EXTRACTS FOR TREATING  THE CYTOKINE STORM SYNDROME	VAXA TECHNOLOGIES LTD.
WO/2021/234716	STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES  THEREOF	SOL-GEL TECHNOLOGIES LTD.
WO/2021/240510	COMPOSITIONS OF CANNABINOIDS AND METHODS OF USING SAME	ASANA BIO GROUP LTD.
WO/2021/240519	INHIBITORS OF AMINO ACIDS TRANSPORTERS AND USE THEREOF	HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
WO/2021/245658	COMPOSITIONS AND METHODS FOR TREATING HEADACHES	TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED
WO/2021/245670	MODIFIED SEMAPHORIN 3A, COMPOSITIONS COMPRISING THE SAME AND  USES THEREOF	MEDICAL RESEARCH & DEVELOPMENT FUND FOR HEALTH SERVICES  BNAI ZION MEDICAL CENTER
WO/2021/245677	COMPOSITIONS AND METHODS FOR TREATING DYSPLASTIC AND  EARLY-STAGE NEOPLASTIC CONDITIONS	DIGESTIX BIOSCIENCE INC.
WO/2021/245679	A SARS-COV-2 VACCINE	THE ISRAEL INSTITUTE OF BIOLOGICAL RESEARCH
WO/2021/245682	NOVEL PEPTIDE VACCINES AND USES THEREOF	BAR-ILAN UNIVERSITY
WO/2021/250661	SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS	THE OPEN UNIVERSITY
WO/2021/255741	EPHB2 ANTIBODY AND USE THEREOF IN COMBINATION THERAPY	4C BIOMED SERVICES LTD.
WO/2021/260692	COMPOSITIONS AND METHODS FOR TREATING INFECTIOUS DISEASE  CAUSED BY CORONAVIRUS	KAMADA LTD.
WO/2021/038577	MESQUITE GUM COMPOSITIONS AS COLON TARGETED DELIVERY SYSTEM	CHOUDHARI, Alap
WO/2021/181402	SARVA JURA KUDINEER	MALARKANNAN, S.P.
WO/2021/106004	PHARMACEUTICAL COMPOSITION OF S-ADENOSYLMETHIONINE	KUSUM HEALTHCARE PVT. LTD.
WO/2021/084548	A METHOD OF MANUFACTURING OF NANO ZINC FOR SLOW RELEASE,  ENHANCED UTILIZATION BY THE PLANTS AND APPLICATION THEREOF	NANO BIOTECHNOLOGY RESEARCH CENTER, INDIAN FARMERS FERTILISER  COOPERATIVE LIMITED (IFFCO) KALOL
WO/2021/048868	A DRUG DELIVERY CARRIER COMPOSITION FOR BRAIN DISORDERS	GUNDALA, Venkata Naveen Kumar
WO/2021/152605	A PAIN-RELIEF FORMULATION AND THE METHOD THEREOF	SOMADE, Prakash Maruti
WO/2021/014459	NOVEL SOLID EMULSION FORMULATION USING SYNBIOTICS AND PROCESS  THEREOF	LOVELY PROFESSIONAL UNIVERSITY
WO/2021/009768	AN ORAL PHARMACEUTICAL COMPOSITION FOR ALPHA- AMYLASE  INHIBITION	LOVELY PROFESSIONAL UNIVERSITY
WO/2021/001860	PHARMACEUTICAL COMPOSITIONS OF BOSWELLIA SERRATA	REDASANI, Vijayendrakumar Virendrakumarji
WO/2021/005623	A VACCINE FORMULATION FOR PROTECTION AGAINST ENTEROTOXIGENIC  <i>E. COLI</i> (ETEC) AND CHOLERA	MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD.
WO/2021/009770	A PROCESS FOR THE PREPARATION OF VENETOCLAX AND ITS POLYMORPHS  THEREOF	NATCO PHARMA LIMITED
WO/2021/240531	TRANSMUCOSAL DOSAGE FORMS OF REMDESIVIR	JUBILANT GENERICS LIMITED
WO/2021/009775	ORAL FORMULATIONS OF EDARAVONE AND METHOD OF MANUFACTURING  THEREOF	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
WO/2021/229591	NOVEL USE OF NON-IONIC SURFACTANT FOR THE TREATMENT OF  COVID–19	KRISHNAMACHARI, Ramu
WO/2021/019576	OPTHALMIC COMPOSITION OF BEVACIZUMAB	GENNOVA BIOPHARMACEUTICALS LIMITED
WO/2021/199056	VACCINE FOR NOVEL CORONA VIRUS	SINHA, Kanishk
WO/2021/024274	A PERSONAL CARE COMPOSITION	FINE ORGANIC INDUSTRIES LIMITED
WO/2021/033198	AN IMPROVED PROCESS FOR PREPARATION OF VILANTEROL OR A  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	MELODY HEALTHCARE PVT. LTD
WO/2021/044434	COMPOSITION FOR TREATMENT OF BURN WITH SCAR REMOVAL	JOSE, Huxley
WO/2021/260712	A LIPOSOMAL COMPOSITION OF PTEROCARPUS SANTALINUS AND THE  PROCESS THEREOF	PHATAK, Rohan Sharadanand
WO/2021/028943	CANNABIDIOL ORALLY DISINTEGRATING TABLETS	TENSHI KAIZEN PRIVATE LIMITED
WO/2021/038596	COMPOSITION FOR POSITRON EMITTING TOMOGRAPHY IMAGING IN  CUSHING'S SYNDROME	WALIA, Dr. Rama
WO/2021/100056	PROLONGED RELEASE PHARMACEUTICAL COMPOSITIONS OF IVABRADINE	ABBOTT HEALTHCARE PVT. LTD.
WO/2021/038601	LIQUID PHARMACEUTICAL COMPOSITIONS OF MELATONIN FOR ORAL AND  PARENTERAL ADMINISTRATION	REDASANI, Vijayendrakumar Virendrakumarji
WO/2021/044436	IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS  FOR ITS PREPARATION THEREOF	SERUM INSTITUTE OF INDIA PRIVATE LIMITED
WO/2021/048871	SYNERGISTIC BIOACTIVE COMPOSITIONS FOR TREATING NEUROLOGICAL  DISORDERS	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/070200	STABLE COMPOSITIONS OF (7AS,2'S)-2-OXOCLOPIDOGREL AND ITS  PHARMACEUTICAL SALTS	IPCA LABORATORIES LIMITED
WO/2021/074930	NITROGEN CONTAINING BICYCLIC COMPOUNDS	WOCKHARDT LIMITED
WO/2021/079380	IMPROVED PROCESS FOR THE PREPARATION OF  (2S)-N-{(1S)-1-(2-CHLOROPHENYL)-2-[(3,3-DIFLUOROCYCLOBUTYL)-AMINO]-2-OXOETHYL}-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/095048	ORALLY DISINTEGRATING PHARMACEUTICAL COMPOSITIONS OF APIXABAN	UNISON PHARMACEUTICALS PVT. LTD.
WO/2021/084559	SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR TREATING  CEREBROVASCULAR DISEASES	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/084560	SYNERGISTIC NUTRITIONAL NEUROPROTECTIVE COMPOSITIONS FOR  AMELIORATING NEURAL DYSFUNCTION	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/100063	ORAL FILM COMPOSITION COMPRISING LEVOTHYROXINE	WOCKHARDT LIMITED
WO/2021/124344	PYRIDAZINE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE-2  INHIBITORS	Abida
WO/2021/111464	A PROCESS FOR THE PREPARATION OF HIGHLY PURE VALSARTAN	HARMAN FINOCHEM LIMITED
WO/2021/124346	NOVEL 4-(6-OXO-3-SUBSTITUTED PHENYLPYRIDAZIN-1(6  <i>H</i>)-YL)BENZALDEHYDES OF PHARMACEUTICAL INTEREST	/, Abida
WO/2021/111470	A PROCESS FOR PREPARATION OF PEGYLATED THERAPEUTIC PROTEINS	INDIAN INSTITUTE OF TECHNOLOGY DELHI
WO/2021/117057	POLYMORPH OF  N-ETHYL-1-(3-(TRIFLUOROMETHYL)PHENYL)PROPAN-2-AMINE HYDROCHLORIDE AND PROCESS  FOR PREPARATION THEREOF	MAITHRI DRUGS PVT LTD
WO/2021/124348	MULTIPLE-COMPARTMENT DEVICE COMPRISING AT LEAST ONE INTERNAL  FRANGIBLE SEAL CONTAINING A KERATIN FIBERS DYEING COMPOSITION	L'ORéAL S.A.
WO/2021/117062	Process for the preparation of  4-[7-(6-Cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-  diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide and its polymorphs	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
WO/2021/117065	FORMULATIONS OF POLYBASIC DRUGS TO REDUCE MULTI-ORGAN TOXICITY	CHAUDHARY, Manu
WO/2021/130779	PHARMACEUTICAL COMPOSITION OF CASR MODULATORS AND METHODS AND  USES THEREOF	LUPIN LIMITED
WO/2021/137257	SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR ENHANCING ATP  EFFICIENCY	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/140524	VIRAL VACCINE COMPOSITIONS AND METHODS OF PREPARATIONS THEREOF	BHARAT BIOTECH INTERNATIONAL LIMITED
WO/2021/186458	6-OXO-3-PHENYLPYRIDAZINE BASED CYCLOOXYGENASE-2 INHIBITORS FOR  THE TREATMENT OF INFLAMMATORY DISEASES	ABIDA
WO/2021/152623	IMPROVED PROCESSES FOR THE PREPARATION OF TAFAMIDIS AND ITS  MEGLUMINE SALT	DR. REDDY’S LABORATORIES LIMITED
WO/2021/152624	NOVEL DENTAL CARE AND CLEANSING COMPOSITION	GROUP PHARMACEUTICALS LIMITED
WO/2021/152635	HAIR CARE COMPOSITION AND A METHOD OF PREPARING THE SAME	BAJAJ CONSUMER CARE LTD.
WO/2021/161346	PROCESS FOR THE PREPARATION OF GAMMA AMINO BUTYRIC ACIDS AND  ANALOGS THEREOF	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/165992	COMPOSITIONS AND THERAPEUTIC USES OF CANNABIDIOL	DR. MERCHANT, Shreema
WO/2021/165998	A STABLE DELIVERY COMPLEX COMPRISING A DIPEPTIDE WITH A  CONFORMATIONALLY RESTRICTED AMINO ACID	INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
WO/2021/171318	TRANSMUCOSAL PHARMACEUTICAL COMPOSITION OF LEVOCETIRIZINE	ALKEM LABORATORIES LTD
WO/2021/176479	COMPOSITION FOR ENHANCING CHANCES OF CONCEPTION AND FEMALE SEX  RATIO IN BOVINES	AGROCLEAN
WO/2021/176480	BIMETALLIC FLUORESCENT NANOCOMPOSITES FOR CANCER THERANOSTICS	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
WO/2021/181420	PROCESS FOR THE SYNTHESIS OF CANNABIDIOL AND INTERMEDIATES  THEREOF	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN  REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860)
WO/2021/186471	SOLID DOSAGE FORMS FOR ORAL CO-ADMINISTRATION OF POLYPHENOLS  AND TRANSITION METAL IONS	INVENTIA HEALTHCARE LIMITED
WO/2021/191926	TASTE MASKED AND RAPIDLY DISINTEGRATING ULTRA THIN IRON  ORODISPERSIBLE FILM AND A PROCESS THEREOF	AAVISHKAR ORAL STRIPS PRIVATE LIMITED
WO/2021/191928	EFLORNITHINE COMPOSITION AND DOSAGE FORMS FOR THE TREATMENT OF  VIRAL INFECTION	NAVIN SAXENA RESEARCH & TECHNOLOGY PVT. LTD.
WO/2021/199076	INJECTABLE ARIPIPRAZOLE FORMULATION	CIPLA LIMITED
WO/2021/199077	RISPERIDONE MICROSPHERES, PROCESS FOR THEIR PREPARTION AND  USES THEREOF	BIOLOGICAL E LIMITED
WO/2021/199078	INTERACTION OF SARS-COV-2 PROTEINS WITH MOLECULAR AND CELLULAR  MECHANISMS OF HOST CELLS AND FORMULATIONS TO TREAT COVID-19.	AKSEERA PHARMA CORP.
WO/2021/199082	ANTIMICROBIAL COMPOUNDS AND USES THEREOF	JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/205471	COMPOSITION, INJECTABLE HYDROGEL AND METHODS THEREOF	JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH
WO/2021/205473	STRUCTURALLY DEFINED, BETTER TOLERATED, ORALLY ADMINSTERED,  PROCESSED ARSENOLITE, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL  COMPOSITION AND USES THEREOF	BENDALE, Yogesh
WO/2021/205474	A NOVEL ANTI-CANCER COMBINATION	NATIONAL CENTRE FOR CELL SCIENCE
WO/2021/210025	COMPOSITIONS AND METHODS FOR COATINGS, ANTIMICROBIAL TEXTILES,  SANITIZATION AND DISINFECTION	INDIAN INSTITUTE OF TECHNOLOGY BOMBAY
WO/2021/210026	A CELL-FREE GROWTH FACTOR CONCENTRATE, METHOD OF PREPARING THE  SAME AND A KIT THEREOF	PALANIVEL, Vasanthi
WO/2021/220293	PRE-SHAMPOO FORMULATION AND METHOD OF PREPARING THE SAME	DAWAR, Premal
WO/2021/220297	A NOVEL POLYHERBAL PHARMACEUTICAL COMPOSITION EXHIBITING  IMMUNOMODULATORY AND ANTI-VIRAL ACTIVITY AND METHOD OF PREPARATION THEREOF	KARNAN, Ramakrishnan
WO/2021/234724	Pharmaceutical formulation containing stable granules of  clavulanic acid	TWENTY FIRST CENTURY PHARMACEUTICALS PVT. LTD.
WO/2021/224938	IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE	NEULAND LABORATORIES LIMITED
WO/2021/224946	CORONAVIRUS VACCINE THROUGH NASAL IMMUNIZATION	BHARAT BIOTECH INTERNATIONAL LIMITED
WO/2021/229602	USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS	GODAVARI BIOREFINERIES LIMITED
WO/2021/229603	FORMULATION OF PURE DIMETHOXY CURCUMIN-HUMAN SERUM ALBUMIN AND  A PROCESS FOR THE PREPARATION THEREOF	SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND  TECHNOLOGY
WO/2021/229609	COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF  CONDITIONS CAUSED BY SARS-COV-2 (COVID-19)	BIOINCEPTION PVT LTD
WO/2021/234731	SUSTAINED RELEASE COMPOSITIONS	DR REDDY'S INSTITUTE OF LIFE SCIENCES
WO/2021/240540	NOVEL SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR TREATING  SEIZURES AND CHRONIC INFLAMMATORY DISEASES	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/240543	TRANSMUCOSAL PHARMACEUTICAL COMPOSITIONS OF ANTIVIRAL DRUGS	JUBILANT GENERICS LIMITED
WO/2021/245696	HERBAL MOUTHWASH FORMULATION	BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS), PILANI
WO/2021/245697	NOVEL SYNERGISTIC MEDICINAL COMPOSITIONS FOR TREATING  DYSFUNCTIONAL D-SERINE SIGNALING	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/245704	PHARMACEUTICAL COMPOSITIONS FOR PERIODONTAL DISEASE	DR. REDDY’S LABORATORIES LTD.
WO/2021/245705	AZIRINE CONTAINING COMPOUNDS AS ANTI-ANGIOGENESIS AGENTS AND A  PROCESS FOR THE PREPARATION THEREOF	COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
WO/2021/245706	SAFE AND HIGHLY EFFECTIVE BROAD SPECTRUM PRESERVATIVE  COMPOSITION GINOGUARD GP	GODREJ INDUSTRIES LTD (CHEMICALS)
WO/2021/245707	SYNTHESIS OF AMINOACID CONJUGATE OF  TRIS(HYDROXYMETHYL)PHOSPHINE AND NANOPARTICLE COMPOSITION THEREOF	DHANVANTARI NANO AYUSHADI PVT. LTD.
WO/2021/250700	PHARMACEUTICAL COMPOSITION OF PANCREATIN	KUSUM HEALTHCARE PVT. LTD.
WO/2021/250702	IMPROVED PROCESS FOR PREPARATION OF SITAGLIPTIN	AARTI INDUSTRIES LIMITED
WO/2021/250705	A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE,  3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOF	COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (AN INDIAN  REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860))
WO/2021/255760	HERBAL FORMULATION FOR THE TREATMENT OF MENOPAUSAL SYNDROME	INDIAN COUNCIL OF MEDICAL RESEARCH
WO/2021/260727	ORAL LIQUID FORMULATIONS OF RUXOLITINIB	NOVARTIS AG
WO/2021/260731	WATER SOLUBLE 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID AND METAL  ION COMPOSITIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF	LAILA NUTRACEUTICALS
WO/2021/260740	NOVEL SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR PROMOTING  AXONAL REGENERATION	CELAGENEX RESEARCH (INDIA) PVT. LTD.
WO/2021/044448	MOUTHWASH COMPRISING BLACK MULBERRY FRUIT EXTRACT	MOHAMMADI, Fatemeh
WO/2021/224947	FORMULATION OF ACUTE RESPIRATORY DISEASE CONTROL FORMULATION	NOROUZI, Mehdi
WO/2021/019580	COMPOSITION COMPRISING 5'-RIBONUCLEOTIDES FOR USE IN THE  TREATMENT OF ALZHEIMER'S DISEASE	PROSOL S.P.A.
WO/2021/100065	SOLUBLE PREPARATION FOR NASAL DOUCHES, CORRESPONDING NASAL  IRRIGATION KIT AND OPERATING PROCEDURE FOR CARRYING OUT NASAL DOUCHES	OTOSAN S.R.L.
WO/2021/005630	RADIOPHARMACEUTICAL COMPOUND AND COMPOSITION FOR POSITRON  EMISSION TOMOGRAPHY (PET) IMAGING OF INTERLEUKIN-2 RECEPTOR POSITIVE CELLS,  PROCESS FOR THE PREPARATION THEREOF, RELATED KIT AND USES THEREOF	SAPIENZA UNIVERSITA' DI ROMA
WO/2021/019588	NANOTECHNOLOGY-BASED DELIVERY SYSTEM OF BERGAMOT ESSENTIAL  OIL, METHOD OF PREPARATION OF THE SYSTEM AND USES THEREOF	UNIVERSITà DELLA CALABRIA
WO/2021/090345	COMPOSITION AND FORMULATION FOR THE TREATMENT OF INTESTINAL  GAS AND BLOATING	BIOFARMA S.R.L.
WO/2021/181436	PEROXIREDOXIN 6 OR A SYNTHETIC ANALOGUE THEREOF FOR USE AS A  HYPOGLYCAEMIC AGENT	UNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/186484	PEROXIREDOXIN 6 (PRDX6) FOR USE IN THE TREATMENT OF  RESPIRATORY DISORDERS	UNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/210033	CATECHIN CONTAINING COMPOSITIONS AND USES	ADAMAS BIOTECH S.R.L
WO/2021/220319	POLYNUCLEOTIDES ENCODING SARS-COV-2 ANTIGENS AND USE THEREOF  IN THE MEDICAL FIELD AS VACCINES	TAKIS S.R.L.
WO/2021/240568	ADENOSINE FOR THE PREVENTION AND TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROME (ARDS)	UNIVERSITà DEGLI STUDI DI ROMA "TOR VERGATA"
WO/2021/181437	A METHOD OF PREPARING ALGINATE MICRO-PARTICULATES	UNIVERSITY OF PETRA
WO/2021/001986	ORAL CAVITY COMPOSITION FOR ANIMAL, AND PERIODONTAL  DISEASE-PREVENTING AGENT, INFECTIOUS DISEASE-PREVENTING AGENT, AND  HALITOSIS-PREVENTING AGENT WHICH ARE FOR ANIMAL AND USE SAME	SOSIN CO., LTD.
WO/2021/005676	COMPOSITIONS FOR PREPARING MICROEMULSION, MICROEMULSION,  METHOD FOR PRODUCING COMPOSITION AND MICROEMULSION, AND USE OF MICROEMULSION	MORESCO CORPORATION
WO/2021/014654	HYDROPHILIZED ORGANIC POWDER AND COSMETIC INCLUDING  HYDROPHILIZED ORGANIC POWDER	MIYOSHI KASEI, INC.
WO/2021/014655	HYDROPHILIZED INORGANIC POWDER AND COSMETIC COMPOUNDED WITH  SAID HYDROPHILIZED INORGANIC POWDER	MIYOSHI KASEI, INC.
WO/2021/014656	HYDROPHILIZED INORGANIC POWDER AND COSMETIC PREPARATION  CONTAINING SAID HYDROPHILIZED INORGANIC POWDER	MIYOSHI KASEI, INC.
WO/2021/024393	CANCER COMBINATION THERAPY USING AZABICYCLIC COMPOUND AND  POLYADENOSINE-5'-DIPHOSPHATE RIBOSE POLYMERASE INHIBITOR	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/024419	PHARMACEUTICAL COMPOSITION	HIRATA CORPORATION
WO/2021/024485	HALAL DISINFECTANT LIQUID	HONBUSANKEI CO., LTD.
WO/2021/029020	ORAL PHARMACEUTICAL COMPOSITION	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/033247	CELL-CONTAINING PHARMACEUTICAL COMPOSITION	CELLAXIA INC.
WO/2021/038679	INTRAORAL SURFACE PATCH	LTASTE INC.
WO/2021/044608	DANTROLENE AQUEOUS FORMULATION AND METHOD FOR PREPARING SAME	CMIC HOLDINGS CO., LTD.
WO/2021/048961	AGENT FOR SUPPRESSING/IMPROVING BAD SKIN CAUSED BY FATIGUE  AND/OR STRESS AND SCREENING METHOD FOR AGENTS FOR SUPPRESSING/IMPROVING BAD  SKIN CAUSED BY FATIGUE AND/OR STRESS	SHISEIDO COMPANY, LTD.
WO/2021/044640	ANTICANCER AGENT	ISHII, Hitoshi
WO/2021/079435	BACTERIOPHAGE COMPOSITION	MEIJI SEIKA PHARMA CO., LTD.
WO/2021/084665	PLATELET-DERIVED GROWTH FACTOR (PDGF)-BB PRODUCTION PROMOTER,  STEM CELL STABILIZER CONTAINING THIS, AND SKIN ANTI-AGING AGENT CONTAINING  THESE	SHISEIDO COMPANY, LTD.
WO/2021/084760	METHOD FOR SKIN STATE EVALUATION USING ACTIVATED PAR-2 IN SKIN  AS INDEX, METHOD FOR SCREENING PAR-2 ACTIVATION PROMOTER OR INHIBITOR, AND  PAR-2 ACTIVATION INHIBITOR	SHISEIDO COMPANY, LTD.
WO/2021/095092	ORALLY DISINTEGRATING TABLET	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/100187	EXTERNAL PREPARATION FOR SKIN	NOEVIR CO., LTD.
WO/2021/106209	ADHESIVE PATCH	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106210	POULTICE	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106212	ADHESIVE PATCH	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106214	ADHESIVE PATCH	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/111636	ANTI-GDF15 ANTIBODY	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/117122	PROPHYLACTIC OR THERAPEUTIC AGENT FOR LYSOSOMAL ACID LIPASE  DEFICIENCY SYNDROME	REBORNA BIOSCIENCES, INC.
WO/2021/111641	GUIDE RNA FOR CONDITIONAL AND POST-TRANSCRIPTIONAL CONTROL OF  CRISPR-CAS PROTEIN	THE UNIVERSITY OF TOKYO
WO/2021/106231	A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D  MUTATION	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/084765	4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF	TAIHO PHARMACEUTICAL CO., LTD
WO/2021/124495	SKIN CLEANSER COMPOSITION	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/124496	SPRAY PREPARATION FOR SKIN CLEANING	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/124497	LIQUID COMPOSITION FOR SKIN CLEANSING	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/131021	ANTI-CTLA-4 ANTIBODY AND USE THEREOF	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/131032	ADHESIVE PATCH	NICHIBAN CO., LTD.
WO/2021/144843	BIOCOSMETIC COMPOSITION	HARBOR LINKS JAPAN INC
WO/2021/144844	ANTIPERSPIRANT COSMETIC COMPOSITION	HARBOR LINKS JAPAN INC
WO/2021/144936	COMPOSITION CONTAINING FULLERENE CLATHRATED WITH ORGANIC  COMPOUND, AND COSMETIC AND EXTERNAL-USE COMPOSITION CONTAINING SAME	YOKOTA, Junji
WO/2021/065027	DYSURIA-ALLEVIATING AGENT	ASKA PHARMACEUTICAL CO., LTD.
WO/2021/038904	MANUFACTURING METHOD FOR COMPOSITION WITH REDUCED URUSHIOL  CONTENT, COMPOSITION MANUFACTURED USING SAID MANUFACTURING METHOD, OBESITY  PREVENTION AGENT, FAT ACCUMULATION SUPPRESSION AGENT, AND SERUM LEPTIN  QUANTITY INCREASE SUPPRESSION AGENT	KIBUN FOODS INC.
WO/2021/009950	AGENT FOR ENHANCING EFFECT OF ANTICANCER AGENT	DELTA-FLY PHARMA, INC.
WO/2021/079536	BACTERIOPHAGE COMPOSITION	MEIJI SEIKA PHARMA CO., LTD.
WO/2021/161511	COMPOUND AND DRUG CONTAINING SAME	OITA UNIVERSITY INSTITUTE OF ADVANCED MEDICINE, INC.
WO/2021/149270	HAIR IMPROVEMENT METHOD	NIPPON FINE CHEMICAL CO., LTD.
WO/2021/181711	ALLERGY THERAPEUTIC AGENT	ISHII, Hitoshi
WO/2021/186579	ORALLY INGESTIBLE ADSORBENT AND METHOD FOR PRODUCING SAME	OHGI TECHNOLOGICAL CREATION CO., LTD.
WO/2021/192113	METHOD FOR TREATING CANCER AND SYSTEM THEREFOR	OTSUKA MEDICAL DEVICES CO., LTD.
WO/2021/106240	PRODUCTION METHOD FOR EDIBLE FILM, FILM PREPARATION, AND  EDIBLE FILM	NISSHA CO.,LTD.
WO/2021/070407	PRODUCTION METHOD AND DETECTION METHOD OF AFRICAN SWINE FEVER  VIRUS	NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
WO/2021/192270	HYDROUS PATCH	NICHIBAN CO., LTD.
WO/2021/065044	DETERGENT	KAO CORPORATION
WO/2021/065045	CLEANING AGENT	KAO CORPORATION
WO/2021/065046	DETERGENT	KAO CORPORATION
WO/2021/065047	DETERGENT	KAO CORPORATION
WO/2021/199239	PACKAGED AQUEOUS COMPOSITION	KOWA COMPANY, LTD.
WO/2021/065050	AQUEOUS LIQUID FORMULATION	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/131092	PHARMACEUTICAL PRODUCT	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/166274	PHARMACEUTICAL PRODUCT	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/205629	METHOD FOR PRODUCING POWDER SURFACE-TREATED WITH GEMINI IONIC  SURFACTANT, ULTRAVIOLET ABSORBER, AND THICKENER, WATER DISPERSION THEREOF,  AND COSMETICS INCORPORATING SAME	MIYOSHI KASEI, INC.
WO/2021/205631	STING AGONISTIC COMPOUND	ONO PHARMACEUTICAL CO., LTD.
WO/2021/210070	PHARMACEUTICAL COMPOSITION FOR ADENOVIRAL CONJUNCTIVITIS	OKUDA Kenji
WO/2021/214905	PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR  TREATING CANCER WITH COMBINED USE OF ANTI-HUMAN FN14 ANTIBODY AND IMMUNE  CHECKPOINT INHIBITOR	ASTELLAS PHARMA INC.
WO/2021/214950	PHARMACEUTICAL COMPOSITION FOR TREATMENT, PREVENTION OR  MANAGEMENT OF MENTAL DISORDER	NATIONAL UNIVERSITY CORPORATION SHIMANE UNIVERSITY
WO/2021/224999	MICROSPHERES IN WHICH BIOACTIVE SUBSTANCE IS UNIFORMLY  DISPERSED, AND SUSTAINED-RELEASE PREPARATION CONTAINING SAME	M. TECHNIQUE CO., LTD.
WO/2021/038975	BIFIDOBACTERIUM SPP. EXPRESSING AND SECRETING DIABODY-TYPE  BSAB	ANAEROPHARMA SCIENCE, INC.
WO/2021/002124	MOISTURIZING FILM COSMETIC MATERIAL	SHISEIDO COMPANY, LTD.
WO/2021/250741	LIQUID COSMETIC PREPARATION FOR EYELINER	NIPPON TELEGRAPH AND TELEPHONE CORPORATION
WO/2021/250742	COSMETIC FOR EYELASHES	NIPPON TELEGRAPH AND TELEPHONE CORPORATION
WO/2021/005941	ALBIZIA JULIBRISSIN EXTRACT-CONTAINING COMPOSITION	TOYOBO CO., LTD.
WO/2021/014812	TREATMENT FOR FIBROBLASTIC OR MYOFIBROBLASTIC TUMOR AND  DISEASE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/260750	SKINCARE COSMETIC FREE OF SODIUM HYDROXIDE AND POTASSIUM  HYDROXIDE	NAKAJIMA SANGYO KABUSHIKIKAISHA
WO/2021/033420	PORCINE CIRCOVIRUS TYPE 2 VLP VACCINE	JECTAS INNOVATORS COMPANY LIMITED
WO/2021/014861	HARMFUL-TO-HEALTH SUBSTANCE REMOVING AGENT AND HEALTH FOOD	DEXERIALS CORPORATION
WO/2021/002250	CELLULOSE ACETATE AND METHOD FOR PRODUCING CELLULOSE ACETATE	DAICEL CORPORATION
WO/2021/002265	CD38-BINDING AGENTS AND USES THEREOF	PEPTIDREAM INC.
WO/2021/084791	COMPOSITION TARGETED TO ADENOSINE A2A RECEPTOR	IMMNO, INC.
WO/2021/010118	COMPOSITION FOR AMELIORATION OR PROPHYLAXIS OF ANXIETY  DISORDERS AND/OR MOOD DISORDERS	COMBI CORPORATION
WO/2021/039084	INJECTION FORMULATION	TERUMO KABUSHIKI KAISHA
WO/2021/002285	OIL-IN-WATER EMULSION COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/131104	COMPOSITION CONTAINING PEPTIDE, PRODUCTION METHOD THEREOF, AND  USE OF PEPTIDE	SUNTORY HOLDINGS LIMITED
WO/2021/131105	FOOD OR BEVERAGE COMPOSITION CONTAINING PEPTIDE AND/OR SALT  THEREOF, PRODUCTION METHOD THEREOF, USE OF HYDROLYZED COLLAGEN TYPE II,  COMPOSITION FOR INHIBITING BONE RESORPTION, AND USE OF CHICKEN EXTRACT	SUNTORY HOLDINGS LIMITED
WO/2021/059639	PREBIOTIC COMPOSITION FOR BUTYRIC ACID BACTERIA	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/131106	COMPOSITION CONTAINING CYCLIC DIPEPTIDE, PURINE NUCLEOSIDE  AND/OR AMINO ACID, AND CHICKEN EXTRACT, PRODUCTION METHOD THEREOF, AND USE OF  CYCLIC DIPEPTIDE, PURINE NUCLEOSIDE AND/OR AMINO ACID, AND CHICKEN EXTRACT	SUNTORY HOLDINGS LIMITED
WO/2021/002334	COMPOSITION FOR INHIBITING TNF-α OR IL-6 PRODUCTION	HOUSE WELLNESS FOODS CORPORATION
WO/2021/002335	COMPOSITION FOR LOWERING BLOOD GLUCOSE LEVEL, REDUCING BLOOD  HEMOGLOBIN A1c CONTENT, OR INCREASING BLOOD HDL-CHOLESTEROL CONTENT	HOUSE WELLNESS FOODS CORPORATION
WO/2021/059645	DENTAL COMPOSITION AND DENTAL RESTORATION KIT	GC CORPORATION
WO/2021/002337	COSMETIC METHOD	SHISEIDO COMPANY, LTD.
WO/2021/002352	COMPOSITION FOR TREATING OR PREVENTING TARDIVE DYSKINESIA, AND  METHOD FOR SCREENING ACTIVE INGREDIENT FOR TREATING OR PREVENTING TARDIVE  DYSKINESIA	KYOTO UNIVERSITY
WO/2021/002355	PHARMACEUTICAL COMPOSITION FOR TREATING INFLUENZA VIRUS  INFECTIONS	AILLIS INC.
WO/2021/002359	NUCLEIC ACID DRUG AND USE THEREOF	VERITAS IN SILICO INC.
WO/2021/065123	SOLID OIL-IN-WATER TYPE EMULSIFIED COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/006143	HAIR COSMETIC	KAO CORPORATION
WO/2021/002411	METHOD FOR MANUFACTURING ORALLY DISINTEGRATING TABLET, AND  ORALLY DISINTEGRATING TABLET	SAWAI PHARMACEUTICAL CO., LTD.
WO/2021/002449	NOVEL LACTIC ACID BACTERIUM DERIVED FROM AMUR CORK TREES  INHABITING SHIRAKAMI MOUNTANEOUS REGION	HIROSAKI UNIVERSITY
WO/2021/006199	TREATMENT OF HEMATOLOGIC CANCER WITH PD-1/CD3 DUAL SPECIFICITY  PROTEIN	ONO PHARMACEUTICAL CO., LTD.
WO/2021/006202	MODIFIED NEURAMINIDASE	TOKUSHIMA UNIVERSITY
WO/2021/002457	AGENT FOR SUPPRESSING BITTERNESS IN ASENAPINE, AND METHOD FOR  SUPPRESSING BITTERNESS	MEIJI SEIKA PHARMA CO., LTD.
WO/2021/006222	NUCLEIC ACID CARRIER AND METHOD FOR ADMINISTERING NUCLEIC ACID	TOKYO MEDICAL UNIVERSITY
WO/2021/014957	BENDAMUSTINE INJECTION FORMULATION	FUJIFILM CORPORATION
WO/2021/075095	HARDENING PASTE AND ALGINATE DENTAL IMPRESSION MATERIAL	GC CORPORATION
WO/2021/006267	SALT OF PYRAZOLE DERIVATIVE AND PREPARATION OF PYRAZOLE  DERIVATIVE	GREEN TECH CO., LTD.
WO/2021/006268	METHOD FOR PRODUCING INSULIN-PRODUCING CELL USING  DIHYDROINDOLIZINONE DERIVATIVES	TOKYO INSTITUTE OF TECHNOLOGY
WO/2021/020047	IMMUNE INDUCER AND PHARMACEUTICAL COMPOSITION FOR PREVENTING  OR TREATING AGING-RELATED DISEASES	NIIGATA UNIVERSITY
WO/2021/029163	COMPOSITION CONTAINING GLYCYRRHETINIC ACID DERIVATIVE	MARUZEN PHARMACEUTICALS CO., LTD.
WO/2021/006279	DATA PROCESSING AND CLASSIFICATION FOR DETERMINING A  LIKELIHOOD SCORE FOR BREAST DISEASE	PREFERRED NETWORKS, INC.
WO/2021/002481	RENAL TARGETING-TYPE DRUG DELIVERY CARRIER HAVING EXCELLENT  BIODEGRABILITY	KYOTO PHARMACEUTICAL UNIVERSITY
WO/2021/006289	LIQUID COSMETIC COMPOSITION	MITSUBISHI PENCIL COMPANY, LIMITED
WO/2021/006305	APTAMER FOR TGF-β1 AND USE OF SAME	RIBOMIC INC.
WO/2021/006316	SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING  CANCER CELLS	NATIONAL CANCER CENTER
WO/2021/006317	NOVEL THERAPEUTIC AGENT FOR PROTOTHECA DISEASE	SEREN PHARMACEUTICALS INC.
WO/2021/010301	ANTISENSE OLIGONUCLEOTIDE CAPABLE OF ALTERING SPLICING OF DUX4  pre-mRNA	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/010303	THERAPEUTIC AGENT FOR DISEASE CAUSED BY DOMINANT MUTANT GENE	RIKEN
WO/2021/014994	BONE REGENERATIVE AGENT AND METHOD OF USING SAME	JFE MINERAL COMPANY, LTD.
WO/2021/010326	ANTI-MUTATION TYPE FGFR3 ANTIBODY AND USE THEREFOR	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/010344	DEVELOPMENT OF THERAPY FOR IMPROVING MYOCARDIAL CONTRACTION  AND METHOD FOR INHIBITING CARDIOMYOCYTE DEATH	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/010346	NEUTRALIZING ANTIBODY FOR TOOTH REGENERATION TREATMENT  TARGETING USAG-1 MOLECULE	KYOTO UNIVERSITY
WO/2021/010348	TRANSFORMING GROWTH FACTOR β1 AS PREVENTIVE OR THERAPEUTIC  AGENT FOR DEPRESSION OR SYMPTOMS OF DEPRESSION	NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
WO/2021/015029	THERAPEUTIC OR PREVENTIVE PHARMACEUTICAL COMPOSITION FOR  DISEASE INVOLVING ALK2 MUTATION	KYOTO UNIVERSITY
WO/2021/015040	HAIR GROWING AGENT AND FOOD AND DRINK CONTAINING SAME	NITTA GELATIN INC.
WO/2021/015041	RETARDANT FOR PROGRESSION OF AGING, AND FOOD OR BEVERAGE  CONTAINING SAME	NITTA GELATIN INC.
WO/2021/020135	COSMETIC AND METHOD FOR PRODUCING COSMETIC	MIYOSHI KASEI, INC.
WO/2021/059689	HYDROGEL	SEKISUI KASEI CO., LTD.
WO/2021/015087	METHOD FOR PRODUCING RUBISCO	NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/015091	ORAL COMPOSITION AND AGENT FOR IMPARTING MASSAGE SENSATION TO  GUMS	LION CORPORATION
WO/2021/131116	CARRIER FOR CELL DELIVERY	KABUSIKIKAISYA ITO
WO/2021/010449	RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA  MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE	THE UNIVERSITY OF TOKYO
WO/2021/015104	AGENT FOR REGULATING FEMALE HORMONE SECRETION AND AGENT FOR  ALLEVIATING UNPLEASANT SYMPTOMS	ASAHI GROUP HOLDINGS, LTD.
WO/2021/015107	COMPOSITION	MEIJI CO., LTD.
WO/2021/229832	WATER-SOLUBLE POLYMERIC DERIVATIVE OF VENETOCLAX	DELTA-FLY PHARMA, INC.
WO/2021/020174	AQUEOUS COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/020209	AGENT FOR PROMOTING GENERATION OF SHORT-CHAIN FATTY ACIDS  WITHIN INTESTINAL DUCT	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/020210	GUT MICROBIOTA REGULATING AGENT	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/024801	COMPOSITION FOR CARTILAGE REGENERATION PROMOTION	SUNTORY HOLDINGS LIMITED
WO/2021/079579	WATER SOLUBLE O-GLYCOSYL FLAVONOID COMPOSITIONS AND METHODS  FOR PREPARING SAME	ALPS PHARMACEUTICAL IND. CO., LTD.
WO/2021/020252	CONTINUAL DRUG RELEASE DEVICE THAT CAN BE REPLENISHED WITH  DRUGS	TOHOKU UNIVERSITY
WO/2021/015218	PREVENTION OR TREATMENT OF FIBROTIC DISEASE WHICH TARGETS  TRANSCRIPTION-ASSOCIATED FACTOR	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/015221	METHOD FOR PRODUCING OPTICALLY ACTIVE 1,  4-BENZOTHIAZEPINE-1-OXIDE DERIVATIVE	AETAS PHARMA CO., LTD.
WO/2021/015222	PEPTIDE	KYOTO UNIVERSITY
WO/2021/020268	BIOGRAFT MATERIAL	FUJIFILM CORPORATION
WO/2021/015234	CHIMERIC MOLECULE, PHARMACEUTICAL COMPOSITION, METHOD FOR  CLEAVING TARGET NUCLEIC ACID, AND KIT FOR TARGET NUCLEIC ACID CLEAVAGE OR  DIAGNOSIS	TOHOKU UNIVERSITY
WO/2021/020282	ANTIBODY RECOGNIZING EXTRACELLULAR REGION OF ALK2/ACVR1	SAITAMA MEDICAL UNIVERSITY
WO/2021/020336	PHARMACEUTICAL COMPOSITION FOR TREATING TUMOR	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/020342	TEMPERATURE-RESPONSIVE DRUG/POLYMER COMPOUND AND APPLICATION  OF COMPOUND TO DRUG DELIVERY	THE UNIVERSITY OF TOKYO
WO/2021/020351	OILY COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/020352	SOLID COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/010492	COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL  USE THEREOF	ONO PHARMACEUTICAL CO., LTD.
WO/2021/015294	COMBINATION THERAPY FOR CANCER TREATMENT	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/020362	HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/020363	HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/029216	DENTIN REGENERATIVE CELL CULTURE	NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY
WO/2021/024854	SOLID COSMETIC PREPARATION AND METHOD FOR PRODUCING SAME	SHISEIDO COMPANY, LTD.
WO/2021/024855	THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR FIBROMYALGIA	TEIJIN PHARMA LIMITED
WO/2021/020412	NUCLEIC ACID DRUG TARGETING MURF1	SHIONOGI & CO., LTD.
WO/2021/020416	BISPECIFIC ANTIBODY	ONO PHARMACEUTICAL CO., LTD.
WO/2021/020429	UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR	TAISHO PHARMACEUTICAL CO., LTD.
WO/2021/024872	ORAL COMPOSITION FOR STRESS REDUCTION AND/OR BODY WEIGHT  RECOVERY, AND METHOD FOR PRODUCING PLASMALOGEN-CONTAINING COMPOSITION	INSTITUTE OF RHEOLOGICAL FUNCTIONS OF FOOD
WO/2021/100251	BASE PASTE AND ADDITION-TYPE SILICONE IMPRESSION MATERIAL FOR  USE IN DENTISTRY	GC CORPORATION
WO/2021/020446	COMPOSITION CONTAINING HERPES SIMPLEX VIRUS	TAKARA BIO INC.
WO/2021/020455	VILDAGLIPTIN-CONTAINING DRY GRANULATED POWDER,  VILDAGLIPTIN-CONTAINING TABLET, AND METHODS FOR PRODUCING THESE	SAWAI PHARMACEUTICAL CO., LTD.
WO/2021/020462	INTRACELLULAR DELIVERY PEPTIDE	KYOTO UNIVERSITY
WO/2021/020481	METHOD FOR PRODUCING INTERMEDIATE OF IGURATIMOD DERIVATIVES,  METHOD FOR PRODUCING IGURATIMOD, IGURATIMOD HAVING NOVEL CRYSTAL STRUCTURE,  AND METHOD FOR PRODUCING SAME	TOKUYAMA CORPORATION
WO/2021/024897	COMBINATION DRUG FOR TREATING MALIGNANT TUMOR, PHARMACEUTICAL  COMPOSITION FOR TREATING MALIGNANT TUMOR, AND PHARMACEUTICAL COMPOSITION FOR  MALIGNANT TUMOR TREATMENT	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/020505	PHARMACEUTICAL COMPOSITION FOR TREATING CANCER	KYOTO UNIVERSITY
WO/2021/020509	COMPOSITION FOR PROMOTING GROWTH OR SUPPRESSING DECREASE OF  MESENCHYMAL STEM CELLS	STEMRIM INC.
WO/2021/024906	HYDROPHILIC-HYDROPHOBIC COPOLYMER CARRYING SHORT-CHAIN FATTY  ACID ESTER	UNIVERSITY OF TSUKUBA
WO/2021/020514	COLLAGEN PRODUCTION PROMOTER, WRINKLE AMELIORATING AGENT,  EXTERNAL PREPARATION FOR SKIN, AND COSMETIC FOOD OR BEVERAGE	REFINE HOLDINGS CO., LTD.
WO/2021/039269	FAT METABOLISM PROMOTER	ASAHI GROUP HOLDINGS, LTD.
WO/2021/020535	PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATION	ASTELLAS PHARMA INC.
WO/2021/015297	TRANSGENIC NON-HUMAN ANIMAL CAPABLE OF CONTROLLING EXPRESSION  OF TRANSCRIPTION FACTOR RP58	TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
WO/2021/024930	HARD CAPSULE FORMULATION SEALED WITH BAND SEAL INCLUDING TAG	QUALICAPS CO., LTD.
WO/2021/020552	COMPOSITION FOR IMPROVING MEMORY	BGG JAPAN CO., LTD.
WO/2021/020554	METHOD FOR TREATING LIVER CANCER WITH COMBINED USE OF  REIC/DKK-3 GENE AND ANTI-TUMOR AGENT	MOMOTARO-GENE INC.
WO/2021/020559	ANTIGEN RECEPTOR	MIE UNIVERSITY
WO/2021/020564	GD2 BINDING MOLECULE	MIE UNIVERSITY
WO/2021/029238	AGENT FOR PREVENTING OR TREATING TH17 CELL-INDUCED DISEASE AND  SCREENING METHOD FOR AGENTS FOR PREVENTING OR TREATING TH17 CELL-INDUCED  DISEASE	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/024986	AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT	NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/029260	α-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR  ABSORPTION INHIBITOR	KINKI UNIVERSITY
WO/2021/025013	WATER-IN-OIL EMULSION COMPOSITION	SHOWA DENKO K.K.
WO/2021/025018	PHARMACEUTICAL COMPOSITION FOR THERAPY AND/OR PROPHYLAXIS OF  COLORECTAL CANCER	KYOTO UNIVERSITY
WO/2021/025020	PHARMACEUTICAL AGENT FOR TRANSMUCOSAL ADMINISTRATION	DENKA COMPANY LIMITED
WO/2021/025022	MODIFIED KONJAC FLOUR-CONTAINING PHYSIOLOGICALLY ACTIVE AGENT  FOR ORAL ADMINISTRATION	ORIHIRO PLANTDEW CO., LTD.
WO/2021/025031	BIOMARKER FOR ACCESSING EFFICACY OF IMMUNE CHECKPOINT  INHIBITOR	ONO PHARMACEUTICAL CO., LTD.
WO/2021/059755	COMPOSITION FOR SYMPATHETIC NERVE ACTIVATION	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/039321	HAIR DYEING METHOD	KOTERA, Kouichi
WO/2021/025065	COMBINATION THERAPY FOR CANCER USING AZABICYCLIC COMPOUND AND  POLY(ADENOSINE 5'-DIPHOSPHATE-RIBOSE) POLYMERASE INHIBITOR	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/025102	MEDICINE FOR PREVENTING AND/OR TREATING INSULIN-DEPENDENT  DIABETES MELLITUS	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/025103	COMPOSITION FOR INHIBITING REDUCTION OF TESTOSTERONE AND/OR  DIHYDROTESTOSTERONE	OKINAWA UKAMI SERICULTURE CO., LTD.
WO/2021/029318	IMMUNE CHECKPOINT INHIBITOR, THERAPEUTIC AGENT FOR IMMUNE  CHECKPOINT-RELATED DISEASE, IMMUNOSUPPRESSANT, ANTI-FIBRONECTIN ANTIBODY OR  DERIVATIVE THEREOF, FIBRONECTIN ANALOG, KIT FOR DETECTING FIBRONECTIN OR  PARTIAL PROTEIN THEREOF, AND METHOD FOR DETECTING FIBRONECTIN OR PARTIAL  PROTEIN THEREOF	TOHOKU UNIVERSITY
WO/2021/084837	THICKENING OR SOLIDIFYING AGENT FOR OIL AGENT	TAIYO KAGAKU CO., LTD.
WO/2021/029322	COMPOSITION FOR PREVENTING OR ALLEVIATING LIFESTYLE DISEASES	MITSUBISHI CORPORATION LIFE SCIENCES LIMITED
WO/2021/025118	COMPOSITION USED FOR FORMING COATING	KAO CORPORATION
WO/2021/025122	METHOD FOR CULTURING DERMAL PAPILLA CELLS	KAO CORPORATION
WO/2021/025129	OPHTHALMIC COMPOSITION FOR PROMOTING TEAR SECRETION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/029334	RNA INTERFERENCE AGENT, MULTIPLE CHEMICALLY MODIFIED  OLIGONUCLEOTIDE, AND USE THEREOF	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/025139	COMPOSITION FOR INHIBITING NERVE CELL INJURY CAUSED BY Aβ	SUMITOMO CHEMICAL COMPANY, LIMITED
WO/2021/029346	AGENT FOR TREATING OR PREVENTING CEREBROVASCULAR DEMENTIA	TOHOKU UNIVERSITY
WO/2021/029347	ANTICANCER DRUG-DECOMPOSING AGENT AND ANTICANCER DRUG  DECOMPOSITION METHOD	SECOM MEDICAL SYSTEM CO., LTD.
WO/2021/025147	SULFATED HYALURONIC ACID	TOKYO CHEMICAL INDUSTRY CO., LTD.
WO/2021/029350	PHARMACEUTICAL COMPOSITION CONTAINING ANTIFUNGAL AGENT AS  ACTIVE INGREDIENT	SATO PHARMACEUTICAL CO., LTD.
WO/2021/025148	THERAPEUTIC AGENT FOR CANCER HAVING RESISTANCE TO ANTI-CCR4  ANTIBODY	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/029368	COMBINED USE OF ARTIFICIAL ADJUVANT VECTOR CELLS AND AN  IMMUNOSTIMULANT	RIKEN
WO/2021/025154	COMPOSITION FOR BABIES AND INFANTS FOR IMPROVING MEMORY  ABILITY IN CHILDHOOD	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/029385	ONCOLYTIC VACCINIA VIRUS	KM BIOLOGICS CO., LTD.
WO/2021/033590	AGENT FOR REDUCING MALODOR OF FLATULENCE AND/OR STOOL	MIYAMOTO Yusei
WO/2021/033599	AGENT FOR IMPROVING DYNAMIC VISUAL ACUITY AND METHOD FOR  IMPROVING DYNAMIC VISUAL ACUITY	PLATINUM HEPBURN CO.,LTD.
WO/2021/039385	ORAL COMPOSITION FOR IMPROVING MEMORIZATION LEARNING ABILITY	UNITEC FOODS CO., LTD.
WO/2021/029424	NOVEL TREATMENT AND PREVENTION OF DISEASE BASED ON  IMMUNOLOGICAL MEMORY	NATIONAL INSTITUTES OF BIOMEDICAL INNOVATION, HEALTH AND  NUTRITION
WO/2021/029425	TOPICAL COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/029429	ORAL PHARMACEUTICAL COMPOSITION	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/029430	ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC  COMPOUND	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/029434	THERAPEUTIC AGENT FOR DROPPED HEAD SYNDROME AND THORACOLUMBAR  DEFORMITY	ISHII, Ken
WO/2021/029438	PARTICLES, PHARMACEUTICAL COMPOSITION, AND METHOD FOR  PRODUCING PARTICLES	RICOH COMPANY, LTD.
WO/2021/039447	COMPOSITION SUITABLE FOR CLEANSING	L'OREAL
WO/2021/039448	COMPOSITION COMPRISING AMPS POLYMER AND POLYSACCHARIDE	L'OREAL
WO/2021/033661	GINGIVAL EPITHELIAL CELL ACTIVATOR	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/033662	GINGIVAL TISSUE DESTRUCTION INHIBITING AGENT	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/033725	COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/033727	MICRORNA EXPRESSION REGULATOR	KEWPIE CORPORATION
WO/2021/049268	POLYMERIZABLE DENTAL COMPOSITION	GC CORPORATION
WO/2021/039554	CANCER CHEMOTHERAPY SUPPORTING AGENT, FOOD, AND DRUG	BIOMEDICAL RESEARCH GROUP INC.
WO/2021/075147	BRAP2 ACTION ENHANCER	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/039574	HEAVY-CHAIN ANTIBODY IN WHICH O-LINKED SUGAR CHAIN  MODIFICATION IS SUPPRESSED	KANEKA CORPORATION
WO/2021/039586	MODIFIED BORON NITRIDE POWDER	TOKUYAMA CORPORATION
WO/2021/039598	RNA ACTION INHIBITOR AND USE THEREOF	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/039610	COMPOSITION COMPRISING MICROCAPSULE AND CELL STRUCTURE	FUJIFILM CORPORATION
WO/2021/039616	COMBINATION THERAPY AND BIOMARKER INDICATING EFFICACY THEREOF	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/039617	SOLID COSMETIC	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/033766	LITHOCHOLIC ACID DERIVATIVE HAVING VITAMIN D ACTIVITY	OCHANOMIZU UNIVERSITY
WO/2021/039645	BIOLOGICAL INTRODUCTION AID AND METHOD OF USE THEREOF	SHINBIOSIS CORPORATION
WO/2021/033773	ABCC11 INHIBITOR	THE UNIVERSITY OF TOKYO
WO/2021/090552	ENTERIC PREPARATION CONTAINING LACTOFERRIN	LION CORPORATION
WO/2021/039721	ORAL COMPOSITION	LION CORPORATION
WO/2021/084869	MANUFACTURING METHOD FOR MICROBUBBLE-CONTAINING ELECTROLYTE  AND MANUFACTURING METHOD FOR MICROBUBBLE-CONTAINING SOLVENT FOR USE IN  PREPARING MICROBUBBLE-CONTAINING ELECTROLYTE	AICHI MEDICAL UNIVERSITY
WO/2021/039748	DIQUAFOSOL OR SALT THEREOF, AND AQUEOUS OPHTHALMIC COMPOSITION  CONTAINING POLYVINYLPYRROLIDONE	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/039791	MEDICINAL COMPOSITION FOR PREVENTING OR TREATING  ANGIOGENESIS-RELATED DISEASES	YAMAGUCHI UNIVERSITY
WO/2021/054063	PARTICLES, METHOD FOR PRODUCING PARTICLES, DRUG, METHOD FOR  PRODUCING DRUG, AND ANTI-CANCER AGENT	THE UNIVERSITY OF KITAKYUSHU
WO/2021/039800	METHOD FOR PREPARING ENANTIOMER OF SULFOXIDE COMPOUND, AND  SYSTEM FOR PREPARING ENANTIOMER	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/039824	RNA METHYLTRANSFERASE INHIBITOR, SCREENING METHOD THEREFOR,  ANTI-CANCER AGENT EFFICACY ASSESSMENT MARKER, AND KIT FOR EFFECTIVELY  PREDICTING FTSJ1 INHIBITOR	NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/039833	METHOD FOR PRODUCING CULTURED TISSUE, AND PREPARATION FOR  EXTERNAL APPLICATION	NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY
WO/2021/039873	COMPOSITE PROTEIN MONOMER HAVING NON-STRUCTURAL PROTEIN OF  VIRUS SUPPORTED THEREON, AGGREGATE OF COMPOSITE PROTEIN MONOMER, AND  COMPONENT VACCINE COMPRISING AGGREGATE AS ACTIVE INGREDIENT	TOKYO INSTITUTE OF TECHNOLOGY
WO/2021/039879	NUCLEIC ACID MEDICINE FOR TARGETING GASTRIC CANCER MOLECULE	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/059840	ANGIOTENSIN CONVERTING ENZYME INHIBITOR	TAIYOKAGAKU CO., LTD.
WO/2021/039882	METHOD FOR CULTURING TIE2-POSITIVE STEM/PROGENITOR  CELL-CONTAINING CELL POPULATION USING CULTURE SUBSTRATE, AND UTILIZATION  THEREOF	TOKAI UNIVERSITY EDUCATIONAL SYSTEM
WO/2021/054079	CELL STRUCTURE AND METHOD FOR PRODUCING SAME	TOPPAN PRINTING CO., LTD.
WO/2021/039932	METHOD FOR DIAGNOSING RELAPSING-REMITTING MULTIPLE SCLEROSIS,  SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS, ATYPICAL MULTIPLE SCLEROSIS, AND  NEUROMYELITIS OPTICA-RELATED DISEASE, AND DIAGNOSTIC BIOMARKER	JUNTENDO EDUCATIONAL FOUNDATION
WO/2021/039936	COMPOSITION COMPRISING POLYION COMPLEX AND TEXTURE AGENT	L'OREAL
WO/2021/039945	CROSS-SPECIES ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF  USE	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/039951	INJECTION FOR MASTITIS	NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
WO/2021/039961	RING-FUSED PYRAZOLE DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/039968	2-AMINOQUINAZOLINONE DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/039972	UROTHELIAL CELL INDUCTION AGENT AND METHOD FOR INDUCING  UROTHELIAL CELLS	CELLAXIA INC.
WO/2021/039975	JELLY PREPARATION CONTAINING LEVOCARNITINE AT HIGH  CONCENTRATION	MARUISHI PHARMACEUTICAL CO., LTD.
WO/2021/044975	WATER-IN-OIL COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/049335	DENTAL POLYMERIZABLE COMPOSITION	GC CORPORATION
WO/2021/040022	CELL-PENETRATING PEPTIDE AND USE THEREOF	UNIVERSITY PUBLIC CORPORATION OSAKA
WO/2021/040027	SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE  MATERIAL, AND METHOD FOR PRODUCING SAME	SAN-EI GEN F.F.I., INC.
WO/2021/040042	PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT IN PATIENT  HAVING SPECIFIC GENE MARKER	J-PHARMA CO., LTD.
WO/2021/040043	PHARMACEUTICAL COMPOSITION USED IN PATIENTS HAVING SPECIFIC  GENE MARKER	J-PHARMA CO., LTD.
WO/2021/045005	COMPOSITION FOR EXTERNAL APPLICATION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/045045	LIVESTOCK FEED OR LIVESTOCK SUPPLEMENT, AGENT FOR PROMOTING  RECOVERY OF PHYSICAL CONDITION DURING OR AFTER TREATMENT OF GASTROINTESTINAL  DISEASE IN LIVESTOCK, AND METHOD FOR PROMOTING RECOVERY OF PHYSICAL CONDITION  DURING OR AFTER TREATMENT OF GASTROINTESTINAL DISEASE IN LIVESTOCK	FUJIFILM CORPORATION
WO/2021/045073	SEASONAL INFLUENZA VACCINE CAPABLE OF INDUCING VIRUS-SPECIFIC  ANTIBODY INTO NASAL CAVITY	DENKA COMPANY LIMITED
WO/2021/065307	ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, BLOOD  PRESSURE-LOWERING AGENT, AND BEVERAGES AND FOOD PRODUCTS	MARUZEN PHARMACEUTICALS CO., LTD.
WO/2021/059908	AEROSOL SPRAY HAIRSTYLING PRODUCT	MANDOM CORPORATION
WO/2021/045138	COMPOSITION FOR IMPROVING IRRITABLE BOWEL SYNDROME	ENEOS CORPORATION
WO/2021/045151	FILM MOLDING COMPOSITION AND FILM	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/045159	THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING  COMBINATION MEDICINE	JAPAN TOBACCO INC.
WO/2021/045161	CHRONIC KIDNEY DISEASE TREATMENT OR PREVENTION METHOD	JAPAN TOBACCO INC.
WO/2021/045176	O/W EMULSION COMPOSITION	KOKYU ALCOHOL KOGYO CO., LTD.
WO/2021/045184	THERAPEUTIC AGENT FOR POLYCYTHEMIA	PERSEUS PROTEOMICS INC.
WO/2021/045190	THERAPEUTIC AGENT FOR MYOCARDITIS	TOHOKU UNIVERSITY
WO/2021/229835	STABLE LIQUID PHARMACEUTICAL PREPARATION CONTAINING  TERIPARATIDE OR SALT THEREOF	ASAHI KASEI PHARMA CORPORATION
WO/2021/054149	AGENT FOR RAISING IN VIVO CONCENTRATION OF ACTIVE SULFUR  MOLECULAR SPECIES	NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/045202	METHOD FOR ACQUIRING DATA FOR DISTINGUISHING PRESENCE OF  CANCER CELLS AND/OR DISTINGUISHING ANTICANCER DRUG RESISTANCE, METHOD FOR  ACQUIRING PREDICTION DATA, USE OF DISTINCTION MARKER IN SAME, AND  DISTINGUISHING KIT	KEIO UNIVERSITY
WO/2021/045210	FERRITIN ENCLOSING PEPTIDE	AJINOMOTO CO., INC.
WO/2021/045217	METHOD FOR PRODUCING CELL AGGREGATE INCLUDING GLIAL PROGENITOR  CELLS	KEIO UNIVERSITY
WO/2021/054190	W/O TYPE EMULSION COSMETIC PREPARATION	TAIKI CORP., LTD.
WO/2021/106312	EXTRACELLULAR VESICLES DERIVED FROM LIVING BODY AND CONTAINING  ONCOLYTIC VIRUS	NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/049496	COMPOSITION FOR PREVENTION AND/OR TREATMENT OF CANCER	TOMOIKE BIO LTD.
WO/2021/049504	GALNAC-OLIGONUCLEOTIDE CONJUGATE FOR LIVER-TARGETED DELIVERY  USE, AND METHOD FOR PRODUCING SAME	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/049519	METHOD FOR PREVENTING PRECIPITATION OF INJECTABLE SOLUTION  CONTAINING p-BORONOPHENYLALANINE	STELLA PHARMA CORPORATION
WO/2021/049520	INJECTION CONTAINING p-BORONOPHENYLALANINE	STELLA PHARMA CORPORATION
WO/2021/095337	INTRA-ORAL SHEET	KAO CORPORATION
WO/2021/049529	FORMULATION	SEKISUI CHEMICAL CO., LTD.
WO/2021/049534	PREVENTIVE OR REMEDY FOR CHILDHOOD OBESITY CAUSED BY PASSIVE  EXPOSURE TO TOBACCO SMOKE	FUKUSHIMA MEDICAL UNIVERSITY
WO/2021/059986	COLLAGEN PRODUCTION ENHANCER, PHARMACEUTICAL, COSMETIC, AND  METHOD FOR PRODUCING COLLAGEN PRODUCTION ENHANCER	MURATA MANUFACTURING CO., LTD.
WO/2021/049587	COMPOSITION FOR ENHANCING EFFECT OF ANTIBODY DRUG	AUREO CO., LTD.
WO/2021/049595	AGRICULTURAL AND HORTICULTURAL PESTICIDE HAVING AS ACTIVE  COMPONENT CONDENSED HETEROCYCLIC COMPOUND HAVING SUBSTITUTED CYCLOPROPANE  OXADIAZOLE GROUP OR SALT THEREOF; ECTOPARASITE OR ENDOPARASITE CONTROL AGENT  FOR ANIMALS; AND USE METHOD THEREOF	NIHON NOHYAKU CO., LTD.
WO/2021/049596	AGRICULTURAL AND HORTICULTURAL INSECTICIDE OR ANIMAL ECTO- OR  ENDO-PARASITE CONTROLLING AGENT WHICH CONTAINS IMIDAZOPYRIDAZINE COMPOUND  HAVING SUBSTITUTED CYCLOPROPANE OXADIAZOLE GROUP OR SALTS THEREOF AS ACTIVE  INGREDIENT, AND USAGE METHOD OF SAME	NIHON NOHYAKU CO., LTD.
WO/2021/049599	PHARMACEUTICAL COMPOSITION CONTAINING P-BORONOPHENYLALANINE  AND METHOD FOR PRODUCING SAME	STELLA PHARMA CORPORATION
WO/2021/049600	PHARMACEUTICAL COMPOSITION HAVING ANTIBACTERIAL ACTIVITY	SHIONOGI & CO., LTD.
WO/2021/049606	DCR3 VARIANT	KYOWA KIRIN CO., LTD.
WO/2021/049612	DRUG FOR IMPROVING FLUID RETENTION IN ACUTE HEART FAILURE	NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA
WO/2021/054257	ROPINIROLE-CONTAINING PATCH AND METHOD FOR IMPROVING SKIN  PERMEABILITY OF ROPINIROLE	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/049617	SERUM-FREE MEDIUM NOT CONTAINING ALBUMIN AND SUITED FOR  CULTURING HUMAN HEMATOPOIETIC STEM CELLS, AND ALBUMIN-FREE CULTURING METHOD	THE UNIVERSITY OF TOKYO
WO/2021/049628	P2X4 RECEPTOR ANTAGONIST	NIPPON CHEMIPHAR. CO.. LTD.
WO/2021/225011	MICROSPHERE HAVING PHYSIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY  DISPERSED THEREIN, AND SUSTAINED-RELEASE PREPARATION CONTAINING SAME	M. TECHNIQUE CO., LTD.
WO/2021/049633	DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL  ALPORT SYNDROME	NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/049634	NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSIN	RESTORE VISION CO., LTD.
WO/2021/040056	GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS  OF USES THEREOF	ASTELLAS PHARMA INC.
WO/2021/060079	COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/060091	RUTIN COMPOSITIONS	ALPS PHARMACEUTICAL IND. CO., LTD.
WO/2021/054370	NUCLEIC ACID COMPLEX	NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/054373	COMPOSITION FOR ELONGATING TELOMERES	OSATO INTERNATIONAL INC.
WO/2021/084952	OXIDATION HAIR DYE	HOYU CO., LTD.
WO/2021/054420	SUGAR CHAIN-PRESENTING PARTICLES AND PRODUCTION METHOD THEREOF	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/054440	PHARMACEUTICAL COMPOSITION	UNIVERSITY OF FUKUI
WO/2021/060185	NEAR-INFRARED SCREENING AGENT AND NEAR-INFRARED SCREENING  EXTERNAL PREPARATION FOR SKIN	TOYO BEAUTY CO., LTD.
WO/2021/054442	AGENT FOR IMPROVING SKIN TEXTURE	KAWASAKI GAKUEN EDUCATIONAL FOUNDATION
WO/2021/065568	INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT  CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD  FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20  ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING  THERETO	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/054448	PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION  FOR CANCER THERAPY CONTAINING SAID PEPTIDE	KOGA Michiko
WO/2021/054453	AMINO-ACID-CONTAINING GRANULES	MEIJI CO., LTD.
WO/2021/054457	CURABLE COMPOSITION FOR DENTISTRY	KURARAY NORITAKE DENTAL INC.
WO/2021/054473	AGENT FOR AMELIORATING AND/OR PREVENTING SICKLE CELL DISEASE	THE UNIVERSITY OF TOKYO
WO/2021/054474	REPEATING DISACCHARIDE FOR OLIGOSACCHARIDE SYNTHESIS AND  METHOD FOR PRODUCING OLIGOMER THEREOF	NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY
WO/2021/060264	COMPOSITION FOR IMPROVING RENAL FUNCTION	ASAHI GROUP HOLDINGS, LTD.
WO/2021/060281	PROSTAGLANDIN E2 RECEPTOR EP2/EP4 DUAL ANTAGONIST	AGC INC.
WO/2021/075219	HAIR GROWTH STIMULANT	ADJUVANT COSME JAPAN CO.,LTD.
WO/2021/060303	MICROPARTICLES	THE UNIVERSITY OF TOKYO
WO/2021/060304	GRANULE HAVING MASKED UNPLEASANT TASTE AND METHOD FOR  PRODUCING SAME	NOBELPHARMA CO., LTD.
WO/2021/060307	IMIDAZOPYRIDINE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL  COMPOSITION	FUJIFILM CORPORATION
WO/2021/060336	NOVEL CROSSLINKED ALGINIC ACID STRUCTURE	MOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/060341	USE OF DNMT INHIBITOR	OHARA PHARMACEUTICAL CO., LTD.
WO/2021/060343	T-CELL RECEPTOR EXPRESSED BY HUMAN T-CELLS THAT RECOGNIZE  PEPTIDE DERIVED FROM URLC10 OR PEPTIDE DERIVED FROM DEPDC1	ONCOTHERAPY SCIENCE, INC.
WO/2021/060351	NSAID-BONDED ALGINIC ACID DERIVATIVE	MOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/065659	COMPOSITION FOR IMPROVING INTESTINAL FUNCTION THROUGH  EXPRESSION CONTROL OF AQUAPORIN 3, AND USE THEREOF	SUNTORY HOLDINGS LIMITED
WO/2021/065661	COMPOSITION FOR SUPPRESSION OF DECREASE IN MUSCLE MASS,  PREVENTION OF DECREASE THEREIN, MAINTENANCE THEREOF, RECOVERY THEREOF OR  INCREASE THEREIN	SUNTORY HOLDINGS LIMITED
WO/2021/065664	COMPOSITION FOR MAINTAINING OR IMPROVING DAILY LIFE ACTIVITY  AMOUNT, OR FOR PREVENTING OR   SUPPRESSING DECREASE IN DAILY LIFE ACTIVITY AMOUNT.	SUNTORY HOLDINGS LIMITED
WO/2021/060380	METHOD FOR INDUCING HEPATOCYTE PLASTICITY	PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY
WO/2021/090594	NEUTROPHIL PROGENITOR CELLS AND METHOD FOR PRODUCING SAME	THE UNIVERSITY OF TOKYO
WO/2021/060395	SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION	MOCHIDA PHARMACEUTICAL CO., LTD.
WO/2021/065686	NUCLEIC ACID THAT INHIBITS EXPRESSION OF MEX3B GENE, MEX3B  GENE EXPRESSION INHIBITING AGENT, METHOD FOR INHIBITING MEX3B GENE  EXPRESSION, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASE CAUSED BY MEX3B  GENE EXPRESSION	THE UNIVERSITY OF TOKYO
WO/2021/060425	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SYSTEMIC  SCLERODERMA	THE UNIVERSITY OF TOKYO
WO/2021/060430	CARBOHYDRATE-RESTRICTED HIGH-FAT DIET FOR ALLEVIATING CHRONIC  KIDNEY DISEASE	OSAKA UNIVERSITY
WO/2021/065697	LAYERED PATCH	MEDRX CO., LTD.
WO/2021/060440	LIPID NANOPARTICLE LYOPHILIZED COMPOSITION	NOF CORPORATION
WO/2021/060441	DEGRADABLE MULTI-ARM POLYETHYLENE GLYCOL DERIVATIVE	NOF CORPORATION
WO/2021/060453	CROSSLINKED OPTICALLY ACTIVE SECONDARY AMINE DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/060460	METHOD FOR MANUFACTURING REPAIRING AGENT FOR BIOLOGICAL TISSUE  DAMAGE, AND REPAIRING AGENT FOR BIOLOGICAL TISSUE DAMAGE	TWO CELLS CO., LTD.
WO/2021/015300	AGENT FOR TREATING, PREVENTING OR IMPROVING PSYCHIATRIC AND  NERVOUS SYSTEM DISORDERS OR SYMPTOMS	TOKYO UNIVERSITY OF SCIENCE FOUNDATION
WO/2021/070644	SOFT CAPSULE	SUNSHO PHARMACEUTICAL CO., LTD.
WO/2021/065768	SPACE-FORMING AGENT, SUBCUTANEOUS INJECTION PREPARATION, AND  SPACE-FORMING METHOD	TERUMO KABUSHIKI KAISHA
WO/2021/065788	EMULSION COMPOSITION, COSMETIC COMPOSITION, AND METHOD FOR  PRODUCING EMULSION COMPOSITION	DAIO PAPER CORPORATION
WO/2021/152910	MANICURE PREPARATION REMOVER	SANKYO CHEMICAL CO.,LTD.
WO/2021/199463	ORAL COMPOSITION	TOYO SHINYAKU CO., LTD.
WO/2021/065893	TETRALIN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE ACID  ADDITION SALT THEREOF	UNIVERSITY OF TSUKUBA
WO/2021/065895	SUNSCREEN COSMETIC	KAO CORPORATION
WO/2021/065898	AZEPAN DERIVATIVE	NIPPON CHEMIPHAR CO., LTD.
WO/2021/192366	PATCH	NICHIBAN CO., LTD.
WO/2021/065971	DILUTION BUFFER SOLUTION FOR CRYOPRESERVED CELLS	TERUMO KABUSHIKI KAISHA
WO/2021/065976	METHOD FOR ENHANCING ACTIVITY IN GRAFT	TERUMO KABUSHIKI KAISHA
WO/2021/065980	BET DEGRADER	KYOWA KIRIN CO., LTD.
WO/2021/065984	METHOD FOR FORMING SHEET OF CARDIOMYOCYTES	OSAKA UNIVERSITY
WO/2021/065987	INTESTINAL ENVIRONMENT-IMPROVING AGENT	ACACIA-NO-KI CO., LTD.
WO/2021/065989	METHOD FOR INCREASING PROPORTION OF CD56+ CELLS	TERUMO KABUSHIKI KAISHA
WO/2021/070696	CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE  THEREOF	GENEFRONTIER CORPORATION
WO/2021/066062	INHIBITOR AGAINST EXPRESSION OF IMMUNE CHECKPOINT MOLECULE	RENASCIENCE INC.
WO/2021/066078	MUSCLE TISSUE-REGENERATING AGENT	SPIBER INC.
WO/2021/066088	NOVEL TRIAZINE DERIVATIVE	MEIJI SEIKA PHARMA CO., LTD.
WO/2021/066094	TOOTH WHITENING METHOD	Precious One Medical Corporation
WO/2021/066098	W/O/W EMULSION COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/066109	MEDICATION AND METHOD FOR INHIBITING NONENAL-INDUCED SKIN  DAMAGE	SHISEIDO COMPANY, LTD.
WO/2021/066134	MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT AGAINST CANINE CD20	NIPPON ZENYAKU KOGYO CO., LTD.
WO/2021/066136	THERAPEUTIC AGENT FOR MUSCULAR DYSTROPHY	THE UNIVERSITY OF TOKYO
WO/2021/066144	PHARMACEUTICAL DRUG CONTAINING HETEROCYCLIDENE ACETAMIDE  DERIVATIVE	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/066149	PHARMACEUTICAL COMPOSITION AND KIT CHARACTERIZED BY CONTAINING  NOVEL PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED  FROM Β-LACTAMASE INHIBITOR COMPOUND, ANTIBACTERIAL COMPOUND AND SALTS OF  THESE	FUJIFILM CORPORATION
WO/2021/066152	BLOOD TREATMENT MATERIAL	TORAY INDUSTRIES, INC.
WO/2021/066175	TRANSMUCOSAL DELIVERY SYSTEM FOR MEDICINAL ACTIVE INGREDIENT  TO SUBMUCOSA OF BLADDER	SEIKAGAKU CORPORATION
WO/2021/070778	NANODISC	KANEKA CORPORATION
WO/2021/070785	METHOD FOR PRODUCING PIG INFECTIOUS VIRUS	NATIONAL AGRICULTURE AND FOOD RESEARCH ORGANIZATION
WO/2021/070829	LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE RIBOSIDE, AND  LACTIC ACID BACTERIA THAT PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND  NICOTINAMIDE RIBOSIDE	NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY
WO/2021/085059	ANTIPERSPIRANT COMPOSITION	LION CORPORATION
WO/2021/066196	THREE-DIMENSIONAL LIVER TISSUE MODEL	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND  TECHNOLOGY (AIST)
WO/2021/085062	COMPOSITION FOR SLEEP IMPROVEMENT COMPRISING ERGOTHIONEINE OR  SALT THEREOF	SUNTORY HOLDINGS LIMITED
WO/2021/075328	EXTERNAL PREPARATION FOR TREATING EPILEPSY OR AUTISM SPECTRUM  DISORDER	OSAKA UNIVERSITY
WO/2021/070873	LIQUID TEMPORARILY HAIR-DYEING AGENT COMPOSITION	KAO CORPORATION
WO/2021/070875	DENTAL COMPOSITION	KURARAY NORITAKE DENTAL INC.
WO/2021/070883	HUMAN NTCP-BINDING ANTIBODY CAPABLE OF INHIBITING INFECTION OF  HEPATITIS B VIRUS (HBV) TO HUMAN HEPATOCYTES	RIKEN
WO/2021/070885	PHARMACEUTICAL COMPOSITION WHICH CAN BE USED FOR PREVENTION  AND/OR TREATMENT OF ACQUIRED HEMOPHILIA A, AND PRODUCT COMPRISING SAID  PHARMACEUTICAL COMPOSITION	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/070893	PHARMACEUTICAL COMPOSITION INCLUDING TEMPERATURE-RESPONSIVE  IONIC LIQUID	TORAY INDUSTRIES, INC.
WO/2021/070896	HALITOSIS ALLEVIATOR OR HALITOSIS PREVENTIVE	SBI PHARMACEUTICALS CO., LTD.
WO/2021/085069	BIOLOGICAL TISSUE ATTACHING FILM AND TRANSFER SHEET	TOPPAN PRINTING CO., LTD.
WO/2021/070920	CYCLIC PEPTIDE	THE UNIVERSITY OF TOKYO
WO/2021/070956	siRNA EXPRESSION VECTOR	TAKARA BIO INC.
WO/2021/070957	BENZENE CONDENSED RING COMPOUND AND MEDICAL COMPOSITION  CONTAINING SAME	TOHOKU UNIVERSITY
WO/2021/070961	COMPOSITION FOR INHIBITING ACE OR SUPPRESSING BLOOD PRESSURE  ELEVATION, METHOD FOR PRODUCING SAME, ENZYME PREPARATION, POLYNUCLEOTIDE AND  TRANSFORMANT	WATER AGENCY INC.
WO/2021/075413	EXTERNAL PREPARATION FOR SKIN	KOSE CORPORATION
WO/2021/079783	WATER-IN-OIL EMULSION SUNSCREEN COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/075422	CARBOHYDRATE-RESTRICTED HIGH-FAT DIET FOR ALLEVIATING LIVER  DISEASE	OSAKA UNIVERSITY
WO/2021/075433	WATER-IN-OIL EMULSION COSMETIC	KAO CORPORATION
WO/2021/079795	LAYERED TRANSDERMAL PATCH	MEDRX CO., LTD.
WO/2021/106408	COMPOSITION FOR ENTERAL INTAKE	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/075476	HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/075477	MOTOR NEURON DEGENERATION INHIBITOR	KYOTO UNIVERSITY
WO/2021/075491	TRANSDERMAL ABSORPTION-TYPE PATCH	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/124663	DENTAL ADHESIVE COMPOSITION	TOKUYAMA DENTAL CORPORATION
WO/2021/075494	METHOD FOR PRODUCING CENTANAFADINE	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/131261	CELL GROUP AND METHOD FOR ACQUIRING SAME	JUNTENDO UNIVERSITY
WO/2021/075525	CELL CULTURE FOR TREATING INFLAMMATORY DISEASE	TERUMO KABUSHIKI KAISHA
WO/2021/075535	DIABETES THERAPY TARGETING ABNORMAL STEM CELLS	NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/075536	THERAPY FOR DIABETES USING STEM CELL MIGRATION AGENT	NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/075544	RI-LABELED HUMANIZED ANTIBODY	NIHON MEDI-PHYSICS CO., LTD.
WO/2021/075545	HUMANIZED ANTIBODY AND METHOD FOR USING THE SAME	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/075549	MULTILAYER CLEANSING COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/075559	CELL GROWTH INHIBITOR OR CELL DEATH INDUCER FOR  CANCER-ASSOCIATED FIBROBLASTS	JUNTENDO EDUCATIONAL FOUNDATION
WO/2021/131264	COMPOSITION CONTAINING BLACK GINGER EXTRACT AND COMPOSITION  FOR ORAL ADMINISTRATION	MARUZEN PHARMACEUTICALS CO., LTD.
WO/2021/075568	METHOD FOR PRODUCING MEGAKARYOCYTE PROGENITOR CELL OR  MEGAKARYOCYTIC CELL	NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
WO/2021/085197	HIGH INTERNAL AQUEOUS PHASE EMULSION	L'OREAL
WO/2021/085211	METHOD FOR SUPPRESSING PRODUCTION OF ASENAPINE-N-OXIDE	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/079869	UREMIC TOXIN REDUCING AGENT	BIOFERMIN PHARMACEUTICAL CO., LTD.
WO/2021/085232	COMPOSITION FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE  DISORDERS	ICHIMARU PHARCOS CO., LTD.
WO/2021/079874	PROLIFERATION INHIBITOR	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/079887	PREVENTATIVE OR THERAPEUTIC AGENT FOR TAUOPATHY	KYOTO UNIVERSITY
WO/2021/085252	PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY  PULMONARY DISEASE	NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/079921	GROWTH INHIBITOR FOR PATHOGENIC BACTERIA IN ORAL CAVITY, ORAL  MICROFLORA IMPROVER, AND COMPOSITION FOR ORAL CAVITY	LION CORPORATION
WO/2021/085291	COMPOSITION FOR TGR5 ACTIVATION	SUNTORY HOLDINGS LIMITED
WO/2021/085295	IMMUNE RESPONSE SUPPRESSOR	UNIVERSITY OF TSUKUBA
WO/2021/079958	COMBINATION OF ANTI-GARP ANTIBODY AND IMMUNOREGULATOR	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/075585	THERAPEUTIC AGENT FOR RENAL DYSFUNCTION	EDUCATIONAL FOUNDATION KYORIN GAKUEN
WO/2021/079962	PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF  HEARING LOSS	OSAKA UNIVERSITY
WO/2021/079978	THERAPEUTIC OR PROPHYLACTIC AGENT FOR CACHEXIA	TORAY INDUSTRIES, INC.
WO/2021/079983	PHARMACEUTICAL COMPOSITION FOR PROTECTING CARTILAGE	KYOTO UNIVERSITY
WO/2021/079984	NOVEL SUBSTITUTED CONDENSED RING COMPOUND	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/079986	BACTERIOPHAGE COMPOSITION	MEIJI SEIKA PHARMA CO., LTD.
WO/2021/079987	MUSCLE QUALITY IMPROVEMENT AGENT	AJINOMOTO CO., INC.
WO/2021/079988	AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND  DIFFERENTIATION	SUN MEDICAL CO., LTD.
WO/2021/131291	DENTAL IMPRESSION MATERIAL AND COMBINED IMPRESSION MATERIAL	GC CORPORATION
WO/2021/080008	METHOD FOR PRODUCING MONOVALENT CCAP PRODUCT	KAGOSHIMA UNIVERSITY
WO/2021/080013	INHIBITORS OF TREK (TWIK RELATED K<sp>+</sp>  CHANNELS) CHANNEL FUNCTION	ONO PHARMACEUTICAL CO., LTD.
WO/2021/080020	NUCLEIC ACID DELIVERY ENHANCER	NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY
WO/2021/085398	METHOD FOR PRODUCING T CELLS HAVING CELL SURFACE MARKERS FOR  CD45RA+ AND CCR7+	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/095510	COMPOSITE SOIL BACTERIA PREPARATION FOR PREVENTING AND  TREATING INFECTIOUS DISEASE AND METHOD FOR PREVENTING AND TREATING INFECTIOUS  DISEASE IN ANIMALS	KAWASHIMA CO., LTD
WO/2021/090739	COMPOSITION AND METHOD FOR TREATING CANDIDA AURIS INFECTION	FUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/090740	OIL-IN-WATER COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/085496	COMPOSITION, ANTIOXIDANT AGENT, ANTISACCHARIFICATION AGENT,  NEURITE OUTGROWTH PROMOTER, AND COGNITIVE FUNCTION IMPROVER	YAMADA BEE COMPANY, INC.
WO/2021/085497	DRUG FOR TREATING CANCER, COMBINATION DRUG, DRUG COMPOSITION,  IMMUNE RESPONSIVE CELL, NUCLEIC ACID DELIVERY VEHICLE, AND PRODUCT	NOILE-IMMUNE BIOTECH INC.
WO/2021/085504	B-CELL ANTIBODY RECEPTOR AND USE THEREOF	KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION
WO/2021/085509	NUCLEOSIDE DERIVATIVE AND USE THEREOF	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/085518	AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING FUSION PROTEIN  OF SERUM ALBUMIN AND GROWTH HORMONE	JCR PHARMACEUTICALS CO., LTD.
WO/2021/090754	POLYPHASE OIL-BASED SOLID COSMETIC	KOSE CORPORATION
WO/2021/166330	METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND  COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD	JBM INCORPORATION
WO/2021/085528	CD4 MIMIC COMPOUND WITH ANTI-HIV ACTIVITY	NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/131314	STABLE FREEZE-DRIED FORMULATION CONTAINING DAPTOMYCIN	NIPRO CORPORATION
WO/2021/152944	GLASS IONOMER CEMENT FOR DENTAL USE	GC CORPORATION
WO/2021/085540	FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND MANUFACTURING  METHOD FOR SAME	UNIMATEC CO., LTD.
WO/2021/111782	DENTAL ADHESIVE COMPOSITION, DENTAL ADHESIVE MEMBER, AND  DENTAL ADHESIVE MEMBER PACKAGING BODY	TOKUYAMA DENTAL CORPORATION
WO/2021/085575	EXERCISE-INDUCED HEMOLYSIS SUPPRESSANT AND COMPOSITION FOR  SUPPRESSING/IMPROVING EXERCISE-INDUCED HEMOLYTIC ANEMIA	ASTAREAL CO., LTD.
WO/2021/085582	PYRAZINE DERIVATIVE OR SALT THEREOF, AND USE OF SAME	FUJIFILM CORPORATION
WO/2021/085584	INSULIN RESISTANCE INHIBITOR FOR RUMINANT ANIMALS	IDEMITSU KOSAN CO., LTD.
WO/2021/085590	SCREENING METHOD FOR OFFENSIVE ODOR SUPPRESSING MATERIAL	TAKASAGO INTERNATIONAL CORPORATION
WO/2021/085591	FRAGRANCE COMPOSITION	TAKASAGO INTERNATIONAL CORPORATION
WO/2021/085592	NUCLEIC ACID FOR SUPPRESSING GENE EXPRESSION OF  DISEASE-SPECIFIC COL3A1 MUTANT ALLELE AND PHARMACEUTICAL COMPOSITION FOR  TREATING VASCULAR EHLERS-DANLOS SYNDROME	NANOCARRIER CO., LTD.
WO/2021/085624	COMPOSITION FOR TREATMENT AND/OR PREVENTION OF TUMOR	FUKUSHIMA MEDICAL UNIVERSITY
WO/2021/085633	METHOD FOR USING ULTRAFINE BUBBLES	SHISEIDO COMPANY, LTD.
WO/2021/085639	THERAPY FOR INTERSTITIAL CYSTITIS BY PLURIPOTENT STEM CELLS	LIFE SCIENCE INSTITUTE, INC.
WO/2021/085640	AGENT FOR INHIBITING DECREASE OF MUSCLE MASS IN PATIENT  REQUIRING FASTING	OSAKA UNIVERSITY
WO/2021/085650	VACCINE	NEROME INSTITUTE OF BIOLOGICAL RESOURCES
WO/2021/095599	PD-1 SIGNAL INHIBITOR COMBINATION THERAPY	KYOTO UNIVERSITY
WO/2021/095604	AQUEOUS POLYMER EMULSION, METHOD FOR PRODUCING SAME, AND  COSMETICS	TOAGOSEI CO., LTD.
WO/2021/095618	GLYCERIN-CONTAINING EMULSIFIED COSMETICS	SEIWA KASEI COMPANY, LIMITED
WO/2021/090894	PEPTIDE, COMPOSITION, AND METHOD FOR TREATING, PREVENTING, OR  IMPROVING MOOD DISORDER	KYOTO UNIVERSITY
WO/2021/100488	WATER-IN-OIL EMULSION COSMETIC COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/090911	METHOD FOR SELECTIVELY KILLING PROTEIN AGGREGATE-CONTAINING  CELLS, KIT THEREFOR, THERAPEUTIC DRUG FOR PROTEIN MISFOLDING DISEASES AND  DRUG PRODUCT FOR REMOVING PROTEIN AGGREGATES FROM BLOOD PRODUCT	CENTRAL GLASS COMPANY, LIMITED
WO/2021/192393	MALARIA TRANSMISSION-BLOCKING VACCINES	PATH
WO/2021/090926	AGENT FOR PREVENTING OR TREATING ARRHYTHMIA AND DEVICE FOR  PREVENTING OR TREATING ARRHYTHMIA	SCHOOL JURIDICAL PERSON THE KITASATO INSTITUTE
WO/2021/085653	4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/149329	NOVEL USE OF HIC-5 INHIBITOR	SHOWA UNIVERSITY
WO/2021/090945	CELL CULTURE FOR TREATING DISEASE OF LOWER EXTREMITY	OSAKA UNIVERSITY
WO/2021/095703	ANTI-HUMAN CRIPTO-1 ANTIBODY	GSP ENTERPRISE, INC.
WO/2021/095712	WATER-IN-OIL EMULSIFIED COSMETIC	KAO CORPORATION
WO/2021/149334	THICKENER	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND  TECHNOLOGY
WO/2021/095775	ANTIPLASMIN AGENT	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/095779	ORALLY DISINTEGRATING TABLET	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/095781	CARRIER FOR TRANSFER INTO IMMUNE CELLS AND USE THEREOF	UNIVERSITY PUBLIC CORPORATION OSAKA
WO/2021/100585	METHOD FOR PRODUCING CHIMERIC ANTIGEN RECEPTOR GENE-MODIFIED  LYMPHOCYTES	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/100600	GLYCERIN DISPERSION AND COSMETIC	MIYOSHI KASEI, INC.
WO/2021/095805	THERAPEUTIC AGENT AND PROPHYLACTIC AGENT FOR FUNCTIONAL  GASTROINTESTINAL DISORDERS AND XEROSTOMIA	NIPPON SHINYAKU CO., LTD.
WO/2021/095809	ENHANCER POLYNUCLEOTIDE RESPONDING TO HEART FAILURE AND  EXPRESSION VECTOR INCLUDING SAID ENHANCER POLYNUCLEOTIDE	OSAKA UNIVERSITY
WO/2021/095814	COMPOSITION FOR IMPROVING MENTAL STATE, PRODUCTION METHOD FOR  COMPOSITION FOR IMPROVING MENTAL STATE, AND USE OF FRUIT OF EGGPLANT FOR  IMPROVING MENTAL STATE	SHINSHU UNIVERSITY
WO/2021/100614	NEUROPSYCHOLOGICAL FUNCTION IMPROVER COMPRISING SOYBEAN  PEPTIDE AND/OR COLLAGEN PEPTIDE	KYOTO UNIVERSITY
WO/2021/095828	O-GLCNACYLATED PROTEIN-LIKE SUBSTANCE AND FIBROSIS THERAPEUTIC  DRUG CONTAINING SAME	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/095835	NOVEL SALT OF TERPHENYL COMPOUND	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/095838	NUCLEIC ACID LIPID PARTICLE VACCINE ENCAPSULATING HPV MRNA	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/095840	METHODS OF TREATING LSD1-RELATED DISEASES and Disorders WITH  LSD1 INHIBITORS	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/095876	LIPID COMPOSITION	FUJIFILM CORPORATION
WO/2021/106653	OIL-BASED SOLID COSMETIC PREPARATION	KOSE CORPORATION
WO/2021/100666	COSMETIC COMPOSITION	MANDOM CORPORATION
WO/2021/106657	LUTEIN BLUE LIGHT CUTTING ABILITY ENHANCER AND COSMETIC  COMPOSITION	TAIKI CORP., LTD.
WO/2021/100676	EXTERNAL PREPARATION FOR SKIN	KAO CORPORATION
WO/2021/100677	COMBINATION DRUG	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/100685	TREATMENT OR PREVENTION OF PSYCHIATRIC DISEASE BASED ON KIF3  MOTOR, AND DRUG SCREENING	THE UNIVERSITY OF TOKYO
WO/2021/100704	COMPOSITION FOR IMPROVING SLEEP QUALITY	ENEOS CORPORATION
WO/2021/100728	6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVE-CONTAINING  SOLID FORMULATION	SHIONOGI & CO., LTD.
WO/2021/106697	BROWN ADIPOCYTE PRODUCTION METHOD	KATAOKA CORPORATION
WO/2021/100744	CROSSLINKED PRODUCT OF AMYLOID-β PROTEIN (Aβ) ABLE TO BE  SUBSTITUTE FOR AMYLOSPHEROID (ASPD), AND ANALYSIS OF ASPD	TAO HEALTH LIFE PHARMA CO., LTD.
WO/2021/100750	WATER-IN-OIL COSMETIC PREPARATION	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/095887	CELL REPROGRAMMING METHOD	KANAZAWA MEDICAL UNIVERSITY
WO/2021/100794	ANTIBODY-CONTAINING PREPARATION	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/106733	POWDERED SOLID COSMETIC PRODUCT	SHISEIDO COMPANY, LTD.
WO/2021/100796	AGENT FOR PREPARING CARTILAGE AND PREPARATION METHOD FOR  CARTILAGE	ICHIMARU PHARCOS CO., LTD.
WO/2021/100812	DETERGENT COMPOSITION FOR FOAMER	AJINOMOTO CO., INC.
WO/2021/100837	COMPOSITION FOR PREVENTING OR REDUCING HYPERURICEMIA, AND  METHOD FOR PRODUCING SAME	HYAKKICHI JAPAN TECHNOLOGICAL DEVELOPMENT CO., LTD.
WO/2021/124793	AGGREGATION INHIBITORY AGENT AND MEDICAL COMPOSITION AND  MEDICAL DEVICE INCLUDING SAME	NIPRO CORPORATION
WO/2021/106760	COMPOSITION FOR PREVENTING DECREASE IN MUSCLE MASS, PREVENTING  WEAKNESS OF MUSCULAR POWER, INCREASING MUSCLE MASS OR STRENGTHENING MUSCULAR  POWER	SUNTORY HOLDINGS LIMITED
WO/2021/100847	CARBALYSOPHOSPHATIDIC ACID	OCHANOMIZU UNIVERSITY
WO/2021/106782	METHOD FOR IMPROVING HOLDING POWER OF ADHESIVE AGENT LAYER IN  ROPINIROLE-CONTAINING TRANSDERMAL PATCH, AND ROPINIROLE-CONTAINING  TRANSDERMAL PATCH HAVING IMPROVED HOLDING POWER	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/100878	PYRAZOLOMORPHINAN DERIVATIVE	THE KITASATO INSTITUTE
WO/2021/131458	FOAMING AGENT	KAO CORPORATION
WO/2021/106856	COMPOSITION FOR IMPROVING URINARY TRACT FUNCTION AND  COMPOSITION FOR IMPROVING BLOOD FLOW IN BLADDER	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106857	COMPOSITION FOR PREVENTING OR RELIEVING URESIESTHESIA STRESS,  AND COMPOSITION FOR IMPROVING SLEEP	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/106874	SKIN CLEANSING AGENT	KAO CORPORATION
WO/2021/106901	ORAL LIQUID COMPOSITION	LION CORPORATION
WO/2021/111946	DRUG FOR PREVENTING OR TREATING HYDROCEPHALUS AND  PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYDROCEPHALUS	NIIGATA UNIVERSITY
WO/2021/106947	NOVEL QUINONE DERIVATIVE AND ANTITRYPANOSOMAL AGENT CONTAINING  SAME AS ACTIVE INGREDIENT	NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY
WO/2021/106952	PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR GRAFT-VERSUS-HOST  DISEASE	TOKYO METROPOLITAN GOVERNMENT
WO/2021/260966	COMPOSITION TARGETING ADENOSINE-PRODUCING ENZYME	SAITAMA MEDICAL UNIVERSITY
WO/2021/106975	HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/106978	PHARMACEUTICAL COMPOSITION	CYTLIMIC INC.
WO/2021/106988	G9a INHIBITOR	KYORIN PHARMACEUTICAL CO., LTD.
WO/2021/131476	CURABLE COMPOSITION FOR DENTISTRY	TOKUYAMA DENTAL CORPORATION
WO/2021/107005	PROPHYLACTIC OR THERAPEUTIC AGENT FOR CYTOMEGALOVIRUS-RELATED  DISEASES	NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
WO/2021/107013	ADJUVANT COMPOSITION	RIKEN
WO/2021/111980	PROPHYLACTIC OR AMELIORATING AGENT FOR ORTHOSTATIC  HYPOTENSION, AND COMPOSITION CONTAINING SAME	LIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/111981	AGENT FOR PREVENTION OR REMEDIATION OF DEMENTIA AND  COMPOSITION CONTAINING SAME	LIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/111982	AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND  COMPOSITION CONTAINING SAME	LIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/111983	AGENT FOR PREVENTING OR AMELIORATING FUNCTIONAL SOMATIC  SYNDROMES AND COMPOSITION INCLUDING THE SAME	LIFE QUALITY KENKYUJYO CO., LTD.
WO/2021/107029	PROPHYLACTIC OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC  STEATOHEPATITIS IN HUMANS	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/107033	PHARMACEUTICAL COMPOSITION	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/107034	MEDICINAL COMPOSITION FOR SOFT CONTACT LENS	SENJU PHARMACEUTICAL CO.,LTD.
WO/2021/107035	PHARMACEUTICAL COMPOSITION FOR SOFT CONTACT LENS	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/140773	PHYSICAL FUNCTION RECOVERY PROMOTER	FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE
WO/2021/107060	MEDICINE FOR REDUCING ADVERSE EFFECTS OF PIRFENIDONE	SHIONOGI & CO., LTD.
WO/2021/107065	POLYCYCLIC PYRIDOPYRAZINE DERIVATIVE	SHIONOGI & CO., LTD.
WO/2021/107066	PROPHYLACTIC AND THERAPEUTIC PHARMACEUTICAL AGENT FOR HIV  INFECTIOUS DISEASES CHARACTERIZED BY COMPRISING COMBINATION OF INTEGRASE  INHIBITOR AND ANTI-HIV AGENT	SHIONOGI & CO., LTD.
WO/2021/107067	PHARMACEUTICAL OR COSMETIC COMPOSITION	MARUHO CO., LTD.
WO/2021/107080	PEPTIDE	KYOTO UNIVERSITY
WO/2021/107082	THERAPEUTIC AGENT FOR CARCINOMATOUS PERITONITIS	PERSEUS PROTEOMICS INC.
WO/2021/107084	INSULIN SECRETION-PROMOTING AGENT AND BLOOD SUGAR LEVEL  IMPROVER USING SAME, DIABETES IMPROVER, AND FOOD	REFINE HOLDINGS CO. LTD.
WO/2021/131490	DENTAL FILLING AND REPAIRING MATERIAL KIT	TOKUYAMA DENTAL CORPORATION
WO/2021/107101	VASODILATOR AND USE THEREOF	BIORADICAL RESEARCH INSTITUTE CORP.
WO/2021/107106	ORAL COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/107110	BENZIMIDAZOLE COMPOUND OR SALT THEREOF, AGRICULTURAL AND  HORTICULTURAL INSECTICIDAL AND ACARICIDAL AGENT COMPRISING SAID COMPOUND, AND  METHOD FOR USING SAID INSECTICIDAL AND ACARICIDAL AGENT	NIHON NOHYAKU CO., LTD.
WO/2021/107122	HYPOXIA RESPONSE CONTROL BY SPECIFIC AMINO ACID OR AMINO  ACID-LIKE SUBSTANCE	KEIO UNIVERSITY
WO/2021/107125	COMPOUND HAVING LYSOPHOSPHATIDIC ACID RECEPTOR AGONISTIC  ACTIVITY AND PHARMACEUTICAL USE OF SAID COMPOUND	ONO PHARMACEUTICAL CO., LTD.
WO/2021/107141	ZWITTERION COMPOUND AND PRODUCTION METHOD AND USE FOR SAME	TOKUSHIMA UNIVERSITY
WO/2021/225013	MICROSPHERES CONTAINING UNIFORMLY DISPERSED PRIMARY AGENT AND  SUSTAINED-RELEASE PREPARATION CONTAINING MICROSPHERES CONTAINING UNIFORMLY  DISPERSED PRIMARY AGENT	M. TECHNIQUE CO., LTD.
WO/2021/107152	DENTAL COMPOSITION	KURARAY NORITAKE DENTAL INC.
WO/2021/112056	METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT VECTOR  CELLS (aAVC)	ASTELLAS PHARMA INC.
WO/2021/112065	SOLID COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/117547	FOOD FOR PREVENTING OR AMELIORATING LOWER URINARY TRACT  SYMPTOMS	BGG JAPAN CO., LTD.
WO/2021/112099	HAIR COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/140789	METHOD FOR DECOMPOSING CHITIN AND METHOD FOR PRODUCING CHITIN  OLIGOSACCHARIDE-CONTAINING COMPOSITION	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/112122	PHOTOOXYGENATION CATALYST COMPOUND AND MEDICINE COMPRISING  SAME	THE UNIVERSITY OF TOKYO
WO/2021/112140	AGENT FOR PREVENTING OR AMELIORATING PERIODONTAL DISEASE	KAO CORPORATION
WO/2021/131568	COMPOSITION FOR SUPPRESSING OR IMPROVING REDUCTION IN AMOUNT  OF PHYSICAL ACTIVITY	SUNTORY HOLDINGS LIMITED
WO/2021/131569	COMPOSITION FOR IMPROVING SLEEP AND COMPOSITION FOR IMPROVING  CIRCADIAN RHYTHM	SUNTORY HOLDINGS LIMITED
WO/2021/131570	COMPOSITION FOR AMELIORATING OR SUPPRESSING DECLINE OF  COGNITIVE FUNCTIONS	SUNTORY HOLDINGS LIMITED
WO/2021/112171	ANTI-INFLAMMATORY AGENT FOR INTESTINAL CELL	IDEMITSU KOSAN CO., LTD.
WO/2021/112174	OPTICAL ANTIMICROBIAL THERAPEUTIC METHOD	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/112176	COMPOSITION FOR IMPROVING QUALITY OF SLEEP	KUREI OKINAWA CO., LTD.
WO/2021/112185	ANTI-GDF15 ANTIBODY	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/124911	THICKENER	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND  TECHNOLOGY
WO/2021/124912	COMPOSITION FOR PROMOTING CHONDROITIN SULFATE SYNTHESIS	SUNTORY HOLDINGS LIMITED
WO/2021/112196	COMPOSITION FOR SUPPRESSING LOSS OF MUSCLE TISSUE	TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES
WO/2021/112203	SKIN ATTACHMENT-USE FILM, AND TRANSFER SHEET	TOPPAN PRINTING CO., LTD.
WO/2021/112207	DRUG FOR TREATING SYMPTOM OF CEREBRAL INFARCTION IN ACUTE  STAGE CEREBRAL INFARCTION PATIENT	NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER
WO/2021/112208	OIL-IN-WATER EMULSION SUNSCREEN COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/112217	COMPOSITION FOR SUPPRESSING INCREASE IN AMOUNT OF NEUTRAL FAT  IN LIVER	AJINOMOTO CO., INC.
WO/2021/112220	THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE WITH ABNORMAL  PROTEIN ACCUMULATION	UNIVERSITY OF MIYAZAKI
WO/2021/112235	MEDICINE AND MEDICINAL COMPOSITION FOR TREATING OR PREVENTING  C3 NEPHROPATHY, AND COMPLEMENT C3B DEGRADATION ACCELERATOR	UNIVERSITY OF MIYAZAKI
WO/2021/112240	RHINENCHYSIS COMPOSITION CONTAINING OLOPATADINE	TOKO YAKUHIN KOGYO CO., LTD.
WO/2021/112242	PHARMACEUTICAL COMPOSITION COMPRISING STEROID COMPOUND AND  OLOPATADINE	TOKO YAKUHIN KOGYO CO., LTD.
WO/2021/112251	AZETIDINE SULFONAMIDE COMPOUND	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/117697	SOLID PHARMACEUTICAL PREPARATION	FUJI YAKUHIN CO., LTD.
WO/2021/117735	METHOD FOR PREVENTING CLOUDINESS OF PREFILLED SYRINGE OR  CARTRIDGE PREPARATION CONTAINING TERIPARATIDE OR SALT THEREOF BY SHAKING	ASAHI KASEI PHARMA CORPORATION
WO/2021/117754	AGENT FOR REPAIRING OR SUPPRESSING DNA DAMAGE	NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER
WO/2021/117769	PHARMACEUTICAL COMPOSITION AND TREATMENT AGENT	FUJIFILM CORPORATION
WO/2021/117770	PHARMACEUTICAL COMPOSITION AND TREATMENT AGENT	FUJIFILM CORPORATION
WO/2021/117771	METHOD FOR PREPARING PEPTIDE EMULSION FORMULATION	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/117792	MELATONIN-CONTAINING GRANULES	NOBELPHARMA CO., LTD.
WO/2021/171735	COSMETIC	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/131720	WATER-IN-OIL EMULSION COSMETIC PREPARATION FOR SKIN	SHISEIDO COMPANY, LTD.
WO/2021/149390	COLORING HAIR DYE AND AEROSOL TYPE COLORING HAIR DYE	PINOLE CO., LTD.
WO/2021/125042	FACILITY AND IMPLEMENTATION METHOD FOR MANUFACTURING OF  ARTICLE USING SAID FACILITY	CUORIPS INC.
WO/2021/131750	EXTERNAL COMPOSITION FOR REDUCING DULLNESS AROUND EYES,  COSMETIC AND QUASI-PHARMACEUTICAL PRODUCT	HORUS CO., LTD.
WO/2021/117824	INCRETIN PRODUCTION ACCELERATOR AND SUGAR UPTAKE ACCELERATOR	INADA Akari
WO/2021/125051	OIL-IN-WATER EMULSION COSMETIC COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/117839	DENTAL COMPOSITION	KURARAY NORITAKE DENTAL INC.
WO/2021/117840	INDUCTION OF PROLIFEROUS PANCREATIC ISLET PRECURSOR CELL-LIKE  CELLS BY TRANSIENT EXPRESSION OF Mycl AND INDUCTION OF DIFFERENTIATION INTO  INSULIN-POSITIVE CELLS	THE UNIVERSITY OF TOKYO
WO/2021/125066	COSMETIC PROCESS USING HYALURONIC ACID DROPLETS	L'OREAL
WO/2021/125068	COMPOSITION INCLUDING CATIONIC POLYSACCHARIDE AND ANIONIC  ANTIOXIDANT	L'OREAL
WO/2021/125069	COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX  PARTICLE	L'OREAL
WO/2021/125070	STABLE COMPOSITION COMPRISING COMBINATION OF CINNAMIC ACID  DERIVATIVES WITH SPECIFIC INGREDIENTS	L'OREAL
WO/2021/117842	POWDER COSMETIC COMPOSITION	L'OREAL
WO/2021/125071	BI-PHASE SUN CARE COMPOSITION	L'OREAL
WO/2021/117846	COMPOUND SERVING AS PDGF RECEPTOR KINASE INHIBITOR, AND  COMPOSITION	NIPPON SHINYAKU CO., LTD.
WO/2021/145113	ANTI-AGING COMPOSITION	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/117857	COMPOSITION FOR LOWERING HEART RATE	MEIJI CO., LTD.
WO/2021/117861	SMALL-SIZED TABLET HAVING EXCELLENT PRODUCIBILITY AND ELUTION  PROPERTIES	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/125093	EYELASH EXTENSION ADHESIVE	SHIMADA, Katsura
WO/2021/117886	FREEZE-DRIED PREPARATION CONTAINING MEGAKARYOCYTES AND  PLATELETS	NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
WO/2021/112263	ADIPONECTIN PRODUCTION PROMOTER	KOHAKU BIO TECHNOLOGY CO.,LTD.
WO/2021/125118	STABLE COMPOSITION COMPRISING COMBINATION OF SPECIFIC  INGREDIENTS	L'OREAL
WO/2021/131849	METHOD FOR PRODUCING POWDERED SOLID COMPOSITION, AND POWDERED  SOLID COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/125139	METHOD FOR IMPROVING OLFACTORY SENSITIVITY	KAO CORPORATION
WO/2021/131868	HAIR-DYEING METHOD	KAO CORPORATION
WO/2021/131872	ORAL COMPOSITION	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/131900	PRENYLFLAVONOID GLYCOSIDE, METHOD FOR PRODUCING SAME, AND  METHOD FOR IMPROVING WATER-SOLUBILITY OF PRENYLFLAVONOID	SUNTORY HOLDINGS LIMITED
WO/2021/125174	OIL-IN-WATER TYPE EMULSION COSMETIC FOR SKIN CARE USING  ELECTROPHORESIS	SHISEIDO COMPANY, LTD.
WO/2021/131915	FIBER TREATMENT AGENT COMPOSITION	KAO CORPORATION
WO/2021/131939	HAIR COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/125211	SUNSCREEN COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/125212	SUNSCREEN COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/131948	OIL-BASED COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/125219	OIL-IN-WATER EMULSION COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/125229	INDAZOLE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL  COMPOSITION	FUJIFILM CORPORATION
WO/2021/131987	COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/145128	MUTANT KLF PROTEIN, AND METHOD FOR PRODUCING INDUCED  PLURIPOTENT STEM CELLS	RIKEN
WO/2021/125246	FLUORESCENT CURABLE DENTAL COMPOSITION AND CURED PRODUCT  THEREOF	KURARAY NORITAKE DENTAL INC.
WO/2021/125261	THERAPEUTIC FOR HIGH-RISK MYELODYSPLASTIC SYNDROME	METROPOLITAN RESEARCH CENTER FOR BLOOD DISORDERS
WO/2021/132018	OILY PARTICLE AND EXTERNAL COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/132019	AGENT FOR IMPROVING CUTANEOUS RESIDENT FLORA BALANCE	HAYASHIBARA CO., LTD.
WO/2021/125263	USE OF ANTIBODY-DRUG CONJUGATES AND ANTIBODIES FOR DRUG  DELIVERY	NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
WO/2021/132021	OIL-IN-WATER EMULSION SUNSCREEN COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/132032	COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN	KAO CORPORATION
WO/2021/132033	COMPOSITION FOR SKIN EXTERNAL APPLICATION	KAO CORPORATION
WO/2021/125291	GLUTATHIONE-CONTAINING COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/125303	EGG ALLERGY PREVENTING AGENT OR THE LIKE, AND FOOD COMPOSITION  CONTAINING SAME	NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
WO/2021/132044	COSMETIC COMPOSITION IN THE FORM OF W/O EMULSION COMPRISING  SPHERICAL HYDROPHOBIC SILICA AEROGEL AND ESTER OIL	L'OREAL
WO/2021/125304	SUN CARE COMPOSITION	L'OREAL
WO/2021/132045	ANHYDROUS COMPOSITION FOR TOPICAL DELIVERY OF ACTIVE  INGREDIENTS	L'OREAL
WO/2021/125311	ANTISENSE NUCLEIC ACID ENABLING EXON SKIPPING	NIPPON SHINYAKU CO., LTD.
WO/2021/125313	THERAPEUTIC AGENT CONTAINING FUSED PYRIMIDINE COMPOUND AS  ACTIVE INGREDIENT	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/132067	COMPOSITION FOR ORAL CAVITY	LION CORPORATION
WO/2021/125315	ANTI-INFLAMMATORY LIQUID COMPOSITION FOR COVERING ORAL MUCOSA,  AND MEDICINAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF STOMATITIS USING  SAME	HANIC WHITE LABO CO., LTD.
WO/2021/132072	FILM-COATED TABLETS HAVING SMOOTH SURFACE	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/132077	COMPOSITION CONTAINING SESAMIN AND PQQ	SUNTORY HOLDINGS LIMITED
WO/2021/132082	POWDERY SOLID COSMETIC PREPARATION	SHISEIDO COMPANY, LTD.
WO/2021/132083	METHOD FOR PRODUCING POWDERED SOLID COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/125342	COMPOSITION FOR SUPPRESSING OBESITY	DAICEL CORPORATION
WO/2021/125345	VASODILATOR AND USE THEREOF	BIORADICAL RESEARCH INSTITUTE CORP.
WO/2021/125346	METHOD FOR ACTIVATING SKIN STEM CELLS THROUGH MPC1  SUPPRESSION, AND SKIN STEM CELL ACTIVATION AGENT	SHISEIDO COMPANY, LTD.
WO/2021/132100	MICRONEEDLE DEVICE AND METHOD FOR PRODUCING SAME	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/125352	METHOD FOR SYNTHESIZING CELOSIANIN II, METHOD FOR SYNTHESIZING  BETAXANTHIN, AMYLOID-β POLYMERIZATION INHIBITOR OR THERAPEUTIC OR  PROPHYLACTIC AGENT FOR ALZHEIMER'S DISEASE, AMYLOID PEPTIDE AGGREGATION  INHIBITOR, AND HIV-1 PROTEASE ACTIVITY INHIBITOR	MORI Masashi
WO/2021/132117	METHOD FOR MEASURING HUMAN HEPATOCYTE REPLACEMENT RATE IN  HUMAN HEPATOCYTE CHIMERIC ANIMAL	SEKISUI MEDICAL CO., LTD.
WO/2021/132157	BRAIN DISEASE THERAPEUTIC AGENT AND USE THEREFOR	PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
WO/2021/132166	METHOD FOR PRODUCING ERIBULIN-BASED ANTIBODY-DRUG CONJUGATE	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/132169	ORAL LIQUID COMPOSITION	LION CORPORATION
WO/2021/132180	ANTIBACTERIAL COMPOSITION FOR ORAL CAVITY	MARUHA NICHIRO CORPORATION
WO/2021/132201	PROPHYLACTIC OR THERAPEUTIC AGENT FOR DEMYELINATING DISEASE	OSAKA UNIVERSITY
WO/2021/132211	ISOBUTYRATE ESTER COMPOUND HAVING CARBONATE GROUP AT  α-POSITION, AND FRAGRANCE COMPOSITION	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/132273	OIL-IN-WATER-TYPE EMULSIFIED COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/149442	FLAVONOID COMPOSITION	HOGAPLANTS CO., LTD.
WO/2021/132301	SOLID COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/132302	DRUG FOR PREVENTING DIALYSIS SHIFT OR RENAL DEATH	TORAY INDUSTRIES, INC.
WO/2021/132309	PHARMACEUTICAL COMPOSITION	NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/132311	ALIPHATIC ACID AMIDE DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/132314	OIL-IN-WATER TYPE EMULSION COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/140913	SOLID LIP COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/132329	BODY FAT REDUCING AGENT AND METHOD FOR SCREENING SUBSTANCE  HAVING BODY FAT REDUCING EFFECT	OSAKA UNIVERSITY
WO/2021/132348	DRUG CONTAINING EFINACONAZOLE	KAKEN PHARMACEUTICAL CO., LTD.
WO/2021/132438	ORALLY DISINTEGRATING TABLET INCLUDING PYRROLE CARBOXAMIDE	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/132444	WATER-IN-OIL-TYPE EMULSIFIED SUNSCREEN COSMETIC	KAO CORPORATION
WO/2021/132453	CAPILLARY BLOOD VESSEL DISORDER INHIBITING AGENT, CAPILLARY  BLOOD VESSEL DISORDER AMELIORATING AGENT, AND CAPILLARY ANGIOGENESIS  ACCELERATING AGENT	NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
WO/2021/132462	PHARMACEUTICAL COMPOSITION CONTAINING DOUBLE-STRANDED  RIBONUCLEIC ACID INHIBITING EXPRESSION OF COMPLEMENT C5	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/132463	DENTAL RESTORATION MATERIAL COMPOSITION	KURARAY NORITAKE DENTAL INC.
WO/2021/132472	PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR CHRONIC  PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME	NIPPON SHINYAKU CO., LTD.
WO/2021/132473	ANTITUMOR DRUG FOR USE IN COMBINATION WITH IMMUNE CHECKPOINT  INHIBITOR	NIPPON SHINYAKU CO., LTD.
WO/2021/132501	TAPE PREPARATION	NICHIBAN CO., LTD.
WO/2021/132516	ROE LIPID COMPOSITION CONTAINING POLYVALENT UNSATURATED FATTY  ACID-BOUND PHOSPHOLIPID	MARUHA NICHIRO CORPORATION
WO/2021/140945	SHEET-PROVIDING METHOD AND SHEET-PROVIDING SYSTEM	KAO CORPORATION
WO/2021/132524	EPOXY AZEPAN DERIVATIVE	NIPPON CHEMIPHAR CO., LTD.
WO/2021/132528	SHORT-CHAIN CPG-CONTAINING OLIGODEOXYNUCLEOTIDE WITH LINKED  POLYDEOXYADENYLIC ACID, COMPLEX CONTAINING SAID OLIGODEOXYNUCLEOTIDE, AND USE  THEREOF	NAPAJEN PHARMA, INC.
WO/2021/132529	WATER-CONTAINING TRANSDERMALLY ABSORPTIVE COMPOSITION	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/132530	COMPOSITE COMPRISING POLYVINYL ALCOHOL AND WATER-SOLUBLE  THICKENER	L'OREAL
WO/2021/132531	COMPOSITE COMPRISING POLYVINYL ALCOHOL AND HYDROPHILIC AND  WATER-DISPERSIBLE FILLER	L'OREAL
WO/2021/132532	COSMETIC COMPOSITION COMPRISING SPHERICAL HYDROPHOBIC SILICA  AEROGEL AND COMPOSITE SILICA PARTICLES AND/OR HOLLOW SILICA PARTICLES	L'OREAL
WO/2021/132541	METHOD FOR SELECTING, ASSESSING, OR PRODUCING SODIUM LAURYL  SULFATE AS RAW MATERIAL FOR PHARMACEUTICAL FORMULATION, OR FORMULATION OR THE  LIKE CONTAINING SAME	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/132543	MATERIAL FOR TREATING FISTULA	EA PHARMA CO., LTD.
WO/2021/192471	PEMETREXED FORMULATION	NAGASE MEDICALS CO., LTD.
WO/2021/192472	PEMETREXED FORMULATION	NAGASE MEDICALS CO., LTD.
WO/2021/132550	POST-OPERATION ADJUVANT THERAPY AGENT	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/132565	AQUEOUS SUSPENSION COMPOSITION CONTAINING SIROLIMUS OR SALT  THEREOF	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/132577	ACYLSULFAMIDE COMPOUND AND PHARMACEUTICAL USE THEREFOR	JAPAN TOBACCO INC.
WO/2021/132589	POLYNUCLEOTIDE AND MEDICINAL COMPOSITION	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/132592	METHOD FOR PREDICTING SENSITIVITY OF CANCER CELL TO GPX4  INHIBITOR	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/132598	AQUEOUS COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/132609	AQUEOUS COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/132626	THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CLASSICAL SWINE FEVER	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/132636	CANCER TREATMENT METHOD AND MEDICINE	NONPROFIT ORGANIZATION NORTH EAST JAPAN STUDY GROUP
WO/2021/132653	ANTI-POLLUTION MATERIAL	NISSAN CHEMICAL CORPORATION
WO/2021/132655	INHIBITOR OF FERTILIZED EGG FRAGMENTATION	NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
WO/2021/132659	DISPERSION LIQUID FOR COMPLEX BETWEEN PROTEIN AND CERIUM OXIDE  NANOPARTICLE, METHOD FOR ELIMINATING ACTIVE SPECIES, AND METHOD FOR PRODUCING  DISPERSION LIQUID FOR COMPLEX BETWEEN PROTEIN AND CERIUM OXIDE NANOPARTICLE	TORAY INDUSTRIES, INC.
WO/2021/132668	MATERIAL FOR PROMOTING PENETRATION	NISSAN CHEMICAL CORPORATION
WO/2021/132673	AGENT FOR PREVENTING OR TREATING ACUTE-PHASE NEUROMYELITIS  OPTICA	OSAKA UNIVERSITY
WO/2021/132691	D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND  SCREENING METHOD OF D-SERINE TRANSPORTER PROTEIN	KAGAMI INC.
WO/2021/132697	NOVEL USE OF STEVIOL	SUNTORY HOLDINGS LIMITED
WO/2021/132698	NEW USES FOR STEVIOL	SUNTORY HOLDINGS LIMITED
WO/2021/132703	PHARMACEUTICAL COMPOSITION FOR TREATING LIPID STORAGE DISORDER	NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/132707	PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR  PRODUCING THE SAME	KURARAY NORITAKE DENTAL INC.
WO/2021/132726	SILICA MICROCAPSULES	KAO CORPORATION
WO/2021/132728	METHOD FOR PRODUCING MICROCAPSULES	KAO CORPORATION
WO/2021/132729	METHOD FOR PREPARING MICROCAPSULE	KAO CORPORATION
WO/2021/132734	COMPOSITION COMPRISING SPHERICAL HYDROPHOBIC SILICA AEROGEL  AND SILICONE POLYMER	L'OREAL
WO/2021/141020	NUCLEIC ACID INTRODUCTION USING TWO TYPES OF TBK1/IKKe  INHIBITORS	OSAKA UNIVERSITY
WO/2021/141038	OIL-IN-WATER EMULSION COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/141041	THERAPEUTIC AGENT FOR TAUOPATHIES	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/141066	PLATELET AGGREGATOR	KAMUI PHARMA, INC.
WO/2021/186855	METHOD FOR DETECTING INDICATOR OF T-CELL LYMPHOMA AND  UTILIZATION THEREOF	MANDOM CORPORATION
WO/2021/141105	HAIR TREATMENT AGENT, ADDITIVE AND HAIR TREATMENT METHOD	SHISEIDO COMPANY, LTD.
WO/2021/153199	IRON-CONTAINING COMPOSITION	TAIYO KAGAKU CO., LTD.
WO/2021/145296	HARD CAPSULE CONTAINING CELLULOSE DERIVATIVE AS BASE MATERIAL  AND HAVING IMPROVED MECHANICAL STRENGTH AND OXYGEN PERMEABILITY	CAPSUGEL JAPAN INC.
WO/2021/145355	PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA, PREVENTING  MYOPIA, AND/OR SUPPRESSING PROGRESSION OF MYOPIA	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/145356	DRUG COMPOSITION FOR TREATING NEARSIGHTEDNESS, PREVENTING  NEARSIGHTEDNESS, AND/OR MINIMIZING PROGRESSION OF NEARSIGHTEDNESS	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/145364	HEMATOPOIETIC-CELL STORAGE SOLUTION CONTAINING TREHALOSE	OTSUKA PHARMACEUTICAL FACTORY,INC.
WO/2021/145368	PHOTOOXYGENATION CATALYST COMPOUND HAVING PHENOTHIAZINE  SKELETON AND MEDICINE CONTAINING SAME	THE UNIVERSITY OF TOKYO
WO/2021/145372	TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/145373	DRUG SUBSTANCE OF LEMBOREXANT AND MEDICINAL COMPOSITION  COMPRISING SAME	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/145385	BIOCOMPATIBLE MATERIAL, AND METHOD FOR PRODUCING BIOCOMPATIBLE  MATERIAL	FUJIFILM CORPORATION
WO/2021/145394	ANTI-INFLAMMATORY AGENT AND METHOD FOR PRODUCING EXTRACELLULAR  VESICLES HAVING ANTI-INFLAMMATORY ACTION	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/145395	ANTIFIBROTIC AGENT, AND METHOD FOR PRODUCING EXTRACELLULAR  VESICLES HAVING ANTIFIBROTIC ACTION	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/145396	ANGIOGENIC AGENT AND PRODUCTION METHOD FOR EXTRACELLULAR  VESICLES HAVING ANGIOGENIC EFFECT	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/145425	KIDNEY REGENERATION ACCELERATOR AND PRODUCTION METHOD FOR SAME	KEIO UNIVERSITY
WO/2021/145432	AGENT FOR PREVENTION OR TREATMENT OF DIABETIC AUTONOMIC  NEUROPATHY	OSAKA UNIVERSITY
WO/2021/145435	PROPHYLACTIC OR THERAPEUTIC AGENT FOR DEMENTIA	OSAKA UNIVERSITY
WO/2021/145450	UV RAY-BLOCKING PARTICULATE COMPOSITION	NISSAN CHEMICAL CORPORATION
WO/2021/157338	HYDROGEN ADDITION DEVICE AND HYDROGEN ADDITION METHOD	NIHON TRIM CO.,LTD.
WO/2021/149692	NOVEL ANTIMALARIAL AGENT CONTAINING HETEROCYCLIC COMPOUND	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/153365	METHOD FOR PRODUCING PANCREATIC ISLET-CONTAINING CAPSULE	OTSUKA PHARMACEUTICAL FACTORY, INC.
WO/2021/149714	AGENT FOR TREATING BONE TUMOR, AND METHOD FOR EVALUATING ION  CHANNEL AGONIST FOR TREATMENT OF BONE TUMOR, ETC.	CHANNELOSEARCH TECHNOLOGY
WO/2021/149767	HETEROCYCLIC DERIVATIVE	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/149776	ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/149786	METHODS OF TREATING CANCER USING DIHYDROPYRIMIDIN-2-ONE  COMPOUNDS	JAPAN TOBACCO INC.
WO/2021/149808	OIL-IN-WATER EMULSION COSMETIC COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/149809	OIL-IN-WATER-TYPE EMULSIFIED COSMETIC MATERIAL	SHISEIDO COMPANY, LTD.
WO/2021/149813	FRAGRANCE COMPOSITION, SCENT DISPENSER AND METHOD FOR REDUCING  MALODOR	KAO CORPORATION
WO/2021/149817	Enhancement of anti-tumor activity of SHP2 inhibitor  pyrimidinone in combination with novel cancer medicines in cancers	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/149818	COMBINATION AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER	NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF  AGRICULTURE AND TECHNOLOGY
WO/2021/153465	POWDER DISPERSION COMPOSITION, EMULSIFICATION COMPOSITION, AND  COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/149827	EXTERNAL PREPARATION CONTAINING RAPAMYCIN	NOBELPHARMA CO., LTD.
WO/2021/153485	COMPOSITION CONTAINING CURCUMIN COMPOUND, AND METHOD FOR  PRODUCING SAME	THERABIOPHARMA INC.
WO/2021/153508	SANITARY PRODUCT BEARING LACTOFERRIN	NRL PHARMA, INC.
WO/2021/157413	COSMETIC, AND METHOD FOR PRODUCING CYCLIC COMPOUND OR  DERIVATIVE THEREOF	SUMITOMO BAKELITE CO., LTD.
WO/2021/153525	ESOMEPRAZOLE ORAL PREPARATION AND METHOD FOR PRODUCING SAME	TOWA PHARMACEUTICAL CO., LTD.
WO/2021/210234	CLEANING AGENT COMPOSITION FOR INTRAORALLY MOUNTED APPLIANCE	KAO CORPORATION
WO/2021/153570	PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)  INHIBITOR AND PHARMACEUTICAL USE THEREFOR	THE KITASATO INSTITUTE
WO/2021/153624	COMPOSITION OR KIT FOR HAIR BLEACHING OR FOR HAIR DYEING	SHISEIDO COMPANY, LTD.
WO/2021/153634	COMPOSITION FOR PREVENTING FADING OF DYED HAIR AND KIT FOR  DYED HAIR	SHISEIDO COMPANY, LTD.
WO/2021/153635	HIGHLY SAFE NON-LAMELLAR LIQUID CRYSTAL FORMING COMPOSITION	FARNEX INCORPORATED
WO/2021/157457	BLONANSERIN-CONTAINING PATCH AND METHOD FOR MANUFACTURING SAME	KANEKA CORPORATION
WO/2021/260986	TESTICULAR FUNCTION IMPROVING AGENT AND TESTICULAR FUNCTION  IMPROVING METHOD	DEXON PHARMACEUTICALS INC.
WO/2021/153651	SUNSCREEN COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/153660	SOLID POWDER COSMETIC	KOSE CORPORATION
WO/2021/153665	NOVEL ALKYNE DERIVATIVE	CARNA BIOSCIENCES, INC.
WO/2021/153673	DRUG FOR PREVENTING AND/OR TREATING IMMUNE-RELATED SIDE  EFFECT, GENETICALLY MODIFIED NON-HUMAN ANIMAL, AND NON-HUMAN MODEL ANIMAL FOR  IMMUNE-RELATED SIDE EFFECT	UNIVERSITY OF TSUKUBA
WO/2021/153690	NOVEL CRYSTAL FORM OF BENZENE DERIVATIVE	ONO PHARMACEUTICAL CO., LTD.
WO/2021/153703	TREATMENT FOR CHONDRODYSTROPHIA	KYOTO UNIVERSITY
WO/2021/153704	WATER-IN-OIL EMULSION COSMETIC	KAO CORPORATION
WO/2021/153705	EXTERNAL SKIN PREPARATION	KAO CORPORATION
WO/2021/153708	CHOLESTEROL ANALOG HAVING ANTI-HELICOBACTER PYLORI ACTIVITY	SHINSHU UNIVERSITY
WO/2021/153716	CONTROLLED RELEASE COMPOSITION	NIPPON SHINYAKU CO., LTD.
WO/2021/153718	FIBROBLAST GROWTH FACTOR 21 INDUCER, AND COMPOSITION FOR  SUPPRESSING ALCOHOL PREFERENCE OR SIMPLE SUGAR PREFERENCE	KYOTO UNIVERSITY
WO/2021/153719	MEDICINAL COMPOSITION COMPRISING DENTAL PULP-DERIVED CELLS	JCR PHARMACEUTICALS CO., LTD.
WO/2021/205719	METHOD FOR PRODUCING CARBON DIOXIDE-CONTAINING HYDROGEL  ARTICLE	KAO CORPORATION
WO/2021/161811	VASODILATOR COMPOSITION, VASODILATOR COMPOSITION KIT,  PHARMACEUTICAL COMPOSITION FOR DISEASES CAUSED BY BLOOD VESSEL CONSTRICTION  OR OBSTRUCTIVE IMPAIRMENT, AND PHARMACEUTICAL COMPOSITION KIT FOR DISEASES  CAUSED BY BLOOD VESSEL CONSTRICTION OR OBSTRUCTIVE IMPAIRMENT	AICHI MEDICAL UNIVERSITY
WO/2021/153744	CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE  THEREOF	TORAY INDUSTRIES, INC.
WO/2021/255978	NON-RINSING-OFF-TYPE STERILIZATION CLEANER COMPOSITION	LION CORPORATION
WO/2021/153771	HYALURONIC ACID PRODUCTION PROMOTER	SHISEIDO COMPANY, LTD.
WO/2021/153773	PHOTOAGING INHIBITOR	SHISEIDO COMPANY, LTD.
WO/2021/153776	ANGIOGENESIS INHIBITOR	SHISEIDO COMPANY, LTD.
WO/2021/153780	ANTIOXIDANT OR SKIN STRESS INHIBITOR	SHISEIDO COMPANY, LTD.
WO/2021/255979	ANTI-OBESITY COMPOSITION AND COMPOSITION FOR ORAL  ADMINISTRATION	TOYO SHINYAKU CO., LTD.
WO/2021/153781	COLLAGEN SACCHARIFICATION INHIBITOR	SHISEIDO COMPANY, LTD.
WO/2021/153783	INFLAMMATION-SUPPRESSING AGENT	SHISEIDO COMPANY, LTD.
WO/2021/153785	AGENT FOR MAINTAINING OR ENHANCING COLLAGEN PRODUCTION ABILITY	SHISEIDO COMPANY, LTD.
WO/2021/153788	SKIN BARRIER FUNCTION ENHANCER	SHISEIDO COMPANY, LTD.
WO/2021/171908	COMPOSITION COMPRISING POLYION COMPLEX AND FATTY ALCOHOL	L'OREAL
WO/2021/171909	COMPOSITION COMPRISING POSITIVELY CHARGED POLYION COMPLEX	L'OREAL
WO/2021/186917	HAIR DYE	NIL CO., LTD.
WO/2021/153798	METHOD FOR ASSESSING POSSIBILITY OF ONSET OR PROGRESSION OF  CHRONIC KIDNEY GRAFT REJECTION AND CHRONIC KIDNEY DISEASE, TEST KIT, AND  PHARMACEUTICAL COMPOSITION	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/157549	TOPICAL COMPOSITION FOR IMPROVING SKIN TEXTURE, COSMETIC  COMPOSITION, AND SKIN TEXTURE IMPROVING METHOD	ADEKA CORPORATION
WO/2021/157569	USE OF POLYETHER COMPOUND	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/157601	ANTI-MEFLIN ANTIBODY FOR USE IN TREATING CANCER IN SUBJECT  HAVING CANCER, AND PHARMACEUTICAL COMPOSITION INCLUDING SAID ANTIBODY	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/157613	PYRAZOLE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION	FUKUOKA UNIVERSITY
WO/2021/157619	AGENT FOR TREATING OR PREVENTING PANCREATIC FISTULA	NOF CORPORATION
WO/2021/161876	BENDAMUSTINE LIQUID PREPARATION	FUJIFILM CORPORATION
WO/2021/157627	ORAL COMPOSITION	TOYO SHINYAKU CO., LTD.
WO/2021/157634	DETERMINATION AGENT AND DETERMINATION METHOD FOR TAUOPATHY AND  DEMENTIA-RELATED DISEASES	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/157650	ANTICANCER AGENT COMPOSITION	CARNA BIOSCIENCES, INC.
WO/2021/157655	CONJUGATE BETWEEN ANTIBODY OR PEPTIDE AND PHTHALOCYANINE DYE	THE UNIVERSITY OF TOKYO
WO/2021/157677	HYALURONIC ACID DERIVATIVE COMPOSITION, PHARMACEUTICAL  COMPOSITION AND HYALURONIC ACID DERIVATIVE-DRUG CONJUGATE COMPOSITION	ASAHI KASEI KABUSHIKI KAISHA
WO/2021/157681	THERAPEUTIC AGENT FOR SUBRETINAL HYPERREFLECTIVE MATERIAL OR  RETINAL DISORDERS ACCOMPANYING SUBRETINAL HYPERREFLECTIVE MATERIAL	RIBOMIC INC.
WO/2021/157682	THERAPEUTIC AGENT FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC  FATIGUE SYNDROME	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/157688	SKIN COMPOSITION FOR EXTERNAL USE	KAO CORPORATION
WO/2021/171972	SOLID PREPARATION	SCREEN HOLDINGS CO., LTD.
WO/2021/157730	NUCLEIC ACID DRUG AND USE THEREOF	VERITAS IN SILICO INC.
WO/2021/161981	NOVEL MEDICAMENT FOR TREATING HEPATIC ENCEPHALOPATHY	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/161982	NOVEL MODIFYING REAGENTS FOR THE PRESENCE RATIO OF INTESTINAL  MICROFLORA	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/161983	NOVEL MEDICAMENT FOR TREATING INFLAMMATORY DISEASE	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/161984	DICLOFENAC SODIUM-CONTAINING PATCH	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/161985	DICLOFENAC SODIUM-CONTAINING PATCH	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/161987	BISPHOSPHONATE-CONTAINING CARBON PARTICLE COMPOSITE AND METHOD  FOR PRODUCING SAME	NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND  TECHNOLOGY
WO/2021/162004	DICLOFENAC SODIUM-CONTAINING ADHESIVE PATCH	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/162020	ANTI-CD137 ANTIGEN-BINDING MOLECULE FOR USE IN CANCER  TREATMENT	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/162032	CLEANING AGENT COMPOSITION	HOYU CO., LTD.
WO/2021/162054	TYPE 2 RYANODINE RECEPTOR ACTIVITY INHIBITOR	JUNTENDO EDUCATIONAL FOUNDATION
WO/2021/215084	MICROEMULSION COMPOSITION AND COSMETIC CONTAINING SAME	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/162068	TRANSFER DEVICE FOR LIVING BODY	TOPPAN PRINTING CO., LTD.
WO/2021/162074	AQUEOUS COSMETIC PREPARATION	KOSE CORPORATION
WO/2021/162106	DISSOLVING AGENT	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/210257	COMPOSITE PARTICLE AND METHOD FOR PRODUCING SAME	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/162126	INHIBITOR OF ASPARTIC ACID SYNTHESIS IN TUMOR CELLS, INHIBITOR  OF SPHEROID FORMATION OF TUMOR CELLS, INHIBITOR OF TUMOR CELL METASTASIS,  ACTIVITY ENHANCER OF GLYCOLYTIC INHIBITOR, AND PHARMACEUTICAL COMPOSITION FOR  SUPPRESSING AND/OR PREVENTING TUMOR METASTASIS	CCI HOLDINGS INC.
WO/2021/192726	CHOLINE UPTAKE INHIBITOR, APOPTOSIS INDUCER, ANTICANCER DRUG,  AND USE THEREOF	TOKYO MEDICAL UNIVERSITY
WO/2021/172088	OIL-IN-WATER TYPE COMPOSITION AND COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/166899	GASTRIC PROTEASE INHIBITOR-CONTAINING DRUG FOR COMBINATION USE  WITH INCRETIN MIMETIC	UBE INDUSTRIES, LTD.
WO/2021/186993	HAIRSTYLING AGENT COMPOSITION	MANDOM CORPORATION
WO/2021/172146	FATTY ACID CALCIUM SALT PARTICLES AND COSMETICS	SHISEIDO COMPANY, LTD.
WO/2021/166981	CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAME	OSAKA UNIVERSITY
WO/2021/166986	PATCH PREPARATION	NITTO DENKO CORPORATION
WO/2021/166987	TRANSDERMAL ABSORPTION PREPARATION	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/172157	EXTERNAL PREPARATION CONTAINING TETRACAINE	KANEKA CORPORATION
WO/2021/166998	STABLE BIOISOSTERE OF RESOLVIN E2	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/172162	DISINFECTING COMPOSITION	NOF CORPORATION
WO/2021/167006	ANTITUMOR EFFECT ENHANCING AGENT CONTAINING URACIL DERIVATIVE  COMPOUND	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/167012	COMPOSITION FOR NEURAL FUNCTION REGULATION	UNIVERSITY OF TSUKUBA
WO/2021/167016	VITELLINE MEMBRANE- AND/OR CHALAZA-DERIVED COSMETIC  COMPOSITION, AND METHOD FOR PRODUCING SAME	PHARMA FOODS INTERNATIONAL CO., LTD.
WO/2021/167017	AEROSOL COMPOSITION AND AEROSOL PREPARATION	HISAMITSU PHARMACEUTICAL CO., INC.
WO/2021/167032	DRUG AND FOOD FOR TREATING AND/OR PREVENTING ENTERITIS AND/OR  HEPATITIS	KEIO UNIVERSITY
WO/2021/167039	OIL-IN-OIL EMULSION COSMETIC COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/167040	OIL-IN-OIL EMULSIFIED COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/167056	MEDICINE CONTAINING USAG-1-TARGETING RNA MOLECULE FOR TOOTH  REGENERATION THERAPY	KYOTO UNIVERSITY
WO/2021/172188	BIOCOMPATIBLE MATERIAL	FUJIFILM CORPORATION
WO/2021/172210	BIOCOMPATIBLE MATERIAL	FUJIFILM CORPORATION
WO/2021/172211	BIOCOMPATIBLE MATERIAL	FUJIFILM CORPORATION
WO/2021/172213	BIOCOMPATIBLE MATERIAL	FUJIFILM CORPORATION
WO/2021/167088	COMPOSITION FOR ALLEVIATING PULMONARY HYPERTENSION, METHOD FOR  PREDICTING PROGNOSIS OF PULMONARY HYPERTENSION, METHOD FOR ASSISTING IN  DETERMINING SEVERITY OF PULMONARY HYPERTENSION, AND METHOD FOR ASSISTING IN  DIAGNOSING PULMONARY HYPERTENSION	NAKAOKA Yoshikazu
WO/2021/177065	COMPOSITION FOR ORAL CAVITY	LION CORPORATION
WO/2021/172269	YELLOW-DULLING REMEDIATION AGENT, COSMETIC COMPOSITION, AND  YELLOW-DULLING REMEDIATION METHOD	ADEKA CORPORATION
WO/2021/199792	FORMULATION FOR PREVENTING OR TREATING PNEUMONIA	OSAKA UNIVERSITY
WO/2021/172304	COMPOSITION FOR ENHANCING ESTROGEN SECRETION	MOTHER & CHILD CO., LTD.
WO/2021/172351	POWDERY SOLID COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/172353	POWDERY SOLID COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/172359	CDK9 INHIBITOR PRODRUG AND LIPOSOME INCLUDING THE SAME	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/172395	COATED BULK DRUG PARTICLES	TOWA PHARMACEUTICAL CO., LTD.
WO/2021/172418	METHOD FOR PRODUCING INACTIVATED INFLUENZA VACCINE AND VACCINE  COMPOSITION THEREOF	DENKA COMPANY LIMITED
WO/2021/172430	OIL-IN-WATER EMULSION COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/182121	BIOFILM TRANSPARENTIZING REAGENT, AND BIOFILM OBSERVATION  METHOD USING SAID TRANSPARENTIZING REAGENT	THE JIKEI UNIVERSITY
WO/2021/172462	DRUG COMPOSITION AND METHOD FOR PROMOTING RECOVERY OF  GASTROINTESTINAL TRACT POST-SURGERY	SHIONOGI & CO., LTD.
WO/2021/172463	COSMETIC CONTAINING SILOXANE LINKAGE-CONTAINING POLYMER  COMPOUND HAVING HOST GROUP AND/OR GUEST GROUP	SHISEIDO COMPANY, LTD.
WO/2021/172490	COMBINATION DRUG, AND DRUG FOR PREVENTING OR SUPPRESSING  DEVELOPMENT OF PYRIMIDINE ANTIMETABOLITE RESISTANCE	FUJIFILM CORPORATION
WO/2021/172498	ANTISENSE NUCLEIC ACID INDUCING SKIPPING OF EXON 51	NIPPON SHINYAKU CO., LTD.
WO/2021/172515	DIAGNOSTIC IMAGING AGENT FOR OLIGOMERIC AMYLOID	NATIONAL UNIVERSITY CORPORATION SHIGA UNIVERSITY OF MEDICAL  SCIENCE
WO/2021/199813	AQUEOUS SUSPENSION CONTAINING REBAMIPIDE OR SALT THEREOF AND  POLYMER	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/199814	SILVER-SALT-CONTAINING OPHTHALMIC AQUEOUS COMPOSITION WITH  WHICH RESIN CONTAINER IS FILLED	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/172519	PANCREATIC CANCER DIAGNOSIS ASSISTANCE METHOD AND  PHARMACEUTICAL COMPOUND FOR TREATING PANCREATIC CANCER	TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INSTITUTE OF  GERONTOLOGY
WO/2021/172546	DIGESTIVE ENZYME AGENT	AMANO ENZYME INC.
WO/2021/177188	OIL-IN-WATER-TYPE EMULSIFIED COSMETIC MATERIAL	KAO CORPORATION
WO/2021/172582	METHOD FOR SCREENING ANTICANCER AGENT AND COMBINATION DRUG OF  KINASE INHIBITORS FOR TREATMENT OF PANCREATIC CANCER	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/177241	CLEANING COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/177247	MINERAL ABSORPTION ENHANCER	CYCLOCHEM BIO CO., LTD.
WO/2021/177248	INTESTINAL TRACT FUNCTION IMPROVING AGENT	CYCLOCHEM BIO CO., LTD.
WO/2021/172595	ANTIGEN-PRESENTING EXTRACELLULAR VESICLES, COMPOSITION  CONTAINING SAME, AND METHODS FOR PRODUCTION THEREOF	NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY
WO/2021/177256	DRUG CONTAINING SOFPIRONIUM BROMIDE	KAKEN PHARMACEUTICAL CO., LTD.
WO/2021/177257	METHOD FOR TREATING PRIMARY AXILLARY HYPERHIDROSIS AND  PHARMACEUTICAL PRODUCT THEREFOR	KAKEN PHARMACEUTICAL CO., LTD.
WO/2021/182163	EMULSION FOR WET SHEET AND WET SHEET	DAIO PAPER CORPORATION
WO/2021/177267	PREVENTION OR TREATMENT OF ANEURYSMS USING MIR-33B INHIBITOR	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/182178	WET SHEET AND METHOD FOR MANUFACTURING SAME	DAIO PAPER CORPORATION
WO/2021/199850	OXIDATIVE STRESS INHIBITOR AND ANTIOXIDANT AGENT	BOSQUET SILICON CORP.
WO/2021/177326	COMPOSITION SUITABLE FOR EYELASHES	L'OREAL
WO/2021/177332	NLRP3 INFLAMMASOME INHIBITOR AND PHARMACEUTICAL COMPOSITION  FOR PREVENTING OR TREATING INFLAMMATORY DISEASE	TOHOKU UNIVERSITY
WO/2021/177335	BRAIN FUNCTION IMPROVING COMPOSITION	SAN-EI GEN F.F.I., INC.
WO/2021/177352	COMPOSITION AND FUNCTIONAL FOOD PRODUCT COMPRISING GREEN TEA  EXTRACT	TOYOTA JIDOSHA KABUSHIKI KAISHA
WO/2021/182269	PASTE-TYPE COSMETIC CONTAINING NATURAL MOISTURIZING FACTOR	COSMED PHARMACEUTICAL CO., LTD.
WO/2021/177397	L-ERGOTHIONEINE-CONTAINING COMPOSITION	NAGASE & CO., LTD.
WO/2021/182283	COMPOSITION FOR SUPPRESSING DECREASE IN OR IMPROVING SKIN  BARRIER FUNCTION, COMPOSITION FOR SUPPRESSING DECREASE IN OR IMPROVING  EXPRESSION OF TYPE 4 COLLAGEN, AND METHOD FOR SCREENING SUBSTANCES HAVING  ACTION TO SUPPRESS DECREASE IN OR IMPROVE SKIN BARRIER FUNCTION	SUNTORY HOLDINGS LIMITED
WO/2021/177400	OIL-IN-WATER EMULSION COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/177430	HAIR GROWTH PROMOTING COMPOSITION AND/OR GRAY HAIR  AMELIORATING COMPOSITION	ICHIMARU PHARCOS CO., LTD.
WO/2021/177432	COMPOSITION CONTAINING LACTIC ACID BACTERIA	SCHOOL CORPORATION, AZABU VETERINARY MEDICINE EDUCATIONAL  INSTITUTION
WO/2021/177438	ANTIBODY-DRUG CONJUGATE INCLUDING NOVEL CYCLIC DINUCLEOTIDE  DERIVATIVE	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/235044	AGENT FOR REVERSING TRIGLYCERIDE DEPOSIT-TYPE ATHEROSCLEROSIS	OSAKA UNIVERSITY
WO/2021/182330	CANCER THERAPY AID FOR ENHANCING ANTICANCER DRUG EFFECT	KEIO UNIVERSITY
WO/2021/182367	CLEANSING AGENT	SHISEIDO COMPANY, LTD.
WO/2021/182377	CLOSTRIDIODES DIFFICILE GROWTH INHIBITOR	NUTRI CO., LTD.
WO/2021/182403	COMPOSITION FOR PREVENTING DETERIORATION IN COGNITIVE FUNCTION  AND/OR IMPROVING COGNITIVE FUNCTION	PHARMA FOODS INTERNATIONAL CO., LTD.
WO/2021/182419	CERAMIDE GROWTH PROMOTING AGENT	TAKASAGO INTERNATIONAL CORPORATION
WO/2021/182430	DETERGENT	SHISEIDO COMPANY, LTD.
WO/2021/182457	NOVEL 3,5-DIAMINOBENZOIC ACID COMPOUND, AND PIN1 INHIBITOR AND  THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES USING SAME	HIROSHIMA UNIVERSITY
WO/2021/182467	GRANULES AND PREPARATION USING SAME	SAWAI PHARMACEUTICAL CO., LTD.
WO/2021/182469	GRANULES AND PREPARATION USING SAME	SAWAI PHARMACEUTICAL CO., LTD.
WO/2021/182473	SOLID POWDER COSMETIC	AJINOMOTO CO., INC.
WO/2021/182490	CRYSTAL OF IMIDAZOPYRIDINONE COMPOUND OR SALT THEREOF	KISSEI PHARMACEUTICAL CO., LTD.
WO/2021/182492	PURIFIED SALACIA PLANT EXTRACT AND METHOD FOR PRODUCING  PURIFIED SALACIA PLANT EXTRACT	FUJIFILM CORPORATION
WO/2021/182498	POLYSACCHARIDE COMPOSITE PARTICLES	NISSAN CHEMICAL CORPORATION
WO/2021/182500	OILY COMPOSITION AND COSMETICS COMPOSITION CONTAINING SAID  OILY COMPOSITION	ADEKA CORPORATION
WO/2021/182517	SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR INDUCING -1 FRAME  SHIFT AND COMPOSITION	YANO, Takamitsu
WO/2021/182538	AGENT/COMPOSITION CONTAINING CARYOPHYLLENE, AND VARIOUS USES  THEREOF	KINKI UNIVERSITY
WO/2021/182552	SHAMPOO COMPOSITION	HOYU CO., LTD.
WO/2021/187289	METHOD FOR PRODUCING PARTICLES	RICOH COMPANY, LTD.
WO/2021/187306	COSMETIC COMPOSITION	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/182570	MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER	TORAY INDUSTRIES, INC.
WO/2021/182571	MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER	TORAY INDUSTRIES, INC.
WO/2021/182572	MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER	TORAY INDUSTRIES, INC.
WO/2021/182573	MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER	TORAY INDUSTRIES, INC.
WO/2021/182574	MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER	TORAY INDUSTRIES, INC.
WO/2021/187314	MITOCHONDRIAL DYSFUNCTION IMPROVING AGENT	FUKUOKA UNIVERSITY
WO/2021/182596	AMELIORATING AGENT FOR DEEPENING OF UPPER EYELID SULCUS	KOWA COMPANY, LTD.
WO/2021/182597	VIRAL INFECTION THERAPEUTIC	THE UNIVERSITY OF TOKYO
WO/2021/182607	DIARRHEA INHIBITOR	TORAY INDUSTRIES, INC.
WO/2021/187380	ARRHYTHMOGENIC-CARDIOMYOPATHY-PATIENT-DERIVED PLURIPOTENT STEM  CELLS, USE THEREOF, AND DRUG FOR TREATING ARRHYTHMOGENIC CARDIOMYOPATHY	OSAKA UNIVERSITY
WO/2021/187396	COENZYME Q PRODUCTION PROMOTER AND COENZYME Q PRODUCTION  PROMOTING METHOD	TANAKA Megumi
WO/2021/193224	PHARMACEUTICAL COMPOSITION FOR TREATING DYSCHROMATOSIS  SYMMETRICA HEREDITARIA, DYSCHROMATOSIS SYMMETRICA HEREDITARIA MODEL MOUSE,  AND SCREENING METHOD FOR COMPOUND FOR TREATING DYSCHROMATOSIS SYMMETRICA  HEREDITARIA	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/187478	COMPOSITION CONTAINING SELF-ASSEMBLING PEPTIDE	KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY
WO/2021/187516	ANIMAL GROWTH PROMOTER AND LIVESTOCK FEED	THE UNIVERSITY OF TOKYO
WO/2021/187546	ANTI-PSYCHIATRIC DISEASE AGENT	UNIVERSITY OF TSUKUBA
WO/2021/187547	CRYSTAL OF PHENYLACETATE COMPOUND	ONO PHARMACEUTICAL CO., LTD.
WO/2021/187548	TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILURE	JAPAN TOBACCO INC.
WO/2021/200214	BODY FAT REDUCING AGENT	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/200216	MUSCLE ENHANCER	MITSUBISHI GAS CHEMICAL COMPANY, INC.
WO/2021/187592	PHARMACEUTICAL COMPOSITION CONTAINING BETAMETHASONE VALERATE	SHIONOGI HEALTHCARE CO., LTD.
WO/2021/187593	COMPOSITION CONTAINING BETAMETHASONE VALERATE	SHIONOGI HEALTHCARE CO., LTD.
WO/2021/187605	NITROGEN-CONTAINING HETEROCYCLIC α-CYANO CARBONYL COMPOUND	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/187608	NOVEL GRANULES AND PRODUCTION METHOD THEREFOR	NOBELPHARMA CO., LTD.
WO/2021/193393	A METHOD OF ADMINISTERING A NANOPARTICLE	KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION
WO/2021/193398	COMPOSITION FOR ORAL CAVITY	NOF CORPORATION
WO/2021/210343	ANTITUMOR AGENT	NATIONAL UNIVERSITY CORPORATION NARA INSTITUTE OF SCIENCE AND  TECHNOLOGY
WO/2021/200275	ORAL COMPOSITION AND METHOD FOR AMELIORATING HARSH TASTE	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/200299	CELLULAR AGING INHIBITOR, BIOLOGICAL TISSUE REPAIR PROMOTER,  GENE EXPRESSION REGULATOR, AND MANUFACTURING METHOD	FUJIFILM WAKO PURE CHEMICAL CORPORATION
WO/2021/205852	BIOLOGICAL FUNCTION REGULATING AGENT, EPIDERMAL METABOLISM  PROMOTING AGENT, FAT ACCUMULATION INHIBITING AGENT, FAT DECOMPOSITION  PROMOTING AGENT, ADIPONECTIN PRODUCTION PROMOTING AGENT, FUNCTIONAL FOOD,  COSMETIC, AND METHOD FOR PRODUCING BIOLOGICAL FUNCTION REGULATING AGENT	NITTA GELATIN INC.
WO/2021/200313	PACKAGED AQUEOUS COMPOSITION	KOWA COMPANY, LTD.
WO/2021/193498	COLLAGENASE ACTIVITY INHIBITOR	TOYO SUGAR REFINING CO., LTD.
WO/2021/193503	COSMETIC COMPOSITION	MANDOM CORPORATION
WO/2021/200351	MAKEUP APPLICATION METHOD	KAO CORPORATION
WO/2021/200352	MAKEUP APPLICATION METHOD	KAO CORPORATION
WO/2021/200353	TOPICAL SKIN PREPARATION COMPOSITION	KAO CORPORATION
WO/2021/200354	TOPICAL SKIN PREPARATION COMPOSITION	KAO CORPORATION
WO/2021/193569	ESSENTIAL OIL DECOLORIZATION METHOD	TAKASAGO INTERNATIONAL CORPORATION
WO/2021/200370	EYELINER COSMETIC PREPARATION	KOSE CORPORATION
WO/2021/200377	OIL-IN-WATER-TYPE EMULSIFIED COSMETIC	KOSE CORPORATION
WO/2021/193602	CROSSLINKED POLYMER, SHIGA TOXIN INHIBITOR, AND PHARMACEUTICAL  COMPOSITION	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/193604	TRANSPARENT LIQUID COMPOSITION AND COSMETIC CONTAINING SAID  COMPOSITION	SEIWA KASEI COMPANY, LIMITED
WO/2021/200393	COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/193659	COMPOSITION WHICH IS FOR TREATING OR PREVENTING RENAL CELL  CANCER AND CONTAINS D-ALLOSE AS ACTIVE INGREDIENT, AND METHOD FOR TREATING OR  PREVENTING CANCER USING SAME	NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY
WO/2021/200419	COSMETIC FOR KERATIN FIBERS	KOSE CORPORATION
WO/2021/193703	CENTRAL NERVOUS SYSTEM POTENTIATING COMPOSITION	SHIBAURA INSTITUTE OF TECHNOLOGY
WO/2021/200447	COSMETIC GEL SHEET INCLUDING WAFER PAPER AS SUPPORT AND  PRODUCTION METHOD THEREFOR	COSMED PHARMACEUTICAL CO., LTD.
WO/2021/193744	METHOD FOR TREATING CANCER AND SYSTEM FOR SAME	OTSUKA MEDICAL DEVICES CO., LTD.
WO/2021/193756	NOVEL BENZIMIDAZOLE DERIVATIVE	CARNA BIOSCIENCES, INC.
WO/2021/205886	BINDER	JAPAN VAM & POVAL CO., LTD.
WO/2021/205887	SUSTAINED RELEASE BASE	JAPAN VAM & POVAL CO., LTD.
WO/2021/193790	AROMATIC HETEROCYCLIC DERIVATIVE HAVING SEROTONIN RECEPTOR  BINDING ACTIVITY	SHIONOGI & CO., LTD.
WO/2021/193820	COMPOSITION FOR PROMOTING HAIR THICKENING, COMPOSITION FOR  SUSTAINING GROWTH PHASE IN HAIR CYCLE AND COMPOSITION FOR PROMOTING VEGF  PRODUCTION, COMPOSITION FOR PROMOTING TRANSITION FROM RESTING PHASE TO GROWTH  PHASE IN HAIR CYCLE AND COMPOSITION FOR PROMOTING FGF7 PRODUCTION, AND  COMPOSITION FOR PROMOTING HAIR CYCLE NORMALIZATION	AJINOMOTO CO., INC.
WO/2021/193835	ANTI-INFLAMMATORY IMMUNOENHANCER	SCENT SCIENCE INTERNATIONAL INC.
WO/2021/200574	SKIN TREATMENT METHOD	KAO CORPORATION
WO/2021/193854	OIL-IN-WATER-TYPE EMULSIFIED COSMETIC MATERIAL	KAO CORPORATION
WO/2021/193856	RENAL FUNCTION PROTECTANT	TOHOKU UNIVERSITY
WO/2021/193874	TRANSDERMAL PATCH	NICHIBAN CO., LTD.
WO/2021/193900	IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND  PHARMACEUTICAL COMPOSITION CONTAINING SAME	THE UNIVERSITY OF KITAKYUSHU
WO/2021/229928	CLEANSER COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/205902	LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION,  AND COMPOSITION FOR AGENT FOR EXTERNAL USE ON SKIN	SHISEIDO COMPANY, LTD.
WO/2021/193918	SKIN COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/200651	CORONAVIRUS INFECTION TREATMENT DRUG	FUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/193921	DOUBLE-LAYER SEAMLESS CAPSULE CONTAINING WATER-SOLUBLE  COMPOSITION	FUJI CAPSULE CO., LTD.
WO/2021/193928	PHARMACEUTICAL DRUG FOR DESTROYING TUMOR CELLS	PHOTOQ3 INC.
WO/2021/200694	NEGAMYCIN DERIVATIVE	TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES
WO/2021/200698	COMPOSITION FOR IMPROVING FRIENDLINESS AND/OR EMPATHETIC  CAPACITY	SUNTORY HOLDINGS LIMITED
WO/2021/200705	AGENT FOR INHIBITING REDUCTION OF DECOMPOSITION OF MODIFIED  ELASTIN, AGENT FOR MAINTAINING NORMAL ELASTIC FIBERS, AGENT FOR INHIBITING  FORMATION OF ELASTIN-ELAFIN COMPLEX, AND COMPOSITION CONTAINING SAID AGENTS	SUNTORY HOLDINGS LIMITED
WO/2021/200767	TABLET, MEDICINE, AND METHOD AND KIT FOR MANUFACTURING SAID  TABLET AND MEDICINE	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/200781	POWDER-CONTAINING COSMETIC	KOSE CORPORATION
WO/2021/200800	VACCINE FOR PREVENTING OR TREATING CORONAVIRUS INFECTION OR  SYMPTOMS ASSOCIATED WITH CORONAVIRUS INFECTION	OSAKA UNIVERSITY
WO/2021/200823	ERIBULIN-CONTAINING PARENTERAL PHARMACEUTICAL SOLUTION	NIPRO CORPORATION
WO/2021/200824	NOVEL XANTHENONE DERIVATIVE	NATIONAL INSTITUTES OF BIOMEDICAL INNOVATION, HEALTH AND  NUTRITION
WO/2021/200857	BISPECIFIC ANTIBODY	MIE UNIVERSITY
WO/2021/200897	COMPOSITION	KOSE CORPORATION
WO/2021/200922	FUSION PROTEIN SUITABLE FOR DISSOLVING FIBRIN CLOT, AND  PHARMACEUTICAL COMPOSITION CONTAINING SAID FUSION PROTEIN	NATIONAL CANCER CENTER
WO/2021/200975	PHARMACEUTICAL COMPOSITION	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/200996	COMPOSITION FOR AMELIORATING OR PREVENTING DECREASES IN BONE  STRENGTH	AJINOMOTO CO., INC.
WO/2021/201004	TOOTH WHITENING AND TOOTH STRENGTHENING METHOD	NISHIO CO., LTD.
WO/2021/201031	OIL-BASED COSMETIC	KOSE CORPORATION
WO/2021/201036	HYDROXYPYRROLIDINE DERIVATIVE AND MEDICINAL APPLICATION  THEREOF	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/201059	COMPOSITION CONTAINING MENTHOL	SUNSHO PHARMACEUTICAL CO., LTD.
WO/2021/215211	COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/201100	THERAPEUTIC AGENT USING GENOME-EDITED PLURIPOTENT STEM CELL	KEIO UNIVERSITY
WO/2021/201120	AGENT FOR TREATING INFLAMMATORY BOWEL DISEASE, AND AMIDE  COMPOUND OR SALT THEREOF	KEIO UNIVERSITY
WO/2021/201126	AMIDE COMPOUND OR SALT THEREOF, PHARMACEUTICAL COMPOSITION AND  HISTONE DEACETYLASE INHIBITOR	FUJIFILM CORPORATION
WO/2021/201128	ORAL COMPOSITION FOR ENHANCING EXPRESSION OR PROMOTING  PRODUCTION OF CILIARY NEUROTROPHIC FACTOR, OR FOR IMPROVING COGNITIVE  FUNCTION	MEIJI CO., LTD.
WO/2021/201134	AQUEOUS COMPOSITION	KOSE CORPORATION
WO/2021/201136	OIL-IN-WATER TYPE COSMETIC EMULSION PREPARATION	KOSE CORPORATION
WO/2021/201152	ADHESIVE PATCH	NICHIBAN CO., LTD.
WO/2021/201169	COMPOSITION FOR ORAL INGESTION FOR IMPROVING SPERM FINDING IN  MALE INFERTILITY	DANTTE CO., LTD.
WO/2021/201170	METHOD FOR SCREENING FOR, METHOD FOR PRODUCING, AND METHOD FOR  DESIGNING DRUG ACTIVE INGREDIENTS	SKY PHARMA CO., LTD.
WO/2021/201171	SUPPRESSION OF NEUROINFLAMMATION AND COMPOSITION AND METHOD  THEREFOR	KYOTO UNIVERSITY
WO/2021/220712	OPHTHALMIC COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/205975	COMPOSITION FOR SUPPRESSING CELLULAR SENESCENCE, AND METHOD  FOR SUPPRESSING CELLULAR SENESCENCE	SUNTORY HOLDINGS LIMITED
WO/2021/201201	PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEW CORONAVIRUS  INFECTION (COVID-19) AND PHARMACEUTICAL COMPOSITION	INTERPROTEIN CORPORATION
WO/2021/201224	MITOCHONDRION PROTECTING AGENT, MITOCHONDRIAL DYSFUNCTION  IMPROVING AGENT, OR MITOCHONDRIAL FUNCTION IMPROVING AGENT	STAGEN CO., LTD.
WO/2021/201238	METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE  PREPARATION	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/201239	METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTS	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/201258	COMPOSITION CONTAINING NUCLEIC ACID, METHOD FOR PRODUCING  COMPOSITION CONTAINING NUCLEIC ACID, AND METHOD FOR INTRODUCING NUCLEIC ACID	STATEART INC.
WO/2021/193982	NERVE CELL DEGENERATION INHIBITOR	KYOTO UNIVERSITY
WO/2021/201260	PEPTIDE HAVING MESENCHYMAL STEM CELL MOBILIZING ACTIVITY	STEMRIM INC.
WO/2021/201261	PAIN TREATMENT DRUG	SHIONOGI & CO., LTD.
WO/2021/201262	MEDICINE FOR TREATING SLEEP APNEA SYNDROME	SHIONOGI & CO., LTD.
WO/2021/201263	COMPOSITION FOR IMPROVING INTESTINAL ENVIRONMENT OR ORAL  ENVIRONMENT	KIRIN HOLDINGS KABUSHIKI KAISHA
WO/2021/201264	PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION FOR  TREATING, PREVENTING OR ALLEVIATING OSTEOARTHRITIS	THERABIOPHARMA INC.
WO/2021/201267	ANTITUMOR AGENT	FUJIFILM CORPORATION
WO/2021/206020	PROPHYLACTIC OR THERAPEUTIC AGENT FOR ATTENTION-DEFICIT  HYPERACTIVITY DISORDER	OSAKA UNIVERSITY
WO/2021/241000	COMPOSITION	TAIYO KAGAKU CO., LTD.
WO/2021/241004	AEROSOL-TYPE HAIR CLEANING AGENT	KAO CORPORATION
WO/2021/241005	AEROSOL TYPE COSMETIC HAIR PREPARATION	KAO CORPORATION
WO/2021/241006	AEROSOL COMPOSITION	KAO CORPORATION
WO/2021/229953	COSMETIC	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/206055	UNIT FOR ANGIOGENESIS PROMOTION AND/OR NERVE REGENERATION	ICHIMARU PHARCOS CO., LTD.
WO/2021/210438	BODY CLEANSER	TOYO BEAUTY CO., LTD.
WO/2021/206078	MEDICINE FOR KILLING TUMOR CELLS	PHOTOQ3 INC.
WO/2021/206103	VACCINE FOR SUBCUTANEOUS ADMINISTRATION	APPLIED MEDICAL ENZYME RESEARCH INSTITUTE CORPORATION
WO/2021/206105	EXTRACELLULAR VESICLE SECRETION INHIBITOR FOR INHIBITING  EXTRACELLULAR VESICLE SECRETION, AND USE OF THE SAME	THEORIA SCIENCE INC.
WO/2021/210490	ADHESIVE SHEET FOR SKIN	COSMED PHARMACEUTICAL CO., LTD.
WO/2021/206158	METHOD OF CANCER THERAPY	ONO PHARMACEUTICAL CO., LTD.
WO/2021/206159	SOLID PREPARATION AND MANUFACTURING METHOD THEREOF	NIPPON SHINYAKU CO., LTD.
WO/2021/206160	ANTIBODY-DRUG COMPLEX	ONO PHARMACEUTICAL CO., LTD.
WO/2021/206167	CANCER THERAPY USING 3,5-DISUBSTITUTED BENZENE ALKYNYL  COMPOUND AND MEK INHIBITOR	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/215274	SKIN EXTERNAL AGENT COMPOSITION AND DEODORANT	SHISEIDO COMPANY, LTD.
WO/2021/210515	AGENT FOR INCREASING CD25-POSITIVE REGULATORY T CELLS IN  KIDNEY	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/210531	FACE MASK AND SHEET-SHAPED BASE MATERIAL	DAIICHI SANKYO HEALTHCARE CO., LTD.
WO/2021/210538	METHOD FOR ADMINISTERING PHARMACEUTICAL PREPARATION	MATSUKAWA YOUETSU
WO/2021/220792	ANTIBACTERIAL AGENT	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/220793	AUTOPHAGY ACTIVATION AGENT	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/229979	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CEREBRAL  SMALL VESSEL DISEASE	NIIGATA UNIVERSITY
WO/2021/210565	AGENT FOR IMPROVING QUALITY OF SLEEP	NIPPON CHEMIPHAR CO., LTD.
WO/2021/210573	BIOTIN-MODIFIED DIMER AND USE THEREOF	THE UNIVERSITY OF TOKYO
WO/2021/250995	CRYSTAL MORPHOLOGY OF  1-[(4-METHYL-QUINAZOLINE-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-(3-(R)-AMINO-PEPERIDINE-1-YL)-XANTHINE	YUKI GOSEI KOGYO CO., LTD.
WO/2021/225063	TEST OBJECT SAFETY PREDICTION METHOD, COSMETIC MANUFACTURING  METHOD, METHOD FOR SPECIFYING HIGH SAFETY RANGE AND/OR LOW SAFETY RANGE FOR  SAFETY PREDICTION, AND SAFETY PREDICTION MEDIUM	MILBON CO., LTD.
WO/2021/210609	BLASTOCYST FORMATION PROMOTING AGENT	WASEDA UNIVERSITY
WO/2021/241049	COSMETIC PREPARATAION	SHIN-ETSU CHEMICAL CO., LTD.
WO/2021/215339	LIQUID COMPOSITION FOR DECORATION	SHISEIDO COMPANY, LTD.
WO/2021/210636	BREAST CANCER THERAPEUTIC AGENT	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/210646	AQUEOUS COMPOSITION CONTAINING EPINASTINE OR SALT THEREOF	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/210648	MEDICINE CONTAINING TREHALOSE OR TREHALOSE DERIVATIVE AND  NASAL SPRAY	NEXT21 KABUSHIKI KAISHA
WO/2021/210673	AGENT FOR IMPROVING SYMPTOMS OF MENOPAUSE	KAO CORPORATION
WO/2021/210681	CEREBRAL INFARCTION TREATMENT COMPOSITION	KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
WO/2021/215364	AGENT FOR PREVENTING OR TREATING INTRAUTERINE INFECTION	OSAKA UNIVERSITY
WO/2021/210683	HEAT-RESISTANT CAPSULE AND FOOD/BEVERAGE INCLUDING SAME	SUNSHO PHARMACEUTICAL CO., LTD.
WO/2021/210684	THERAPEUTIC AGENT FOR HYPERKINESIA	KYOWA KIRIN CO., LTD.
WO/2021/210686	CORONAVIRUS VACCINE	VLP THERAPEUTICS, INC.
WO/2021/215375	FORMULATION CONTAINING HMGB1 PARTIAL PEPTIDE	SHIONOGI & CO., LTD.
WO/2021/215405	IMMUNOSTIMULANT AND COMPOSITION FOR TREATMENT OR PREVENTION	OSAKA UNIVERSITY
WO/2021/220869	METHOD FOR MANUFACTURING SOLID COSMETIC AND PRESS HEAD	SHISEIDO COMPANY, LTD.
WO/2021/215409	AGENT FOR PREVENTING AND/OR IMPROVING PHOTOAGING AND/OR DERMAL  PIGMENTATION, COSMETIC METHOD USING SAME, AND COSMETIC DEVICE TO BE APPLIED  IN SAID METHOD	SHISEIDO COMPANY, LTD.
WO/2021/215411	SKIN ANTI-AGING AGENT, BEAUTIFICATION METHOD FOR SKIN  ANTI-AGING, AND BEAUTIFICATION INSTRUMENT FOR USE IN METHOD	SHISEIDO COMPANY, LTD.
WO/2021/215420	CLEANSING AGENT	SHISEIDO COMPANY, LTD.
WO/2021/215423	COSMETIC PREPARATION	SHISEIDO COMPANY, LTD.
WO/2021/215440	HYALURONIC ACID PRODUCTION PROMOTER	SHISEIDO COMPANY, LTD.
WO/2021/215462	IMPROVED PEPTIDE VACCINE	BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
WO/2021/256077	COGNITIVE FUNCTION IMPROVING AGENT, COGNITIVE FUNCTION  MAINTAINING AGENT, HIPPOCAMPUS FUNCTION IMPROVING AGENT, AND HIPPOCAMPUS  FUNCTION MAINTAINING AGENT	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/215469	PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTING OR  TREATING CANCER WITH COMBINED USE OF ANTI-HUMAN Fn14 ANTIBODY AND IMMUNE  CHECKPOINT INHIBITOR	ASTELLAS PHARMA INC.
WO/2021/215473	AGENT FOR PREVENTING OR TREATING FRAILTY	OSAKA UNIVERSITY
WO/2021/215478	PHARMACEUTICAL COMPOSITION FOR TREATMENT, PREVENTION, OR  MANAGEMENT OF PSYCHIATRIC DISORDER	NATIONAL UNIVERSITY CORPORATION SHIMANE UNIVERSITY
WO/2021/241091	COSMETIC OR EXTERNAL SKIN PREPARATION IN WHICH AQUEOUS POLYMER  EMULSION IS BLENDED	NIKKO CHEMICALS CO., LTD.
WO/2021/215517	THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE  2019 (COVID-19)	NEOPHARMA JAPAN CO., LTD.
WO/2021/220947	OIL-IN-WATER EMULSION COMPOSITION	DAIICHI SANKYO HEALTHCARE CO., LTD.
WO/2021/215522	LINDERAPYRONE, AND ANALOGUE THEREOF	KYOTO PHARMACEUTICAL UNIVERSITY
WO/2021/230064	BLONANSERIN-CONTAINING PATCH AND PRODUCTION METHOD THEREFOR	KANEKA CORPORATION
WO/2021/221043	CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH  COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION  THERAPEUTIC DRUG	FUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/221066	IMMUNE FUNCTION ENHANCING COMPOSITION	INSTITUTE OF RHEOLOGICAL FUNCTION OF FOOD CO., LTD.
WO/2021/221074	LIQUID PREPARATION CONTAINING BRIMONIDINE	SENJU PHARMACEUTICAL CO., LTD.
WO/2021/251023	DENTAL CURABLE COMPOSITION	TOKUYAMA DENTAL CORPORATION
WO/2021/221101	LIQUID FORMULATION AND PHARMACEUTICAL PRODUCT CONTAINING  CILASTATIN	DENKA COMPANY LIMITED
WO/2021/221111	PROPHYLACTIC OR THERAPEUTIC AGENT FOR RNA VIRUS-RELATED  DISEASES	KYOTO UNIVERSITY
WO/2021/221116	PROPHYLACTIC OR THERAPEUTIC AGENT FOR AT LEAST ONE TYPE OF  CANCER SELECTED FROM GROUP CONSISTING OF PANCREATIC CANCER, LUNG CANCER,  COLORECTAL CANCER, BILIARY TRACT CANCER AND LIVER CANCER, PROPHYLACTIC OR  THERAPEUTIC AGENT FOR SAID CANCER WHICH IS USED IN COMBINATION DRUG IN  COMBINATION WITH SAID AGENT, COMBINATION DRUG COMPRISING SAID AGENTS, AND  METHOD FOR SCREENING FOR PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER	THE UNIVERSITY OF TOKYO
WO/2021/221135	ORAL SOFT COMPOSITION	ALIMENT INDUSTRY CO., LTD.
WO/2021/221137	MEDICINE AND TEST KIT EACH USING ANTI-SARS-COV-2 ANTIBODY	KAO CORPORATION
WO/2021/221149	OIL-IN-WATER EMULSION COMPOSITION	SHISEIDO COMPANY, LTD.
WO/2021/225113	METHOD FOR CONCENTRATING IONIC CHEMICAL SPECIES	NATIONAL UNIVERSITY CORPORATION KYOTO INSTITUTE OF TECHNOLOGY
WO/2021/221159	STORAGE CONTAINER FOR ANTIBODY DRUG MEDICINE SOLUTION	NISSAN CHEMICAL CORPORATION
WO/2021/221167	CANCER THERAPEUTIC AGENT AND CANCER THERAPEUTIC METHOD	NAGASAKI UNIVERSITY
WO/2021/221168	ORAL COMPOSITION	TRESSBIO LABORATORY CO., LTD.
WO/2021/221169	PYRIMIDIN-4(3H)-ONE DERIVATIVES AS TRPV4 ANTAGONISTS	RAQUALIA PHARMA INC.
WO/2021/225135	THERAPEUTIC AGENT FOR NAKAJO-NISHIMURA SYNDROME	KYOTO UNIVERSITY
WO/2021/230131	THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENT	SHIMADZU CORPORATION
WO/2021/225149	NOVEL THERAPEUTIC AGENT FOR VASCULAR DISORDER	NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
WO/2021/230145	NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) CONCENTRATION  INCREASING AGENT	SUNTORY HOLDINGS LIMITED
WO/2021/230146	COMPOSITION CONTAINING SESAMIN OR LIKE AND NR AND/OR NMN	SUNTORY HOLDINGS LIMITED
WO/2021/225161	ANTIDEPRESSANT/ANXIOLYTIC DRUG IN WHICH PAC1 RECEPTOR  ANTAGONIST IS USED	KAGOSHIMA UNIVERSITY
WO/2021/215545	ANTICANCER COMBINATION THERAPY WITH  N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE  INHIBITOR OF KRAS-G12C	TAIHO PHARMACEUTICAL CO., LTD.
WO/2021/230179	MEDICINE FOR TREATING RELAPSED OR REFRACTORY MULTIPLE MYELOMA	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/230233	THERAPEUTIC OR PROPHYLACTIC AGENT FOR INFECTIOUS DISEASE	NIPPON MEDICAL SCHOOL FOUNDATION
WO/2021/235275	HYALURONIC ACID PRODUCTION PROMOTOR AND COLLAGEN PRODUCTION  PROMOTOR	SHISEIDO COMPANY, LTD.
WO/2021/230247	PHARMACEUTICAL COMPOSITION FOR TREATING CANCER	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/230252	COMPOSITION AND METHOD FOR ACTIVATING IMMUNITY OF FISH AND  SHELLFISH	MITSUBISHI CORPORATION LIFE SCIENCES LIMITED
WO/2021/235278	QOL IMPROVING COMPOSITION FOR 40-YEAR-OLD OR OLDER MENOPAUSAL  WOMEN WITHOUT POSTMENOPAUSAL SYNDROME	DAICEL CORPORATION
WO/2021/230256	REBAUDIOSIDE D-RICH STEVIA PLANT	SUNTORY HOLDINGS LIMITED
WO/2021/230264	AGENT FOR DIAGNOSIS-ASSISTING, PREVENTING OR TREATING DISEASES  IN BILIARY SYSTEM	SCOHIA PHARMA, INC.
WO/2021/230286	COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING  EXPRESSION OF ATAXIN 3	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/235293	CUG REPEAT SEQUENCE BINDING AGENT	OSAKA UNIVERSITY
WO/2021/230308	IMPURITY PRODUCTION-INHIBITED DRUG COMPOSITION	SHIONOGI & CO., LTD.
WO/2021/230310	WATER-IN-OIL-TYPE EMULSIFIED SUNSCREEN COSMETIC	KAO CORPORATION
WO/2021/230317	PHARMACEUTICAL COMPOSITION USED TO TREAT SUBJECT IN HYPOXIC  STATE DUE TO RESPIRATORY FAILURE, ETC.	NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL  UNIVERSITY
WO/2021/230340	NOVEL INHALANT	KOWA COMPANY, LTD.
WO/2021/235352	EMULSIFIABLE PREPARATION, AQUEOUS COSMETIC, FOOD OR BEVERAGE  AND PHARMACEUTICAL COMPOSITION	DAICEL CORPORATION
WO/2021/230358	ANTIVIRAL AGENT	JNC CORPORATION
WO/2021/230359	ANTIVIRAL AGENT	JNC CORPORATION
WO/2021/230369	GOLD NANOPARTICLE-CONTAINING MEDICINE	OSAKA UNIVERSITY
WO/2021/230374	SHEET PRODUCT	KAO CORPORATION
WO/2021/235372	SOLUBILIZER FOR PRODUCING SOLID DISPERSION AND SOLID  DISPERSION COMPRISING SAME	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/235390	ANTI-SARS-COV-2 DRUG	KAGOSHIMA UNIVERSITY
WO/2021/235392	ANTI-SARS-COV-2 DURG	ONCOLYS BIOPHARMA, INC.
WO/2021/235424	COMPOSITION FOR ORAL CAVITY	LION CORPORATION
WO/2021/241316	COSMETIC	SHISEIDO COMPANY, LTD.
WO/2021/235425	PARTICLE CONTAINING LIPID NANOPARTICLES, AND METHOD FOR  PRODUCING SAME	RICOH COMPANY, LTD.
WO/2021/235436	APOMORPHINE-CONTAINING PERCUTANEOUS ABSORPTION TYPE  PREPARATION	MEDRX CO., LTD.
WO/2021/246172	OPHTHALMIC COMPOSITION, PHOTOSTABILIZATION METHOD AND METHOD  FOR SUPPRESSING DISCOLORATION	LION CORPORATION
WO/2021/235481	TASTE IMPROVING COMPOSITION	LION CORPORATION
WO/2021/235482	TASTE-IMPROVING AGENT FOR MINT-BASED AROMA SUBSTANCE AND AROMA  SUBSTANCE COMPOSITION CONTAINING SAID AGENT, AND METHOD FOR IMPROVING TASTE  OF AROMA SUBSTANCE COMPOSITION CONTAINING MINT-BASED AROMA SUBSTANCE	LION CORPORATION
WO/2021/235486	COMPOSITION FOR PROMOTING INTESTINAL TRACT DEVELOPMENT,  COMPOSITION FOR IMPROVING PULMONARY FUNCTION AND COMPOSITION FOR ENHANCING  IMMUNE FUNCTION	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/235494	MEDICAL AGENT CONTAINING ACTIVE SULFUR COMPOUND AS MAIN  INGREDIENT	AKAIKE, Takaaki
WO/2021/235506	EPITHELIAL CANCER THERAPEUTIC AGENT	OSAKA UNIVERSITY
WO/2021/235508	PHARMACEUTICAL FOR TREATING FATTY LIVER DISEASES	SHIONOGI & CO., LTD.
WO/2021/235512	ANTI-ALLERGY FUNCTIONAL FOOD COMPOSITION, COSMETIC, AND  TRANSDERMAL TOPICAL DRUG	SOSIN CO., LTD.
WO/2021/235517	NOVEL T-CELL ACTIVATOR	RIKEN
WO/2021/235527	LIQUID PREPARATION CONTAINING BRIMONIDINE	EYE THERAPIES, LLC
WO/2021/235532	DRUG FOR ENHANCING FIBRINOLYTIC SYSTEM, AND USE THEREFOR	RENASCIENCE INC.
WO/2021/241428	ELASTIN PRODUCTION PROMOTER AND COSMETIC PREPARATION FOR SKIN	SHIZUOKA PREFECTURAL UNIVERSITY CORPORATION
WO/2021/246200	MUSCLE ATROPHY SUPPRESSING AGENT	ICHIMARU PHARCOS CO., LTD.
WO/2021/241444	DISPERSION	DNP FINE CHEMICALS CO., LTD.
WO/2021/241504	AGENT FOR PROTECTING AND/OR REGENERATING NEUROMUSCULAR  JUNCTIONS	ONO PHARMACEUTICAL CO., LTD.
WO/2021/256181	METHOD FOR PRODUCING AMINOALKYL TETRAHYDROPYRAN DERIVATIVE	KANEKA CORPORATION
WO/2021/241523	PD-1 AGONIST-CONTAINING PHARMACEUTICAL COMPOSITION FOR  TREATING OR PREVENTING Th2-MEDIATED DISEASE	FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE
WO/2021/241529	COSMETIC COMPOSITION AND EXTERNAL PREPARATION FOR SKIN	KOSE CORPORATION
WO/2021/241559	OIL-IN-WATER COSMETIC COMPOSITION	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/241582	SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING  PRESBYOPIA	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/241613	THERAPEUTIC AGENT FOR RNA VIRAL INFECTION OBTAINED BY  COMBINING PYRAZINE DERIVATIVE AND THIOPURINE DERIVATIVE	FUJIFILM TOYAMA CHEMICAL CO., LTD.
WO/2021/256200	CATHEPSIN K INHIBITOR	OCHANOMIZU UNIVERSITY
WO/2021/241621	METHOD FOR PRODUCING ORGANOID FROM LUNG EPITHELIAL CELLS OR  LUNG CANCER CELLS	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/241666	ANTIVIRAL AGENT	KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION
WO/2021/246272	COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/246273	COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/246274	COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/246275	COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/246301	BEAUTY MICRONEEDLE ARRAY	COSMED PHARMACEUTICAL CO., LTD.
WO/2021/241719	IMPROVED GRANZYME B VARIANT	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/241720	ANTIBODY-CONTAINING FORMULATION	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/246332	COMPOSITION FOR TREATING, IMPROVING, AND/OR PREVENTING  PROGRESSION OF BOVINE PAPILLOMATOSIS CAUSED BY BOVINE PAPILLOMAVIRUS	KINOPHARMA, INC.
WO/2021/246352	EXTERNAL DERMATOLOGICAL COMPOSITION FOR GERMICIDAL AND  VIRUCIDAL USE	KAO CORPORATION
WO/2021/246385	ULTRAVIOLET LIGHT SENSITIVITY REDUCING AGENT	KAO CORPORATION
WO/2021/256233	HAIR GRAYING INHIBITOR	NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER  EDUCATION AND RESEARCH SYSTEM
WO/2021/246399	THERAPEUTIC DRUG FOR DISEASE CAUSED BY INTESTINAL IMMUNE  DISORDER	KEIO UNIVERSITY
WO/2021/246453	ANTIMICROBIAL AGENT FOR NONHUMAN ANIMAL	ISHIHARA SANGYO KAISHA, LTD.
WO/2021/246455	ANTIFUNGAL AGENT FOR USE IN HUMANS	ISHIHARA SANGYO KAISHA, LTD.
WO/2021/251268	COSMETIC COMPOSITION	KAO CORPORATION
WO/2021/246496	METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED  DYSFUNCTION	THE UNIVERSITY OF TOKYO
WO/2021/251337	NOVEL COMPOUND USEFUL AS TOLL-LIKE RECEPTOR 7 ACTIVATION  INHIBITOR	TOYAMA PREFECTURAL UNIVERSITY
WO/2021/251340	AGENT FOR REVERSING RESISTANCE TO ANTICANCER DRUGS	Y'S AC CO., LTD.
WO/2021/251428	COMPOSITION FOR SUPPRESSING OR IMPROVING DEPRESSION	KIRIN HOLDINGS KABUSHIKI KAISHA
WO/2021/251450	PROPHYLACTIC OR THERAPEUTIC AGENT FOR PORPHYRIA	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/251452	PREVENTIVE OR THERAPEUTIC AGENT FOR ACTINIC SKIN DISEASE	MITSUBISHI TANABE PHARMA CORPORATION
WO/2021/251453	NUCLEIC ACID LIPID PARTICLE VACCINE	DAIICHI SANKYO COMPANY, LIMITED
WO/2021/251458	SCRUBBING AGENT, SCRUBBING AGENT-CONTAINING COMPOSITION, AND  SCRUBBING AGENT PRODUCTION METHOD	DAICEL CORPORATION
WO/2021/251460	COMPOSITION FOR TREATING CANCER HAVING CAFS	NATIONAL UNIVERSITY CORPORATION KOCHI UNIVERSITY
WO/2021/251485	CLEANSING COMPOSITION	MERRY PLUS CORPORATION
WO/2021/256427	SENSITISER FOR CANCER TREATMENT	KORTUC INC
WO/2021/251505	MITOCHONDRIAL FUNCTION-IMPROVING COMPOSITION	MORINAGA MILK INDUSTRY CO., LTD.
WO/2021/256451	ENCAPSULATED ISLET	OTSUKA PHARMACEUTICAL FACTORY, INC.
WO/2021/256470	BETA-GLUCAN FOR IMMUNO-ENHANCEMENT AND/OR IMMUNO-BALANCING,  AND FOR ADJUVANT USE	SOPHY INC.
WO/2021/261330	THERAPEUTIC AGENT FOR FIBROSIS	NIITSU Yoshiro
WO/2021/256473	ANTI-CORONAVIRUS AGENT	KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION
WO/2021/261341	COMPOSITION FOR INHIBITING PHOSPHODIESTERASE 5 ACTIVITY AND  IMPROVING ERECTILE FUNCTION	KOBAYASHI PHARMACEUTICAL CO., LTD.
WO/2021/256495	INHIBITION OF VIRUS THROUGH INHIBITION OF IMPORTIN	OSAKA UNIVERSITY
WO/2021/256547	COMPOSITION FOR TREATING, PREVENTING, OR ALLEVIATING  SARS-COV-2 INFECTIOUS DISEASE	THERABIOPHARMA INC.
WO/2021/256555	ANTI-T CELL ANTIGEN-BINDING MOLECULE FOR USE IN COMBINATION  WITH ANGIOGENESIS INHIBITOR	CHUGAI SEIYAKU KABUSHIKI KAISHA
WO/2021/256566	COMPOSITION FOR EXTERNAL USE ON SKIN CONTAINING ASCORBIC ACID  AND/OR SALT THEREOF	ROHTO PHARMACEUTICAL CO., LTD.
WO/2021/256569	CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS	SATO PHARMACEUTICAL CO., LTD.
WO/2021/261423	COMPOSITION FOR PROMOTING PRODUCTION OF INTERLEUKIN-10	MEIJI CO., LTD.
WO/2021/261444	ADJUVANT WITH TLR4 AGONIST ACTIVITY	SUMITOMO DAINIPPON PHARMA CO., LTD.
WO/2021/261462	COMPOSITION FOR ORAL CAVITY	LION CORPORATION
WO/2021/261471	THERAPEUTIC AGENT FOR OBSESSIVE-COMPULSIVE DISORDER	KYOTO UNIVERSITY
WO/2021/261490	TESTOSTERONE SECRETAGOGUE	JAPAN PHARMA CO.,LTD.
WO/2021/261528	COMPOSITION COMPRISING TINOSPORA CORDIFOLIA, PLANT ANALOGOUS  THERETO OR PLANT BELONGING TO SAME ORDER/FAMILY FOR PREVENTING AND TREATING  INFECTION WITH NEW COVID-19 AND ONSET THEREOF AND FOR REDUCING NEW COVID-19  AGGRAVATION RISK, AND METHOD FOR USING SAME	MATSUYAMA Futoshi
WO/2021/261571	BLOOD-CEREBROSPINAL FLUID BARRIER PROTECTING AGENT	NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
WO/2021/261576	LIPID SECRETION PROMOTING AGENT	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/261592	REPEAT BINDING AGENT	KYOTO UNIVERSITY
WO/2021/261598	THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND  BRADYARRHYTHMIA	OSAKA UNIVERSITY
WO/2021/261599	PROPHYLACTIC/THERAPEUTIC AGENT FOR NOVEL CORONA VIRUS  INFECTIOUS DISEASE	ARAKI Seiichi
WO/2021/261601	METHOD FOR SELECTING CANCER PATIENT FOR WHICH COMBINATION  THERAPY OF RETINOID AND CANCER TREATMENT AGENT WILL BE EFFECTIVE, AND  COMBINED DRUG OF RETINOID AND CANCER TREATMENT AGENT	RAQUALIA PHARMA INC.
WO/2021/029443	LOCAL HEMOSTATIC COMPOSITION	RIM, Chun Mok
WO/2021/015342	COMPOSITION FOR PREVENTING OR TREATING SPINAL CORD INJURY,  COMPRISING TRPV4 ANTAGONIST	SUNGKWANG MEDICAL FOUNDATION
WO/2021/020612	METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVE	JEIL PHARMACEUTICAL CO.,LTD
WO/2021/020618	PHARMACEUTICAL COMPOSITION COMPRISING TRIMETHOBENZAMIDE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTING  OR TREATING NEUROPATHIC PAIN	FRONTBIO INC.
WO/2021/006413	DUAL MODELING FACIAL PACK	CHO, Sung Min
WO/2021/029467	A SOLID DOSAGE FORM FOR ORALLY ADMINISTRATION	SAM CHUN DANG PHARM. CO., LTD.
WO/2021/040064	PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND  HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER	BIONOXX INC.
WO/2021/040065	PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING  ANTICANCER VIRUS, IMMUNE CHECKPOINT INHIBITOR AND HYDROXYUREA AS ACTIVE  INGREDIENTS	BIONOXX INC.
WO/2021/006418	PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN OF TENTONIN AS  ACTIVE INGREDIENT FOR TREATMENT OF DIABETES MELLITUS	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/040085	COMPOSITION FOR ALLEVIATING AND TREATING NARCOLEPSY,  CONTAINING FERMENTED RICE BRAN POWDER AS ACTIVE INGREDIENT, AND PREPARATION  METHOD THEREFOR	RAPHAGEN
WO/2021/045242	COMPOSITION FOR AMELIORATING PREMENSTRUAL SYNDROME SYMPTOMS,  INCLUDING CHRYSANTHEMUM SIBIRICUM EXTRACT	GENENCELL INC.
WO/2021/054493	METHOD FOR PRODUCTION OF FUNCTIONAL POLYSACCHARIDE AND  COSMETIC COMPOSITION	CABOEXPERT INC.
WO/2021/015357	COSMETICS MANUFACTURING APPARATUS	MOMSEE LIFE & HEALTH CARE CO., LTD.
WO/2021/054510	COMPOSITION FOR PREVENTING AND TREATING BREAST CANCER  INCLUDING SELENOPSAMMAPLIN A AS ACTIVE INGREDIENT	SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
WO/2021/006426	BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH AND USE THEREOF	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/070999	COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING  METABOLIC SYNDROMES INCLUDING OBESITY, DIABETES, HYPERLIPIDEMIA, AND FATTY  LIVER	NUTRACORE CO., LTD.
WO/2021/080037	COMPOSITION COMPRISING PATIENT'S JOINT FLUID-DERIVED  MESENCHYMAL STEM CELL FOR TREATMENT OF RHEUMATOID ARTHRITIS	GYEONGSANG NATIONAL UNIVERSITY HOSPITAL
WO/2021/085696	SMALL LIPID NANOPARTICLES, AND CANCER VACCINE INCLUDING SAME	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/095910	COSMETIC COMPOSITION CONTAINING HORSE OIL AND SKIN CARE METHOD  USING SAME	JEJUUDA CO.,LTD.
WO/2021/095921	AGRIMONIA EUPATORIA EXTRACT PREPARATION METHOD, AND  COMPOSITION FOR IMPROVING LIVER FUNCTIONS OR TREATING LIVER DISEASES,  CONTAINING EXTRACT	BIONIC TRADING CORPORATION
WO/2021/095945	USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR  SEQUELAE FOLLOWING STROKE	SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION  FOUNDATION
WO/2021/095946	COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES,  INCLUDING CCR2 AS ACTIVE INGREDIENT	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/015369	ORAL MUCOADHESIVE FILM COMPOSITION COMPRISING LOW-MOLECULAR  WEIGHT COLLAGEN PEPTIDE AND NATURAL EXTRACT COMPLEX, AND ORAL MUCOADHESIVE  FILM MANUFACTURED USING SAME	KOREA PRIME PHARM CO., LTD.
WO/2021/100884	COMPOSITION, COMPRISING VINEGAR PICKLED EGG AS ACTIVE  INGREDIENT, FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DIABETIC FOOT ULCER	KANG, U Pong
WO/2021/100889	COMPOSITION FOR TREATING SPINAL CORD INJURY, COMPRISING STEM  CELLS TREATED WITH NOVEL COMPOUND	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/100897	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING BIGUANIDE-BASED COMPOUND AND FERROCENE OR FERROCENE DERIVATIVE AS  ACTIVE INGREDIENTS	FRONTBIO INC.
WO/2021/054523	LIQUID TREATMENT COMPOSITION, AND METHOD FOR PRODUCING SAME	MACKLIN COSMETIC
WO/2021/066248	COMPOSITION COMPRISING EXOSOME DERIVED FROM NEST OF  FORK-TAILED STORM-PETREL AS ACTIVE INGREDIENT FOR IMPROVING SKIN CONDITION	SD BIOTECHNOLOGIES CO., LTD
WO/2021/095966	SKIN-WHITENING COSMETICS COMPOSITION CONTAINING CHLORELLA  EXTRACT AS ACTIVE INGREDIENT	GENECELLPHARM CO., LTD.
WO/2021/100940	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MACULAR  DEGENERATION, CONTAINING PRUNELLA VULGARIS EXTRACT AS ACTIVE INGREDIENT	CHONG KUN DANG HEALTHCARE CORP.
WO/2021/054526	NANOPARTICLES WITH SPECIAL COATING AND USE THEREOF	SUNGKWANG MEDICAL FOUNDATION
WO/2021/107233	HEALTH FUNCTIONAL COMPOSITION COMPRISING NATURAL COMPOSITE  MATERIALS, AND PREPARATION METHOD THEREFOR	FRIEND OF GREENBELT
WO/2021/085734	METHOD FOR PREPARING COMPOSITION FOR CONTROLLING BLOOD SUGAR,  CONTAINING COMPLEX-CULTURED MUSHROOM MYCELIUM	GIUNCHAN CO., LTD.
WO/2021/060624	COMPOSITION FOR PREVENTING OR TREATING KELOID OR HYPERTROPHIC  SCAR	TEGO SCIENCE INC.
WO/2021/054531	STABILIZED EFINACONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING ANTIOXIDANT	BIOBELIEF CO., LTD
WO/2021/054532	EFINACONAZOLE-CONTAINING STABILIZED PHARMACEUTICAL COMPOSITION  COMPRISING CHELATING AGENT	BIOBELIEF CO., LTD
WO/2021/054533	STABILIZED EFICONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING SORBIC ACID AS ACID	BIOBELIEF CO., LTD
WO/2021/054534	STABILIZED EFINACONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING COMBINATION OF CHELATING AGENT AND ANTIOXIDANT	BIOBELIEF CO., LTD
WO/2021/054535	STABILIZED EFINACONAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION  COMPRISING COMBINATION OF CHELATING AGENT, ANTIOXIDANT, AND ACID	BIOBELIEF CO., LTD
WO/2021/054536	STABILIZED PHARMACEUTICAL COMPOSITION COMPRISING EPINACONAZOLE	BIOBELIEF CO., LTD
WO/2021/112297	COSMETIC COMPOSITION COMPRISING COMPOSITE FERMENTED PRODUCT OF  GALACTOMYCES AND LICHEN-DERIVED MINERALS	NATURE IN LAB. INC
WO/2021/112298	METHOD FOR PRODUCING COMPLEX FERMENTATION PRODUCT OF  LICHEN-DERIVED MINERALS AND GALACTOMYCES	NATURE IN LAB. INC
WO/2021/112299	TIME-LAG FERMENTATION METHOD OF GALACTOMYCES CONTAINING  LICHEN-DERIVED MINERAL AND COSMETIC COMPOSITION USING SAME	NATURE IN LAB. INC
WO/2021/020663	COMPOSITION COMPRISING LACTOBACILLUS REUTERI ATG-F4 FOR  PREVENTION OR TREATMENT OF MUSCULAR DISORDER	ATOGEN CO.,LTD
WO/2021/071028	CORE-SHELL PCM MICROCAPSULE HAVING AUTOMATIC TEMPERATURE  CONTROL FUNCTION AND COOLING COSMETIC COMPOSITION COMPRISING SAME FOR  EXTERNAL APPLICATION TO SKIN	BIOGENICS, INC.
WO/2021/112325	CLEANSER COMPOSITION, FOR HUMAN BODY, FOR MOISTURIZING OR  SOOTHING SKIN, COMPRISING SEAWEED-DERIVED POLYSACCHARIDE AS ACTIVE INGREDIENT	ATHENA CO., LTD.
WO/2021/132783	FOAMABLE COSMETIC	YOSHIMOTO R&D INC.
WO/2021/137305	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  BACTERIAL INFECTION	GYEONGSANG NATIONAL UNIVERSITY HOSPITAL
WO/2021/095989	DAPSONE TO TREAT BRAIN INFLAMMATION FOR HUMAN WELL-BEING	LEE, Jon-hon
WO/2021/149853	COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/153823	METHOD FOR PREPARING CHITOSAN HYDROGEL-CHELATOR FOR CANCER  THERAPY	KAI BIOTECH CO., LTD
WO/2021/157753	COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR  REGROWTH	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/149860	COMPOSITION FOR ALLEVIATING ATOPIC DERMATITIS AND REDUCING  SKIN WRINKLES, USING LACTOBACILLUS-FERMENTED THYME EXTRACT AS EFFECTIVE  COMPONENT	SD BIOTECHNOLOGIES CO., LTD
WO/2021/162145	COMPOSITION FOR IMPROVING SKIN CONDITION	CJ CHEILJEDANG CORPORATION
WO/2021/167120	ANTI-ALLERGY COMPOSITION FOR ATOPIC DERMATITIS ALLEVIATION OR  SKIN REGENERATION, CONTAINING GUAIYL ACETATE AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/167121	COMPOSITION FOR ALLERGY PREVENTION, ATOPIC DERMATITIS  ALLEVIATION, OR SKIN REGENERATION, COMPRISING NONANE AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/167123	COMPOSITION COMPRISING STRAIGHT CHAIN ALKANE HAVING 14 TO 17  CARBON ATOMS AS ACTIVE INGREDIENT, FOR MUSCLE STRENGTHENING, MUSCLE  ENHANCEMENT, MUSCLE DIFFERENTIATION, MUSCLE REGENERATION, OR SARCOPENIA  SUPPRESSION	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/167146	COMPOSITION FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT  CONTAINING LAURUS NOBILIS EXTRACT AS ACTIVE INGREDIENT, AND FUNCTIONAL HEALTH  FOOD	KOSABIO INC.
WO/2021/060632	METHOD FOR EFFECTIVELY ENHANCING SKIN PENETRATION AND BEAUTY  CARE EFFECT USING EXTRACELLULAR MATRIX PROTEIN SOLUTION, ENCAPSULATED IN  UNILAMELLAR LIPOSOME, FOR PREVENTING SKIN AGING OR REDUCING WRINKLES	SOGANG UNIVERSITY RESEARCH BUSINESS DEVELOPMENT FOUNDATION
WO/2021/172624	MULTI-USE HEMOSTATIC COMPOSITION AND METHOD FOR PRODUCING SAME	THERACION BIOMEDICAL CO. LTD.
WO/2021/075645	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FAMILIAL  ADENOMATOUS POLYPOSIS, COMPRISING NICLOSAMIDE AND METFORMIN	BAOBAB AIBIO CO., LTD.
WO/2021/177494	TOOTHPASTE COMPOSITION	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/182654	METHOD FOR PREPARING POLYDOPAMINE NANOMOTOR USING UREASE, AND  USE OF SAME	PHI BIOMED INC.
WO/2021/002561	MICRONEEDLE CONTAINING SYMPLOCARPUS FOETIDUS EXTRACT	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/025254	POLYMER COATING AGENT HAVING CONCURRENTLY EXCELLENT WATER AND  OIL REPELLENT PROPERTIES AND COSMETIC COMPOSITION COMPRISING SAME SHOWING  EXCELLENT MAKE-UP PERSISTENCY	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/182661	COMPOSITION FOR IMPROVING ANTIBACTERIAL, ANTI-INFLAMMATORY,  ANTIVIRAL, AND IMMUNE FUNCTIONS, COMPRISING EXTRACT OF LIGULARIA STENOCEPHALA  AS ACTIVE INGREDIENT	NATURESENSE CO.,LTD.
WO/2021/182662	ANTIMICROBIAL, ANTI-INFLAMMATORY, ANTIVIRAL, AND IMMUNOLOGICAL  FUNCTION-ENHANCING COMPOSITION COMPRISING EXTRACTS OF BRASSICA OLERACEA VAR.  BOTRYTIS OR ITALIANA L. AND CIRSIUM JAPONICUM VAR. MAACKII (MAXIM)	FAMENITY CO.,LTD.
WO/2021/182663	VITAMIN B6-COUPLED POLYOL-BASED POLYDIXYLITOL GENE TRANSPORTER  COMPRISING PEPTIDE BINDING SPECIFICALLY TO CANCER STEM CELL AND CANCER STEM  CELL-TARGETED THERAPY TECHNIQUE	ELBIO INCORPORATED
WO/2021/187635	PRODUCTION OF MIXTURE FOR PREVENTING AND TREATING RESPIRATORY  INFECTIOUS DISEASES AND VIRAL PNEUMONIA	SEUNG, Kyungsun
WO/2021/201303	FUNCTIONS OF DAPSONE AND DERIVATIVES OF REGULATING NLRP3  INFLAMMASOME ACTIVATION IMPLICATED IN VARIOUS HUMAN DISEASES, SUCH AS  ALZHEIMER'S DISEASE, PRION DISEASES, TYPE 2 DIABETES, AND INFECTIOUS DISEASES	LEE, Jong-hoon
WO/2021/201310	ETHOSOME COMPOSITION HAVING VITAMIN AND DEXPANTHENOL  ENCAPSULATED THEREIN, AND PREPARATION METHOD THEREFOR	HYUNDAIBIOSCIENCE CO.,LTD.
WO/2021/206187	COMPOSITION COMPRISING GOLD NANOPARTICLE AS ACTIVE INGREDIENT  FOR PREVENTION OR TREATMENT OF CORONA VIRUS-19	CHIN, Chur
WO/2021/193999	ELASTIC MAKEUP POWDER DERIVED FROM NATURAL INORGANIC  PARTICULATES AND METHOD OF PREPARING SAME	SUNJIN BEAUTY SCIENCE CO., LTD.
WO/2021/045343	STRUCTURE FOR PROMOTING TRANSDERMAL ABSORPTION, PREPARATION  METHOD THEREFOR, AND COSMETIC COMPOSITION COMPRISING SAME	HNB9 CO.,LTD
WO/2021/201333	COSMETIC COMPOSITION FOR ALLEVIATING OR PREVENTING ACNE,  CONTAINING NATURAL EXTRACTS AS ACTIVE INGREDIENTS	KPT LTD
WO/2021/145512	SOLID PERSONAL CARE PRODUCT AND PRODUCTION METHOD THEREOF	BLISSPACK CO., LTD.
WO/2021/221196	COMPOSITION FOR IMPROVING DAMAGED HAIR	BEAUTEE COLLAGEN CO., LTD.
WO/2021/085769	COMPOSITION COMPRISING BOTULINIUM TOXIN OR SALT THEREOF FOR  INCREASING ENDOMETRIAL BLOOD FLOW RATE	CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/033871	SOFT CAPSULE CONTAINING TYNDALIZED BACTERIA IN FILM	PHIL INTERNATIONAL CO., LTD.
WO/2021/020700	COMPOSITION FOR PREVENTING, IMPROVING, OR TREATING ISCHEMIC  BRAIN DISEASES, COMPRISING LACTOBACILLUS GASSERI SWPM102	SUNGWUN PHARMACOPIA CORPORATION
WO/2021/230388	IMPROVED ANTICANCER DRUG COMBINING CARBOPLATIN AS PLATINUM  ANTICANCER DRUG WITH POLYSUCCINIMIDE	CHAE, Chang Hoon
WO/2021/002588	PHARMACEUTICAL COMPOSITION CONTAINING TAMSULOSIN OR  HYDROCHLORIDE THEREOF AND PREPARATION METHOD THEREFOR	HANMI PHARM. CO., LTD
WO/2021/045345	ORAL PHARMACEUTICAL COMPOSITION COMPRISING TERIPARATIDE AND  METHOD FOR PREPARING SAME	ICURE BNP CO., LTD.
WO/2021/029517	PHARMACEUTICAL COMPOSITION FOR IMPROVING OR TREATING  POST-SURGICAL HYPOPARATHYROIDISM AND TREATMENT METHOD USING THE SAME	DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/010586	COSMETIC COMPOSITION FOR SKIN LIFTING FOR ANTI-AGING AND SKIN  CARE METHOD USING SAME	SIMFLE-STICK CO.LTD
WO/2021/201335	STAMINA-IMPROVING COMPOSITION AND STAMINA-IMPROVING NATURAL  TEA COMPRISING SAME	NAM, Jong Hyun
WO/2021/167168	COMPOSITION, CONTAINING AGASTACHE RUGOSA AND LICORICE EXTRACT  AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING RESPIRATORY DISEASES CAUSED  BY FINE DUST	COSMAX NBT, INC.
WO/2021/215574	DISPERSANT OR DISPERSION MEDIA COMPOSITION COMPRISING  2,3-BUTANEDIOL, AND COSMETIC COMPOSITION COMPRISING SAME	GS CALTEX CORPORATION
WO/2021/241780	COMPOSITION FOR INHIBITING HAIR GRAYING, AND USE THEREOF	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/241786	TRILAYER LIPOSOME COMPOSITION COMPRISING CATIONIC POLYMER  CONJUGATE AND LIPOSOME, AND COSMETIC COMPOSITION COMPRISING SAME	H&A PHARMACHEM CO., LTD
WO/2021/241788	COMPOSITION FOR PREVENTING OR TREATING DIABETES	LEE, Sam Goo
WO/2021/187670	COMPOSITION FOR ALLEVIATING CORONAVIRUS INFECTION USING  RALOXIFENE	GYEONGGIDO BUSINESS AND SCIENCE ACCELERATOR
WO/2021/246557	URATE OXIDASE-ALBUMIN CONJUGATE HAVING CERTAIN NUMBER OF  CONJUGATED ALBUMINS, AND METHOD FOR PRODUCING SAME	PROABTECH CO., LTD.
WO/2021/251508	METHOD FOR EXTRACTING EXTRACT OF LIQUOR PRODUCTION BY-PRODUCT  AND COMPOSITION FOR WHITENING, WRINKLE IMPROVEMENT AND ANTI-AGING COMPRISING  THE EXTRACT ACCORDING TO THE METHOD	KIM, Sang Wook
WO/2021/010596	COSMETIC COMPOSITION COMPRISING GRAPHENE OXIDE AS ACTIVE  INGREDIENT	COSMAX, INC.
WO/2021/006490	COSMETIC COMPOSITION CONTAINING GRAPHENE QUANTUM DOTS AS  ACTIVE INGREDIENT	COSMAX, INC.
WO/2021/194010	COMPOSITION FOR TREATMENT AND PREVENTION OF INFLAMMATORY  DISEASES CONTAINING COMPLEX EXTRACT OF BEET, RED ONION, AND PURPLE-FLESHED  SWEET POTATO AS ACTIVE INGREDIENT	GUSTAR CO., LTD.
WO/2021/075663	COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING  NON-ALCOHOLIC FATTY LIVER DISEASE COMPRISING LACTOBACILLUS HELVETICA AND  BIFIDOBACTERIUM STRAINS	CKD BIO CORPORATION
WO/2021/033898	SODIUM DEOXYCHOLATE-CONTAINING AQUEOUS COMPOSITION STABLE  AGAINST PRECIPITATION	AH, Youngchang
WO/2021/256579	COMPOSITION FOR TREATMENT OF GLUTARIC ACIDURIA AND  ADMINISTRATION METHOD THEREFOR	NOVEL PHARMA INC.
WO/2021/071051	METHOD FOR PREPARING ENTERIC-COATED PANCREATIN PELLETS	NENSYS CO., LTD.
WO/2021/221228	WATER-DISPERSIBLE COSMETIC COMPOSITION FOR BLOCKING  ULTRAVIOLET RADIATION COMPRISING DIFFERENT KINDS OF ORGANIC THICKENERS	KOLMAR KOREA CO., LTD.
WO/2021/033899	COMPOSITION FOR WOUND HEALING OR ACCELERATING WOUND HEALING,  CONTAINING, AS ACTIVE INGREDIENT, COMBINATION OF HYALURONIC ACID AND  LYOPHILIZED EXOSOMES DERIVED FROM STEM CELLS	EXOCOBIO INC.
WO/2021/157785	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  DIABETES COMPRISING HENEICOSANE, AND FOOD COMPOSITION COMPRISING SAME	REPUBLIC OF KOREA(RURAL DEVELOPMENT ADMINISTRATION)
WO/2021/010604	COSMETIC COMPOSITION COMPRISING MICROSPHERES CONTAINING HIGH  CONCENTRATION OF OXYGEN AND METHOD FOR PREPARING SAME	COIZ. CO., LTD.
WO/2021/167175	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENT	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/241796	COSMETIC COMPOSITION AND METHOD FOR PRODUCING SAME	MACBIOTECH CO., LTD.
WO/2021/015426	AQUEOUS ANTISEPTIC COMPOSITION HAVING IMPROVED ANTIBACTERIAL  PERSISTENCE COMPRISING CHLORHEXIDINE OR DERIVATIVE THEREOF AND FABRIC TYPE  ANTISEPTIC COMPRISING SAME	HUONS CO., LTD.
WO/2021/149880	COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH,  COMPRISING, AS ACTIVE INGREDIENT, MIXED EXTRACT OF CUCUMBER, EGGPLANT AND  SNAIL	LEE, Dong wan
WO/2021/225214	COMPOSITION HAVING ANTI-INFLAMMATORY AND ANTIVIRAL EFFECT,  COMPRISING PLACENTAL EXTRACELLULAR VESICLES	TS CELL BIO CO., LTD.
WO/2021/002637	TOOTHPASTE FOR PREVENTING COLD TEETH AND PERIODONTAL DISEASES  AND MANUFACTURING METHOD THEREFOR	KIM, Cheon-Gyun
WO/2021/006507	METHOD FOR PREPARING COMPOSITION POWDER FOR FEMININE WASH  CONTAINING PROPOLIS AND NATURAL EXTRACT	INVENTAGE LAB INC.
WO/2021/261635	NOVEL IMMUNOSTIMULANT AND VACCINE COMPOSITION COMPRISING SAME	REPUBLIC OF KOREA(ANIMAL AND PLANT QUARANTINE AGENCY)
WO/2021/002642	COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS,  COMPRISING SNAKE VENOM	DNBIO PHARM, INC.
WO/2021/194013	RECOMBINANT PROTEIN FOR ELIMINATING BOAR TAINT AND VACCINE  COMPOSITION COMPRISING SAME	BIOAPPLICATIONS INC.
WO/2021/002645	COMPOSITION FOR EXCRETION OF SUGAR COMPRISING HYDROGEL AND  EGFR LIGAND AS ACTIVE INGREDIENTS	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/015437	COMPOSITION FOR PREVENTING, TREATING, OR AMELIORATING VIRAL  INFECTION DISEASE, CONTAINING ACTIVE OXYGEN PRODUCTION INHIBITOR AND ACTIVE  OXYGEN SCAVENGER COMPLEX AS ACTIVE INGREDIENTS	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/002664	COMPOSITION FOR PREVENTING, RELIEVING OR TREATING CANCER	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/002697	USE OF RECOMBINANT ANTIBACTERIAL PROTEIN ABLYSIN FOR  EFFECTIVELY KILLING MULTIDRUG-RESISTANT PATHOGENIC BACTERIA	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/006549	METHOD FOR PREPARING DERMOBIOTICS BLOCK COMPOSITION HAVING  SKIN MOISTURIZING AND SKIN REGENERATION FUNCTIONS	HYUNDAI BIOLAND CO., LTD.
WO/2021/002735	CELL SURFACE ANTIGEN OF T CELL AND VARIOUS USES THEREOF	GOOD T CELLS, INC.
WO/2021/025302	MAGNETICALLY ACTUATED MICROROBOT USING BIO-BASED ORGANISM	DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/141192	COMPOSITION FOR PREVENTING OR TREATING DRY EYE SYNDROME,  CONTAINING SPARASSIS CRISPA EXTRACT	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/006603	NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING ALLERGIC  DISEASES	PROGEN CO., LTD.
WO/2021/006607	COMPOSITION, FOR PREVENTING, TREATING, OR ALLEVIATING  DIABETES, COMPRISING LGI3-DERIVED PEPTIDE AS EFFECTIVE COMPONENT	CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/125477	PHARMACEUTICAL COMPOSITION CONTAINING PRION PROTEIN-SPECIFIC  ANTIBODY	STEM BIO CO., LTD
WO/2021/029541	ELASTIC LIPOSOME COMPOSITION COMPRISING SUCROSE-BASED  SURFACTANT AND COSMETIC COMPOSITION CONTAINING SAME	KOLMAR KOREA CO., LTD.
WO/2021/006615	CAPSULE FOR COSMETICS	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/049742	COSMETIC COMPOSITION HAVING EXCELLENT PERCUTANEOUS ABSORPTION	KOLMAR KOREA CO., LTD.
WO/2021/006637	COSMETIC COMPOSITION COMPRISING 5-BENZYLAMINOSALICYLIC ACID  DERIVATIVE AND LOCAL ADMINISTRATION METHOD THEREOF	GNT PHARMA CO., LTD.
WO/2021/006663	COMPOSITION COMPRISING O-CYCLIC PHYTOSPHINGOSINE-1-PHOSPHATE  FOR PREVENTING OR TREATING PARKINSON′S DISEASE	AXCESO BIOPHARMA CO.,LTD.
WO/2021/006684	METHOD FOR PREPARATION OF ULTRASONICATED YEAST EXTRACT HAVING  EXCELLENT INHIBITORY ACTIVITY AGAINST SKIN CANCER AND SKIN CANCER-INHIBITING  COMPOSITION COMPRISING ULTRASONICATED YEAST EXTRACT PREPARED BY SAME METHOD	KOREA FOOD RESEARCH INSTITUTE
WO/2021/006707	USE OF SGK1 INHIBITOR AS THERAPEUTIC AGENT FOR INFLAMMATORY  NEUROLOGICAL DISEASES	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
WO/2021/010698	CANCER CELL-TARGETED DRUG DELIVERY CARRIER AND COMPOSITION FOR  PROMOTING PHOTO-THERMAL TREATMENT EFFECTS, BOTH OF WHICH CONTAIN M1  MACROPHAGES AS ACTIVE INGREDIENT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/010702	COMPOSITION FOR REGENERATING GROWTH PLATE	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/010704	COMPOSITION FOR REGENERATING NUCLEUS PULPOSUS	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/010715	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE  DISEASES	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/010719	LONG-LASTING FORMULATION CONTAINING RIVASTIGMINE, AND METHOD  FOR PREPARING SAME	G2GBIO, INC.
WO/2021/010728	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BONE  DISEASES	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/020771	STABLE PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE AND  SODIUM BICARBONATE	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/010762	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  METABOLIC BONE DISEASES, CONTAINING BENTONITE AS ACTIVE INGREDIENT	KOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES
WO/2021/187679	COMPOSITION, COMPRISING SEA CUCUMBER-DERIVED SAPONIN COMPOUND,  FOR PREVENTING, ALLEVIATING, OR TREATING NEUROPATHY	KOREA INSTITUTE OF OCEAN SCIENCE ＆ TECHNOLOGY
WO/2021/010790	ANTICANCER COMPOSITION COMPRISING SALVIA MILTIORRHIZA  BIOCONVERSION EXTRACT AND RED GINSENG BIOCONVERSION EXTRACT	RE BIO, INC.
WO/2021/010791	COMPOSITION FOR ALLEVIATING, PREVENTING, OR TREATING  CARDIOVASCULAR DISORDERS, CONTAINING BIOCONVERTED SALVIA MILTIORRHIZA EXTRACT  AND BIOCONVERTED RED GINSENG EXTRACT	RE BIO, INC.
WO/2021/010798	IMMUNOGENIC COMPOSITION COMPRISING MULTIVALENT STREPTOCOCCUS  PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES	CELLTRION, INC.
WO/2021/040233	COSMETIC COMPOSITION COMPRISING CALAMINE DISPERSED IN  BIOPOLYMER, AND SHEET MASK USING SAME	COSMAX, INC.
WO/2021/080129	COMPOSITION FOR STRENGTHENING SKIN BARRIER AND ALLEVIATING  ATOPIC DERMATITIS, HAVING HYDRANGENOL OR PHYLLODULCIN AS ACTIVE INGREDIENT	COSMAX BIO CO., LTD.
WO/2021/060688	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING INHIBITOR OF MYO1D EXPRESSION AS EFFECTIVE COMPONENT	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/020820	PHARMACEUTICAL COMPOSITION COMPRISING UDENAFIL	COREPHARM BIO CO., LTD.
WO/2021/020841	COMPOSITION FOR PREVENTING OR TREATING METABOLIC LIVER DISEASE	STANDIGM INC.
WO/2021/020857	USE OF COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF  BONE LOSS DISORDERS, CONTAINING EXTRACTS OF REYNOUTRIA JAPONICA AND CASSIAE  CORTEX INTERIOR	NOVMETAPHARMA CO., LTD.
WO/2021/020860	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  ARTERIOSCLEROSIS CONTAINING CYCLODEXTRIN POLYMER AS ACTIVE INGREDIENT	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/020885	PHARMACEUTICAL COMPOSITION FOR TREATING LEVODOPA-INDUCED  DYSKINESIA OR FOR SUPPRESSING PROGRESSION THEREOF	PEPTRON, INC.
WO/2021/118004	COMPLEX FORMULATION COMPRISING DONEPEZIL AND MEMANTINE	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/045392	PHARMACEUTICAL COMPOSITION COMPRISING HDAC INHIBITOR AND  ANTI-PD1 ANTIBODY OR ANTI PD-L1 ANTIBODY	CRYSTALGENOMICS, INC.
WO/2021/020902	NOVEL ANTICANCER COMPOUND AND PHARMACEUTICAL COMPOSITION  COMPRISING SAME AS ACTIVE INGREDIENT	HAIM BIO CO., LTD.
WO/2021/020912	USE OF COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING  COGNITIVE DYSFUNCTION COMPRISING EXTRACT OF POLYGONUM CUSPIDATUM ROOT AND  CINNAMOMUM CASSIA	NOVMETAPHARMA CO., LTD.
WO/2021/020923	COMPOSITION AND METHOD FOR PREVENTING, ALLEVIATING, OR  TREATING LIVER INJURY	KOBIOLABS, INC.
WO/2021/020945	ANTICANCER AGENT AND METHOD FOR PREPARATION OF POROUS SILICA  PARTICLE	LEMONEX INC.
WO/2021/125488	LIPOLYSIS COMPOSITION USING SURFACE-MODIFIED GAS-GENERATING  NANOPARTICLES	SUPERNOVA BIO CO., LTD.
WO/2021/020950	COMPOSITION COMPRISING HYALURONIC ACID AND PLURONIC FOR  PREVENTING OR TREATING ARTICULAR AND CARTILAGE INJURY	HA, Yoo Jin
WO/2021/025415	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  METABOLIC DISEASES, CONTAINING DEHYDRO-6-GINGERDIONE	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/040257	PHARMACEUTICAL FORMULATIONS COMPRISING SODIUM  PALMITOYL-L-PROLYL-L-PROLYL-GLYCYL-L-TYROSINATE AND METHODS FOR PREPARING THE  SAME	BRIDGE BIOTHERAPEUTICS, INC.
WO/2021/182685	USE OF L-NUCLEOSIDE FOR TREATING CORONAVIRUS	BUKWANG PHARMACEUTICAL CO., LTD.
WO/2021/206227	COSMETIC COMPOSITION COMPRISING QUERCUS ACUTA THUNB FRUIT  EXTRACT FOR PREVENTING AND ALLEVIATING ULTRAVIOLET LIGHT-CAUSED SKIN AGING	JEONNAM BIOINDUSTRY FOUNDATION
WO/2021/029619	COSMETIC COMPOSITION COMPRISING BENTONITE AS ACTIVE INGREDIENT	KOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES
WO/2021/033973	COMPOSITION FOR INHIBITING MYELOID-DERIVED SUPPRESSOR CELL  COMPRISING MITF INHIBITOR AS ACTIVE INGREDIENT	SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/025529	SKIN WHITENING COMPOSITION CONTAINING  DIHYDRO-5-METHYLFURAN-2(3H)-ONE DERIVATIVE	STEMORE CO., LTD.
WO/2021/025532	ANTICANCER COMPOSITION USING SLC1A5 TRANSCRIPT VARIANT,  ANTICANCER DRUG SCREENING METHOD, AND CANCER DIAGNOSIS METHOD	UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY
WO/2021/025533	COMPOSITION COMPRISING SKELETAL MUSCLE STEM CELL-DERIVED  EXOSOME AS ACTIVE INGREDIENT FOR IMPROVING SKIN CONDITION	KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP
WO/2021/029631	INTRAORAL FAST-DISINTEGRATING FORMULATION CONTAINING HEMP OIL  EXTRACT OR HEMP POWDER EXTRACT AS RAW MATERIAL OF FORMULATION	CTC SCIENCE INC.
WO/2021/049768	CHITOSAN-COATED NANOCAPSULE CONTAINING RETINOL OR RETINOL  DERIVATIVE, AND USE THEREOF	SKINMED CO., LTD.
WO/2021/040275	DISPERSION OF CERIUM OXIDE FOR ENHANCING SKIN BARRIER, SKIN  MOISTURIZING, AND/OR BLOCKING FINE DUST, AND COSMETIC COMPOSITION COMPRISING  SAME	KOLMAR KOREA CO., LTD.
WO/2021/033990	COMPOSITION COMPRISING EXOSOMES DERIVED FROM INDUCED  PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELL PRECURSOR FOR PREVENTION  OR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS	BREXOGEN INC.
WO/2021/101019	COMPOSITION FOR INDUCING DIFFERENTIATION OF CANINE  ADIPOSE-DERIVED STEM CELLS INTO BROWN ADIPOCYTES USING BOMBYX MORI EXTRACT,  METHOD FOR INDUCING DIFFERENTIATION, AND PET FEED ADDITIVE FOR REDUCING BODY  FAT AND PREVENTING OBESITY CONTAINING SAME	GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/029656	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NONALCOHOLIC STEATOHEPATITIS, CONTAINING HYDROQUINONE DERIVATIVE AND  OBETICHOLIC ACID	BIOTOXTECH CO., LTD.
WO/2021/029659	COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES OR  ATOPIC DERMATITIS COMPRISING ETHYL VANILLIN, SUBERIC ACID, THIAZOLE OR SALT  THEREOF AS EFFECTIVE COMPONENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/033994	COMPOSITION COMPRISING SALVIA MILTIORRHIZA OR PAEONIA  LACTIFLORA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF LIPID  METABOLISM DISORDER	USCAREPHARM CO.,LTD
WO/2021/033995	COMPOSITION COMPRISING AMOMUM TSAOKO EXTRACT FOR PREVENTION,  ALLEVIATION, OR TREATMENT OF SARCOPENIA-RELATED DISEASE	KOREAN DRUG CO., LTD.
WO/2021/029673	COMPOSITION FOR INHIBITING TOXICITY OF NANOPARTICLES AND  ENVIRONMENTALLY-DERIVED FINE PARTICLES	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/029679	COSMETIC COMBINATION COMPRISING PEPTIDE COMPLEX MICRONEEDLE  FOR EFFECTIVE REDUCTION OF DEEP WRINKLE AND APPLICATION METHOD THEREOF	SR BIOTEK INC.
WO/2021/029684	PEPTIDE-COMPLEXED MICRONEEDLE AND COSMETIC COMPOSITION  COMPRISING SAME	SR BIOTEK INC.
WO/2021/177518	PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD CHOLESTEROL,  PREVENTING OR TREATING CARDIOVASCULAR DISEASES AND REDUCING INFLAMMATION	SEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/034080	COMPOSITION FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASE OR  ATOPIC DERMATITIS COMPRISING CARVONE OR SALT THEREOF AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034082	COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES OR  ATOPIC DERMATITIS, COMPRISING OCIMENE, CAMPHOR, OR SALT THEREOF AS ACTIVE  INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034094	COMPOSITION COMPRISING KAEMPFERIDE AS ACTIVE INGREDIENT FOR  PREVENTION OR TREATMENT OF PROTEIN CONFORMATIONAL DISORDER	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034095	COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASE  COMPRISING KAEMPFERIDE AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/034098	USE OF IMMUNOCYTOKINE COMPRISING INTERFERON-BETA OR VARIANT  THEREOF FOR TREATING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE CANCER	GENOPHARM INC.
WO/2021/034121	ULTRAVIOLET BLOCKING COSMETIC COMPOSITION IN CHROMATIC  EMULSION STATE	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/177519	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER  CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND  FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE  DERIVATIVE, OR FLAVANONE DERIVATIVE	FRONTBIO INC.
WO/2021/040337	NICLOSAMIDE DELAYED-RELEASE COMPOSITION AND ANTIVIRAL USE  THEREOF	DAEWOONG THERAPEUTICS INC.
WO/2021/034150	COSMETIC COMPOSITION COMPRISING EUTECTIC MIXTURE	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/060714	COSMETIC COMPOSITION FOR PREVENTING SKIN AGING AND REDUCING  SKIN WRINKLES, COMPRISING SELAGINELLA ROSSII WARB. EXTRACT	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/049775	ADDITIVE COMPOSITION FOR PREVENTING VITAMIN C PRECIPITATION	AMOREPACIFIC CORPORATION
WO/2021/034162	PHARMACEUTICAL COMPOSITION COMPRISING LATE-PASSAGE HUMAN  MESENCHYMAL STEM CELLS INDUCED TO DIFFERENTIATE TO GLIA-LIKE CELLS AS ACTIVE  INGREDIENT FOR TREATMENT OF STROKE	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/034164	PHARMACEUTICAL COMPOSITION FOR ALZHEIMER'S TREATMENT  CONTAINING AS ACTIVE INGREDIENT LATE-STAGE HUMAN MESENCHYMAL STEM CELLS  INDUCED TO DIFFERENTIATE INTO GLIA-LIKE CELLS	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/040371	ANTI-INFLAMMATORY COMPOSITION	OSTEONEUROGEN INC.
WO/2021/040389	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SOLID  CANCER, CONTAINING EPIDITHIODIOXOPIPERAZINE DERIVATIVE OR PHARMACEUTICALLY  ACCEPTABLE SALTS THEREOF	EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/167192	ANTIBACTERIAL, ANTI-INFLAMMATORY COMPOSITION FOR IMPROVING  BLOOD CIRCULATION, DISSOLVING WASTE, ACTIVATING AND REGENERATING CELLS, AND  STRENGTHENING IMMUNE FUNCTION AND ORGAN FUNCTION, AND INCLUDING ESSENTIAL  AROMA OIL AS ACTIVE INGREDIENT	SINK CUP CO., LTD.
WO/2021/040416	PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING BONE  LOSS INDUCED BY METABOLIC BONE DISEASES, COMPRISING ARTEMISIA SCOPARIA  EXTRACT AS ACTIVE INGREDIENT	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/054637	COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING  DEGENERATIVE BRAIN DISEASE, COMPRISING PERIOSTRACUM CICADAE EXTRACT	KOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/107341	TRANSDERMAL ABSORPTION PREPARATION CONTAINING RASAGILINE OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	WOOSHIN LABOTTACH CO., LTD.
WO/2021/040439	INFLUENZA VACCINE COMPOSITION BASED ON NOVEL NUCLEIC ACID	NA VACCINE INSTITUTE
WO/2021/040440	PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING  NONALCOHOLIC STEATOHEPATITIS (NASH)	CELLTRION INC.
WO/2021/040449	COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING  ANGELICA GIGAS, ACONITUM CARMICHAELI DEBEAUX, AND ZINGIBER OFFICINALE ROSCOE  MIXED EXTRACT AS ACTIVE INGREDIENT	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/040470	COMPOSITION CONTAINING EXTRACT OF LILIUM HANSONII LEICHTLIN EX  BAKER	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/040496	PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING  VACCINIA VIRUS AND GRANULOPOIESIS INHIBITOR AS ACTIVE INGREDIENTS	BIONOXX INC.
WO/2021/045485	IMMUNE MICROBUBBLE COMPLEX, AND USE THEREOF	IMGT CO, LTD.
WO/2021/045501	COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING IL-2  SURFACE EXPRESSION-EXTRACELLULAR VESICLES AS ACTIVE INGREDIENT	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/045504	COSMETIC MATERIAL COMPOSITION COMPRISING SOLID PHASE POLYMER  HAVING IMPROVED SOLUBILITY	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/045520	COSMETIC COMPOSITION COMPRISING FIBROBLAST GROWTH FACTOR 17	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/045538	COMPOSITION FOR DIAGNOSING OR TREATING CONDITIONS ASSOCIATED  WITH INCREASED ELF4E ACTIVITY COMPRISING ELF4E INHIBITOR	SOVARGEN CO., LTD.
WO/2021/045554	PHARMACEUTICAL COMPOSITION COMPRISING PROCESSED FISH PRODUCT  AND/OR PROCESSED SOYBEAN PRODUCT AS ACTIVE INGREDIENT	JANG, Young Jin
WO/2021/045567	COMPOSITION FOR PREVENTING OR TREATING SALIVARY GLAND DISESAES  USING CELL-DERIVED VESICLE	MDIMUNE INC.
WO/2021/045569	COMPOSITION COMPRISING BILBERRY EXTRACT AS ACTIVE INGREDIENT  FOR PREVENTING OR TREATING SENSORINEURAL HEARING IMPAIRMENT	IMDPHARM INC.
WO/2021/071102	LIQUID CRYSTALLINE STRUCTURE-FORMING OMEGA-3-FATTY ACID  COMPOSITION	IMDPHARM INC.
WO/2021/049825	NANOEMULSION OPHTHALMIC COMPOSITION COMPRISING CYCLOSPORINE  AND MENTHOL, AND PREPARATION METHOD THEREOF	TAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/045595	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY  OR NON-ALCOHOLIC FATTY LIVER, CONTAINING DENTAL TISSUE-DERIVED MULTIPOTENT  STEM CELLS	INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL  UNIVERSITY
WO/2021/049850	ANTICANCER THERANOSTIC AGENT ACTIVATED BY ANTI-ANGIOGENESIS  AND HYPOXIC ENVIRONMENT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/221239	PHARMACEUTICAL BOTULINUM TOXIN COMPOSITION CONTAINING TANNIC  ACID	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/049852	LACTOBACILLUS PARACASEI SUBSP. TOLERANS SW1 STRAIN HAVING SKIN  WRINKLE IMPROVEMENT ABILITY AND PRODUCING HIGHLY FUNCTIONAL NATURAL  METABOLITES, AND USE THEREOF	UNIVERSITY OF SEOUL INDUSTRY COOPERATION FOUNDATION
WO/2021/049864	COMPOSITION FOR AMELIORATING DRY EYE SYNDROME CONTAINING  ARALIA ELATA EXTRACT	MEDVILL
WO/2021/049920	SURFACE-MODIFIED EXTRACELLULAR VESICLE AND COMPOSITION  COMPRISING SAME	THERABEST CO.,LTD
WO/2021/085849	PHARMACEUTICAL COMPOSITION COMPRISING ISOLIQUIRITIGENIN  DERIVATIVE FOR PREVENTION OR TREATMENT OF BONE DISEASE	CATHOLIC KWANDONG UNIVERSITY INDUSTRY FOUNDATION
WO/2021/172678	COMPOSITION FOR AMELIORATING HYPERURICEMIA COMPRISING  DENDROPANAX MORBIFERA LEV. EXTRACT	HURIMHWANGCHILCORP.
WO/2021/080184	SMALL-SIZED, SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION  COMPRISING CHOLINE ALFOSCERATE	KOREA UNITED PHARM. INC.
WO/2021/080185	SUSTAINED-RELEASE, SMALL-SIZED ORALLY ADMINISTERED PREPARATION  CONTAINING CHOLINE ALFOSCERATE	KOREA UNITED PHARM. INC.
WO/2021/080188	COMPOSITION FOR PREVENTION OR TREATMENT OF DEPRESSION  COMPRISING PROTEIN EXPRESSION INHIBITOR AND USE THEREOF	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/080189	COMPOSITION FOR SKIN WHITENING, AND USE THEREOF	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/085853	COMPOSITION FOR ENHANCING IMMUNE ACTIVITY AND METHOD THEREFOR	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/060773	COSMETIC COMPOSITION FOR AMELIORATING ACNE COMPRISING  QUERCETIN, TERPENE, AND VITAMIN K AS ACTIVE INGREDIENTS	INCODONBIOCOSMETIC CO.,LTD.
WO/2021/071126	COMPOSITION, FOR PREVENTION OR TREATMENT OF CANCER DISEASE,  COMPRISING CYTOTOXIC T CELLS ACTIVATED BY T HELPER CELL-DERIVED EXTRACELLULAR  VESICLES AS ACTIVE INGREDIENT	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/054767	CARBON-COATED GADOLINIUM OXIDE, AND METHOD FOR PREPARING SAME	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/071127	COMPOSITION COMPRISING INHIBITOR AGAINST EXPRESSION OF  EXOSOMAL PD-L1 AS ACTIVE INGREDIENT FOR ENHANCING ANTICANCER EFFECT	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/054773	COSMETIC COMPOSITION WITH MULTIPLE EMULSION FORMULATION FOR  ACTIVE INGREDIENT STABILIZATION AND SKIN ABSORPTION ACCELERATION	COSMAX, INC.
WO/2021/091080	COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS, OR PROMOTING  HAIR GROWTH OR HAIR THICKENING, COMPRISING COMPLEX EXTRACT OF BEET, RED ONION  AND PURPLE-FLESHED SWEET POTATO AS ACTIVE INGREDIENT	GUSTAR CO., LTD.
WO/2021/060792	IMMUNOSUPPRESSIVE COMPOSITION COMPRISING CHITOSAN AND USE  THEREOF	POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
WO/2021/060797	MULTILAYERED CATIONIC LIPOSOME FOR ENHANCING SKIN ABSORPTION  AND PREPARATION METHOD THEREFOR	COSMAX, INC.
WO/2021/235609	ANTIBACTERIAL AND BIOFILM FORMATION-INHIBITING COMPOSITION  CONTAINING MYRISTOLEIC ACID AS ACTIVE INGREDIENT	RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY
WO/2021/066381	RETINAL-CONTAINING MULTILAMELLAR VESICLE AND COSMETIC  COMPOSITION COMPRISING SAME	DAREUN COSMETICS CO., LTD.
WO/2021/060824	VACCINE COMPOSITION AGAINST SEVERE FEVER WITH THROMBOCYTOPENIA  SYNDROME VIRUS	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/060841	NOVEL MULTILAYER SUPPOSITORY AGENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/060862	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MALARIA,  CONTAINING FUCOIDAN AS ACTIVE INGREDIENT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG  CAMPUS
WO/2021/060868	CERIUM OXIDE INORGANIC FILLER-REINFORCED POLYMER AND  TWO-COMPONENT COSMETIC COMPOSITION USING SAME	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/060869	MICROPARTICLE-STRUCTURED THICKENER HAVING IMPROVED SENSATION  OF USE	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/060870	COSMETIC COMPOSITION CONTAINING FERMENTATION PRODUCT OF SPROUT  GINSENG, AND PREPARATION METHOD THEREFOR	DAEBONG LS CO., LTD.
WO/2021/107370	CORE TABLET PREPARATION COMPRISING PROTON PUMP INHIBITOR AND  MOSAPRIDE	KOREA UNITED PHARM. INC.
WO/2021/060880	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  SARCOPENIA, CONTAINING UNNATURAL AMINO ACID	MYO-TEC-SCI
WO/2021/118026	CORE TABLET FORMULATION CONTAINING PROTON PUMP INHIBITOR AND  MOSAPRIDE	KOREA UNITED PHARM. INC.
WO/2021/060884	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  SARCOPENIA CONTAINING NON-NATURAL AMINO ACID DERIVATIVE	MYO-TEC-SCI
WO/2021/060922	COMPOSITION FOR PREVENTING OR TREATING NEUROPATHIC PAIN,  CONTAINING SYRINGARESINOL	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/215598	COMPOSITION FOR PREVENTION OR TREATMENT OF EPILEPSY AND  PREPARATION METHOD THEREFOR	KWON, Hyeok Bun
WO/2021/060927	COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING  SARCOPENIA, CONTAINING WHEY PROTEIN HYDROLYSATE AS ACTIVE INGREDIENT	MAEIL DAIRIES CO., LTD.
WO/2021/060933	COMPOSITION FOR PREVENTING OR TREATING INFECTIOUS DISEASES  CAUSED BY MYCOBACTERIUM TUBERCULOSIS, NONTUBERCULOUS MYCOBACTERIA OR  GRAM-POSITIVE BACTERIA, CONTAINING MMAGNU2 COMPOUND AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL  UNIVERSITY
WO/2021/066425	GINGER-DERIVED EXTRACELLULAR VESICLES AND USE THEREOF	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/066429	DIOSCOREA JAPONICA THUNB-DERIVED EXTRACELLULAR VESICLES AND  USE THEREOF	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/066431	POMEGRANATE-DERIVED EXTRACELLULAR VESICLES AND USE THEREOF	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/060944	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER  COMPRISING YAP-TEAD INTERACTION INHIBITOR AND HYPOGLYCEMIC AGENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/060949	CO-CRYSTALLINE EFINACONAZOLE, AND METHOD FOR PRODUCING SAME	DAEBONG LS, LTD
WO/2021/060950	AMORPHOUS EFINACONAZOLE SOLID DISPERSION	DAEBONG LS, LTD
WO/2021/080206	COMPOSITION CONTAINING SWEET POTATO STEM OR LEAF EXTRACT AS  ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF EAR DISEASE	VIVOIN CO. LTD
WO/2021/066443	PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE MYELOID LEUKEMIA  CONTAINING FLT3 INHIBITOR AND MDM2 INHIBITOR	HANMI PHARM. CO., LTD.
WO/2021/071159	ANTIDIABETIC, HYPOTENSIVE, OR ANTIOXIDANT COMPOSITION  COMPRISING YEAST FERMENTATE OF RHYNCHOSIA NULUBILIS AND METHOD FOR PREPARING  SAME COMPOSITION	COENBIO CO., LTD.
WO/2021/066510	COSMETIC COMPOSITION FOR HAIR AND SCALP CARE TREATMENT, AND  METHOD FOR PRODUCING SAME	SIN, Hong Chul
WO/2021/162196	PHARMACEUTICAL COMPOSITION CONTAINING MACROLIDE COMPOUND,  PRODUCTION METHOD THEREFOR, AND METHOD USING SAME	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/085876	COMPOSITION INCLUDING TREMELLA FUCIFORMIS CULTURE MEDIUM  EXTRACT	DAEBONG LS, LTD
WO/2021/066600	GLUCAGON, COMPOSITION COMPRISING GLP-1 RECEPTOR AND GIP  RECEPTOR DUAL AGONIST AND THERAPEUTIC USE THEREOF	HANMI PHARM. CO., LTD.
WO/2021/107381	COMPOSITION COMPRISING FERULIC ACID AND ANALOGS THEREOF FOR  PREVENTING AND TREATING SKIN DISEASES CAUSED BY GENETIC MUTATION	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/071269	COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL  DISEASE COMPRISING EXTRACTS OF COMPLEX HERBAL MEDICINES	HELIXMITH CO., LTD
WO/2021/256619	COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING COGNITIVE  DYSFUNCTION, COMPRISING PEPTIDE CAPABLE OF CONTROLLING SYNAPTIC PLASTICITY	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/071308	COMPOSITION FOR DEODORIZING THIOL COMPOUND	SNVIA CO., LTD.
WO/2021/071317	PHARMACEUTICAL COMPOSITION COMPRISING COMPLEX CRUDE DRUG  EXTRACT AND CELECOXIB	PMG PHARM CO., LTD
WO/2021/071321	COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE  DISEASES CONTAINING MIXED HERBAL EXTRACT OF GENKWAE FLOS, CLEMATIDIS RADIX,  AND GASTRODIAE RHIZOMA	MTHERA PHARMA CO., LTD.
WO/2021/071326	STABLE LIQUID COMPOSITION, METHOD FOR PREPARING SAME, AND  FORMULATION COMPRISING SAME	SAMSUNG BIOEPIS CO., LTD.
WO/2021/071334	PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING TYPE 2  DIABETES, CONTAINING QUERCETIN-3-O-XYLOSIDE	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/085890	PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING TYPE 2  DIABETES, INCLUDING QUERCETIN-3-O-RHAMNOSIDE	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/075818	ANTARCTIC LICHEN UMBILICARIA ANTARCTICA EXTRACT HAVING  ANTI-INFLAMMATORY ACTIVITY, AND COMPOSITION CONTAINING SAME	KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
WO/2021/091107	COMPOSITION FOR ENHANCING RADIATION SENSITIVITY CONTAINING  AGELOXIME D AS ACTIVE INGREDIENT	KOREA INSTITUTE OF OCEAN SCIENCE ＆ TECHNOLOGY
WO/2021/075853	COMPOSITION COMPRISING EMP3 INHIBITOR FOR INHIBITING GROWTH OF  CANCER STEM CELL AND USE THEREOF	KOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/075864	METHOD FOR PRODUCING HIGH-CONCENTRATION CYTOKINE-CONTAINING  ANTI-AGING ESSENCE THROUGH MATURING AND CYTOKINE PRODUCTION SYSTEM MODULE  THEREFOR	SENIOR SCIENCE & LIFE CO. LTD.
WO/2021/075870	COMPOSITION, COMPRISING RIP KINASE INHIBITOR, FOR PREVENTING  HAIR LOSS OR PROMOTING HAIR REGROWTH	STEMORE CO., LTD.
WO/2021/080256	ANTIFUNGAL COMPOSITION CONTAINING CARBAZOLE COMPOUND AS ACTIVE  INGREDIENT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/080257	COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL  DISEASE, COMPRISING SULGLYCOTIDE AS ACTIVE INGREDIENT	SAMIL PHARMACEUTICAL CO., LTD.
WO/2021/075911	MICELLE HAVING DRUG RESISTANCE AND CONTAINING SURFACE-MODIFIED  METAL NANOPARTICLES THEREIN, USE THEREOF, AND PREPARATION METHOD THEREFOR	FUSION BIOTECHNOLOGY CO., LTD.
WO/2021/075923	DIPROPYLENE GLYCOL COMPOSITION AND PREPARATION METHOD THEREFOR	SK PICGLOBAL CO., LTD.
WO/2021/075926	PHARMACEUTICAL COMPOSITION COMPRISING PROTON PUMP INHIBITOR  AND ANTACID	HANMI PHARM. CO., LTD.
WO/2021/075928	COMPOSITION FOR ENHANCING OR IMPROVING IMMUNE SYSTEM  COMPRISING BIFIDOBACTERIUM BIFIDUM	GENOME AND COMPANY
WO/2021/075929	COMPOSITION, COMPRISING AN ARTEMISIA PRINCEPS LEAF EXTRACT,  FOR ALLEVIATION OF SKIN DAMAGE	DONG-A PHARMACEUTICAL CO., LTD.
WO/2021/075931	COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFECTIOUS  DISEASE CAUSED BY TUBERCULOSIS AND NON-TUBERCULOUS MYCOBACTERIAL INFECTION	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/112398	COMPOSITION COMPRISING VITAMIN C	E•CIS COSMETIC CO., LTD.
WO/2021/235616	PREVENTIVE OR THERAPEUTIC COMPOSITION FOR SEVERE ACUTE  RESPIRATORY SYNDROME CORONAVIRUS TYPE 2 INFECTIOUS DISEASE	SYNTEKABIO, INC.
WO/2021/080297	COMPOSITION CONTAINING EVENING PRIMROSE FLOWER EXTRACT AS  ACTIVE INGREDIENT FOR PREVENTING OR TREATING OBESITY OR METABOLIC SYNDROMES  INDUCED THEREBY	DOCTOR TJ CO., LTD
WO/2021/080298	COMPOSITION CONTAINING ENTEROCCOCUS FAECALIS AS ACTIVE  INGREDIENT FOR PREVENTING OR TREATING OBESITY OR METABOLIC SYNDROMES INDUCED  THEREBY	DOCTOR TJ CO., LTD
WO/2021/080312	USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUNDS FOR  PREVENTION, ALLEVIATION, OR TREATMENT OF COGNITIVE DISORDERS, OR FOR  IMPROVING COGNITIVE FUNCTION	SK BIOPHARMACEUTICALS CO., LTD.
WO/2021/080313	USE OF IMIDAZOPYRIMIDINE OR IMIDAZOTRIAZINE COMPOUND FOR  PREVENTION, ALLEVIATION, OR TREATMENT OF DEVELOPMENTAL DISABILITY	SK BIOPHARMACEUTICALS CO., LTD.
WO/2021/096089	NOVEL COMPOSITION COMPRISING STEM CELL-DERIVED EXOSOMES AND  POLYDEOXYRIBONUCLEOTIDE AS ACTIVE INGREDIENTS	EXOCOBIO INC.
WO/2021/118044	COSMETIC COMPOSITION FOR STABILIZING POORLY SOLUBLE MATERIAL	COSMAX, INC.
WO/2021/080331	COMPOSITION FOR ENHANCING THERAPEUTIC EFFECT OF STEM CELL,  COMPRISING IMMUNOSUPPRESSANT, AND METHOD FOR ENHANCING THERAPEUTIC EFFECT OF  STEM CELL USING SAME	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/080345	INJECTABLE INTRAOCULAR MICROGEL AS DRUG DELIVERY SYSTEM, AND  HYDROGEL COMPRISING SAME	SEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/096093	COMPOSITION FOR HAIR TREATMENT, CONTAINING OLEFIN-BASED  UNSATURATED HYDROCARBON-CONTAINING OIL	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/080363	COMPOSITION FOR PREVENTING OR TREATING CANCER	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/080373	RV2299C-ESAT6-HSPX-RIPA FUSION PROTEIN COMPOSITION FOR  BOOSTING BCG VACCINE	THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL  UNIVERSITY (IAC)
WO/2021/080375	A PHARMACEUTICAL PREPARATION COMPRISING AN AMIDE DERIVATIVE  INHIBITING THE GROWTH OF CANCER CELL AND A PHARMACEUTICAL PRODUCT CONTAINING  THE SAME	HANMI PHARM. CO., LTD.
WO/2021/172692	INGESTIBLE TABLET OR POWDERED ORAL CLEANING COMPOSITION	BAREUN CO., LTD.
WO/2021/080388	COMPOSITION FOR PREVENTING OR TREATING PORCINE EPIDEMIC  DIARRHEA VIRUS INFECTION, COMPRISING COMPLEX CONTAINING CURCUMINOID-BASED  COMPOUND AND LICORICE EXTRACT OR FRACTION THEREOF	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/080396	COMPOSITION FOR PREVENTING OR TREATING VALVULAR HEART DISEASE  COMPRISING RSPO3 INHIBITOR	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/172694	DRUG DELIVERY COMPOSITION USING CROSSLINKED HYALURONIC ACID  AND MANUFACTURING METHOD THEREFOR	JP CARES
WO/2021/086042	COSMETIC COMPOSITION COMPRISING RED GINSENG MARC-DERIVED  OLIGOSACCHARIDE, AND METHOD FOR PRODUCING SAME	DAEBONG LS CO., LTD.
WO/2021/091164	PHAMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY  OR ALLERGY COMPRISING ROSE EXTRACT AS ACTIVE INGREDIENT	CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/086076	COMPOSITION FOR PREVENTING OR INHIBITING AXONAL DEGENERATION	CHECKMATE THERAPEUTICS INC.
WO/2021/086097	POWDER-TYPE HEMOSTATIC COMPOSITION AND PREPARATION METHOD  THEREFOR	SAMYANG BIOPHARMACEUTICALS CORPORATION
WO/2021/086120	COMPOSITION, COMPRISING SALVIA MILTIORRHIZA BUNGE EXTRACT AS  ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF BENIGN PROSTATIC  HYPERPLASIA OR ALOPECIA	CUROME BIOSCIENCES CO., LTD.
WO/2021/107427	COSMETIC COMPOSITION FOR SKIN BARRIER ENHANCEMENT OR SKIN  BIOACTIVE SUBSTANCE ABSORPTION PROMOTION	COSMAX, INC.
WO/2021/251565	PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE  COMPOUND	HK INNO.N CORPORATION
WO/2021/096134	MOISTURIZING OR ANTI-ATOPIC COMPOSITION CONTAINING FATTY ACIDS  OR FATTY ACID DERIVATIVES	DAEBONG LS, LTD
WO/2021/091188	SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION FOR ORAL  ADMINISTRATION, CONTAINING REBAMIPIDE OR PHARMACEUTICALLY ACCEPTABLE SALT  THEREOF	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101128	FINE BUBBLE-CONTAINING COSMETIC FOR IMPROVING DERMAL  PENETRATION, MANUFACTURING SYSTEM OF FINE BUBBLE-CONTAINING COSMETIC FOR  IMPROVING DERMAL PENETRATION, AND MANUFACTURING METHOD OF FINE  BUBBLE-CONTAINING COSMETIC FOR IMPROVING DERMAL PENETRATION	LEE, Sung-Joo
WO/2021/091209	COMPOSITION FOR HOST-DIRECTED THERAPY	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/091210	COMPOSITION FOR HOST-DIRECTED THERAPY	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/125551	COSMETIC MANUFACTURING DEVICE, AND DISCHARGE INFORMATION  DETERMINATION METHOD FOR COSMETIC MANUFACTURING DEVICE	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/091246	SUSTAINED-RELEASE MICROSPHERES CAPABLE OF CONTROLLING INITIAL  RELEASE, AND PREPARATION METHOD THEREFOR	NEXTBIOMEDICAL CO., LTD.
WO/2021/091272	POLYMER NANOPARTICLE COMPOSITION FOR INDUCING IMMUNITY AND  PREPARATION METHOD THEREFOR	SAMYANG BIOPHARMACEUTICALS CORPORATION
WO/2021/091284	COSMETIC COMPOSITION FOR PREVENTING SKIN AGING AND REDUCING  SKIN WRINKLES, COMPRISING VIBURNUM STELLATO-TOMENTOSUM EXTRACT	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/157818	GRAPHENE-BASED COMPOSITION FOR TREATING KIDNEY DISEASE	BIOGRAPHENE INC.
WO/2021/145543	CONJUGATE CONSISTING OF EXTRACELLULAR MATRIX AND ANTICANCER  DRUG, AND MEDICAL USE THEREOF	DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/091316	COMPOSITION, COMPRISING TMEM176B OR AN EXPRESSION OR ACTIVITY  REGULATOR THEREOF AS AN ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF  DEGENERATIVE BRAIN DISEASE	AMYLOID SOLUTION INC.
WO/2021/091319	GLYPICAN-3-SPECIFIC MODIFIED APTAMER AND USE THEREOF	APTAMER SCIENCES INC.
WO/2021/091333	MICROSPHERE FOR CONTINUOUS RELEASE AND METHOD FOR  MANUFACTURING SAME	WHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/251566	WATER-DISPERSIBLE COSMETIC COMPOSITION FOR ULTRAVIOLET  BLOCKING CONTAINING INORGANIC THICKENER AND ORGANIC THICKENER	KOLMAR KOREA CO., LTD.
WO/2021/091356	COMPOSITION FOR PREVENTING OR TREATING STRESS-RELATED DISEASES  INCLUDING METHYL BENZOATE AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/096186	COSMETIC COMPOSITION FOR SKIN IMPROVEMENT COMPRISING TARAXACUM  OFFICINALE LEAF EXTRACT	RADIANT.CO.LTD
WO/2021/125558	COMPOSITION FOR HAIR BLACKENING, PREVENTING HAIR WHITENING, OR  HAIR DYEING, COMPRISING EXOSOME DERIVED FROM STEM CELL AS ACTIVE INGREDIENT	EXOCOBIO INC.
WO/2021/096199	PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF  IMMUNE-RELATED DISEASES COMPRISING PYRIMETHAMINE AS ACTIVE INGREDIENT	SK CHEMICALS CO., LTD.
WO/2021/132879	COMPOSITION FOR PREVENTION AND TREATMENT OF ATOPIC DERMATITIS  COMPRISING, AS ACTIVE INGREDIENT, NOVEL BIFIDOBACTERIUM ANIMALIS SUBSP.  LACTIS LM1017 DERIVED FROM KOREAN INFANTS	LACTOMASON CO., LTD.
WO/2021/096217	PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED  GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND  BONE DISEASE	GBIOLOGICS INC.
WO/2021/096220	COMPOSITION FOR PREVENTING OR TREATING RENAL DISEASES,  COMPRISING EXOSOMES DERIVED FROM PRECURSOR CELLS OF INDUCED PLURIPOTENT STEM  CELL-DERIVED MESENCHYMAL STEM CELLS	BREXOGEN INC.
WO/2021/112437	TRANSDERMAL DELIVERY COMPOSITE USING COVALENT ORGANIC  FRAMEWORK AND POLYMER	H&A PHARMACHEM CO., LTD
WO/2021/096270	PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE SCLEROSIS ON  BASIS OF AMPK INHIBITORY FUNCTION AND ZINC HOMEOSTASIS CONTROL FUNCTION	ZINCURE CORP.
WO/2021/096278	LIQUID PHASE COMPOSITION FOR ANTIBODY DRUG	SAMSUNG BIOEPIS CO., LTD.
WO/2021/194038	METHOD FOR PRODUCING SERUM COMPOSITION FOR PREVENTING OR  TREATING MUCOSA-RELATED INFECTIOUS DISEASE IN YOUNG MAMMALS, SERUM  COMPOSITION PRODUCED THEREBY, AND USE THEREOF	AHN, Byung Chul
WO/2021/118080	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCLE  DISEASES COMPRISING GINSENOSIDES RG2, RG4, RG6, RH1, AND RH4 AS ACTIVE  INGREDIENTS	AREZ CO., LTD.
WO/2021/112441	COMPOSITION FOR PREVENTING OR TREATING PIGMENTATION,  CONTAINING IRE 1α BLOCKER AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/096303	CONTRAST AGENT COMPOSITION FOR OPTICAL IMAGE, FOR EARLY  DIAGNOSIS OF RHEUMATOID ARTHRITIS	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/125570	DEVICE, METHOD, AND SYSTEM FOR MANUFACTURING COSMETICS	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/101187	NOVEL VACCINE IMMUNE ADJUVANT COMPOSITION CONTAINING BAVACHIN	KOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/149902	COMPOSITION COMPRISING SALVIA MILTIORRHIZA EXTRACT AS ACTIVE  INGREDIENT FOR PREVENTION AND TREATMENT OF DEPRESSION IN MENOPAUSAL WOMEN	UNDBIO.CO.,LTD
WO/2021/101244	COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING  ANTI-CD300C MONOCLONAL ANTIBODIES	CENTRICS BIO
WO/2021/101257	COMPOSITION FOR DIAGNOSING, PREVENTING, OR TREATING COGNITIVE  DYSFUNCTION COMPRISING COTL1 AS ACTIVE INGREDIENT	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101259	COMPOSITION, COMPRISING COTL1 AS ACTIVE INGREDIENT, FOR  DIAGNOSIS OF BONE DISEASE OR OBESITY	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/101265	KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY	SAMYANG BIOPHARMACEUTICALS CORPORATION
WO/2021/101268	BENZAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND  PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR  PREVENTION OR TREATMENT OF CANCER	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/101295	ORAL PHARMACEUTICAL COMPOSITION COMPRISING CARBAMATE COMPOUND  AND PREPARATION METHOD THEREFOR	SK BIOPHARMACEUTICALS CO., LTD.
WO/2021/162211	STABILIZER FOR ADENO-ASSOCIATED VIRUSES AND METHOD FOR  STABILIZING ADENO-ASSOCIATED VIRUSES BY USING SAME	INNOTHERAPY INC.
WO/2021/101340	ANTICANCER THERAPY-AIDING COMPOSITION INCLUDING LIPOSOME  COMPOSITION AND DRUG DELIVERY METHOD USING SAME	CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/145552	THERAPEUTIC USE OF LONG-ACTING CONJUGATE OF TRIPLE AGONIST  HAVING ACTIVITY WITH RESPECT TO ALL OF GLUCAGON AND GLP-1 AND GIP RECEPTORS  AGAINST LUNG DISEASE	HANMI PHARM. CO., LTD.
WO/2021/101344	EYE DROP COMPOSITION FOR PREVENTING OR TREATING EYE DISEASE	SAMJIN PHARMACEUTICAL CO., LTD.
WO/2021/132897	COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF  CANCER CACHEXIA COMPRISING PIPERINE	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/107547	COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF  RESPIRATORY DISEASE	DANDI BIOSCIENCE INC.
WO/2021/107576	COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING SKIN  PHOTOAGING, OR FOR WHITENING, COMPRISING RACEMIC DHPV OR ENANTIOMERS THEREOF	SUNGKWANG MEDICAL FOUNDATION
WO/2021/137439	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, FOR  TREATMENT OF LIVER CANCER	MIRAEBIOPHARM
WO/2021/107644	USE OF COMPOSITION FOR ENHANCING ANTICANCER EFFECT, COMPRISING  ERRγ INHIBITOR AS ACTIVE INGREDIENT	NOVMETAHEALTH CO., LTD.
WO/2021/125611	ECO-FRIENDLY SMART PHOTOSENSITIZER AND PHOTO-STEM CELL THERAPY  PRODUCT COMPRISING SAME	KIM, Jin Wang
WO/2021/107689	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING  IMMUNE CHECKPOINT INHIBITOR AND FUSION PROTEIN INCLUDING IL-2 PROTEIN AND  CD80 PROTEIN	GI INNOVATION, INC.
WO/2021/107690	COMBINATION THERAPY OF CYCLOSERINE AND LITHIUM FOR THE  TREATMENT OF DEPRESSION	NEURORIVE INC
WO/2021/107692	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  OPTIC NERVE DISEASE	SUNGKWANG MEDICAL FOUNDATION
WO/2021/107706	NOVEL USE OF MILK EXOSOMES	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/107719	COMPOSITION FOR PREVENTING OR TREATING HYPERTENSION	HELIXMITH CO., LTD
WO/2021/107747	RNA INTERFERENCE-INDUCING NUCLEIC ACID COMPRISING  8-OXOGUANINE, MODIFIED NUCLEIC ACID BINDING TO MICRORNA COMPRISING  8-OXOGUANINE, AND USES THEREOF	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/112541	PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF  SECONDARY CANCER, COMPRISING ALDEHYDE INHIBITOR AND BIGUANIDE-BASED COMPOUND	HAIM BIO CO., LTD.
WO/2021/112548	PHARMACEUTICAL COMPOSITION	JIN YANG PHARM. CO., LTD.
WO/2021/177553	TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING  RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	NAM, Jong Hyun
WO/2021/235637	COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF  RESPIRATORY DISEASE	NAM, Jong Hyun
WO/2021/125632	EXTERNAL USE COMPOSITION COMPRISING PAEONOL AND PANTHENOL OR  PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS ACTIVE INGREDIENTS	GENTRIBIO INC.
WO/2021/112563	COMPOSITION FOR PREVENTING OR TREATING CRANIAL NERVE SYSTEM  DISEASES COMPRISING RITA OR DERIVATIVE THEREOF	DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/112587	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING NDPK ACTIVATOR AND SGLT-2 INHIBITOR	HAIM NATURE CO., LTD.
WO/2021/118162	ADDITIVE COMPOSITION FOR FORMULATION, CAPABLE OF STABILIZING  PORES OF SOLID PREPARATION PARTICLES, AND PREPARATION METHOD THEREFOR	NATUREPUREKOREA CO., LTD.
WO/2021/132926	PROBIOTIC PASTE FOR ANIMALS, AND MANUFACTURING METHOD THEREFOR	YEO, Jang Wook
WO/2021/125641	METHOD FOR CONTROLLING ACTIVE DISCHARGE OF SELF-HEALING  PEPTIDE MOTIF ACCORDING TO BIOLOGICAL ENVIRONMENT AND EXTERNAL STIMULI	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/112597	COMPOSITION FOR TREATING DIABETIC RETINOPATHY, COMPRISING RAAV  CONTAINING SOLUBLE VEGFR-1 VARIANT CDNA	CDMOGEN CO., LTD
WO/2021/112614	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BEHCET'S  DISEASE AND RHEUMATOID ARTHRITIS, CONTAINING PEPTIDE OR MIXTURE THEREOF AS  ACTIVE INGREDIENT	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/112615	COMPOSITION CONTAINING PEPTIDE OR PEPTIDE COMPOUND AS ACTIVE  INGREDIENT, AND MEDICAL USE THEREFOR	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/112654	METHODS OF TREATING CHEMOTHERAPY OR RADIOTHERAPY INDUCED  NEUTROPENIA	HANMI PHARM. CO., LTD.
WO/2021/118199	COMPOSITION COMPRISING P53-ACTIVATING PEPTIDE	KNU-INDUSTRY COOPERATION FOUNDATION
WO/2021/118212	PHARMACEUTICAL COMPOSITION COMPRISING PEPTIDE THAT INHIBITS  INTERACTION OF P53 AND FOXO4	KNU-INDUSTRY COOPERATION FOUNDATION
WO/2021/235638	METHOD FOR PREPARING BAMBOO MULTI-COMPLEX HAVING ANTIBACTERIAL  AND COSMETIC FUNCTIONS, AND COSMETIC COMPOSITION CONTAINING SAME	DAMYANG JUKSOON FARMING ASSOCIATION CORPORATION
WO/2021/132949	COMPOSITION FOR PREVENTING OR TREATING ADVANCED GLYCATION END  PRODUCT-ASSOCIATED DISEASE, COMPRISING AUCUBIN	INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY
WO/2021/132950	PHARMACEUTICAL COMPOSITION CONTAINING AUCUBIN FOR PREVENTING  OR TREATING MACULAR DEGENERATION	INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY
WO/2021/118286	COMPOSITION FOR STIMULATING AND INDUCING CHANGES IN  ENVIRONMENT AROUND AGING SKIN CELLS	AMOREPACIFIC CORPORATION
WO/2021/182725	USE OF CONDITIONED MEDIUM FOR ALLEVIATING AND PREVENTING HAIR  LOSS CONTAINING HIGH CONCENTRATION OF EXTRACELLULAR VESICLE WITH ENHANCED  FUNCTION	BIOSOLUTION CO., LTD
WO/2021/118292	COMPOSITION FOR WOUND HEALING, CONTAINING METAL-ORGANIC  FRAMEWORK	SEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/118298	PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING  FIBROSIS, COMPRISING PHEOPHORBIDE COMPOUND AS ACTIVE INGREDIENT	PAEAN BIOTECHNOLOGY INC.
WO/2021/118321	STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATION	SAMSUNG BIOEPIS CO., LTD.
WO/2021/118323	TANDEM INSULIN-LIKE GROWTH FACTOR-1 AND COMPOSITION COMPRISING  SAME AS ACTIVE INGREDIENT FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH	NEXGEN BIOTECHNOLOGIES, INC.
WO/2021/118324	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/132970	COMPOSITION FOR SKIN ELASTICITY ENHANCEMENT AND WRINKLE  IMPROVEMENT COMPRISING MILK EXOSOMES	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/118328	ANTICANCER THERANOSTIC COMPOUNDS HAVING HEPATOCELLULAR  CARCINOMA SPECIFICITY	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/125733	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HAIR  LOSS	CELROS BIOTECH
WO/2021/125762	COMPOSITION FOR PREVENTING OR TREATING DEMENTIA, CONTAINING  PEPTIDE NUCLEIC ACID COMPLEX WITH BLOOD-BRAIN BARRIER PENETRATION ABILITY AS  ACTIVE INGREDIENT	SEASUN THERAPEUTICS
WO/2021/125783	HAIR PERM FORMING METHOD USING ELECTROLYZED WATER	KUNKUK UNIVERSITY INDUSTRIAL COOPERATION CORP
WO/2021/125788	SOLID PREPARATION FOR ORAL ADMINISTRATION, COMPRISING  SUNITINIB HYDROCHLORIDE, AND METHOD FOR PREPARING SAME	SAMYANG HOLDINGS CORPORATION
WO/2021/125797	COMPOSITION HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY OF  OLAPARIB	SAMYANG HOLDINGS CORPORATION
WO/2021/125800	COMPOUND FOR INHIBITING ANGIOGENESIS FACTOR, AND USE THEREOF	UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY)
WO/2021/125805	KIT FOR PREPARING NANOPARTICLE COMPOSITION FOR DRUG DELIVERY,  COMPRISING POLYLACTIC ACID SALT	SAMYANG HOLDINGS CORPORATION
WO/2021/125810	COMPOSITION FOR TREATING SYNUCLEINOPATHIES	STANDIGM INC.
WO/2021/125811	COMPOSITION FOR TREATING SYNUCLEINOPATHIES	STANDIGM INC.
WO/2021/125824	PHARMACEUTICAL FORMULATION COMPRISING CIBENZOLINE OR SALT  THEREOF	CELLTRION INC.
WO/2021/125841	PHARMACEUTICAL COMPOSITION FOR ARTERIAL ADMINISTRATION,  COMPRISING ADULT STEM CELL LINE CONTAINING BASIC HELIX-LOOP-HELIX (BHLH)  NEUROGENIC TRANSCRIPTION FACTOR GENES	CELL&BRAIN CO., LTD.
WO/2021/125847	METHOD FOR SCREENING FOR MATERIAL FOR REGULATING PEXOPHAGY BY  USING N-TERMINAL ARGINYLATION OF N-DEGRON PATHWAY, AND FOR PREVENTING,  ALLEVIATING OR TREATING PBD, METHOD FOR DIAGNOSING PBD, AND COMPOSITION FOR  REGULATING PEXOPHAGY OR PREVENTING, ALLEVIATING OR TREATING PBD	PROTECH CO., LTD.
WO/2021/125852	NOVEL INJECTABLE FORMULATION	PROGEN CO., LTD.
WO/2021/125868	COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING  POLYP AS ACTIVE INGREDIENT	KIM, Hong Yeoul
WO/2021/125874	LIQUID PHARMACEUTICAL COMPOSITION OF  1-(5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROLE-3-YL)-N-METHYLMETHANEAMINE	DAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/133000	ANTI-INFLAMMATORY OR ANTIANGIOGENIC PHARMACEUTICAL COMPOSITION	LG CHEM, LTD.
WO/2021/125894	PATCH ATTACHABLE TO TEETH	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/125906	LIPOLYTIC SUBSTANCE AND PREPARATION METHOD THEREFOR	AMMEDICS CO., LTD.
WO/2021/137491	ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING  PROBIOTICS AND ANTIBIOTICS, AND METHOD USING SAME	SHIM, Min Bo
WO/2021/125910	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING NDPK ACTIVATOR AND H-PRUNE INHIBITOR	HAIM NATURE CO., LTD.
WO/2021/137494	COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPRISING  BUTYRICIMONAS SP. STRAIN AS ACTIVE INGREDIENT	SAHMYOOK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/137495	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  NON-ALCOHOLIC FATTY LIVER DISEASE COMPRISING BUTYRICIMONAS SP. STRAIN AS  ACTIVE INGREDIENT	SAHMYOOK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/133014	COMPOSITION CONTAINING DMT-TIC PEPTIDE DERIVATIVE FOR  PREVENTING OR TREATING HAIR LOSS	STEMORE CO., LTD.
WO/2021/133017	COLONIC PURGATIVE COMPOSITION	VIVOZON,INC.
WO/2021/133023	COMPLEX FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN,  AND PREPARATION METHOD THEREFOR	HANMI PHARM. CO., LTD.
WO/2021/137504	PHARMACEUTICAL FORMULATION HAVING IMPROVED STABILITY AND  MANUFACTURING METHOD THEREFOR	DAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/137506	COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS,  CONTAINING WDR34 INHIBITOR, AND USE THEREOF	KOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/149925	PHARMACEUTICAL COMPOSITION FOR TREATING TRPV1  ACTIVITY-MEDIATED DISEASES	RUDACURE CORPOARATION
WO/2021/133046	METFORMIN SUSTAINED RELEASE FORMULATION AND METHOD FOR  PREPARATION THEREOF	DAEWOONG PHARMACEUTICAL CO., LTD.
WO/2021/133051	MICROSPHERES COMPRISING ROPINIROLE, AND INJECTION COMPOSITION  COMPRISING SAME	WHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/215616	COMPOSITION FOR TREATING CORONAVIRUS INFECTION OR INFECTIOUS  DISEASE, COMPRISING POLYPHOSPHATES	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/215617	COMPOSITION FOR DISINFECTING, OR PREVENTING INFECTION BY OR  INFECTIOUS DISEASES CAUSED BY CORONAVIRUS, COMPRISING POLYPHOSPHATE	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/133087	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  METABOLIC BONE DISEASES, COMPRISING GLP-2 OR CONJUGATE THEREOF	HANMI PHARM. CO., LTD.
WO/2021/133091	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NONALCOHOLIC STEATOHEPATITIS, CONTAINING ASTER KORAIENSIS NAKAI EXTRACT	MAYJUNE LIFE & HEALTH, CO., INC.
WO/2021/145586	GAS-GENERATING MICELLE FOR REDUCING LOCALIZED FAT	SUPERNOVA BIO CO., LTD.
WO/2021/137561	PHARMACEUTICAL COMPOSITION COMPRISING 4-HEXYLRESORCINOL AS  ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF BONE DISEASE	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/145589	COSMETIC NYLON FIBER AND MANUFACTURING METHOD THEREFOR	KOREA DYEING & FINISHING TECHNOLOGY INSTITUTE
WO/2021/137606	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING SGLT-2 INHIBITOR AND GOSSYPOL	HAIM BIO CO., LTD.
WO/2021/137610	METHOD FOR PRODUCING NANOPARTICLES COMPRISING  LOW-MOLECULAR-WEIGHT AMPHIPHILIC BLOCK COPOLYMER	SAMYANG HOLDINGS CORPORATION
WO/2021/137611	IMMUNE CELLS HAVING NANOSTRUCTURE ATTACHED THERETO	THERABEST CO.,LTD
WO/2021/141319	NANOPARTICLES FOR DRUG DELIVERY SURFACE-MODIFIED WITH PEPTIDE  FOR TARGETING BRAIN CANCER CELLS, METHOD FOR PREPARING SAME, AND USE THEREOF	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/137647	UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED  FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND	ATHENA CO., LTD.
WO/2021/137656	NOVEL FORMULATION FOR LOCAL INJECTION	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/145595	LIPID NANOPARTICLES FOR IN-VIVO DRUG DELIVERY, AND USES  THEREOF	ENHANCEDBIO INC.
WO/2021/002739	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  INFLAMMATORY SKIN DISEASES, CONTAINING INTERLEUKIN-32 PROTEIN AS ACTIVE  INGREDIENT	CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/020957	SKIN-WHITENING COMPOSITION COMPRISING ROYAL AZALEA ROOT  EXTRACT AS EFFECTIVE COMPONENT	KOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/096330	COMPOSITION FOR PREVENTION OR TREATMENT OF EAR DISEASE  COMPRISING CASTANOPSIS CUSPIDATA PLANT EXTRACT OR FRACTION AS ACTIVE  INGREDIENT	INVIVOTEC CO., LTD.
WO/2021/125920	METHOD FOR ALLEVIATING CANCER-INDUCED PAIN THROUGH CONTROL OF  PAIN SIGNALS IN CENTRAL NERVOUS SYSTEM	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
WO/2021/137667	COMPOSITION FOR TREATING PARKINSON’S DISEASE CONTAINING  BOTULINUM NEUROTOXIN, AND METHOD FOR TREATING PARKINSON’S DISEASE USING SAME	ATGC CO.LTD
WO/2021/137668	ORAL DISINFECTANT WITH IMPROVEMENT IN STAINING SIDE EFFECT	OSSTEMIMPLANT CO., LTD.
WO/2021/137677	COMPOSITION CONTAINING PLANT EXTRACT	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/137678	COMPOSITION CONTAINING PAPER MULBERRY EXTRACTS	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/141355	COMPOSITION COMPRISING VGF-DERIVED PEPTIDE FOR PREVENTION OR  TREATMENT OF BONE DISEASE	THE ASAN FOUNDATION
WO/2021/141368	COMPOSITION FOR PREVENTING OR TREATING MACULAR DEGENERATION,  CONTAINING CELL PERMEABLE NUCLEIC ACID COMPLEX AS ACTIVE INGREDIENT	SEASUN THERAPEUTICS
WO/2021/149945	FUSION PROTEIN COMPRISING PD-L1 PROTEIN AND USE THEREOF	GENEXINE, INC.
WO/2021/141425	PHARMACEUTICAL COMPOSITION, FOR PREVENTING AND TREATING  HEMATOLOGICAL CANCER, COMPRISING BIGUANIDE-BASED COMPOUND AS ACTIVE  INGREDIENT	HAIM BIO CO., LTD.
WO/2021/141426	COMPOSITION FOR TREATING FRAGILE X SYNDROME OR RELATED  DEVELOPMENTAL DISORDERS, COMPRISING LISURIDE COMPOUND AS ACTIVE INGREDIENT	KONKUK UNIVERSITY GLOCAL INDUSTRYACADEMIC COLLABORATION  FOUNDATION
WO/2021/141439	COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE  CONTAINING COFFEE SILVER SKIN EXTRACT, FRACTION THEREOF, OR COMPOUND ISOLATED  THEREFROM	GANGNEUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY  COOPERATION GROUP
WO/2021/141446	COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDERS  COMPRISING MESENCHYMAL STEM CELLS	CORESTEM CO.,LTD.
WO/2021/141465	COMPOSITION FOR PREVENTING OR TREATING ANTICANCER  AGENT-INDUCED ALLODYNIA AND THERAPEUTIC METHOD USING SAME	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/145618	PHARMACEUTICAL COMPOSITION INCLUDING R-THIOCTIC ACID OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OIL, AND DISPERSION AID	KOREA UNITED PHARM. INC.
WO/2021/145622	PHARMACEUTICAL COMPOSITION INCLUDING R-THIOCTIC ACID OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND EMULSIFIER	KOREA UNITED PHARM. INC.
WO/2021/145625	PHARMACEUTICAL COMPOSITION COMPRISING R-THIOCTIC ACID OR  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ENTERIC COATING BASE MATERIAL	KOREA UNITED PHARM. INC.
WO/2021/141473	NOVEL LACTOBACILLUS PLANTARUM STRAIN, POLYSACCHARIDES DERIVED  FROM STRAIN, AND USE THEREOF	IMMUNOBIOME INC.
WO/2021/157883	HARD CAPSULE AGENT COMPRISING ENTERIC PROTON PUMP INHIBITOR  AND MOSAPRIDE SUSTAINED-RELEASE FORMULATION	KOREA UNITED PHARM. INC.
WO/2021/210762	ANTICANCER ADJUVANT AND PHARMACEUTICAL COMPOSITION FOR  TREATING ANTICANCER-AGENT-RESISTANT CANCER, AND KIT COMPRISING SAME	DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY  COOPERATION
WO/2021/145672	ARGININE ASPARTATE-CONTAINING COMPOSITION FOR SUPPRESSING OLD  PERSON SMELL	HUMEDIX CO., LTD.
WO/2021/145676	TABLET COMPRISING ATORVASTATIN AND EZETIMIBE	ILDONG PHARMACEUTICAL CO., LTD.
WO/2021/145699	COMPOSITION FOR TREATING SKIN DISEASES, COMPRISING COLCHICINE	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/145703	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  ALZHEIMER'S AND USE THEREOF	TOOLGEN INCORPORATED
WO/2021/149974	MICRO-SPICULE COMPOSITION TO CONTROL ITS SHAPE AND METHOD FOR  PRODUCING THE SAME	PAEAN AESTHETICS INC.
WO/2021/145720	ANTIGEN COMPOSITION FOR PREVENTING OR TREATING VIRAL  INFECTIOUS DISEASES	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG  CAMPUS
WO/2021/172755	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  INFLUENZA VIRUS INFECTION, COMPRISING GREEN PLUM EXTRACT AS ACTIVE INGREDIENT	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/145742	COMPOSITION FOR IMPROVING ATHLETIC FUNCTION, COMPRISING  PHLOROTANNIN AS ACTIVE INGREDIENT	MANNAS INC.
WO/2021/201395	STABILIZING AGENT FOR RADIOPHARMACEUTICAL, AND  RADIOPHARMACEUTICAL COMPOSITION COMPRISING SAME	THE ASAN FOUNDATION
WO/2021/150003	COMPOSITION COMPRISING ROSA LAEVIGATA FRUIT EXTRACT FOR  ALLEVIATION OF RESPIRATORY DISEASE	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/150027	2-PART SKINCARE FORMULATION	SHIN, Seungyun
WO/2021/157916	UNSATURATED FATTY ACID-CONJUGATED CP2C-TARGETING PEPTIDE-BASED  ANTICANCER AGENT	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
WO/2021/251581	SOLID COSMETIC COMPOSITION FOR BLOCKING ULTRAVIOLET RADIATION  HAVING WATER RESISTANCE AND CLEANSING PROPERTIES	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/150050	PHARMACEUTICAL COMPOSITE FORMULATION COMPRISING PROTON PUMP  INHIBITOR AND ANTACID	HANMI PHARM. CO., LTD.
WO/2021/150066	PHARMACEUTICAL COMPOSITION COMPRISING SMALL OCTOPUS-DERIVED  PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASE	NATIONAL MARINE BIODIVERSITY INSTITUTE OF KOREA
WO/2021/150076	PHARMACEUTICAL COMPOSITION OR HEALTH FUNCTIONAL FOOD FOR  PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES	FNG RESEARCH CO.,LTD.
WO/2021/150077	PHARMACEUTICAL COMPOSITION OR HEALTH FUNCTIONAL FOOD FOR  PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	FNG RESEARCH CO.,LTD.
WO/2021/187745	PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING  CHARCOT-MARIE-TOOTH DISORDER, COMPRISING MESENCHYMAL STEM CELLS OR INSULIN  SECRETED BY MESENCHYMAL STEM CELLS	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/150088	PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION FOR  ANIMAL, AND FOOD COMPOSITION, EACH COMPRISING NATURAL SUBSTANCE EXTRACT, AND  PREPARATION METHOD THEREFOR	LK. INC.
WO/2021/162282	COMPOSITION USING NOVEL LACTOBACILLUS PLANTARUM KC3 STRAIN FOR  PREVENTION OR TREATMENT OF IMMUNE IMPAIRMENT, RESPIRATORY INFLAMMATORY  DISEASE, ALLERGY, AND ASTHMA AND USE THEREOF	KT&G CORPORATION
WO/2021/153980	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE INGREDIENT	LISCURE BIOSCIENCES CO., LTD.
WO/2021/177600	PHARMACEUTICAL COMPOSITION COMPRISING GENUS LEUCONOSTOC STRAIN  AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER	LISCURE BIOSCIENCES CO., LTD.
WO/2021/157939	COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES,  CONTAINING SAHA AS ACTIVE INGREDIENT	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/153981	ANTIBODY-DRUG CONJUGATE COMPRISING IMMUNE CHECKPOINT INHIBITOR  AND EXOSOME SECRETION INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING  SAME	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/154012	PULSE-TYPE COMPOSITION FOR MAINTAINING WEAKLY ACIDIC  ENVIRONMENT IN VAGINA	D-NATURE CO., LTD.
WO/2021/154016	PHARMACEUTICAL ADJUVANT COMPOSITION COMPRISING  2S-2`METHOXY-KURARINONE AS ACTIVE INGREDIENT FOR TREATMENT OF CARDIOVASCULAR  DISEASE	SEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/154017	COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES  OF DIGESTIVE SYSTEM OR COLITIS, COMPRISING REOVIRUS AS ACTIVE INGREDIENT	VIROCURE, INC.
WO/2021/154027	STABLE ANTI-PD-1 ANTIBODY PHARMACEUTICAL PREPARATION	SAMSUNG BIOEPIS CO., LTD.
WO/2021/154038	EXTENDED-RELEASE TYPE METAL-ORGANIC FRAMEWORK USING  CYCLODEXTRIN AND MANUFACTURING METHOD THEREFOR	SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/157968	CONTROLLED-RELEASE FORMULATION FOR HEARING LOSS AND  PREPARATION METHOD THEREFOR	MICROBIO CO., LTD.
WO/2021/215627	COMPOSITION FOR PREVENTING OR TREATING LIPID-RELATED METABOLIC  DISEASES, COMPRISING LACTOBACILLUS PLANTARUM ATG-K2 OR ATG-K6	ATOGEN CO., LTD.
WO/2021/215629	FOAM TYPE SEMI-PERMANENT HAIR DYEING COMPOSITION	KOLMAR KOREA CO., LTD.
WO/2021/246610	COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES,  COMPRISING LACTOBACILLUS SAKEI CVL-001 STRAIN	INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
WO/2021/167269	WHITENING COMPOSITION COMPRISING PLUM SEED EXTRACT AS ACTIVE  INGREDIENT	INDUSTRY ACADEMIC COOPERATION FOUNDATION KEIMYUNG UNIVERSITY
WO/2021/158008	COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS, COMPRISING  3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE DERIVATIVE	STEMORE CO.,LTD.
WO/2021/158013	HYDROGEL AND METHOD FOR PREPARING THE SAME	KOREA ATOMIC ENERGY RESEARCH INSTITUTE
WO/2021/158045	COMPOSITION FOR INTRAPERICARDIAL INJECTION COMPRISING STEM  CELLS AND USE THEREOF	HIERABIO INC.
WO/2021/158053	PULMONARY SURFACTANT PARTICLE LOADED WITH NUCLEIC ACID OR  PROTEIN FOR INHALED DELIVERY, AND METHOD FOR PRODUCING SAME	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/177608	COMPOSITION HAVING ANTIOXIDATIVE EFFECT, COMPRISING SUBSTANCE  P	BIOSOLUTION CO.,LTD
WO/2021/158059	COMPOSITION COMPRISING RILMENIDINE COMPOUND AS ACTIVE  INGREDIENT FOR TREATMENT OF FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL  DISABILITY	KONKUK UNIVERSITY GLOCAL INDUSTRYACADEMIC COLLABORATION  FOUNDATION
WO/2021/158071	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCERS ASSOCIATED WITH KRAS MUTATION	WELLMARKER BIO CO., LTD.
WO/2021/158084	HYBRID COMPOUND AND PREPARATION METHOD THEREFOR	BORYUNG PHARMACEUTICAL CO., LTD
WO/2021/162375	EXOSOME COMPRISING PHOTOCLEAVABLE PROTEIN, AND USE THEREOF	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/158091	COMPOSITION COMPRISING CHEMOKINE INHIBITOR, COLONY STIMULATING  FACTOR INHIBITOR, AND CANCER IMMUNOTHERAPY AGENT FOR PREVENTION OR TREATMENT  OF CANCER AND COMBINATION THERAPY	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/162408	WATER-DISPERSIBLE, OIL-FREE, AND UV-BLOCKING COSMETIC  COMPOSITION AND PREPARATION METHOD THEREFOR	KOLMAR KOREA CO., LTD.
WO/2021/162415	COSMETIC COMPOSITION FOR SKIN IMPROVEMENT COMPRISING, AS  ACTIVE INGREDIENTS, POLYSACCHARIDES, YEAST EXTRACT, AND STRAIN FERMENTATION  PRODUCT WITH CHARACTERISTICS OF PROBIOTICS	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/162417	COMPOSITION FOR PREVENTING OR TREATING CANCER BY USING  MATURATION INDUCTION OF IMMATURE DENDRITIC CELLS	LISCURE BIOSCIENCES CO., LTD.
WO/2021/162419	CANCER PREVENTION OR TREATMENT COMPOSITION USING MATURATION  INDUCTION OF IMMATURE DENDRITIC CELLS	LISCURE BIOSCIENCES CO., LTD.
WO/2021/162421	COMPOSITION FOR CANCER PREVENTION OR TREATMENT, USING  MATURATION INDUCTION OF IMMATURE DENDRITIC CELLS	LISCURE BIOSCIENCES CO., LTD.
WO/2021/162426	METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FOR PREVENTION OR  TREATMENT OF BRAIN NEURONAL DISEASES, COMPRISING GHRELIN TREATMENT, AND USE  THEREOF	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/162448	WATER-SOLUBLE CATECHIN COMPLEX, AND COMPOSITION FOR PREVENTING  OR TREATING ATOPIC DERMATITIS COMPRISING SAME	KOLON INDUSTRIES, INC.
WO/2021/162451	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  CONTAINING BILE ACIDS OR DERIVATIVES THEREOF, BIGUANIDE-BASED COMPOUNDS, AND  TWO OR MORE KINDS OF ANTIVIRAL AGENTS AS ACTIVE INGREDIENTS	FRONTBIO INC.
WO/2021/162457	ANTICANCER THERAPY USING FAECALIBACTERIUM SP. MICROORGANISM	CHUNLAB, INC.
WO/2021/162460	NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING NON-ALCOHOLIC  LIVER DISEASE	GENEXINE, INC.
WO/2021/162463	COMPOSITION FOR PREVENTING, TREATING, AND ALLEVIATING ATOPIC  DERMATITIS COMPRISING FLAVONE-RESVERATROL CONJUGATE COMPOUND	AGERA BIOTECH, INC.
WO/2021/162478	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  COMPRISING GENIPIN AND ELESCLOMOL	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/162525	PHARMACEUTICAL COMPOSITION FOR INHIBITING INFLAMMATORY  RESPONSE COMPRISING HYDROXYUREA	BIONOXX INC.
WO/2021/167308	NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATE	UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
WO/2021/162532	PHARMACEUTICAL COMPOSITION COMPRISING SUSTAINED-RELEASE  MICROSPHERES INCLUDING GLP-1 ANALOGUE OR PHARMACEUTICALLY ACCEPTABLE SALT  THEREOF	G2GBIO, INC.
WO/2021/167346	COMPOSITION FOR PREVENTING OR TREATING DIABETES	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/167350	COMPOSITION FOR TREATING CLIMACTERIC DISORDER COMPRISING  LACTOBACILLUS GASSERI BNR17	ACEBIOME INC.
WO/2021/167364	PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE AND SODIUM  BICARBONATE HAVING EXCELLENT RELEASE PROPERTIES	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/167389	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  CONTAINING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENT	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/167418	NOVEL TUMOR-ASSOCIATED ANTIGEN PROTEIN OLFM4 AND USES THEREOF	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/225260	COMPOSITION FOR HEALING WOUNDS COMPRISING REGULATORY T  CELL-CONDITIONED MEDIA	IMMUNISBIO CO., LTD.
WO/2021/167429	TARGETED CRYSTALLIZATION OF MIXED-CHARGE NANOPARTICLES IN  LYSOSOMES FOR INDUCING SELECTIVE DEATH OF CANCER CELLS	INSTITUTE FOR BASIC SCIENCE
WO/2021/172897	PHARMACEUTICAL COMPOSITION COMPRISING DEOXYCHOLIC ACID	LG CHEM, LTD.
WO/2021/177660	WEIGHT LOSS COMPOSITION COMPRISING OENOTHEIN B ANALOGUES AS  ACTIVE INGREDIENT	METAIMMUNETECH INC.
WO/2021/172908	COMPOSITION HAVING IMPROVED USABILITY	AMOREPACIFIC CORPORATION
WO/2021/177679	LIVE-PATHOGEN-MIMETIC NANOPARTICLES BASED ON PATHOGEN CELL  WALL SKELETON, AND PRODUCTION METHOD THEREOF	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/172960	SUSTAINED-RELEASE PREPARATION FOR TREATING HEART FAILURE,  COMPRISING SACUBITRIL AND VALSARTAN, AND MULTIPLE-RELEASE COMPLEX PREPARATION  COMPRISING SAME AND PREPARATION METHOD THEREFOR	ELYSON PHARM CO., LTD.
WO/2021/194110	COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES,  CONTAINING JUJUBOSIDE A AS ACTIVE INGREDIENT	UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
WO/2021/177693	NANOPARTICLE STRUCTURE AND FORMATION METHOD THEREFOR	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/194112	METHOD FOR PRODUCING LARGE-DIAMETER SIO2 POWDER, AND COSMETIC  COMPOSITION CONTAINING SAME	SUKGYUNG AT CO., LTD.
WO/2021/221287	NANOPARTICLES HAVING APOPTOSIS-INDUCING GAS PRECURSOR  IMPREGNATED THEREIN, AND PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR  TREATMENT, COMPRISING SAME AS ACTIVE INGREDIENT	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/221288	COMBINATION DRUG COMPRISING MOSAPRIDE AND PROTON PUMP  INHIBITOR	KOREA UNITED PHARM. INC.
WO/2021/177721	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCER IN WHICH KRAS MUTATION AND ACTIVATED RON ARE PRESENT	WELLMARKER BIO CO., LTD.
WO/2021/177728	USE OF 2,3,5-SUBSTITUTED THIOPHENE COMPOUND FOR PREVENTING,  AMELIORATING, OR TREATING OVARIAN CANCER	PHAROS IBIO CO., LTD
WO/2021/177779	COMPOSITION FOR PREVENTING OR TREATING SJÖGREN'S SYNDROME,  CONTAINING SPHINGOSYLPHOSPHORYLCHOLINE AS ACTIVE INGREDIENT	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/235659	COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF  ATOPIC DERMATITIS DISEASE	NAM, Jong Hyun
WO/2021/187787	METHOD FOR SCREENING PLK-1 INHIBITOR, INHIBITOR SCREENED  THEREBY, AND USE THEREOF	INNOPHARMASCREEN INC.
WO/2021/201451	PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING  LIPID-PHOTOTHERMAL NANOPARTICLE HAVING ANTIBODY BOUND TO SURFACE	SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
WO/2021/235661	ENTEROENDOCRINE CELL TARGET POLYMER CONJUGATED WITH  PHOTOSENSITIZER, AND MEDICAL USE THEREOF FOR AMELIORATING METABOLIC DISEASE	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/182864	A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS  COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER  AND THE USE THEREOF.	MEDIHELPLINE CO., LTD
WO/2021/182865	A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS  COMPRISING LONGANAE ARILLUS FOR TLSP INHIBITION AND THE TREATMENT OR  ALLEVIATION OF SKIN INFLAMMATORY DISEASE AND THE USE THEREOF.	MEDIHELPLINE CO., LTD.
WO/2021/182866	COMPOSITION FOR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH  COMPRISING GROWTH FACTOR	MEDICOSBIOTECH INC.
WO/2021/182873	A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS  COMPRISING LONGANAE ARILLUS FOR THE SKIN REGENERATION AND THE TREATMENT OR  ALLEVIATION OF SKIN WOUND AND THE USE THEREOF.	MEDIHELPLINE CO., LTD.
WO/2021/182874	LIQUID PHARMACEUTICAL COMPOSITION HAVING IMPROVED STABILITY	SAMSUNG BIOEPIS CO., LTD.
WO/2021/182876	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  NONALCOHOLIC STEATOHEPATITIS	DONG-A ST CO., LTD.
WO/2021/182877	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  DIABETES AND METABOLIC DISEASES ASSOCIATED THEREWITH	DONG-A ST CO., LTD.
WO/2021/187804	PHOTO-CURABLE COMPOSITION FOR TOOTH RESTORATION	GRAPHY INC.
WO/2021/182894	COMPOSITION FOR PREVENTING OR TREATING CARDIOMETABOLIC  DISEASES, CONTAINING ELAEOCARPUS PETIOLATUS	SEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/182895	COSMETIC COMPOSITION FOR INCREASING BENEFICIAL BACTERIA OF  SKIN	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/182897	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NK/T-CELL LYMPHOMA OR NK-CELL LEUKEMIA, COMPRISING PHOSPHODIESTERASE TYPE 5  INHIBITOR	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/182900	METHOD FOR PREVENTING OR TREATING MTOR-ASSOCIATED DISEASES  THROUGH REGULATION OF VEGFR-3 EXPRESSION	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/182901	COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES,  COMPRISING TAT PEPTIDE VARIANT AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/182903	COMPOSITION COMPRISING PI3 KINASE INHIBITOR AND BTK INHIBITOR	BORYUNG PHARMACEUTICAL CO., LTD
WO/2021/256665	COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL OR MENTAL  DISORDERS COMPRISING VESICLES DERIVED FROM LACTOBACILLUS PARACASEI	MD HEALTHCARE INC.
WO/2021/201461	ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND  METFORMIN	HANMI PHARM. CO., LTD.
WO/2021/187809	TRANQUILIZING COMPOSITION	NATURAL ENDOTECH CO., LTD.
WO/2021/187813	DEFORMABLE HYDROGEL PARTICLES AND PHARMACEUTICAL COMPOSITION  FOR CANCER TREATMENT COMPRISING SAME	SCHOLAR FOXTROT CO., LTD.
WO/2021/182913	COMPOSITION, COMPRISING PLACENTA EXTRACT, FOR PREVENTING OR  TREATING LIVER DISEASE AND IMPROVING LIVER FUNCTION	GREEN CROSS WELLBEING CORPORATION
WO/2021/194142	RECOMBINANT PROTEIN FOR NEUTERING OR SPAYING ANIMAL, AND  VACCINE COMPOSITION COMPRISING SAME	BIOAPPLICATIONS INC.
WO/2021/182917	COMPOSITION FOR INDUCING APOPTOSIS OF CELLS HAVING GENOMIC  SEQUENCE VARIATION AND METHOD FOR INDUCING APOPTOSIS OF CELLS BY USING  COMPOSITION	INSTITUTE FOR BASIC SCIENCE
WO/2021/182927	PHARMACEUTICAL COMPOSITION FOR TREATING NOVEL METABOLIC  SYNDROME AND DISEASES ASSOCIATED THEREWITH	SL METAGEN
WO/2021/187842	PHARMACEUTICAL PREPARATION FOR TREATING SARS-CORONAVIRUS  INFECTIONS, AND MEDICAL USE THEREOF	INSTITUT PASTEUR KOREA
WO/2021/187851	PARTICLES ENCAPSULATING TARGETED APTAMER CONJUGATES, AND USE  THEREOF	KIM, Sung Chun
WO/2021/187880	NOVEL USE OF CROSS-FLOW FILTRATION DEVICE FOR PREPARING  FUNCTIONAL EXOSOME	EXOSTEMTECH CO., LTD.
WO/2021/194152	COMPOSITE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF FIBROSIS  DISEASE	KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
WO/2021/194153	DEVELOPMENT OF COMBINED THERAPEUTIC AGENT FOR FIBROTIC  DISEASES	KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
WO/2021/241862	PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR TREATMENT,  COMPRISING INOSITOL POLYPHOSPHATE MULTIKINASE INHIBITOR AS ACTIVE INGREDIENT	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/187896	PHARMACEUTICAL COMPOSITION COMPRISING DIABETES THERAPEUTIC  AGENT AND HYPERLIPIDEMIA THERAPEUTIC AGENT	DAEWOONG THERAPEUTICS INC.
WO/2021/187897	FUSION PROTEIN PREPARATION COMPRISING IL-2 AND CD80 PROTEINS	GI INNOVATION, INC.
WO/2021/187902	NUCLEIC ACID-BASED ANTICANCER AGENT	KIM, Sung Chun
WO/2021/187905	PHARMACEUTICAL COMPOSITION FOR CANCER AND RESISTANT CANCER  COMPRISING TRICHOSANTHES KIRILOWII MAXIM, DICTAMNUS DASYCARPUS TURCZ AND  MORUS ALBA L.	SONGHEON R&D
WO/2021/187922	PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING  FUSION PROTEIN INCLUDING IL-2 PROTEIN AND CD80 PROTEIN AND ANTICANCER DRUG	GI INNOVATION, INC.
WO/2021/187932	VACCINE COMPOSITION FOR PREVENTING HAND, FOOT, AND MOUTH  DISEASE, COMPRISING GLA-SE	KNU-INDUSTRY COOPERATION FOUNDATION
WO/2021/187942	USE OF CYCLO-HISPRO (CHP) FOR LOWERING BLOOD PRESSURE	NOVMETAPHARMA CO., LTD.
WO/2021/187944	THERAPEUTIC USE OF COENZYME Q10 SOLUBILIZING COMPOSITION	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/206309	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  DISEASES CAUSED BY SARS-COV-2	DONG WHA PHARM. CO., LTD.
WO/2021/230487	COMPOSITION COMPRISING AMNION EPITHELIAL CELL-DERIVED EXOSOME  AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OCULAR DISEASE	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/210798	PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN  DISEASE, INCLUDING GLYCINE TRANSPORTER AS ACTIVE INGREDIENT	AMYLOID SOLUTION INC.
WO/2021/261712	HEMOGLOBIN DERIVATIVE CO-CONJUGATED WITH FATTY ACID-LINKED PEG  AND ALKOXY PEG AS A BLOOD SUBSTITUTE	SUNBIO, INC.
WO/2021/206316	AGENT FOR TREATING CONTRAST-INDUCED ACUTE KIDNEY INJURY	APTABIO CO., LTD.
WO/2021/210799	PULMONARY FIBROSIS MEDICINE CONTAINING PYRAZOLE DERIVATIVE	APTABIO CO., LTD.
WO/2021/215677	COMPOSITION FOR ALLEVIATING SKIN DAMAGE BY USING RED  ALGAE-DERIVED CELLULOSE NANOMATERIAL, AND PREPARATION METHOD THEREFOR	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/194228	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCER	L-BASE CO., LTD.
WO/2021/201488	THROMBUS IMAGING RADIOPHARMACEUTICAL AND COMPOSITION	THE ASAN FOUNDATION
WO/2021/194253	ORAL TABLET COMPOSITION OF POMALIDOMIDE AND METHOD FOR  PREPARING SAME	SAMYANG HOLDINGS CORPORATION
WO/2021/194256	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  RETINITIS PIGMENTOSA, COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM HUMAN  EMBRYONIC STEM CELLS	SEOUL NATIONAL UNIVERSITY HOSPITAL
WO/2021/206328	NOVEL RECOMBINANT EXOSOME AND USE THEREOF	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/194276	PHARMACEUTICAL COMPOSITION, FOR PREVENTION OR TREATMENT OF  CANCER, COMPRISING 13-HYDROXYOCTADECADIENOIC ACID AS ACTIVE INGREDIENT	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/194280	NOVEL PHARMACEUTICAL FORMULATION WITH IMPROVED STABILITY  CONTAINING TAXANE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR HYDRATE  THEREOF	BORYUNG PHARMACEUTICAL CO., LTD
WO/2021/194281	TARS DERIVED FROM AKKERMANSIA MUCINIPHILA OR FRAGMENT THEREOF,  AND USE THEREOF	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/246627	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  PARKINSON'S DISEASE, COMPRISING  2-(4-(1-HYDROXYPROPANE-2-YL)PHENYL)ISOINDOLINE-1-ONE COMPOUND	YEP BIO CO. LTD.
WO/2021/201502	AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF  COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION  OF INFLAMMATORY DISEASE AND THE USE THEREOF.	MEDIHELPLINE CO., LTD.
WO/2021/201503	AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF  COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION  OF ARTHRITIS DISEASE AND THE USE THEREOF.	MEDIHELPLINE CO., LTD.
WO/2021/194287	NOVEL CERIUM OXIDE NANOCOMPOSITE AND USE THEREOF	CENYX BIOTECH INC.
WO/2021/194290	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING EPIDEMIC  RNA VIRAL INFECTIOUS DISEASE	SHIN POONG PHARMACEUTICAL CO., LTD.
WO/2021/210804	METHOD FOR PREPARING RED ALGAL MICROFIBRILLATED CELLULOSE, AND  USE THEREOF	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/206335	PEPTIDE FOR PREVENTING OR TREATING HAIR LOSS, AND USE THEREOF	DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/201532	COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING FEMALE  MENOPAUSAL SYNDROME, CONTAINING ROSA RUGOSA EXTRACT AS ACTIVE INGREDIENT	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/241873	COMPOSITION FOR PREVENTING OR TREATING SARS CORONAVIRUS 2  DISEASE	KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION
WO/2021/206355	ANTI-POLLUTION COMPOSITE POWDER HAVING UV AND FINE DUST  BLOCKING FUNCTION AND COSMETIC COMPOSITION COMPRISING SAME	CQV CO., LTD.
WO/2021/246628	COSMETIC COMPOSITION FOR LIPS	KOLMAR KOREA CO., LTD.
WO/2021/201588	HEPARIN-BILE ACID OLIGOMER CONJUGATES FOR ANTICANCER THERAPY	ST PHARM CO., LTD.
WO/2021/206360	BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT  FACILITATES DISCHARGE RATE CONTROL AND IS STABLE	MEDYTOX INC.
WO/2021/201612	NOVEL VACCINE COMPOSITION FOR PREVENTION AND TREATMENT OF  CORONAVIRUS	SL VAXIGEN, INC.
WO/2021/251602	COMPOSITION FOR PREVENTING OR TREATING DISEASE CAUSED BY  MUSCLE LOSS, COMPRISING AGENT INHIBITING PHF20	MITOS THERAPEUTICS INC.
WO/2021/221330	SONOSENSITIVE LIPOSOME AND METHOD FOR PREPARING SAME	IMGT CO, LTD.
WO/2021/201647	HAND SANITIZER COMPOSITION HAVING CAPSULES CONTAINING ACTIVE  SUBSTANCE AND METHOD FOR PREPARING SAME	ACTIVON CO., LTD.
WO/2021/206379	COMPOSITION FOR CANCER PREVENTION OR TREATMENT, CONTAINING, AS  ACTIVE INGREDIENT, SALVIANOLIC ACID B OR TANSHINONE I	PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION  FOUNDATION
WO/2021/201654	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  MUCOSITIS INDUCED BY RADIOTHERAPY, CHEMOTHERAPY, OR COMBINATION THEREOF,  COMPRISING GLP-2 DERIVATIVES OR LONG-ACTING CONJUGATE OF SAME	HANMI PHARM. CO., LTD.
WO/2021/201657	COMPOSITION FOR CANCER DIAGNOSIS, PREVENTION OR TREATMENT,  CONTAINING EPHA10 INHIBITOR, AND USE THEREOF	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/201660	CELL CAPSULATING LAYER, CAPSULATED CELLS, CELL CAPSULATING  COMPOSITION AND PREPARATION METHOD THEREFOR	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/206397	NOVEL ANTIBACTERIAL PEPTIDE OR PEPTIDE ANALOG AND USE THEREOF	CAMP THERAPEUTICS INC.
WO/2021/251603	ADIPOCYTE DIFFERENTIATION INHIBITOR AND COMPOSITION COMPRISING  SAME	HNB9 CO., LTD
WO/2021/215700	COMPOSITION FOR PREVENTING OR TREATING ISCHEMIA REPERFUSION  INJURY COMPRISING NADPH OXIDASE 1 INHIBITOR AS ACTIVE INGREDIENT	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/235685	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER	VIROCURE, INC.
WO/2021/206455	FRACTION EXTRACT OF MELISSA OFFICINALIS LEAVES AND NOVEL  PHARMACEUTICAL COMPOSITION INCLUDING SAME	ANGIOLAB, INC.
WO/2021/215709	WHITENING COSMETIC COMPOSITION COMPRISING SODIUM PYRUVATE AS  ACTIVE INGREDIENT	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/206459	STEM CELL-DERIVED EXOSOMES CONTAINING PAIN REGULATORS, AND  USES THEREOF	EXOSTEMTECH CO., LTD.
WO/2021/206470	COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF  URINATION-RELATED DISEASES COMPRISING CEPHALOTOCIN	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/206480	COMPOSITION AND METHOD FOR AN ANTIBIOTIC-INDUCING IMBALANCE IN  MICROBIOTA	PSOMAGEN, INC.
WO/2021/235695	PREVENTIVE OR THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR  CORONAVIRUS INFECTION COMPRISING TETRAARSENIC HEXOXIDE	CHEMAS CO., LTD.
WO/2021/210851	ANTIVIRAL COMPOSITION COMPRISING PLACENTA EXTRACT	GREEN CROSS WELLBEING CORPORATION
WO/2021/210852	ANTI-VIRAL COMPOSITION COMPRISING PLACENTA-DERIVED MATERIAL	GREEN CROSS WELLBEING CORPORATION
WO/2021/210853	ANTIVIRAL COMPOSITION COMPRISING PLACENTA-EXTRACT-DERIVED  MICRORNA	GREEN CROSS WELLBEING CORPORATION
WO/2021/206498	FLAVONOID GLYCOSIDE HAVING ANTI-CORONAVIRUS ACTIVITY	KWON, Dur Han
WO/2021/210872	COMPOSITION FOR PREVENTING OR TREATING DIABETIC SKIN DISEASE,  COMPRISING EXOSOME DERIVED FROM THROMBIN-TREATED STEM CELL	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
WO/2021/210897	METHOD AND COMPOSITION FOR EVALUATING RESPONSE TO  NEURODEGENERATIVE DISEASE TREATMENT AGENT	GENUV INC.
WO/2021/230506	HERBAL MEDICINE COMPOSITION FOR TREATING COVID-19 AND OTHER  VIRAL DISEASES	KANG, Seong Cheon
WO/2021/261726	COMPOSITION FOR TREATING HAIR OR FIBERS, COMPRISING ALKYL  KETENE COMPOUND	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/210929	NOVEL PHARMACEUTICAL FORMULATION HAVING IMPROVED STABILITY  COMPRISING AMORPHOUS EMPAGLIFLOZIN	BORYUNG PHARMACEUTICAL CO., LTD
WO/2021/210962	CONTRAST AGENT COMPOSITION FOR DETECTING LESIONAL MARGINS OF  ASTROCYTOSIS-RELATED DISEASES COMPRISING QUINOLINE DERIVATIVE AS ACTIVE  INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/210963	CONTRAST AGENT COMPOSITION FOR DETECTING LESION MARGINS OF  DEMENTIA CAUSED BY DEGENERATIVE BRAIN DISEASE, COMPRISING QUINOLINE  DERIVATIVE AS ACTIVE INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/210964	CONTRAST MEDIUM COMPOSITION, COMPRISING C11-ACETATE AS ACTIVE  INGREDIENT, FOR DETECTING MARGINS OF LESION OF ASTROCYTOSIS-RELATED DISEASE	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/210965	CONTRAST COMPOSITION FOR DETECTING LESION MARGINS OF DEMENTIA  CAUSED BY DEGENERATIVE BRAIN DISEASE, CONTAINING C11-ACETATE AS ACTIVE  INGREDIENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/215798	PHARMACEUTICAL COMPOSITION FOR TREATING SARS-CORONAVIRUS  INFECTION, AND MEDICAL USE THEREOF	INSTITUT PASTEUR KOREA
WO/2021/215801	PREVENTIVE OR THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR  HYPERLIPIDEMIA COMPRISING TRIPLE AGONIST ACTING ON ALL OF GLUCAGON, GLP-1 AND  GIP RECEPTORS, OR CONJUGATE THEREOF, AND PREVENTIVE OR THERAPEUTIC METHOD	HANMI PHARM. CO., LTD.
WO/2021/221377	COMPOSITION FOR INHIBITING ANTICANCER-AGENT-INDUCED  OVOTOXICITY, CONTAINING MIXED EXTRACT OF MEDICINAL HERBS AS ACTIVE INGREDIENT	KOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/215836	PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING EYE  DISEASES COMPRISING VERBENONE DERIVATIVE	SHIN POONG PHARMACEUTICAL CO., LTD.
WO/2021/221384	SKIN WHITENING COMPOSITION CONTAINING ITACONIC ACID DERIVATIVE	STEMORE C0., LTD.
WO/2021/251616	COMPOSITION COMPRISING EXOSOMES DERIVED FROM FELINE  MESENCHYMAL STEM CELLS AND METHOD OF TREATING INFLAMMATORY DISEASES BY USING  SAME	DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION
WO/2021/251617	CRUDE DRUG COMPOSITION FOR ALLEVIATING OR TREATING RHINITIS,  PHARMACOPUNCTURE SOLUTION OF ORIENTAL MEDICINE COMPRISING SAME, INJECTION  COMPRISING SAME, AND PHARMACOPUNCTURING METHOD USING SAME	OSUNG NATURAL BIO CO., LTD.
WO/2021/215852	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC  CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION	CELLTRION INC.
WO/2021/241892	NOVEL PHARMACEUTICAL COMPOSITION FOR TREATING DRY EYE SYNDROME	NOVACELL TECHNOLOGY INC.
WO/2021/215856	ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING  IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAME	YUNGJIN PHARM. CO., LTD.
WO/2021/215882	COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH  COMPRISING CAMELLIA PERICARP EXTRACT AS ACTIVE INGREDIENT	BIOSPECTURM, INC.
WO/2021/215887	COMPOSITION COMPRISING CRICKET OR EXTRACT THEREOF FOR  IMPROVING BOWEL MOVEMENT FUNCTION	CJ CHEILJEDANG CORPORATION
WO/2021/215891	HEPATIC REGENERATION PROMOTING COMPOSITION COMPRISING  6-O-TRANS-FERULOYL CATALPOL AS ACTIVE INGREDIENT	EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
WO/2021/221405	FUNCTIONAL COSMETIC COMPOSITION COMPRISING PLANT EXTRACT AS  ACTIVE INGREDIENT AND PREPARATION METHOD THEREFOR	THE GARDEN OF NATURALSOLUTION CO., LTD.
WO/2021/215896	METHOD FOR TREATING CERVICAL CANCER	GENEXINE, INC.
WO/2021/221435	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  CORONAVIRUS DISEASE-19	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/241898	VETERINARY ORALLY-DISINTEGRATING-FILM FORMULATION FOR TREATING  OR PREVENTING PARASITIC INFECTIOUS DISEASES IN ANIMALS	KYONGBO PHARM.CO.,LTD.
WO/2021/221447	USE OF ACTIVE ANDROGEN RECEPTOR ANTAGONIST FOR CANCER  TREATMENT	LEE, Kyung Il
WO/2021/221472	MICELLE PARTICLES COMPRISING AMPHIPATHIC GINSENOSIDE,  COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREOF	MODNBIO, INC. CO., LTD.
WO/2021/221482	NOVEL PROTEIN CONJUGATE, AND USE THEREOF FOR PREVENTING OR  TREATING NONALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETES	ONEGENE BIOTECHNOLOGY INC.
WO/2021/225343	COMPOSITION FOR PREVENTING OR TREATING COGNITIVE DISORDER,  COMPRISING IRIS LACTEA EXTRACT	KOREA INSTITUTE OF ORIENTAL MEDICINE
WO/2021/225349	COMPOSITION FOR PREVENTING OR TREATING HEAD TRAUMA	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/225363	ANTI-INFLAMMATORY OR ANTIDIABETIC COMPOSITION COMPRISING  METABOLITE OF MARINE-DRIVED FUNGUS PENICILLIUM GLABRUM SF-7123	KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
WO/2021/225397	CYCLOSERINE AND PENTOXIFYLLINE COMBINATION THERAPY FOR  TREATMENT OF DEPRESSION	NEURORIVE INC
WO/2021/246666	ANTICANCER DRUG COMPOSITION COMPRISING AS ACTIVE INGREDIENT  TLR5 AGONIST DERIVED FROM FLAGELLIN	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/225410	PHARMACEUTICAL COMPOSITION FOR BRAIN CANCER TREATMENT	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/230600	ANTICANCER COMPOSITION COMPRISING METABOLIC ANTICANCER DRUG	NOAHM INC.
WO/2021/241914	ANTIBACTERIAL SUBSTANCE HAVING LYTIC ACTIVITY AGAINST  ACTINOBACILLUS PLEUROPNEUMONIAE AND METHOD FOR PRODUCING SAME	INTRON BIOTECHNOLOGY, INC.
WO/2021/230647	PERCUTANEOUS ABSORPTION PREPARATION COMPRISING DONEPEZIL WITH  IMPROVED STABILITY	DONG-A ST CO., LTD.
WO/2021/230664	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEART  FAILURE AND ISCHEMIC HEART DISEASE, COMPRISING SACUBITRIL, VALSARTAN, AND  NEBIVOLOL, AND PHARMACEUTICAL COMPLEX FORMULATION COMPRISING SAME	ELYSON PHARM CO., LTD.
WO/2021/230667	CORONAVIRUS THERAPEUTIC AGENT COMPRISING ZANTHOXYLUM PIPERITUM  LEAF EXTRACT AS ACTIVE INGREDIENT	MECOX CUREMED CO., LTD.
WO/2021/230677	NOVEL POLYPHENOL COMPOUND AND ANTIFUNGAL COMPOSITION  CONTAINING SAME AS ACTIVE INGREDIENT	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/235773	PHARMACEUTICAL LIQUID COMPOSITION COMPRISING BOTULINUM TOXIN	OSSTEMIMPLANT CO., LTD.
WO/2021/230704	COMPOSITION FOR ENHANCING IMMUNE RESPONSE BY USING ACTIVATION  FUNCTION OF DENDRITIC CELLS OF STROMAL VASCULAR FRACTIONS ISOLATED FROM  ADIPOSE TISSUES	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
WO/2021/235807	ORAL HEALTH CARE COMPOSITION COMPRISING AS ACTIVE INGREDIENT  NIPA PALM-DERIVED COMPOSITE NATURAL MATERIAL CONTAINING PHYTO-SALT,  PREPARATION METHOD THEREFOR, AND ORAL HEALTH CARE PRODUCT MANUFACTURED USING  COMPOSITION	HIM CO., LTD.
WO/2021/235811	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  SMALL-CELL LUNG CANCER ASSOCIATED WITH RON MUTANTS AND METHOD USING SAME	WELLMARKER BIO CO., LTD.
WO/2021/235812	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  NON-SMALL CELL LUNG CANCER ASSOCIATED WITH RON MUTATION, AND METHOD USING  SAME	WELLMARKER BIO CO., LTD.
WO/2021/235813	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  PANCREATIC CANCER ASSOCIATED WITH RON MUTATION AND METHOD USING SAME	WELLMARKER BIO CO., LTD.
WO/2021/246684	COMPOSITION FOR ANTI-INFLAMMATION, WOUND HEALING OR WOUND  HEALING PROMOTION, COMPRISING ROSE STEM CELL-DERIVED EXOSOMES AS ACTIVE  INGREDIENT	EXOCOBIO INC.
WO/2021/251644	COMPLEX PHARMACEUTICAL PREPARATION, FOR PREVENTING OR TREATING  CARDIOVASCULAR DISEASE, COMPRISING AMLODIPINE, LOSARTAN AND CHLORTHALIDONE IN  SINGLE-LAYER TABLET	HANMI PHARM. CO., LTD.
WO/2021/241941	LIMAPROST-CONTAINING SUSTAINED RELEASE FORMULATION	YONSUNG FINE CHEMICAL CO., LTD.
WO/2021/241943	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  CANCER	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/241953	FERMENTED NANO-EMULSIFIER COMPOSITION AND PREPARATION METHOD  THEREFOR	UNITED ACTIVE INC.
WO/2021/235907	LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLUCAGON  DERIVATIVE	HANMI PHARM. CO., LTD.
WO/2021/241966	PRUSSIAN BLUE/PLURONIC NANOPARTICLE COMPLEX FOR REMOVAL OF  REACTIVE OXYGEN AND USE THEREOF	KOREA INSTITUTE OF CERAMIC ENGINEERING AND TECHNOLOGY
WO/2021/235913	LIQUID FORMULATION OF LONG-ACTING CONJUGATE OF GLP-2	HANMI PHARM. CO., LTD.
WO/2021/246704	UV-BLOCKING COSMETIC COMPOSITION HAVING INCREASED UV-BLOCKING  EFFICIENCY DUE TO HEAT AND UV LIGHT	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/235915	LIQUID FORMULATION	HANMI PHARM. CO., LTD.
WO/2021/235916	LIQUID PREPARATION OF LONG-ACTING CONJUGATE OF  GLUCAGON/GLP-1/GIP TRIGONAL AGONIST	HANMI PHARM. CO., LTD.
WO/2021/241981	COMPOSITION FOR PREVENTING OR TREATING CANCER	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/242002	LSP1-DEFICIENT T CELL	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/242021	CONTROLLED RELEASE MICROSPHERES CONTAINING GLUCAGON-LIKE  PEPTIDE 1 AGONIST, AND METHOD FOR PRODUCING SAME	AULBIO CO.,LTD.
WO/2021/242040	SUSTAINED-RELEASE METFORMIN COATED TABLET HAVING CONTROLLED  RELEASE BY OSMOTIC PRESSURE	KOREA UNITED PHARM. INC.
WO/2021/242043	COMPOSITION FOR PREVENTING, TREATING OR AMELIORATING METABOLIC  SYNDROME COMPRISING LACTOBACILLUS FERMENTED PRODUCT OF PEONY EXTRACT OR  β-GENTIOBIOSYL PAEONIFLORIN AS ACTIVE INGREDIENT	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/242044	COMPOSITION COMPRISING HIBISCUS, ROSEMARY, AND GRAPE SEED  EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DEGENERATIVE BRAIN  DISEASE	POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
WO/2021/242056	BIFIDOBACTERIUM SP. STRAIN AND EXTRACELLULAR VESICLE DERIVED  THEREFROM, AND ANTI-INFLAMMATORY AND ANTI-BACTERIAL USES THEREOF	BIOBANKHEALING INC.
WO/2021/256730	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER,  CONTAINING, AS ACTIVE INGREDIENT, ISOSAKURANETIN OR PHARMACEUTICALLY  ACCEPTABLE SALT THEREOF	AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/242070	PHOTOREACTIVE COSMETIC COMPOSITION FOR ENHANCING SKIN  ELASTICITY AND REDUCING SKIN WRINKLES, AND PREPARATION METHOD THEREFOR	D.R. NANO CO., LTD
WO/2021/246744	COMPOSITION COMPRISING OSTEOPONTIN INHIBITOR AS ACTIVE  INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF NEURODEGENERATIVE  DISEASE	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/246755	COMPOSITION, FOR PREVENTING, ALLEVIATING OR TREATING METABOLIC  DISEASE, COMPRISING PHOSPHOLIPASE D2 INHIBITOR	RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
WO/2021/246757	PHARMACEUTICAL COMPOSITION FOR ENHANCING RADIOTHERAPY  COMPRISING FUSION PROTEIN CONTAINING IL-2 PROTEIN AND CD80 PROTEIN	GI INNOVATION, INC.
WO/2021/251673	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING  PERIODONTAL DISEASE OR LUXATED TEETH	HYSENSBIO
WO/2021/246797	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER  CONTAINING ANTIVIRAL AGENT AND ANTIDEPRESSANT AS ACTIVE INGREDIENTS	FRONTBIO INC.
WO/2021/256751	COMPOSITION COMPRISING FIBROBLAST-DERIVED EXTRACELLULAR  VESICLE AS ACTIVE INGREDIENT FOR TREATING SKIN AND MUCOSAL WOUND	KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/246833	COMPOSITION, FOR PREVENTING OR TREATING INFLAMMATORY DISEASE,  COMPRISING HYDROLYSIS EXTRACT OF PULSATILLA KOREANA AND ANEMONE RADDEANA AS  ACTIVE INGREDIENT	BACK, Ju Youn
WO/2021/251710	ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
WO/2021/251723	CONDITIONING SHAMPOO COMPOSITION HAVING LAMELLAR STRUCTURE	COSMAX, INC.
WO/2021/251730	COMPOSITION COMPRISING REGENTIDE-034 AND REGENTIDE-041 FOR  SKIN CARE OR WRINKLE REDUCTION	NINEBIOPHARM CO.,LTD.
WO/2021/251756	N-ACYLHYDRAZONE-DERIVATIVE-MARKER CONJUGATE AND PHARMACEUTICAL  COMPOSITION CONTAINING SAME	KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
WO/2021/256773	COSMETIC COMPOSITION COMPRISING FERMENTED CHESTNUT HUSK  EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT	KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
WO/2021/251788	COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING ALLERGIC  DISEASES OR PRURITUS, CONTAINING PENTAPEPTIDE AS ACTIVE INGREDIENT	CAREGEN CO., LTD.
WO/2021/251789	COMPOSITION COMPRISING PENTAPEPTIDE AS ACTIVE INGREDIENT	CAREGEN CO., LTD.
WO/2021/251790	DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY  ACTIVITY AND USE THEREOF	CAREGEN CO., LTD.
WO/2021/251792	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COVID-19  RESPIRATORY SYNDROME	CHONG KUN DANG PHARMACEUTICAL CORP.
WO/2021/256793	COMPOSITION COMPRISING LACTOBACILLUS BACTERIUM-DERIVED VESICLE  FOR PREVENTING OR TREATING METABOLIC DISEASE OR MUSCULAR DISEASE	MD HEALTHCARE INC.
WO/2021/261824	CATIONIC COSMETIC COMPOSITION FOR REINFORCING ADHESION OF  MAKEUP AND PREVENTING RUBBING-OFF THEREOF	COSMAX, INC.
WO/2021/256844	PHARMACEUTICAL COMPOSITION	WHAN IN PHARMACEUTICAL CO., LTD.
WO/2021/256854	COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF  SEPSIS OR SEPTIC SHOCK	INDUSTRIAL COOPERATION FOUNDATION JEONBUK NATIONAL UNIVERSITY
WO/2021/256855	COMPOSITION FOR TREATING METASTATIC SOLID CANCER, COMPRISING  TSG6 INHIBITOR	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY  ERICA CAMPUS
WO/2021/256858	COMPOSITION FOR IMPROVING, PREVENTING OR TREATING  NON-ALCOHOLIC FATTY LIVER DISEASE AND PREPARATION METHOD THEREFOR	WELLNESSBIO INC.
WO/2021/256865	PHARMACEUTICAL COMPOSITION CONTAINING SAURURUS CHINENSIS  FRACTION, AND PREPARATION METHOD THEREFOR	DADANGANDBIO CO., LTD.
WO/2021/261837	ORAL PHARMACEUTICAL COMPOSITION COMPRISING NAFAMOSTAT MESYLATE  AS ACTIVE INGREDIENT	NEWGLAB PHARMA CO.,LTD
WO/2021/261844	ANTI-OBESITY, ANTI-DYSLIPIDEMIA, ANTIOXIDANT OR  ANTI-INFLAMMATORY COMPOSITION CONTAINING ANGELICA DAHURICA EXTRACT	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/256901	COMPOSITION FOR BONE REGENERATION COMPRISING METTL7A  OVEREXPRESSING STEM CELLS, METHOD FOR PREPARING SAME, AND CELL THERAPY  PRODUCT COMPRISING SAME	DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
WO/2021/256904	COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING  COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY  CONTROL FUNCTION	UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY
WO/2021/261855	ZINC TRANSPORTER ACTIVATOR COMPOSITION	METACEN THERAPEUTICS
WO/2021/261870	COMPOSITION COMPRISING 6'-HYDROXY JUSTCIDIN-B, FOR PREVENTING,  AMELIORATING OR TREATING ALLERGIC DISEASES	DONG WHA PHARM. CO., LTD.
WO/2021/261871	COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING  RESPIRATORY DISEASES COMPRISING 6'-HYDROXY JUSTICIDIN B	DONG WHA PHARM. CO., LTD.
WO/2021/261891	METHOD AND COMPOSITION FOR ENHANCING CANCER TREATMENT EFFICACY  OF BACTERIA EXTRACELLULAR VESICLES	ROSETTA EXOSOME CO., LTD.
WO/2021/261895	SOLID CLEANSER COMPOSITION	SHIM, Yeonjeong
WO/2021/261903	COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION FOR  AMELIORATING, PREVENTING, OR TREATING SKIN DISEASES COMPRISING  NATURAL-KILLER-CELL CULTURE-DERIVED EXOSOMES	GREEN CROSS WELLBEING CORPORATION
WO/2021/261909	COMPOSITION FOR PREVENTING OR TREATING FIBROSIS	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/261916	ALCOHOL-BASED DISINFECTANT COMPOSITION HAVING MOISTURIZING  EFFECT, AND PREPARATION METHOD THEREFOR	JINWOO BIO CO., LTD.
WO/2021/261926	LONG-ACTING INJECTION FOR DEMENTIA TREATMENT	AULBIO CO.,LTD.
WO/2021/261927	EYEDROP COMPOSITION COMPRISING DIQUAFOSOL	TAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/261930	OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOL	TAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/261931	OPHTHALMIC COMPOSITION COMPRISING DIQUAFOSOL	TAEJOON PHARMACEUTICAL CO., LTD.
WO/2021/261936	COMPOSITION FOR PREVENTING OR TREATING ENCEPHALITIS AND  DEGENERATIVE BRAIN DISEASES	INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
WO/2021/261941	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS,  COMPRISING FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDES	INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY  ERICA CAMPUS
WO/2021/261965	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF  RETINAL NEURODEGENERATIVE DISEASES, COMPRISING PROX1 INHIBITOR AS ACTIVE  INGREDIENT	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
WO/2021/261966	CYCLODEXTRIN-BASED COMPOSITE COMPOSITION FOR ORAL  ADMINISTRATION AND METHOD FOR PRODUCING SAME	SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION  FOUNDATION
WO/2021/261968	COSMETIC MATERIAL FOR ALLEVIATING DEHYDRATED SKIN, COSMETIC  PRODUCT RECOMMENDATION METHOD BASED ON SELF-DIAGNOSIS OF DEHYDRATED SKIN,  METHOD FOR EVALUATING DEHYDRATED SKIN, AND COSMETIC PRODUCT RECOMMENDATION  METHOD BASED ON MEASUREMENT OF DEHYDRATED SKIN	LG HOUSEHOLD & HEALTH CARE LTD.
WO/2021/261971	COMPOSITION FOR ACNE TREATMENT OR SKIN IMPROVEMENT	PARK, Si Hun
WO/2021/060962	THERAPEUTIC AND PROPHYLACTIC COMPOSITION FOR USE IN DENTISTRY	IBRAGIMOV, Zainulla Faritovich
WO/2021/145755	METHOD FOR SYNERGISTICALLY REDUCING ADVERSE EFFECTS OF AIR  TRAVEL ON HUMAN HEALTH	LURYE, Arman Zhenisovich
WO/2021/187968	PHARMACEUTICAL KIT AND METHOD OF TREATING INFLAMMATORY  PROCESSES	KAMIL LTD
WO/2021/235923	METHOD OF OBTAINING OF THE INACTIVATED VACCINE FOR COVID-19  PROPHYLAXIS	RSE ON ECR "RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY  PROBLEMS" OF CS MES RK
WO/2021/071350	BASIC COMPOSITION FOR MOUTH OR BODY HYGIENE OR FOR HEALTH,  COMPRISING A GROUND SUBSTANCE OR A POWDER OR AN EXTRACT FROM A PLANT OF THE  GENUS WHITE HOREHOUND OR COMMON HOREHOUND	UNINVERSITé INTERNATIONALE D'AGADIR - UNIVERSIAPOLIS
WO/2021/080409	RADIOLABELLED (LYS<sp>3</sp>)BN-IPSMA FOR THE DUAL  RECOGNITION OF THE PSMA AND GRPR PROTEINS <i>IN VIVO</i>	INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES
WO/2021/107752	INK FOR TEMPORARY TATTOOS AND PROCESS FOR PRODUCING IT	ALATORRE MARTíN, Carlos Enrique
WO/2021/125931	SUPPLEMENT COMPRISING A MIXTURE OF CAPSAICIN AND SULFORAPHANE  AS AN ANTI-INFLAMMATORY, ANTI-FIBROTIC AND ANALGESIC COADJUVANT FOR  INFLAMMATION OF THE GASTRIC MUCOSA, GASTRITIS CAUSED BY DIFFERENT AGENTS	CENTRO DE RETINA MéDICA Y QUIRúRGICA, S.C.
WO/2021/010812	SYNERGISTIC COMBINATION OF S-KETOROLAC AND PREGABALIN IN A  PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROPATHIC PAIN	AMEZCUA AMEZCUA, Federico
WO/2021/010814	COMPOSITIONS OF FILM COATINGS FOR TABLETS WITH INCREASED  GLOSS, METHOD FOR PRODUCTION THEREOF AND APPLICATION OF SAME	DVA FARMA MEXICANA S.A. DE C.V.
WO/2021/025550	NANOEMULSION OF 18β-GLYCYRRHETINIC ACID	ATSO CORPORATE AFFAIRS, S.A. DE C.V.
WO/2021/045606	OPHTHALMIC PHARMACEUTICAL COMPOSITION, PREPARATION METHODS AND  USES OF SAME	SOPHIA HOLDINGS, S.A. DE C.V.
WO/2021/125934	FORMULATIONS FOR USE IN THE TREATMENT OF DIFFERENT TYPES OF  ADDICTIONS AND DEPENDENCE ON ADDICTIVE SUBSTANCES	UNIBIOLABS INTERNACIONAL S.A DE C.V
WO/2021/020961	EXTRACT OF <i>PERSICARIA MINOR</i> AND USE FOR  TREATING OR ALLEVIATING SYMPTOMS AND/OR CONDITIONS ASSOCIATED WITH  HYPERURICEMIA	BIOTROPICS MALAYSIA BERHAD
WO/2021/025551	COMPOSITION FOR IMMUNOTHERAPY AND PREPARATION METHOD THEREOF	BADEN R&D LABORATORIES GMBH
WO/2021/235924	METHOD AND COMPOSITIONS FOR IMPROVING SCALP HEALTH	WIPRO MANUFACTURING SERVICES SDN. BHD.
WO/2021/101367	USE OF A COMPOSITION COMPRISING VITAMIN E TOCOTRIENOLS FOR  MANAGING CEREBRAL AUTOSOMAL-DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS  AND LEUKOENCEPHALOPATHY (CADASIL)	HOVID BERHAD
WO/2021/045607	A SUSTAINED RELEASE HYDROGEL COMPOSITION	MALAYSIAN PALM OIL BOARD
WO/2021/101369	A SYNBIOTIC ORAL CARE COMPOSITION	INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA
WO/2021/101370	COMPOSITION(S) COMPRISING AQUEOUS OIL PALM FRUIT EXTRACT FOR  INCREASING TYROSINE HYDROXYLASE LEVELS AND IMPROVING BRAIN HEALTH	MALAYSIAN PALM OIL BOARD
WO/2021/225431	NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING  DAMAGED RETINA AND TREATING VISUAL LESION	LOH, Hui Ling
WO/2021/225432	NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR REPAIRING  DAMAGED LIVER, TREATING DISEASE ASSOCIATED WITH DAMAGED LIVER AND IMPROVING  FUNCTIONS OF LIVER	LOH, Hui Ling
WO/2021/246861	COMPOSITION FOR NORMALISATION OF FATTY LIVER AND METHOD FOR  PRODUCING THE SAME	HOVID BERHAD
WO/2021/246862	POLYOL ESTERS FROM BIOBASED FEEDSTOCKS FOR USE AS EMOLLIENT IN  PERSONAL CARE APPLICATIONS	PETROLIAM NASIONAL BERHAD (PETRONAS)
WO/2021/086172	COMPOSITION COMPRISING EPA, MA AND LEUCINE FOR IMPROVING  MUSCLE FUNCTION	N.V. NUTRICIA
WO/2021/010824	ORAL DISODIUM PYROPHOSPHATE FOR USE IN REDUCING CALCIFICATION	STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/025554	COMBINATION COMPRISING AN ACTIVATOR OF THE GLUCOCORTICOID  RECEPTOR AND AN INHIBITOR OF IFG-1 SIGNALING FOR CARCINOMA TREATMENT	STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/025556	IDENTIFICATION AND ELIMINATION OF HCMV-INFECTED CELLS	STICHTING VU
WO/2021/034192	PHARMACEUTICAL EUTECTIC SALT FORMULATION	SERANOVO HOLDING B.V.
WO/2021/040526	Q-ER PEPTIDE	BIOTEMPT B.V.
WO/2021/066649	METHODS OF TREATMENT FOR MODIFYING HEMODYNAMICS	EBI ANTI SEPSIS B.V.
WO/2021/080421	NOVEL DRUG COMBINATIONS FOR TREATMENT OF A CARCINOMA	STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/080427	CHIMERIC POLYPEPTIDE FOR REGULATING IMMUNE CELLS	STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/086180	HYPER-LOADED METAL-COMPLEXED POLYMERS	STICHTING VUMC
WO/2021/086188	DOSAGE FORM FOR EXTENDED RELEASE OF AN ANTIBODY OR LARGE  PROTEIN	INNOCORE TECHNOLOGIES B.V.
WO/2021/086190	COMPOSITION COMPRISING EPA, MA AND LEUCINE FOR IMPROVING  MUSCLE FUNCTION	N.V. NUTRICIA
WO/2021/091381	PHARMACEUTICAL LIQUID COMPOSITION, KIT OF PARTS COMPRISING THE  PHARMACEUTICAL LIQUID COMPOSITION, AND METHOD FOR PREPARING THE  PHARMACEUTICAL LIQUID COMPOSITION	MPERIUM B.V.
WO/2021/091382	PHARMACEUTICAL LIQUID COMPOSITION, KIT OF PARTS COMPRISING THE  PHARMACEUTICAL LIQUID COMPOSITION, AND METHOD FOR PREPARING THE  PHARMACEUTICAL LIQUID COMPOSITION	MPERIUM B.V.
WO/2021/107775	TEIPP PEPTIDE VARIANT AND USES THEREOF	ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC)
WO/2021/107779	METHOD FOR OBTAINING CAR-NK CELLS	GLYCOSTEM THERAPEUTICS B.V.
WO/2021/118359	COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE	SULFATEQ B.V.
WO/2021/125951	PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR STOPPING  METASTASES	LOGICK ENERGETICS B.V.
WO/2021/133167	TGF-BETA-RII BINDING PROTEINS	MERUS N.V.
WO/2021/141494	PROCESS FOR PREPARING CANNABINOID-CONTAINING PARTICLES	STABICAN B.V.
WO/2021/150109	ABT-751 AND IONIZING RADIATION	STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/158115	ANTIMICROBIAL PEPTIDE FOR TREATMENT AND CONTROLLING SKIN  DISORDERS RELATING TO MICROBIAL INFECTION	CBMR SCIENTIFIC NANOSCIENCE B.V.
WO/2021/167458	USE OF A SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATOR OR OF A  COMBINATION OF A SGC STIMULATOR AND AN SGC ACTIVATOR FOR CONDITIONS WHEREIN  THE HEME GROUP OF SGC IS OXIDIZED OR WHEREIN SGC IS DEFICIENT IN HEME	UNIVERSITEIT MAASTRICHT
WO/2021/172982	THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA  AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA	UNIVERSITEIT MAASTRICHT
WO/2021/172987	TOPICAL DICLOFENAC COMPOSITIONS AND METHODS	FERRING B.V.
WO/2021/177822	MODULATING ANTI-TUMOR IMMUNITY	STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN  LEEUWENHOEK ZIEKENHUIS
WO/2021/182951	SOLID DEEP EUTECTIC SOLVENT FORMULATION PLATFORM	SERANOVO HOLDING B.V.
WO/2021/182958	COMPOSITIONS FOR DISRUPTING BIOFILM FORMATION AND FOR TREATING  BIOFILM-RELATED DISORDERS	AHV INTERNATIONAL
WO/2021/201677	COMPOSITIONS AND METHODS TARGETING INFLUENZA	KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
WO/2021/201679	COMPOSITIONS AND METHODS TARGETING CORONAVIRUSES	KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
WO/2021/201680	TREATMENT OF HYPERINFLAMMATORY SYNDROME	HASAN, Djohan
WO/2021/201685	COMPOSITION AND METHOD FOR PRODUCING A COMPOSITION	BIOPRONEO B.V.
WO/2021/206547	METHODS AND MEANS FOR MODIFYING HEMODYNAMICS IN INFECTIONS	BIOTEMPT B.V.
WO/2021/206548	ANTIMICROBIAL PEPTIDE FOR TREATMENT AND CONTROLLING VIRUS  INFECTIONS	CBMR SCIENTIFIC NANOSCIENCE B.V.
WO/2021/206549	USE OF PHENOL IN TREATMENT OF MICROBIALLY INDUCED DYSPNOEA	LIN, Wen Zhi
WO/2021/206560	USE OF VITAMIN K IN PREVENTING OR COUNTERACTING COVID-19  DISEASE AND DIAGNOSTIC TEST TO ESTIMATE THE RISK OF DEVELOPING SEVERE DISEASE  OR MORTALITY BY COVID-19	EMPHYSEMA SOLUTIONS BV
WO/2021/210984	CORONAVIRUS VACCINE	ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
WO/2021/235936	METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES	MERUS N.V.
WO/2021/246868	CHROMANOL, QUINONE OR HYDROQUINONE COMPOUNDS FOR TREATMENT OF  SEPSIS	SULFATEQ B.V.
WO/2021/261992	CONJUGATE OF GALNAC AND SAPONIN, THERAPEUTIC COMPOSITION  COMPRISING SAID CONJUGATE AND A GALNAC-OLIGONUCLEOTIDE CONJUGATE	SAPREME TECHNOLOGIES B.V.
WO/2021/261993	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COVID-19 AND  RELATED PATHOLOGIES	UNTHREADT B.V.
WO/2021/261995	COMBINATION OF AN ANTIBODY-DRUG CONJUGATE AND AN  ANTIBODY-SAPONIN CONJUGATE	SAPREME TECHNOLOGIES B.V.
WO/2021/261996	HYDRAZONE-BASED SAPONIN DERIVATIVES	SAPREME TECHNOLOGIES B.V.
WO/2021/261998	THERAPEUTIC COMBINATION OF GALNAC-OLIGONUCLEOTIDE CONJUGATE  AND SAPONIN, AND USES THEREOF	SAPREME TECHNOLOGIES B.V.
WO/2021/080438	TREATMENT OF PANCREATIC CANCER	EXACT THERAPEUTICS AS
WO/2021/002763	USE OF A COMPOSITION COMPRISING 3,6,7-TRIMETHYLLUMAZINE FOR  PREVENTING, AMELIORATING OR TREATING MMP-9 ASSOCIATED CONDITIONS AND  INFLAMMATION	COMVITA LIMITED
WO/2021/010843	TRANSDERMAL SOLVENT SYSTEM AND METHODS OF USE	DONAGHYS LIMITED
WO/2021/045632	CANCER VACCINE	VICTORIA LINK LTD
WO/2021/071365	NANOFIBRE MATRIX MADE OF NATURAL POLYMERS WITH NATURAL  FUNCTIONAL INGREDIENTS FOR COSMETIC PRODUCTS	REVOLUTION FIBRES LIMITED
WO/2021/154102	METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEMANGIOMA	DAVIS, Paul Frank
WO/2021/201699	ANTIVIRAL TREATMENT COMPRISING BLIS CONTAINING PROBIOTIC  PRODUCTS	BLIS TECHNOLOGIES LIMITED
WO/2021/206566	VIRAL TREATMENTS INVOLVING MANUKA HONEY AND COMPONENTS THEREOF	MANUKAMED LIMITED PARTNERSHIP
WO/2021/215938	ANTI-VIRAL METHODS AND COMPOSITIONS	OHA HONEY LIMITED PARTNERSHP
WO/2021/242123	MEDICAMENT BASED ON EXTRACTS OF EIGHT (8) MEDICINAL PLANTS FOR  COVID-19 TREATMENT	KLEDA, Samuel
WO/2021/242124	MEDICAMENT BASED ON A MIXTURE OF ESSENTIAL OILS OF SEVEN (7)  MEDICINAL PLANTS FOR COVID-19 TREATMENT, USED ALONE OR IN COMBINATION WITH  THE MIXTURE OF EXTRACTS OF EIGHT (8) OTHER MEDICINAL PLANTS	KLEDA, Mgr Samuel
WO/2021/173017	ANNONA RE-GROWTH HAIR CREAM	AL KHANBASHI, Manal
WO/2021/071371	A HERBAL MEDICINE COMPOSITIONS FOR TREATMENT OF DENGUE AND  THEIR PRODUCTION	DE LA SALLE MEDICAL AND HEALTH SCIENCES INSTITUTE
WO/2021/060998	PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF NERVOUS TISSUE  DYSFUNCTION, IN PARTICULAR VIRAL LATENCY, AND THE USE OF J05 ATC GROUP  SUBSTANCES IN TREATMENT OF NERVOUS TISSUE DYSFUNCTION, IN PARTICULAR VIRAL  LATENCY	CHUPTYŚ CONTISSI, Janusz
WO/2021/118374	INTRATHECAL ADMINISTRATION OF T REGULATORY CELLS IN THE  TREATMENT OF MULTIPLE SCLEROSIS	GDAŃSKI UNIWERSYTET MEDYCZNY
WO/2021/141506	AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A1, THEIR  SYNTHESIS AND USE	UNIWERSYTET JAGIELLOŃSKI
WO/2021/141507	AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR  SYNTHESIS AND USE	UNIWERSYTET JAGIELLOŃSKI
WO/2021/006753	A BASE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT	BIOTTS S.A.
WO/2021/020978	POWDERED PLANT PREPARATION, THE MANNER IN WHICH IT IS  OBTAINED, MICROGRANULES AND TABLETS OBTAINED FROM THAT PREPARATION AND THE  WAYS OF PRODUCING THEM	BIOFITON SP. Z O.O.
WO/2021/235954	COMPOSITION FOR TREATMENT OF AMERICAN FOULBROOD IN BEES AND  EXTRACT FROM POLYPOROID FUNGUS, IN PARTICULAR <i>TYROMYCES  FISSILIS</i>, FOR USE IN TREATMENT AND/OR PROPHYLAXIS OF AMERICAN  FOULBROOD IN BEES	INSTYTUT INNOWACJI I TECHNOLOGII POLITECHNIKI BIAŁOSTOCKIEJ  SP. Z O.O.
WO/2021/049963	PHARMACEUTICAL COMPOSITION OF BIMATOPROST AND TIMOLOL	WARSZAWSKIE ZAKŁADY FARMACEUTYCZNE POLFA SA
WO/2021/075988	RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC  AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING  IT AND USES THEREOF	MIĘDZYNARODOWY INSTYTUT BIOLOGII MOLEKULARNEJ I KOMóRKOWEJ W  WARSZAWIE
WO/2021/107794	METHOD OF MAKING A SYSTEM CONTAINING GOLD NANOPARTICLES AND  USE OF THE SYSTEM IN ANTITUMOR THERAPY	INSTYTUT FIZYKI JĄDROWEJ IM. HENRYKA NIEWODNICZAŃSKIEGO PAN
WO/2021/162562	STABLE RAMIPRIL COMPOSITION AND FIXED DOSE COMPOSITION  COMPRISING THEREOF	ADAMED PHARMA S.A.
WO/2021/201705	USE OF SULFONATED POLYSTYRENE DERIVATIVES IN THE TREATMENT  AND/OR PROPHYLAXIS OF INFECTION CAUSED BY ZIKA VIRUS	UNIWERSYTET JAGIELLONSKI
WO/2021/215942	COSMETIC COMPOSITION COMPRISING HEMP OIL	JANKOWIAK, Janusz Ryszard
WO/2021/221521	A SOLID CO-AMORPHOUS DISPERSION OF VALSARTAN, A METHOD FOR  SYNTHETIZING THE SAME AND A MEDICAL USE OF THE DISPERSION	UNIWERSYTET HUMANISTYCZNO-PRZYRODNICZY IM JANA DLUGOSZA W  CZESTOCHOWIE
WO/2021/162563	LIPOPOLYSACCHARIDES FOR TREATING FOOD ALLERGIES	UNIWERSYTET WARSZAWSKI
WO/2021/167477	METHOD OF OBTAINING OF PREPARATION FROM MUCUS OF ARION RUFUS  OR LIMAX MAXIMUS SLUGS, EXHIBITING BIOLOGICAL PROPERTIES AGAINST  KERATINOCYTES AND MELANOMA CELLS	UNIWERSYTET MEDYCZNY IM. PIASTóW ŚLĄSKICH WE WROCŁAWIU
WO/2021/173020	FORMULATION OF A TURMERIC EXTRACT COMPRISING CURCUMINOIDS,  METHOD OF PRODUCTION THEREOF, THE USE OF THE FORMULATION AND PRODUCTS  COMPRISING THEREOF	NOMI BIOTECH CORPORATION SP. Z O.O.
WO/2021/210997	WATER-SOLUBLE, MODIFIED AMINO ACID DERIVATIVES FOR TREATMENT  OF NEUROLOGICAL DISEASES, AND SELECTED PSYCHIATRIC DISORDERS	UNIWERSYTET JAGIELLOŃSKI
WO/2021/246884	COMPOSITION CONTAINING CANNABINOIDS	HEALTHCANNSP.ZO.O.
WO/2021/246886	COMPOUNDS FOR THE TREATMENT OR DIAGNOSIS OF COVID-19	POLITECHNIKA WROCŁAWSKA
WO/2021/262019	SYNERGISTIC COMPOSITION OF PHAGES AND ITS FORMATION METHOD	PROTEON PHARMACEUTICALS S.A.
WO/2021/167478	4-PYRROLIDIN-1-YL-5-P-TOLYL-THIENO[2,3-D] PYRIMIDINE FOR USE  IN THE TREATMENT OF AGING-ASSOCIATED AND PREMATURE AGING DISEASES THROUGH  RESTORED CHROMOSOMAL STABILITY AND INHIBITION OF CELLULAR SENESCENCE	IBMC - INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR
WO/2021/182981	MICRONISED OPICAPONE	BIAL - PORTELA & Ca, S.A.
WO/2021/201710	THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND  ASSOCIATED BIOMARKERS BASED ON TRK-B	INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/246890	DIETARY SUPPLEMENT FOR IMPROVED IMMUNE HEALTH AND METHOD OF  TREATMENT FOR CORONAVIRUS USING SAME	QATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY  DEVELOPMENT
WO/2021/251842	TARGETING OF LACTATE DEHYDROGENASE C, METHODS OF PREPARING  SAME, AND METHODS OF USING SAME IN COMBINATION WITH ANTI-CANCER TREATMENTS	QATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY  DEVELOPMENT
WO/2021/107799	MEDICAL DEVICE FOR TEMPORIZATION	ARAMA, Stefan Sorin
WO/2021/066672	USE OF ALHAGI PSEUDALHAGI PLANT EXTRACT (VARIANTS)	MUSAKHANOVA, Oygul Mirzayusufovna
WO/2021/025584	FULLERENE-CONTAINING ORAL CARE PRODUCTS	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SPLAT  GLOBAL"
WO/2021/025585	USE OF DENDRIMERS IN AGENTS FOR CARE OF THE TEETH AND ORAL  CAVITY	OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'YU "SPLAT  GLOBAL"
WO/2021/133191	COMPOSITION FOR REMINERALIZING TOOTH ENAMEL	MATELO, Svetlana Konstantinovna
WO/2021/040563	EXFOLIATING POWDER	EGOROVSKAIA, Irina Sergeevna
WO/2021/167481	MICELLIZED SOLUTION OF FULLERENES, AND METHOD FOR THE  PRODUCTION AND USE THEREOF	JOINT STOCK COMPANY AQUANOVA RUS
WO/2021/002771	CONJUGATE OF FLUORESCENT DYE FOR THE VISUALIZATION OF PSMA  EXPRESSING CELLS	OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU IZVARINO FARMA
WO/2021/020992	METHOD FOR PURGING THE INTESTINE AND KIT FOR IMPLEMENTING SAME	OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU  "GELESPON"
WO/2021/206581	GENETIC CONSTRUCT-BASED VACCINE AGAINST CORONAVIRUS INFECTION	DUKHOVLINOV, Ilya Vladimirovich
WO/2021/225463	ANTI-RNA VIRAL PHARMACEUTICAL COMPOSITION AVIFAVIR EFFECTIVE,  INTER ALIA, AGAINST SARS-COV-2	LIMITED LIABILITY COMPANY "CHROMIS" (LLC  "CHROMIS")
WO/2021/096388	COMPOSITION WITH A PROLONGED ANTIBACTERIAL EFFECT	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SPLAT  GLOBAL"
WO/2021/061006	COMPOSITION FOR CORRECTING THE BEHAVIOUR OF CATS AND DOGS	OBSHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU  "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "SKIFF"
WO/2021/242134	METHOD FOR TREATING RNA VIRAL INFECTIONS, INTER ALIA COVID-19  (SARS-COV-2)	LIMITED LIABILITY COMPANY "CROMIS" (LLC  "CROMIS")
WO/2021/020997	TREATMENT FOR HOT FLUSHES, AND RE-ESTABLISHING A MENSTRUAL  CYCLE DURING THE PERIMENOPAUSE	OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTJU  "PARAPHARM"
WO/2021/221532	SARS-COV-2 ANTIVIRAL DRUG ANTIPROVIR	IVASHCHENKO, Andrey Alexandrovich
WO/2021/002776	IMMUNOBIOLOGICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST  SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2	FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH  CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN  N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION
WO/2021/211006	INHALED HEXAPEPTIDE FOR TREATING INTERLEUKIN-6 RELATED  RESPIRATORY DISEASES	FEDERAL STATE BUDGETARY INSTITUTION CENTER OF BIOMEDICAL  TECHNOLOGIES OF FEDERAL MEDICAL AND BIOLOGICAL AGENCY
WO/2021/061009	PANCREATIN MICROCAPSULES	AVVA RUS, JOINT STOCK COMPANY
WO/2021/118400	PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGICAL  DISEASES (VARIANTS)	BARANNIKOV, Aleksandr Evgen'evich
WO/2021/080464	METHOD FOR RESTORING REPRODUCTIVE FUNCTION IN WOMEN	KISELEV, Vsevolod Ivanovich
WO/2021/076009	EXPRESSION VECTOR AGAINST SEVERE ACUTE RESPIRATORY SYNDROME  VIRUS SARS-COV-2	FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH  CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN  N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION
WO/2021/076010	PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST  SARS-COV-2	FEDERAL STATE BUDGETARY INSTITUTION "NATIONAL RESEARCH  CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAMED AFTER THE HONORARY ACADEMICIAN  N.F. GAMALEYA" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION
WO/2021/137722	PHARMACEUTICAL COMPOSITION CONTAINING COMPLEXES OF ALLOFERON  AND ZINC	BEKKER, German Petrovich
WO/2021/101409	METHOD FOR PREVENTING AND TREATING MOTION SICKNESS	PASTUSHENKOV, Vladimir Leonidovich
WO/2021/118403	SYSTEM FOR DELIVERING 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE  SUCCINATE FOR PERORAL ADMINISTRATION	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU  "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "PHARMASOFT"
WO/2021/015647	EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACTS	KORSAKOVA, Nadezhda Vitalevna
WO/2021/133221	MEANS FOR IMPROVING REPRODUCTIVE FUNCTION	FLOROVA, Marina Aleksandrovna
WO/2021/021005	USE OF N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3.3.1]NONANE  DERIVATIVES FOR TREATING DEPRESSION	OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "KIU EM  FARMA"
WO/2021/049978	HEMOSTATIC COMPOSITION WITH REPARATIVE PROPERTIES (VARIANTS)	LIMITED LIABILITY COMPANY "KHIMIKO-FARMATSEVTICHESKIE  TEKHNOLOGII"
WO/2021/040570	MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES	EPSHTEIN, Oleg Iliich
WO/2021/034228	AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-PD1 ANTIBODY  PROLGOLIMAB AND USE THEREOF	JOINT STOCK COMPANY "BIOCAD"
WO/2021/049980	NOVEL COMPOSITIONS FOR TREATMENT AND PROPHYLAXIS OF VIRAL  DISEASES	LTD "VALENTA-INTELLEKT"
WO/2021/054863	STIMULATOR OF TESTICULAR TISSUE REPARATIVE REGENERATION  PROCESSES	ROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054864	USE OF A COMPLEX OF  9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH B-CYCLODEXTRIN TO  CORRECT DISORDERS OF SPERMATOGENESIS	ROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054865	USE OF A COMPLEX OF  9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH B-CYCLODEXTRIN TO  TREAT PATHOZOOSPERMIA	ROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054866	USE OF A PHARMACEUTICAL COMPOSITION OF B-CYCLODEXTRIN WITH  9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE TO INCREASE/RESTORE  LIBIDO	ROZIEV, Rakhimdzhan Akhmetdzhanovich
WO/2021/054867	IMMUNOCYTOKINE COMPRISING HETERODIMERIC PROTEIN COMPLEX BASED  ON IL-15/IL-15Rα	JOINT STOCK COMPANY "BIOCAD"
WO/2021/118407	METHOD FOR A COSMETIC EFFECT ON FACIAL KERATIN MATERIAL	REM, Anastasia Valerievna
WO/2021/211013	PHARMACEUTICAL COMPOSITION COMPRISING MACOZINONE FOR TREATING  TUBERCULOSIS	OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "NIARMEDIK  PLYUS"
WO/2021/076020	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PROPHYLAXIS  OF INFECTIOUS INFLAMMATORY DISEASES	GAPONOV, Andrey Mikhaylovich
WO/2021/194375	DRUG FOR TREATING CORONAVIRAL AND RETROVIRAL INFECTIONS AND  HEPATITIS C	LASKAVYI, Vladislav Nikolaevich
WO/2021/112724	MIRTAZAPINE AND TIZANIDINE COMBINATION FOR USE IN PAIN  DISORDERS	LTD "VALENTA-INTELLEKT"
WO/2021/137738	COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES OF THE THROAT	SHAMTSYAN, Mark Markovich
WO/2021/221537	SARS-COV-2 ANTIVIRAL DRUG ANTIPROVIR	IVASHCHENKO, Andrey Alexandrovich
WO/2021/242136	DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY  BETACORONAVIRUSES	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU  "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "PHARMASOFT"
WO/2021/173036	PHARMACEUTICAL COMPOSITION BASED ON DIPEPTIDYL PEPTIDASE-4  INHIBITOR	OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU  "NEOBIOTEK"
WO/2021/225467	SARS-COV-2 ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE  THEREOF	LIMITED LIABILITY COMPANY "CROMIS" (LLC  "CROMIS")
WO/2021/225468	SARS-COV-2 ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE  THEREOF	LIMITED LIABILITY COMPANY "CROMIS" (LLC  "CROMIS")
WO/2021/188012	DRUG IN THE FORM OF A COMPLEX OF 3,3’-DIINDOLYLMETHANE WITH  β-CYCLODEXTRIN	KISELEV, Vsevolod Ivanovich
WO/2021/188013	METHOD FOR TREATING ENDOMETRIOSIS AND CONCOMITANT FORMATION OF  ADHESIONS	KISELEV, Vsevolod Ivanovich
WO/2021/145795	BIOADHESIVE ANTIBACTERIAL AGENT AND METHOD FOR MANUFACTURING  SAME (VARIANTS)	AKCIONERNOE OBSHCHESTVO "PROIZVODSTVENNAYA  FARMACEVTICHESKAYA KOMPANIYA OBNOVLENIE"
WO/2021/225469	BIOLOGICALLY ACTIVE COMPLEX, AND TOOTHPASTE AND MOUTHWASH  BASED THEREON	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "SPLAT  GLOBAL"
WO/2021/206587	SARS-COV-2 DNA VACCINE BASED ON GENE THERAPY DNA VECTOR  GDTT1.8NAS12	GENETIC DIAGNOSTICS AND THERAPY 21 LTD
WO/2021/242142	STABLE AQUEOUS PHARMACEUTICAL COMPOSITION FOR INHALATION  CONTAINING A HEXAPEPTIDE	FEDERAL STATE BUDGETARY INSTITUTION SCIENTIFIC CENTER OF  BIOMEDICAL TECHNOLOGIES OF FEDERAL MEDICAL AND BIOLOGICAL AGENCY
WO/2021/256961	SINGLE USE PERFUME AND COSMETIC DRY PRODUCT	SHKOLNY, Vladimir Nikolaevich
WO/2021/225471	METHOD FOR TRANSLUCENT DYEING OF HAIR (VARIANTS) AND  COMPOSITION FOR THE IMPLEMENTATION THEREOF	DIKUNOVA-PERTSEVA, Yulia
WO/2021/206589	COMPOSITION FOR THE PREVENTION OR TREATMENT OF ENDOTHELIAL  DYSFUNCTION	SOLOVYEV, Nikolay Vladimirovich
WO/2021/235977	METHOD FOR TREATING ENDOMETRIOSIS WITH ASSOCIATED PAIN  SYNDROME	KISELEV, Vsevolod Ivanovich
WO/2021/235983	DRUG WITH PROLONGED ANALGESIC ACTION	FEDERALNOJE GOSUDARSTVENNOJE BUDZHETNOJE UCHREZHDENIE NAUKI  TIKHOOKEANSKY INSTITUT BIOORGANICHESKOI KHIMII IM. G.B.ELYAKOVA  DALNEVOSTOCHNOGO OTDELENIYA ROSSYSKOI AKADEMII NAUK (TIBOKH DVO RAN)
WO/2021/262040	USE OF A GLUTARIMIDE DERIVATIVE FOR TREATING DISEASES  ASSOCIATED WITH ABERRANT INTERLEUKIN-6 ACTIVITY	LTD “VALENTA-INTELLEKT”
WO/2021/107825	X-RAY SENSITIVE STAIN FOR TEETH FRACTURE DETECTION	ALJARBOU, Fahd
WO/2021/137743	UNIQUE HERBAL COMBINATION FOR THE TREATMENT OF ANAL FISSURES  AND WOUNDS IN PHARMACEUTICAL DOSAGE FORM	SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES  CORPORATION SPIMACO ADDWAEIH
WO/2021/010888	NOVEL BSSL ANTIBODIES	LIPUM AB
WO/2021/029813	PREVENTING AND TREATING HYPOGLYCEMIA	DIAMYD MEDICAL AB
WO/2021/040600	DESLORATADINE AND/OR LORATADINE FOR TREATMENT AND/OR  PROPHYLACTIC TREATMENT OF MELANOMA	HAKMED AB
WO/2021/071413	YEAST FOR THE TREATMENT OF ALLERGY	MILMED UNICO AB
WO/2021/071419	VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER	WAI, Sun Nyunt
WO/2021/076033	DESLORATADINE FOR THE TREATMENT AND/OR PROPHYLAXIS OF CANCERS	HAKMED AB
WO/2021/076043	USE OF TERM AMNIOTIC FLUID CELLS FOR THE TREATMENT OF ACUTE  AND CHRONIC RESPIRATORY DISEASES	AMNIOTICS AB
WO/2021/080500	TREATMENT OF INFLAMMATORY CONDITION IN MUCOUS MEMBRANE OR SKIN	MUCOCORT AB
WO/2021/086252	STABILIZED AMORPHOUS CALCIUM MAGNESIUM PHOSPHATE PARTICLE  COMPOSITIONS	PSILOX AB
WO/2021/091474	SEROTONIN PRODUCING BACTERIA	BIOGAIA AB
WO/2021/107835	ORAL ADMINISTRATION OF IRON SUCCINATE FOR USE IN TREATING IRON  DEFICIENCY IN PATIENTS HAVING HEART FAILURE	DOUBLE BOND PHARMACEUTICALS AB
WO/2021/101433	CARBAZATE-ACTIVATED POLYVINYL ALCOHOL (PVAC) AS A  POLYMER-BASED ANTITUMORAL AGENT	BERGLUND, David
WO/2021/145807	PEG-LIPID	ICOAT MEDICAL AB
WO/2021/173069	NANOPARTICLES FOR USE IN THE TREATMENT AND DIAGNOSIS OF CNS  DISORDERS	UPPSALA THERAPEUTICS AB
WO/2021/177882	FORMULATION COMPRISING CALCIUM SILICATE	ADURO MATERIAL AB
WO/2021/201765	NEW COMPOSITIONS FOR ORAL OR NASAL USE	LIW INNOVATION AB
WO/2021/206623	SOLUBLE ACE2 FOR TREATMENT OF COVID-19	MARKO-VARGA, György
WO/2021/211039	MIV-818/LENVATINIB COMBINATION THERAPY FOR LIVER CANCER	MEDIVIR AB
WO/2021/211043	TREATMENT OF CORONAVIRUS INFECTIONS	TX MEDIC AB
WO/2021/211044	TREATMENT OF SEPSIS AND HYPERCYTOKINEMIA	TX MEDIC AB
WO/2021/215987	COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF  RESPIRATORY INFECTIONS	BONOSS MEDICAL AKTIEBOLAG
WO/2021/225509	NEW COMPOSITIONS FOR ORAL OR NASAL USE	LIW INNOVATION AB
WO/2021/225510	A SUNSCREEN COMPOSITION COMPRISING HIGHLY POROUS AMORPHOUS  MESOPOROUS MAGNESIUM CARBONATE AND A CHEMICAL UV FILTER	DISRUPTIVE MATERIALS OPERATIONS AB
WO/2021/230804	FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY	TRANSMED GOTHENBURG AB
WO/2021/040610	RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOF	IMUNAMI LABORATORIES PTE. LTD.
WO/2021/021014	PHARMACEUTICAL PREPARATION WITH CURCUMINOIDS NANOPARTICLES AND  A METHOD FOR PRODUCING THE SAME	AASTAR PTE LTD
WO/2021/262081	RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE  TREATMENT OF CANCER	IMUNAMI LABORATORIES PTE. LTD.
WO/2021/066740	METHOD OF PREPARATION WHITE EMULSIFIED SCENTED CROCODILE OIL	LIANG CHIEH, Wee
WO/2021/034267	FORMULATIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF  PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES.	LOH, Yin Sze
WO/2021/010898	TREATMENT/PREVENTION OF DISEASE BY LINC COMPLEX INHIBITION	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/021021	TREATMENT OF DILATED CARDIOMYOPATHY AND/OR CARDIAC FIBROSIS	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/025618	USE OF AN OSMOLYTE IN MANUFACTURE OF A MEDICAMENT FOR  TREATMENT OF OCULAR DISORDERS	SINGAPORE HEALTH SERVICES PTE LTD
WO/2021/025625	COMPOUNDS FOR HEPATITIS B TREATMENT	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/034272	TREATMENT OF IDIOPATHIC HYPOHIDROSIS	NATIONAL SKIN CENTRE (SINGAPORE) PTE LTD
WO/2021/040627	A METHOD OF PROMOTING SURVIVAL AND/OR FUNCTION OF A MOTOR  NEURON AND RELATED AGENTS, USES AND METHODS	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/045686	HETEROCYCLIC COMPOUNDS AS MODULATORS OF BETA-CATENIN / TCF4  INTERACTION	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/066747	SELF-ADMINISTRABLE AND IMPLANTABLE POLYMERIC MICRO-LANCE  SHAPED DEVICE FOR CONTROLLED AND TARGETED DELIVERY	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/071431	GENETICALLY MODIFIED T CELLS AND USES THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/086266	DNMT1 -SPECIFIC APTAMERS AND PRODUCTION AND USES THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/112772	INFLAMMATION-RESPONSIVE ANTI-INFLAMMATORY HYDROGELS	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/118465	A PHARMACEUTICAL FORMULATION FOR INHIBITING BODY MALODOUR	NATIONAL SKIN CENTRE (SINGAPORE) PTE LTD
WO/2021/118469	USE OF VALPROIC ACID FOR REDUCING POST-OPERATIVE SCARRING  FOLLOWING A GLAUCOMA SURGERY	SANTEN PHARMACEUTICAL CO., LTD.
WO/2021/126087	METHOD FOR TREATING ANGELMAN SYNDROME AND RELATED DISORDERS	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/141538	COMBINATION THERAPY	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/145821	NUCLEIC ACID LOADED RED BLOOD CELL EXTRACELLULAR VESICLES	CARMINE THERAPEUTICS PTE. LTD.
WO/2021/183059	METHODS OF TREATING, PREVENTING OR AMELIORATING DEPRESSION OR  ANXIETY WITH CAROTENOIDS	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
WO/2021/188052	USE OF A COMPOUND OR COMPOSITION COMPRISING AN INHIBITOR OF  NLRP1 INFLAMMASOME ACTIVATION FOR THE TREATMENT OF HUMAN AIRWAY INFLAMMATION	NANYANG TECHNOLOGICAL UNIVERSITY
WO/2021/188055	MODULATION OF CXCR3 CHEMOKINE SIGNALLING FOR OSTEOPOROSIS  THERAPY	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/194428	RINSE-FREE SANITIZER	CHAMPS INNOVATIONS PTE. LTD.
WO/2021/206633	METHODS AND COMPOSITIONS FOR TREATING LIVER CANCER	ENGINE BIOSCIENCES PTE. LTD.
WO/2021/236016	COMPOSITIONS AND METHODS FOR THE DELIVERY OF AGENTS TO  BIOLOGICAL TARGETS	FORMULYTICA PTY LTD.
WO/2021/246966	COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOF	NATIONAL UNIVERSITY OF SINGAPORE
WO/2021/188059	COLLOID SILVER FOR USE AND METHOD FOR ITS PREPARATION	MARKOVIĆ, Danijela
WO/2021/006822	PHARMACEUTICAL COMPOSITIONS HAVING SYNERGISTIC EFFECTS OF  NATURAL EXTRACTS FOR CANCER TREATMENT UNDERGOING CHEMOTHERAPY	CHIANGMAI UNIVERSITY
WO/2021/021032	A COMPOSITION CONTAINING CASHEW LEAF EXTRACT AND PRODUCTION  METHOD THEREOF	MARK ONE INNOVATION CENTER COMPANY LIMITED
WO/2021/034276	YEAST HAVING IMPROVEMENT OF LACTIC ACID TOLERANCE AND USE  THEREOF	PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED
WO/2021/080519	SNAIL MUCUS COLLECTION PROCESS AND ITS USE	PUTTARATHUVANUN, Kitpong
WO/2021/242180	A COMPOSITION AND A METHOD OF REJUVENATING DNA AND PREVENTING  DNA DAMAGE	CHULALONGKORN UNIVERSITY
WO/2021/066754	COMPOSITION OF DURIAN AND MANGOSTEEN EXTRACTS AND METHOD OF  PREPARATION THEREOF	TIPSURAT CO., LTD.
WO/2021/236023	FERMENTED - CONCENTRATED EXTRACTION METHOD OF HOUTTUYNIA  CORDATA FOR MEDICAL USING	RINCOME, Udom
WO/2021/257006	A PHYTOMEDICINE AND ITS DERIVATIVES EFFECTIVE AGAINST HAND,  FOOT AND MOUTH DISEASE (HFMD) BASED UPON <i>OROXYLUM INDICUM </i>	MAHIDOL UNIVERSITY
WO/2021/257007	AN ANTIVIRAL PHARMACEUTICAL COMPOSITION WITH THERAPEUTIC AGENT  ORIGINATED FROM<i> ASTRAEUS ASIATICUS</i>	MAHIDOL UNIVERSITY
WO/2021/242184	A PHARMARCEUTICAL COMPOSITION CAPABLE OF INHIBITING  REPLICATION OF CORONAVIRUS	MAHIDOL UNIVERSITY
WO/2021/101458	LOTION FOR HAIR AND HAIR SKIN	ÇETİN, Aydın
WO/2021/034281	A METHOD FOR PRODUCING A BIOACTIVE COMPONENT-CONTAINING  NANO-COMPOSITE, AND A MONTMORILLONITE-BASED, BIOACTIVE COMPONENT-CONTAINING  NANO-COMPOSITE	BEZMIALEM VAKIF UNIVERSITESI
WO/2021/071444	A UNIQUE GRANULATION PROCESS FOR RIVAROXABAN CONTAINING  GRANULES	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/076066	ORAL FORMULATIONS COMPRISING SITAGLIPTIN HCI MONOHYDRATE WITH  IMPROVED PHARMACEUTICAL CHARACTERISTICS	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/080527	TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING DIFLUOCORTOLONE  AND ISOCONAZOLE	PHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/080529	SOLID PHARMACEUTICAL FORMULATIONS COMPRISING TICAGRELOR	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/091498	PHARMACEUTICAL COMPOSITIONS COMPRISING TENOFOVIR AND  EMTRICITABINE	PHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/096444	PHARMACEUTICAL COMPOSITIONS COMPRISING TICAGRELOR	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/096446	ASC SPECKS IN CANCER IMMUNOTHERAPY	BOGAZICI UNIVERSITESI
WO/2021/101461	ORAL SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING LANTHANUM  CARBONATE OCTAHYDRATE	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/101466	A METHOD FOR PRODUCING MULTIVIRUS SPECIFIC T CELLS	ACIBADEM LABMED SAĞLIK HİZMETLERİ A.Ş.
WO/2021/126096	2-[2-({12,12-DIMETHYL-4-OXO-6-PHENYL-3,11-DIOXATRICYCLO[8.4.0.0,2,7]TETRADECA-1,5,7,9-TETRAEN-8-YL}OXY)ACETAMIDO]BENZAMIDE  AND DERIVATIVES AS INHIBITOR OF CLOCK:BMAL1 INTERACTION FOR THE TREATMENT OF  CIRCADIAN RHYTHM DISEASES AND DISORDERS	KOC UNIVERSITESI
WO/2021/101467	A METHOD FOR REDESIGN AND EXPANSION OF NK92 CELLS FOR USE IN  IMMUNOTHERAPY	ACIBADEM MEHMET ALİ AYDINLAR üNİVERSİTESİ
WO/2021/126098	GASTRO-RESISTANT PELLET COMPRISING DULOXETINE	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/126099	AN ENTERIC COATED PELLET COMPRISING DULOXETINE HYDROCHLORIDE  WITH OPTIMIZED DEGREES OF NEUTRALIZATION	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/025643	COMPOUNDS EXHIBITING ANTI-TUBERCULOSIS ACTIVITY	ANADOLU üNİVERSİTESİ
WO/2021/096449	SKIN-PRICK TEST MATERIAL AND PRODUCTION METHOD TO BE USED IN  THE DIAGNOSIS OF ALLERGY FROM CLADOSPORIUM HERBARUM, CLADOSPORIUM  CLADOSPORIOIDES AND ALTERNARIA ALTERNATA MOLDS	CUKUROVA UNIVERSITESI REKTORLUGU
WO/2021/118485	A PRODUCTION METHOD OF BIOACTIVE SUBSTANCE THYMOKINONE BY  USING AY-YLDIZ CATALYST WHITH USE POTENTIAL IN CANCER TREATMENT	CUKUROVA UNIVERSITESI REKTORLUGU
WO/2021/133279	A SOLID ORAL PHARMACEUTICAL GEMIFLOXACIN MESYLATE COMPOSITION  WITH IMPROVED RELEASE PATTERN AND DISINTEGRATION MECHANISM	SANTA FARMA İLAÇ SANAYİ A.Ş.
WO/2021/101469	A DRUG FOR ANTICANCER AND ANTIVIRAL TREATMENT AND SYNTHESIS  METHOD THEREOF	GAZIANTEP UNIVERSITESI REKTORLUGU
WO/2021/137771	11-(4-CHLOROPHENYL)-4-(2,3-DIHYDRO-1H-INDOLE-1-CARBONYL)-3,11-DIMETHYL-5,10,DIOXATRICYCLO[7.4.0.0,2,6,]TRIDECA-1,3,6,8-TETRAEN-13-ONE  AND DERIVATIVES AS DESTABILIZER OF CRY1 FOR THE TREATMENT OF CIRCADIAN RHYTHM  ASSOCIATED DISEASES AND DISORDERS	KOC UNIVERSITESI
WO/2021/257009	A DRUG-FREE ANTIBACTERIAL LOTION	ERDOGAN, Fatma Gulru
WO/2021/145830	PHARMACEUTICAL COMPOSITIONS COMPRISING MESALAMINE AND RELEVANT  EXCIPIENTS IN THE TREATMENT OF ULCERATIVE COLITIS	PHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/145831	PHARMACEUTICAL COMPOSITIONS COMPRISING TADALAFIL AND RELEVANT  EXCIPIENTS	PHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/150178	PHARMACEUTICAL COMPOSITIONS COMPRISING IBUPROFEN,  PSEUDOEPHEDRINE AND ASCORBIC ACID	PHARMACTİVE İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/137780	PREPARATION OF FILM TABLET COMPOSITION COMPRISING HEME IRON  FOR IRON DEFICIENCY	İLKO İLAÇ SANAYİ VE TİCARET A.Ş.
WO/2021/133284	A COMPOSITION OF HYALURONIC ACID AND HYDROLYZED COLLAGEN WITH  VITAMINS AND ITS PRODUCTION METHOD	MELİKOĞLU, Ahmet
WO/2021/133285	A HERBAL PERFORMANCE ENHANCEMENT MIX AND ITS PRODUCTION  PROCESS	MELİKOĞLU, Ahmet
WO/2021/162647	A NOVEL PROCESS FOR PREPARATION OF PAZOPANIB HYDROCHLORIDE	DEVA HOLDING
WO/2021/173091	A HAIR CARE PRODUCT	QUEENSMED İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ
WO/2021/177907	AN HERBAL MEDICINE	GüVEN, Şefik
WO/2021/167554	USE OF SYNTHESIZED COMPOUNDS AS AN INHIBITOR OF EF2-KINASE  ENZYME	CANAKKALE ONSEKIZ MART UNIVERSITESI REKTORLUGU
WO/2021/025644	COMPOUNDS EXHIBITING ANTI-TUBERCULOSIS ACTIVITY	ANADOLU üNİVERSİTESİ
WO/2021/194436	THE NATURAL ANTIVIRAL AND ANTI-INFLAMMATORY COMPOUND CONSIST  OF BIOFLAVONOIDS WHICH EXTRACTED FROM PAPAVER RHOEAS RED PETALS	NANOBIOMED SAĞLIK VE YAŞAM BILIMLERI A. Ş.
WO/2021/188066	A PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION HAVING  ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER  CHARACTERISTICS	BASLIK, Hakan
WO/2021/054909	A METHOD OF OBTAINING STROMAL VASCULAR FRACTION	T-BİYOTEKNOLOJİ LABORATUVAR ESTETİK MEDİKAL KOZMETİK SAN TİC  LTD ŞTİ
WO/2021/216012	A SYSTEM THAT PREVENTS COVID19 VIRUSES FROM GETTING INTO THE  BODY AND REMOVES IT FROM THE BODY	ÇALIŞ, Bilal
WO/2021/225533	A STAR BLOCK COPOLYMER USED AS DRUG CARRIER FOR TREATMENT OF  CANCER	İLMOR KİMYA VE TEKSTİL SANAYİ VE TİCARET LİMİTED ŞİRKETİ
WO/2021/101475	SYNTHESIS AND IMPROVEMENT OF A NUCLEOSIDE ANALOGUE AS AN  ANTI-CANCER AND ANTI-VIRAL DRUG	GAZIANTEP UNIVERSITESI REKTORLUGU
WO/2021/201791	PROPOLIS EXTRACT CONTAINING LACTIC ACID	APİPARK ARICILIK üRETİM DANIŞMANLIK EĞİTİM ISLAH VE ARGE  İTHALAT İHRACAT SANAYİ TİCARET A.Ş.
WO/2021/242191	A MIXTURE FOR CORONA VIRUS (COVID-19) DISEASE	YONAS İLAÇ VE KİMYA SANAYİ TİCARET LĺMİTED. ŞİRKETİ.
WO/2021/076076	CYSTITIS SOLUTION COMPRISING HYALURONIC ACID AND POLYETHYLENE  GLYCOL AND PRODUCTION METHOD THEREOF	BETATECH MEDIKAL CIHAZLAR SANAYI MUMESSILLIK IC VE DIS TICARET  LIMITED SIRKETI
WO/2021/262103	FORMATION OF A CREAM AND LOTION THAT ENSURES PROTECTION OF  SKIN HEALTH	CANPOLAT, Cevdet
WO/2021/242194	A MIXTURE FOR CORONA VIRUS (COVID-19) DISEASE	YONAS İLAÇ VE KİMYA SANAYİ TİCARET LİMİTED ŞİRKETİ
WO/2021/006839	METHOD FOR OBTAINING SOLID PLASMA AS A FILLING MATERIAL	GAZİ ENDüSTRİ ANONİM ŞİRKETİ
WO/2021/002821	A METHOD FOR OBTAINING SAPONIN MOLECULES AND UTILIZING ACTIVE  MOLECULES AS IMMUNOMODULATOR	İZMİR YüKSEK TEKNOLOJİ ENSTİTüSü
WO/2021/010920	A STABLE COMPOSITION COMPRISING TETRACYCLIN AND TRETINOIN FOR  TOPICAL ACNE TREATMENT	ASSOS İLAÇ KİMYA GIDA üRüNLERİ üRETİM VE TİCARET ANONİM  ŞİRKETİ
WO/2021/006845	SMART TEMPERATURE-SENSITIVE HYDROGELS WITH ANTIFUNGAL PROPERTY  THAT PERFORM CONTROLLED DRUG RELEASE	AKDENIZ UNIVERSITESI
WO/2021/006850	CURCUMINOID ORAL COMPOSITIONS COMPRISING SILICA	PISAK, Mehmet Nevzat
WO/2021/010924	AN EFFERVESCENT TABLET COMPOSITION OF SITAGLIPTIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/025647	A SACHET FORMULATION COMPRISING POLYETHYLENE GLYCOL	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/034289	USE OF CANNABINOID 1 RECEPTOR AGONIST ARACHIDONOYL  CYCLOPROPYLAMIDE (ACPA) IN NON SMALL CELL LUNG CANCER	HACETTEPE üNİVERSİTESİ
WO/2021/015703	NANOPROPOLIS SYNTHESIS METHOD WITH HEALING EFFECT AGAINST SIDE  EFFECTS OF CANCER DRUG CISPLATIN	FIRAT UNIVERSITESI REKTORLUGU
WO/2021/021049	A DEXTRAN COATED SILICA AEROGEL USED AS A DRUG CARRIER SYSTEM  AND A DEXTRAN COATED SILICA AEROGEL PRODUCTION METHOD	YILDIZ TEKNIK UNIVERSITESI
WO/2021/021050	CAROB TREE (CERATONIA SILIQUA L.) LEAVES IN THE TREATMENT OF  AIRWAY INFLAMMATION OCCURRING IN ALLERGIC ASTHMA	T.C. ERCİYES üNİVERSİTESİ
WO/2021/021051	PLATELET RICH-FIBRIN DERIVED MESENCHYMAL STEM CELLS	T.C. ERCİYES üNİVERSİTESİ
WO/2021/021054	MOVABLE SPACE MAINTAINERS WHICH REALIZE CONTROLLED ION RELEASE	T.C. ERCIYES UNIVERSITESI
WO/2021/021055	COMBINATION OF OXOLAMINE AND TERBUTALINE	EĞİLMEZ, Mehmet Vedat
WO/2021/021062	ANTIBODY-POLYMER-CONJUGATES	BOGAZICI UNIVERSITESI
WO/2021/021063	PLANT EXOSOMES USED FOR TREATMENT OF DISEASES ORIGINATING FROM  PROTEIN AGGREGATES FORMED IN CELLS	YEDITEPE UNIVERSITESI
WO/2021/025652	AN EXTRACT FROM CANNABIS AND PEGANUM	T.C. ERCİYES üNİVERSİTESİ
WO/2021/045706	A COMBINATION COMPRISING VILDAGLIPTIN AND METFORMIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/054912	EFFERVESCENT TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND  METFORMIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/061065	SOLID ORAL PHARMACEUTICAL FORMULATIONS COMPRISING SAPROPTERIN  DIHYDROCHLORIDE AND AT LEAST ONE PHARMACEUTICAL EXCIPIENT	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/061066	EFFERVESCENT FORMULATIONS OF SAPROPTERIN DIHYDROCHLORIDE	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/061067	PHARMACEUTICAL FORMULATIONS COMPRISING SAPROPTERIN  DIHYDROCHLORIDE AND AT LEAST ONE ANTIOXIDANT	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/091502	A METHOD FOR PRODUCING A PRODUCT SUITABLE FOR USE IN THE  TREATMENT OF HAIR LOSS AND SCAR	OVALI, Ercüment
WO/2021/040645	AN ANTI-AGING COSMETIC PRODUCT	T.C. ERCIYES UNIVERSITESI
WO/2021/040646	SELF MICROEMULSIFYING DRUG DELIVERY SYSTEMS (SMEDDS)  COMPRISING OLMESARTAN MEDOXOMIL	KOMESLİ, Yelda
WO/2021/045712	USE OF PLANT EXOSOMES FOR ENHANCING VIABILITY AND HAIR GROWTH  CAPACITY OF SKIN CELLS	YEDITEPE UNIVERSITESI
WO/2021/201796	TARGETED RELEASE OF NICLOSAMIDE COMPOSITIONS WITH HIGH  SOLUBILITY AND BIOAVAILABILITY	IMUNEKS FARMA ILAC SAN. VE TIC.A.S
WO/2021/066772	CELL CULTURE MEDIUM FOR REDUCING FUCOSYLATION AND BASIC  VARIANTS IN THE PRODUCTION OF ANTIBODIES	ARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/045717	A PHARMACEUTICAL COMPOSITION CONTAINING EPIBRASSINOLIDE (EBR)	T.C. ISTANBUL KULTUR UNIVERSITESI
WO/2021/045718	A PHARMACEUTICAL COMPOSITION CONTAINING EPIBRASSINOLIDE (EBR)  AND ROSCOVITINE (ROSC)	T.C. ISTANBUL KULTUR UNIVERSITESI
WO/2021/080531	A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR  INHALATION	ARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/054921	METHOD OF PRODUCING CRYOGELS WITH NATURAL BIOMATERIALS AND USE  OF SUCH CRYOGELS AS SOFT TISSUE SCAFFOLDS OR DRUG DELIVERY SYSTEMS	YEDITEPE UNIVERSITESI
WO/2021/076081	BOSENTAN MONOHYDRATE LOADED LIQUID SELF NANOEMULSIFYING DRUG  CARRIER SYSTEM AND TABLET FORMULATION	TEKSİN, Zeynep Şafak
WO/2021/126112	A METHOD FOR PRODUCING GARLIC EXTRACT	GüVEN, Şefik
WO/2021/080541	PRODUCTION OF MONOCLONAL ANTIBODY SPECIFIC TO CELL RECEPTOR  CD24	ANKARA üNIVERSITESI REKTÖRLüĞü
WO/2021/080542	PRODUCTION OF MONOCLONAL ANTIBODY SPECIFIC TO STEM CELL  SURFACE MARKER CD133	ANKARA üNIVERSITESI REKTÖRLüĞü
WO/2021/080544	MICROORGANISM-BASED NATURAL FOOD SUPPLEMENT DEVELOPED TO  PREVENT CONSTIPATION PROBLEMS IN HUMANS	ANKARA üNİVERSİTESİ REKTÖRLüĞü
WO/2021/086292	BILAYER TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND  METFORMIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/091510	A CAPSULE COMPRISING ELTROMBOPAG OLAMINE	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/101481	A PELLET COMPOSITION COMPRISING PROPIVERINE OR A  PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/101482	A SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS  DAPAGLIFLOZIN ISOLATED FROM A POLAR SOLVENT	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/133299	ORALLY DISINTEGRATING TABLETS COMPRISING FLURBIPROFEN AND  ELETRIPTAN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/101483	A PHARMACEUTICAL FORM COMPRISING ACIDIC SUBSTANCE	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/091511	CONJUGATION OF PROTEIN DRUGS WITH BIOPOLYMERS BY AN ENZYMATIC  METHOD	HACETTEPE üNİVERSİTESİ
WO/2021/096464	A NOVEL NANOTECHNOLOGIC APPROACH TO GLIOBLASTOMA TREATMENT  WITH SOLID LIPID CARRIERS	EGE üNİVERSİTESİ
WO/2021/257018	ANTI-SCAR AND ANTI-AGING TOPICAL COMPOSITIONS	MONTERO GIDA SANAYI VE TICARET ANONIM SIRKETI
WO/2021/112795	ORAL DOSAGE FORMS CONTAINING INDOMETHACIN	ATATüRK üNİVERSİTESİ BİLİMSEL ARAŞTIRMA PROJELERİ BİRİMİ
WO/2021/201797	A COSMETIC AND TOPICAL COMPOSITION WHICH INCREASES CELL  VIABILITY	YILDIZ TEKNIK UNIVERSITESI
WO/2021/126116	SPOT LIGHTENING HERBAL COSMETIC FORMULATION	GAZI UNIVERSITESI REKTORLUGU
WO/2021/133307	COSMETIC FORMULATION CONTAINING THE SMOKE TREE EXTRACT	GAZI UNIVERSITESI REKTORLUGU
WO/2021/133308	GROWTH AND OSTEOGENIC DIFFERENTIATION MEDIUM FOR THE DENTAL  PULP MESENCHYMAL STEM CELLS	GAZI UNIVERSITESI REKTORLUGU
WO/2021/133309	RED CALIFORNIAN WORM EXTRACT AND THE USE THEREOF	GAZI UNIVERSITESI
WO/2021/126118	SYNTHESIS OF 2-(SUBSTITUTEDPHENYL)-5-(SUBSTITUTEDHETEROARYL)-  1H-BENZIMIDAZOLE DERIVATIVES AND INVESTIGATION OF THEIR BIOLOGICAL EFFECTS	ANADOLU üNİVERSİTESİ
WO/2021/118501	HAEMOSTATIC GEL FORMULATION PRODUCTION FROM FOMES FOMENTARIUS  EXTRACT	TRAKYA UNIVERSITESI REKTORLUGU
WO/2021/242197	NOVEL USE CHANGING MITOCHONDRIAL MEMBRANE POTENTIAL IN OLIVE  OIL	ANKARA üNIVESITESI REKTÖRLüĞü
WO/2021/133319	SYNTHESIS OF UREA DERIVATIVES WHICH HAVE P38 MAPK INHIBITION  AND ANTICANCER EFFICACY	T.C. ERCIYES UNIVERSITESI
WO/2021/137808	THE USE OF BETA-CASOMORPHIN PEPTIDES IN MULTIPLE SCLEROSIS  (MS)	T. C. ERCIYES UNIVERSITESI
WO/2021/137809	PHARMACEUTICAL SOLUTION THAT FACILITATES DENTAL  REMINERALISATION AND ELIMINATES LESION PAIN	AKDENIZ UNIVERSITESI
WO/2021/133335	THERAPEUTIC USE OF A CERAMIDASE INHIBITOR B13 AND ITS NANO  FORM IN LUNG CANCER CELLS	ESKISEHIR TEKNIK UNIVERSITESI
WO/2021/251918	USE OF PROPOLIS OBTAINED BY SPECIAL EXTRACTION METHOD IN  SPREADABLE MIXTURES	SBS BİLİMSEL BİO ÇÖZüMLER SANAYİ VE TİCARET A.Ş.
WO/2021/133362	USE OF SPECIFIC FRACTIONS OBTAINED FROM THE CLADODES OF  <i>OPUNTIA FICUS-INDICA </i>PLANT FOR TREATING CANCER	ISTANBUL MEDIPOL UNIVERSITESI
WO/2021/137835	PENICILLIN DERIVATIVES AND METHOD FOR THEIR SYNTHESIS	T.C. ERCİYES üNİVERSİTESİ
WO/2021/145841	METHOD OF PRODUCING A COMPOSITION FOR THE TREATMENT OF  CARDIOVASCULAR AND CEREBROVASCULAR DISEASES	HABERDAR, Aslan Yavuz
WO/2021/137837	A NOVEL VISCOELASTIC FORMULATION FOR OSTEOARTHRITIS TREATMENT  AND A PRODUCTION METHOD THEREOF	VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI
WO/2021/251920	USE OF PROPOLIS OBTAINED BY SPECIAL EXTRACTION METHOD IN  LIQUID MIXTURES	SBS BİLİMSEL BİO ÇÖZüMLER SANAYİ VE TİCARET A.Ş.
WO/2021/137840	METHOD OF INDUCING AND STIMULATING PANCREATIC CANCER STEM  CELLS AND CANCER CELLS TO APOPTOSIS	DİCLE üNİVERSİTESİ REKTÖRLüK ÖZEL KALEM
WO/2021/150187	CAPSULE-IN-CAPSULE COMPRISING DABIGATRAN ETEXILATE	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/150188	CRYSTALLINE FORM C OF VORTIOXETINE HYDROBROMIDE	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/194446	A SACHET FORMULATION COMPRISING METFORMIN AND DAPAGLIFLOZIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/257020	TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE  TREATMENT OF LUNG CANCER	ANADOLU üNİVERSİTESİ
WO/2021/162659	NUTRITIONAL COMPOSITIONS FOR PROMOTING GERIATRIC HEALTH  MAINTENANCE	MONTERO GIDA SANAYI VE TICARET ANONIM SIRKETI
WO/2021/154188	PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL DELIVERY	EXELTIS ILAC SANAYII VE TICARET ANONIM SIRKETI
WO/2021/162662	USE OF BMP INHIBITORS IN THE TREATMENT OF MOLAR PREGNANCY	BOGAZICI UNIVERSITESI
WO/2021/162664	PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS  FOR USE AS A BCL-2 INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/162666	PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS  FOR USE AS A BCL-2 INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/162667	PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS  FOR USE AS A BCL-2 INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/162668	PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS  FOR USE AS A BCL-2 INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/167571	DRG-MDM2-2 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/167572	DRG-MDM2-3 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/167573	DRG-MDM2-4 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/167574	DRG-MDM2-5 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/167575	DRG-MDM2-6 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2)  INHIBITOR	BAHCESEHIR UNIVERSITESI
WO/2021/173102	A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF  NEURODEGENERATIVE DISEASES	BAHCESEHIR UNIVERSITESI
WO/2021/173103	A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN  TREATMENT OF NEURODEGENERATIVE DISEASES	BAHCESEHIR UNIVERSITESI
WO/2021/206652	TARGETING TIM-3 AND LAG-3 RECEPTORS INDUCED BY CD44+ CD90+  CANCER STEM CELLS IN SMALL CELL LUNG CANCER	HACETTEPE üNİVERSİTESİ
WO/2021/201800	FLURBIPROFEN NANOSUSPENSION BASED GEL FORMULATION	GAZI UNIVERSITESI REKTORLUGU
WO/2021/194455	FERULA ELEAOCHYTRIS ROOT EXTRACT SOLUTION FOR USE IN ERECTILE  DISFUNCTION TREATMENT	KAHRAMANMARAŞ SüTÇü İMAM üNİVERSİTESİ
WO/2021/201803	DEVELOPMENT OF MICROEMULSION FORMULATION FROM  <i>ROSMARINUS</i> <i>OFFICINALIS</i> ESSENTIAL OIL  AND THE ANTIFUNGAL EFFECT OF THESE FORMULATIONS	ISTANBUL MEDIPOL UNIVERSITESI
WO/2021/201805	NICLOSAMIDE COMPOSITIONS WITH HIGH SOLUBILITY AND  BIOAVAILABILITY	IMUNEKS FARMA ILAC SAN. VE TIC. A.S.
WO/2021/216022	GEL FORMULATION COMPRISING ETODOLAC NANOSUSPENSION	GAZI UNIVERSITESI REKTORLUGU
WO/2021/251924	HERBAL SUPPLEMENT CREAM SUPPORTING WOUND HEALING AND REDUCTION  OF INFLAMMATION	AKMAN, Enes Emre
WO/2021/251925	HERBAL SUPPLEMENT CREAM USED IN CANCER PATIENTS	AKMAN, Enes Emre
WO/2021/221587	MULTI-PROBIOTIC OIL COMBINATION CONTAINING CALENDULA OIL AND  PRODUCTION METHOD THEREOF	HLY AROMATERAPİ HİZMETLERİ KOZMETİK SANAYİ TİCARET ANONİM  ŞİRKETİ
WO/2021/225548	A NOVEL METHOD FOR CARRYING BIOACTIVE MOLECULES USING  NANOCARRIERS	OZMEN, Zekeriya
WO/2021/225551	USE OF EXTRACELLULAR VESICLES AS IMMUNOPROPHILACTICS AND  IMMUNOTHERAPEUTICS FOR LEISHMANIASIS	YEDITEPE UNIVERSITESI
WO/2021/246985	THE PROCESS FOR THE PREPARATION OF A FILM COATED TABLET  COMPRISING LINAGLIPTIN AND METFORMIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/262114	AN ORALLY DISINTEGRATING TABLET FORMULATION COMPRISING  SITAGLIPTIN	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/262115	A STABLE COMBINATION OF VILDAGLIPTIN AND METFORMIN HCI	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/262116	A FILM COATED TABLET COMPRISING VILDAGLIPTIN AND METFORMIN HCI	SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
WO/2021/242204	GEL FORMULATIONS OBTAINED FROM <i>PHLOMIS</i>  PLANT EXTRACT AND THEIR USE IN WOUND TREATMENT	İSTANBUL MEDİPOL üNİVERSİTESİ
WO/2021/242205	GEL FORMULATIONS OBTAINED FROM <i>CISTUS  CRETICUS</i> EXTRACT AND THE USE OF THESE AS HEMOSTATIC AGENTS	İSTANBUL MEDİPOL üNİVERSİTESİ
WO/2021/246989	A COMBINATION OF CAMOSTAT MESYLATE AND UMIFENOVIR  HYDROCHLORIDE	ATABAY KIMYA SANAYI VE TICARET ANONIM SIRKETI
WO/2021/257027	AN EFFECTIVE COMPOSITION IN HEALING WOUNDS	T.C. ISTANBUL AYDIN UNIVERISTESI
WO/2021/251934	METHOD OF OBTAINING SEA BUCKTHORN (HIPPOPHAE RHAMNOIDES)  EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS	YEDITEPE UNIVERSITESI
WO/2021/257029	A URACIL COMPOUNDS WITH ANTICANCER ACTIVITY	BURSA TEKNİK üNİVERSİTESİ REKTÖRLüĞü
WO/2021/251939	CONCOMITANT USAGE OF VITAMIN C AND PARP INHIBITOR IN TREATMENT  OF CANCERS WHERE ETS FUSION IS DETECTED	DEMIRAY, Mutlu
WO/2021/257033	GENETIC MOLECULE ENCAPSULATION IN MESOPOROUS  SILICA/POLYETHYLENE GLYCOL HYBRID STRUCTURE	GAZIANTEP UNIVERSITESI REKTORLUGU
WO/2021/230849	PHARMACEUTICAL COMPOSITIONS PREPARED BY DRY MILLING METHOD AND  CONTAINING CELECOXIB WITH INCREASED DISSOLUTION RATE	HACETTEPE üNİVERSİTESİ
WO/2021/006856	MEDICINE IN THE FORM OF EYE DROPS	ALMAKAIEVA, Liudmyla Hryhorivna
WO/2021/177930	PHARMACEUTICAL COMPOSITION WITH INCREASED SOLUBILITY OF  GESPERIDINE AND METHOD OF ITS PREPARATION	VYSHNEVSKYY, Ihor Anatoliyovych
WO/2021/167580	WATER-SOLUBLE SOLID DISPERSION OF QUERCETIN, FORMS THEREOF, A  METHOD OF OBTAINING THEREOF, USE OF ALKALINE AGENT, AND A KIT	SCIENTIFIC INDUSTRIAL CENTRE BORSHCHAHIVSKIY CHEMICAL  PHARMACEUTICAL PLANT" PUBLIC JOINT STOCK COMPANY
WO/2021/201813	THE METHOD OF INHIBITING OF THE FIBRIN POLYMERIZATION	PALLADIN INSTYTUTE OF BIOCHEMISTRY OF THE NATIONAL ACADEMY OF  SCIENCES OF UKRAINE
WO/2021/211085	METHOD OF PREVENTING AND TREATING DISEASES CAUSED BY ENVELOPED  VIRUSES, INCLUDING CORONAVIRUSES (VARIANTS), AND A SET OF PHARMACEUTICAL  PREPARATIONS FOR IMPLEMENTING SAID METHOD	GUNJAN, Kumar
WO/2021/010937	METHODS AND COMPOSITIONS FOR THE TREATMENT OF SICKLE CELL  DISEASES AND THALASSEMIA	EMMAUS MEDICAL, INC.
WO/2021/034298	COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF  CHRONIC HYPOXEMIA AND DYSPNEA	MARTIN, Alain
WO/2021/040673	METHODS FOR THE TREATMENT OF CHRONIC HYPOXEMIA AND INHIBITING  LUNG FIBROSIS IN PATIENTS WITH PULMONARY FIBROSIS WITH AND WITHOUT COPD	MARTIN, Alain
WO/2021/002855	MAMMARY TUMOR VIRUS VACCINE	VIRAGO VAX INC.
WO/2021/006877	TOPICAL SCALP CARE COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/010951	MODIFIED NATURAL KILLER CELLS AND METHODS OF USING THE SAME	CHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/010953	TOPICAL SKINCARE COMPOSITIONS COMPRISING CENTELLA ASIATICA	THE PROCTER & GAMBLE COMPANY
WO/2021/011002	COMPOSITIONS AND METHODS FOR INDUCING DEFECATION	DIGNIFY THERAPEUTICS, LLC
WO/2021/029861	METHODS AND SYSTEMS FOR TREATING ACNE AND OTHER INFLAMMATORY  SKIN CONDITIONS	DATTNER, Alan M.
WO/2021/029893	WETTING COMPOSITION INCLUDING SILICONE POLYMER SOFTENING AGENT  AND WET WIPES INCLUDING THE SAME	KIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/029896	SPLICE MODULATING OLIGONUCLEOTIDES TARGETING RECEPTOR FOR  ADVANCED GLYCATION END PRODUCTS AND METHODS OF USE	LIFESPLICE PHARMA LLC
WO/2021/040735	XENOGEN-FREE MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF  USE	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/040736	TANDEM CD19 CAR-BASED COMPOSITIONS AND METHODS FOR  IMMUNOTHERAPY	OBSIDIAN THERAPEUTICS, INC.
WO/2021/040744	PATHOGENIC CONTROL COMPOSITIONS AND METHODS	BRACEWELL, JR., John Kenneth
WO/2021/034334	TOPICAL DOXYCYCLINE HYDROGEL WITH IMPROVED LONG-TERM STABILITY	NANOPHARMACEUTICS, INC.
WO/2021/034335	METHODS OF ADMINISTERING TESETAXEL WITH GLUCOCORTICOIDS THAT  ARE CYP3A4 INDUCERS	ODONATE THERAPEUTICS, INC.
WO/2021/050064	ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR  MITIGATING DISEASE-INDUCED TISSUE DAMAGE	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/050089	GENETIC TEST FOR IDENTIFYING CATS AT A HIGH RISK FOR  DEVELOPING TUBULOINTERSTITIAL FIBROSIS	WASHINGTON STATE UNIVERSITY
WO/2021/054971	PROCESS FOR PREPARING POTENT PLANT BASED COSMETIC ACTIVES AND  APPLICATION TO AN ANTIPERSPIRANT ACTIVE	MENETRIER, David Benoît Camille
WO/2021/054978	CARDIAC CARDENOLIDES TO REDUCE FIBROSIS AND ENHANCE EPITHELIAL  DIFFERENTIATION	POLLARD, Bette, Silver
WO/2021/034336	COMPOSITIONS AND METHODS FOR IN VIVO GENE EDITING	SALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/061128	DISPERSIBLE ADHESIVELY BONDED TISSUE LAMINATE	KIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/061154	DIASTEREOMERIC LINKING REAGENTS FOR NUCLEOTIDE PROBES	BRENTANO BIOTECHNOLOGY ASSOCIATES
WO/2021/066840	ANTI-CD25 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE  THEREOF	R.P. SCHERER TECHNOLOGIES, LLC
WO/2021/071468	NEOEPITOPE VACCINE AND IMMUNE STIMULANT COMBINATIONS AND  METHODS	NANTCELL, INC.
WO/2021/071499	RUBIDIUM AND/OR ZINC COMPOUNDS FOR TREATING PARKINSON'S AND  OTHER NEURODEGENERATIVE DISEASES	VECTOR VITALE IP LLC
WO/2021/076124	USE OF JAK1 INHIBITORS FOR THE TREATMENT OF CUTANEOUS LUPUS  ERYTHEMATOSUS AND LICHEN PLANUS (LP)	INCYTE CORPORATION
WO/2021/080608	BRANCHED MOIETY FOR USE IN CONJUGATES	MEDIMMUNE, LLC
WO/2021/086312	REDUCED ADAPTIVE MICROBIAL RESISTANCE TREATMENT FOR FLESH  EATING DISEASE	SALAZAR, Jennie
WO/2021/086403	STABLE LOW pH PERSONAL CARE COMPOSITIONS AND METHODS FOR THE  SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/050093	A METHOD OF REDUCING VIABILITY OF CANCER CELLS BY APPLYING  ALTERNATING ELECTRIC FIELDS AND ADMINISTERING CHECKPOINT INHIBITORS TO THE  CANCER CELLS	NOVOCURE GMBH
WO/2021/091532	METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/091535	TREATING MYELOPROLIFERATIVE DISORDERS WITH CPI-0610 AND A JAK  INHIBITOR	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/091541	IDENTIFYING CANCER NEOANTIGENS FOR PERSONALIZED CANCER  IMMUNOTHERAPY	KRI TECHNOLOGIES INCORPORATED
WO/2021/091560	ONCOLYTIC VIROTHERAPY AND IMMUNOTHERAPY	BAYLOR COLLEGE OF MEDICINE
WO/2021/096479	TREATMENT FOR INFLAMMATORY BOWEL DISEASE AND RADIATION-INDUCED  INTESTINAL INJURY	TRIM-EDICINE, INC.
WO/2021/096518	PERSONAL CARE COMPOSITIONS FOR TREATING ODOR CAUSING BACTERIA  AND METHODS FOR THE SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/050094	METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2  VARIANTS ENCODING AFLIBERCEPT	ADVERUM BIOTECHNOLOGIES, INC.
WO/2021/101521	COMPOSITION AND METHOD FOR TREATING HEMATOLOGIC CANCERS	PROVECETUS PHARMATECH, INC.
WO/2021/101569	METHOD OF PREVENTING THE DEVELOPMENT OF MELANOMA	VECTOR VITALE IP LLC
WO/2021/107926	A FILL FORMULATION METHOD FOR HARD, SOFT, AND LIQUID CAPSULES  COMPRISING THE MIXTURE OF A POLYMER AND A FILL COMPONENT THAT WILL MIGRATE  INTO OR THROUGH A CAPSULE SHELL WITH SERVICEABLE FUNCTIONS	LEACH, Connor
WO/2021/107946	ORAL COMPOSITIONS	ARNOLD, Michael
WO/2021/025719	METHODS OF BULK DROPLET VITRIFICATION	THE GENERAL HOSPITAL CORPORATION
WO/2021/071534	MUTANT VACCINIA VIRUSES AND USE THEREOF	ICELL KEALEX THERAPEUTICS
WO/2021/126140	ESTERIFICATION OF ACETIC ACID RECOVERED FROM WOOD ACETYLATION  WITH ETHER-ALCOHOLS	EASTMAN CHEMICAL COMPANY
WO/2021/126142	ESTERIFICATION OF ACETIC ACID RECOVERED FROM WOOD ACETYLATION  WITH ALCOHOLS	EASTMAN CHEMICAL COMPANY
WO/2021/126227	COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF  OBESITY	VECTOR VITALE IP LLC
WO/2021/126228	COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF  TYPE 2 DIABETES	VECTOR VITALE IP LLC
WO/2021/126230	A METHOD OF TREATING NONALCOHOLIC STEATOHEPATITIS	VECTOR VITALE IP LLC
WO/2021/126231	COMPOSITION AND METHOD FOR THE TREATMENT OF TYPE I DIABETES	VECTOR VITALE IP LLC
WO/2021/025723	SMALL MOLECULE DRUGS AND RELATED METHODS FOR TREATMENT OF  DISEASES RELATED TO TDP-43, ALPHA-SYNUCLEIN, HUNTINGTIN'S PROTEIN AND TAU  PROTEIN OLIGOMER FORMATION	ACELOT, INC.
WO/2021/066869	ANTIBODY COMPOSITIONS COMPRISING FC MUTATIONS AND  SITE-SPECIFIC CONJUGATION PROPERTIES	TAE LIFE SCIENCES
WO/2021/091582	NEUROSOME/ASTROSOME COMPOSITIONS AND METHODS OF USE	THE METHODIST HOSPITAL
WO/2021/096542	FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS  CONTAINING IDO ANTAGONIST PRODRUGS USEFUL IN THE TREATMENT OF CANCER AND  METHODS THEREOF	NAMMI THERAPEUTICS, INC.
WO/2021/126281	FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS  CONTAINING TOLL-LIKE RECEPTOR ("TLR") AGONIST PRODRUGS USEFUL IN  THE TREATMENT OF CANCER AND METHODS THEREOF	NAMMI THERAPEUTICS, INC.
WO/2021/002887	GUT-TARGETED NLRP3 ANTAGONISTS AND THEIR USE IN THERAPY	NOVARTIS INFLAMMASOME RESEARCH, INC.
WO/2021/141595	PREPARATION AND PRESERVATION OF COLLAGEN MICROBUBBLES	ADVANCED MICROBUBBLES LABORATORIES LLC
WO/2021/034345	NOVEL USES OF CRENOLANIB	AROG PHARMACEUTICALS, INC.
WO/2021/054999	THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS	PLASMA TECHNOLOGIES, LLC
WO/2021/141602	TONGKAT ALI EXTRACT PRODUCTION PROCESSES AND USES THEREOF	INNOVUS PHARMACEUTICALS, INC.
WO/2021/141603	POLYMER EXCIPIENTS FOR DRUG DELIVERY APPLICATIONS	TYNDALL FORMULATION SERVICES, LLC
WO/2021/141605	FORMULATIONS OF PACLITAXEL WITH POLY(AMINO ACID) BLOCK  POLYMERS	TYNDALL FORMULATION SERVICES, LLC
WO/2021/145871	A METHOD OF TREATMENT IN PREDISPOSED SUBJECTS FOR LMNA-RELATED  DILATED CARDIOMYOPATHY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/015818	HIV PRE-EXPOSURE PROPHYLAXIS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/080635	FREE-FLOWING POWDER FROM CANNABINOID OILS	NIICHEL, Robert
WO/2021/154205	EXOSOME-MEDIATED TRANSFECTION FOR DELIVERY OF NUCLEIC ACIDS	3P BIOTECHNOLOGIES, INC.
WO/2021/154216	FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT  DYSREGULATION USING THE SAME	ALEXION PHARMACEUTICALS, INC.
WO/2021/154220	PHOSPHOLIPID COMPOUNDS AND FORMULATIONS	APPLAUD MEDICAL, INC.
WO/2021/107967	PHARMACEUTICAL COMPOSITIONS OF LURASIDONE	SLAYBACK PHARMA LLC
WO/2021/158219	COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND  METHODS OF USING SAME	MOLECULAR TARGETING TECHNOLOGIES, INC.
WO/2021/150253	EPHEDRINE COMPOSITIONS AND METHODS	NEVAKAR INC.
WO/2021/162696	HIGH EFFICIENCY SUNSCREEN COMPOSITION	DECKNER CONSULTING SERVICES, LLC
WO/2021/076176	LIQUID EMULSION THERAPY FOR TREATING ACUTE CANNABINOID  INTOXICATION	DONALDSON, Jack
WO/2021/167608	BIOACTIVE MEDICAL CERAMIC CEMENT	NUSMILE, LTD.
WO/2021/167609	METHOD FOR TREATING AND PREVENTING CORONAVIRUS (COVID-19)  INFECTION BY DIRECT PULMONARY ADMINISTRATION OF A SELECTED MICROORGANISM	XIA, Xin, Rui
WO/2021/086426	D-AMPHETAMINE COMPOUNDS, COMPOSITIONS, AND PROCESSES FOR  MAKING AND USING THE SAME	KEMPHARM, INC.
WO/2021/086427	D-AMPHETAMINE COMPOUNDS, COMPOSITIONS, AND PROCESSES FOR  MAKING AND USING THE SAME	KEMPHARM, INC.
WO/2021/015820	ENHANCED ANTIBIOTIC AND DRUG DELIVERY FOR AQUEOUS TOPICAL  APPLICATIONS FOR HUMAN AND VETERINARY USES	OTIKO, Christopher, Ayo
WO/2021/173130	NOVEL CANNABINOID GLYCOSIDES AND USES THEREOF	VITALITY BIOPHARMA, INC.
WO/2021/173160	HAIR GROWTH AND SCALP PREPARATIONS	ZAVERI, Chanda
WO/2021/177936	CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS	GHALILI, Babak
WO/2021/177937	CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS	GHALILI, Babak
WO/2021/177938	VETERINARY CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS	GHALILI, Babak
WO/2021/177939	VETERINARY CANNABINOID, MENTHOL AND ANESTHETIC COMPOSITIONS  AND METHODS	GHALILI, Babak
WO/2021/177940	CANNABINOID AND MENTHOL GEL COMPOSITIONS, PATCHES AND METHODS	GHALILI, Babak
WO/2021/177941	CANNABINOID, MENTHOL AND CAFFEINE DISSOLVABLE FILM  COMPOSITIONS, DEVICES AND METHODS	GHALILI, Babak
WO/2021/177942	CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND  METHODS	GHALILI, Babak
WO/2021/034349	METHODS FOR PREVENTING DENGUE AND HEPATITIS A	TAKEDA VACCINES, INC.
WO/2021/050102	METHODS OF RESTORING LYSOSOMAL FUNCTION OF RETINAL PIGMENT  EPITHELIAL CELLS BY ACTIVATION OF TFEB	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/177979	BACTERIAL VECTOR VACCINE AGAINST PARASITIC WORMS AND METHOD OF  VACCINATION	THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL  UNIVERSITY
WO/2021/029914	COMPOSITIONS AND METHODS OF ENHANCING OPIOID RECEPTOR  ENGAGEMENT BY OPIOID HEXADIENOATES AND OPTIONALLY SUBSTITUTED HEXADIENOATES	KAPPA-PHARMA LLC
WO/2021/091585	CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE	NOCION THERAPEUTICS, INC.
WO/2021/091586	CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE	NOCION THERAPEUTICS, INC.
WO/2021/183131	DOSAGE FORMS FOR IMPROVING ORGAN TRANSPLANTATION, GRAFT VERSUS  HOST DISEASE AND STEM CELLS TRANSPLANTS	APHIOS CORPORATION
WO/2021/150256	FULLERENE PHOSPHONATES, METHOD, AND MEDICAMENT	BUTZLOFF, Peter, Robert
WO/2021/188096	METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS	DST PHARMA, INC.
WO/2021/055011	COMPOUNDS AND METHODS USEFUL FOR MODULATING GENE SPLICING	AGRAWAL, Sudhir
WO/2021/061192	NOVEL TRIMETHYLGLYCYLGLYCERIN COMPOSITIONS AND THEIR USE IN  DEVELOPING ANTI-CANCER DRUGS AND RNA VACCINES	WJWU & LYNN INSTITUTE FOR STEM CELL RESEARCH
WO/2021/194481	DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-PD-L1 ANTAGONIST  ANTIBODIES	GENENTECH, INC.
WO/2021/055013	PROCESSES AND AGENTS FOR GLAUCOMA	AUFBAU MEDICAL INNOVATIONS LIMITED
WO/2021/055014	METHODS AND COMPOSITIONS FOR REDUCING HAIR GREYING	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/194491	IMMODULATOR PEPTIDES COVALENTLY MODIFIED WITH SMALL MOLECULES	MASCARENHAS, Desmond
WO/2021/150259	COMPOSITIONS AND METHODS FOR WEIGHT LOSS	BARKEY, Daniel, Q.
WO/2021/002910	ORAL CARE COMPOSITIONS AND METHODS	COLGATE-PALMOLIVE COMPANY
WO/2021/206688	AROMATHERAPY COMPOSITIONS	MONQ, LLC
WO/2021/173166	COMPOSITIONS AND METHODS FOR TREATING URINARY CONDITIONS	INNOVUS PHARMACEUTICALS, INC.
WO/2021/118629	NOVEL CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION  ACTIVITY AND USES THEREOF	ACCUTAR BIOTECHNOLOGY INC.
WO/2021/211098	PREVENTION AND TREATMENT OF VIRAL INFECTION-INDUCED ORGAN  FAILURE	TRIM-EDICINE, INC.
WO/2021/133430	PROGESTERONE FORMULATION TO TRIGGER OVULATION AND PROVIDE  LUTEAL PHASE SUPPORT	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/211100	METHODS AND COMPOSITIONS FOR INDUCING AUTOPHAGY	SELECTA BIOSCIENCES, INC.
WO/2021/211104	PROCESS FOR GENERATING GENETICALLY ENGINEERED AUTOLOGOUS T  CELLS	AMGEN INC.
WO/2021/211123	ADJUVANT-ANTIBIOTIC COMBINATION AGAINST GRAM-NEGATIVE BACTERIA	UNIVERSITY OF NOTRE DAME DU LAC
WO/2021/158248	METHOD FOR TREATING CORONAVIRUS INFECTIONS	OYAGEN, INC.
WO/2021/045804	METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF  PHOSPHODIESTERASE-4 INHIBITORS	ARCUTIS, INC.
WO/2021/021259	FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT  INHIBITS MCL1 PROTEIN	AMGEN INC.
WO/2021/080646	BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT  HOPKINS SYNDROME	NEUREN PHARMACEUTICALS LIMITED
WO/2021/034353	PHARMACEUTICAL FORMULATION FOR TREATING SYMPTOMS OF MIGRAINE  AND CLUSTER HEADACHES, AND METHOD OF USING THE SAME	BN INTELLECTUAL PROPERTIES, INC.
WO/2021/002920	METHOD AND APPARATUS FOR ACCUMULATING CROSS-ALIGNED FIBER IN  AN ELECTROSPINNING DEVICE	UNIVERSITY OF CENTRAL OKLAHOMA
WO/2021/006941	TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN  DOGS	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/006942	TELMISARTAN FOR THE TREATMENT OF HYPERTENSION IN DOGS	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/221656	COMPOSITIONS AND METHODS OF USE THEREOF	SYNEDGEN, INC.
WO/2021/221668	ANTI-SARS-COV-2 MONOCLONAL ANTIBODY COMPOSITIONS	IREPERTOIRE, INC.
WO/2021/183162	ENHANCING GERMICIDAL ACTIVITIES OF ALCOHOL BY COMPOUNDS  DERIVED FROM PLANTS	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/091593	ROCK KINASE INHIBITORS	CERVELLO THERAPEUTICS, LLC
WO/2021/112914	FINISHED PHARMACEUTICAL DOSAGE FORM OF A METHENAMINE SALT SUCH  AS METHENAMINE MANDELATE	EDENBRIDGE PHARMACEUTICALS, LLC
WO/2021/055022	ASSOCIATION BETWEEN 4 COPIES OF EXON 3 OF fAIM AND PROGRESSIVE  CHRONIC KIDNEY DISEASE IN CATS	WASHINGTON STATE UNIVERSITY
WO/2021/225606	COMPOSITIONS AND METHODS FOR PROMOTING PROLIFERATION IN  CARDIOMYOCYTES	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/061203	METHODS OF IMPROVING EXERCISE PERFORMANCE, SINGLE VENTRICULAR  PERFORMANCE, AND MYOCARDIAL PERFORMANCE INDEX (MPI) IN SINGLE VENTRICLE HEART  DISEASE, USING UDENAFIL COMPOSITIONS	MEZZION PHARMA CO., LTD.
WO/2021/230886	A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN  FGFR4 INHIBITOR	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/236080	METHODS OF TREATING CANCERS	FOGHORN THERAPEUTICS INC.
WO/2021/080648	SILICON-BASED CANNABIDIOL DERIVATIVES AND COMPOSITIONS THEREOF	GELEST TECHNOLOGIES, INC.
WO/2021/015841	BORON-CONTAINING PHARMACOPHORE	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/236108	TOPICAL COMPOSITIONS, PROCESS OF LARGE-SCALE MANUFACTURE, AND  METHOD OF USE	PROGENERON, LLC
WO/2021/021276	MULTI-TARGETED, TUNABLE, SUSTAINED DELIVERY OF PAYLOADS TO  CHARGED AVASCULAR TISSUES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/242235	PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PSYCHIATRIC  SYMPTOMS OF PATIENTS WITH ALZHEIMER'S DISEASE AND FOR PSYCHIATRIC DISORDERS	LA PHARMATECH INC.
WO/2021/021277	STABILIZED FORMULATIONS OF 4-AMINO-3-SUBSTITUTED BUTANOIC ACID  DERIVATIVES	SAOL INTERNATIONAL LIMITED
WO/2021/236116	ANTIVIRAL MEDICINAL TEMPLATE	DELAHOUSSAYE, Kevin
WO/2021/242258	TREATMENT OF HOMOCYSTINURIA AND HYPERHOMOCYSTEINEMIA USING  CYSTATHIONINE-GAMMA-LYASE	AEGLEA BIOTHERAPEUTICS, INC.
WO/2021/247000	METHODS OF TREATMENT USING ICAM-MODULATING AGENTS	AVM BIOTECHNOLOGY, LLC
WO/2021/247003	METHODS OF TREATING AGING-RELATED DISORDERS	HCW BIOLOGICS, INC.
WO/2021/158251	NOVEL CANNABINOID CARRIER COMPOSITIONS HAVING ENHANCE  PHARMACOKINETIC PROPERTIES AND METHODS OF USE THEREOF	DESERT HARVEST, INC.
WO/2021/247009	COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING  COMPLEX AND HORMONE THERAPY AGENT	GALERA LABS, LLC
WO/2021/002994	A METHOD OF PREPARING A RADIOACTIVE YTTRIUM PHOSPHATE PARTICLE  SUSPENSION	KORENKO, Michael
WO/2021/247020	METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION  DISORDERS ASSOCIATED WITH MSH3 ACTIVITY	TRIPLET THERAPEUTICS, INC.
WO/2021/247029	METHODS AND SYSTEMS FOR SUPPORT TEAMS AND ANXIETY DISORDERS  RECOVERY	WHITNEY, Theresa, Jo
WO/2021/076196	METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE  LARGE B-CELL LYMPHOMA	GENENTECH, INC.
WO/2021/236128	METHODS AND COMPOSITIONS FOR REDUCING ADIPOCYTE NUMBERS	SU, Shih-Horng
WO/2021/251975	ALLOGENEIC TUMOR CELL VACCINE	ALLOPLEX BIOTHERAPEUTICS
WO/2021/251987	METHOD OF DISPERSING HYDROPHOBIC SUBSTANCES IN AQUEOUS  CLEANSING SYSTEM	RENMATIX, INC.
WO/2021/003015	COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES	CLOUDBREAK THERAPEUTICS LLC
WO/2021/015894	COMPOSITION FOR AND METHOD OF IMPROVING TISSUE PERFORMANCE	TRIM-EDICINE, INC.
WO/2021/007007	COMPOSITIONS AND METHODS FOR DIAGNOSING URINARY TRACT  INFECTIONS	ZOMEDICA PHARMACEUTICALS CORP.
WO/2021/257073	METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM NEONATAL STEM  CELLS	KONG, Joy
WO/2021/257089	METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED  DIARRHEA	NAPO PHARMACEUTICALS, INC.
WO/2021/257092	NEW COMPOUNDS AND THEIR USE AS THERAPEUTICALLY ACTIVE  SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF DISEASES INVOLVING THE  RETINAL PIGMENT EPITHELIUM	ENDOGENA THERAPEUTICS, INC.
WO/2021/034403	CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF	EPM GROUP, INC.
WO/2021/007020	ORAL CARE GUMMIES	BASF SE
WO/2021/262141	PERSONAL LUBRICANTS COMPRISING LAMBDA-CARRAGEENAN	TREMBLAY, Mario Elmen
WO/2021/034405	PLATINUM COMPLEX ANTI-NEOPLASTIC AGENTS COMPRISING A  CANNABINOID LIGAND	DIVERSE BIOTECH, INC.
WO/2021/076197	CONJUGATE MOLECULES	DIVERSE BIOTECH, INC.
WO/2021/007035	AEROSOL TEXTURIZING HAIR FILLER AND COLORANT WITH FIBERS	AMERICAN SPRAYTECH, L.L.C.
WO/2021/034406	HEMOSTATIC DEVICE AND METHOD	JU, Chien-Ping
WO/2021/040873	THIXOTROPIC DELIVERY SYSTEMS	UNIVERSITY OF MONTANA
WO/2021/021349	METHODS OF TREATING PAIN CONDITIONS AND COMPOSITIONS RELATED  THERETO	NXGEN MEDICINE, INC.
WO/2021/045836	ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND  ANTIGEN-BINDING FRAGMENTS	REGENERON PHARMACEUTICALS, INC.
WO/2021/262186	HP-HMG FOR USE IN THE TREATMENT OF INFERTILITY IN A PATIENT  WITH POLYCYSTIC OVARY SYNDROME	FERRING B.V.
WO/2021/262196	COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND  PARKINSON'S DISEASE	LA PHARMATECH INC.
WO/2021/003074	ANTI-CD38 ANTIBODY AND METHODS OF USE THEREOF	CRYSTAL BIOSCIENCE INC.
WO/2021/003075	ANTI-B7-H3 ANTIBODY AND METHODS OF USE THEREOF	CRYSTAL BIOSCIENCE INC.
WO/2021/003084	P2X7R ANTAGONISTS	QIAN, Ligang
WO/2021/003086	TASIMELTEON USE IN TREATING SLEEP ABERRATIONS	VANDA PHARMACEUTICALS INC.
WO/2021/007062	PROCESS FOR REMOVING COBALT, LEAD, CADMIUM AND CHROMIUM IONS  FROM BODILY FLUIDS USING METALLATE ION EXCHANGE COMPOSITIONS	UOP LLC
WO/2021/040881	IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS  OF USE	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/003132	ENGINEERED SUCROSE PHOSPHORYLASE VARIANT ENZYMES	CODEXIS, INC.
WO/2021/141628	KRAS G12C INHIBITORS	MIRATI THERAPEUTICS, INC.
WO/2021/003138	METHODS AND COMPOSITIONS FOR TREATMENT OF PANCREATIC CANCER	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/007070	CHIMERIC ANTIGENS FOR TREATING VIRAL INFECTION	AKSHAYA BIO INC.
WO/2021/003163	TREATING CANCER WITH A BROMODOMAIN AND EXTRA-TERMINAL (BET)  FAMILY INHIBITOR	FORMA THERAPEUTICS, INC.
WO/2021/003189	HETERODIMERIC ANTIBODIES THAT BIND TO CD38 AND CD3	SORRENTO THERAPEUTICS, INC.
WO/2021/003192	METHODS OF TREATING BRAF-MUTATED CANCER CELLS	EFFECTOR THERAPEUTICS, INC.
WO/2021/003194	EIF4E INHIBITORS FOR USE AS IMMUNE CHECKPOINT MODULATORS AND  RELATED METHODS	EFFECTOR THERAPEUTICS, INC.
WO/2021/003195	RECOMBINANT AAV VECTORS WITH ALTERED IMMUNOGENCITY AND METHODS  OF MAKING THE SAME	WRIGHT, John, Fraser
WO/2021/003197	GENOMIC AND EPIGENOMIC COMPARATIVE, INTEGRATIVE PATHWAY  DISCOVERY	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/003223	HYDROPHILIC LINKERS FOR MULTIVALENT PEPTIDE CONJUGATES	VALITOR, INC.
WO/2021/003246	PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY	ACCURE HEALTH INC.
WO/2021/003254	CRYOPRESERVATION MEDIUM COMPRISING A TISSUE EXTRACT	AUXOCELL LABORATORIES, INC.
WO/2021/003277	EXENATIDE COMPOSITIONS FOR PULMONARY ADMINISTRATION AND USE  THEREOF	AERAMI THERAPEUTICS, INC.
WO/2021/003279	SYSTEM FOR ENHANCING THERAPEUTIC COMPLIANCE OF THE ANTI-CANCER  COMPOUND E7766	EISAI R&D MANAGEMENT CO., LTD..
WO/2021/003314	HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS	NUVATION BIO INC.
WO/2021/003315	TRANSDERMAL PATCH PROVIDING IMPROVED PERMEABILITY	ROWLEY, Clifford, T.
WO/2021/003330	INHIBITING THE RNA METHYLTRANSFERASE METTL3 OR ITS INTERACTION  WITH EIF3H TO SUPPRESS ONCOGENE TRANSLATION AND TUMORIGENESIS	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/007091	PREBIOTIC COSMETIC COMPOSITIONS AND METHODS FOR THE  PREPARATION THEREOF	COSMEVIA LLC
WO/2021/003339	AMP-ACTIVATED PROTEIN KINASE INHIBITORS AND METHODS OF MAKING  AND USING THE SAME	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/003340	COMPOSITIONS AND METHODS FOR TREATING MYOCARDIUM WITH  MESENCHYMAL STEM CELL SCAFFOLD	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/003341	HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN  ANIMALS	ELLEVET SCIENCES
WO/2021/007094	ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMORS, FIBROSIS AND  ACUTE LUNG INJURY	MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/003348	HIV ANTIGENS AND MHC COMPLEXES	GRITSTONE ONCOLOGY, INC.
WO/2021/003352	METHODS OF FUNCTIONAL VASCULARIZATION OF PANCREATIC ISLETS AND  BETA-CELL ORGANOIDS	CORNELL UNIVERSITY
WO/2021/003357	ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1)  ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/034414	MODULATION OF DENDRITIC CELL FUNCTION BY THE PHOSPHOLIPID  MESSENGER LPA	CORNELL UNIVERSITY
WO/2021/003393	METHOD, COMPOSITION, AND APPARATUS FOR TREATING HEADACHE	EQUINOX OPHTHALMIC, INC.
WO/2021/194540	METHODS, SYSTEMS, AND A KIT FOR DETECTION, DIAGNOSIS,  MONITORING AND TREATMENT OF COVID-19	BASELINE VIRAL DIAGNOSTICS, INC.
WO/2021/007107	ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR  USE AGAINST GRAM-NEGATIVE AND ACID-FAST BACTERIA	CONTRAFECT CORPORATION
WO/2021/007108	METHOD FOR PREVENTING HAIR LOSS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/003403	NEURODEGENERATIVE DISEASE THERAPIES UTILIZING THE SKIN-BRAIN  AXIS	OHIO STATE INNOVATION FOUNDATION
WO/2021/007109	DESIGN AND EFFICIENT SYNTHESIS OF LIPID-FLUORESCEIN CONJUGATES  FOR CAR-T CELL THERAPY	PURDUE RESEARCH FOUNDATION
WO/2021/007111	VIRAL VECTOR THERAPY	APELLIS PHARMACEUTICALS, INC.
WO/2021/003421	MAMMARY TUMOR VIRUS SUPPRESSION	VIRAGO VAX INC.
WO/2021/007113	POLYMER PARTICLES FOR NEUTROPHIL INJURY	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/003433	SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFEN	ATOSSA THERAPEUTICS, INC.
WO/2021/003467	METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC  COMPOUNDS	SW HOLDINGS, INC.
WO/2021/007146	REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS	OLEMA PHARMACEUTICALS, INC.
WO/2021/007147	WOUND DEBRIDEMENT SYSTEMS	REGENICS AS
WO/2021/007151	NANO-DISPERSION METHODS FOR CANNABIS EXTRACT	UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE
WO/2021/007155	PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF  2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE  HEMISUCCINATE, AND PREPARATION OF  2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE  ACETATE	ELI LILLY AND COMPANY
WO/2021/007160	TRANS-CYCLOOCTENE BIOORTHOGONAL AGENTS AND USES IN CANCER AND  IMMUNOTHERAPY	TAMBO, INC.
WO/2021/007165	METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF  SEIZURES	ALLERGAN, INC.
WO/2021/007172	FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE	BELITE BIO, LLC
WO/2021/007189	CRYSTALLINE FORMS OF PLASMA KALLIKREIN INHIBITORS	REZOLUTE, INC.
WO/2021/007192	USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/007196	METHODS AND COMPOSITIONS TO INCREASE THE HARDNESS AND  RESISTANCE OF ENAMEL	THE PROCTER & GAMBLE COMPANY
WO/2021/007208	CXCR6 INHIBITORS AND METHODS OF USE	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/007245	NOVEL METHODS	INTRA-CELLULAR THERAPIES, INC.
WO/2021/007277	COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF  FIBROTIC DISEASE STATES AND CANCER	PURDUE RESEARCH FOUNDATION
WO/2021/007278	IMPROVED MRNA-LOADED LIPID NANOPARTICLES AND PROCESSES OF  MAKING THE SAME	TRANSLATE BIO, INC.
WO/2021/007283	POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/007286	COMPOSITIONS AND METHODS FOR CANCER THERAPY	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/007303	NANOPARTICLE FORMULATION OF BCL-2 INHIBITOR	RECURIUM IP HOLDINGS, LLC
WO/2021/236134	COMPOSITIONS AND METHODS FOR INHIBITION OF SARS-COV-2 VIRAL  INFECTIONS	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/007318	COMPOSITION AND METHOD FOR TREATING GASTROINTESTINAL DISORDER	ARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/007322	METHODS OF USING MODIFIED CYTOTOXINS TO TREAT CANCER	NORTHWESTERN UNIVERSITY
WO/2021/007329	TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1  SIALIDASE	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/007330	CERDULATINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL  COMPOSITIONS AND USES THEREOF	DERMAVANT SCIENCES GMBH
WO/2021/007338	ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK) ANTIBODIES,  IMMUNOCONJUGATES, AND METHODS OF USE	IMCARE BIOTECH, LLC.
WO/2021/007341	LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS	BIOPLX, INC.
WO/2021/007361	ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF	MYTHIC THERAPEUTICS, INC.
WO/2021/007378	COMPOUNDS FOR USE IN TREATING HUNTINGTON'S DISEASE	PTC THERAPEUTICS, INC.
WO/2021/150266	AGENTS THAT INTERFERE WITH IL-1BETA RECEPTOR SIGNALLING	TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/007382	COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S  DISEASE	VOYAGER THERAPEUTICS, INC.
WO/2021/007383	MODIFIED CELLS AND RELATED METHODS	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/007386	INDANES AS PD-L1 INHIBITORS	CHEMOCENTRYX, INC.
WO/2021/011283	INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE  FRAGMENTS	NORTHWESTERN UNIVERSITY
WO/2021/007396	ENGINEERED REGULATORY T CELLS	THE CHILDREN'S MERCY HOSPITAL
WO/2021/007402	PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS  THERAPEUTICS	CYBREXA 3, INC.
WO/2021/007409	MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND  METHODS FOR THE TREATMENT OF DENTAL DISEASE	KYTODENT, LLC
WO/2021/011299	MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINE	PACIRA PHARMACEUTICALS, INC.
WO/2021/007434	MODULATOR OF ANTIGEN SPECIFIC T CELL (MODASTC) MOLECULES AND  USES THEREOF	TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/011309	BIOLOGICAL TRANSPORT SYSTEMS AND METHODS	CUMBO, Thomas, A.
WO/2021/007470	METHOD AND COMPOSITION FOR TREATING PAIN	SHIH, Ming-Che
WO/2021/011327	COMPOUND FOR TREATING CYSTIC FIBROSIS	ORPHOMED, INC.
WO/2021/007474	PHENYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND  THEIR THERAPEUTIC APPLICATIONS	CURA THERAPEUTICS, LLC
WO/2021/007487	FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS  OF USE THEREOF	PRAXIS PRECISION MEDICINES, INC.
WO/2021/007488	SUBSTITUTED HETEROCYCLES AS ANTIVIRAL AGENTS	ENANTA PHARMACEUTICALS, INC.
WO/2021/055081	ENDOTHELIAL AND SMOOTH MUSCLE LIKE TISSUE PRODUCED FROM URINE  CELLS AND USES RELATED THERETO	EMORY UNIVERSITY
WO/2021/007489	POLYURETHANE GELS	NANOMETICS LLC (D.B.A. PHD BIOSCIENCES)
WO/2021/007491	TARGETING PTPN22 IN CANCER THERAPY	THE JOHNS HOPKINS UNIVERSITY
WO/2021/007504	METHODS AND COMPOSITIONS COMPRISING REDUCED LEVEL OF HOST CELL  PROTEINS	REGENERON PHARMACEUTICALS, INC.
WO/2021/007506	COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS	NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD.
WO/2021/011368	TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY  NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNASE)  ACTIVITY	GENKIN, Dmitry Dmitrievich
WO/2021/011369	METHODS OF TREATMENT USING ENCAPSULATED CELLS	PRIMEGEN BIOTECH, LLC
WO/2021/011377	METHODS OF ENHANCING IMMUNOGENICITY OF CANCERS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/007521	METHOD AND COMPOUNDS FOR TREATING OR PREVENTING AUTOIMMUNE  DISORDERS OR IMMUNE RESPONSES MODULATED BY THE EXPRESSION OF IDO1	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/007525	METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER	CASE WESTERN RESERVE UNIVERSITY
WO/2021/007527	COMPOSITIONS AND METHODS FOR TREATING PEROXISOMAL BIOGENESIS  DISORDERS	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/007533	AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN  (TSLP)-RECEPTOR SIGNALING	TAVOTEK BIOTHERAPEUTICS (HONG KONG) LIMITED
WO/2021/011398	FUNCTIONALIZED NANOPARTICLES AND THEIR USE IN TREATING  BACTERIAL INFECTIONS	BEKALE, Laurent
WO/2021/011404	THERAPEUTIC PROTEIN FORMULATIONS COMPRISING ANTIBODIES AND  USES THEREOF	CONTRAFECT CORPORATION
WO/2021/007563	NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS	ARBOR BIOTECHNOLOGIES, INC.
WO/2021/011421	COMPOSITIONS AND METHODS FOR TREATING ALZHEIMERS DISEASE	UNIVERSITY OF SOUTH FLORIDA
WO/2021/011431	RECOMBINANT SPIDER SILK EXTRUDATE FORMULATIONS	BOLT THREADS, INC.
WO/2021/011432	COMPOSITIONS AND METHODS FOR TREATING DEMENTIA WITH LEWY  BODIES	EIP PHARMA, INC.
WO/2021/011437	PEPTIDES AND METHODS FOR TREATING DISEASES	OP-T LLC
WO/2021/007572	METHODS FOR GROWING AFRICAN SWINE FEVER VIRUS IN FETAL PORCINE  LUNG ALVEOLAR MACROPHAGE CELLS	APTIMMUNE BIOLOGICS, INC.
WO/2021/007573	ENGINEERING NOTCH LIGANDS TO ENHANCE THE ANTI-TUMOR ACTIVITY  OF ADOPTIVELY TRANSFERRED T CELLS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/011456	EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS	RESEARCH DEVELOPMENT FOUNDATION
WO/2021/011462	METHODS FOR THE NON-TOXIC TREATMENT FOR OPIOID DRUG WITHDRAWAL  COMBINING NORIBOGAINE AND CANNABINOIDS	DEMERX, INC.
WO/2021/011465	METHOD FOR VACCINATING AVIANS AGAINST REOVIRUS	BIOMUNE COMPANY
WO/2021/011466	USE OF NANOPARTICLES FOR TREATING RESPIRATORY INFECTIONS  ASSOCIATED WITH CYSTIC FIBROSIS	ATTOSTAT, INC.
WO/2021/011471	TREATMENT OF HEART DEFECTS AND CONDITIONS IN PEDIATRIC  PATIENTS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/011480	COMPOSITIONS AND METHODS TO BLOCK AND BIND CXCR4 TO MODULATE  CELLULAR FUNCTION	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/011488	COMPOSITIONS COMPRISING ALDOXORUBICIN HYDROCHLORIDE AND  IFOSFAMIDE AND THEIR USE FOR THE TREATMENT OF SOFT TISSUE SARCOMA	NANTKWEST, INC.
WO/2021/011496	IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/011500	USE OF A BENZOATE CONTAINING COMPOSITION TO TREAT  NEURODEGENERATIVE DISORDERS	RUSH UNIVERSITY MEDICAL CENTER
WO/2021/011501	THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF MITOTIC KINASE  INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/011503	MOSQUITO EGG CRYOPRESERVATION	SANARIA INC.
WO/2021/011504	NANOPARTICLE SYSTEMS FOR TARGETED DELIVERY OF CRISPR/CAS13 AND  METHODS OF USING SAME	DUKE UNIVERSITY
WO/2021/015986	CANCER VACCINE COMPOSITIONS AND METHODS FOR USING SAME TO  PREVENT AND/OR TREAT CANCER	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/015987	ANTIGENIC GLYCOPROTEIN E POLYPEPTIDES, COMPOSITIONS, AND  METHODS OF USE THEREOF	MERCK SHARP & DOHME CORP.
WO/2021/011529	OPIOID GROWTH FACTOR RECEPTOR (OGFR) ANTAGONISTS, IN  PARTICULAR NALOXONE AND/OR NALTREXONE FOR TREATING CANCER	ROVAXA
WO/2021/011538	CAPSULE DOSAGE FORMS, METHODS OF PREPARATION AND METHODS OF  USE THEREOF	R.P. SCHERER TECHNOLOGIES, LLC
WO/2021/011544	HIV VACCINES AND METHODS OF MAKING AND USING	GILEAD SCIENCES, INC.
WO/2021/015997	METHODS AND COMPOSITIONS FOR GENE DELIVERY	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/011548	SKIN CARE COMPOSITIONS COMPRISING SYNERGISTIC BLEND OF SACRED  LOTUS AND TEA PLANT OR SACRED LOTUS AND GERMAN CHAMOMILE AND COSMETIC  APPLICATIONS THEREOF	ISP INVESTMENTS LLC
WO/2021/011550	METHODS AND COMPOSITIONS FOR TREATING PULMONARY ARTERIAL  HYPERTENSION	YALE UNIVERSITY
WO/2021/011572	ENHANCING THE ANTIVIRAL EFFICACY OF RNA VIRUS INHIBITION BY  COMBINATION WITH MODULATORS OF PYRIMIDINE METABOLISM	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/201903	METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION	PHOENIX BIOTECHNOLOGY, INC.
WO/2021/011579	EVOLVED BOTULINUM NEUROTOXINS AND USES THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/011592	COMPOUNDS AS NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS  AND USES THEREOF	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/011597	PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR  THERAPEUTIC TREATMENT	OVID THERAPEUTICS INC.
WO/2021/011609	METHODS OF TREATING OVARIAN, FALLOPIAN TUBE AND PERITONEAL  CANCER	TESARO, INC.
WO/2021/011614	METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN  IL-4R ANTAGONIST	SANOFI BIOTECHNOLOGY
WO/2021/016012	PRETOMANID COMPOSITIONS	THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/011619	SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS  THEREFROM	SOUTH DAKOTA BOARD OF REGENTS
WO/2021/011622	SECNIDAZOLE SOFT GELATIN CAPSULE AND METHODS AND USES THEREOF	LUPIN INC.
WO/2021/011634	PROTEIN DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/011645	EQUINE ESOMEPRAZOLE FORMULATIONS AND METHODS OF USE	KINDRED BIOSCIENCES, INC.
WO/2021/011660	METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF LUNG  CANCER	ONCOCYTE CORPORATION
WO/2021/011662	COMPOSITIONS AND METHODS FOR BROILER HEALTH AND PERFORMANCE	NATIVE MICRO BIALS, INC.
WO/2021/011664	COMPOSITION AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS	BIODERM, INC.
WO/2021/011669	COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION	CUTISPHARMA, INC.
WO/2021/011674	METHODS USEFUL IN TREATING CANCERS HARBORING A KRAS OR HRAS  MUTATION OR AMPLIFICATION	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/066922	ANTIVIRAL HETEROCYCLIC COMPOUNDS	ENANTA PHARMACEUTICALS, INC.
WO/2021/011747	METHOD FOR TREATMENT OF MUSCULAR DYSTROPHY	CHILDREN’S NATIONAL MEDICAL CENTER
WO/2021/011778	SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/011779	MESENCHYMAL STEM CELL COMPOSITIONS	AKAN BIOSCIENCES LLC
WO/2021/011781	UNIVERSAL CHIMERIC ANTIGEN RECEPTORS AND METHODS FOR MAKING  AND USING THEM	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016043	IMPROVED HOMOLOGY DEPENDENT REPAIR GENOME EDITING	INARI AGRICULTURE, INC.
WO/2021/011799	INFLAMMATORY BOWEL DISEASES THERAPY INVOLVING DISRUPTING  CCR9:DRD5 HETEROMER ASSEMBLY	FUNDACIóN CIENCIA PARA LA VIDA (FCV)
WO/2021/011800	METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC  INHIBITOR	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/011802	METHODS AND COMPOSITIONS FOR UNSILENCING IMPRINTED GENES	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/011806	IMMUNE TOLERIZATION AGENTS AND POTENTIATORS	ANTOLRX, INC.
WO/2021/011807	POLYMORPHS OF  (R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE	CYTOKINETICS, INC.
WO/2021/011808	CARDIAC SARCOMERE INHIBITOR ORAL FORMULATIONS	CYTOKINETICS, INC.
WO/2021/011809	POLYMORPHS OF  (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOLE-5-CARBOXAMIDE	CYTOKINETICS, INC.
WO/2021/016049	ACETYLCHOLINE MODULATION OF IMMUNE FUNCTION	BCELL SOLUTIONS, INC.
WO/2021/011826	PROCESS OF MAKING MEMBRANE LIPID COATED NANOPARTICLES	COASTAR THERAPEUTICS INC.
WO/2021/011842	SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL  DNA VECTORS	GENERATION BIO CO.
WO/2021/016054	SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING  CANCER	THE GENERAL HOSPITAL CORPORATION
WO/2021/011844	COMBINATION CANCER THERAPY AGENTS AND METHODS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016061	INHIBITORS OF MICRORNA 451A FOR TREATMENT OF ENDOMETRIOSIS	YALE UNIVERSITY
WO/2021/011857	USE OF PLATELETS IN TREATING INFECTIONS	CELLPHIRE, INC.
WO/2021/055090	DEGRADABLE PHASE CHANGING POLYMERS FOR DENTAL/MEDICAL  APPLICATIONS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/011871	MERTK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/011873	BORON-CONTAINING RHO KINASE INHIBITORS	PERCIPIAD, INC.
WO/2021/011874	GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS	UNIVERSITY OF MIAMI
WO/2021/016081	METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL  DISORDERS	FINCH THERAPEUTICS HOLDINGS LLC.
WO/2021/011875	COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016082	COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/016083	METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL  DISORDERS	FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/011878	METHOD OF TREATING PARKINSON'S DISEASE	VENTURIS THERAPEUTICS, INC.
WO/2021/016090	COMPOSITIONS AND METHODS FOR INDIVIDUALIZED CHARACTERIZATION  OF NON-IGE MEDIATED FOOD ALLERGIES	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/016091	CHIMERIC ANTIGEN RECEPTORS FOR DIRECT AND INDIRECT TARGETING  OF FIBRONECTIN-POSITIVE TUMORS	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/011882	LONG LIVED T CELLS FOR TREATING HIV INFECTION	CASE WESTERN RESERVE UNIVERSITY
WO/2021/011887	CLOSTRIDIA CONSORTIA COMPOSITIONS AND METHODS OF TREATING  OBESITY, METABOLIC SYNDROME AND IRRITABLE BOWEL DISEASE	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/011891	LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDE	GILEAD SCIENCES, INC.
WO/2021/016102	INHIBITORS OF TYROSINE KINASE	BRIDGENE BIOSCIENCES, INC.
WO/2021/011896	LONG-ACTING FORMULATIONS AND VEHICLES	DURECT CORPORATION
WO/2021/016106	MULTILAMELLAR RNA NANOPARTICLES	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED
WO/2021/016112	NON-SEDATING DEXMEDETOMIDINE TREATMENT REGIMENS	BIOXCEL THERAPEUTICS, INC.
WO/2021/011903	FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF	GEMINI THERAPEUTICS INC.
WO/2021/011907	ORDERED PROCESSING OF BLOOD PRODUCTS TO PRODUCE  THERAPEUTICALLY ACTIVE CELLS	GPB SCIENTIFIC, INC.
WO/2021/016118	COMPOSITIONS FOR THE TREATMENT OF CONDITIONS BY DERMAL FILLERS	DERMATA THERAPEUTICS, LLC
WO/2021/011912	COMBINATION OF INTEGRIN-TARGETING KNOTTIN-FC FUSION AND  ANTI-CD47 ANTIBODY FOR THE TREATMENT OF CANCER	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/011913	TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE	ARVINAS OPERATIONS, INC.
WO/2021/016126	AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY IN HUMANS	UNIVERSITY OF FLORIDA RESEARCHFOUNDATION, INCORPORATED
WO/2021/011925	TREATMENT OF UROTHELIAL AND KIDNEY CANCERS BY USE OF  ENDOTHELIN B RECEPTOR ANTAGONISTS	ENB THERAPEUTICS, INC.
WO/2021/016134	PREPARATION OF LIPOPHILIC ACTIVE INGREDIENTS	SPI PHARMA, INC.
WO/2021/011929	USE OF FRATAXIN FOR TREATING LEIGH SYNDROME, FRENCH CANADIAN  TYPE	CHONDRIAL THERAPEUTICS, INC.
WO/2021/011930	SLIRP FUSION PROTEINS AND USE THEREOF FOR TREATING LEIGH  SYNDROME	CHONDRIAL THERAPEUTICS, INC.
WO/2021/016141	ANTI-COCCIDIAL PHYTOGENIC FORMULATIONS	ACADEMIA SINICA
WO/2021/016174	FUSION POLYPEPTIDE FOR IMMUNOTHERAPY	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/011935	PREPARATIONS COMPRISING MESENCHYMAL STEM CELLS AND  CANNABINOIDS AND METHODS OF THEIR USE	DIRECT BIOLOGICS, LLC
WO/2021/016190	COMPOSITIONS AND METHODS FOR MODULATING DRUG-USE DISORDERS	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/173180	LIQUID BIOPSY YIELD ENHANCEMENT	SINGHAL, Seema
WO/2021/016194	SECOND GENERATION SENECA VALLEY VIRUS ONCOLYTIC THERAPY:  COMPOSITIONS AND METHODS THEREOF	RACANIELLO, Vincent, R.
WO/2021/016203	PDLIM2 AS A BIOMARKER FOR CANCER AND AS AN ANTI-CANCER  TREATMENT TARGET	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/016204	ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN  IMMUNOTHERAPY	IMMUNESENSOR THERAPEUTICS, INC.
WO/2021/016208	METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA	SPRUCE BIOSCIENCES, INC.
WO/2021/016211	POROUS SELF-HEALING POLYMER MATRIX FOR ENCAPSULATION OF ACTIVE  MACROMOLECULES AND METHODS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/016227	SYNTHETIC GENETIC ELEMENTS FOR BIOMANUFACTURE	JANSSEN BIOTECH, INC.
WO/2021/016228	COMBINATION THERAPY FOR TREATING RAS-MUTANT CANCERS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/016236	METHOD OF REMOTELY CONTROLLING PAIN	NOVILLA PHARMACEUTICALS, INC.
WO/2021/016249	TARGET PEPTIDES FOR CANCER THERAPY AND DIAGNOSTICS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/016261	CELL TREATMENTS AND THERAPEUTIC REINFUSION METHODS	ALAMIN, Todd
WO/2021/021499	THERMALLY-MODULATED ULTRASOUND CONTRAST AGENTS	PURDUE RESEARCH FOUNDATION
WO/2021/021503	USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG  DISEASES AND DISORDERS	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/016293	IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USING	UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/016305	SOFTSHELL CAPSULE FORMULATIONS, AND METHODS OF PREPARATION AND  USE THEREOF	R.P. SCHERER TECHNOLOGIES, LLC
WO/2021/016314	ANAVEX2-73 FOR THE TREATMENT OF GENETIC NEURODEVELOPMENTAL  DISORDERS	ANAVEX LIFE SCIENCES CORP.
WO/2021/016330	POLYPEPTIDES HAVING ANTI-SENESCENT EFFECTS AND USES THEREOF	ONESKIN, INC.
WO/2021/016333	ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS	UNIVERSITY OF HAWAII
WO/2021/016338	METHODS OF TREATING SLEEP DISORDERS ASSOCIATED WITH PAIN	ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
WO/2021/016347	COMPOSITIONS AND METHODS FOR TREATING SKIN INFECTIONS AND  OTHER DISEASES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/016353	COMPOSITION AND METHOD FOR ADOPTIVE IMMUNOTHERAPY	YANG, Wen
WO/2021/021519	SELF-FOAMING CLEANSING COMPOSITION COMPRISING A VOLATILE  SILICONE OIL	STEBBINS, Nicholas David
WO/2021/021520	NRF2 ACTIVATION FOR TREATMENT OF NEPHROGENIC DIABETES  INSIPIDUS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/016361	METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE  NUCLEIC ACID-BASED AGENTS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/021523	DNA-AFFIBODY-DRUG NANOPARTICLES FOR INHIBITING THE METASTASIS  OF CANCER CELLS OVEREXPRESSING HER2	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/016368	TOPICAL EXOSOME COMPOSITIONS AND ASSOCIATED METHODS	ERIVAN BIO, LLC
WO/2021/016369	PIMAVANSERIN FOR TRATING SCHIZOPHRENIA OR FOR TREATING  PSYCHOSIS SECONDARY TO NEURODEGENERATIVE DISORDERS OR DEPRESSIVE DISORDER	ACADIA PHARMACEUTICALS INC.
WO/2021/021528	METHODS OF PREVENTING OR TREATING FATTY DEGENERATION OF  SKELETAL MUSCLE	BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/016388	INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/016392	MULTIVALENT FIBROBLAST-TARGETED AGENTS AND METHODS OF USE	PURDUE RESEARCH FOUNDATION
WO/2021/016401	NOVEL ANTICANCER DRUG FL118 FORMULATION IN COMBINATION WITH  IMMUNOTHERAPY FOR TREATMENT OF HUMAN CANCER	CANGET BIOTEKPHARMA
WO/2021/016409	EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF  CANCERS	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/021535	GLUCOSE-RESPONSIVE INSULIN CONJUGATES	MERCK SHARP & DOHME CORP.
WO/2021/016414	CRYSTALLINE FORMS OF  7-CHLORO-2-(4-(3-METHOXYAZETIDIN-1-YL)CYCLOHEXYL)-2,4-DIMETHYL-N-((6-METHYL-4-(METHYLTHIO)-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)BENZO[D][1,3]DIOXOLE-5-CARBOXAMIDE	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/021543	COMPOSITIONS AND METHODS FOR ATTENUATING SIDE EFFECTS OF  IMMUNE CHECKPOINT INHIBITOR THERAPY	CORBUS PHARMACEUTICALS, INC.
WO/2021/016422	METHODS AND COMPOSITIONS FOR TREATING ANDROGEN RECEPTOR  DEFICIENT, ANDROGEN RECEPTOR LOW, AND CASTRATION-RESISTANT PROSTATE CANCERS	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/016423	COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS	CAAMTECH LLC
WO/2021/021548	SELF-FOAMING CLEANSING COMPOSITION	L'OREAL
WO/2021/016430	STABLE COMPOSITIONS OF MRNA-LOADED LIPID NANOPARTICLES AND  PROCESSES OF MAKING	TRANSLATE BIO, INC.
WO/2021/016435	TWO-STEP LONG-WEAR COSMETIC SYSTEM	L'OREAL
WO/2021/021559	A MODULAR, INTEGRATED PROCESS AND APPARATUS FOR EXTRACTING,  REFINING AND REMEDIATING ACTIVE SUBSTANCES FROM PLANT MATERIAL	BIOMASS OIL SEPARATION SOLUTIONS, LLC
WO/2021/016451	CD63 AGONIST-RELATED METHODS AND COMPOSITIONS	AGONOX, INC.
WO/2021/021563	FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC  ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE	ESPERVITA THERAPEUTICS, INC.
WO/2021/016457	METHODS OF CREATING A SUBSTANCE WITH DIFFERENT FREEZING POINTS  BY ENCAPSULATION	THE GENERAL HOSPITAL CORPORATION
WO/2021/016462	THE PEPTIDOMIMETIC COMPOUND  (R)-2-AMINO-N-((S)-L-(((S)-5-AMINO-L-(3-BENZYL-1,2,4-OXADIAZOL-5-YL)PENTYL)AMINO)-3-(4-HYDROXY-2,6-DIMETHYLPHENYL)-I-OXOPROPAN-2-YL)-5-GUANIDINOPENTANAMIDE  IN THE TREATMENT OF NEURODEGENERATIVE DISEASES	STEALTH BIOTHERAPEUTICS CORP
WO/2021/021567	METHODS AND ASSEMBLIES FOR PREPARING AND DISPENSING LYOSPHERES  OF PHARMACEUTICAL COMPOSITIONS	MERCK SHARP & DOHME CORP.
WO/2021/016464	METHODS AND COMPOSITIONS FOR TREATING CANCER	CITY OF HOPE
WO/2021/021572	ANTIOXIDANT AND ANTIVIRAL COMPOSITIONS AND METHODS	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/016505	COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE	VOYAGER THERAPEUTICS, INC.
WO/2021/021593	ADOPTIVE TRANSFER OF PLASMACYTOID DENDRITIC CELLS TO PREVENT  OR TREAT HAIR LOSS	TUFTS MEDICAL CENTER, INC.
WO/2021/016520	LIPOSOMAL NUTRACEUTICAL COMPOSITIONS AND METHODS OF MAKING THE  SAME	VASAYO, LLC
WO/2021/016521	PHOTO INDUCED CONTROL OF PROTEIN DESTRUCTION	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/021603	ENGINEERED HCV E2 IMMUNOGENS AND RELATED VACCINE COMPOSITIONS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/021607	YAP INHIBITION FOR WOUND HEALING	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/016529	METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV)	THE JOHNS HOPKINS UNIVERSITY
WO/2021/016531	ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF	AGENUS INC.
WO/2021/021613	A DERMAL PATCH FOR TRANSDERMAL ADMINISTRATION OF GHRELIN  PATHWAY BLOCKER	HAMRAH, Pedram
WO/2021/016537	CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF	NORTH CAROLINA STATE UNIVERSITY
WO/2021/021615	RECOMBINANT HEME OXYGENASE-1 (HO-1) FOR THE TREATMENT OF  SICKLE CELL DISEASE	SHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/016543	ANTIVIRAL COMBINATIONS OF THIAZOLIDE COMPOUNDS	ROMARK LABORATORIES L.C.
WO/2021/016548	POLYIODIDE BINDING COMPOUNDS AND METHODS OF USE THEREOF	NORTH CAROLINA STATE UNIVERSITY
WO/2021/016552	N-CADHERIN BINDING MOLECULES AND USES THEREOF	ZOMEDICA PHARMACEUTICALS CORP.
WO/2021/016554	CUPTSM FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS	ALS THERAPY DEVELOPMENT INSTITUTE
WO/2021/021631	IMMUNE CELLS WITH ENHANCED CYTOTOXICITY AND METHODS OF USE  THEREOF	LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
WO/2021/021644	COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA	ALLERGAN SALES, LLC
WO/2021/016576	TOPICAL COMPOSITIONS	SKIN MEDICINALS LLC
WO/2021/021647	DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST  DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINS	GENENTECH, INC.
WO/2021/021649	METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCE	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/021668	PEPTIDES FOR TREATING NON-EXUDATIVE MACULAR DEGENERATION AND  OTHER DISORDERS OF THE EYE	ALLEGRO PHARMACEUTICALS, LLC
WO/2021/016601	METHODS AND AGENTS FOR TREATING ACUTE NEUROINFLAMMATORY INJURY	IMPLICIT BIOSCIENCE LIMITED
WO/2021/016609	CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC  STIMULATING RECEPTORS AND USES THEREOF	EUREKA THERAPEUTICS, INC.
WO/2021/016612	MEDICATION COATED WITH HEMP OR OTHER CANNABINOID	HEMPVANA, LLC
WO/2021/021705	ANTIBODY PRE-LOADED CD16+NK-92 CELLS AS AN EFFECTIVE  THERAPEUTIC PRODUCT FOR TUMOR LYSIS	NANTKWEST, INC.
WO/2021/021708	COMPOSITIONS FOR TREATING SEXUAL DYSFUNCTION	CHEMISTYRX
WO/2021/021713	COMPOSITIONS AND METHODS OF USING C/EBP ALPHA SARNA	MINA THERAPEUTICS LIMITED
WO/2021/021716	COMPOSITIONS AND METHODS FOR INHIBITING NEOINTIMAL FORMATION	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/021717	ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING  THE SAME	BRII BIOSCIENCES, INC.
WO/2021/021729	MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE  COMPOSITIONS AND METHODS OF USING THE SAME	SANOFI PASTEUR INC.
WO/2021/016621	POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC  ANTIGEN RECEPTOR	CELULARITY INC.
WO/2021/021741	TREATMENT OF P53-DEFICIENT CANCERS	HEALTH RESEARCH, INC.
WO/2021/021753	A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE	NDSU RESEARCH FOUNDATION
WO/2021/021759	DETECTION OF MEDIATORS OF DOPAMINE TRANSMISSION	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/021765	NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS	EVOLVE BIOSYSTEMS, INC.
WO/2021/021767	ANTI-PD-1/LAG3/TIGIT TRISPECIFIC ANTIBODIES AND ANTI-PD-1/LAG3  BISPECIFIC ANTIBODIES	MERCK SHARP & DOHME CORP.
WO/2021/021774	COMPOSITION AND METHOD FOR PROMOTING WOUND HEALING	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/021778	A COMPOSITION FOR MUCOSAL ADMINISTRATION TO AVIANS	PHIBRO ANIMAL HEALTH CORPORATION
WO/2021/025899	PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER PHARMACEUTICAL  COMPOSITIONS	SAREPTA THERAPEUTICS, INC.
WO/2021/021811	MYOSIN DERIVED PEPTIDES AND RELATED COMPOUNDS WITH  ANTICOAGULANT ACTIVITIES	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/021816	CALPAIN INHIBITORS AND USES THEREOF FOR TREATING NEUROLOGICAL  DISORDERS	BLADE THERAPEUTICS, INC.
WO/2021/091605	COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS  AND ANTI-PD-1 ANTIBODIES	COMPUGEN LTD.
WO/2021/021837	ANTI-PVRIG ANTIBODIES FORMULATIONS AND USES THEREOF	COMPUGEN LTD.
WO/2021/021846	ANTIBODIES FOR THE DIAGNOSIS AND TREATMENT OF B-CELL ACUTE  LYMPHOBLASTIC LEUKEMIA	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/021873	COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22)  PEPTIDE ANALOGS AND METHODS OF USE	OKYO PHARMA LIMITED
WO/2021/021877	GIPR-AGONIST COMPOUNDS	ELI LILLY AND COMPANY
WO/2021/021885	METHODS OF TREATING ADVANCED PROSTATE CANCER	THE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/021893	COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERS	CONSTELLATION PHARMACEUTICALS, INC.
WO/2021/021904	PHARMACOLOGICAL INHIBITORS OF THE ENL YEATS DOMAIN	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/021907	METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND  CYTOTOXICITY OF NATURAL KILLER CELLS	NKARTA, INC.
WO/2021/021909	DOSING REGIMENS FOR ORAL COMPLEMENT FACTOR D INHIBITORS	BIOCRYST PHARMACEUTICALS, INC.
WO/2021/021915	COMPOSITIONS COMPRISING CHEMERIN ANALOGS AND METHODS OF USE	OKYO PHARMA LIMITED
WO/2021/021922	COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/021927	COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG  INFLAMMATION	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/021937	ANTIGEN-SPECIFIC T CELL BANKS AND METHODS OF MAKING AND USING  THE SAME THERAPEUTICALLY	BAYLOR COLLEGE OF MEDICINE
WO/2021/021939	PLANT-BASED CHEMICALS FOR VARROA MITE CONTROL	BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/021944	SYSTEMS AND METHODS FOR ASSESSING A TARGET MOLECULE	AXBIO INC.
WO/2021/021951	WDR5-MYC INHIBITORS	VANDERBILT UNIVERSITY
WO/2021/021959	SUBCUTANEOUS DELIVERY OF MULTIMERIC OLIGONUCLEOTIDES WITH  ENHANCED BIOACTIVITY	MPEG LA, L.L.C.
WO/2021/021978	COMPOSITIONS CONTAINING COPOLYMER OF VINYLPYRROLIDONE AND  ACRYLIC ACID AND FILM FORMING AGENT	L'OREAL
WO/2021/021988	TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED MRNA  ENCODING CFTR	TRANSLATE BIO, INC.
WO/2021/021989	CELLS FOR IMPROVED IMMUNOTHERAPY AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/150268	METHODS OF TREATMENT OF ASTHMA AND COPD	BRIDGE PHARMA, INC.
WO/2021/025935	DNA-FISH METHOD FOR MEASUREMENT OF TELOMERE LENGTH	GEORGETOWN UNIVERSITY
WO/2021/021994	USE OF HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS FOR  TREATING SICKLE CELL DISEASE	GLYCOMIMETICS, INC.
WO/2021/021996	METHODS OF TREATING DISORDERS ASSOCIATED WITH ELEVATED LEVELS  OF ANTIBODIES THAT INTERACT WITH THE NMDA RECEPTOR	APTINYX INC.
WO/2021/021999	COMPOSITIONS AND METHODS FOR UPREGULATION OF HUMAN FETAL  HEMOGLOBIN	THE UAB RESEARCH FOUNDATION
WO/2021/022001	VACCINE COMPOSITIONS AND METHODS OF SELECTING ANTIGENS	TRUSTEES OF TUFTS COLLEGE
WO/2021/022005	FOCAL TREATMENT OF PROSTATE CANCER	NYMOX CORPORATION
WO/2021/022012	METHODS AND COMPOSITION FOR TREATING RESPIRATORY OBSTRUCTIVE  DISEASES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022015	METHODS OF TREATING MULTIFOCAL CANCER	NYMOX CORPORATION
WO/2021/022037	IL-38-SPECIFIC ANTIOBODIES	IMMUNOME, INC.
WO/2021/022039	ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF	MYTHIC THERAPEUTICS, INC.
WO/2021/022044	DEPLETION REGIMES FOR ENGINEERED T-CELL OR NK-CELL THERAPY	FORTY SEVEN, INC.
WO/2021/022056	COMPOSITIONS AND METHODS AND USES THEREOF	FOAMIX PHARMACEUTICALS LTD.
WO/2021/022058	ANTIARRHYTHMIC FORMULATION	INCARDA THERAPEUTICS, INC.
WO/2021/022061	ARYL HYDROCARBON RECEPTOR ACTIVATORS	OREGON STATE UNIVERSITY
WO/2021/022065	WATER-SOLUBLE CANNABIS COMPOSITION	ETAIN IP, LLC
WO/2021/022066	COMPOSITIONS AND METHODS FOR INHIBITING BACTERIAL VIRULENCE  AND FLIM-BASED DEVICE AND METHOD FOR ANTIBIOTIC SUSCEPTIBILITY TESTING	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022070	PREBIOTIC-INDUCED ANTI-TUMOR IMMUNITY	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/025959	TARGETING THE GASTROINTESTINAL BARRIER TO TREAT AGE-RELATED  DISORDERS	THE GENERAL HOSPITAL CORPORATION
WO/2021/022076	MOLECULES AND METHODS RELATED TO TREATMENT OF UNCONTROLLED  CELLULAR PROLIFERATION	ST. JUDE CHILDREN'S RESEARCH HOSPITAL
WO/2021/022078	DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY	XRAD THERAPEUTICS, INC.
WO/2021/022081	METHOD FOR TREATING SOLID TUMORS	BREAKBIO CORP.
WO/2021/022083	ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF	ALECTOR LLC
WO/2021/022088	INTRACRANIAL DELIVERY OF MEDICINAL SOLUTION	INCUBE LABS, LLC
WO/2021/022103	COCRYSTALS OF POSACONAZOLE, METHODS OF MAKING AND USING SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/003488	COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES	TRUETIVA, INC.
WO/2021/022105	COMPOSITIONS AND METHODS FOR TREATING CANCER WITH  NUCLEOSIDE-METABOLISM MODULATORS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022107	MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/022110	INDUCING IMMUNE EFFECTS USING BACTERIA OF THE GENUS  <i>BIFIDOBACTERIUM</i>	EVELO BIOSCIENCES, INC.
WO/2021/025976	SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS,  ANALOGUES THEREOF, AND METHODS USING SAME	ARBUTUS BIOPHARMA, INC.
WO/2021/022112	ALGINATE-BASED MICROCAPSULATION FOR THE DELIVERY OF ALPHA-CGRP  IN CARDIOVASCULAR DISEASES	UNIVERSITY OF SOUTH CAROLINA
WO/2021/022113	MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/022116	INSULIN ANALOGUES WITH GLUCOSE REGULATED CONFORMATIONAL SWITCH	THERMALIN INC.
WO/2021/022117	A PEPTOID-PEPTIDE HYBRID, NMEG-ACGRP, AND ITS USE IN  CARDIOVASCULAR DISEASES	UNIVERSITY OF SOUTH CAROLINA
WO/2021/022121	NITRILOTRIACETIC ACID-CONTAINING LIPIDOID NANOPARTICLES	TRUSTEES OF TUFTS COLLEGE
WO/2021/025984	RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/022132	USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF  RECONSTITUTED, BONE MARROW-DEPLETED HOSTS	MAGNANI, John L.
WO/2021/022134	BIOACTIVE COMPOSITIONS AND APPLICATIONS THEREOF	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/025985	METHODS OF TREATING SUBSTANCE ABUSE DISORDER, DYSPNEA,  TINNITUS, AND CHILD AND ADOLESCENT DEPRESSION	PRAXIS PRECISION MEDICINES, INC.
WO/2021/025988	DOSING PROTOCOLS AND REGIMENS FOR AMINOSTEROL TREATMENT	ENTERIN, INC.
WO/2021/022147	COMPOSITIONS AND METHODS FOR TREATMENT OF INTRACRANIAL  DISEASES	DUKE UNIVERSITY
WO/2021/025997	MATERIALS AND METHODS FOR MULTIDIRECTIONAL BIOTRANSPORTATION	JANSSEN BIOTECH, INC.
WO/2021/025999	METHODS AND COMPOSITIONS TO PROMOTE TARGETED GENOME  MODIFICATIONS USING HUH ENDONUCLEASES	MONSANTO TECHNOLOGY LLC
WO/2021/026000	MATERIALS AND METHODS FOR POLYMERIC ANTIBODY RECEPTOR  TARGETING	JANSSEN BIOTECH, INC.
WO/2021/066931	MOLECULAR GUIDE SYSTEM PEPTIDES AND USES THEREOF	BROWN, Kathlynn C.
WO/2021/022166	ANTIBODY SPECIFIC FOR GPC3 AND METHODS OF USE THEREOF	R.P. SCHERER TECHNOLOGIES, LLC
WO/2021/022172	A DOSING REGIMEN FOR AN IDO INHIBITOR	INCYTE CORPORATION
WO/2021/022173	COMPOSITIONS AND METHODS FOR DELIVERY OF RNA INTERFERENCE  AGENTS TO IMMUNE CELLS	MODERNATX, INC.
WO/2021/022185	POLY(BETA-THIOESTER) POLYMERS AND POLYMERIC NANOPARTICLES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/022186	DEUTERATED MK2 PATHWAY INHIBITORS AND METHODS OF USING THE  SAME	ACLARIS THERAPEUTICS, INC.
WO/2021/022189	COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026021	METHODS OF ADMINISTERING ANTI-SIGLEC-8 ANTIBODIES AND  CORTICOSTEROIDS	ALLAKOS INC.
WO/2021/026024	COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V  BETA-3 -POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT AND  METASTATIC CANCERS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/022208	TARGETED GENE THERAPY TO TREAT NEUROLOGICAL DISEASES	KAPLITT, Michael G.
WO/2021/022213	INTRAVENOUS VITAMIN C THERAPY PROTOCOL FOR THE TREATMENT OF  CANCER	RIORDAN CLINIC
WO/2021/022215	INHIBITORS OF ADVANCED GLYCATION END PRODUCTS	KHALIFAH, Raja, G.
WO/2021/026028	METHODS FOR TREATING OR PREVENTING CANCERS INVOLVING THE  ADMINISTRATION OF ANTI-CCR5 RECEPTOR AGENTS	CYTODYN INC.
WO/2021/022220	ANTICANCER AGENTS	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/022223	DUX4 EXPRESSING CELLS AND USES THEREOF	SANA BIOTECHNOLOGY, INC.
WO/2021/022224	COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF THEIR  USE IN THE INHIBITION OF INTERACTION BETWEEN IL18 AND IL18R	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/026046	TREATMENT OF CANINE CANCERS	ONEHEALTHCOMPANY, INC.
WO/2021/022249	FCRN ANTIBODIES AND METHODS OF USE THEREOF	MOMENTA PHARMACEUTICALS, INC.
WO/2021/026066	COMPOSITIONS OF TROFINETIDE	NEUREN PHARMACEUTICALS LIMITED
WO/2021/026071	METHOD FOR TREATING SEXUAL DYSFUNCTION	CATALYST PHARMACEUTICALS, INC.
WO/2021/026074	BISPECIFIC ANTIBODY TARGETING OF T REGULATORY CELLS FOR  TREATMENT OF INFLAMMATORY CONDITIONS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/026075	EXON 44-TARGETED NUCLEIC ACIDS AND RECOMBINANT  ADENO-ASSOCIATED VIRUS COMPRISING SAID NUCLEIC ACIDS FOR TREATMENT OF  DYSTROPHIN-BASED MYOPATHIES	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/026084	COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS	ANEIRA PHARMA, INC.
WO/2021/022256	COMBINED CANCER THERAPY OF ANTI-GALECTIN-9 ANTIBODIES AND  CHEMOTHERAPEUTICS	NEW YORK UNIVERSITY
WO/2021/022258	TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF HEMATOLOGICAL  CANCERS	TETRAPHASE PHARMACEUTICALS, INC.
WO/2021/026091	PREMIXED ULTRA-STABLE SINGLE-CHAIN INSULIN ANALOGUE  FORMULATIONS	CASE WESTERN RESERVE UNIVERSITY
WO/2021/026100	PYRIDINE DERIVATIVES AS KIF18A INHIBITORS	AMGEN INC.
WO/2021/026124	GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS	MARINUS PHARMACEUTICALS, INC.
WO/2021/026130	COMPOSITIONS AND METHODS OF TREATING PSORIASIS AND ATOPIC  DERMATITIS USING PREVOTELLA HISTICOLA	EVELO BIOSCIENCES, INC.
WO/2021/026150	METHODS FOR THE TREATMENT OF APOC3-RELATED DISEASES AND  DISORDERS	ARROWHEAD PHARMACEUTICALS, INC.
WO/2021/026153	ESTROGEN RECEPTOR MODULATORS FOR TREATING MUTANTS	RECURIUM IP HOLDINGS, LLC
WO/2021/026160	METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA  GRAVIS WITH ECULIZUMAB	ALEXION PHARMACEUTICALS, INC.
WO/2021/026169	ANTI-ISCHEMIC COMPOSITIONS	SERAPHIM THERAPEUTICS, INC.
WO/2021/026177	ANHYDROUS COMPOSITIONS AND ARTICLES FOR MAKEUP REMOVAL	L'OREAL
WO/2021/026185	INDOLE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES  THEREOF	NEW YORK UNIVERSITY
WO/2021/026195	AUTOLOGOUS THYMIC TISSUE TRANSPLANTATION	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/026203	METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC  IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST	REGENERON PHARMACEUTICALS, INC.
WO/2021/026232	KETAMINE FOR THE TREATMENT OF POSTPARTUM SYMPTOMS AND  DISORDERS	THE KETAMINE RESEARCH FOUNDATION
WO/2021/026233	MANIPULATION AND USE OF ANTIGEN-SPECIFIC REGULATORY T CELLS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/026247	USE OF SEPIAPTERIN AND METABOLITES THEREOF TO TREAT RADIATION  EXPOSURE	PTC THERAPEUTICS MP, INC.
WO/2021/026248	NON-WOVEN WATER-SOLUBLE WIPE	L'OREAL
WO/2021/026273	SCALEABLE PREPARATION OF POLYKETIDES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026275	GENETICALLY MODIFIED ENTEROVIRUS VECTORS	VIROGIN BIOTECH CANADA LTD
WO/2021/026285	FORMULATIONS INCLUDING DIHYDROHONOKIOL	KIRKLAND, Justin
WO/2021/026287	DISSOLVED C60 AND METHOD OF PRODUCING DISSOLVED C60	INNOVATION FOR SUCCESS, LLC
WO/2021/026289	Microsphere-Based Injectible Celecoxib Formulation	AVIDENCE THERAPEUTICS, INC.
WO/2021/026290	T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/026310	PROCESSES OF PREPARING POLYGLUTAMATED ANTIFOLATES AND USES OF  THEIR COMPOSITIONS	L.E.A.F. HOLDINGS GROUP LLC
WO/2021/026312	USE OF TGF-ALPHA POLYPEPTIDE OR ANTI-TGF-ALPHA ANTIBODIES FOR  THE TREATMENT OF DISEASES AND DISORDERS	TODARO, George, J.
WO/2021/030136	ANTIBODY CHEMICALLY INDUCED DIMERIZERS (AbCID) AS MOLECULAR  SWITCHES AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026337	METHOD OF TREATING KELOIDS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/040996	SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVES AND METHODS  FOR DELIVERING AND ANCHORING THE SAME	VDYNE, INC.
WO/2021/026349	COMBINATION THERAPY FOR TREATMENT OF CANCER	INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF  FOX CHASE CANCER CENTER
WO/2021/026353	THERAPEUTIC EXTRACELLULAR VESICLES	OHIO STATE INNOVATION FOUNDATION
WO/2021/030145	SYSTEMS AND METHODS FOR MECHANOGENETIC FUNCTIONAL ULTRASOUND  IMAGING	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/026358	COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF AGENTS	MODERNA TX, INC.
WO/2021/026375	FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF PAIN	ALKERMES, INC.
WO/2021/026377	LACTAM-CONTAINING COMPOUNDS FOR THE TREATMENT OF PAIN	ALKERMES, INC.
WO/2021/026378	INDOLE COMPOUNDS FOR THE TREATMENT OF PAIN	ALKERMES, INC.
WO/2021/026380	PHENYLTRIAZOLE COMPOUNDS FOR THE TREATMENT OF PAIN	ALKERMES, INC.
WO/2021/030155	COMPOSITION OF PHARMACEUTICAL CARRIER SOLUTION FOR MESENCHYMAL  STEM CELLS AND USE OF THE SAME	BAYLX, INC.
WO/2021/030156	COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF  BLADDER CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026391	CELL PENETRATING PEPTIDE FUNCTIONALIZED PERFLUOROCARBON  NANOEMULSION COMPOSITIONS AND METHODS FOR IMAGING CELL POPULATIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/026393	CETUXIMAB-IR700 CONJUGATE COMPOSITIONS	RAKUTEN MEDICAL, INC.
WO/2021/026395	COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF THEIR  USE IN REVERSING CANCER CHEMORESISTANCE	THE GENERAL HOSPITAL CORPORATION
WO/2021/030165	TRPSWITCH − A STEP FUNCTION CHEMO-OPTOGENETIC LIGAND	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/030166	ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION  AND USE THEREOF	SIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/026413	PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF  NEUROLOGICAL DISEASES	ACLIPSE ONE INC.
WO/2021/026421	PHARMACEUTICAL COMPOSITIONS OF  (6AS)-6-METHYL-5,6,6A,7-TETRAHYDRO-4H-DIBENZO[DE,G]QUINOLINE-10,11-DIOL	ACLIPSE ONE INC.
WO/2021/040999	METHODS AND COMPOSITIONS FOR STIMULATING EXOSOME SECRETION	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/026429	BUTYRYLCHOLINESTERASE COMPOUNDS AND USE IN DISEASES OF THE  NERVOUS SYSTEM	TREVENTIS CORPORATION
WO/2021/030182	BIFUNCTIONAL SINGLE VARIABLE DOMAIN T CELL RECEPTORS AND USES  THEREOF	A2 BIOTHERAPEUTICS, INC.
WO/2021/030183	COMBINATION TREATMENT OF SYSTEMIC FUNGAL INFECTIONS	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/026447	METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A  MUTATION IN THE GLA GENE	AMICUS THERAPEUTICS, INC.
WO/2021/026450	HYBRID AMPHOTERICIN B DERIVATIVES WITH REDUCED TOXICITY	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/026451	COMPOUNDS AND METHOD FOR TREATING CYTOKINE RELEASE SYNDROME	RIGEL PHARMACEUTICALS, INC.
WO/2021/030190	CBD FORMULATIONS AND USES THEREOF	JUPITER WELLNESS, INC.
WO/2021/026454	METHOD OF TREATING CANCER	LAEKNA LIMITED
WO/2021/026455	ANTIBIOTIC PEPTIDES, COMPOSITIONS AND USES THEREOF	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/026456	WATER-SOLUBLE CANNABINOIDS	OROCHEM TECHNOLOGIES, INC.
WO/2021/030196	ELP FUSION PROTEINS COMPRISING PARATHYROID HORMONE FOR  CONTROLLED AND SUSTAINED RELEASE	PHASEBIO PHARMACEUTICALS, INC.
WO/2021/026465	JAK INHIBITORS	VIMALAN BIOSCIENCES, INC.
WO/2021/030198	COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS	VEDANTA BIOSCIENCES, INC.
WO/2021/026480	COMPOSITIONS AND METHODS FOR DECREASING INTRAOCULAR PRESSURE	DUKE UNIVERSITY
WO/2021/026483	ADDITIONAL MASS TAG POLYMERS FOR MASS CYTOMETRY	FLUIDIGM CANADA INC.
WO/2021/026484	IMPLANTABLE CONSTRUCTS AND USES THEREOF	WILLIAM MARSH RICE UNIVERSITY
WO/2021/030212	METHOD OF ENHANCING THE EFFICACY AND STABILITY OF INGREDIENTS  IN SUSPENSIONS	NANOPHASE TECHNOLOGIES CORPORATION
WO/2021/026491	FUSION PROTEINS AGAINST SIALOSYLATED GLYCOSPHINGOLIPIDS AND  SIALATED GLYCOPROTEINS AND USES THEREOF	ON. TARGET MOLECULES BIOTECH INC.
WO/2021/026492	KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS	HUMANWELL PHARMACEUTICAL US
WO/2021/026507	METHODS OF IMPROVING ORGAN FUNCTION	CEDARS-SINAI MEDICAL CENTER
WO/2021/030218	LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID  DELIVERY	NUTCRACKER THERAPEUTICS, INC.
WO/2021/030232	OLFACTORY DELIVERY OF THERAPEUTIC COMPOUNDS TO THE CENTRAL  NERVOUS SYSTEM	LOCUS IP COMPANY, LLC
WO/2021/026520	HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/026522	METHOD OF GENERATING ACTIVATED T CELLS FOR CANCER THERAPY	CEDARS-SINAI MEDICAL CENTER
WO/2021/030248	TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES  COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND  FULVESTRANT	GENENTECH, INC.
WO/2021/030250	METHODS FOR INCREASING THE BIOAVAILABILITY OF OTC AND  PHARMACEUTICAL DRUGS	LOCUS IP COMPANY, LLC
WO/2021/045870	MIRTAZAPINE AS A PRE-SHIPPING INHIBITOR OF BOVINE RESPIRATORY  DISEASE	IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/026529	INHIBITION OF INTERACTION BETWEEN OCT4 AND MAPKAPK2 OR  DNA-PKCS TO REGULATE C-MYC IN CANCER	TEXAS TECH UNIVERSITY SYSTEM
WO/2021/030260	PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONS	TESORX PHARMA, LLC
WO/2021/030292	COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED  METHODS	AXOLOTL BIOLOGIX, INC.
WO/2021/030306	DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/030326	BRUSH POLYMERS FOR THERAPEUTIC APPLICATIONS	NORTHWESTERN UNIVERSITY
WO/2021/030335	A STEREOISOMERICALLY PURE NK-3 RECEPTOR ANTAGONIST AND  CRYSTALLINE FORMS THEREOF	MILLENDO THERAPEUTICS, INC.
WO/2021/030343	1,4 DIHYDROPYRIDINE COMPOSITIONS, METHODS OF MAKING AND USE	AMERICAN REGENT, INC.
WO/2021/030358	MACROPHAGE STIMULATING 1 RECEPTOR (MST1R) VARIANTS AND USES  THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/030359	PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL  NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER	PEPTINOVO BIOPHARMA, LLC
WO/2021/034548	MITOCHONDRIAL MODULATION TO IMPROVE METABOLIC SYNDROME DURING  AGING	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/030404	METHODS AND COMPOSITIONS FOR TREATING VASCULAR MALFORMATIONS	DECIPHERA PHARMACEUTICALS, LLC
WO/2021/030405	RIPRETINIB FOR TREATING GASTROINTESTINAL STROMAL TUMORS	DECIPHERA PHARMACEUTICALS, LLC
WO/2021/030407	DIAGNOSTIC TEST FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	UNIVERSITY OF MASSACHUSETTS
WO/2021/030411	HYDROPHOBIC PEPTIDE SALTS FOR EXTENDED RELEASE COMPOSITIONS	BIOMARIN PHARMACEUTICAL INC.
WO/2021/030433	GENETICALLY ENGINEERED HUMAN FETAL LIVER NICHE AS PLATFORM FOR  BIOMANUFACTURING OF HEMATOPOIETIC STEM CELLS	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/030438	COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN	GILEAD SCIENCES, INC.
WO/2021/030451	GLYCEROL AS A PERMEATION ENHANCER AND COMPOSITIONS CONTAINING  THE SAME	DECIBEL THERAPEUTICS, INC
WO/2021/030452	PERMEATION ENHANCERS, COMPOSITIONS CONTAINING THEM, AND  METHODS OF USING THE SAME	DECIBEL THERAPEUTICS, INC.
WO/2021/030469	THERAPEUTIC MITOCHONDRIAL PEPTIDES	COHBAR, INC.
WO/2021/030472	NANOPARTICLE COMPOSITIONS	JANUARY THERAPEUTICS, INC.
WO/2021/030474	ARTICLES AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/030482	IMPROVED FORMULATIONS FOR IMMUNE CELLS	BELLICUM PHARMACEUTICALS, INC.
WO/2021/030488	4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND  METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40	BIENVENUE, David Leonard
WO/2021/030511	PROCESS FOR PREPARING  1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES AND 4-AMINOQUINOLINE COMPOUNDS  THEREFROM	LOHOCLA RESEARCH CORPORATION
WO/2021/034582	LARGE SCALE PRODUCTION OF EXOSOME MIMETICS AND USES THEREOF	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/030526	METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME	RIGEL PHARMACEUTICALS, INC.
WO/2021/030528	COMPOSITION AND METHOD FOR TREATMENT OF HIPPOCAMPAL SYNAPSE  DYSFUNCTION AND COGNITIVE DEFICITS IN ALZHEIMER'S DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/030538	HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT  A COSMETIC CONDITION	STANDARD OF CARE CORPORATION
WO/2021/030542	URACIL DERMAL PHARMACEUTICAL FORMULATION	NANOMETICS LLC (D.B.A PHD BIOSCIENCES)
WO/2021/030550	NON-ACTIVATED, AMORPHOUS, pH NEUTRAL, TWO-PART BEDSIDE-READY  CLAY DELIVERY SYSTEM THAT TREATS PATHOGEN INFECTIONS IN HUMANS AND ANIMALS	MCCORD, Darlene E.
WO/2021/030553	METHODS OF TREATING <i>CRYPTOCOCCUS</i> INFECTIONS	MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
WO/2021/030559	DISAGGREGATION OF NANODIAMOND PARTICLES	THE CURATORS OF THE UNIVERSITY OF MISSOURI
WO/2021/030571	METHODS OF TREATING PSYCHOLOGICAL AND BRAIN DISORDERS	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/041046	BIO-BASED AND BIODEGRADABLE ELASTOMER FOR COSMETIC AND  PERSONAL CARE	GRANT INDUSTRIES, INC.
WO/2021/030582	THERAPEUTIC AGENT EFFECTIVENESS AND ITS ROUTE OF  ADMINISTRATION	ALTIMMUNE, INC.
WO/2021/030586	DUAL BISPECIFIC ANTIBODY COMPOUNDS AND USES THEREOF	CITY OF HOPE
WO/2021/030588	ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I  LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASE	COURIER THERAPEUTICS, INC.
WO/2021/030604	URINARY RNA SIGNATURES IN RENAL CELL CARCINOMA (RCC)	UNIVERSITY OF MASSACHUSETTS
WO/2021/034616	METHODS OF TREATING A SUBJECT WITH A CDC42-SPECIFIC INHIBITOR	CHILDREN' S HOSPITAL MEDICAL CENTER
WO/2021/030607	PIMAVANSERIN FOR TREATING NEURODEGENERATIVE DISEASES	ACADIA PHARMACEUTICALS INC.
WO/2021/030619	METHODS OF TREATING CANCER	F. HOFFMANN-LA ROCHE AG
WO/2021/034627	SMALL MOLECULE STIMULATORS OF THE CORE PARTICLE OF THE  PROTEASOME	PURDUE RESEARCH FOUNDATION
WO/2021/034629	LARAZOTIDE FORMULATIONS	9 METERS BIOPHARMA, INC.
WO/2021/034631	METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING  4,6-BIS(BENZYLTHIO)HEXANOIC ACID FOR TREATING CANCER	RAFAEL PHARMACEUTICALS, INC.
WO/2021/034634	COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM	NEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE  HOSPITAL FOR SPECIAL SURGERY
WO/2021/034635	THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER USING  6,8-BIS-BENZYLTHIO-OCTANOIC ACID AND A GLUTAMINASE INHIBITOR	RAFAEL PHARMACEUTICALS, INC.
WO/2021/030662	TGF-BETA TRAP	NANTBIO, INC.
WO/2021/030665	FORMULATIONS OF BENZAZEPINE CONJUGATES AND USES THEREOF	SILVERBACK THERAPEUTICS, INC.
WO/2021/030671	TETRACYCLIC COMPOUNDS AND THEIR SALTS, COMPOSITIONS, AND  METHODS FOR THEIR USE	SENHWA BIOSCIENCES, INC.
WO/2021/030679	COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF  METABOLIC DISEASES AND DISORDERS	UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/034653	COMBINATION THERAPY WITH GOLD CONTROLLED TRANSGENES	CHIMERA BIOENGINEERING, INC.
WO/2021/030686	CRYSTALLINE FORMS OF QUINOLINE ANALOGS AND SALTS THEREOF,  COMPOSITIONS, AND THEIR METHODS FOR USE	SENHWA BIOSCIENCES, INC.
WO/2021/030687	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/030689	ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND  ADMINISTRATION	CYTOLYF THERAPEUTICS LLC
WO/2021/030698	SENSITIZATION CREAM COMPRISING L-ARGININE AND L-CITRULLINE AND  THERAPEUTIC USES THEREOF	INNOVUS PHARMACEUTICALS, INC.
WO/2021/030701	IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS	ACUITAS THERAPEUTICS, INC.
WO/2021/030702	DRINKABLE SUPPLEMENT COMPOSITION FOR IMPROVED HEALTH AND  HYDRATION	LOCUS IP COMPANY, LLC
WO/2021/030703	DEPALMITOYLATING COMPOSITIONS AND THE USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030706	IMMUNO ONCOLOGY COMBINATION THERAPIES WITH IL-2 CONJUGATES	SYNTHORX, INC.
WO/2021/034684	CHIMERIC ANTIGEN RECEPTORS FOR TREATING MYELOID MALIGNANCIES	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/030717	HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF  HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP.	GE NUTRIENTS, INC.
WO/2021/034689	ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY  CELLS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/030730	METHODS FOR TREATING DISEASE ASSOCIATED WITH SENESCENCE	STEADMAN PHILIPPON RESEARCH INSTITUTE
WO/2021/034697	COMBINED CANCER THERAPY INVOLVING CHEMICAL ACTIVATION OF  INTEGRINS AND TARGETED CELL IMMUNOTHERAPY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030745	COMBINED TRANSGENE AND INTRON-DERIVED MIRNA THERAPY FOR  TREATMENT OF SCA1	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/030749	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/030752	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/034716	THROMBOSOMES AS AN ANTICOAGULANT REVERSAL AGENT	CELLPHIRE, INC.
WO/2021/034718	WATER-BASED EXTRACTION AND PURIFICATION PROCESSES FOR  CANNABINOID ACIDS	MEDPHARM IOWA LLC
WO/2021/034719	THROMBOSOMES AS AN ANTIPLATELET AGENT REVERSAL AGENT	CELLPHIRE, INC.
WO/2021/030763	MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF	IONIS PHARMACEUTICALS, INC.
WO/2021/030766	COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY	BIOGEN MA INC.
WO/2021/034728	COMPOSITIONS AND PARTICLES FOR PAYLOAD DELIVERY	APPLIED MOLECULAR TRANSPORT INC.
WO/2021/030777	EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF	CODIAK BIOSCIENCES, INC.
WO/2021/034729	N-ARYL SULFONAMIDE DERIVATIVES AS VACCINE ADJUVANT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/030783	COMPOSITIONS AND METHODS FOR THE TREATMENT CANCER AND CNS  DISORDERS	DUKE UNIVERSITY
WO/2021/030785	METHOD FOR THE PREPARATION OF LOW MOLECULAR WEIGHT PORCINE  LYMPHO-RETICULAR POLYPEPTIDES AND FORMULATIONS THEREOF	DE URBINA GAVIRIA, Santiago
WO/2021/030787	MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS  ADMINISTRATION AND ON-DEMAND TREATMENT	CATALYST BIOSCIENCES, INC.
WO/2021/076217	EDIBLE UNCLONABLE FUNCTIONS	PURDUE RESEARCH FOUNDATION
WO/2021/030789	NANOENCAPSULATED CANNABIDIOL	CASTOR, Trevor, P.
WO/2021/030792	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/030794	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/030799	THERAPEUTIC PEPTIDES	COHBAR, INC.
WO/2021/034774	FUCOSYLATION AND IMMUNE MODULATION IN CANCER	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/030808	PHOSPHATIDYLSERINE BINDING MOLECULES BLOCK IMMUNE SUPPRESSION  OF TUMOR ASSOCIATED EXOSOMES	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/055124	DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE  BUPROPION	AXSOME THERAPEUTICS, INC.
WO/2021/034804	PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDE	GILEAD SCIENCES, INC.
WO/2021/050217	EPITOPES OF ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK)  ANTIBODIES	IMCARE BIOTECH, LLC.
WO/2021/034834	COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOF	PMIDG, LLC
WO/2021/034850	IN-SITU GEL FORMING OPHTHALMIC FORMULATIONS CONTAINING  DIFLUPREDNATE	IVIEW THERAPEUTICS, INC.
WO/2021/034863	CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND  COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN  PRODRUGS	CHORDA PHARMA, INC.
WO/2021/101606	COMPOSITIONS FOR SUNSCREEN COMPOUNDS AND METHODS THEREOF	PMIDG, LLC
WO/2021/050219	PHARMACEUTICAL COMPOSITION FOR TREATING INSOMNIA	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/034879	PROBIOTIC DELIVERY OF GUIDED ANTIMICROBIAL PEPTIDES	BAYLOR UNIVERSITY
WO/2021/034883	TOPICAL NEUROSTEROID FORMULATIONS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/034890	TARGETED IMMUNOTOLERANCE WITH A PD-1 AGONIST	PANDION THERAPEUTICS, INC.
WO/2021/034920	SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS  ESSENTIAL FOR SOCIAL MEMORY	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/034924	TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO  LABELED TETRAZINE AND METHODS	BIOGEN MA INC.
WO/2021/034943	IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12	WAYNE STATE UNIVERSITY
WO/2021/034952	ANTI-CD19 ANTIBODIES AND USES THEREOF	ELPIS BIOPHARMACEUTICALS
WO/2021/034953	COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2  MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS	NAVIDEA BIOPHARMACEUTICALS, INC.
WO/2021/034958	MATERIALS FOR DELIVERY OF TETHERABLE PROTEINS IN BONE IMPLANTS	THERADAPTIVE, INC.
WO/2021/034962	POLYMORPHIC FORMS OF DEOXYCYTIDINE, COMPOSITIONS COMPRISING  THE SAME AND USES	MODIS THERAPEUTICS, INC.
WO/2021/034963	IMMUNOLOGICALLY ACTIVE FRAGMENTS OF TOXOPLASMA GONDII	WASHINGTON UNIVERSITY
WO/2021/034982	IMMUNE CELLS FOR ADOPTIVE CELL THERAPIES	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/034984	SKELETAL MYOBLAST PROGENITOR CELL LINEAGE SPECIFICATION BY  CRISPR/CAS9-BASED TRANSCRIPTIONAL ACTIVATORS	DUKE UNIVERSITY
WO/2021/034986	CROTON LECHLERI COMPOSITIONS FOR USE IN TREATING BLEEDING,  WOUNDS AND INFECTIONS	ALPHYN BIOLOGICS
WO/2021/034992	METHOD OF TREATING KRAS-ASSOCIATED CANCERS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/034996	TREATMENT OF CARDIOVASCULAR DISEASES	STEMCYTE INC.
WO/2021/035010	CORROLE-BASED FRAMEWORKS AND METHODS OF USE THEREOF	MA, Shengqian
WO/2021/035031	INHIBITORS OF PHOSPHOLIPID SYNTHESIS AND METHODS OF USE	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/035037	METHOD TO INCREASE SYSTEMIC BLOOD PRESSURE IN SHOCK	GEORGETOWN UNIVERSITY
WO/2021/035048	USE OF INHIBITORS OF YAP AND SOX2 FOR THE TREATMENT OF CANCER	GEORGETOWN UNIVERSITY
WO/2021/035049	IMPROVED RECOMBINANT PMHC MOLECULES	UTI LIMITED PARTNERSHIP
WO/2021/066958	INHIBITOR OF BTK AND MUTANTS THEREOF	NEWAVE PHARMACEUTICAL INC.
WO/2021/035054	LYMPHODEPLETION DOSING REGIMENS FOR CELLULAR IMMUNOTHERAPIES	PRECISION BIOSCIENCES, INC.
WO/2021/035068	INHIBITORS OF ZIKA VIRUS INFECTION	NEW YORK BLOOD CENTER, INC.
WO/2021/035078	TYPE III NKT CELLS AND RELATED COMPOSITIONS AND METHODS	AKESO THERAPEUTICS, INC.
WO/2021/035086	SOLVENT DELIVERY SYSTEM FOR TOPICAL DELIVERY OF ACTIVE AGENTS	TIMBER PHARMACEUTICALS, INC.
WO/2021/035093	CHIMERIC INHIBITORY RECEPTOR	SENTI BIOSCIENCES, INC.
WO/2021/035101	MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC  LATERAL SCLEROSIS AND RELATED DISORDERS	BIOHAVEN THERAPEUTICS LTD.
WO/2021/035102	PROCESS AND COMPOSITION MATTER OF NANOPARTICLE FORMULATION FOR  SYSTEMIC TREATMENT OF SEPSIS	PURDUE RESEARCH FOUNDATION
WO/2021/041171	INTERCELLULAR ADHESION MOLECULE 1 (ICAM1) ANTIBODY DRUG  CONJUGATE AND USES THEREOF	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/041173	BACTERIAL STRAIN USEFUL FOR TREATMENT OF AGE-RELATED  CONDITIONS	WAKE FOREST UNIVERSITY HEALTH SCIENCES
WO/2021/035114	PRODRUGS AND FORMULATIONS THEREOF	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
WO/2021/035126	MEDICAL APPARATUS WITH <i>CANNABIS SATIVA</i> L.	PURE GREEN PHARMACEUTICALS, INC.
WO/2021/035128	COMPOSITIONS AND METHODS FOR TREATING CHRONIC MYELOMONOCYTIC  LEUKEMIA	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/141637	COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL  SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES	THE SALLIE ASTOR BURDINE BREAST FOUNDATION
WO/2021/041206	IL-15 CONJUGATES AND USES THEREOF	SYNTHORX, INC.
WO/2021/041208	METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS TO  PATIENTS WITH SEVERE RENAL IMPAIRMENT	NEUROCRINE BIOSCIENCES, INC.
WO/2021/035142	JUST SUNSCREEN	POUCH PAC INNOVATIONS, LLC
WO/2021/035144	OPTICAL BASED METHODS FOR DETERMINING ANTIMICROBIAL DOSING  REGIMENS	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/041222	MULTI-ARMED POLYOXAZOLINES AND COMPOSITIONS, SYSTEMS AND  METHODS PERTAINING TO THE SAME	BOSTON SCIENTIFIC SCIMED, INC.
WO/2021/041230	RADIOPAQUE MULTI-ARMED POLYMERS AND COMPOSITIONS, SYSTEMS AND  METHODS PERTAINING TO THE SAME	BOSTON SCIENTIFIC SCIMED, INC.
WO/2021/112931	COMPOSITIONS COMPRISING MEROTERPENES AND LINOLEIC ACID  DERIVATIVES AND THEIR USE FOR REGULATING THE ENDOCANNABINOID SYSTEM	SYTHEON LIMITED
WO/2021/035163	METHODS FOR ENHANCING DNA DAMAGE AND APOPTOSIS OF LEUKEMIC  CELLS	THOMAS JEFFERSON UNIVERSITY
WO/2021/035168	METHODS FOR REPROGRAMMING CANCER CELLS	THOMAS JEFFERSON UNIVERSITY
WO/2021/035172	DIAGNOSTICS AND METHODS FOR PROGNOSING RESPONSE TO  IMMUNOTHERAPY BASED ON THE METHYLATION STATUS OF IMMUNE SYNAPSE GENE  SIGNATURE	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/041246	POZIOTINIB COMBINATION WITH VEGFR2 INHIBITORS AND METHODS OF  USE THEREOF	SPECTRUM PHARMACEUTICALS, INC.
WO/2021/035177	VARIANT FC DOMAINS AND USES THEREOF	CIDARA THERAPEUTICS, INC.
WO/2021/035178	MONOUNSATURATED FATTY ACID COMPOSITION AND USE FOR TREATING  FATTY LIVER DISEASE	BURKE & BOYER, INC.
WO/2021/041247	O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES	UNIVERSITY OF MASSACHUSETTS
WO/2021/041250	IGM GLYCOVARIANTS	IGM BIOSCIENCES, INC.
WO/2021/035181	UBE3A FOR THE TREATMENT OF ANGELMAN SYNDROME	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/035188	NOVEL IL-21 PRODRUGS AND METHODS OF USE THEREOF	ASKGENE PHARMA, INC.
WO/2021/041264	USE OF A NEUTROPHIL ELASTASE INHIBITOR IN LUNG DISEASE	PH PHARMA CO., LTD.
WO/2021/035194	COMBINATION THERAPY OF A T CELL THERAPY AND AN ENHANCER OF  ZESTE HOMOLOG 2 (EZH2) INHIBITOR AND RELATED METHODS	JUNO THERAPEUTICS, INC.
WO/2021/035196	COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES	OXALURX, INC.
WO/2021/035198	COMPOSITIONS AND METHODS USING NON-STEROIDAL ANTI-INFLAMMATORY  DRUGS	APPLIED BIOLOGICAL LABORATORIES, INC.
WO/2021/035200	INTEGRATED IMAGE LAYER CONSTRUCTIONS	MABBOTT, Robert, J.
WO/2021/035205	METHOD OF PREPARING A DE-FIBRINATED PLATELET LYSATE, AND USES  OF SAID METHOD	AWIDI, Abdalla S.
WO/2021/041299	METHOD AND KIT FOR DETERMINING BENEFIT OF CHEMOTHERAPY	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/041301	MODIFICATION OF PLANT MESSENGER PACKS WITH CHARGED LIPIDS	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/035210	A SINGLE CHAIN ANTIBODY THAT BINDS TAU OLIGOMERS AND INHIBITS  SEEDING BY PATHOLOGICAL EXTRACTS FROM ALZHEIMER'S DISEASE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/035214	NUCLEOSIDE PRODRUGS AND USES RELATED THERETO	EMORY UNIVERSITY
WO/2021/041312	SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING  PROPERTIES	L'OREAL
WO/2021/041316	CD24 EXPRESSING CELLS AND USES THEREOF	SANA BIOTECHNOLOGY, INC.
WO/2021/041317	DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASES	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/041320	TREPROSTINIL PRODRUGS	UNITED THERAPEUTICS CORPORATION
WO/2021/041326	SUPER ABSORBENT POLYMER RECYCLING TO PRESSURE SENSITIVE  ADHESIVES	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/041335	BIO-REMEDIAL NON-IMMUNOGENIC CANNABINOID DELIVERY	SORSE TECHNOLOGY CORPORATION
WO/2021/041347	METHODS OF TREATMENT USING BCN057 AND BCN512	BCN BIOSCIENCES L.L.C.
WO/2021/041348	METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE  DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS	ARVINAS OPERATIONS, INC.
WO/2021/041350	MUCOADHESIVE COMPOSITIONS AND METHOD OF USE THEREOF	ISP INVESTMENTS LLC
WO/2021/041355	DIFFERENTIALLY-METHYLATED REGIONS OF THE GENOME USEFUL AS  MARKERS OF EMBRYO-ADULT TRANSITIONS	AGEX THERAPEUTICS, INC.
WO/2021/041357	FEED ADDITIVE FORMULATION FOR FISH AND METHODS OF MAKING AND  USING THE SAME	BIORESOURCE INTERNATIONAL, INC.
WO/2021/041363	SKIN CARE COMPOSITION COMPRISING MEVALONOLACTONE	DANISCO US INC
WO/2021/041374	LIPOSOME FORMULATION OF FLUTICASONE FUROATE AND METHOD OF  PREPARATION	HUANG, Cai Gu
WO/2021/041392	SUBSTITUTED (7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO COMPOUNDS  USEFUL AS JAK1 INHIBITORS	CHEMWERTH, INC.
WO/2021/041430	A SYSTEM AND METHOD USING PHOTOCHEMICAL OXYGEN STORAGE AND  RELEASE	PORTLAND STATE UNIVERSITY
WO/2021/041443	ORGANOID MESODERM LINEAGE DIVERSIFICATION	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/041495	METHOD TO MAINTAIN OR ENHANCE TISSUE	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/041496	ZINC PHOSPHATE CONTAINING COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/041506	RATIONALLY DESIGNED LAWSONE DERIVATIVES AS ANTIMICROBIALS  AGAINST MULTIDRUG-RESISTANT <i>STAPHYLOCOCCUS AUREUS</i>	KENT STATE UNIVERSITY
WO/2021/041515	ORAL CARE COMPOSITIONS HAVING INCREASED FOAM PRODUCTION AND  METHODS FOR THE SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/041518	METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST NEOANTIGENS	TURNSTONE BIOLOGICS CORP.
WO/2021/041532	USE OF HEPARIN TO PROMOTE TYPE 1 INTERFERON SIGNALING	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/041559	PLANT ACTIVES AND THEIR ANTI-POLLUTION EFFECTS THEREOF	MAJEED, Muhammed
WO/2021/041561	TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND INFLAMMATORY  STEATOHEPATITIS WITH SLC25A1 INHIBITORS	AVANTAGGIATI, Mauria Laura
WO/2021/041572	COMPOSITIONS COMPRISING DECARBOXYLATED CANNABINOIDS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/041583	COMPOUNDS TO IDENTIFY BETA-LACTAMASES, AND METHODS OF USE  THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041608	SYSTEM AND METHOD OF MULTI-DRUG DELIVERY	ABBVIE INC.
WO/2021/041616	ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS  AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS	ARIXA PHARMACEUTICALS, INC.
WO/2021/041637	COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN  GLYCEROL	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/177999	METHODS OF ADMINISTERING ELAGOLIX	ABBVIE INC.
WO/2021/041662	PERIPHERAL NERVE AGONISTS SUPPRESS INFLAMMATION	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/041664	CEREBLON E3 LIGASE INHIBITORS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/041669	IMMUNE SIGNATURES PREDICTIVE OF RESPONSE TO PD-1 BLOCKADE IN  RICHTER'S TRANSFORMATION	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/041671	KRAS G12D INHIBITORS	MIRATI THERAPEUTICS, INC.
WO/2021/041672	METHODS OF TREATING CANCER USING TNFRSF25 ANTIBODIES	PELICAN THERAPEUTICS, INC.
WO/2021/041673	VAPOR PHASE COATING TECHNOLOGY FOR PHARMACEUTICAL ABUSE  DETERRENT FORMULATIONS	APPLIED MATERIALS, INC.
WO/2021/041675	VAPOR PHASE COATINGS FOR PHARMACEUTICAL SOLUBILITY CONTROL	APPLIED MATERIALS, INC.
WO/2021/041678	ANTI-CD20 ANTIBODIES, ANTI-CD37 ANTIBODIES, AND MIXTURES  THEREOF	QILU PUGET SOUND BIOTHERAPEUTICS CORPORATION
WO/2021/041702	MODULATORS OF CIRCADIAN RHYTHMS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041711	HEPARIN AND HEPARAN SULFATE FROM MODIFIED MST CELLS AND  METHODS OF MAKING AND USING	TEGA THERAPEUTICS, INC.
WO/2021/076238	CLEAR NAIL TOP COAT COMPOSITIONS AND METHODS OF MAKING	ILNP COSMETICS INC.
WO/2021/041721	ANTIMICROBIAL VACCINE COMPOSITIONS	ONEBIOPHARMA, INC.
WO/2021/041725	SYNTHETIC CARS TO TREAT IL13Rα2 POSITIVE HUMAN AND CANINE  TUMORS	THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA
WO/2021/041730	COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS	DELPOR, INC.
WO/2021/041740	COMPOSITIONS OF OPIOID ANTAGONISTS, IMPLANT DEVICES, AND  TREATMENT METHODS FOR OPIOID USE DISORDER	DELPOR, INC.
WO/2021/041744	ARYL BENZOYL IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF LUNG  CANCER	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/041749	Brown Adipose Tissue Myosin II Activators for Metabolic  Therapy	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/041760	COSMETIC COMPOSITION HAVING A LAMELLAR NETWORK	L'OREAL
WO/2021/041773	METHODS FOR THE TREATMENT OF THYROID EYE DISEASE	HZNP LIMITED
WO/2021/041776	LIPOSOMAL TROPONOID COMPOUND FORMULATIONS	UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/041784	HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERY	OHIO STATE INNOVATION FOUNDATION
WO/2021/041791	METHODS AND USES FOR APELIN RECEPTOR AGONISTS	RTI INTERNATIONAL, INC.
WO/2021/041800	TRANSDERMAL DEVICE COMPRISING PAIN MOLECULES	REMEDY DIAGNOSTICS LLC
WO/2021/041806	CHIMERIC CYTOKINE RECEPTORS COMPRISING TGF BETA BINDING  DOMAINS	ALLOGENE THERAPEUTICS, INC.
WO/2021/041824	DRUG-POLYMER AMORPHOUS SOLID DISPERSIONS USING LINEAR POLY  (ACRYLIC ACID) POLYMERS	LUBRIZOL ADVANCED MATERIALS, INC.
WO/2021/041834	DEVELOPING AN EFFICIENT HYBRIDOMA PLATFORM FOR THERAPEUTIC  ANTIBODY DISCOVERY	GENENTECH, INC.
WO/2021/041855	LACTOCOCCAL EXPRESSION OF IL-35 FOR TREATMENT OF DISEASE	MONTANA STATE UNIVERSITY
WO/2021/041858	DIFFERENTIATED TENDON CELLS DERIVED FROM PLURIPOTENT  PROGENITOR CELLS AND METHODS OF USE THEREOF	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/041860	METHODS FOR PRODUCING HOLLOW CERAMIC SPHERES	PLASSEIN TECHNOLOGIES LTD. LLC
WO/2021/041866	SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/041891	USE OF DEOXYCHOLIC ACID, DERIVATIVES, OR SALTS THEREOF IN  MANAGING BACTERIAL INFECTIONS AND COMPOSITIONS RELATED THERETO	EMORY UNIVERSITY
WO/2021/041895	STAPLED BETA-CATENIN LIGANDS	OHIO STATE INNOVATION FOUNDATION
WO/2021/041896	NOVEL THERANOSTIC AGENTS FOR PSMA POSITIVE CANCERS	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/041906	PEPTIDES FOR THE TREATMENT OF RENAL DISORDERS	THE GEORGE WASHINGTON UNIVERSITY
WO/2021/041912	REACTIVATING P53 MUTANTS FOR CANCER TREATMENT BY TARGETING  PROLIDASE (PEPD)	HEALTH RESEARCH, INC.
WO/2021/041923	TRANSMISSION PREVENTION OF VIRUSES WITH APPLICATION OF  ANTISEPTIC COMPOSITION	3M INNOVATIVE PROPERTIES COMPANY
WO/2021/041936	CD25 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF	MONTEFIORE MEDICAL CENTER
WO/2021/126320	TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED  DISORDERS	AMYLYX PHARMACEUTICALS INC.
WO/2021/041942	COLLAGEN P4H1 INHIBITOR AND ITS USE	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/041956	NON-FLAMMABLE, DRY PERSONAL CARE PRODUCT CONTAINING  trans-1233zd AND ETHANOL	HONEYWELL INTERNATIONAL INC.
WO/2021/041964	CONJUGATED INHIBITORS OF DNA DAMAGE RESPONSE	PROLYNX LLC
WO/2021/041972	ANTI-IL31 ANTIBODIES FOR VETERINARY USE	KINDRED BIOSCIENCES, INC.
WO/2021/041981	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETO	ASSEMBLY BIOSCIENCES, INC.
WO/2021/041982	NEUROTOXIN COMPOSITIONS FOR USE IN TREATING NEUROLOGIC AND  PSYCHIATRIC DISORDERS	AEON BIOPHARMA, INC.
WO/2021/041986	IMPROVED PRODUCTION OF RECOMBINANT AAV USING EMBRYONATED AVIAN  EGGS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/041989	COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA A  INFECTION	VIR BIOTECHNOLOGY, INC.
WO/2021/041991	HYDROPHILIC BIOPOLYMER MEDICAMENT DELIVERY MECHANISM	DIOMICS CORPORATION
WO/2021/041997	CO-POTENTIATORS FOR THERAPY OF CYSTIC FIBROSIS CAUSED BY  MINIMAL FUNCTION CFTR MUTANTS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/042000	ANTIBODY COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B  VIRUS INFECTION	VIR BIOTECHNOLOGY, INC.
WO/2021/042001	COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/042015	BIODEGRADABLE SOFT ELASTOMERS FOR REGENERATIVE ENGINEERING	NORTHWESTERN UNIVERSITY
WO/2021/042019	ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF	AGENUS INC.
WO/2021/042020	METHODS FOR TREATING CLN2 DISEASE IN PEDIATRIC SUBJECTS	BIOMARIN PHARMACEUTICAL INC.
WO/2021/042024	STING MODULATORS, COMPOSITIONS, AND METHODS OF USE	UNIVERSITY OF SOUTH FLORIDA
WO/2021/042027	METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/042029	OXYTOCIN COMPOSITIONS FOR TREATMENT OF TINNITUS	NEW YORK UNIVERSITY
WO/2021/042038	TREATMENT OF PAIN BY TARGETING NR4A1	UNIVERSITY OF CINCINNATI
WO/2021/042039	SYNTHETIC ANTIMICROBIAL PEPTIDES	AJK PHARMACEUTICAL LLC
WO/2021/042045	METHODS FOR SCALABLE GENE INSERTIONS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/042046	MEMBRANE-ACTIVE ANTI-BACTERIAL COMPOUNDS AND USES THEREOF	TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/042048	COPPER-ATSM FOR TREATING NEURODEGENERATIVE DISORDERS  ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/042050	RNA-REGULATED FUSION PROTEINS AND METHODS OF THEIR USE	CORNELL UNIVERSITY
WO/2021/042055	PEGLOTICASE FOR TREATMENT OF GOUT IN RENAL TRANSPLANT  RECIPIENTS	HORIZON PHARMA RHEUMATOLOGY LLC
WO/2021/173184	FORMULATION INCLUDING A COMBINATION OF β-ENDORPHIN AND  ADRENOCORTICOTROPIC HORMONE	ADAMIS PHARMACEUTICALS CORPORATION
WO/2021/042060	COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO  CELLS	YALE UNIVERSITY
WO/2021/042064	PEPTIDE INHIBITORS OF FOCAL ADHESION KINASE ACTIVITY AND USES  THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/042066	KMT2A-MAML2 FUSION MOLECULES AND USES THEREOF	FOUNDATION MEDICINE, INC.
WO/2021/042071	RECOVERY OF HEPATIC FUNCTION OF CULTURED HEPATOCYTES	LI, Albert
WO/2021/042080	N-ARYL ARYLSULFONAMIDES THAT FUNCTION AS MITOCHONDRIAL  UNCOUPLERS FOR THE TREATMENT OF METABOLIC DISEASE AND CANCER	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/046033	BIOMIMETIC NANOEMULSIONS FOR OXYGEN DELIVERY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046034	SMALL MOLECULE LIVER X RECEPTOR MODULATORS AND USES THEREOF	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/050320	PHARMACEUTICAL COMPOSITIONS COMPRISING HEPARINOIDS AND METHODS  FOR PREPARING THEREOF	HARROW IP, LLC
WO/2021/046047	ENHANCED TOOTHPASTE AND KITS	BEAUTYPASTE LLC
WO/2021/046048	METHODS AND COMPOSITIONS FOR IMPROVING ONCOLYTIC VIRUS  INFECTION FOR NONPERMISSIVE CANCERS	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/046078	COMB POLYMER AND BLOCK COPOLYMER STABILIZED NANOPARTICLES  ENCAPSULATING NUCLEIC ACIDS AND OTHER SOLUBLE HYDROPHILIC COMPOUNDS	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/046081	METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING  DISORDERS	RUSH UNIVERSITY MEDICAL CENTER
WO/2021/046092	A NOVEL POLYMORPH AND USES THEREOF	PROCYPRA THERAPEUTICS, LLC
WO/2021/046100	METHODS FOR TREATMENT USING PHTHALOCYANINE DYE-TARGETING  MOLECULE CONJUGATES	RAKUTEN MEDICAL, INC.
WO/2021/046112	AMINOQUINOLINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOF	BOLT BIOTHERAPEUTICS, INC.
WO/2021/046125	A NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA  VIRUS	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/046130	COMPOSITIONS OF FULVIC ACID AND CANNABINOID AND USES THEREOF	OMNI BIOCEUTICAL INNOVATIONS, INC.
WO/2021/046133	IL-22 ORAL, INTRA-RECTAL, OR OTHER GUT-RELATED COMPOSITIONS  AND METHODS OF USE THEREOF	AMGEN INC.
WO/2021/046139	DOUBLE-DIGESTION ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATES	SEAGEN INC.
WO/2021/046169	METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS	UNIVERSITY OF CINCINNATI
WO/2021/046178	COMPOUNDS AND METHODS FOR TREATING CANCER	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/046179	NOVEL COMPOUNDS	INTRA-CELLULAR THERAPIES, INC.
WO/2021/046183	METHODS OF TREATING EPILEPSY USING THE SAME	TREVENA, INC.
WO/2021/046186	VACCINE FOR TREATMENT OF CANCER AND METHOD OF MAKING BY STRESS  REPROGRAMMING	VCELL THERAPEUTICS, INC.
WO/2021/046190	CYSTATHIONINE BETA-SYNTHASE ENZYME THERAPY FOR TREATMENT OF  ELEVATED HOMOCYSTEINE LEVELS	ORPHAN TECHNOLOGIES LTD.
WO/2021/050348	PEROXIDASE ACTIVITY TOWARDS 10-ACETYL-3,7-DIHYDROXYPHENOXAZINE	CODEXIS, INC.
WO/2021/046196	MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND  TERPENES	QUICKSILVER SCIENTIFIC, INC.
WO/2021/046200	STABLE LONG-TERM INFUSABLE FORMULATIONS AND METHODS	CYLERUS, INC.
WO/2021/046205	ADOPTIVE CELL THERAPY AND METHODS OF DOSING THEREOF	TMUNITY THERAPEUTICS INC.
WO/2021/046216	METHODS FOR IDENTIFYING BIOMARKERS TO PREDICT TREATMENT  RESPONSE	ARCH ONCOLOGY, INC.
WO/2021/046220	COMPOUNDS AND METHODS FOR TREATING CANCER	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/046233	CHELATE-CONTAINING PSMA INHIBITORS	CANCER TARGETED TECHNOLOGY LLC
WO/2021/046250	METHODS OF TREATMENT	INTRA-CELLULAR THERAPIES, INC.
WO/2021/046254	LIPOSOMAL SPHERICAL NUCLEIC ACID (SNA) CONSTRUCTS FOR SPLICE  MODULATION	EXICURE, INC.
WO/2021/046260	ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF  THERAPEUTICALLY ACTIVE CONJUGATES	ARCTURUS THERAPEUTICS, INC.
WO/2021/046265	LIPID NANOPARTICLE COMPOSITIONS COMPRISING CLOSED-ENDED DNA  AND CLEAVABLE LIPIDS AND METHODS OF USE THEREOF	GENERATION BIO CO.
WO/2021/046296	PALATABLE SOFT-CHEW	BAYER HEALTHCARE LLC
WO/2021/046303	CANNABIGEROL PROLINE COCRYSTALS	EBERS TECH INC.
WO/2021/046305	PALATABLE GRANULAR VETERINARY COMPOSITIONS	BAYER HEALTHCARE LLC
WO/2021/046307	HYBRIDIZED POLY(AMIDOAMINE)-AMINO ACID DENDRIMERS	NORTH CAROLINA STATE UNIVERSITY
WO/2021/046315	INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/046322	A SMALL MOLECULE THERAPEUTIC FOR PARKINSON'S DISEASE PAIRED  WITH A BIOMARKER OF THERAPEUTIC ACTIVITY	WANG, Xinnan
WO/2021/046325	INHIBITORS OF SGLT AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/046339	NONINVASIVE METHOD TO QUANTIFY KIDNEY FUNCTION AND FUNCTIONAL  DECLINE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046347	IMMUNOCONJUGATE SYNTHESIS METHOD	BOLT BIOTHERAPEUTICS, INC.
WO/2021/046350	RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC  DERMATITIS	INCYTE CORPORATION
WO/2021/046363	GENE EDITING FOR VIRAL INFECTIONS	THEMBA INC.
WO/2021/046368	METHODS AND COMPOUNDS MODIFYING MITOCHONDRIAL FUNCTION	WANG, Xinnan
WO/2021/046371	TREATMENT AND PREVENTION OF PULMONARY INJURY	THE UAB RESEARCH FOUNDATION
WO/2021/046374	MICROEMULSION DELIVERY SYSTEMS FOR ALCOHOL-SOLUBLE SPECIES  INCLUDING NONDERIVATIZED HORMONES	QUICKSILVER SCIENTIFIC, INC.
WO/2021/046388	COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF  POLLINATORS AGAINST PESTICIDES	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/046398	COMBINATION ANTIVIRAL THERAPY FOR MEASLES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/046404	METHOD FOR INCREASING LYMPHOCYTE COUNT BY USING IL-7 FUSION  PROTEIN IN TUMORS	GENEXINE, INC.
WO/2021/046405	PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND  GLUCOSE CONTENT	BAXTER INTERNATIONAL INC.
WO/2021/046408	DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH	TERRAGENICS NUTRITION, INC.
WO/2021/046417	COMPOSITIONS AND METHODS FOR DETECTING ALLERGEN REACTIVE TH2  CELLS	BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
WO/2021/046426	CYCLIC DINUCLEOTIDE STING AGONISTS TETHERED TO A PD-1 OR  CTLA-4 ANTIBODIES	SPEROVIE BIOSCIENCES, INC.
WO/2021/046432	CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND  COMPOSITIONS FOR THE TREATMENT OF CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046438	REGENERATING FUNCTIONS AND PHENOTYPES OF CONNECTIVE TISSUE  THROUGH NPAS2 SUPPRESSION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046443	METHOD FOR CAPTURING AND PURIFICATION OF BIOLOGICS	AMICUS THERAPEUTICS, INC.
WO/2021/046444	TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID FOR THE  TREATMENT OF PSORIASIS IN PEDIATRIC PATIENTS	ENCORE DERMATOLOGY, INC.
WO/2021/046445	DIMERIC ANTIGEN RECEPTORS (DAR) THAT BIND BCMA	SORRENTO THERAPEUTICS, INC.
WO/2021/046446	COMPOSITIONS AND METHODS OF USE FOR ENHANCING FERTILITY	YOURCHOICE THERAPEUTICS, INC.
WO/2021/046448	VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID  HYDROXYLATED DERIVATIVES, AND METHODS OF USE	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/046450	NUTRITIONAL SUPPLEMENTS AND METHODS OF SUPPLEMENTATION  AFFECTING THE ENDOCANNABINOID SYSTEM	AMARE GLOBAL
WO/2021/046451	COMPOSITIONS AND METHODS FOR DHFR TUNABLE PROTEIN REGULATION	OBSIDIAN THERAPEUTICS, INC.
WO/2021/046456	NITRITE FORMULATIONS AND USES THEREOF FOR THE TREATMENT OF  LUNG INJURY	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/046480	NUCLEIC ACID-MEDIATED DELIVERY OF THERAPEUTICS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/046497	ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF	SHEN, Haifa
WO/2021/046500	TRANSDUCTION EFFICIENCY ASSAY	BLUEBIRD BIO, INC.
WO/2021/046532	ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS  AND TISSUE	THE JOHNS HOPKINS UNIVERSITY
WO/2021/050429	TOPICAL COMPOSITION FOR TREATMENT OF PAIN	PUREFORM GLOBAL, INC.
WO/2021/050430	DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/046549	COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS	CIDARA THERAPEUTICS, INC.
WO/2021/050445	COMPOSITIONS COMPRISING RARE GENETIC SEQUENCE VARIANTS  ASSOCIATED WITH PULMONARY FUNCTION AND METHODS OF USE THEREOF FOR DIAGNOSIS  AND TREATMENT OF ASTHMA IN AFRICAN AMERICAN PATIENTS	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/046550	EXTRACELLULAR VESICLE-FENRETINIDE COMPOSITIONS, EXTRACELLULAR  VESICLE-C-KIT INHIBITOR COMPOSITIONS, METHODS OF MAKING AND USES THEREOF	MANTRA BIO, INC.
WO/2021/050449	COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF  PHARMACEUTICALS AND INGESTIBLE MATERIALS	MONELL CHEMICAL SENSES CENTER
WO/2021/050469	HIGH SPF SUNSCREEN COMPOSITIONS	VI-JON, LLC
WO/2021/050470	SUSTAINED RELEASE THERMOSETTING GELS COMPRISING SODIUM CHANNEL  BLOCKERS AND THE METHODS OF MAKING THE SAME	FLEXION THERAPEUTICS, INC.
WO/2021/050490	METHODS OF ENHANCING RADIOTHERAPY USING FERROPTOSIS INDUCERS  AS RADIOSENSITIZERS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/050510	ENGINEERED PEPTIDE AND PEPTIDE MIMETIC COMPOSITIONS AND  METHODS	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/050521	COMPOSITIONS, METHODS AND USES FOR FREE FATTY ACID SCREENING  OF CELLS AT SCALE	THE BROAD INSTITUTE, INC.
WO/2021/050527	COMPOSITIONS AND METHODS FOR MAKING AND USING MULTISPECIFIC  ANTIBODIES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/050532	COMPOSITIONS FOR TREATING FUNGAL INFECTIONS	AFYX THERAPEUTICS A/S
WO/2021/050534	NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS	ARBOR BIOTECHNOLOGIES, INC.
WO/2021/050538	METHODS AND MATERIALS FOR INCREASING LEVEL OF PHOSPHORYLATED  AMPK PROTEIN	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/050547	MITOCHONDRIAL COMPLEX I INHIBITORS AND METHODS OF USE	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/050554	IL-2 CONJUGATES AND METHODS OF USE TO TREAT AUTOIMMUNE  DISEASES	SYNTHORX, INC.
WO/2021/050558	NEUROTOXIN COMPOSITIONS FOR USE IN TREATING GASTROPARESIS	AEON BIOPHARMA, INC.
WO/2021/050563	ANTIBODY TREATMENT FOR LESIONAL TISSUE OF HIDRADENITIS  SUPPURATIVA	THE ROCKEFELLER UNIVERSITY
WO/2021/050568	NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE	YALE UNIVERSITY
WO/2021/050571	NOVEL NUCLEOBASE EDITORS AND METHODS OF USING SAME	BEAM THERAPEUTICS INC.
WO/2021/050580	CRYSTALLINE FORM OF A MULTI-TYROSINE KINASE INHIBITOR, METHOD  OF PREPARATION, AND USE THEREOF	MIRATI THERAPEUTICS, INC.
WO/2021/050591	BISPECIFIC ANTIBODY CAR CELL IMMUNOTHERAPY	CYTOIMMUNE THERAPEUTICS, INC.
WO/2021/050606	COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED  WITH CLEC16A DYSFUNCTION OR LOSS	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/050629	POLYMER DRUGS FOR CANCER THERAPIES	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/050645	COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS	GENENTECH, INC.
WO/2021/050648	METHODS OF TREATING CANCER	RGENIX, INC.
WO/2021/050649	METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2  VARIANTS ENCODING AFLIBERCEPT	ADVERUM BIOTECHNOLOGIES, INC.
WO/2021/050653	PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE  INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/050666	AAV-ZYME AND USE FOR INFUSION REPLACEMENT THERAPY	AAV GENE THERAPEUTICS, INC.
WO/2021/050687	STABLE AQUEOUS FORMULATIONS OF AFLIBERCEPT	COHERUS BIOSCIENCES, INC.
WO/2021/050689	COMPOSITIONS, METHODS AND USES FOR TARGETING C-TERMINAL  BINDING PROTEIN (CtBP) IN TRAUMATIC BRAIN INJURY	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/050696	COMPOSITIONS AND METHODS FOR IMPROVING TUMOR PENETRATION OF  TUMOR SPECIFIC ANTIBODIES	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/050700	CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF	THE BROAD INSTITUTE, INC.
WO/2021/050702	KDM INHIBITORS AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/050708	BENZYL AMINE-CONTAINING 5,6-HETEROAROMATIC COMPOUNDS USEFUL  AGAINST MYCOBACTERIAL INFECTION	SHIONOGI & CO., LTD.
WO/2021/050718	METHODS OF TREATMENT RELATED TO COMPLEXES OF VON WILLEBRAND  FACTOR AND COMPLEMENT C1Q	BAXALTA INCORPORATED
WO/2021/050721	QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER	EMORY UNIVERSITY
WO/2021/050722	AN IMMUNOTHERAPEUTIC FOR PROSTATE CANCER TREATMENT	HEXAMER THERAPEUTICS, INC.
WO/2021/050727	ANTI-VIRAL COMPOSITIONS AND METHODS OF MAKING AND USING	UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATIONS,INC.
WO/2021/050732	METHODS OF TREATING KRAS MUTANT CANCERS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/050743	COMPOSITIONS AND METHODS FOR TREATING SLOW-FLOW VASCULAR  MALFORMATIONS	YALE UNIVERSITY
WO/2021/050752	CHIMERIC ORTHOGONAL RECEPTOR PROTEINS AND METHODS OF USE	GARCIA, Kenan Christopher
WO/2021/050754	INHALED DELIVERY OF PEPTIDE MIMICS OF CXCL10 FOR TARGETED  ANTI-FIBROTIC THERAPY	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/050778	LIPOPOLYSACCHARIDE MOLECULES FOR ENHANCING IMMUNE RESPONSES	THE PENN STATE RESEARCH FOUNDATION
WO/2021/050779	ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES	UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/050786	CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND  THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF	CALIFORNIA AMBER INC.
WO/2021/050799	COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING  ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES	PURDUE RESEARCH FOUNDATION
WO/2021/050800	METHODS AND COMPOSITIONS FOR THE TREATMENT OF HPV-RELATED  CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/050812	METABOLIC REPROGRAMMING OF IMMUNE CELLS FOR THE TREATMENT OR  PREVENTION OF DISEASES AND DISORDERS	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/050824	CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS	PRELUDE THERAPEUTICS INCORPORATED
WO/2021/050848	ENGINEERED CELLS AND USES THEREOF	OHIO STATE INNOVATION FOUNDATION
WO/2021/050862	ANTIGEN RECOGNIZING RECEPTORS TARGETING CD371 AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/050864	HUMAN CYTOMEGALOVIRUS VACCINE	MODERNATX, INC.
WO/2021/050877	COMPOSITIONS INCLUDING MOLECULES OF MODIFIED MRNA AND METHODS  OF USING THE SAME	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/050885	NEUROLOGICAL DISEASE TREATMENT WITH COMPLEMENT INHIBITORS	RA PHARMACEUTICALS, INC.
WO/2021/050890	PEPTIDE-BASED COMPOSITIONS AND METHODS FOR TREATING  ALZHEIMER'S DISEASE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/050900	RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN  KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/050913	INHIBITORS OF SARM1	DISARM THERAPEUTICS, INC.
WO/2021/050917	PHOSPHOLIPID ETHER CONJUGATES AS CANCER-TARGETING DRUG  VEHICLES	CELLECTAR BIOSCIENCES, INC.
WO/2021/050936	METHODS OF TREATMENT WITH CD8 T CELL-MEDIATED IMMUNE THERAPY	PROVIDENCE HEALTH & SERVICES - OREGON
WO/2021/050937	METHODS FOR THE TREATMENT OF ARID1A-DEFICIENT CANCERS	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/050940	TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS  DELIVERED BY LIPID NANOPARTICLES	REGENERON PHARMACEUTICALS, INC.
WO/2021/050945	THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS	TERNS, INC.
WO/2021/050948	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION  PROTEINS	TCR2 THERAPEUTICS INC.
WO/2021/050953	COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC  BIOLOGICS FOR TREATMENT OF DISEASE	ELEKTROFI, INC.
WO/2021/050954	COMPOSITIONS AND METHODS RELATED TO HUMAN NEUTRALIZING  ANTIBODIES TO HEPATITIS B	THE ROCKEFELLER UNIVERSITY
WO/2021/050956	ANTIVIRAL PRODRUGS AND PHARMACEUTICAL COMPOSITIONS THEREOF	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/050961	ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOF	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/050964	HPK1 ANTAGONISTS AND USES THEREOF	NIMBUS SATURN, INC.
WO/2021/050965	COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER	CRESTOVO HOLDINGS LLC
WO/2021/050974	ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS	THE BROAD INSTITUTE, INC.
WO/2021/050975	USE OF GHOST NANOVESICLES AS THERAPEUTICS	LOTVALL, Jan
WO/2021/050978	TREATMENT OF SKIN BLISTERING DISEASES USING ANTIBODIES	UNIVERSITY OF CINCINNATI
WO/2021/050980	DRUGGABLE TARGET TO TREAT RETINAL DEGENERATION	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH & HUMAN SERVICES
WO/2021/050986	LNP-FORMULATED MRNA THERAPEUTICS AND USE THEREOF FOR TREATING  HUMAN SUBJECTS	MODERNATX, INC.
WO/2021/050991	COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA	LACERTA THERAPEUTICS, INC
WO/2021/050994	HETEROBICYCLIC CARBOXAMIDES AND USES THEREOF	AERIE PHARMACEUTICALS, INC.
WO/2021/051003	OPHTHALMIC FORMULATIONS OF METHOTREXATE	ALDEYRA THERAPEUTICS, INC.
WO/2021/051009	METHODS AND COMPOSITIONS TO DIRECT BREAKDOWN OF INSULIN MRNA  IN BENIGN FASHION	CITY OF HOPE
WO/2021/051015	COMPOSITIONS AND METHODS FOR RESCUING RETINAL AND CHOROIDAL  STRUCTURE AND FUNCTION	AUCKLAND UNISERVICES LIMITED
WO/2021/051016	SYSTEMS AND ASSAYS FOR IDENTIFYING PU.1 INHIBITORS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/051033	POLYGENIC SCORE FOR CARDIAC HEART FAILURE	HENRY FORD HEALTH SYSTEM
WO/2021/051042	UNIVERSAL DONOR SELECTION METHOD TO IDENTIFY NK-CELL-DONORS	THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/051043	HYDROGEN GAS ELIMINATORS	DAVIES, Benjamin Rhys
WO/2021/055273	ANIONIC POLAR PHOSPHOLIPID COMPOSITION AND RELATED METHODS FOR  TREATMENT OF MUCOSAL CONDITIONS	ESSENTIAL LIPID TECHNOLOGIES, LLC
WO/2021/051065	TERT, WT-1, PMSA IMMUNOGENIC COMPOSITIONS AND METHODS OF  TREATMENT USING THE SAME	INOVIO PHARMACEUTICALS, INC.
WO/2021/051066	HER3 PULSED DC1 THERAPY	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/051079	METHODS AND COMPOSITIONS FOR ASSESSING AND PREDICTING  THERAPEUTIC RESPONSE	LANKENAU INSTITUTE FOR MEDICAL RESEARCH
WO/2021/051080	OPIOID INDEPENDENT SURGICAL ANESTHETIC	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/055288	NANOPARTICLE PHARMACEUTICAL DELIVERY SYSTEM	ADEIRA PHARMA, LLC
WO/2021/051088	NK CELL IMMUNOTHERAPY COMPOSITIONS, METHODS OF MAKING AND  METHODS OF USING SAME	OHIO STATE INNOVATION FOUNDATION
WO/2021/247064	COMBINATION OF RUXOLITINIB WITH INCB057643 FOR TREATMENT OF  MYELOPROLIFERATIVE NEOPLASMS	INCYTE CORPORATION
WO/2021/061437	CO-DELIVERY OF TGF-β SIRNA AND PDL1 SIRNA TO TREAT CANCER	SIRNAOMICS, INC.
WO/2021/055329	ANTI-CD39 ANTIBODY COMPOSITIONS AND METHODS	SURFACE ONCOLOGY, INC.
WO/2021/055352	METHODS AND COMPOSITIONS FOR PRESERVING BACTERIA	VEDANTA BIOSCIENCES, INC.
WO/2021/096589	SMALL MOLECULES POLYMERASE INHIBITORS	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/055383	METHODS OF BLOCKING ASFV INFECTION THROUGH INTERRUPTION OF  CELLULAR RECEPTORS	CHEN, Dalu
WO/2021/055385	DIAGNOSTIC ASSAY FOR CANCER	STITCH BIO, LLC
WO/2021/055409	ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF IN  RENAL DISEASE	OPSIDIO, LLC
WO/2021/055419	COMPOSITIONS FOR IMPROVING EYE HEALTH AND METHODS OF MAKING  AND USING THEREOF	OASIS MEDICAL, INC.
WO/2021/055437	CD70 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AND USES  THEREOF	THE GENERAL HOSPITAL CORPORATION
WO/2021/055448	TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF  PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS  THEREOF	FIGENE, LLC
WO/2021/055459	HIGHLY EFFICIENT DNA BASE EDITORS MEDIATED BY RNA-APTAMER  RECRUITMENT FOR TARGETED GENOME MODIFICATION AND USES THEREOF	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/055467	ORALLY ADMINISTRABLE NANO-MEDICINE FOR VIRAL DISEASES	UNIVERSITY OF MIAMI
WO/2021/055489	COMPOSITIONS AND METHODS FOR THE TREATMENT OF SWI-SNF MUTANT  TUMORS	GROHAR, Patrick, J.
WO/2021/055492	SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF  ENDOTOXEMIA	MICROBIOME LABS, LLC
WO/2021/055493	TREATMENT OF SYNGAP1 ENCEPHALOPATHY	ZYNERBA PHARMACEUTICALS, INC.
WO/2021/055497	CNP VARIANTS AND CONJUGATES THEREOF	BIOMARIN PHARMACEUTICAL INC.
WO/2021/055499	TREATMENT OF BEHAVIORAL IMPAIRMENT IN DEVELOPMENTAL AND  EPILEPTIC ENCEPHALOPATHY	ZYNERBA PHARMACEUTICALS, INC.
WO/2021/055505	SUBCUTANEOUSLY INJECTABLE INSULIN FORMULATIONS AND METHODS OF  ADMINISTRATION	CASS PHARMACEUTICALS, INC.
WO/2021/055506	ANTIMICROBIAL AGENTS AND COMPOSITIONS AND USES THEREOF	CHEMIC LABORATORIES, INC.
WO/2021/055518	BENZIMIDAZOLES AND METHODS OF USING SAME	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/055530	PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF  PROTEIN/PROTEIN-FUSIONS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/101620	BROAD-SPECTRUM CARBAPENEMS	VENATORX PHARMACEUTICALS, INC.
WO/2021/055553	SPRAYABLE LIQUID LIDOCAINE SOLUTION	CELISTA PHARMACEUTICALS LLC
WO/2021/055554	METHODS TO IMPROVE PATIENT RESPONSE TO IMMUNE CHECKPOINT  INHIBITORS AND FUNCTIONAL TESTS TO PREDICT RESPONSE	BIOMARKER STRATEGIES, LLC
WO/2021/055562	METHODS TO INCREASE THE SENSITIVITY AND REVERSING THE  RESISTANCE TO DRUGS	BIOMARKER STRATEGIES, LLC
WO/2021/055575	CONTROLLED NUTRIENT DELIVERY TO PANCREATIC ISLETS USING A  NOVEL MESOPOROUS SILICA-BASED NANOPARTICLE PLATFORM	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/055576	COMBINATION OF MODAFINIL AND AN AMPAKINE FOR IMPROVING  COGNITION	PURDUE PHARMA L.P.
WO/2021/055580	AN ANAPLASTIC LYMPHOMA KINASE (ALK) CANCER VACCINE AND METHODS  OF USE	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/055583	HUMAN ANTI-PD-L1 PEPTIDE VACCINES AND METHODS OF THEIR USE	OHIO STATE INNOVATION FOUNDATION
WO/2021/055589	HETEROARYL PLASMA KALLIKREIN INHIBITORS	SHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/055625	BEE VACCINES AND METHODS OF USE	DALAN ANIMAL HEALTH, INC.
WO/2021/055636	THERAPEUTIC USES AND METHODS OF DELIVERY OF VISCOUS  COMPOSITIONS DURING PRE AND POST SURGICAL PERIODS, FOR TREATMENT OF  RESPONSIVE DISEASES OF THE EAR, NOSE, AND THROAT	TOPICAL SINUS THERAPEUTICS, INC.
WO/2021/055637	COMPOUNDS AND USES THEREOF	PANO THERAPEUTICS, INC.
WO/2021/055638	RADIOLABELING OF ANTI-CD45 IMMUNOGLOBULIN AND METHODS OF USE  THEREOF	ACTINIUM PHARMACEUTICALS, INC.
WO/2021/055641	FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND  THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES	PURDUE RESEARCH FOUNDATION
WO/2021/055651	EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/055652	DOSAGE FORMS FOR TYK2 INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/055658	IMPLANIMPLANTABLE SCAFFOLDS AND USES THEREOF FOR IMMUNOTHERAPY  OTHER USES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055660	PROTEIN PRODUCING NANOLIPOSOMES AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055668	INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X	FORMA THERAPEUTICS, INC.
WO/2021/055672	COMPOSITIONS OF CANNABINOIDS FOR DELIVERY BY INHALATION	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/055690	PEPTIDE-CONJUGATED PRODRUGS	BRANDEIS UNIVERSITY
WO/2021/055697	IMMUNOACTIVE MICROPARTICLES AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055703	TOUGH GEL-BASED DRUG DELIVERY COMPOSITIONS AND METHODS THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/055713	INTEGRIN RECEPTOR ALPHA V BETA 3 AND ITS LIGAND INVOLVED IN  CHRONIC ITCH	NORTH CAROLINA STATE UNIVERSITY
WO/2021/061515	SHP2 INHIBITORS AND USES THEREOF	SYNBLIA THERAPEUTICS, INC.
WO/2021/055725	USE OF A PPAR-DELTA AGONIST IN THE TREATMENT OF KIDNEY DISEASE	RENEO PHARMACEUTICALS, INC.
WO/2021/055731	IL-36 CYTOKINE EXPRESSING ONCOLYTIC VIRUSES FOR TREATING  CANCER	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/055744	4-SUBSTITUTED INDOLE AND INDAZOLE SULFONAMIDO DERIVATIVES AS  PARG INHIBITORS	IDEAYA BIOSCIENCES, INC.
WO/2021/055747	THERAPEUTIC CONJUGATES	TOTUS MEDICINES INC.
WO/2021/055749	THERAPEUTIC CONJUGATES	TOTUS MEDICINES INC.
WO/2021/055753	METHODS AND COMPOSITIONS FOR INHIBITION OF CMP-SUGAR  SYNTHETASES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055756	SPIROCYCLIC ANDROGEN RECEPTOR PROTEIN DEGRADERS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/055760	SYNTHETIC DNA VECTORS AND METHODS OF USE	INTERGALACTIC THERAPEUTICS, INC.
WO/2021/055777	METHODS FOR REDUCTION OF BITTERNESS IN CANNABINOIDS USING  MYCELIAL MATERIALS	MYCOTECHNOLOGY, INC.
WO/2021/086513	METHODS FOR THE PRODUCTION OF PSILOCYBIN AND INTERMEDIATES OR  SIDE PRODUCTS	MIAMI UNIVERSITY
WO/2021/055785	ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND  CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF	PHARMA COSMETIX RESEARCH, LLC
WO/2021/055788	HIGH DENSITY LIPOPROTEIN-LIKE NANOPARTICLES AS INDUCERS OF  FERROPTOSIS IN CANCER	NORTHWESTERN UNIVERSITY
WO/2021/055789	USE OF DKK-1 INHIBITORS FOR TREATING CANCER	LEAP THERAPEUTICS, INC.
WO/2021/055801	IMPROVED ALPHA-GALACTOSIDASE PROTEIN FOR ENZYME REPLACEMENT  THERAPY (ERT) AND METHODS OF USE	THE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/055807	ACTIVATING PYRUVATE KINASE R	FORMA THERAPEUTICS, INC.
WO/2021/055808	ANTIBODIES DIRECTED AGAINST TENOFOVIR AND DERIVATIVES THEREOF	ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
WO/2021/055809	METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF  METABOLIC DISEASES AND DISORDERS	RESEARCH DEVELOPMENT FOUNDATION
WO/2021/055814	POSITRON EMISSION TOMOGRAPHY GUIDED DELIVERY OF MITOCHONDRAL  COMPLEX I INHIBITORS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/055817	STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE  OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION	NEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE  HOSPITAL FOR SPECIAL SURGERY
WO/2021/055820	3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC  ACID AND ITS SALTS FORMULATION	NOVARTIS AG
WO/2021/154339	NUTRACEUTICAL EXTRACTS OF <i>HIPPOPHAE  RHAMNOIDES</i> AND <i>TERMINALIA CHEBULA</i> AND USES  THEREOF	BIOMICS, LLC
WO/2021/055846	METHODS AND COMPOSITIONS FOR TREATING MYC-DRIVEN CANCERS	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/055860	EFFECTIVE DOSAGES OF AN ADENOVIRAL-BASED BIOLOGICAL DELIVERY  AND EXPRESSION SYSTEM FOR USE IN THE TREATMENT OF OSTEOARTHRITIS IN HUMANS,  AND COMPOSITIONS COMPRISING THE SAME	FLEXION THERAPEUTICS, INC.
WO/2021/055863	PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONS	FORMA THERAPEUTICS, INC.
WO/2021/055865	SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF  BIOLOGICALLY ACTIVE COMPOUNDS	SEAGEN INC.
WO/2021/055875	COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION	ANCILIA, INC.
WO/2021/055876	COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN  BINDING DOMAIN CONSTRUCTS TARGETED TO CD38	MOMENTA PHARMACEUTICALS, INC.
WO/2021/055890	CONTROLLED RELEASE FORMULATIONS OF RILUZOLE AND THEIR USES	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/055895	ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/055907	TREATMENT OF CANCER	ABBVIE INC.
WO/2021/061554	IBUDILAST ORAL FORMULATIONS AND METHODS OF USING SAME	MEDICINOVA, INC.
WO/2021/055933	NOVEL MIMETICS OF HEPARIN OLIGOSACCHARIDES	BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/055936	SMALL-MOLECULE INHIBITORS FOR THE  <i>Β</i>-CATENIN/B-CELL LYMPHOMA 9 PROTEIN−PROTEIN INTERACTION	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/055939	NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS	OHIO STATE INNOVATION FOUNDATION
WO/2021/055956	METHODS OF TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) AND  NF1-MEDIATED CONDITIONS AND COMPOSITIONS FOR USE IN SUCH METHODS	THE UAB RESEARCH FOUNDATION
WO/2021/055985	IPSC-DERIVED, HYPOIMMUNOGENIC, MYELOID PROGENITOR CELLS	CELLERANT THERAPEUTICS, INC.
WO/2021/061586	MICROENCAPSULATED PROBIOTIC AND COMPOSITIONS CONTAINING THE  SAME	GPCP IP HOLDINGS LLC
WO/2021/061642	NOVEL UREAS HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND  USES THEREOF	ACCUTAR BIOTECHNOLOGY INC.
WO/2021/061643	METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION	PMV PHARMACEUTICALS, INC.
WO/2021/061644	NOVEL SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES WITH  ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF	ACCUTAR BIOTECHNOLOGY INC.
WO/2021/061648	METHODS AND COMPOSITIONS FOR STIMULATION OF ENDOGENOUS T CELL  RESPONSES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/061665	INTEGRIN AGONIST PRODRUGS	GB006, INC.
WO/2021/061676	MULTI-ANTIGENIC PEPTIDE MIMICS OF GONOCOCCAL  LIPO-OLIGOSACCHARIDE (LOS) EPITOPES	UNIVERSITY OF MASSACHUSETTS
WO/2021/061687	COMPOSITIONS AND METHODS FOR RESTORING OR INCREASING TISSUE  PERFUSION	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/035226	METHODS FOR SOLUBILIZATION OF ARSENIC SULFIDE MINERALS AND  THEIR USE AS THERAPEUTICS	SAVARINO, Andrea
WO/2021/067076	METHODS FOR TREATING OR PREVENTING OBESITY AND BODY WEIGHT  MANAGEMENT	BRILLIAN PHARMA INC.
WO/2021/061695	TREATMENT OF EGFR MUTANT-RELATED CANCERS USING A COMBINATION  OF EGFR AND CDK4/6 INHIBITORS	BETA PHARMA, INC.
WO/2021/061701	SOLID STATE FORMS OF LUCERASTAT SALTS AND PROCESS FOR  PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/061708	MONOCLONAL ANTIBODY AGAINST CANINE FIBROBLAST ACTIVATION  PROTEIN THAT CROSS-REACTS WITH MOUSE AND HUMAN FIBROBLAST ACTIVATION PROTEIN  (FAP)	THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA
WO/2021/076281	SYSTEM AND PROCESS FOR FORMING CURVED GLASS LAMINATE ARTICLE  USING SEPARATION MATERIAL	CORNING INCORPORATED
WO/2021/061719	METHODS FOR TREATING METASTATIC TRIPLE NEGATIVE BREAST CANCER  WITH ANTI-PD-1 ANTIBODIES	MERCK SHARP & DOHME CORP.
WO/2021/061721	PERSONAL CARE FORMULATION WITH ORGANIC-INORGANIC COMPOSITE	ROHM AND HAAS COMPANY
WO/2021/067089	COMPOSITIONS THAT PREFERENTIALLY POTENTIATE SUBTYPES OF GABAA  RECEPTORS AND METHODS OF USE THEREOF	ATHENEN THERAPEUTICS, INC.
WO/2021/061749	COMBINATION THERAPIES	MIRATI THERAPEUTICS, INC.
WO/2021/061763	ALDOKETO REDUCTASE INHIBITORS AND USES THEREOF	CASE WESTERN RESERVE UNIVERSITY
WO/2021/061770	COSMETIC COMPOSITIONS	L'OREAL
WO/2021/061775	IMMUNE ASSAY FOR MONITORING RESPONSE TO ONCOLYTIC VACCINIA  VIRUS AND USES THEREOF	SILLAJEN, INC.
WO/2021/061789	COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF  IMMUNOTHERAPIES AND VACCINES	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/067098	THIN-FILM VEHICLES THAT STABILIZE HIGHLY REACTIVE ACTIVE  INGREDIENTS	L'OREAL
WO/2021/067100	COMPOSITIONS AND METHODS FOR EXTENDING LIFESPAN	MARVELBIOME, INC.
WO/2021/061801	BICYCLIC INHIBITORS OF CBX CHROMODOMAINS	ICAHN SCHOOL OF MEDICINE AT MT. SINAI
WO/2021/061803	PHOSPHODIESTERASE INHIBITORS AND USE	NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD.
WO/2021/061807	BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF  HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION	ASCENDO BIOTECHNOLOGY, INC.
WO/2021/061809	NOVEL RECEPTORS HAVING A FIBRONECTIN REPEAT FOR  LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061818	METHOD FOR INDUCING TUMOR REGRESSION	VEROSCIENCE LLC
WO/2021/061837	BIOMATERIAL-BASED ANTIGEN FREE VACCINE AND THE USE THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/061847	METHODS OF TREATMENTS TO PROLONG GESTATION AND COMPLICATIONS  OF MENSTRUATION OR GESTATION	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/061853	CBL INHIBITORS AND COMPOSITIONS FOR USE IN ADOPTIVE CELL  THERAPY	NURIX THERAPEUTICS, INC.
WO/2021/061856	RECEPTORS WITH HETEROLOGOUS TRANSMEMBRANE DOMAIN	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061862	NOTCH RECEPTORS WITH HINGE DOMAIN	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061863	NOTCH RECEPTORS WITH MINIMAL LINKER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061867	ANTI-CD47 ANTIBODIES, ACTIVATABLE ANTI-CD47 ANTIBODIES, AND  METHODS OF USE THEREOF	CYTOMX THERAPEUTICS, INC.
WO/2021/061870	CBL INHIBITORS AND COMPOSITIONS FOR EXPANSION OF IMMUNE CELLS	NURIX THERAPEUTICS, INC.
WO/2021/061872	NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE  FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061873	METHODS, COMPOSITIONS, AND KITS FOR TREATING POLYCYSTIC KIDNEY  DISEASE	ELOXX PHARMACEUTICALS, INC.
WO/2021/061874	METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/061888	HAIR COSMETIC COMPOSITIONS CONTAINING GUMS FATTY ALCOHOL, AND  ESTERS	L'OREAL
WO/2021/061894	ERK5 DEGRADERS AS THERAPEUTICS IN CANCER AND INFLAMMATORY  DISEASES	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/061909	METHOD OF TARGETING NEURONAL APOE TO TREAT A NEUROCOGNITIVE  DISORDER	THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST  ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE
WO/2021/061913	DICLOFENAC SODIUM TOPICAL SOLUTION	ENCUBE ETHICALS, PVT. LTD.
WO/2021/061929	BICYCLIC CARBOXYLATES AS MODULATORS OF TRANSPORTERS AND USES  THEREOF	NIROGY THERAPEUTICS, INC.
WO/2021/108022	INCLUSION COMPLEXES OF PHARMACEUTICALS AND CYCLIC OLIGOMERS	DISPERSOL TECHNOLOGIES, LLC
WO/2021/061940	BIOARTIFICIAL PANCREAS	ISLA TECHNOLOGIES, INC.
WO/2021/061944	CREATINE FOR IMMUNOTHERAPY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/061952	METHODS AND SYSTEMS FOR ANALYZING BRAIN LESIONS WITH  LONGITUDINAL 3D MRI DATA	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/061991	COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY AND  IMMUNE DISEASES	PROLACTA BIOSCIENCE, INC.
WO/2021/062003	PHARMACEUTICAL COMPOSITION COMPRISING THROMBOLYTIC  PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATE	LUMOSA THERAPEUTICS CO., LTD
WO/2021/062007	TREATMENT OF MITOCHONDRIAL DEFICITS AND AGE-RELATED DISEASES  USING BLOOD PRODUCTS	CYTEGEN CORP.
WO/2021/062012	USE OF KLK10 AND ENGINEERED DERIVATIZATIONS THEREOF	EMORY UNIVERSITY
WO/2021/062018	COMPOSITE BIOMARKER FOR CANCER THERAPY	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/062022	METABOLIC RESCUE OF RETINAL DEGENERATION	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/062030	DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)	K-GEN, INC.
WO/2021/062036	JAK INHIBITORS	VIMALAN BIOSCIENCES, INC.
WO/2021/062037	PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER  IMMUNE RESPONSE AGAINST CD47	AUBURN UNIVERSITY
WO/2021/062039	T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME	CHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/062048	METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR  RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/062049	BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN A	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/062056	ORAL ADMINISTRATION OF GENETICALLY ENGINEERED BACTERIA	NOVOME BIOTECHNOLOGIES, INC.
WO/2021/062057	EXOGENOUS LOADING OF EXOSOMES VIA LYOPHILIZATION	CODIAK BIOSCIENCES, INC.
WO/2021/062058	STING AGONIST COMPRISING EXOSOMES FOR TREATING  NEUROIMMUNOLOGICAL DISORDERS	CODIAK BIOSCIENCES, INC.
WO/2021/062060	STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12  DISPLAYING EXOSOMES FOR TREATING A TUMOUR	CODIAK BIOSCIENCES, INC.
WO/2021/062061	ORAL PHARMACEUTICAL IMMEDIATE RELEASE COMPOSITION AND METHOD  OF TREATMENT FOR WEIGHT LOSS	AARDVARK THERAPEUTICS INC.
WO/2021/062084	NOVEL COMPOSITIONS AND METHODS FOR BONE GRAFTS AND FUSIONS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/062089	XANTHINE CB1 INHIBITORS	GOLDFINCH BIO, INC.
WO/2021/062122	COMBINATION ANTI-CD30 ADC, ANTI-PD-1 AND CHEMOTHERAPEUTIC FOR  TREATMENT OF HEMATOPOIETIC CANCERS	SEAGEN INC.
WO/2021/062128	METHODS AND COMPOSITIONS FOR TREATING A DISEASE OR DISORDER	YALE UNIVERSITY
WO/2021/062157	COMPOSITIONS AND METHODS FOR TREATING METASTATIC  GASTROINTESTINAL CANCER	THE ROCKEFELLER UNIVERSITY
WO/2021/062163	METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS	DISC MEDICINE, INC.
WO/2021/062169	METHODS AND COMPOSITIONS FOR THE EXPRESSION OF CONSTITUTIVELY  ACTIVE RAP1A FROM A VMD2 PROMOTER	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/062171	METHODS FOR TREATING ANEMIA OF CHRONIC DISEASE	DISC MEDICINE, INC.
WO/2021/062181	CONJUGATED CHIMERIC PROTEINS	ORIONIS BIOSCIENCES, INC.
WO/2021/062189	ISOXAZOLE-3-CARBOXAMIDE DERIVATIVES AND THEIR USE FOR  TREATMENT OF DISEASES CAUSED BY VIRUS INFECTION	COLLABORATIONS PHARMACEUTICALS, INC.
WO/2021/108025	CELL-BASED CANCER VACCINES AND CANCER THERAPIES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/062196	MINIMAL ARRESTIN DOMAIN CONTAINING PROTEIN 1 (ARRDC1)  CONSTRUCTS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/062200	ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICS	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/062201	COMPOSITIONS AND METHODS FOR NUCLEOPROTEIN TARGETING AND  EXPRESSION	SPOTLIGHT THERAPEUTICS
WO/2021/062202	METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMES	UNIVERSITY OF MASSACHUSETTS
WO/2021/062208	BIPHASE CHEMICAL PEEL	L'OREAL
WO/2021/062212	VACCINES AND IMMUNOGLOBULINS TARGETING AFRICAN SWINE FEVER  VIRUS, METHODS OF PREPARING SAME, AND METHODS OF USING SAME	IGY IMMUNE TECHNOLOGIES AND LIFE SCIENCES INC.
WO/2021/062217	ANTI-INFLAMMATORY THERAPY IN ARRHYTHMOGENIC CARDIOMYOPATHY  (ACM)	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/062227	COMPOSITIONS AND METHODS FOR TREATMENT OF LIQUID CANCERS	BEAM THERAPEUTICS INC.
WO/2021/062232	METHODS FOR REDUCING REWARDING EFFECTS OF MORPHINE WITHOUT  AFFECTING ITS ANALGESIC EFFECTS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/062238	METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE AND  THALASSEMIA	THE UNIVERSITY OF CHICAGO
WO/2021/062246	CRF RECEPTOR ANTAGONISTS AND METHODS OF USE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/062263	METHODS OF EVALUATING POLYPEPTIDE-MODIFIED POLYMERS IN  COMPOSITIONS	SIGILON THERAPEUTICS, INC.
WO/2021/062264	METHODS FOR TREATING HYPERPHENYLALANINEMIA	PTC THERAPEUTICS MP, INC.
WO/2021/062268	THERAPEUTIC NEUTRALIZATION ANTIBODIES FOR THE TREATMENT OF  PEANUT ALLERGY	THE GENERAL HOSPITAL CORPORATION
WO/2021/062273	METHODS OF EVALUATING SMALL MOLECULE-MODIFIED POLYMERS IN  COMPOSITIONS	SIGILON THERAPEUTICS, INC.
WO/2021/062282	COMBINATION THERAPY WITH CGRP ANTAGONISTS	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/062298	BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL  ONTOLOGY OF GLYCOCALYX DISRUPTION	ARTEREZ, INC.
WO/2021/062307	NOVEL METHODS	INTRA-CELLULAR THERAPIES, INC.
WO/2021/062313	IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE  TREATMENT OF CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/062316	AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF  MYCOBACTERIAL INFECTIONS	THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/062317	EXTRACELLULAR VESICLE COMPOSITIONS	CODIAK BIOSCIENCES, INC.
WO/2021/062318	THIAZOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE  TREATMENT OF MYCOBACTERIAL INFECTIONS	THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/062319	INDOLE CARBOXAMIDE COMPOUNDS AND USE THEREOF FOR THE TREATMENT  OF MYCOBACTERIAL INFECTIONS	THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/042083	HAIR TREATMENT COMPOSITIONS CONTAINING PECTIN AND CATIONIC  COMPOUNDS	L'OREAL
WO/2021/067158	COSMETIC COMPOSITION COMPRISING BIODEGRADABLE POLYMERS	L'OREAL
WO/2021/067164	HAIR COSMETIC COMPOSITIONS CONTAINING CATIONIC COMPOUNDS,  PANTHENOL, AND OILS	L'OREAL
WO/2021/067167	CLOSTRODIOIDES DIFFICILE TREATMENT	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/062347	COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF  PANCREATITIS	DUKE UNIVERSITY
WO/2021/067173	HAIR COSMETIC COMPOSITIONS CONTAINING CATIONIC POLYMERS,  ACRYLATE-BASED POLYMERS, GUMS, AND POLYOLS	L'OREAL
WO/2021/062355	METHODS AND COMPOSITIONS FOR TREATING DIABETIC RETINOPATHY	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/067181	HBV VACCINES AND METHODS TREATING HBV	GILEAD SCIENCES, INC.
WO/2021/062374	TABLETIZATION OF PEPTIDE SELF-ASSEMBLIES AND METHODS OF MAKING  AND USING THE SAME	DUKE UNIVERSITY
WO/2021/062405	ALPHA-LACTALBUMIN VACCINATION FOR INHIBITING GROWTH AND  DEVELOPMENT OF MALE BREAST CANCERS	CLEVELAND CLINIC FOUNDATION
WO/2021/062412	LUNG FIBROSIS MODEL AND METHODS OF USING THE SAME	DUKE UNIVERSITY
WO/2021/067216	HAIR TREATMENT COMPOSITION	L'OREAL
WO/2021/067217	PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS AS IMMUNOMODULATORS	INCYTE CORPORATION
WO/2021/067243	TREHALOSE FORMULATIONS AND USES THEREOF	SEELOS THERAPEUTICS, INC.
WO/2021/067248	ANHYDROUS MAGNETIC EYELINER COMPOSITION	L'OREAL
WO/2021/067261	KNOTTIN-IMMUNOSTIMULANT CONJUGATES AND RELATED COMPOSITIONS  AND METHODS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/067290	HUMANIZED ANTI-GDNF FAMILY ALPHA-RECEPTOR 4 (GRF-ALPHA-4)  ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS (CARs)	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/067297	TREATMENT OF ALCOHOLIC HEPATITIS	DURECT CORPORATION
WO/2021/067299	CHARCOAL ADHESIVE COMPOSITION FOR LASHES OR LASH EXTENSIONS	LASHIFY, INC.
WO/2021/067310	COMBINATION GMCI AND ATRI CANCER TREATMENT	CANDEL THERAPEUTICS, INC.
WO/2021/067313	EUKARYOTIC SEMI-SYNTHETIC ORGANISMS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/067324	METHODS OF TREATING POMPE DISEASE	ACADEMIA SINICA
WO/2021/067335	BENZOXAZINONE COMPOUNDS AS KLK5/7 DUAL INHIBITORS	MOLECULAR SKIN THERAPEUTICS, INC.
WO/2021/067336	METHOD OF TREATMENT USING SYNERGISTIC DIETARY SUPPLEMENTS TO  RELIEVE PHYSICAL DISCOMFORT AND PAIN, OR MENTAL DISCOMFORT LINKED TO  MENSTRUATION	SEMAINE HEALTH CO.
WO/2021/046562	ANTIVIRAL PEPTOID COMPOSITIONS	MAXWELL BIOSCIENCES, INC.
WO/2021/067388	POLY-DIOXANONE MULTI-BLOCK COPOLYMER FOR OCULAR PROTEIN  DELIVERY	ALLERGAN SALES, LLC
WO/2021/067393	SMALL MOLECULE INHIBITORS OF Id PROTEINS	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/067403	BIOMARKERS FOR ANTIBODY-DRUG CONJUGATE MONOTHERAPY OR  COMBINATION THERAPY	IMMUNOMEDICS, INC.
WO/2021/067417	POLYGENIC RISK SCORE FOR IN VITRO FERTILIZATION	MYOME, INC.
WO/2021/067421	PREPARING THERAPEUTICALLY ENHANCED HUMAN MESENCHYMAL STEM  CELLS AND USES THEREOF	UNIVERSITY OF MIAMI
WO/2021/067439	RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF	THE JOHNS HOPKINS UNIVERSITY
WO/2021/067448	ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF GENETIC  HEARING LOSS	APPLIED GENETIC TECHNOLOGIES CORPORATION
WO/2021/067458	PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF	BEIJING XUANYI PHARMASCIENCES CO., LTD.
WO/2021/067465	TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH  UPADACITINIB	ABBVIE INC.
WO/2021/067479	COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET  LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS	NAVIDEA BIOPHARMACEUTICALS, INC.
WO/2021/067480	COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS  INFECTION	UNIVERSITY OF WASHINGTON
WO/2021/067491	LONG ACYL-CHAIN PHOSPHOLIPID OXYGEN MICROBUBBLES FOR TREATING  TUMOR HYPOXIA	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/067506	METHODS OF TREATING CONDITIONS RELATED TO THE  S1P<sb>1</sb> RECEPTOR	ARENA PHARMACEUTICALS, INC.
WO/2021/067521	COMPOUNDS USEFUL AS IMMUNOMODULATORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/067526	COMPLEMENT INHIBITORS FOR TREATING DRUG-INDUCED  COMPLEMENT-MEDIATED RESPONSE	ALEXION PHARMACEUTICALS, INC.
WO/2021/067528	COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/071728	DOSING REGIMEN FOR INJECTABLE CETIRIZINE	JDP THERAPEUTICS LLC
WO/2021/067545	NON-TOXIC LISTERIOLYSIN O POLYPEPTIDES AND USES THEREOF	OHIO STATE INNOVATION FOUNDATION
WO/2021/067546	IMMUNOMODULATORY IMIDE DRUGS AS ZETA-CHAIN-ASSOCIATED PROTEIN  KINASE 70 (ZAP70) AGONISTS AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/126341	METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS	BLAZE BIOSCIENCE, INC.
WO/2021/067549	18-MC FOR TREATMENT OF SUBSTANCE USE DISORDERS	MIND MEDICINE, INC.
WO/2021/067569	SUBSTITUTED 1, 6-NAPHTHYRIDINE INHIBITORS OF CDK5	GOLDFINCH BIO, INC.
WO/2021/067571	TARGETED PULMONARY DELIVERY COMPOSITIONS AND METHODS USING  SAME	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/067577	HEAVY ATOM-FUNCTIONALIZED UPCONVERTERS FOR INCREASING  UPCONVERSION THRESHOLDS FOR 3D PRINTING	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/067584	METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/067585	METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS AND REDUCING  CANDIDIASIS	ADARE PHARMACEUTICALS US, L.P.
WO/2021/067630	DUAL-CHANNEL HEATING AND COOLING APPARATUS AND METHOD	GENTHERM MEDICAL, LLC
WO/2021/067644	COMBINATION THERAPY WITH IMMUNE STIMULATORY CONJUGATES	SILVERBACK THERAPEUTICS, INC.
WO/2021/067654	INDAZOLE CARBOXAMIDES AS KINASE INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/067655	USE OF GDF15 FOR TREATING CARDIOMETABOLIC SYNDROME AND OTHER  CONDITIONS	AMGEN INC.
WO/2021/067668	ADAMTS13 TREATMENT TO ENHANCE GRAFT SURVIVAL	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/067673	ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF	MYTHIC THERAPEUTICS, INC.
WO/2021/067682	TRICYCLIC KINASE INHIBITORS AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/067683	CARBOMER BASED TOOTH PASTE COMPOSITION COMPRISING CROSSLINKED  POLYVINYLPYRROLIDONE FOR BUILDING VISCOSITY	ISP INVESTMENTS LLC
WO/2021/126344	COMPOSITIONS AND METHODS COMPRISING ENGINEERED BACTERIOPHAGE	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/067696	ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4	VANDERBILT UNIVERSITY
WO/2021/067697	METHODS AND MATERIALS FOR TREATING NEUROTOXICITY	CAVION, INC.
WO/2021/071751	BONDED POWDERS FOR THE TREATMENT OF BODILY LESIONS	COOK MEDICAL TECHNOLOGIES LLC
WO/2021/067702	COMBINATIONS OF GABA-A RECEPTOR POSITIVE ALLOSTERIC MODULATORS  AND NMDA ANTAGONISTS, NMDA NEGATIVE ALLOSTERIC MODULATORS OR NMDA PARTIAL  AGONISTS	PRAXIS PRECISION MEDICINES, INC.
WO/2021/067732	MULTI-LAYERED NANOPARTICLE COATED SUBSTRATES FOR DRUG DELIVERY	THE UAB RESEARCH FOUNDATION
WO/2021/067738	DEVELOPMENT OF IMAGING AND THERAPEUTIC GLUCOSE ANALOGUES FOR  SODIUM DEPENDENT GLUCOSE TRANSPORTERS	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/067741	GLYCOPEPTIDES FOR INDUCING AN IMMUNE RESPONSE AND METHODS OF  USE	AVCI, Fikri
WO/2021/067746	PRESERVATIVE-FREE FORMULATIONS OF TETRACAINE HCL	ALTAIRE PHARMACEUTICALS, INC.
WO/2021/067752	TARGETING CAP-DEPENDENT TRANSLATION TO REDUCE SEIZURES IN MTOR  DISORDERS	YALE UNIVERSITY
WO/2021/067761	COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES	ATYR PHARMA, INC.
WO/2021/067775	ANTO-CONNEXIN ANTIBODY FORMULATIONS	ALAMAB THERAPEUTICS, INC.
WO/2021/067792	A METHOD FOR DIFFERENTIATING INNATE LYMPHOID CELLS FOR  IMMUNOTHERAPY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/067799	METHODS AND MATERIALS FOR MODULATING NRF2 PATHWAY	THE GENERAL HOSPITAL CORPORATION
WO/2021/067800	ANTI-KIR3DL3 ANTIBODIES AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/067806	TRANSDERMAL DELIVERY OF DRONABINOL	STARTON THERAPEUTICS, INC.
WO/2021/067807	LYOPHILIZED COMPOSITION COMPRISING (S)-ISOPROPYL  2-((S)-2-ACETAMIDO-3-(1H-INDOL-3-YL)PROPANAMIDO)-6-DIAZO-5-OXOHEXANOATE FOR  INTRAVENOUS ADMINISTRATION AND THE USE THEREOF	DYKSTRA, Steven
WO/2021/067818	METHODS AND APPARATUS FOR FABRIC INTERFACE POLLING	GIGAIO NETWORKS, INC.
WO/2021/067820	FORMULATION OF ANTIBODY-DRUG CONJUGATE	SEAGEN INC.
WO/2021/067834	CANNABINOIDS AND USES THEREOF	CORBUS PHARMACEUTICALS, INC.
WO/2021/067850	METHODS OF DETECTING circRNA	WASHINGTON UNIVERSITY
WO/2021/067852	EVALUATING AND SCREENING BIOLOGICAL SAMPLES	PREDICTIVE TECHNOLOGY GROUP, INC.
WO/2021/067859	5-FLUORONICOTINAMIDE DERIVATIVES AND USES THEREOF	TENAYA THERAPEUTICS, INC.
WO/2021/067861	CAMPTOTHECIN PEPTIDE CONJUGATES	SEAGEN INC.
WO/2021/067863	TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINS	XENCOR, INC.
WO/2021/067864	ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR TREATMENT OF  PRION DISEASE	SANGAMO THERAPEUTICS, INC.
WO/2021/067872	ORAL CAVITY CLEANING COMPOSITION, METHOD, AND APPARATUS	NOVAFLUX, INC.
WO/2021/211159	METHODS AND COMPOSITION FOR IMPROVED ANTISEPSIS	VELOCE BIOPHARMA LLC
WO/2021/211160	METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF SINUS  DISEASE	VELOCE BIOPHARMA LLC
WO/2021/067897	STORAGE STABLE SOMATOSTATIN-DOPAMINE CHIMERIC COMPOUNDS AND  SALT FORMS THEREOF	TIBURIO THERAPEUTICS INC.
WO/2021/067914	COMBINATION THERAPY FOR ACUTE MYELOID LEUKEMIA,  MYELODYSPLASTIC SYNDROMES AND OTHER BLOOD DISEASES AND DISORDERS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/067917	TREATMENT OF EOSINOPHILIC DISORDERS WITH AVAPRITINIB	BLUEPRINT MEDICINES CORPORATION
WO/2021/067930	TUMOR-TARGETING POLYPEPTIDE NANOPARTICLE DELIVERY SYSTEM FOR  NUCLEIC ACID THERAPEUTICS	SIRNAOMICS, INC.
WO/2021/067938	HYDROPHOBICALLY-MODIFIED BIOPOLYMER MATERIALS	MEDCURA, INC.
WO/2021/067943	PIEZO1 AGONISTS FOR THE PROMOTION OF BONE FORMATION	BIOVENTURES, LLC
WO/2021/067945	COSMETIC COMPOSITIONS COMPRISING CHITOSAN AND HYDROXYPROPYL  METHYLCELLULOSE AND THEIR USE FOR IMPROVING HAIR STRENGTH AND RELATED  PROPERTIES	LIVING PROOF, INC.
WO/2021/067946	BIOMARKER-BASED TREATMENT OF FOCAL SEGMENTAL  GLOMERULOSCLEROSIS AND DIABETIC KIDNEY DISEASE	GOLDFINCH BIO, INC.
WO/2021/067947	NUTRITIONAL COMPOSITIONS FOR THE MANAGEMENT OF HYPONATREMIA	NEPHCENTRIC, LLC
WO/2021/067967	PREPARATION OF PYRAZOLO[3,4-B]PYRIDINES AS ANTIMALARIALS	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/067971	MICROBIOME INTERVENTIONS	MARS, INCORPORATED
WO/2021/071800	COMBINATIONS AND METHODS FOR TREATING CANCER	UNIVERSITY OF SOUTH FLORIDA
WO/2021/071802	ARYL HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER CHANNEL  BLOCKERS	D. E. SHAW RESEARCH, LLC
WO/2021/071803	ARYL HETEROBICYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERS	D.E. SHAW RESEARCH, LLC
WO/2021/071806	ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERS	D. E. SHAW RESEARCH, LLC
WO/2021/071812	ARYLMETHYLENE HETEROCYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERS	D.E SHAW RESEARCH, LLC
WO/2021/071821	ARYLMETHYLENE AROMATIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERS	D.E. SHAW RESEARCH, LLC
WO/2021/071823	COMPOSITIONS AND METHODS FOR PULMONARY SURFACTANT-BIOMIMETIC  NANOPARTICLES	THE GENERAL HOSPITAL CORPORATION
WO/2021/071830	MODULATING LYMPHATIC VESSELS IN NEUROLOGICAL DISEASE	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/071832	ARYL HETEROBICYCLIC COMPOUNDS AS KV1.3 POTASSIUM SHAKER  CHANNEL BLOCKERS	D.E. SHAW RESEARCH, LLC
WO/2021/071835	ADENO-ASSOCIATED VIRUS VECTOR PHARMACEUTICAL COMPOSITION AND  METHODS	REGENXBIO INC.
WO/2021/071846	METHODS AND MATERIALS FOR TREATING EOSINOPHILIC ESOPHAGITIS  AND OTHER EOSINOPHILIC DISORDERS	MG LABS, INC.
WO/2021/071857	FACILITATING CONTROLLED MOLECULAR ASSEMBLY OF NANOSCALE  STRUCTURES VIA DYNAMIC CONFINEMENT OF SOLVENT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/071864	THERAPEUTIC PHARMACEUTICAL COMPOSITIONS	SIOLTA THERAPEUTICS, INC.
WO/2021/071867	ORAL CARE COMPOSITION COMPRISING A CANNABINOID	COLGATE-PALMOLIVE COMPANY
WO/2021/071875	CHONDROGENIC HUMAN MESENCHYMAL STEM CELL (MSC) SHEETS	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/071876	PHOTOLYTIC COMPOUNDS AND TRIPLET-TRIPLET ANNIHILATION MEDIATED  PHOTOLYSIS	UNIVERSITY OF MASSACHUSETTS
WO/2021/071902	MICRONIZED DRUG RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND  METHODS OF PREPARATION THEREOF	BRILLIAN PHARMA INC.
WO/2021/071919	HCK AS A THERAPEUTIC TARGET IN MYD88 MUTATED DISEASES	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/071922	A PYRAZOLOPYRIMIDINE DERIVATIVE AS A HCK INHIBITOR FOR USE IN  THERAPY, IN PARTICULAR MYD88 MUTATED DISEASES	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/071931	THREE-DIMENTIONAL SURFACE FOR PROTEIN AND SMALL MOLECULE  MICROARRAYS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/071932	ANTIMICROBIAL AND ANTIVIRAL EFFECTS OF C2-C7<sb>  </sb>ALKYL BORONIC ACIDS	CORNELL UNIVERSITY
WO/2021/071934	POLYMERIC METHYLPREDNISOLONE CONJUGATES AND USES THEREOF	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/071941	COMBINATION THERAPY WITH GLUCARPIDASE WITH  METHOTREXATE/RITUXIMAB TO TREAT CNS LYMPHOMA	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/071965	ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF  PHOSPHOMANNOMUTASE 2 DEFICIENCY	APPLIED THERAPEUTICS INC.
WO/2021/071967	COMPOSITIONS FOR PULMONARY DELIVERY OF CANNABINOIDS AND  ASSOCIATED METHODS AND SYSTEMS	ISLAND BREEZE SYSTEMS CA, LLC
WO/2021/071974	ORALLY IMPLANTABLE DRUG DELIVERY DEVICE	OAK CREST INSTITUTE OF SCIENCE
WO/2021/071977	IN VITRO METHODS AND COMPOSITIONS FOR ENHANCING THE ACTIVATION  OF DENDRITIC CELLS AND T CELLS, AND FOR INDUCING A TH-1 IMMUNE RESPONSE	NORTHWEST BIOTHERAPEUTICS, INC.
WO/2021/071979	COMPOSITIONS AND METHODS FOR INCREASING EPITHELIAL BARRIER  FUNCTION	BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/242294	PEPTIDES FOR COVID-19 PREVENTION AND TREATMENT	SOTIRA COVID, LLC
WO/2021/086565	WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL  FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF	DISPERSOL TECHNOLOGIES, LLC
WO/2021/072017	METHOD OF INDUCTION OF TUMOR ASSOCIATED ANTIGENS WITH  BRYOSTATIN	BRYOLOGYX INC.
WO/2021/072028	ACTIVATORS OF HEME REGULATED INHIBITOR KINASE (HRI)	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/072034	METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/072044	METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS  T-CELL IMMUNOTHERAPY	PACT PHARMA, INC.
WO/2021/086567	COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITY	UNIVERSITY OF NOTRE DAME DU LAC
WO/2021/072045	THERAPEUTIC CANNABIS EXTRACTS	JENNY'S ROSE, LLC
WO/2021/072050	EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS	REFORM BIOLOGICS, LLC
WO/2021/072055	COMPOSITIONS AND METHODS FOR PREVENTING, REDUCING AND  REVERSING OPIOID-INDUCED RESPIRATORY DEPRESSION	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/072075	MULTI-DOMAIN PROTEIN VACCINE	FRITSCH, Edward
WO/2021/072076	DAUGHTERLESS MALE MAMMALS FOR NON-HUMAN POPULATION SUPPRESSION	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/072083	Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCER	MARSHALL UNIVERSITY RESEARCH CORPORATION
WO/2021/072095	METHODS OF TREATING PEMPHIGUS BY ADMINISTERING  (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/072098	BIOMARKERS FOR GRAFT-VERSUS-HOST DISEASE	INCYTE CORPORATION
WO/2021/072103	METHODS FOR DETECTING A FOOD SPECIFIC IMMUNE RESPONSE	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/072113	COMPOSITIONS FOR THE DELIVERY OF PROTEINS	AFYX THERAPEUTICS A/S
WO/2021/072115	CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORS	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/072116	BIOMARKERS FOR GRAFT-VERSUS-HOST DISEASE	INCYTE CORPORATION
WO/2021/072129	PROTEINS CONTAINING MULTIPLE, DIFFERENT UNNATURAL AMINO ACIDS  AND METHODS OF MAKING AND USING SUCH PROTEINS	TRUSTEES OF BOSTON COLLEGE
WO/2021/072136	LASER ETCHED CAPSULES AND METHODS OF MAKING THEM	BAYER HEALTHCARE LLC
WO/2021/072139	FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/072159	ANODIC OXIDATION OF 5-AMINOURACIL	MEDIBEACON INC.
WO/2021/072167	COMPOSITIONS AND METHODS FOR <i>IN VIVO</i>  SYNTHESIS OF UNNATURAL POLYPEPTIDES	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/072172	COMPOSITIONS, METHODS AND USES OF MESSENGER RNA	TRANSLATE BIO, INC.
WO/2021/072184	METHODS OF FORMING CURED COMPOSITE MATERIALS WITH OPTIMIZED PH  AND RELATED COMPOSITIONS AND SYSTEMS	SOLIDIA TECHNOLOGIES, INC.
WO/2021/072194	STABILIZED HEMOGLOBIN COMPOSITIONS AND PHARMACEUTICAL  FORMULATIONS THEREOF	MEDICAL TECHNOLOGY ASSOCIATES II, INC.
WO/2021/072198	ORAL COMPLEMENT FACTOR D INHIBITORS	BIOCRYST PHARMACEUTICALS, INC.
WO/2021/072201	RAAV-MEDIATED IN VIVO DELIVERY OF SUPPRESSOR TRNAS	UNIVERSITY OF MASSACHUSETTS
WO/2021/072203	TGFBETAR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOF	SILVERBACK THERAPEUTICS, INC.
WO/2021/072211	COMPOSITIONS AND METHODS FOR TREATING CYTOTOXIC T CELL  RESISTANT TUMORS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/072218	METHOD OF TREATING IMMUNOTHERAPY NON-RESPONDERS WITH AN  AUTOLOGOUS CELL THERAPY	PACT PHARMA, INC.
WO/2021/072225	MODULATING INTERLEUKIN-10 SIGNALING TO BOOST HEALING IN  DIABETIC WOUNDS	RUSH UNIVERSITY MEDICAL CENTER
WO/2021/072235	FRACTIONATED DOSING OF A PHOSPHOLIPID ETHER ANALOG FOR THE  TREATMENT OF CANCER	CELLECTAR BIOSCIENCES, INC.
WO/2021/072238	FEEDER-BASED AND FEEDER-FREE STEM CELL CULTURE SYSTEMS FOR  STRATIFIED EPITHELIAL STEM CELLS, AND USES RELATED THERETO	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/072246	ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR  RECEPTORS	YALE UNIVERSITY
WO/2021/072250	RECOMBINANT POLYPEPTIDES FOR REGULATABLE CELLULAR LOCALIZATION	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/072255	LIGHT ACTIVATED NANOPARTICLE COMPOSITIONS AND USES THEREOF	MOLECULAR EXPRESS, INC.
WO/2021/072260	A TERPENE-REDUCED CANNABINOID ADJUNCT	JAMAICAN BREW HOUSE
WO/2021/072264	ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL  ENGAGERS	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/072265	METHODS OF TREATING AN EYE DISORDER	KODIAK SCIENCES INC.
WO/2021/072269	TARGETED BIFUNCTIONAL DEGRADERS	YALE UNIVERSITY
WO/2021/072272	EPICARDIAL DELIVERY OF GENE THERAPY	XYLOCOR THERAPEUTICS, INC.
WO/2021/072273	ONCOLYTIC VIRUS COMPRISING IMMUNOMODULATORY TRANSGENES AND  USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/072276	COMPOSITIONS AND METHODS FOR UPREGULATING ISOFORMS OF  DYSTROPHIN AS THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY (DMD)	YALE UNIVERSITY
WO/2021/072281	MODIFIED ENDONUCLEASES AND RELATED METHODS	UNIVERSITY OF WASHINGTON
WO/2021/072286	CANCER COMBINATION TREATMENTS USING ANTI-STAT3 NUCLEIC ACID  CONJUGATES	CITY OF HOPE
WO/2021/072289	METHODS AND SYSTEMS USING PEPTIDES FOR TARGETING AND MAPPING  HUMAN NERVES IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY	ALUME BIOSCIENCES, INC.
WO/2021/072298	PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH  IMPROVED PROPERTIES	GENENTECH, INC.
WO/2021/072302	MODIFIED STEM CELLS AND METHODS OF USE THEREOF	NEW YORK STEM CELL FOUNDATION, INC.
WO/2021/072306	METHODS AND SYSTEMS FOR MICROFLUIDIC SCREENING	1859, INC.
WO/2021/072311	COMPOSITIONS WITH PURIFIED <i>BOMBYX MORI</i>  COCOON SILK PEPTIDE FIBER AND REFINED <i>BUGLOSSOIDES</i>  <i>ARVENSIS</i> SEED OIL, AND RELATED METHODS	BRAINI LLC
WO/2021/072312	COMPOSITIONS AND METHODS FOR TARGETING CD13 AND TIM-3 WITH CAR  T CELLS TO TREAT ACUTE MYELOID LEUKEMIA	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/072319	TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST  GROWTH FACTOR RECEPTOR SIGNALING	G1 THERAPEUTICS, INC.
WO/2021/072325	COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF	CORBUS PHARMACEUTICALS, INC.
WO/2021/072330	GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER  DISEASES	SILVERBACK THERAPEUTICS, INC.
WO/2021/072332	METHODS FOR COSMETIC SKIN REMODELING	ELC MANAGEMENT LLC
WO/2021/072349	SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR  TREATING CANCER	TOBEBIO NOVEL DRUG CO., LTD.
WO/2021/072350	SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR  TREATING CANCER	TOBEBIO NOVEL DRUG CO., LTD.
WO/2021/072351	DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS USING  ALTERED RATIOS OF METABOLITE CONCENTRATIONS	STEMINA BIOMARKER DISCOVERY, INC.
WO/2021/072353	CHIMERIC ANTIGEN RECEPTORS AGAINST HUMAN CYTOMEGALOVIRUS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076444	METHODS FOR TREATING BREAST CANCER	OLATEC THERAPEUTICS LLC
WO/2021/072359	MANUFACTURE METHOD FOR AQUEOUS FORMULATION OF  MANGANESE-CONTAINING COORDINATION COMPLEX, FORMULATION AND METHOD OF  TREATMENT	GALERA LABS, LLC
WO/2021/072369	LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF  MAKING AND USING THE SAME	DUKE UNIVERSITY
WO/2021/076448	SOMATOSTATIN MODULATORS FOR TREATING PITUITARY ADENOMAS	CRINETICS PHARMACEUTICALS, INC.
WO/2021/072372	VARIANT IGF2 CONSTRUCTS	AMICUS THERAPEUTICS, INC.
WO/2021/072385	COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/072390	USE OF ENTPD3 FOR IDENTIFICATION, ISOLATION, AND ENHANCING  MATURE STEM CELL DERIVED INSULIN-PRODUCING CELLS	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/072395	MODIFIED OLIGONUCLEOTIDES	ALNYLAM PHARMACEUTICALS, INC.
WO/2021/076465	CANNABIDIOL ADJUVANT THERAPY FOR TREATMENT OF DISC  DEGENERATIVE DISEASE	FIGENE, LLC
WO/2021/076474	WATER-RESISTANT AND/OR PHOTOPROTECTIVE COMPOSITIONS COMPRISING  NON-SOLUBILIZED MICRONIZED WAXES	LUBRIZOL ADVANCED MATERIALS, INC
WO/2021/080814	FILM COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/072399	ENGINEERING BACILLUS SUBTILIS AS A VERSATILE AND STABLE  PLATFORM FOR PRODUCTION OF NANOBODIES	NORTHEASTERN UNIVERSITY
WO/2021/076485	METHODS AND COMPOSITIONS FOR TREATING IRON DISORDERS	BEYONDSPRING PHARMACEUTICALS, INC.
WO/2021/076506	A STABLE EFFERVESCENT CO-PROCESSED EXCIPIENT COMPOSITION AND A  PROCESS FOR PREPARING THE SAME	ISP INVESTMENTS LLC
WO/2021/076514	METHODS FOR TREATING IMMUNE THROMBOCYTOPENIA BY ADMINISTERING  (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/072407	DELIVERY SYSTEM COMPLEXES COMPRISING A PRECIPITATE OF AN  ACTIVE AGENT AND METHODS OF USE	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/076525	TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH  ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY  FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS	FIGENE, LLC
WO/2021/076543	EPCAM BINDING FIBRONECTIN TYPE III DOMAINS	ARO BIOTHERAPEUTICS COMPANY
WO/2021/076562	PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION	PEREZ, Pedro, P.
WO/2021/076565	METHOD OF NORMALIZING THE NEUTROPHIL TO LYMPHOCYTE RATIO IN  CANCER PATIENTS WITH A SELECTIVE GLUCOCORTICOID RECEPTOR ANTAGONIST	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/076566	COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASE	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/076572	ERGOLINE-LIKE COMPOUNDS FOR PROMOTING NEURAL PLASTICITY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/080827	SEQUENTIAL MULTI-STEP FLASH NANOPRECIPITATION FOR THE  FORMATION OF NANOPARTICLES WITH HIGH CORE LOADINGS	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/086610	COMPOSITIONS AND METHODS OF USE	VERA BIOTECHNOLOGY, INC.
WO/2021/076600	COMPOSITIONS COMPRISING NOVEL PROKARYOTIC SODIUM CHANNELS AND  ASSOCIATED METHODS	DUKE UNIVERSITY
WO/2021/076602	BICYCLIC HETEROCYCLES AS FGFR INHIBITORS	INCYTE CORPORATION
WO/2021/076610	SHIGELLA MULTI-EPITOPE FUSION ANTIGEN PROTEINS AND METHODS OF  USE	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/076616	COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER  DISEASES (NAFLD)	COHERUS BIOSCIENCES, INC.
WO/2021/076618	TREATMENT OF UTERINE FIBROIDS USING PURIFIED COLLAGENASE	THE JOHNS HOPKINS UNIVERSITY
WO/2021/076630	NANO-ENABLED IMMUNOTHERAPY IN CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076655	COMBINATION THERAPY OF KRAS INHIBITOR AND SHP2 INHIBITOR FOR  TREATMENT OF CANCERS	AMGEN INC.
WO/2021/076666	METHODS OF TREATING CANCER WITH A STING AGONIST	IMMUNESENSOR THERAPEUTICS, INC.
WO/2021/076674	FIBROBLAST-BASED IMMUNOTHERAPY OF GRAVES DISEASE	FIGENE, LLC
WO/2021/076675	PREVENTION OF RECURRENT MISCARRIAGES THROUGH ADMINISTRATION OF  FIBROBLASTS AND FIBROBLAST-EDUCATED PATERNAL CELLS	FIGENE, LLC
WO/2021/076687	COMPOSITIONS, SYSTEMS AND METHODS FOR CONFERRING DURABLE  SHAPING OF KERATINOUS FIBERS	L'OREAL
WO/2021/076688	HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES	CHEMOCENTRYX, INC.
WO/2021/076691	HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES	CHEMOCENTRYX, INC.
WO/2021/076703	COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINS	VIVIDION THERAPEUTICS, INC.
WO/2021/076709	DOSAGES AND USES OF ORNITHINE PHENYLACETATE FOR TREATING  HYPERAMMONEMIA	OCERA THERAPEUTICS, INC.
WO/2021/076710	N-ACYLATED HISTIDINE DIPEPTIDES AS ANTICANCER AGENTS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/076712	EARLY MANAGEMENT AND PREVENTION OF SEPSIS AND SEPSIS-LIKE  SYNDROMES	OPHIREX, INC.
WO/2021/076714	METHODS TO TREAT HEPATITIS DELTA VIRAL INFECTIONS	EIGER BIOPHARMACEUTICALS, INC.
WO/2021/076718	OIL-IN-WATER EMULSIONS AND METHODS OF USE	CAPSUGEL BELGIUM NV
WO/2021/076722	COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING	CUROLOGY, INC.
WO/2021/076723	ALKYLESTERS OF ALPHA-METHYL-DL-TYROSINE FOR USE IN TREATING  CANCER	TYME, INC.
WO/2021/076728	BICYCLIC HETEROCYCLES AS FGFR INHIBITORS	INCYTE CORPORATION
WO/2021/080846	NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTIBODY 38C2	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/076755	AN ACTIVITY-GUIDED MAP OF ELECTROPHILE-CYSTEINE INTERACTIONS  IN PRIMARY HUMAN IMMUNE CELLS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/080847	SYSTEMS AND METHODS FOR CELL CULTURING	FLASKWORKS, LLC
WO/2021/076766	CURCUMINOID COMPOSITION FOR THERAPEUTIC MANAGEMENT OF  METABOLIC SYNDROME	MAJEED, Muhammed
WO/2021/076778	A BIODISSOLVABLE FILM FOR LOCALIZED AND EFFICIENT TREATMENT OF  VULVODYNIA	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/076780	METHODS AND COMPOSITIONS FOR CANCER TREATMENT USING  NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON NK  CELLS	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/076792	COMPOSITIONS COMPRISING HYALURONIDASE AND/OR COLLAGENASE  AND/OR 4-METHYLUMBELLIFERONE (4-MU) AND METHODS OF TREATMENT USING SAME	STANDARD OF CARE CORPORATION
WO/2021/076794	METHODS FOR MODULATING LEVEL OF EXPRESSION FROM GENE THERAPY  EXPRESSION CASSETTE	CORNELL UNIVERSITY
WO/2021/076808	METHODS FOR DETECTING AND INHIBITING BRAIN METASTASIS	CORNELL UNIVERSITY
WO/2021/076811	MRNAS ENCODING GRANULOCYTE-MACROPHAGE COLONY STIMULATING  FACTOR FOR TREATING PARKINSON'S DISEASE	MODERNA TX, INC.
WO/2021/076814	METHODS OF INHIBITING LIVER-TYPE GLUTAMINASE, GLS2	CORNELL UNIVERSITY
WO/2021/076817	METHODS AND COMPOSITIONS RELATED TO TREATMENT AND PREVENTION  OF CANCER BY INHIBITION OF DGAT1 AND DGAT2	OHIO STATE INNOVATION FOUNDATION
WO/2021/076852	SMALL EXTRACELLULAR VESICLE-ASSOCIATED VEGF AS A PREDICTOR FOR  THERAPEUTIC RESPONSES	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/076856	MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING  MYOTONIC DYSTROPHY	DYNE THERAPEUTICS, INC.
WO/2021/076860	SULFATE-FREE SURFACTANT SYSTEM	ETHOX CHEMICALS, LLC
WO/2021/076865	POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND  USING THEREOF	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/076866	GENERATION OF INDUCED PLURIPOTENT STEM CELLS WITH  POLYCISTRONIC SOX2, KLF4, AND OPTIONALLY C-MYC	THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST  ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE
WO/2021/076875	A NOVEL ACTIVE INGREDIENT IN SUNSCREEN COMPOSITIONS	UNIVERSITY OF MARYLAND
WO/2021/086635	PHARMACEUTICAL UNIT DOSE SYSTEMS FOR ORAL DRY SOLUTION AND  SUSPENSION	BRILLIAN PHARMA INC.
WO/2021/076883	MUSCLE REGENERATION AND GROWTH	BROWN UNIVERSITY
WO/2021/076890	INHIBITING HUMAN INTEGRIN  α<sb>4</sb>β<sb>7</sb>	MORPHIC THERAPEUTIC, INC.
WO/2021/076906	TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING  INDIVIDUALS	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/076908	COMBINATION THERAPIES FOR TREATING MYELODYSPLASTIC SYNDROMES  AND ACUTE MYELOID LEUKEMIA	FORTY SEVEN, INC.
WO/2021/076920	METHOD AND COMPOSITION FOR INCREASING MUSCLE PROTEIN SYNTHESIS	CAPSUGEL BELGIUM NV
WO/2021/076926	METHOD AND COMPOSITION FOR INCREASING MUSCLE PROTEIN SYNTHESIS	CAPSUGEL BELGIUM NV
WO/2021/076930	PLXDC ACTIVATORS AND THEIR USE IN THE TREATMENT OF BLOOD  VESSEL DISORDERS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/076936	COMPOSITIONS COMPRISING CANNABINOID MOLECULES THAT ARE  DISSOLVED IN WATER-MISCIBLE SOLVENTS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/076939	HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE  THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/076942	USE OF SUCCINATE AS BIOMARKER IN DIAGNOSIS AND TREATMENT OF  CANCERS	NATIONAL HEALTH RESEARCH INSTITUTES
WO/2021/076945	TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON  REGULATION IN ANIMALS	AMBYS MEDICINES, INC.
WO/2021/076947	REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEUROLOGICAL  DISORDERS	THE PENN STATE RESEARCH FOUNDATION
WO/2021/096638	ANTIPERSPIRANT/DEODORANT COMPOSITIONS	REVLON CONSUMER PRODUCTS CORPORATION
WO/2021/076960	LIVE VIRUS VACCINE INJURY RISK	ANAND, Rene
WO/2021/076961	COMPOSITIONS AND METHODS OF TREATMENT FOR INHIBITING CAPILLARY  TUBE REGRESSION	UNIVERSITY OF SOUTH FLORIDA
WO/2021/076964	STATHMIN 2 (STMN2) AS A THERAPEUTIC TARGET FOR PARKINSON'S  DISEASE	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/076965	NUCLEIC ACIDS ENCODING HIV NEUTRALIZING ANTIBODIES AND USES  THEREOF	MINICIRCLE, INC.
WO/2021/076966	PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE  TREATMENT OF CANCER	IKENA ONCOLOGY, INC.
WO/2021/076973	EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE  TREATMENT OF NEUROPATHIC DISORDERS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/076980	MATERIALS AND METHODS FOR TREATING VITILIGO	NORTHWESTERN UNIVERSITY
WO/2021/076983	REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD  INJURY AND ALS	THE PENN STATE RESEARCH FOUNDATION
WO/2021/076985	CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR  LEUKEMIAS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/076991	COMPOSITIONS AND METHODS FOR TREATING BLOOD DISORDERS	ANNEXON, INC.
WO/2021/076998	PRODUCER VIRUSES FOR GENERATION OF RETROVIRUSES IN SITU	KALIVIR IMMUNOTHERAPEUTICS LLC
WO/2021/076999	FECAL-DERIVED STERILE POSTBIOTIC COMPOSITION AND METHOD  THEREFOR	HUBBLE BIOSCIENCE INC.
WO/2021/077018	COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE  SIGNALING PATHWAYS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/080880	NMDAR INHIBITING AGENTS AND GABAAR POTENTIATING AGENTS AND  USES THEREOF	COVEY, Douglas
WO/2021/077031	COMPOUNDS AND METHODS TARGETING QSOX1	SAPPHIRE BIOTECH, INC.
WO/2021/077034	2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR  SUPPRESSING AND TREATING HEMOGLOBINOPATHY, THALASSEMIA, SICKLE CELL DISEASE  AND OTHER DISORDERS	PTC THERAPEUTICS, INC.
WO/2021/077055	BOTULINUM TOXIN FOR USE IN TREATMENT	PENLAND FOUNDATION
WO/2021/077058	EXTENDED HALF-LIFE G-CSF AND GM-CSF VITAMIN D CONJUGATES	RAMEA LLC
WO/2021/077061	SELF-MICROEMULSIFYING MULTI-DELIVERABLE SYSTEMS	QUICKSILVER SCIENTIFIC, INC.
WO/2021/077066	LIPID AND LIPID NANOPARTICLE FORMULATION FOR DRUG DELIVERY	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/077067	LIPID NANOPARTICLES AND FORMULATIONS THEREOF FOR CAR MRNA  DELIVERY	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/077070	COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING  ANTIBODIES	YALE UNIVERSITY
WO/2021/077105	HUMAN PERIVENTRICULAR ENDOTHELIAL CELL THERAPY FOR  NEUROPSYCHIATRIC DISORDERS	THE MCLEAN HOSPITAL CORPORATION
WO/2021/077108	METHOD OF TREATING AUTISM	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/077113	METHODS OF TREATMENT OF BLADDER CANCER BY USING MODIFIED  BACILLUS CALMETTE-GUéRIN	TEXAS BIOMEDICAL RESEARCH INSTITUTE
WO/2021/077114	COMPOSITIONS AND METHODS FOR DELIVERING EXOSOMES USING  MICRONEEDLE DEVICES TO THE SKIN	AQUAVIT PHARMACEUTICALS, INC.
WO/2021/077115	GENE THERAPY TARGETING COCHLEAR CELLS	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/077119	ANTIMICROBIAL ORGANOSILANES	TOPIKOS PHARMACEUTICALS, INC.
WO/2021/080929	N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2  INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF	MERCK SHARP & DOHME CORP.
WO/2021/080935	METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING  2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZ  YL)AMINO)ISOINDOLINE-1,3-DIONE	CELGENE CORPORATION
WO/2021/080936	METHODS OF TREATING CHRONIC LYMPHOCYTIC LEUKEMIA USING  2-(2,6-DIOXOPIPERIDIN-3YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1.  3-DIONE	CELGENE CORPORATION
WO/2021/080937	PHARMACEUTICAL COMPOSITIONS COMPRISING  (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE  AND METHODS OF USING THE SAME	CELGENE CORPORATION
WO/2021/086679	MODIFIED ZEOLITE CATALYST COMPOSITIONS AND METHODS OF USE	W.R. GRACE & CO.-CONN.
WO/2021/101646	PROPHYLACTIC SKIN TREATMENT FOR RADIATION THERAPY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/126359	VITAMIN A AND VITAMIN C COMBINATIONS WITH ENHANCED STABILITY	BARNET PRODUCTS, LLC
WO/2021/080955	SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND  ACTIVE AGENTS FOR COMBINED USE	CELGENE CORPORATION
WO/2021/101647	RECOMBINANT MICELLE AND METHOD OF IN VIVO ASSEMBLY	MOZZA
WO/2021/080972	ORALLY INGESTIBLE DELIVERY SYSTEM	SOANE PHARMA LLC
WO/2021/080975	COMPOSITIONS AND METHODS FOR REDUCING CHOLESTEROL LEVELS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/080983	METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB  IN COMBINATION WITH CAPECITABINE AND TRASTUZUMAB	SEAGEN INC.
WO/2021/086689	4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF	PRIME REACH TRADING LIMITED
WO/2021/081006	COMPOSITIONS AND METHODS FOR MITIGATION OF ISCHEMIC  REPERFUSION INJURY	JAAN BIOTHERAPEUTICS LLC
WO/2021/081011	METHODS OF ADMINISTERING CANNABINOID TO PEOPLE DIAGNOSED WITH  HIV	TILRAY INC.
WO/2021/081022	TETRABENAZINE TRANSDERMAL DELIVERY DEVICE	SHINKEI THERAPEUTICS LLC
WO/2021/081043	MUCUS PENETRATING PARTICLE COMPOSITIONS AND METHODS OF USE  THEREOF ENHANCING IMMUNE RESPONSE	THE JOHNS HOPKINS UNIVERSITY
WO/2021/081052	HIGH AFFINITY NANOBODIES TARGETING B7H3 (CD276) FOR TREATING  MULTIPLE SOLID TUMORS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/081058	COMPOSITIONS, METHODS AND USES OF MESSENGER RNA	TRANSLATE BIO, INC.
WO/2021/081062	METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASES AND  DISORDERS	SELECTA BIOSCIENCES, INC.
WO/2021/086698	METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONS	ROCHAL INDUSTRIES, LLC
WO/2021/081069	COMPOSITIONS AND METHODS FOR ENHANCING RETINAL GANGLION CELL  DEVELOPMENT AND PLURIPOTENT STEM CELL-DERIVED THREE-DIMENSIONAL TISSUE	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/081081	METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING CANCER  USING PYRVINIUM COMPOSITIONS	THOMAS JEFFERSON UNIVERSITY
WO/2021/081108	METHODS OF TREATING PROSTATE CANCER	ARVINAS OPERATIONS, INC.
WO/2021/081110	PEPTIDES AND USE THEREOF	ANEXIGEN, INC.
WO/2021/081115	COMPOSITIONS AND METHODS FOR IN VITRO ACTIVATION AND EXPANSION  OF SERIAL KILLER T CELL POPULATIONS AND PASSIVE IMMUNIZATION OF A CANCER  PATIENT WITH TUMOR CELL KILLING CELLS	ALLOPLEX BIOTHERAPEUTICS
WO/2021/081120	RECOMBINANT NEURAMINIDASE AND USES THEREOF	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/081130	USE OF PINE RESIN FOR TREATING AND PREVENTING MUSCLE SORENESS  AND FOOT & JOINT PAIN	SPRAINGO, LLC
WO/2021/081133	ENGINEERED NATURAL KILLER CELLS AND METHODS FOR USING THE SAME  IN IMMUNOTHERAPY AND AUTOPHAGY INHIBITION TECHNIQUES	PURDUE RESEARCH FOUNDATION
WO/2021/081138	COMPOSITIONS COMPRISING SUPERFINE COMPOUNDS AND PRODUCTION  THEREOF	ESOLATE LTD
WO/2021/081140	SUPERFINE COMPOUNDS AND PRODUCTION THEREOF	ESOLATE LTD
WO/2021/081141	GLUCOSYLCERAMIDE SYNTHASE INHIBITORS AND THERAPEUTIC METHODS  USING THE SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/081149	TREATMENT AND CONTROL OF BACTERIAL AND FUNGAL DISEASE IN  HONEYBEES	TALLGRASS BIOLOGICS L.L.C.
WO/2021/081167	PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF  NEIMODEGENERATIVE DISEASES	XAVIER UNIVERSITY OF LOUISIANA
WO/2021/081193	METHODS OF ADMINISTRATION OF IL-2 RECEPTOR AGONISTS	NEOLEUKIN THERAPEUTICS, INC.
WO/2021/081203	ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF  AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES AND DISORDERS	APPLIED GENETIC TECHNOLOGIES CORPORATION
WO/2021/081204	DISRUPTION OF VASCULAR SMOOTH MUSCLE RELAXATION BY CARFILZOMIB  MAY BE THE PRIMARY REASON FOR CFZ-INDUCED VASCULAR DYSFUNCTION	AMGEN INC.
WO/2021/081225	ORNITHINE TRANSCARBAMYLASE (OTC) CONSTRUCTS AND METHODS OF  USING THE SAME	GENEVANT SCIENCES GMBH
WO/2021/081229	CORTICAL NEURAL PROGENITOR CELLS FROM IPSCS	CEDARS-SINAI MEDICAL CENTER
WO/2021/081231	USE OF MBV FOR TREATING AUTOIMMUNE DISEAE	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/081232	MODIFIED CYTOTOXIC T CELLS AND METHODS OF USE THEREOF	CUE BIOPHARMA, INC.
WO/2021/081251	LIPID COATED IRON OXIDE NANOPARTICLES FOR OTITIS MEDIA	OTOMAGNETICS, INC.
WO/2021/086726	IMPROVED METHODS, KITS, COMPOSITIONS AND DOSING REGIMENS FOR  THE USE OF HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2	ASAN BIOSCIENCES, LLC
WO/2021/081258	TGF-β POLYPEPTIDES	CUE BIOPHARMA, INC.
WO/2021/081276	STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING ESTRADIOL AND  PROGESTERONE FOR ORAL ADMINISTRATION	SLAYBACK PHARMA LLC
WO/2021/081292	METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH α1A-AR  PARTIAL AGONISTS	CURASEN THERAPEUTICS, INC.
WO/2021/081293	COMPOSITIONS FOR TREATMENT OF ANNULAR SPINAL DISC INJURY	WARSAW ORTHOPEDIC, INC
WO/2021/081296	NOVEL ANTIBODIES FOR DETECTING EPSTEIN BARR VIRUS-POSITIVE  GASTRIC CANCER	LABAER, Joshua
WO/2021/081301	COMPUTATIONAL DESIGN OF ALPHA(V) BETA (6) INTEGRIN BINDING  PROTEINS	ROY, Anindya
WO/2021/081313	METHODS FOR IDENTIFYING STRUCTURAL FEATURES OF LIPIDS	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/081315	COMPOUNDS AND METHODS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS	THE BROAD INSTITUTE, INC.
WO/2021/081326	COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW  PROTEIN CONCENTRATIONS	AMGEN INC.
WO/2021/081337	METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE	CASE WESTERN RESERVE UNIVERSITY
WO/2021/081338	COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE  DISORDERS	AUDENTES THERAPEUTICS, INC.
WO/2021/086751	COSMETIC COMPOSITIONS COMPRISING VINYLPYRROLIDONE COPOLYMERS	L'OREAL
WO/2021/081348	METHODS FOR TREATING PATIENTS HAVING CFI MUTATIONS WITH  RECOMBINANT CFI PROTEINS	GEMINI THERAPEUTICS INC.
WO/2021/081357	TREATMENT OF EPILEPTIC CONDITIONS WITH  GABA<sb>A</sb> RECEPTOR MODULATORS	NEUROCYCLE THERAPEUTICS, INC.
WO/2021/108050	COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR  MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED  IMMUNE-GENE THERAPY	YALE UNIVERSITY
WO/2021/086753	AMORPHOUS SOLID SUCCINYLATED 3-(FATTY ACID  AMIDO)-2-HYDROXY-1-(PROTECTED HYDROXY)-PROPANE SALTS AND METHODS OF MAKING  THE SAME	GERON CORPORATION
WO/2021/081365	HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES  THEREOF	PROMETHEUS BIOSCIENCES, INC.
WO/2021/081366	PIMOBENDAN FORMULATION AND METHOD OF USE THEREOF	PIEDMONT ANIMAL HEALTH INC.
WO/2021/086754	CRYSTALLINE SOLIDS OF 3-PALMITOYL-AMIDO-1,2-PROPANEDIOL AND  3-PALMITOYL-AMIDO-2-HYDROXY-1-DIMETHOXYTRIPHENYLMETHYLETHER-PROPANE AND  METHODS OF MAKING AND USING THE SAME	GERON CORPORATION
WO/2021/081375	INHIBITORS OF RAF KINASES	KINNATE BIOPHARMA INC.
WO/2021/081376	METHODS OF TREATING THE SYMPTOMS OF AUTISM SPECTRUM DISORDER	MAPLIGHT THERAPEUTICS, INC.
WO/2021/081378	GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF  SAME IN IMMUNOTHERAPY	IOVANCE BIOTHERAPEUTICS, INC.
WO/2021/081384	SYNTHETIC NUCLEASES	GREENVENUS, LLC
WO/2021/081395	METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH  RECOMBINANT CFH PROTEINS	GEMINI THERAPEUTICS INC.
WO/2021/081401	METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH  CFH-ENCODING VECTORS	GEMINI THERAPEUTICS INC.
WO/2021/081402	MACROMOLECULE-SUPPORTED THIENOAZEPINE COMPOUNDS, AND USES  THEREOF	BOLT BIOTHERAPEUTICS, INC.
WO/2021/081405	METHODS FOR DETECTION OF MACRO-HETEROPLASMY AND  MICRO-HETEROPLASMY IN MITOCHONDRIAL DNA	IMEL BIOTHERAPEUTICS, LTD.
WO/2021/081407	THIENOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF	BOLT BIOTHERAPEUTICS, INC.
WO/2021/081430	FIBRIN-BINDING COMPOUNDS FOR IMAGING AND TREATMENT	COLLAGEN MEDICAL, LLC
WO/2021/081440	CHIMERIC CYTOKINE MODIFIED ANTIBODIES AND METHODS OF USE  THEREOF	MINOTAUR THERAPEUTICS, INC.
WO/2021/081448	SYNERGISTIC INHIBITORS OF CREB-MEDIATED GENE TRANSCRIPTION	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/081466	POLYNUCLEOTIDE-LINKED BIOCONJUGATES AND METHODS OF MAKING AND  USING	PHITONEX, INC.
WO/2021/086773	AQUEOUS CONDITIONER FORMULATION FOR THERMALLY STYLED HAIR	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/081481	LOW DOSE ADJUVANT EPIGENETIC CANCER THERAPY	THE JOHNS HOPKINS UNIVERSITY
WO/2021/133460	COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMPROVING  EPITHELIAL HOMEOSTASIS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/081495	POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY	THE JOHNS HOPKINS UNIVERSITY
WO/2021/086785	BIFUNCTIONAL COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/081499	CHIKUNGUNYA VIRUS-LIKE PARTICLE VACCINE AND METHODS OF USING  THE SAME	EMERGENT TRAVEL HEALTH INC.
WO/2021/081500	MITOCHONDRIA-TARGETED ATOVAQUONE: A MORE POTENT AND MORE  EFFECTIVE ANTITUMOR, ANTIMICROBIAL, AND ANTIMALARIAL DRUG	THE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/108051	ATROPINE-SCOPOLAMINE WITH ENHANCED STABILITY	CMC PHARMACEUTICALS, INC.
WO/2021/081515	COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN  IMMUNODEFICIENCY VIRUS	CIDARA THERAPEUTICS, INC.
WO/2021/091718	ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR  DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD	IVERIC BIO, INC.
WO/2021/081540	PREPARATION AND USE OF THERAPEUTIC HYDROGELS	BRIOPRYME BIOLOGICS, INC.
WO/2021/086806	CANNABINOID PRODUCTS WITH HIGH BIOAVAILABILITY	THE CHEMIST'S CABINET, LLC
WO/2021/086829	METHODS FOR TREATING LEUKEMIA AND USE OF A LEUKEMIC STEM CELL  SIGNATURE TO PREDICT CLINICAL SENSITIVITY TO THERAPIES	CELGENE CORPORATION
WO/2021/086830	USE OF BIOMARKERS TO PREDICT CLINICAL SENSITIVITY TO  2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-  OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE	CELGENE CORPORATION
WO/2021/086879	COMPOUNDS AND METHODS OF USE	TANGO THERAPEUTICS, INC.
WO/2021/086889	METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND  INFECTIOUS DISEASES	CHINOOK THERAPEUTICS, INC.
WO/2021/086892	METHODS AND COMPOSITIONS FOR TREATMENT OF RETT SYNDROME	ACADIA PHARMACEUTICALS INC.
WO/2021/086904	SMALL MOLECULE ACTIVATORS OF TIE-2	AERPIO PHARMACEUTICALS, INC.
WO/2021/086909	COMBINATION OF A PD-1 ANTAGONIST, A VEGFR/FGFR/RET TYROSINE  KINASE INHIBITOR AND A CBP/BETA-CATENIN INHIBITOR FOR TREATING CANCER	EISAI R&D MANAGMENT CO., LTD.
WO/2021/086912	COMBINED PIKFYVE AND P38 MAP KINASE INHIBITION FOR TREATING  CANCER	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/086914	DIMERIC NAPHTHALIMIDE FORMULATIONS	ALUCENT BIOMEDICAL, INC.
WO/2021/086917	PSMA-TARGETING IMAGING AGENTS	THE CLEVELAND CLINIC FOUNDATION
WO/2021/086938	DRIP-FREE CLEANSING MASK WITH ENHANCED ACTIVE DEPOSITION	L'OREAL
WO/2021/086946	PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCIN	ABRAXIS BIOSCIENCE, LLC
WO/2021/086953	COMPOSITIONS AND METHODS FOR PROPHYLAXIS OF HIV	GEORGIA TECH RESEARCH CORPORATION
WO/2021/086958	IMMUNE CELL RECEPTOR ANTIBODIES CONJUGATED TO HIGH AFFINITY  SIGLEC-LIGANDS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/086962	SODIUM-DEPENDENT GLUCOSE TRANSPORTER 2 AS A DIAGNOSTIC AND  THERAPEUTIC TARGET FOR PRE-MALIGNANT LESIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/086964	METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE  APPLICATIONS	PRECISION BIOLOGICS
WO/2021/086967	TREATMENT OF DIABETIC NEPHROPATHY WITH AN SGC STIMULATOR	CYCLERION THERAPEUTICS, INC.
WO/2021/086973	FORMULATION FOR DELIVERY OF LUBRICIN GENE	UNIVERSITY OF IOWA RESEARCH FOUNDATION
WO/2021/086981	COMPOSITIONS AND METHODS FOR TREATING CANCER USING ANTI-HER2  ANTIBODY DRUG CONJUGATE	CSPC DOPHEN CORPORATION
WO/2021/086991	METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/086997	TREATING TISSUE FIBROSIS AND/OR INJURY AND-OR ORGAN FAILURE  WITH INTERLEUKIN 24 OR INTERLEUKIN 20 ANTAGONIST	LBL BIOTECHNOLOGY INC.
WO/2021/086999	THERAPEUTIC APPROACH FOR TREATING INFLAMMATORY BOWEL DISEASE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/087007	GENE THERAPY VECTORS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/087015	ENGINEERED ANTIBODIES TO HIV ENV	INTERNATIONAL AIDS VACCINE INITIATIVE
WO/2021/087018	PYRIDAZINONES AS PARP7 INHIBITORS	RIBON THERAPEUTICS, INC.
WO/2021/087019	ONCOLYTIC VIROTHERAPY WITH INDUCED ANTI-TUMOR IMMUNITY	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/091751	SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC  ACETYLCHOLINE RECEPTORS	MERCK SHARP & DOHME CORP.
WO/2021/087021	PEPTIDE-NANOPARTICLE CONJUGATES	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/087025	PYRIDAZINONES AS PARP7 INHIBITORS	RIBON THERAPEUTICS, INC.
WO/2021/087031	PEPTIDE MIMETICS OF DKK3B AND METHODS OF USE	ACWORTH PHARMACEUTICALS, INC.
WO/2021/087035	ANKLE BRACE WITH ANTI-ROTATION FEATURE	KILBEY, Bryan, E.
WO/2021/087037	LUNG-SPECIFIC TARGETING-PEPTIDE (LTP), COMPOSITIONS, AND USES  THEREOF	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/087050	CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATION	NOVARTIS AG
WO/2021/087051	TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF	PS THERAPY LTD.
WO/2021/087058	SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS,  DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED  EFFICACY	TRANEXAMIC TECHNOLOGIES, LLC
WO/2021/087071	METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS	STITCH BIO, LLC
WO/2021/087072	COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING  RESPIRATORY SYNCYTIAL VIRUS INFECTION	MOHAPATRA, Shyam S.
WO/2021/087074	THERAPEUTIC FORMULATIONS AND USES THEREOF	PIEDMONT ANIMAL HEALTH INC.
WO/2021/087082	PRODRUGS OF ITACONATE AND METHYL ITACONATE	THE JOHNS HOPKINS UNIVERSITY
WO/2021/087083	USE OF ITACONATE AND ITS DERIVATIVES/ANALOGUES TO INDUCE HAIR  GROWTH	THE JOHNS HOPKINS UNIVERSITY
WO/2021/087093	SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/087096	P53 MODULATORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/096692	ARTIFICIAL MELANIN NANOPARTICLES AND PRECURSOR MOLECULES AS  HAIR DYES	NORTHWESTERN UNIVERSITY
WO/2021/087105	IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN  IMMUNOTOXIN	DUKE UNIVERSITY
WO/2021/087113	LOCAL ANESTHETICS WITH SELECTIVE-SENSORY NERVE BLOCKADE	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/087114	ANTI-ANGIOPOIETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF  USE	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/087127	CANNABINOIDS AND USES THEREOF	CORBUS PHARMACEUTICALS, INC.
WO/2021/087138	METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS  WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)	SYROS PHARMACEUTICALS, INC.
WO/2021/087141	METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER  PATIENTS TO PARP INHIBITORS	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/087144	THERAPEUTIC METHODS USING VADADUSTAT	AKEBIA THERAPEUTICS, INC.
WO/2021/087145	HUMAN CELLULAR MODEL FOR INVESTIGATING  CORTICO-STRIATAL-MIDBRAIN NEURAL PATHWAYS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/087177	TARGETING P73 FOR CANCERS RESISTANT TO BH3 MIMETICS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/087181	SUBSTITUTED PYRAZOLE COMPOUNDS AS TOLL RECEPTOR INHIBITORS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/087186	DENTAL VARNISH	DENTSPLY SIRONA INC.
WO/2021/087195	COMPOSITIONS AND USES THEREOF FOR TREATING IRRADIATION-INDUCED  INTESTINAL DAMAGE	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/087200	SYSTEM AND METHOD FOR SEPARATION OF BLOOD COMPONENTS	OWL MANOR MEDICAL, LLC
WO/2021/087205	CHIMERIC RECEPTOR SENSORS	SENTI BIOSCIENCES, INC.
WO/2021/087207	SYNTHESIS OF HOLLOW SILICA PARTICLES AND USE IN SUN CARE  COMPOSITIONS	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/087234	LINEAGE REPROGRAMMING AS A CANCER IMMUNOTHERAPY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/087239	METHOD FOR TREATING SKIN	KAO CORPORATION
WO/2021/087248	ANTI-CD37 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE  THEREOF	R.P. SCHERER TECHNOLOGIES, LLC
WO/2021/091788	MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES  THEREOF	CRINETICS PHARMACEUTICALS, INC.
WO/2021/087258	COMPOSITIONS AND METHODS FOR TREATING ALCOHOL USE DISORDER OR  A RELATED CONDITION THEREOF	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/112987	METHODS OF TREATING COGNITIVE IMPAIRMENT ASSOCIATED WITH  NEURODEGENERATIVE DISEASE	APTINYX INC.
WO/2021/091791	INHIBITION OF THE VE-PTP PHOSPHATASE PROTECTS THE KIDNEY FROM  ISCHEMIA-REPERFUSION INJURY	NORTHWESTERN UNIVERSITY
WO/2021/087291	COMPOSITIONS AND METHODS RELATED TO ORGANIC OXIDES	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/087314	FIBROUS PRODUCT FOR MEDICINAL, COSMETIC OR DERMATOLOGIC USE	SWM LUXEMBOURG SARL
WO/2021/087359	PRODRUG COMPOSITIONS AND METHODS OF TREATMENT	AQUESTIVE THERAPEUTICS, INC.
WO/2021/087360	COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A  SUBJECT FOR TREATMENT OF CONDITIONS OF THE EYE	COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/087361	ZINC FINGER NUCLEASE VARIANTS FOR TREATING OR PREVENTING  LYSOSOMAL STORAGE DISEASES	SANGAMO THERAPEUTICS, INC.
WO/2021/087366	COMPOSITIONS AND METHODS FOR GENOME ENGINEERING	SANGAMO THERAPEUTICS, INC.
WO/2021/087372	LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE	WORCESTER POLYTECHNIC INSTITUTE
WO/2021/087381	HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/087382	SYSTEMS AND METHODS FOR INCREASING NITROGEN MONOXIDE  CONCENTRATION AND REMOVING NITROGEN DIOXIDE FROM A GAS STREAM	THIRD POLE, INC.
WO/2021/087392	IMPROVING RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION	ANGION BIOMEDICA CORP.
WO/2021/087401	METHODS AND COMPOSITIONS FOR TREATING A PREMATURE TERMINATION  CODON-MEDIATED DISORDER	TEVARD BIO, INC.
WO/2021/087406	DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND  PROGENTOR CELLS	MAGENTA THERAPEUTICS, INC.
WO/2021/087408	OTIC FORMULATIONS FOR DRUG-INDUCED OTOTOXICITY	OTONOMY, INC.
WO/2021/087415	METHOD OF TREATING INFECTIONS BY BACTERIOLYTIC ENZYMES AND  MANUFACTURE THEREOF	UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/087419	NANOPARTICLE COMPOSITION AND METHOD OF USE AND MANUFACTURE	VERTELOVA, Regina
WO/2021/091801	COMPOSITIONS OF CLOFAZIMINE, COMBINATIONS COMPRISING THEM,  PROCESSES FOR THEIR PREPARATION, USES AND METHODS OF TREATMENT COMPRISING  THEM	MANNKIND CORPORATION
WO/2021/091806	CHANGING GUT MICROBIOTA TO REDUCE ALCOHOL CRAVING	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/087432	METHODS OF TREATMENT USING AN MTORC1 MODULATOR	NAVITOR PHARMACEUTICALS, INC.
WO/2021/087436	FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITION	FIGENE, LLC
WO/2021/087439	INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICS	FIGENE, LLC
WO/2021/087441	COMPOSITION AND METHODS FOR PREVENTING AND TREATING AFRICAN  SWINE FEVER IN WILD AND DOMESTIC SWINE	ANUBIS BIO CORPORATION
WO/2021/091815	ANTI-CD30 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE  TREATMENT OF HIV INFECTION	SEAGEN INC.
WO/2021/091823	SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/087458	TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR  THE TREATMENT OF CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/087466	GENERATION OF CD38 KNOCK-OUT PRIMARY AND EXPANDED HUMAN NK  CELLS	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/087492	SUBSTANTIALLY ANHYDROUS, CONCENTRATED SURFACTANT COMPOSITIONS	RITA CORPORATION
WO/2021/091846	TREATMENT OF MAST CELL DISEASES AND EOSINOPHILIC DISORDERS	BLUEPRINT MEDICINES CORPORATION
WO/2021/091855	BLOOD PLASMA FRACTIONS FOR USE IN MUSCLE REGENERATION	ALKAHEST, INC.
WO/2021/091862	CAROTENOID COMPOSITIONS AND USES THEREOF	L.E.A.F. HOLDINGS GROUP LLC
WO/2021/091869	AZAPODOPHYLLOTOXIN DERIVATIVES AND METHODS OF TREATING  LYMPHOMA AND KIDNEY CANCER	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/091871	HIGH AFFINITY AND DUAL-SPECIFICITY PEPTIDE ANTAGONISTS OF MDM2  AND MDMX FOR P53 ACTIVATION	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/091881	HIGH CONCENTRATION CELL PENETRATING CASPASE INHIBITOR  CONJUGATES COMPOSITIONS AND METHODS THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/091896	METHOD FOR TREATING CANCER	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/091899	BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1 (BAI1) ANTIBODIES AND  USES THEREOF	GENISPHERE, LLC
WO/2021/091902	COMBINATION PHARMACOLOGICAL INTERVENTIONS FOR MULTIPLE  MECHANISMS OF OBSTRUCTIVE SLEEP APNEA	APNIMED, INC. (DELAWARE)
WO/2021/091904	USE OF A JANUS KINASE INHIBITOR AND A TELOMERASE INHIBITOR FOR  THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS	GERON CORPORATION
WO/2021/091905	LIPOSOMAL FORMULATIONS FOR DELIVERY OF CANNABINOIDS AND  METHODS OF MAKING THEREOF	VELLA BIOSCIENCE, INC.
WO/2021/091906	METHODS FOR TREATING LEUKEMIA	AMGEN INC.
WO/2021/091916	SELF-EMULSIFYING CANNABINOID FORMULATION AND METHOD	LANDRACE BIOSCIENCE INC.
WO/2021/091924	PH RESPONSIVE BLOCK COPOLYMER COMPOSITIONS, MICELLES, AND  METHODS OF USE	ONCONANO MEDICINE, INC.
WO/2021/137932	USE OF IODIDE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF  CHEMOTHERAPY-ASSOCIATED CACHEXIA AND CARDIOTOXICITY	FARADAY PHARMACEUTICALS, INC.
WO/2021/091935	ALLOGENEIC T-CELLS AND METHODS FOR PRODUCTION THEREOF	LONZA WALKERSVILLE, INC.
WO/2021/091937	HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS	ALEXION PHARMACEUTICALS, INC.
WO/2021/091938	COCHLEAR OUTER HAIR CELL PROMOTERS AND USES THEREOF	DECIBEL THERAPEUTICS, INC.
WO/2021/091946	COMBINATION THERAPY WITH  2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)  METHYL)-2,2-DIFLUOROACETAMIDE	CELGENE CORPORATION
WO/2021/091950	VESTIBULAR SUPPORTING CELL PROMOTERS AND USES THEREOF	DECIBEL THERAPEUTICS, INC.
WO/2021/091953	N-TERMINAL SCFV MULTISPECIFIC BINDING MOLECULES	REGENERON PHARMACEUTICALS, INC.
WO/2021/091958	RIG-I INNATE IMMUNE RECEPTOR ANTAGONISTS AND METHODS OF USING  SAME	YALE UNIVERSITY
WO/2021/091967	RAS INHIBITORS	REVOLUTION MEDICINES, INC.
WO/2021/108096	CAR T CELLS WITH ENHANCED METABOLIC FITNESS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/091978	USES OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS	CELGENE CORPORATION
WO/2021/091981	COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CHECKPOINT  INHIBITOR THERAPY	VEDANTA BIOSCIENCES, INC.
WO/2021/091982	RAS INHIBITORS	REVOLUTION MEDICINES, INC.
WO/2021/091986	INTERLEUKIN 10 CONJUGATES AND USES THEREOF	SYNTHORX, INC.
WO/2021/091997	VARICELLA ZOSTER	ADJUVANCE TECHNOLOGIES, INC.
WO/2021/092007	METHODS OF MAKING CELLULAR THERAPIES	VERASTEM, INC.
WO/2021/092020	METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/092030	DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND  MPN-RELATED DISORDERS WITH NAVITOCLAX	ABBVIE INC.
WO/2021/137935	NOVEL SUPEREBASTINE AGAINST THERAPY RESISTANT PROSTATE CANCER	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/092050	COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF SKIN  DISEASES AND DISORDERS WITH LEKTI	AZITRA INC
WO/2021/092056	METHODS OF TREATMENT WITH ANTIBODIES AGAINST BCMA AND CD3	ENGMAB SàRL
WO/2021/092059	CYTOTOXIC LIPID PARTICLES FOR TREATING GLIOBLASTOMA	NORTHWESTERN UNIVERSITY
WO/2021/092060	METHODS OF TREATMENT	ENGMAB SARL
WO/2021/092062	ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS	REVBIO, INC.
WO/2021/092065	ULTRASMALL NANOPARTICLES AND METHODS OF MAKING, USING AND  ANALYZING SAME	CORNELL UNIVERSITY
WO/2021/092079	TREATMENTS FOR SYSTEMIC SCLEROSIS	ACCELERON PHARMA INC.
WO/2021/092080	EXTRACELLULAR VESICLES AND USES THEREOF FOR ANTIBODY DELIVERY	ARUNA BIO, INC.
WO/2021/092084	CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN DOSING REGIMENS	FIVE PRIME THERAPEUTICS, INC.
WO/2021/092090	METHODS FOR PALMAR OR PLANTAR ADMINISTRATION OF PHARMACEUTICAL  COMPOSITIONS	DERMIRA, INC.
WO/2021/092094	ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS	GRITSTONE ONCOLOGY, INC.
WO/2021/092095	NEOANTIGEN VACCINE THERAPY	GRITSTONE ONCOLOGY, INC.
WO/2021/092096	INDIVIDUALIZED DOSING OF RADIOACTIVE TRACERS FOR IMAGING	LIKEMINDS, INC.
WO/2021/092110	MICROBIAL DETECTION PLATFORM	NUCLEASE PROBE TECHNOLOGIES, INC.
WO/2021/092120	METHODS AND COMPOSITIONS FOR ENHANCING OVERALL HEALTH AND  LONGEVITY IN MAMMALS	MYOS RENS TECHNOLOGY INC.
WO/2021/092130	COMPOSITIONS AND METHODS FOR RNA-ENCODED DNA-REPLACEMENT OF  ALLELES	PAIRWISE PLANTS SERVICES, INC.
WO/2021/092134	DOSING REGIMEN FOR ANTI-DLL3 AGENTS	AMGEN INC.
WO/2021/092140	METHODS OF REDUCING LACTATE IN LIVER DISEASE PATIENTS USING  VARIANTS AND FUSIONS OF FGF19/FGF21 POLYPEPTIDES	NGM BIOPHARMACEUTICALS, INC.
WO/2021/092143	MICRORNA BLOCKADE FOR THE TREATMENT OF DISEASE	YALE UNIVERSITY
WO/2021/092151	SELECTIVE HDAC6 DEGRADERS AND METHODS OF USE THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/092153	SELECTIVE DUAL HISTONE DEACETYLASE 6/8 (HDAC6/8) DEGRADERS AND  METHODS OF USE THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/092159	PAPD5 INHIBITION AS A TREATMENT FOR DYSKERATOSIS CONGENITA,  APLASTIC ANEMIA AND MYELODYSPLASTIC SYNDROME CAUSED BY REDUCED TELOMERASE RNA  LEVELS	THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE
WO/2021/096753	CD200 RECEPTOR ANTAGONIST BINDING MOLECULES	ELI LILLY AND COMPANY
WO/2021/092166	METHODS OF TREATING NEURODEGENERATIVE DISEASES CAUSED BY G4C2  EXPANSION IN C90RF72	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/092172	FUNCTIONALLY MODIFIED MAYTANSINOIDS AND COMPOSITIONS AND  METHODS OF USE THEREOF	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/092174	SELECTIVE HISTONE DEACETYLASE (HDAC) DEGRADERS AND METHODS OF  USE THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/096755	METHODS OF TREATING ASCITES	MARTIN PHARMACEUTICALS, INC.
WO/2021/092187	DETECTION AND TREATMENT OF CONDITIONS RELATED TO LUTEINIZING  HORMONE/FOLLICLE-STIMULATING HORMONE (LH/FSH) LEVELS	UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH
WO/2021/092190	COMBINATION THERAPY FOR CANCER	HEALTH RESEARCH, INC.
WO/2021/092196	ANTI-TIGIT ANTIBODIES AND USES THEREOF	MERCK PATENT GMBH
WO/2021/092199	ISOLATION, PRESERVATION, AND EXPANSION OF CANINE UMBILICAL  CORD MESENCHYMAL STROMAL CELLS	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/092200	BIOSYNTHESIS OF CHEMICALLY DIVERSIFIED NON-NATURAL TERPENE  PRODUCTS	BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/092204	METHODS AND COMPOSITIONS FOR NUCLEIC ACID-GUIDED NUCLEASE CELL  TARGETING SCREEN	SPOTLIGHT THERAPEUTICS
WO/2021/092206	MYCOBACTERIAL COMPOSITIONS AND BIOMARKERS FOR USE IN TREATMENT  AND MONITORING OF THERAPEUTIC RESPONSIVENESS	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
WO/2021/092209	BOVINE MILK-ISOLATED POWDERED EXOSOMES, NUTRITIONAL  COMPOSITIONS AND METHODS	ABBOTT LABORATORIES
WO/2021/092214	HYGIENE PRODUCT POD AND METHODS OF USING SAME	NOHBO, LLC
WO/2021/092223	HLA RESTRICTED HORMAD1 T CELL RECEPTORS AND USES THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/092225	NANOPARTICLES COMPRISING PRODRUGS STABILIZED BY ALBUMIN FOR  TREATMENT OF CANCER AND OTHER DISEASES	LUMINUS BIOSCIENCES, INC.
WO/2021/092227	DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE  GENE USING GUIDES 21-30 NUCLEOTIDES IN LENGTH	EMENDOBIO INC.
WO/2021/092236	SYSTEMS AND METHODS FOR DECONVOLUTING TUMOR ECOSYSTEMS FOR  PERSONALIZED CANCER THERAPY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/092238	TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR  USE	SMARTECH TOPICAL, INC.
WO/2021/092239	TOPICAL COMPOSITIONS COMPRISING IRAK4 INHIBITORS FOR USE IN  TREATING DERMATOLOGICAL CONDITIONS CHARACTERISED BY INFLAMMATION	DERMIRA, INC.
WO/2021/092240	MRGPRX2 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY  DISORDERS	DERMIRA, INC.
WO/2021/092242	ROR GAMMA T INHIBITORS AND TOPICAL USES THEREOF	DERMIRA, INC.
WO/2021/092246	TYK2 PSEUDOKINASE LIGANDS	VENTYX BIOSCIENCES, INC.
WO/2021/092252	GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM  STEM CELLS AND THERAPEUTIC USES THEREOF	FORMAN, Stephen J.
WO/2021/092254	PHAGE COMPOSITIONS COMPRISING CRISPR-CAS SYSTEMS AND METHODS  OF USE THEREOF	LOCUS BIOSCIENCES, INC.
WO/2021/092262	MRGPRX2 ANTAGONISTS AND USES THEREOF	DERMIRA, INC.
WO/2021/092266	GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHOD OF MAKING  AND USING THEREOF	SYSTIMMUNE, INC.
WO/2021/092286	AMORPHOUS FORM OF A COMPLEMENT COMPONENT C5A RECEPTOR	CHEMOCENTRYX, INC.
WO/2021/092287	CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF	NORTH CAROLINA STATE UNIVERSITY
WO/2021/092290	CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY	KITE PHARMA, INC.
WO/2021/092292	FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a  RECEPTOR	CHEMOCENTRYX, INC.
WO/2021/092295	SALT FORMS OF A COMPLEMENT COMPONENT C5A RECEPTOR	CHEMOCENTRYX, INC.
WO/2021/092307	COMPOSITIONS CONTAINING FENCHOLS AND METHODS OF USE	BEDOUKIAN RESEARCH, INC.
WO/2021/092315	ANTIPERSPIRANT FORMULATIONS COMPRISING HEMISQUALANE	AMYRIS, INC.
WO/2021/092332	METHODS AND COMPOSITIONS RELATING TO SELECTIVE INTRACELLULAR  DELIVERY OF CD38 INHIBITORS	OHIO STATE INNOVATION FOUNDATION
WO/2021/096773	A PRECISION MEDICINE METHOD FOR IMMUNOTHERAPY	EDIFICE HEALTH, INC.
WO/2021/092340	COMPOSITIONS AND METHODS FOR DELIVERING CANNABINOIDS TO SKIN	AMYRIS, INC.
WO/2021/092341	SODIUM-GLUCOSE LINKED TRANSPORTER INHIBITORS FOR THE  MANAGEMENT OF CHRONIC KIDNEY DISEASE, HYPERTENSION, AND HEART FAILURE IN  COMPANION ANIMALS	INCREVET, INC.
WO/2021/092347	METHODS AND COMPOSITIONS FOR TYPE 2 DIABETES THERAPY	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/092349	LIPID-BASED FORMULATIONS OF SCY-078 SALTS	SCYNEXIS, INC.
WO/2021/173193	USE OF BRAIN-SPECIFIC ANTIGENS TO HOME, BLOCK AND DELIVER  CELL-BASED TREATMENTS TO THE BRAIN	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/092354	FORMULATIONS AND DOSES OF PEGYLATED URICASE	SELECTA BIOSCIENCES, INC.
WO/2021/092380	LAG-3 ANTAGONIST THERAPY FOR MELANOMA	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/092392	USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT  AGAINST ENVELOPED VIRUSES	CORNELL UNIVERSITY
WO/2021/092406	TRAMADOL HYDROCHLORIDE SOLUTION	ATHENA BIOSCIENCE, LLC
WO/2021/092407	INHIBITORS OF INFLUENZA VIRAL ENTRY	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/092417	VACCINES AND RELATED METHODS FOR TREATMENT OF PSEUDOMONAS  BACTERIAL INFECTIONS	MARSHALL UNIVERSITY RESEARCH CORPORATION
WO/2021/092421	ENDOTHELIAL LIPASE ANTIBODIES FOR THE TREATMENT OF  CARDIOVASCULAR DISEASES	MEDIMMUNE, LLC
WO/2021/092427	REPLICATION-ENHANCED ONCOLYTIC ADENOVIRUSES	MEMGEN, INC.
WO/2021/092428	HEMP EXTRACT AND METHODS OF USE THEREOF	ELLEVET SCIENCES
WO/2021/092439	METHODS OF TREATING DEPRESSIVE DISORDERS	XENON PHARMACEUTICALS INC.
WO/2021/092440	SYNTHETIC MODIFIED RNA AND USES THEREOF	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/092446	FENTANYL HAPTEN, FENTANYL HAPTEN-CONJUGATES, AND METHODS FOR  MAKING AND USING	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/092452	THERAPEUTIC PROTEIN-BASED NANOPARTICLES AND METHODS FOR MAKING  THE SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/092459	COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION	IONIS PHARMACEUTICALS, INC.
WO/2021/096783	USE OF MOG FOR PRIMING A TREATMENT FOR GLIOBLASTOMA	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/092470	COMPOUNDS AND IMPLANTS FOR TREATING OCULAR DISORDERS	RETINA FOUNDATION OF THE SOUTHWEST
WO/2021/092471	METABOLIC REPROGRAMMING OF IMMUNE CELLS TO ENHANCE THE  EFFICACY OF PROPHYLACTIC AND THERAPEUTIC VACCINES	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/092472	METHODS OF TREATING HYPEROXALURIA	ALLENA PHARMACEUTICALS, INC.
WO/2021/092474	TREATING LIVER DISORDERS	TERNS, INC.
WO/2021/092483	GASTRIC RESIDENCE SYSTEMS HAVING A FILAMENT FOR IMPROVED  GASTRIC RESIDENCE	LYNDRA, INC.
WO/2021/092484	GASTRIC RESIDENCE SYSTEMS HAVING ARMS WITH CONTROLLED  STIFFNESS FOR IMPROVED GASTRIC RESIDENCE	LYNDRA, INC.
WO/2021/092485	COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE	SYROS PHARMACEUTICALS, INC.
WO/2021/092486	FORMULATIONS FOR RELEASE-RATE MODULATING FILMS FOR GASTRIC  RESIDENCE SYSTEMS	LYNDRA, INC.
WO/2021/092487	POLYMERIC LINKERS FOR A GASTRIC RESIDENCE SYSTEM	LYNDRA, INC.
WO/2021/092491	GASTRIC RESIDENCE SYSTEMS FOR ADMINISTRATION OF ACTIVE AGENTS	LYNDRA, INC.
WO/2021/092496	THIAZOLIDINEDIONE ANALOGS FOR THE TREATMENT OF NAFLD AND  METABOLIC DISEASES	CIRIUS THERAPEUTICS, INC.
WO/2021/092498	COMBINATION OF A T CELL THERAPY AND (S)-3-[4-(4-MORPHOLIN-4  YLMETHYL-BENZYLOXY)-L-OXO-L,3-DIHYDRO-ISOINDOL-2-YL]- PIPERIDINE-2,6-DIONE	JUNO THERAPEUTICS, INC.
WO/2021/092499	TREATMENTS OF MENIERE'S DISEASE	SPIRAL THERAPEAUTICS, INC.
WO/2021/092513	CRISPR AND AAV STRATEGIES FOR X-LINKED JUVENILE RETINOSCHISIS  THERAPY	REGENERON PHARMACEUTICALS, INC.
WO/2021/092515	REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA  ULTRASOUND-MODULATED MOLECULAR DIFFUSION	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/092522	TOPICAL DELIVERY OF TOFACITINIB USING IONIC LIQUID	CAGE BIO, INC.
WO/2021/101739	HUMAN ANTIBODIES THAT NEUTRALIZE ZIKA VIRUS AND METHODS OF USE  THEREFOR	VANDERBILT UNIVERSITY
WO/2021/092535	METABOLITE-BASED POLYMERS AND MICROPARTICLES FOR DELIVERY OF  THERAPEUTIC AGENTS AND TISSUE REGENERATION	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/096794	METHOD OF TREATING AN INDIVIDUAL WITH A HEALTH CONDITION WITH  FECAL MICROBIOTA TRANSPLANT	HAZAN, Sabine
WO/2021/092543	CERAMIDE ANALOG SACLAC MODULATES SPHINGOLIPID LEVELS AND MCL-1  SPLICING TO INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/092554	PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HBV  DISORDERS	ASSEMBLY BIOSCIENCES, INC.
WO/2021/133476	COMBINATION THERAPY USING AN IL-2 RECEPTOR AGONIST AND AN  IMMUNE CHECKPOINT INHIBITOR	NEOLEUKIN THERAPEUTICS, INC.
WO/2021/092560	EPHA3 DIRECTED CAR-T CELLS FOR TREATMENT OF TUMORS	HUMANIGEN, INC.
WO/2021/092562	EXON SKIPPING OF FC-EPSILON-RI-BETA AND MS4A6A IN COMBINATION  FOR THE TREATMENT OF ALLERGIC DISEASES	NORTH CAROLINA STATE UNIVERSITY
WO/2021/092564	CULTIVATED AUTOLOGOUS LIMBAL EPITHELIAL CELL (CALEC)  TRANSPLANTATION	MASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/092577	METHODS AND MATERIALS FOR USING ENGINEERED MESENCHYMAL STEM  CELLS TO TREAT INFLAMMATORY CONDITIONS AND DEGENERATIVE DISEASES	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/096813	EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR ENRICHING BIOACTIVE  METABOLITE IN AN EXTRACT	BRIGHTSEED, INC
WO/2021/092589	METHODS FOR ENGINEERING THERAPEUTICS AND USES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/092593	USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/113027	METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA	PHOENIX BIOTECHNOLOGY, INC.
WO/2021/141662	PROTEOLYSIS TARGETING CHIMERIC MOLECULES (PROTACS) WITH  FUNCTIONAL HANDLES AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/096860	MCL1 INHIBITORS	GILEAD SCIENCES, INC.
WO/2021/242297	NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MENOPAUSE  RELATED ANXIETY AND DEPRESSION	LA PHARMA TECH INC.
WO/2021/096871	TYPE V PHOSPHODIESTERASE INHIBITOR COMPOSITIONS, METHODS OF  MAKING THEM AND METHODS OF USING THEM	AMERICAN REGENT, INC.
WO/2021/096882	COMPOSITIONS, METHODS AND KITS FOR ALTERING ADIPOCYTES	NUSIRT SCIENCES, INC.
WO/2021/096886	METHODS TO SEPARATE CANNABINOIDS FROM IMPURITIES BY  CRYSTALLIZATION	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/092598	METHODS OF TREATMENT WITH MYOSIN MODULATOR	MYOKARDIA, INC.
WO/2021/096912	CRISPR/CAS9 SYSTEM AS AN AGENT FOR INHIBITION OF POLYOMA JC  INFECTION	TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/096921	LOW CONTAMINANT ANTIMICROBIAL VACCINES	ONEBIOPHARMA, INC.
WO/2021/096926	CONTRACEPTIVE MEDICAL DEVICES	POLY-MED, INC.
WO/2021/096927	COMPOSITIONS AND USES THEREOF FOR TREATING, PROGNOSING AND  DIAGNOSING PULMONARY HYPERTENSION	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/096941	SYSTEMS CHEMICO-PHARMACOLOGY DRUGS AND METHODS OF USE	THE MEDICAL COLLEGE OF WISCONSIN
WO/2021/096948	ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/096951	LIPOSOME COMPOSITIONS AND METHODS OF TREATMENT TARGETED TO  TUMOR ENDOTHELIUM	WASHINGTON UNIVERSITY
WO/2021/096970	NATURAL KILLER CELL THERAPIES	IMMUNITYBIO, INC.
WO/2021/096971	COMPOSITION AND METHOD FOR IN VIVO ASSAY OF OPIOID RECEPTORS	THE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/096972	POLYMERIC NANOPARTICLES THAT TARGET LIVER SINUSOIDAL  ENDOTHELIAL CELLS TO INDUCE ANTIGEN-SPECIFIC IMMUNE TOLERANCE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/096997	BIOMARKERS FOR NANOPARTICLE COMPOSITIONS	ABRAXIS BIOSCIENCE, LLC
WO/2021/097002	USE OF PYRIDYLOXYPYRIMIDINES FOR TREATING INFECTIOUS DISEASES	BP ASSET V, INC.
WO/2021/097003	METHODS FOR TREATING DISEASES	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/101777	SELF-SOLIDIFYING TOPICAL FORMULATIONS WITH LOCAL ANESTHETIC	ZHANG, Jie
WO/2021/097008	USE OF PYRIDYLOXYPYRIDINES FOR TREATING INFECTIOUS DISEASES	BP ASSET V, INC.
WO/2021/097009	SMALL MOLECULE FURIN INHIBITORS FOR TREATING INFECTIOUS  DISEASES	BP ASSET V, INC.
WO/2021/097021	TREATMENT AND PROTECTION AGAINST  <i>ASPERGILLUS</i> INFECTION AND ASPERGILLOSIS DISEASE	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/097024	HUMAN HENDRA VIRUS AND NIPAH VIRUS ANTIBODIES AND METHODS OF  USE THEREFOR	VANDERBILT UNIVERSITY
WO/2021/097027	SELADELPAR FOR USE IN THE TREATMENT OF ALCOHOLIC LIVER DISEASE	CYMABAY THERAPEUTICS, INC.
WO/2021/097034	SELADELPAR FOR USE IN THE TREATMENT OF INTESTINAL BARRIER  DYSFUNCTION AND ASSOCIATED DISEASES	CYMABAY THERAPEUTICS, INC.
WO/2021/097035	AN APPARATUS AND METHODS TO RAPIDLY DETECT, SEPARATE, PURIFY,  AND QUANTIFY VARIOUS VIRUSES FROM CELLS, CULTURED MEDIUM AND OTHER FLUIDS	FLUID-SCREEN, INC.
WO/2021/097038	NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS	TREMEAU PHARMACEUTICALS, INC.
WO/2021/097039	TRIAZOLE CARBAMATE PYRIDYL SULFONAMIDES AS LPA RECEPTOR  ANTAGONISTS AND USES THEREOF	GILEAD SCIENCES, INC.
WO/2021/097060	PRO IMMUNE MODULATING MOLECULE COMPRISING A CLUSTERING MOIETY	HARPOON THERAPEUTICS, INC.
WO/2021/097061	ANTIMICROBIAL COMPOUNDS AND METHODS	CURZA GLOBAL, LLC
WO/2021/097069	OLEIC ACID DERIVATIVES AS TREATMENTS FOR FRIEDREICH ATAXIA AND  INHIBITORS OF FERROPTOSIS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/097075	SUBSTITUTED ISOINDOLONYL 2,2'-BIPYRIMIDINYL COMPOUNDS,  ANALOGUES THEREOF, AND METHODS USING SAME	ARBUTUS BIOPHARMA, INC.
WO/2021/097077	SHORT CONJUGATED OLIGOELECTROLYTES AND ANTIBIOTICS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097084	METHODS FOR TREATING IMMUNOSUPPRESSION AND DISEASES ASSOCIATED  WITH IMMUNOSUPPRESSION	THE UAB RESEARCH FOUNDATION
WO/2021/097109	LENTIVIRAL VECTORS IN HEMATOPOIETIC STEM CELLS TO TREAT  X-LINKED CHRONIC GRANULOMATOUS DISEASE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097120	METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A  SUBJECT WITH ATRIAL FIBRILLATION AND/OR ATRIAL FLUTTER	AMARIN PHARMACEUTICALS IRELAND LIMITED
WO/2021/097122	SREBP INHIBITOR COMPRISING A THIOPHENE CENTRAL RING	CAPULUS THERAPEUTICS, LLC
WO/2021/097123	THIOPHENE COMPOUNDS WITH CYCLIC AMIDES, AND USES THEREOF	CAPULUS THERAPEUTICS, LLC
WO/2021/097125	LENTIVIRAL VECTORS IN HEMATOPOIETIC STEM CELLS TO TREAT  RECOMBINATION-ACTIVATING GENE 1 (RAG1) SEVERE COMBINED IMMUNODEFICIENCY  (SCID)	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097131	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S  DISEASE	ORCHARD THERAPEUTICS (EUROPE) LIMITED
WO/2021/097146	METHODS AND COMPOSITIONS FOR TREATING CANCER	ABCENTRA, LLC
WO/2021/097159	METHOD FOR PREPARING HETEROLEPTIC TRIARYLBISMUTHANES AND  COMPOUNDS PRODUCED BY THE SAME	UNIVERSITY OF HAWAII
WO/2021/097160	PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER	CELGENE CORPORATION
WO/2021/097163	PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABINOID ANIONS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/097174	NANOEMULSION COMPOSITIONS FOR TREATING AEROALLERGEN ASSOCIATED  ALLERGY AND INFLAMMATION	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/097191	METHODS OF TREATING OXIDATIVE STRESS TO MODULATE REDOX  BALANCE, PREVENTING OXIDATIVE STRESS INDUCED CELL DAMAGE AND DEATH	REDOX BALANCE, LLC
WO/2021/101802	PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE	BIOVENTUS, LLC .
WO/2021/097213	COMBINATION OF A BTK INHIBITOR AND AN MDM2 INHIBITOR FOR  CANCER TREATMENT	QUOGUE IP HOLDINGS LLC
WO/2021/097220	METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB  IN COMBINATION WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE	SEAGEN INC.
WO/2021/097223	BIPARATOPIC CD73 ANTIBODIES	GENZYME CORPORATION
WO/2021/097227	IL-15 FUSION PROTEIN ENHANCED ADOPTIVE CELL THERAPEUTICS	ALTOR BIOSCIENCE, LLC
WO/2021/097240	COMPOUNDS AND USES THEREOF	YUMANITY THERAPEUTICS, INC.
WO/2021/097243	COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES  THEREOF	APRINOIA THERAPEUTICS INC.
WO/2021/097246	METHODS AND PRODUCTS FOR TREATING RENAL DISEASE	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/097247	MULTIMODAL COMPOSITIONS AND METHODS OF TREATMENT	AQUESTIVE THERAPEUTICS, INC.
WO/2021/097254	HIV IMMUNOGENS, VACCINES, AND METHODS RELATED THERETO	EMORY UNIVERSITY
WO/2021/097271	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETO	ASSEMBLY BIOSCIENCES, INC.
WO/2021/097278	COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY	LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
WO/2021/097286	DRUG FORMULATIONS AND METHODS OF TREATMENT FOR METABOLIC  DISORDERS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097288	COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE  DISEASES	FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/097289	PEGYLATED RECOMBINANT IMMUNOTOXINS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/097294	COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY	SURFACE ONCOLOGY, INC.
WO/2021/097299	METHODS AND COMPOSITIONS FOR SMOKING CESSATION	BEHAVIORAL DIAGNOSTICS, LLC
WO/2021/097305	SUPRAMOLECULAR NANOSUBSTRATE-MEDIATED DELIVERY SYSTEM ENABLES  CRISPR/CAS9 KNOCKIN OF HEMOGLOBIN BETA GENE-A POTENTIAL THERAPEUTIC SOLUTION  FOR HEMOGLOBINOPATHIES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/097306	DUAL SUPRAMOLECULAR NANOPARTICLE VECTORS ENABLE  CRISPR/CAS9-MEDIATED KNOCKIN OF RETINOSCHISIN 1 GENE-A POTENTIAL NON-VIRAL  THERAPEUTIC SOLUTIONS FOR X-LINKED JUVENILE RETINOSCHISIS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/101813	HYBRID VIRUS-LIKE PARTICLES AND USES THEREOF AS A THERAPEUTIC  HEPATITIS B VACCINE	VLP BIOTECH, INC.
WO/2021/101814	INTRANASAL LEPTIN PREVENTS OPIOID-INDUCED RESPIRATORY  DEPRESSION IN OBESITY	THE GEORGE WASHINGTON UNIVERSITY
WO/2021/097327	TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/097329	IMMORTALIZED CARDIAC STEM CELLS FOR CARDIAC REPAIR	NEOPROGEN, INC.
WO/2021/145946	MULTISPECIFIC TREG BINDING MOLECULES	INVENRA INC.
WO/2021/097345	HEPARAN SULFATE (HS) OLIGOSACCHARIDES EFFECT IN LIVER ISCHEMIA  REPERFUSION INJURY	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/097351	FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR  THE TREATMENT OF RADIATION DERMATITIS AND OTHER SKIN DISORDERS	KANNALIFE SCIENCES, INC.
WO/2021/108151	TRANSDERMAL DELIVERY SYSTEM	BAI, Xuefei
WO/2021/097387	SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/113062	PDIA4 INHIBITORS AND USE THEREOF FOR INHIBITING ß-CELL  PATHOGENESIS AND TREATING DIABETES	ACADEMIA SINICA
WO/2021/097390	CELLULAR MOLECULAR THERANOSTICS NANOPROBE SYSTEMS AND METHODS	DUKE UNIVERSITY
WO/2021/097401	COMBINATION THERAPY WITH PROTEIN KINASE B ACTIVATION INHIBITOR  TO TREAT CANCER	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/097411	ANTI-FUNGAL COMPOSITIONS AND METHODS FOR USING SAME	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/101836	ANTIMALARIAL AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/097423	FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF  STROKE	FIGENE, LLC
WO/2021/216118	ANTIVIRAL & VIRUCIDAL NASAL SPRAY COMPOSITIONS AND RELATED  TREATMENT METHODS	FERRER MEDICAL INNOVATIONS, LLC
WO/2021/097427	XANOMELINE DERIVATIVES AND METHODS FOR TREATING NEUROLOGICAL  DISORDERS	KARUNA THERAPEUTICS, INC.
WO/2021/097434	FIBROBLAST THERAPY FOR INFLAMMATORY BOWEL DISEASE	FIGENE, LLC
WO/2021/097437	OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER	THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
WO/2021/141672	STABLE FORMULATIONS OF SILK-DERIVED PROTEIN	SILK TECHNOLOGIES, LTD.
WO/2021/101854	COMPOUNDS AND METHODS OF PREPARING COMPOUNDS S1P1 MODULATORS	TREVENA, INC.
WO/2021/101902	COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING  ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY	YALE UNIVERSITY
WO/2021/101903	DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/101905	PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF  IMAGING A TUMOR	ONCONANO MEDICINE, INC.
WO/2021/101910	METHODS OF ADMINISTERING VOXELOTOR	GLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/101926	TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH	STAMETS, Paul, Edward
WO/2021/101927	WDR5-MYC INHIBITORS	VANDERBILT UNIVERSITY
WO/2021/101929	INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE  TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/101943	PERSONAL CARE COMPOSITION COMPRISING A MULTISTAGE POLYMER	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/118775	PERSONAL CARE COMPOSITION COMPRISING A SILICON GLYCAN	ROHM AND HAAS COMPANY
WO/2021/101956	COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR IDENTIFICATION	ROOTPATH GENOMICS, INC.
WO/2021/101966	TREATMENT OF FIBROSIS WITH COMBINED BLOCKADE OF IL-6 AND  IMMUNE CHECKPOINT	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/101975	METHODS OF TREATING WARM AUTOIMMUNE HEMOLYTIC ANEMIA USING  ANTI-FCRN ANTIBODIES	IMMUNOVANT SCIENCES GMBH
WO/2021/101983	TOUGH TISSUE SEALANTS AND THE USE THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/101989	AQUEOUS MIXTURES COMPRISING CELLULOSE NANOCRYSTALS AND  SULFONATED POLYESTER	NORTH CAROLINA STATE UNIVERSITY
WO/2021/101998	INTRAVAGINAL RING DEVICES	DARé BIOSCIENCE, INC.
WO/2021/102004	DOSING REGIMENS FOR A PROTEIN KINASE C INHIBITOR	IDEAYA BIOSCIENCES, INC.
WO/2021/102021	PRESERVATION OF NEURON HEALTH AND REGENERATIVE CAPACITY  FOLLOWING NERVOUS SYSTEM INJURY	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/102032	BLOOD PLASMA FRACTIONS FOR USE IN LIVER REGENERATION	ALKAHEST, INC.
WO/2021/102038	AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCE	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/102052	DIRECTED CONJUGATION TECHNOLOGIES	KLEO PHARMACEUTICALS, INC.
WO/2021/102053	VITAMIN B12 COMPOUND SUPPLEMENTATION METHODS AND COMPOSITIONS	LUPIN, INC.
WO/2021/102057	HYPERACTIVE DENDRITIC CELLS ENABLE DURABLE ADOPTIVE CELL  TRANSFER-BASED ANTI-TUMOR IMMUNITY	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/102058	STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER  IMMUNOTHERAPY	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/102063	CYTOKINE FUSION PROTEINS, AND THEIR PHARMACEUTICAL  COMPOSITIONS AND THERAPEUTIC APPLICATIONS	ANWITA BIOSCIENCES, INC.
WO/2021/102068	USER-FRIENDLY INGREDIENT LABEL	THE PROCTER & GAMBLE COMPANY
WO/2021/108195	BDELLOVIBRIO TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/102072	COMPOSITION AND METHOD FOR SKIN TREATMENT	RYTHERA THERAPEUTICS, INC.
WO/2021/102084	IONIC LIQUIDS FOR DRUG DELIVERY	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/102085	HIGH-THROUGHPUT MONODISPERSE AEROSOLS OF MICRO-SHELL PARTICLES	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/145952	USE OF KETAMINE IN THE TREATMENT OF CACHEXIA	ASTROMEDICAL BIOTECHNOLOGY, LTD.
WO/2021/102090	NUTRITIONAL COMPOSITIONS FOR TREATING A CLOSTRIDIUM DIFFICILE  INFECTION	ABBOTT LABORATORIES
WO/2021/102092	CANCER TREATMENT USING CAMPTOTHECIN DERIVATIVES	VIVACITAS ONCOLOGY, INC.
WO/2021/108202	MODIFIED VIRAL THERAPEUTICS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102113	SUNSCREEN COMPOSITIONS WITH MULTIPLE PHOTOPROTECTING UV  FILTERS	COTY INC.
WO/2021/102114	SUBSTITUTED HETEROCYCLICS WITH THERAPEUTIC ACTIVITY IN HIV	NEW YORK BLOOD CENTER, INC.
WO/2021/102115	PROCESSES FOR THE PREPARATION OF ALPHA-HYDROXY ESTERS VIA  GRIGNARD COUPLING AND THIOLATION REACTIONS	KEMIN INDUSTRIES, INC.
WO/2021/113083	TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND  METHODS OF MAKING AND USING THE SAME	JLABS BEAUTY LLC
WO/2021/102124	METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR  (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSE	YALE UNIVERSITY
WO/2021/102142	OKN-007 AS A THERAPEUTIC AGENT	OKLAHOMA MEDICAL RESEARCH FOUNDATION
WO/2021/102161	METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE	ANGION BIOMEDICA CORP.
WO/2021/102170	CANNABIS PLANT EXTRACTS WITH BUTANE	JENNY'S ROSE, LLC
WO/2021/102182	SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT  OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS	SPARK THERAPEUTICS, INC.
WO/2021/102204	HETEROARYL COMPOUNDS	VIVACE THERAPEUTICS, INC.
WO/2021/102234	ADENO-ASSOCIATED VIRAL VECTOR VARIANTS	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/102235	USE OF GELSOLIN TO TREAT OR PREVENT LUNG INJURY AND DISEASE	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/102251	USE OF SGLT2 INHIBITORS TO TREAT PRIMARY BILLIARY CHOLANGITIS	AVOLYNT
WO/2021/102258	COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2  INHIBITOR	INCYTE CORPORATION
WO/2021/102267	GENERATION OF KIDNEY GLOMERULAR SPECIFIC ENDOTHELIAL CELLS AND  METHODS OF USE	CORNELL UNIVERSITY
WO/2021/108255	LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102279	ANTI-CANCER COMPOSITIONS AND METHODS	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/102287	METHODS OF TREATING GLIOBLASTOMA	ZIOPHARM ONCOLOGY, INC.
WO/2021/102288	PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS	SENDA BIOSCIENCES, INC.
WO/2021/102299	CASPASE 6 INHIBITORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102302	COMPOSITIONS AND METHODS FOR TREATING CCR9-MEDIATED DISEASES  USING CCR9 INHIBITOR AND ANTI-TNF-ALPHA BLOCKING ANTIBODIES	CHEMOCENTRYX, INC.
WO/2021/102305	METHODS AND COMPOSITIONS FOR GENERATING FUNCTIONALLY MATURE  BETA CELLS AND USES THEREOF	WASHINGTON UNIVERSITY
WO/2021/102307	VACCINIA VIRUSES AND METHODS FOR USING VACCINIA VIRUSES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/102313	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETO	ASSEMBLY BIOSCIENCES, INC.
WO/2021/102320	METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG  COMPRISING MICROBES	ONEBIOPHARMA, INC.
WO/2021/102322	CELL-PERMEABLE CYCLIC PEPTIDES AND USES THEREOF	UNNATURAL PRODUCTS INC.
WO/2021/102323	PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT  ADMINISTRATION OF RADIOTRACERS	LIKEMINDS, INC.
WO/2021/102326	TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY  DISCOMFORT AND OTHER CONDITIONS	SIAMON, Al
WO/2021/102328	PROPHYLAXIS AND REVERSAL OF STIMULANT AND OPIOID/OPIATE  OVERDOSE AND/OR TOXIC EXPOSURE	TORRALVA MEDICAL THERAPEUTICS LLC
WO/2021/102330	COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN	SYNVENTA LLC
WO/2021/102332	TGFBETAR2 INHIBITOR-LRRC15 ANTIBODY CONJUGATES AND USES  THEREOF	SILVERBACK THERAPEUTICS, INC.
WO/2021/102337	COMPOSITIONS AND METHODS FOR TREATING CANCER WITH DUOCARS	LENTIGEN TECHNOLOGY, INC.
WO/2021/102343	SOLID DOSE PHARMACEUTICAL COMPOSITION	SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/102352	TUMOR ORGANOID CULTURE COMPOSITIONS, SYSTEMS, AND METHODS	TEMPUS LABS, INC.
WO/2021/102353	COMBINATION CANNABINOID-NAD+ PRECURSOR FORMULATION FOR  TREATMENT OF INFLAMMATION AND METHODS RELATED THERETO	CANOLE LLC
WO/2021/102356	COMBINATION THERAPY OF A COENZYME Q10 COMPOUND AND RADIATION  THERAPY FOR TREATMENT OF GLIOMA	BERG LLC
WO/2021/102357	METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR	ARENA PHARMACEUTICALS, INC.
WO/2021/102358	COMBINATION CANNABINOID-PHENYLETHANOID FORMULATION FOR  TREATMENT OF INFLAMMATION AND METHODS RELATED THERETO	CANOLE LLC
WO/2021/102361	CASPASE 6 INHIBITORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102369	MICRONEEDLE PATCH FOR IMMUNOSTIMULATORY DRUG DELIVERY	VERADERMICS INCORPORATED
WO/2021/102370	METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/102372	MONOCLONAL ANTIBODIES THAT TARGET HUMAN OX40	ABVISION, INC.
WO/2021/102376	MONOCLONAL ANTIBODIES THAT TARGET HUMAN CD47 PROTEIN	ABVISION, INC.
WO/2021/102379	METHODS OF REDUCING NEUROLOGICAL DAMAGE IN WILSON DISEASE  PATIENTS	ALEXION PHARMACEUTICALS, INC.
WO/2021/102389	TETANUS TOXOID AND CRM-BASED PEPTIDES AND METHODS OF USE	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/236154	RAPID VIRAL ASSAY	BARNHIZER, Bret, T.
WO/2021/108288	SALTS/COCRYSTALS OF  (R)-N-(4-CHLOROPHENYL)-2-((1S,4S)-4-(6-FLUOROQUINOLIN-4-YL)CYCLOHEXYL)PROPANAMIDE	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/118796	BIOMARKERS FOR THE DIAGNOSIS OF ATRIAL FIBRILLATION CAUSE OF  STROKE	ISCHEMIA CARE LLC
WO/2021/102403	METHODS OF TREATING CANCER USING DKK-1-INHIBITORS	LEAP THERAPEUTICS, INC.
WO/2021/108302	CELA-1 INHIBITION FOR TREATMENT OF LUNG DISEASE	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/108303	PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PULMONARY  HYPERTENSION	PHPRECISIONMED, LLC
WO/2021/113105	SKIN CARE PRODUCT AND METHOD FOR ITS PRODUCTION	SKB LLC
WO/2021/108308	SYSTEMS AND DEVICES FOR DELIVERING CARGO MATERIAL AND METHODS  OF DELIVERING CARGO MATERIALS	GEORGIA TECH RESEARCH CORPORATION
WO/2021/102420	INTERFERON SIGNALING AS A CANCER BIOMARKER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/102423	COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING  AGE-ASSOCIATED INFLAMMATION AND DISORDERS	BROWN UNIVERSITY
WO/2021/102428	CANNABIDIOL AND/OR COBICISTAT COMBINATION DRUG THERAPY	SHINKEI THERAPEUTICS, INC.
WO/2021/102433	COMPOSITIONS AND METHODS FOR USE IN TYPE 1 DIABETES	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/108331	COMBINATION THERAPY FOR HEAD AND NECK CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/108338	A COMBINATION OF A BTK INHIBITOR AND ABATACEPT FOR THE  TREATMENT OF RHEUMATOID ARTHRITIS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/108343	FORMULATIONS COMPRISING LIPID-LOWERING AND BLOOD  PRESSURE-LOWERING DRUGS	FORDOZ PHARMA C0RP.
WO/2021/108350	COMBINATION THERAPY USING FABP5 INHIBITORS WITH TAXANES FOR  TREATMENT OF CANCER	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/108353	TREATMENT OF CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT  BIND TO 191P4D12 PROTEINS	AGENSYS, INC.
WO/2021/108360	METHODS OF USING SOLUBLE SOLID DISPERSIONS FOR RIFAXIMIN	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/108389	METHOD OF PRODUCING NATURAL KILLER CELLS AND COMPOSITIONS  THEREOF	NKMAX CO., LTD.
WO/2021/108408	HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND  METHODS OF USE	AMGEN INC.
WO/2021/102445	USES OF CD20-BINDING MOLECULES AND ADDITIONAL THERAPEUTIC  AGENTS	MOLECULAR TEMPLATES, INC.
WO/2021/108427	EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS	REFORM BIOLOGICS, LLC
WO/2021/108442	MODULATORS OF CAS9 POLYPEPTIDE ACTIVITY AND METHODS OF USE  THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/108447	METHODS FOR TREATING AND/OR PREVENTING IDIOPATHIC PNEUMONIA  SYNDROME (IPS) AND/OR CAPILLARY LEAK SYNDROME (CLS) AND/OR ENGRAFTMENT  SYNDROME (ES) AND/OR FLUID OVERLOAD (FO) ASSOCIATED WITH HEMATOPOIETIC STEM  CELL TRANSPLANT	OMEROS CORPORATION
WO/2021/108455	METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING  LYMPHOCYTES	KSQ THERAPEUTICS, INC.
WO/2021/108462	IMMUNE CELL DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE  CELLS AND THE TUMOR MICROENVIRONMENT	ANSUN BIOPHARMA, INC.
WO/2021/108469	AHR INHIBITORS AND USES THEREOF	IKENA ONCOLOGY, INC.
WO/2021/108472	NOVEL ORGANOLEPTIC COMPOUNDS	INTERNATIONAL FLAVORS & FRAGRANCES INC.
WO/2021/108474	METHOD FOR EXTRACTION AND PURIFICATION OF AI18F-LABELED HBED  CONJUGATES	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108482	PENTAPEPTIDE AND METHODS OF USE THEREOF	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/108483	THERAPEUTIC COMPOUNDS	GENENTECH, INC.
WO/2021/113136	METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF  TYPE 1 DIABETES	DR. MARY MORRIS & ASSOCIATES, LLC
WO/2021/108508	HAIR TREATMENT COMPOSITIONS, KITS, AND METHODS OF USE	L'OREAL
WO/2021/108513	ION CHANNEL MODULATORS	PRAXIS PRECISION MEDICINES, INC.
WO/2021/108538	PLATELETS LOADED WITH mRNA	CELLPHIRE, INC.
WO/2021/108539	PLATELET DIAGNOSTIC IMAGING AGENTS	CELLPHIRE, INC.
WO/2021/108543	ANTI-CD3 SCFV AND CYTOKINE PRODUCING ARTIFICIAL ANTIGEN  PRESENTING CELLS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/108544	CAPSID INHIBITORS FOR THE PREVENTION OF HIV	GILEAD SCIENCES, INC.
WO/2021/108548	SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS EMULSIONS	REGENERON PHARMACEUTICALS, INC.
WO/2021/108549	NOVEL THYROMIMETICS	AUTOBAHN THERAPEUTICS, INC.
WO/2021/108561	METHODS AND COMPOSITIONS FOR MODULATING HETEROCHROMATIN  DYSFUNCTION, GENOMIC INSTABILITY, AND ASSOCIATED CONDITIONS	LA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/108565	CHEMOTHERAPY FOR GLIOMA THROUGH NEURONAL CONVERSION	THE PENN STATE RESEARCH FOUNDATION
WO/2021/108581	POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/108601	FORMULATIONS OF TERAMEPROCOL AND TEMOZOLOMIDE AND THEIR USE IN  STIMULATION OF HUMORAL IMMUNITY IN TUMORS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/108605	COMPOSITION AND METHOD FOR CONVERTING HUMAN GLIAL CELLS INTO  NEURONS	THE PENN STATE RESEARCH FOUNDATION
WO/2021/108609	BRAIN REPAIR AFTER TRAUMATIC BRAIN INJURY THROUGH  NEUROD1-MEDIATED ASTROCYTE-TO-NEURON CONVERSION	THE PENN STATE RESEARCH FOUNDATION
WO/2021/108613	CD19 AND CD22 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF	NOVARTIS AG
WO/2021/108616	SOLID DISPERSION OF PAN-RAF KINASE INHIBITOR	DOT THERAPEUTICS-1, INC.
WO/2021/108623	COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF  BABESIOSIS	TUFTS MEDICAL CENTER, INC.
WO/2021/108625	FORMULATIONS OF ION CHANNEL MODULATORS AND METHODS OF  PREPARATION AND USE OF ION CHANNEL MODULATORS	PRAXIS PRECISION MEDICINES, INC.
WO/2021/108640	COMPOUNDS AND METHODS FOR THE TREATMENT OF DUCHENNE MUSCULAR  DYSTROPHY	DTX PHARMA, INC.
WO/2021/108643	COMPOSITIONS FOR IMPROVING ATHLETIC PERFORMANCE AND METHODS OF  USE THEREOF	FITBIOMICS INC.
WO/2021/108649	TLR7 AGONISTS	PRIMMUNE THERAPEUTICS, INC.
WO/2021/108650	LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING  OF B CELLS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108661	CHIMERIC ANTIGEN RECEPTORS BINDING BCMA AND CD19 AND USES  THEREOF	NOVARTIS AG
WO/2021/108662	COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION  MOTIF	DTX PHARMA, INC.
WO/2021/108665	LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING  OF MSC CELLS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108670	COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR  CELLS	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/108671	LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING  OF NK CELLS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/108682	COMBINATION THERAPY INVOLVING DIARYL MACROCYCLIC COMPOUNDS	TURNING POINT THERAPEUTICS, INC.
WO/2021/108683	COVALENT RAS INHIBITORS AND USES THEREOF	REVOLUTION MEDICINES, INC.
WO/2021/108689	METHODS FOR USE OF AN ANGIOCRINE FACTOR IN TREATING A PATIENT  EXPOSED TO MYELOABLATIVE INSULT	HACKENSACK MERIDIAN HEALTH CENTER FOR DISCOVERY AND INNOVATION
WO/2021/108693	COMBINATION THERAPIES FOR TREATING CANCER	ALX ONCOLOGY INC.
WO/2021/108705	NUCLEAR FACTOR KAPPA B PATHWAY INHIBITION TO ARREST CALCIFIC  AORTIC STENOSIS	CORNELL UNIVERSITY
WO/2021/108720	LOBINALINE N-OXIDES AS POSITIVE ALLOSTERIC MODULATORS OF THE  DOPAMINE TRANSPORTER WITH POTENTIAL VALUE IN THE TREATMENT OF SUBSTANCE ABUSE  DISORDERS	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/108722	SUSTAINED RELEASE DRUG DELIVERY DEVICE	OAK CREST INSTITUTE OF SCIENCE
WO/2021/108727	METHOD OF PRODUCING TUMOR-REACTIVE T CELL COMPOSITION USING  MODULATORY AGENTS	MYST THERAPEUTICS, INC.
WO/2021/108731	APOSOME COMPOSITIONS AND METHODS OF USE	THE METHODIST HOSPITAL
WO/2021/108737	MAGNETIC COMPOSITION COMPRISING A POLYMER BLEND AND HIGH  LOADING OF MAGNETIC MATERIAL	L'OREAL
WO/2021/108748	ACELLULAR PLACENTAL THERAPIES FOR NECROTIZING ENTEROCOLITIS	PLAKOUS THERAPEUTICS, INC.
WO/2021/108751	HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT  CELLULITE	STANDARD OF CARE CORPORATION
WO/2021/108761	BROADLY NEUTRALIZING AND POTENT ANTIBODIES AGAINST HIV	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/108764	DENTAL MATERIAL COMPOSITION FOR FORMING MINERAL APATITE BONDS  AND CARIES PREVENTION	INTER-MED, INC.
WO/2021/108769	COMPOSITIONS AND METHODS FOR CULTURING HEMATOPOIETIC STEM AND  PROGENITOR CELLS	DEVERRA THERAPEUTICS INC.
WO/2021/113163	USE OF REBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS	AXSOME THERAPEUTICS, INC.
WO/2021/108790	PURIFICATION OF REPTILIAN HYALURONIC ACID AND ITS USE FOR SOFT  AND HARD TISSUE REPAIR AND REGENERATION	LACERTA LIFE SCIENCES, LLC
WO/2021/113170	METHODS FOR DRUG SCREENING AND COMPOSITIONS USEFUL FOR THE  INHIBITION OF CELL PROLIFERATION AND/OR CELL SURVIVAL	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/108792	METHOD OF PURIFYING POLYSACCHARIDES	LONZA LTD
WO/2021/113206	ATTENUATED AVIAN REOVIRUS STRAINS 94826 C140 AND 96139 C140	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/113209	HAIR CONDITIONER COMPOSITIONS CONTAINING BEHENAMIDOPROPYL  DIMETHYLAMINE	THE PROCTER & GAMBLE COMPANY
WO/2021/113211	HAIR CONDITIONER COMPOSITIONS WITH A PRESERVATION SYSTEM  CONTAINING SODIUM BENZOATE AND GLYCOLS AND/OR GLYCERYL ESTERS	THE PROCTER & GAMBLE COMPANY
WO/2021/113212	THERAPY FOR THE TREATMENT OF CANCER	CELGENE CORPORATION
WO/2021/118826	DEUTERIUM-ENRICHED SUBSTITUTED PHENOXYPHENYL ACETIC ACIDS AND  ACYLSULFONAMIDES	DHANOA, Daljit
WO/2021/113219	COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER	GENENTECH, INC.
WO/2021/113261	COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/113266	TREATING COGNITIVE DISORDERS USING TRAPIDIL	SINOPIA BIOSCIENCES, INC.
WO/2021/113286	STABLE LIQUID FORMULATIONS COMPRISING A GLUCAGON-LIKE PEPTIDE  1 AND USES THEREOF	ROSE PHARMA LLC
WO/2021/113311	TREATMENT OF CANCER USING ACETYLCHOLINE MODULATION AND  IMMUNOTHERAPY	BCELL SOLUTIONS, INC.
WO/2021/113328	TUMOR CELL VACCINES	NEUVOGEN, INC.
WO/2021/113347	TARGETING MB2 OF THE MYC ONCOGENE AND ITS INTERACTION WITH  TRRAP IN CANCER	THE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/113357	SALTS AND POLYMORPHS OF CETHROMYCIN FOR THE TREATMENT OF  DISEASE SALTS AND POLYMORPHS OF CETHROMYCIN	ALIQUANTUMRX, INC.
WO/2021/113364	SELECTIVE INHIBITION OF T FOLLICULAR HELPER CELLS FOR  TREATMENT OF AUTOIMMUNE DISORDERS	NEW YORK UNIVERSITY
WO/2021/113376	COMPOSITIONS AND METHODS FOR EPITOPE SCANNING	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/113377	ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEREOF	OHIO STATE INNOVATION FOUNDATION
WO/2021/113381	PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM  CHANNEL OPENER EZOGABINE	XENON PHARMACEUTICALS INC.
WO/2021/113382	COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL  NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY	CORNELL UNIVERSITY
WO/2021/113401	HISTONE DEACYTLASE 6 MODULATION OF TITIN PROTEIN MEDIATED  CARDIAC TISSUE STIFFNESS AND METHOD FOR SAME	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/113403	POLYPHOSPHAZENE DRUG CARRIERS	ONSELEX PHARMACEUTICALS, INC.
WO/2021/113409	TRANSDERMAL PENETRATION BY MODULATING EPITHELIAL JUNCTIONS	AMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/113410	TRANSDERMAL PENETRANT FORMULATIONS FOR VITAMINS, MINERALS AND  SUPPLEMENTS	AMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/113411	TRANSDERMAL PENETRANT FORMULATIONS FOR VITAMINS, MINERALS AND  SUPPLEMENTS	AMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/113412	Lipid-DNA Labeling of Lipid Bilayer Particles for  Amplification Quantitation	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/113433	<i>MYCOPLASMA</i> VACCINE COMPOSITION AND METHODS	UNIVERSITY OF CONNECTICUT
WO/2021/113434	PEPTIDES AND COMPOSITIONS FOR INHIBITING HAIR GROWTH	RODAN & FIELDS, LLC
WO/2021/113436	INHIBITORS OF HIF-2ALPHA	ARCUS BIOSCIENCES, INC.
WO/2021/113440	OLIGOPEPTIDE, TESTING KIT THEREOF, MEDICAL COMPOSITION THEREOF  AND USE OF MEDICAL COMPOSITION	CHINA MEDICAL UNIVERSITY
WO/2021/113450	METHODS OF IMAGING USING MULTIPLE IMAGING AGENTS	IMAGINAB, INC.
WO/2021/113473	COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS	THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/113478	MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE	NEUROCRINE BIOSCIENCES, INC.
WO/2021/113492	CYCLIC COMPOUNDS AND METHODS OF USING SAME	SCHRÖDINGER, INC.
WO/2021/113497	DOSING OF A BRUTON'S TYROSINE KINASE INHIBITOR	LOXO ONCOLOGY, INC.
WO/2021/113498	CYCLOOXYGENASE-2 INHIBITION FOR THE TREATMENT OF SAA-HIGH  ASTHMA	THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH  AND HUMAN SERVICES
WO/2021/113500	COMBINATION THERAPIES FOR THE TREATMENT OF CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/113506	ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE  THEREOF	CHDI FOUNDATION, INC.
WO/2021/113512	ENHANCING BLOOD-BRAIN BARRIER DRUG TRANSPORT BY TARGETING  ENDOGENOUS REGULATORS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/113515	INJECTABLE HYDROGELS FOR CELL DELIVERY TO THE VITREOUS	THE SCHEPENS EYE RESEARCH INSTITUTE, INC.
WO/2021/113519	NANOPARTICLE COMPOSITIONS AND METHODS OF USE	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/113524	GLP2 RECEPTOR AGONISTS AND METHODS OF USE	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/113528	MODULATORS OF PROGRAMMED DEATH-LIGAND-1 AND/OR PROGRAMMED  DEATH-LIGAND-2	SOUTHERN RESEARCH INSTITUTE
WO/2021/113535	PEPTIDE CONJUGATES AND METHODS OF USE	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/113536	SYSTEMS AND METHODS FOR LIPID NANOPARTICLE DELIVERY OF GENE  EDITING MACHINERY	DUKE UNIVERSITY
WO/2021/113541	ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES	STOKE THERAPEUTICS, INC.
WO/2021/113543	METHODS FOR CANCER IMMUNOTHERAPY, USING LYMPHODEPLETION  REGIMENS AND CD19, CD20 OR BCMA ALLOGENEIC CAR T CELLS	PRECISION BIOSCIENCES, INC.
WO/2021/113544	COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION	ACCELERON PHARMA INC.
WO/2021/113551	THERAPEUTIC COMPOUNDS FOR METHODS OF USE IN INSULIN RESISTANCE	BAYLOR COLLEGE OF MEDICINE
WO/2021/113557	BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN  PROTEOSOME PATHWAY	NURIX THERAPEUTICS, INC.
WO/2021/077125	COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES (PDSP) AND  USES THEREOF	BRIM BIOTECHNOLOGY, INC.
WO/2021/113566	PROCESSES FOR PREPARING  2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE	CELGENE CORPORATION
WO/2021/113574	A T CELL-BASED IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM VIRAL  INFECTIONS AND TUMORS	YALE UNIVERSITY
WO/2021/113580	OPHTHALMIC PHARMACEUTICAL COMPOSITIONS	VANDA PHARMACEUTICALS INC.
WO/2021/113583	SULFATE FREE COMPOSITION WITH ENHANCED DEPOSITION OF SCALP  ACTIVE	THE PROCTER & GAMBLE COMPANY
WO/2021/173203	ANTI-DANDRUFF COMPOSITIONS WITH SULFUR HAVING ENHANCED  EFFICACY AND AESTHETICS	THE PROCTER & GAMBLE COMPANY
WO/2021/113585	METHOD OF TREATING CANCER BY ADMINISTRATION OF AN ANTI-PD-1 OR  ANTI-PD-L1 THERAPEUTIC AGENT VIA A LYMPHATIC DELIVERY DEVICE	SORRENTO THERAPEUTICS, INC.
WO/2021/113591	VEGF MINI-TRAPS AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/113595	PHOSPHORUS DERIVATIVES AS KRAS INHIBITORS	BETA PHARMA, INC.
WO/2021/113596	COMPOSITIONS AND METHODS COMPRISING AN ANTI-CD47 ANTIBODY IN  COMBINATION WITH A TUMOR TARGETING ANTIBODY	SORRENTO THERAPEUTICS, INC.
WO/2021/113605	METHODS, COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF  CANCER BY INHIBITING NOTCH-1 MATURATION	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/118873	METHOD FOR PREPARING CD7-NEGATIVE, CD3-POSITIVE T CELLS	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/113611	SPLIT DEAMINASE BASE EDITORS	THE GENERAL HOSPITAL CORPORATION
WO/2021/118877	KRAS G12C INHIBITORS	ELI LILLY AND COMPANY
WO/2021/113620	ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE  TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE	FLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/113625	COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS  THEREFOR	PLEXXIKON INC.
WO/2021/113628	ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSION	THE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/113632	A COMBINATION THERAPY APPROACH TO ELIMINATE HIV INFECTIONS	THE METHODIST HOSPITAL SYSTEM
WO/2021/113634	TRANSGENE CASSETTES DESIGNED TO EXPRESS A HUMAN MECP2 GENE	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS
WO/2021/113635	ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE  TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE	FLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/113637	OPHTHALMIC FORMULATIONS FOR THE TREATMENT OF PRESBYOPIA	RESTORE VISION, LLC.
WO/2021/113638	PROTEIN-LOADED PLGA NANOSPHERES	WEST VIRGINIA UNIVERSITY
WO/2021/113642	METHODS FOR TREATING OSTEOARTHRITIS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/113648	AFFINITY MOLECULES THAT DIRECT THE METABOLISM AND POLARIZATION  OF MACROPHAGES AND SYNERGIZE THE IMMUNE CHECKPOINT BLOCKADE THERAPY	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/113651	DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY	ASHVATTHA THERAPEUTICS, INC.
WO/2021/113656	CANNABINOIDS AND USES THEREOF	CORBUS PHARMACEUTICALS, INC.
WO/2021/113657	TRIANTENNARY N-ACETYLGALACTOSAMINE MODIFIED HYDROXYL  POLYAMIDOAMINE DENDRIMERS AND METHODS OF USE THEREOF	ASHVATTHA THERAPEUTICS, INC.
WO/2021/113658	METHODS AND COMPOSITIONS OF PREVENTING AND TREATING DENTAL  CARIES	FORSYTH DENTAL INFIRMARY FOR CHILDREN
WO/2021/113662	DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY TO THE  EYE	ASHVATTHA THERAPEUTICS, INC.
WO/2021/113665	RAPAMYCIN ANALOGS AND USES THEREOF	NAVITOR PHARMACEUTICALS, INC.
WO/2021/188169	OPHTHALMIC COMPOSITION AND METHOD OF USE	AWH, Carl C.
WO/2021/113669	CANNABINOIDS AND USES THEREOF	CORBUS PHARMACEUTICALS, INC.
WO/2021/118885	PRE-TARGETING IMAGING AGENTS	ELI LILLY AND COMPANY
WO/2021/113682	MASP-2 INHIBITORS AND METHODS OF USE	OMEROS CORPORATION
WO/2021/113685	REGULATORY T CELL (TREG) COMPOSITIONS AND METHODS FOR TREATING  NEURODEGENERATIVE DISEASE	THE METHODIST HOSPITAL
WO/2021/113686	MASP-2 INHIBITORS AND METHODS OF USE	OMEROS CORPORATION
WO/2021/113688	COMBINATION THERAPIES FOR TREATMENT OF MYELODYSPLASTIC  SYNDROME	SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
WO/2021/113689	SPAK/OSR INHIBITORS AND METHODS OF USING SAME	YALE UNIVERSITY
WO/2021/113694	HDAC INHIBITOR SOLID STATE FORMS	VIRACTA THERAPEUTICS, INC.
WO/2021/113696	METHODS FOR CONTROLLING EXTRACORPOREAL MEMBRANE OXYGENATION  (ECMO) COAGULATION	DUKE UNIVERSITY
WO/2021/113697	ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES	SEAGEN INC.
WO/2021/113701	METHODS OF TREATING MULTIPLE MYELOMA WITH BISPECIFIC ANTI-BCMA  X ANTI-CD3 ANTIBODIES	REGENERON PHARMACEUTICALS, INC.
WO/2021/113702	METHODS OF TREATMENT USING ILT7 BINDING PROTEINS	VIELA BIO, INC.
WO/2021/113707	METHODS FOR TREATING COPD BY ADMINISTERING AN IL-33 ANTAGONIST	SANOFI BIOTECHNOLOGY
WO/2021/113709	ORAL CARE PRODUCTS AND METHODS	COLGATE-PALMOLIVE COMPANY
WO/2021/113734	METHODS FOR ENHANCING IMMUNITY AND TUMOR TREATMENT	RAKUTEN MEDICAL, INC.
WO/2021/113740	COMPOSITIONS AND METHODS FOR REDUCING OFF-TARGET TOXICITY OF  ANTIBODY DRUG CONJUGATES	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/113743	SMALL MOLECULE RPN13 INHIBITORS WITH ANTITUMOR PROPERTIES	THE JOHNS HOPKINS UNIVERSITY
WO/2021/113747	METHODS OF DECELLULARIZATION AND RECELLULARIZATION OF ORGANS  AND PORTIONS OF ORGANS	MIROMATRIX MEDICAL INC.
WO/2021/113748	COMPOSITION OF TRIAXIAL ANTIBODIES AND METHOD OF MAKING AND  USING THEREOF	ARBELE CORP.
WO/2021/113757	USE OF A KV7 POTASSIUM CHANNEL OPENER FOR TREATING PAIN	XENON PHARMACEUTICALS INC.
WO/2021/113759	PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF	CELULARITY INC.
WO/2021/113761	EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES  ASSOCIATED WITH FIBROSIS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/113764	RNAI-BASED TARGETING COMPOUNDS AND USES THEREOF TO PREVENT  ACQUIRED HEARING LOSS	MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/113775	METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL  DIURETICS	RESQ PHARMACEUTICALS LLC
WO/2021/113777	CIRCULAR RNA COMPOSITIONS AND METHODS	ORNA THERAPEUTICS, INC.
WO/2021/113786	A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND  METHODS OF USE THEREOF	SAGE THERAPEUTICS, INC.
WO/2021/113788	RECRUITMENT METHODS AND COMPOUNDS, COMPOSITIONS AND SYSTEMS  FOR RECRUITMENT	PAIRWISE PLANTS SERVICES, INC.
WO/2021/113795	COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS	FLATLEY DISCOVERY LAB, LLC
WO/2021/113800	COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/113802	METHOD OF TREATMENT WITH KCNQ CHANNEL OPENERS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/118918	RADIOMICS-BASED TREATMENT DECISION SUPPORT FOR LUNG CANCER	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/113812	INJECTABLE MICRO-ANNEALED POROUS SCAFFOLD FOR ARTICULAR  CARTILAGE REGENERATION	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/118927	METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF NUCLEIC ACID  THERAPEUTICS	INSIDEOUTBIO, INC.
WO/2021/118929	COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA	PTC THERAPEUTICS, INC.
WO/2021/113820	CONJUGATES AND METHODS FOR TREATING LIVER FIBROSIS	GENEVANT SCIENCES GMBH
WO/2021/113824	STABILIZATION OF RETROMER FOR THE TREATMENT OF ALZHEIMER'S  DISEASE AND OTHER NEURODEGENERATIVE DISORDERS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/113826	ROTARY SEPARATION APPARATUS AND PROCESS OF USE	THE ORIGINAL RESINATOR, LLC
WO/2021/113829	COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLES	THE GENERAL HOSPITAL CORPORATION
WO/2021/113831	ANTI-PVRIG AND ANTI-TIGIT ANTIBODIES FOR ENHANCED NK-CELL  BASED TUMOR KILLING	COMPUGEN LTD.
WO/2021/113834	GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX	MARINUS PHARMACEUTICALS, INC.
WO/2021/118955	METHODS AND SYSTEMS FOR TREATING OR PREVENTING  PREGNANCY-RELATED HYPERTENSIVE DISORDERS	AGGAMIN LLC
WO/2021/118957	METHODS AND SYSTEMS FOR TREATING OR PREVENTING  PREGNANCY-RELATED HYPERTENSIVE DISORDERS	AGGAMIN LLC
WO/2021/118976	M. TUBERCULOSIS AG85 PROTEINS AND METHODS OF USE	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/118988	COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER	YALE UNIVERSITY
WO/2021/118997	BCG CAR CONSTRUCTS AND METHODS OF THEIR MANUFACTURE AND USE	VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC.
WO/2021/119008	METHODS OF PREPARING CANCER TREATMENTS AND METHODS OF TREATING  CANCER	NANT HOLDINGS IP, LLC
WO/2021/119012	ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN  C3d AND USE THEREOF	THE UNITED STATES OF AMERICA, as represented by the secretary,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/119018	A METHOD TO IMPROVE SLEEP QUALITY IN THE ELDERLY BY  CONTROLLING EXCITABILITY OF HYPOCRETIN NEURONS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/119019	OLIGONUCLEOTIDES FOR TREATMENT OF ANGIOPOIETIN LIKE 4  (ANGPTL4) RELATED DISEASES	EMPIRICO INC.
WO/2021/119020	COMPOSITIONS AND METHODS OF PRODUCING DE-FLAVORED PEPPERCORN	BRIGHTSEED, INC.
WO/2021/119023	MULTIPLE MYELOMA COMBINATION THERAPIES BASED ON PROTEIN  TRANSLATION INHIBITORS AND IMMUNOMODULATORS	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/119030	ENHANCED CARDIOMYOCYTE REGENERATION	ANIMATUS BIOSCIENCES, LLC
WO/2021/119033	COMPOSITIONS AND METHODS OF TREATMENT	GB004, INC.
WO/2021/119053	ADENO ASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF HUNTER  DISEASE	SHIRE HUMAN GENETIC THERAPIES, INC.
WO/2021/119061	METHODS FOR GENERATING HEMATOPOIETIC STEM CELLS	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/119081	HEPATITIS B CAPSID ASSEMBLY MODULATORS	VENATORX PHARMACEUTICALS, INC.
WO/2021/119096	PHARMACEUTICAL COMPOSITIONS AND METHODS	TYME, INC.
WO/2021/119105	COMBINATION THERAPY WITH LIV1-ADC AND PD-1 ANTAGONIST	SEAGEN INC.
WO/2021/119108	USE OF FGFR INHIBITORS FOR TREATMENT OF IDIOPATHIC SHORT  STATURE	CEDARS-SINAI MEDICAL CENTER
WO/2021/119135	STABILIZED FORMULATIONS CONTAINING ANTI-CD20 X ANTI-CD3  BISPECIFIC ANTIBODIES	REGENERON PHARMACEUTICALS, INC.
WO/2021/119146	BIOMOLECULE FOR TREATMENT OF CORNEAL PATHOLOGIES	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/119159	IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/119166	CARIPRAZINE RELEASE FORMULATIONS	HALO SCIENCE LLC
WO/2021/119172	COMPOSITIONS AND METHODS FOR TARGETING GLYPICAN-2 IN THE  TREATMENT OF CANCER	SHEPHERD THERAPEUTICS, INC.
WO/2021/126637	METHODS OF TREATING PANCYTOPENIA	NANTCELL, INC.
WO/2021/119189	COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING  THROMBOTIC CONDITIONS IN A CANCER PATIENT	BETH ISRAEL DEACONESS MEDICAL CENTER, INC.,
WO/2021/119199	ALPHA-5 BETA-1 INHIBITORS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119206	TARGETED PHAGE THERAPY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119215	ALDH3A2 INHIBITION AND FERROPTOSIS INDUCTION FOR CANCER  THERAPY	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/119218	ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF	ALEXION PHARMACEUTICALS, INC.
WO/2021/119221	METHODS OF PREPARING VIRAL VECTORS	REPLIGEN CORPORATION
WO/2021/119234	GLYCOSYLATED ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I  RECEPTOR AND USES THEREOF	HORIZON PHARMA IRELAND LTD.
WO/2021/119254	ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4	VANDERBILT UNIVERSITY
WO/2021/119257	ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOF	HOMOLOGY MEDICINES, INC.
WO/2021/119265	ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4	VANDERBILT UNIVERSITY
WO/2021/119276	COMPOSITIONS AND METHODS FOR CONTROLLING CERUMEN PRODUCTION	FREE STATE PHARMA INC
WO/2021/119291	MICROBIAL COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION  OF DISEASE	NORTHEASTERN UNIVERSITY
WO/2021/119293	T-CELL EPITOPES OF HUMAN PARAINFLUENZA VIRUS 3 FOR ADOPTIVE  T-CELL IMMUNOTHERAPY	CHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/119298	COMBINATION THERAPIES FOR THE TREATMENT OF CANCER	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/247076	METHOD FOR IMPROVING SUBSTITUTION RATE AND/OR SUBSTITUTION  EFFICIENCY OF HYALURONAN-DRUG CONJUGATE	AIHOL CORPORATION
WO/2021/119316	METHODS OF TREATING CANCER	RGENIX, INC.
WO/2021/119321	USE OF A PCSK9 INHIBITOR TO TREAT HOMOZYGOUS FAMILIAL  HYPERCHOLESTEROLEMIA	REGENERON PHARMACEUTICALS, INC.
WO/2021/119327	TRANSPORE DELIVERY OF CANNABINOID AND USES THEREOF	STUDIN, Joel
WO/2021/119330	POLYMER MATRIXES FOR DIFFERENT COMPOSITIONS OF MITOCHONDRIALLY  TARGETED ANTIOXIDANTS	SKULACHEV, Maxim
WO/2021/119332	MICRONEEDLE DELIVERY DEVICE WITH DETACHABLE HYBRID MICRONEEDLE  DEPOTS FOR LOCALIZED DELIVERY OF CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119334	ORGANIC COMPOUND	INTRA-CELLULAR THERAPIES, INC.
WO/2021/126667	SURFACTANTS FOR USE IN PERSONAL CARE AND COSMETIC PRODUCTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/119343	COMPOSITIONS AND METHODS FOR SUBSTITUTED  7-(PIPERAZIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDINE ANALOGS AS INHIBITORS OF KRAS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/119347	TRANSDERMAL COLD ATMOSPHERIC PLASMA-MEDIATED IMMUNE CHECKPOINT  BLOCKADE THERAPY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119350	TISSUE CATALYZED GROWTH OF POLYMER AS EPITHELIAL LININGS FOR  THERAPY	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/119354	SYNTHETIC TISSUE BARRIERS AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/119358	DEBARYOMYCES SPECIES AS AN INDICATOR OF NON-HEALING ULCERS IN  CROHN'S DISEASE	WASHINGTON UNIVERSITY
WO/2021/119376	PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER  IMMUNOTHERAPY	NE1 INC.
WO/2021/126672	COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC  ANTIGEN RECEPTORS TARGETING GLYPICAN 3	MEDIMMUNE, LLC
WO/2021/119415	METHODS OF INCREASING MUSCULAR STRENGTH AND MUSCULAR ENDURANCE  WITH <i>ASPARAGUS RACEMOSUS</i>	NATREON, INC.
WO/2021/119423	NEAR INFRARED FLUORESCENT DYES, FORMULATIONS AND RELATED  METHODS	WASHINGTON UNIVERSITY
WO/2021/119424	EPITOPIC VACCINE FOR AFRICAN SWINE FEVER VIRUS	EPIVAX, INC.
WO/2021/119429	NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF	CUGENE INC.
WO/2021/119432	METHODS OF TREATING ANTIPSYCHOTIC-INDUCED WEIGHT GAIN WITH  MIRICORILANT	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/119439	COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF BCL-2 AND  BCL-XL ANTAGONISTS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/119456	LIQUID TASIMELTEON FORMULATIONS AND METHODS OF USE THEREOF	VANDA PHARMACEUTICALS INC.
WO/2021/119464	COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE  DELIVERY OF VARIOUS AGENTS AND USE THEREOF	VERI NANO INC.
WO/2021/119475	CYSTINE DIAMIDE ANALOGS FOR CYSTINURIA	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/138025	COMPOSITION AND THERAPY FOR TREATMENT OF GAG REFLEXES	OLSON, Robert
WO/2021/119497	MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/119500	VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION	IMMUNOLUX INTERNATIONAL CORP.
WO/2021/119503	CONTROLLED-DELIVERY CROMAKALIM PRODRUGS	QLARIS BIO, INC.
WO/2021/119505	ANTI-LY6G6D ANTIBODIES AND METHODS OF USE	GENENTECH, INC.
WO/2021/119508	ANTI-MERTK ANTIBODIES AND METHODS OF USE THEREOF	ALECTOR LLC
WO/2021/119516	CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES  THEREOF	CUGENE INC.
WO/2021/119522	COMPOUNDS, POLYMERS, DEVICES, AND USES THEREOF	SIGILON THERAPEUTICS, INC.
WO/2021/119523	USE OF ATR INHIBITORS IN COMBINATION WITH PARP INHIBITORS	REPARE THERAPEUTICS INC.
WO/2021/119525	SHP1 AND SHP2 INHIBITORS AND THEIR METHODS OF USE	TIAKI THERAPEUTICS INC.
WO/2021/119534	IL-2 ORTHOLOGS AND METHODS OF USE	SYNTHEKINE, INC.
WO/2021/119536	CANNABINOID ENRICHED COMPOSITION AND METHOD OF USING	CANNABIS GLOBAL, INC.
WO/2021/119538	THERAPEUTIC CELL COMPOSITIONS AND METHODS FOR MANUFACTURE AND  USES THEREOF	MYELOID THERAPEUTICS, INC.
WO/2021/119539	METHOD AND COMPOSITIONS FOR REGULATED ARMORING OF CELLS	SENTI BIOSCIENCES, INC.
WO/2021/126716	SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/119545	DURABLE VACCINATION	GRITSTONE BIO, INC.
WO/2021/119555	COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE RESPONSE	KUMQUAT BIOSCIENCES INC.
WO/2021/119561	INHIBITORS OF CANCER BIOMARKERS AND USES THEREOF	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/119563	NOVEL ENZYMES	INSCRIPTA, INC.
WO/2021/126725	NOVEL SUBSTITUTED 1,3,8-TRIAZASPIRO[4,5]DECANE-2,4-DIONE  COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND/OR TRYPTOPHAN  2,3-DIOXYGENASE (TDO) INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/126728	PRMT5 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/126729	PRMT5 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/126732	PRMT5 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/133579	COMPOSITIONS AND METHODS FOR SINGLE-STEP MULTIPURPOSE SURFACE  FUNCTIONALIZATION	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/138031	PPAR AGONIST COMPLEX AND METHODS OF USE	RODAN & FIELDS, LLC
WO/2021/119583	LANTHANIDE COMPOUNDS FOR LUMINESCENCE "TURN-ON"  DETECTION	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/119585	COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES	DNALITE THERAPEUTICS, INC.
WO/2021/081543	COMPOSITIONS AND PROCESSES FOR REMEDIATING  H<sb>2</sb>S, SULFUR-CONTAINING COMPOSITIONS, AND CONTAMINANTS IN  CONTAMINATED FLUIDS	GAPS TECHNOLOGY, LLC
WO/2021/119594	REDUCING ANTIBIOTIC RESISTANCE IN BACTERIA USING PRO-ACTIVE  GENETICS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/119607	STABLE MONOMERIC INSULIN FORMULATIONS ENABLED BY  SUPRAMOLECULAR PEGYLATION OF INSULIN ANALOGUES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/119615	METHODS FOR TREATING PARKINSON'S DISEASE	MEIRAGTX UK II LIMITED
WO/2021/119623	METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE	NORTHWESTERN UNIVERSITY
WO/2021/119639	COMPOSITIONS, SYSTEMS, AND METHODS FOR MEASURING PROTEIN  SECRETION AT A SINGLE-CELL LEVEL	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/141733	METHOD OF MODULATING A FIBROTIC CONDITION	THE PROCTER & GAMBLE COMPANY
WO/2021/126799	MACROCYCLIC PEPTIDES AS POTENT INHIBITORS OF K-RAS G12D MUTANT	MERCK SHARP & DOHME CORP.
WO/2021/126804	INDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE  TREATMENT OF HERPES VIRUSES	MERCK SHARP & DOHME CORP.
WO/2021/126816	DOSING REGIMEN OF A KRAS G12C INHIBITOR	AMGEN INC.
WO/2021/126822	THROMBOMODULIN FUNCTIONAL DOMAINS FOR USE IN PROMOTING  OSTEOBLAST FUNCTIONS AND BONE HEALING	BLUE BLOOD BIOTECH CORP.
WO/2021/126829	CONTINUOUS PROCESSES FOR MANUFACTURING IMPREGNATED POROUS  CARRIERS AND FOR MANUFACTURING PHARMACEUTICALS CONTAINING IMPREGNATED POROUS  CARRIERS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/126855	METHODS FOR TREATING PROGRESSIVE HYPERBILIRUBINEMIA	MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
WO/2021/126870	COMPOSITIONS OF BILE ACIDS AND PHENYLBUTYRATE COMPOUNDS	AMYLYX PHARMACEUTICALS INC.
WO/2021/126872	MULTI-SPECIFIC T CELL RECEPTORS	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/126874	OPHTHALMIC COMPOSITIONS COMPRISING D2O	SYDNEXIS, INC.
WO/2021/126880	COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE  DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC)	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/126884	LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART  FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF)	TENAX THERAPEUTICS, INC.
WO/2021/146016	SUSTAINED RELEASE COMPOSITIONS COMPRISING LIOTHYRONINE	KASHIV SPECIALTY PHARMACEUTICALS, LLC
WO/2021/126902	AMIDO-SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE  THEREOF FOR THE TREATMENT OF HERPES VIRUSES	MERCK SHARP & DOHME CORP.
WO/2021/126905	MAGNETIC MINIATURE DEVICE AND SYSTEM FOR REMOTELY MANEUVERING  IT	BIONAUT LABS LTD.
WO/2021/126906	METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1  ANTAGONIST, AN ILT4 ANTAGONIST, AND CHEMOTHERAPEUTIC AGENTS	MERCK SHARP & DOHME CORP.
WO/2021/126929	MODIFIED INTERFERON-ALPHA-2 HAVING REDUCED IMMUNOGENICITY	EPIVAX, INC.
WO/2021/126942	INHIBITORS OF MHC-I NEF DOWNMODULATION FOR TREATING HIV	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/126944	GEL COMPOSITIONS FOR MITIGATION OF BURN INJURIES, KITS  CONTAINING THE GEL COMPOSITIONS, AND ASSOCIATED METHODS	YUSUF, Zaki
WO/2021/126957	METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING FIBROSIS	MIE UNIVERSITY
WO/2021/126973	COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION	ORIONIS BIOSCIENCES, INC.
WO/2021/126974	BIFUNCTIONAL AGENTS FOR PROTEIN RECRUITMENT AND/OR DEGRADATION	ORIONIS BIOSCIENCES, INC.
WO/2021/126977	METHODS OF TREATING IGA NEPHROPATHY WITH ATRASENTAN	CHINOOK THERAPEUTICS, INC.
WO/2021/126989	TWO-WAY MAGNETIC RESONANCE TUNING NANOPROBE ENHANCED  SUBTRACTION IMAGING	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/126990	OXYTOCIN DERIVATIVES WITH IMPROVED PROPERTIES	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/127000	MYELOID CELL-TARGETED NANOPARTICLES AND RELATED COMPOSITIONS  AND METHODS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/127003	TREATING HEART DISEASE IN MUSCULAR DYSTROPHY PATIENTS	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/127007	ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE	BLUEBIRD BIO, INC.
WO/2021/127008	COMPOSITIONS AND METHODS FOR TREATING NEUROMUSCULAR DISORDERS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/127013	HIGHLY EFFICIENT MYELOPEROXIDASE ACTIVATABLE IMAGING AGENTS	THE GENERAL HOSPITAL CORPORATION
WO/2021/127017	COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES,  EPITOPES, AND METHODS AND USES THEREOF	LA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/127024	CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND  METHODS OF MAKING AND USING SAME	WASHINGTON UNIVERSITY
WO/2021/127036	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127039	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127041	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127042	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127043	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127044	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127045	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127046	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127047	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/127048	METHODS OF PRODUCTION OF ARGININE-SILICATE COMPLEXES	NUTRITION 21, LLC
WO/2021/127052	DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN  APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR,  A TUMOR NECROSIS FACTOR-α (TNF-α) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL  PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC  PROTEASE INHIBITOR	CELLA THERAPEUTICS, LLC
WO/2021/127057	METHODS AND COMPOSITIONS FOR CORRECTION OF DMD MUTATIONS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/127070	INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CGRP INHIBITORS	BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
WO/2021/127071	BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE  TREATMENT OF HERPES VIRUSES	MERCK SHARP & DOHME CORP.
WO/2021/127088	MATERIALS AND METHODS FOR IN VIVO BIOLOGICAL TARGETING	JANSSEN BIOTECH, INC.
WO/2021/127107	TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING ONYCHOMYCOSIS	GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
WO/2021/127124	DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE  LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A  NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR  A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION	CELLA THERAPEUTICS, LLC
WO/2021/127133	N-(3-AMINO-3-OXOPROPYL)-2-[(1-METHYL-4-NITRO-1H-IMIDAZOL-5-YL)THIO]BENZAMIDE  AND ITS USE FOR TREATING HIV INFECTION	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/127135	METHODS AND COMPOSITIONS FOR DIAGNOSIS OF TUBERCULOSIS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/127166	INHIBITORS OF ENL/AF9 YEATS	KHAN, Tanweer A.
WO/2021/127176	UNNATURAL AMINO ACIDS AND USES THEREOF	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/127185	NOVEL DDR1 ANTIBODIES AND USES THEREOF	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127189	POTENTIATION OF HELMINTH TREATMENT	ELANCO TIERGESUNDHEIT AG
WO/2021/127190	IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/127210	METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS	CURASEN THERAPEUTICS, INC.
WO/2021/127217	COMBINATION ANTI-CANCER THERAPIES WITH INDUCERS OF  IRON-DEPENDENT CELLULAR DISASSEMBLY	FLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/127231	SOLID FORMS OF  2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/127235	COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS,  ENHANCING DRUG POTENCY AND TREATING CANCER, AND METHODS FOR MAKING AND USING  SAME	PERSEPHONE BIOSCIENCES, INC.
WO/2021/127254	METHODS FOR TREATING GLIOBLASTOMA	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127261	ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF	THE GENERAL HOSPITAL CORPORATION
WO/2021/127271	LIVE ATTENUATED LEISHMANIA PARASITE VACCINES WITH ENHANCED  SAFETY CHARACTERISTICS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/127275	GSK-3 MODULATOR OTIC FORMULATIONS	OTONONY, INC.
WO/2021/127278	IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/127294	PEPTOID-CONTAINING PERSONAL LUBRICANT	MAXWELL BIOSCIENCES, INC.
WO/2021/127305	METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM  CELLS	VIRGINIA COMMONWEALTH UNIVERSITY
WO/2021/133643	STAPLED OLEFIN CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS	MERCK SHARP & DOHME CORP.
WO/2021/133644	STAPLED TRIAZOLE CO-AGONISTS OF THE GLUCAGON AND GLP-1  RECEPTORS	MERCK SHARP & DOHME CORP.
WO/2021/141751	ARGINASE INHIBITORS AND METHODS OF USE	MERCK SHARP & DOHME CORP.
WO/2021/138079	COMBINATION CANCER TREATMENT USING A PD-1 ANTAGONIST, AN ILT4  ANTAGONIST, AND LENVATINIB OR SALTS THEREOF.	MERCK SHARP & DOHME CORP.
WO/2021/127308	GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME	OVID THERAPEUTICS INC.
WO/2021/127309	NONINVASIVE QUANTITATION OF FULL VERSUS EMPTY CAPSIDS USING  WATER PROTON NMR	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/262228	SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/262229	AZOXYSTROBIN EFFICACY IN PERSONAL CARE FORMULATIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/262230	AZOXYSTROBIN IN A SULFATE FREE PERSONAL CARE COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/127318	TRANSPARENT COMPOSITION WITH SOLUBLE SCALP HEALTH ACTIVE	THE PROCTER & GAMBLE COMPANY
WO/2021/127328	TRPML MODULATORS	CASMA THERAPEUTICS, INC.
WO/2021/127333	TRPML MODULATORS	CASMA THERAPEUTICS, INC.
WO/2021/127337	TRPML MODULATORS	CASMA THERAPEUTICS, INC.
WO/2021/133653	THERAPY FOR THE TREATMENT OF CANCER	MACROGENICS, INC.
WO/2021/127353	SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS AND USES  THEREOF	ARO BIOTHERAPEUTICS COMPANY
WO/2021/127356	Substituted Bicyclic and Tricyclic Ureas and Amides, Analogues  Thereof, and Methods Using Same	ARBUTUS BIOPHARMA, INC.
WO/2021/127359	USE OF LEMBOREXANT FOR TREATING INSOMNIA	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/127367	METHODS FOR INHIBITION OF ALPHA-SYNUCLEIN mRNA USING SMALL  MOLECULES	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/127376	TREATMENT OF, AND DIFFERENTIAL DIAGNOSIS BETWEEN,  ACTH-DEPENDENT CUSHING'S SYNDROME AND ACTH-INDEPENDENT CUSHING'S SYNDROME	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/127391	MOLECULAR TARGETS FOR ADDICTION	THE JACKSON LABORATORY
WO/2021/127398	CAFFEINE CITRATE FORMULATIONS	OYE THERAPEUTICS, INC
WO/2021/127404	TRICYCLIC PYRIDONES AND PYRIMIDONES	ERASCA, INC.
WO/2021/133667	T CELL PERFORMANCE ASSAY AS A PROGNOSTIC FACTOR FOR CLINICAL  OUTCOME	BAYLOR COLLEGE OF MEDICINE
WO/2021/127407	CAI NANOEMULSIONS	FORWARDVUE PHARMA, INC.
WO/2021/127413	FILTER AIDS FOR NON AQUEOUS LIQUIDS	IMERYS USA, INC.
WO/2021/127414	USE OF FUCOSYLATION INHIBITOR FOR PRODUCING AFUCOSYLATED  ANTIBODY	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/127428	CHIMERIC ANTIGEN RECEPTORS TARGETING B7-H3 (CD276) AND  ASSOCIATED METHODS	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/127429	SOS1 INHIBITORS	MIRATI THERAPEUTICS, INC.
WO/2021/127434	AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED  BY NANOTECHNOLOGY AND PROTEOMICS	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/127438	COMPOSITION AND METHOD FOR TREATING DERMATOLOGICAL DISORDERS  USING RETINAMIDES	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/127452	COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND  POTENTIATION OF ANTIBIOTICS	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/127455	METHODS FOR TREATING HUNTINGTON'S DISEASE	ASKLEPIOS BIOPHARMACEUTICAL, INC.
WO/2021/127456	METHODS OF INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR  PROTEINS	RAIN THERAPEUTICS INC.
WO/2021/127459	GPR139 RECEPTOR MODULATORS	BLACKTHORN THERAPEUTICS, INC.
WO/2021/127460	PCSK9 ANTAGONIST COMPOUNDS	MERCK SHARP & DOHME CORP.
WO/2021/127463	NOVEL PRIME-BOOST INFLUENZA VACCINE	VIVALDI BIOSCIENCES INC.
WO/2021/127466	COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN  INHIBITORS	NOVARTIS AG
WO/2021/141758	UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS  THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTION	XU, Jian, Qing
WO/2021/127472	LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED  THEREWITH, AND THERAPIES USING SAME	LANDOS BIOPHARMA, INC.
WO/2021/127473	COMPOSITIONS AND METHODS FOR MANAGING INFECTIONS OF A URINARY  TRACT	METAGENICS, INC.
WO/2021/127483	COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN  INHIBITORS	NOVARTIS AG
WO/2021/127486	SMALL-MOLECULE COVALENT INHIBITION OF RAL GTPASES	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/127496	COMBINATION TREATMENTS FOR WALDENSTROM'S MACROGLOBULINEMIA	X4 PHARMACEUTICALS, INC.
WO/2021/127500	ANTIBODIES AGAINST INTEGRIN ALPHA 11 BETA 1	MOMENTA PHARMACEUTICALS, INC.
WO/2021/127517	NOVEL USES	INTRA-CELLULAR THERAPIES, INC.
WO/2021/127525	PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR FACTOR  XI/XIA ANTIBODIES	ANTHOS THERAPEUTICS, INC.
WO/2021/127541	METHODS OF TREATING BRAIN DISORDERS	NEURONASAL, INC.
WO/2021/127546	ORAL TABLETS COMPRISING ROLLER-COMPACTED GRANULES OF NAPROXEN  SODIUM, METHODS OF PREPARING THEREOF, AND METHODS OF USING THEREOF	BAYER HEALTHCARE LLC
WO/2021/133689	LIPOXYGENASE INHIBITORS	SRI INTERNATIONAL
WO/2021/127554	COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/127556	METHODS FOR TREATING CANCER COMPRISING LOW DOSE RADIATION	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127559	COMPOSITIONS COMPRISING CANNABINOID ANIONS AND ANTI-NUCLEATING  AGENTS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/127561	ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF  EGFR	C4 THERAPEUTICS, INC.
WO/2021/127572	METHODS OF SCHIZOPHRENIA TREATMENT	INTRA-CELLULAR THERAPIES, INC.
WO/2021/127573	COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A  MYCOBACTERIUM TUBERCULOSIS INFECTION	SAN DIEGO STATE UNIVERSITY (SDSU) FOUNDATION, DBA SAN DIEGO  STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/127580	POWASSAN VIRAL ANTIGENS AND RELATED COMPOSITIONS, AND USES  THEREOF TO VACCINATE AND TREAT PATIENTS	MASLOW, Joel
WO/2021/127583	SELECTIVE HIGH AFFINITY LIGAND DIAGNOSTICS AND THERAPEUTICS	SHAL TECHNOLOGIES, INC.
WO/2021/127589	NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY  DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS  AND TREATMENT USING THE SAME	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/127594	ENGINEERED CELLS FOR THERAPY	EDITAS MEDICINE, INC.
WO/2021/127617	VACCINES AGAINST AFRICAN SWINE FEVER VIRUS, AND METHODS OF  USING SAME	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/133712	HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS	PROMAB BIOTECHNOLOGIES, INC.
WO/2021/127623	CROSSLINKED PLA-BASED COPOLYMERS	PENDANT BIOSCIENCES, INC.
WO/2021/133723	APOLIPOPROTEIN L1-SPECIFIC ANTIBODIES AND METHODS OF USE	GENENTECH, INC.
WO/2021/138116	OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO  NERVE IMAGING	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/127639	STEM CELL DELIVERY	UNIVERSITY OF MIAMI
WO/2021/127641	IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES	TRANSLATE BIO, INC.
WO/2021/127643	FLUOROALKYL-OXADIAZOLES AND USES THEREOF	TENAYA THERAPEUTICS, INC.
WO/2021/127650	COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS	ENTRADA THERAPEUTICS, INC.
WO/2021/127651	MODEL ORGANISMS HUMANIZED FOR DRUG DISCOVERY AND SCREENING	NEMAMETRIX, INC
WO/2021/127653	COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST  STAPHYLOCOCCUS AUREUS	WASHINGTON UNIVERSITY
WO/2021/133742	STABILIZATION OF MHC COMPLEXES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133777	MONOAMINE OXIDASE INHIBITORS AS MODIFIERS OF BETA CELL  VULNERABILITY IN TYPE 1 DIABETES	JOSLIN DIABETES CENTER
WO/2021/133778	GAMMA-HYDROXYBUTYRATE (GHB) DOSING	JAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/133782	METHODS OF TREATING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE  REGULATOR (CFTR) DYSFUNCTION	NATIONAL JEWISH HEALTH
WO/2021/133784	NATURE-BASED COMPOSITIONS, DISPENSING SYSTEMS AND METHODS FOR  PROVIDING SENSORIAL AND AESTHETIC BENEFITS TO ACNE PRONE SKIN	L'OREAL
WO/2021/133790	PREVENTION AND TREATMENT OF KIDNEY FAILURE BY ADMINISTRATION  OF FIBROBLASTS AND PRODUCTS THEREOF	FIGENE, LLC
WO/2021/133793	SUPPRESSION OF INTERLEUKIN-17 PRODUCTION AND INHIBITION OF  TH17 CELL GENERATION BY FIBROBLASTS AND PRODUCTS THEREOF	FIGENE, LLC
WO/2021/133798	INHIBITION OF TNF-ALPHA BY FIBROBLASTS AND FIBROBLAST EXOSOMES	FIGENE, LLC
WO/2021/133800	THERAPEUTIC AMOEBA AND USES THEREOF	AMEBAGONE, LLC
WO/2021/133811	SOLID STATE FORMS OF CENICRIVIROC AND PROCESS FOR PREPARATION  THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/133812	COMPOSITIONS COMPRISING MICROBES AND METHODS OF USE AND MAKING  THEREOF	PENDULUM THERAPEUTICS, INC.
WO/2021/138156	BIOFILM PREVENTION AND TREATMENT	ARMS PHARMACEUTICAL LLC
WO/2021/133821	MANAGING MICROBIAL DYSBIOSIS WITH TEMOCILLIN	ENTASIS THERAPEUTICS, INC.
WO/2021/133822	REGENERATIVE POLYPEPTIDES AND USES THEREOF	JUVENA THERAPEUTICS,INC.
WO/2021/133844	TREATMENT OF MILD TRAUMATIC BRAIN INJURY	OXEIA BIOPHARMACEUTICALS, INC.
WO/2021/133854	METHODS AND COMPOSITIONS FOR PRODUCING A HETEROLOGOUS  ANTIVIRAL COMPOUND IN A HOST CELL	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133858	HEPARIN-ASSOCIATED POLYPEPTIDES AND USES THEREOF	JUVENA THERAPEUTICS, INC.
WO/2021/133862	TARGETING THE INTRINSIC APOPTOTIC MACHINERY IN GLIOBLASTOMA	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133866	COMPOUNDS FOR THE TREATMENT OF MYELOFIBROSIS	ACTUATE THERAPEUTICS, INC.
WO/2021/133867	COMPOSITIONS AND METHODS FOR STYLING HAIR	PAREKH, Aakash Jagat
WO/2021/133874	COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/133877	CONTROL OF HISTAMINE TO PROMOTE HEALTH AND CONTROL  ENTEROCOLITIS USING PROBIOTIC COMPOSITIONS AND/OR HISTAMINE DEGRADING ENZYMES	IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/138183	MACHINE LEARNING SYSTEM FOR INTERPRETING HOST PHAGE RESPONSE	ADAPTIVE PHAGE THERAPEUTICS, INC.
WO/2021/133896	TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION  FACTOR INHIBITORS AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/133904	SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL  EXTRACELLULAR VESICLES	EVELO BIOSCIENCES, INC.
WO/2021/133908	PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF  MULTIPLE INFLAMMATORY DISORDERS	AARDVARK THERAPEUTICS INC.
WO/2021/133914	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING SKIN  DAMAGE	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/133917	SMARCA INHIBITORS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/133920	SMARCA DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/162790	COLLOIDAL PARTICLE FORMULATIONS WITH ADVANCED FUNCTIONALITY	BENANOVA INC.
WO/2021/133940	COMPOSITIONS AND METHODS INVOLVING AMINO ACIDS FOR THE  TREATMENT OF FAT INFILTRATIONS IN MUSCLE	AXCELLA HEALTH INC.
WO/2021/133941	OLIGONUCLEOTIDES FOR TISSUE SPECIFIC GENE EXPRESSION  MODULATION	UNIVERSITY OF MASSACHUSETTS
WO/2021/138205	FTNIR SPECTROSCOPY FOR REACTION MONITORING OF ACRYLAMIDE  SYNTHESIS	KEMIRA OYJ
WO/2021/133948	COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES  AND DISORDERS	AXCELLA HEALTH INC.
WO/2021/133950	POLYPHENOL COMPOSITIONS AND USES THEREOF	METAGENICS, INC.
WO/2021/133957	BENZIMIDAZOLE COMPOUNDS AS HDAC6 INHIBITORS	ONKURE, INC.
WO/2021/133962	CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR  MAKING, AND APPLICATIONS THEREOF	GROVE COLLABORATIVE, INC.
WO/2021/138209	METHODS FOR CULTURING CANCER CELLS AND FOR INHIBITING INVASION  OF CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/133971	MASCARA BASED ON POLYPHENOL AND FILM FORMING POLYMER AND  METHODS FOR MAKING UP EYELASHES	L'OREAL
WO/2021/133977	PROGRAMMABLE DNA NUCLEASE-ASSOCIATED LIGASE AND METHODS OF USE  THEREOF	THE BROAD INSTITUTE, INC.
WO/2021/133989	PREPARATION OF CANNABICHROMENE AND RELATED CANNABINOIDS	BAYMEDICA, INC.
WO/2021/133993	METHODS AND SYSTEMS FOR MOLECULAR DISEASE ASSESSMENT VIA  ANALYSIS OF CIRCULATING TUMOR DNA	LEXENT BIO, INC.
WO/2021/134010	METHODS OF NORMALIZING ABERRANT GLYCOLYTIC METABOLISM IN  CANCER CELLS	PATEL, Chirag Bihesh
WO/2021/134012	COMPOSITIONS, DISPENSING SYSTEMS AND METHODS FOR PROVIDING  SENSORIAL AND AESTHETIC BENEFITS TO ACNE PRONE SKIN	L'OREAL
WO/2021/134023	COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY	AJK PHARMACEUTICAL LLC
WO/2021/134026	COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY	AJK PHARMACEUTICAL LLC
WO/2021/134029	TOPICAL NICOTINE FOR SMOKING CESSATION	AMPERSAND BIOPHARMACEUTICALS, INC.
WO/2021/134042	METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE  DEHYDROGENASE	OHIO STATE INNOVATION FOUNDATION
WO/2021/134045	METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE  DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT	OHIO STATE INNOVATION FOUNDATION
WO/2021/138257	COMPOSITIONS FOR IMPARTING COLOR AND TONE TO THE HAIR	SHI, Minli
WO/2021/138258	COMPOSITIONS FOR TREATING HAIR	SHI, Minli
WO/2021/134081	AUGMENTATION OF FIBROBLAST MEDIATED REGENERATION OF  INTRAVERTEBRAL DISCS	FIGENE, LLC
WO/2021/134082	CROSSLINKED HA-COLLAGEN HYDROGELS AS DERMAL FILLERS	ALLERGAN, INC.
WO/2021/134084	PHYSICAL MIX HA-COLLAGEN DERMAL FILLERS	ALLERGAN, INC.
WO/2021/134086	ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT  OF PSYCHIATRIC DISORDERS	GILGAMESH PHARMACEUTICALS, INC.
WO/2021/138279	SYSTEM AND METHOD FOR SALT HOLDING INTEGRATABLE PILLOW	WIESINGER, Paulette K.
WO/2021/138280	INDIVIDUALIZED VACCINES FOR CANCER TREATMENT AND PREVENTION	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/138286	SELF-COMPLEMENTARY AAV DELIVERY SYSTEM FOR CRISPR/CAS9	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/138298	MALT1 MODULATORS AND USES THEREOF	RHEOS MEDICINES, INC.
WO/2021/138302	INTRAPANCREATIC M2 POLARIZATION OF MACROPHAGES TO TREAT TYPE 1  DIABETES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/138314	COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS	BLUE OAK PHARMACEUTICALS, INC.
WO/2021/138315	COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS	BLUE OAK PHARMACEUTICALS, INC.
WO/2021/138332	NOVEL ANUCLEATED CELLS FOR DRUG DELIVERY AND METHODS OF USE  THEREOF	PLATELET BIOGENESIS, INC.
WO/2021/138335	DEODORANT AND PERSONAL CARE COMPOSITIONS	REM BRANDS, INC.
WO/2021/138350	MAMMALIAN CELLS SECRETING GDNF AND THEIR THERAPEUTIC USE	GLORIANA THERAPEUTICS
WO/2021/138364	KINASES AS BIOMARKERS FOR NEURODEGENERATIVE CONDITIONS	CHASE THERAPEUTICS CORPORATION
WO/2021/138378	ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	OBI PHARMA, INC.
WO/2021/138386	PROPELLANT-FREE FORMULATION FOR INHALATION	HUANG, Cai Gu
WO/2021/162796	COMPOSITIONS COMPRISING DESOXIMETASONE AND TAZAROTENE	TARO PHARMACEUTICAL INDUSTRIES LTD.
WO/2021/138390	MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS,  DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/138391	INDAZOLE COMPOUNDS	TYRA BIOSCIENCES, INC.
WO/2021/138423	METHODS FOR GENETICALLY MODIFYING CANNABIS PLANTS, MODIFIED  CANNABIS PLANTS, AND PRODUCTS THEREFROM	ARCADIA BIOSCIENCES, INC.
WO/2021/138446	COMPOSITIONS CONTAINING EXOSOME CARRYING NF-kB INHIBITORS AND  METHODS OF USING THEREOF	ILIAS BIOLOGICS INC.
WO/2021/138448	TEMPERATURE-BASED TRANSIENT DELIVERY OF ZSCAN4 NUCLEIC ACIDS  AND PROTEINS TO CELLS AND TISSUES	ELIXIRGEN THERAPEUTICS, INC.
WO/2021/138450	NOVEL SMALL MOLECULE SHC BLOCKERS FOR TREATING LIVER DISEASE  AND METABOLIC DISEASE	BUTO CORPORATION
WO/2021/138454	METHODS OF MAKING AND USING REGULATORY T CELLS AND EFFECTOR T  CELLS HAVING CHIMERIC ANTIGEN RECEPTORS TARGETED TO CD6, CD19, AND/OR AN  IL-13R FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS	CITY OF HOPE
WO/2021/138456	COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR  FLAVONOIDS AND USES THEREOF	CALIBRATED THERAPEUTICS, LLC
WO/2021/138467	ANTI-CD73 ANTIBODIES AND USES THEREOF	INCYTE CORPORATION
WO/2021/138483	AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE  THEREOF	DECIPHERA PHARMACEUTICALS, LLC
WO/2021/138485	COMPOSITIONS OF  1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHENYL)-3-PHENYLUREA	DECIPHERA PHARMACEUTICALS, LLC
WO/2021/138498	CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR  COMBINATION THERAPY	INCYTE CORPORATION
WO/2021/138525	TOPICAL COMPOSITION COMPRISING TOFACITINIB AND FINGOLIMOD	VYNE PHARMACEUTICALS LTD.
WO/2021/138561	NOVEL TETRAHYDROCURCUMIN COMPOSITIONS, METHODS OF MAKING, AND  METHODS OF USING THE SAME	RENIBUS THERAPEUTICS, INC.
WO/2021/138562	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETO	ASSEMBLY BIOSCIENCES, INC.
WO/2021/141828	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETO	ASSEMBLY BIOSCIENCES, INC.
WO/2021/138564	ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING  THE SAME	CURE PHARMACEUTICAL HOLDING CORP.
WO/2021/158317	METHODS FOR PREVENTING AND REVERSING OPIOID ANALGESIC  TOLERANCE IN SUBJECTS WITH CHRONIC PAIN	THE REASEARCH FOUNDATION FOR SUNY
WO/2021/138571	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED  THERETO	ASSEMBLY BIOSCIENCES, INC.
WO/2021/178036	STABLE PICKERING-TYPE EMULSIONS	CIELLA JAMES, LLC
WO/2021/138578	REPURPOSING FDA-APPROVED DRUGS AS A NOVEL CANCER THERAPEUTIC  AVENUE THROUGH INHIBITION OF PRMT5	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/138581	TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/138582	FUSION PROTEINS AND METHODS OF USE THEREOF	THE JOHNS HOPKINS UNIVERSITY
WO/2021/138588	COMPOSITIONS OF HYDROGELS AND METHODS OF USE THEREOF	REPERTOIRE IMMUNE MEDICINES, INC.
WO/2021/138597	WATER-SOLUBLE CANNABINOID FORMULATIONS AND METHODS OF THEIR  MAKING	SOLUSCIENCE, LLC
WO/2021/138599	COSMETIC COMPOSITIONS	FORTE SUBSIDIARY, INC.
WO/2021/003492	FIBROUS STRUCTURES CONTAINING CATIONIC SURFACTANTS AND SOLUBLE  ACIDS	THE PROCTER & GAMBLE COMPANY
WO/2021/007587	PERSONAL CARE CLEANING COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/007593	COMPOUNDS USEFUL FOR INHIBITING BFL1 AND THEIR USE IN THERAPY	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/007594	IRE1 ACTIVATING COMPOUNDS FOR USE IN THERAPY	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/007596	HAIR CONDITIONING COMPOSITION COMPRISING BRANCHED FATTY  ALCOHOL AND TRIESTER	THE PROCTER & GAMBLE COMPANY
WO/2021/016637	COMPOSITIONS FOR TREATMENT OF SUBSTANCE USE DISORDER	UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
WO/2021/016640	COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED  THERAPEUTIC AGENTS	THE UNIVERSITY OF CHICAGO
WO/2021/022306	WATER-SOLUBLE PERSONAL CLEANSING PRODUCTS COMPRISING FIBROUS  ELEMENTS COMPRISING NATURAL OR MODIFIED STARCH, USES, METHODS AND KIT	THE PROCTER & GAMBLE COMPANY
WO/2021/026565	DISSOLVABLE VITAMIN C AND RETINOL FILM	MARY KAY INC.
WO/2021/026572	PERSONAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/035257	MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/035258	BICYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/042127	A PACKAGED HAIR CARE COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/042128	HAIR CONDITIONING PRODUCT COMPRISING FIRST AND SECOND  COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/051130	COMBINATION THERAPY FOR THE TREATMENT OF MIGRAINES	THE UNIVERSITY OF CHICAGO
WO/2021/051133	PERSONAL CARE COMPOSITIONS COMPRISING ANTI-DANDRUFF AGENTS	THE PROCTER & GAMBLE COMPANY
WO/2021/051135	PIKFYVE INHIBITORS FOR CANCER THERAPY	AI THERAPEUTICS, INC.
WO/2021/056029	METHODS AND COMPOSITIONS FOR TREATING PAIN AND OTHER EPH  RECEPTOR-ASSOCIATED CONDITIONS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/127668	METHOD AND SYSTEM FOR MANUFACTURING OF PHARMACEUTICAL FORMULAS  IN FORM OF ORALLY DISINTEGRATING FILMS (ODF)	VUONG, Dieu, Cam
WO/2021/067992	METHODS OF USE OF ORAL CARE COMPOSITIONS COMPRISING HOPS	THE PROCTER & GAMBLE COMPANY
WO/2021/067993	ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND FLUORIDE	THE PROCTER & GAMBLE COMPANY
WO/2021/067994	FLUORIDE-FREE ANTICAVITY ORAL CARE COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/067995	ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND METAL ION	THE PROCTER & GAMBLE COMPANY
WO/2021/067996	ORAL CARE COMPOSITIONS WITH ANTICARIES ACTIVITY	THE PROCTER & GAMBLE COMPANY
WO/2021/072419	PERSONAL CARE COMPOSITIONS AND METHODS	COLGATE-PALMOLIVE COMPANY
WO/2021/072422	ORAL CARE COMPOSITIONS AND METHODS OF USE	COLGATE-PALMOLIVE COMPANY
WO/2021/072423	ORAL CARE COMPOSITIONS AND METHODS OF USE	COLGATE-PALMOLIVE COMPANY
WO/2021/081554	METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA	CHEMISTRYRX
WO/2021/081556	PERSONAL CARE COMPOSITION PRESERVATIVES LEVEL OPTIMIZATION	THE PROCTER & GAMBLE COMPANY
WO/2021/081557	PERSONAL CARE COMPOSITION PRESERVATIVES LEVEL OPTIMIZATION	THE PROCTER & GAMBLE COMPANY
WO/2021/081558	PERSONAL CARE COMPOSITION PRESERVATIVES LEVEL OPTIMIZATION	THE PROCTER & GAMBLE COMPANY
WO/2021/092613	METHODS OF MODIFYING BIOFILM	COLGATE-PALMOLIVE COMPANY
WO/2021/087520	BROADLY PROTECTIVE BOVINE PARAINFLUENZA 3 VIRUS AND BOVINE  VIRAL DIARRHEA VIRUS VACCINE	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/127672	MULTI-BENEFIT PERSONAL CARE COMPOSITIONS AND METHODS FOR THE  SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/097483	ORAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/097484	ORAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/119650	VISCOSITY STABLE SLS FREE TOOTHPASTES CONTAINING ZINC  COMPOUNDS AND ARGININE	COLGATE-PALMOLIVE COMPANY
WO/2021/127674	ORAL CARE COMPOSITIONS CONTAINING INULIN	COLGATE-PALMOLIVE COMPANY
WO/2021/127675	PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/127676	PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/127677	PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/127681	PERSONAL CARE COMPOSITIONS AND METHODS FOR THE SAME	COLGATE-PALMOLIVE COMPANY
WO/2021/113871	ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE THEREOF	COLGATE-PALMOLIVE COMPANY
WO/2021/119660	HAIR STRENGTHENING COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/119664	HERBAL COSMETIC COMPOSITION FOR TREATING SKIN	MARY KAY INC.
WO/2021/138628	PERSONAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/119669	METHODS AND COMPOSITIONS FOR TREATMENT OF ACUTE MYELOID  LEUKEMIA	LOMA LINDA UNIVERSITY PATHOLOGY MEDICAL GROUP, INC.
WO/2021/134096	ORAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/134097	METHODS FOR IMPROVING BARRIER INTEGRITY OF GINGIVAL TISSUE	COLGATE-PALMOLIVE COMPANY
WO/2021/127699	ORAL CARE COMPOSITIONS AND METHODS OF USE	COLGATE-PALMOLIVE COMPANY
WO/2021/167703	FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS  CONTAINING TGFB ANTAGONIST PRODRUGS USEFUL IN THE TREATMENT OF CANCER AND  METHODS THEREOF	NAMMI THERAPEUTICS, INC.
WO/2021/154455	LIGAND-MEDIATED DELIVERY OF THERAPEUTIC PROTEINS AND THE USES  THEREOF	PURDUE RESEARCH FOUNDATION
WO/2021/138646	SYSTEMS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT BY  DIRECT INJECTION OF A TARGETED POPULATION OF CELLS	PRIVO TECHNOLOGIES, INC.
WO/2021/138674	A NOVEL METHOD TO MANUFACTURE SYNTHETIC MEAT	FYBRAWORKS FOODS, INC.
WO/2021/141862	METHODS OF MODULATING STING PATHWAY ACTIVATION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/138678	RNA SPLICING MODULATION	THE GENERAL HOSPITAL CORPORATION
WO/2021/138681	BIOACTIVE PLASTICS WITH PROGRAMMABLE DEGRADATION AND  MICROPLASTIC ELIMINATION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/138682	COMPOSITIONS HAVING THIOREDOXIN ACTIVITY AND RELATED METHODS	ORPRO THERAPEUTICS, INC.
WO/2021/141890	TWO-STEP GENE SWAP	PIONEER HI-BRED INTERNATIONAL, INC.
WO/2021/141892	METHODS OF TREATING CLEAR CELL RENAL CARCINOMA (CCRCC) USING  AXL DECOY RECEPTORS	ARAVIVE INC.
WO/2021/141901	LASSO PEPTIDES FOR TREATMENT OF CANCER	LASSOGEN, INC.
WO/2021/141902	HIGHLY SIALYLATED MULTIMERIC BINDING MOLECULES	IGM BIOSCIENCES, INC.
WO/2021/141917	ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF NEUROLOGICAL  DISORDERS	AUM LIFETECH, INC.
WO/2021/141919	TREATMENT OF MEMBRANOUS NEPHROPATHY, IGG4-RELATED DISEASE, AND  ANTIPHOSPHOLIPID SYNDROME USING BTK INHIBITOR  2-[(3R)-3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/194604	THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND  BETA-TCP BINDING PEPTIDES AND USES THEREOF	THERADAPTIVE, INC.
WO/2021/141944	FORMULATIONS FOR DELIVERY OF OLIGONUCLEOTIDES TO LUNG CELLS	TRANSLATE BIO MA, INC.
WO/2021/141955	COMPOSITIONS AND METHODS FOR INCREASING CELLULAR VITALITY AND  LONGEVITY AND DECREASING MOLECULAR AGEING	JUVN3 HOLDINGS, LLC
WO/2021/141956	TREATMENT OF PAIN ASSOCIATED WITH CESAREAN SECTION SURGERY  WITH SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS	PACIRA PHARMACEUTICALS, INC,
WO/2021/141959	TREATMENT OF PAIN BY ADMINISTRATION OF SUSTAINED-RELEASE  LIPOSOMAL ANESTHETIC COMPOSITIONS	PACIRA PHARMACEUTICALS, INC.
WO/2021/141960	CYANO-PYRIMIDINE INHIBITORS OF EGFR/HER2	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/141963	TREATMENT OF PAIN BY SUBARACHNOID ADMINISTRATION OF  SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS	PACIRA PHARMACEUTICALS, INC.
WO/2021/146082	BIHETEROCYCLIC INHIBITORS OF ISPF FOR TREATMENT OF MICROBIAL  INFECTIONS	POINT LOMA NAZARENE UNIVERSITY
WO/2021/141970	RECRUITMENT OF DNA POLYMERASE FOR TEMPLATED EDITING	PAIRWISE PLANTS SERVICES, INC.
WO/2021/141974	COMBINATION CANCER THERAPY USING CHK INHIBITOR	WU, Fan
WO/2021/141980	COMBINATION CANCER THERAPY USING CHK INHIBITOR	WU, Fan
WO/2021/141985	NOVEL DOMINANT NEGATIVE FAS POLYPEPTIDES, CELLS COMPRISING  THEREOF AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/141986	CHIMERIC GMCSF-IL18 RECEPTOR	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/142002	ANTI-CCR8 ANTIBODIES AND USES THEREOF	VACCINEX, INC.
WO/2021/142020	FORMULATIONS OF SN-38 WITH POLY(AMINO ACID) BLOCK POLYMERS	TYNDALL FORMULATION SERVICES, LLC
WO/2021/142026	SHP2 INHIBITOR DOSING AND METHODS OF TREATING CANCER	REVOLUTION MEDICINES, INC.
WO/2021/142030	METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR	ARENA PHARMACEUTICALS, INC.
WO/2021/142039	ANTI-PSMA ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF  USE THEREOF	CYTOMX THERAPEUTICS, INC.
WO/2021/142043	ANTI-SLC34A2 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS  OF USE THEREOF	CYTOMX THERAPEUTICS, INC.
WO/2021/142056	COMBINATIONS OF TIE-2 ACTIVATORS AND PROSTAGLANDINS AND USES  THEREOF	AERPIO PHARMACEUTICALS, INC.
WO/2021/142074	METHOD FOR CHEMICAL SEPARATION OF CANNABINOIDS	PRECISION EXTRACTION CORPORATION
WO/2021/142075	MICROWAVE ASSISTED DECARBOXYLATION OF CANNABIS RESINS	PRECISION EXTRACTION CORPORATION
WO/2021/142083	A METHOD FOR ENHANCING THE PHARMACOKINETICS OR INCREASING THE  PLASMA CONCENTRATION OF METHYL  3-((METHYLSULFONYL)AMINO)-2-(((4-PHENYLCYCLOHEXYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE  OR A SALT THEREOF WITH AN INHIBITOR OF CYTOCHROME P450	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/142086	ALK5 INHIBITOR CONJUGATES AND USES THEREOF	SYNTHIS THERAPEUTICS, INC.
WO/2021/142088	SOURCE SPECIFIC EXOSOMES FOR DETERMINING AVOIDANCE OF CANCER  TREATMENT AND AVOIDANCE OF CHECKPOINT INHIBITOR THERAPIES	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/142115	SANGLIFEHRIN ANALOGS AND USES THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/142124	TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING  2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4,4-DIMETHYLPENT-2-ENENITRILE	PRINCIPIA BIOPHARMA INC.
WO/2021/142127	A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET  CD70-POSITIVE TUMORS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/142128	BIOMARKER AND DRUGGABLE TARGET OF NEURODEGENERATION	UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
WO/2021/142132	COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE BY  MANIPULATION OF SERINE METABOLISM	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/142143	FGF-21 CONJUGATE FORMULATIONS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/142145	TARGETED STEROID COMPOUNDS	GARDEEN, Spencer S.
WO/2021/142148	SOLID STATE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR  PRODUCING AND USING SAME	ARMIS BIOPHARMA, INC.
WO/2021/142150	LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF	UNIVERSITY OF WASHINGTON
WO/2021/142163	TREATMENT OF ALZHEIMER'S DISEASE	SELONTERRA, INC.
WO/2021/142171	TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	APELLIS PHARMACEUTICALS, INC.
WO/2021/142180	AHR INHIBITORS AND USES THEREOF	IKENA ONCOLOGY, INC.
WO/2021/142183	METHODS OF TREATING CORTICAL DEMENTIA ASSOCIATED WANDERING	WOOLSEY PHARMACEUTICALS, INC
WO/2021/162808	METHODS OF TREATING PSEUDOBULBAR AFFECT AND OTHER EMOTIONAL  DISTURBANCES	WOOLSEY PHARMACEUTICALS, INC
WO/2021/194607	METHODS OF USING RHO KINASE INHIBITORS TO TREAT FRONTOTEMPORAL  DEMENTIA	WOOLSEY PHARMACEUTICALS, INC
WO/2021/142186	PHARMACEUTICAL COMPOSITION AND USE THEREOF	ALPHALA CO., LTD.
WO/2021/194608	METHODS OF TREATING PROTEINOPATHY- ASSOCIATED WANDERING	WOOLSEY PHARMACEUTICALS, INC
WO/2021/216139	METHODS OF USING RHO KINASE INHIBITORS TO TREAT ALZHEIMER'S  DISEASE	WOOLSEY PHARMACEUTICALS, INC
WO/2021/257122	METHODS OF USING RHO KINASE INHIBITORS TO TREAT VASCULAR  DEMENTIA	WOOLSEY PHARMACEUTICALS, INC
WO/2021/262250	METHODS OF TREATING NEURODEVELOPMENTAL DISORDERS	WOOLSEY PHARMACEUTICALS, INC
WO/2021/142191	TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	REGENERON PHARMACEUTICALS, INC.
WO/2021/142192	MICROPARTICLE-BASED ENZYME SYSTEMS FOR SELECTIVE REMOVAL OF  TARGET MOLECULES	SYNLIFE, INC.
WO/2021/142199	SITE SPECIFIC ANTIBODY-DRUG CONJUGATES WITH PEPTIDE-CONTAINING  LINKERS	MERSANA THERAPEUTICS, INC.
WO/2021/142202	COMPOSITIONS OF IXABEPILONE	R-PHARM US OPERATING LLC
WO/2021/142212	ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED  TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME	VIRION THERAPEUTICS, LLC
WO/2021/142217	MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF  MILCK1	DYNE THEREAPEUTICS, INC.
WO/2021/142227	MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF  GENES ASSOCIATED WITH MUSCLE HEALTH	DYNE THERAPEUTICS, INC.
WO/2021/142230	METHODS TO ALTER LATENCY IN EBV+ MALIGNANCIES	CORNELL UNIVERSITY
WO/2021/142231	SUSTAINED IMMUNOTHERAPY	FUSION PHARMACEUTICALS INC.
WO/2021/154476	ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF	DYNE THERAPEUTICS, INC.
WO/2021/142234	MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING  MYOTONIC DYSTROPHY	DYNE THERAPEUTICS, INC.
WO/2021/142237	METHODS FOR ADMINISTERING LUCITANIB AND COMBINATIONS THEREOF	CLOVIS ONCOLOGY, INC.
WO/2021/142238	DEUTERATED NICLOSAMIDE	FIRST WAVE BIO, INC.
WO/2021/142240	COMPOSITIONS COMPRISING NICLOSAMIDE FOR USE IN TREATING  CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSE	FIRST WAVE BIO, INC.
WO/2021/142244	SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL  DELIVERY OF ACTIVE AGENTS	TOPIX PHARMACEUTICALS, INC.
WO/2021/154477	ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF	DYNE THERAPEUTICS, INC.
WO/2021/142247	SMARCA2-VHL DEGRADERS	AMGEN INC.
WO/2021/142256	BROADLY REACTIVE VIRAL ANTIGENS AS IMMUNOGENS, COMPOSITIONS  AND METHODS OF USE THEREOF	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/142257	METHODS OF TREATING SPLENOMEGALY	TELIOS PHARMA, INC.
WO/2021/142258	MACROCYCLIC CHELATES AND USES THEREOF	FUSION PHARMACEUTICALS INC.
WO/2021/142260	MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF  ACVR1	DYNE THERAPEUTICS, INC.
WO/2021/142279	COMPOSITIONS AND METHODS OF TREATMENT USING VEILLONELLA  PARVULA	EVELO BIOSCIENCES, INC.
WO/2021/142280	METHODS OF MAKING TOLEROGENIC DENDRITIC CELLS	MODERNATX, INC.
WO/2021/142282	COMPOSITIONS AND METHODS FOR AMELIORATING PAIN AND REDUCING  FEVER	THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/142287	HIGH TRIPLET YIELD PHENOTHIAZINE DONOR-ACCEPTOR COMPLEXES FOR  PHOTOREDOX CATALYSIS	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/142288	METHODS OF ADMINISTERING NALBUPHINE	TREVI THERAPEUTICS, INC.
WO/2021/142291	STIMULATION OF HAIR GROWTH	THE GENERAL HOSPITAL CORPORATION
WO/2021/142300	METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS  ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/142302	COMPOSITIONS AND METHODS FOR AUTOIMMUNITY REGULATION	TCR2 THERAPEUTICS INC.
WO/2021/150383	COSMECEUTICAL COMPOSITION	TRIM-EDICINE, INC.
WO/2021/142305	METHODS OF TREATING TUMORS	COIMMUNE, INC.
WO/2021/142315	METHODS AND COMPOUNDS FOR THE TREATMENT OF FRAGILE X	DESIGN THERAPEUTICS, INC.
WO/2021/142317	TOPICAL COMPOSITIONS CONTAINING ROFECOXIB AND METHODS OF  MAKING AND USING THE SAME	BRIORI BIOTECH, LLC
WO/2021/142320	METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND  ISOLIQUIRITIGENIN AND DERIVATIVES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/142322	METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS  MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF	REAL ISOLATES, LLC
WO/2021/142329	METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED  PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT  INHIBITORS	DISC MEDICINE, INC.
WO/2021/142347	COMPOSITIONS AND METHODS FOR NON-ALCOHOLIC STEATOHEPATITIS  (NASH)	FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/142353	COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B (HBV) AND  HEPATITIS D (HDV)	FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/142355	NANOPARTICLES FOR EXPRESSION OF GENES OF INTEREST AND/OR  REGULATION OF SIGNALING PATHWAYS	APRIKYAN, Andranik Andrew
WO/2021/142358	COMPOSITIONS AND METHODS FOR TREATING HEPATIC ENCEPHALOPATHY  (HE)	FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/142359	STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION	AMGEN INC.
WO/2021/142360	STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION	AMGEN INC.
WO/2021/142373	METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH α4β7  INTEGRIN ANTAGONISTS	PROTAGONIST THERAPEUTICS, INC.
WO/2021/142395	THERAPEUTIC COMBINATIONS OF DRUGS AND METHODS OF USING THEM	CONSYNANCE THERAPEUTICS, INC.
WO/2021/142408	ESTROGEN METABOLITE LEVELS AND CANCER DRIVER GENE MUTATIONS IN  LUNG CANCER RISK STRATIFICATION AND TREATMENT	INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF  FOX CHASE CANCER CENTER
WO/2021/142410	NEURAL REGENERATION WITH SYNTHETIC PROTEIN ADMINISTRATION	RETINAL SOLUTIONS, LLC
WO/2021/142413	HUMAN ANTIBODIES TO CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS	VANDERBILT UNIVERSITY
WO/2021/146127	USE OF N2-QUINCLINE OR ISOQUINOLINE SUBSTITUTED PURINE  DERIVATIVES IN CANCER TREATMENT	WU, Zhanggui
WO/2021/142420	PYRAZOLO[1,5-<i>a</i>]PYRIMIDIN-7(4<i>H</i>)-ONE  INHIBITORS OF DYNEIN	KAPOOR, Tarun M.
WO/2021/142425	TREATMENT OF NEUROLOGICAL DISORDERS WITH AVERMECTINS	EQUILIBRE NEUROSCIENCE LTD.
WO/2021/142427	TGFβ INHIBITORS AND USE THEREOF	SCHOLAR ROCK, INC.
WO/2021/142435	COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY	SOLID BIOSCIENCES INC.
WO/2021/142447	VIRAL VECTOR FOR COMBINATION THERAPY	SOLID BIOSCIENCES INC.
WO/2021/142448	TGF-BETA INHIBITORS AND USE THEREOF	SCHOLAR ROCK,INC.
WO/2021/146147	BCMA-DIRECTED CELLULAR IMMUNOTHERAPY COMPOSITIONS AND METHODS	NKARTA, INC.
WO/2021/142450	SUPPRESSION OF INFLAMMASOME ACTIVATION	SAH, Rajan
WO/2021/142454	TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES	ONCOLMMUNIN, INC.
WO/2021/142460	METHOD FOR DETERMINING SENSITIVITY TO 2,2'-DITHIO-BIS-ETHANE  SULFONATE	LANTERN PHARMA INC.
WO/2021/142467	METHOD AND DEVICE FOR EVALUATING HAIR GROWTH TREATMENTS	LASERCAP COMPANY - TRANSDERMAL CAP, INC.
WO/2021/146153	SEMI-RIGID DISPLAY BOARD	THE GILMAN BROTHERS COMPANY
WO/2021/201950	METHOD FOR REDUCING THE OCCURRENCE OF THROMBOSIS OR  THROMBOEMBOLISM	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/146160	PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING  PEDIATRIC HEREDITARY ANGIOEDEMA ATTACK	TAKEDA PHARMACEUTICAL COMPANY LIMITED
WO/2021/146163	PYRIDAZINE AND 1,2,4-TRIAZINE DERIVATIVES AS FGFR KINASE  INHIBITORS	BETA PHARMA, INC.
WO/2021/146176	MEDICINAL COMPOSITIONS FOR CARBON DIOXIDE BASED METERED DOSE  INHALERS	KINDEVA DRUG DELIVERY L.P.
WO/2021/146187	EMULSION BASED DRUG SCREENING	FLUENT BIOSCIENCES INC.
WO/2021/146191	METHOD OF TREATING A TUMOR WITH A COMBINATION OF IL-7 PROTEIN  AND A BISPECIFIC ANTIBODY	NEOIMMUNETECH, INC.
WO/2021/146192	SUBSTITUTED PYRAZOLO-PYRIMIDINES AND USES THEREOF	VERGE ANALYTICS, INC.
WO/2021/142476	SINGLE-CHAIN POLYPEPTIDES	DRAGONFLY THERAPEUTICS, INC.
WO/2021/146199	PREDICTION OF PANCREATIC DUCTAL ADENOCARCINOMA USING COMPUTED  TOMOGRAPHY IMAGES OF PANCREAS	CEDARS-SINAI MEDICAL CENTER
WO/2021/146213	METHODS FOR TREATING CANCERS USING GM-CSF ENCODING  POLYNUCLEOTIDE AND ADDITIONAL AGENTS	GRADALIS, INC.
WO/2021/146215	SUSTAINED RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED  IMPURITIES AND RELATED METHODS	DURECT CORPORATION
WO/2021/146257	CONCENTRATED SODIUM VALPROATE FOR RAPID DELIVERY	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/146258	COMBINATION THERAPY FOR CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146265	CELL DELIVERY ARTICLES AND METHODS OF ADMINISTRATION	INCUBE LABS, LLC
WO/2021/146266	METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/146272	METHODS FOR TREATING VIRAL INFECTIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146273	PERSONAL CARE COMPOSITION COMPRISING ALOE VERA	THE PROCTER & GAMBLE COMPANY
WO/2021/146291	SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE	ARCH BIOSURGERY, INC.
WO/2021/146292	TARGETING PAR1 AND PAR2 TO REGULATE LIPID AND CHOLESTEROL  ABUNDANCE	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/146296	SWALLOWABLE DEVICES FOR DRUG DELIVERY IN AN INTESTINAL TRACT	RANI THERAPEUTICS, LLC
WO/2021/146309	TREATMENT OF VOMITING AND NAUSEA WITH MINIMUM DOSE OF  OLANZAPINE	STARTON THERAPEUTICS, INC.
WO/2021/146318	REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF  FREQUENT MIGRAINE HEADACHES	IMPEL NEUROPHARMA, INC.
WO/2021/146322	CIRCULATING TUMOR DNA AS A BIOMARKER FOR LEUKEMIA TREATMENT	CARDIFF ONCOLOGY, INC.
WO/2021/146327	INHIBITION OF DENND5B EXPRESSION FOR TREATING HEPATIC  STEATOSIS	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/146328	FORMULATIONS FOR PROTEIN THERAPEUTICS	APTEVO RESEARCH AND DEVELOPMENT LLC
WO/2021/146331	POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION  OF BIOPROSTHETIC HEART VALVES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/146334	FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE	THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF  MILITARY MEDICINE, INC.
WO/2021/146336	METHODS AND COMPOSITIONS FOR PREVENTING ADSORPTION OF  THERAPEUTIC PROTEINS TO DRUG DELIVERY SYSTEM COMPONENTS	APTEVO RESEARCH AND DEVELOPMENT LLC
WO/2021/146344	COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING  PATHWAYS	LIFEVANTAGE CORPORATION
WO/2021/146373	RADIONUCLIDE-LHRH CONJUGATES FOR DIAGNOSIS OF REPRODUCTIVE  CANCERS	EASTERN KENTUCKY UNIVERSITY
WO/2021/146378	COMPOSITIONS OF SUBSTITUTED PYRAZOLOPYRIMIDINES AND USES  THEREOF	KSQ THERAPEUTICS, INC.
WO/2021/146390	COMPOSITIONS AND METHODS FOR TARGETED PROTEIN STABILIZATION BY  REDIRECTING ENDOGENOUS DEUBIQUITINASES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/146393	HIGH THROUGHPUT GENETIC BARCODING AND ANALYSIS METHODS	WILLIAM MARSH RICE UNIVERSITY
WO/2021/146397	BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS  DETRIMENTAL	SYNLOGIC OPERATING COMPANY, INC.
WO/2021/146399	COMPOSITIONS COMPRISING A NOVEL MAMMALIAN ORTHOREOVIRUS AND  METHODS FOR MAKING AND USING	PHIBRO ANIMAL HEALTH CORPORATION
WO/2021/146400	METHODS AND COMPOSITIONS RELATING TO PROLONGED INFLAMMATORY  INHIBITION AND/OR PROLONGED TREATMENT OF SPINAL PAIN BY CHIMERA DECOY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/150420	TOPICAL FORMULATION FOR BINDING TO DERMATOLOGICAL CANNABINOID  RECEPTORS	KADO, Jessica
WO/2021/146408	CARBONIC ANHYDRASE II COMPOSITIONS AND METHODS OF USE THEREOF	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/146413	HUMANIZED ANTIBODIES SPECIFIC FOR MYELOMA AND OVARIAN CANCER  CELLS	CAERUS THERAPEUTICS, INC.
WO/2021/146425	METHODS OF TREATING ACUTE MUSCLE SPASMS	NEURANA PHARMACEUTICALS, INC.
WO/2021/146428	NITRO-FATTY ACID-CONTAINING MICROBUBBLES AND USED THEREFOR	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/146436	BIASED IL2 MUTEINS METHODS AND COMPOSITIONS	SYNTHEKINE, INC.
WO/2021/146464	PERICYTE-SPARING THERAPY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/146471	TRANSPLANTED CELL PROTECTION VIA INHIBITION OF  POLYMORPHONUCLEAR CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146481	IL2 MUTEINS	SYNTHEKINE, INC.
WO/2021/146483	UTROPHIN UPREGULATION COMPOUNDS FOR DUCHENNE MUSCULAR  DYSTROPHY THERAPY	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/146506	TYROSINE DERIVATIVES FOR MODULATING CANCER	TYME, INC.
WO/2021/146523	SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES	EVELO BIOSCIENCES, INC.
WO/2021/146539	CROSSLINKED DEXTRAN-BASED HYDROGELS AND USES THEREOF	THE JOHNS HOPKINS UNIVERSITY
WO/2021/146553	MACROMOLECULAR PRODRUGS FOR LIGHT-EMITTING DIODES AND USES  THEREOF	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/146566	ENGINEERED FIBROBLASTS AS CELL THERAPY TO TREAT CANCER VIA  TUMOR STROMA STABILIZATION	THE JOHNS HOPKINS UNIVERSITY
WO/2021/146571	TUMOR CELL-DERIVED EXOSOMES AND METHOD OF TREATING COLORECTAL  CANCER	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/146582	COMPOSITIONS AND METHODS FOR CONTROLLING UNDESIRABLE MICROBES  AND IMPROVING ANIMAL HEALTH	AGBIOME, INC.
WO/2021/146598	METHODS AND COMPOSITIONS FOR TREATING ATOPIC DERMATITIS	SECOND GENOME, INC.
WO/2021/146604	COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING  B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORS	ALLOGENE THERAPEUTICS, INC.
WO/2021/146625	GENE THERAPY FOR TREATMENT OF <i>CRX-</i>AUTOSOMAL  DOMINANT RETINOPATHIES	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/146628	COMPOSITIONS AND METHODS FOR ALTERING GAMMA DELTA T CELL  ACTIVITY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146629	HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS	NUVATION BIO INC.
WO/2021/146631	HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS	NUVATION BIO INC.
WO/2021/146632	METHODS AND COMPOSITIONS FOR TREATING TYPE 2 DIABETES	SECOND GENOME, INC.
WO/2021/146639	METHODS AND COMPOSITIONS FOR TREATING COLORECTAL CANCER	SECOND GENOME, INC.
WO/2021/146644	METHODS AND COMPOSITIONS FOR TREATING ULCERATIVE COLITIS	SECOND GENOME, INC.
WO/2021/146647	METHODS AND COMPOSITIONS FOR TREATING CANCER	SECOND GENOME, INC.
WO/2021/146648	COMPOSITIONS FOR MANAGING CHRONIC OBSTRUCTIVE PULMONARY  DISEASE	MAJEED, Muhammed
WO/2021/146651	PROCESS AND COMPOSITIONS FOR ENHANCING ENERGY EXPENDITURE	MAJEED, Muhammed
WO/2021/146662	THERAPEUTIC COMPOSITIONS AND METHODS FOR PULMONARY FIBROSIS	MAJEED, Muhammed
WO/2021/146668	CHANGING EYE COLOR BY GENE TRANSDUCTION	HILL, James W.
WO/2021/146678	METHODS FOR PRODUCING CANNABINOID-CONTAINING CRYSTALS USING  SUPERCRITICAL FLUID	CALDERA GROUP LLC
WO/2021/146681	MULTIVALENT STREPTOCOCCUS VACCINES	INVENTPRISE, LLC
WO/2021/188191	TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS	PURDUE RESEARCH FOUNDATION
WO/2021/146687	A CANNABOSIDE COMPOSITION AND METHOD TO PRODUCE	CANNABIS GLOBAL, INC.
WO/2021/150471	LIPOSOME FORMULATION OF VILANTEROL TRIFENATATE	HUANG, Cai, Gu
WO/2021/162827	COMPOSITIONS OF FREE FLOWING HYDROPHOBIC CARBOHYDRATE  DERIVATIVES AND METHODS FOR USE	CORN PRODUCTS DEVELOPMENT, INC.
WO/2021/150476	THERAPEUTIC TYROSINE KINASE INHIBITORS FOR RELAPSING MULTIPLE  SCLEROSIS (RMS)	GENZYME CORPORATION
WO/2021/150477	AQUEOUS SUNCASE FORMULATION BASED ON SULFATED A CRYSTALLINE  CELLULOSE SPF BOOSTER	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/150489	INHALABLE FORMULATION OF A SOLUTION CONTAINING GLYCOPYRROLATE  AND OLODATEROL HYDROCHLORIDE	HUANG, Cai, Gu
WO/2021/221741	NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR  TREATING OR PREVENTING AN INFECTION IN A MAMMAL	LONZA CONSUMER HEALTH INC.
WO/2021/150501	EXPANDED FOAM FOR DELIVERY OF FUNCTIONAL INGREDIENTS	BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
WO/2021/146704	THE KINASE NEK10 AND ITS USE IN TREATING AND DIAGNOSING  BRONCHIECTASIS AND OTHER RESPIRATORY DISORDERS	THE GENERAL HOSPITAL CORPORATION
WO/2021/146713	METHODS OF TREATING FRAGILE X SYNDROME WITH REELIN	UNIVERSITY OF SOUTH FLORIDA
WO/2021/146715	NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOF	CASE WESTERN RESERVE UNIVERSITY
WO/2021/146719	<i>T-CELL DEATH ASSOCIATED GENE 8</i>  (<i>TDAG8</i>) MODULATION TO ENHANCE CELLULAR CANCER THERAPIES	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/146735	CBD ORAL FORMULATION	CLEAR LAKE RESEARCH, LLC
WO/2021/150543	NOVEL AND POTENT JAK/STAT INHIBITOR	TEXAS TECH UNIVERSITY SYSTEM
WO/2021/150559	DOSING REGIMENS AND METHODS FOR TREATING CANCER	PANBELA THERAPEUTICS, INC.
WO/2021/188194	ENGINEERED INCOHERENT FEED FORWARD LOOP AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/150570	TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN  GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)	REGENXBIO INC.
WO/2021/150574	SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS	GENENTECH, INC.
WO/2021/150595	NOVEL FORMULATIONS COMPRISING CANNABIS	NUTRAMAX LABORATORIES, INC.
WO/2021/150598	AFFINITY PEPTIDE CONJUGATED WITH ANTIOXIDANT FOR PROTECTION OF  PROTEINS FROM OXIDATION	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/150603	ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/150621	SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/150635	DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE  TUMOR MICROENVIRONMENT	ANSUN BIOPHARMA, INC.
WO/2021/150645	NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF	CRESCENTA BIOSCIENCES
WO/2021/206783	VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE	XIE, Qiyi
WO/2021/150662	TREATMENT OF PERIODONTITIS VIA INDUCTION OF M2 MACROPHAGES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/150694	HUMAN IMMUNOGENIC EPITOPES OF HEMO AND HHLA2 HUMAN ENDOGENOUS  RETROVIRUSES (HERVS)	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/150695	CONSTRAINED N-SUBSTITUTED TETRAHYDROBENZOAZEPINE SULFONAMIDES  AS ANTICANCER AND NEUROPROTECTIVE AGENTS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/150701	ANTI-PD-L1 ANTIBODIES	BOLT BIOTHERAPEUTICS, INC.
WO/2021/150713	HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS  RETROVIRUSES (HERVS)	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/183218	COMPOSITIONS AND METHODS FOR MODULATING THE INTERACTION  BETWEEN SS18-SSX FUSION ONCOPROTEIN AND NUCLEOSOMES	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/150744	CONTINUOUS PRODUCTION OF KERATIN FIBERS	NUTECH VENTURES
WO/2021/150747	PHENYLEPHRINE HYDROCHLORIDE COMPOSITIONS AND CONTAINERS	NEVAKAR INC.
WO/2021/150756	INHIBITORS OF GLUTATHIONE S-TRANSFERASES (GSTS) AND  NAD(P)H:QUINONE OXIDOREDUCTASE 1 (NQO1), PHARMACEUTICAL COMPOSITIONS, AND  USES IN MANAGING CANCER	EMORY UNIVERSITY
WO/2021/150760	COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8  AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS	WASHINGTON UNIVERSITY
WO/2021/150767	HEPATOPANCREATIC NECROSIS DISEASE SIGNATURES AND USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/150770	ONCOGENIC TRIM37 IS A TARGETABLE EPIGENETIC DRIVER OF  METASTASIS AND LINKS CHEMORESISTANCE AND METASTATIC FATE IN TRIPLE-NEGATIVE  BREAST CANCER	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/150774	SYSTEMS AND COMPOSITIONS FOR DELIVERING ACTIVE PLANT  COMPONENTS	KINSTATE, INC.
WO/2021/150775	DISCRIMINATING PARKINSON'S DISEASE FROM MULTIPLE SYSTEM  ATROPHY USING ALPHA-SYNUCLEIN PMCA	BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/150785	SYSTEMS AND METHODS FOR PROCESSING AND STABILIZING PLANT  MATERIALS	E.&J. GALLO WINERY
WO/2021/150794	LOW MOLECULAR WEIGHT PROTEIN COMPOSITIONS	ADVANCE INTERNATIONAL INC.
WO/2021/150806	HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS	ENANTA PHARMACEUTICALS, INC.
WO/2021/150807	SKIN CARE COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/150829	STABLE ANTIBODY FORMULATION	REGENERON PHARMACEUTICALS, INC.
WO/2021/154591	THERAPEUTIC USES OF DULAGLUTIDE	ELI LILLY AND COMPANY
WO/2021/150835	HETEROCYCLIC LSF INHIBITORS AND THEIR USES	TRUSTEES OF BOSTON UNIVERSITY
WO/2021/154593	THERAPEUTIC USES OF TIRZEPATIDE	ELI LILLY AND COMPANY
WO/2021/150840	ANTAGONISM AS A THERAPY FOR TDP-43 PROTEINOPATHIES	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/150867	DESIGNING ANTISENSE OLIGONUCLEOTIDE DELIVERY PEPTIDES BY  INTERPRETABLE MACHINE LEARNING	SAREPTA THERAPEUTICS, INC.
WO/2021/150871	COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE  DISORDERS WITH RIPK1/RIPK3 INHIBITORS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/150874	RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA	WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF)
WO/2021/150884	CHIMERIC ANTIGEN RECEPTOR T-CELL IMMUNOTHERAPY IN THE  TREATMENT OF CANCER	B CELL SOLUTIONS, INC.
WO/2021/150912	THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF	TVARDI THERAPEUTICS, INC.
WO/2021/150925	USES OF BIOMARKERS FOR IMPROVING IMMUNOTHERAPY	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/150928	PREVENTION AND TREATMENT OF EFFECTS OF AGING AND  AGE-ASSOCIATED DISORDERS WITH KETONE SUPPLEMENTATION	KOUTNIK, Andrew Paul
WO/2021/150943	ARSENIC TRIOXIDE MICROCRYSTAL-LOADED MICROSPHERES	MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/150945	METHODS OF DIAGNOSING AND TREATING CANCER	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/150958	TREATMENT METHODS USING A COMBINATION OF PANTETHINE AND A  VANIN AGONIST	SCHELLING, D. Christopher
WO/2021/150962	SUSTAINED-RELEASE MATRICES FOR ADVENTITIAL OR PERIADVENTITIAL  NEURAL ABLATION AND USES THEREOF	W. L. GORE & ASSOCIATES, INC.
WO/2021/173273	CONTROLLING EFFECTS AFTER 5HT2A AGONISTS ADMINISTRATION	UNIVERSITÄTSSPITAL BASEL
WO/2021/150979	OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVE-SPECIFIC IMAGING	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/150981	AMORPHOUS SOLID DISPERSIONS OF DASATINIB AND USES THEREOF	NANOCOPOEIA, LLC
WO/2021/150983	METHODS FOR TREATING PARKINSON'S DISEASE WITH SEPIAPTERIN	PTC THERAPEUTICS MP, INC.
WO/2021/150985	REDUCING SIDE EFFECTS OF NMDA ANTAGONISTS	SEELOS THERAPEUTICS, INC.
WO/2021/150987	NOVEL ERYTHROID SPECIFIC ENHANCERS AND USES THEREOF	ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
WO/2021/150997	LOCALIZED EXPRESSION OF THERAPEUTIC NUCLEIC ACIDS IN LUNG  EPITHELIAL CELLS	ENGENE, INC.
WO/2021/150998	COMPOSITIONS FOR INHIBITION OF HERPESVIRUSES	BOGER, Ravit
WO/2021/151003	COMPOSITIONS OF OXYHYDROGEN AND THE THERAPEUTIC USE THEREOF  FOR OCULAR CONDITIONS	KHJ BIOLOGICAL LLC
WO/2021/151004	COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING  TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING  IMMUNOGLOBULINS	SPARK THERAPEUTICS, INC.
WO/2021/151005	INHALED DAS181 TO TREAT CANCER IN THE LUNG	ANSUN BIOPHARMA, INC.
WO/2021/151008	METHODS FOR DOSING AND TREATMENT OF FOLLICULAR LYMPHOMA AND  MARGINAL ZONE LYMPHOMA IN ADOPTIVE CELL THERAPY	JUNO THERAPUETICS, INC.
WO/2021/151011	TREATMENT OF NEURODEGENERATIVE PROTEINOPATHIES USING FAS  APOPTOSIS INHIBITORY MOLECULE (FAIM) OR A FRAGMENT AND/OR A MIMETIC THEREOF	KAKU, Hiroaki
WO/2021/151013	GROWTH FACTOR FORMULATION FOR CONDITION ASSOCIATED WITH OTIC  EVENT	OTONOMY, INC.
WO/2021/151014	PGDH INHIBITORS AND METHODS OF MAKING AND USING	MYOFORTE THERAPEUTICS, INC.
WO/2021/151018	METHODS AND COMPOSITIONS FOR GENERATING TYPE I VESTIBULAR HAIR  CELLS	DECIBEL THERAPEUTICS, INC.
WO/2021/151019	NOVEL METHOD OF ENHANCED DRUG DELIVERY TO THE NERVOUS SYSTEM	THE GENERAL HOSPITAL CORPORATION
WO/2021/151029	THERAPEUTIC EXOSOMES AND METHOD OF PRODUCING THEM	AGEX THERAPEUTICS, INC.
WO/2021/151031	PROTEIN-ANTIVIRAL COMPOUND CONJUGATES	REGENERON PHARMACEUTICALS, INC.
WO/2021/151038	QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS  EXPRESSING UNIVERSAL IMMUNE RECEPTORS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/151043	METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL  INFECTION	HAN, Jang Hyun
WO/2021/151044	PRODRUG FOR THE TREATMENT OF DISEASE AND INJURY OF OXIDATIVE  STRESS	NACUITY PHARMACEUTICALS, INC.
WO/2021/194618	METHODS FOR TISSUE REGENERATION AND KITS THEREFOR	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/151062	HETEROCYCLIC COMPOUNDS AND USES THEREOF	THE TRUSTEES OF PRINCETON UNIVERISTY
WO/2021/154647	USE OF STATINS TO TREAT OR PREVENT DRUG-INDUCED HEARING LOSS	THE UNITED STATE OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/151079	MODULATING LYMPHATIC VESSELS IN NEUROLOGICAL DISEASE	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/151099	THERAPEUTIC DOUBLE STRANDED RNA AND METHODS FOR PRODUCING THE  SAME	AIM IMMUNOTECH INC.
WO/2021/154682	TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERY	CONVERGASCENT LLC
WO/2021/154687	METHODS FOR TREATING SARS COV-2 INFECTIONS	GILEAD SCIENCES, INC.
WO/2021/154703	COMPOSITIONS INCLUDING ANTIMICROBIAL POLYMER-PEPTIDE  CONJUGATES AND USES THEREOF	UNIVERSITY OF PUERTO RICO
WO/2021/154709	CLATHRIN-CHIMERIC ANTIBODY RECEPTOR CONSTRUCTS FOR IMMUNE CELL  ACTIVATION THERAPY IN VIVO	NANOTOMER, INC.
WO/2021/151104	SALICYLAMIDE DERIVATIVES AND RELATED METHODS OF MAKING	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/257124	TREATMENT WITH ANTI-TIGIT ANTIBODIES AND PD-1 AXIS BINDING  ANTAGONISTS	GENENTECH, INC.
WO/2021/154735	SREBP INHIBITORS COMPRISING A THIOPHENE CENTRAL RING	CAPULUS THERAPEUTICS, LLC
WO/2021/154745	GONORRHEA SUBUNIT VACCINE	OREGON STATE UNIVERSITY
WO/2021/154750	TREATMENT OF ADRENOCORTICAL CARCINOMA WITH SELECTIVE  GLUCOCORTICOID RECEPTOR MODULATORS (SGRMs) AND ANTIBODY CHECKPOINT INHIBITORS	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/154752	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HEPATITIS  B AND D	SVENSKA VACCINFABRIKEN PRODUKTION AB
WO/2021/154761	METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST  ANTIBODY	GENENTECH, INC.
WO/2021/154763	CORONAVIRUS RNA VACCINES	MODERNATX, INC.
WO/2021/154767	METHOD FOR TREATMENT OF ACQUIRED COGNITIVE DEFICITS	CORNELL UNIVERSITY
WO/2021/154773	METHOD OF IMPROVING RESILIENCE AND RECOVERY IN HEALTHY MAMMALS	LONZA CONSUMER HEALTH INC.
WO/2021/154774	JOINT HEALTH COMPOSITION AND USE THEREOF IN HEALTHY MAMMALS	LONZA CONSUMER HEALTH INC.
WO/2021/154812	CORONAVIRUS VACCINE FORMULATIONS	NOVAVAX, INC.
WO/2021/154828	DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES THEREOF	CODAGENIX INC.
WO/2021/154833	IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED  NITRIC OXIDE (iNO) TREATMENT	BELLEROPHON THERAPEUTICS
WO/2021/154839	BISPECIFIC TRANSDUCTION ENHANCER	UMOJA BIOPHARMA, INC.
WO/2021/154845	BIOLOGIC FILLER FOR RESTORING AND REGENERATING TISSUE	GENIPHYS, LLC
WO/2021/154872	COMPOSITIONS INCLUDING PROBIOTIC BACTERIA FOR THE EXPRESSION  AND SECRETION OF ENTEROCINS TO CONTROL CLOSTRIDIA PERFRINGENS-INDUCED  NECROTIC ENTERITIS IN LIVESTOCK AND RELATED METHODS	GENERAL PROBIOTICS, INC.
WO/2021/154882	HDAC6-INHIBITED HUMAN REGULATORY T CELLS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/154886	NATURAL KILLER CELLS FOR TREATMENT OF CORONAVIRUS INFECTION	SORRENTO THERAPEUTICS, INC.
WO/2021/154893	LUNG BIOMARKERS AND METHODS OF USE THEREOF	PROGNOMIQ INC
WO/2021/154917	METHODS OF USING MOMELOTINIB TO TREAT JOINT INFLAMMATION	SIERRA ONCOLOGY, INC.
WO/2021/154921	STRUCTURAL OPTIMIZATION METHOD TO IMPROVE THE THERANOSTIC  PERFORMANCE OF PEPTIDE RECEPTOR-TARGETED RADIONUCLIDE THERAPY FOR CANCERS	UNIVERSITY OF IOWA RESEARCH FOUNDATION
WO/2021/154922	BIOMARKER, METHODS, AND COMPOSITIONS THEREOF FOR EVALUATION OR  MANAGEMENT OF KIDNEY FUNCTION OR DIAGNOSING OR AID IN DIAGNOSING KIDNEY  DYSFUNCTION OR KIDNEY DISEASE	SEQUELA, INC.
WO/2021/154929	COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH	VERASTEM, INC.
WO/2021/154938	BACTERIAL ADMIXTURES	THE JACKSON LABORATORY
WO/2021/154940	LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS,  LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF	CONTRAFECT CORPORATION
WO/2021/154948	PRODRUGS USEFUL IN ADOPTIVE CELL THERAPY	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/154954	COMPOSITIONS AND METHODS FOR TREATING BIOFILMS, INFECTIONS AND  PERIODONTITIS	ETHEIM BIOTICS, LLC
WO/2021/154958	METHODS FOR MATURING AN ARTERIOVENOUS FISTULA	ALUCENT BIOMEDICAL, INC.
WO/2021/154963	TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN  IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS	REGENXBIO INC.
WO/2021/154966	COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS	KAMARI PHARMA LTD.
WO/2021/154969	HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT  FIBROSIS	STANDARD OF CARE CORPORATION
WO/2021/154972	VACCINATION AGAINST ANTIGENS INDUCED IN PATHOGEN-INFECTED  CELLS	UNIVERSITY OF MIAMI
WO/2021/154974	SCREENING FOR INHIBITORS OF PROSTAGLANDIN E SYNTHASE 3 USEFUL  FOR TREATMENT OF PROSTATE CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/154976	METHODS OF TREATING BRAIN CANCER WITH PANOBINOSTAT	SECURA BIO, INC.
WO/2021/154979	STABILIZED MENTHOL AND OTHER VOLATILE COMPOUND COMPOSITIONS  AND METHODS	GHALILI, Babak
WO/2021/154980	SOLID STATE FORMS OF ASCIMINIB AND PROCESSES FOR THE  PREPARATION THEREOF	TEVA PHARMACEUTICALS INTERNATIONAL GMBH
WO/2021/154992	PROCESS AND SYSTEM FOR ACELLULAR THERAPY	ORGENESIS INC.
WO/2021/155002	COMPOSITIONS AND METHODS FOR HAIR	FEREBEE, Rachel
WO/2021/155007	COMPOSITIONS COMPRISING A COMPOUND COMPRISING A PHOSPHATE  GROUP, AND METHODS FOR PROTECTING HAIR	FEREBEE, Rachel
WO/2021/155016	ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND  METHODS OF USE	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/155025	METHOD OF PREVENTING OR TREATING PANCREATIC DYSFUNCTION OR  DIABETES BY UPREGULATING HUMAN CATHELICIDIN LL-37 TO INHIBIT ISLET AMYLOID  POLYPEPTIDE (IAPP) SELF-ASSEMBLY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/155034	COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING MUC16  SPECIFIC FUSION PROTEINS	TCR2 THERAPEUTICS INC.
WO/2021/155042	IL15/IL15R ALPHA HETERODIMERIC FC-FUSION PROTEINS FOR THE  TREATMENT OF CANCER	GENENTECH, INC.
WO/2021/155050	KINASE MODULATORS, PHARMACEUTICAL COMPOSITIONS, AND  THERAPEUTIC APPLICATIONS	BIOTHERYX, INC.
WO/2021/155087	METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/155097	CD40-L BLOCKADE TO ENHANCE SYNTHETIC ANTIBODY THERAPY	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/155100	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/155115	METAL OXIDE SUNSCREEN FORMULATIONS	AMYRIS, INC.
WO/2021/155118	COMPOSITIONS AND METHODS FOR MICROBIAL TREATMENT OF SKIN  DISORDERS	DUPONT US HOLDING, LLC
WO/2021/155119	THERAPEUTICS FOR COVID-19	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/155128	TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION	TEXAS CHILDREN'S HOSPITAL
WO/2021/155129	ANTI-CD30 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE  TREATMENT OF NON-HODGKIN LYMPHOMA	SEAGEN INC.
WO/2021/155130	USE OF POZIOTINIB FOR THE TREATMENT OF CANCERS WITH NRG1  FUSIONS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/155149	METHODS OF INDUCING NEOEPITOPE-SPECIFIC T CELLS WITH A PD-1  AXIS BINDING ANTAGONIST AND AN RNA VACCINE	GENENTECH, INC.
WO/2021/155171	DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR  POLYRIBONUCLEOTIDES	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/155173	TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND  PLASMA HALF-LIFE	ARCUTIS BIOTHERAPEUTICS, INC.
WO/2021/155175	COMPOSITIONS FOR TRANSLATION AND METHODS OF USE THEREOF	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/155177	COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN  MODULATION AND USES THEREOF	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/155178	EYE TREATMENTS EMPLOYING SERUM FROM WHOLE BLOOD	MULLER, David
WO/2021/158440	IMMUNOGENIC COMPOSITIONS TO TREAT AND PREVENT MICROBIAL  INFECTIONS	LONGHORN VACCINES AND DIAGNOSTICS, LLC
WO/2021/155195	COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE,  NEURODEVELOPMENTAL, MYODEGENERATIVE, AND LYSOSOMAL STORAGE DISORDERS	GEORGETOWN UNIVERSITY
WO/2021/155198	NANOMATERIALS FOR TARGETED TREATMENT AND IMAGING OF ANEURYSMAL  MICROENVIRONMENT	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/155212	NOVEL ANTAGONISTS FOR TREATMENT OF GI TRACT CONDITIONS	AIM BIOLOGICS, INC.
WO/2021/155225	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/155229	GUT BACTERIUM-BASED TREATMENT TO INCREASE POULTRY GUT HEALTH  AND FOOD SAFETY	IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/155243	RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS	MODERNATX, INC.
WO/2021/167770	IMMUNE CELL MODULATORS	OCTAGON THERAPEUTICS, INC.
WO/2021/155253	ANAT INHIBITORS AND METHODS OF USE THEREOF	ATOMWISE INC.
WO/2021/155254	AMORPHOUS NILOTINIB MICROPARTICLES AND USES THEREOF	NANOCOPOEIA, LLC
WO/2021/155259	METHODS OF TREATING PSMA-POSITIVE CANCER USING RADIONUCLIDE  THERAPY	CANCER TARGETED TECHNOLOGY LLC
WO/2021/155262	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/155264	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/155265	COMPOSITIONS AND METHODS FOR STEM CELL CHONDROGENESIS	WASHINGTON UNIVERSITY
WO/2021/155267	MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES  THEREOF	MODERNATX, INC.
WO/2021/155274	METHODS OF PREPARING LIPID NANOPARTICLES	MODERNATX, INC.
WO/2021/155277	MODULATION OF IMMUNE CELLS	OCTAGON THERAPEUTICS, INC.
WO/2021/155279	COMPOSITIONS AND METHODS FOR REGULATING FATTY ACIDS	WASHINGTON UNIVERSITY
WO/2021/155281	COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE	APPLIED MOLECULAR TRANSPORT INC.
WO/2021/155288	FIBROBLAST ACTIVATION PROTEIN (FAP) - TARGETED ANTIFIBROTIC  THERAPY	LOW, Philip, Stewart
WO/2021/155292	FIBROBLAST ACTIVATION PROTEIN (FAP) - TARGETED ANTIFIBROTIC  THERAPY	LOW, Philip, Stewart
WO/2021/155296	GENE THERAPY FOR NEURODEGENERATIVE DISORDERS USING  POLYNUCLEOTIDE SILENCING AND REPLACEMENT	PAROS BIO, INC.
WO/2021/155297	METHODS FOR LABELING AND TARGETING CELLS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/155312	PLACENTAL DERIVED NATURAL KILLER CELLS FOR TREATMENT OF  CORONAVIRUS INFECTIONS	CELULARITY INC.
WO/2021/155316	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/155320	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/162879	METHODS AND COMPOSITIONS FOR ANTIMICROBIAL USE OF SYNTHETIC  LYSINE ANALOGS, DERIVATIVES, MIMETICS, AND PRODRUGS	TRANEXAMIC TECHNOLOGIES, LLC
WO/2021/162880	COMPOSITIONS OF VITAMIN A PALMITATE, PROCESSES FOR THEIR  PREPARATION, USES AND METHODS COMPRISING THEM	ADVENT THERAPEUTICS INC.
WO/2021/206787	NOVEL N-ARYL OXAMIC ACIDS	PURDUE RESEARCH FOUNDATION
WO/2021/155337	COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/158463	DIAMINE-LINKED RECEPTOR-SPECIFIC CYCLIC PEPTIDES	PALATIN TECHNOLOGIES, INC.
WO/2021/158464	REVERSE AMIDE-LINKED MELANOCORTIN RECEPTOR-SPECIFIC CYCLIC  PEPTIDES	PALATIN TECHNOLOGIES, INC.
WO/2021/158466	SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF  TREATING REFRACTIVE OCULAR DISORDERS	VTV THERAPEUTICS LLC
WO/2021/158476	MICRORNA-7 COMPOSITIONS FOR PROMOTING FUNCTIONAL RECOVERY  FOLLOWING SPINAL CORD INJURY AND METHODS OF USE THEREOF	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/155355	NANOMATERIALS FOR TARGETED TREATMENT OF PULMONARY TISSUE	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/155383	METHODS AND COMPOSITIONS FOR TARGETED DELIVERY, RELEASE,  AND/OR ACTIVITY	PROTZ, Jonathan M.
WO/2021/158496	DRUG FORMULATIONS FOR RESERVOIR-BASED DELIVERY	MEDTRONIC, INC.
WO/2021/158516	IRE1α MODULATORS AND USES THEREOF	NIMBUS IASO, INC.
WO/2021/158517	COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF  MASTITIS	CUREMAST, INC.
WO/2021/158534	METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN  RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS	SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH  INSTITUTE)
WO/2021/158560	TOPICAL MONTELUKAST FORMULATIONS	TARO PHARMACEUTICAL INDUSTRIES LTD.
WO/2021/158561	METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES	TRANEXAMIC TECHNOLOGIES, LLC
WO/2021/158565	POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA  AND USES THEREOF	CITY OF HOPE
WO/2021/158573	METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS  TO MOLECULES	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158574	COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158575	COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM  ANIONS TO MOLECULES	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158583	REGULATION OF VON WILLEBRAND FACTOR (VWF)	BAND THERAPEUTICS, LLC
WO/2021/158601	METHODS AND COMPOSITIONS RELATED TO THE USE OF ERGOTHIONEINE	BLUE CALIFORNIA
WO/2021/158611	PARTICLES FUNCTIONALIZED WITH IMAGEABLE RADIOISOTOPES AND  METHODS OF MAKING AND USE THEREOF	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/158622	ANTI-FIBRINOLYTIC LOADED PLATELETS	CELLPHIRE, INC.
WO/2021/158625	METHODS OF TREATING ACQUIRED HEMOPHILIA WITH ANTI-FIBRINOLYTIC  LOADED PLATELETS	CELLPHIRE, INC
WO/2021/158626	ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES  THEREOF	ETERNITY BIOSCIENCE INC.
WO/2021/158627	COMPOSITIONS COMPRISING NANOPARTICLES AND METHODS THEREOF	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/158632	FORMULATIONS OF DOCETAXEL	ZHUHAI BEIHAI BIOTECH CO., LTD.
WO/2021/158634	IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/158635	ANTI-VIRAL COMPOSITIONS AND METHODS OF USE	AL THERAPEUTICS, INC.
WO/2021/158645	METHODS OF TREATING CONGENITAL HEMOPHILIA WITH  ANTI-FIBRINOLYTIC LOADED PLATELETS	CELLPHIRE, INC.
WO/2021/158646	TREATMENT OF VON WILLEBRAND DISEASE	CELLPHIRE, INC.
WO/2021/158648	RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS IN PLANTS	VECPROBIO, INC.
WO/2021/158701	METHOD FOR TREATING CORONAVIRUS INFECTIONS	OYAGEN, INC.
WO/2021/158713	FOAM COMPOSITIONS FOR THE TREATMENT OF CANCER	TDL INNOVATIONS LLC
WO/2021/158714	COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/158739	DRUG-LOADED AMINO ACID-BASED POLY(ESTER UREA) FILMS FOR  CONTROLLED LOCAL RELEASE OF NON-OPIOID ANALGESIC COMPOUNDS	BECKER, Matthew
WO/2021/162928	WATER DISPERSIBLE COMPOSITE PARTICLES, METHODS OF MAKING, AND  COATINGS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/158755	LEPTOSPIRAL PROTEINS AND USES THEREOF	YALE UNIVERSITY
WO/2021/158777	TREATMENT OF MENORRHAGIA IN PATIENTS WITH SEVERE VON  WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF	BAXALTA INCORPORATED
WO/2021/158780	SELF-ASSEMBLING PRODRUGS AS IMMUNE BOOSTERS FOR CANCER  IMMUNOTHERAPY	THE JOHNS HOPKINS UNIVERSITY
WO/2021/158783	METHOD OF TREATING A SOLID TUMOR WITH A COMBINATION OF AN IL-7  PROTEIN AND CAR-BEARING IMMUNE CELLS	WASHINGTON UNIVERSITY
WO/2021/158789	CHAOTROPIC AGENTS FOR REDUCING FORMATION OF DOUBLE-STRANDED  RNA	ULTRAGENYX PHARMACEUTICAL INC.
WO/2021/158792	METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY DISEASES OR  DISORDERS	AGIOS PHARMACEUTICALS, INC.
WO/2021/158799	PROPHYLACTIC USES OF ANNEXIN A2	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/158814	GENE THERAPY SYSTEMS AND RELATED METHODS FOR TREATMENT OF  HEARING LOSS	RESCUE HEARING INC.
WO/2021/158815	ZIKA VIRUS IMMUNOGENIC COMPOSITIONS	NEW YORK BLOOD CENTER, INC.
WO/2021/158820	NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND  SYSTEMIC ADMINISTRATION	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/158823	METHODS FOR THE TREATMENT OF SCLERODERMA AND RELATED  CONDITIONS	HZNP LIMITED
WO/2021/158825	COMPOSITIONS AND METHODS FOR NUTRITIONAL SUPPLEMENTS	DAILYCOLORS HEALTH INC.
WO/2021/211191	NOVEL LYMPHOID-SPECIFIC TYROSINE PHOSPHATASE (LYP) INHIBITORS	PURDUE RESEARCH FOUNDATION
WO/2021/158838	DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158839	TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158841	TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158843	TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158844	TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158845	TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158847	TREATMENT AND DOSING REGIMEN FOR S1P RECEPTOR MODULATOR	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158848	DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST	ARGENTUM PHARMACEUTICALS LLC
WO/2021/158850	CHIMERIC ANTIGEN RECEPTORS WITH CD28 MUTATIONS AND USE THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/158851	PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR	HUANG, Cai Gu
WO/2021/158857	ASSAYS FOR DETECTING PEANUT ALLERGIES	ALLERGENIS LLC
WO/2021/162943	2-[2-METHYLAZETIDIN-1-YL]-4-PHENYL-6-(TRIFLUOROMETHYL)-PYRIMIDINE  COMPOUNDS	ELI LILLY AND COMPANY
WO/2021/162944	SUBSTITUTED  7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES	ELI LILLY AND COMPANY
WO/2021/158884	TREATMENT REGIMEN FOR CANCER USING IMMUNOMODULATION	BIOXCEL THERAPEUTICS, INC.
WO/2021/158888	PSYCHEDELIC TREATMENT FOR HEADACHE DISORDERS	YALE UNIVERSITY
WO/2021/158899	ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/158907	COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS	AETIO BIOTHERAPY, INC.
WO/2021/158936	PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS  FOR AMELIORATING HEARING LOSS	GNEDEVA, Ksenia
WO/2021/158937	BORTEZOMIB-LOADED NANOPARTICLES	THE JOHNS HOPKINS UNIVERSITY
WO/2021/158947	COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCER	LI, Xiang
WO/2021/158949	COMBINATION THERAPIES AND BIOMARKERS FOR TREATING B-CELL  LYMPHOMAS	LI, Xiang
WO/2021/158957	DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF	SUMMIT BIOSCIENCES INC.
WO/2021/158960	ANTIBODIES PROTECTIVE AGAINST INFLUENZA B	ELLEBEDY, Ali
WO/2021/158962	T CELL RECEPTORS TARGETING DEFECTIVE DNA REPAIR PROTEINS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/158968	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES	OCULAR THERAPEUTIX, INC.
WO/2021/158969	POLYPEPTIDE AFFINITY LIGANDS AND METHODS OF USING	AVANTOR PERFORMANCE MATERIALS, LLC
WO/2021/158990	THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM  DUST	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/158991	METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/158992	IMPROVED METHODS AND COMPOSITIONS FOR CROMAKALIM PRODRUG  THERAPY	QLARIS BIO, INC.
WO/2021/158996	RNA-LOADED NANOPARTICLES AND USE THEREOF FOR THE TREATMENT OF  CANCER	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/158999	GENE EDITING METHODS FOR TREATING SPINAL MUSCULAR ATROPHY	THE BROAD INSTITUTE, INC.
WO/2021/159011	METHOD FOR TREATING NERVOUS SYSTEM INJURIES USING BOLDINE AND  ANALOGS THEREOF	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/159016	ARTIFICIAL SYNAPSES	DIADEM BIOTHERAPEUTICS INC.
WO/2021/159021	LIPID PRODRUGS OF NEUROSTEROIDS	PURETECH LYT, INC.
WO/2021/159027	TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA	EIGER BIOPHARMACEUTICALS, INC.
WO/2021/225657	PROTECTION FROM IONIZING RADIATION	AVISA MYKO, INC.
WO/2021/159035	ONCOLYTIC VIRUS COMPOSITIONS AND METHODS FOR THE TREATMENT OF  CANCER	CITY OF HOPE
WO/2021/159038	METHODS TO REFINE CANNABINOIDS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/159040	SARS-COV-2 MRNA DOMAIN VACCINES	MODERNATX, INC.
WO/2021/159042	COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS  FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS	UNIGEN, INC.
WO/2021/159044	N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED  THERETO	EMORY UNIVERSITY
WO/2021/159050	COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTION	SHI, Yuenian
WO/2021/167805	TWO-STEP REACTIVE LIP SYSTEM	L'OREAL
WO/2021/159058	NOVEL CANNABINOIDS FORMULATIONS AND THEIR USE FOR THE  TREATMENT OF ACUTE FLACCID MYELITIS	DIVERSE BIOTECH, INC.
WO/2021/159059	COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF  CARDIAC, PULMONARY, DERMAL, AND RENAL FIBROSIS	EMERALD HEALTH PHARMACEUTICALS INC.
WO/2021/159062	COMPOUNDS, COMPOSITIONS, AND METHODS TO TREAT METABOLIC  DISEASE	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/159068	COMPOSITION AND METHOD OF USING GERMINATIVE COMPOUNDS IN  PROBIOTICS FOR INFLAMMATION REDUCTION IN HUMANS	NCH CORPORTION
WO/2021/159075	ATTENUATED <i>SALMONELLA</i> SYNTHESIZING ANTIGENS  FOR VACCINATING AGAINST <i>HELICOBACTER PYLORI</i>	CURTISS, Roy
WO/2021/159076	USES OF GLYCYRRHETINIC ACID, GLYCYRRHIZIC ACID FOR TREATMENT  OF PNEUMONITIS/PNEUMONIA/PULMONARY FIBROSIS	ZHANG, Lurong
WO/2021/159077	COMPOSITIONS AND METHODS FOR ATTENUATING OPIOID INDUCED CARDIO  AND/OR RESPIRATORY DEPRESSION	CASE WESTERN RESERVE UNIVERSITY
WO/2021/167810	COMPOSITIONS FOR SKINCARE AND USE THEREOF	ANJON BIOLOGICS, INC.
WO/2021/159088	GAS PHASE METHODS TO EXTRACT NATURAL PRODUCTS	NATURAL EXTRACTION SYSTEMS, LLC
WO/2021/159092	COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE	GENZYME CORPORATION
WO/2021/159093	INHIBITION OF BETA-ARRESTIN OLIGOMERIZATION IN TAUOPATHY	UNIVERSITY OF SOUTH FLORIDA
WO/2021/159118	COMPOSITION AND METHOD OF MRNA VACCINES AGAINST NOVEL  CORONAVIRUS INFECTION	RNALMMUNE, INC.
WO/2021/163002	HPV VACCINE	MERCK SHARP & DOHME CORP.
WO/2021/163007	THERAPEUTIC COMPOSITION AND METHODS	VISCERA LABS, INC.
WO/2021/163023	STABLE FORMULATIONS OF DRONABINOL	TRYAGX LABS INC.
WO/2021/163024	COMPOSITIONS INCLUDING DICHOTOMOUS COMPOSITE PARTICLES,  ARTICLE INCLUDING THE COMPOSITION, AND STRUCTURES HAVING SUPERHYDROPHOBIC,  SUPEROLEOPHOBIC, OR OMNIPHOBIC SURFACES	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/163037	METHODS OF TREATING AND PREVENTING ENGRAFTMENT ARRHYTHMIAS	UNIVERSITY OF WASHINGTON
WO/2021/163058	METHODS OF STIMULATING AN ANTI-TUMOR RESPONSE USING A  SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/163064	ANTIBODIES AND FUSION PROTEINS THAT BIND TO CCR8 AND USES  THEREOF	JOUNCE THERAPEUTICS, INC.
WO/2021/206799	COMPOUNDS FOR THE TREATMENT OF SARS	PURDUE RESEARCH FOUNDATION
WO/2021/163069	CANCER IMMUNOTHERAPY USING TRANSFUSIONS OF ALLOGENEIC,  TUMOR-SPECIFIC CD4+ T CELLS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/163072	METHOD OF TREATING PANCREATIC CANCER	CEDARS-SINAI MEDICAL CENTER
WO/2021/163131	DEVICE, KIT, AND METHOD FOR ISLET TRANSPLANTATION	YOUHEALTH BIOTECH, LIMITED
WO/2021/163172	OMECAMTIV MECARBIL TABLET	AMGEN INC.
WO/2021/163183	METHODS OF TREATING FABRY DISEASE	AMICUS THERAPEUTICS, INC.
WO/2021/163186	DEUTERATED POLYUNSATURATED FATTY ACIDS OR ESTERS THEREOF FOR  COSMETIC APPLICATIONS	RETROTOPE, INC.
WO/2021/163190	HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR  DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/163192	MYC INHIBITORS AND USES THEREOF	STEMSYNERGY THERAPEUTICS, INC.
WO/2021/163199	TREATMENT OF INFECTIOUS DISEASES	DURECT CORPORATION
WO/2021/163238	CANNABINOID AND MENTHOL TRANSDERMAL DELIVERY SYSTEMS AND  METHODS	GHALILI, Babak
WO/2021/163242	METHODS FOR IMPROVED DELIVERY OF THERAPEUTIC AGENTS	WILLIAM MARSH RICE UNIVERSITY
WO/2021/163246	IMPROVED AQUACULTURE FEED ADDITIVE	HP INGREDIENTS CORP.
WO/2021/163252	TOPICAL NALOXONE COMPOSITIONS AND METHODS FOR USING THE SAME	TEIKOKU PHARMA USA, INC.
WO/2021/163253	PROGESTERONE COMBINATIONS	GLIA, LLC
WO/2021/163272	PLATELET FACTORS AND COGNITIVE IMPROVEMENT	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/163273	USES OF GLUCOCORTICOID RECEPTOR ANTAGONISTS	ORIC PHARMACEUTICALS, INC.
WO/2021/163274	METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS	THE GENERAL HOSPITAL CORPORATION
WO/2021/163281	ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATING PENDRED  SYNDROME	ACCUTAR BIOTECHNOLOGY INC.
WO/2021/163302	COMPOUNDS, COMPOSITIONS, AND METHODS FOR PROTEIN DEGRADATION	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/163304	ACTIVATION OF NEUROPEPTIDE RECEPTORS ON PLASMACYTOID DENDRITIC  CELLS TO TREAT OR PREVENT OCULAR DISEASES ASSOCIATED WITH NEOVASCULARIZATION  AND INFLAMMATION	TUFTS MEDICAL CENTER, INC.
WO/2021/173364	TREATMENT FOR CHEMOBRAIN	YALE UNIVERSITY
WO/2021/163327	COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR  DISORDERS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/163329	ANTI-BCMA THERAPY IN AUTOIMMUNE DISORDERS	CELGENE CORPORATION
WO/2021/188234	METHOD OF TREATING AN INDIVIDUAL WITH A HEALTH CONDITION WITH  FECAL MICROBIOTA TRANSPLANT	HAZAN, Sabine
WO/2021/163338	XPO1 INHIBITORS FOR USE IN TREATING CANCER	KARYOPHARM THERAPEUTICS INC.
WO/2021/163339	CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF  THERAPEUTICS TO HEPATIC STELLATE CELLS	GENEVANT SCIENCES GMBH
WO/2021/173366	SHORT AND LONG-TERM SURFACE DISINFECTANTS UTILIZING ALCOHOL  AND ZINC PYRITHIONE COMPOSITIONS	CAO GROUP, INC
WO/2021/163357	GENE THERAPY VECTORS FOR TREATING HEART DISEASE	TENAYA THERAPEUTICS, INC.
WO/2021/163364	TRISPECIFIC BINDING MOLECULES	ABBVIE BIOTECHNOLOGY LTD.
WO/2021/163365	SARS-COV-2 VACCINE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/163367	EXOGENOUS NITRIC OXIDE FOR IMPROVED SUSCEPTIBILITY AND LOWERED  ANTIBIOTIC RESISTANCE IN RESISTANT RESPIRATORY BACTERIA	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/163375	MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY  AND TREATMENT	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/163386	DEVICES AND METHODS FOR DETERMINING PHOSPHATE LEVELS IN  NATURAL WATER	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/163389	BCMA-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS  AND METHODS AND USES THEREOF	JUNO THERAPEUTICS, INC.
WO/2021/163391	CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS  AND METHODS AND USES THEREOF	JUNO THERAPEUTICS, INC.
WO/2021/163398	T CELL EPITOPE CLUSTERS AND RELATED COMPOSITIONS USEFUL IN THE  PREVENTION, DIAGNOSIS, AND TREATMENT OF COVID-19	EPIVAX, INC.
WO/2021/163400	COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS	CYTOAGENTS, INC.
WO/2021/173367	POWDER COMPOSITIONS HAVING REDUCED FRAGILITY	L'OREAL
WO/2021/163416	METHODS OF MEASURING AND PURIFYING EXTRACELLULAR VESICLES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/163425	MARGARIC ACID DECREASES PIEZ02-MEDIATED PAIN	THE UNITED STATES OF AMERICA, as represented by THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/163427	REGULATORY T CELL EPITOPES AND DETOLERIZED SARS-COV-2 ANTIGENS	EPIVAX, INC.
WO/2021/163429	CONDITIONED MEDIUM FROM CELLS CULTURED UNDER HYPOXIC  CONDITIONS AND USES THEREOF	ALLERGAN SALES, LLC
WO/2021/163432	CO-ADMINISTRATION OF PREDNISOLONE/METHYL PREDNISOLONE AND  ZOLEDRONIC ACID TO TREAT AND PREVENT OSTEOARTHRITIS	LEVOLTA PHARMACEUTICALS, INC.
WO/2021/163438	POLYPEPTIDES, COMPOSITIONS, AND THEIR USE TO TREAT OR LIMIT  DEVELOPMENT OF AN INFECTION	UNIVERSITY OF WASHINGTON
WO/2021/163448	VACCINE AND METHODS FOR DETECTING AND PREVENTING FILARIASIS	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/163452	SMARTCORE COMPOSITIONS AND METHODS	NPI, LLC
WO/2021/211198	INDUCING PRODUCTION OF ANTI-OLIGOMANNOSE ANTIBODIES	SRI INTERNATIONAL
WO/2021/163455	SCALABLE AND FACILE CELL-MEMBRANE-COATING TECHNOLOGY FOR BOTH  POSITIVELY AND NEGATIVELY CHARGED PARTICLES	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/163456	T CELL EPITOPES AND RELATED COMPOSITIONS USEFUL IN THE  PREVENTION, DIAGNOSIS, AND TREATMENT OF COVID-19	EPIVAX, INC.
WO/2021/163466	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBTORS FOR TREATING  <i>TP53</i>-MUTATED ACUTE MYELOID LEUKEMIA	CHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/163467	LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF,  AND USE THEREOF	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/163472	MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION	THE GENERAL HOSPITAL CORPORATION
WO/2021/163484	METHODS OF GENERATING AND USING SENESCENT-INDUCED CELLS FOR  TREATMENT OF CANCER AND COMPOSITIONS RELATING THERETO	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/163490	TARGETED DEPLETION OF BACTERIA FROM MIXED POPULATIONS THROUGH  PROGRAMMABLE CELL-CELL ADHESION	UNIVERSITY OF WASHINGTON
WO/2021/163499	TAZ GENE OR ENZYME REPLACEMENT THERAPY	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/163501	GAS AND LIQUID FLOW REGULATION SYSTEM FOR CELL CULTURE	XCELL BIOSCIENCES, INC.
WO/2021/163504	FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF  TREATING INFLAMMATORY DISEASE	AMGEN INC.
WO/2021/163513	HEAT SHOCK PROTEIN MODULATORS AND ANTI-HUNTINGTON DISEASE  THERAPEUTIC AGENTS	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/163520	POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND  THEIR MEDICAL USES	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/163528	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PRURITUS	LENUS THERAPEUTICS, LLC
WO/2021/163529	BUPRENORPHINE TREATMENTS	BIODELIVERY SCIENCES INTERNATIONAL, INC.
WO/2021/163530	THERAPEUTIC COMBINATIONS COMPRISING  UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS AND POLY  (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS	KSQ THERAPEUTICS, INC.
WO/2021/167845	ORAL CARE COMPOSITION	SUNSTAR AMERICAS, INC.
WO/2021/163549	COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS	SANOFI BIOTECHNOLOGY
WO/2021/163550	HAPLOTYPE-BASED TREATMENT OF RP1 ASSOCIATED RETINAL  DEGENERATIONS	MASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/163580	METHODS FOR TREATING TAUOPATHY	RETROTOPE, INC.
WO/2021/163585	TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION	TEXAS CHILDREN'S HOSPITAL
WO/2021/163594	TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS	FIGENE, LLC
WO/2021/163602	RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER	THE JOHNS HOPKINS UNIVERSITY
WO/2021/163610	TREATMENT OF OTIC DISEASES AND CONDITIONS	SPIRAL THERAPEUTICS INC.
WO/2021/163620	PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF	THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/163622	VACCINES AND USES THEREOF TO INDUCE AN IMMUNE RESPONSE TO  SARS-COV2	GEOVAX, INC.
WO/2021/163627	MACROCYCLIC ULK1/2 INHIBITORS	SALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/163629	INHIBITORS OF ULK1/2 AND METHODS OF USING SAME	SALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/163631	CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENT	WESTERN UNIVERSITY OF HEALTH SCIENCES
WO/2021/163633	MONO AND COMBINATION THERAPIES WITH ULK1/2 INHIBITORS	SALK INSTITUTE FOR BIOLOGICAL STUDIES
WO/2021/211201	NOVEL FLAME RETARDANT RESIN	PURDUE RESEARCH FOUNDATION
WO/2021/173373	INJECTABLE CONTROLLED-RELEASE FORMULATIONS OF PROGESTOGEN  DRUGS	FORDOZ PHARMA CORP.
WO/2021/183259	FAMOTIDINE AND FAMOTIDINE ANALOGS FOR CORONA VIRUS TREATMENT	NANOPHARMACEUTICS, INC.
WO/2021/167860	GEMFIBROZIL FORMULATION	POLARYX THERAPEUTICS, INC.
WO/2021/163666	SMALL MOLECULE REGULATORS OF NOTCH1 AND USES THEREOF	SHARMA, Arun K.
WO/2021/163672	TRANSFERABLE MICROBIOTA FOR THE TREATMENT OF ULCERATIVE  COLITIS	CORNELL UNIVERSITY
WO/2021/167879	TELOMERE LENGTH MODULATION USING FIBROBLASTS	SPINALCYTE, LLC
WO/2021/167882	ANTIVIRAL COMPOUNDS	GILEAD SCIENCES, INC.
WO/2021/167883	METHOD FOR TREATING ASTHMA OR ALLERGIC DISEASE	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/167885	CD137 BINDING MOLECULES AND USES THEREOF	MACROGENICS, INC.
WO/2021/163683	INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS  AND USES THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/167894	COMPOSITIONS AND METHODS FOR TREATING MALARIA	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/163693	METHODS OF MANUFACTURING EXTRACELLULAR MATRIX USING ASPARTYL  ALANYL DIKETOPIPERAZINE (DA-DKP)	PUR BIOLOGICS, INC.
WO/2021/167915	HUMAN 4-1BB AGONIST ANTIBODIES AND METHODS OF USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/167920	DEVICES, SYSTEMS AND METHODS FOR SENSING AND DISCERNING  BETWEEN FAT AND MUSCLE TISSUE DURING MEDICAL PROCEDURES	APYX MEDICAL CORPORATION
WO/2021/167942	TRANSMUCOSAL DRUG DELIVERY SYSTEM	NORTH ATLANTIC HOLDINGS LLC
WO/2021/167949	COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASE	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/167964	PILRA ANTIBODIES AND METHODS OF USE THEREOF	ALECTOR LLC
WO/2021/167974	<i>N</i>-ACETYLCYSTEINE COMPOSITIONS AND METHODS	NEVAKAR INC.
WO/2021/173399	COSMETIC COMPOSITIONS CONTAINING A SUGAR ALCOHOL, A SACCHARIDE  COMPOUND AND PECTIN AND METHODS OF USE	L'OREAL
WO/2021/167996	GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH  POLYSACCHARIDE-PROTEIN CONJUGATES	VAXCYTE, INC.
WO/2021/168004	ANTIVIRAL COMPOUNDS	GILEAD SCIENCES, INC.
WO/2021/168008	A  5-(4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZIN-7-YL)-2-CYANO-3,4-DIHYDROXYTETRAHYDROFURANE  DERIVATIVE AS ANTIVIRAL AGENT	GILEAD SCIENCES, INC.
WO/2021/168015	METHODS OF BARCODING NUCLEIC ACID FOR DETECTION AND SEQUENCING	UNIVERSAL SEQUENCING TECHNOLOGY CORPORATION
WO/2021/168042	CELL-CULTURE BIOREACTOR	ORGENESIS INC.
WO/2021/168043	THERAPEUTIC AGENT NANOPARTICLES AND METHODS OF PREPARATION	NANO PHARMASOLUTIONS, INC.
WO/2021/168044	COMPOSITION AND METHOD TO ENHANCE COGNITIVE SUPPORT AND BRAIN  HEALTH	NUTRISCIENCE INNOVATIONS LLC
WO/2021/168082	SPECIFIC TRYPTAMINES FOR USE IN THE TREATMENT OF MOOD  DISORDERS	GILGAMESH PHARMACEUTICALS, INC.
WO/2021/168100	FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF  USING THE SAME	AMGEN INC.
WO/2021/168106	DEUTERATED NEUROSTEROID	PRAXIS PRECISION MEDICINES, INC.
WO/2021/173419	COMPOSITIONS AND METHODS OF TREATING CANCER	TILLEAD THERAPEUTICS, INC.
WO/2021/168110	THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS  ASSOCIATED WITH ABNORMAL EXPRESSION OF A NEURAL-ASSOCIATED GENE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/168122	SINGLE CHAIN TRIMER MHC CLASS II NUCLEIC ACIDS AND PROTEINS  AND METHODS OF USE	INSTITUTE FOR SYSTEMS BIOLOGY
WO/2021/168133	ISOPROTERENOL COMPOSITIONS AND METHODS	NEVAKAR INC.
WO/2021/168135	COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE IN  TRANSPLANTATION RECIPIENTS	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/168140	ADENO-ASSOCIATED VIRAL (AAV)-MEDIATED SGPL1 GENE THERAPY FOR  TREATMENT OF SPHINGOSINE-1-PHOSPHATE LYASE INSUFFICIENCY SYNDROME (SPLIS)	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND
WO/2021/168147	BACTERIOPHAGE COMPOSITIONS FOR TREATING  <i>STAPHYLOCOCCUS</i> INFECTION	ARMATA PHARMACEUTICALS, INC.
WO/2021/168161	USE OF CYCLOSPORINE ANALOGUES FOR TREATING FIBROSIS	HEPION PHARMACEUTICALS, INC.
WO/2021/168169	ANTI-BAFF RECEPTOR ANTIBODIES AND USES THEREOF	YINNUOLAI BIOTECH LTD.
WO/2021/168170	COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT  AMORPHOUS GRADE POLYLACTIC ACID RESIN	NATUREWORKS LLC
WO/2021/168173	METHODS AND COMPOSITIONS FOR TREATING VIRAL RESPIRATORY  INFECTIONS	SYNKINE THERAPEUTICS, INC.
WO/2021/168186	RECOMBINANT MYXOMA VIRUSES AND USES THEREOF	BARTEE, Eric
WO/2021/168194	ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS	DENALI THERAPEUTICS INC.
WO/2021/168199	GENERATION OF AIRWAY BASAL STEM CELLS FROM HUMAN PLURIPOTENT  STEM CELLS	TRUSTEES OF BOSTON UNIVERSITY
WO/2021/168200	IDENTIFICATION OF AN EGFR-BIN3 PATHWAY THAT ACTIVELY  SUPPRESSES INVASION AND REDUCES TUMOR SIZE IN GLIOBLASTOMA	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/168202	EGFR INHIBITION TRIGGERS AN ADAPTIVE RESPONSE BY CO-OPTING  ANTIVIRAL SIGNALING PATHWAYS IN LUNG CANCER	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/168206	L-SEPIAPTERIN AND METHODS OF USE FOR TREATING DISEASES AND  DISORDERS	MUSC FOUNDATION FOR RESEARCH DEVELOPMENT
WO/2021/168216	CRISPR/CAS9 CORRECTION OF MUTATIONS IN DYSTROPHIN EXONS 43, 45  AND 52	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/168218	COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING  OCULAR DISORDERS	CLEARSIDE BIOMEDICAL, INC.
WO/2021/168235	COMPOSITIONS OF SOLUBLE BETA GLUCAN AND RELATED METHODS	KEMIN INDUSTRIES, INC.
WO/2021/168239	SUPRACHOROIDAL DELIVERY OF DRUG PARTICLES TO REDUCE TOXICITY	THE JOHNS HOPKINS UNIVERSITY
WO/2021/173442	IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION  OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/168266	ERADICATION OF MERKEL CELL POLYOMAVIRUS	TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/168271	DROPLET FORMATION AND PARTICLE MORPHOLOGY	ELEKTROFI, INC.
WO/2021/168274	NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF	SILVERBACK THERAPEUTICS, INC.
WO/2021/168283	THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER USING  BRAF AND/OR MEK INHIBITOR COMBINATION THERAPY	VANDERBILT UNIVERSITY
WO/2021/168290	MULTILAMELLAR RNA NANOPARTICLES AND METHODS OF SENSITIZING  TUMORS TO TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/168295	USE OF NICOLSAMIDE FORMULATIONS FOR ANTIVIRAL THERAPY	YOURCHOICE THERAPEUTICS, INC.
WO/2021/168303	FLT3 BINDING PROTEINS AND METHODS OF USE	HARPOON THERAPEUTICS, INC.
WO/2021/168312	AFFINITY MOLECULES AND ASSAYS FOR SARS-COV-2 NUCLEOCAPSID  ANTIGENS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/168318	VACCINE COMPOSITIONS FOR PREVENTING CORONAVIRUS DISEASE	INTERNATIONAL AIDS VACCINE INITIATIVE INC.
WO/2021/168321	COMPOSITION AND METHODS FOR TREATING INFECTIOUS AGENTS USING  PATHOGEN-SPECIFIC ANTIBODIES	ANUBIS BIO CORPORATION
WO/2021/168328	NICLOSAMIDE FORMULATIONS FOR USE AS CONTRACEPTIVE	YOURCHOICE THERAPEUTICS, INC.
WO/2021/173449	ORTHOGONAL SAFETY SWITCHES TO ELIMINATE GENETICALLY ENGINEERED  CELLS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/168349	PHARMACEUTICAL COMPOSITIONS OF ALPHA-2-ADRENERGIC RECEPTOR  AGONISTS AND THEIR USE FOR IMPROVING VISION	ALLERGAN, INC.
WO/2021/168350	ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR REDUCING REDNESS AND  INCREASING WHITENESS IN EYES AND OTHER OPHTHALMIC PURPOSES	ALLERGAN, INC.
WO/2021/168363	SYSTEMS AND METHODS RELATED TO CANCER	PREDICTIVE TECHNOLOGY GROUP, INC.
WO/2021/168375	CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY	KITE PHARMA, INC.
WO/2021/168376	CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY	KITE PHARMA, INC.
WO/2021/168379	BISPECIFIC GD2 AND B7H2 BINDING MOLECULES AND METHODS OF USE	WIN THERAPEUTICS, INC.
WO/2021/168386	GLP-1R AND GCGR AGONISTS, FORMULATIONS, AND METHODS OF USE	SPITFIRE PHARMA LLC
WO/2021/168388	YEAST DISPLAY LIBRARIES, ASSOCIATED COMPOSITIONS, AND  ASSOCIATED METHODS OF USE	3T BIOSCIENCES, INC.
WO/2021/173459	PLATELET ACTIVATION USING SPECIFIC FREQUENCIES	CELL CODE, LLC
WO/2021/173468	USE OF RADIATION TO PREDISPOSE PLATELET ACTIVATION	CELL CODE, LLC
WO/2021/173474	CYCLOSPORINE COMPOSITIONS AND METHODS OF USE	BACAINN BIOTHERAPEUTICS, LTD.
WO/2021/173476	COMPOUNDS, PHARMACEUTICAL FORMULATIONS, AND METHODS FOR  TREATMENT OF CANCER	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/173482	IMPROVED ALKYL BENZOATE SOLUBILIZED ORGANIC SUNSCREEN FILTERS	ETHOX CHEMICALS, LLC
WO/2021/168403	METHODS OF TREATING IDIOPATHIC HYPERSOMNIA	JAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/168405	COMPOSITIONS AND METHODS FOR ORGAN-PROTECTIVE EXPRESSION AND  MODULATION OF CODING RIBONUCLEIC ACIDS	COMBINED THERAPEUTICS, INC.
WO/2021/168410	ELECTROSPUN STRUCTURES HAVING A PHARMACEUTICAL AND METHODS OF  MAKING AND USING THE SAME	NANOFIBER SOLUTIONS, LLC
WO/2021/168413	BASIC DOMAIN-DELETED DNASE1-LIKE 3 AND USES THEREOF	NEUTROLIS, INC.
WO/2021/168421	METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY  INHIBITORS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/168430	COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY	CASE WESTERN RESERVE UNIVERSITY
WO/2021/168434	IGG VARIANTS FOR INDUCTION OF IMMUNE RESPONSE WITHOUT ADJUVANT	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/202013	ANTI-GIPR ANTIBODY AND METHODS OF USE THEREOF	CRYSTAL BIOSCIENCE INC.
WO/2021/194672	COMPOSITIONS AND METHODS FOR DELIVERY OF RNA	HDT BIO CORP.
WO/2021/168446	COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATMENT OF  NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE	MITOKININ, INC.
WO/2021/168447	NANO-PENETRATIVE CANNABINOID OIL BLENDS AND COMPOSITIONS AND  METHODS OF FORMULATION THEREOF	THERAGUN, INC.
WO/2021/173523	HOT MELT EXTRUDED SOLID DISPERSIONS CONTAINING A BCL2  INHIBITOR	NEWAVE PHARMACEUTICAL INC.
WO/2021/173524	SOS1 INHIBITORS	MIRATI THERAPEUTICS, INC.
WO/2021/173526	THERAPEUTIC DELIVERY OF LOCKED NUCLEIC ACID CONJUGATED  ANTISENSE MIR-1	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/202014	ANTI-ANDROGEN OR AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATMENT  OF A VIRAL RESPIRATORY INFECTION	APPLIED BIOLOGY, INC.
WO/2021/173533	COMPOSITIONS COMPRISING METHYLPHENIDATE-PRODRUGS, PROCESSES OF  MAKING AND USING THE SAME	KEMPHARM, INC.
WO/2021/173537	FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIES	MEDIMMUNE, LLC
WO/2021/173538	METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN ALLERGY  OR ANAPHYLAXIS	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/173550	APOAEQUORIN AND CURCUMIN CONTAINING COMPOSITIONS AND METHODS	QUINCY BIOSCIENCE, LLC
WO/2021/178166	COMPOSITIONS AND METHODS FOR ASSESSING THE EFFICACY OF  INHIBITORS OF NEUROTRANSMITTER TRANSPORTERS	DENOVO BIOPHARMA LLC
WO/2021/173586	NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR  RECEPTORS AND USE FOR TREATING CANCER	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/173592	SYNTHETIC ROCAGLATES WITH BROAD-SPECTRUM ANTIVIRAL ACTIVITIES  AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/173593	INDOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE  DISEASES	GALYAN BIO, INC.
WO/2021/173598	COMBINATION DECITABINE AND CEDAZURIDINE SOLID ORAL DOSAGE  FORMS	OTSUKA PHARMACEUTICAL CO., LTD.
WO/2021/173614	SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATING KERATINOUS  SUBSTRATES	L'OREAL
WO/2021/173624	EUTECTIC BASED ANESTHETIC COMPOSITIONS AND APPLICATIONS  THEREOF	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/173632	METHODS FOR MONITORING THE PROGRESS OF POLYSACCHARIDE  SIZE-REDUCTION	MERCK SHARP & DOHME CORP.
WO/2021/173641	IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT	VANDA PHARMACEUTICALS INC.
WO/2021/173650	PLACENTAL TISSUE COMPOSITIONS AND METHODS	AZIYO BIOLOGICS INC.
WO/2021/173658	NAPHTHOQUINONE-BASED CHALCONE DERIVATIVES AND USES THEREOF	HOFMANN, Robert F.
WO/2021/173677	POTENT AND SELECTIVE DEGRADERS OF ALK	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/183287	STEM CELL COMPOSITIONS AND METHODS OF REPAIRING TISSUE	SMSBIOTECH, INC.
WO/2021/173702	COMPOSITIONS AND METHODS FOR TREATING CANCER AND TUMOR	OBLATO, INC.
WO/2021/173707	COMPOSITIONS AND METHODS FOR TREATMENT OF CYTOKINE STORM AND  CYTOKINE RELEASE SYNDROME	YINUOKE MEDICINE SCIENCE TECHNOLOGY COMPANY LTD.
WO/2021/173712	MOLECULAR BIOMARKERS AND TARGETS FOR FUCHS' ENDOTHELIAL  CORNEAL DYSTROPHY AND GLAUCOMA	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/173713	HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19	ATEA PHARMACEUTICALS, INC.
WO/2021/173721	SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND  METHODS OF USE THEREOF	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/173723	USE OF CYCLOSPORINE ANALOGUES FOR TREATING CANCER	HEPION PHARMACEUTICALS, INC.
WO/2021/173724	SYSTEMS AND METHODS FOR PROTECTING NUCLEIC-ACID MOLECULES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/173731	SELECTIVE ANDROGEN RECEPTOR COVALENT ANTAGONISTS (SARCAS) AND  METHODS OF USE THEREOF	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/173740	METHODS OF TREATING PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS  USING AN INHIBITOR OF BRUTON'S TYROSINE KINASE	GENENTECH, INC.
WO/2021/173741	COMFREYNS, ARYLNAPHTHALENE LIGNANS THAT INHIBIT  PRO-INFLAMMATORY GENE EXPRESSION, AND PHARMACEUTIC COMPOSITION COMPRISING  THEM	THE PROCTER & GAMBLE COMPANY
WO/2021/173744	METHODS OF TREATMENT OF INFLAMMATORY CYTOKINE-RELATED  ARTHRITIC DISORDERS	BRIDGE PHARMA, INC.
WO/2021/173749	COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH	AMPLIFICA, INC.
WO/2021/173770	POLYMERIC STABILIZING AGENTS FOR IMPLANTABLE DRUG DELIVERY  DEVICES	NANO PRECISION MEDICAL, INC.
WO/2021/173773	CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOF	MEDIBOSTON, INC.
WO/2021/173783	ANTIBODIES CONJUGATED WITH FATTY ACID MOLECULES AND USES  THEREOF	PHANES THERAPEUTICS, INC.
WO/2021/173797	ENZYMES FOR SIALYLATION OF GLYCANS	MOMENTA PHARMACEUTICALS, INC.
WO/2021/173802	CHEMICALLY-STABILIZED ALLOSTERIC MODULATORS OF LEUCINE-RICH  REPEAT KINASE 2 (LRRK2)	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/173806	METHOD OF TREATING DISEASES	ERGO HEALTH LLC
WO/2021/173808	RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES ASSOCIATED  WITH URIC ACID AND METHODS OF USE THEREOF	SYNLOGIC OPERATING COMPANY, INC.
WO/2021/178209	APTAMERS AND USE THEREOF	APTITUDE MEDICAL SYSTEMS, INC.
WO/2021/173829	VACCINES AGAINST CORONAVIRUS AND METHODS OF USE	INOVIO PHARMACEUTICALS, INC.
WO/2021/173832	CANCER TREATMENT METHODS	BOLT BIOTHERAPEUTICS, INC.
WO/2021/173838	METHODS, KITS AND COMPOSITIONS FOR NOVEL AGAROSE-BASED DERMAL  FILLER WITH ENHANCED RHEOLOGICAL PROPERTIES PROVIDING SAFETY FEATURES	ADVANCED AESTHETIC TECHNOLOGIES, INC.
WO/2021/173840	IMPROVED PROCESSES OF PREPARING MRNA-LOADED LIPID  NANOPARTICLES	TRANSLATE BIO, INC.
WO/2021/173847	COBRA1/NELF-B AS A BOOSTER FOR EFFICACY OF CD8+ T CELL-BASED  THERAPY	THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED  NOT-FOR-PROFIT CORPORATION
WO/2021/178218	NAIL LACQUER WITHOUT NITROSAMINE	COTY INC.
WO/2021/173870	COMPOSITION AND METHOD TO PREPARE LONG-ACTING INJECTABLE  SUSPENSION CONTAINING MULTIPLE CANCER DRUGS	UNIVERSITY OF WASHINGTON
WO/2021/173879	IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF	LIGANDAL, INC.
WO/2021/173889	USES OF ANTI-CD3 ANTIBODY FOLATE BIOCONJUGATES	AMBRX, INC.
WO/2021/173892	ANIMAL MODELS OF LIPID METABOLISM AND METHODS OF TREATING  HYPERLIPIDEMIA OR HYPERLIPIDEMIA-RELATED DISEASES	ACADEMIA SINICA
WO/2021/173896	MATERIALS AND METHODS FOR MODULATING AN IMMUNE RESPONSE	JANSSEN BIOTECH, INC.
WO/2021/173907	HIGH DOSE INFLUENZA VACCINE FOR PEDIATRIC SUBJECTS	SANOFI PASTEUR, INC.
WO/2021/173920	METHODS FOR DETECTING FOOD ALLERGIES	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/173922	CATALASE NANOCAPSULES AND METHODS FOR USE	VIVIBABA, INC.
WO/2021/173923	PYRROLIDINE-FUSED HETEROCYCLES	ERASCA, INC.
WO/2021/173925	NONVIRAL GENERATION OF GENOME EDITED CHIMERIC ANTIGEN RECEPTOR  T CELLS	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/173929	COMPOSITIONS AND METHODS FOR TREATING MISFOLDED PROTEIN OCULAR  DISORDERS	CASE WESTERN RESERVE UNIVERSITY
WO/2021/173930	KCNT1 INHIBITORS AND METHODS OF USE	PRAXIS PRECISION MEDICINES, INC.
WO/2021/173936	ORAL FAST-DISPERSING DOSAGE FORM OF RIMEGEPANT	BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
WO/2021/178232	INHALABLE FORMULATION OF A SOLUTION CONTAINING GLYCOPYRRONIUM  BROMIDE	HUANG, Cai Gu
WO/2021/173948	METHODS FOR ENRICHING MARROW INFILTRATING LYMPHOCYTES  ("MILS"), COMPOSITIONS CONTAINING ENRICHED MILS, AND METHODS OF  USING ENRICHED MILS	WINDMIL THERAPEUTICS, INC.
WO/2021/173954	COMPOSITIONS COMPRISING HYDROLYSED PROTEINS	CRODA, INC.
WO/2021/173960	TREATMENT OF CARM1-OVEREXPRESSING AND/OR ARID1A MUTANT CANCERS  WITH IRE-1/XBP-1 INHIBITORS	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/173962	METHODS AND MATERIALS FOR DIAGNOSIS AND TREATMENT OF NEURONAL  DISORDER	GENEMO, INC.
WO/2021/173964	METHODS FOR ACTIVATION AND EXPANSION OF TUMOR INFILTRATING  LYMPHOCYTES	KSQ THERAPEUTICS, INC.
WO/2021/173965	IDENTIFICATION OF VARIABLE INFLUENZA RESIDUES AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/173972	PENTAGALLOYL GLUCOSE DERIVED FROM SCHINUS PLANTS AND METHODS  OF USE	EMORY UNIVERSITY
WO/2021/178239	SYSTEMS AND METHODS FOR CARBON DIOXIDE ENHANCED DELIVERY OF  TOPICAL SUBSTANCES	CRYOCONCEPTS LP
WO/2021/173985	METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS	NOVARTIS AG
WO/2021/173987	CELL-TARGETED NANOPARTICLES TO INHIBIT RNA CARGO	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/183303	COMPOSITIONS AND METHODS FOR NALOXONE DELIVERY	PURDUE PHARMA L. P.
WO/2021/173999	METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING  INTRAOCULAR PRESSURE	NORTHWESTERN UNIVERSITY
WO/2021/174000	STABILIZED COATED BUTYRATE FOR COLON RELEASE	BIOKIER, INC.
WO/2021/174003	COMPOSITIONS AND METHODS FOR REDUCING RESISTANCE TO OR  ENHANCING IMMUNOTHERAPY	WASHINGTON UNIVERSITY
WO/2021/174013	METHODS AND COMPOSITIONS USING SYNTHETIC NANOCARRIERS  COMPRISING IMMUNOSUPPRESSANT	SELECTA BIOSCIENCES, INC.
WO/2021/174019	COMPOUNDS AND METHODS FOR MODULATING SMN2	IONIS PHARMACEUTICALS, INC.
WO/2021/174021	TUNABLE EXTENDED RELEASE HYDROGELS	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/174024	METHODS OF TREATING IATROGENIC AUTOIMMUNE COLITIS	FIRST WAVE BIO, INC.
WO/2021/174026	RADIATION CURABLE PHASE CHANGE MATERIAL SOLUTIONS AND SHAPE  STABLE THERMOSET PHASE CHANGE MATERIAL GELS FORMED THEREFROM	MICROTEK LABORATORIES, INC.
WO/2021/174034	MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION	GENZYME CORPORATION
WO/2021/174039	DELIVERY OF LOW VISCOSITY FORMULATIONS	JAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/174041	COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION	EVELO BIOSCIENCES, INC.
WO/2021/174045	RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND  THERANOSTIC USES THEREOF	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/174052	MITIGATION OF STATISTICAL BIAS IN GENETIC SAMPLING	FOUNDATION MEDICINE, INC.
WO/2021/174055	TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED TUMOR REACTIVITY	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC.
WO/2021/174059	METHOD FOR REMOVING HOST CELL DNA FROM VIRUS PREPARATION	TAKEDA VACCINES, INC.
WO/2021/174069	DIROFILARIA VOLATILE ORGANIC COMPOUND SIGNATURES AND USES  THEREOF	AUBURN UNIVERSITY
WO/2021/178246	GENE VECTOR CONTROL BY CARDIOMYOCYTE-EXPRESSED MICRORNAS	TENAYA THERAPEUTICS, INC.
WO/2021/174109	DISSEMINATED NEOPLASIA CELLS AND METHODS OF THEIR USE TO  CONTROL INVASIVE OR PEST SPECIES	BIOMILAB, LLC
WO/2021/174113	BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND  METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/174116	METHODS FOR OPIATE AND OPIOID OVERDOSE PREVENTION AND REVERSAL	TORRALVA MEDICAL THERAPEUTICS LLC
WO/2021/174128	COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST  SARS-COV-2	UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/174132	COMPOSITIONS COMPRISING SELF-ASSEMBLING VACCINES AND METHODS  OF USING THE SAME	THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY
WO/2021/174134	FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE SKIN GRAFT HEALING	MICROCURES, INC.
WO/2021/174135	COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF  DOING THE SAME	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/174142	RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-COV-2 VIRUS	TONIX PHARMACEUTICALS HOLDING CORP.
WO/2021/174149	FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING	MICROCURES, INC.
WO/2021/178253	ANTI-CD19 ANTIBODIES AND METHODS OF USING AND MAKING THEREOF	SYSTIMMUNE, INC.
WO/2021/174164	COMPOUNDS AND METHODS FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/174165	HETEROCYCLIC AMIDES AND THEIR USE FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/174167	COMPOUNDS AND METHODS FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/174168	METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE  EDITING AND GENE THERAPY	BLUEALLELE, LLC
WO/2021/178257	VIRUS-LIKE PARTICLE VACCINES FOR OPIOID DRUGS	UNM RAINFOREST INNOVATIONS
WO/2021/174173	TREATING AUTOSOMAL DOMINANT BESTROPHINOPATHIES AND METHODS FOR  EVALUATING SAME	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/178260	DELIVERY OF COSMETIC AGENTS, COMPOSITIONS AND USE THEREOF	ELC MANAGEMENT LLC
WO/2021/178261	METHODS FOR REPAIRING SKIN USING NANOFIBERS	ELC MANAGEMENT LLC
WO/2021/174183	ENCAPSULATED CLEANSING COMPOSITION	HENKEL IP & HOLDING GMBH
WO/2021/174188	A PERSONAL CARE PRODUCT AND A METHOD FOR MAKING A PERSONAL  CARE PRODUCT BY AN ADDITIVE PROCESS	HENKEL IP & HOLDING GMBH
WO/2021/178296	THERAPEUTIC USES OF MACROCYCLIC COMPOUNDS	TURNING POINT THERAPEUTICS, INC.
WO/2021/174192	CONDITIONING COMPOSITION	HENKEL IP & HOLDING GMBH
WO/2021/174193	METHOD OF MANUFACTURING PEPTIDE NANOPARTICLES	DUPAGE MEDICAL TECHNOLOGY, INC.
WO/2021/178306	CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST	DYNAVAX TECHNOLOGIES CORPORATION
WO/2021/174195	USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER	THE UNIVERSITY OF VERMON
WO/2021/174198	SELECTIVE MODULATION OF TRANSFORMING GROWTH FACTOR BETA  SUPERFAMILY SIGNALING VIA MULTI-SPECIFIC ANTIBODIES	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/221782	CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/174205	PRODRUGS OF NEUROACTIVE STEROIDS	BRII BIOSCIENCES, INC.
WO/2021/178318	CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST	DYNAVAX TECHNOLOGIES CORPORATION
WO/2021/178321	CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST	DYNAVAX TECHNOLOGIES CORPORATION
WO/2021/174217	COMPOSITIONS, METHODS, DEVICES, AND KITS FOR DETECTING THE  NUMBER AND GENOMIC LOCATIONS OF POLYMORPHIC LINE-1 ELEMENTS IN AN INDIVIDUAL	ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/178346	METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS BY  ADMINISTRATION OF TAFENOQUINE	60 DEGREES PHARMACEUTICALS LLC
WO/2021/178351	TRICYCLIC DITERPENE ISOLATED FROM PINE ROSIN FOR THE TREATMENT  OF PAIN AND INFLAMMATION	UNIVERSITY OF SOUTH FLORIDA
WO/2021/178355	NEW INHIBITORS FOR THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/178371	A PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING  SERRATIOPEPTIDASE, MANNOSE OR ITS DERIVATIVE, AND OPTIONALLY ANTINFECTION  AGENTS	PATEL, Nimesh
WO/2021/178395	FIBROBLAST AND TLR ACTIVATED FIBROBLAST TREATMENT OF VIRAL  INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME	FIGENE, LLC
WO/2021/178396	IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY  INTO IMMUNE CELLS	TRUSTEES OF TUFTS COLLEGE
WO/2021/202031	PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY  FOR CORONAVIRUS	FIGENE, LLC
WO/2021/202032	FIBROBLAST MEDIATED EXPANSION AND AUGMENTATION OF IMMUNE  REGULATORY CELLS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)	FIGENE, LLC
WO/2021/178406	USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS	AMPLYX PHARMACEUTICALS, INC.
WO/2021/178416	IMMUNE-MEDIATED CORONAVIRUS TREATMENTS	HEAT BIOLOGICS, INC.
WO/2021/178417	COMPOSITIONS CONTAINING RAPID-ACTING INSULIN ANALOGUES	THERMALIN INC.
WO/2021/178437	GLUCOSE TRIPTOLIDE CONJUGATES AND USES THEREOF	THE JOHNS HOPKINS UNIVERSITY
WO/2021/178449	COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATIC  CANCER	WASHINGTON UNIVERSITY
WO/2021/178465	BUCCAL AND ENTERIC DELIVERY OF FATTY ACIDS WITH ORAL HYGIENE  PRACTICES	CLEAR LAKE RESEARCH, LLC
WO/2021/178471	USE OF QX314 TO PREVENT SYMPATHOEXCITATION ASSOCIATED WITH  ADMINISTRATION OF TRPV1 MODULATORS	NEUCURES, INC.
WO/2021/178481	PROTEIN NANOPARTICLE DESIGN AND APPLICATION	DUKE UNIVERSITY
WO/2021/178485	PYRIMIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USES	SHIH, Chuan
WO/2021/178488	EIF4E INHIBITORS AND USES THEREOF	PIC THERAPEUTICS, INC.
WO/2021/178510	COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE  TRANSCARBAMYLASE DEFICIENCY	ARCTURUS THERAPEUTICS, INC.
WO/2021/178514	CARDIOSPHERE-DERIVED CELLS, EXOSOMES DERIVED THEREFROM, AND  METHODS OF USING SAME TO TREAT VOLUMETRIC MUSCLE LOSS	CEDARS-SINAI MEDICAL CENTER
WO/2021/178525	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CANCER  USING DEUBIQUITINASE INHIBITORS	THE UNIVERSITY OF CHICAGO
WO/2021/178531	THE RAD51 INHIBITOR COMPOUND 67A (2301085-06-1) AT A SPECIFIC  DOSAGE FOR TREATING CANCER	CYTEIR THERAPEUTICS, INC.
WO/2021/178541	DRUG COMBINATIONS FOR INHIBITING INFLAMMATION AND SRC KINASE  ACTIVATION FOLLOWING INVASIVE SURGICAL PROCEDURES	SINTETICA S.A.
WO/2021/188296	METHODS OF TREATING XANTHINE OXIDASE-RELATED DISEASES WITH  NIFLUMIC ACID AND DERIVATIVES THEREOF	BAYLOR COLLEGE OF MEDICINE
WO/2021/178555	METHOD OF TREATMENT OR ALLEVIATING SYMPTOMS OF A DISORDER WITH  CURCUMIN	ANOTHER CHANCE NUTRA, LLC
WO/2021/178561	USE OF DOWNSTREAM FACTORS IN THE KLOTHO PATHWAY TO ASSESS  KLOTHO ACTIVITY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/178565	METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF  TYPE 1 DIABETES	ADITXT, INC.
WO/2021/178569	ANTI-DR5 POLYPEPTIDES AND METHODS OF USE THEREOF	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/178571	ON DEMAND EXPRESSION OF EXOGENOUS FACTORS IN LYMPHOCYTES TO  TREAT HIV	AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
WO/2021/178579	CANNABIS TREATMENT OF INSOMNIA, PAIN, AND SKIN CONDITIONS	ALTE VERDE LLC
WO/2021/178582	SYSTEMS AND METHODS FOR TREATING PATIENTS INFECTED WITH  SARS-COV-2	HDL THERAPEUTICS, INC.
WO/2021/178612	COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION	JANSSEN PHARMACEUTICALS, INC.
WO/2021/178621	ENGINEERED INFLUENZA NEURAMINIDASE ANTIGENS	UNIVERSITY OF WASHINGTON
WO/2021/178623	IMMUNOGENIC COMPOSITIONS AGAINST SEVERE ACUTE RESPIRATORY  SYNDROME CORONAVIRUS 2	NEW YORK BLOOD CENTER, INC.
WO/2021/178637	IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2	IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/178639	COMPOSITIONS DERIVED FROM SALVIA HISPANICA SEEDS	SIGNUM BIOSCIENCES, INC.
WO/2021/178650	LOW-TEMPERATURE SYNTHESIS OF THYMOQUINONE AND HARMALINE  COMPOUNDS	ANKH LIFE SCIENCES LIMITED
WO/2021/178657	METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1  ANTAGONIST, A CTLA4 ANTAGONIST, AND LENVATINIB OR A PHARMACEUTICALLY  ACCEPTABLE SALT THEREOF	MERCK SHARP & DOHME CORP.
WO/2021/178661	COMPOSITIONS CONTAINING A PATHOGENIC ANTIGEN AND AN IMMUNE  STIMULATOR	ONCOSEC MEDICAL INCORPORATED
WO/2021/178663	COMPOSITIONS AND METHODS FOR TREATMENT OF PLATINUM-BASED  CHEMOTHERAPEUTIC RESISTANT TUMORS	THE GEORGE WASHINGTON UNIVERSITY
WO/2021/178684	CAR AND NRF2 DUAL ACTIVATOR AGENTS FOR CYCLOPHOSPHAMIDE-BASED  AND DOXORUBICIN-BASED TREATMENTS OF CANCER	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/178691	IBOGAINE ANALOGS AS THERAPEUTICS FOR NEUROLOGICAL AND  PSYCHIATRIC DISORDERS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/178700	METHODS AND COMPOSITIONS FOR TREATING CANNABIS USE DISORDER  AND MITIGATING CANNABINOID WITHDRAWAL	PLEOPHARMA, L.L.C.
WO/2021/178701	METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED  LYMPHOCYTE AGGREGATES	EXUMA BIOTECH CORP.
WO/2021/178705	ANTI-CANCER AND ANTI-PROLIFERATIVE COMPOSITIONS, AND METHODS  FOR THEIR USE IN TREATING CANCER	NATREON, INC.
WO/2021/178707	COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC LIVER  DISORDERS	POSEIDA THERAPEUTICS, INC.
WO/2021/178714	ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES  THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/178725	COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY	VERVE THERAPEUTICS, INC.
WO/2021/178734	METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH  MYELOPEROXIDASE INHIBITOR	BIOHAVEN THERAPEUTICS LTD.
WO/2021/178737	METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A  MUTATION IN THE GLA GENE	AMICUS THERAPEUTICS, INC.
WO/2021/178740	INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF  THE SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/178741	INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF  THE SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/183370	COMPOUNDS WITH IMMUNOMODULATORY ACTIVITY AND THERAPEUTIC USES  THEREOF	PURDUE RESEARCH FOUNDATION
WO/2021/183371	NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN	PURDUE RESEARCH FOUNDATION
WO/2021/206831	ETHANOLAMINE FORMULATION FOR TREATING EPITHELIAL OVARIAN  CARCINOMA	METANOI THERAPEUTICS, INC.
WO/2021/178752	SERINE PROTEASE INHIBITORS FOR SUPPRESSING OR PREVENTING  ANAPHYLACTIC REACTION	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/178768	METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL  GLOMERULOSCLEROSIS	VERTEX PHARMACEUTICALS INCORPORATED
WO/2021/178779	COMBINATION THERAPY COMPRISING AXL/MER AND PD-1/PD-L1  INHIBITORS	INCYTE CORPORATION
WO/2021/178780	INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS	ESCAPE BIO, INC.
WO/2021/178789	METHODS OF USING REBASTINIB IN THE TREATMENT OF DIFFERENT  CANCEROUS DISORDERS	DECIPHERA PHARMACEUTICALS, LLC
WO/2021/216205	VACCINES FORMED BY VIRUS AND ANTIGEN CONJUGATION	KENTUCKY BIOPROCESSING, INC.
WO/2021/178807	COMBINATION OF AN LSD-1 INHIBITOR AND NIVOLUMAB FOR USE IN  TREATING SCLC OR SQNSCLC	CELGENE QUANTICEL RESEARCH, INC.
WO/2021/178818	THERAPEUTIC AGENTS AND CONJUGATES THEREOF	BEIJING XUANYI PHARMASCIENCES CO., LTD.
WO/2021/178834	TOPICAL PHARMACEUTICAL FORMULATIONS OF A CYCLIC DEPSIPEPTIDE	LIFEMAX LABORATORIES, INC.
WO/2021/178841	HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS	JANPIX, LTD.
WO/2021/178843	ULINASTATIN POLYPEPTIDES	DIAMEDICA USA INC.
WO/2021/178846	METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES	OLEMA PHARMACEUTICALS, INC.
WO/2021/178850	METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL  AND RELATED SERRULATANE-TYPE DITERPENES	BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/178857	ALPHA SUBSTITUTED STAT INHIBITORS AND COMPOSITIONS THEREOF	JANPIX, LTD.
WO/2021/178860	AMINO ACID COMPOSITIONS AND METHODS FOR MUSCLE AND MYOTUBE  MODULATION	AXCELLA HEALTH INC.
WO/2021/178863	METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS  NEPHROPATHY	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/178864	TREATMENTS FOR IMPROVING OR LESSENING IMPAIRMENT OF  MITOCHONDRIAL FUNCTION	ALLEGRO PHARMACEUTICALS, LLC
WO/2021/178866	IRF MODULATOR-EXPRESSING ONCOLYTIC VIRUSES FOR TREATING CANCER	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/178871	CANNABIDIOL NANODRUG FORMULATIONS AND METHODS FOR USE THE SAME	UNIVERSITY OF MIAMI
WO/2021/178877	PRODUCTION OF VACCINES COMPRISING INACTIVATED SARS-COV-2 VIRAL  PARTICLES	THE COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/178878	METHODS AND COMPOSITIONS FOR TREATING MUSCLE ATROPHY	NELLONE THERAPEUTICS, INC.
WO/2021/178879	2019-NCOV SUBUNIT VACCINE AND MICRONEEDLE ARRAY DELIVERY  SYSTEM	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/206833	METHODS AND COMPOSITIONS FOR TREATING TISSUE DAMAGE RESULTING  FROM VIRAL INFECTIONS	NELLONE THERAPEUTICS, INC.
WO/2021/178886	CORONAVIRUS DISEASE (COVID-19) VACCINE	THOMAS JEFFERSON UNIVERSITY
WO/2021/178887	METHODS, COMPOUNDS, AND COMPOSITIONS FOR MODIFYING CAR-T CELL  ACTIVITY	PURDUE RESEARCH FOUNDATION
WO/2021/178890	INNATE IMMUNITY KILLER CELLS TARGETING PSMA POSITIVE TUMOR  CELLS	SORRENTO THERAPEUTICS, INC.
WO/2021/178891	LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN  ANTIGENS AND METHODS OF USE THEREOF	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/178899	USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC  RETINOPATHY	PANIGRAHI, Dipak
WO/2021/178902	METHODS OF INHIBITING MASP-2 FOR THE TREATMENT AND/OR  PREVENTION OF CORONAVIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME	OMEROS CORPORATION
WO/2021/178903	TREATMENT OF PAIN AND VASOCONSTRICTION	AISA PHARMA, INC.
WO/2021/178907	STAT INHIBITORY COMPOUNDS AND COMPOSITIONS	JANPIX, LTD.
WO/2021/178920	COMPOUNDS FOR TARGETED DEGRADATION OF BRD9	C4 THERAPEUTICS, INC.
WO/2021/178930	POLYMER IMPLANTS	FOUNDRY THERAPEUTICS, INC.
WO/2021/183407	NORRIN REGULATION OF PLASMALEMMA VESICLE-ASSOCIATED PROTEIN  AND USE TO TREAT MACULAR DEGENERATION	RETINAL SOLUTIONS, LLC
WO/2021/178949	ANTIBODY FRAGMENTS CONJUGATED TO PEG-PLGA NANOPARTICLES  IMPROVE IMMUNOTHERAPY AGAINST CANCER CELLS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/178951	TUMOR TARGETED FLUORESCENCE GUIDANCE FOR INTRAOPERATIVE MARGIN  ASSESSMENT	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/183431	FEM1B PROTEIN BINDING AGENTS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183433	GENE REPLACEMENT THERAPY FOR FOXG1 SYNDROME	UNIVERSITY OF MASSACHUSETTS
WO/2021/178964	SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN  SUBJECTS USING MICROCHANNEL DELIVERY DEVICES	AQUAVIT PHARMACEUTICALS, INC.
WO/2021/178968	COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR  BACTERIAL INFECTIONS	ENDOLYTIX TECHNOLOGY, INC.
WO/2021/178969	COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR  BACTERIAL INFECTIONS	ENDOLYTIX TECHNOLOGY, INC.
WO/2021/178971	VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSES	THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF  MILITARY MEDICINE, INC.
WO/2021/178973	COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR  (CAR)-MODIFIED CELL MODULATION	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/178974	COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR  BACTERIAL INFECTIONS	ENDOLYTIX TECHNOLOGY, INC.
WO/2021/178975	A METHOD TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS  (CAR-T CELLS) FROM PATHOGEN-SPECIFIC CYTOTOXIC LYMPHOCYTES TO ENABLE THE  SUBSEQUENT IN VIVO MODULATION OF THEIR FUNCTIONAL ACTIVITY	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/178977	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/183462	PERSONAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/183463	COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/183464	PERSONAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/194735	MODULATION OF MAMMALIAN CELL LINEAGE BY SYNTHETIC IMMODULATOR  PEPTIDES	MASCARENHAS, Desmond
WO/2021/183467	PROCESS FOR MAKING A WATER SOLUBLE, FULL SPECTRUM HEMP OIL	NORTHEAST KIND ASSETS, LLC
WO/2021/183469	CEREBROSPINAL FLUID ASSAY CONTROL SOLUTION	AMPRION, INC.
WO/2021/183474	INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD  STEM CELLS, AND USES RELATED THERETO	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/183485	HETEROMULTIVALENT SPHERICAL NUCLEIC ACIDS AND USES IN  THERAPEUTIC AND DIAGNOSTIC APPLICATIONS	EMORY UNIVERSITY
WO/2021/183502	ENGINEERED NUCLEIC ACIDS AND USES THEREOF	THE METHODIST HOSPITAL SYSTEM
WO/2021/183505	PERSONAL CARE COMPOSITION COMPRISING MANNOSE OLIGOSACCHARIDES	CARGILL, INCORPORATED
WO/2021/183533	ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND  PERTUSSIS	DYNAVAX TECHNOLOGIES CORPORATION
WO/2021/206837	A PHARMACEUTICAL COMPOSITION AND ITS USE TO INHIBIT MEMBRANE  ACE2 EXPRESSION	RATH, Matthias, W.
WO/2021/183540	SHINGLES VACCINES COMPRISING A TLR9 AGONIST	DYNAVAX TECHNOLOGIES CORPORATION
WO/2021/183551	SODIUM PERCARBONATE DISSOLVING BATH PRODUCT FORMULATION	SOAKNESS LLC
WO/2021/183554	MANIPULATING GLYCOGEN IN ALZHEIMER'S DISEASE, EPILEPSY,  TRAUMATIC BRAIN INJURY, AND ALS AS A TREATMENT	UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
WO/2021/183556	IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS OF PRODUCTION FOR  CORONAVIRUS	ADMA BIOLOGICS, INC.
WO/2021/183562	SURFACTANTS FOR PERSONAL CARE AND COSMETIC PRODUCTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/183563	CORONAVIRUS VACCINE COMPOSITIONS AND METHODS	ARCTURUS THERAPEUTICS, INC.
WO/2021/183564	COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES	ARCTURUS THERAPEUTICS, INC.
WO/2021/183582	SURFACTANTS FOR HEALTHCARE PRODUCTS	ADVANSIX RESINS & CHEMICALS LLC
WO/2021/183588	LIPOSOME COMPOSITION AND PREPARATION METHOD THEREOF	CHUNG YUAN CHRISTIAN UNIVERSITY
WO/2021/183590	ANTISEPTIC-ANTIBIOTIC GUMBOS EFFECTIVE AGAINST GRAM-NEGATIVE  PATHOGENS	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/188326	SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF  CORONAVIRUS INFECTION	ENZO BIOCHEM, INC.
WO/2021/183595	ENHANCED EFFICACY OF COMBINATION OF GEMCITABINE AND  PHOSPHATIDYLSERINE-TARGETED NANOVESICLES AGAINST PANCREATIC CANCER	UNIVERSITY OF CINCINNATI
WO/2021/183596	MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE	UNIVERSITY OF CINCINNATI
WO/2021/183624	DELIVERY OF GENE EXPRESSION MODULATING AGENTS FOR THERAPY  AGAINST CANCER AND VIRAL INFECTION	UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/188334	USE OF ST266 TO TREAT SEVERE SYSTEMIC INFLAMMATION AND  POST-ACUTE COVID-19 SYNDROME	NOVEOME BIOTHERAPEUTICS, INC.
WO/2021/183628	NOVEL MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE  DISORDER, PAINT AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY  PROCESSES	TEXAS TECH UNIVERSITY SYSTEM
WO/2021/183640	METHODS OF TREATING CANCER USING CHECKPOINT INHIBITORS IN  COMBINATION WITH PURINE CLEAVING ENZYMES	EMORY UNIVERSITY
WO/2021/183650	METHODS FOR TREATING NEUTROPENIA	X4 PHARMACEUTICALS, INC.
WO/2021/183675	METHODS FOR GENERATING ENGINEERED MEMORY-LIKE NK CELLS AND  COMPOSITIONS THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/183685	FUSION MOLECULES OF PSGL-1 OR TSGL ANIONIC DOMAINS TO  CHECKPOINT-MODULATING ANTIBODIES AND OTHER ANTIBODIES	SHAW, Gray, D.
WO/2021/183691	COMBINED INHIBITION OF EGFR AND NRF2 IN THE TREATMENT OF  MALIGNANT GLIOMA	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/183701	MICROBIAL CONSORTIA FOR THE TREATMENT OF DISEASE	FEDERATION BIO INC.
WO/2021/183702	GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND  THEIR USE FOR TREATING GPX4-MEDIATED DISEASES	EUBULUS BIOTHERAPEUTICS INC.
WO/2021/183716	COMPOSITIONS FOR COLORING HAIR INCLUDING ULTRA-EFFICIENT HIGH  AQUEOUS, MULTI-LAMELLAR EMULSION SYSTEMS, AND METHODS OF MAKING THE SAME	COMBE INCORPORATED
WO/2021/183725	USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT  METASTASIS	ASCLEA CORP.
WO/2021/188349	METHODS OF TREATING MITOCHONDRIAL DISORDERS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183735	PULMONARY AGENT DELIVERY METHODS AND COMPOSITIONS FOR  PRACTICING THE SAME	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/183740	METHODS OF TREATING DIARRHEA OR INFLAMMATORY CONDITIONS OF THE  GUT	ABBOTT LABORATORIES
WO/2021/183752	DAPTOMYCIN FORMULATIONS CONTAINING A COMBINATION OF SORBITOL  AND MANNITOL	BAXTER INTERNATIONAL INC.
WO/2021/183760	METHODS OF MODULATING T-CELL ACTIVATION USING ESTROGEN  RECEPTOR BETA (ERΒ) AGONISTS	OHIO STATE INNOVATION FOUNDATION
WO/2021/183764	METHODS OF MODULATING T-CELL ACTIVATION USING CARBORANES AND  CARBORANE ANALOGS	OHIO STATE INNOVATION FOUNDATION
WO/2021/183776	NK CELLS AND USES THEREOF FOR TREATMENT OF MICROBIAL  INFECTIONS	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/183779	GENE THERAPY FOR NMNAT1-ASSOCIATED RETINAL DEGENERATION	MASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/183780	LICHENASE-COVID-19 BASED VACCINE	IBIO, INC.
WO/2021/183781	METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS	SELECTA BIOSCIENCES, INC.
WO/2021/183790	METHOD FOR TREATMENT OF COVID-19-ASSOCIATED CONDITIONS	RIGEL PHARMACEUTICALS, INC.
WO/2021/183791	WNT/CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF	CITY OF HOPE
WO/2021/183796	CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF	3+2 PHARMA
WO/2021/183814	METABOLITES RELEASED FROM APOPTOTIC CELLS ACT AS NOVEL TISSUE  MESSENGERS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/183819	SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR  TREATING RENAL DISEASES OR CONDITIONS	ACCELERON PHARMA INC.
WO/2021/183830	METHODS FOR TREATING FIBROSIS USING PKM2 ACTIVATORS	PRODA BIOTECH L.L.C.
WO/2021/183832	INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND METHODS OF USE  THEREOF	AMBRX, INC.
WO/2021/183850	COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183851	HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF	OSIRIS THERAPEUTICS, INC.
WO/2021/183860	AGENTS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOMA	UNIVERSITY OF CINCINNATI
WO/2021/183863	METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS  INFECTION	CONSTANT THERAPEUTICS LLC
WO/2021/202084	TREATING PULMONARY INFLAMMATORY DISEASE ASSOCIATED WITH  COVID-19 BY ADMINISTERING RESINIFERATOXIN	SORRENTO THERAPEUTICS, INC.
WO/2021/183873	SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-DG, CHECKPOINT  INHIBITORS AND RADIATION THERAPY	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/183884	COMPOSITIONS AND METHODS FOR MODIFYING A TARGET NUCLEIC ACID	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/183905	METHODS OF TREATING MULTIPLE SCLEROSIS	SIMARD, Marc J.
WO/2021/183908	GPX4 COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATMENT USING  SAME	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/183910	GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST  MEDIATED EDUCATION	FIGENE, LLC
WO/2021/183913	FENTANYL HAPTENS, FENTANYL HAPTEN CONJUGATES, AND METHODS FOR  MAKING AND USING	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/183918	METHODS OF TREATING ILLNESSES CAUSED BY CORONAVIRUS, SWINE FLU  AND AVIAN FLU	CMTX BIOTECH INC.
WO/2021/183928	ASSESSING AND TREATING ACUTE DECOMPENSATED HEART FAILURE	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/183931	TARGETED NANOBUBBLE THERAPY	CASE WESTERN RESERVE UNIVERSITY
WO/2021/183934	A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED  THERAPY AND USES THEREOF	SPRINGWORKS THERAPEUTICS, INC.
WO/2021/188387	COMBINATION THERAPY FOR ACUTE MYELOID LEUKEMIA	CELGENE CORPORATION
WO/2021/183937	SUBSTITUTED ISOXAZOLES AS SELECTIVE NAV1.7 INHIBITORS FOR PAIN  TREATMENT AND METHOD OF PAIN TREATMENT	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/183942	INHIBITORS OF HSP70 PROTEINS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/188388	USE OF CANNABIDIOL IN TREATING ANTI-DEPRESSANT-INDUCED FEMALE  SEXUAL DYSFUNCTION	VELLA BIOSCIENCE, INC.
WO/2021/188390	COMPOSITIONS AND METHODS OF TREATING FACIOSCAPULOHUMERAL  MUSCULAR DYSTROPHY	AVIDITY BIOSCIENCES, INC.
WO/2021/183983	A METHOD FOR CONTROLLING CLOSTRIDIUM INFECTION IN ANIMALS	KEMIN INDUSTRIES, INC.
WO/2021/188409	TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTS	KINIKSA PHARMACEUTICALS, LTD.
WO/2021/188415	ANDROGEN RECEPTOR MODULATORS	TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/183995	COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF VIRAL  DISORDERS	FURST-MCNESS COMPANY
WO/2021/230973	COMPOUNDS FOR THE TREATMENT OF SARS	GHOSH, Arun K.
WO/2021/184008	PROBIOTIC COMPOSITIONS FOR IMPROVING HUMAN HEALTH AND ATHLETIC  PERFORMANCE	FITBIOMICS INC.
WO/2021/184009	KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAME	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/184010	NOVEL NANO-FORMULATION OF CANNABIDIOL (CBD) AND OTHER  CANNABINOIDS FOR TREATMENT OF OCULAR DISORDERS	MILANE, Michael
WO/2021/188448	STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/188450	NLRP3 MODULATORS	ZOMAGEN BIOSCIENCES LTD
WO/2021/184014	STABLE REACTIVE COMPOSITIONS FOR BIOCONJUGATION, PROBES, AND  PROTEIN LABELING	ARIZONA BOARD OF REGETNS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/184017	EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS	CODIAK BIOSCIENCES, INC.
WO/2021/184020	METHODS OF TREATING NEUROINFLAMMATION	CODIAK BIOSCIENCES, INC.
WO/2021/184022	TARGETED DELIVERY OF EXTRACELLULAR VESICLES	CODIAK BIOSCIENCES, INC.
WO/2021/188467	COMPOSITIONS AND METHODS OF TREATING GLIOMA	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/146740	SOLUTION AND METHOD FOR REDUCING THE VIRULENCE OF MICROBES	CHANGARIS, David, G.
WO/2021/188473	DELTA OPIOID RECEPTOR ANTAGONISTS REPROGRAM IMMUNOSUPPRESSIVE  MICROENVIRONMENT TO BOOST IMMUNOTHERAPY	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/188500	MULTI-OMIC ANALYSIS IN MONODISPERSE DROPLETS	FLUENT BIOSCIENCES INC.
WO/2021/188504	INJECTABLE FORMULATION OF POLY(LACTIC-CO-GLYCOLIC (PLGA))  MICROSPHERES ENCAPSULATING SILTUXIMAB	FLOW PHARMA, INC.
WO/2021/188517	CONTINUOUS MELT-COATING OF ACTIVE PHARMACEUTICAL INGREDIENTS  USING SURFACTANTS FOR DISSOLUTION ENHANCEMENT	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/188518	PERSISTANT TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF  USING THE SAME	BLUEWILLOW BIOLOGICS, INC.
WO/2021/188520	METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING  THE OCCURRENCE OF VIRAL INFECTION	GLOBAL BIOLIFE INC.
WO/2021/188537	SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/188563	5-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF  MAKING, AND USE THEREOF	CHENGDU SCIMOUNT PHARMATECH CO., LTD.
WO/2021/188564	METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND	FIRST WAVE BIO, INC.
WO/2021/188575	DIETARY SUPPLEMENT COMPRISING ALDEHYDE FUNCTIONAL  MONOTERPENOIDS	COE, William, B.
WO/2021/188576	MODIFIED ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND USE  THEREOF	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/188578	SCREENING METHODS TO IDENTIFY SMALL MOLECULE COMPOUNDS THAT  PROMOTE OR INHIBIT THE GROWTH OF CIRCULATING TUMOR CELLS, AND USES THEREOF	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/188580	RAPID DIAGNOSTIC TEST	DETECT, INC.
WO/2021/188586	METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE  MONOSACCHARIDES AND ANALOGS THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/188592	RADIONUCLIDE TRACERS OF  1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES  THEREOF	EMORY UNIVERSITY
WO/2021/188599	NOVEL ANTIGEN BINDING DOMAINS AND SYNTHETIC ANTIGEN RECEPTORS  INCORPORATING THE SAME	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/188601	METHODS TO PREVENT, AMELIORATE AND TREAT COMPLICATIONS FROM  VIRAL INFECTIONS	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/194804	HAIR CARE FORMULATION	ROHM AND HAAS COMPANY
WO/2021/194805	HAIR CLEANSER	ROHM AND HAAS COMPANY
WO/2021/194806	SKIN CLEANSING FORMULATION	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/188606	OXAZOLIDINONE COMPOUND AND METHODS OF USE THEREOF AS AN  ANTIBACTERIAL AGENT	MERCK SHARP & DOHME CORP.
WO/2021/194807	HAIR CLEANSING FORMULATION	ROHM AND HAAS COMPANY
WO/2021/194809	HAIR OIL FORMULATION	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/206877	INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION	COCRYSTAL PHARMA, INC.
WO/2021/188612	MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING,  AND METHODS OF TREATMENT	TAURIGA SCIENCES INC.
WO/2021/188614	COMPOSITION, METHODS OF MAKING AND USING FOR TREATING A VIRAL  INFECTION, INCLUDING CORONAVIRUS INFECTION	DEJIA HARMONY LLC
WO/2021/188616	DESIGNER EXTRACELLULAR VESICLES FOR TREATING EXCITOTOXICITY	OHIO STATE INNOVATION FOUNDATION
WO/2021/188618	BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE  CATABOLISM OF LEUCINE	SYNLOGIC OPERATING COMPANY, INC.
WO/2021/188619	HETEROCLITIC CANCER VACCINES	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/188630	COMBINATION TUMOR TREATMENT	BOSTON SCIENTIFIC SCIMED, INC.
WO/2021/188631	ANTI-IL4 RECEPTOR ANTIBODIES FOR VETERINARY USE	KINDRED BIOSCIENCES, INC.
WO/2021/188659	HELICAL STAPLED PEPTIDES AND USES THEREOF	FOG PHARMACEUTICALS, INC.
WO/2021/188667	TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER  PBB3	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/188681	COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND  APPLICATIONS THEREOF	CELLULAR BIOMEDICINE GROUP HK LIMITED
WO/2021/188688	FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE	METACRINE, INC.
WO/2021/188690	FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE	METACRINE, INC.
WO/2021/188692	CRYSTALLINE FORMS OF A FARNESOID X RECEPTOR AGONIST	METACRINE, INC.
WO/2021/188695	FORMULATIONS OF A FARNESOID X RECEPTOR AGONIST	METACRINE, INC.
WO/2021/188696	STAT DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/202103	METHOD AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTION	PHOENIX BIOTECHNOLOGY, INC.
WO/2021/188709	TREATING SARS-COV-2 INFECTED SUBJECTS WITH SMALL MOLECULE  COMPOUNDS	ANIVIVE LIFESCIENCES, INC.
WO/2021/188742	EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR  PROLONGED DRUG RELEASE	BLAESI, Aron, H.
WO/2021/188745	METHOD AND APPARATUS FOR 3D-MICRO-PATTERNING	BLAESI, Aron, H.
WO/2021/188747	MODIFIED SHORT-INTERFERING RNA COMPOSITIONS AND THEIR USE IN  THE TREATMENT OF CANCER	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/188749	ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE	GENENTECH, INC.
WO/2021/188753	OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS	CARA THERAPEUTICS, INC.
WO/2021/188761	MODIFIED ARRESTIN-1 TO ENHANCE PHOTORECEPTOR SURVIVAL IN  RETINAL DISEASE	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/188770	ANTI-CERAMIDE ANTIBODIES	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/188772	COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN  ASSOCIATED WITH MALIGNANT GROWTH DISORDER	DUKE UNIVERSITY
WO/2021/188773	SOFTGEL CAPSULES	R.P. SCHERER TECHNOLOGIES, LLC
WO/2021/188802	MOLECULAR TRANSPORT SYSTEM TO THE CENTRAL NERVOUS SYSTEM	BROWN, Kathlynn C.
WO/2021/188803	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS	CLEARSIDE BIOMEDICAL, INC.
WO/2021/188809	INHALABLE FORMULATION OF A SOLUTION CONTAINING LEVALBUTEROL  TARTRATE	HUANG, Cai Gu
WO/2021/188812	CRYSTALLINE NORPSILOCIN COMPOUNDS	CAAMTECH, INC.
WO/2021/188815	INHALATIONAL THERAPY FOR COVID-19	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/188818	VACCINE CONSTRUCTS AND COMPOSITIONS AND METHODS OF USE THEREOF	THE UNITED STATES OF AMERICA AS represented by THE SECRETARY  OF THE NAVY
WO/2021/188828	METHODS FOR TREATING CANCER BY INHIBITING CARM1	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/188831	ANTIBODY GENE EDITING IN B LYMPHOCYTES AND CO-EXPRESSION OF  CARGO PROTEIN	THE ROCKEFELLER UNIVERSITY
WO/2021/188835	MULTIVALENT CHEMOKINE RECEPTOR BINDING COMPLEXES	CITY OF HOPE
WO/2021/188836	UPREGULATION OF CATHELICIDIN GENE EXPRESSION AS AN ADJUVANT TO  OTHER TREATMENTS FOR DISEASES	BARRON, Annelise E.
WO/2021/188837	PROPHYLAXIS AND TREATMENT OF PATHOGENIC CORONAVIRUS INFECTIONS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/188841	GENE SILENCING AGENTS FOR TARGETING CORONAVIRUS GENES AND USES  THEREOF	QIANGXIN INSTITUTE OF TECHNOLOGY
WO/2021/188844	INJECTABLE BOTULINUM TOXIN METHODS FOR TREATING HEADACHES	REVANCE THERAPEUTICS, INC.
WO/2021/188849	METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND  FIBROTIC PULMONARY DISORDERS	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/188855	SYMBIOTIC PRODRUGS FOR THE TREATMENT OF CANCER AND OTHER  DISEASES	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
WO/2021/188865	CANNABINOID MEDICAL CARRIER	NEW YORK MEDICAL COLLEGE
WO/2021/188866	RIBONUCLEASES FOR TREATING VIRAL INFECTIONS	ORGENESIS INC.
WO/2021/188870	PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF  USING AND MAKING THE SAME	ORTHOGONAL THINKER, INC.
WO/2021/188871	SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4	TRUSTEES OF BOSTON UNIVERSITY
WO/2021/188880	BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES  THEREOF	AMATHUS THERAPEUTICS, INC.
WO/2021/188882	SULFATED GLYCOSAMINOGLYCAN BIOMATERIALS AS PROTEOGLYCAN MIMICS	GLYCOLOGIX, LLC
WO/2021/188883	METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASE  USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/188886	ANTIMICROBIAL COMPOSITIONS AND METHODS	CREDO SCIENCE, LLC
WO/2021/188887	COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL  CANCER	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/236222	COMPOSITIONS AND METHODS FOR PREVENTING POST-ERCP PANCREATITIS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/188899	CARDIOSPHERE-DERIVED CELL (CDC) THERAPY FOR THE TREATMENT OF  VIRAL INFECTIONS	CEDARS-SINAI MEDICAL CENTER
WO/2021/188906	NOVEL MRNA-BASED COVID-19 MULTI-VALENT VACCINE AND METHODS OF  SCALED PRODUCTION OF THE SAME	NATURE'S TOOLBOX, INC.
WO/2021/188907	PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES  THEREOF	AMATHUS THERAPEUTICS, INC.
WO/2021/194878	SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND  ASSOCIATED METHODS OF USE	ARVINAS OPERATIONS, INC.
WO/2021/188910	NRTIS, NRTI METABOLITES, AND NRTI ANALOGS FOR MACULAR  DEGENERATION AND VIRAL INFECTIONS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/188911	CYCLIC SULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES  THEREOF	AMATHUS THERAPEUTICS, INC.
WO/2021/188915	METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS  INFECTION	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/188948	MDM2 DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/188949	3-DIARYLMETHYLENES AND USES THEREOF	ATUX ISKAY LLC
WO/2021/188960	GENE THERAPY FOR COCKAYNE SYNDROME	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/194890	HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A  RESPIRATORY VIRUS	ATOSSA THERAPEUTICS, INC.
WO/2021/188966	SARS-COV-2 SPIKE PROTEIN BINDING PEPTIDES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/188969	CORONAVIRUS VACCINES AND METHODS OF USE	BIONTECH US INC.
WO/2021/236225	METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES	TAKEDA VACCINES, INC.
WO/2021/188974	RIBONUCLEASES FOR TREATING VIRAL INFECTIONS	ORGENESIS INC.
WO/2021/188977	ION SELECTIVE MEMBRANES FOR ORGANIC ELECTROCHEMICAL PROCESSES	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/188978	PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULES	ACADEMIA SINICA
WO/2021/194893	TREATMENT OF CHEMOSENSORY DYSFUNCTION FROM A CORONAVIRUS  INFECTION	CYRANO THERAPEUTICS, INC.
WO/2021/188983	CANNABINOID COMPOSITIONS	THE QUEEN'S MEDICAL CENTER
WO/2021/188991	HAPTENIZED CORONAVIRUS SPIKE PROTEINS	BIOVAXYS INC.
WO/2021/194906	NEURONAL DIENCEPHALON STEM CELLS AND EXOSOMES THEREOF FOR THE  TREATMENT AND PREVENTION OF DISEASES	FLORICA THERAPEUTICS, INC.
WO/2021/189004	CAR PEPTIDE FOR IMPROVED CORONAVIRUS SURVIVAL	VASCULAR BIOSCIENCES
WO/2021/189006	METHODS OF USING ACTIVIN RECEPTOR TYPE IIA VARIANTS	KEROS THERAPEUTICS, INC.
WO/2021/189010	METHODS OF USING ACTIVIN RECEPTOR TYPE IIB VARIANTS	KEROS THERAPEUTICS, INC.
WO/2021/189013	METHODS AND COMPOSITIONS FOR TREATING ACUTE LUNG INJURY AND  ACUTE RESPIRATORY DISTRESS SYNDROME	CALCIMEDICA, INC.
WO/2021/189017	STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND  METHODS OF USE AND MANUFACTURE THEREOF	CLEAR CREEK BIO, INC.
WO/2021/189018	METHODS OF TREATING VIRAL INFECTIONS USING INHIBITORS OF  NUCLEOTIDE SYNTHESIS PATHWAYS	CLEAR CREEK BIO, INC.
WO/2021/189019	ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF	KEROS THERAPEUTICS, INC.
WO/2021/194909	BISPECIFIC AND TRISPECIFIC FUNCTIONAL MOLECULES OF ACE2 AND  COMPLEMENT PATHWAYS AND THEIR USE	LARIX BIOSCIENCES, LLC
WO/2021/194918	METHODS OF TREATING PULMONARY INJURY WITH CGRP INHIBITORS	BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
WO/2021/189032	CORONAVIRUS: EARLY DETECTION AND TREATMENT	YU, Ruey, J.
WO/2021/194919	COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS  (TTFIELDS)	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/194927	COMPOSITION OF ANTIVIRAL AGENT FOR USE IN PROPHYLACTIC OR  POST-EXPOSURE TREATMENT OF INFECTIOUS OR RESPIRATORY DISEASES	TLC BIOPHARMACEUTICALS, INC.
WO/2021/194929	METHODS, SYSTEMS AND APPARATUS FOR REDUCING PATHOGEN LOADS IN  CIRCULATING BODY FLUIDS	MI2 HOLDINGS LLC
WO/2021/189036	TAF1 INHIBITORS	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
WO/2021/194938	UNIVERSAL NANOSPONGE FOR TREATING RESPIRATORY VIRAL INFECTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/194940	SARS-COV-2-SPECIFIC T CELLS AND METHODS OF TREATMENT USING  THEM	CHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/194946	COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR	ELI LILLY AND COMPANY
WO/2021/194948	COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR CONDITIONS	EYEGATE PHARMACEUTICALS, INC.
WO/2021/236227	METHODS FOR TREATING PLASMA PROTEIN IMBALANCES OR DEPLETION	OHIO STATE INNOVATION FOUNDATION
WO/2021/194950	COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR AND A BCL-2  INHIBITOR	ELI LILLY AND COMPANY
WO/2021/194953	METHOD FOR TREATING IDH1 INHIBITOR-RESISTANT SUBJECTS	ELI LILLY AND COMPANY
WO/2021/194954	SUBSTITUTED AZOLE DIONE COMPOUNDS WITH ANTIVIRAL ACTIVITY	STEMLINE THERAPEUTICS, INC.
WO/2021/194959	TREATMENT OF EYE DISORDERS WITH URIDINE PHOSPHATE DERIVATIVES	GLIAGUARD, INC.
WO/2021/202144	METHODS FOR TREATMENT OF VIRAL INFECTIONS	ELYSIUM HEALTH INC.
WO/2021/189046	COMPOSITIONS AND METHODS FOR TREATMENT OF SARS-COV-2	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/194970	METHODS OF PREVENTING AND TREATING COVID-19 INFECTION	HAZAN, Sabine
WO/2021/194975	METHOD FOR TREATING DIABETES	OLATEC THERAPEUTICS LLC
WO/2021/194982	POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/194983	COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/189051	ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/194991	USE OF LOSMAPIMOD FOR TREATMENT OF COVID-19	FULCRUM THERAPEUTICS, INC.
WO/2021/194992	RECOMBINANT VIRUSES, INSECT CELLS AND THEIR USES IN VIRAL  DETECTION AND VACCINATION	ACADEMIA SINICA
WO/2021/189056	SARS-CORONAVIRUS 2 (SARS-COV-2) SUBUNIT VACCINE CANDIDATES	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/194994	SPRAYABLE FILM FORMING COMPOSITIONS FOR IMPROVING THE  PERFORMANCE OF TOPICAL PREPARATIONS	ELC MANAGEMENT LLC
WO/2021/195011	IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF VIRAL  RESPIRATORY INFECTION	INTRINSIC MEDICINE, INC.
WO/2021/195016	COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY  CONTACT LENS MEDIATED DRUG DELIVERY	EYEGATE PHARMACEUTICALS, INC.
WO/2021/195017	IODINE COMPOUNDS FOR TREATING RESPIRATORY PATHOGENS	IOCURE, INC.
WO/2021/195020	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS  RESULTING FROM A CORONAVIRUS INFECTION	G3 PHARMACEUTICALS, INC.
WO/2021/202156	MATTIFYING NAIL COMPOSITIONS	L'OREAL
WO/2021/195024	ADJUVANT COMPOUNDS, SALT FORMS, AND FORMULATIONS	ADJUVANCE TECHNOLOGIES, INC.
WO/2021/195036	TNFAIP3 AS A BIOMARKER FOR AUTOIMMUNE DISEASES	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/195039	METHODS OF TREATING OR PREVENTING A VIRAL INFECTION USING  BACTERIOPHAGES	CHEN, Shu-Chih
WO/2021/195064	CELL ACTIVATABLE IRON CHELATORS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195069	CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES AND ASSOCIATED  IMMUNOMODULATORY CELLS FOR TREATING ASPERGILLOSIS	ATARA BIOTHERAPEUTICS, INC.
WO/2021/195088	TGF-Bβ1 INHIBITORS FOR PREVENTING AND TREATING SARS-COV-2	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/195108	T CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF	CUE BIOPHARMA, INC.
WO/2021/195110	IMPROVED METHODS FOR MANUFACTURING ARGININE DENTIFRICE	COLGATE-PALMOLIVE COMPANY
WO/2021/195113	COMPOSITIONS AND METHODS FOR TARGETING CORONAVIRUS USING LIPID  VESICLES INCLUDING EXOSOMES	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195116	TRANSFERRIN RECEPTOR 1 TARGETING FOR CARCINOGENESIS PREVENTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/195119	METHODS OF REDUCING THE RISK OF, SEVERITY OF, AND TREATING  CORONAVIRUS INFECTIONS	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/195124	STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASE	RENIBUS THERAPEUTICS, INC.
WO/2021/195126	ANTI-INFECTIVE AND ANTI-VIRAL COMPOUNDS AND COMPOSITIONS	BURNET, Michael, W.
WO/2021/195128	EIF4A INHIBITOR COMBINATIONS	EFFECTOR THERAPEUTICS, INC.
WO/2021/195131	FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF	FUSION PHARMACEUTICALS INC.
WO/2021/195137	CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USING SAME	LOYOLA UNIVERSITY OF CHICAGO
WO/2021/195163	OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR	OCULAR THERAPEUTIX, INC.
WO/2021/202183	QTY FC FUSION WATER SOLUBLE GPCR PROTEINS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/195173	SOLID CANNABINOID FORMULATION FOR ORAL ADMINISTRATION	MOLECULAR INFUSIONS, LLC
WO/2021/195176	PROCESSES AND AGENTS FOR GLAUCOMA	AUFBAU MEDICAL INNOVATIONS LIMITED
WO/2021/195182	ANTIPERSPIRANT AND DEODORANT COMPOSITIONS FOR INCREASED SKIN  LUBRICITY	THE PROCTER & GAMBLE COMPANY
WO/2021/195185	METHOD OF TREATING CORONAVIRUS INFECTION BY ADMINISTRATION OF  ETHYL MERCURY OR THIOL DERIVATIVE THEREOF	BEECH TREE LABS, INC.
WO/2021/195198	FAP-TARGETED RADIOPHARMACEUTICALS AND IMAGING AGENTS, AND USES  RELATED THERETO	TRUSTEES OF TUFTS COLLEGE
WO/2021/195205	TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH  TRADIPITANT	VANDA PHARMACEUTICALS INC.
WO/2021/195209	MORPHINAN ISOMERS AND THEIR STRUCTURAL MODIFICATIONS AS NMDAR  ANTAGONISTS AND NEUROPLASTOGENS	UNIVERSITY OF PADOVA
WO/2021/206910	NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL  EFFECTOR	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/195236	BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF  TREATING MICROBIAL CO-INFECTIONS	MICROBION CORPORATION
WO/2021/195254	PROTEIN KINASE C MODULATORS	YOUNG THERAPEUTICS, LLC
WO/2021/195256	PHARMACEUTICAL PREPARATION	AERIE PHARMACEUTICALS, INC.
WO/2021/195258	LPXC INHIBITOR, FORMULATIONS, AND USES THEREOF	FORGE THERAPEUTICS, INC.
WO/2021/195260	LPXC INHIBITOR AND METHODS OF MAKING	FORGE THERAPEUTICS, INC.
WO/2021/195265	METHODS FOR TREATING DISEASES ASSOCIATED WITH RESPIRATORY  VIRUSES	AMPIO PHARMACEUTICALS, INC.
WO/2021/202208	TARGETED DEGRADATION OF THE ONCOGENIC MICRORNA 17-92 CLUSTER  BY STRUCTURE-TARGETING LIGANDS	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/195278	TRICYCLIC INHIBITORS OF INFLUENZA VIRUS ENDONUCLEASE	WEBB, Thomas, R.
WO/2021/195286	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING  CORONAVIRUSES	SVENSKA VACCINFABRIKEN PRODUKTION AB
WO/2021/195295	BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF	FLAGSHIP PIONEERING, INC.
WO/2021/195297	USE OF AGENTS FOR TREATMENT OF RESPIRATORY CONDITIONS	SAGE THERAPEUTICS, INC.
WO/2021/195300	INHALED INTERFERONS FOR VIRAL RESPIRATORY INFECTIONS	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/195301	USE OF GABA<sb>A</sb> MODULATORS FOR TREATMENT OF  RESPIRATORY CONDITIONS	SAGE THERAPEUTICS, INC.
WO/2021/195308	USE OF PHYCOBILIPROTEIN (PBP) TO INHIBIT OR TREAT SARS-COV-2  INFECTION	BACK OF THE YARDS ALGAE SCIENCES LLC
WO/2021/195319	PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION  AND- METHODS FOR MAKING AND USING SAME	PLX OPCO INC.
WO/2021/202224	SOLID FORMS OF  (S)-6-(((1-(BICYCLO[1.1.1]PENTAN-1-YL)-1H-1,2,3-TRIAZOL-4-YL)2-METHYL-1-OXO-1,2-  DIHYDROISOQUINOLIN-5-YL)METHYL)))AMINO)8-CHLORO-(NEOPENTYLAMINO)QUINOLINE-3-CARB  ONITRILE A COT INHIBITOR COMPOUND	GILEAD SCIENCES, INC.
WO/2021/195325	ANTI-CORONAVIRUS COMPOSITIONS, ASSAYS, AND METHODS RELATED  THERETO	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/195326	HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY  SYNDROME CORONAVIRUS 2 (SARS-COV-2)	VANDERBILT UNIVERSITY
WO/2021/195344	COMPOSITIONS AND METHODS FOR DIABETES TREATMENT	THE GENERAL HOSPITAL CORPORATION
WO/2021/195346	LIPOXYGENASE INHIBITORS	SRI INTERNATIONAL
WO/2021/202232	CELL IMMUNOTHERAPY FOR THE TREATMENT OF CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195367	HAIR CARE COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/195372	LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL  DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY	NUTRIVERT LLC
WO/2021/195390	METHOD FOR TREATING CANCER	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/195395	BETA-ARRESTIN COMPOSITIONS AND ASSOCIATED METHODS	DUKE UNIVERSITY
WO/2021/195400	NOVEL USES OF HALOGENATED XANTHENES IN ONCOLOGY AND VIROLOGY	PROVECTUS PHARMATECH, INC.
WO/2021/195401	TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS	BIOHAVEN THERAPEUTICS LTD.
WO/2021/195406	NEW THERAPEUTIC USES OF COMPOUNDS	PROXIMAGEN, LLC
WO/2021/195410	RECOMBINANT MULTIVALENT INFLUENZA VIRUSES	WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF)
WO/2021/195411	T-CELL MODULATORY MULTIMERIC POLYPEPTIDES WITH CONJUGATION  SITES AND METHODS OF USE THEREOF	CUE BIOPHARMA, INC.
WO/2021/202245	VIRAL TREATMENT REGIMENS	EGACEUTICAL CORPORATION
WO/2021/195415	ANTI-PD-1 ANTIBODIES AND METHODS OF USE	CUREIMMUNE THERAPEUTICS INC.
WO/2021/195424	COMPOSITIONS CONTAINING NEUTRALIZED AMINO ACID ESTERS AND  GLYCERIDES	STEPAN COMPANY
WO/2021/195425	ISOTOPICALLY-LABELLED TRAPIDIL DERIVATIVES	SINOPIA BIOSCIENCES, INC.
WO/2021/195426	HYPOIMMUNOGENIC NEURAL CELLS FOR THE TREATMENT OF NEUROLOGICAL  DISORDERS AND CONDITIONS	SANA BIOTECHNOLOGY, INC.
WO/2021/195427	2-BROMO-LYSERGIC ACID DIETHYLAMIDE FOR SUBSTANCE ABUSE	CH TAC, LLC
WO/2021/195431	INHALED XENON THERAPY IN NEURODEGENERATIVE DISEASE	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/195435	TREATMENT OF RESPIRATORY DISORDERS	TERNS, INC.
WO/2021/195439	ENTERIC NITRERGIC NEURONS AND METHODS OF USING THE SAME	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247124	COMPOSITION, SYSTEM AND METHOD FOR A PIG CONTRACEPTIVE	CORONA FEED ADDITIVES, L.L.C.
WO/2021/195442	COMPOSITIONS AND METHODS FOR TREATING CLONAL HEMATOPOIESIS	PRESIDENT AND FELLOWS HARVARD COLLEGE
WO/2021/195445	HYDROPHOBIC SILK FIBROIN COMPOSITIONS AND METHODS OF MAKING  THE SAME	TRUSTEES OF TUFTS COLLEGE
WO/2021/195452	USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING  VIRAL AGENTS	MOHAPATRA, Subhra
WO/2021/202254	FACTOR XI ACTIVATION INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/206930	COMPOSITIONS AND METHODS FOR TREATING ONE OR MORE AILMENTS  WITH A NASAL RINSE COMPRISING N-ACETYLCYSTEINE	PACIFIC SINUS SOLUTIONS LLC
WO/2021/221836	COMPOSITION OF SCALABLE THYROINTEGRIN ANTAGONISTS WITH  IMPROVED BLOOD BRAIN BARRIER PENETRATION AND RETENTION IN BRAIN TUMORS	NANOPHARMACEUTICALS, LLC
WO/2021/195465	TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND RELATED  CONDITIONS WITH ANTAGONISTS OF E-SELECTIN	MAGNANI, John L.
WO/2021/195467	RNAi AGENTS FOR INHIBITING EXPRESSION OF PNPLA3,  PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE	ARROWHEAD PHARMACEUTICALS, INC.
WO/2021/195469	COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY	AVIDITY BIOSCIENCES, INC.
WO/2021/195470	IDENTIFICATION AND USE OF COMPOUNDS IN THE TREATMENT OR  PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2	VANDA PHARMACEUTICALS INC.
WO/2021/195475	PROCESS, COMPOSITIONS, AND CRYSTALLINE FORMS OF SUBSTITUTED  PYRIDINONE-PYRIDINYL COMPOUNDS	ACLARIS THERAPEUTICS, INC.
WO/2021/195477	KETONE ESTER AS A THERAPEUTIC TREATMENT OF COVID-19, LONG  COVID, AND RELATED VIRAL INFECTIONS	KETONEAID, INC.
WO/2021/195493	DEVICES, SYSTEMS, AND METHODS FOR TREATING SEPSIS AND/OR VIRAL  INFECTION	ADVANCED COOLING THERAPY, INC.
WO/2021/195496	NOVEL ANUCLEATED CELLS AND USES THEREOF	PLATELET BIOGENESIS, INC.
WO/2021/195507	METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS	ACLARIS THERAPEUTICS, INC.
WO/2021/195510	DUAL-ACTING SIRNA BASED MODULATION OF  <i>C9ORF72</i>	UNIVERSITY OF MASSACHUSETTS
WO/2021/195513	BISPECIFIC COMBINATION THERAPY FOR TREATING PROLIFERATIVE  DISEASES AND AUTOIMMUNE DISORDERS	NOVARTIS AG
WO/2021/195521	METHODS OF TREATING CORONAVIRUS INFECTIONS	ACER THERAPEUTICS INC.
WO/2021/195522	COMPOSITIONS AND METHODS RELATING TO PIGMENTATION	ALASTIN SKINCARE, INC.
WO/2021/202286	COMPOSITIONS AND METHODS FOR TREATING AUTONOMIC DYSREFLEXIA	DIGNIFY THERAPEUTICS, LLC
WO/2021/195536	IMMUNOTHERAPEUTIC TARGETS IN MULTIPLE MYELOMA AND METHODS FOR  THEIR IDENTIFICATION	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/195540	CANNABINOID BASED COMPOSITION FOR MITIGATION OF VIRAL EFFECTS	RADIENT TECHNOLOGIES INNOVATIONS INC.
WO/2021/195544	NOVEL ANUCLEATED CELLS FOR THE TREATMENT OF DISEASES	PLATELET BIOGENESIS, INC.
WO/2021/202305	METHOD FOR PREVENTING OR TREATING LUNG INFECTION AND LUNG  INFLAMMATION	OLATEC THERAPEUTICS LLC
WO/2021/195553	LYTIC DOMAIN FUSION CONSTRUCTS, CHECKPOINT INHIBITORS, AND  METHODS OF MAKING AND USING SAME	ESPERANCE PHARMACEUTICALS, INC
WO/2021/195555	PALMITOYLETHANOLAMIDE COMPOUNDS	TRAVECTA THERAPEUTICS, PTE. LTD.
WO/2021/195559	METHODS FOR GENERATING IMMUNE RESPONSES AGAINST CANCER  ANTIGENS USING MICROCHANNEL DELIVERY DEVICES	AQUAVIT PHARMACEUTICALS, INC.
WO/2021/195562	ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF  IMMUNE CONDITIONS	ACLARIS THERAPEUTICS, INC.
WO/2021/195573	TREATMENT OF SOLID CANCEROUS TUMORS BY ORAL ADMINISTRATION OF  A HALOGENATED XANTHENE	PROVECTUS PHARMATECH, INC.
WO/2021/195575	ORAL CARE COMPOSITIONS AND METHODS OF USE	COLGATE-PALMOLIVE COMPANY
WO/2021/195577	COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS,  ENHANCING DRUG POTENCY AND TREATING VIRAL INFECTIONS, AND METHODS FOR MAKING  AND USING SAME	PERSEPHONE BIOSCIENCES, INC.
WO/2021/195580	PREVENTION AND TREATMENT OF CORONAVIRUS-ASSOCIATED DISEASES  USING AN APELIN PEPTIDE AND FORMULATIONS THEREOF	CHAN, John
WO/2021/195581	AEROSOLIZED FORMULATIONS OF AN APELIN PEPTIDE AND USES THEREOF	CHAN, John
WO/2021/195582	METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT  USING MEDICAL ICE SLURRY	STEFATER, James Anthony, III
WO/2021/195589	METHOD FOR TREATING THERAPY-RESISTANT MUC4+ CANCER	CONSEJO NACIONAL DE INVESTIGACIONES CIENTíFICAS Y TéCNICAS
WO/2021/195590	ORAL CARE COMPOSITIONS AND METHODS OF USE	COLGATE-PALMOLIVE COMPANY
WO/2021/195594	COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING  INFECTIONS	SAN DIEGO STATE UNIVERSITY (SDSU) FOUNDATION, DBA SAN DIEGO  STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/195598	DEGRADER-ANTIBODY CONJUGATES AND METHODS OF USING SAME	ANGIEX, INC.
WO/2021/195599	MTORC1 MODULATORS AND USES THEREOF	AEOVIAN PHARMACEUTICALS, INC.
WO/2021/195602	ALZHEIMER'S DIAGNOSTIC METHOD	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202317	NOVEL METHODS OF USING NITRIC OXIDE DONOR COMPOUNDS FOR  TREATMENT OF COVID-19 AND OTHER INFECTIOUS DISEASES	COEURATIVE, INC.
WO/2021/195603	ANTI-MALARIAL COMPOUNDS AND USES THEREOF	VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
WO/2021/202320	METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISEASES AND  DISORDERS	YALE UNIVERSITY
WO/2021/202321	PREVENTATIVE TREATMENT OF MIGRAINE	BIOHAVEN PHARMACEUTICAL IRELAND DAC
WO/2021/236231	COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR  CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA	CDA RESEARCH GROUP, INC.
WO/2021/195605	VACCINE FORMULATION TO PROTECT AGAINST PERTUSSIS	WEST VIRGINIA UNIVERSITY
WO/2021/202329	TRANSDERMAL DELIVERY OF DEXTROMETHORPHAN	SHINKEI THERAPEUTICS LLC
WO/2021/202332	AQUEOUS FORMULATIONS CONTAINING POVIDONE IODINE FOR EFFECTIVE  TREATMENT AND PREVENTION OF VIRUS INFECTIONS	IVIEW THERAPEUTICS, INC.
WO/2021/195613	HIGH-EFFICIENCY GOLD RECOVERY WITH CUCURBIT[6]URIL	NORTHWESTERN UNIVERSITY
WO/2021/202354	IL-2/IL-15 COMPOSITIONS AND METHODS OF USE THEREOF	PROVIVA THERAPEUTICS (HONG KONG) LIMITED
WO/2021/195619	FEED MITIGANT COMPOSITIONS FOR INACTIVATING SWINE VIRUSES AND  RELATED METHODS	RALCO NUTRITION, INC.
WO/2021/202361	ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS	NORTH CAROLINA STATE UNIVERSITY
WO/2021/202363	COMBINED ANIMAL-DERIVED AND SYNTHETICALLY PRODUCED PANCREATIC  ENZYME REPLACEMENT THERAPY	WALL, Jai
WO/2021/202376	METHOD FOR BLOCKING UPTAKE OF PROSTATE-SPECIFIC MEMBRANE  ANTIGEN (PSMA)-TARGETED RADIONUCLIDES BY EXOCRINE ORGANS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/202381	METHODS AND COMPOSITIONS FOR MODULATING LIPID STORAGE IN  ADIPOSE TISSUE	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/195627	METHOD OF TREATMENT FOR ANOREXIA NERVOSA, BULIMIA AND RELATED  CLINICAL SYNDROMES	HOMEOSTASIS THERAPEUTICS, LIMITED
WO/2021/202399	METHODS OF TREATING CORONAVIRUS INFECTIONS USING  ANGIOTENSIN-CONVERTING ENZYME 2 INHIBITORS	KUMUDA, INC.
WO/2021/202400	PERSONAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/202413	SYSTEMS, METHODS, AND COMPOSITIONS FOR INFECTIONS	OJAI ENERGETICS PBC
WO/2021/202414	MULTIANALYTE TEST FOR IMMUNE RESPONSE TO SARS-COV-2 VIRUS  LEADING TO COVID-19	RUSH UNIVERSITY MEDICAL CENTER
WO/2021/202419	USE OF BUPROPION AND DEXTROMETHORPHAN COMBINATIONS FOR  TREATING NEUROLOGICAL DISORDERS	ANTECIP BIOVENTURES II LLC
WO/2021/195636	MICROBIOME-BASED THERAPEUTICS	CORNELL UNIVERSITY
WO/2021/202421	METHODS FOR INTEGRATING DNA INTO GENES WITH GAIN-OF-FUNCTION  OR LOSS-OF-FUNCTION MUTATIONS	BLUEALLELE, LLC
WO/2021/202429	METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19	ESRAIL MEDICAL CORP.
WO/2021/202437	METHODS AND PHARMACEUTICAL COMPOSITIONS OF THROMBOXANE A2  RECEPTOR ANTAGONIST FOR THE TREATMENT OF COVID-19	OGLETREE, Martin
WO/2021/202449	NANOPARTICLE-LOADED SILICIFIED CELLS, METHODS OF MAKING, AND  METHODS OF USE	UNM RAINFOREST INNOVATIONS
WO/2021/202456	SYNTHETIC SOLUBLE RECEPTOR MIMICS AND METHODS OF USE FOR  TREATMENT OF COVID-19	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/202459	COMPOSITIONS AND METHODS RELATING TO EXOSOMES DERIVED FROM  HUMAN DERMAL PAPILLA CELLS	NORTH CAROLINA STATE UNIVERSITY
WO/2021/202478	PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS	IGIA PHARMACEUTICALS, INC.
WO/2021/202481	COMPOSITIONS AND METHODS FOR INHIBITING TYPE 1 COLLAGEN  PRODUCTION	FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/202493	CERAMIDE CONTAINING CAPSULES, CERAMIDE COMPOSITIONS, AND  COSMETIC COMPOSITIONS THEREOF	L'OREAL
WO/2021/206955	MACROCYCLIC COMPOUNDS AS KINASES INHIBITORS AND USES THEREOF	ANGEX PHARMACEUTICAL, INC.
WO/2021/202523	ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE  RESPIRATORY DISTRESS SYNDROME, ACUTE LUNG INFLAMMATION/INJURY, CARDIAC INJURY  AND ANTI-VIRAL THERAPY	APPLIED THERAPEUTICS, INC.
WO/2021/202530	CASPASE INHIBITORS TO ENHANCE INJURY REPAIR AND TO TREAT  BACTERIAL AND VIRAL INFECTIONS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/202533	HIGH-STRENGTH COLLAGEN COMPOSITIONS AND METHODS OF USE	GENIPHYS, INC.
WO/2021/202535	METHODS FOR TREATING, AMELIORATING, OR PREVENTING VIRAL  INFECTIONS	THOMAS JEFFERSON UNIVERSITY
WO/2021/202540	HSP70 INHIBITORS AND METHODS OF USING SAME	THE WISTAR INSTITUTE
WO/2021/202546	EARLY DRUG INTERVENTIONS TO REDUCE COVID-19 RELATED  RESPIRATORY DISTRESS, NEED FOR VENTILATOR ASSISTANCE AND DEATH	CYCLERION THERAPEUTICS, INC.
WO/2021/202553	CXCR5 ANTAGONISTS AND METHODS OF TREATING DISEASES OR  DISORDERS USING SAME	YALE UNIVERSITY
WO/2021/202563	METHODS OF TREATING CORONAVIRUS INFECTION	CYTODYN INC.
WO/2021/206965	ANTIBODY FORMULATION	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202570	USE OF STEM CELLS FOR TREATMENT OF EXCESSIVE INFLAMMATION	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/202577	STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION	3-D MATRIX, LTD.
WO/2021/206968	HIGH-POTENCY AGONISTS AND ANTAGONISTS OF THE WNT SIGNALING  PATHWAY	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202592	MONOCLONAL ANTIBODIES FOR INTRACELLULAR DELIVERY OF PAYLOADS	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/202599	ADENO-ASSOCIATED VIRUS BASED COMPOSITIONS AND RELATED METHODS  FOR INDUCING HUMORAL IMMUNITY	VALIANT BIOSCIENCES, LLC
WO/2021/202608	SERUM METABOLITES AS BIOMARKERS FOR CARNITINE TREATMENT OF  SEPSIS	PUSKARICH, Michael A.
WO/2021/211294	BASIC CHEMOTHERAPEUTIC INTRATUMOUR INJECTION FORMULATION	US NANO FOOD & DRUG INC
WO/2021/202630	RECOMBINANT BACTERIA PRODUCING CHEMICALS INHIBITORY TO  SALMONELLA INVASION	CORNELL UNIVERSITY
WO/2021/202632	COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTION	CORNELL UNIVERSITY
WO/2021/202642	IMMUNOTHERANOSTIC AGENT TARGETING MESENCHYMAL STEM  CELL-DERIVED CANCER CELLS AND MESENCHYMAL STEM CELL ASSOCIATED DISEASE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/202644	THERAPEUTIC COMPOSITIONS	WINTERMUTE BIOMEDICAL, INC.
WO/2021/202650	CYSTEAMINE PRECURSOR COMPOUNDS FOR THE TREATMENT OF  BETACORONAVIRUS INFECTIONS	THIOGENESIS THERAPEUTICS, INC.
WO/2021/202652	TYROSINE KINASE 2 INHIBITORS, PREPARATION METHODS AND  MEDICINAL USES THEREOF	ETERNITY BIOSCIENCE INC.
WO/2021/202656	HAIR CARE COMPOSITIONS COMPRISING POLYOL, C2-6 MONOALCOHOL AND  CATIONIC SURFACTANT	L'OREAL
WO/2021/202669	NUCLEOSIDE AND NUCLEOTIDE CONJUGATE COMPOUNDS AND USES THEREOF	REYOUNG CORPORATION
WO/2021/202675	MASKED IL-2 CYTOKINES AND THEIR CLEAVAGE PRODUCTS	XILIO DEVELOPMENT, INC.
WO/2021/202678	MASKED IL-12 CYTOKINES AND THEIR CLEAVAGE PRODUCTS	XILIO DEVELOPMENT, INC.
WO/2021/202680	KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA	AKER BIOMARINE ANTARCTIC AS
WO/2021/202690	VIRUS TREATMENT METHODS, AND RELATED PHARMACEUTICAL  COMPOSITIONS, VACCINE COMPOSITIONS, SANITIZING COMPOSITIONS, AND DRUG  DISCOVERY METHODS	CASHMAN, Daniel Patrick
WO/2021/202708	METHODS FOR TREATING VIRAL INFECTIONS WITH NAFAMOSTAT	ENSYSCE BIOSCIENCES, INC.
WO/2021/202720	USE OF TRITERPENOID NRF2 INHIBITORS	FRONTHERA U.S. PHARMACEUTICALS LLC
WO/2021/202726	ANTI-CD33 ANTIBODIES AND USES THEREOF	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202731	COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL  DISEASE USING CCR9 INHIBITOR AND ANTI-IL-23 BLOCKING ANTIBODIES	CHEMOCENTRYX, INC.
WO/2021/202734	UNIVERSAL INFLUENZA VACCINE USING NUCLEOSIDE-MODIFIELD MRNA	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/202735	THE USE OF DIFFUSION ENHANCING COMPOUNDS FOR TREATMENT OF  VIRAL AND BACTERIAL INDUCED RESPIRATORY DISEASE	DIFFUSION PHARMACEUTICALS LLC
WO/2021/202745	TREATMENT OF COVID-19 WITH A SINE COMPOUND	KARYOPHARM THERAPEUTICS INC.
WO/2021/202765	SARS-COV-2 VACCINES FOR POPULATION-SCALE IMMUNITY	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/202767	ENTERIC AEROBIZATION THERAPY	LPOXY THERAPEUTICS, INC
WO/2021/202772	MULTILAMELLAR RNA NANOPARTICLE VACCINE AGAINST SARS-COV-2	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/202780	METHODS AND COMPOSITIONS FOR TREATING CANCER	ENGINE BIOSCIENCES PTE. LTD.
WO/2021/202798	ANTIGEN BINDING PROTEINS TO CLASS 5 ETEC ADHESINS	THE UNITED STATES OF AMERICA as represented by THE SECRETARY  OF THE NAVY
WO/2021/202801	AUGMENTING ANTIGEN-NEGATIVE CELL DEATH IN ANTIGEN-TARGETED  IMMUNOTHERAPIES	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/202802	CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS	PROTOMER TECHNOLOGIES INC.
WO/2021/202806	COMPOSITIONS COMPRISING NON-VIABLE FECAL MICROBIOTA AND  METHODS OF USE THEREOF	FINCH THERAPEUTICS HOLDINGS LLC
WO/2021/159128	METHODS AND KIT FOR DETECTION OF ANALYTES	ALLEN, Randy Leiman
WO/2021/202816	BROAD-SPECTRUM ANTIVIRAL PEPTIDES	THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/202817	DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT  OF USH1B	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/202822	COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES AND  PREMATURE AGING DISORDERS	SIRTSEI PHARMACEUTICALS, INC.
WO/2021/202823	THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19	MOLLICK, Peter J.
WO/2021/202825	METHODS OF TREATING RELAPSING MULTIPLE SCLEROSIS USING AN  INHIBITOR OF BRUTON'S TYROSINE KINASE	GENENTECH, INC.
WO/2021/202826	MATERIALS AND METHODS FOR IMMUNOSUPPRESSIVE TUMOR  MICROENVIRONMENT-TARGETED CANCER THERAPY	UNIVERSITY OF CINCINNATI
WO/2021/202830	HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF	TARVEDA THERAPEUTICS, INC.
WO/2021/202836	FACTOR B INHIBITORS AND USES THEREOF	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/202858	RNA APTAMERS AND USE THEREOF FOR TREATING CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202861	METHOD OF CHARACTERISATION	INVIVOSCRIBE, INC.
WO/2021/202863	HUMAN ROR-1 ANTIBODY AND ANTI-ROR-1-CAR-T CELLS	PROMAB BIOTECHNOLOGIES, INC.
WO/2021/211303	ANTIVIRAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE  AGAINST VIRUSES	CONTRAFECT CORPORATION
WO/2021/202874	FURIN INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS	BP ASSET V, INC.
WO/2021/202875	COSMETIC COMPOSITIONS	TWINMEDIX LLC
WO/2021/202885	TNFα SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN  BE TARGETED TO THERAPY	BAYLOR COLLEGE OF MEDICINE
WO/2021/202886	METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202893	DETECTING ADAPTIVE IMMUNITY TO CORONAVIRUS	NONIGENEX, INC.
WO/2021/202898	METHODS OF MAKING PLURIPOTENT STEM CELLS AND USES THEREOF	NATIONAL JEWISH HEALTH
WO/2021/202904	ENGINEERED ANTIBODIES THAT BIND LAGS	SORRENTO THERAPEUTICS, INC.
WO/2021/202906	METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA	APNIMED, INC. (DELAWARE)
WO/2021/202908	CD5L-BINDING ANTIBODIES AND USES FOR THE SAME	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202912	COMPOSITIONS FOR TREATMENT OF VIRAL RESPIRATORY INFECTIONS AND  METHODS OF USE THEREOF	WASHINGTON UNIVERSITY
WO/2021/202917	A NONINVASIVE MULTIPARAMETER APPROACH FOR EARLY IDENTIFICATION  OF THERAPEUTIC BENEFIT FROM IMMUNE CHECKPOINT INHIBITION FOR LUNG CANCER	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/202919	TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS	THE UNIVERSITY OF CHICAGO
WO/2021/202921	IMIDAZOQUINOLINE-TYPE COMPOUNDS AND USES THEREOF	ALTIMMUNE UK LIMITED
WO/2021/202923	IMMUNOMODULATOR FOR THE PREVENTION AND TREATMENT OF  CORONOVIRUS INFECTION AND OTHER CONDITIONS	NEKTAR THERAPEUTICS
WO/2021/202928	PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/202936	PYRAZOLYLPROPANAMIDE COMPOUNDS AND USES THEREOF FOR TREATMENT  OF PROSTATE CANCER	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/202943	TREATMENT OF PHENYLKETONURIA WITH AAV AND THERAPEUTIC  FORMULATIONS	BIOMARIN PHARMACEUTICAL, INC.
WO/2021/202945	NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF	CORNELL UNIVERSITY
WO/2021/202947	METHOD FOR TREATING LUNG DISEASE WITH CELL-FREE AMNIOTIC FLUID	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/202948	PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING  ACUTE RESPIRATORY DISTRESS SYNDROME	DYAX CORP.
WO/2021/202949	COMPOSITIONS AND METHODS FOR TREATING VULVAR DYSPLASIA	INOVIO PHARMACEUTICALS, INC.
WO/2021/202952	COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR  INHIBITING SARS-COV-2	LINHARDT, Robert, John
WO/2021/202957	USE OF ARGINASE FOR TREATMENT OF CORONAVIRUS INFECTION	AEGLEA BIOTHERAPEUTICS, INC.
WO/2021/202961	METHODS OF TREATING IMMUNOTHERAPY RESISTANT METASTATIC  MELANOMA	UNITED STATES AS REPRESENTED BY DEPT OF VETERANS AFFAIRS
WO/2021/202971	COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORM	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/207020	CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY	TIBA BIOTECH LLC
WO/2021/202975	IMPLANTABLE CELL MACROENCAPSULATION DEVICE AND METHOD OF  MANUFACTURE AND USE	THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
WO/2021/202977	PYRROLOPYRIMIDINE AMINES AS COMPLEMENT INHIBITORS	BIOCRYST PHARMACEUTICALS, INC.
WO/2021/202981	CO-ADMINISTRATION OF MIRDAMETINIB AND LIFIRAFENIB FOR USE IN  TREATING CANCERS	BEIGENE, LTD.
WO/2021/202984	ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS	MERSANA THERAPEUTICS, INC.
WO/2021/207024	PREPARATION OF A 1,3,5-TRIAZINYL BENZIMIDAZOLE	MEI PHARMA, INC.
WO/2021/202988	COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE	TURTLE BEAR HOLDINGS, LLC
WO/2021/202990	METHODS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS	TEPPER, Mark, Allan
WO/2021/203001	METHOD OF TREATING PATIENTS INFECTED WITH A VIRAL INFECTION  WITH AN INHIBITOR OF SMALL UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME	MILLENNIUM PHARMACEUTICALS, INC.
WO/2021/203013	METHODS OF TREATING IMMUNE MEDIATED PULMONARY INJURY	VIELA BIO, INC.
WO/2021/203017	BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR PREVENTION OF  SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) INFECTION	ASCENDO BIOTECHNOLOGY, INC.
WO/2021/203022	TREATMENT METHODS	GENOCEA BIOSCIENCES, INC.
WO/2021/203024	ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF	VISTERRA, INC.
WO/2021/203033	METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO  TREAT OBESITY-RELATED CONDITIONS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/203038	DELIVERY OF GINSENOSIDES TO THE RESPIRATORY SYSTEM VIA  ELECTRONIC BREATH ACTUATED DROPLET DELIVERY DEVICE	PNEUMA RESPIRATORY, INC.
WO/2021/203042	A UNIVERSAL ADOPTIVE IMMUNOTHERAPY APPROACH TO TREAT COVID-19  AND FUTURE EMERGING INFECTIOUS DISEASES	LINEAGE CELL THERAPEUTICS, INC.
WO/2021/203048	NOVEL 2-PYRIMIDONE ANALOGS AS POTENT ANTIVIRAL AGENTS AGAINST  ALPHAVIRUSES	SOUTHERN RESEARCH INSTITUTE
WO/2021/203051	AEROSOLIZED HYALURONIDASE AND/OR 4-METHYLUMBELLIFERONE  COMPOSITIONS AND METHODS OF USING SAME TO TREAT RESPIRATORY DISEASES OR  DISORDERS	STANDARD OF CARE CORPORATION
WO/2021/203055	VIRAL ENTRY INHIBITORS AND RNA POLYMERASE INHIBITORS	SELVA THERAPEUTICS, INC.
WO/2021/203061	STEM CELL IMMUNOMODULATORY THERAPY FOR COVID-19 INFECTION	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/203062	REDUCING OR INHIBITING OCULAR DAMAGE BY HYALURONIDASE  ADMINISTRATION	MED PROGRESS, LLC
WO/2021/207047	COMPOSITIONS AND METHODS FOR THE TREATMENT OF  INFECTION-INDUCED CARDIOMYOPATHY	DUKE UNIVERSITY
WO/2021/207049	INHALATION FORMULATIONS OF 1'-CYANO SUBSTITUTED  CARBANUCLEOSIDE ANALOGS	GILEAD SCIENCES, INC.
WO/2021/207051	METHODS OF TREATING ACUTE RESPIRATORY DISORDERS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/207052	ARGININE METHYLTRANSFERASE 5 (PRMT5) DEGRADERS AND USES  THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/207054	METHODS OF REDUCING PLASMA LEVEL OF MACROPHAGE MIGRATORY  INHIBITORY FACTOR IN PATIENTS WITH IBUDILAST	MEDICINOVA, INC.
WO/2021/203087	METHODS TO ENRICH ENTEROENDOCRINE CELLS AND THEIR SUBTYPES IN  THE CONTIGUOUS, INTESTINAL MONOLAYER SYSTEMS	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/207060	METHODS OF TREATMENT OF CORONAVIRUS-INDUCED INFLAMMATION  CONDITIONS	THE GENERAL HOSPITAL CORPORATION
WO/2021/252054	COMPOSITIONS AND USES IN METHOD FOR POST-OPERATIVE OCULAR CARE	OCULAR SCIENCE, INC.
WO/2021/203093	RAPID POINT OF CARE ASSAY FOR THE DETECTION OF THE  ASYMPTOMATIC CARRIER STATE OF COVID-19	LOOMIS, Lawrence
WO/2021/207072	ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF	MABWELL THERAPEUTICS INC.
WO/2021/207077	ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR IDS GENE TRANSFER AND  METHODS OF USE THEREOF	HOMOLOGY MEDICINES, INC.
WO/2021/207082	METHOD FOR TREATING IMPLANTABLE DEVICE INFECTIONS	ADAPTIVE PHAGE THERAPEUTICS, INC.
WO/2021/207086	TEM-1-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF	FUSION PHARMACEUTICALS INC.
WO/2021/203100	METHODS OF TREATING CORONAVIRUS	VERU INC.
WO/2021/203101	HYPOCHLOROUS ACID SOLUTIONS AND METHODS OF USE	PHASE ONE HEALTH, LLC
WO/2021/207099	CORONAVIRUS THERAPEUTICS AND TREATMENT METHODS	HAMILTON, Douglas, A.
WO/2021/203103	ACE2 RECEPTOR POLYMORPHISMS AND VARYING SUSCEPTIBILITY TO  SARS-COV-2, METHODS FOR DIAGNOSIS AND TREATMENT	SESHAGIRI, Somasekar
WO/2021/203104	INFECTIOUS DISEASE ANTIGENS AND VACCINES	GRITSTONE BIO, INC.
WO/2021/216276	RAPID, POINT OF CARE DETECTION OF NEUTRALIZING ANTIBODIES  AGAINST A VIRUS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/207121	HYPOIMMUNOGENIC CELLS AND METHODS AND COMPOSITIONS FOR THEIR  PRODUCTION	RXCELL INC.
WO/2021/207126	COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS	THE TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/207130	HYALURONATE COMPOSITIONS AND SOFT TISSUE FILLERS	AMC GROUP LLC
WO/2021/207137	CRYSTALLINE 5-METHOXY-<i>N,N</i>-DIALLYLTRYPTAMINE  COMPOUNDS	CAAMTECH, INC.
WO/2021/207141	METHODS OF USING NEUROKININ-1 RECEPTOR (NK-1R) ANTAGONISTS TO  TREAT β-CORONAVIRUS INFECTION INCLUDING SARS-COV-2 INFECTION AND/OR COVID-19  DISEASE	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/207149	SYSTEM AND METHOD FOR AEROSOL PARTICLE PRODUCTION OF SUBMICRON  AND NANO STRUCTURED MATERIALS	THE TRUSTEES OF PRINCETON UNIVERSITY
WO/2021/207152	CROSS-REACTIVE CORONAVIRUS ANTIBODIES AND USES THEREOF	VANDERBILT UNIVERSITY
WO/2021/207155	AIRWAY EPITHELIAL ALKALINE THERAPY TO TREAT VIRAL RESPIRATORY  INFECTION	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/207164	COMPOSITIONS AND USES OF LOCALLY APPLIED SYNTHETIC AMINO ACID  POLYMERS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS	AMICROBE, INC.
WO/2021/207168	METHODS FOR USING EXTRACELLULAR MICROVESICLES WITH  SYNCYTIOTROPHOBLAST MARKERS TO DIAGNOSE PREECLAMPSIA	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/207172	COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF KRAS	ARVINAS OPERATIONS, INC.
WO/2021/207176	GENISTEIN TREATMENT OF INFLAMMATORY PULMONARY INJURY	HUMANETICS CORPORATION
WO/2021/211325	CRISPR-INHIBITION FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY	BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON  BEHALF OF THE UNIVERSITY OF NEVADA, RENO
WO/2021/207178	SILVER NANOPARTICLES FOR USE IN INHIBITING AND TREATING  CORONAVIRUS INFECTION	AGARWAL, Ankit
WO/2021/207180	NUTRITIONAL FORMULATIONS FOR MODULATING RESPIRATORY-INDUCED  CYTOKINES	ABBOTT LABORATORIES
WO/2021/207182	CBD SUNSCREEN FORMULATIONS AND USES THEREOF	JUPITER WELLNESS, INC.
WO/2021/207192	METHODS AND COMPOSITIONS FOR ALLERGY AND ASTHMA TREATMENT  USING FIBROBLASTS	FIGENE, LLC
WO/2021/207197	BISPECIFIC APTAMER COMPOSITIONS FOR THE TREATMENT OF RETINAL  DISORDERS	DRIVE THERAPEUTICS L.L.C.
WO/2021/207206	ANTI-OBESITY PEPTIDES AND USES THEREOF	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/207213	METHODS TO PREVENT SARS-COV-2 INFECTION AND TREAT COVID-19	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/207217	COMPOSITIONS AND METHODS FOR TREATING VIRUSES	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/207218	TREATMENT OF NIDOVIRALES INFECTION WITH ERITORAN	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/207230	METHODS OF TREATING CYTOKINE RELEASE SYNDROME USING A PI3K  INHIBITOR	VERASTEM, INC.
WO/2021/207247	SPERMIDINE-SUPPLEMENTED FOOD PRODUCTS	KALIN HEALTH LLC
WO/2021/207249	VACCINE PLATFORM FOR THE INDUCTION OF SYSTEMIC IMMUNE  RESPONSES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/207253	PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM	AXSOME THERAPEUTICS, INC.
WO/2021/207271	ORGANOSELENIDE GLUTATHIONE PEROXIDASE MIMETICS FOR THE  TREATMENT OF INFLAMMATORY PULMONARY DISORDERS	EBVIA INC.
WO/2021/207273	MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS  DELIVERY OF THERAPEUTICS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207281	VACCINES, ADJUVANTS, AND METHODS OF GENERATING AN IMMUNE  RESPONSE	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/207290	ENGINEERED IMMUNE CELLS	SYNTHEKINE, INC.
WO/2021/221863	RAPID TESTING MECHANISM AND METHOD FOR RESPIRATORY VIRAL  PATHOGENS	HEEGER, Brandon
WO/2021/207291	COMPOUNDS AND USES THEREOF	FOGHORN THERAPEUTICS INC.
WO/2021/207295	TREATING ARDS USING A POLY-OXYGENATED ALUMINUM HYDROXIDE	HEMOTEK LLC
WO/2021/207300	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AND  PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH VIRAL  INFECTIONS	HISTA RX LLC
WO/2021/207303	IMMUNE STIMULATION AGAINST CORONAVIRUS INFECTIONS	ALSATECH, INC.
WO/2021/207305	COMPOSITIONS AND METHODS USING INTERFERON FOR TREATING VIRAL  RESPIRATORY INFECTIONS	NOSTRUM PHARMACEUTICALS, LLC
WO/2021/207306	RECOMBINANT BACTERIA FOR USE AS A VACCINE TO PREVENT COVID19  INFECTION	SYNLOGIC OPERATING COMPANY, INC.
WO/2021/207307	COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND/OR TREATMENT  OF VIRAL INFECTIONS OR CONDITIONS ASSOCIATED THEREWITH	NOSTRUM PHARMACEUTICALS, LLC
WO/2021/207312	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RETINAL  NERVE DAMAGE	G3 PHARMACEUTICALS, INC.
WO/2021/207325	NATURAL EXTRACT AND THEIR COMPONENTS FOR USE IN MITIGATING  ACUTE RESPIRATORY DISTRESS SYNDROME	SYTHEON LIMITED
WO/2021/207327	METHODS FOR REHABILITATING HEART FAILURE USING GENE THERAPY	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/207329	MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE  RESERVOIR DEVICE	RESEARCH TRIANGLE INSTITUTE
WO/2021/207336	ORAL FORMULATIONS FOR SUSTAINED RELEASE AND GASTROINTESTINAL  RETENTION	VERTé THERAPEUTICS, LLC
WO/2021/207343	MALT1 INHIBITORS AND USES THEREOF	RHEOS MEDICINES, INC.
WO/2021/207348	METHOD OF TREATING AND PREVENTING OCULAR DISEASE WITH HSV-2  DELTA GD	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/207349	PREVENTION AND TREATMENT OF VIRIAL INFECTIONS	HABBOUSHE, Joseph
WO/2021/207352	COMPOSITIONS AND METHODS FOR TREATMENT OF ANTICANCER-DRUG  RESISTANT CANCERS	THE GEORGE WASHINGTON UNIVERSITY
WO/2021/207359	COMPOSITIONS AND METHODS FOR THE PREVENTION OF STRESS-INDUCED  FEAR, DEPRESSIVE-LIKE AND ANXIETY- LIKE BEHAVIOR	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/207365	REAWAKENING OF DORMANT TUMOR CELLS BY MODIFIED LIPIDS DERIVED  FROM STRESS ACTIVATED NEUTROPHILS	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/207367	RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS	HOFSETH BIOCARE ASA
WO/2021/207380	THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST  INJURY	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/207384	METHODS OF TREATING AND/OR PREVENTING VIRAL INFECTIONS AND/OR  DISEASES CAUSED BY VIRUSES IN A SUBJECT IN NEED THEREOF	JIAO, Lixia
WO/2021/207386	METHODS, COMPOSITIONS, AND DOSING REGIMENS FOR TREATMENT OF  SARS-COV-2 INFECTIONS	BIOCRYST PHARMACEUTICALS, INC.
WO/2021/207387	USE OF BROMODOMAIN INHIBITORS FOR TREATMENT OF HUNTINGTON'S  DISEASE	RUMI SCIENTIFIC HOLDINGS, INC.
WO/2021/207388	COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL  INFECTIONS AND OTHER RESPIRATORY DISORDERS	FIRSTSTRING RESEARCH, INC.
WO/2021/207394	SYNTHESIS AND APPLICATIONS OF POLYMERS OF PENTADECYL  CAPROLACTONE	REGENTS OF THE UNIVERSITY OF MINNESOTA
WO/2021/207396	GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN  MUSCLE DISEASES AND AUTOIMMUINE DISORDERS	BRIGHAM YOUNG UNIVERSITY
WO/2021/207399	HYDROLYSABLE TANNINS FOR USE IN MITIGATING ACUTE RESPIRATORY  DISTRESS SYNDROME	SYTHEON LIMITED
WO/2021/211343	ZIKA VIRUS MRNA VACCINES	MODERNATX, INC.
WO/2021/207420	AN INNOVATIVE DNA VACCINE FOR SARS-COV, SARS-COV-2, AND  MERS-COV	THE JOHNS HOPKINS UNIVERSITY
WO/2021/207436	RHEOLOGICAL SOLID COMPOSITION FOR USE IN SHAVING	THE PROCTER & GAMBLE COMPANY
WO/2021/207437	STRUCTURED RHEOLOGICAL SOLID COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/207438	ORAL CARE PRODUCT COMPRISING A RHEOLOGICAL SOLID COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/207439	RHEOLOGICAL SOLID COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/207440	RHEOLOGICAL SOLID COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/207442	RHEOLOGICAL SOLID ORAL COMPOSITION	THE PROCTER & GAMBLE COMPANY
WO/2021/207443	METHODS OF TREATING SARS-COV-2 INFECTIONS	EAGLE PHARMACEUTICALS, INC.
WO/2021/207444	METHODS OF TREATING SEVERE ACUTE RESPIRATORY SYNDROME	EAGLE PHARMACEUTICALS, INC.
WO/2021/207445	METHODS OF TREATING CORONAVIRUS INFECTIONS	EAGLE PHARMACEUTICALS, INC.
WO/2021/207446	METHODS OF TREATING VIRAL INFECTIONS	EAGLE PHARMACEUTICALS, INC.
WO/2021/207451	STRUCTURED RHEOLOGICAL SOLID PERSONAL CARE COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/207469	NOVEL INHIBITORS OF HISTONE ACETYLTRANSFERASE P300/CBP FOR  CANCER THERAPY	BAYLOR COLLEGE OF MEDICINE
WO/2021/207478	COMPOSITIONS AND METHODS FOR TREATING HOT FLASHES	THE PROCTER & GAMBLE COMPANY
WO/2021/207483	MICRONEEDLE ARRAY DELIVERY OF ADENOVIRUS VECTORED VACCINES  WITH AND WITHOUT ADJUVANTS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/207486	TREATMENTS	AERIE PHARMACEUTICALS, INC.
WO/2021/207487	METHODS OF TREATING CONDITIONS CHARACTERIZED BY INSULIN  DEFICIENCY IN ANIMALS	HOFFMAN TECHNOLOGIES LLC
WO/2021/207489	METHODS AND PHARMACEUTICAL COMPOSITIONS TO TREAT PULMONARY  INFLAMMATION IN INFECTED PATIENTS	RTU PHARMACEUTICALS, LLC
WO/2021/207500	TGFβ THERAPY FOR OCULAR AND NEURODEGENERATIVE DISEASES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/207514	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG  DISEASE	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/221879	COMPOSITIONS AND METHODS FOR USING TRANSPLANTED MICROGLIA AS A  VEHICLE FOR WIDESPREAD DELIVERY OF CELLS AND OTHER BIOLOGIC AGENTS TO THE  BRAIN	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/211358	LSD DOSE IDENTIFICATION	UNIVERSITÄTSSPITAL BASEL
WO/2021/207526	HUMANIZED NOTCH RECEPTORS WITH HINGE DOMAIN	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207554	COMPOUNDS AND METHODS FOR MODULATING SPLICING	REMIX THERAPEUTICS INC.
WO/2021/207561	CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION	TONIX PHARMACEUTICALS HOLDING CORP.
WO/2021/207566	CAROTENOID SOLUTIONS AND USES THEREOF	L.E.A.F. HOLDINGS GROUP LLC
WO/2021/207577	PROCESS FOR PRODUCING TCA CYCLE INTERMEDIATE CONJUGATES AND  POLYMORPHS OF A TCA CYCLE INTERMEDIATE CONJUGATE	IMBRIA PHARMACEUTICALS, INC.
WO/2021/211365	MULTIMODAL AUTOMATED DISINFECTING SYSTEM	GMA INTERNATIONAL SERVICES, INC.
WO/2021/207587	GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST  CORONAVIRUS INFECTIONS	GENETICURE INC.
WO/2021/207592	USE OF VIRAL VECTORS FOR CORONAVIRUS VACCINE PRODUCTION	4MVAC LLC
WO/2021/207595	RECOMBINANT VACCINES AND METHODS OF USE THEREOF	VANDERBILT UNIVERSITY
WO/2021/207597	COMPOUNDS SPECIFIC TO CORONAVIRUS S PROTEIN AND USES THEREOF	ADAGIO THERAPEUTICS, INC.
WO/2021/207598	COMBINATION TREATMENT WITH AN AGONIST OF P53 AND A SECOND  THERAPEUTIC AGENT	APREA THERAPEUTICS, INC.
WO/2021/207601	CROSS-LINKED COMPOSITIONS AND THEIR USE	VERTELLUS HOLDINGS LLC
WO/2021/207606	METHODS FOR TREATMENT OF CORONAVIRUS INFECTIONS	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
WO/2021/211382	COMPOUNDS AND METHODS FOR MODIFYING IAGE	EDIFICE HEALTH, INC.
WO/2021/207630	OXIDIZED TUMOR CELL LYSATES ENCAPSULATED IN LIPOSOMAL  SPHERICAL NUCLEIC ACIDS AS POTENT CANCER IMMUNOTHERAPEUTICS	NORTHWESTERN UNIVERSITY
WO/2021/207632	SMALL MOLECULE THERAPEUTICS FOR THE TREATMENT OF VIRAL  INFECTIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/207634	BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING  THE SAME	SENDA BIOSCIENCES, INC.
WO/2021/207635	PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY  REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS  THEREOF	THE GEORGE WASHINGTON UNIVERSITY
WO/2021/207644	COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS	BIOVISTA, INC.
WO/2021/207653	USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19	IDERA PHARMACEUTICALS, INC.
WO/2021/207657	COMPOSITIONS CONTAINING ACTIVATABLE ANTIBODIES	CYTOMX THERAPEUTICS, INC.
WO/2021/207662	USE OF IL-22FC FOR THE TREATMENT OR PREVENTION OF PNEUMONIA,  ACUTE RESPIRATORY DISTRESS SYNDROME, OR CYTOKINE RELEASE SYNDROME	GENENTECH, INC.
WO/2021/207667	COMPOSITIONS AND METHODS FOR TREATING LUNG INJURY OR ACUTE  RESPIRATORY DISTRESS SYNDROME (ARDS)	KINEVANT SCIENCES GMBH
WO/2021/207671	TREATING AUTOIMMUNE DISEASES WITH GENETICALLY MODIFIED CELLS	WALLKILL BIOPHARMA, INC.
WO/2021/207673	COMPOSITIONS, METHODS AND USES FOR PRODUCTION OF HEMATOPOIETIC  STEM CELLS (HSCS)	THE REGENTS OF THE UNIVERSITY OF COLORODO, A BODY CORPORATE
WO/2021/207676	METHODS OF SYNTHESIZING CAROTENOIDS	L.E.A.F. HOLDINGS GROUP LLC
WO/2021/207678	KAPPA OPIOID RECEPTOR ANTAGONISTS FOR TREATING PAIN-RELATED  SLEEP DISORDERS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/207679	POLYPEPTIDE COMPOSITIONS AND USES THEREOF	LIBERTY BIOSECURITY, LLC
WO/2021/207681	TARGETED REDUCTION OF ACTIVATED IMMUNE CELLS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/207687	POLYPEPTIDE COMPOSITIONS AND USES THEREOF	LIBERTY BIOSECURITY LLC
WO/2021/207689	METHODS AND USES RELATED TO CELL THERAPY ENGINEERED WITH A  CHIMERIC ANTIGEN RECEPTOR TARGETING B-CELL MATURATION ANTIGEN	JUNO THERAPEUTICS, INC.
WO/2021/207690	TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS	L.E.A.F. HOLDINGS GROUP LLC
WO/2021/207691	PHTHALOCYANINE DYE COMPOUNDS, CONJUGATES AND METHODS OF USE  THEREOF	RAKUTEN MEDICAL, INC.
WO/2021/207697	TREATMENT OF ACUTE LUNG INJURY	CANTEX PHARMACEUTICALS, INC.
WO/2021/207701	CHARGE VARIANT LINKERS	SEAGEN INC.
WO/2021/207704	APPARATUS FOR DECARBOXYLATION OF CANNABIS EXTRACTS	JENNY'S ROSE, LLC
WO/2021/207706	METHODS AND COMPOSITIONS FOR INACTIVATING  INTERLEUKIN-2-INDUCIBLE T-CELL KINASE (ITK)	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSTIY OF NEW YORK
WO/2021/207709	BINDERS AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR  INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN	SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH  INSTITUTE)
WO/2021/207716	METHODS AND COMPOSITION FOR TREATMENT OF COVID-19 ILLNESS  REQUIRING HOSPITALIZATION	OHIO STATE INNOVATION FOUNDATION
WO/2021/211386	TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION	FIGENE, LLC
WO/2021/207717	SYSTEMS, DEVICES, AND METHODS FOR DELIVERING A SUBSTANCE  WITHIN A TARGET TISSUE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211393	HAIR COLOR MODIFICATION ADDITIVE AND RELATED METHODS	PWAI, LLC
WO/2021/211406	TMPRSS2-TARGETED COMPOSITIONS AND METHODS FOR TREATING  COVID-19	MADDON ADVISORS LLC
WO/2021/207723	METHODS OF TREATING DIABETIC KIDNEY DISEASE	CHINOOK THERAPEUTICS, INC.
WO/2021/207725	LIPOCALIN-2 ASSAY FOR INTESTINAL ADAPTATION	THE JOHNS HOPKINS UNIVERSITY
WO/2021/211414	BISPECIFIC ANTIBODY COMPOSITIONS AND METHODS FOR TREATING  COVID-19	MADDON ADVISORS LLC
WO/2021/211416	ACE2- AND TMPRSS2-TARGETED COMPOSITIONS AND METHODS FOR  TREATING COVID-19	MADDON ADVISORS LLC
WO/2021/211418	METHODS FOR TREATING ANEMIA USING AN ACTRIIB LIGAND TRAP AND  FEDRATINIB	CELGENE CORPORATION
WO/2021/207727	COMBINATORIAL TARGETED THERAPY METHODS	POSTSURGICAL THERAPEUTICS, INC.
WO/2021/211441	MODIFIED SUGAR POLYMERS WITH LOW ANTICOAGULANT ACTIVITY AND  THERAPEUTIC ACTIVITY	THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
WO/2021/207729	COMPOSITIONS AND METHODS FOR MODULATING ACE2 RECEPTOR	MUBARAK, Kamal Khan
WO/2021/207730	VACCINES FOR CORONAVIRUS AND METHODS OF USING THE SAME	THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY
WO/2021/211460	CELL-RECEPTOR TARGETED EXOSOMES	CITY OF HOPE
WO/2021/207737	LONG-ACTING APOMORPHINE FORMULATIONS AND INJECTORS FOR  THERAPEUTIC DELIVERY OF THE SAME	SCIENTURE, INC.
WO/2021/207738	HYDROXYUREAMETHYL-ACYLFULVENE FOR TREATING BRAIN CANCER OR CNS  CANCER	LANTERN PHARMA INC.
WO/2021/211468	ANHYDROUS SILKY COSMETIC PRODUCT	AKI, INC.
WO/2021/207742	NANOPARTICLES FOR USE IN PHOTODYNAMIC THERAPIES AND METHODS OF  MAKING, EVALUATING AND USING THE SAME	MI2 HOLDINGS LLC
WO/2021/211487	COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR  OTHER NEGATIVELY CHARGED MOLECULES	SIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/211489	(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE  FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS	SUNOVION PHARMACEUTICALS INC.
WO/2021/211504	NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS	GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
WO/2021/211540	DIAGNOSIS AND TREATMENT OF ADDICTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/221902	MULTI-CHROME COSMETIC HAIR COMPOSITION	HOLECKO, Hana
WO/2021/211552	COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL  INFECTIONS	UT-BATTELLE, LLC
WO/2021/211558	TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEM COMPRISING  HYDROXYCHLOROQUINE AND/OR CHLOROQUINE	GLANIS PHARMACEUTICAL INC.
WO/2021/211572	ANTISENSE THERAPEUTICS FOR THE TREATMENT OF CORONAVIRUS	OREGON STATE UNIVERSITY
WO/2021/211575	COMPOSITIONS COMPRISING PROPOFOL, KETAMINE, AND NON-OPIOID  ANALGESIC, AND METHODS OF USE	THE REGENTS OF THE UNIVEFISITY OF CALIFORNIA
WO/2021/211614	AAV-BASED GENE THERAPIES FOR TREATMENT OF AUTOIMMUNE DISEASES	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/211620	METHOD AND SYSTEM FOR DETECTING AND TREATING EXPOSURE TO AN  INFECTIOUS PATHOGEN	SUN GENOMICS, INC.
WO/2021/211625	QUINOLINE COMPOUNDS FOR TREATING LUNG, LIVER, AND KIDNEY  DISEASES, DISORDERS, OR CONDITIONS	ALDEYRA THERAPEUTICS, INC.
WO/2021/211628	COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF CANCER	POSEIDA THERAPEUTICS, INC.
WO/2021/211629	METHODS OF MAKING AND USING A VACCINE AGAINST CORONAVIRUS	MASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/211640	ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS  IN MULTIPLE SCLEROSIS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/216325	COMPOSITIONS AND METHODS FOR TREATING METABOLIC AND  CARDIOVASCULAR DISEASES	UNIVERSITY OF ROCHESTER
WO/2021/211660	METHOD OF PREVENTING OR TREATING VIRAL INFECTIONS	VECTOR VITALE IP LLC
WO/2021/211670	POROUS NANOCOMPOSITE MEDICAL IMPLANT DEVICE	LYNTHERA CORPORATION
WO/2021/211688	SARS-2 SPIKE PROTEIN DESIGNS, COMPOSITIONS AND METHODS FOR  THEIR USE	DUKE UNIVERSITY
WO/2021/211691	YEAST LYSATE COVID-19 VACCINE	IMMUNITYBIO, INC.
WO/2021/211698	TREATING OR PREVENTING TRAVELERS DIARRHEA	SCALED MICROBIOMICS, LLC
WO/2021/211700	COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL  DISORDERS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/231018	PLANT-BASED PHYTONUTRIENT COMPOSITION FOR REGULATION OF SIGNAL  TRANSDUCTION CASCADES IN THE BODY AND RELATED METHODS	BRILLIANT LAB LLC
WO/2021/211704	SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED  ON VESICULAR STOMATITIS VIRUS VECTORS	WASHINGTON UNIVERSITY
WO/2021/225760	COPPER-CONTAINING THERAGNOSTIC COMPOUNDS AND METHODS OF USE	CORNELL UNIVERSITY
WO/2021/211705	TREATMENT OF SARCOPENIA USING NT-3 GENE THERAPY	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/257169	MDMA RESPONSE PREDICTION	UNIVERSITÄTSSPITAL BASEL
WO/2021/211713	TREATMENT OF CHARCOT-MARIE-TOOTH AXONAL TYPE 2D USING NT-3  GENE THERAPY	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/211738	METHODS AND COMPOSITIONS FOR ANTIVIRAL TREATMENT	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
WO/2021/211740	PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACID	SPECTRUM SOLUTIONS L.L.C.
WO/2021/211742	USE OF GCN2 INHIBITORS IN TREATING MITOCHONDRIAL MYOPATHIES  AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION	THE GENERAL HOSPITAL CORPORATION
WO/2021/211745	PIRFENIDONE FOR CORONAVIRUS TREATMENT	EXCALIBUR PHARMACEUTICALS, INC.
WO/2021/211746	METHODS FOR TREATING POLYMICROBIAL INFECTIONS	CAP DIAGNOSTICS, LLC, DBA PATHNOSTICS
WO/2021/211748	PAN-CORONAVIRUS VACCINE COMPOSITIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211749	MULTI-EPITOPE PAN-CORONAVIRUS VACCINE COMPOSITIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211753	TAU BINDING COMPOUNDS	VOYAGER THERAPEUTICS, INC.
WO/2021/211757	METHOD FOR TREATING <i>ARENAVIRIDAE</i> INFECTIONS	OYAGEN, INC.
WO/2021/211759	METHOD FOR TREATING POXVIRIDAE INFECTIONS	OYAGEN, INC.
WO/2021/211760	LARGE SEQUENCE PAN-CORONAVIRUS VACCINE COMPOSITIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/211761	TARGETING ABCB5 IN GLIOBLASTOMA MULTIFORME	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/211772	IMPROVED IMMUNE RESPONSE AND DECREASED IMMUNOPARALYSIS WITH  IMMUNOMODULATING TREATMENT	CYTOSORBENTS CORPORATION
WO/2021/211775	ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME	VIR BIOTECHNOLOGY, INC.
WO/2021/211782	METHODS OF TREATING ACUTE LUNG INJURY AND ACUTE RESPIRATORY  DISTRESS SYNDROME	TELIOS PHARMA, INC.
WO/2021/211792	TREATMENT OF CORONAVIRUS INFECTIONS WITH AURANOFIN	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/211795	LARAZOTIDE DERIVATIVES COMPRISING D-AMINO ACIDS	9 METERS BIOPHARMA, INC.
WO/2021/211796	STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN  INJURY	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/211808	COMPOSITIONS AND METHODS TO REDUCE THE INFECTIVITY OF A VIRUS	ATOSSA THERAPEUTICS, INC.
WO/2021/211819	INHIBITION OF BAX-MEDIATED CELL DEATH BY ELTROMBOPAG	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/211839	MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED  PRODUCTS AND METHODS	ESCIENT PHARMACEUTICALS, INC.
WO/2021/211841	CONTROL OF REPLICATION AND TRANSCRIPTION OF SELF-REPLICATING  RNA IN RESPONSE TO SMALL MOLECULES	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/211847	SYNTHETIC PEPTIDES FOR MODULATING THE METABOTROPIC GLUTAMATE  RECEPTOR 5	LACTOCORE, INC.
WO/2021/211848	ENGINEERED CELLS SECRETING THERAPEUTIC ENZYMES	CARTESIAN THERAPEUTICS, INC.
WO/2021/211850	INHALABLE FORMULATION OF A SOLUTION CONTAINING OLODATEROL	ANOVENT PHARMACEUTICAL(U.S.)., LLC
WO/2021/211854	INHALABLE FORMULATION OF A SOLUTION CONTAINING TIOTROPIUM  BROMIDE	HUANG, Cai Gu
WO/2021/211857	IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS  INHIBITORS	ALKERMES PHARMA IRELAND LIMITED
WO/2021/211858	INHALABLE FORMULATION OF A SOLUTION CONTAINING TIOTROPIUM  BROMIDE AND OLODATEROL	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/211860	IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS  INHIBITORS	ALKERMES PHARMA IRELAND LIMITED
WO/2021/211864	FUSED TRICYCLIC KRAS INHIBITORS	INCYTE CORPORATION
WO/2021/211867	KV7 MODULATORS FOR TREATING SLEEP OR ANXIETY DISORDERS	ATTUNE NEUROSCIENCES, INC.
WO/2021/225767	METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2	THE SCRIPPS RESEARCH INSTITUTE
WO/2021/211882	METHODS FOR PREPARING TYROSINE RECEPTOR KINASE INHIBITORS	PYRAMID BIOSCIENCES, INC.
WO/2021/211885	MATRIX BOUND VESICLES (MBV) FOR TREATMENT OF ACUTE RESPIRATORY  DISTRESS SYNDROME	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/211890	COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE  THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS	ADIMABIO LLC
WO/2021/211894	TARGETED RNA EDITING USING ENGINEERED ADENOSINE DEAMINASE  ACTING ON TRNA (ADAT) SYSTEMS	SHAPE THERAPEUTICS INC.
WO/2021/211898	MULTI-COMPONENT PACKAGED DOSAGE FORM AND METHOD	APRECIA PHARMACEUTICALS LLC
WO/2021/211903	TWIN BASE LINKERS FOR VIRUS INACTIVATION	NORTHEASTERN UNIVERSITY
WO/2021/211909	USE OF DIRECT THROMBIN INHIBITORS IN THE TREATMENT OF  NEURODEGENERATIVE DISEASES	GRAMMAS, Paula
WO/2021/211915	POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE	UNIVERSITY OF CONNECTICUT
WO/2021/211916	TREPROSTINIL FOR USE IN THE TREATMENT OF INTERSITIAL LUNG  DISEASE	UNITED THERAPEUTICS CORPORATION
WO/2021/211919	ECLITASERTIB FOR USE IN TREATING CONDITIONS INVOLVING SYSTEMIC  HYPERINFLAMMATORY RESPONSE	GENZYME CORPORATION
WO/2021/211921	METHODS OF REDUCING OR PREVENTING CLOSTRIDIOIDES DIFFICILE  COLONIZATION	BIOVECTOR, INC.
WO/2021/211923	COMPOSITIONS AND METHODS FOR TREATING DISEASE	PULMOQUINE THERAPEUTICS, INC.
WO/2021/211924	TREATMENT OF ATOPIC DERMATITIS	JANSSEN BIOTECH, INC.
WO/2021/211927	TREATMENT OF HIDRADENITIS SUPPURATIVA	JANSSEN BIOTECH, INC.
WO/2021/211940	METHODS FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY  VIRUSES	ASSISTANCE PUBLIQUE, HOPITAUX DE PARIS
WO/2021/211942	PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC  TARGETS IN PLANTS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/211961	REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS,  METHODS OF PRODUCTION, AND METHODS OF USE THEREOF	CROWN SCIENTIFIC, L.L.C.
WO/2021/211963	ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES	WASHINGTON UNIVERSITY
WO/2021/211974	HSD17B13 INHIBITORS AND USES THEREOF	INIPHARM, INC.
WO/2021/211984	DIELS-ALDER CONJUGATION METHODS	REGENERON PHARMACEUTICALS, INC.
WO/2021/211990	LIPID COMPOSITIONS AND METHODS OF PREPARATION THEREOF	WAKE FOREST UNIVERSITY
WO/2021/212000	SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES	EVELO BIOSCIENCES, INC.
WO/2021/212006	ION CAPTURE COMPOSITION FOR INGESTION	NO-DIUM LLC
WO/2021/212013	BIOACTIVE PEPTIDES AND METHODS OF USE THEREOF	OP-T LLC
WO/2021/212019	METHODS OF FORMING PARTICLES BY CONTINUOUS DROPLET FORMATION  AND DEHYDRATION	ELEKTROFI, INC.
WO/2021/212022	AEROSOLIZED FORMULATIONS OF HIV PROTEASE INHIBITORS FOR THE  TREATMENT OF AIRWAY REFLUX	THE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/216372	SUBCUTANEOUS ABSORPTION AND BIOAVAILABILITY OF ANTIBODIES	ELI LILLY AND COMPANY
WO/2021/212032	SOLID FORMS OF AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR  INHIBITOR AND USES THEREOF	ESSA PHARMA, INC.
WO/2021/212037	IMMUNE CELL REDIRECTING COMPOSITIONS AND THERAPEUTIC USES  THEREOF	EMORY UNIVERSITY
WO/2021/212039	INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF	PARDES BIOSCIENCES, INC.
WO/2021/212044	METHODS AND COMPOSITIONS FOR IMPROVING SC-BETA CELLS OR  ENHANCING THEIR UTILITY	WASHINGTON UNIVERSITY
WO/2021/212048	BITTER BLOCKERS AND RELATED METHODS OF USE	CONAGEN INC.
WO/2021/212049	ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES	WASHINGTON UNIVERSITY
WO/2021/216378	METHODS AND MATERIALS FOR TREATMENT OF FIBROSIS	THE SCHEPENS EYE RESEARCH INSTITUTE, INC.
WO/2021/212054	METHODS AND COMPOSITIONS FOR TREATING SUBJECTS WITH METABOLIC  DISORDERS AND CORONAVIRUS INFECTIONS	CIRIUS THERAPEUTICS, INC.
WO/2021/212055	DEFIBROTIDE TREATMENT FOR THE PREVENTION OF ORGAN REJECTION  AND INJURY	JAZZ PHARMACEUTICALS IRELAND LIMITED
WO/2021/212069	FLT3-TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS FOR  TREATMENT OF FLT3-POSITIVE MALIGNANCIES	CITY OF HOPE
WO/2021/212073	HIGH-POTENCY VITAMIN C AND SUGAR ALCOHOL TOPICAL FORMULATIONS	BAEK CLINICAL INC.
WO/2021/212075	STABILIZING VITAMIN C APPLICATION FORMULATIONS	BAEK CLINICAL INC.
WO/2021/212079	HIGH-POTENCY VITAMIN C CHEMICAL PEELING SOLUTIONS	BAEK CLINICAL INC.
WO/2021/212080	ANHYDROUS AZELAIC ACID TOPICAL FORMULATIONS	BAEK CLINICAL INC.
WO/2021/212087	CRYβB2 PREDICTS POOR BREAST CANCER OUTCOME AND SENSITIZES  TUMORS TO NUCLEOLIN AND CDK INHIBITION	THE JOHNS HOPKINS UNIVERSITY
WO/2021/216385	METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND  COVID-19	TRAN, Lloyd, Hung Loi
WO/2021/216394	TOOTHPASTE COMPOSITIONS COMPRISING SILICA AND SURFACE ACTIVE  POLYMER	THE PROCTER & GAMBLE COMPANY
WO/2021/216399	PULMONARY AMINOSTEROL COMPOSITIONS AND METHODS OF USING THE  SAME TO TREAT MICROBIAL INFECTIONS	ENTERIN, INC.
WO/2021/216403	COMPOSITIONS AND METHODS FOR TREATING CORNEAL ENDOTHELIUM	D&D BIOPHARMACEUTICALS, INC.
WO/2021/216418	COMBINATION THERAPY USING AN IL-20 ANTAGONIST AND AN IMMUNE  CHECKPOINT INHIBITOR	LBL BIOTECHNOLOGY INC.
WO/2021/212097	CONTROLLED RELEASE HYALURONIC ACID COMPOSITIONS	PURCELL, Brendan Patrick
WO/2021/212100	METHODS, COMPOSITIONS AND USES THEREOF FOR REVERSING  SACROPENIA	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/212101	COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS  INFECTIONS	VYRIAD, INC.
WO/2021/216441	AAK1 INHIBITORS FOR USE IN TREATING VIRAL INFECTIONS	LEXICON PHARMACEUTICALS, INC.
WO/2021/257173	ANTIBIOTIC ADJUVANT COMPOUNDS	UNIVERSITY OF NOTRE DAME DU LAC
WO/2021/212108	METHOD OF STABLE FORMULATION OF MICROBIAL AND MICROBE DERIVED  PRODUCTS AND USE OF SAME	ADVANCED BIOLOGICAL MARKETING, INC.
WO/2021/216450	OPIOID ANTAGONIST FORMULATIONS	EMERGENT PRODUCT DEVELOPMENTGAITHERSBURG INC.
WO/2021/216454	4-(3-(PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIMIDIN-5-YL)PIPERAZINE  FOR USE IN THE THE TREATMENT OF COV-229E OR COV-OC43 CORONAVIRUSES INFECTIONS	LEXICON PHARMACEUTICALS, INC.
WO/2021/212111	COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/216461	SMALL MOLECULES FOR TREATING AGE-RELATED RETINAL DISEASES	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/212114	WOUND PREVENTION AND/OR TREATMENT AND RELATED COMPOUNDS,  MATRICES, COMPOSITIONS, METHODS AND SYSTEMS	CALIFORNIA INSTITUTE OF TECHNOLOGY
WO/2021/216467	A NANO-ENABLED VACCINATION APPROACH FOR CORONAVIRUS DISEASE  (COVID-19) AND OTHER VIRAL DISEASES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216468	HUMAN TIGIT SPECIFIC SINGLE DOMAIN ANTIBODIES AND METHODS OF  USE	ASKGENE PHARMA INC.
WO/2021/212122	ENGINEERED PROBIOTICS FOR TREATMENT AND IMMUNITY AGAINST  VIRUSES	UNIVERSITY OF CINCINNATI
WO/2021/216475	COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL  AGENTS	POVIVA CORP.
WO/2021/216480	NOVEL ANHYDROUS COMPOSITIONS COMPRISED OF MARINE OILS	OMEZA, LLC
WO/2021/216489	METHODS FOR TREATING MILD TRAUMATIC BRAIN INJURY, POST  TRAUMATIC STRESS DISORDER AND MILD TRAUMATIC BRAIN INJURY	LOBE SCIENCES LTD.
WO/2021/216494	COMPOSITIONS AND METHODS FOR TREATMENT OF GASTROINTESTINAL  BLEEDING	INTACT THERAPEUTICS, INC.
WO/2021/216496	PROCESS FOR THE PREPARATION OF 1,3-BIS(ALLYLAMINO)PROPANE	TRICIDA, INC.
WO/2021/216530	TREATMENT OF VIRAL INFECTIONS, OF ORGAN INJURY, AND OF RELATED  CONDITIONS USING A HIF PROLYL HYDROXYLASE INHIBITOR OR A HIF-ALPHA STABILIZER	AKEBIA THERAPEUTICS, INC.
WO/2021/216537	ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF	AB STUDIO INC.
WO/2021/221953	PYRIDINE INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE AND  THERAPEUTIC METHODS USING THE SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/216541	BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF  THEIR MANUFACTURE AND USE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216545	ORAL SOLID MELOXICAM FORMULATIONS FOR THE TREATMENT OF ACUTE  PAIN	MYLAN SPECIALTY L.P.
WO/2021/216547	PULMONARY ADMINISTRATION OF ACE2 POLYPEPTIDES	SORRENTO THERAPEUTICS, INC.
WO/2021/216548	METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED MACULAR  DEGENERATION	UNIVERSITY OF MASSACHUSETTS
WO/2021/216562	ZINC FOR TREATING COVID-19	FINZI, Eric
WO/2021/262298	ELECTROPHILIC COMPOUNDS AND ELECTROPHILIC PRODRUGS FOR  TREATING ANEURYSM	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/216569	ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED  DESIGNS AND USES	GREFFEX, INC.
WO/2021/216572	LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND  USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/216573	SCALABLE, EASY-TO-DEPLOY SYSTEM AND REAGENTS THEREOF FOR  CRISPR-ASSOCIATED NUCLEASE-BASED DETECTION OF PATHOGEN GENETIC MATERIAL	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216575	RECOMBINANT ROTAVIRUS EXPRESSION SYSTEM AND RECOMBINANT  ROTAVIRUSES	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/216577	LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216581	METHOD OF TREATING AND PREVENTING CORONAVIRUS DISEASE 19  (COVID-19) USING A SELENIUM ADMINISTRATION	GHOWEBA, Mohamed Samir Elsayed
WO/2021/216584	USE OF SURFACTANT PROTEIN D TO TREAT VIRAL INFECTIONS	AIRWAY THERAPEUTICS, INC.
WO/2021/216586	USE OF HUMAN AMYLIN ANALOG POLYPEPTIDES FOR PROVIDING SUPERIOR  GLYCEMIC CONTROL TO TYPE 1 DIABETICS	INTARCIA THERAPEUTICS, INC.
WO/2021/216592	LOX ENZYME INHIBITING METHODS AND COMPOSITIONS	ANOVIA BIOSCIENCES, INC.
WO/2021/225781	ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL-  AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/216615	HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION	THE GENERAL HOSPITAL CORPORATION
WO/2021/216618	COMPOSITIONS AND METHODS COMPRISING CLOSTRIDIUM BUTYRICUM FOR  THE TREATMENT OF CANCER	CITY OF HOPE
WO/2021/216620	METHODS FOR TREATING BLADDER CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/216625	OPTIMIZED PROTEIN FUSIONS AND LINKERS	INTEGRATED DNA TECHNOLOGIES, INC.
WO/2021/216640	COMPOSITION, ARTICLE AND METHOD FOR AFFECTING A MAMMAL	COOLHOUSE SOURCING LLC
WO/2021/216642	PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV	ASSEMBLY BIOSCIENCES, INC.
WO/2021/216659	MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND USES THEREOF	LUNG THERAPEUTICS, INC.
WO/2021/216661	PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV	ASSEMBLY BIOSCIENCES, INC.
WO/2021/216674	IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING  PLATFORMS	UNIVERSITY OF MASSACHUSETTS
WO/2021/216678	RENIN-ANGIOTENSIN SYSTEM (RAS) MODULATORS FOR TREATMENT OF  VIRAL INFECTIONS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME	TROCAR PHARMA INC.
WO/2021/216686	TREATING AND CURING COVID-19 INFECTION UTILIZING A LASER	ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
WO/2021/216687	PEPTIDES FOR THE TREATMENT OF COVID-19	RUSH UNIVERSITY MEDICAL CENTER
WO/2021/216691	METHODS OF DETECTING AND TREATING CANCERS CHARACTERIZED BY  LOSS OF MIR15 AND MIR16 EXPRESSION	CROCE, Carlo, M.
WO/2021/216696	TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND OTHER  DISORDERS INVOLVING CYTOKINE STORM USING BTK INHIBITORS	PRINCIPIA BIOPHARMA INC.
WO/2021/216698	COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN	DUKE UNIVERSITY
WO/2021/216699	COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF  VIRAL INFECTIONS	NED BIOSYSTEMS, INC.
WO/2021/216701	COMPOSITIONS FOR TREATMENT OF VASCULAR DISEASE	HOUSTON GENE THERAPEUTICS LLC
WO/2021/216710	USE OF SALMETEROL AS AN ANTI-CORONAVIRAL AGENT	THE MEDICAL COLLEGE OF WISCONSIN, INC.
WO/2021/216722	STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE  PHOSPHORAMIDATES	ATEA PHARMACEUTICALS, INC.
WO/2021/216729	CELLULAR VACCINE PLATFORM AND METHODS OF USE	INTIMA BIOSCIENCE, INC.
WO/2021/216731	POLYSPECIFIC BINDING MOLECULES AND THEIR USE IN CELL THERAPY	INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
WO/2021/216749	METHOD FOR TREATING VIRAL AND BACTERIAL INFECTION THROUGH  INHALATION THERAPY	HOAG, George, Edward
WO/2021/216754	USE OF P38 MAPK INHIBITORS FOR PREVENTION AND TREATMENT OF  AGING AND AGING-RELATED DISORDERS AND FOR BOOSTING AN IMMUNE SYSTEM	SPRING DISCOVERY, INC.
WO/2021/216755	COMPOSITIONS AND METHODS FOR INTRANASAL TREATMENT WITH DOUBLE  STRANDED RNA	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/216759	QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE	COHEN, Noam
WO/2021/216777	ERK INHIBITORS FOR CANCER THERAPY	THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY
WO/2021/216781	AFMT ANALOGS AND THEIR USE IN METHODS OF TREATING PARKINSON'S  DISEASE	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/216785	BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF	FLAGSHIP PIONEERING, INC.
WO/2021/216786	BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF	FLAGSHIP PIONEERING, INC.
WO/2021/216789	SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND  CULTURE	UNIVERSITY OF MARYLAND, COLLEGE PARK
WO/2021/216801	PEGYLATED INTERFERON TAU AND COMPOSITIONS AND METHODS THEREOF	SOUTHLAKE PHARMACEUTICALS, INC.
WO/2021/221983	INTERFERON TAU AS ANTIVIRAL THERAPY	SOUTHLAKE PHARMACEUTICALS, INC.
WO/2021/216807	BIODEGRADABLE COPOLYMERS AND NANOFIBROUS SCAFFOLD THEREOF	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/216810	LONG-ACTING ANTI-IL31 ANTIBODIES FOR VETERINARY USE	KINDRED BIOSCIENCES, INC.
WO/2021/216812	GALACTOKINASE INHIBITORS	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/216814	BTK INHIBITORS TO TREAT PULMONARY DISTRESS IN COVID-19  PATIENTS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/216816	COMPOSITIONS COMPRISING EXTRACELLULAR MATERIAL WITH ANTIVIRAL  ACTIVITY AND USES THEREOF	FETTECH, LLC
WO/2021/216828	CHIMERIC DEGRADERS OF CYCLIN-DEPENDENT KINASE 9 AND USES  THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/216832	CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES	REMD BIOTHERAPEUTICS, INC.
WO/2021/216841	COMPOSITIONS AND METHODS FOR MODULATING TRP CHANNEL ACTIVITY	DUKE UNIVERSITY
WO/2021/225794	METHODS FOR ORGANOIDS PRODUCTION	CITY OF HOPE
WO/2021/257179	VAGINAL GEL	NATIONAL MEDICAL SUPPLY, LLC
WO/2021/216866	METHODS FOR TREATING DISEASES BY TARGETING ONCOGENIC LIPIDS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/216869	NASAL SPRAY COMPOSITION	SCIVOLETTO, Joseph
WO/2021/221995	MODIFIED NUCLEIC ACIDS ENCODING ASPARTOACYLASE (ASPA) AND  VECTOR FOR GENE THERAPY	PFIZER INC.
WO/2021/216896	TREATMENT OF CONDITIONS ASSOCIATED WITH THYROID HORMONE	SCOTT, Linzy O.
WO/2021/216903	METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS  ASSOCIATED WITH INFECTIOUS DISEASE	PETTINE, Kenneth Allen
WO/2021/216909	TREATMENT OF VIRAL CONJUNCTIVITIS	OKOGEN, INC.
WO/2021/216916	FORMULATION, DOSAGE REGIMEN, AND MANUFACTURING PROCESS FOR  HETERODIMERIC FC-FUSED PROTEINS	DRAGONFLY THERAPEUTICS, INC.
WO/2021/225796	MDMA TREATMENT TO ENHANCE ACUTE EMOTIONAL EFFECTS PROFILE OF  LSD, PSILOCYBIN OR OTHER PSYCHEDELICS	UNIVERSITÄTSSPITAL BASEL
WO/2021/216925	TRANSDERMAL ACTIVE AGENT DELIVERY DEVICES HAVING CORONAVIRUS  VACCINE COATED MICROPROTRUSIONS	ZOSANO PHARMA CORPORATION
WO/2021/216928	LONG-ACTING BUPIVACAINE MICROSPHERE FORMULATIONS	SCIENTURE, INC.
WO/2021/216934	CLEARANCE OF SENESCENT CELLS BY ACTIVATION OF iNKT CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216936	COMPOSITION FOR TREATING BLOOD CANCER USING  4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOF	SOUTHERN RESEARCH INSTITUTE
WO/2021/222006	POLYETHYLENE GLYCOL-FUNCTIONALIZED TRIGLYCERIDE POLYOL  POLYMERS	KANSAS SOYBEAN COMMISSION
WO/2021/216944	METHODS OF INCREASING MICROVASCULAR BLOOD FLOW	ABBOTT LABORATORIES
WO/2021/222009	CLOBAZAM TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF	TAHO PHARMACEUTICALS LTD.
WO/2021/216973	NURR1 RECEPTOR MODULATORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/216975	AAV NATIVE-NEURO PLATFORM AND USE FOR NEURONAL DISEASE GENE  THERAPY	AAV GENE THERAPEUTICS, INC.
WO/2021/216980	TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT  INFLAMMATORY DISEASES	CORNELL UNIVERSITY
WO/2021/216993	METHODS OF DETERMINING GENE EDITING EFFICIENCIES IN CELLS	PACT PHARMA, INC.
WO/2021/216994	GRP78 TARGETED ADOPTIVE CELL THERAPY	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/216998	MODIFIED NUCLEOTIDES AND USES THEREOF	SINGULAR GENOMICS SYSTEMS, INC.
WO/2021/217006	(S)-2-AMINO-6-((3-AMINOPROPYL)AMINO)HEXANOIC ACID (APL) FOR  USE IN THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH), LIVER  INFLAMMATION, HEPATOCELLULAR BALLOONING, LIVER FIBROSIS AND STEATOSIS	TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER  EDUCATION
WO/2021/217010	SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS	KALOCYTE, INC.
WO/2021/222025	COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34	ELI LILLY AND COMPANY
WO/2021/217014	COMBINATION THERAPY OF ARTEMISININ-RELATED COMPOUNDS AND  HISTONE DEACETYLASE INHIBITORS FOR TREATMENT OF HPV-RELATED BENIGN,  PREMALIGNANT, AND MALIGNANT DISEASES	GEORGETOWN UNIVERSITY
WO/2021/217018	MICROPARTICLE-ASSISTED TREG THERAPY FOR TREATMENT OF TISSUE  INJURY AND FIBROSIS	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/217019	RAS INHIBITORS AND USES THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/217024	ANTI-CD19 ANTIBODIES AND USES THEREOF	MILLENNIUM PHARMACEUTICALS, INC.
WO/2021/217028	COMPOSITIONS AND METHODS FOR <i>IN VIVO</i> LUNG  AND BLOOD SNO REPLETION	UNIVERSITY HOSPITALS - CLEVELAND MEDICAL CENTER
WO/2021/217036	GPER PROTEOLYTIC TARGETING CHIMERAS	SALEM, Aliasger K.
WO/2021/217038	SIRPα DEFICIENT MACROPHAGES FOR TREATING CANCER	GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/262306	DEVICES AND METHODS FOR THE TREATMENT OF SKIN DEPIGMENTATION	TEVIDO BIODEVICES, INC.
WO/2021/217043	METHODS OF TREATING ACUTE LUNG INJURY USING EBSELEN	SOUND PHARMACEUTICALS INC.
WO/2021/217053	PLASMA KALLIKREIN INHIBITORS FOR THE TREATMENT OF ARDS AND  RELATED CONDITIONS	REZOLUTE, INC.
WO/2021/217063	COMPOSITIONS AND METHODS FOR TREATING LUNG INJURY	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/217072	USE OF IGF-2 FOR TREATMENT OF EPILEPTIC SEIZURES	NEW YORK UNIVERSITY
WO/2021/217082	POLYMER WITH CATIONIC AND HYDROPHOBIC SIDE CHAINS	GENEDIT INC.
WO/2021/217084	USE OF NITRO-FATTY ACIDS AND ANALOGUES THEREOF FOR THE  PREVENTION AND/OR TREATMENT OF ACUTE LUNG INJURY AND/OR SARS-COV-2 INFECTION	IMARA INC.
WO/2021/217086	COMPOSITIONS AND METHODS COMPRISING DENDRIMERS AND THERAPEUTIC  AGENTS	THE JOHNS HOPKINS UNIVERSITY
WO/2021/217098	TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME	ABT HOLDING COMPANY
WO/2021/222045	NOVEL PHARMACEUTICAL FORMULATION FOR C-MET INHIBITOR	APOLLOMICS INC.
WO/2021/217109	METHODS AND COMPOSITIONS FOR ENHANCING IMMUNOGENICITY OF  VACCINE	ZHANG, Kang
WO/2021/217111	PH RESPONSIVE BLOCK COPOLYMER COMPOSITIONS AND MICELLES THAT  INHIBIT MCT 1 AND RELATED PROTEINS	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/217117	TARGETED THERAPY FOR THE TREATMENT & PREVENTION OF  LIFE-THREATENING COMPLICATIONS OF INFECTION	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/222079	SOLID COMPOSITIONS CONTAINING AMINE, PROTONATED AMINE OR  QUATERNARY AMMONIUM COMPOUNDS	STEPAN COMPANY
WO/2021/217122	COMPOSITION, KIT AND METHOD FOR DIAGNOSIS AND TREATMENT OF  PROSTATE CANCER	RADIOMEDIX, INC.
WO/2021/217131	DENDRIMER COMPOSITIONS AND METHODS FOR TREATMENT OF SEVERE  ACUTE RESPIRATORY DISTRESS SYNDROME	ASHVATTHA THERAPEUTICS, INC.
WO/2021/262311	SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 AGONIST AND LIPOSOMAL  FORMULATIONS THEREOF	THE PENN STATE RESEARCH FOUNDATION
WO/2021/222094	CODON OPTIMIZED GLA GENES AND USES THEREOF	4D MOLECULAR THERAPEUTICS INC.
WO/2021/217143	AMINOPIPERIDINE AMIDES, DERIVATIVES, COMPOSITIONS, AND USES  RELATED TO CXCR4 MODULATION	EMORY UNIVERSITY
WO/2021/217145	COMPOSITIONS AND METHODS FOR REGULATION OF CELL ACTIVITY VIA  MODULATION OF BETA-CYTOKINE ACTIVITY	THE CHILDREN'S HOSPITAL OF PHILADELPHIA
WO/2021/222129	METHOD OF TREATING AN INFLAMMATORY DISORDER	THE UNIVERSITY OF MIAMI
WO/2021/242461	NUTRIENT COMPOSITION ABLE TO INHIBIT QUORUM SENSING	BRILLIANT LAB LLC
WO/2021/222138	COMPOUNDS FOR MUTANT RAS PROTEIN DEGRADATION	DEVELOPMENT CENTER FOR BIOTECHNOLOGY
WO/2021/222145	METHODS OF TREATING AGITATION ASSOCIATED WITH ALZHEIMER'S  DISEASE	AVANIR PHARMACEUTICALS INC.
WO/2021/222147	HETEROCYCLIC GCN2 MODULATORS	HIBERCELL, INC.
WO/2021/222156	COMPOUNDS AND COMPOSITIONS FOR TREATING HEMATOLOGIC  MALIGNANCIES	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/222163	PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURE USING  THERMALLY CONDUCTIVE EXCIPIENTS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/222165	ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL  DEHYDROGENASE DEFICIENCY	APPLIED THERAPEUTICS, INC.
WO/2021/222174	BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS	PRELUDE THERAPEUTICS INCORPORATED
WO/2021/222178	ADJUNCT THERAPY FOR SUPPRESSING IMMUNE RESPONSE AGAINST GENE  THERAPY	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/222189	METHOD FOR INCREASING SERUM ADIPONECTIN FOR TREATMENT AND  REDUCTION OF THE RISK OF CARDIOVASCULAR, VASCULAR, AND RELATED DISEASES	FIRST FRUITS BUSINESS MINISTRY, LLC
WO/2021/222196	METHODS AND COMPOSITIONS RELATING TO IONIC LIQUID ADJUVANTS	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/222227	CHIMERIC ANTIGEN RECEPTORS TARGETING CD127 AND USE THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
WO/2021/222228	A LIVE ATTENUATED MEASLES VIRUS VECTORED VACCINE FOR  SARS-COV-2	OHIO STATE INNOVATION FOUNDATION
WO/2021/222230	LOCAL ADMINISTRATION OF NICOTINIC ACETYLCHOLINE RECEPTOR  AGONISTS FOR THE INHIBITION OF CORONAVIRUS INFECTIONS	OYSTER POINT PHARMA, INC.
WO/2021/222231	PPARγ AGONISTS FOR TREATMENT OF KIDNEY DISEASE	THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/222232	COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN  SYNDROME	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/222239	PRECISION DOSING REGIMEN	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/222240	DRUG COMBINATIONS FOR INHIBITING INFECTIVITY OF INFLUENZA AND  CORONA VIRUSES	SYSTAMEDIC INC.
WO/2021/222242	METHODS FOR GENERATION OF MOUSE AND HUMAN URETERIC BUD  ORGANOIDS AND COLLECTING DUCT ORGANOIDS	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/222243	STRUCTURALLY-STABILIZED AND HDMX-SELECTIVE P53 PEPTIDES AND  USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/222249	COMPOSITIONS AND METHODS FOR REDUCING NUCLEASE EXPRESSION AND  OFF-TARGET ACTIVITY USING A PROMOTER WITH LOW TRANSCRIPTIONAL ACTIVITY	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/222257	BACTERIOPHAGE COMPOSITIONS FOR TREATING  <i>PSEUDOMONAS</i> INFECTION	ARMATA PHARMACEUTICALS, INC.
WO/2021/222262	NATURALLY BASED PRESERVATIVES FOR PERSONAL CARE APPLICATIONS	CARGILL, INCORPORATED
WO/2021/222268	CRISPR/CAS9 THERAPIES FOR CORRECTING DUCHENNE MUSCULAR  DYSTROPHY BY TARGETED GENOMIC INTEGRATION	DUKE UNIVERSITY
WO/2021/222270	PERSONAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/222278	METHODS OF TREATING ABNORMAL CELL GROWTH	VERASTEM, INC.
WO/2021/222288	COMPOSITIONS AND METHODS FOR ENHANCING RECOMBINANT  BIOSYNTHESIS OF CANNABINOIDS	WILLOW BIOSCIENCES, INC.
WO/2021/222291	PHARMACEUTICAL COMPOSITION COMPRISING CHLORINE DIOXIDE FOR THE  TREATMENT OF COVID-19	RADINOR, LLC
WO/2021/222295	BINDING AGENTS AND USES THEREOF FOR CENTRAL NERVOUS SYSTEM  DELIVERY	ARUNA BIO, INC.
WO/2021/222297	METHODS FOR GENERATING THYMIC CELLS IN VITRO	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222298	MECHANICAL AND BIOCHEMICAL ACTIVATION AND CONTROL OF SKELETAL  STEM CELLS FOR CARTILAGE REGENERATION	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/222304	SARS-COV-2 RNA VACCINES	MODERNATX, INC.
WO/2021/222308	SSAO INHIBITORS FOR THE TREATMENT OF DISEASE	METACRINE, INC.
WO/2021/222309	DETECTION AND MODIFICATION OF GUT MICROBIAL POPULATION	IXCELA, INC.
WO/2021/222322	ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY  HYPERTENSION	ACCELERON PHARMA INC.
WO/2021/222327	A HIGH-THROUGHPUT SCREENING METHOD TO DISCOVER OPTIMAL GRNA  PAIRS FOR CRISPR-MEDIATED EXON DELETION	DUKE UNIVERSITY
WO/2021/222330	COMBINATION OF BCMA-DIRECTED T CELL THERAPY AND AN  IMMUNOMODULATORY COMPOUND	JUNO THERAPEUTICS, INC.
WO/2021/222342	METHODS OF USE OF T-TYPE CALCIUM CHANNEL MODULATORS	PRAXIS PRECISION MEDICINES, INC.
WO/2021/222347	PHARMACEUTICAL FORMULATION	AMGEN INC.
WO/2021/222355	PHARMACEUTICAL FORMULATION	AMGEN INC.
WO/2021/222366	IRAK INHIBITORS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/222368	SODIUM CHLORITE COMPOSITIONS WITH ENHANCED ANTI-VIRAL AND  ANTI-MICROBIAL EFFICACY AND REDUCED TOXICITY	IRENIX MEDICAL, INC.
WO/2021/222369	MODIFIED RELEASE PHARMACEUTICAL FORMULATION COMPRISING  HYDROXYPROPYL CELLULOSE	HERCULES LLC
WO/2021/222370	A SERINE PROTEASE INHIBITOR FOR TREATING CORONAVIRUS INFECTION	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/222385	GLUCOCORTICOID RECEPTOR (GR) MODULATORS FOR TREATING A  SARS-COV-2 VIRUS	AVM BIOTECHNOLOGY, LLC
WO/2021/222389	MESENCHYMAL STEM CELL THERAPIES	FACTOR BIOSCIENCE INC.
WO/2021/222424	HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS FOR  TREATING AGING-RELATED CONDITIONS	BIOAGE LABS, INC.
WO/2021/222453	FAST-ACTING TOPICAL ANESTHETIC FORMULATIONS	ACHELON, INC.
WO/2021/222483	METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS	GLOBAL BLOOD THERAPEUTICS, INC.
WO/2021/222485	MINT FLAVOR COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/222488	MINT FLAVOR COMPOSITIONS	THE PROCTER & GAMBLE COMPANY
WO/2021/225851	METHODS OF TREATING CANCER USING A COMBINATION OF A PD-1  ANTAGONIST, A CHEMORADIATION THERAPY AND A PARP INHIBITOR	MERCK SHARP & DOHME CORP.
WO/2021/222513	HAIR TREATMENT COMPOSITIONS	L'OREAL
WO/2021/222519	ENCAPSULATED COMPOSITIONS AND USE OF OCTENYLSUCCINIC ANHYDRIDE  STARCH AS EMULSIFYING AGENT	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/222525	BRIMONIDINE COMPOSITIONS AND METHODS OF USE	EYE THERAPIES, LLC
WO/2021/222534	COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF  CORONAVIRUS INFECTIONS	ARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/222535	METHOD FOR TREATING RESPIRATORY VIRAL INFECTIONS COMPRISING  ADMINISTRATION OF FATTY ACID COMPOSITIONS	IRAZU BIO
WO/2021/222541	METAL COMPOSITIONS AND METHODS OF USE THEREOF	THE UNIVERSITY OF MASSACHUSETTS
WO/2021/222545	NALOXONE NANOPARTICLE COMPOSITIONS AND METHODS THEREOF	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/222549	COMPLEMENT FACTOR B (CFB) IRNA COMPOSITIONS AND METHODS OF USE  THEREOF	ALNYLAM PHARMACEUTICALS, INC.
WO/2021/222552	METHODS OF TREATING CYTOKINE-RELATED ADVERSE EVENTS	CELGENE CORPORATION
WO/2021/222565	NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF CYTOKINE  STORM SYNDROME (CSS) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)	ONCOUR PHARMA, INC.
WO/2021/231094	DOXYCYCLINE OR MINOCYCLINE INJECTION FOR SCLEROTHERAPY OF  LOWER EYELID FESTOONS AND MALAR EDEMA	FREUND, Robert
WO/2021/222575	FLUORESCENT DYE IN TERNARY COMPLEX	DAXOR CORP.
WO/2021/222577	N-ACETYLSEROTONIN DERIVATIVES AS TRKB ACTIVATORS AND USES  THEREOF	EMORY UNIVERSITY
WO/2021/222578	MULTISPECIFIC HEAVY CHAIN ANTIBODIES WITH MODIFIED HEAVY CHAIN  CONSTANT REGIONS	TENEOBIO, INC.
WO/2021/222589	COMBINATION TREATMENT OF RHAMNOLIPID AND NICLOSAMIDE	LEIGHTON, Anton
WO/2021/222593	PD-L1 BINDING PEPTIDES	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/222616	METHODS OF TREATING MULTIPLE MYELOMA	TENEOBIO, INC.
WO/2021/222618	METHODS AND SYSTEMS FOR ASSESSING FIBROTIC DISEASE WITH DEEP  LEARNING	CEDARS-SINAI MEDICAL CENTER
WO/2021/222623	COMPOSITIONS AND METHODS FOR INHIBITING VIRAL RECOGNITION  SITES	WASHINGTON UNIVERSITY
WO/2021/222639	RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/222653	COMPOSITIONS AND METHODS FOR TREATMENT OF FAMILIAL  HYPERCHOLESTEROLEMIA AND ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL	SALIOGEN THERAPEUTICS, INC.
WO/2021/222654	COMPOSITIONS AND METHODS FOR TREATMENT OF INHERITED MACULAR  DEGENERATION	SALIOGEN THERAPEUTICS, INC.
WO/2021/222660	OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR  TREATING VIRAL INFECTIONS	KALEIDO BIOSCIENCES, INC.
WO/2021/222682	APPLICATION OF AAV44.9 VECTOR IN GENE THERAPY FOR THE INNER  EAR	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/222696	LIVE SELF-DESTRUCTING BACTERIAL ADJUVANTS TO ENHANCE INDUCTION  OF IMMUNITY	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/222700	COMPOSITIONS AND METHODS FOR TREATING CANCER WITH  ANDROGRAPHOLIDE AND MELATONIN COMBINATION THERAPY	UNIVERSITY OF MARYLAND, BALTIMORE
WO/2021/222702	CRYSTALLINE FORMS, COMPOSITIONS CONTAINING THEM, AND METHODS  OF THEIR USE	FLAGSHIP PIONEERING INNOVATIONS V, INC.
WO/2021/222717	METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS,  NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELS) AS IMMUNOGENS	PRIMEX CLINICAL LABORATORIES
WO/2021/222727	COMPOSITIONS AND METHODS OF USE THEREOF	SYNEDGEN, INC.
WO/2021/222733	OVERCOMING IMMUNE SUPPRESSION WITH TGF-β RESISTANT NK CELLS	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/222738	COMPOUNDS FOR ESTROGEN RECEPTOR POSITIVE CANCERS	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/222739	ORALLY DISINTEGRATING TABLET COMPRISING AMORPHOUS SOLID  DISPERSION OF NILOTINIB	NANOCOPOEIA, LLC
WO/2021/222740	CLOFAZIMINE COMPOSITION AND METHOD FOR THE TREATMENT OR  PROPHYLAXIS OF VIRAL INFECTIONS	MANNKIND CORPORATION
WO/2021/222759	ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF  CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/222764	WATER-IN-OIL EMULSIONS CONTAINING SURFACTANT, SILICONE GUM  AND/OR LATEX, AND SILOXYSILICATE RESIN	L'OREAL
WO/2021/225892	ANTIBODY-DRUG CONJUGATES (ADCS) COMPRISING AN ANTI-TROP-2  ANTIBODY, COMPOSITIONS COMPRISING SUCH ADCS, AS WELL AS METHODS OF MAKING AND  USING THE SAME	LEVENA (SUZHOU) BIOPHARMA CO., LTD.
WO/2021/222773	COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED  METHODS	MBI DISTRIBUTING
WO/2021/222781	COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORMS	TOBIA, Annette M.
WO/2021/222783	ANTI-TM4SF1 ANTIBODY DRUG CONJUGATES AND METHODS OF USING SAME	ANGIEX, INC.
WO/2021/222789	INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE  THEREOF	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/222793	MULTISPECIFIC ANTI-FLT3 CHIMERIC ANTIGEN RECEPTORS	THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
WO/2021/222807	FATTY ACYL AND FATTY ETHER CONJUGATES OF REMDESIVIR AND ITS  ACTIVE METABOLITES AS ANTIVIRALS	AJK PHARMACEUTICAL LLC
WO/2021/222817	COMPOSITIONS AND METHODS FOR SOLIDIFIED FERMENTED ANIMAL FEED	PACKERLAND WHEY PRODUCTS D/B/A FERMENTED NUTRITION
WO/2021/222835	COMPOSITIONS AND METHODS COMPRISING STABLE REDUCED GLUTATHIONE	PURSER, Danny, C.
WO/2021/225908	TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING  IN CANCERS WITH LOW IMMUNOGENICITY	BEYONDSPRING PHARMACEUTICALS, INC.
WO/2021/222851	COMBINATIONS OF VIRAL PROTEINS, PEPTIDE SEQUENCES, EPITOPES,  AND METHODS AND USES THEREOF	LA JOLLA INSTITUTE FOR IMMUNOLOGY
WO/2021/222852	METHODS OF TREATMENT COMPRISING STABLE REDUCED GLUTATHIONE	PURSER, Danny C.
WO/2021/222855	NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER  IMMUNOTHERAPY	THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
WO/2021/222861	ANTIBODIES SPECIFIC TO ABCB5 AND USES THEREOF	CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/222865	METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND  MITOCHONDRIA ASSOCIATED DISEASES	LARIMAR THERAPEUTICS, INC.
WO/2021/222875	METHODS OF USING ALK2 INHIBITORS	KEROS THERAPEUTICS, INC.
WO/2021/225912	TREATMENT OF RESPIRATORY DISEASES WITH AMINO ACID COMPOUNDS	PLIANT THERAPEUTICS, INC.
WO/2021/225918	SEMI-SOLID CHEWABLE COMPOSITIONS AND METHODS OF MAKING AND  USING THEREOF	SEATTLE GUMMY COMPANY
WO/2021/225926	COMBINATION CANCER THERAPY USING N2-QUINOLINE OR ISOQUINOLINE  SUBSTITUTED PURINE DERIVATIVES	WU, Zhanggui
WO/2021/225932	FURAN SURFACTANT COMPOSITIONS AND METHODS	SIRONIX RENEWABLES, INC.
WO/2021/225937	COMPOSITIONS COMPRISING GELSOLIN FOR TREATING FRAILTY	BIOAEGIS THERAPEUTICS INC.
WO/2021/222884	AQUEOUS ANTI MICROBIAL COMPOSITION USEFUL AS A THERAPEUTIC  MATERIAL	TYGRUS LLC
WO/2021/222885	TRANSDERMAL DRUG DELIVERY DEVICES HAVING PSILOCYBIN, LYSERGIC  ACID DIETHYLAMIDE OR 3,4-METHYLENEDIOXYMETHAMPHETAMINE COATED  MICROPROTRUSIONS	ZOSANO PHARMA CORPORATION
WO/2021/222886	COMPOSITIONS AND METHODS TO TREAT POLYCYSTIC KIDNEY DISEASE	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/225950	DOSING METHODS FOR TREATMENT OF CARDIOVASCULAR CONDITIONS	IMBRIA PHARMACEUTICALS, INC.
WO/2021/222890	CORONAVIRUS ASSAYS, DIAGNOSTIC METHODS, TREATMENT METHODS, AND  COMPOSITIONS RELATED THERETO	EMORY UNIVERSITY
WO/2021/222894	ANTI-DECTIN-2 ANTIBODIES	BOLT BIOTHERAPEUTICS, INC.
WO/2021/222903	COMPOSITIONS COMPRISING ANTI-VEGF AND NANOPARTICLES AND  METHODS OF USING THE SAME FOR THE TREATMENT OF ABNORMAL OR EXCESSIVE  ANGIOGENESIS	PHAM, Randal Tanh Hoang
WO/2021/225969	IMINO SULFANONE INHIBITORS OF ENPP1	VOLASTRA THERAPEUTICS, INC.
WO/2021/225973	NALOXONE PHARMACEUTICAL FORMULATIONS FOR INTRANASAL (IN)  DELIVERY	AMPHASTAR PHARMACEUTICALS, INC.
WO/2021/225974	EPINEPHRINE PHARMACEUTICAL FORMULATIONS FOR INTRANASAL  DELIVERY	AMPHASTAR PHARMACEUTICALS, INC.
WO/2021/225976	SAFE USE OF BILE ACIDS AND THEIR SALTS AS ENHANCERS FOR NASAL  DELIVERY OF PHARMACEUTICALS	AMPHASTAR PHARMACEUTICALS, INC.
WO/2021/225982	SOS1 ALLOSTERIC SITE TARGETING	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/225983	SYSTEM AND METHOD TO USE SUCTION TO ENHANCE PERMEABILIZATION  AND TRANSFECTION OF CELLS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/225987	TOPICAL FORMULATIONS COMPRISING DUTASTERIDE FOR TREATING  DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS	XYON HEALTH INC.
WO/2021/225996	METHODS AND COMPOUNDS FOR PREVENTING AND ARRESTING COVID-19  MORBIDITY AND MORTALITY, VIA INHIBITION OF INTERLEUKIN-6, TNF-ALPHA, AND  OTHER CYTOKINES, AND VIA REDUCTION OF C-REACTIVE PROTEINS	BIOVED PHARMACEUTICALS, INC.
WO/2021/226015	NEUROQUIESCENCE - A TREATMENT FOR NEURODEVELOPMENTAL AND  NEURODEGENERATIVE BIOELECTRICAL DYSREGULATION AND DEMYELINATION	ZUCCO SASSI YONEZAWA SIVIGLIA, Debora
WO/2021/226022	PHOTOCHEMICAL SYNTHESIS OF MARMYCIN ANALOGUES THROUGH A NEW  PHOTOCHEMICAL REACTION INVOLVING CARBONYL COMPOUNDS	BOWLING GREEN STATE UNIVERSITY
WO/2021/226024	METHOD FOR TREATING SYMPTOMS OF VIRAL INFECTIONS	WAINER, Irving, W.
WO/2021/226033	HYALURONIC ACID DRUG CONJUGATES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/226037	TREATMENT OF VIRAL INFECTIONS	SULFAGENIX, INC.
WO/2021/257193	TRIAMCINOLONE ACETONIDE-LOADED LIPOSOMES TOPICAL OPHTHALMIC  FORMULATIONS AS PRIMARY THERAPY FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL  VEIN OCCLUSION	OPKO PHARMACEUTICALS, LLC
WO/2021/226039	MODULAR THERAPEUTICS HAVING ANTI-RNA ACTIVITY AND METHODS  THEREOF	SANATIO BIOSCIENCE CORP.
WO/2021/226042	BIOMARKERS FOR ASSESSING LIVER DISEASE	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/226044	PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES	CONAGEN INC.
WO/2021/226054	DROPLET ENCAPSULATION OF A CELL AND CONTROLLED RELEASE  PARTICLE	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/226060	FORMULATIONS OF HYALURONIC ACID AND AMNIOTIC OR GESTATIONAL  FLUID, AND USES OF THE SAME	GENESIS BIOLOGICS, INC.
WO/2021/226076	POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND  METHOD FOR DETECTION OF BACTERIAL INFECTION	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
WO/2021/226088	VACCINE ADJUVANTS	VIROVAX LLC
WO/2021/226092	SYNTHETIC LIPID-LIKE MATERIALS FOR BRAIN DELIVERY	TRUSTEES OF TUFTS COLLEGE
WO/2021/226099	TOPICAL ANTI-INFLAMMATORY CANNABINOID COMPOSITIONS	AGRONOMED MANAGEMENT, LLC
WO/2021/226107	COMPOSITIONS AND METHODS OF TREATING POMPE DISEASE	AVIDITY BIOSCIENCES, INC.
WO/2021/226108	PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES	ACCELERATED BIOSCIENCES CORP.
WO/2021/226110	CELL-FREE DNA BIOMARKERS AND THEIR USE IN DIAGNOSIS,  MONITORING RESPONSE TO THERAPY, AND SELECTION OF THERAPY FOR PROSTATE CANCER	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/226111	IMMUNOTHROMBOSIS IN COVID-19 ACUTE RESPIRATORY DISTRESS  SYNDROME	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/226129	SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3  AND METHODS OF USE THEREOF	NEURALEXO, INC.
WO/2021/226135	HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON  MYELOID CELLS 2 AGONISTS AND METHODS OF USE	AMGEN INC.
WO/2021/226136	ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE	ANGARUS THERAPEUTICS, INC.
WO/2021/226137	COMPOSITIONS, DEVICES AND METHODS FOR INDUCING IMMUNE  RESPONSES TO INFECTIOUS AGENTS	SIGILON THERAPEUTICS, INC.
WO/2021/226148	METHODS FOR TREATING PANCREATIC CANCER AND OTHER SOLID TUMORS	DRUGCENDR AUSTRALIA PTY LTD.
WO/2021/226153	ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/226154	ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/226155	ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/226156	ORAL CARE COMPOSITIONS COMPRISING MONODENTATE AND POLYDENTATE  LIGAND	THE PROCTER & GAMBLE COMPANY
WO/2021/226157	REMINERALIZING ORAL CARE COMPOSITIONS COMPRISING TIN	THE PROCTER & GAMBLE COMPANY
WO/2021/226158	REMINERALIZING ORAL CARE COMPOSITIONS COMPRISING TIN	THE PROCTER & GAMBLE COMPANY
WO/2021/226159	ORAL CARE COMPOSITIONS COMPRISING TIN	THE PROCTER & GAMBLE COMPANY
WO/2021/226161	PROCESS FOR THE PREPARATION OF VERDIPERSTAT	BIOHAVEN THERAPEUTICS LTD.
WO/2021/226162	EP4 ANTAGONISTS AND THEIR USE IN THE TREATMENT OF  PROLIFERATIVE DISEASES	ARRYS THERAPEUTICS, INC.
WO/2021/226174	METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL  INFECTION	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
WO/2021/226193	PROTEINS BINDING NKG2D, CD16 AND CLEC12A	DRAGONFLY THERAPEUTICS, INC.
WO/2021/226196	MINERAL SUNSCREEN COMPOSITION	EDGEWELL PERSONAL CARE BRANDS, LLC
WO/2021/226206	CANNABINOID RECEPTOR TYPE 2 (CB2) MODULATORS AND USES THEREOF	TEON THERAPEUTICS, INC.
WO/2021/226244	VASOACTIVE INTESTINAL PEPTIDE FUSION PROTEINS FOR THE  TREATMENT OF COVID-19	PHASEBIO PHARMACEUTICALS, INC.
WO/2021/226256	NICLOSAMIDE FORMULATIONS AND METHODS OF USE	NEUROBO PHARMACEUTICALS, INC.
WO/2021/226258	FORMULATIONS OF PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR  MODULATORS	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/226263	COMBINATIONS	RECURIUM IP HOLDINGS, LLC
WO/2021/226269	HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS	NUVALENT, INC.
WO/2021/226278	AN ULTRASENSITIVE RAPID AND PORTABLE CASE13D-BASED DIAGNOSTIC  ASSAY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/226294	TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION	ACADEMIA SINICA
WO/2021/236335	PHARMACEUTICAL COMPOSITION	GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
WO/2021/226329	PURIFICATION AND SANITIZATION USING DIRECTED ENERGY	ARGOSY HOLDINGS, LLC
WO/2021/226330	AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE  INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDB	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/226336	COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN STRUCTURE  DETERMINATION	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/226343	DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HEPATITIS B VIRUS	THE WISTAR INSTITUTE OF ANATOMY ANDBIOLOGY
WO/2021/226358	REDUCTION OF VIRAL DISEASE TRANSMISSION BY AVIAN ANTIBODIES	CAMAS INCORPORATED
WO/2021/262329	SUBCUTANEOUS (SC) ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR  TREATMENT OF COMPLEMENT-ASSOCIATED CONDITIONS	ALEXION PHARMACEUTICALS, INC.
WO/2021/226368	LIPOSOME FORMULATIONS FOR TREATMENT OF CANCERS AND DRUG  RESISTANCE OF CANCERS	NANOTECH PHARMA INC.
WO/2021/226370	TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE  ANIONIC SURFACTANTS	ARCUTIS BIOTHERAPEUTICS, INC.
WO/2021/226384	METHODS OF TREATMENT FOR DISEASE FROM CORONAVIRUS EXPOSURE	ENSEMLBLE GROUP HOLDINGS
WO/2021/226390	PROGESTOGEN FORMULATIONS AND USES THEREOF	SHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/226391	USE OF GHRELIN OR GHRELIN VARIANT FOR INCREASING DOSE  INTENSITY OF CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH CANCER	OXEIA BIOPHARMACEUTICALS, INC.
WO/2021/226402	PROGESTOGEN FORMULATIONS FOR USE IN MODULATING A CYTOKINE  STORM MEDIATOR	SHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/226403	METHODS OF MONITORING KRAS MUTATIONS	CARDIFF ONCOLOGY, INC.
WO/2021/226404	USE OF IL-6 ANTIBODIES AND VEGF TRAPS, AND FUSION CONSTRUCTS  AND CONJUGATES THEREOF	KODIAK SCIENCES INC.
WO/2021/226405	COVID-19 ANTIBODIES AND USES THEREOF	INTERNATIONAL AIDS VACCINE INITIATIVE INC.
WO/2021/226412	METHODS AND COMPOSITIONS FOR TREATING AN RNA VIRUS INDUCED  DISEASE	GOLDEN BIOTECHNOLOGY CORPORATION
WO/2021/226416	NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS	PSILERA INC.
WO/2021/226432	METHODS OF DETECTING AND TREATING LUNG DAMAGE IN  RESPIRATORY-RELATED VIRAL INFECTIONS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/226436	OPTIMIZED NUCLEOTIDE SEQUENCES ENCODING SARS-COV-2 ANTIGENS	TRANSLATE BIO, INC.
WO/2021/226437	SARS-COV-2 IMMUNOASSAY AND MATERIALS THEREFOR	BIO-RAD LABORATORIES, INC.
WO/2021/226440	ELASTASE-SUBSTRATE, PEPTIDE LINKER IMMUNOCONJUGATES, AND USES  THEREOF	BOLT BIOTHERAPEUTICS, INC.
WO/2021/231208	METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR  ANALOGS THEREOF	REATA PHARMACEUTICALS, INC.
WO/2021/226454	LINKER COMPOUNDS	MPEG LA, L.L.C.
WO/2021/226455	METHODS AND COMPOSITIONS FOR REDUCING JOINT INFLAMMATION USING  MESENCHYMAL STEM CELLS	PRIMEGEN BIOTECH, LLC
WO/2021/231211	COMPLEMENT COMPONENT C1S INHIBITORS FOR TREATING A  NEUROLOGICAL DISEASE, AND RELATED COMPOSITIONS, SYSTEMS AND METHODS OF USING  SAME	GENENTECH, INC.
WO/2021/226458	AKT3 MODULATORS	GEORGIAMUNE LLC
WO/2021/226465	GLUCOCORTICOID RECEPTOR MODULATORS	TRUSTEES OF DARTMOUTH COLLEGE
WO/2021/226468	IMPROVED COMPOSITIONS FOR CFTR MRNA THERAPY	TRANSLATE BIO, INC.
WO/2021/226476	COCRYSTAL ANTIOXIDANTS OF PROTOCATECHUIC ACID WITH L-THEANINE  FOR THE TREATMENT OF OXIDATIVE STRESS AND INFLAMMATORY CONDITIONS	THEAPRIN PHARMACEUTICALS INC.
WO/2021/226477	AKT3 MODULATORS	GEORGIAMUNE LLC
WO/2021/226478	DHODH INHIBITOR FOR THE TREATMENT OF COVID-19	PTC THERAPEUTICS, INC.
WO/2021/226479	INHALED STATINS FOR TREATMENT OF VIRAL RESPIRATORY DISEASES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/226485	ANTISENSE THERAPEUTICS FOR BETACORONAVIRUS TREATMENT	OREGON STATE UNIVERSITY
WO/2021/242504	METHODS FOR TREATING DEPRESSION	JANSSEN PHARMACEUTICALS, INC.
WO/2021/226510	AKT3 MODULATORS AND METHODS OF USE THEREOF	GEORGIAMUNE LLC
WO/2021/226520	PEPTIDE COMPOSITIONS FOR THE TREATMENT OF PATHOGENIC  INFECTIONS	KIROMIC BIOPHARMA, INC.
WO/2021/242505	INHIBITORS OF NEK7 KINASE	HALIA THERAPEUTICS, INC.
WO/2021/226532	TRANSLATION BLOCKERS REPURPOSED FOR COVID-19 THERAPY	THE GENERAL HOSPITAL CORPORATION
WO/2021/226533	CHIMERIC INFLUENZA VACCINES	ACADEMIA SINICA
WO/2021/226536	CANNABINOID POUCHES	TRINIDAD CONSULTING, LLC
WO/2021/226542	POUCHES	TRINIDAD CONSULTING, LLC
WO/2021/226546	PROTEASE INHIBITORS FOR TREATMENT OR PREVENTION OF CORONAVIRUS  DISEASE	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/226561	COVID-19 THERAPEUTICS AND METHODS OF TREATMENT	BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND  AGRICULTURAL AND MECHANICAL COLLEGE
WO/2021/231250	TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES  COMPRISING GDC-9545 AND A CDK4/6 INHIBITOR	GENENTECH, INC.
WO/2021/226572	PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND  VACCINATION	RESEARCH DEVELOPMENT FOUNDATION
WO/2021/231272	ADMINISTRATION OF GUT-SELECTIVE JAK3 INHIBITOR	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/231278	COMBINATION THERAPY WITH MODIFIED PBMCS AND AN IMMUNOCONJUGATE	F. HOFFMANN-LA ROCHE AG
WO/2021/226583	ANTIVIRAL COMPOSITIONS AND METHODS	WAYNE STATE UNIVERSITY
WO/2021/226584	SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES BY ADP-RIBOSYL CYCLASES	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/231304	MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED  COVID-19 TREATMENT METHODS	CHAN ZUCKERBERG BIOHUB, INC.
WO/2021/231309	METHODS FOR THE USE OF A B7-H3 ANTIBODY-DRUG CONJUGATE ALONE  OR IN COMBINATION	MACROGENICS, INC.
WO/2021/226592	METHOD FOR TREATING PANCREATIC CANCER	LANTERN PHARMA INC.
WO/2021/231314	METHODS OF TREATING COVID-19 USING TETRACYCLINE COMPOUNDS	PARATEK PHARMACEUTICALS INC.
WO/2021/231316	IL-2 FUSION POLYPEPTIDE COMPOSITIONS AND METHODS OF MAKING AND  USING THE SAME	ALKERMES PHARMA IRELAND LIMITED
WO/2021/231319	IL-2 FUSION POLYPEPTIDE COMPOSITIONS AND METHODS OF MAKING AND  USING THE SAME	ALKERMES PHARMA IRELAND LIMITED
WO/2021/231327	METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEM	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/226597	CIRCULAR RNA COMPOSITIONS AND METHODS	ORNA THERAPEUTICS, INC.
WO/2021/226600	TREATMENT OF METABOLIC DISORDERS THROUGH THE TARGETING OF A  NOVEL CIRCULATING HORMONE COMPLEX	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/226602	PLACENTA-DERIVED ADHERENT (PDA) STEM CELL FOR THE TREATMENT OF  ADULTS WITH SARS-COV-2 RELATED ACUTE RESPIRATORY FAILURE AND ARDS (COVID-19)	CELULARITY INC.
WO/2021/231335	NOVEL INTERMEDIATES AND SYNTHESIS FOR ENDOCHIN-LIKE QUINOLONE  COMPOUNDS	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/231343	SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR  ALLERGEN-BINDING MOIETIES	BARRON, Annelise E.
WO/2021/231346	DOSING AND ADMINISTRATION OF ACTIVATABLE ANTI-CTLA-4 ANTIBODY	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/231350	COMPOSITIONS OF POLYMERIC MICRODEVICES AND THEIR USE IN CANCER  IMMUNOTHERAPY	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/231361	PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF  REMDESIVIR FOR INHALATION	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/231383	ORAL DELIVERY OF NANOPARTICLES FOR KIDNEY DISEASE	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/231397	THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/231405	METHODS FOR TREATING GLIOBLASTOMA	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/231410	METHOD OF TREATING CANCER WITH TELOTRISAT OR A PRODRUG THEREOF	TERSERA THERAPEUTICS LLC
WO/2021/231413	A TREATMENT APPROACH INVOLVING KIF18A INHIBITION FOR  CHROMOSOMALLY UNSTABLE TUMORS	UNIVERSITY OF VERMONT
WO/2021/231421	THIOL-CONTAINING COMPOUNDS FOR USE IN TREATING CORONAVIRUS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247208	TOPICAL OPHTHALMOLOGICAL COMPOSITIONS AND METHODS FOR TREATING  ABNORMAL ANGIOGENESIS	ADS THERAPEUTICS LLC
WO/2021/231431	METHODS OF TREATING PROSTATE CANCER	ARVINAS OPERATIONS, INC.
WO/2021/231434	PSMA TARGETING TRITACS AND METHODS OF USE	HARPOON THERAPEUTICS, INC.
WO/2021/231436	THERAPEUTIC METHODS FOR TREATING COVID-19 INFECTIONS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/231441	COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST  CLASS I FUSION PROTEIN VIRUSES	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/231443	COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/231463	VIRAL CLEARANCE BY LOW PH HOLD	REGENERON PHARMACEUTICALS, INC.
WO/2021/231470	USE OF COMPLEMENT FACTOR D INHIBITORS ALONE OR IN COMBINATION  WITH ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	ALEXION PHARMACEUTICALS, INC.
WO/2021/231474	METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION	PMV PHARMACEUTICALS, INC.
WO/2021/231486	CANCER TREATMENT BY SENESCENCE INDUCTION FOLLOWED BY A  SENOLYTIC	UNITY BIOTECHNOLOGY, INC.
WO/2021/231499	COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS	REVIR, INC.
WO/2021/231505	VECTORS AND METHODS FOR IN VIVO TRANSDUCTION	ABINTUS BIO, INC.
WO/2021/231509	SHAMPOO COMPOSITION COMPRISING DECYL GLUCOSIDE AND A CATIONIC  GUAR	THE PROCTER & GAMBLE COMPANY
WO/2021/231510	SHAMPOO COMPOSITION COMPRISING ALKYL GLUCOSIDE	THE PROCTER & GAMBLE COMPANY
WO/2021/231518	NUCLEIC ACID LIGAND CONJUGATES AND USE THEREOF FOR DELIVERY TO  CELLS	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
WO/2021/231528	COMPOSITIONS AND METHODS FOR TREATING CANCER	RUSH UNIVERSITY MEDICAL CENTER
WO/2021/231539	ALLEVIATION OF LIVER INJURY BY ACTIVATING THE SIGNALING  PATHWAY MEDIATED BY FARNESOID X RECEPTOR	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/231541	POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD	NUTCRACKER THERAPEUTICS, INC.
WO/2021/231546	SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF  NEUROMUSCULAR DISEASES	EDGEWISE THERAPEUTICS, INC.
WO/2021/236389	TREATMENT OF KNOWN AND UNKNOWN VIRAL INFECTION WITH LIPID  AGENTS	BOND, Jason R.
WO/2021/231552	COMPOSITIONS AND METHODS FOR CONTROLLING BLOOD PRESSURE	DUKE UNIVERSITY
WO/2021/231560	ENGINEERING CORONAVIRUS SPIKE PROTEINS AS VACCINE ANTIGENS,  THEIR DESIGN AND USES	GREFFEX, INC.
WO/2021/231563	GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER  EAR	SPIRAL THERAPEUTICS INC.
WO/2021/231565	PYRIDAZINONE COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR  DISEASES	EDGEWISE THERAPEUTICS, INC.
WO/2021/231566	THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR  APOE4-RELATED DISORDERS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/231568	METHODS OF TREATING CANCER USING A COMBINATION OF ANTI-CD30  ANTIBODY-DRUG CONJUGATES	SEAGEN INC.
WO/2021/231570	CYSTEAMINE FOR THE TREATMENT OF SARS-COV-2 INFECTION	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/231572	PYRIDAZINONE COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR  DISEASES	EDGEWISE THERAPEUTICS, INC.
WO/2021/231575	IMMUNOSUPPRESSIVE AGENTS AND VIRAL DELIVERY RE-DOSING METHODS  FOR GENE THERAPY	MYOGENE BIO LLC
WO/2021/231577	GENE THERAPY WITH DYSFERLIN DUAL VECTORS	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/231581	METHODS OF TREATING OR PREVENTING VIRAL INFECTION WITH  FLUORINATED α <sb>V</sb> INTEGRIN ANTAGONISTS	SCIFLUOR LIFE SCIENCES, INC.
WO/2021/231611	METHODS FOR TREATING CANCER USING SPL-108 POLYPEPTIDE BASED ON  TP53 MUTATIONAL STATUS	SPLASH PHARMACEUTICALS, INC.
WO/2021/231615	SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF  NEUROMUSCULAR DISEASES	EDGEWISE THERAPEUTICS, INC.
WO/2021/231630	SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF  NEUROMUSCULAR DISEASES	EDGEWISE THERAPEUTICS, INC.
WO/2021/231639	USE OF A MULTIMERIC ANTI-DR5 BINDING MOLECULE IN COMBINATION  WITH A CANCER THERAPY FOR TREATING CANCER	IGM BIOSCIENCES, INC.
WO/2021/231644	COMBINATION TREATMENT OF LIVER DISORDERS	TERNS PHARMACEUTICALS, INC.
WO/2021/231646	COMBINATION TREATMENT OF LIVER DISORDERS	TERNS PHARMACEUTICALS, INC.
WO/2021/231648	CANCER THERAPEUTICS COMPRISING CHEMOKINE OR ITS ANALOG	GIGAGEN, INC.
WO/2021/231652	USING THE P62 PLASMID TO TREAT OR REDUCE THE SEVERITY OF  CORONAVIRUS INFECTIONS	CURELAB ONCOLOGY, INC.
WO/2021/231658	SHEAR-THINNING COSMETIC COMPOSITION	ELC MANAGEMENT LLC
WO/2021/231659	NEUTRALIZING ANTIBODY TESTING AND TREATMENT	SAPPHIRE BIOTECH, INC.
WO/2021/231660	TREATMENT OF DYSLEXIA USING BOTULINUM TOXIN <u>  </u>	PENLAND FOUNDATION
WO/2021/231665	NOVEL ENCAPSULATED COSMETIC COMPOSITIONS AND USES THEREOF	ELC MANAGEMENT LLC
WO/2021/231666	TREATMENT OF ASTHMA USING BOTULINUM TOXIN	PENLAND FOUNDATION
WO/2021/231668	TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING  BOTULINUM TOXIN	PENLAND FOUNDATION
WO/2021/231669	TREATMENT OF CARDIAC ARRHYTHMIA USING BOTULINUM TOXIN	PENLAND FOUNDATION
WO/2021/231671	TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING BOTULINUM  TOXIN	PENLAND FOUNDATION
WO/2021/231672	TREATMENT OF CIRRHOSIS USING BOTULINUM TOXIN	PENLAND FOUNDATION
WO/2021/231676	EXTENDED TIME ACTION ACYLATED INSULIN COMPOUNDS	ELI LILLY AND COMPANY
WO/2021/231678	REDUCING PROMININ2-MEDIATED RESISTANCE TO FERROPTOTIC CELL  DEATH	UNIVERSITY OF MASSACHUSETTS
WO/2021/231689	PHAGE-MEDIATED DELIVERY OF GENES TO GUT MICROBIOME	CHAN ZUCKERBERG BIOHUB, INC.
WO/2021/236410	ANTIFIBROTIC COMPOUNDS AND RELATED METHODS	FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/231697	PEG LIPIDOID COMPOUNDS	TRANSLATE BIO, INC.
WO/2021/236415	SAFE POTENT SINGLE VECTOR PLATFORM VACCINE AGAINST COVID-19	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/231701	CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS AND METHODS OF  MANUFACTURING SUCH COMPOUNDS	SAVAGE, Paul B.
WO/2021/231702	COMPOSITIONS AND METHODS FOR TREATING WOUNDS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/231712	HYPOIMMUNOGENIC CELLS AND USES THEREOF IN IMMUNE RESPONSES	RXCELL INC.
WO/2021/231721	TETRAHYDROCURCUMINOID-METAL COMPLEXES, MANUFACTURING METHODS  THEREOF, AND USES THEREOF	PROBIOTICSMART, LLC
WO/2021/231727	TOPICAL DUTASTERIDE EMULSIONS FOR TREATING ENDOCRINE  THERAPY-INDUCED ALOPECIA	VARSONA THERAPEUTICS, INC.
WO/2021/231729	ADJUVANTED STABILIZED STEM HEMAGGLUTININ NANOPARTICLES AND  METHODS OF USING THE SAME TO INDUCE BROADLY NEUTRALIZING ANTIBODIES AGAINST  INFLUENZA	SANOFI
WO/2021/231730	COMPOSITIONS AND METHODS FOR TREATING GM1 GANGLIOSIDOSIS AND  OTHER DISORDERS	LYSOGENE
WO/2021/231732	ANTIBODIES TO GARP	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/231750	2'-FUCOSYLLACTOSE FOR THE PREVENTION AND TREATMENT OF  CORONAVIRUS-INDUCED INFLAMMATION	GLYCOSYN LLC
WO/2021/247217	LPA RECEPTOR ANTAGONISTS AND USES THEREOF	GILEAD SCIENCES, INC.
WO/2021/231762	COMBINATION THERAPY FOR THE TREATMENT OF TNBC WITH A PI3K  PATHWAY INHIBITOR THAT TARGETS PI3KDELTA AND PI3KGAMMA TNBC	THE TRUSTEES OF INDIANA UNIVERSITY
WO/2021/231773	COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOF	GOOD THERAPEUTICS, INC.
WO/2021/231778	CORONAVIRUS PROTEASE DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/231782	PERK INHIBITORS FOR TREATING VIRAL INFECTIONS	HIBERCELL, INC.
WO/2021/231784	PERK INHIBITING IMIDAZOLOPYRAZINE COMPOUNDS	HIBERCELL, INC.
WO/2021/231788	PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS TO TREAT VIRAL  INFECTIONS	HIBERCELL, INC.
WO/2021/231792	PHARMACEUTICAL FORMULATIONS AND USES THEREOF	ALDEYRA THERAPEUTICS, INC.
WO/2021/231795	METHODS AND COMPOSITIONS FOR TREATING A TUMOR	RAKUTEN MEDICAL, INC.
WO/2021/231798	ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS	DISC MEDICINE, INC.
WO/2021/231800	ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING ANEMIA OF  CHRONIC DISEASE	DISC MEDICINE, INC.
WO/2021/231802	METHODS OF TREATING SJÖGREN'S SYNDROME	VANDERBILT UNIVERSITY
WO/2021/231804	METHODS AND COMPOSITIONS FOR SUPPRESSING INFLAMMATION INDUCED  BY GUT MICROBES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/231807	NOVEL ANUCLEATED CELLS AS A SOURCE FOR TREATMENT OF PLATELET  RICH PLASMA DEPENDENT DISORDERS	PLATELET BIOGENESIS, INC.
WO/2021/231810	CANNABIDIOL AS A THERAPEUTIC MODALITY FOR COVID-19	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/236430	C-TERMINAL FRAGMENT OF TETANUS TOXIN (HC) FOR TREATMENT OF  DEPRESSION	HOWARD UNIVERSITY
WO/2021/231814	COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF  VASCULAR MALFORMATIONS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/231830	METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF  ABCA4	KORRO BIO, INC.
WO/2021/231845	COMPOSITIONS AND METHODS FOR TREATING AND DETECTING  CORONAVIRUS INFECTION	HOWARD UNIVERSITY
WO/2021/231847	OLEOGEL AND OLEOPASTE COMPOSITIONS AND USES THEREOF	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/231851	METHODS AND COMPOSITIONS FOR TREATING ANEMIA USING ACTRIIB  LIGAND TRAPS AND MTOR INHIBITORS	CELGENE CORPORATION
WO/2021/231854	LNP COMPOSITIONS COMPRISING AN MRNA THERAPEUTIC AND AN  EFFECTOR MOLECULE	MODERNATX, INC.
WO/2021/236440	ATHLETIC PERFORMANCE ENHANCEMENT COMPOSITION USING MENTHOL	ADVANCED FOOD CONCEPTS, INC.
WO/2021/231860	SOLID DOSAGE FORM FOR TRANSMUCOSAL DRUG DELIVERY	PRIMO PHARMATECH LLC
WO/2021/231863	COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/231866	CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND  DETECTING OCULAR TUMORS	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/231869	USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS	ZIVO BIOSCIENCE, INC.
WO/2021/231872	COMPOSITIONS AND METHODS FOR INCREASING EFFICACY OF A DRUG	HEALION BIO, INC.
WO/2021/231877	ADMINISTRATION OF SUMO-ACTIVATING ENZYME INHIBITOR AND  ANTI-CD38 ANTIBODIES	MILLENNIUM PHARMACEUTICALS, INC.
WO/2021/231885	COMPOSITIONS AND METHODS FOR PROMOTING HAIR CELL REGENERATION	DECIBEL THERAPEUTICS, INC.
WO/2021/236449	P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS	GEN1E LIFESCIENCES INC.
WO/2021/231887	COMPOSITIONS AND METHODS OF DETECTION OF PRE-SYMPTOMATIC ALS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
WO/2021/231893	COMPOUNDS FOR INHIBITING LY6K AND METHODS OF USING SAME	THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF  MILITARY MEDICINE, INC.
WO/2021/231901	LIPID NANOPARTICLE FORMULATIONS FOR MRNA DELIVERY	TRANSLATE BIO, INC.
WO/2021/231904	DETECTION AND INDICATION OF COVID-19, OTHER VIRUSES AND  PATHOGENS AND VACCINE ASSOCIATED EFFICACY	DIOMICS CORPORATION
WO/2021/231905	KETAMINE TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS	THE UNIVERSITY OF KANSAS
WO/2021/231908	COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/231922	AGONISTIC TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY  POLYPEPTIDES	THE GENERAL HOSPITAL CORPORATION
WO/2021/231923	COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A  SARS-COV-2 INFECTION	METACLIPSE THERAPEUTICS CORPORATION
WO/2021/231925	VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS  OF USING THE SAME	INOVIO PHARMACEUTICALS, INC.
WO/2021/231927	ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON  LIGAND	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/231928	A METHOD FOR TREATING CANCER WITH AN ORAL DOSAGE FORM OF AN  FGFR4 INHIBITOR	EISAI R&D MANAGEMENT CO., LTD.
WO/2021/242545	AGENTS AND METHODS FOR TREATING TAUOPATHIES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/231929	RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION	MODERNATX, INC.
WO/2021/231930	IMMUNE BOOSTER SUPPLEMENT TREATMENT KIT AND METHODS OF USE	ALTERED LABS LLC
WO/2021/231931	METHODS OF TREATING SARS-COV-2 INFECTIONS	TYME, INC.
WO/2021/231933	ANTI-EPILEPTIC PHARMACEUTICAL COMPOSITIONS AND USE THEREOF	NEUCYTE PHARMACEUTICALS
WO/2021/231936	METHODS OF USING BILE ACIDS TO TREAT VIRAL INFECTIONS	HOFFMAN, Steven
WO/2021/231941	TLR7/8 ANTAGONISTS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	MERCK HEALTHCARE KGAA
WO/2021/231942	TOLL-LIKE RECEPTOR (TLR) AGONIST NANOPARTICLES AND USES  THEREOF	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/231945	ASSAYS FOR ASSESSING ANTI-SEIZURE ACTIVITY OF CHEMICAL  COMPOUNDS	NEUCYTE PHARMACEUTICALS
WO/2021/231946	COMPOSITIONS AND METHODS FOR HARDENING	SPI PHARMA, INC.
WO/2021/231950	APPARATUS FOR CANNABINOL GENERATION AND METHODS OF USING THE  SAME	AZDT HOLDINGS, LLC
WO/2021/231954	METHODS FOR IMMUNOTHERAPY	PRECISION BIOSCIENCES, INC.
WO/2021/231959	METHODS FOR IMMUNOTHERAPY	PRECISION BIOSCIENCES, INC.
WO/2021/231960	METHODS OF TREATING LEFT VENTRICLE HYPERTROPHY	AMGEN INC.
WO/2021/231963	RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF  USING THE SAME FOR TREATING COVID-19	MODERNATX, INC.
WO/2021/231969	HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3	XENCOR, INC.
WO/2021/231971	SELECTIVE TARGETING OF THE TREML1/MD2 INTERACTION BY SMALL  PEPTIDE OR PROTEIN AND ITS USE FOR VACCINE ADJUVANTS	ASCENDO BIOTECHNOLOGY, INC.
WO/2021/231975	HUMANIZED CD38 AND ICAM1 ANTIBODIES AND USES THEREOF	VIRTUOSO BINCO, INC.
WO/2021/231976	HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE  ANTIGEN (PSMA) AND CD3	XENCOR, INC.
WO/2021/231982	SMC1A ANTIBODIES AND USES THEREOF	CITY OF HOPE
WO/2021/231988	MITOCHONDRIAL-DERIVED PEPTIDES AND ANALOGS THEREOF FOR USE AS  A THERAPY FOR AGE-RELATED DISEASES INCLUDING CANCER	UNIVERSITY OF SOUTHERN CALIFORNIA
WO/2021/236474	NOVEL PROCESSES FOR PREPARING CONJUGATES OF THE IL-2 PROTEIN	MERCK SHARP & DOHME CORP.
WO/2021/242547	BELVARAFENIB FOR USE IN CANCER TREATMENT	HANMI PHARM. CO., LTD.
WO/2021/236489	BIOMASS DERIVED DIKETONES AS EFFICIENT VISIBLE LIGHT  PHOTOINITIATORS	BOWLING GREEN STATE UNIVERSITY
WO/2021/236491	BENZOYLHYDRAZIDE-DERIVED HDAC DEGRADERS AS THERAPEUTICS FOR  TREATING CANCER AND OTHER HUMAN DISEASES	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
WO/2021/236496	ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/236498	TREATMENT OF KRAS-VARIANT CANCERS WITH SEROTONIN UPTAKE  INHIBITORS	YALE UNIVERSITY
WO/2021/236508	KITS AND METHODS FOR DETERMINING COPY NUMBER OF MOUSE TCR GENE	CELLULAR BIOMEDICINE GROUP HK LIMITED
WO/2021/236509	ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF	ELPIS BIOPHARMACEUTICALS
WO/2021/236513	VACCINE COMPOSITIONS COMPRISING ENDOGENOUS GAG POLYPEPTIDES	VNV NEWCO INC.
WO/2021/236518	LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF SEPSIS AND  SYMPTOMS THEREOF	IRR, INC.
WO/2021/232012	SMALL MOLECULE CB002-ANALOGUES RESTORE THE P53 PATHWAY AND  TARGET S-PHASE CHECKPOINT	BROWN UNIVERSITY
WO/2021/232013	BIOACTIVE TISSUE DERIVED NANOCOMPOSITE HYDROGELS FOR PERMANENT  ARTERIAL EMBOLIZATION AND ENHANCED VASCULAR HEALING	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/236522	USES OF ORNITHINE PHENYLACETATE FOR TREATING HYPERAMMONEMIA	OCERA THERAPEUTICS, INC.
WO/2021/236526	COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA	BIOASIS TECHNOLOGIES, INC.
WO/2021/232015	PLATELET DERIVED EXTRACELLULAR VESICLES	CELLPHIRE, INC.
WO/2021/232019	STING AGONIST COMBINATION TREATMENTS WITH IMMUNE CHECKPOINT  INHIBITORS	IMMUNESENSOR THERAPEUTICS, INC.
WO/2021/236543	TREATMENT FOR AMYLOIDOSIS	RECURIUM IP HOLDINGS, LLC
WO/2021/236550	SYNTHETIC MODIFIED VACCINIA ANKARA (SMVA) BASED CORONAVIRUS  VACCINES	CITY OF HOPE
WO/2021/236570	PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS  ACTIVE METABOLITES FOR DRY POWDER INHALATION	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/236579	DELIVERY OF AMNIOTIC MEMBRANE COMPONENTS TO OCULAR EPITHELIA  FOR WOUND HEALING	ARLINGTON VISION, LLC
WO/2021/236581	GRANULES FOR 3D PRINTING TECHNOLOGY	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/236599	CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF	IONIS PHARMACEUTICALS, INC.
WO/2021/236606	TREATMENT OF ADJUSTMENT DISORDERS	VISTAGEN THERAPEUTICS, INC.
WO/2021/236607	SKIN CARE PRODUCT WITH PROTEIN MATRIX	EIGHTH DAY LABS, LLC
WO/2021/236614	TARGETED ANTIVIRAL DRUGS	NORTHWESTERN UNIVERSITY
WO/2021/236626	MUCORETENTIVE ANTIVIRAL TECHNOLOGIES	N-FOLD LLC
WO/2021/236629	UNIVERSAL MULTI-FUNCTIONAL GSH-RESPONSIVE SILICA NANOPARTICLES  FOR DELIVERY OF BIOMOLECULES INTO CELLS	WISCONSIN ALUMNI RESEARCH FOUNDATION
WO/2021/236636	MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE  AGAINST GRAM-POSITIVE BACTERIA	CONTRAFECT CORPORATION
WO/2021/236654	ANTI-CANCER SPIROCYCLIC-GUANIDINE COMPOUNDS AND USES THEREOF	THE JOHNS HOPKINS UNIVERSITY
WO/2021/236658	BINDING MOLECULES FOR THE TREATMENT OF CANCER	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/236671	LOW-DOSE CARBACHOL COMPOSITIONS AND METHODS FOR TREATMENT OF  NIGHT VISION DISTURBANCE	VYLUMA INC.
WO/2021/236672	COMPOSITIONS AND METHODS FOR PREVENTION OF CORONAVIRUS  INFECTION	UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
WO/2021/236685	METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF  PANCREATIC CANCER	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/236689	ORTHOGONALLY LINKED MULTIMERIC OLIGONUCLEOTIDES	MPEG LA, L.L.C.
WO/2021/236711	CALCINEURIN INHIBITOR TO IMPROVE CD3+CELL SURVIVAL TO THEREBY  FACILITATE ENGRAFTMENT OF DONOR CD34+ CELLS IN A RECIPIENT	MEDEOR THERAPEUTICS, INC.
WO/2021/236718	ANTI-FIBROTIC COMPOSITION AND RELATED METHODS	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/236748	CANNABIDIOL AND ACTIVE DELIVERY SYSTEMS	ELEMENTIS SPECIALTIES, INC.
WO/2021/236751	SELENIUM-BASED COMPOSITIONS AND THERAPEUTIC METHODS	HESS PHARMACEUTICALS, INC.
WO/2021/236779	COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN  DEHYDROGENASE ACTIVITY	RODEO THERAPEUTICS CORPORATION
WO/2021/236782	TOPICAL COMPOSITIONS AND METHODS FOR TREATING PAIN	MIG USA, LLC
WO/2021/236789	METHOD OF TREATING OBESITY-INDUCED GLUCOSE INTOLERANCE AND  LIVER FIBROSIS	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/236808	USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC  DISEASES	ARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/236811	USE OF TERPENOIDS IN THE TREATMENT OR PREVENTION OF FIBROTIC  DISEASES	ARJIL BIOTECH HOLDING COMPANY LIMITED
WO/2021/252157	ANTI-BDNF ANTIBODIES AND METHODS OF USE THEREOF	CRYSTAL BIOSCIENCE INC.
WO/2021/236820	METHODS AND COMPOSITIONS FOR TREATING ACUTE KIDNEY INJURY	CALCIMEDICA, INC.
WO/2021/236841	CONJUGATE POLYPEPTIDES AND VACCINES FOR INDUCING IMMUNE  RESPONSES	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/236845	METHOD FOR DETECTION OF ZIKA VIRUS SPECIFIC ANTIBODIES	TAKEDA VACCINES, INC.
WO/2021/236852	METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTIONS	SANA BIOTECHNOLOGY, INC.
WO/2021/236855	CIRCULAR RNA COMPOSITIONS AND METHODS	ORNA THERAPEUTICS, INC.
WO/2021/236859	SYNTHESIS OF FLUORINATED NUCLEOTIDES	MERCK SHARP & DOHME CORP.
WO/2021/236879	METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES WITH HISTATIN  PEPTIDES	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
WO/2021/236885	PIPERIDINE-2,6-DIONES AS SMALL MOLECULE DEGRADERS OF HELIOS  AND METHODS OF USE	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/236890	COMPOSITIONS AND METHODS FOR ACTIVATING SIGNALING THROUGH THE  CB2 CANNABINOID RECEPTOR FOR TREATING AND PREVENTING LYSOSOMAL STORAGE  DISEASES AND DISORDERS	WYLDER NATION FOUNDATION
WO/2021/236891	GUT-TARGETED PHOSPHODIESTERASE INHIBITORS	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
WO/2021/236922	ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS	WAYNE STATE UNIVERSITY
WO/2021/236927	SILICONE-FREE CONDITIONING CLEANSING COMPOSITION	MANHATTAN COLLEGE
WO/2021/236930	IMMUNOGENIC COMPOSITIONS AND USES THEREOF	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/236935	COMPOSITIONS AND METHODS FOR TREATING LUNG INJURIES ASSOCIATED  WITH VIRAL INFECTIONS	QX THERAPEUTICS INC.
WO/2021/236938	COMPOSITIONS AND METHODS RELATING TO AGING SKIN	ALASTIN SKINCARE, INC.
WO/2021/236944	PHARMACEUTICAL COMPOSITIONS COMPRISING BICTEGRAVIR	GILEAD SCIENCES, INC.
WO/2021/236952	COMPOSITIONS AND METHODS FOR PRODUCING HUMAN POLYCLONAL  ANTIBODIES	FLAGSHIP PIONEERING, INC.
WO/2021/236958	COMPOSITIONS AND METHODS OF TREATMENT WITH GLUTATHIONE	AURO PHARMACEUTICALS, INC.
WO/2021/236980	CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/236985	METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH  ACTIVATORS OF TIE-2	AERPIO PHARMACEUTICALS, INC.
WO/2021/237022	COMPOSITIONS AND METHODS FOR TREATING BREAST CANCER	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/237039	COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF  GONADOTROPIN-RELEASING HORMONE (GNRH) ANTAGONISTS	VERU INC.
WO/2021/237048	MICRONEEDLE DEVICE FOR CONTROL OF THYROID HORMONE LEVELS	EQUILIBRATE THERAPEUTICS, LLC
WO/2021/237061	METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE	TRUSTEES OF BOSTON UNIVERSITY
WO/2021/242630	MAGNETO-ENDOSOMALYTIC THERAPY FOR CANCER	UNIVERSITY OF WASHINGTON
WO/2021/237084	METHYLENE BLUE STABILIZED MRNA COMPOSITIONS	MODERNATX, INC.
WO/2021/237096	DURABLE IMPLANTS AND MICROPARTICLES FOR LONG-TERM OCULAR  THERAPY	GRAYBUG VISION, INC.
WO/2021/237100	METHODS OF TARGETING EXTRACELLULAR VESICLES TO LUNG	CODIAK BIOSCIENCES, INC.
WO/2021/237109	COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS	TRAILHEAD BIOSYSTEMS INC.
WO/2021/237110	METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING  AN IL-4R INHIBITOR	REGENERON PHARMACEUTICALS, INC.
WO/2021/237121	SUBSTITUTED PYRIDINES	GOSSAMER BIO SERVICES, INC.
WO/2021/237124	SARS-COV-2 SPIKE PROTEIN PSEUDOTYPED VSV-DELTA G PARTICLES AND  USES THEREOF	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/242642	COMPOSITION FOR TREATING PAIN WHILE MINIMIZING THE RISK OF  OPIOID ADDICTION	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/237143	TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)	DURECT CORPORATION
WO/2021/237145	COMPOSITION FOR SUNSCREEN COSMETICS	FE:I BEAUTY TECH, INC.
WO/2021/237146	TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)	DURECT CORPORATION
WO/2021/237155	COMPOSITION FOR COSMETICS	FE:I BEAUTY TECH, INC.
WO/2021/237159	METHODS AND COMPOSITIONS TO TREAT VASCULAR LEAK	YALE UNIVERSITY
WO/2021/237174	COMPOSITIONS AND DEVICES FOR VACCINE RELEASE AND USES THEREOF	VAXESS TECHNOLOGIES, INC.
WO/2021/242649	TISSUE-MIMICKING MATERIAL FOR A MULTI-MODALITY IMAGING PHANTOM	ENDRA LIFE SCIENCES INC.
WO/2021/242650	THROMBOMODULIN DOMAIN 1 FOR TREATING EYE DISEASES ASSOCIATED  WITH PATHOLOGICAL OCULAR ANGIOGENESIS	WU, Hua-Lin
WO/2021/237193	USE OF NAD+ PRECURSORS, STING INHIBITORS, AND FXR AGONISTS FOR  INHIBITING SARS-COV-2 (COVID-19)-INDUCED CYTOKINE RELEASE	GEORGETOWN UNIVERSITY
WO/2021/247262	ADHESIVE MATERIAL WITH TRIGGERABLE ON-DEMAND DETACHMENT	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/242683	INHIBITION OF ARENAVIRUSES BY COMBINATIONS OF APPROVED  THERAPEUTIC DRUGS	UNIVERSITY OF WASHINGTON
WO/2021/237209	METAL-ORGANIC FRAMEWORKS DELIVER SMALL MOLECULES AND  BIOMACROMOLECULES FOR CANCER IMMUNOTHERAPY	THE UNIVERSITY OF CHICAGO
WO/2021/237213	ANTI-MYOCILIN OLF ANTIBODIES AND METHODS OF USE THEREOF	GEORGIA TECH RESEARCH CORPORATION
WO/2021/237214	COMPOSITIONS FOR TREATING ACNE AND DERMATOLOGICAL CONDITIONS	ILERA DERM LLC
WO/2021/242711	ADJUVANTED CONJUGATE OPIOID VACCINE	UNIVERSITY OF HOUSTON SYSTEM
WO/2021/242724	A NO MALODOR HAIR PERM FORMULATION AND METHOD OF USE	CALI-CURL, LLC
WO/2021/242728	METHODS OF TREATING CERVICAL CANCER BY ADMINISTERING THE PD-1  INHIBITOR ANTIBODY CEMIPLIMAB	REGENERON PHARMACEUTICALS, INC.
WO/2021/257252	COMPOSITION FOR TREATING VIRAL INFECTIONS	HOFLEITNER, Peter
WO/2021/242751	COMPOSITIONS AND METHODS FOR TREATING SARS-COV-2	HU, Mickey
WO/2021/242752	METHODS OF CONTROLLING ACUTE INFLAMMATORY RESPONSE	ENDOCYTE, INC.
WO/2021/242753	MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF  ASSOCIATED DISEASES	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/242757	MONOCOLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS  USING SAME	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/242758	IMPROVED NITRO-FATTY ACID ORAL DOSE REGIMENS	IMARA INC.
WO/2021/242760	METHODS OF TREATING VIRAL INFECTION USING PROTEASE INHIBITORS	LOWELL THERAPEUTICS, INC.
WO/2021/247293	METHODS AND PHARMACEUTICAL PREPARATIONS FOR ELEVATING KETONE  UTILIZATION	GLYKON TECHNOLOGIES GROUP, LLC
WO/2021/242788	METHODS AND COMPOSITIONS FOR TREATING RETINAL DISEASES AND  CONDITIONS	LINEAGE CELL THERAPEUTICS, INC.
WO/2021/242798	SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES  THEREOF	SYNLOGIC OPERATING COMPANY, INC.
WO/2021/242808	CANNABINOID COMPOSITIONS AND DOSAGE FORMS FOR INTRANASAL OR  INHALATIONAL DELIVERY	RHODES TECHNOLOGIES
WO/2021/242821	COMPOSITIONS AND METHODS FOR TREATING MORPHINE, HEROIN, AND  ALCOHOL DEPENDENCE	BEHNAM, Babak
WO/2021/242823	Compositions and Methods for Treating Cocaine, Nicotine, and  Methamphetamine Dependence	BEHNAM, Babak
WO/2021/242826	COMPOSITIONS AND METHODS FOR TRANSDIFFERENTIATING CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/242838	COMPOSITIONS COMPRISING PERSONAL CARE PRODUCTS AND RELATED  METHODS	ONE FUN COMPANY, INC.
WO/2021/242848	ANTI-GD2 SADA CONJUGATES AND USES THEREOF	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/242849	ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  USING SAME	THE ROCKEFELLER UNIVERSITY
WO/2021/242850	COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING  SARS-COV-2 INFECTION	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/242859	COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID  LEUKEMIAS TO CHEMOTHERAPY	DUKE UNIVERSITY
WO/2021/242883	SYNTHETIC OLIGONUCLEOTIDES HAVING REGIONS OF BLOCK AND CLUSTER  MODIFICATIONS	UNIVERSITY OF MASSACHUSETTS
WO/2021/242896	NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL  ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING	UNM RAINFOREST INNOVATIONS
WO/2021/242905	CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR  MODULATOR RELACORILANT AND CYP2C8 SUBSTRATES	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/242912	CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR  MODULATOR RELACORILANT AND PACLITAXEL, A DUAL SUBSTRATE OF CYP2C8 AND CYP3A4	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/242913	FORMULATIONS AND METHODS FOR TREATING ERECTILE DYSFUNCTION	STRATEGIC DRUG SOLUTIONS, INC.
WO/2021/242916	CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR  MODULATOR RELACORILANT AND CYP2C9 SUBSTRATES	CORCEPT THERAPEUTICS INCORPORATED
WO/2021/242917	TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY  DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS	GEORGETOWN UNIVERSITY
WO/2021/242923	TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES  THEREOF	AXIAL THERAPEUTICS, INC.
WO/2021/242935	ANTIGEN PRESENTING POLYPEPTIDE COMPLEXES AND METHODS OF USE  THEREOF	CUE BIOPHARMA, INC.
WO/2021/242937	ANTIGEN PRESENTING POLYPEPTIDE COMPLEXES AND METHODS OF USE  THEREOF	CUE BIOPHARMA, INC.
WO/2021/242942	PROCESS FOR REDUCING HAIR DAMAGE UPON EXPOSURE TO HEAT	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/242945	GLUCOSYL ESTERS FOR INFECTION SCREENING	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/242961	HUMAN MONOCLONAL ANTIBODIES TO VENEZUELAN EQUINE ENCEPHALITIS  VIRUS AND USES THEREFOR	VANDERBILT UNIVERSITY
WO/2021/242970	METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING  3,3'-DIINDOLYLMETHANE	BOULDER BIOSCIENCE LLC
WO/2021/242976	FUNCTIONAL SKIN COATING POLYMER	THE JOHNS HOPKINS UNIVERSITY
WO/2021/242988	AIRWAY MEDICAMENTS	TRENCH THERAPEUTICS, INC.
WO/2021/243007	COMPOSITIONS AND METHODS FOR TREATING ACUTE RESPIRATORY  DISTRESS SYNDROME (ARDS) AND INFLAMMATORY DISORDERS CAUSED BY CORONAVIRUSES	PHOR-MED, INC.
WO/2021/247360	PARENTERAL NUTRITION FORMULATION	BAXTER INTERNATIONAL INC.
WO/2021/243015	ANTIBACTERIAL COMPOUNDS	THE PENN STATE RESEARCH FOUNDATION
WO/2021/243023	METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF  SERPINA1	KORRO BIO, INC.
WO/2021/243028	BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/243031	COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL ARTERY  DISEASE	INOZYME PHARMA, INC.
WO/2021/247367	COMPOUNDS AND COMPOSITIONS FOR TREATING, AMELIORATING, AND/OR  PREVENTING SARS-COV-2 INFECTION AND/OR COMPLICATIONS THEREOF	YALE UNIVERSITY
WO/2021/243041	PRINTING DROPLETS CONTAINING BIOLOGICAL MATERIAL	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/243054	COMPOSITIONS AND METHODS FOR INHIBITING VASCULAR SMOOTH MUSCLE  CELL PROLIFERATION	INOZYME PHARMA, INC.
WO/2021/243055	PHOTOCURABLE RESIN FOR HIGH-RESOLUTION 3-D PRINTING	UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF  VETERANS AFFAIRS
WO/2021/243060	USE OF EZH2 INHIBITORS FOR TREATING CANCER	EPIZYME, INC.
WO/2021/243081	COMPOSITIONS AND METHODS FOR TREATING COVID-19 INFECTIONS	APIQUEST USA, INC
WO/2021/243093	METHODS AND COMPOSITIONS FOR TREATING AND RECOVERING FORM  VIRAL INFECTIONS	IMMUNOFLEX THERAPEUTICS INC.
WO/2021/243118	INHIBITORS OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME  VIRUS	UNIVERSITY OF CONNECTICUT
WO/2021/243123	METHODS OF TREATING HER2 POSITIVE CANCER WITH TUCATINIB IN  COMBINATION WITH TRASTUZUMAB AND AN OXALIPLATIN-BASED CHEMOTHERAPY	SEAGEN INC.
WO/2021/243136	METHODS AND COMPOSITIONS FOR TREATING, PREVENTING THE ONSET  AND/OR SLOWING PROGRESSION OF OSTEOARTHRITIS	NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED,  MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY
WO/2021/243148	METHODS AND COMPOSITIONS FOR TREATING ALCOHOLIC LIVER DISEASE	VANDERBILT UNIVERSITY
WO/2021/243157	REMDESIVIR TREATMENT METHODS	GILEAD SCIENCES, INC.
WO/2021/243162	USE OF RIGOSERTIB TO TREAT RNA VIRUS INFECTIONS	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/247396	COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND  PROTECTION OF NORMAL HEMATOPOIESIS	MAGNANI, John L.
WO/2021/243171	METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES	AMO PHARMA LTD
WO/2021/243172	ENCAPSULATED RNA REPLICONS AND METHODS OF USE	ONCORUS, INC.
WO/2021/243182	DEVICES COMPRISING HYALURONIC ACID AND SILK FIBROIN	UNIVERSITY OF MONTANA
WO/2021/243183	FORMULATIONS AND METHODS FOR TREATING ACUTE RESPIRATORY  DISTRESS SYNDROME, ASTHMA, OR ALLERGIC RHINITIS	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/243186	PRALSETINIB PHARMACEUTICAL COMPOSITIONS	BLUEPRINT MEDICINES CORPORATION
WO/2021/243188	POWDERIZED CANNABIS OIL	HEMP SYNERGISTICS
WO/2021/247412	MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE	NEW YORK UNIVERSITY
WO/2021/243201	TOPICAL COMPOSITIONS FOR TREATING PERIPHERAL NEUROPATHIC PAIN	THE UNIVERSITY OF MISSISSIPPI
WO/2021/243204	ANTI-CD200R1 ANTIBODIES AND METHODS OF USE THEREOF	23ANDME, INC.
WO/2021/243207	USE OF MRNAS ENCODING OX40L, IL-23 AND IL-36GAMMA FOR TREATING  CANCER	MODERNATX, INC.
WO/2021/243210	METHOD OF REDUCING ENVIRONMENTAL METHYLMERCURY AND LIMITING  ITS UPTAKE INTO PLANTS AND ORGANISMS	ALBEMARLE CORPORATION
WO/2021/243226	METHODS FOR THE TREATMENT OF INFANTILE SPASMS USING MEDIUM  CHAIN TRIGLYCERIDES	CERECIN INC.
WO/2021/247423	ABCG2 EFFLUX PUMP-CANCER ANTIGEN MULTI-SPECIFIC ANTIBODIES AND  COMPOSITIONS, REAGENTS, KITS AND METHODS RELATED THERETO	KENJOCKETY BIOTECHNOLOGY, INC.
WO/2021/243256	RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR DUAL CELL  AGGREGATES AND METHODS OF USE THEREOF	FUJIFILM CELLULAR DYNAMICS, INC.
WO/2021/243259	HAIR GROWTH COMPOSITIONS	WALLER, Edmund
WO/2021/247426	ANTI-ABCG2 ANTIBODIES AND USES THEREOF	KENJOCKETY BIOTECHNOLOGY, INC.
WO/2021/243270	DEVICES, SYSTEMS, AND METHODS FOR FACILITATING TISSUE DELIVERY  OF DRUG	GEORGIA TECH RESEARCH CORPORATION
WO/2021/243273	BACTERIAL EFFLUX PUMP INHIBITORS	TAXIS PHARMACEUTICALS, INC.
WO/2021/247430	COMBINATION THERAPIES COMPRISING A HYPOMETHYLATION AGENT FOR  TREATING CANCER	ALX ONCOLOGY INC.
WO/2021/243280	METHODS OF TREATING CANCER IN PATIENTS WITH AN ANOMALOUS KRAS  GENE OR DELETIONS WITHIN CHROMOSOME 9	SYROS PHARMACEUTICALS, INC.
WO/2021/243284	ANTIBODY FORMULATIONS AND USES THEREOF	AMGEN INC.
WO/2021/243295	IDENTIFICATION OF HLA-RESTRICTED PRAME PEPTIDE EPITOPES,  PRAME-SPECIFIC T CELLS SUITABLE FOR "OFF-THE-SHELF" TREATMENT OF  CANCER EXPRESSING PRAME	CHILDREN'S NATIONAL MEDICAL CENTER
WO/2021/243298	METHODS OF TREATING IGA NEPHROPATHY WITH AN APRIL BINDING  ANTIBODY	CHINOOK THERAPEUTICS, INC.
WO/2021/243309	PARENTERAL DELIVERY OF AVIZAFONE	SOLLIEVO PHARMACEUTICALS, INC
WO/2021/247447	ANTIVIRAL COMPOSITIONS	KLELE, Luke
WO/2021/247454	METHODS AND TREATMENT INVOLVING ANTIBODIES TO IL-18	AVALO THERAPEUTICS, INC.
WO/2021/243319	BIARYLSULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF,  AND THEIR USE FOR TREATING FIBROTIC LUNG DISEASE	NOVOMEDIX, LLC
WO/2021/247463	FORMULATION OF MONODISPERSE KINETICALLY FROZEN POLYMER  MICELLES VIA EQUILIBRATION-NANOPRECIPITATION	PURDUE RESEARCH FOUNDATION
WO/2021/247473	METHODS OF TREATMENT USING ICAM-MODULATING AGENTS	AVM BIOTECHNOLOGY, LLC
WO/2021/247476	MATERIALS AND METHODS FOR VIRAL PURIFICATION	JANSSEN BIOTECH, INC.
WO/2021/247480	ENGINEERED MICROORGANISMS FOR DIAGNOSTIC IMAGING	SANARX BIOTHERAPEUTICS, INC.
WO/2021/247487	RECOMBINANT FUSION PROTEINS TARGETING P-SELECTIN, AND METHODS  OF USE THEREOF FOR TREATING DISEASES AND DISORDERS	MEDICAL UNIVERSITY OF SOUTH CAROLINA
WO/2021/247495	LOW-pH SKIN CARE COMPOSITION AND METHODS OF USING THE SAME	THE PROCTER & GAMBLE COMPANY
WO/2021/247496	METHOD OF IMPROVING PENETRATION OF A VITAMIN B3 COMPOUND INTO  SKIN	THE PROCTER & GAMBLE COMPANY
WO/2021/247497	COMPOSITIONS AND METHODS COMPRISING R-SPONDINS FOR TREATMENT  OF TUMORS	CHILDREN'S HOSPITAL MEDICAL CENTER
WO/2021/247499	USE OF A COMBINATION OF COLCHICINE AND A CXCR-2 INHIBITOR FOR  THE TREATMENT OR PREVENTION OF FAMILIAL MEDITERRANEAN FEVER (FMF) AND  FLARE-UPS THEREOF	ARISTEA THERAPEUTICS, INC.
WO/2021/247512	METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY	MERCK PATENT GMBH
WO/2021/243328	METHODS OF USING HSV-2 SINGLE CYCLE VIRUS DELTA-GD AND HSV-2  RECOMBINANT GLYCOPROTEIN D	ALBERT EINSTEIN COLLEGE OF MEDICINE
WO/2021/257273	TLR7/8 ANTAGONISTS AND USES THEREOF	MERCK PATENT GMBH
WO/2021/247535	LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING  GLUCOSE-6-PHOSPHATASE AND USES THEREOF	MODERNATX, INC.
WO/2021/247537	METAL DI-AMINO ACID CHELATES OR METAL TRI-AMINO ACID CHELATES	BALCHEM CORPORATION
WO/2021/247540	METHODS FOR MODULATING MHC-I EXPRESSION AND IMMUNOTHERAPY USES  THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/247542	PHARMACEUTICAL COMPOSITIONS COMPRISING INSOLUBLE ACTIVE  INGREDIENTS	ADVENT THERAPEUTICS, INC.
WO/2021/247567	CORONAVIRUS VACCINE CONSTRUCTS AND METHODS OF MAKING AND USING  SAME	WASHINGTON UNIVERSITY
WO/2021/247571	VAGINAL MICROBIOTA COMPOSITIONS	FERRING B.V.
WO/2021/247594	DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC	BUCK INSTITUTE FOR RESEARCH ON AGING
WO/2021/247601	METHODS AND COMPOSITIONS FOR TREATING RNA VIRAL INFECTIONS	MODEL MEDICINES, INC.
WO/2021/247604	METHODS OF TREATING AGING-RELATED DISORDERS	HCW BIOLOGICS, INC.
WO/2021/247606	NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS  UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS	KSQ THERAPEUTICS, INC.
WO/2021/247620	USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS	VANDERBILT UNIVERSITY
WO/2021/247632	SYSTEMS AND METHODS FOR TREATING CANCER	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/247634	INHIBITORS OF TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD)  AND USES THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/247635	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH LEVOCABASTINE, A SELECTIVE HISTAMINE H1-RECEPTOR ANTAGONIST, AND  DERIVATIVES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/247647	SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE	HAMDAN, Mohamed Hussein
WO/2021/247652	FORMULATIONS AND METHODS FOR TREATING DIARRHEA	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/247690	RHO KINASE INHIBITOR RELEASING IMPLANTS AND RELATED METHODS OF  USE	GLAUKOS CORPORATION
WO/2021/247703	MAMMALIAN MILK OLIGOSACCHARIDES PREVENT VIRAL INFECTION OF  HUMAN EPITHELIUM	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247714	COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING  COMPLEX AND HORMONE THERAPY AGENT	GALERA LABS, LLC
WO/2021/247718	ANTAGONISTIC BIPARATOPIC ANTIBODIES THAT SPECIFICALLY BIND  FIBROBLAST GROWTH FACTOR RECEPTOR 2 AND METHODS OF USING SAME	THE BROAD INSTITUTE, INC.
WO/2021/247724	FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT	FAETH THERAPEUTICS, INC.
WO/2021/247743	AUTOLOGOUS DENDRITIC CELL VACCINE KIT AND USES	AIVITA BIOMEDICAL, INC.
WO/2021/247748	KINASE INHIBITORS	GB005, INC.
WO/2021/247756	RECOMBINANT HUMAN CC10 PROTEIN FOR TREATMENT OF INFLUENZA,  EBOLA, AND CORONAVIRUS	APC RESEARCH ASSETS LLC
WO/2021/247758	1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME  FOR USE IN THE PREVENTION AND TREATMENT OF CANCER	ARTEMIFLOW GMBH
WO/2021/247769	ANTI-CD93 CONSTRUCTS AND USES THEREOF	DYNAMICURE BIOTECHNOLOGY LLC
WO/2021/247776	BIOLOGICALLY ACTIVE COMPOSITIONS AND METHODS OF USING	MEDIWEL LABS, LLC
WO/2021/247798	BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1  AND USES THEREOF	MERCK PATENT GMBH
WO/2021/247805	HUMANIZED ANTIBODIES DIRECTED AGAINST KCNK9	THE JOHNS HOPKINS UNIVERSITY
WO/2021/252254	NOVEL PREVENTIVE AND THERAPEUTIC TREATMENT FOR COVID 19 AND  ANY OTHER DISEASE CAUSED BY SARS COV 2	AMCYTE PHARMA, INC
WO/2021/247809	PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF USE  THEREOF FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISORDERS	MERCK SHARP & DOHME CORP.
WO/2021/247821	MONOCLONAL ANTIBODIES AGAINST HUMAN SIGLEC-9 AND USE THEREOF  FOR IMMUNOTHERAPY	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/247824	PROFRAGRANCE CONJUGATES	INTERNATIONAL FLAVORS & FRAGRANCES INC.
WO/2021/252261	COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION	WASHINGTON UNIVERSITY
WO/2021/247836	METHODS FOR TARGETING SHP-2 TO OVERCOME RESISTANCE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/247838	FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONENT AND A  NON-ODOROUS FRAGRANCE MODULATOR	COTY INC.
WO/2021/247841	PURINES AND METHODS OF THEIR USE	YUMANITY THERAPEUTICS, INC.
WO/2021/247845	QUINAZOLINE-DERIVED HCK INHIBITORS FOR USE IN THE TREATMENT OF  MYD88 MUTATED DISEASES	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/247862	BICYCLIC HETEROARENES AND METHODS OF THEIR USE	YUMANITY THERAPEUTICS, INC.
WO/2021/247880	SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL  INFECTIONS	APTINYX INC.
WO/2021/247889	INHIBITION OF BMI1 ELIMINATES CANCER STEM CELLS AND ACTIVATES  ANTITUMOR IMMUNITY	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247890	ZONAL AND TARGETED METHODS AND USES FOR TREATING A MIGRAINE  DISORDER	MIOTOX, LLC
WO/2021/247895	METHODS AND ANTIBODIES IN TREATMENT OF FOCAL SEGMENTAL  GLOMERULOSCLEROSIS (FSGS)	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/247897	DEUTERATED IRAK DEGRADERS AND USES THEREOF	KYMERA THERAPEUTICS, INC.
WO/2021/247899	CRYSTALLINE FORMS OF IRAK DEGRADERS	KYMERA THERAPEUTICS, INC.
WO/2021/247900	COMPOUNDS AND METHODS FOR THE TREATMENT OF EYE DISORDERS	OCCURX PTY. LTD.
WO/2021/247901	COMPOUNDS AND METHODS FOR THE TREATMENT OF EYE DISORDERS	OCCURX PTY. LTD.
WO/2021/247908	TROPHOBLAST CELL-SURFACE ANTIGEN-2 (TROP-2) ANTIBODIES	BIONECURE THERAPEUTICS, INC.
WO/2021/247921	BENZOTHIAZOLE COMPOUNDS AND USES THEREOF	YUMANITY THERAPEUTICS, INC.
WO/2021/247923	PERSONALIZED METHODS OF TREATING CANCER	FAETH THERAPEUTICS, INC.
WO/2021/247925	STRUCTURE-GUIDED IMMUNOTHERAPY AGAINST SARS-COV-2	VIR BIOTECHNOLOGY, INC.
WO/2021/247933	EXTRACTION TECHNIQUES TO PRESERVE CANNABINOID AND TERPENOID  PROFILES	CREDO SCIENCE, LLC
WO/2021/247934	FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST	CURASEN THERAPEUTICS, INC.
WO/2021/247963	(S)-ALPHA-FLUOROMETHYLTYROSINE AS DECARBOXYLASE INHIBITORS FOR  USE IN THE TREATMENT OF HYPOTENSION	SENDA BIOSCIENCES, INC.
WO/2021/247969	INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES	KINNATE BIOPHARMA INC.
WO/2021/247971	INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES	KINNATE BIOPHARMA INC.
WO/2021/247977	METHODS OF TREATING PROSTATE CANCER	CELGENE QUANTICEL RESEARCH, INC.
WO/2021/247978	ANTIBACTERIAL SYNTHETIC-BIOINFORMATIC NATURAL PRODUCTS AND  USES THEREOF	THE ROCKEFELLER UNIVERSITY
WO/2021/248001	SERUM BIOMARKERS FOR PREDICTING AND PREVENTING HEMORRHAGIC  STROKE	TEXAS TECH UNIVERSITY SYSTEM
WO/2021/248008	ARYLAMIDE COMPOUNDS FOR TREATMENT AND PREVENTION OF VIRAL  INFECTIONS	INNOVATION PHARMACEUTICALS INC.
WO/2021/248022	METHODS OF TREATING A CORONAVIRUS INFECTION	THE GENERAL HOSPITAL CORPORATION
WO/2021/248033	CADHERIN-11 INHIBITOR FORMULATION AND ITS USES IN  IMMUNOTHERAPY	GEORGETOWN UNIVERSITY
WO/2021/248052	COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA	THE BROAD INSTITUTE, INC.
WO/2021/252290	COMPOSITIONS AND METHODS FOR TREATING NOVEL CORONAVIRUS  SARS-COV-2-MEDIATED INFLAMMATORY CONDITIONS	GRI BIO, INC.
WO/2021/248061	NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS	CARISMA THERAPEUTICS INC.
WO/2021/248081	ACVR1 (ALK2) RECEPTOR INHIBITION TO TREAT NEUROLOGICAL  DISEASES	THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST  ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE
WO/2021/248086	LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/248093	DACLATASVIR FOR USE IN TREATING LUNG AND PROSTATE CANCER	HENRY FORD HEALTH SYSTEM
WO/2021/252307	RIPK1 INHIBITORS AND METHODS OF USE	MERCK SHARP & DOHME CORP.
WO/2021/252309	CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-  CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL} -ACETIC ACID AND AND USES THEREOF	VTV THERAPEUTICS LLC
WO/2021/252311	SALTS OR CO-CRYSTALS OF  {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC  ACID AND USES THEREOF	VTV THERAPEUTICS LLC
WO/2021/252314	METHODS OF TREATING FEMALE HEALTH CONDITIONS RELATED TO SEX  HORMONES	ELIEM THERAPEUTICS, INC.
WO/2021/252316	GRANULAR COMPOSITION OF AN ERK INHIBITOR AND USES THEREOF	MERCK SHARP & DOHME CORP.
WO/2021/248109	DYNAMICALLY CROSSLINKED INJECTABLE HYDROGELS WITH CHEMICALLY  STABILIZED MULTILAMELLAR VESICLES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY  OFFICE OF THE GENERAL COUNSEL
WO/2021/248111	MATERIALS AND METHODS FOR INHIBITING A VIRAL INFECTION,  INCLUDING A CORONAVIRUS INFECTION	QUORUM INNOVATIONS, LLC
WO/2021/252323	DESIGNED ANTIBODY-BOUND NANOPARTICLES	UNIVERSITY OF WASHINGTON
WO/2021/252327	ANTIBODY-BOUND NANOPARTICLES	UNIVERSITY OF WASHINGTON
WO/2021/252347	THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMS	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/252358	ANTI-CD171 CHIMERIC ANTIGEN RECEPTORS	SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH  INSTITUTE)
WO/2021/248122	COATED DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME	APPLIED MATERIALS, INC.
WO/2021/252371	USE OF ATOVAQUONE AND PROGUANIL FOR TREATMENT OF  GASTROINTESTINAL DISEASES AND INFLAMMATION	ELEVAID THERAPEUTICS, INC.
WO/2021/252373	TREATMENT OF CYSTINOSIS	NACUITY PHARMACEUTICALS, INC.
WO/2021/257314	METHOD OF TREATING DIFFICULT TO ACCESS TUMORS WITH  PHOTOACTIVATED CANCER THERAPY	IMMUNOLIGHT, LLC
WO/2021/252378	PREVENTION OR TREATMENT OF COVID-19	NACUITY PHARMACEUTICALS, INC.
WO/2021/252382	THERAPEUTIC CARBON NANOMATERIAL H2S OXIDANTS FOR BIOLOGICAL  POLYSULFIDE SYNTHESIS	THE TEXAS A&M UNIVERSITY SYSTEM
WO/2021/248133	ANTI-TRANSFERRIN EXTRACELLULAR VESICLES	CODIAK BIOSCIENCES, INC.
WO/2021/248134	COMPOSITIONS AND METHODS FOR TREATING LONG COVID	AIM IMMUNO TECH INC.
WO/2021/252421	METHODS OF TREATING VISUAL DISORDERS USING DAILY LOW DOSING OF  A RETINOID COMPOUND	RETINAGENIX HOLDINGS LLC
WO/2021/252422	USE OF CXCL13 BINDING MOLECULES TO PROMOTE PERIPHERAL NERVE  REGENERATION	VACCINEX, INC.
WO/2021/252426	COLORED COSMETIC SOLID DISPERSIONS	SUN CHEMICAL CORPORATION
WO/2021/252432	COMPOSITIONS AND METHODS FOR DELIVERING POLYNUCLEOTIDES	NEONC TECHNOLOGIES, INC.
WO/2021/252448	IMAGING COMPOUNDS SELECTIVE FOR NAV1.7	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/252449	STERILIZED FORMULATIONS	HARM REDUCTION THERAPEUTICS, INC.
WO/2021/252450	PHAGE DISPLAY VACCINE FOR COVID-19 USING A NOVEL PEPTIDE  SEQUENCE	ADAPTIVE PHAGE THERAPEUTICS, INC.
WO/2021/252455	ANTI-TGFβ ANTIBODIES AND THERAPEUTIC USES THEREOF	ZOETIS SERVICES LLC
WO/2021/252459	USE OF CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS TO  DEACTIVATE CORONAVIRUS	SAVAGE, Paul B.
WO/2021/262430	LONG WEAR LIP COSMETIC SYSTEM AND TOPCOAT	L'OREAL
WO/2021/252484	COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND  METHODS OF USE AND MAKING THEREOF	DISRUPTION LABS INC.
WO/2021/252496	ENGINEERED ADENOVIRUS VECTORS AND USES THEREOF	LOWENTHAL, Richard
WO/2021/252505	ARYLACETAMIDE ANALOGS OF  PIPERAZINE-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINES	UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE
WO/2021/252507	THERMOGEL SUSTAINED-RELEASE MICROPARTICLE-BASED DELIVERY TO A  PARANASAL AND/OR NASAL CAVITY	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/252513	USES OF HYALURONAN CONJUGATE	AIHOL CORPORATION
WO/2021/252517	ENGINEERED T CELL RECEPTORS AND METHODS OF USE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/252519	MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF  CANCER	UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
WO/2021/262437	USE OF IL13 FOR PREVENTION AND TREATMENT OF COVID-19	DESAI, Ketan
WO/2021/252566	REAGENT STRIP COUNTERFEIT PROTECTION	SIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/252577	PHARMACEUTICAL FORMULATION CONTAINING UMECLIDINIUM BROMIDE AND  VILANTEROL TRIFENATATE	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/252581	DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A  BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING β-GLUCAN AS A VACCINE  ADJUVANT	MEMORIAL SLOAN KETTERING CANCER CENTER
WO/2021/252583	SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF  MACROMOLECULAR DRUG DELIVERY PLATFORM	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/252586	PHARMACEUTICAL FORMULATION CONTAINING GLYCOPYRROLATE AND  INDACATEROL MALEATE	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262439	REDUCED GLYCOL FATTY ALCOHOL ETHOXYLATES AND REDUCED GLYCOL  SULFATE ETHOXY LATED|SURFACTANTS	THE PROCTER & GAMBLE COMPANY
WO/2021/252604	CORONAVIRUS DISEASE 2019 (COVID-19) COMBINATION VACCINE	THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
WO/2021/252612	UNDENATURED TYPE II COLLAGEN AS A SUPPLEMENT FOR IMPROVED  ENDURANCE, LIPID METABOLISM, AND OXIDATIVE STRESS	LONZA CONSUMER HEALTH INC.
WO/2021/252618	METHODS AND MATCHA GREEN TEA CONTAINING COMPOSITIONS FOR  PREVENTING AND TREATING TOOTH EROSION	UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
WO/2021/252626	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH FENOTEROL HYDROBROMIDE, A β2- ADRENERGIC RECEPTOR AGONIST, AND  DERIVATIVES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252628	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH TRICHOSTATIN A, A HISTONE DEACETYLASE (HDAC) INHIBITOR, AND DERIVATIVES  THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252630	METHODS FOR TREATING OR PREVENTING CHRONIC KIDNEY DISEASE	ARTHROSI THERAPEUTICS, INC.
WO/2021/252632	PHYSIOLOGICALLY ACCEPTABLE COMPOSITIONS CONTAINING  MICROORGANISMS OR MICROBIAL PRODUCTS	FLAGSHIP PIONEERING, INC.
WO/2021/252634	DEUTERATED PROTEASE INHIBITORS	KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
WO/2021/252636	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH FINGOLIMOD, A SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, AND  DERIVATIVES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252647	METHODS OF IMPROVING RETINA-ASSOCIATED DISEASE OUTCOME USING  CCR3-INHIBITORS	ALKAHEST INC.
WO/2021/252650	HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/252654	CELL/GENE THERAPIES TARGETING MAGE-A4 PEPTIDE	INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
WO/2021/252659	MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE	VECTIVBIO AG
WO/2021/252661	ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/252664	GRANZYME B DIRECTED IMAGING AND THERAPY	CYTOSITE BIOPHARMA INC.
WO/2021/252669	CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL  ADRENAL HYPERPLASIA	NEUROCRINE BIOSCIENCES, INC.
WO/2021/252685	BLOOD IRRADIATION DEVICE AND METHODS FOR TREATING VIRAL  INFECTIONS USING SAME	ASCEPI MEDICAL GROUP, LLC
WO/2021/257353	PLASMA KALLIKREIN INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/252708	STABILIZED TRIOXACARCIN ANTIBODY DRUG CONJUGATES AND USES  THEREOF	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/252709	COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING,  AMELIORATING, AND/OR PREVENTING SIGMA RECEPTOR RELATED DISEASES AND/OR  DISORDERS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/257356	METHODS FOR TESTING ANDEXANET POTENCY	ALEXION PHARMACEUTICALS, INC.
WO/2021/252717	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH BERBERINE, A BERBERIDACEAEN ALKALOID, AND DERIVATIVES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252718	TLR7 INHIBITOR IN COMBINATION WITH PREDNISOLONE OR  HYDROXYCHLOROQUINE FOR TREATING CUTANEOUS LUPUS ERYTHEMATOSUS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/252719	METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA  WITH S-METHYL-L-THIOCITRULLINE, A SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE  (NNOS) INHIBITOR, AND DERIVATIVES THEREOF	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
WO/2021/252741	OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS  OF USE THEREOF	AUSPEX PHARMACEUTICALS, INC.
WO/2021/252745	METHOD FOR TREATING OR MITIGATING PARKINSON'S DISEASE USING  NICOTINE INHALER OR NICOTINE NASAL SPRAY	HOWARD UNIVERSITY
WO/2021/252760	SWINE ORIGIN PROBIOTICS THAT PROMOTE HEALTH AND GROWTH  PERFORMANCE IN PIGS	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
WO/2021/252761	MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS  CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,  DEPARTMENT OF HEALTH AND HUMAN SERVICES
WO/2021/252769	PH-RESPONSIVE LIPIDOID NANOPARTICLES FOR INTRACELLULAR MRNA  DELIVERY	TRUSTEES OF TUFTS COLLEGE
WO/2021/252776	COMBINATION THERAPIES	MEI PHARMA, INC.
WO/2021/252786	EFFECTIVE TEETH WHITENING COMPOSITION UTILIZING BROMELAIN  ENZYMES	AMARILLO JUNIOR COLLEGE DISTRICT
WO/2021/252793	3D LASER SINTERING PROCESSES FOR IMPROVED DRUG DELIVERY	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/252803	NANOLIPOPROTEIN-POLYPEPTIDE CONJUGATES AND COMPOSITIONS,  SYSTEMS, AND METHODS USING SAME	GENENTECH, INC.
WO/2021/252818	CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS	AMGEN INC.
WO/2021/252821	ENHANCED IMMUNOGENIC DNA/RNA COMPOSITIONS AND METHODS	MBF THERAPEUTICS INC.
WO/2021/252838	COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS  USING <i>FOURNIERELLA MASSILIENSIS</i>	EVELO BIOSCIENCES, INC.
WO/2021/252844	SYSTEMS, DEVICES, COMPOSITIONS, AND METHODS FOR TREATING  DIABETES	ABVANCE THERAPEUTICS INC.
WO/2021/252861	COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS  USING <i>MEGASPHAERA SP</i>	EVELO BIOSCIENCES, INC.
WO/2021/252874	XPO1 INHIBITORS FOR USE IN TREATING CANCER	KARYOPHARM THERAPEUTICS INC.
WO/2021/252877	COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS  USING OSCILLOSPIRACEAE MICROBIAL EXTRACELLULAR VESICLES	EVELO BIOSCIENCES, INC.
WO/2021/252881	ENGINEERED PROBES FOR SIALOGLYCAN BINDING	VANDERBILT UNIVERSITY
WO/2021/257398	COMPOSITIONS AND METHODS FOR OVERCOMING  MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING	MAGNANI, John L.
WO/2021/252889	NANOSPHERE SIZE CONTROL BY VARYING THE RATIO OF COPOLYMER  BLENDS	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/252895	COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF  NEUROLOGICAL DISORDERS	YUMANITY THERAPEUTICS, INC.
WO/2021/252896	METHODS AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTIOUS  DISEASE	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/252900	BIOMARKERS FOR RESPONSE TO EXPORTIN-1 INHIBITORS IN MULTIPLE  MYELOMA PATIENTS	KARYOPHARM THERAPEUTICS INC.
WO/2021/252904	RIBONUCLEOPROTEIN APPROACH TO BOOST THE STING SIGNALING FOR  CANCER IMMUNOTHERAPY	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/252905	BIOMARKERS FOR RESPONSE TO EXPORTIN-1 INHIBITORS IN DIFFUSE  LARGE B-CELL LYMPHOMA PATIENTS	KARYOPHARM THERAPEUTICS INC.
WO/2021/252910	C-TYPE NATRIURETIC PEPTIDES AND METHODS THEREOF IN TREATING  ACUTE LUNG INJURY	PHARMAIN CORPORATION
WO/2021/252915	GASDERMIN D (GSDMD) SUCCINATION FOR THE TREATMENT OF  INFLAMMATORY DISEASE	UNIVERSITY OF MASSACHUSETTS
WO/2021/252924	ARRDC1-MEDIATED MICROVESICLE-BASED DELIVERY TO THE NERVOUS  SYSTEM	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/252931	C-TYPE NATRIURETIC PEPTIDES AND METHODS THEREOF IN TREATING  CANCER	PHARMAIN CORPORATION
WO/2021/252936	REJUVENATION OF AGED TISSUES AND ORGANS BY INHIBITION OF THE  PGE2 DEGRADING ENZYME, 15-PGDH	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/252950	T-TYPE CALCIUM CHANNEL ENHANCER FOR TREATING TAF1 ASSOCIATED  NEUROLOGICAL DEFECTS	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF  ARIZONA
WO/2021/252951	METHODS OF TREATMENT FOR GASTROINTESTINAL MOTILITY DISORDERS	VANDERBILT UNIVERSITY
WO/2021/252954	INACTIVATION OF GENOME ENVELOPED WITHIN CORONAVIRUS SPHERICAL  OR PLEOMORPHIC PARTICLES OR SHELLS TO FORM A VACCINE	SCHOSSAU, Tom M.
WO/2021/252957	CANNABINOID COMPLEXES AND METHODS OF MAKING AND USING THEM	TEST KITCHENS, INC.
WO/2021/252959	SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL  FIBRILLATION	HUYABIO INTERNATIONAL, LLC
WO/2021/252962	METHODS AND COMPOSITIONS FOR DELIVERING BIOACTIVE COMPOSITIONS  TO OCULAR TISSUE USING MICRONEEDLE DEVICES	AQUAVIT PHARMACEUTICALS, INC,
WO/2021/257409	COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASE	GENZYME CORPORATION
WO/2021/252970	GENETIC MODIFICATION	PETER BIOTHERAPEUTICS, INC.
WO/2021/252986	TLR7/8-MEDIATED TISSUE REPAIR BY REGULATORY T CELLS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/257418	2-OXO-OXAZOLIDINE-5-CARBOXAMIDES AS NAV1.8 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/257420	5-OXOPYRROLIDINE-3-CARBOXAMIDES AS NAV1.8 INHIBITORS	MERCK SHARP & DOHME CORP.
WO/2021/257456	TREATMENT OF ATRIAL DYSFUNCTION	MYOKARDIA, INC.
WO/2021/257461	COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR  ANTIBACTERIAL THERAPY	MYLAN LABORATORIES LIMITED
WO/2021/257466	COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR  ANTIBACTERIAL THERAPY	THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
WO/2021/253007	DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2  GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION	EMORY UNIVERSITY
WO/2021/253008	PARTIALLY DESULFATED HEPARIN FOR TREATING CORONAVIRAL  INFECTIONS	IHP THERAPEUTICS INC.
WO/2021/257479	DERMAL PATCHES AND GLASS SWABS FOR APPLICATION OF TOPICAL  IMMUNOSENSITIZERS	SQUAREX, LLC
WO/2021/257494	METHODS FOR MODULATING TLR4 SIGNALING	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/257500	METHODS AND COMPOSITIONS FOR TREATING MILD TRAUMATIC BRAIN  INJURY, POST-TRAUMATIC STRESS DISORDER AND MILD TRAUMATIC BRAIN INJURY WITH  POST TRAUMATIC STRESS DISORDER	LOBE SCIENCES LTD.
WO/2021/257503	METHODS AND COMPOSITIONS FOR TREATING TRIPLE-NEGATIVE BREAST  CANCER	GENENTECH, INC.
WO/2021/257510	MEASLES VIRUS VACCINE EXPRESSING SARS-COV-2 PROTEIN(S)	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/257522	SOLID STATE FORMS OF AVAPRITINIB SALTS	TEVA CZECH INDUSTRIES S.R.O
WO/2021/257523	USE OF ARGINASE FOR TREATMENT OF INFLUENZA INFECTIONS	AEGLEA BIOTHERAPEUTICS, INC.
WO/2021/257532	ALK2 INHIBITORS FOR THE TREATMENT OF ANEMIA	INCYTE CORPORATION
WO/2021/257533	MICROPARTICLES FOR CONTROLLED RELEASE OF EXTRACELLULAR  VESICLES AND METHODS FOR FABRICATING THE SAME	THE REGENTS OF THE UNIVERSITY OF MICHIGAN
WO/2021/257544	SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/257562	COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE  (HMB) AND CHEMOTHERAPY AGENTS	METABOLIC TECHNOLOGIES, LLC
WO/2021/257569	ANTI-VIRAL COMPOUNDS AND METHODS OF USE	METRO INTERNATIONAL BIOTECH, LLC
WO/2021/257574	TRI-SWITCH TECHNOLOGY FOR MULTI-DIMENSIONAL CONTROL OF CELL  THERAPY	KIROMIC BIOPHARMA INC.
WO/2021/257587	MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE  THEREOF	G1 THERAPEUTICS, INC.
WO/2021/257595	ADENO-ASSOCIATED VIRUS VECTOR DELIVERY FOR MUSCULAR  DYSTROPHIES	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
WO/2021/262484	COMBINATION THERAPY FOR TREATMENT OF CANCER	PMV PHARMACEUTICALS, INC.
WO/2021/257605	COMPOSITIONS AND METHODS RELATING TO ANTIVIRAL THERAPEUTICS	NORTH CAROLINA STATE UNIVERSITY
WO/2021/257607	TREATMENT FOR HUMAN CORONAVIRUS INFECTION	THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
WO/2021/257626	EXCIPIENTS PROVIDING STABILIZATION AND ENHANCED WATER  SOLUBILIZATION AND THEIR USES	NANOSYNTHONS LLC
WO/2021/257643	CRYSTALLINE FORMS OF A CD73 INHIBITOR AND USES THEREOF	ARCUS BIOSCIENCES, INC.
WO/2021/257655	ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE	ACCELERON PHARMA INC.
WO/2021/262498	METHODS AND MATERIALS FOR TREATING NON-MALIGNANT DISORDERS OR  DISEASES WITH CORD BLOOD	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF  HIGHER EDUCATION
WO/2021/257660	SMALL MOLECULE COVALENT ACTIVATORS OF UCP1	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/257668	COMPOSITIONS AND METHODS FOR TREATMENT OF GENE THERAPY  PATIENTS	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/257670	COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS	AMPLYX PHARMACEUTICALS, INC.
WO/2021/257673	METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR  DYSTROPHY	STEALTH BIOTHERAPEUTICS INC.
WO/2021/257678	COMPOSITIONS AND METHODS FOR REGULATING ENTEROENDOCRINE CELL  DIFFERENTIATION AND USES THEREOF	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/257696	ISOFORM-SPECIFIC ALDEHYDE DEHYDROGENASE INHIBITORS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257697	COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING  AUTOPHAGY	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/257700	METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER	MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO/2021/257706	RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND  IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF	BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
WO/2021/257723	COMPOSITION AND METHOD FOR NEW THERAPEUTIC AGENTS INCLUDING  GUANIDINIUM-PRESENTING DENDRIMERS AND BRANCHED STRUCTURES	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257736	METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED  RESISTANCE TO RAS INHIBITORS	REVOLUTION MEDICINES, INC.
WO/2021/257754	SMALL MOLECULE VE-PTP INHIBITORS	RIPKA, Amy
WO/2021/257781	COMPOSITIONS AND METHODS FOR TREATING COVID-19	VAST SEA BIOTECHNOLOGY, INC.
WO/2021/257784	INJECTABLE MELOXICAM FORMULATIONS	VERTé THERAPEUTICS, LLC
WO/2021/257788	METHODS FOR MANUFACTURING ADAS	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/257799	MESHED UMBILICAL CORD TISSUE GRAFTS	MIMEDX GROUP, INC.
WO/2021/257800	MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTAT	AKEBIA THERAPEUTICS, INC.
WO/2021/257802	COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/257803	ADAS COMPRISING BACTERIAL SECRETION SYSTEMS	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
WO/2021/257804	THYROMIMETICS	AUTOBAHN THERAPEUTICS, INC.
WO/2021/257806	IODIDE FOR TREATMENT OF NONTHYROIDAL ILLNESS SYNDROME	FRED HUTCHINSON CANCER RESEARCH CENTER
WO/2021/257812	PLURIPOTENT STEM CELL-DERIVED HEART ORGANOID	BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
WO/2021/257816	MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF  PATHOGEN-INDUCED LUNG INJURY	LUNG THERAPEUTICS, INC.
WO/2021/257832	PHARMACEUTICAL GRANULATIONS OF WATER-SOLUBLE ACTIVE  PHARMACEUTICAL INGREDIENTS	XWPHARMA LTD.
WO/2021/257841	CHIMERIC RSV AND CORONAVIRUS PROTEINS, IMMUNOGENIC  COMPOSITIONS, AND METHODS OF USE	MEISSA VACCINES, INC.
WO/2021/257842	SMARCA4 INHIBITION FOR THE TREATMENT OF CANCER	EPIZYME, INC.
WO/2021/257843	NON-PORCINE FORMULATIONS AND METHODS THEREOF	AZURRX BIOPHARMA, INC.
WO/2021/257880	USE OF ALDH MODULATORS OR GASDERMIN D INHIBITORS FOR  PREVENTION AND TREATMENT OF AGING AND AGING-RELATED DISORDERS AND FOR  BOOSTING AN IMMUNE SYSTEM	SPRING DISCOVERY, INC.
WO/2021/257884	VACCINES, VACCINE PRIMING, AND ANTIGEN DOSE SPARING	ADJUVANCE TECHNOLOGIES, INC.
WO/2021/257886	CONTROLLED RELEASE GRANULATIONS OF WATER-SOLUBLE ACTIVE  PHARMACEUTICAL INGREDIENTS	XWPHARMA LTD.
WO/2021/257887	USE OF INHIBITORS OF THE ACTIVATOR PROTEIN 1 (AP-1) FOR  PREVENTING ADHESIONS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/257888	TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS  THERAPEUTIC TARGETS FOR COVID-19	UNIVERSITY OF VIRGINIA PATENT FOUNDATION
WO/2021/257894	ANTI-BST2 ANTIBODIES TARGETING BST2 LONG ISOFORM	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/257899	METHODS FOR TREATING HEMOPHILIA A AND POPULATION  PHARMACOKINETICS TOOLS FOR DETERMINING TREATMENTS AND USES THEREOF	BIOVERATIV THERAPEUTICS INC.
WO/2021/257910	BIOMARKER BASED PATIENT SELECTION FOR PROTEASOME INHIBITOR  TREATMENT	UNIVERSITY OF UTAH RESEARCH FOUNDATION
WO/2021/257913	COMPOSITIONS FOR SOLUBILIZING WATER-INSOLUBLE ACTIVE  INGREDIENTS	CHAVAN, Neha
WO/2021/257916	UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES	ARCTURUS THERAPEUTICS, INC.
WO/2021/257917	UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES	ARCTURUS THERAPEUTICS, INC.
WO/2021/257924	METHODS AND COMPOSITIONS FOR CATEGORIZING AND/OR TREATING CHIN  RETRUSION IN A SUBJECT IN NEED THEREOF	ALLERGAN, INC.
WO/2021/262536	METHOD OF MAKING AND USING A SKIN MOISTURIZING FORMULATION	ROHM AND HAAS COMPANY
WO/2021/257935	NANOPARTICLE-ENCAPSULATED CANNABINOIDS AND METHODS FOR MAKING  AND USING SAME	LUCAS, Naomie
WO/2021/257936	CANNABINOID SYRUP AND METHODS FOR MAKING AND USING SAME	LUCAS, Naomie
WO/2021/257937	CHEMICALLY CROSS-LINKED ELASTOMERS FORMED BY MICHAEL ADDITION  AND COMPOSITIONS COMPRISING SUCH ELASTOMERS	NANOMETICS LLC (D.B.A. PHD BIOSCIENCES)
WO/2021/257938	MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY  DRUG CONJUGATES (ADC)	AGENSYS, INC,
WO/2021/257940	TREATMENT OF VIRAL INFECTIONS WITH ESTROGEN RECEPTOR  MODULATORS AND ANTI-INFLAMMATORY AGENTS	THE CLEVELAND CLINIC FOUNDATION
WO/2021/257947	ACTIVIN A ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF	REGENERON PHARMACEUTICALS, INC.
WO/2021/257953	READY-TO-USE PROBIOTIC COMPOSITIONS AND USES THEREOF	HEALTHY COW CORPORATION
WO/2021/257956	ADMINISTRATION OF RESINIFERATOXIN FOR TREATMENT OF BLADDER  PAIN OR BLADDER CANCER	SORRENTO THERAPEUTICS, INC.
WO/2021/257969	ORAL DELIVERY OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) AND  OTHER NUTRITIONAL SUPPLEMENTS	KONIVER, Craig
WO/2021/258008	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL  INFECTION	IMMUNACOR LLC
WO/2021/258013	OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING  OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF	AKAGERA MEDICINES, INC.
WO/2021/258030	SILK-HYALURONIC ACID COMPOSITIONS FOR TISSUE FILLING, TISSUE  SPACING, AND TISSUE BULKING	EVOLVED BY NATURE, INC.
WO/2021/262561	TREATING RHEUMATOID ARTHRITIS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/262562	METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING  A COMBINATION OF A PD-1 ANTAGONIST, A HIF-2 ALPHA INHIBITOR, AND LENVATINIB  OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	MERCK SHARP & DOHME CORP.
WO/2021/262563	METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING  A COMBINATION OF A HIF-2 ALPHA INHIBITOR AND LENVATINIB	MERCK SHARP & DOHME CORP.
WO/2021/262567	ANTHOCYANIN AND QUERCETIN BASED FORMULATIONS FOR IMPROVED  RESPIRATORY HEALTH	ZESTT WELLNESS LIMITED
WO/2021/262579	COMPOSITIONS AND METHODS RELATING TO COMBINATORIAL HYALURONIC  ACID CONJUGATES	PRESIDENT AND FELLOWS OF HARVARD COLLEGE
WO/2021/258042	POLYMERIC BILE ACID ESTER NANOPARTICLES COMPRISING AN  IMMUNOMODULATOR AGENT TO INDUCE ANTIGEN-SPECIFIC TOLERANCE	YALE UNIVERSITY
WO/2021/262591	PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF  PROTEIN/PROTEIN-FUSIONS	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/262596	METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION	PMV PHARMACEUTICALS, INC.
WO/2021/262604	ADMINISTRATION OF CEBP-BETA ANTAGONIST AND METHODS OF USE	SAPIENCE THERAPEUTICS, INC.
WO/2021/262607	ORONASAL CANNABINOID FORMULATIONS AND USES THEREOF	JUPITER WELLNESS, INC.
WO/2021/258055	SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN  THE TREATMENT OF NON-HUMAN ANIMALS	KIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/258056	SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN  THE TREATMENT OF NON-HUMAN ANIMALS	KIMBERLY-CLARK WORLDWIDE, INC.
WO/2021/262608	COMBINATION VERAPAMIL AND MOMETASONE THERAPY FOR THE TREATMENT  OF CHRONIC RHINOSINUSITIS	MASSACHUSETTS EYE AND EAR INFIRMARY
WO/2021/262617	TREATMENT OF SYSTEMIC IMMUNE ACTIVATION SYNDROMES	TRANQUIS THERAPEUTICS, INC.
WO/2021/262619	GENERATION OF PERINATAL-LIKE MESENCHYMAL STEM CELLS FROM HUMAN  INDUCED PLURIPOTENT STEM CELLS	MA, Zhen
WO/2021/262622	PROBIOTIC SKIN FORMULATIONS	CROWN LABORATORIES, INC.
WO/2021/262627	METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE  DERIVATIVES	CHEMOCENTRYX, INC.
WO/2021/262628	POLY HETEROCYCLIC CONJUGATES AND THEIR PHARMACEUTICAL USES	SHIH, Chuan
WO/2021/262633	ELECTROCHEMICAL TOOTH WHITENING COMPOSITION AND METHOD THEREOF	COLGATE-PALMOLIVE COMPANY
WO/2021/262645	REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY  OF THERAPEUTICS	OHIO STATE INNOVATION FOUNDATION
WO/2021/262648	PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL AND  BUDESONIDE	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262659	FLAVIVIRUS SIGNAL PEPTIDES, VACCINE CONSTRUCTS, AND METHODS  THEREFOR	UNIVERSITY OF CONNECTICUT
WO/2021/262662	ANTIBODIES THAT BIND TGF-ALPHA AND EPIREGULIN FOR USE IN THE  TREATMENT OF PAIN	ELI LILLY AND COMPANY
WO/2021/262675	PREPARATION OF A PHARMACEUTICAL COMPOSITION OF OLODATEROL,  TIOTROPIUM BROMIDE AND BUDESONIDE	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262695	METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA	GENZYME CORPORATION
WO/2021/262715	PHARMACEUTICAL FORMULATION CONTAINING ACTIVE METABOLITES OF  REMDESIVIR OR ITS ANALOG FOR INHALATION	ANOVENT PHARMACEUTICAL (U.S.), LLC
WO/2021/262718	ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL  HYPERTENSION (PAH)	ACCELERON PHARMA INC.
WO/2021/262743	PROCESS FOR SYNTHESIZING TARGETING MOLECULES	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/262745	PROCESS FOR SYNTHESIZING CATIONIC LIPIDS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/262746	PROCESS FOR SYNTHESIZING LIPIDS	BRISTOL-MYERS SQUIBB COMPANY
WO/2021/262749	COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING VIRAL  INFECTION	RESEARCH CANCER INSTITUTE OF AMERICA
WO/2021/262765	TSP-1 INHIBITORS FOR THE TREATMENT OF AGED, ATROPHIED OR  DYSTROPHIED MUSCLE	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/262773	COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF CAS  NUCLEASES	OBSIDIAN THERAPEUTICS, INC.
WO/2021/262779	TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE	BIOHAVEN THERAPEUTICS LTD.
WO/2021/262787	COSMETIC COMPOSITIONS COMPRISING BIODEGRADABLE POLYMERS	L'ORéAL
WO/2021/262791	HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT  SERINE 413	MERCK SHARP & DOHME CORP.
WO/2021/262799	ANTI-VIRAL COMPOUNDS AND METHODS OF USING SAME	FLAGSHIP PIONEERING, INC.
WO/2021/262803	COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC SHOCK	VIRTECH BIO, INC
WO/2021/262810	CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  OF TREATMENT THEREWITH	CELGENE CORPORATION
WO/2021/262812	CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  OF TREATMENT THEREWITH	CELGENE CORPORATION
WO/2021/262813	DR5 RADIOIMMUNOTHERAPY IN THE TREATMENT OF SOLID CANCERS	ACTINIUM PHARMACEUTICALS, INC.
WO/2021/262814	IMIQUIMOD COCRYSTALS	CELISTA PHARMACEUTICALS LLC
WO/2021/262815	CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS  OF TREATMENT THEREWITH	CELGENE CORPORATION
WO/2021/262840	ENGINEERED HEPATITIS B VIRUS NEUTRALIZING ANTIBODIES AND USES  THEREOF	VIR BIOTECHNOLOGY, INC.
WO/2021/262850	ANTIVIRAL THERAPY WITH IMIQUIMOD AND COCRYSTALS THEREOF	CELISTA PHARMACEUTICALS LLC
WO/2021/262869	COMBINATION THERAPY COMPRISING ANTI-CD137 ANTIBODIES	ADAGENE PTE. LTD.
WO/2021/262874	USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER  THERAPY	SERVIER PHARMACEUTICALS , LLC
WO/2021/262876	METHODS OF TREATING THYROID EYE DISEASE AND GRAVES' ORBITOPAHY  USING INTERLEUKIN-17 (IL-17) ANTAGONISTS	NOVARTIS AG
WO/2021/262878	NOVEL MOLECULE FOR MODULATION OF INNATE IMMUNE RESPONSES  CONTROLLED BY STING PROTEIN	OREGON HEALTH & SCIENCE UNIVERSITY
WO/2021/262879	EXTRACELLULAR VESICLES WITH IMMUNE MODULATORS	CHAMELEON BIOSCIENCES, INC.
WO/2021/262881	USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER  THERAPY	SERVIER PHARMACEUTICALS, LLC
WO/2021/262892	COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG  DELIVERY SYSTEM	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
WO/2021/262898	COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER	MOMA THERAPEUTICS, INC.
WO/2021/262903	METHOD AND COMPOUND FOR THE TREATMENT AND ELIMINATION OF AN  IMMUNODEFICIENCY CONDITION	SEIFU, Lydia
WO/2021/262910	TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES	REGENERON PHARMACEUTICALS, INC.
WO/2021/262912	DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC  SURFACTANTS	THE PROCTER & GAMBLE COMPANY
WO/2021/262914	COMPOSITIONS AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE  DISORDER	BIOHAVEN THERAPEUTICS LTD.
WO/2021/262916	PHARMACEUTICAL FORMULATIONS OF GRISEOFULVIN FOR LONG-TERM  OCULAR DELIVERY	PURDUE RESEARCH FOUNDATION
WO/2021/262917	TOPICAL PHARMACEUTICAL COMPOSITIONS	DERMAVANT SCIENCES GMBH
WO/2021/262956	TOPICAL GEL FORMULATIONS AND THEIR USE IN TREATING SKIN  CONDITIONS	ROIVANT SCIENCES GMBH
WO/2021/262962	METHODS FOR TREATING CANCER WITH COMBINATION THERAPIES	CELGENE CORPORATION
WO/2021/262963	METHODS FOR THE REMOVAL OF FREE FACTOR VIII FROM PREPARATIONS  OF LENTIVIRAL VECTORS MODIFIED TO EXPRESS SAID PROTEIN	BIOVERATIV THERAPEUTICS INC.
WO/2021/262985	CYTOKINE CONJUGATES	AMUNIX PHARMACEUTICALS, INC.
WO/2021/262992	GEMCABENE FOR TREATMENT OF CYTOKINE STORMS AND VIRAL-INDUCED  INFLAMMATION	NEUROBO PHARMACEUTICALS, INC.
WO/2021/262998	COMPOUNDS FOR SENSING REACTIVE OXYGEN SPECIES AND METHODS FOR  USING THE SAME	WAKE FOREST UNIVERSITY HEALTH SCIENCES
WO/2021/263026	IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND  ANTI-EGFR ANTIBODIES	SYNTHORX, INC.
WO/2021/263040	STABLE PEPTIBODY FORMULATIONS	SHIRE-NPS PHARMACEUTICALS, INC.
WO/2021/263056	DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT  OF AMYOTROPHIC LATERAL SCLEROSIS	ALEXION PHARMACEUTICALS, INC.
WO/2021/263072	METHODS OF TREATING DISEASE	DANA-FARBER CANCER INSTITUTE, INC.
WO/2021/263074	ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS	PREVENIAL, LLC
WO/2021/263081	BREAST CANCER VACCINE	NATIONAL BREAST CANCER COALITION
WO/2021/263085	COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND  HEMATOLOGICAL CANCERS	ARCH ONCOLOGY, INC.
WO/2021/263097	METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS	THE CHILDREN'S MEDICAL CENTER CORPORATION
WO/2021/263128	ACE2-FC FUSION PROTEINS AND METHODS OF USE	GLIKNIK INC.
WO/2021/263129	KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
WO/2021/263131	COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE  AGAINST CORONAVIRUS	ELICIO THERAPEUTICS, INC.
WO/2021/263132	RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY	APRECIA PHARMACEUTICALS LLC
WO/2021/263139	METHODS OF TREATING CORONAVIRUS INFECTION USING HSP90  INHIBITORS	DUKE UNIVERSITY
WO/2021/263151	ORAL CARE COMPOSITIONS	COLGATE-PALMOLIVE COMPANY
WO/2021/263152	mRNA TRANSFECTION OF IMMUNE CELLS	CARISMA THERAPEUTICS INC.
WO/2021/263171	SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOS
WO/2021/263173	USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING  NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION	DURECT CORPORATION
WO/2021/263177	USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE  CONDITIONS	DURECT CORPORATION
WO/2021/263178	STABLE <i>CANNABINOID</i> COMPOSITIONS	CBDMD, INC.
WO/2021/263179	TARGETING THE HUMAN CCR5 LOCUS AS A SAFE HARBOR FOR THE  EXPRESSION OF THERAPEUTIC PROTEINS	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
WO/2021/263180	USE OF OXYGENATED CHOLESTEROL SULFATES FOR CANCERS AND  NON-CANCEROUS TRANSFORMATIONS RELATED TO EPSTEIN-BARR VIRUS	DURECT CORPORATION
WO/2021/263185	USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST  ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES	DURECT CORPORATION
WO/2021/263186	USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING  INFLAMMATORY CONDITIONS	DURECT CORPORATION
WO/2021/263189	ENDOTHELIAL CELLS FOR MITIGATION OF CHEMOTHERAPY-INDUCED  TOXICITY	ANGIOCRINE BIOSCIENCE, INC.
WO/2021/263197	STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC  POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME	XERIS PHARMACEUTICALS, INC.
WO/2021/263201	SANITIZING COMPOSITIONS CONTAINING IONIC LIQUID	CAGE BIO INC.
WO/2021/263205	COMBINATION THERAPY WITH DEOXYURIDINE TRIPHOSPHATASE  INHIBITORS	CV6 THERAPEUTICS (NI) LIMITED
WO/2021/263206	COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19	PROTHIONE, LLC
WO/2021/263221	BINDING MODULATOR	NOVATHER, INC.
WO/2021/263227	ANTI-NME ANTIBODY AND METHOD OF TREATING CANCER OR CANCER  METASTASIS	MINERVA BIOTECHNOLOGIES CORPORATION
WO/2021/263241	METHODS FOR DERIVING DOPAMINERGIC NEURONS FROM PLURIPOTENT  STEM CELLS	MINERVA BIOTECHNOLOGIES CORPORATION
WO/2021/263246	NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF	CRESCENTA BIOSCIENCES
WO/2021/222913	MICRO DOSING OF VIRAL VACCINES	KOZIOL, Jeffrey E.
WO/2021/237228	METHOD AND COMPOUND FOR THE TREATMENT OF COVID-19	TESFAZION, Amanuel
WO/2021/258086	GALLIUM IN THE TREATENT OF CORONAVIRUS DISEASE	BERNSTEIN, Lawrence
WO/2021/263250	METHOD OF TREATING SEVERE FORMS OF PULMONARY HYPERTENSION	REVERSPAH LLC
WO/2021/146749	TOLL-LIKE RECEPTOR AGONIST FORMULATIONS AND METHODS OF USE	THE UNIVERSITY OF CHICAGO
WO/2021/155390	ANTIMICROBIAL COMPOSITIONS	SHAMAN NATURALS, LLC.
WO/2021/155398	LIP COMPOSITION	MARY KAY INC.
WO/2021/163727	PIKFYVE KINASE INHIBITORS	ACURASTEM INCORPORATED
WO/2021/168474	TOPICAL COSMETIC COMPOSITIONS	MARY KAY INC.
WO/2021/179003	ORAL CARE COMPOSITION CONTAINING CETYLPYRIDINIUM  TETRACHLOROZINCATE	COLGATE-PALMOLIVE COMPANY
WO/2021/179014	TOOTHPASTES CONTAINING CALCIUM CARBONATE, XANTHAN GUM AND  POLYACRYLIC ACID POLYMER	COLGATE-PALMOLIVE COMPANY
WO/2021/189077	METHODS FOR TREATING ACNE	CHEMISTRYRX
WO/2021/189080	METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA	THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/195661	ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOF	GREGG, John, M.H.
WO/2021/195672	DETECTION AND TREATMENT OF INTESTINAL FIBROSIS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/203127	SULFATE-FREE PERSONAL CARE COMPOSITIONS AND METHODS FOR  PREVENTING AND TREATING POLLUTION DAMAGE TO SKIN	COLGATE-PALMOLIVE COMPANY
WO/2021/203128	PERSONAL CARE COMPOSITIONS COMPRISING CANNABIDIOL AND LICORICE	COLGATE-PALMOLIVE COMPANY
WO/2021/203132	IMPROVING, MAINTAINING, PROTECTING AND REPAIRING TISSUE  INTEGRITY, BARRIER FUNCTION AND IMMUNITY USING A COMPOSITION COMPRISING A  SOURCE OF ZINC IONS	COLGATE-PALMOLIVE COMPANY
WO/2021/203136	METHODS FOR TREATING HYPERPIGMENTATION AND COMPOSITIONS FOR  SAME	CHEMISTRYRX
WO/2021/203141	FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSIS	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
WO/2021/203143	COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING MULTIPLE  ORGAN DYSFUNCTION SYNDROME	VIVACELLE BIO, INC.
WO/2021/207759	MODIFIED KISSPEPTIN RECEPTOR AGONISTS FOR FATTY LIVER DISEASE	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
WO/2021/207767	METHODS OF TREATMENT USING ANTIFOLATES AND PHARMACEUTICAL  FORMULATIONS COMPRISING ANTIFOLATES	EMPHASCIENCE, INC.
WO/2021/207770	HUMANIZED ANTIBODY TARGETING THE TUMOR ASSOCIATED ANTIGEN  IL13Ra2	NORTHWESTERN UNIVERSITY
WO/2021/217176	TOPICAL COSMETIC COMPOSITIONS	MARY KAY INC.
WO/2021/217178	CALIBRATION AND QUALITY CONTROL REAGENTS FOR USE WITH  IMMUNOASSAYS FOR ANTIBODIES	SIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/217179	COMPOSITIONS, KITS, AND METHODS FOR ANTI-MICROBIAL SEROLOGY  ASSAYS USING ANTI-HUMAN IMMUNOGLOBULIN ANTIBODY	SIEMENS HEALTHCARE DIAGNOSTICS INC.
WO/2021/217186	TOPICAL COSMETIC COMPOSITIONS	MARY KAY INC.
WO/2021/222927	VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN  RECEPTORS	BAYLOR COLLEGE OF MEDICINE
WO/2021/222928	TREATMENT AND PREVENTION OF CANCER USING VIRUS-SPECIFIC IMMUNE  CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS	BAYLOR COLLEGE OF MEDICINE
WO/2021/222929	TREATMENT AND PREVENTION OF ALLOREACTIVITY USING  VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS	BAYLOR COLLEGE OF MEDICINE
WO/2021/222933	COSMETIC COMPOSITIONS AND METHODS COMPRISING PLUMERIA ALBA  FLOWER EXTRACT	MARY KAY INC.
WO/2021/222935	NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES AND METHODS OF USE  THEREOF	THE ROCKEFELLER UNIVERSITY
WO/2021/222939	ANTIBIOTIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF  USE	THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
WO/2021/222943	IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING  CANCER FIBROBLASTS	FIGENE, LLC
WO/2021/222944	ANTI-CD79B ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS AND  METHODS OF USE THEREOF	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/226629	HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON  MYELOID CELLS 2 AGONISTS AND METHODS OF USE	AMGEN INC.
WO/2021/226632	COSMETIC COMPOSITION COMPRISING GLUCONOLACTONE AND GLYCOLIC  ACID	MARY KAY INC.
WO/2021/226637	METHOD OF TREATING A PATIENT INFECTED WITH A CORONAVIRUS WITH  NEZULCITINIB	THERAVANCE BIOPHARMA R&D IP, LLC
WO/2021/232040	BRIGHTENING BOOSTER TECHNOLOGY AND BRIGHTENING AMPULE	MARY KAY INC.
WO/2021/232041	N-ACETYLCYSTEINE AND GLYCINE FOR TREATMENT OF COVID-19 AND  POST COVID-19 SYMPTOMS	BAYLOR COLLEGE OF MEDICINE
WO/2021/232048	SARS-COV-2-SPECIFIC T CELLS	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/232052	MICROENCAPSULATED DELIVERY SYSTEM FOR RELEASE OF  ANTI-INFLAMMATORY AGENTS INTO THE LUNG	TEXAS BIOMEDICAL RESEARCH INSTITUTE
WO/2021/232054	COMPOSITIONS FOR TREATING HAIR LOSS	CHEMISTRYRX
WO/2021/232055	METHODS FOR TREATING HAIR LOSS AND COMPOSITIONS FOR SAME	CHEMISTRYRX
WO/2021/232057	METHODS FOR BREAST CANCER TREATMENT AND PREDICTION OF  THERAPEUTIC RESPONSE	INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI ISUNYER  (IDIBAPS)
WO/2021/232062	FIBROBLAST BASED THERAPY FOR TREATMENT OF PARKINSON'S DISEASE	FIGENE, LLC
WO/2021/232064	TREATMENT OF OVARIAN FAILURE USING REGENERATIVE CELLS	FIGENE, LLC
WO/2021/232066	VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS  TREATMENT AND PREVENTION	BAYLOR COLLEGE OF MEDICINE
WO/2021/232067	STATS3 INHIBITION FOR TREATMENT AND PREVENTION OF HUMAN  CORONAVIRUS INFECTION	GLG PHARMA, LLC
WO/2021/237239	ACTIVE LOW MOLECULAR WEIGHT VARIANT OF ANGIOTENSIN CONVERTING  ENZYME 2 (ACE2) FOR THE TREATMENT OF DISEASES AND CONDITIONS OF THE EYE	NORTHWESTERN UNIVERSITY
WO/2021/243350	MULTI-CAVITY CUSTOMIZABLE DOSAGE FORMS	JOHNSON & JOHNSON CONSUMER INC.
WO/2021/243359	TOPICAL COMPOSITIONS AND METHODS	MARY KAY INC.
WO/2021/243376	FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS	FIGENE, LLC
WO/2021/243380	AUGMENTATION OF FIBROBLAST CELL THERAPY EFFICACY BY MICROBIOME  MANIPULATION	FIGENE, LLC
WO/2021/248158	FIBROBLASTS AS A REGENERATIVE CELLULAR SOURCE FOR THE  TREATMENT OF BLINDNESS	FIGENE, LLC
WO/2021/248160	METHODS OF TREATMENT OF A CYTOKINE STORM	LOMA LINDA UNIVERSITY HEALTH
WO/2021/248164	LARGE SCALE PURIFICATION OF CASTANOSPERMINE	FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
WO/2021/253049	NANOEMULSION SYSTEM FOR TRANSDERMAL DELIVERY OF PHARMACEUTICAL  COMPOSITIONS AND OTHER ACTIVE AGENTS	DE MENEZES, Sergio, Bezerra
WO/2021/253053	TOPICAL COMPOSITIONS AND METHODS	MARY KAY INC.
WO/2021/258099	COSMETIC COMPOSITION	MARY KAY INC.
WO/2021/263270	ANTIMICROBIAL MOISTURE AVOIDANCE POWERS AND SUBSTANCES	ATACAMA, LLC
WO/2021/263279	ANTIBODIES RECOGNIZING SORTILIN	PROTHENA BIOSCIENCES LIMITED
WO/2021/263282	EDIBLE CELL BASED VACCINES	TRUSTEES OF TUFTS COLLEGE
WO/2021/263285	LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL  STROMAL CELLS FOR CLINICAL USE	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
WO/2021/042137	NATURAL ESSENTIAL OIL COMPOSITION FOR RELAXING NERVES,  SLEEPING WELL AND PREVENTING COLD AND FLU	SUNSTAR JOINT STOCK COMPANY
WO/2021/151122	THERAPEUTIC COMPOSITIONS COMPRISING SODIUM DIACETATE FOR  CANCER PAIN AND METABOLIC ABNORMALITIES	THAI MINH PHARMACEUTIAL JOINT STOCK COMPANY
WO/2021/163736	PROBIOTIC-CONTAINING NATURAL COMPOSITION FOR CLEANING THE  BODY, WHICH IS CAPABLE OF DEODORIZING, DECOMPOSING ORGANIC MATTERS ADHERED TO  THE BODY AND THE BODY CLEANING PRODUCTS MADE FROM THIS COMPOSITION	PHU, Nguyen
WO/2021/113885	HERB HAIR DYE PREPARATIONS	SUNSTAR JOINT STOCK COMPANY
WO/2021/232070	ORGANIC SOL-GEL NANO-COMPOSITION FROM PANAX NOTOGINSENG,  RUTIN, GINKGO BILOBA EFFECTIVE IN ENHANCING CEREBRAL AND CARDIOVASCULAR  PROTECTION AND METHOD OF PRODUCING THEREOF	VAN, Nguyen Anh
WO/2021/232071	SOLID LIPID NANO-COMPOSITION CONTAINING BERBERINE AND  CINNAMONALDEHYDE EFFECTIVE IN TREATING DIABETES, DYSLIPIDEMIA, AND METHOD OF  PREPARING THE SAME	VAN, Nguyen Anh
WO/2021/232072	TRICOMPONENT SOLID LIPID NANO-COMPOSITION COMPRISING CURCUMIN,  GINGER OLEORESIN, RUTIN HAVING A CANCER-CELL-KILLING PROPERTY AND METHOD OF  PREPARING THE SAME	VAN, Nguyen Anh
WO/2021/203146	PAIN-RELIEVING AND ANTI-INFLAMMATORY PREPARATION FOR  PREVENTING AND TREATING THROMBOSIS	SUNSTAR JOINT STOCK COMPANY
WO/2021/000001	ROMAN BLIND WITH A CURVED CONTOUR	NUTS HANDELS GMBH

转载本文请联系原作者获取授权，同时请注明本文来自陈立新科学网博客。
链接地址：https://blog.sciencenet.cn/blog-681765-1365691.html

上一篇：2021年医学治疗和护理领域的PCT专利申请状况——中国占12.5%，美国占33.6%，日本占10%，欧洲占15.1%
下一篇：2021年分离和混合加工作业领域的PCT专利申请状况——中国占19%，美国占21%，日本占18%，欧洲占18%